FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Klein, RC
   Party, E
   Gershey, EL
AF Klein, RC
   Party, E
   Gershey, EL
TI Removable surface contamination at a biomedical research institution
SO HEALTH PHYSICS
LA English
DT Article
DE wipe tests; contamination; sampling; surface contamination
AB rigorous, unannounced, campus-wide survey for removable surface contamination was performed at our institution. Wipe samples (n = 1,090) were collected from a variety of standardized locations in 45 large biomedical research laboratories that routinely use kBq-MBq (mu Ci-mCi) amounts of H-3, C-14, P-32, S-35, Cr-51, and I-125. The results showed a log-normal distribution for contamination, with about 90% of all samples below ten times background. Although working surfaces and equipment used in these laboratories can become contaminated with radioactive materials, especially by transfer from soiled gloves, the magnitude of the contamination is very small and typically restricted to surfaces, instruments, and equipment that are directly handled in the course of experimental work and which can be reasonably anticipated to be contaminated. These data suggest that contamination is not a significant problem in biomedical research laboratories at this institution and that the best protection from workplace contamination appears to continue to be the use of well-reviewed standard operating procedures and good work practices.
C1 ROCKEFELLER UNIV, OFF LAB SAFETY, NEW YORK, NY 10021 USA.
CR CAMPBELL JL, 1993, HEALTH PHYS, V64, P540, DOI 10.1097/00004032-199305000-00014
   KLEIN RC, 1992, HEALTH PHYS, V62, P186, DOI 10.1097/00004032-199202000-00010
   *NAT COMM RAD PROT, 1964, 30 NCRP
   *NAT COMM RAD PROT, 1951, NAT BUR STAND HDB, V48
   National Council on Radiation Protection and Measurements, 1978, 57 NCRP
   *US NUCL REG COMM, 1981, US NRC REG GUID 8 23
NR 6
TC 3
Z9 3
U1 0
U2 2
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0017-9078
EI 1538-5159
J9 HEALTH PHYS
JI Health Phys.
PD FEB
PY 1997
VL 72
IS 2
BP 296
EP 299
DI 10.1097/00004032-199702000-00014
PG 4
WC Environmental Sciences; Public, Environmental & Occupational Health;
   Nuclear Science & Technology; Radiology, Nuclear Medicine & Medical
   Imaging
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health; Nuclear Science & Technology; Radiology, Nuclear Medicine &
   Medical Imaging
GA WE857
UT WOS:A1997WE85700015
PM 9003716
DA 2018-10-20
ER

PT J
AU Eichler, HJ
   Findeisen, J
   Liu, B
   Kaminskii, AA
   Butachin, AV
   Peuser, P
AF Eichler, HJ
   Findeisen, J
   Liu, B
   Kaminskii, AA
   Butachin, AV
   Peuser, P
TI Highly efficient diode-pumped 3-mu m Er3+:BaY2F8 laser
SO IEEE JOURNAL OF SELECTED TOPICS IN QUANTUM ELECTRONICS
LA English
DT Article
DE crystals; diodes; erbium materials; infrared radiation effects; laser
   biomedical applications; solid lasers
ID MU-M
AB A systematic investigation on a series of monoclinic Er3+:BaY2F8 crystals with different dopant concentrations (C-Er = 5%-30%) and crystal orientations was conducted to optimize the laser performance in this new 3-mu m laser medium by laser diode pumping, The highest slope efficiency of 32% near the quantum defect (35%) was obtained with a 10% doped Er3+:BaY2F8 crystal with the orientation (010) and a length of 3.5 mm, A maximum output power of 160 mW was achieved at an absorbed pump power of 550 mW at a wavelength of 970 nm.
C1 RUSSIAN ACAD SCI,INST CRYSTALLOG,MOSCOW 117333,RUSSIA.
   DAIMLER BENZ AG,FORSCH & TECH,D-81663 MUNICH,GERMANY.
RP Eichler, HJ (reprint author), TECH UNIV BERLIN,INST OPT,D-10623 BERLIN,GERMANY.
CR AUZEL F, 1992, PHYS STATUS SOLIDI A, V131, pK63, DOI 10.1002/pssa.2211310146
   Jensen T, 1996, OPT LETT, V21, P585, DOI 10.1364/OL.21.000585
   KAMINSKII AA, 1988, IAN SSSR NEORG MATER, V24, P2080
   KAMINSKII AA, 1990, OPT QUANT ELECTRON, V22, P95
   KNOWLES DS, 1992, IEEE J QUANTUM ELECT, V28, P1197, DOI 10.1109/3.135247
   Pollnau M, 1996, OPT LETT, V21, P48, DOI 10.1364/OL.21.000048
   POLLNAU M, 1994, PHYS REV A, V49, P3390
   STONEMAN RC, 1992, IEEE J QUANTUM ELECT, V28, P1041, DOI 10.1109/3.135226
NR 8
TC 21
Z9 22
U1 0
U2 3
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017-2394
SN 1077-260X
J9 IEEE J SEL TOP QUANT
JI IEEE J. Sel. Top. Quantum Electron.
PD FEB
PY 1997
VL 3
IS 1
BP 90
EP 94
DI 10.1109/2944.585819
PG 5
WC Engineering, Electrical & Electronic; Optics; Physics, Applied
SC Engineering; Optics; Physics
GA XE895
UT WOS:A1997XE89500015
DA 2018-10-20
ER

PT J
AU Burger, W
   Richter, HG
   Piconi, C
   Vatteroni, R
   Cittadini, A
   Boccalari, M
AF Burger, W
   Richter, HG
   Piconi, C
   Vatteroni, R
   Cittadini, A
   Boccalari, M
TI New Y-TZP powders for medical grade zirconia
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID PARTIALLY-STABILIZED ZIRCONIA
AB There is interest in using zirconia for biomedical applications as ball heads for total hip prostheses. Two potential types are under discussion: partially stabilized zirconia (PSZ) and tetragonal zirconia polycrystals (TZP) materials. Because of its enhanced material properties, TZP stabilized with yttria is favourable. To eliminate high amounts of natural radioactive impurities, the precursors are purified. The kind of precursor and purification method determine the powder impurity level. The disadvantage of Y-TZP is that the hydrothermal decomposition reaction method is that it depends very strongly on the grain size and the distribution of the stabilizing yttria within the zirconia grains. Thermodynamical and kinetic investigations on high purity coprecipitated and yttria-coated zirconia powders show different behaviours. Y-TZP materials based on yttria-coated zirconia powders show excellent mechanical strength of more than 1000 MPa, a Weibull modulus of up to 20 and a fracture toughness of 9 MPa root m. The material properties of Y-TZP ceramics based on coprecipitated powders and prepared under the same conditions are less attractive. It is expected that materials based on yttria-coated zirconia will show enhanced properties compared to materials derived from coprecipitated powders. Therefore Y-TZP materials derived from yttria-coated powders are very attractive as medical grade zirconia.
C1 ENEA,DIPARTIMENTO INNOVAZ,ROME,ITALY.
   UNIV CATTOLICA SACRO CUORE,ROME,ITALY.
   FABBRICAZ NUCL,BOSCO MARENGO,AL,ITALY.
RP Burger, W (reprint author), CERASIV GMBH,POB 1149,PLOCHINGEN,GERMANY.
CR BURGER W, 1993, BIOCERAMICS, V6, P299
   CHRISTEL P, 1989, J BIOMED MATER RES, V23, P45, DOI 10.1002/jbm.820230105
   DRANSFIELD GP, 1989, EUROCERAMICS, V1, P275
   Dworak U., 1978, Berichte der Deutschen Keramischen Gesellschaft, V55, P98
   GARVIE RC, 1975, NATURE, V258, P703, DOI 10.1038/258703a0
   GARVIE RC, 1984, J MATER SCI, V19, P3224, DOI 10.1007/BF00549808
   Haberko K, 1975, CERAMURGIA INT, V1, P111
   HARMSWORTH P, UNPUB
   RICHTER HG, 1994, BIOCERAMICS, V7, P401
   RUHLE M, 1984, ADV CERAM, V12, P352
NR 10
TC 69
Z9 70
U1 0
U2 9
PU CHAPMAN HALL LTD
PI LONDON
PA 2-6 BOUNDARY ROW, LONDON, ENGLAND SE1 8HN
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD FEB
PY 1997
VL 8
IS 2
BP 113
EP 118
DI 10.1023/A:1018562917779
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA WG209
UT WOS:A1997WG20900008
PM 15348779
DA 2018-10-20
ER

PT J
AU Otto, C
   deGrauw, CJ
   Duindam, JJ
   Sijtsema, NM
   Greve, J
AF Otto, C
   deGrauw, CJ
   Duindam, JJ
   Sijtsema, NM
   Greve, J
TI Applications of micro-Raman imaging in biomedical research
SO JOURNAL OF RAMAN SPECTROSCOPY
LA English
DT Article
ID SINGLE LIVING CELLS; CHROMOSOMES; SPECTROSCOPY; MICROSPECTROSCOPY;
   CHOLESTEROL; EXCITATION; DETECTOR; FILIPIN; DNA
AB Recent results are presented of the application of imaging micro-Raman spectrometers in cellular biophysics and biomedical research. Various micro-Raman spectrometers have been developed that are now routinely applied in these fields. Results are presented that were obtained with a linescan Raman microspectrometer and with a Raman imaging microscope. Applications of Raman linescan spectrometry concern the investigation of polytene chromosomes obtained from the salivary gland of Chironomus thummi thummi. The distribution of DNA and proteins was investigated in bands and interbands. In a second example of Raman linescan spectrometry, bone implants were investigated. These bone implants were coated with thin layers of materials that improve biocompatibility. The density, crystallinity and protein distribution can be investigated. Information from Raman imaging may help in selecting the proper materials for maximum biocompatibility, Raman imaging microscopy is used whenever two-dimensional spatial information is required on the distribution of molecules or molecular components. Raman images are presented of filipine and phenylalanine in human eye-lenses in and around radial shades. Raman imaging is a particularly important toot for the study of the distribution of non-fluorescent drugs inside living cells. This is illustrated for the non-fluorescent drug cobalt octacarboxyphthalocyanine. (C) 1997 by John Wiley & Sons, Ltd.
C1 UNIV TWENTE,BIOMED TECHNOL INST,NL-7500 AE ENSCHEDE,NETHERLANDS.
RP Otto, C (reprint author), UNIV TWENTE,APPL OPT GRP,POB 217,NL-7500 AE ENSCHEDE,NETHERLANDS.
CR BARBILLAT J, 1994, J RAMAN SPECTROSC, V25, P3, DOI 10.1002/jrs.1250250103
   BATCHELDER DN, 1991, MAKROMOL CHEM-M SYMP, V46, P171, DOI 10.1002/masy.19910460121
   BITTMAN R, 1978, LIPIDS, V13, P686, DOI 10.1007/BF02533746
   BOWDEN M, 1990, J RAMAN SPECTROSC, V21, P37, DOI 10.1002/jrs.1250210108
   DELHAYE M, 1975, J RAMAN SPECTROSC, V3, P33, DOI 10.1002/jrs.1250030105
   DEMUL FFM, 1986, J DENT RES, V65, P437, DOI 10.1177/00220345860650031301
   DEMUL FFM, 1984, J RAMAN SPECTROSC, V15, P268, DOI 10.1002/jrs.1250150412
   DUINDAM HJ, 1995, J LIPID RES, V36, P1139
   Duindam JJ, 1996, OPHTHALMIC RES, V28, P86, DOI 10.1159/000267978
   DUINDAM JJ, UNPUB
   GREVE J, 1993, ADV SPECTROSC, V20, P231
   KUBASEK WL, 1986, BIOCHEMISTRY-US, V25, P7440, DOI 10.1021/bi00371a028
   PUPPELS GJ, 1991, EXP CELL RES, V195, P361, DOI 10.1016/0014-4827(91)90385-8
   PUPPELS GJ, 1993, APPL SPECTROSC, V47, P1256, DOI 10.1366/0003702934068017
   PUPPELS GJ, 1990, NATURE, V347, P301, DOI 10.1038/347301a0
   PUPPELS GJ, 1991, J RAMAN SPECTROSC, V22, P217, DOI 10.1002/jrs.1250220405
   PUPPELS GJ, 1994, BIOCHEMISTRY-US, V33, P3386, DOI 10.1021/bi00177a032
   PUPPELS GJ, 1991, THESIS U TWENTE
   ROBERT M, 1971, CHROMOSOMA, V36, P1, DOI 10.1007/BF00326419
   ROBINSON JM, 1980, J HISTOCHEM CYTOCHEM, V28, P161, DOI 10.1177/28.2.6766487
   SHARONOV S, 1994, J RAMAN SPECTROSC, V25, P699, DOI 10.1002/jrs.1250250733
   TREADO PJ, 1994, APPL SPECTROSC REV, V29, P1, DOI 10.1080/05704929408000896
   WILSON T, 1987, OPT LETT, V12, P227, DOI 10.1364/OL.12.000227
NR 23
TC 49
Z9 50
U1 0
U2 12
PU JOHN WILEY & SONS LTD
PI W SUSSEX
PA BAFFINS LANE CHICHESTER, W SUSSEX, ENGLAND PO19 1UD
SN 0377-0486
J9 J RAMAN SPECTROSC
JI J. Raman Spectrosc.
PD FEB-MAR
PY 1997
VL 28
IS 2-3
BP 143
EP 150
PG 8
WC Spectroscopy
SC Spectroscopy
GA WV161
UT WOS:A1997WV16100012
DA 2018-10-20
ER

PT J
AU Friedrich, CR
   Coane, PJ
   Vasile, MJ
AF Friedrich, CR
   Coane, PJ
   Vasile, MJ
TI Micromilling development and applications for microfabrication
SO MICROELECTRONIC ENGINEERING
LA English
DT Article; Proceedings Paper
CT Micro and Nano Engineering Conference 1996 (MNE 96)
CY SEP 22-25, 1996
CL UNIV GLASGOW, GLASGOW, SCOTLAND
SP Univ Glasgow, Glasgow Dev Agcy, Oxford Instruments, Leica Cambridge Ltd, Elsevier, Greater Glasgow & Clyde Valley Tourist Board, City Glasgow, Motorola, IEEE LEOS Scott Chapter
HO UNIV GLASGOW
ID ION
AB In conventional machining, milling is the most versatile of the cuffing processes. Micromechanical milling has also been shown to be a very versatile and rapid method for the removal of material and the creation of microstructures. These microstructures range form direct fabrication of molds in polymethyl methacrylate (PMMA) to direct fabrication of x-ray lithography masks using a machinable carrier and one of several metallic absorbers, or various combinations of absorbers to better suit the machining environment. The micromilling tools are commercially available in diameters larger than 50 micrometers and custom-fabricated tools 22 micrometers in diameter are made at the Institute for Micromanufacturing (IfM). The custom-fabricated tools are made using the focused ion beam process and the resulting microstructures are machined on a very high precision, custom-built milling machine. The focused ion beam process has also been used to fabricate very small probe tips for biomedical use and microscalpels with extremely sharp cutting edges. These devices are currently under study and development for research applications.
RP Friedrich, CR (reprint author), LOUISIANA TECH UNIV,INST MICROMANUFACTURING,RUSTON,LA 71272, USA.
CR Friedrich CR, 1996, J MICROELECTROMECH S, V5, P33, DOI 10.1109/84.485213
   Lucca D.A., 1991, ANN CIRP, V40, P69
   ORLOFF J, 1993, REV SCI INSTRUM, V64, P1105, DOI 10.1063/1.1144104
   VASILE M, 1996, J PRECISION ENG  OCT
   VASILE MJ, 1994, J VAC SCI TECHNOL B, V12, P2388, DOI 10.1116/1.587769
NR 5
TC 32
Z9 33
U1 2
U2 7
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-9317
J9 MICROELECTRON ENG
JI Microelectron. Eng.
PD FEB
PY 1997
VL 35
IS 1-4
BP 367
EP 372
DI 10.1016/S0167-9317(96)00198-0
PG 6
WC Engineering, Electrical & Electronic; Nanoscience & Nanotechnology;
   Optics; Physics, Applied
SC Engineering; Science & Technology - Other Topics; Optics; Physics
GA WM329
UT WOS:A1997WM32900085
DA 2018-10-20
ER

PT B
AU Powell, DJ
   Wojcik, GL
   Desilets, CS
   Gururaja, TR
   Guggenberger, K
   Sherrit, S
   Mukherjee, BK
AF Powell, DJ
   Wojcik, GL
   Desilets, CS
   Gururaja, TR
   Guggenberger, K
   Sherrit, S
   Mukherjee, BK
BE Schneider, SC
   Levy, M
   McAvoy, BR
TI Incremental "model-build-test" validation exercise for a 1-D biomedical
   ultrasonic imaging array
SO 1997 IEEE ULTRASONICS SYMPOSIUM PROCEEDINGS, VOLS 1 & 2
LA English
DT Proceedings Paper
CT 1997 IEEE Ultrasonics Symposium
CY OCT 05-08, 1997
CL TORONTO MARRIOTT EATON CTR, TORONTO, CANADA
SP IEEE, Ultrason Ferroelect & Frequency Control Soc
HO TORONTO MARRIOTT EATON CTR
AB Quantitative validation is critical to the effective utilization of large-scale modeling in advanced biomedical ultrasonic imaging applications. This work describes an incremental "model-build-test" validation exercise centered around a nonproprietary, 5MHz, 1D linear array design. The step-by-step sequence reported here includes piezoceramic slivers, slivers with matching and slivers with both backing and matching. Furthermore, prior to the fabrication process, all the active and passive material components are accurately characterized. PZFlex, an explicit time-domain finite element modeling package, is used to predict the performance of the incremental array components at each stage of the validation exercise. Deviations between experimental results and finite element predictions are identified and subsequently analyzed. Although the manufacturing techniques used do not push the current operational envelope, observed process effects should be relevant to today's devices.
C1 Weidlinger Associates, Los Altos, CA 94022 USA.
RP Powell, DJ (reprint author), Weidlinger Associates, Los Altos, CA 94022 USA.
NR 0
TC 2
Z9 2
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 0-7803-4153-8
PY 1997
BP 1669
EP 1674
PG 6
WC Acoustics; Engineering, Biomedical; Engineering, Electrical &
   Electronic; Radiology, Nuclear Medicine & Medical Imaging
SC Acoustics; Engineering; Radiology, Nuclear Medicine & Medical Imaging
GA BK64T
UT WOS:000072927100356
DA 2018-10-20
ER

PT B
AU Chen, YH
   Erber, EA
   Faris, G
AF Chen, YH
   Erber, EA
   Faris, G
BE Thompson, RB
TI Spectroscopic characterization of upconverting phosphor reporters
SO ADVANCES IN FLUORESCENCE SENSING TECHNOLOGY III
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Conference on Advances in Fluorescence Sensing Technology III
CY FEB 09-11, 1997
CL SAN JOSE, CA
SP Soc Photo Opt Instrumentat Engineers, Chiron Diag Corp, Ciencia Inc, Coherent Inc Laser Grp, ISS Inc, Jobin Yvon SPEX Instruments SA Inc, LiCONiX, Opt Sensors Inc, Perkin Elmer Corp, PicoQuant, Adv Photon Int, Programmed Test Sources Inc, Spectronics Inc, SpectRx Inc
DE upconverting phosphors; immunoassay; nucleic acid assay; in vivo
   diagnostics
AB We examined the spectroscopic properties of a novel class of reporters for biomedical diagnostics called upconverting phosphors. These materials exhibit high emission efficiencies, extremely low background levels, no photobleaching, minimal phototoxicity and a variety of emission bands suitable for multi-analyte assays. In addition, they are buffer insensitive and can be excited with inexpensive and compact diode lasers. These properties are very useful for immunoassays, nucleic acid assays, in vivo diagnostics, and other applications. We synthesized submicron monodisperse phosphors and measured the emission spectra, excitation spectra, and power dependencies for a variety of phosphor materials containing different active rare earth ions and host materials. In this paper, we discuss the relation between spectral properties and diagnostic applications.
RP Chen, YH (reprint author), SRI INT,333 RAVENSWOOD AVE,MENLO PK,CA 94025, USA.
NR 0
TC 5
Z9 5
U1 1
U2 1
PU SPIE - INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA PO BOX 10, BELLINGHAM, WA 98227-0010
BN 0-8194-2391-2
J9 P SOC PHOTO-OPT INS
PY 1997
VL 2980
BP 338
EP 342
PG 5
WC Medicine, Research & Experimental; Optics; Spectroscopy
SC Research & Experimental Medicine; Optics; Spectroscopy
GA BH84B
UT WOS:A1997BH84B00038
DA 2018-10-20
ER

PT B
AU Teoh, SH
   Thampuran, R
   Seah, WKH
   Goh, JCH
AF Teoh, SH
   Thampuran, R
   Seah, WKH
   Goh, JCH
BE Karihaloo, BL
   Mai, YW
   Ripley, MI
   Ritchie, RO
TI Fracture evaluation of a new wear resistant titanium-graphite composite
   for biomedical applications
SO ADVANCES IN FRACTURE RESEARCH, VOLS 1-6
LA English
DT Proceedings Paper
CT 9th International Conference in Fracture (ICF9)
CY APR 01-05, 1997
CL SYDNEY, AUSTRALIA
SP Int Congress Fracture
DE titanium-graphite composites; fracture toughness tests; radial crush
   strength tests; porous materials; pore morphology
AB Fracture studies on a powder metallurgically processed (P/M) titanium-graphite composite has been investigated. The composite was developed to address some of the major concerns with poor wear resistance in many pure titanium prosthetic devices. Wear resistance of the triphasic composition of pure titanium, titanium carbide and free graphite comes from the smearing of graphite on both articulating wear surfaces. Fracture of porous structures is a result of ligamental failure arising from shear localisation introduced by elongating pores. In the composite, fracture of the titanium-graphite bimaterial ligaments occurs along the brittle titanium carbide interdiffusion zone and ligaments of pure titanium. In addition to the influence of graphite composition on the fracture properties of titanium, the experiments also demonstrated the detrimental role of pores and pore morphology.
RP Teoh, SH (reprint author), NATL UNIV SINGAPORE, CTR BIOMED MAT APPLICAT & TECHNOL, INST MAT RES & ENGN, DEPT MECH & PROD ENGN, SINGAPORE 117548, SINGAPORE.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU PERGAMON PRESS LTD
PI OXFORD
PA THE BOULEVARD LANGFORD LANE KIDLINGTON, OXFORD OX5 1GB, ENGLAND
BN 0-08-042820-7
PY 1997
BP 689
EP 699
PG 11
WC Engineering, Mechanical; Materials Science, Multidisciplinary;
   Mechanics; Metallurgy & Metallurgical Engineering
SC Engineering; Materials Science; Mechanics; Metallurgy & Metallurgical
   Engineering
GA BJ89P
UT WOS:A1997BJ89P00075
DA 2018-10-20
ER

PT S
AU Kastner, AJ
   Narayan, C
   OConnor, M
   Kegel, G
   Mittler, A
AF Kastner, AJ
   Narayan, C
   OConnor, M
   Kegel, G
   Mittler, A
BE Duggan, JL
   Morgan, IL
TI Trace elemental analysis of coral and bone samples
SO APPLICATION OF ACCELERATORS IN RESEARCH AND INDUSTRY - PROCEEDINGS OF
   THE FOURTEENTH INTERNATIONAL CONFERENCE, PTS 1 AND 2
SE AIP CONFERENCE PROCEEDINGS
LA English
DT Proceedings Paper
CT 14th International Conference on Application of Accelerators in Research
   and Industry
CY NOV 06-09, 1996
CL UNIV N TEXAS, PHYS DEPT, DENTON, TX
SP US DOE, Natl Sci Fdn, UNT, Amer Phys Soc, Div Nucl Phys
HO UNIV N TEXAS, PHYS DEPT
AB Biomaterials have been developed for various medical applications. Strength factors as well as the deterioration rate of the biomaterials in the human body must be considered. Extensive research covers the use of hydroxyapatite, a coralline substance for biomedical applications. Coral, bone and hydroxyapatite were examined using external beam Proton Induced X-ray Emission (PIXE), Neutron Activation Analysis (NAA) and X-ray Diffraction (XRD) to determine the similarities among these materials.
RP Kastner, AJ (reprint author), SUSQUEHANNA UNIV,DEPT PHYS,BOX 756,SELINSGROVE,PA 17870, USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AIP PRESS
PI WOODBURY
PA AMERICAN INSTITUTE OF PHYSICS 500 SUNNYSIDE BOULEVARD, WOODBURY, NY
   11797-2999
SN 0094-243X
BN 1-56396-652-2
J9 AIP CONF PROC
PY 1997
IS 392
BP 543
EP 545
PG 3
WC Nuclear Science & Technology; Physics, Applied; Physics, Atomic,
   Molecular & Chemical; Physics, Nuclear
SC Nuclear Science & Technology; Physics
GA BJ23A
UT WOS:A1997BJ23A00132
DA 2018-10-20
ER

PT B
AU Shakesheff, KM
   Davies, MC
   Domb, A
   Roberts, CJ
   Shard, AJ
   Tendler, SJB
   Williams, PM
AF Shakesheff, KM
   Davies, MC
   Domb, A
   Roberts, CJ
   Shard, AJ
   Tendler, SJB
   Williams, PM
BE Cohen, SH
   Lightbody, ML
TI Visualization of the surface degradation of biomedical polymers in situ
   with an atomic force microscope
SO ATOMIC FORCE MICROSCOPY/SCANNING TUNNELING MICROSCOPY 2
LA English
DT Proceedings Paper
CT 2nd Natick-Research-Development-and-Engineering-Center of
   US-Army-Soldier-System-Command Atomic Force Microscopy/Scanning
   Tunneling Microscopy (AFM/STM) Symposium
CY JUN 07-09, 1994
CL NATICK, MA
SP USA Soldier Syst Command, Natick Res Dev & Engn Ctr
AB The ability of the atomic force microscope (AFM) to observe dynamic polymer/liquid interfaces has been utilized to visualize in situ morphological changes occurring during the biodegradation of polymer surfaces. Using this technique we demonstrate the differential rate of degradation of amorphous and crystalline material and study the kinetics of erosion of an immiscible polymer blend. The use of atomic force microscopy in this applied area of research is furthering our knowledge of the importance of the relationship between surface morphology and degradation kinetics and promises to become an invaluable tool in the evaluation of novel biodegradable materials.
RP Shakesheff, KM (reprint author), UNIV NOTTINGHAM,DEPT PHARMACEUT SCI,LAB BIOPHYS & SURFACE ANAL,UNIV PK,NOTTINGHAM NG7 2RD,ENGLAND.
RI Williams, Philip/C-6947-2009; Roberts, Clive/C-6970-2009
OI Williams, Philip/0000-0002-1822-2133; Roberts, Clive/0000-0001-9443-3445
NR 0
TC 0
Z9 0
U1 0
U2 0
PU PLENUM PRESS DIV PLENUM PUBLISHING CORP
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013
BN 0-306-45596-X
PY 1997
BP 93
EP 98
PG 4
WC Microscopy
SC Microscopy
GA BH52R
UT WOS:A1997BH52R00011
DA 2018-10-20
ER

PT B
AU Mucalo, MR
   Johnson, GS
   Lorier, MA
AF Mucalo, MR
   Johnson, GS
   Lorier, MA
BE Sedel, L
   Rey, C
TI Processing and characterisation of biological hydroxyapatite derived
   from cattle, sheep and deer bone
SO BIOCERAMICS, VOL 10
LA English
DT Proceedings Paper
CT 10th International Symposium on Ceramics in Medicine
CY OCT 05-09, 1997
CL PARIS, FRANCE
SP European Soc Biomat, Soc Biomat (USA), European Soc Orthopaed Res, Japanese Soc Biomat, Ceram Soc Japan, Japanese Soc Orthopaed Ceram Implants, Natl Inst Sci & Med Res (INSERM France), Natl Ctr Sci Res (CNRS France)
DE bone; hydroxyapatite; implants; defatting; deproteination; FTIR/NMR
ID RAMAN
AB In New Zealand, the routine slaughter of cattle, sheep and deer produces a large amount of waste bone which is normally converted to low-cost blood-and-bone fertiliser. The porous architecture of bone makes it a valuable material for use in biomedical implants and thus this poster will describe a study into the processing and characterisation of waste bone from animal species for conversion to materials for clinical purposes. Bone samples from these species were defatted using novel methods such as microwaving which was found to be a highly rapid fat removal method. Defatted bone cubes were then bleached using hypochlorite reagents. Infrared spectroscopy monitored bulk fat removal and have demonstrated that the hypochlorite treatment decollagenated bone cubes while leaving carbonate intact. Solid state NMR showed there was still some tenaciously held organic matter in the samples even after hypochlorite treatment. The work demonstrates that waste animal bone can be efficiently processed to produce modifiable materials for clinical use.
C1 Univ Waikato, Dept Chem, Hamilton, New Zealand.
RP Mucalo, MR (reprint author), Univ Waikato, Dept Chem, Private Bag 3105, Hamilton, New Zealand.
RI Mucalo, Michael/E-5263-2013
OI Mucalo, Michael/0000-0002-7655-9885
CR AKAZAWA T, 1991, PHOSPHORUS RES B, V1, P215
   FRAYSSINET P, 1995, J MATER SCI-MATER M, V6, P473, DOI 10.1007/BF00123372
   REHMAN I, 1995, J BIOMED MATER RES, V29, P1287, DOI 10.1002/jbm.820291016
   WALSH WR, 1994, J MATER SCI-MATER M, V5, P72, DOI 10.1007/BF00121694
   WALTERS MA, 1990, J INORG BIOCHEM, V39, P193, DOI 10.1016/0162-0134(90)84002-7
NR 5
TC 0
Z9 0
U1 0
U2 5
PU PERGAMON PRESS LTD
PI OXFORD
PA THE BOULEVARD LANGFORD LANE KIDLINGTON, OXFORD OX5 1GB, ENGLAND
BN 0-08-042692-1
PY 1997
BP 321
EP 324
DI 10.1016/B978-008042692-1/50076-5
PG 4
WC Engineering, Biomedical; Materials Science, Biomaterials; Orthopedics
SC Engineering; Materials Science; Orthopedics
GA BM24P
UT WOS:000078165600076
DA 2018-10-20
ER

PT B
AU Martinetti, R
   Dolcini, L
   Ravaglioli, A
   Krajewski, A
   Mangano, C
AF Martinetti, R
   Dolcini, L
   Ravaglioli, A
   Krajewski, A
   Mangano, C
BE Sedel, L
   Rey, C
TI Experimental study on hydroxyapatite N-Carboxymethyl chitosan fillers
SO BIOCERAMICS, VOL 10
LA English
DT Proceedings Paper
CT 10th International Symposium on Ceramics in Medicine
CY OCT 05-09, 1997
CL PARIS, FRANCE
SP European Soc Biomat, Soc Biomat (USA), European Soc Orthopaed Res, Japanese Soc Biomat, Ceram Soc Japan, Japanese Soc Orthopaed Ceram Implants, Natl Inst Sci & Med Res (INSERM France), Natl Ctr Sci Res (CNRS France)
DE N-Carboxymethyl chitosan coating; porous hydroxyapatite; bioactive
   fillers
AB Hydroxyapatite / N-Carboxymethyl chitosan (HA / N-CMC) fillers were prepared and studied as a new biomaterial for medical use.
   N-CMC could either be a suitable structure where calcium and phosphate ions could arrange to begin mineralisation process or to influence the metabolism of the cells, inducing the synthesis of specific protein able to control the natural mechanism of hydroxyapatite crystals growth and consequently the mineralisation of new osteoid tissue.
   Starting materials and final samples were characterised: morphology and microstructure were evaluated by SEM and IR spectroscopy was used to detect the typical bands.
   N-CMC solution used for the preparation of the fillers coating was also characterised from the reological point of view.
   This experimental work underlines the important role of N-CMC for biomedical application, when in association with hydroxyapatite.
C1 FAENZA Srl, CERAMICA, FIN, I-48018 Faenza, Italy.
RP Martinetti, R (reprint author), FAENZA Srl, CERAMICA, FIN, Via Ravegnana 186, I-48018 Faenza, Italy.
CR LOBIANCO F, 1993, DENT CADMOS, V10, P40
   MATTIOLIBELMONTE M, 1995, J BIOACT COMPAT POL, V10, P249, DOI 10.1177/088391159501000304
   RAVAGLIOLI A, 1996, BIOCERAMICS, V9, P185
   Takechi M, 1996, J MATER SCI-MATER M, V7, P317, DOI 10.1007/BF00154542
NR 4
TC 0
Z9 0
U1 0
U2 3
PU PERGAMON PRESS LTD
PI OXFORD
PA THE BOULEVARD LANGFORD LANE KIDLINGTON, OXFORD OX5 1GB, ENGLAND
BN 0-08-042692-1
PY 1997
BP 503
EP 506
DI 10.1016/B978-008042692-1/50119-9
PG 4
WC Engineering, Biomedical; Materials Science, Biomaterials; Orthopedics
SC Engineering; Materials Science; Orthopedics
GA BM24P
UT WOS:000078165600119
DA 2018-10-20
ER

PT J
AU Taylor, GT
   Zheng, D
   Lee, M
   Troy, PJ
   Gyananath, G
   Sharma, SK
AF Taylor, GT
   Zheng, D
   Lee, M
   Troy, PJ
   Gyananath, G
   Sharma, SK
TI Influence of surface properties on accumulation of conditioning films
   and marine bacteria on substrata exposed to oligotrophic waters
SO BIOFOULING
LA English
DT Article
DE bacterial attachment; adhesion; critical surface tension; wettability;
   thermodynamics
ID PROTEIN ADSORPTION; SOLID SUBSTRATA; ADHESION; SEAWATER; ATTACHMENT;
   HYDROPHOBICITY; SORPTION
AB The influence of interfacial wettabilities on initial conditioning and bacterial colonization of polished surfaces was examined in the oligotrophic, subtropical waters off O'ahu's south shore and in the laboratory. After exposures to seawater for 3 d, accumulations of attached bacteria on 11 types of substrata during two deployments varied as a second order function of substratum wettability. As observed in previous biomedical and mesotrophic field studies, surfaces with intermediate critical surface tensions (gamma(crit) = 20-30 mN m(-1)) and extremes in the polar and dispersive components of the composite surface free energy were least colonized by bacteria. Conditioning film thicknesses, varied by a factor of 100 among materials and also appeared to be a second order function of gamma(crit). Sorbed films produced interfaces with a range of wettabilities, dependent upon substratum and sorbate properties. Bacteria isolated from surfaces exhibited four basic partitioning patterns into non-aqueous solvents which demonstrates that cell surface wettabilities vary widely among isolates and are characterized as (i) broadly hydrophobic, (ii) broadly hydrophilic, (iii) only compatible in phases with surface tensions < 20 mN m(-1), or (iv) only compatible in phases with surface tension > 27 mN m(-1). Partitioning patterns of cultured isolates are consistent with held observations of denser colonization of low and high gamma(crit) surfaces. The results support the hypothesis that substratum surface properties influence conditioning film attributes and continue to exert control over bacterial adsorption and attachment even after conditioning films are established.
C1 SUNY STONY BROOK, MARINE SCI RES CTR, STONY BROOK, NY 11794 USA.
   UNIV HAWAII, DEPT OCEANOG, HONOLULU, HI 96822 USA.
   PG CTR, DEPT BIOTECHNOL, NANDED, INDIA.
   UNIV HAWAII, HAWAII INST GEOPHYS, HONOLULU, HI 96822 USA.
RI Taylor, Gordon/A-6735-2009
OI Taylor, Gordon/0000-0002-6925-7571
CR ABSOLOM DR, 1983, APPL ENVIRON MICROB, V46, P90
   Baier R. E., 1970, ADHESION BIOL SYSTEM, P15
   Baier R.E., 1972, 3RD P INT C MAR CORR, P633
   BAIER RE, 1980, ADSORPTION MICROORGA, P59
   BAIER RE, 1981, FOULING HEAT TRANSFE, P293
   Characklis W. G., 1990, BIOFILMS, P195
   DECHO AW, 1990, OCEANOGR MAR BIOL, V28, P73
   DEXTER SC, 1979, J COLLOID INTERF SCI, V70, P346, DOI 10.1016/0021-9797(79)90038-9
   DEXTER SC, 1975, APPL MICROBIOL, V30, P298
   FLETCHER M, 1979, APPL ENVIRON MICROB, V37, P67
   FLETCHER RL, 1984, MAR BIOL LETT, V5, P251
   HOBBIE JE, 1977, APPL ENVIRON MICROB, V33, P1225
   KIRCHMAN DL, 1989, MAR CHEM, V27, P201, DOI 10.1016/0304-4203(89)90048-0
   KJELLEBERG S, 1982, APPL ENVIRON MICROB, V43, P1166
   KJELLEBERG S, 1980, FEMS MICROBIOL LETT, V7, P41, DOI 10.1111/j.1574-6941.1980.tb01572.x
   Little B.J., 1990, BIOFILMS, P635
   Loeb G.I., 1975, ADV CHEM SER, V145, DOI 10.1021/ba-1975-0145.ch016
   Marshall K.C., 1985, BACTERIAL ADHESION M, P133
   MARSHALL KC, 1971, J GEN MICROBIOL, V68, P337, DOI 10.1099/00221287-68-3-337
   MARSHALL KC, 1971, CAN J MICROBIOL, V17, P1413, DOI 10.1139/m71-225
   MARSZALEK DS, 1979, APPL ENVIRON MICROB, V38, P987
   NYILAS E, 1977, J BIOMED MATER RES S, V8, P51
   PRINGLE JH, 1986, APPL ENVIRON MICROB, V51, P1321
   Rittle K. H., 1990, Biofouling, V2, P121
   ROSENBERG M, 1980, FEMS MICROBIOL LETT, V9, P29, DOI 10.1016/0378-1097(80)90106-8
   RUTTER P, 1980, J GEN MICROBIOL, V102, P301
   TAYLOR GT, 1993, APPL SPECTROSC, V47, P1140, DOI 10.1366/0003702934068053
   TAYLOR GT, 1994, MAR CHEM, V47, P21, DOI 10.1016/0304-4203(94)90011-6
   TAYLOR GT, 1994, MAR CHEM, V45, P15, DOI 10.1016/0304-4203(94)90088-4
   VANDEVIVERE P, 1993, APPL ENVIRON MICROB, V59, P3280
   VANLOOSDRECHT MCM, 1989, MICROBIAL ECOL, V17, P1, DOI 10.1007/BF02025589
   VANLOOSDRECHT MCM, 1987, APPL ENVIRON MICROB, V53, P1893
   VANLOOSDRECHT MCM, 1987, APPL ENVIRON MICROB, V53, P1898
   VANLOOSDRECHT MCM, 1990, AQUAT SCI, V52, P103, DOI 10.1007/BF00878244
   WAHL M, 1989, MAR ECOL PROG SER, V58, P175, DOI 10.3354/meps058175
   ZAIDI BR, 1984, APPL ENVIRON MICROB, V48, P519
   ZHENG DQ, 1994, BIOFOULING, V8, P107, DOI 10.1080/08927019409378266
   Zimmermann R, 1977, MICROBIAL ECOLOGY BR, V25, P103, DOI 10.1007/978-3-642-66791-6_10
   Zisman W. A, 1964, ADV CHEM SER, P1
NR 39
TC 40
Z9 43
U1 1
U2 18
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0892-7014
EI 1029-2454
J9 BIOFOULING
JI Biofouling
PY 1997
VL 11
IS 1
BP 31
EP 57
DI 10.1080/08927019709378319
PG 27
WC Biotechnology & Applied Microbiology; Marine & Freshwater Biology
SC Biotechnology & Applied Microbiology; Marine & Freshwater Biology
GA WM451
UT WOS:A1997WM45100003
DA 2018-10-20
ER

PT J
AU Tang, YW
   Santerre, JP
   Labow, RS
   Taylor, DG
AF Tang, YW
   Santerre, JP
   Labow, RS
   Taylor, DG
TI Application of macromolecular additives to reduce the hydrolytic
   degradation of polyurethanes by lysosomal enzymes
SO BIOMATERIALS
LA English
DT Article
DE polyurethanes; polymeric additives; biodegradation; cholesterol
   esterase; biostability; surface chemistry
ID SURFACE; URETHANES; ADHESION
AB Of the various polymers used in medical devices, polyurethanes have been relatively successful because of their acceptable mechanical and biological properties. However, over the past decade, increasing concerns have arisen in relation to the long-term biostability of polyurethanes when exposed to the harsh environment of the human body. Lysosomal enzymes released from inflammatory cells have been proposed to be important mediators in the degradation of biomedical polyurethanes. In order to increase the biostability of polyurethanes to lysosomal enzymes, a series of surface-modifying macromolecules (SMMs) were synthesized in this work and then combined into a base polyurethane to reduce the material's susceptibility to hydrolysis. X-ray photoelectron spectroscopy (XPS) studies showed that the SMMs were enriched within the upper 10 nm of the surface. In vitro biodegradation test results indicated that the degradation of a polyester-urea-urethane could be inhibited by the new SMM surface. It was also found that different SMM formulations provided varying degrees of inhibition against the biodegradation of the polyester-urea-urethane. Certain formulations of the SMMs were shown to be physically incompatible with the polyurethane and distorted surface morphology to the extent that biodegradation was enhanced. (C) 1996 Elsevier Science Limited
C1 UNIV TORONTO,FAC DENT,DEPT BIOMAT,TORONTO,ON M5G 1G6,CANADA.
   UNIV OTTAWA,INST HEART,CARDIOVASC DEVICES DIV,OTTAWA,ON,CANADA.
   UNIV OTTAWA,DEPT CHEM ENGN,OTTAWA,ON,CANADA.
CR AMIJI M, 1992, J BIOMAT SCI-POLYM E, V3, P375, DOI 10.1163/156856292X00196
   BRINKMAN E, 1990, BIOMATERIALS, V11, P200, DOI 10.1016/0142-9612(90)90156-K
   BRUNSTEDT MR, 1990, BIOMATERIALS, V11, P370, DOI 10.1016/0142-9612(90)90089-9
   BRUNSTEDT MR, 1993, J BIOMED MATER RES, V27, P255, DOI 10.1002/jbm.820270216
   DERMANN K, 1982, J DENT RES, V61, P1250, DOI 10.1177/00220345820610110901
   HAN DK, 1993, J APPL POLYM SCI, V47, P761, DOI 10.1002/app.1993.070470502
   HUBBELL JA, 1993, CARDIOVASC PATHOL, V2, pS121
   HUNTER SK, 1983, T AM SOC ART INT ORG, V29, P250
   KAMBIC HE, 1986, CHEM ENG NEWS   0414, P31
   KAO WYJ, 1994, J BIOMED MATER RES, V28, P819, DOI 10.1002/jbm.820280709
   LABOW RS, 1994, J BIOMAT SCI-POLYM E, V6, P169, DOI 10.1163/156856294X00293
   LABOW RS, 1995, BIOMATERIALS, V16, P51, DOI 10.1016/0142-9612(95)91096-H
   LALAH MD, 1986, POLYURETHANES MED
   MARCHANT RE, 1984, J BIOMED MATER RES, V18, P309, DOI 10.1002/jbm.820180307
   NOJIRI C, 1988, T ASAIO, V34, P386
   RATNER BD, 1988, J BIOMED MATER RES, V22, P509, DOI 10.1002/jbm.820220607
   RATNER BD, 1993, CARDIOVASC PATHOL, V2, pS87, DOI 10.1016/1054-8807(93)90049-8
   RATNER BD, 1987, POLYURETHANES BIOMED, V2, P213
   RAUZEL DG, 1994, FUNDAM APPL TOXICOL, V22, P195
   SANTERRE JP, 1994, J BIOMED MATER RES, V28, P1187, DOI 10.1002/jbm.820281009
   SANTERRE JP, 1993, J BIOMED MATER RES, V27, P97, DOI 10.1002/jbm.820270113
   SUBRAMONIAM A, 1991, TOXICOL LETT, V57, P245, DOI 10.1016/0378-4274(91)90198-F
   TANG YW, 1996, IN PRESS J APPL POLY
   TANG YW, IN PRESS J BIOMED MA
   WANG FGB, IN PRESS J BIOMED MA
   WANG TL, 1992, POLYM BULL, V27, P549, DOI 10.1007/BF00300603
   Ward RS, 1984, POLYURETHANES BIOMED, P181
   WILLIAMS DF, 1986, FUNDAMENTAL ASPECTS, V1
NR 28
TC 37
Z9 37
U1 1
U2 20
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 1997
VL 18
IS 1
BP 37
EP 45
DI 10.1016/S0142-9612(96)00101-9
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA WA345
UT WOS:A1997WA34500008
PM 9003895
DA 2018-10-20
ER

PT B
AU Hielscher, AH
   Eick, AA
   Mourant, JR
   Freyer, JP
   Bigio, IJ
AF Hielscher, AH
   Eick, AA
   Mourant, JR
   Freyer, JP
   Bigio, IJ
BE VoDinh, T
   Lieberman, RA
   Vurek, GG
   Katzir, A
TI Biomedical diagnostic with diffusely backscattered linearly and
   circularly polarized light
SO BIOMEDICAL SENSING, IMAGING, AND TRACKING TECHNOLOGIES II
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Conference on Biomedical Sensing, Imaging, and Tracking Technologies II
CY FEB 11-13, 1997
CL SAN JOSE, CA
SP Int Biomed Opt Soc, Soc Photo Opt Instrumentat Engineers, Amer Soc Laser Med & Surg Inc
DE mueller matrix; Stokes vector polarization; backscattering; polystyrene
   spheres; biological-cell suspensions; fibroblasts; cancer
AB We report on the development of a method that records spatially dependent intensity patterns of polarized Light that is diffusely backscattered from turbid materials. It is demonstrated that these intensity patterns can be used to differentiate between suspensions of cancerous and noncancerous cells and to observe different metabolic cell processes. Our technique employs polarized light from a He-Ne laser (lambda = 513 nm), which is focused onto the surface of the scattering medium. A surface area of approximately 4 x 4 cm around the light input point is imaged through polarization-analysis optics onto a CCD camera One can observe a manifold of intensity patterns by varying the polarization state of the incident laser light and changing the analyzer configuration to detect different polarization components of the backscattered light Introducing the Mueller-matrix concept for diffusely backscattered light, a framework is provided to select a subset of measurements which comprehensively describe the optical properties of backscattering media.
RP Hielscher, AH (reprint author), LOS ALAMOS NATL LAB,CST-4,MS E535,LOS ALAMOS,NM 87545, USA.
NR 0
TC 24
Z9 24
U1 0
U2 2
PU SPIE - INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA PO BOX 10, BELLINGHAM, WA 98227-0010
BN 0-8194-2387-4
J9 P SOC PHOTO-OPT INS
PY 1997
VL 2976
BP 298
EP 305
DI 10.1117/12.275538
PG 8
WC Engineering, Biomedical; Optics; Radiology, Nuclear Medicine & Medical
   Imaging
SC Engineering; Optics; Radiology, Nuclear Medicine & Medical Imaging
GA BJ12R
UT WOS:A1997BJ12R00033
DA 2018-10-20
ER

PT B
AU Ottova, AL
   Hianik, T
   Ziegler, W
   Tvarozek, V
   Sabo, J
   Passechnik, VI
   Ivanov, SA
   Tien, HT
AF Ottova, AL
   Hianik, T
   Ziegler, W
   Tvarozek, V
   Sabo, J
   Passechnik, VI
   Ivanov, SA
   Tien, HT
BE VoDinh, T
   Lieberman, RA
   Vurek, GG
   Katzir, A
TI Self-assembled and supported BLMs as a smart system for biosensors
SO BIOMEDICAL SENSING, IMAGING, AND TRACKING TECHNOLOGIES II
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Conference on Biomedical Sensing, Imaging, and Tracking Technologies II
CY FEB 11-13, 1997
CL SAN JOSE, CA
SP Int Biomed Opt Soc, Soc Photo Opt Instrumentat Engineers, Amer Soc Laser Med & Surg Inc
DE bilayer lipid membranes; BLMs; planar lipid bilayers; biosensors; metal
   substrate; hydrogels; agar; interface
AB In the last few years there have been a number of research papers on self-assemblies of molecules as 'advanced materials' or 'smart sensors'. The inspiration for this exciting research, without question, comes from the biological world where, for example, the lipid bilayer of the cell membrane is the most important self-assembling system. Although the first report on self-assembled bilayer lipid membranes (BLMs) in vivo was published in 1962, interface science including surface and colloid science has been dealing with these interfacial self-assemblies of amphiphilic molecules since Robert Hooke's time (1672). In this communication, we present results of extensive study of physical chemical properties of two new membrane systems: metal and hydrogel supported bilayer lipid membranes (BLMs for short, also known as planar lipid bilayers). Several methods have been used to investigate the properties of these metal supported s-BLMs and hydrogel supported salt-bridge sb-BLMs. With the electrostriction method we observed different behavior of the planar lipid bilayer on metal substrate. The obtained results gave possibility to choose optimal properties of the support for constructing s-BLM-based biosensors. The capacitance relaxation method was used to determine the changes of dielectric relaxation times (reorientation of dipole moments of polar groups of individual lipid molecules or lipid clusters) and showed different dynamic properties of Lipids on the metal substrate and in free standing BLMs. Analysis of membrane current noise allowed the examination of the dynamic properties of supported BLMs. Examples of a number of practical applications of s-BLMs for the construction of a glucose sensor for biomedical use as well as applications of agar supported BLMs for determining several toxins will be presented.
RP Ottova, AL (reprint author), MICHIGAN STATE UNIV,DEPT PHYSIOL,E LANSING,MI 48824, USA.
NR 0
TC 1
Z9 1
U1 0
U2 2
PU SPIE - INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA PO BOX 10, BELLINGHAM, WA 98227-0010
BN 0-8194-2387-4
J9 P SOC PHOTO-OPT INS
PY 1997
VL 2976
BP 342
EP 349
DI 10.1117/12.275542
PG 8
WC Engineering, Biomedical; Optics; Radiology, Nuclear Medicine & Medical
   Imaging
SC Engineering; Optics; Radiology, Nuclear Medicine & Medical Imaging
GA BJ12R
UT WOS:A1997BJ12R00037
DA 2018-10-20
ER

PT B
AU Tvarozek, V
AF Tvarozek, V
BE Nikolelis, DP
   Krull, UJ
   Wang, J
   Mascini, M
TI Microsystem technology in biosensors
SO BIOSENSORS FOR DIRECT MONITORING OF ENVIRONMENTAL POLLUTANTS IN FIELD
SE NATO ADVANCED SCIENCE INSTITUTES SERIES, SUB-SER 2, ENVIRONMENTAL
   SECURITY
LA English
DT Proceedings Paper
CT NATO Advanced Research Workshop on Biosensors for Direct Monitoring of
   Environmental Pollutants in Field
CY MAY 04-08, 1997
CL SMOLENICE, SLOVAKIA
SP NATO, Sci Comm
AB Miniaturization of biosensors has increased the importance of microsystem technology particulary of microelectronics, micromachining and thin film technology. Thin-film technology microelectrodes and microsystems serve as well-defined and reproducible interfaces between sensing, recognition and transduction sites. Solving the compatibility of bilayer lipid membranes with planar thin-film microsystems is esential for future applications of that very "adaptive" material in the field of microbiosensors. Microsystem technology gives comprehensive and synergetic effect on the innovation and mass-production of microinstruments for biomedical analysis and enviromental monitoring.
C1 Slovak Univ Technol Bratislava, Dept Microelect, Bratislava 81219, Slovakia.
RP Tvarozek, V (reprint author), Slovak Univ Technol Bratislava, Dept Microelect, Ilkovicova 3, Bratislava 81219, Slovakia.
NR 0
TC 2
Z9 2
U1 0
U2 0
PU SPRINGER
PI DORDRECHT
PA PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
BN 0-7923-4867-2
J9 NATO ASI 2
PY 1997
VL 38
BP 351
EP 371
PG 21
WC Biology; Chemistry, Multidisciplinary; Chemistry, Analytical;
   Environmental Sciences
SC Life Sciences & Biomedicine - Other Topics; Chemistry; Environmental
   Sciences & Ecology
GA BK63J
UT WOS:000072818700031
DA 2018-10-20
ER

PT S
AU Leclaire, P
   Kelders, L
   Lauriks, W
   Glorieux, C
   Thoen, J
AF Leclaire, P
   Kelders, L
   Lauriks, W
   Glorieux, C
   Thoen, J
BE Lowet, G
   Ruegsegger, P
   Weinans, H
   Meunier, A
TI Ultrasonic wave propagation in porous media: Determination of acoustic
   parameters and high frequency limit of the classical models
SO BONE RESEARCH IN BIOMECHANICS
SE STUDIES IN HEALTH TECHNOLOGY AND INFORMATICS
LA English
DT Proceedings Paper
CT 10th Conference of the European-Society-of-Biomechanics
CY AUG 28-31, 1996
CL LOUVAIN, BELGIUM
SP European Soc Biomech
AB Results on the ultrasonic wave propagation in porous materials are presented with emphasis on the measurement of acoustic parameters and on the discrepancy between experimental results and theoretical predictions for the attenuation at high frequencies. This discrepancy can be observed in Biomedical Engineering where the propagation in different sorts of bones is studied as well as in the fields of Geophysics and Material Science. In the present study, the slow wave propagation in polyurethane foams saturated by different gases is investigated in a frequency range of [70-800 kHz]. Methods are presented to determine the tortuosity and the viscous and thermal characteristic lengths. The experimental results, obtained using standard ultrasonic and vacuum equipments, show that an excess attenuation occurs when the wavelength is not sufficiently large compared to the lateral dimensions of the fibers. This effect constitutes a limit of the classical models of equivalent phases. It is evaluated with the help of a model of ultrasonic scattering. A numerical simulation of osteoporosis using Blot's model is also presented.
RP Leclaire, P (reprint author), KATHOLIEKE UNIV LEUVEN,DEPT NATUURKUNDE,LAB AKOESTIEK & THERM FYS,CELESTIJNENLAAN 200D,B-3001 LOUVAIN,BELGIUM.
NR 0
TC 3
Z9 3
U1 0
U2 5
PU I O S PRESS
PI AMSTERDAM
PA VAN DIEMENSTRAAT 94, 1013 CN AMSTERDAM, NETHERLANDS
SN 0926-9630
BN 90-5199-327-7
J9 ST HEAL T
PY 1997
VL 40
BP 139
EP 155
PG 17
WC Engineering, Biomedical; Medical Informatics; Orthopedics
SC Engineering; Medical Informatics; Orthopedics
GA BH94B
UT WOS:A1997BH94B00011
PM 10168875
DA 2018-10-20
ER

PT J
AU Rizkalla, AS
   Jones, DW
   Hall, GC
AF Rizkalla, AS
   Jones, DW
   Hall, GC
TI Synthesis of experimental biomedical glass cement forming systems
SO BRITISH CERAMIC TRANSACTIONS
LA English
DT Article
ID IONOMER CEMENTS
AB Five experimental glass formulations, (SiO2-Al2O3CaF2-AlPO4-AlF3-NaF), were designed to undergo crystallisation during slow cooling or heat treatment. Precursor materials for the five compositions were synthesised by a wet chemical method with various amounts of fluoride and sodium incorporated to act as pur or nucleating agents. Colloidal suspensions of Al2O3, SiO2, and H3PO4 were spray dried, calcined at 1000 degrees C, and mixed with calcium, aluminium and sodium fluorides to produce the precursor powders. Following calcination, the glasses were melted at 1600 degrees C and quenched to produce a clear transparent glass. The bulk chemical compositions were determined by atomic absorption spectrophotometry, and ultraviolet spectroscopy and an ion specific electrode were used to determine the P and F contents respectively. The calcium content of the final glasses varied from 10.64 to 20.03% and the aluminium content from 15.64 to 20.53%. The compositions of all Jive glasses were statistically, significantly different. Setting characteristics were determined by means of an oscillating rheometer. Cements of various reactivities were produced by all five ion leachable glasses when mixed with different ratios of poly(acrylic acid) to tartaric acid. The shear moduli for three experimental cements were comparable with two commercial materials.
C1 DALHOUSIE UNIV,FAC MED,HALIFAX,NS B3H 3J5,CANADA.
RP Rizkalla, AS (reprint author), DALHOUSIE UNIV,FAC DENT,DIV BIOMAT,HALIFAX,NS B3H 3J5,CANADA.
RI Rizkalla, Amin/D-8845-2015
OI Rizkalla, Amin/0000-0003-0548-3817
CR BARRY TI, 1979, J DENT RES, V58, P1072, DOI 10.1177/00220345790580030801
   BERNAS B, 1968, ANAL CHEM, V40, P1682, DOI 10.1021/ac60267a017
   CRISP S, 1974, J DENT RES, V53, P1414, DOI 10.1177/00220345740530062001
   ELLIS J, 1992, DENT MATER, V8, P79, DOI 10.1016/0109-5641(92)90060-P
   HALL GC, 1989, J DENT RES, V68, P978
   HALMANN M, 1972, ANAL CHEM PHOSPHORUS, P51
   JONES DW, 1988, MAT SCI ENG A-STRUCT, V105, P207, DOI 10.1016/0025-5416(88)90498-3
   JONES DW, 1991, J MATER SCI, V26, P6501, DOI 10.1007/BF00551904
   JONES DW, 1991, 17 ANN M SOC BIOM SC
   KNIBBS PJ, 1988, J ORAL REHABIL, V15, P103, DOI 10.1111/j.1365-2842.1988.tb00150.x
   MOUNT JG, 1990, AM J DENT, V3, P79
   MOUNT JG, 1984, CLIN DENT
   RIZKALLA AS, 1991, BRIT CERAM TRANS J, V90, P81
   RIZKALLA AS, 1991, BRIT CERAM TRANS J, V90, P1
   RIZKALLA AS, 1988, J DENT RES, V67, P119
   Smith D.C., 1983, DENT CLIN N AM, V6, P763
   TAY WM, 1989, IR DENT ASS, V35, P53
   TAY WM, 1989, IR DENT ASS, V35, P59
   WALLS AWG, 1986, J DENT, V14, P231, DOI 10.1016/0300-5712(86)90030-8
   Wilson A D, 1989, Int J Prosthodont, V2, P438
   WILSON AD, 1989, J DENT RES, V68, P89, DOI 10.1177/00220345890680021401
   WILSON AD, 1973, Patent No. 1316129
   WILSON AD, 1988, GLASS IONOMER CEMENT
   WILSON AD, 1978, CEMENT RES PROGR, pCH4
   WILSON AD, 1978, CHEM SOC REV, V77, P265
   WOOD D, 1991, BIOMATERIALS, V12, P164, DOI 10.1016/0142-9612(91)90195-G
NR 26
TC 2
Z9 2
U1 0
U2 1
PU INST MATERIALS
PI LONDON
PA 1 CARLTON HOUSE TERRACE, LONDON, ENGLAND SW1Y 5DB
SN 0967-9782
J9 BRIT CERAM T
JI Br. Ceram. Trans.
PY 1997
VL 96
IS 1
BP 16
EP 20
PG 5
WC Materials Science, Ceramics
SC Materials Science
GA XJ646
UT WOS:A1997XJ64600003
DA 2018-10-20
ER

PT J
AU Rizkalla, AS
   Jones, DW
AF Rizkalla, AS
   Jones, DW
TI Differential thermal analysis of experimental ion leachable glasses
SO BRITISH CERAMIC TRANSACTIONS
LA English
DT Article
ID CRYSTALLIZATION KINETICS; FLUORIDE GLASSES; DEVITRIFICATION; PARAMETERS;
   DTA
AB Five, six component experimental glass formulations were developed as ion leachable biomedical cement forming systems. The precursor powders were synthesised by wet chemistry. Following calcination, the glasses were melted at 1600 degrees C and rapidly cooled to produce clear transparent glass. All five glasses crystallised during heat treatment producing glass ceramics with various degrees of opacity. Crystallisation kinetics were studied by means of differential thermal analysis. Three samples of each glass were heated from 23 to 1200 degrees C in N-2 at heating rates ranging from 5 to 50 K min(-1). The activation energy of crystallisation for each composition wets calculated from an expression relating log hearing late and the reciprocal of the exothermic peak temperature. The compositions of the five glasses were significantly different at the 0.95 level of confidence. The activation energy values ranged from 335 to 678 kJ mol(-1). The results indicate that four of the five glasses underwent bulk crystallisation. The crystalline phases, present in each of the five formulations following heat treatment, were gehlenite, anorthite, and fluoroapatite. Different ratios of the first two phases were present in each of the five materials. (C) 1997 The Institute of Materials.
RP Rizkalla, AS (reprint author), DALHOUSIE UNIV,FAC MED,DIV BIOMAT,HALIFAX,NS B3H 3J5,CANADA.
RI Rizkalla, Amin/D-8845-2015
OI Rizkalla, Amin/0000-0003-0548-3817
CR AUGIS JA, 1978, J THERM ANAL, V13, P283, DOI 10.1007/BF01912301
   Avrami M, 1941, J CHEM PHYS, V9, P177, DOI 10.1063/1.1750872
   Avrami M., 1940, Journal of Chemical Physics, V8, P212, DOI 10.1063/1.1750631
   Avrami M, 1939, J CHEM PHYS, V7, P1103, DOI 10.1063/1.1750380
   BANSAL NP, 1984, J THERM ANAL, V29, P115, DOI 10.1007/BF02069946
   BANSAL NP, 1985, J NON-CRYST SOLIDS, V70, P379, DOI 10.1016/0022-3093(85)90108-5
   BARO MD, 1977, J THERM ANAL, V11, P271
   BRANDA F, 1984, THERMOCHIM ACTA, V80, P269, DOI 10.1016/0040-6031(84)87204-4
   CHEN HS, 1978, J NON-CRYST SOLIDS, V27, P257, DOI 10.1016/0022-3093(78)90128-X
   GAO YQ, 1986, J NON-CRYST SOLIDS, V81, P135, DOI 10.1016/0022-3093(86)90263-2
   HENDERSON DW, 1984, J NON-CRYST SOLIDS, V64, P43, DOI 10.1016/0022-3093(84)90205-9
   Johnson WA, 1939, T AM I MIN MET ENG, V135, P416
   KING HW, 1993, CAN CERAM QUART, V62, P248
   KISSINGER HE, 1956, J RES NAT BUR STAND, V57, P217, DOI 10.6028/jres.057.026
   KISSINGER HE, 1957, ANAL CHEM, V29, P1702, DOI DOI 10.1021/AC60131A045
   MACFARLANE DR, 1984, J NON-CRYST SOLIDS, V64, P351, DOI 10.1016/0022-3093(84)90188-1
   MACKENZIE RC, 1957, DIFFERENTIAL THERMAL, P51
   Matusita K, 1981, B I CHEM RES KYOTO U, V59, P159
   RAY CS, 1991, J AM CERAM SOC, V74, P60, DOI 10.1111/j.1151-2916.1991.tb07297.x
   Rizkalla AS, 1997, BRIT CERAM T, V96, P16
   SUSIC MV, 1986, J MATER SCI, V21, P1297, DOI 10.1007/BF00553266
   YINNON H, 1983, J NON-CRYST SOLIDS, V54, P253, DOI 10.1016/0022-3093(83)90069-8
NR 22
TC 0
Z9 0
U1 0
U2 1
PU INST MATERIALS
PI LONDON
PA 1 CARLTON HOUSE TERRACE, LONDON, ENGLAND SW1Y 5DB
SN 0967-9782
J9 BRIT CERAM T
JI Br. Ceram. Trans.
PY 1997
VL 96
IS 2
BP 57
EP 60
PG 4
WC Materials Science, Ceramics
SC Materials Science
GA YC394
UT WOS:A1997YC39400003
DA 2018-10-20
ER

PT J
AU Rondelli, G
   Vicentini, B
   Cigada, A
AF Rondelli, G
   Vicentini, B
   Cigada, A
TI Localised corrosion tests on austenitic stainless steels for biomedical
   applications
SO BRITISH CORROSION JOURNAL
LA English
DT Article
AB Electrochemical localised corrosion tests (cyclic potentiodynamic, potentiostatic with scratch, modified ASTM F746) were conducted in artificial physiological solutions on two traditional austenitic stainless steels, types AISI 316L and ASTM F138, and a new high nitrogen austenitic stainless steel, type 20Cr9Ni2Mo0.39N. The results pointed to the superiority of the 20Cr9Ni2Mo0.39N steel with respect to the traditional ones. No effects on localised corrosion resistance owing to addition of 10% serum to physiological solutions were detected. The possibility that the modified ASTM F746 test could give I ise, for the new 20Cr9Ni2Mo0.39N steel. to a controversial classification of the material's performance, depending on different interpretations of localised corrosion stimulation criteria, is discussed. (C) 1997 The Institute of Materials.
C1 Ist Tecnol Mat, I-20133 Milan, Italy.
   Univ Aquila, Dipartimento Chim Ingn Chim & Mat, I-67040 Laquila, Italy.
OI Cigada, Alberto/0000-0002-0925-5558
CR ANDERSON DB, 1976, ASTM STP, V576, P231
   [Anonymous], 1993, ANN BOOK ASTM STAND
   CHAVA SK, 1990, CORROSION, V46, P147
   CIGADA A, 1938, P 12 INT CORR C HO B, V3
   GURD FRN, 1956, ADV PROTEIN CHEM, V9, P312
   HOAR TP, 1966, PROC R SOC LON SER-A, V294, P486, DOI 10.1098/rspa.1966.0220
   HSU HM, 1984, P 10 ANN M SOC BIOM, P124
   KRUGER J, 1979, STP, V684, P109
   KUHN AT, 1988, STP, V970, P79
   Menzel J., 1990, P 2 INT C HIGH NITR, P365
   PAYER JH, 1990, ADV LOCALIZED CORROS, P235
   PESSAI N, 1971, ELECTROCHIM ACTA, V16, P1997
   SINIGAGLIA D, 1980, WERKST KORROS, V31, P851
   Speidel M.O., 1990, P 2 INT C HIGH NITR
   SPEIDEL MG, 1992, P C CORR 92 NASHV TN
   SPRUIT D, 1980, DERMATOLOGIC EFFECT, P601
   SUTOW EJ, 1981, BIOCOMPATIBILITY CLI, V1, P45
   Williamson D H, 1985, Yeast, V1, P1, DOI 10.1002/yea.320010102
NR 18
TC 17
Z9 18
U1 1
U2 7
PU INST MATERIALS
PI LONDON
PA 1 CARLTON HOUSE TERRACE, LONDON SW1Y 5DB, ENGLAND
SN 0007-0599
J9 BRIT CORROS J
JI Br. Corros. J.
PY 1997
VL 32
IS 3
BP 193
EP 196
PG 4
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA ZU596
UT WOS:000074213900005
DA 2018-10-20
ER

PT S
AU Boyer, CN
   Holland, GE
   Seely, JF
AF Boyer, CN
   Holland, GE
   Seely, JF
BE Freund, AK
   Freund, HP
   Howells, MR
TI A pulsed hard x-ray source for nondestructive testing and medical
   imaging
SO COHERENT ELECTRON-BEAM X-RAY SOURCES: TECHNIQUES AND APPLICATIONS
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Conference on Coherent Electron-Beam X-Ray Sources - Techniques and
   Applications
CY JUL 31-AUG 01, 1997
CL SAN DIEGO, CA
SP Soc Photo Opt Instrumentat Engineers
DE Marx generator; field emission; high voltage; ultraviolet; x-ray;
   trigatron
AB The ability to nondestructively image living organisms, examine biological materials, and inspect packages without the necessity of removing the contents are applications well suited to x-ray radiography. We have developed a portable flash x-ray (FX) source having adjustable peak x-ray photon energy, which delivers a 34 milliroentgen rr-ray dose at 30 cm in a 60-ns full-width at half-maximum (FWHM) pulse using less than 5 joules of stored energy. This technology has generated considerable interest in the biomedical imaging community and promises to replace older x-ray systems that were not readily portable.
C1 Univ Space Res Assoc, Washington, DC 20024 USA.
RP Boyer, CN (reprint author), Univ Space Res Assoc, 300 D St SW, Washington, DC 20024 USA.
NR 0
TC 1
Z9 2
U1 0
U2 1
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-2576-1
J9 P SOC PHOTO-OPT INS
PY 1997
VL 3154
BP 16
EP 26
DI 10.1117/12.279390
PG 11
WC Optics; Physics, Multidisciplinary
SC Optics; Physics
GA BK08U
UT WOS:000071156600002
DA 2018-10-20
ER

PT J
AU Festing, MFW
AF Festing, MFW
TI Variation and its implications for the design of experiments in
   toxicological research
SO COMPARATIVE HAEMATOLOGY INTERNATIONAL
LA English
DT Article
DE experimental design; inbred strains; outbred stocks; statistics
AB The controlled experiment is one of the most powerful tools available in biomedical research, and thousands of such experiments are conducted annually. However, the basic principles of designing such experiments do not seem to be widely understood. If the experimental material is heterogeneous, then the treated and control groups may not be identical at the start of the experiment, even if large sample sizes are used. Yet genetically heterogeneous 'outbred' stocks of laboratory mice and rats are widely used in the pharmaceutical industry in spite of the availability of more homogeneous inbred strains. The use of such stocks is justified on two grounds: that humans are also heterogeneous, and that such stocks offer a wide range of phenotypes for toxicological screening. Both arguments are spurious. It is not necessary for a toxicological model of humans to be a good genetic model. Models do not have to resemble their target in every respect. Were they to do so they would no longer be models. The genetic heterogeneity within an outbred stock simply creates 'noise' when comparing treated and control groups, and prevents more exact matching of groups before the experiment starts. Phenotypic heterogeneity can be achieved without this disadvantage using a factorial experimental design involving more than one strain, with groups exactly matched genetically, but without increasing total numbers.
   The lack of understanding of good experimental design seems to extend to other areas, with few research workers using techniques such as blocking and factorial experimental designs which have been known for over 60 years, and which are widely used in other disciplines. Experiments are often unnecessarily large and surveys suggest that more than half have obvious statistical errors. Better training in experimental design would be cost effective in making better use of scarce resources, and would help to reduce the use of laboratory animals, which is an ethically desirable goal.
C1 Univ Leicester, MRC, Toxicol Unit, Leicester LE1 9HN, Leics, England.
RP Festing, MFW (reprint author), Univ Leicester, MRC, Toxicol Unit, Hodgkin Bldg,POB 138,Lancaster Rd, Leicester LE1 9HN, Leics, England.
CR Altman D G, 1982, Stat Med, V1, P59, DOI 10.1002/sim.4780010109
   ALTMAN DG, 1982, STAT PRACTICE, P1
   ARCOS JC, 1968, CHEM INDUCTION CANC
   Balls M, 1995, ATLA-ALTERN LAB ANIM, V23, P838
   Cox DR, 1958, PLANNING EXPT
   ELASHOFF JD, 1995, NQUERY ADVISOR USERS
   FELTON RP, 1989, J TOXICOL ENV HEALTH, V26, P399, DOI 10.1080/15287398909531264
   FESTING MFW, 1993, J EXP ANIM SCI, V35, P210
   FESTING MFW, 1987, CRIT REV TOXICOL, V18, P1, DOI 10.3109/10408448709089855
   FESTING MFW, 1995, ENVIRON HEALTH PERSP, V103, P44, DOI 10.2307/3432255
   FESTING MFW, 1995, MUTAT RES-FUND MOL M, V329, P221, DOI 10.1016/0027-5107(95)00050-S
   FESTING MFW, 1994, LAB ANIM, V28, P212, DOI 10.1258/002367794780681697
   Festing MFW, 1982, ILAR NEWS, V25, P6
   FESTING MFW, 1996, STAT TOXICOLOGY, P3
   FESTING MFW, 1979, INBRED STRAINS BIOME
   Festing Michael F. W., 1992, Laboratory Animals (London), V26, P256, DOI 10.1258/002367792780745788
   FISHER RA, 1960, DESIGN EXPT
   GARTNER K, 1990, LAB ANIM, V24, P71, DOI 10.1258/002367790780890347
   GORE SM, 1977, BRIT MED J, V1, P85, DOI 10.1136/bmj.1.6053.85
   HESTON WE, 1968, JPN CANC ASS GANN MO, V5, P3
   Mead R, 1988, DESIGN EXPT, V620
   NOHYNEK GJ, 1993, HUM EXP TOXICOL, V12, P87, DOI 10.1177/096032719301200201
   PAPAIOANNOU VE, 1980, LAB ANIM, V14, P11, DOI 10.1258/002367780780943015
   SONTAG JM, 1976, NCI CARCINOGENESIS T, V1
NR 24
TC 4
Z9 4
U1 2
U2 9
PU SPRINGER VERLAG
PI NEW YORK
PA 175 FIFTH AVE, NEW YORK, NY 10010 USA
SN 0938-7714
J9 COMP HAEMATOL INT
JI Comp. Haematol. Int.
PY 1997
VL 7
IS 4
BP 202
EP 207
DI 10.1007/BF02658690
PG 6
WC Hematology
SC Hematology
GA YN148
UT WOS:000071137900003
DA 2018-10-20
ER

PT B
AU GonzalezCarrasco, JL
   Escudero, ML
   Chao, J
   Rubio, JC
   GarciaAlonso, MC
   Lopez, MF
   Ruiz, J
   Cebollada, F
   Adeva, P
   Canahua, H
AF GonzalezCarrasco, JL
   Escudero, ML
   Chao, J
   Rubio, JC
   GarciaAlonso, MC
   Lopez, MF
   Ruiz, J
   Cebollada, F
   Adeva, P
   Canahua, H
BE Sarton, LAJ
   Zeedijk, HB
TI The MA 956 superalloy: a potential biomaterial for surgical implants.
SO EUROMAT 97 - PROCEEDINGS OF THE 5TH EUROPEAN CONFERENCE ON ADVANCED
   MATERIALS AND PROCESSES AND APPLICATIONS: MATERIALS, FUNCTIONALITY &
   DESIGN, VOL 3: SURFACE ENGINEERING AND FUNCTIONAL MATERIALS
LA English
DT Proceedings Paper
CT 5th European Conference on Advanced Materials and Processes and
   Applications (EUROMAT 97)
CY APR 21-23, 1997
CL MAASTRICHT, NETHERLANDS
SP Federat European Mat Soc, Netherlands Soc Mat Sci
AB Thermal oxidation treatment (1100 degrees C/100 h) of MA 956 produces on the surface a tightly adherent alpha-alumina scale, about 5 mu m thick. The scale/metal system resembles an alumina coated material with the advantage that the coating is easier to perform than by other conventional processes. In vitro experiments have proved that MA 956 with and without scale exhibits an excellent corrosion behaviour being the corrosion intensities lower than those of metallic biomaterials in use. It is worth to remark that scale decreases the corrosion intensity at least up to two orders of magnitude with respect to the uncoated material, which corrosion behaviour is also excellent. The elevated compressive residual stresses in the scale guarantee its integrity during tensile deformation and account for the good fatigue and wear behaviour. SEM examination of implanted samples reveals a bone response similar to that for other biomaterials. These promising results provides with a window of opportunity for preoxidized Ma 956 in biomedical applications.
RP GonzalezCarrasco, JL (reprint author), CSIC,CTR NACL INVEST MET,AVDA GREGORIO DEL AMO 8,E-28040 MADRID,SPAIN.
RI Escudero, Maria Lorenza/L-7113-2014
OI Escudero, Maria Lorenza/0000-0002-2181-448X
NR 0
TC 0
Z9 0
U1 0
U2 0
PU NETHERLANDS SOC MATERIALS SCIENCE
PI ZWIJNDRECHT
PA PO BOX 390, N-3330 ZWIJNDRECHT, NETHERLANDS
BN 90-803513-3-4
PY 1997
BP 597
EP 600
PG 4
WC Engineering, Multidisciplinary; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA BJ43N
UT WOS:A1997BJ43N00138
DA 2018-10-20
ER

PT J
AU Salako, Q
   DeNardo, SJ
AF Salako, Q
   DeNardo, SJ
TI Analysis of long-lived radionuclidic impurities in short-lived
   radiopharmaceutical waste using gamma spectrometry
SO HEALTH PHYSICS
LA English
DT Article
DE nuclear medicine; radioactive materials; waste management; spectrometry,
   gamma
ID LEVEL RADIOACTIVE-WASTE; DISPOSAL
AB Large hospitals and biomedical research centers utilize decay-in-storage programs to minimize the volume of their low level radioactive waste. However, some medically useful radionuclides often contain small amounts of long-lived radionuclidic impurities which may complicate simple waste management procedures. We have evaluated the extent of this problem in low level radioactive waste involving Cu-67 and In-111 over a 6-mo cycle of decay-in-storage by identifying the residual radionuclides in our dry waste using a multichannel analyzer. The multichannel analyzer was also used to quantify the radionuclide constituents of our liquid waste at the beginning of a decay-in-storage cycle. Radionuclides were identified by the presence of characteristic photopeaks of each isotope in the gamma spectrum and quantified by region of interest analysis. After a decay-in-storage cycle, long-lived Co-58, Co-57, and Co-56 isotopes were observed in dry Cu-67 waste and In-114 m identified in dry In-111 waste. The In-114 m was detected in dry In-111 waste containing initial In-114 m activity of 740 kBq (20 mu Ci), while the cobalt radionuclides were detected in dry Cu-67 waste containing initial Co-58, Co-57, and Co-56 activities of 444, 148, and 148 kBq (12, 4, and 4 mu Ci), respectively. Such dry low level radioactive waste was thus disqualified from short-term radioactive waste storage programs. The radionuclide constituents in the liquid waste were quantified in mu Ci mL(-1) and confirmed to be within the Nuclear Regulatory Commission set limits of 2 x 10(-4), 6 x 10(-4) and 6 x 10(-5) mu Ci mL(-1) for Co-58, Co-57, and Co-56, respectively, before disposal. The highest levels of long-lived isotopes that have been found in our liquid low level radioactive waste at the beginning of decay-in-storage were 5.5 x 10(-4), 4.8 x 10(-4), and 1.4 x 10(-4) mu Ci mL(-1) for Co-58, Co-57, and Co-56, respectively. Gamma spectrometry can be used to aid waste segregation and final management decisions on low level radioactive waste.
C1 UNIV CALIF DAVIS, MOL CANC INST, SACRAMENTO, CA 95816 USA.
FU NCI NIH HHS [PHS CA47829]
CR BRILL DR, 1991, INVEST RADIOL, V26, P94, DOI 10.1097/00004424-199101000-00022
   BROWNE E, 1978, TABLE ISOTOPES, P185
   Earley D L, 1993, Med Waste Anal, V2, P5
   EMERY R, 1992, HEALTH PHYS, V62, P183, DOI 10.1097/00004032-199202000-00009
   HAMANO DM, 1993, HEALTH PHYS, V64, P192, DOI 10.1097/00004032-199302000-00011
   HENDEE WR, 1993, JAMA-J AM MED ASSOC, V269, P2403, DOI 10.1001/jama.269.18.2403
   *INT COMM RAD PROT, 1983, ICRP PUBL, V38
   TRIPODES JG, 1993, MED WASTE ANAL, V2, P3
   VETTER RJ, 1992, HEALTH PHYS, V62, P121
   1991, FED REGISTER, V56, P23404
NR 10
TC 0
Z9 0
U1 1
U2 5
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0017-9078
EI 1538-5159
J9 HEALTH PHYS
JI Health Phys.
PD JAN
PY 1997
VL 72
IS 1
BP 56
EP 59
DI 10.1097/00004032-199701000-00008
PG 4
WC Environmental Sciences; Public, Environmental & Occupational Health;
   Nuclear Science & Technology; Radiology, Nuclear Medicine & Medical
   Imaging
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health; Nuclear Science & Technology; Radiology, Nuclear Medicine &
   Medical Imaging
GA VY758
UT WOS:A1997VY75800010
PM 8972828
DA 2018-10-20
ER

PT B
AU White, MJ
   Iskander, MF
AF White, MJ
   Iskander, MF
GP IEEE
TI A new 3D FDTD multi-grid techniques with dielectric traverse
   capabilities
SO IEEE ANTENNAS AND PROPAGATION SOCIETY INTERNATIONAL SYMPOSIUM 1997, VOLS
   1-4
LA English
DT Proceedings Paper
CT IEEE Antennas-and-Propagation-Society International Symposium / North
   American Radio Science Meeting
CY JUL 13-18, 1997
CL MONTREAL, CANADA
SP IEEE Antennas & Propagat Soc, Natl Res Council Canada, Canadian Natl Comm URSI, US Natl Comm URSI
AB The finite-difference time-domain technique(FDTD) has become increasingly popular and is being used to model extremely complex and electrically large structures. These simulations are computationally demanding and often exceed available limits of computer resources. In this paper we present a FDTD sub-gridding technique that allows for increased resolution in regions of interest without increasing the overall computational requirements beyond the available resources. Furthermore, the formulation presented here is the first to allow for traversing dielectric boundaries using any integer refinement factor and the maximum Courant number. The technique presented here uses a weighted current value from the coarse region at the boundary between the fine-and coarse-grid regions to update the fine-region tangential fields on that boundary. The weighting function depends on the material properties and the relative position of the line-region electric field within the current contour at the boundary. The complete formulation of this new technique is described and some results of simulation cases are presented to validate the accuracy and stability of the developed FDTD code. In some simulation examples, computer memory savings as high as 70 times what would have been necessary with a uniform-grid code were achieved. It is shown that errors less than 2 percent are achievable with coarse-to-fine-grid ratios exceeding 10. The new technique is expected to be used in simulating many electrically large and complex structures in the biomedical, microwave precessing of materials, and cellular-communications areas.
RP White, MJ (reprint author), UNIV UTAH,SALT LAKE CITY,UT 84112, USA.
NR 0
TC 1
Z9 1
U1 0
U2 0
PU I E E E
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017
BN 0-7803-4178-3
PY 1997
BP 2160
EP 2163
PG 4
WC Engineering, Electrical & Electronic
SC Engineering
GA BJ61W
UT WOS:A1997BJ61W00515
DA 2018-10-20
ER

PT B
AU Chen, F
   Suter, D
AF Chen, F
   Suter, D
GP IEEE COMP SOC
TI Elastic spline models for human cardiac motion estimation
SO IEEE NONRIGID AND ARTICULATED MOTION WORKSHOP, PROCEEDINGS
LA English
DT Proceedings Paper
CT IEEE Nonrigid and Articulated Motion Workshop
CY JUN   16, 1997
CL SAN JUAN, PR
SP IEEE Comp Soc, Tech Comm Pattern Anal & Machine Intelligence
AB Elastic splines (including dynamic ''snakes'' and elastic contours), minimising an energy norm of the membrane and/or thin-plate types, have been used to model many surfaces in visual reconstruction and related biomedical applications. In this paper, we model the displacement of the material between successive cardiac images using vector splines. We define a family of elastic splines. These splines can be tuned to enforce different type and different degrees of smoothness. We assess how well these splines can be used to reconstruct human cardiac motion.
RP Chen, F (reprint author), MONASH UNIV,DEPT ELECT & COMP SYST ENGN,CLAYTON,VIC 3168,AUSTRALIA.
OI Suter, David/0000-0001-6306-3023
NR 0
TC 10
Z9 10
U1 0
U2 0
PU I E E E, COMPUTER SOC PRESS
PI LOS ALAMITOS
PA 10662 LOS VAQUEROS CIRCLE, LOS ALAMITOS, CA 90720
BN 0-8186-8040-7
PY 1997
BP 120
EP 127
DI 10.1109/NAMW.1997.609862
PG 2
WC Computer Science, Artificial Intelligence
SC Computer Science
GA BJ14K
UT WOS:A1997BJ14K00014
DA 2018-10-20
ER

PT B
AU He, BL
   Ma, JB
AF He, BL
   Ma, JB
GP INST POLYM CHEM
TI Novel polymeric adsorbents as biomedical materials for blood
   purification
SO INTERNATIONAL CONFERENCE ON BIORELATED POLYMERS CONTROLLED RELEASE DRUGS
   AND REACTIVE POLYMERS
LA English
DT Proceedings Paper
CT International Conference on Biorelated Polymers Controlled Release Drugs
   and Reactive Polymers
CY MAY 08-11, 1997
CL XIAN, PEOPLES R CHINA
SP Chinese Chem Soc, Beijing, China, Nankai Univ, Tianjin, China, Wuhan Univ, Wuhan, China, Beijing Univ, Beijing, China, Funct Polym Mat Adsorpt & Separat, State Key Lab, Tianjin, China, Natl Nat Sci Fdn China, State Educ Commiss China
AB In this brief review it is summarized the recent development of polymeric adsorbents for blood purification in our laboratory. The researches on the polymeric adsorbents for adsorption of small organic molecules, middle molecular substance, and biological macromolecules from the blood have been carried out for nearly two decades. Some adsorbents with perfect adsorption properties and good biocompatibility have been prepared and begun to apply in clinical hemoperfusion.
   Blood carries the nutrients to the tissues of human body and brings the wastes over to the liver and kidney for metabolism and excrement while it is circulated all over the body. Once the liver or kidney or the immune system is in disorder or in failure, some excessive chemical components, including small molecules, middle molecular substances, and biological macromolecules; would be accumulated in blood and cause many kinds of diseases. In addition, an excess or wrong intrusion of toxic chemicals such as soporifics, anesthetics, pesticides, and so on would cause a patient poisoned. All excessive substances, whether they are endogenous or exogenous: can be eliminated via extracorporeal circulation of blood either by hemodialysis, hemofiltration, hemoperfusion or by plasma exchange. In hemoperfusion, adsorbents play a key role for removing toxic chemicals from blood. Their structures can be designed and synthesized to fit every actual case of diseases. Since the end of 1970s, polymeric adsorbents for blood purification have been studied in our laboratory for adsorption of small molecules, middle molecular substances. and even biological macromolecules. Some perfect results are briefly reviewed as follows.
RP He, BL (reprint author), NANKAI UNIV,INST POLYMER CHEM,STATE KEY LAB FUNCT POLYMER MAT ADSORPT & SEPARAT,TIANJIN 300071,PEOPLES R CHINA.
NR 0
TC 0
Z9 0
U1 1
U2 2
PU INSTITUTE POLYMER CHEMISTRY
PI TIANJIN
PA NANKAI UNIVERSITY, TIANJIN 300071, PEOPLES R CHINA
PY 1997
BP 7
EP 14
PG 8
WC Biotechnology & Applied Microbiology; Chemistry, Applied; Chemistry,
   Medicinal; Engineering, Chemical; Pharmacology & Pharmacy; Polymer
   Science
SC Biotechnology & Applied Microbiology; Chemistry; Pharmacology &
   Pharmacy; Engineering; Polymer Science
GA BJ47W
UT WOS:A1997BJ47W00004
DA 2018-10-20
ER

PT J
AU Kawashima, K
   Sato, H
AF Kawashima, K
   Sato, H
TI Calcium effect on the membrane preparation of segmented
   poly(ether/urethane/amide) (PEUN) as a biomedical material
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE polyether urethane amide (PEUN); calcium chloride; solution and
   mechanical properties; permeability; biocompatibility
ID BIOMIMETIC PROCESS; ORGANIC POLYMERS; POLYURETHANE; ADSORPTION;
   PROTEINS; SURFACES
AB Poly(ether/urethane/amide) (PEUN), a segmented polyurethane, was characterized concerning phase relationship, viscosity in solution, hydraulic permeability, mechanical properties, and in vivo biocompatibility with tissue and blood. PEUN was dissolved at the highest concentration of 0.5% in N,N-dimethylformamide (DMF). Addition of calcium chloride at concentrations up to 3.1% progressively increased the solubility of PEUN in DME PEUN2 membrane was prepared by casting from mixtures of PEUN, 3% calcium chloride, and DMF, from which calcium chloride was sufficiently removed. The PEUN2 membrane thus obtained was compared with PEUN membrane which was prepared by casting from DMF solution without the addition of calcium chloride. The water permeability across PEUN2 membrane was higher than that across PEUN membrane. PEUN2 membrane in the swollen state exhibited a lower tensile modulus and much greater elastic property than PEUN membrane. Tissue compatibility of PEUN2 membrane was better than that of PEUN membrane. Thromboresistance of PEUN membrane was good, while PEUN2-coated surface was thrombogenic to some extent in vivo. Our characterization suggested that PEUN2 membrane is more hydrophilic than PEUN membrane, possibly because of the assembly of polar groups on the segments of PEUN molecules which show affinity to calcium chloride in membrane processing.
C1 KYOTO UNIV,DEPT POLYMER CHEM,KYOTO 60601,JAPAN.
CR BALASUBRAMANIAN D, 1975, BIOPOLYMERS, V14, P1019, DOI 10.1002/bip.1975.360140510
   Boretos J W, 1971, J Biomed Mater Res, V5, P373, DOI 10.1002/jbm.820050408
   BORETOS JW, 1972, J BIOMED MATER RES, V6, P473, DOI 10.1002/jbm.820060513
   BORETOS JW, 1967, SCIENCE, V158, P1481, DOI 10.1126/science.158.3807.1481
   Colman RW, 1987, HEMOSTASIS THROMBOSI
   Fung YC, 1984, BIOMECHANICS
   GRASEL TG, 1987, J BIOMED MATER RES, V21, P815, DOI 10.1002/jbm.820210702
   HASEGAWA M, 1981, J SOC RHEOL JAP, V9, P9
   HILBERT SL, 1987, J THORAC CARDIOV SUR, V94, P419
   KAWABATA S, 1988, P 4 JAP US C COMP MA, V4, P253
   KIMURA I, 1974, MACROMOLECULES, V7, P355, DOI 10.1021/ma60039a018
   NAGAOKA S, 1982, THESIS KYOTO U
   NOISHIKI Y, 1980, JPN J ARTIF ORGANS, V9, P678
   SAKAI Y, 1978, J APPL POLYM SCI, V22, P1085
   SATO H, 1985, J BIOMED MATER RES, V19, P1135, DOI 10.1002/jbm.820190921
   SATO H, 1984, POLYM J, V16, P1, DOI 10.1295/polymj.16.1
   SATO H, 1993, J DISPER SCI TECHNOL, V14, P117, DOI 10.1080/01932699308943390
   SATO H, 1987, ACS SYM SER, V343, P76
   TAKAHARA A, 1982, KOBUNSHI RONBUNSHU, V39, P203, DOI 10.1295/koron.39.203
   TANAHASHI M, 1994, J AM CERAM SOC, V77, P2805, DOI 10.1111/j.1151-2916.1994.tb04508.x
   TANAHASHI M, 1995, J BIOMED MATER RES, V29, P349, DOI 10.1002/jbm.820290310
   WALSER M, 1961, J CLIN INVEST, V40, P723, DOI 10.1172/JCI104306
   WHALEM RL, 1980, T AM SOC ART INT ORG, V24, P487
   WILKES GL, 1979, J BIOMED MATER RES, V13, P189, DOI 10.1002/jbm.820130204
   YASUDA H, 1971, J POLYM SCI A2, V9, P1537, DOI 10.1002/pol.1971.160090901
   YASUDA H, 1971, J POLYM SCI A2, V9, P1117, DOI 10.1002/pol.1971.160090608
NR 26
TC 0
Z9 0
U1 0
U2 2
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 1997
VL 8
IS 6
BP 467
EP 480
DI 10.1163/156856297X00399
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA WY732
UT WOS:A1997WY73200005
PM 9151194
DA 2018-10-20
ER

PT J
AU Bruck, SD
AF Bruck, SD
TI Current and future directions of biomedical materials research
SO JOURNAL OF LONG-TERM EFFECTS OF MEDICAL IMPLANTS
LA English
DT Editorial Material
DE biomaterials; polymers; implants; medical devices; directions;
   biomedical materials research
AB Biomedical materials and implants are not synonymous. Materials pw se are not implanted-after configuring, processing, and finishing operations, they constitute parts of implants and other devices. The U.S. Food and Drug Administration currently does not ''approve'' biomaterials; rather, it approves medical devices, biologicals, and drugs. There have been important advances during the past 40 years in the clinical uses of medical implants and other devices, especially in ophthalmology, cardiology, orthopaedics, surgery, and dialysis. In the 21st Century, there will be increased emphasis on curing and preventing major genetic diseases. There will be many nontraditional clinical applications of biomaterials, such as viral-and nonviral-mediated delivery agents in gene therapy, synthetic biomaterials with pharmacologic effects, and biomaterials that can integrate with the biological system to form a long-term, living, renewable interface with prosthetic implants. Therefore, those working in the field of biomaterials must become familiar with new molecular biological techniques and be able to collaborate effectively with molecular biologists.
RP Bruck, SD (reprint author), STEPHEN D BRUCK ASSOCIATES INC,BIOMAT & MED DEVICES CONSULTING GRP,9 FENTON PL,CHAPEL HILL,NC 27514, USA.
CR BRUCK SD, 1990, INT J ARTIF ORGANS, V13, P39
   BRUCK SD, 1990, S BIOC POL POL SCI M
   *NIH, 1982, BIOM CONS C
   Williams D. F., 1987, DEFINITIONS BIOMATER
NR 4
TC 0
Z9 0
U1 0
U2 2
PU BEGELL HOUSE INC
PI NEW YORK
PA 79 MADISON AVE, SUITE 1205, NEW YORK, NY 10016-7892
SN 1050-6934
J9 J LONG-TERM EFF MED
JI J. Long-Term Eff. Med. Implants
PY 1997
VL 7
IS 2
BP 115
EP 117
PG 3
WC Engineering, Biomedical; Medicine, Research & Experimental; Orthopedics;
   Pathology
SC Engineering; Research & Experimental Medicine; Orthopedics; Pathology
GA YA462
UT WOS:A1997YA46200001
PM 10174267
DA 2018-10-20
ER

PT J
AU Kontou, E
   Spathis, G
   Kavadias, C
AF Kontou, E
   Spathis, G
   Kavadias, C
TI Viscoplastic behaviour of PMMA blends - The effect of moisture
   absorption
SO JOURNAL OF REINFORCED PLASTICS AND COMPOSITES
LA English
DT Article
ID MECHANICAL-PROPERTIES; THERMAL-EXPANSION; GLASSY-POLYMERS
AB The mechanical properties of a polymeric blend based on PMMA and Poly(butyl methacrylate, methylmethacrylate) were studied. This mixture is the main component of the so-called bone cement used for various biomedical applications. Different types of samples have been prepared with varying the antibiotic content. The compressive stress-strain behaviour has been studied at various strain rates, before and after immersion in water at 37 degrees C, simulating in this way the physiological environment of these materials. Moreover, thermal expansion coefficient tests were carried out in order to check the dimensional stability of the materials examined.
RP Kontou, E (reprint author), NATL TECH UNIV ATHENS,DEPT THEORET & APPL MECH,GR-15773 ATHENS,GREECE.
CR ADAM G, 1965, J CHEM PHYS, V43, P139, DOI 10.1063/1.1696442
   ADAMSON MJ, 1980, J MATER SCI, V15, P1736, DOI 10.1007/BF00550593
   ARGON AS, 1977, PHILOS MAG, V35, P917, DOI 10.1080/14786437708232634
   BECKENBAUGH RD, 1978, J BONE JOINT SURG AM, V60, P306, DOI 10.2106/00004623-197860030-00005
   BOYCE MC, 1988, MECH MATER, V7, P15, DOI 10.1016/0167-6636(88)90003-8
   BRAND J, 1977, IPCTTP152
   DROTNING WD, 1989, J MATER SCI, V24, P3137, DOI 10.1007/BF01139031
   HAWARD RN, 1968, PROC R SOC LON SER-A, V302, P453, DOI 10.1098/rspa.1968.0029
   HAWARD RN, 1973, PHYSICS GLASSY POLYM
   HOPE PS, 1980, J APPL POLYM SCI, V25, P1373, DOI 10.1002/app.1980.070250711
   HOPE PS, 1980, J MATER SCI, V15, P2207, DOI 10.1007/BF00552308
   JOHNSON JA, 1994, J MATER SCI, V29, P870, DOI 10.1007/BF00351404
   KRAUSE W, 1988, J BIOMED MATER RES-A, V22, P37
   Matsuoka S., 1992, RELAXATION PHENOMENA
   SAHA S, 1984, J BIOMED MATER RES, V18, P435, DOI 10.1002/jbm.820180411
   SMITH LSA, 1988, POLYMER, V29, P1871, DOI 10.1016/0032-3861(88)90405-3
   STAFFORD GD, 1983, J DENT, V11, P294, DOI 10.1016/0300-5712(83)90113-6
   STRUIK LCE, 1991, J NON-CRYST SOLIDS, V131, P395, DOI 10.1016/0022-3093(91)90333-2
   YOSHIOKA S, 1994, J NONCRYSTALLINE SOL, V171, P765
NR 19
TC 1
Z9 1
U1 0
U2 2
PU TECHNOMIC PUBL CO INC
PI LANCASTER
PA 851 NEW HOLLAND AVE, BOX 3535, LANCASTER, PA 17604
SN 0731-6844
J9 J REINF PLAST COMP
JI J. Reinf. Plast. Compos.
PY 1997
VL 16
IS 4
BP 306
EP 320
DI 10.1177/073168449701600402
PG 15
WC Materials Science, Composites; Polymer Science
SC Materials Science; Polymer Science
GA WR684
UT WOS:A1997WR68400002
DA 2018-10-20
ER

PT S
AU Hussain, I
   Kumar, A
   Mangiaracina, A
   Perlaky, SC
   McCombs, CC
   Zhong, F
   Weimer, JJ
   Sanderson, L
AF Hussain, I
   Kumar, A
   Mangiaracina, A
   Perlaky, SC
   McCombs, CC
   Zhong, F
   Weimer, JJ
   Sanderson, L
BE George, EP
   Gotthardt, R
   Otsuka, K
   TrolierMcKinstry, S
   WunFogle, M
TI Fabrication of piezoelectric sensors for biomedical applications
SO MATERIALS FOR SMART SYSTEMS II
SE MATERIALS RESEARCH SOCIETY SYMPOSIUM PROCEEDINGS
LA English
DT Proceedings Paper
CT Symposium on Materials for Smart Systems II, at the 1996 MRS Fall
   Meeting
CY DEC 02-05, 1996
CL BOSTON, MA
SP Mat Res Soc, USA Res Off, Furukawa Elect Co Ltd, Oak Ridge Natl Lab, PIOLAX Inc
AB Biosensors are a special class of chemical sensors that take advantage of the high selectivity and sensitivity of biologically active material. We are currently investigating the characteristics of various deposited electrode coatings (Au and Pt) on 10 MHz quartz crystals using the sputtering method. We are also investigating the effect of magnetic behavior (by intermixing Fe and Ni with electrodes) on the binding nature of antigen with the substrate. A change in mass occurs due to the binding of antigens and antibodies on the surface of the thin film coating. The frequency change as a result of a change in mass makes it possible to use these crystals as biological sensor devices. This paper describes the construction of antibody-based piezoelectric crystals capable of detecting mycobacterial antigens in diluted cultures of attenuated PA. tuberculosis. The microstructural features of these crystals have been studied using scanning electron microscopy (SEM) and atomic force microscopy (AFM) techniques. The crystallographic properties have been characterized using the X-ray diffraction (XRD) method. The long term objective of this research is to develop a rapid quantitative method of analysis for the diagnosis of tuberculosis (TB) and other infections caused by mycobacteria, using biosensor technology.
RP Hussain, I (reprint author), UNIV S ALABAMA,DEPT ELECT ENGN,MOBILE,AL 36688, USA.
OI Weimer, Jeffrey/0000-0002-3460-4000
NR 0
TC 0
Z9 0
U1 0
U2 2
PU MATERIALS RESEARCH SOCIETY
PI WARRENDALE
PA 506 KEYSTONE DRIVE, WARRENDALE, PA 15088-7563
SN 0272-9172
BN 1-55899-363-0
J9 MATER RES SOC SYMP P
PY 1997
VL 459
BP 501
EP 506
PG 6
WC Materials Science, Multidisciplinary; Materials Science, Coatings &
   Films; Materials Science, Composites
SC Materials Science
GA BH71E
UT WOS:A1997BH71E00071
DA 2018-10-20
ER

PT S
AU Lotters, JC
   Olthuis, W
   Veltink, PH
   Bergveld, P
AF Lotters, JC
   Olthuis, W
   Veltink, PH
   Bergveld, P
GP IEEE
TI Theory, technology and assembly of a highly symmetrical capacitive
   triaxial accelerometer
SO MEMS 97, PROCEEDINGS - IEEE THE TENTH ANNUAL INTERNATIONAL WORKSHOP ON
   MICRO ELECTRO MECHANICAL SYSTEMS: AN INVESTIGATION OF MICRO STRUCTURES,
   SENSORS, ACTUATORS, MACHINES AND ROBOTS
SE PROCEEDINGS: IEEE MICRO ELECTRO MECHANICAL SYSTEMS WORKSHOP
LA English
DT Proceedings Paper
CT IEEE 10th Annual International Workshop on Micro Electro Mechanical
   Systems
CY JAN 26-30, 1997
CL NAGOYA, JAPAN
SP IEEE Robot & Automat Soc, ASME Dynam Syst & Control Div, ASME Micromachine Ctr
AB A highly symmetrical cubic easy-to-assemble capacitive triaxial accelerometer for biomedical applications has been designed, realized and tested. The outer dimensions of the sensor are 5 x 5 x 5 mm(3) and the device is mounted on a standard IC package. New aspects of the sensor are an easy assembly procedure, the use of the polymers polydimethylsiloxane (PDMS) as spring material between the capacitor plates and the mass and polyimide (PI) as flexible interconnection layer between the capacitor plates, and the highly symmetrical cubic structure. The mathematical model, technology and assembly procedure of the sensor are described. The measurement results show a good linearity in the output voltage for accelerations up to at least 5 g and a bandwidth of DC - > 50 Hz. In the x-axis the sensitivity was found to be 175 mV/g which is in good correspondence with the theory. The sensitivity can be increased when the PDMS layer is patterned, which was shown in previous versions of the highly symmetrical triaxial accelerometer.
RP Lotters, JC (reprint author), UNIV TWENTE,MESA RES INST,POB 217,NL-7500 AE ENSCHEDE,NETHERLANDS.
RI Veltink, Peter/L-3738-2016
OI Veltink, Peter/0000-0002-1796-9999
NR 0
TC 5
Z9 5
U1 0
U2 1
PU I E E E
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017
SN 1084-6999
BN 0-7803-3745-X
J9 PROC IEEE MICR ELECT
PY 1997
BP 31
EP 36
DI 10.1109/MEMSYS.1997.581760
PG 6
WC Automation & Control Systems; Engineering, Multidisciplinary;
   Engineering, Electrical & Electronic; Engineering, Mechanical
SC Automation & Control Systems; Engineering
GA BH55X
UT WOS:A1997BH55X00006
DA 2018-10-20
ER

PT B
AU Gourley, PL
   McDonald, AE
AF Gourley, PL
   McDonald, AE
BE Gourley, PL
   Katzir, A
TI Semiconductor microlasers with intracavity microfluidics for biomedical
   applications
SO MICRO- AND NANOFABRICATED ELECTRO-OPTICAL MECHANICAL SYSTEMS FOR
   BIOMEDICAL AND ENVIRONMENTAL APPLICATIONS, PROCEEDINGS OF
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT 1st SPIE Conference on Microfabricated and Nanofabricated
   Electro-Optical Mechanical Systems for Biomedical and Environmental
   Applications
CY FEB 10-11, 1997
CL SAN JOSE, CA
SP Soc Photo Opt Instrumentat Engineers
DE microfabrication; microfluidics; semiconductors; glass; microcavities;
   lasers; spectroscopy; biomedical; cells; surface tension; capillarity;
   micro-optical-electrical-mechanical systems
AB Microfrabricated electro-optical-mechanical systems are expected to play an important role in future biomedical, biochemical and environmental technologies. Semiconductor photonic materials and devices are attractive components of such systems because of their ability to generate, transmit, modulate, and detect light. In this paper we report investigations of light-emitting semiconductor/glass microcavities filled with simple fluids. We examine surface tension for transporting liquids into the intracavity space and study the influence of the liquid on the spectral emission of the microcavity.
RP Gourley, PL (reprint author), SANDIA NATL LABS,POB 5800,ALBUQUERQUE,NM 87185, USA.
NR 0
TC 3
Z9 3
U1 0
U2 2
PU SPIE - INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA PO BOX 10, BELLINGHAM, WA 98227-0010
BN 0-8194-2389-0
J9 P SOC PHOTO-OPT INS
PY 1997
VL 2978
BP 186
EP 196
DI 10.1117/12.269968
PG 3
WC Engineering, Biomedical; Engineering, Electrical & Electronic; Optics
SC Engineering; Optics
GA BH52D
UT WOS:A1997BH52D00023
DA 2018-10-20
ER

PT B
AU Gourley, MF
   Gourley, PL
AF Gourley, MF
   Gourley, PL
BE Gourley, PL
   Katzir, A
TI Integration of electro-optical mechanical systems and medicine: Where
   are we and where can we go?
SO MICRO- AND NANOFABRICATED ELECTRO-OPTICAL MECHANICAL SYSTEMS FOR
   BIOMEDICAL AND ENVIRONMENTAL APPLICATIONS, PROCEEDINGS OF
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT 1st SPIE Conference on Microfabricated and Nanofabricated
   Electro-Optical Mechanical Systems for Biomedical and Environmental
   Applications
CY FEB 10-11, 1997
CL SAN JOSE, CA
SP Soc Photo Opt Instrumentat Engineers
DE biomedical; analysis; DNA; flow cytometry; microelectromechanical
   systems; Microchip; DNA amplification; fluorescent activated cell
   sorting; diagnosis; medicine
AB The marriage of microfabricated materials with microbiological systems will allow advances in medicine to proceed at an unprecedented pace. Biomedical research is placing new demands on speed and limits of detection to assay body tissues and fluids. Emerging microfabricated chip technologies from the engineering community offer researchers novel types of analysis of human samples. In guiding these developments, the ability to swiftly and accurately gain useful information for identification and establish a diagnosis, is of utmost importance. Current examples of such technology include DNA amplification and analysis, and fluorescent cell analysis by flow cytometry. Potential applications include the development of rapid techniques for examining large number of cells in tissue or in blood. These could serve as screening tools for the detection and quantification of abnormal cell types; for example malignant or HIV infected cells. Micro/Nanofabrication methods will make these devices compact, providing access of this technology to point of care providers; in a clinic, ambulance, or on a battlefield. Currently, these tools are in the construction phase. Upon delivery to researchers, validation of these instruments will lead to clinical demand that requires approval from the Food and Drug Administration. This paper will outline criteria that successful devices must satisfy.
RP Gourley, MF (reprint author), WASHINGTON HOSP CTR,WASHINGTON,DC 20010, USA.
NR 0
TC 1
Z9 1
U1 0
U2 0
PU SPIE - INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA PO BOX 10, BELLINGHAM, WA 98227-0010
BN 0-8194-2389-0
J9 P SOC PHOTO-OPT INS
PY 1997
VL 2978
BP 197
EP 204
DI 10.1117/12.269969
PG 4
WC Engineering, Biomedical; Engineering, Electrical & Electronic; Optics
SC Engineering; Optics
GA BH52D
UT WOS:A1997BH52D00024
DA 2018-10-20
ER

PT J
AU McCarthy, DW
   Shefer, RE
   Klinkowstein, RE
   Bass, LA
   Margeneau, WH
   Cutler, CS
   Anderson, CJ
   Welch, MJ
AF McCarthy, DW
   Shefer, RE
   Klinkowstein, RE
   Bass, LA
   Margeneau, WH
   Cutler, CS
   Anderson, CJ
   Welch, MJ
TI Efficient production of high specific activity Cu-64 using a biomedical
   cyclotron
SO NUCLEAR MEDICINE AND BIOLOGY
LA English
DT Article
DE PET; Cu-64; production; cyclotron; targetry; Ni-64
ID POSITRON EMISSION TOMOGRAPHY; EXCITATION-FUNCTIONS; MONOCLONAL-ANTIBODY;
   COLORECTAL-CARCINOMA; COPPER-PTSM; PET TRACER; BLOOD-FLOW; MAB 1A3;
   RADIOIMMUNOTHERAPY; PERFUSION
AB Copper-64 (T-1/2 = 12.7 h) is an intermediate lived positron emitting radionuclide that is a useful radiotracer for positron emission tomography (PET) as well as a promising radiotherapy agent for the treatment for cancer. Currently, copper-64 suitable for biomedical studies is produced in the fast neutron flux trap (irradiation of zinc with fast neutrons) at the Missouri University Research Reactor. Access to the fast neutron flux trap is only possible on a weekly basis, making the availability of this tracer very limited. In order to significantly increase the availability of this intermediate-lived radiotracer, we have investigated and developed a method for the efficient production of high specific activity Cu-64 using a small biomedical cyclotron.
   It has been suggested that it may be possible to produce Cu-64 on a small biomedical cyclotron utilizing the Ni-64(p,n)(CU)-C-64 nuclear reaction. We have irradiated both natural nickel and enriched (95% and 98%) Ni-64 plated on gold disks. Nickel has been electroplated successfully at thicknesses of similar to 20-300 mm and bombarded with proton currents of 15-45 mu A A Special water-cooled target had been designed to facilitate the irradiations on a biomedical cyclotron up to 60 mu A.
   We have shown that it is possible to separate Cu-64 from Ni-64 and other reaction byproducts rapidly and efficiently by using ion exchange chromatography. Production runs using 19-55 mg of 95% enriched Ni-64 have yielded 150-600 mCi of Cu-64 (2.3-5.0 mCi/mu Ah) with specific activities of 94-310 mCi/mu g Cu. The cyclotron produced Cu-64 had been used to radiolabel PTSM [pyruvaldehyde bis-(N-4- methylthiosemicarbazone), used to quantify myocardial, cerebral, renal, and tumor blood flow], MAb 1A3 [monoclonal antibody MAb to colon cancer], and octreotide. A recycling technique for the costly Ni-64 target material has been developed. This technique allows the nickel eluted off the column to be recovered and reused in the electroplating of new targets with an overall efficiency of greater than 90%. Copyright (C) 1997 Elsevire Science Inc.
C1 WASHINGTON UNIV,SCH MED,EDWARD MALLINCKRODT INST RADIOL,ST LOUIS,MO 63110.
   NEWTON SCI INC,WINCHESTER,MA 01890.
OI Anderson, Carolyn/0000-0002-5663-282X
FU NCI NIH HHS [R43-CA66411-01]
CR Anderson C. J., 1996, Journal of Nuclear Medicine, V37, p128P
   ANDERSON CJ, 1995, J NUCL MED, V36, P2315
   ANDERSON CJ, 1995, J NUCL MED, V36, P850
   ANDERSON CJ, 1994, J NUCL MED, V35, pP161
   ANDERSON CJ, 1992, J NUCL MED, V33, P1685
   ANDERSON CJ, 1993, J NUCL MED, V34, pP134
   CLARKE ET, 1991, INORG CHIM ACTA, V190, P36
   Connett J. M., 1995, Journal of Nuclear Medicine, V36, p92P
   CONNETT JM, 1993, J NUCL MED, V34, pP216
   HERR W, 1950, Z NATURFORSCH A, V5, P629
   HERRERO P, 1993, CIRCULATION, V87, P173, DOI 10.1161/01.CIR.87.1.173
   *INT AT EN AG, 1971, 128 IAEA, P164
   KIRBY LJ, 1961, RADIOCHEMISTRY NICKE
   Lynn KG, 1987, NATO ASI SER B, VB169, P161
   MATHIAS CJ, 1991, NUCL MED BIOL, V18, P807
   MATHIAS CJ, 1990, J NUCL MED, V31, P351
   MAZIERE B, 1983, INT J APPL RADIAT IS, V34, P595, DOI 10.1016/0020-708X(83)90061-3
   NICKLES R J, 1991, Journal of Labelled Compounds and Radiopharmaceuticals, V30, P120
   Philpott G. W., 1995, Journal of Nuclear Medicine, V36, p9P
   PHILPOTT GW, 1995, J NUCL MED, V36, P1818
   PIEL H, 1992, RADIOCHIM ACTA, V57, P1
   SEVIOR ME, 1983, AUST J PHYS, V36, P463, DOI 10.1071/PH830463
   SHEFER RE, 1992, P 4 INT WORKSH TARG
   SHELTON ME, 1989, J NUCL MED, V30, P1843
   SZELECSENYI F, 1993, APPL RADIAT ISOTOPES, V44, P575, DOI 10.1016/0969-8043(93)90172-7
   WEBER DA, 1989, MIRD RADIONUCLIDE DA
   WELCH MJ, 1988, RADIOLABELED MONOCLO, P261
   ZINN KR, 1993, J NUCL MED, V34, pP238
   ZWEIT J, 1991, APPL RADIAT ISOTOPES, V42, P193
NR 29
TC 378
Z9 381
U1 0
U2 39
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
SN 0883-2897
J9 NUCL MED BIOL
JI Nucl. Med. Biol.
PD JAN
PY 1997
VL 24
IS 1
BP 35
EP 43
DI 10.1016/S0969-8051(96)00157-6
PG 9
WC Radiology, Nuclear Medicine & Medical Imaging
SC Radiology, Nuclear Medicine & Medical Imaging
GA WK820
UT WOS:A1997WK82000006
PM 9080473
DA 2018-10-20
ER

PT B
AU DellaVecchia, MA
   Beard, RB
   Dai, X
   Priezzhev, AV
AF DellaVecchia, MA
   Beard, RB
   Dai, X
   Priezzhev, AV
BE Priezzhev, AV
   Asakura, T
   Leif, RC
   Katzir, A
TI Method for the measurements of photonic effects on blood
SO OPTICAL DIAGNOSTICS OF BIOLOGICAL FLUIDS AND ADVANCED TECHNIQUES IN
   ANALYTICAL CYTOLOGY, PROCEEDINGS OF
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Conference on Optical Diagnostics of Biological Fluids and Advanced
   Techniques in Analytical Cytology
CY FEB 11-14, 1997
CL SAN JOSE, CA
SP Int Biomed Opt Soc, Soc Photo Opt Instrumentat Engineers, Amer Soc Laser Med & Surg Inc
DE terminology; leukocyte; polymorphonuclear; mononuclear; erythrocyte;
   cytotaxis; chemotaxis
AB At the Department of Biomedical Engineering of Drexel University, the study of the reactivity of human white blood cells (leukocytes) had been undertaken originally for biocompatibility measurements. Acute (polymorphonuclear) and chronic (mononuclear) inflammatory white blood cells (leukocytes) have been studied for their response to chemoattractant and chemorepellant implantable materials. Further experiments have lead to the enhancement and retardation of this cytotaxis via electromagnetic fields. These techniques are now being adapted to study the photonic effects of leukocytes.
   Human whole blood is attained through sterile peripheral vacuum venipuncture technique. The whole blood is separated to isolated the white blood cell series using a Sigma Procedure No. 1119. The erythrocytes are lysed and through a series of steps the leukocytes are further isolated to produce a sample of polymorphonuclear (PMN) or mononuclear (MN) leukocytes.
   The leukocytic samples are then placed within a Boyden chamber or an agarose plate. The experiments were conducted in an enclosed incubator to maintain temperature and to isolated light exposure. A control experiment is conducted with a standard chemattractant such as Formyl-L-Methionyl-L-Leucyl-L Phenylalanine. A similar experiment may then be conducted analogous to this control, with the introduction of light of varying intensity or frequency as an experimental variable. The effect of light as a variable in the experiment is then measured as a function of the leukocyte cell migration. This can be measured by direct microscopy or by computer analysis. Results are expressed as a ratio of the variable migration distance divided by the controlled migration distance.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU SPIE - INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA PO BOX 10, BELLINGHAM, WA 98227-0010
BN 0-8194-2393-9
J9 P SOC PHOTO-OPT INS
PY 1997
VL 2982
BP 271
EP 283
DI 10.1117/12.273624
PG 13
WC Engineering, Biomedical; Medical Laboratory Technology; Optics
SC Engineering; Medical Laboratory Technology; Optics
GA BH79V
UT WOS:A1997BH79V00032
DA 2018-10-20
ER

PT S
AU Tsuruta, T
AF Tsuruta, T
TI Contemporary topics in polymeric materials for biomedical applications
   (vol 126, pg 1, 1996)
SO POLYMER SYNTHESIS / POLYMER CATALYSIS
SE Advances in Polymer Science
LA English
DT Correction
CR Tsuruta T, 1996, ADV POLYM SCI, V126, P1
NR 1
TC 0
Z9 0
U1 0
U2 1
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
SN 0065-3195
BN 3-540-61288-2
J9 ADV POLYM SCI
JI Adv. Polym. Sci.
PY 1997
VL 127
BP U7
EP U7
PG 1
WC Polymer Science
SC Polymer Science
GA BG42C
UT WOS:A1997BG42C00001
DA 2018-10-20
ER

PT J
AU Ravaglioli, A
   Krajewski, A
AF Ravaglioli, A
   Krajewski, A
TI Implantable porous bioceramics
SO POROUS MATERIALS FOR TISSUE ENGINEERING
SE MATERIALS SCIENCE FORUM
LA English
DT Article
DE bioceramic(s); ceramic(s); porous ceramic; porosity
AB Ceramic materials are more and more object of interest in biomedical field for their peculiar biological performances. Their mechanical behaviour (e.g. hardness, compressive resistance, tribology) and their chemical properties are the main parameters considered for production of devices to adopt in many surgical applications, in particular concerning skeletal implants. These materials exhibit two different types of biological behaviour: inert or bioactive. Inert ceramics have good tolerability but no influence on surrounding tissue(s); on the contrary bioactive ones are even able to influence bone growth. They include also resorbable materials which find application in both soft and hard tissues.
   The introduction of porosity in a ceramic body allow the enlargement of the number of possible applications in the biomedical field. With some renounces on the side of mechanical performances, porous ceramic can find application when trapping of biological products is the main target, thanks the general good performances of their surface physical properties. In the following a topic on their production and possibility of application and limits is matter of discussion.
C1 CNR, IRTEC, I-48018 Faenza, Italy.
RP Ravaglioli, A (reprint author), CNR, IRTEC, Via Granarola 64, I-48018 Faenza, Italy.
CR Braunauer S, 1938, J AM CHEM SOC, V60, P309
   GIBBS JW, COLLECTED WORKS
   JOYNER LG, 1948, J AM CHEM SOC, V73, P2359
   JUHOLA AJ, 1952, J AM CHEM SOC, V74, P61, DOI 10.1021/ja01121a015
   RITTER HL, 1945, IND ENG CHEM, V17, P782, DOI 10.1021/i560148a013
   Washburn EW, 1921, P NATL ACAD SCI USA, V7, P115, DOI 10.1073/pnas.7.4.115
   WASHBURN EW, 1922, J AM CERAM SOC, V4, P983
NR 7
TC 14
Z9 14
U1 0
U2 5
PU TRANSTEC PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 0255-5476
J9 MATER SCI FORUM
PY 1997
VL 250
BP 221
EP 230
DI 10.4028/www.scientific.net/MSF.250.221
PG 10
WC Materials Science, Multidisciplinary
SC Materials Science
GA BK32D
UT WOS:000071779800014
DA 2018-10-20
ER

PT B
AU Hong, HD
   Sheffer, DB
   Loughry, CW
AF Hong, HD
   Sheffer, DB
   Loughry, CW
BE Benton, SA
   Trout, TJ
TI Holographic interferometry for detection of breast lesions
SO PRACTICAL HOLOGRAPHY XI AND HOLOGRAPHIC MATERIALS III
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Conference on Practical Holography XI and Holographic Materials III
CY FEB 10-11, 1997
CL SAN JOSE, CA
SP Soc Imaging Sci & Technol, Soc Photo Opt Instrumentat Engineers
DE holographic interferometry; breast lesions; ruby laser; holocamera;
   pressure stressing
AB Holographic Interferometry (HI) has been utilized in industry to inspect material for defects or the dynamic characteristics of a laminated structure(1). Application of the HI technique for biomedical diagnostic instrumentation was also reported(2-3). For detection of breast lesions, which could lead to breast cancer, we have utilized the HT technique to create a superficial fringe contour distortion over the underlying lesion. In the HI technique, an appropriate stressing mechanism is crucial to obtain proper density and contrast of fringe patterns. To apply pressure as the stressing mechanism, we have designed the Lucite pressure chamber to enclose both of the subject's breasts. Preliminary results have demonstrated the feasibility of fringe distortions occurring around breast lesions. The location of the possible lesions have been compared with an X-ray mammography.
RP Hong, HD (reprint author), AKRON CITY HOSP,BIOSTEREOMETR LAB,AKRON,OH 44304, USA.
NR 0
TC 1
Z9 1
U1 0
U2 0
PU SPIE - INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA PO BOX 10, BELLINGHAM, WA 98227-0010
BN 0-8194-2422-6
J9 P SOC PHOTO-OPT INS
PY 1997
VL 3011
BP 121
EP 130
DI 10.1117/12.271345
PG 10
WC Optics; Imaging Science & Photographic Technology
SC Optics; Imaging Science & Photographic Technology
GA BH70H
UT WOS:A1997BH70H00015
DA 2018-10-20
ER

PT B
AU Meenan, BJ
   Parker, M
   McAdams, ET
   Zhou, M
   McLaughlin, JA
   Anderson, JM
AF Meenan, BJ
   Parker, M
   McAdams, ET
   Zhou, M
   McLaughlin, JA
   Anderson, JM
BE Boom, H
   Robinson, C
   Rutten, W
   Neuman, M
   Wijkstra, H
TI Ultra-violet (UV) curable hydrogels for biomedical electrode
   applications
SO PROCEEDINGS OF THE 18TH ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE
   ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY, VOL 18, PTS 1-5
SE PROCEEDINGS OF THE ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE
   ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY
LA English
DT Proceedings Paper
CT 18th Annual International Conference of IEEE
   Engineering-in-Medicine-amd-Biology-Society
CY OCT 31-NOV 03, 1996
CL AMSTERDAM, NETHERLANDS
SP IEEE Engn Med & Biol Soc
AB UV curable hydrogel formulations based on a photoinitiated polymerization cross-linking process have been prepared and cured, The chosen system is found to result in a high degree of polymerization with significant attendant adhesive characteristics. A degree of control of the effective UV-curing of the photo-reactive hydrogel system is found to result from adjustments to the curing exposure duration and the distance from the source to the sample. Variation of the amount of the photoinitator is show to cause changes in the properties of the cured material. The effectiveness of deliberate changes in the viscosity of the solutions, prior to UV curing, caused by the addition of polyvinylpyrrolidone (PVP) have also been studied, Electrical resistivity values for the various solutions, before and after UV curing, have been calculated and found to be commensurate with good quality commercially available hydrogel adhesives.
C1 Univ Ulster, Sch Elect & Mech Engn, No Ireland Bioengn Ctr, Newtownabbey BT37 0QB, Co Antrim, North Ireland.
RP Meenan, BJ (reprint author), Univ Ulster, Sch Elect & Mech Engn, No Ireland Bioengn Ctr, Newtownabbey BT37 0QB, Co Antrim, North Ireland.
NR 0
TC 0
Z9 0
U1 1
U2 7
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 0-7803-3812-X
J9 P IEEE EMBS
PY 1997
VL 18
BP 104
EP 105
PG 2
WC Engineering, Biomedical
SC Engineering
GA BK41A
UT WOS:000072079000052
DA 2018-10-20
ER

PT B
AU Mabuchi, K
   Chinzei, T
   Fujimasa, I
AF Mabuchi, K
   Chinzei, T
   Fujimasa, I
BE Boom, H
   Robinson, C
   Rutten, W
   Neuman, M
   Wijkstra, H
TI Thermal endoscopic systems and their applications in the biomedical
   field
SO PROCEEDINGS OF THE 18TH ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE
   ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY, VOL 18, PTS 1-5
SE PROCEEDINGS OF THE ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE
   ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY
LA English
DT Proceedings Paper
CT 18th Annual International Conference of IEEE
   Engineering-in-Medicine-amd-Biology-Society
CY OCT 31-NOV 03, 1996
CL AMSTERDAM, NETHERLANDS
SP IEEE Engn Med & Biol Soc
AB Thermal endoscopic systems could provide not only useful information concerning abnormalities In spaces within tubular tissues or inside the body, but could also have other applications such as in emergency rescue situations. This project examined the possibility of developing endoscopic systems to produce thermal images using fibers and their bundles which can transmit infrared (IR) light, and investigated the feasibility of such systems. Athough it was possible to identify and observe the organs inside a subject's oral cavity and the viscella of experimental animals through the fiber bundle, the transmitted quality of the thermal images is still not good enough for diagnostic purposes. However, recent advances in infrared light detectors, the development of new materials for IR fibers, and improvements in the IR electronic endoscopic system should lead to the development of endoscopic systems for thermal images with the required temperature resolution in the near future.
C1 Univ Tokyo, Adv Sci & Technol Res Ctr, Meguro Ku, Tokyo 153, Japan.
RP Mabuchi, K (reprint author), Univ Tokyo, Adv Sci & Technol Res Ctr, Meguro Ku, 4-6-1 Komaba, Tokyo 153, Japan.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 0-7803-3812-X
J9 P IEEE EMBS
PY 1997
VL 18
BP 2103
EP 2104
PG 2
WC Engineering, Biomedical
SC Engineering
GA BK41A
UT WOS:000072079001017
DA 2018-10-20
ER

PT B
AU Petraitis, D
AF Petraitis, D
BE Boom, H
   Robinson, C
   Rutten, W
   Neuman, M
   Wijkstra, H
TI Silicone biomaterials
SO PROCEEDINGS OF THE 18TH ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE
   ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY, VOL 18, PTS 1-5
SE PROCEEDINGS OF THE ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE
   ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY
LA English
DT Proceedings Paper
CT 18th Annual International Conference of IEEE
   Engineering-in-Medicine-amd-Biology-Society
CY OCT 31-NOV 03, 1996
CL AMSTERDAM, NETHERLANDS
SP IEEE Engn Med & Biol Soc
AB Silicone polymers are of relatively recent invention and commercial production was started in the 1940's. Shortly thereafter it was found that glass surfaces treated with silicone fluid delayed the clotting of blood. By the mid-1950s medical applications of silicones had greatly increased and many studies of the biological properties of these materials were undertaken. Silicones are one of the most widely used and one of the most studied of all artificial materials for medical applications and no discussion of biomaterials is complete without their inclusion.
   This paper will give an overview of silicone chemistry including synthesis, types and curing mechanisms, followed by a review of some of the more important biomedical applications of these materials.
C1 NuSil Technol, Carpinteria, CA 93013 USA.
RP Petraitis, D (reprint author), NuSil Technol, 1050 Cindy Lane, Carpinteria, CA 93013 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 0-7803-3812-X
J9 P IEEE EMBS
PY 1997
VL 18
BP 2177
EP 2179
PG 3
WC Engineering, Biomedical
SC Engineering
GA BK41A
UT WOS:000072079001048
DA 2018-10-20
ER

PT S
AU Kramer, CD
   Kalla, EM
AF Kramer, CD
   Kalla, EM
BE Bumgardner, JD
   Puckett, AD
TI The challenge of designing biomedical equipment during human research
   for long duration low-gravity NASA missions
SO PROCEEDINGS OF THE 1997 16TH SOUTHERN BIOMEDICAL ENGINEERING CONFERENCE
SE SOUTHERN BIOMEDICAL ENGINEERING CONFERENCE. PROCEEDINGS
LA English
DT Proceedings Paper
CT 16th Southern Biomedical Engineering Conference
CY APR 04-06, 1997
CL BILOXI, MS
SP Mississippi State Univ, Dept Agr & Biol Engn, Univ Mississippi Med Ctr, Dept Restorat Dent Biomat Orthopaed Surg, Whitaker Fdn, Natl Sci Fdn, IEEE Engn Med & Biol Soc, Biomed Engn Soc, Inst Biol Engn, Soc Biomat
AB NASA has been studying human adaptation to low-gravity (zero-g) environments for several years, beginning with the first manned space flight in 1961. As both flight and scientific opportunities have steadily increased, NASA has advanced in the development of sophisticated human experiments. Difficulties encountered include the ability to preserve samples for extended duration flights and the development of flight certifiable biomedical hardware.
   A major challenge to the development of flight biomedical hardware is that it requires minimal power, must accommodate multi-usages, must meet material concern for small enclosed environments, be functional in space radiation environments, and possess minimal volume.
   Discussion will include the types of equipment development for use during previous NASA Space Shuttle missions, including the recent joint NASA/Russian mission flown of the Russian Space Station Mir. Also addressed will be the focus on future needs as NASA prepares for the International Space Station, Lunar Mars Exploration, and a dedicated Neuroscience Spacelab mission.
   All NASA Human Life Sciences experiments are managed at the Lyndon B. Johnson Space Center in Houston, Texas. Principal Investigators (PI's) from around the world have teamed up to perform experiments in a range of disciplines requiring international cooperation.
   Spacelab 1 (SLS-1) opened the door as the first Space Shuttle Spacelab Mission that was totally dedicated to Human Life Sciences research. Over 400 proposals were submitted in response to the 1978 Announcement of Opportunity, of which 20 experiments were selected. These 20 experiments were grouped into four disciplines: 1) Cardiopulmonary; 2) Musculoskeletal, 3) Neuroscience, and 4) Regulatory Physiology. The disciplines allowed sharing of common hardware and scientific data. Equipment required for Human Life Sciences experiments included: echocardiograph, venous occlusion cuff, bicycle ergometer, baroreflex cuff, cardiopulmonary rebreathing unit, gas analyzer, mass spectrometer, Bag in Box (mixing bag, oxygen bag, and exhaust bag), electronic control assemblies, pneumotachograph, blood sampling equipment, body mass measurement devices, urine sampling and measuring devices, rotating chair, accelerometer recording unit, electro-oculograph, rotating dome assembly, otolith-spinal reflex apparatus, centrifuge, incubators, physiological monitoring systems, systems for venous occlusion plethysmography (SVOP), strip chart recorder, video and data tape recorder, and a system for measurement of the central venous pressure (SMCVP).
   The above listed hardware outlines the enormous amount of equipment developed for space flight. Since SLS-1 other Human Life Sciences missions have been successfully accomplished including D-2, IML-1, IML-2, SLS-2, and the NASA/Mir missions.
   Future funded missions include the Neurolab mission (STS-90, March 1998), which is dedicated to the science of Neurology, the International Space Station, and NASA/Mir missions. Studies are currently in progress to meet the needs of the Lunar and Mars exploration. Known requirements for these missions will be addressed, emphasizing the need for biomedical engineers to focus not only on earth-bound medical treatment environments, but also, applications for research in the zero-g environment of space.
RP Kramer, CD (reprint author), NASA,JOHNSON SPACE CTR,BIOMED HARDWARE DEV & ENGN OFF,MAIL CODE EA5,HOUSTON,TX 77058, USA.
NR 0
TC 4
Z9 4
U1 0
U2 2
PU I E E E
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017
SN 1086-4105
BN 0-7803-3869-3
J9 SO BIOMM ENGN CONF P
PY 1997
BP 30
EP 37
DI 10.1109/SBEC.1997.583208
PG 8
WC Engineering, Biomedical
SC Engineering
GA BH56F
UT WOS:A1997BH56F00008
DA 2018-10-20
ER

PT S
AU Love, BJ
   Sabourin, E
   Shires, PK
   Freer, RJ
AF Love, BJ
   Sabourin, E
   Shires, PK
   Freer, RJ
BE Bumgardner, JD
   Puckett, AD
TI Compact disk educational supplements for biomaterials and biomedical
   education
SO PROCEEDINGS OF THE 1997 16TH SOUTHERN BIOMEDICAL ENGINEERING CONFERENCE
SE SOUTHERN BIOMEDICAL ENGINEERING CONFERENCE. PROCEEDINGS
LA English
DT Proceedings Paper
CT 16th Southern Biomedical Engineering Conference
CY APR 04-06, 1997
CL BILOXI, MS
SP Mississippi State Univ, Dept Agr & Biol Engn, Univ Mississippi Med Ctr, Dept Restorat Dent Biomat Orthopaed Surg, Whitaker Fdn, Natl Sci Fdn, IEEE Engn Med & Biol Soc, Biomed Engn Soc, Inst Biol Engn, Soc Biomat
AB One new way to cost-effectively distribute educational materials is through the use of CD-ROM supplements. We proposed that the creation of a CD-ROM in biomaterials would be useful to two target audiences. One audience includes clinicians who can benefit from a second, more scientific approach to clinical uses of biomaterials. The second group includes scientists and engineers who are involved in device development yet may not have a strong understanding of the clinical environment. This manuscript outlines our approach in creating the CD-ROM. The metrics to analyse the effectiveness of the CD-ROM are not complete.
RP Love, BJ (reprint author), VIRGINIA POLYTECH INST & STATE UNIV,DEPT MAT SCI & ENGN,BLACKSBURG,VA 24061, USA.
OI Love, Brian/0000-0002-7319-5481
NR 0
TC 0
Z9 0
U1 0
U2 0
PU I E E E
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017
SN 1086-4105
BN 0-7803-3869-3
J9 SO BIOMM ENGN CONF P
PY 1997
BP 171
EP 173
DI 10.1109/SBEC.1997.583242
PG 3
WC Engineering, Biomedical
SC Engineering
GA BH56F
UT WOS:A1997BH56F00039
DA 2018-10-20
ER

PT S
AU Nall, B
   Benghuzzi, H
   Puckett, A
   Parsell, D
   Robert, B
   Tucci, M
AF Nall, B
   Benghuzzi, H
   Puckett, A
   Parsell, D
   Robert, B
   Tucci, M
BE Bumgardner, JD
   Puckett, AD
TI Interrelationship between bioceramics and mice osteoclast in culture
SO PROCEEDINGS OF THE 1997 16TH SOUTHERN BIOMEDICAL ENGINEERING CONFERENCE
SE SOUTHERN BIOMEDICAL ENGINEERING CONFERENCE. PROCEEDINGS
LA English
DT Proceedings Paper
CT 16th Southern Biomedical Engineering Conference
CY APR 04-06, 1997
CL BILOXI, MS
SP Mississippi State Univ, Dept Agr & Biol Engn, Univ Mississippi Med Ctr, Dept Restorat Dent Biomat Orthopaed Surg, Whitaker Fdn, Natl Sci Fdn, IEEE Engn Med & Biol Soc, Biomed Engn Soc, Inst Biol Engn, Soc Biomat
AB The relationship between various bioceramics (similar to bone) used in surgical implantation and osteoclastic response has not been fully elucidated. The objective of this study was to investigate the effect of various biomedical ceramics such as tricalcium phosphate (TCP), hydroxyapatite (HA), and aluminum-calcium-phosphorous oxide (ALCAP) on the adherence and viability of mice osteoclast (OT) in vitro The OT cells were isolated from adult male mice and seeded at a density of 5 x 10(5) cells/well according to standard laboratory procedures. Cells were plated in each micrometer-well pretreated with ceramic capsules (HA, TCP and ALCAP) and buffered control. At the end of 1, 2, 3 and 5 days the viability and cell number of OT were determined using an established assay. Cell number was determined in control wells with known number of cells, and a standard curve was generated by plotting absorbency units versus cell number. Biochemical analysis was performed on the aliquots obtained from the experimental and control wells at the end of each phase of the investigation. The data from this experiment suggest that : (I) OT are capable of adhering to the surface of HA, TCP and ALCAP in an in vitro environment for over a 5 day period. (II) Long term incubation of ceramic capsules with OT revealed that the cells experienced gradual disassociation phenomenon with a greater numbers of cell detachment seen in the ALCAP contained wells. (III) SEM analysis of representative capsules demonstrated that there is an increase in the number of micropores and macropores on the surface of the materials after contacting a cellular environment. This observation suggest that the material surface has been modified (TCP > HA= ALCAP). Information obtained from this study provided new insights on the interrelationship between bioceramics and the possible OT response during chronic inflammation at the site of implantation.
RP Nall, B (reprint author), UNIV MISSISSIPPI,MED CTR,2500 N STATE ST,JACKSON,MS 39216, USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU I E E E
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017
SN 1086-4105
BN 0-7803-3869-3
J9 SO BIOMM ENGN CONF P
PY 1997
BP 279
EP 282
DI 10.1109/SBEC.1997.583285
PG 4
WC Engineering, Biomedical
SC Engineering
GA BH56F
UT WOS:A1997BH56F00063
DA 2018-10-20
ER

PT S
AU Blanchard, SM
   Dewolf, DK
   Dillon, AE
AF Blanchard, SM
   Dewolf, DK
   Dillon, AE
GP IEEE
   IEEE
TI Biomedical engineering applications - A prototype World Wide Web
   textbook
SO PROCEEDINGS OF THE 19TH ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE
   ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY, VOL 19, PTS 1-6:
   MAGNIFICENT MILESTONES AND EMERGING OPPORTUNITIES IN MEDICAL ENGINEERING
SE PROCEEDINGS OF ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING
   IN MEDICINE AND BIOLOGY SOCIETY
LA English
DT Proceedings Paper
CT International Conference of the IEEE
   Engineering-in-Medicine-and-Biology-Society
CY OCT 30-NOV 02, 1997
CL CHICAGO, IL
SP IEEE Engn Med & Biol Soc, Natl Inst Hlth
AB A prototype electronic textbook, Biomedical Engineering Applications, is now available on the World Wide Web. It contains 11 chapters - Introduction, Electrodes and Transducers, Cardiovascular System, Respiratory System, Nervous System, Muscular System, Skeletal System, Computers in Medicine, Radiology and Nuclear Medicine, Medical Imaging, and Lasers in Medicine - suitable for an overview course in biomedical engineering. Each chapter includes links to selected topics, instructional objectives, sample tests, and related information. At this time, the textbook is considered to be a prototype since only student-generated projects are associated with each chapter and supplementary reading material, in the form of traditional textbooks, is required. The long-term goal is to have instructor-written material as well as student-generated projects for each topic and to include interactive simulations to illustrate appropriate concepts.
C1 N Carolina State Univ, Dept Biol & Agr Engn, Raleigh, NC 27695 USA.
RP Blanchard, SM (reprint author), N Carolina State Univ, Dept Biol & Agr Engn, Box 7625, Raleigh, NC 27695 USA.
CR Blanchard S M, 1997, Biomed Sci Instrum, V33, P400
   DIXON JW, 1996, BARORECEPTOR MODELIN
   Washington N, 1997, Biomed Sci Instrum, V33, P41
NR 3
TC 0
Z9 0
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1094-687X
BN 0-7803-4262-3
J9 P ANN INT IEEE EMBS
PY 1997
VL 19
BP 922
EP 923
PN 1-6
PG 2
WC Engineering, Biomedical
SC Engineering
GA BM91F
UT WOS:000080103400264
DA 2018-10-20
ER

PT S
AU Singh, VR
AF Singh, VR
GP IEEE
   IEEE
TI Novel bone micro-sensors
SO PROCEEDINGS OF THE 19TH ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE
   ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY, VOL 19, PTS 1-6:
   MAGNIFICENT MILESTONES AND EMERGING OPPORTUNITIES IN MEDICAL ENGINEERING
SE PROCEEDINGS OF ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING
   IN MEDICINE AND BIOLOGY SOCIETY
LA English
DT Proceedings Paper
CT International Conference of the IEEE
   Engineering-in-Medicine-and-Biology-Society
CY OCT 30-NOV 02, 1997
CL CHICAGO, IL
SP IEEE Engn Med & Biol Soc, Natl Inst Hlth
DE bone; micro-sensor; piezo-ceramics; vibration sensors; diagnostic sensor
AB Bone is now a well estblished pizoelectric material. A systematic and detailed study has been carried out to investigate this property in the bone by using invitro and invivo samples in the laboratory. Conventional ceramic processing technique is utilized to develop transducer elements from the bone material. Different types of micro-sensors developed for various biomedical applicatios, are described.
C1 Natl Phys Lab, Instrumentat & Sensors Grp, New Delhi 110012, India.
RP Singh, VR (reprint author), Natl Phys Lab, Instrumentat & Sensors Grp, Dr Ks Krishnan Rd, New Delhi 110012, India.
CR Fukuda E., 1957, J PHYS SOC JPN, V12, P1158
   FUKUDA E, 1964, JPN J APPL PHYS, V3, P117
   LEWIN PA, 1981, ULTRASONICS, V19, P213, DOI 10.1016/0041-624X(81)90005-6
   SINGH VR, 1988, PROCEEDINGS OF THE ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY, PTS 1-4, P755, DOI 10.1109/IEMBS.1988.95003
   YADAV S, 1990, INNOV TECH BIOL MED, V11, P89
NR 5
TC 0
Z9 0
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1094-687X
BN 0-7803-4262-3
J9 P ANN INT IEEE EMBS
PY 1997
VL 19
BP 2260
EP 2263
PN 1-6
PG 4
WC Engineering, Biomedical
SC Engineering
GA BM91F
UT WOS:000080103400648
DA 2018-10-20
ER

PT S
AU Katz, DF
   Dunmire, EN
   Henderson, MH
   Owen, DH
   Plenys, AM
AF Katz, DF
   Dunmire, EN
   Henderson, MH
   Owen, DH
   Plenys, AM
GP IEEE
   IEEE
TI Applications of biomedical engineering in reproductive biomedicine:
   Sensing and drug delivery to the lower female reproductive tract
SO PROCEEDINGS OF THE 19TH ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE
   ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY, VOL 19, PTS 1-6:
   MAGNIFICENT MILESTONES AND EMERGING OPPORTUNITIES IN MEDICAL ENGINEERING
SE PROCEEDINGS OF ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING
   IN MEDICINE AND BIOLOGY SOCIETY
LA English
DT Proceedings Paper
CT International Conference of the IEEE
   Engineering-in-Medicine-and-Biology-Society
CY OCT 30-NOV 02, 1997
CL CHICAGO, IL
SP IEEE Engn Med & Biol Soc, Natl Inst Hlth
DE contraception; prophylaxis; sexually transmitted diseases; drug
   delivery; optical sensing
ID CERVICAL-MUCUS; MUCOADHESION; POLYMERS
AB Current intravaginal products for contraception and prophylaxis against sexually transmitted diseases lack the efficacy that is both needed and technically possible. A multidisciplinary effort - that integrates gynecology, pathology, microbiology, and reproductive biology with engineering and materials science - can provide critical and missing information to the process of design and development of better products. Several engineering sub-disciplines can contribute to this effort, including electrical, mechanical and chemical engineering. Specific contributions will pertain to the polymeric delivery vehicles for drug delivery, the active ingredients of those vehicles, and to methods of testing, both in vitro and in vivo.
C1 Duke Univ, Dept Biomed Engn, Durham, NC 27708 USA.
RP Katz, DF (reprint author), Duke Univ, Dept Biomed Engn, Box 90281, Durham, NC 27708 USA.
CR DONCEL GF, 1994, BARRIER CONTRACEPTIV, P145
   Dunmire EN, 1997, CONTRACEPTION, V55, P115, DOI 10.1016/S0010-7824(96)00281-8
   DUNMIRE EN, 1997, IN PRESS CONTRACEPTI
   ESPOSITO P, 1994, BIOMATERIALS, V15, P177, DOI 10.1016/0142-9612(94)90064-7
   HENDERSON MH, 1997, IN PRESS AM SOC REPR
   KATZ DF, 1993, ADV DRUG DELIVER REV, V11, P385, DOI 10.1016/0169-409X(93)90017-X
   Leung S. H., 1988, J CONTROL RELEASE, V5, P223
   OWEN DH, AM SOC REPR MED ANN, pS57
   OWEN DH, 1997, IN PRESS AM SOC REPR
   PARK HHS, 1984, J PHARM SCI, V74, P399
   RILLOSI M, 1995, PHARMACEUT RES, V12, P669, DOI 10.1023/A:1016299223369
   SangiHaghpeykar H, 1996, CONTRACEPTION, V53, P353, DOI 10.1016/0010-7824(96)00084-4
NR 12
TC 3
Z9 3
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1094-687X
BN 0-7803-4262-3
J9 P ANN INT IEEE EMBS
PY 1997
VL 19
BP 2656
EP 2658
PN 1-6
PG 3
WC Engineering, Biomedical
SC Engineering
GA BM91F
UT WOS:000080103400761
DA 2018-10-20
ER

PT B
AU Devender
   Ramasamy, SR
AF Devender
   Ramasamy, SR
GP SOC EMC ENGINEERS INDIA
TI A review of EMI shielding and suppression materials
SO PROCEEDINGS OF THE INTERNATIONAL CONFERENCE ON ELECTROMAGNETIC
   INTERFERENCE AND COMPATIBILITY '97
LA English
DT Proceedings Paper
CT International Conference on Electromagnetic Interference and
   Compatibility 97 (INCEMIC 97)
CY DEC 03-05, 1997
CL HYDERABAD, INDIA
SP Soc Electromagnet Compatibil Engineers India, Hyderabad
AB The effect of growth of electronic industry and its widespread use of electronic equipment in communications, computations, automations, biomedical, space and other purposes has led to many Electromagnetic Interference (EMI) problems to the designers as their systems/subsystems operate in close proximity. It is likely to become more severe in future, unless designers follow EMI control methodology/techniques to meet the EMC requirements during the design stage itself. The elimination or suppression of EMI should be a prime objective of the designer. In this paper the authors have made an attempt to present technical data/details fo various EMI suppression materials/devices available in the market and simplified the job of designer to verify different catalogues and which may be directly applied to problem and harden the system/subsystem in compliance to EMC Standards. As the design and development proceeds, the number of available noise reduction techniques also decreases and at the same time cost of mitigating noise goes up. Hence selecting a right component in right time is very essential. This paper gives a quick reference to the designer to reduce the noise at source level in the system during design and development stages by choosing appropriate component/device and fixing it correctly into the problem.
C1 Res Ctr Imarat, Hyderabad 500069, Andhra Pradesh, India.
RP Devender (reprint author), Res Ctr Imarat, Hyderabad 500069, Andhra Pradesh, India.
NR 0
TC 3
Z9 3
U1 0
U2 3
PU SOCIETY ELECTROMAGNETIC COMPATIBILITY ENGINEERS INDIA
PI HYDERABAD
PA 306, AVIONICS RESEARCH CTR IMARAT, HYDERABAD 500 069, INDIA
BN 81-900652-0-3
PY 1997
BP 459
EP 466
DI 10.1109/ICEMIC.1997.669850
PG 4
WC Engineering, Electrical & Electronic
SC Engineering
GA BK95U
UT WOS:000073941000090
DA 2018-10-20
ER

PT B
AU Morais, S
   Sousa, JP
   Carvalho, GS
AF Morais, S
   Sousa, JP
   Carvalho, GS
BE Ricco, AJ
   Vanyek, P
   Horvai, G
   Silva, AF
TI Quantification of AISI 316L stainless steel corrosion products in cell
   culture using a mercury microelectrode
SO PROCEEDINGS OF THE SYMPOSIUM ON CHEMICAL AND BIOLOGICAL SENSORS AND
   ANALYTICAL ELECTROCHEMICAL METHODS
SE ELECTROCHEMICAL SOCIETY SERIES
LA English
DT Proceedings Paper
CT Symposium on Chemical and Biological Sensors and Analytical
   Electrochemical Methods
CY 1997
CL PARIS, FRANCE
SP Int Soc Electrochem, Electrochem Soc
AB The main goal of this study was to investigate the effects of stainless steel AISI 316L (a commonly used material in orthopedics) corrosion products on in vitro biomineralization process. Adsorptive stripping voltammetric (AdSV) procedures for the determination of the major alloying elements, i.e. Fe, Cr and Ni, were optimized and used to quantify these elements in cell culture medium using a mercury film microelectrode (MFM). The organic ligand and optimized analytical conditions for each metal ion were: a) catechol 5.00x10(-4) mol/L, PIPES buffer 0.01 mol/L (pH=8.0) and deposition potential -1.80 V for Fe; b) diethylenetriaminepentaacetic acid (DTPA) 7.50x10(-3) mol/L, sodium nitrate 0.70 mol/L, sodium acetate 0.05 mol/L (pH=5.9) and deposition potential -1.00 V for Cr; c) dimethylglioxime (DMG) 5.00x10(-4) mol/L, ammonium chloride buffer 0.10 mol/L (pH=9.2) and deposition potential -0.70 V for Ni. The limits of detection achieved (1.93x10(-8) mol/L Fe, 2.80x10(-10) mol/L Cr and 7.70x10(-9) mol/L Ni for a collection time of 30 s, 40 s and 10 s, respectively) are adequate for future applications in the biomaterials/biomedical field.
RP Morais, S (reprint author), UNIV OPORTO,INST BIOMED ENGN,DEPT ENGN QUIM,FAC ENGN,PRACA CORONEL PACHECO 1,P-4050 OPORTO,PORTUGAL.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU ELECTROCHEMICAL SOCIETY INC
PI PENNINGTON
PA 10 S MAIN ST, PENNINGTON, NJ 08534-2896
BN 1-56677-147-1
J9 ELEC SOC S
PY 1997
VL 97
IS 19
BP 587
EP 596
PG 10
WC Electrochemistry
SC Electrochemistry
GA BJ30V
UT WOS:A1997BJ30V00073
DA 2018-10-20
ER

PT S
AU Cibuzar, G
   Polla, D
   McGlennen, R
AF Cibuzar, G
   Polla, D
   McGlennen, R
GP IEEE
TI Biomedical MEMS research at the University of Minnesota
SO PROCEEDINGS OF THE TWELFTH BIENNIAL UNIVERSITY/GOVERNMENT/INDUSTRY
   MICROELECTRONICS SYMPOSIUM
SE PROCEEDINGS - UNIVERSITY/GOVERNMENT/INDUSTRY MICROELECTRONICS SYMPOSIUM
LA English
DT Proceedings Paper
CT 12th Biennial University/Government/Industry Microelectronics Symposium
CY JUL 20-23, 1997
CL ROCHESTER INST TECHNOL, ROCHESTER, NY
SP IEEE, Electron Devices Soc, IEEE, Rochester Sect, Rochester Inst Technol, Microelectr Engn Dept
HO ROCHESTER INST TECHNOL
AB Microelectromechanical systems (MEMS) technology has often been characterized as an enabling technology. As MEMS technology expands with improved designs, refined processes, and extension to materials beyond standard silicon substrates, opportunities for applications in new research areas are growing rapidly. Beyond the more traditional MEMS areas of accelerometers and pressure sensors, there are many possibilities in research fields such as biology, agriculture, and veterinary and human medicine.
   Over the past two years, the Microtechnology Laboratory at the University of Minnesota has been cultivating a research program based on applying MEMS to biomedical and medical situations. The program was motivated by a fruitful series of discussions between MEMS researchers from the engineering disciplines and faculty from medical Laboratory Medicine and Pathology. These applications of traditional MEMS technology to specialized small surgical tools. The process of applications to reality has been a difficult and rewarding one. In this talk we will give a historical view of development of the program. Some of the topics that will be discussed include: disparate disciplines working collaboratively, funding, organization and management, and interaction with industry.
RP Cibuzar, G (reprint author), UNIV MINNESOTA,MICROTECHNOL LAB,200 UNION ST SE,MINNEAPOLIS,MN 55455, USA.
NR 0
TC 4
Z9 4
U1 0
U2 1
PU I E E E
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017
SN 0749-6877
BN 0-7803-3791-3
J9 P UNIV GOVT IND MICR
PY 1997
BP 145
EP 149
DI 10.1109/UGIM.1997.616710
PG 5
WC Engineering, Electrical & Electronic
SC Engineering
GA BJ65E
UT WOS:A1997BJ65E00033
DA 2018-10-20
ER

PT J
AU Lambrecht, RM
   Tomiyoshi, K
   Sekine, T
AF Lambrecht, RM
   Tomiyoshi, K
   Sekine, T
TI Radionuclide generators
SO RADIOCHIMICA ACTA
LA English
DT Review
DE radiochemical separations; radiopharmaceutical chemistry; isotope
   production; double neutron capture; generator automation
ID INDUCED NUCLEAR-REACTIONS; POSITRON EMISSION TOMOGRAPHY; RB-81 KR-81M
   GENERATOR; HIGHLY ENRICHED XE-124; CARRIER-FREE HO-166; HIGH-PURITY
   I-123; EXCITATION-FUNCTIONS; RB-81/KR-81M GENERATOR; ZN-62/CU-62
   GENERATOR; MONOCLONAL-ANTIBODIES
AB The present status and future directions of research and development on radionuclide generator technology are reported. The recent interest to develop double-neutron capture reactions for production of in vivo generators; neutron rich nuclides for radioimmunotherapeutic pharmaceuticals; and advances with ultrashort lived generators is highlighted. Emphasis is focused on: production of the parent radionuclide; the selection and the evaluation of support materials and eluents with respect to the resultant radiochemical yield of the daughter, and the breakthrough of the radionuclide parent; and, the uses of radionuclide generators in radiopharmaceutical chemistry, biomedical and industrial applications. The Zn-62 --> Cu-62, Ni-66 --> Cu-66, Rh-103m --> Rh-103, W-188 --> Re-188 and the Ac-225 --> Fr-221 --> Bi-213 generators are predicted to be emphasized for future development. Coverage of the Mo-99 --> Tc-99m generator was excluded, as it the subject of another review. The literature search ended June, 1996.
C1 UNIV WOLLONGONG,DEPT CHEM,WOLLONGONG,NSW 2522,AUSTRALIA.
   GUNMA UNIV,DEPT NUCL MED,MARBASHI 317,JAPAN.
   JAPAN ATOM ENERGY RES INST,DEPT RADIOISOTOPES,TAKASAKI,GUMMA 37012,JAPAN.
RP Lambrecht, RM (reprint author), UNIV TUBINGEN,POSTFACH 35,D-72076 TUBINGEN,GERMANY.
CR AGEEV VA, 1992, RADIOKHIMYA, V34, P122
   AMBE S, 1988, APPL RADIAT ISOTOPES, V39, P49
   ANSARI AN, 1976, Patent No. 3959455
   Arif M, 1996, RADIOCHIM ACTA, V73, P45
   ASANO T, 1978, J INORG NUCL CHEM, V40, P957, DOI 10.1016/0022-1902(78)80487-4
   ASANO T, 1974, J INORG NUCL CHEM, V36, P1433, DOI 10.1016/0022-1902(74)80601-9
   ATCHER RW, 1989, J RADIOAN NUCL CH LE, V135, P215, DOI 10.1007/BF02164974
   ATCHER RW, 1988, APPL RADIAT ISOTOPES, V39, P238
   BABICH JW, 1989, RADIOPHARMACEUTICALS, P3
   Bao B, 1996, J RADIOAN NUCL CH LE, V213, P233, DOI 10.1007/BF02163569
   BARTOS B, 1995, J RADIOAN NUCL CH LE, V201, P89, DOI 10.1007/BF02163720
   BELKOVA MN, 1993, J RADIOAN NUCL CH AR, V173, P3, DOI 10.1007/BF02102692
   BEYER GJ, 1991, APPL RADIAT ISOTOPES, V42, P141
   BIALY J, KFK NACHR JAHRG, V21, pS17
   BILEWICZ A, 1995, RADICHIM ACTA, V69, P127
   BLACHOT J, 1969, INT J APPL RADIAT IS, V20, P467, DOI 10.1016/0020-708X(69)90138-0
   BLAUENSTEIN P, 1996, J RADIOANAL NUCL CHE, V204, P94
   BORMANS G, 1992, APPL RADIAT ISOTOPES, V43, P1437
   BOTROS N, 1986, ISOTOPENPRAXIS, V22, P386
   BREMMER KH, 1989, Patent No. 304780
   BRIHAYE C, 1986, J RADIOAN NUCL CH AR, V102, P399, DOI 10.1007/BF02047914
   BRIHAYE C, 1986, J NUCL MED, V27, P380
   BRIHAYE C, 1989, APPL RADIAT ISOTOPES, V40, P183
   BRIHAYE C, 1988, RADIOACTIVE ISOTOPES IN CLINICAL MEDICINE AND RESEARCH /, P397
   BRITS RJN, 1989, APPL RADIAT ISOTOPES, V40, P103
   BRUCER M, 1965, ISOT RAD TECH, V3, P1
   CACKETTE MR, 1993, APPL RADIAT ISOTOPES, V44, P917, DOI 10.1016/0969-8043(93)90045-C
   CALLAHAN A P, 1987, Journal of Nuclear Medicine, V28, P657
   CALLAHAN AP, 1992, APPL RADIAT ISOTOPES, V43, P801
   CALLAHAN AP, 1989, NUC COMPACT, V20, P3
   CAMPS JAJ, 1990, NUCL MED BIOL, V17, P269
   CHENG C, 1980, J NUCL MED, V21, P1169
   CHINOL M, 1996, J NUCL MED, V37
   Chuang JT, 1996, J RADIOAN NUCL CH AR, V204, P83, DOI 10.1007/BF02060869
   COENEN HH, 1979, THESIS U KOLN KOLN
   COENEN HH, 1979, BER KERNFORSCHUN JUL, V1590
   COURSEY BM, 1992, RADIOACT RADIOCHEM, V3, P42
   DADACHOV M, 1994, J RADIOAN NUCL CH LE, V188, P267, DOI 10.1007/BF02164887
   DADACHOV M, IN PRESS J MAT CHEM
   DADACHOV MS, 1995, J RADIOAN NUCL CH LE, V200, P211, DOI 10.1007/BF02164083
   DADACHOVA E, 1995, J PHYS CHEM-US, V99, P10976, DOI 10.1021/j100027a044
   DADACHOVA E, 1994, ANAL CHEM, V66, P4272, DOI 10.1021/ac00095a024
   DADACHOVA E, 1995, J RADIOAN NUCL CH LE, V199, P115, DOI 10.1007/BF02162474
   DANIELS RJ, 1987, J NUCL MED BIOL, V36, P326
   DAS NR, 1993, RADIOCHIM ACTA, V62, P213
   Das SK, 1996, APPL RADIAT ISOTOPES, V47, P643, DOI 10.1016/0969-8043(96)00025-5
   DEJONG D, 1982, INT J APPL RADIAT IS, V33, P69, DOI 10.1016/0020-708X(82)90208-3
   DEPTULA C, 1989, 689354 JINRR
   DEUTSCH EA, 1989, Patent No. 4839467
   EAKINS MN, 1992, RADIOACT RADIOCHEM, V3, P61
   EHRHARDT G J, 1987, Journal of Nuclear Medicine, V28, P656
   EHRHARDT GJ, 1992, RADIOACT RADIOCHEM, V38, P40
   EHRHARDT GJ, 1990, TECHNETIUM RHENIUM C, V3, P631
   FAILLA G, 1925, Patent No. 1553794
   FAILLA G, 1926, Patent No. 1609614
   FIROUZBAKHT ML, 1987, RADIOCHIM ACTA, V41, P1
   FRANKEN K, 1990, RADIOCHIM ACTA, V50, P97
   FRANKEN PR, 1984, NUKLEARMED-NUCL MED, V30, P1025
   FRITZBERG AR, 1988, PHARMACEUT RES, V5, P325, DOI 10.1023/A:1015995208444
   FRITZBERG AR, 1988, Patent No. 284871
   FUJIBAYASHI Y, 1990, CHEM PHARM BULL, V38, P1946
   FUJIBAYASHI Y, 1989, J NUCL MED, V30, P1838
   GALLORINI M, 1995, J RADIOAN NUCL CH AR, V193, P39, DOI 10.1007/BF02041915
   GLENWORTH P, 1961, J INORG NUCL CHEM, V39, P1049
   GRAHAM D, 1985, J NUCL MED, V26, P105
   GRANT PM, 1985, J RADIOAN NUCL CH LE, V96, P629, DOI 10.1007/BF02165043
   GREEN MA, 1988, J NUCL MED, V29, P1549
   GREEN MA, 1987, NUCL MED BIOL, V14, P59
   GREEN MA, 1990, J NUCL MED, V31, P1989
   GRIFFITHS GL, 1992, BIOCONJUGATE CHEM, V3, P91, DOI 10.1021/bc00014a001
   GRIFFITHS GL, 1991, CANCER RES, V51, P4594
   GUILLAUME M, 1987, RADIOCHIM ACTA, V41, P119
   HAFELI U, 1991, NUCL MED BIOL, V18, P449
   HANSER A, 1989, APPL RADIAT ISOTOPES, V40, P309
   HAYES RL, 1965, J NUCL MED, V7, P797
   HAYES RL, 1965, 1017477 ORAN
   HELLMAN C, 1989, J NUCL MED, V30, P450
   HELUS F, 1990, J RADIOAN NUCL CH AR, V140, P111, DOI 10.1007/BF02037368
   HELUS F, 1996, COMMUNICATION
   Herrero P, 1996, J NUCL MED, V37, P1294
   HETHERINGTON ELR, 1984, INT J APPL RADIAT IS, V35, P68, DOI 10.1016/0020-708X(84)90135-2
   HNATOWICH DJ, 1977, RADIOLOGY, V123, P189, DOI 10.1148/123.1.189
   HSIEH BT, 1991, NUCL SCI, V28, P413
   HUFFMAN EH, 1956, J INORG NUCL CHEM, V3, P49, DOI 10.1016/0022-1902(56)80113-9
   *IAEA, 1995, 852 IAEA TECHDOC
   ILJIN LA, 1987, CURRENT QUESTIONS ME, P97
   ISSACHAR D, 1989, J NUCL MED, V30, P538
   IWATA R, 1992, J RADIOANAL NUCL CHE, V159, P23
   Jackson TW, 1996, AUST J CHEM, V49, P239
   JACKSON TW, 1993, AUST J CHEM, V46, P1093, DOI 10.1071/CH9931093
   JACKSON TW, 1993, Patent No. 93112038
   JACKSON TW, 1993, Patent No. 8099179
   JANNSEN AGM, 1992, J LABELLED COMPD RAD, V30, P478
   JANSSEN AGM, 1990, APPL RADIAT ISOTOPES, V41, P847
   JONES CJ, 1977, J HAZARD MATER, V2, P219
   KAMIOKI H, 1995, SYNTHESIS AND APPLICATIONS OF ISOTOPICALLY LABELLED COMPOUNDS 1994, P237
   KAMIOKI H, 1994, RADIOCHIM ACTA, V65, P39
   KLOCKOW D, 1968, J RADIOANAL CHEM, V1, P325, DOI 10.1007/BF02513687
   KLOFUTAR C, 1970, J RADIOANAL CHEM, V5, P3, DOI 10.1007/BF02513694
   Knapp F.F., 1993, U.S. Patent, Patent No. [5,186,913, 5186913]
   Knapp F. F., 1994, U. S. Patent, Patent No. [5, 275, 802, 5275802]
   KNAPP FF, 1994, EUR J NUCL MED, V21, P1151
   KNAPP FF, 1994, APPL RADIAT ISOTOPES, V45, P1123, DOI 10.1016/0969-8043(94)90026-4
   KNAPP FF, 1992, ORNL12159
   KNAPP FF, 1992, NUCL MED RES PRACTIC, P183
   KNAPP FF, 1988, J NUCL MED, V29, P927
   KNAPP FF, 1993, ORNLTM12485
   KODINA G, 1990, TECHNETIUM RHENIUM C, V3, P635
   KOJIMA M, UNPUB J RADIOANAL NU
   KONYAHIN NA, 1989, ATOM ENERG, V67, P129
   KOVACS Z, 1991, APPL RADIAT ISOTOPES, V42, P329
   KOZAK RW, 1986, P NATL ACAD SCI USA, V83, P474, DOI 10.1073/pnas.83.2.474
   KURENKOV NV, 1989, J RADIOAN NUCL CH LE, V135, P39, DOI 10.1007/BF02165458
   LACY JL, 1991, J NUCL MED, V32, P2158
   LACY JL, 1988, J NUCL MED, V29, P1526
   LAGUNASSOLAR MC, 1990, APPL RADIAT ISOTOPES, V41, P521
   LAMBRECHT RM, 1988, APPL RADIAT ISOTOPES, V39, P1081
   LAMBRECHT RM, 1983, RADIOCHIM ACTA, V34, P9
   LAMBRECHT RM, 1988, RADIOCHIM ACTA, V43, P171
   LAMBRECHT RM, 1972, J NUCL MED, V13, P266
   LAMBRECHT RM, 1976, P 4 INT C POS SOURC
   LAMBRECHT RM, 1976, BORDEAUX MED, V9, P1294
   LAMBRECHT RM, 1975, RADIOPHARMACEUTICALS, P111
   LEDERER CM, 1978, TABLE ISOTOPES
   LEE TW, 1991, ISOTOPENPRAXIS, V27, P269, DOI 10.1080/10256019108622539
   Lenz J. W., 1995, P 6 WORKSH TARG TARG, P149
   LERF A, 1987, HYPERFINE INTERACT, V36, P326
   LEWIS RA, 1965, J NUCL MED, V7, P804
   LUNDQVIST H, 1991, APPL RADIAT ISOTOPES, V42, P447
   MA D, 1993, J NUCL MED, V34
   MACHULLA HJ, 1977, RADIOCHIM ACTA, V24, P42
   MALININ AB, 1991, MED RADIOL, V35, P34
   Malyshev K.V., 1975, RADIOKHIMIYA, V17, P249
   MANI RS, 1987, RADIOCHIM ACTA, V41, P103
   MANSUR MS, 1995, J RADIOAN NUCL CH LE, V201, P205, DOI 10.1007/BF02164828
   MATHIAS CJ, 1991, J NUCL MED, V32, P475
   MATHIAS CJ, 1991, APPL RADIAT ISOTOPES, V42, P317
   MATSUURA T, 1992, P INT SEM CHEM HIGH
   MAUSNER L F, 1989, Journal of Labelled Compounds and Radiopharmaceuticals, V26, P177
   MAUSNER LF, 1987, APPL RADIAT ISOTOPES, V38, P181
   MERRIGAN JA, 1966, J PHYS CHEM-US, V70, P2417, DOI 10.1021/j100879a507
   Mikheev N.S., 1972, ISOTOPENPRAXIS, V8, P248
   Mirzadeh S, 1996, J RADIOAN NUCL CH AR, V203, P471, DOI 10.1007/BF02041524
   Mirzadeh S, 1996, J RADIOAN NUCL CH AR, V202, P7, DOI 10.1007/BF02037941
   MIRZADEH S, 1991, Journal of Nuclear Medicine, V32, P1089
   MIRZADEH S, 1993, RADIOCHIM ACTA, V60, P1
   Mirzadeh S., 1992, P INT C NUCL DAT SCI, P595
   MIRZADEH S, 1992, RADIOACT RADIOCHEM, V3, P31
   MIRZADEH S, 1996, 212 AM ACS M ORL FL
   MIRZADEH SM, 1995, P 6 WORKSH TARG TARG, P129
   MOERLEIN SM, 1983, J AM CHEM SOC, V105, P5418, DOI 10.1021/ja00354a039
   Mushtaq A, 1996, APPL RADIAT ISOTOPES, V47, P727, DOI 10.1016/0969-8043(96)00032-2
   NEIRINCKX RD, 1977, INT J APPL RADIAT IS, V28, P808, DOI 10.1016/0020-708X(77)90121-1
   NORMAN JH, 1991, Patent No. 5038046
   Nozaki T, 1996, J RADIOAN NUCL CH AR, V203, P151, DOI 10.1007/BF02060390
   OKAZAWA H, 1994, J NUCL MED, V35, P1910
   ORVANESSIANT YT, 1982, J PHYS G, V18, P393
   PACKARD AB, 1987, J NUCL MED, V28, P1571
   PACKARD AB, 1985, INT J APPL RADIAT IS, V36, P164, DOI 10.1016/0020-708X(85)90238-8
   PACKARD AB, 1986, INT J APPL RADIAT IS, V36, P519
   PACKARD AB, 1992, RADIOACT RADIOCHEM, V3, P49
   PHILLIPS DR, 1989, CONF891206, P608
   PLOTNOKOV V, 1966, ZH ANAL KHIM, V21, P1260
   PROBST HJ, 1976, INT J APPL RADIAT IS, V27, P431, DOI 10.1016/0020-708X(76)90062-4
   QAIM SM, 1987, RADIOCHIM ACTA, V41, P111
   RACK EP, 1961, J CHEM PHYS, V34, P1855, DOI 10.1063/1.1731784
   RACK EP, 1992, P INT SEM CHEM HIGH, P55
   RAMAMOORTHY N, 1981, RADIOCHEM RADIOA LET, V46, P371
   RAYUDU GVS, 1990, SEMIN NUCL MED, V20, P100, DOI 10.1016/S0001-2998(05)80163-1
   RICHARDS P, 1989, TECHNETIUM RHENIUM C, V3, P5
   Rosch F, 1997, APPL RADIAT ISOTOPES, V48, P19, DOI 10.1016/S0969-8043(96)00041-3
   ROSENSTEIN LM, 1989, J NUCL MED, V30, P1574
   RUBINSON W, 1949, J CHEM PHYS, V17, P542, DOI 10.1063/1.1747317
   RUEGG CL, 1990, CANCER RES, V50, P4221
   SAHA GB, 1990, ADV RADIOPHARMACOLOG, P45
   SAJJAD M, 1986, ANAL CHEM, V53, P667
   SCHINDLER J, 1996, Patent No. 3621189
   SEKINE T, 1981, J INORG NUCL CHEM, V43, P1107, DOI 10.1016/0022-1902(81)80001-2
   SEKINE T, 1978, J INORG NUCL CHEM, V40, P1977, DOI 10.1016/0022-1902(78)80184-5
   SEKINE T, 1978, J INORG NUCL CHEM, V40, P1457, DOI 10.1016/0022-1902(78)80451-5
   SEKINE T, 1980, 1266 JAERI
   Shigeta N, 1996, APPL RADIAT ISOTOPES, V47, P171, DOI 10.1016/0969-8043(95)00254-5
   SHIOKAWA T, 1965, B CHEM SOC JPN, V38, P1340, DOI 10.1246/bcsj.38.1340
   SHIOKAWA T, 1965, CHEM EFFECTS ASSOCIA, V38, P1892
   SHIOKAWA T, 1970, CHEM EFFECTS ASS BET, V43, P2076
   SHIOKAWA T, 1969, CHEM EFFECTS ASSOCIA, V42, P696
   SHOCHAT D, 1989, Patent No. 8909405
   SHOOP D, 1996, J RADIOANAL NUCL CHE, V211
   SIMPSON BRS, 1994, APPL RADIAT ISOTOPES, V45, P669, DOI 10.1016/0969-8043(94)90245-3
   SINGH J, 1991, CHEM SOC CHEM COMMUN, V1115
   SLEWYN AP, 1978, CIRC RES, V42, P771
   SMITH SV, 1995, APPL RADIAT ISOTOPES, V46, P759, DOI 10.1016/0969-8043(94)00149-T
   SPITSIN VI, 1971, ATOM ENERGY REV, V9, P797
   SQOURUS G, 1996, J NUCL MED, V37
   SRIVISTAVA SC, 1988, RADIOLABELLED MONOCL
   STEYN GF, 1991, APPL RADIAT ISOTOPES, V42, P361
   SZELECSENYI F, 1995, P 6 WORKSH TARG TARG
   TARKANYI F, 1990, APPL RADIAT ISOTOPES, V41, P91
   TARKANYI F, 1991, APPL RADIAT ISOTOPES, V42, P221
   TARKANYI F, 1991, APPL RADIAT ISOTOPES, V42, P229
   THOMAS KE, 1987, APPL RADIAT ISOTOPES, V38, P175
   TOBIN MJ, 1991, APPL RADIAT ISOTOPES, V42, P412
   TREVES S, 1980, J NUCL MED, V21, P1151
   TREVES S, 1979, RADIOLOGY, V130, P741
   TSANG BW, 1993, INORG CHEM, V32, P988, DOI 10.1021/ic00058a039
   TsoupkoSitnikov V, 1996, J RADIOAN NUCL CH AR, V205, P75, DOI 10.1007/BF02040552
   Uhlir V, 1996, J RADIOAN NUCL CH AR, V204, P423, DOI 10.1007/BF02060330
   *USDOE, 1996, USDOE WORKSH ALPH EM
   VANDERHEYDEN JL, 1992, Patent No. 51456368
   WEBER DA, 1989, MIRD RADIONUCLIDE DA
   WENZEL W, 1989, Patent No. 8909342
   WIKE JS, 1990, APPL RADIAT ISOTOPES, V41, P861
   WITSENBOER AJ, 1986, J LABELLED COMPD RAD, V23, P1284
   WU C, 1996, 212 ACS SOC M ORL FL
   Yamashita M., 1989, U.S. patent, Patent No. [4,859,931, 4859931]
   YANO Y, 1989, Journal of Nuclear Medicine, V30, P849
   YANO Y, 1989, NUCL INSTRUM METH B, V40-1, P1105, DOI 10.1016/0168-583X(89)90549-1
   YANO Y, 1968, J NUCL MED, V9, P1
   YOKOYAMA A, 1986, Radioisotopes, V35, P249
   YOONG M, 1973, RADIOCHIM ACTA, V19, P124
   ZAITSEVA NG, 1991, J RADIOAN NUCL CH AR, V149, P235, DOI 10.1007/BF02062049
   ZAITSEVA NG, 1994, RADIOCHIM ACTA, V64, P1
   ZAITSEVA NG, 1994, RADIOCHIM ACTA, V65, P157
   ZAITSEVA NG, 1994, RADIOCHIM ACTA, V65, P151
   Zhuikov B.L., 1996, P 6 WORKSH TARG TARG, P112
   ZUCCHINI GL, 1982, INT J NUCL MED BIOL, V9, P83, DOI 10.1016/0047-0740(82)90082-1
   ZURAVLEV BV, 1986, ATOM ENERG, V60, P337
   ZWEIT J, 1992, EUR J NUCL MED, V19, P418
   1990, OAK RIDGE NATL LAB R, P63
NR 229
TC 24
Z9 24
U1 3
U2 11
PU R OLDENBOURG VERLAG
PI MUNCHEN
PA LEKTORAT M/N, K BERBER-NERLINGER, POSTFACH 80 13 60, D-81613 MUNCHEN,
   GERMANY
SN 0033-8230
J9 RADIOCHIM ACTA
JI Radiochim. Acta
PY 1997
VL 77
IS 1-2
BP 103
EP 123
PG 21
WC Chemistry, Inorganic & Nuclear; Nuclear Science & Technology
SC Chemistry; Nuclear Science & Technology
GA XQ718
UT WOS:A1997XQ71800015
DA 2018-10-20
ER

PT B
AU Schuppel, W
   Muller, R
   Ulbrich, C
   Steinmetz, H
AF Schuppel, W
   Muller, R
   Ulbrich, C
   Steinmetz, H
BE Hafeli, U
   Schutt, W
   Teller, J
   Zborowski, M
TI Magnetic oxide particles prepared by glass crystallization - Properties
   and applications
SO SCIENTIFIC AND CLINICAL APPLICATIONS OF MAGNETIC CARRIERS
LA English
DT Proceedings Paper
CT International Conference on Scientific and Clinical Applications of
   Magnetic Carriers
CY SEP 05-07, 1996
CL ROSTOCK, GERMANY
AB Glass crystallization was used and further developed for preparation of micro- and nano-crystalline particulate oxide media of different compositions and with different properties. These media may find applications in high-density magnetic recording devices, in novel ferrofluids, in microwave devices, in glass-ceramic materials, as initial materials for composites and for biomedical purposes. The properties of these media and the performance of this method are discussed as well as its limitations.
RP Schuppel, W (reprint author), INST PHYS HOCHTECHNOL,HELMHOLTZWEG 4,D-07743 JENA,GERMANY.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU PLENUM PRESS DIV PLENUM PUBLISHING CORP
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013
BN 0-306-45687-7
PY 1997
BP 109
EP 115
PG 7
WC Biochemical Research Methods; Biotechnology & Applied Microbiology;
   Pharmacology & Pharmacy
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Pharmacology & Pharmacy
GA BJ32T
UT WOS:A1997BJ32T00008
DA 2018-10-20
ER

PT B
AU Tabrizian, M
   Lerouge, S
   Debrie, A
   Yahia, L
AF Tabrizian, M
   Lerouge, S
   Debrie, A
   Yahia, L
BE Claus, RO
TI New sterilization technologies alternative to ethylene oxide
SO SMART SENSING, PROCESSING, AND INSTRUMENTATION - SMART STRUCTURES AND
   MATERIALS 1997
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Conference on Smart Sensing, Processing, and Instrumentation - Smart
   Structures and Materials 1997
CY MAR 03-05, 1997
CL SAN DIEGO, CA
SP Soc Photo Opt Instrumentat Engineers, Soc Exptl Mech Inc, Amer Soc Mech Engineers, USAF Wright Lab, Def Adv Res Projects Agcy, Amer Inst Chem Engineers, Amer Phys Soc, Div Mat Phys, Ceram Soc Japan, USA Res Lab, Intelligent Mat Forum, Japan
DE sterilization; biomedical devices; polymer; surface modification; gas
   plasma; ethylene oxide; photoelectron spectroscopy; oxidation
AB Sterilization of biomedical devices may induce bulk and surface modification, responsible for the decrease or loss of their biofunctionality. Pure ethylene oxide (EO) at low temperature and new alternative techniques such as cold gas plasma sterilization have been developed for heat-sensitive polymers. There is a lack of the knowledge concerning their safety in terms of materials damage and consequences on the biofunctionality of sterilized devices. The objective of our work consists in studying bulk and surface changes in biomedical devices induced by these two sterilization techniques. Samples from PVC, Polyurethane, Polyacrylate and Polyethylene-based medical devices are subjected to 1, 5, and 10 sterilization cycles try Steri-Vac-3M (pure EO), Sterrad-100(R), J & J (gas plasma+H2O2), and studied by X-rays photoelectron spectroscopy (XPS). Preliminary results show an increasing in Oxygen/Carbon ratio by a factor of 1.3 to 4.4 between the first and tenth cycle indicating the surface oxidation by gas plasma sterilization processes. Some changes in C-C chemical bounding are associated with EO sterilization.
RP Tabrizian, M (reprint author), ECOLE POLYTECH,BIOMECH & BIOMAT RES GRP,STN DOWNTOWN,POB 6079,MONTREAL,PQ H3C 3A7,CANADA.
NR 0
TC 1
Z9 1
U1 0
U2 2
PU SPIE - INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA PO BOX 10, BELLINGHAM, WA 98227-0010
BN 0-8194-2455-2
J9 P SOC PHOTO-OPT INS
PY 1997
VL 3042
BP 45
EP 51
DI 10.1117/12.275767
PG 7
WC Engineering, Mechanical; Instruments & Instrumentation; Materials
   Science, Characterization & Testing; Optics
SC Engineering; Instruments & Instrumentation; Materials Science; Optics
GA BJ06W
UT WOS:A1997BJ06W00006
DA 2018-10-20
ER

PT S
AU Deuser, MS
   Vellinger, JC
   Weber, JT
AF Deuser, MS
   Vellinger, JC
   Weber, JT
BE ElGenk, MS
TI Advanced flight hardware for organic separations
SO SPACE TECHNOLOGY AND APPLICATIONS INTERNATIONAL FORUM, PTS 1-3: 1ST
   CONFERENCE ON FUTURE SCIENCE & EARTH SCIENCE MISSIONS; 1ST CONFERENCE ON
   SYNERGISTIC POWER & PROPULSION SYSTEMS TECHNOLOGY; 1ST CONFERENCE ON
   APPLICATIONS OF THERMOPHYSICS IN MICROGRAVITY; 2ND CONFERENCE ON
   COMMERCIAL DEVELOPMENT OF SPACE; - 2ND CONFERENCE ON NEXT GENERATION
   LAUNCH SYSTEMS; 14TH SYMPOSIUM ON SPACE NUCLEAR POWER AND PROPULSION
SE AIP CONFERENCE PROCEEDINGS
LA English
DT Proceedings Paper
CT Space Technology and Applications International Forum (STAIF-97)
CY JAN 26-30, 1997
CL ALBUQUERQUE, NM
SP Def Special Weapons Agcy, NASA, UN DOE, USAF
AB Aqueous Two-Phase Partitioning (ATPP) is a unique separation technique which allows purification and classification of biological materials. SHOT has employed the ATPP process in separation equipment developed for both space and ground applications. Initial equipment development and research focused on the ORganic SEParation (ORSEP) space flight experiments that were performed on suborbital rockets and the shuffle. ADvanced SEParations (ADSEP) technology was developed as the next generation of ORSEP equipment through a NASA Small Business Innovation Research (SBIR) contract. Under the SBIR contract, a marketing study was conducted, indicating a growing commercial market exists among biotechnology firms for ADSEP equipment and associated flight research and development services. SHOT is preparing to begin manufacturing and marketing laboratory versions of the ADSEP hardware for the ground-based market. In addition, through a self-financed SBIR Phase III effort, SHOT fabricated and integrated the ADSEP flight hardware for a commercially-driven flight experiment as the initial step in marketing space processing services. The ADSEP ground-based and microgravity research is expected to play a vital role in developing important new biomedical and pharmaceutical products.
RP Deuser, MS (reprint author), SHOT INC,5605 FEATHERENGILL RD,FLOYDS KNOBS,IN 47119, USA.
NR 0
TC 0
Z9 0
U1 1
U2 2
PU AIP PRESS
PI WOODBURY
PA AMERICAN INSTITUTE OF PHYSICS 500 SUNNYSIDE BOULEVARD, WOODBURY, NY
   11797-2999
SN 0094-243X
BN 1-56396-679-4
J9 AIP CONF PROC
PY 1997
IS 387
BP 785
EP 790
DI 10.1063/1.52081
PG 6
WC Engineering, Aerospace; Nuclear Science & Technology
SC Engineering; Nuclear Science & Technology
GA BH56D
UT WOS:A1997BH56D00121
DA 2018-10-20
ER

PT S
AU Samson, J
   Peterson, L
   Harmon, L
   Conrad, D
   Clark, K
AF Samson, J
   Peterson, L
   Harmon, L
   Conrad, D
   Clark, K
BE ElGenk, MS
TI The Remote Scientist
SO SPACE TECHNOLOGY AND APPLICATIONS INTERNATIONAL FORUM, PTS 1-3: 1ST
   CONFERENCE ON FUTURE SCIENCE & EARTH SCIENCE MISSIONS; 1ST CONFERENCE ON
   SYNERGISTIC POWER & PROPULSION SYSTEMS TECHNOLOGY; 1ST CONFERENCE ON
   APPLICATIONS OF THERMOPHYSICS IN MICROGRAVITY; 2ND CONFERENCE ON
   COMMERCIAL DEVELOPMENT OF SPACE; - 2ND CONFERENCE ON NEXT GENERATION
   LAUNCH SYSTEMS; 14TH SYMPOSIUM ON SPACE NUCLEAR POWER AND PROPULSION
SE AIP CONFERENCE PROCEEDINGS
LA English
DT Proceedings Paper
CT Space Technology and Applications International Forum (STAIF-97)
CY JAN 26-30, 1997
CL ALBUQUERQUE, NM
SP Def Special Weapons Agcy, NASA, UN DOE, USAF
AB Observation and interaction are fundamental aspects of empirical scientific research. While individual requirements for observation and interaction vary across disciplines, there are important common elements. These ''common elements'' are the basis of the $15 billion dollar laboratory automation industry. The United States presently leads the world in this industry, providing products for sample manipulation, sensing (e.g. microscopic and macroscopic imaging devices), data analysis (e.g. image processing, 3D modeling, exploratory data analysis), and human-computer interfaces (e.g. computer graphics, visualization).
   This paper outlines the preliminary design of a unique and innovative system for conducting experiments at a distance, the ''Remote Scientist''. The Remote Scientist extends laboratory automation capability to the microgravity environment. While the Remote Scientist conceptually encompasses a broad spectrum of elements and functionalities, the development approach taken is to:
   establish a baseline capability that is both flexible and versatile incrementally augment the baseline with additional functionalities over time.
   The baseline capability that we have identified as having the most significant impact across multiple research disciplines is the ability to observe on-going experiments during exposure to the microgravity environment. This capability is achievable with technology available today and, additionally, will be able to take advantage of the rapid advances in the underlying technologies that are taking place in the commercial sector.
   The Remote Scientist will support a wide range of experiments through customizable components for: data collection (observation and measurement) manipulation (automated and semi-automated experiment control) investigator interaction (communication between experiment and researcher independent of location)
   By designing for multiple levels of automation, from fully automatic action through remote control and telemanipulation, investigator interaction can be incorporated into experiments at any desired level. The Remote Scientist is designed to offer a full range of digital imaging on both microscopic and macroscopic scales. The system will support spatial and spectral analysis for on-board extraction of important features, thus reducing bandwidth requirements for communications to ground-based investigators. Confocal imaging (optical sectioning), hyperspectral imaging, interferometry, laser scattering, and fluorescence can also be considered as value-added instrumentation within the proposed framework without significant redesign.
   The system is designed to operate within the constraints of a microgravity environment while offering innovative functionality to enhance ground-based experiments as well. The Remote Scientist is initially focused on applications currently being pursued in microgravity such as tissue culture, protein crystal growth and zeolite crystal growth. The real-world requirements of these biomedical and materials applications provide important insight in establishing design-criteria for the system. However, the longer-term applications are envisioned to be much broader.
RP Samson, J (reprint author), NASA,SPACE APPLICAT TECHNOL CTR,ERIM,POB 134001,ANN ARBOR,MI 48113, USA.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU AIP PRESS
PI WOODBURY
PA AMERICAN INSTITUTE OF PHYSICS 500 SUNNYSIDE BOULEVARD, WOODBURY, NY
   11797-2999
SN 0094-243X
BN 1-56396-679-4
J9 AIP CONF PROC
PY 1997
IS 387
BP 877
EP 879
DI 10.1063/1.52094
PG 3
WC Engineering, Aerospace; Nuclear Science & Technology
SC Engineering; Nuclear Science & Technology
GA BH56D
UT WOS:A1997BH56D00134
DA 2018-10-20
ER

PT B
AU Cheang, P
   Khor, KA
AF Cheang, P
   Khor, KA
BE Sudarshan, TS
   Khor, KA
   Jeandin, M
TI Properties and microstructure of plasma sprayed hydroxyapatite coatings
   produced with different powder feedstocks
SO SURFACE MODIFICATION TECHNOLOGIES X
LA English
DT Proceedings Paper
CT 10th International Conference on Surface Modification Technologies
CY SEP 02-04, 1996
CL SINGAPORE, SINGAPORE
SP Nanyang Technol Univ, Sch Mech & Prod Engn, Singapore, Inst Mat, Mat Minerals & Meta Soc, US, ASM Int, Natl Sci Fdn, US
AB Hydroxyapatite (HA) is a bioactive material with Ca to P ratio that is comparable to that of natural bone. This similarity encourages rapid bone growth and bonding between bone tissue and the implant surface. Plasma spraying is an efficient coating method of depositing HA onto biomedical implants. However, the biocompatibility of HA changes after plasma spraying. This paper reports the preparation and characterisation of HA coatings using different feedstocks such as agglomerated calcined HA (CHA) and dense flame spheroidised HA (SHA). The results indicate that the state of the starting powder in terms of geometry, shape and structure can produce efficacious effects on the coating characteristics. Both calcined HA and flame spheroidised HA powders were plasma sprayed onto metallic substrates and stubs. Coatings generated from spheroidised HA (SHA) powders have unique surface and microstructure characteristics while the coatings produced with CHA are porous and contain unmelted particles, SEM observation of the coating surface reveals well-formed splats that spread and flatten to a disc configuration without disintegration. This reflects adequate melting of the HA in the plasma with good deposition consistency. The surface topography is generally flat with considerable overlapping of subsequent spreading droplets. Porosity in the form of macropores is substantially reduced compared to CHA coatings. The cross-section microstructure reveals a highly dense coating comprising of randomly stacked lamellae. The tensile adhesion test (TAT) recorded the highest cohesive strength in the flame spheroidised HA coating. This suggests that having a structurally stable powder that is both dense and spherical promotes mechanically strong and coherent coatings.
RP Cheang, P (reprint author), NANYANG TECHNOL UNIV,SCH APPL SCI,NANYANG AVE,SINGAPORE 639798,SINGAPORE.
RI Khor, Khiam Aik/G-2827-2010; Khor, Khiam Aik (Michael)/B-6929-2009
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ASHGATE PUBLISHING LTD
PI ALDERSHOT
PA GOWER HOUSE, CROFT ROAD, ALDERSHOT, ENGLAND
BN 1-86125-022-3
PY 1997
BP 747
EP 758
PG 12
WC Engineering, Mechanical; Materials Science, Coatings & Films
SC Engineering; Materials Science
GA BJ63U
UT WOS:A1997BJ63U00062
DA 2018-10-20
ER

PT B
AU Wang, Y
   Khor, KA
   Cheang, P
AF Wang, Y
   Khor, KA
   Cheang, P
BE Sudarshan, TS
   Khor, KA
   Jeandin, M
TI Thermal spraying of functionally graded bioceramic coatings
SO SURFACE MODIFICATION TECHNOLOGIES X
LA English
DT Proceedings Paper
CT 10th International Conference on Surface Modification Technologies
CY SEP 02-04, 1996
CL SINGAPORE, SINGAPORE
SP Nanyang Technol Univ, Sch Mech & Prod Engn, Singapore, Inst Mat, Mat Minerals & Meta Soc, US, ASM Int, Natl Sci Fdn, US
AB Biomedical requirements in a prosthesis are often complex and diverse in nature. Biomaterials for implants have to display a wide range of adaptability to suit the various stages of the bio-integration of the foreign material into the human body. Often a combination of materials is needed. This paper reports the preparation of a functionally graded bioceramic coating composed of essentially calcium phosphate compounds. The coating is graded in accordance to adhesive strength and bioresorbability. The bond coat On the metal stub is deposited with a particle range of the hydroxyapatite materials that will provide a high adhesive strength and bioactivity but have poor bioresorption properties. The top coat however is composed of mainly alpha-tricalcium phosphate that is highly bioresorbable. This arrangement has the propensity of allowing accelerated bio-integration of the coating by the body tissues as the top layer is rapidly resorbed, leaving the more bioactive intermediate layer to facilitate the much needed bioactive properties for proper osteoconduction. The processing steps and problems will be highlighted in this paper as well as the results of post-spray treatment with hot isostatic pressing.
RP Wang, Y (reprint author), NANYANG TECHNOL UNIV,SCH MECH & PROD ENGN,SINGAPORE 639798,SINGAPORE.
RI Khor, Khiam Aik/G-2827-2010; Khor, Khiam Aik (Michael)/B-6929-2009
NR 0
TC 0
Z9 0
U1 0
U2 2
PU ASHGATE PUBLISHING LTD
PI ALDERSHOT
PA GOWER HOUSE, CROFT ROAD, ALDERSHOT, ENGLAND
BN 1-86125-022-3
PY 1997
BP 925
EP 933
PG 9
WC Engineering, Mechanical; Materials Science, Coatings & Films
SC Engineering; Materials Science
GA BJ63U
UT WOS:A1997BJ63U00079
DA 2018-10-20
ER

PT B
AU Lotters, JC
   Olthuis, W
   Veltink, PH
   Bergveld, P
AF Lotters, JC
   Olthuis, W
   Veltink, PH
   Bergveld, P
GP IEEE
TI Characterisation of a highly symmetrical miniature capacitive triaxial
   accelerometer
SO TRANSDUCERS 97 - 1997 INTERNATIONAL CONFERENCE ON SOLID-STATE SENSORS
   AND ACTUATORS, DIGEST OF TECHNICAL PAPERS, VOLS 1 AND 2
LA English
DT Proceedings Paper
CT 1997 International Conference on Solid-State Sensors and Actuators
CY JUN 16-19, 1997
CL CHICAGO, IL
SP IEEE Electron Devices Soc
DE triaxial accelerometer; capacitive sensor; three-dimensional structure
AB A highly symmetrical cubic capacitive triaxial accelerometer for biomedical applications has been designed, realised and tested. The sensors are available in two outer dimensions, namely 2x2x2 and 5x5x5 mm(3). The devices are mounted on a standard IC package for easy testing. Features of the sensor are a highly symmetrical cubic structure, capacitive coupling of the high frequency input voltage to the seismic mass and the use of the polymers polydimethylsiloxane (PDMS:) as spring material between the capacitor plates and the mass and polyimide (PI) as flexible interconnection layer between the capacitor plates. The sensor structure and its basic operating principle, its mathematical mass-spring-damper model and the necessary cleanroom technology are described. The measurement results show a sensitivity of similar to 0.15 V/(m/s(2)) with a corresponding resolution of 0.01 m/s(2), an off-axis sensitivity of < 5 %, a good linearity in the output voltage for accelerations up to at least 50 m/s(2) and a bandwidth of DC - 500 Hz.
RP Lotters, JC (reprint author), UNIV TWENTE,MESA RES INST,POB 217,NL-7500 AE ENSCHEDE,NETHERLANDS.
RI Veltink, Peter/L-3738-2016
OI Veltink, Peter/0000-0002-1796-9999
NR 0
TC 3
Z9 3
U1 0
U2 0
PU I E E E
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017
BN 0-7803-3829-4
PY 1997
BP 1177
EP 1180
PG 4
WC Engineering, Electrical & Electronic
SC Engineering
GA BJ35B
UT WOS:A1997BJ35B00288
DA 2018-10-20
ER

PT S
AU Moscato, U
   De Belvis, AG
   Romano-Spica, V
AF Moscato, U
   De Belvis, AG
   Romano-Spica, V
BE Manzo, L
   Descotes, J
   Hoskins, J
TI Indoor pollution by aromatic hydrocarbons: Results of a survey in the
   histopathology laboratories of an Italian hospital
SO VOLATILE ORGANIC COMPOUNDS IN THE ENVIRONMENT - RISK ASSESSMET AND
   NEUROTOXICITY
SE ADVANCES IN OCCUPATIONAL MEDICINE & REHABILITATION
LA English
DT Proceedings Paper
CT International Conference on Volatile Organic Compounds
CY OCT 05-07, 1997
CL SALVATORE MAUGERI FDN MED CTR, PAVIA, ITALY
SP Univ Pavia, Salvatore Maugeri Fdn, Int Soc Built Environm, Natl Res Council, Rome, AgipPetroli, BASF, CON TEC Engn, DANI, Draeger Italiana, FIAT Auto, FKV, Instrumentat Lab, IPSOA Editore Indicitalia, Perkin Elmer, Pollut Srl Clean Air Syst, San Air Ambiente, Tecnol Ind & Ambientali, Unione Petrolifera, Zambelli
HO SALVATORE MAUGERI FDN MED CTR
DE hospital; histopathology laboratories; aromatic hydrocarbons; gas
   chromatography; geostatistics
AB The purpose of this study was to evaluate indoor pollution by benzene, toluene and the xylene isomers (BTX) in the histopathology laboratories of a hospital using spatial data modelling techniques to identify. sources and distribution of air pollutants. Indoor-outdoor and personal sampling were performed in several laboratory environments using diffusive charcoal samplers (radial type). Analysis was carried out using capillary gas-chromatography and mass-spectrometry. All values of BTX were higher in indoor environments than outdoors. These results suggest indoor hospital sources of BTX, such as building materials, office equipment, radiography developers or, in particular, histological slide fixing procedures. We believe that geostatistical methods could he very helpful in the assessment and management of indoor pollution risk. The importance of such risk should not be overlooked as exposure to BTX, deriving from hospital biomedical activities, could involve people other than hospital staff (patients, relatives and hospital visitors).
C1 Catholic Univ, Inst Hyg, I-00168 Rome, Italy.
RP Moscato, U (reprint author), Catholic Univ, Inst Hyg, Largo F Vito 1, I-00168 Rome, Italy.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU FONDAZIONE SALVATORE MAUGERI EDIZIONI, PI-ME PRESS
PI PAVIA 27100
PA VIALE SARDEGNA 64, PAVIA 27100, ITALY
SN 1123-8364
BN 88-7963-085-7
J9 ADV OCCUP MED REHAB
PY 1997
VL 3
IS 3
BP 55
EP 68
PG 14
WC Environmental Sciences; Public, Environmental & Occupational Health;
   Rehabilitation; Toxicology
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health; Rehabilitation; Toxicology
GA BM07W
UT WOS:000077556200006
DA 2018-10-20
ER

PT J
AU Kobayashi, K
   Kamiya, S
   Enomoto, N
AF Kobayashi, K
   Kamiya, S
   Enomoto, N
TI Amylose-carrying styrene macromonomer and its homo- and copolymers:
   Synthesis via enzyme-catalyzed polymerization and complex formation with
   iodine
SO MACROMOLECULES
LA English
DT Article
ID DIMETHYL-SULFOXIDE; BEHAVIOR; MODEL
AB The objective of our research was to prepare novel conjugates between polysaccharides and vinyl polymers by applying enzymes as polymerization catalyst for polysaccharide synthesis. An approach was attained using amylose-substituted styrene macromonomers (vinylbenzyl amylose amide, VAA; the number-average degree of polymerization of amylose = 24 and 150) which were synthesized from maltopentaose-substituted styrene (VM5A) by phosphorylase-catalyzed polymerization of glucose 1-phosphate. Radical homo- and copolymerization of VAA gave an uncommon type of graft copolymers consisting of polystyrene and polyacrylamide backbones and amylose side chains of uniform length. Water-insoluble amylose was solubilized into water by incorporating VAA units into polyacrylamide main chains and also by hydroxypropylation of the amylose moieties of water-insoluble copolymers. Structural features of these graft copolymers were discussed on the basis of amylose-iodine complexation investigated by UV spectroscopy. Schematic structures of two different types of polystyrene-graft-amylose prepared via homopolymerization of VAA and via enzymatic elongation from poly(VM5A) were proposed. These amylose-carrying polyacrylamide and polystyrene prepared by applying enzyme-catalyzed polymerization are of interest as a new type of biomedical material and a well-defined model for conformational analysis.
C1 NAGOYA UNIV,SCH AGR SCI,NAGOYA,AICHI 46401,JAPAN.
   NAKANO VINEGAR CO LTD,HANDA,AICHI 475,JAPAN.
CR ANDRESZ H, 1978, MAKROMOL CHEM, V179, P301
   BANKS W, 1971, CARBOHYD RES, V17, P25, DOI 10.1016/S0008-6215(00)81539-6
   CESARO A, 1986, J PHYS CHEM-US, V90, P2787, DOI 10.1021/j100403a047
   DAVIS H, 1994, J POLYM SCI POL CHEM, V32, P2267, DOI 10.1002/pola.1994.080321208
   DORDICK JS, 1994, CHEMTECH, P33
   Fiske CH, 1925, J BIOL CHEM, V66, P375
   Guilbot A., 1985, POLYSACCHARIDES, V3, P209
   HANDA T, 1981, BIOPOLYMERS, V20, P2051, DOI 10.1002/bip.1981.360201003
   ITO K, 1991, MACROMOLECULES, V24, P2348, DOI 10.1021/ma00009a035
   KAMOGAWA A, 1963, J BIOCH, V63, P361
   KOBAYASHI K, 1987, MACROMOLECULES, V20, P906, DOI 10.1021/ma00170a035
   KOBAYASHI K, 1994, J CARBOHYD CHEM, V13, P753, DOI 10.1080/07328309408011678
   Kobayashi Kazukiyo, 1994, P261
   LEE DS, 1982, CARBOHYD RES, V106, P1, DOI 10.1016/S0008-6215(00)80728-4
   MISCHNICK P, 1989, CARBOHYD RES, V192, P233, DOI 10.1016/0008-6215(89)85182-1
   NAKANISHI Y, 1993, MACROMOLECULES, V26, P4220, DOI 10.1021/ma00068a023
   PARFONDRY A, 1977, CARBOHYD RES, V57, P39, DOI 10.1016/S0008-6215(00)81918-7
   PATIL DR, 1991, BIOTECHNOL BIOENG, V37, P639, DOI 10.1002/bit.260370706
   PFANNEMULLER B, 1975, NATURWISSENSCHAFTEN, V62, P231, DOI 10.1007/BF00603168
   STJACQUES M, 1976, J AM CHEM SOC, V98, P4386, DOI 10.1021/ja00431a007
   TSUKAHARA Y, 1990, MACROMOLECULES, V23, P5201, DOI 10.1021/ma00227a006
   TSUKAHARA Y, 1989, MACROMOLECULES, V22, P1546, DOI 10.1021/ma00194a007
   VONBRAUNMUHL V, 1995, MACROMOLECULES, V28, P17
   WULFF G, 1992, MAKROMOL CHEM, V193, P1071
   YAJIMA H, 1987, CARBOHYD RES, V163, P155, DOI 10.1016/0008-6215(87)80179-9
   ZIEGAST G, 1987, CARBOHYD RES, V160, P185, DOI 10.1016/0008-6215(87)80311-7
NR 26
TC 65
Z9 65
U1 1
U2 8
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036
SN 0024-9297
J9 MACROMOLECULES
JI Macromolecules
PD DEC 30
PY 1996
VL 29
IS 27
BP 8670
EP 8676
DI 10.1021/ma9603443
PG 7
WC Polymer Science
SC Polymer Science
GA WB741
UT WOS:A1996WB74100015
DA 2018-10-20
ER

PT J
AU Schiager, KJ
   McDougall, MM
   Christman, EA
   Party, E
   Ring, J
   Carlson, DE
   Warfield, CA
   Barkley, WE
AF Schiager, KJ
   McDougall, MM
   Christman, EA
   Party, E
   Ring, J
   Carlson, DE
   Warfield, CA
   Barkley, WE
TI Consensus radiation protection practices for academic research
   institutions
SO HEALTH PHYSICS
LA English
DT Article
DE radiation protection; monitoring, personnel; bioassay; safety standards
AB Under the auspices of the Howard Hughes Medical Institute, a set of consensus guidelines for Radiation Protection Practices has been developed for biomedical research using radioactive materials. The purposes of the guidelines are (1) to promote good radiation protection practices consistent with the needs of biomedical research, the ALARA principle, and regulatory requirements; (2) to establish common goals and consistent practices within radiation safety programs; and (3) to build a meaningful partnership between radiation safety professionals and the biomedical research community, These practices are intended to enhance radiation protection and the efficiency of the research staff, The consensus guidelines will lessen the variability in radiation safety practices that is evident among many academic research institutions and nib encourage better acceptance and regulatory compliance by users of radioactive materials in biomedical research.
C1 UNIV UTAH, SALT LAKE CITY, UT 84112 USA.
   UNIV CALIF SAN DIEGO, SAN DIEGO, CA 92093 USA.
   COLUMBIA UNIV HLTH SCI, NEW YORK, NY 10032 USA.
   ROCKEFELLER UNIV, NEW YORK, NY 10021 USA.
   HARVARD UNIV, CAMBRIDGE, MA 02138 USA.
   UNIV TEXAS, SW MED CTR, DALLAS, TX 75235 USA.
   HOWARD HUGHES MED INST, CHEVY CHASE, MD 20815 USA.
CR *INT COMM RAD PROT, 1979, ANN ICRP, V2, P1
NR 1
TC 1
Z9 1
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0017-9078
EI 1538-5159
J9 HEALTH PHYS
JI Health Phys.
PD DEC
PY 1996
VL 71
IS 6
BP 960
EP 965
DI 10.1097/00004032-199612000-00015
PG 6
WC Environmental Sciences; Public, Environmental & Occupational Health;
   Nuclear Science & Technology; Radiology, Nuclear Medicine & Medical
   Imaging
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health; Nuclear Science & Technology; Radiology, Nuclear Medicine &
   Medical Imaging
GA VW160
UT WOS:A1996VW16000020
PM 8919082
DA 2018-10-20
ER

PT J
AU Zaichik, VE
   Zaichik, SV
AF Zaichik, VE
   Zaichik, SV
TI Instrumental effect on the contamination of biomedical samples in the
   course of sampling
SO JOURNAL OF ANALYTICAL CHEMISTRY
LA English
DT Article
ID NEUTRON-ACTIVATION ANALYSIS; BIOLOGICAL-MATERIALS; TISSUES; ELEMENTS
AB The effect of surgical instruments on the contamination of human soft tissues with trace elements in the course of sampling was examined. Samples were taken with the use of a common scalpel and a knife of titanium from a thyroid gland of a male patient who died in an automobile accident. In these samples, Ag, Co, Cr, Fe, Hg, Rb, Sb, Se, and Zn were determined by instrumental neutron activation analysis. The average concentrations of elements in the samples taken with the scalpel were higher than those in the samples taken with the knife by a factor of 1.4-2.5, and this factor was 48 for chromium. Statistically reliable differences were found only for Cr and Co because of high variances of concentrations caused by nonuniformly distributed trace elements in the bulk of the thyroid gland. Recommendations on the choice of sampling instruments in biomedical examinations were given.
C1 RUSSIAN STATE MED UNIV,MOSCOW 117437,RUSSIA.
RP Zaichik, VE (reprint author), RUSSIAN ACAD MED SCI,MED RADIOL RES INST,UL KOROLEVA 4,OBNINSK 249020,KALUZHSKAYA OBL,RUSSIA.
CR BYRNE AR, 1978, SCI TOTAL ENVIRON, V10, P17, DOI 10.1016/0048-9697(78)90046-3
   CORNELIS R, 1986, MODERN TRENDS ACTIVA, V7, P93
   GILLS TE, 1977, J RADIOANAL CHEM, V39, P285, DOI 10.1007/BF02517234
   HAMILTON EI, 1994, SCI TOTAL ENVIRON, V158, P165, DOI 10.1016/0048-9697(94)04317-G
   Hamilton EI, 1973, SCIENCE TOTAL ENVIRO, V1, P341, DOI DOI 10.1016/0048-9697(73)90024-7
   HEYDORN K, 1984, ELEMENTS HLTH DIS, P42
   HEYDORN K, 1984, NEUTRON ACTIVATION A, V2
   HISLOP JS, 1973, ANALYST, V98, P694, DOI 10.1039/an9739800694
   IYENGAR GV, 1978, ELEMENTAL COMPOSITIO
   IYENGAR GV, 1988, QUANTITATIVE TRACE A, P401
   IYENGAR GV, 1984, DOC323 IAEA TEC, P83
   KABATOV YF, 1977, MEDITSINSKII INSTRUM
   KORELO AM, 1993, D1493325 OIYAI, P326
   MALETSKOS CJ, 1970, TRACE SUBSTANCES ENV, V4, P367
   MOSULISHVILI LM, 1975, J RADIOANAL CHEM, V26, P175, DOI 10.1007/BF02516523
   Parr R., 1980, 2 IAEA
   PARR RM, 1977, J RADIOANAL CHEM, V39, P421, DOI 10.1007/BF02517247
   PIETRA R, 1985, J RADIOAN NUCL CH AR, V92, P247, DOI 10.1007/BF02219754
   PIETRA R, 1990, ANALYST, V115, P1025, DOI 10.1039/an9901501025
   PLANTIN LO, 1972, NUCLEAR ACTIVATION T, P73
   SATEL EF, 1964, SPRAVOCHNIK MASHINOS, V6
   SPEECKE A, 1975, NBS SPECIAL PUBL, V422
   VERSIECK J, 1973, CLIN CHEM, V19, P472
   VERSIECK J, 1982, TALANTA, V29, P973, DOI 10.1016/0039-9140(82)80238-5
   VERSIECK J, 1972, NUCLEAR ACTIVATION T, P39
   Ward N. I., 1993, Trace elements in man and animals - TEMA 8: Proceedings of the Eighth International Symposium on Trace Elements in Man and Animals., P108
   Zaichick V, 1978, LAB DELO, V2, P109
NR 27
TC 6
Z9 8
U1 0
U2 0
PU MAIK NAUKA/INTERPERIODICA
PI NEW YORK
PA C/O PLENUM/CONSULTANTS BUREAU 233 SPRING ST, NEW YORK, NY 10013
SN 1061-9348
J9 J ANAL CHEM+
JI J. Anal. Chem.
PD DEC
PY 1996
VL 51
IS 12
BP 1200
EP 1205
PG 6
WC Chemistry, Analytical
SC Chemistry
GA VX862
UT WOS:A1996VX86200015
DA 2018-10-20
ER

PT J
AU Schubert, MA
   Wiggins, MJ
   DeFife, KM
   Hiltner, A
   Anderson, JM
AF Schubert, MA
   Wiggins, MJ
   DeFife, KM
   Hiltner, A
   Anderson, JM
TI Vitamin E as an antioxidant for poly(etherurethane urea): In vivo
   studies
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
ID POLYURETHANE ELASTOMERS; GIANT-CELLS; INVIVO; BIOCOMPATIBILITY;
   DEGRADATION; INVITRO; FORM
AB Poly(etherurethane) elastomers are useful materials in medical devices because of their mechanical properties and biocompatibility. However, it is necessary to stabilize these elastomers against the oxidation of their ether soft segments. Synthetic antioxidants such as Santowhite(R) and Irganox(R) are often satisfactory; however, particularly for biomedical applications, it was of interest to test the natural antioxidant vitamin E in poly(etherurethane urea) (PEUU) elastomers in vivo. The alpha-tocopherol form of vitamin E was added to PEUU at 5% by weight. Biaxially strained PEUU specimens with and without vitamin E were tested in vivo in the cage implant system. The influence of vitamin E on PEUU biostability was analyzed by attenuated total reflectance-Fourier transform infrared (ATR-FTIR) spectroscopy and scanning electron microscopic (SEM) characterization of the PEUU surface. ATR-FTIR results showed that vitamin E prevented chemical degradation of the PEUU surface up to 5 weeks implantation, and at 10 weeks 82% of the ether remained. In contrast, without an antioxidant, only 18% of the ether remained after 10 weeks. No surface pitting or cracking was observed by SEM on PEUU with vitamin E; PEUU without antioxidant ruptured owing to extensive pitting and cracking. It was concluded that the antioxidant properties of vitamin E prevented oxidation of strained PEUU elastomers in vivo. The influence of vitamin E on PEUU biocompatibility was characterized by exudate leukocyte counts, density of leukocytes adherent to the PEUU, and morphology of adherent leukocytes. These results indicated decreased leukocyte counts in the exudate and less active adherent cells on the PEUU with vitamin E compared to PEUU without antioxidant. A proposed cell-polymer feedback system demonstrates how vitamin E improves both biostability and biocompatibility of PEUU elastomers in vivo. (C) 1996 John Wiley & Sons, Inc.
C1 CASE WESTERN RESERVE UNIV,DEPT MACROMOL SCI,CLEVELAND,OH 44106.
   CASE WESTERN RESERVE UNIV,INST PATHOL,CLEVELAND,OH 44106.
FU NHLBI NIH HHS [HL-25239, HL-33849]
CR ANDERSON JM, 1984, BIOMATERIALS, V5, P5, DOI 10.1016/0142-9612(84)90060-7
   Andrade JD, 1985, SURFACE INTERFACIAL, V2, P1
   BURTON GW, 1985, J AM CHEM SOC, V107, P7053, DOI 10.1021/ja00310a049
   GREEN J, 1965, BIOCH QUINONES, P261
   HAKIM RM, 1993, CARDIOVASC PATHOL, V2, pS187
   HEIPLE JM, 1990, CELL MOTIL CYTOSKEL, V15, P260, DOI 10.1002/cm.970150408
   *INF INC, 1973, GRAS FOOD INGR TOC, P237
   KAMBIC HE, 1986, CHEM ENG NEWS   0414, P31
   Lelah M. D., 1986, POLYURETHANES MED
   LIEBLER DC, 1994, METHOD ENZYMOL, V234, P310
   MARCHANT R, 1983, J BIOMED MATER RES, V17, P301, DOI 10.1002/jbm.820170209
   MEIJS GF, 1993, J BIOMED MATER RES, V27, P345, DOI 10.1002/jbm.820270308
   MEYDANI M, 1995, LANCET, V345, P170, DOI 10.1016/S0140-6736(95)90172-8
   MOUDJOU M, 1989, J CELL SCI, V94, P237
   MURCH AR, 1982, J PATHOL, V137, P177, DOI 10.1002/path.1711370302
   Packer Lester, 1993, P179
   PARINS DJ, 1981, IN VIVO DEGRADATION
   SCHUBERT MA, 1995, J BIOMED MATER RES, V29, P337, DOI 10.1002/jbm.820290309
   SUTTON JS, 1966, J CELL BIOL, V28, P303, DOI 10.1083/jcb.28.2.303
   Szycher M, 1988, J Biomater Appl, V3, P297, DOI 10.1177/088532828800300207
   WU Y, 1992, J APPL POLYM SCI, V46, P201, DOI 10.1002/app.1992.070460202
   ZHAO QH, 1993, J BIOMED MATER RES, V27, P379, DOI 10.1002/jbm.820270311
   ZHAO QH, 1992, J BIOMED MATER RES, V26, P1019, DOI 10.1002/jbm.820260805
NR 23
TC 38
Z9 38
U1 1
U2 10
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD DEC
PY 1996
VL 32
IS 4
BP 493
EP 504
DI 10.1002/(SICI)1097-4636(199612)32:4<493::AID-JBM1>3.3.CO;2-H
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA VV829
UT WOS:A1996VV82900001
PM 8953138
DA 2018-10-20
ER

PT J
AU Nickell, D
   Herzog, HA
AF Nickell, D
   Herzog, HA
TI Ethical ideology and moral persuasion: Personal moral philosophy,
   gender, and judgments of pro- and anti-animal research propaganda
SO SOCIETY & ANIMALS
LA English
DT Article
ID ATTITUDES; KNOWLEDGE
AB We examined the relationship between personal moral philosophy, gender, and judgments of the effectiveness of materials designed by advocacy groups to sway public opinion about biomedical research using nonhuman animals. Twenty-six male and 74 female undergraduates evaluated 16 advertisements or brochures developed by groups which either supported or opposed animal research. The subjects also completed the Ethics Position Questionnaire (EPQ) and were offered the opportunity to sign postcards urging their congressperson to either support or eliminate federal funding of animal research. Females perceived the anti-animal research materials to be more effective than did the males, a difference that was not found in the case of the pro-animal research materials. The idealism dimension of the EPQ and gender accounted for a significant portion of the variation in judgments of the effectiveness of the anti-animal research materials but not the pro-animal research materials. The pattern of postcard signing was predicted by the subjects' evaluations of the stimulus materials but not gender or the EPQ variables.
C1 WESTERN CAROLINA UNIV, DEPT PSYCHOL, CULLOWHEE, NC 28723 USA.
CR BALZAR J, 1993, LOS ANGELES TIM 1225, P30
   BALZAR J, 1993, LOS ANGELES TIM 1225, P1
   BALZAR J, 1993, LOS ANGELES TIM 1225, P31
   Bowd A. D., 1989, ANTHROZOOS, V3, P20
   Broida John, 1993, SOC ANIM, V1, P129, DOI DOI 10.1163/156853093X00037
   DRISCOLL JW, 1992, ANTHROZOOS, V5, P32, DOI 10.2752/089279392787011575
   EAGLY A, 1993, PSYCHOL ATTITUDES
   FORSYTH DR, 1984, J PERS SOC PSYCHOL, V46, P1365, DOI 10.1037/0022-3514.46.6.1365
   FORSYTH DR, 1980, J PERS SOC PSYCHOL, V39, P175, DOI 10.1037//0022-3514.39.1.175
   FORSYTH DR, 1982, J SOC PSYCHOL, V117, P53, DOI 10.1080/00224545.1982.9713406
   FORSYTH DR, 1988, J PSYCHOL, V122, P243, DOI 10.1080/00223980.1988.9915511
   GALLUP GG, 1988, AM PSYCHOL, V43, P474, DOI 10.1037/0003-066X.43.6.474
   Galvin Shelley L, 1992, Ethics Behav, V2, P263
   Galvin Shelley L, 1992, Ethics Behav, V2, P141, DOI 10.1207/s15327019eb0203_1
   GALVIN SL, 1994, M SE PSYCH ASS NEW O
   HERZOG HA, 1993, J SOC ISSUES, V49, P103, DOI 10.1111/j.1540-4560.1993.tb00911.x
   HERZOG HA, IN PRESS RESPONSIBLE
   HERZOG HA, IN PRESS ANTHROPOMOR
   Herzog Jr H. A., 1990, ANTHROZOOS, V4, P184, DOI DOI 10.2752/089279391787057170
   JASEPR JM, 1992, ANIMAL RIGHTS CRUSAD
   KELLERT SR, 1987, WILDLIFE SOC B, V15, P363
   KELLERT SR, 1980, INT J STUD ANIM PROB, V1, P87
   PAUL ES, 1993, ANIM WELFARE, V2, P321
   PETERSON C, 1984, PSYCHOL REV, V91, P347, DOI 10.1037/0033-295X.91.3.347
   PETERSON C, 1982, COGNITIVE THER RES, V6, P287, DOI 10.1007/BF01173577
   PLOUS S, 1991, PSYCHOL SCI, V2, P194, DOI 10.1111/j.1467-9280.1991.tb00131.x
   SCHLENKER BR, 1977, J EXP SOC PSYCHOL, V13, P369, DOI 10.1016/0022-1031(77)90006-3
   SHAPIRO K, 1994, SOC ANIM, V2, P145, DOI 10.1163/156853094X00153
   Singer P., 1975, ANIMAL LIBERATION
   SINGH B, 1989, B PSYCHONOMIC SOC, V27, P160, DOI 10.3758/BF03329928
   SPERLING S, 1988, ANIMAL LIBERATORS RE
   WUENSCH KL, 1992, M AN BEH SOC KINGST
NR 32
TC 10
Z9 11
U1 0
U2 10
PU BRILL ACADEMIC PUBLISHERS
PI LEIDEN
PA PLANTIJNSTRAAT 2, P O BOX 9000, 2300 PA LEIDEN, NETHERLANDS
SN 1063-1119
EI 1568-5306
J9 SOC ANIM
JI Soc. Anim.
PD WIN
PY 1996
VL 4
IS 1
BP 53
EP 64
DI 10.1163/156853096X00043
PG 12
WC Sociology; Veterinary Sciences
SC Sociology; Veterinary Sciences
GA UC991
UT WOS:A1996UC99100004
PM 11654529
DA 2018-10-20
ER

PT J
AU Bernatchez, SF
   Parks, PJ
   Gibbons, DF
AF Bernatchez, SF
   Parks, PJ
   Gibbons, DF
TI Interaction of macrophages with fibrous materials in vitro
SO BIOMATERIALS
LA English
DT Article
DE fibres; macrophages; adhesion; cytokines
ID RAT ALVEOLAR MACROPHAGES; BIOMEDICAL POLYMERS; INTERLEUKIN-1 GENERATION;
   CYTOKINE PRODUCTION; SYNTHETIC-FIBERS; COLLAGEN SPONGE; TISSUE-RESPONSE;
   ASBESTOS FIBERS; HUMAN-MONOCYTES; POROUS POLYMER
AB Fibrous materials have the potential of being used for tissue scaffolding. The interaction of macrophages with fibres of various compositions and sizes was observed in vitro. The following materials were tested: individual gold fibres; woven fibres of polyester and nylon; non-woven fibres of polybutylene/polypropylene 80:20 and polyester. All fibres had diameters between 2 and 40 mu m. At the end of the 24 h incubation time, culture media were retrieved for the assay of tumour necrosis factor alpha (TNF-alpha) and interleukin-6 (IL-6), two cytokines secreted by activated macrophages. Fibre samples were processed for scanning electron microscopy (SEM), or for immunofluorescence labelling of the MAC-1 and ICAM-1 cell surface markers. Confocal microscopy was used for the latter, which was performed with the woven and non-woven samples. None of the fibre samples induced significant amounts of TNF-alpha or IL-6 secretion in the culture medium, suggesting that the cells did not activate this pathway. SEM on individual gold fibres showed that the fibre diameter had an effect on the morphology of the cells, namely on their extent of spreading. Larger fibres had a higher number of cells, which tended to cluster together without spreading extensively. When comparing woven and non-woven fibres, SEM showed that cells spread extensively on the woven fibres, whereas they tended to maintain their spherical shape on the non-woven fibres. Confocal microscopy demonstrated a difference between materials in the number of MAC-1 and ICAM-1 positive cells. These results demonstrate that a combination of morphological, immune and biochemical markers can be used to distinguish the response of elicited macrophages to various materials. The cells appeared to be only moderately activated on all materials tested, with changes in their morphology but without increased secretion of cytokines. The measured responses imply interactions between nominal fibre composition and fibre diameter. (C) 1996 Elsevier Science Limited
C1 UNIV MINNESOTA, CTR INTERFACIAL ENGN, SHEPHERD LABS 187, MINNEAPOLIS, MN 55455 USA.
   3M CO, LIFE SCI SECTOR LAB, ST PAUL, MN 55144 USA.
CR ADAMSON IYR, 1991, LAB INVEST, V64, P339
   ANDERSON JM, 1984, BIOMATERIALS, V5, P5, DOI 10.1016/0142-9612(84)90060-7
   ANDERSON JM, 1988, ASAIO, V11, P101
   ANDESON JM, 1993, CARDIOVASC PATHOL, V4, pS33
   BARBUL A, 1990, CLIN PLAST SURG, V17, P433
   BELLAMKONDA R, 1995, J BIOMED MATER RES, V29, P663, DOI 10.1002/jbm.820290514
   BERTHOD F, 1993, BIOMATERIALS, V14, P749, DOI 10.1016/0142-9612(93)90039-5
   BONFIELD TL, 1992, J BIOMED MATER RES, V26, P837, DOI 10.1002/jbm.820260702
   BONFIELD TL, 1992, J BIOMED MATER RES, V26, P457, DOI 10.1002/jbm.820260404
   BRANDWOOD A, 1992, BIOMATERIALS, V13, P646, DOI 10.1016/0142-9612(92)90035-M
   CARDONA MA, 1992, J BIOMED MATER RES, V26, P851, DOI 10.1002/jbm.820260703
   CLARK RAF, 1988, MOL CELLULAR BIOL WO, P1
   CLARKE IC, 1992, AM SOC TEST MATER, V1144, P7, DOI 10.1520/STP14848S
   DARVILLE T, 1992, IMMUNOL INVEST, V21, P539, DOI 10.3109/08820139209069389
   Doillon C J, 1988, J Biomater Appl, V2, P562
   DOILLON CJ, 1987, BIOMATERIALS, V8, P195, DOI 10.1016/0142-9612(87)90063-9
   DUBOIS CM, 1989, AM REV RESPIR DIS, V139, P1257, DOI 10.1164/ajrccm/139.5.1257
   EJIM OS, 1993, BIOMATERIALS, V14, P743, DOI 10.1016/0142-9612(93)90038-4
   FORNASIER V, 1994, SCI REG INT S MONTR, P53
   FREED LE, 1993, J BIOMED MATER RES, V27, P11, DOI 10.1002/jbm.820270104
   Gibbons D. F., 1994, Clinical Materials, V15, P37, DOI 10.1016/0267-6605(94)90007-8
   GIBBONS DF, 1994, STUD POLYM SCI, V12, P470
   GIBSON SJ, 1995, J INTERF CYTOK RES, V15, P537, DOI 10.1089/jir.1995.15.537
   GOODGLICK LA, 1990, CANCER RES, V50, P5153
   JANSEN JA, 1994, J MATER SCI-MATER M, V5, P284, DOI 10.1007/BF00122398
   JAURAND MC, 1987, J NATL CANCER I, V79, P797
   LEAKE ES, 1975, J RETICULOENDOTH SOC, V17, P370
   LEENEN PJM, 1994, J IMMUNOL METHODS, V174, P5, DOI 10.1016/0022-1759(94)90005-1
   LEENEN PJM, 1993, BLOOD CELL BIOCH, V5, P29
   LUOTO K, 1994, ENVIRON RES, V66, P198, DOI 10.1006/enrs.1994.1055
   MAROIS Y, 1993, BIOMATERIALS, V14, P255, DOI 10.1016/0142-9612(93)90115-I
   MCPHERSON GK, 1985, CLIN ORTHOP RELAT R, P186
   MILLER KM, 1989, BIOMATERIALS, V10, P187, DOI 10.1016/0142-9612(89)90023-9
   MILLER KM, 1988, J BIOMED MATER RES, V22, P713, DOI 10.1002/jbm.820220805
   MILLER KM, 1989, J BIOMED MATER RES, V23, P911, DOI 10.1002/jbm.820230808
   OXLEY HR, 1993, BIOMATERIALS, V14, P1064, DOI 10.1016/0142-9612(93)90207-I
   Pizzoferrato Arturo, 1994, Clinical Materials, V15, P173, DOI 10.1016/0267-6605(94)90081-7
   RASP FL, 1979, J RETICULOENDOTH SOC, V25, P101
   Robinson D, 1993, Agents Actions Suppl, V39, P231
   RUTHERFORD MS, 1993, J LEUKOCYTE BIOL, V53, P602
   SHANBHAG AS, 1994, J BIOMED MATER RES, V28, P81, DOI 10.1002/jbm.820280111
   SHIEH SJ, 1990, J BIOMED MATER RES, V24, P789, DOI 10.1002/jbm.820240702
   STONE KR, 1992, AM J SPORT MED, V20, P104, DOI 10.1177/036354659202000202
   THORENS B, 1987, CELL, V48, P671, DOI 10.1016/0092-8674(87)90245-5
   TRINKAUSRANDALL V, 1991, INVEST OPHTH VIS SCI, V32, P3245
   TRINKAUSRANDALL V, 1990, INVEST OPHTH VIS SCI, V31, P1321
   TRUSKEY GA, 1993, BIOMATERIALS, V14, P243, DOI 10.1016/0142-9612(93)90114-H
   VONSCHROEDER HP, 1991, J BIOMED MATER RES, V25, P329, DOI 10.1002/jbm.820250305
   WALD HL, 1993, BIOMATERIALS, V14, P270, DOI 10.1016/0142-9612(93)90117-K
   WYNN TA, 1992, CELL IMMUNOL, V140, P184, DOI 10.1016/0008-8749(92)90186-S
   YUN JK, 1995, J BIOMED MATER RES, V29, P257, DOI 10.1002/jbm.820290217
   ZIATS NP, 1988, BIOMATERIALS, V9, P5, DOI 10.1016/0142-9612(88)90063-4
NR 52
TC 42
Z9 45
U1 0
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD NOV
PY 1996
VL 17
IS 21
BP 2077
EP 2086
DI 10.1016/0142-9612(96)00014-2
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA VM787
UT WOS:A1996VM78700009
PM 8902241
DA 2018-10-20
ER

PT J
AU Goodman, SL
   Sims, PA
   Albrecht, RM
AF Goodman, SL
   Sims, PA
   Albrecht, RM
TI Three-dimensional extracellular matrix textured biomaterials
SO BIOMATERIALS
LA English
DT Article
DE extracellular matrix; endothelial cells; biomimetic materials;
   three-dimensional texture; surface topography
ID CELLULAR TENSEGRITY; SURFACE TEXTURE; TISSUE; ADHESION; REORGANIZATION;
   MORPHOGENESIS; CYTOSKELETON; PP125(FAK); CHEMISTRY; AIR
AB Clinical and experimental investigations have reported that manufactured surface topographies have significant effects on cell adhesion and tissue integration. However, essentially all previously examined topographies bear little relation to cell adhesion substrates found in biological tissues. In vivo, many cells are adherent to extracellular matrices (ECM), which have an extremely complex 3-D topography in the micrometre to nanometre range. In addition, many studies indicate that micro- and nano-scale mechanical stresses generated by cell-matrix adhesion have significant effects on cellular phenotypic behaviour. In this report we describe methodology for the fabrication of topographic replicas of the subendothelial ECM topography with a biomedical polyurethane. Using three-dimensional high resolution scanning electron microscopy, accurate replication of subendothelial ECM topography from the macroscopic to the macromolecular scale is demonstrated. Bovine aortic endothelial cells cultured on the ECM replicas spread more rapidly and had a three-dimensional appearance and spread areas at confluence which appeared more like endothelial cells in native arteries, compared with cells cultured on untextured control surfaces. Since the fabrication process may be used with many different types of materials, including polymers of synthetic and biological origin, these biomimetic ECM-textured surfaces may find both research and clinical applications. (C) 1996 Elsevier Science Limited
RP Goodman, SL (reprint author), UNIV WISCONSIN,DEPT ANIM HLTH & BIOMED SCI,1655 LINDEN DR,MADISON,WI 53706, USA.
CR ALBRECHT RM, 1976, J MICROSC-OXFORD, V108, P21, DOI 10.1111/j.1365-2818.1976.tb01075.x
   BJORLING DE, 1992, J PHARMACOL TOXICOL, V28, P149, DOI 10.1016/1056-8719(92)90077-E
   BOYDE A, 1974, SCANNING ELECTRON MI, P277
   BRUNETTE DM, 1986, EXP CELL RES, V164, P11, DOI 10.1016/0014-4827(86)90450-7
   BURRIDGE K, 1992, J CELL BIOL, V119, P893, DOI 10.1083/jcb.119.4.893
   CLARK P, 1991, J CELL SCI, V99, P73
   DIDISHEIM P, 1983, T AM SOC ART INT ORG, V29, P169
   GEISLER HP, 1991, NEW BIOL SYNTHETIC V
   Girard Peggy R., 1993, Frontiers of Medical and Biological Engineering, V5, P31
   Goodman S L, 1989, Scanning Microsc Suppl, V3, P285
   GOODMAN SL, 1989, J BIOMED MATER RES, V23, P105, DOI 10.1002/jbm.820230109
   GOODMAN SL, 1995, CELL MATER, V5, P15
   GOODMAN SL, 1990, COLLOIDAL GOLD METHO, P369
   GOODMAN SL, 1993, BIOMATERIALS, V14, P557
   GUIDOIN R, 1992, BIOMATERIALS, V13, P281, DOI 10.1016/0142-9612(92)90051-O
   HILDEBRAND JD, 1993, J CELL BIOL, V123, P993, DOI 10.1083/jcb.123.4.993
   INGBER DE, 1993, CELL, V75, P1249, DOI 10.1016/0092-8674(93)90612-T
   INGBER DE, 1994, INT REV CYTOL, V150, P173
   INGBER DE, 1993, J CELL SCI, V104, P613
   INGBER DE, 1991, J CELL BIOL, V99, pS34
   MASER MD, 1977, J HISTOCHEM CYTOCHEM, V25, P247, DOI 10.1177/25.4.67137
   PAWLEY JB, 1992, ADV ELECT ELECT PHYS, P203
   RATNER BD, 1985, SURFACE INTERFACIAL, P373
   REITH EJ, 1977, ATLAS DESCRIPTIVE HI
   ROSLOWSKY M, 1991, European Journal of Pharmacology, V193, P293
   SEDLARIK KM, 1990, BIOMATERIALS, V11, P4, DOI 10.1016/0142-9612(90)90043-P
   SIMS PA, 1993, SCANNING MICROSCOPY, V7, P637
   SNOW J, 1981, T AM SOC ART INT ORG, V27, P485
   SZYCHER M, 1980, T AM SOC ART INT ORG, V26, P493
   TAYLOR SR, 1983, J BIOMED MATER RES, V17, P205, DOI 10.1002/jbm.820170202
   WECHEZAK AR, 1989, J CELL PHYSIOL, V139, P136, DOI 10.1002/jcp.1041390120
   Whalen R L, 1988, ASAIO Trans, V34, P887
   WILLIAMS SK, 1987, ANN NY ACAD SCI, V516, P154
NR 33
TC 80
Z9 88
U1 1
U2 23
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD NOV
PY 1996
VL 17
IS 21
BP 2087
EP 2095
DI 10.1016/0142-9612(96)00016-6
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA VM787
UT WOS:A1996VM78700010
PM 8902242
DA 2018-10-20
ER

PT J
AU Kitano, H
   Kawabata, J
   Muramoto, T
AF Kitano, H
   Kawabata, J
   Muramoto, T
TI Polymer microspheres prepared with a macroinitiator .2. Sugar balls from
   2-methacryloyloxyethyl-D-glucopyranoside
SO MACROMOLECULAR CHEMISTRY AND PHYSICS
LA English
DT Article
ID LIPOPHILIC RADICAL INITIATOR; COAGULATION; LIPOSOMES
AB Macroinitiator was prepared by the coupling of the disuccinimidyl ester of 4,4'-azobis(cyanovaleric acid) with poly(methacryloyloxyethyl-D-glucopyranoside) (PMEGlc) with an amino group at its end. Styrene and divinylbenzene were copolymerized using the initiator in the presence of sodium dodecylsulfate. The polymer microspheres obtained have PMEGlc chains on their surfaces (''sugar balls''). Aggregation phenomena were observed when a solution of lectin (Con-A) was added to the suspension, due to a specific recognition of sugar residues on the microsphere by a tetrameric lectin molecule. A suspension of sugar balls could not be flocculated even upon addition of an aqueous 3M NaCl solution due to the thick diffuse layer composed of PMEGlc chains on their surfaces. The utility of macroinitiators to prepare various polymer materials which have biomedical functions on their surfaces is suggested.
RP Kitano, H (reprint author), TOYAMA UNIV,DEPT CHEM & BIOCHEM ENGN,TOYAMA 930,JAPAN.
CR BARAKAT I, 1994, MACROMOL SYMP, V88, P227, DOI 10.1002/masy.19940880118
   CHARREYRE MT, 1993, COLLOID POLYM SCI, V271, P668, DOI 10.1007/BF00652829
   EVERETT DH, 1988, BASIC PRINCIPLE COLL
   HASEGAWA M, 1992, THESIS KYOTO U
   HONIG EP, 1971, J COLLOID INTERF SCI, V36, P97, DOI 10.1016/0021-9797(71)90245-1
   Kitano H, 1996, MACROMOL CHEM PHYSIC, V197, P1721, DOI 10.1002/macp.1996.021970513
   KITANO H, 1991, MACROMOLECULES, V24, P42, DOI 10.1021/ma00001a007
   KITANO H, 1994, LANGMUIR, V10, P4131, DOI 10.1021/la00023a036
   KITANO H, 1995, BIOCONJUGATE CHEM, V6, P131, DOI 10.1021/bc00031a016
   LEE YC, 1994, METHODS ENZYMOLOGY, V242
   LICHTENBELT JW, 1974, J COLLOID INTERF SCI, V49, P281, DOI 10.1016/0021-9797(74)90363-4
   Napper DH, 1983, POLYM STABILIZATION
   OHNO K, 1995, BIOCONJUGATE CHEM, V6, P361, DOI 10.1021/bc00034a004
   QUIRK RP, 1995, RING OPENING POLYM, P263
   REVILLA J, 1995, POLYM ADVAN TECHNOL, V6, P55
   Sharon N., 1989, LECTINS
   TAKEUCHI S, 1993, MAKROMOL CHEM, V194, P551
   TAMAI H, 1987, J COLLOID INTERF SCI, V118, P176, DOI 10.1016/0021-9797(87)90446-2
   TAUER K, 1995, POLYM ADVAN TECHNOL, V6, P435, DOI 10.1002/pat.1995.220060703
   VANDENHUL HJ, 1968, J COLLOID INTERF SCI, V28, P336, DOI 10.1016/0021-9797(68)90139-2
   von Smoluchowski M, 1916, PHYS Z, V17, P557
   von Smoluchowski M, 1916, PHYS Z, V17, P585
   1992, TOYOBO ENZYME MANUAL
NR 23
TC 15
Z9 15
U1 0
U2 1
PU HUTHIG & WEPF VERLAG
PI BASEL
PA AUF DEM WOLF 4 FX#001-41-61-317-94-11, CH-4052 BASEL, SWITZERLAND
SN 1022-1352
J9 MACROMOL CHEM PHYSIC
JI Macromol. Chem. Phys.
PD NOV
PY 1996
VL 197
IS 11
BP 3657
EP 3666
DI 10.1002/macp.1996.021971113
PG 10
WC Polymer Science
SC Polymer Science
GA VU056
UT WOS:A1996VU05600013
DA 2018-10-20
ER

PT J
AU Butterworth, MD
   Bell, SA
   Armes, SP
   Simpson, AW
AF Butterworth, MD
   Bell, SA
   Armes, SP
   Simpson, AW
TI Synthesis and characterization of polypyrrole-magnetite-silica particles
SO JOURNAL OF COLLOID AND INTERFACE SCIENCE
LA English
DT Article
DE polypyrrole; conducting polymer; magnetite; silica; nanocomposite;
   superparamagnetism
ID COLLOIDAL NANOCOMPOSITES; BIOMEDICAL APPLICATIONS; COMPOSITES;
   POLYANILINE; MATRIX
AB The synthesis of colloidal polypyrrole-magnetite-silica nanocomposites is described. First, silica-coated magnetite particles were prepared by the aqueous deposition of silica onto ultrafine (5-20 nm) magnetite particles via controlled hydrolysis of sodium silicate, Then pyrrole was chemically polymerized using (NH4)(2)S2O8, H2O2/Fe3+/HCl, or FeCl3 oxidants in the presence of these silica-coated magnetite particles to yield colloidal dispersions of polypyrrole-magnetite-silica particles. The magnetite contents of these materials were as high as 17.5% by mass. Vibrating sample magnetometry measurements confirmed that these nanocomposites were superparamagnetic, with bulk saturation magnetization values of up to 10.9 emu g(-1). Disc centrifuge photosedimentometry was used to assess particle size and degree of dispersion, yielding weight-average particle diameters in the range 100-520 nm. Electron microscopy studies indicated a rather ill-defined particle morphology but provided some evidence for the magnetite component within the nanocomposites. Stable colloidal dispersions were obtained using the H2O2/Fe3+/HCl and (NH4)(2)S2O8, oxidants, whereas FeCl3-based syntheses yielded only flocculated particles or macroscopic precipitates under similar conditions. Solid-state electrical conductivities of nanocomposites synthesized using (NH4)(2)S2O8, H2O2/Fe3+/HCl, and FeCl3 were about 10(-3), 10(-2), and 10(-1) S cm(-1), respectively. (C) 1996 Academic Press, Inc.
C1 UNIV SUSSEX, SCH CHEM & MOL SCI, BRIGHTON BN1 9QJ, E SUSSEX, ENGLAND.
   UNIV SUSSEX, SCH ENGN, BRIGHTON BN1 9QJ, E SUSSEX, ENGLAND.
OI Armes, Steven/0000-0002-8289-6351
CR ARMES SP, 1987, SYNTHETIC MET, V20, P367
   ARSHADY R, 1993, BIOMATERIALS, V14, P5, DOI 10.1016/0142-9612(93)90015-T
   BIDAN G, 1994, ADV MATER, V6, P152, DOI 10.1002/adma.19940060213
   BUTTERWORTH MD, 1995, J COLLOID INTERF SCI, V174, P510, DOI 10.1006/jcis.1995.1418
   BUTTERWORTH MD, 1994, J CHEM SOC CHEM COMM, P2129, DOI 10.1039/c39940002129
   BUTTERWORTH MD, UNPUB
   FORDER C, 1993, J MATER CHEM, V3, P563, DOI 10.1039/jm9930300563
   FURUSAWA K, 1994, COLLOID POLYM SCI, V272, P1104, DOI 10.1007/BF00652379
   GILL M, 1992, J CHEM SOC CHEM COMM, P108, DOI 10.1039/c39920000108
   HALLING PJ, 1980, ENZYME MICROB TECH, V2, P2, DOI 10.1016/0141-0229(80)90002-2
   JARJAYES O, 1995, SYNTHETIC MET, V69, P343, DOI 10.1016/0379-6779(94)02477-G
   KANATZIDIS MG, 1989, J AM CHEM SOC, V111, P4139, DOI 10.1021/ja00193a078
   Kawaguchi H., 1993, BIOMEDICAL APPL POLY, P299
   KAWAI K, 1990, J ELECTROCHEM SOC, V137, P1793, DOI 10.1149/1.2086806
   LIU CF, 1993, POLYM J, V25, P363, DOI 10.1295/polymj.25.363
   MAEDA S, 1994, J MATER CHEM, V4, P935, DOI 10.1039/jm9940400935
   MAEDA S, 1995, CHEM MATER, V7, P171, DOI 10.1021/cm00049a026
   MAEDA S, 1993, J COLLOID INTERF SCI, V159, P257, DOI 10.1006/jcis.1993.1323
   MAEDA S, 1995, LANGMUIR, V11, P1899, DOI 10.1021/la00006a014
   MASSART R, 1981, IEEE T MAGN, V17, P1247, DOI 10.1109/TMAG.1981.1061188
   MEHROTRA V, 1991, J NON-CRYST SOLIDS, V136, P97, DOI 10.1016/0022-3093(91)90124-O
   NUSTAD K, 1990, NATO ADV SCI I C-MAT, V303, P517
   PARTCH R, 1991, J COLLOID INTERF SCI, V144, P27, DOI 10.1016/0021-9797(91)90234-Y
   PHILIPSE AP, 1994, LANGMUIR, V10, P92, DOI 10.1021/la00013a014
   SENNA M, 1975, COLLOID POLYM SCI, V273, P76
   UGELSTAD J, 1993, BLOOD PURIFICAT, V11, P349, DOI 10.1159/000170129
NR 26
TC 76
Z9 90
U1 1
U2 34
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0021-9797
J9 J COLLOID INTERF SCI
JI J. Colloid Interface Sci.
PD OCT 15
PY 1996
VL 183
IS 1
BP 91
EP 99
DI 10.1006/jcis.1996.0521
PG 9
WC Chemistry, Physical
SC Chemistry
GA VV314
UT WOS:A1996VV31400011
DA 2018-10-20
ER

PT J
AU Cheang, P
   Khor, KA
   Teoh, LL
   Tam, SC
AF Cheang, P
   Khor, KA
   Teoh, LL
   Tam, SC
TI Pulsed laser treatment of plasma-sprayed hydroxyapatite coatings
SO BIOMATERIALS
LA English
DT Article
DE hydroxyapatite; plasma spraying; microstructure; pulsed laser; pore
   network
AB Plasma-sprayed hydroxyapatite (HA) coatings have complex microstructures. There are often variations in phase, structure and chemical composition among the starting material and coating. Some of these changes may not be acceptable for biomedical applications. Attaining all the requirements for a functional coating in a single spraying process is not easily achieved. Additional post-treatment may be necessary. This study examines the use of a pulsed laser to enhance the coating characteristics of plasma-sprayed HA coatings. Preliminary results show the laser-treated coatings having a modified microstructure with crack networks and pores in the size range 5-30 mu m. The pores and cracks were quantified by an image analyser. The crack network is less significant in coatings that are treated at lower energy intensity and this could be interesting in that the laser can be used to alter the surface phase composition as well as the morphology. However, repetitive passes with the pulsed laser did not help to seal the cracks that formed. (C) 1996 Elsevier Science Limited
C1 NANYANG TECHNOL UNIV,SCH MECH & PROD ENGN,SINGAPORE 2263,SINGAPORE.
   NANYANG TECHNOL UNIV,SCH APPL SCI,SINGAPORE 2263,SINGAPORE.
   NANYANG TECHNOL UNIV,SCH EEE,SINGAPORE 2263,SINGAPORE.
RI Khor, Khiam Aik/G-2827-2010; Khor, Khiam Aik (Michael)/B-6929-2009
OI KHOR, Khiam/0000-0003-1954-8423
CR CHEANG P, 1995, J MATER PROCESS TECH, V48, P429, DOI 10.1016/0924-0136(94)01679-U
   CHEANG P, 1994, P 8 INT C BIOM ENG S, P530
   GROSS KA, 1990, THESIS MONASH U AUST
   IWAMOTO N, 1988, SURF COAT TECH, V34, P59, DOI 10.1016/0257-8972(88)90089-8
   JASIM KM, 1988, J MATER SCI LETT, V3, P1307
   Khor K. A., 1994, THERMAL SPRAY IND AP, P147
   KHOR KA, 1994, J THERM SPRAY TECHN, V3, P45, DOI 10.1007/BF02648998
   KHOR KA, 1992, CERAMICS ADDING VALU, P810
   KHOR KE, UNPUB
NR 9
TC 35
Z9 40
U1 0
U2 3
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD OCT
PY 1996
VL 17
IS 19
BP 1901
EP 1904
DI 10.1016/0142-9612(95)00146-8
PG 4
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA VH744
UT WOS:A1996VH74400010
PM 8889071
DA 2018-10-20
ER

PT J
AU Lim, GK
   Wang, J
   Ng, SC
   Gan, LM
AF Lim, GK
   Wang, J
   Ng, SC
   Gan, LM
TI Processing of fine hydroxyapatite powders via an inverse microemulsion
   route
SO MATERIALS LETTERS
LA English
DT Article
DE hydroxyapatite; microemulsion; nanoparticles; processing; biomedical
   materials
ID CALCIUM HYDROXYAPATITE; PRECURSORS
AB A submicrometer-sized hydroxyapatite powder has been synthesized via an inverse microemulsion processing route, which uses cyclohexane as the oil phase, mixed poly(oxyethylene)(5) nonyl phenol ether (NP-5) and poly(oxyethylene)(9) nonyl phenol ether (NP-9) as the surfactant phase, and an aqueous CaCl2 solution as the water phase. In comparison with the hydroxyapatite powder prepared by directly reacting (NH4)(2)HPO4 with CaCl2 in an aqueous solution, the microemulsion processing route led to a significant refinement in the particle size, particle size distribution, and the degree of particle agglomeration. XRD phase analysis indicates that a high-purity crystalline hydroxyapatite powder was obtained when the microemulsion-derived precursor was calcined at 800 degrees C. In contrast, there existed impurity phases such as beta-Ca-3(PO4)(2) and CaO in the conventionally processed hydroxyapatite powder after calcination at various temperatures up to 1200 degrees C. This shows that the microemulsion processing route results in the formation of a more homogeneous ultrafine powder precursor than that obtained from the conventional processing route.
C1 NATL UNIV SINGAPORE,DEPT MAT SCI,SINGAPORE 119260,SINGAPORE.
   NATL UNIV SINGAPORE,DEPT PHYS,SINGAPORE 119260,SINGAPORE.
   NATL UNIV SINGAPORE,DEPT CHEM,SINGAPORE 119260,SINGAPORE.
CR BURGARD D, 1994, MATER RES SOC SYMP P, V346, P101
   DEPTULA A, 1992, J NON-CRYST SOLIDS, V147, P537, DOI 10.1016/S0022-3093(05)80672-6
   GAN LM, 1994, MATER CHEM PHYS, V37, P263, DOI 10.1016/0254-0584(94)90162-7
   GOBE M, 1983, J COLLOID INTERF SCI, V93, P293, DOI 10.1016/0021-9797(83)90411-3
   HATTORI T, 1990, J AM CERAM SOC, V73, P1803, DOI 10.1111/j.1151-2916.1990.tb09841.x
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   HENCH LL, 1993, ADV SERIES CERAMICS, V1, pCH9
   HINGORANI S, 1995, J MATER RES, V10, P461, DOI 10.1557/JMR.1995.0461
   KANDORI K, 1995, CHEM MATER, V7, P26, DOI 10.1021/cm00049a007
   LANGE FF, 1989, J AM CERAM SOC, V72, P3, DOI 10.1111/j.1151-2916.1989.tb05945.x
   LANGEVIN D, 1988, ACCOUNTS CHEM RES, V21, P257
   LEE WE, 1994, CERAMIC MICROSTRUCTU, pCH1
   LIN CH, 1994, MATER RES SOC SYMP P, V346, P237
   MURRAY MGS, 1995, J MATER SCI, V30, P3661
   PUAJINDANETR S, 1994, BRIT CERAM T, V93, P96
   VALLETREGI M, 1994, J SOLID STATE CHEM, V112, P58, DOI 10.1006/jssc.1994.1264
   WANG J, 1993, 3 EUR CER, V1, P715
   ZHENG JM, 1992, AM CERAM SOC BULL, V71, P1410
NR 18
TC 80
Z9 93
U1 0
U2 12
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-577X
J9 MATER LETT
JI Mater. Lett.
PD OCT
PY 1996
VL 28
IS 4-6
BP 431
EP 436
DI 10.1016/0167-577X(96)00095-X
PG 6
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA VQ345
UT WOS:A1996VQ34500034
DA 2018-10-20
ER

PT J
AU Rodriguez, AJ
   HerandezVelez, M
   RoqueMalherbe, R
   Aragon, EG
   OnateMartinez, J
AF Rodriguez, AJ
   HerandezVelez, M
   RoqueMalherbe, R
   Aragon, EG
   OnateMartinez, J
TI Synthesis and characterization of molecular sieve with AlPO4-5
   framework. Preliminary biomedical essays
SO MATERIALS LETTERS
LA English
DT Article
DE aluminophosphate; molecular sieve; hydrothermal synthesis; bioactive
   material; osseous implantation
ID CRYSTALLINE INORGANIC SOLIDS
AB A molecular sieve including Ca in AlPO4-5 framework was synthesized. The highly crystalline synthetic products were characterized by X-ray fluorescence analysis, X-ray diffraction and NH3 adsorption. Sterilized CaAPO-5 was implanted in powder form in alive animals and a preliminary evaluation of their bioactive properties was made by elementary preclinical tests.
C1 FAC FIS, ISP EJ VARONA, GRP ZEOLITAS & PROPIEDADES DIELECT SOLIDOS, MARIANAO 46022, LA HABANA, CUBA.
   UNIV POLITECN VALENCIA, CSIC, INST TECNOL QUIM, CH-8092 VALENCIA, SPAIN.
   SWISS FED INST TECHNOL, ETH ZENTRUM, LAB KRISTALLOG, ZURICH, SWITZERLAND.
CR Bering B.P., 1974, IAN SSSR KH, P2427
   CHOUDHARY VR, 1988, J CATAL, V111, P23, DOI 10.1016/0021-9517(88)90062-0
   Dubinin M. M, 1975, PROGR SURFACE MEMBRA, V9, P1
   GIER TE, 1991, NATURE, V349, P508, DOI 10.1038/349508a0
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P331, DOI 10.1002/jbm.820240306
   LOK BM, 1984, J AM CHEM SOC, V106, P6092, DOI 10.1021/ja00332a063
   MARTENS JA, 1994, STUD SURF SCI CATAL, V85, P653
   MONTES C, 1990, J PHYS CHEM-US, V94, P6431, DOI 10.1021/j100379a050
   ORTEGA R, UNPUB
   RIGUTTO MS, 1993, J MOL CATAL, V81, P77, DOI 10.1016/0304-5102(93)80024-O
   ROSS S, 1964, PHYSICAL ADSORPTION, P31
   THOMANN JM, 1990, CALCIFIED TISSUE INT, V46, P121, DOI 10.1007/BF02556096
   Wilson S. T, 1986, U.S. Patent, Patent No. [4,567,029, 4567029, 4,567,029A]
   WILSON ST, 1982, J AM CHEM SOC, V104, P1146, DOI 10.1021/ja00368a062
   ZENJI H, PARTICLE PACKED FIBE
NR 15
TC 1
Z9 1
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-577X
J9 MATER LETT
JI Mater. Lett.
PD OCT
PY 1996
VL 28
IS 4-6
BP 507
EP 511
DI 10.1016/0167-577X(96)00105-X
PG 5
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA VQ345
UT WOS:A1996VQ34500048
DA 2018-10-20
ER

PT J
AU Patriarca, M
AF Patriarca, M
TI The contribution of inductively coupled plasma mass spectrometry to
   biomedical research
SO MICROCHEMICAL JOURNAL
LA English
DT Article; Proceedings Paper
CT VII Italian/Hungarian Symposium on Spectrochemistry - Innovative
   Methodologies for Health and Environmental Protection
CY NOV 27-DEC 01, 1995
CL ROME, ITALY
ID TRACE-ELEMENT ABSORPTION; STABLE ISOTOPES; ICP-MS;
   LIQUID-CHROMATOGRAPHY; HUMAN-SERUM; MINERAL METABOLISM; IRON-ABSORPTION;
   LEC RATS; SPECIATION; COPPER
AB The most striking features of inductively coupled plasma mass spectrometry (ICP-MS) are its superior sensitivity for a wide range of elements and its capability to determine the isotope composition of a sample using less cumbersome pretreatment procedures than other mass spectrometry techniques. Both these capabilities have been exploited in biomedical research. The application of ICP-MS to samples of body fluids and tissues extends the investigation of reference values and biological role to elements present at the ultra-trace level, The availability of simplified methods for the determination of isotope ratios in biological samples allows a more extensive use of stable isotopes as tracers to study mineral metabolism in man, overcoming the restrictions due to safety concerns and short lifetime of radioisotopes. The high sample throughput of ICP-MS significantly increases the information available. for kinetic models in human nutrition and toxicology. By means of on-line coupling with chromatographic techniques, such information could be further extended to the speciation of minerals and their time-dependent biochemical transformations. Multielemental metabolic studies could be performed, taking advantage of the capability of ICP-MS for simultaneous determinations. Finally, the development of high accuracy methods based on isotopic dilution and ICP-MS is important to improve the reliability of analytical data and for the certification of reference and control materials. (C) 1996 Academic Press, Inc.
RP Patriarca, M (reprint author), IST SUPER SANITA,BIOCHIM CLIN LAB,VIALE REGINA ELENA 299,I-00161 ROME,ITALY.
RI PATRIARCA, MARINA/E-3680-2015
CR ABRAMS SA, 1994, J PEDIATR GASTR NUTR, V19, P151, DOI 10.1097/00005176-199408000-00003
   AGGARWAL SK, 1994, CRIT REV CL LAB SCI, V31, P35, DOI 10.3109/10408369409084673
   AMARASIRIWARDENA CJ, 1990, J ANAL ATOM SPECTROM, V5, P457, DOI 10.1039/ja9900500457
   BARNES RM, 1993, ANAL CHIM ACTA, V283, P115, DOI 10.1016/0003-2670(93)85214-5
   BARRETT JFR, 1992, CLIN SCI, V83, P213, DOI 10.1042/cs0830213
   BOWINS RJ, 1994, J ANAL ATOM SPECTROM, V9, P1233, DOI 10.1039/ja9940901233
   BYRDY FA, 1995, ENVIRON HEALTH PERSP, V103, P21, DOI 10.2307/3432006
   CORNELIS R, 1994, J ANAL ATOM SPECTROM, V9, P945, DOI 10.1039/ja9940900945
   CORNELIS R, 1993, ANAL CHIM ACTA, V283, P183, DOI 10.1016/0003-2670(93)85221-5
   CREWS HM, 1994, ANALYST, V119, P2491, DOI 10.1039/an9941902491
   DAMS R, 1994, BIOL TRACE ELEMENT R, P539
   DAVIDSSON L, 1994, ACTA PAEDIATR, V395, P38
   DEBIEVRE P, 1994, FRESEN J ANAL CHEM, V350, P277, DOI 10.1007/BF00322482
   DOUGLAS DJ, 1985, PROG ANAL ATOM SPECT, V8, P1
   FOMON SJ, 1989, PEDIATR RES, V26, P250, DOI 10.1203/00006450-198909000-00019
   FOMON SJ, 1988, PEDIATR RES, V24, P20, DOI 10.1203/00006450-198807000-00006
   GIESSMAN U, 1994, FRESEN J ANAL CHEM, V50, P186
   GRAY AL, 1985, SPECTROCHIM ACTA B, V40, P1525, DOI 10.1016/0584-8547(85)80176-2
   HILL SJ, 1993, J ANAL ATOM SPECTROM, V8, P499, DOI 10.1039/ja9930800499
   HORLICK G, 1987, INDUCTIVELY COUPLED, P361
   JANGHORBANI M, 1989, MIKROCHIM ACTA, V3, P315
   KIRLEW PW, 1996 WINT C PLASM SP
   LASZTITY A, 1995, J ANAL ATOM SPECTROM, V10, P505, DOI 10.1039/ja9951000505
   LEVENSON CW, 1994, ANAL BIOCHEM, V221, P243, DOI 10.1006/abio.1994.1408
   LU Q, 1996 WINT C PLASM SP
   LU QH, 1995, ANAL CHEM, V67, P2949, DOI 10.1021/ac00113a033
   LYON TDB, 1991, J ANAL ATOM SPECTROM, V6, P559, DOI 10.1039/ja9910600559
   LYON TDB, 1988, J ANAL ATOM SPECTROM, V3, P265, DOI 10.1039/ja9880300265
   Lyon TDB, 1996, MICROCHEM J, V54, P236, DOI 10.1006/mchj.1996.0099
   LYON TDB, 1990, J ANAL ATOM SPECTROM, V5, P135, DOI 10.1039/ja9900500135
   LYON TDB, 1992, FOOD CHEM, V43, P299, DOI 10.1016/0308-8146(92)90217-P
   LYON TDB, 1995, CLIN SCI, V8, P727
   MELLON FA, 1993, ANAL CHIM ACTA, V283, P190, DOI 10.1016/0003-2670(93)85222-6
   MICHALKE B, 1996 WINT C PLASM SP
   MOENS L, 1995, J RADIOAN NUCL CH AR, V192, P29, DOI 10.1007/BF02037733
   MOENS L, 1994, J ANAL ATOM SPECTROM, V9, P1075, DOI 10.1039/ja9940901075
   NUTTALL KL, 1995, ANN CLIN LAB SCI, V25, P264
   OGRA Y, 1995, RES COMMUN MOL PATH, V88, P196
   OLSON LK, 1995, SPECTROCHIM ACTA B, V50, P355, DOI 10.1016/0584-8547(94)00170-Z
   PASCHAL DC, 1995, J ANAL ATOM SPECTROM, V10, P67
   Patriarca M, 1996, J ANAL ATOM SPECTROM, V11, P297, DOI 10.1039/ja9961100297
   Patriarca M, 1996, MIKROCHIM ACTA, V123, P261, DOI 10.1007/BF01244399
   PATRIARCA M, 1995, 5 COMTOX S TOX CLIN
   PATRIARCA M, 1995, RECENT ADV PLASMA SO, P224
   SABBIONI E, 1994, SCI TOTAL ENVIRON, V158, P228
   Sandstrom B., 1993, Nutrition Research Reviews, V6, P71, DOI 10.1079/NRR19930007
   SCHRAMEL P, 1995, FRESEN J ANAL CHEM, V353, P115, DOI 10.1007/BF00322942
   SCHUETTE SA, 1992, J NUTR BIOCHEM, V3, P38, DOI 10.1016/0955-2863(92)90066-R
   SERFASS RE, 1986, ANAL CHIM ACTA, V188, P73, DOI 10.1016/S0003-2670(00)86031-6
   SERFASS RE, 1989, J NUTR, V119, P1661
   SEUBERT A, 1994, FRESEN J ANAL CHEM, V350, P210, DOI 10.1007/BF00322472
   SOLTANINESHAN MA, 1992, ISOTOPENPRAXIS, V28, P101, DOI 10.1080/00211919208050834
   SULAIMAN AB, 1996 WINT C PLASM SP
   SUZUKI KT, 1994, J INORG BIOCHEM, V54, P157, DOI 10.1016/0162-0134(94)80010-3
   SUZUKI KT, 1995, J CHROMATOGR B, V666, P13, DOI 10.1016/0378-4347(94)00561-I
   SUZUKI KT, 1995, RES COMMUN MOL PATH, V88, P187
   THOMPSON JJ, 1986, ANAL CHEM, V58, P2541, DOI 10.1021/ac00125a039
   TING BTG, 1987, SPECTROCHIM ACTA B, V42, P21, DOI 10.1016/0584-8547(87)80046-0
   TOMLINSON MJ, 1995, ANALYST, V120, P583, DOI 10.1039/an9952000583
   TOMLINSON MJ, 1994, J ANAL ATOM SPECTROM, V9, P957, DOI 10.1039/ja9940900957
   TYLER G, 1995, SPECTROSCOPY EUROPE, V7, P14
   Vanhaecke F, 1996, ANAL CHEM, V68, P567, DOI 10.1021/ac9507247
   VANHOE H, 1989, ANAL CHEM, V61, P1851, DOI 10.1021/ac00192a014
   VANHOE H, 1994, J ANAL ATOM SPECTROM, V9, P23, DOI 10.1039/ja9940900023
   VAUGHAN MA, 1990, CLIN CHEM, V27, P210
   VELA NP, 1993, ANAL CHEM, V65, pA585, DOI 10.1021/ac00061a002
   WATSON WS, 1995, 5 COMTOX S TOX CLIN
   WHITTAKER PG, 1992, J ANAL ATOM SPECTROM, V7, P109, DOI 10.1039/ja9920700109
   WHITTAKER PG, 1991, BRIT J NUTR, V65, P457, DOI 10.1079/BJN19910104
   YANG KL, 1995, ANAL CHIM ACTA, V307, P109, DOI 10.1016/0003-2670(95)00010-W
   YERGEY AL, 1994, ADV EXP MED BIOL, V352, P279
   ZIEGLER EE, 1989, J NUTR, V119, P1647
NR 72
TC 16
Z9 18
U1 0
U2 4
PU ACADEMIC PRESS INC JNL-COMP SUBSCRIPTIONS
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495
SN 0026-265X
J9 MICROCHEM J
JI Microchem J.
PD OCT
PY 1996
VL 54
IS 3
BP 262
EP 271
DI 10.1006/mchj.1996.0102
PG 10
WC Chemistry, Analytical
SC Chemistry
GA VT161
UT WOS:A1996VT16100011
DA 2018-10-20
ER

PT J
AU Jourlin, M
   Bertrand, C
   Coudert, JL
   Darsonville, F
   Gremillet, P
   Martinez, S
   Pinoli, JC
   Revol, C
   Trunde, F
AF Jourlin, M
   Bertrand, C
   Coudert, JL
   Darsonville, F
   Gremillet, P
   Martinez, S
   Pinoli, JC
   Revol, C
   Trunde, F
TI 3D imaging applications at the LISA laboratory during the last ten years
SO MICROSCOPY MICROANALYSIS MICROSTRUCTURES
LA English
DT Article; Proceedings Paper
CT 20th Annual Meeting of the French Section of the
   International-Society-for-Stereology
CY FEB, 1997
CL ECOLE NATL SUPER MINES, PARIS, FRANCE
SP Int Soc Stereol
HO ECOLE NATL SUPER MINES
ID TIME CONFOCAL MICROSCOPY; HUMAN SKIN; IN-VIVO
AB This article ambitiously aims at illustrating the tremendous potentialities offered by new imaging technologies (electron microscopy, confocal microscopy and atomic force microscopy...), that give access to either volumic or surfacic informations, and the necessity to create high-level tools and models that are essential for the treatment of the information provided by the sensors, as well from a mathematical point of view (modeling, interpolation, correlation, reconstruction...) as under the computing aspect (facettisation, smoothing, visualization... but also data structures adapted to the storage and use of voluminous files, parallel architectures...). Since ten years the LISA Laboratory has focused in the field of 3D imaging on the creation, development and implementation of such theoretical and practical tools. This article briefly presents the main works on image analysis at LISA Laboratory and especially illustrates by images the main successfully addressed three dimensional imaging applications. The overviewed examples concern the biomedical domain (biological cells, hairs, jaws, epidermis) and that of materials (textiles, concretes, aluminium alloys).
C1 LOREAL, LAB RECH AVANCEE, F-93600 AULNAY SOUS BOIS, FRANCE.
   FAC ODONTOL, F-69372 LYON 08, FRANCE.
   MISIS, F-42000 ST ETIENNE, FRANCE.
   PECHINEY, CTR RECH, F-38340 VOREPPE, FRANCE.
RP Jourlin, M (reprint author), ECOLE SUPER CHIM PHYS & ELECT, CNRS, EP0092, LAB IMAGE SIGNAL & ACOUST, 43 BLVD 11 NOVEMBRE 1918, F-69616 VILLEURBANNE, FRANCE.
CR BERTRAND C, 1994, SCANNING, V16, P150
   BERTRAND C, 1994, THESIS U SAINT ETIEN
   BRON C, 1990, J MICROSC-OXFORD, V157, P115, DOI 10.1111/j.1365-2818.1990.tb02952.x
   CORCUFF P, 1993, DERMATOLOGY, V186, P50, DOI 10.1159/000247302
   CORCUFF P, 1993, J SOC COSMET CHEM, V44, P1
   CORCUFF P, 1993, ARCH DERMATOL RES, V285, P475, DOI 10.1007/BF00376820
   DARSONVILLE F, 1994, SUIVI DYNAMIQUE PAYS
   FORTIN T, 1994, ENCY MED CHIR
   GREMILLET P, 1994, J MICROSC-OXFORD, V174, P31, DOI 10.1111/j.1365-2818.1994.tb04321.x
   GREMILLET P, 1995, P IEEE WORKSH NONL I, P819
   GREMILLET P, 1992, THESIS U SAINT ETIEN
   Gremillet Ph., 1991, Machine Vision and Applications, V4, P263, DOI 10.1007/BF01815303
   JOURLIN M, 1995, SIGNAL PROCESS, V41, P225, DOI 10.1016/0165-1684(94)00102-6
   JOURLIN M, 1987, ACTA STEREOL, V6, P651
   JOURLIN M, 1988, J MICROSC-OXFORD, V149, P21, DOI 10.1111/j.1365-2818.1988.tb04559.x
   MARTINEZ S, UNPUB 3 DIMENSIONAL
   MARTINEZ S, 1994, ETUDE DISTRIBUTION T
   MARTINEZ S, 1996, IN PRESS INT C 3D IM
   PINOLI JC, IN PRESS J MATH IMAG
   REVOL C, 1996, THESIS U SAINT ETIEN
   REVOL C, UNPUB NEW MINIMUM VA
   REVOL C, 1996, IN PRESS P 37 C SOC
NR 22
TC 1
Z9 1
U1 0
U2 1
PU EDP SCIENCES S A
PI LES ULIS CEDEX A
PA 17, AVE DU HOGGAR, PA COURTABOEUF, BP 112, F-91944 LES ULIS CEDEX A,
   FRANCE
SN 1154-2799
J9 MICROSC MICROANAL M
JI Microsc. Microanal. Microstruct.
PD OCT-DEC
PY 1996
VL 7
IS 5-6
BP 289
EP 295
DI 10.1051/mmm:1996124
PG 7
WC Microscopy; Spectroscopy
SC Microscopy; Spectroscopy
GA XH270
UT WOS:A1996XH27000003
OA Bronze
DA 2018-10-20
ER

PT J
AU Pang, Z
   Gu, XH
   Yekta, A
   Masoumi, Z
   Coll, JB
   Winnik, MA
   Manners, I
AF Pang, Z
   Gu, XH
   Yekta, A
   Masoumi, Z
   Coll, JB
   Winnik, MA
   Manners, I
TI Phosphorescent oxygen sensors utilizing sulfur-nitrogen-phosphorus
   polymer matrices
SO ADVANCED MATERIALS
LA English
DT Article
ID TRANSITION-METAL COMPLEXES; MOLECULAR RECOGNITION
AB Luminescent sensors based on composites comprising transition metal complexes immobilized in polymer matrices have attracted attention as oxygen sensors for both biomedical and barometric applications. Typically, phosphorescent dyes are dispersed in a polymer matrix of high gas permeability are used, Here, S-N-P polymers are used as a novel matrix material allowing the sensitivity of the sensors to be controlled over a wide range.
C1 UNIV TORONTO,DEPT CHEM,TORONTO,ON M5S 3H6,CANADA.
   ONTARIO LASER & LIGHTWAVE RES CTR,TORONTO,ON M5S 1A7,CANADA.
   DE HAVILLAND INC,DOWNSVIEW,ON M3K 1Y5,CANADA.
CR ALLCOCK HR, 1993, MACROMOLECULES, V26, P1493, DOI 10.1021/ma00059a003
   BACON JR, 1987, ANAL CHEM, V59, P2780, DOI 10.1021/ac00150a012
   Barlet P. N., 1993, SYNTHETIC MET, V61, P15
   BAUERLE P, 1993, ADV MATER, V5, P848, DOI 10.1002/adma.19930051113
   BONDI MCM, 1990, ANAL CHEM, V62, P2377
   CARRAWAY ER, 1991, ANAL CHEM, V63, P337, DOI 10.1021/ac00004a007
   Czarnik A. W., 1993, ACS S SERIES, V538
   DEMAS JN, 1991, ANAL CHEM, V63, pA829, DOI 10.1021/ac00017a001
   DIMARCO G, 1995, ADV MATER, V7, P468, DOI 10.1002/adma.19950070512
   DORN R, 1992, ADV MATER, V4, P464, DOI 10.1002/adma.19920040703
   Gouterman M., 1993, U. S. Patent, Patent No. [5,186,046, 5186046]
   GOUTERMAN M, 1995, WORKSH PRESS TEMP SH
   KAVANDI J, 1990, REV SCI INSTRUM, V61, P3341
   KLIMANT I, 1995, ANAL CHEM, V67, P3160, DOI 10.1021/ac00114a010
   LI XM, 1993, ANALYST, V118, P289, DOI 10.1039/an9931800289
   LIANG M, 1991, J AM CHEM SOC, V113, P4044, DOI 10.1021/ja00010a085
   LIEBMAN RA, 1989, CHEM BIOCH ENV SENSO, V1172
   MASOUMI Z, UNPUB
   MOSHAROV V, 1994, Patent No. 5307675
   NI YZ, 1992, MACROMOLECULES, V25, P7119, DOI 10.1021/ma00052a008
   Ni YZ, 1996, MACROMOLECULES, V29, P3401, DOI 10.1021/ma951611s
   PREININGER C, 1994, ANAL CHEM, V66, P1841, DOI 10.1021/ac00083a011
   SCHWAB SD, 1994, Patent No. 5359887
   SWAGER TM, 1994, ADV MATER, V6, P595, DOI 10.1002/adma.19940060717
   Yekta A, 1995, CAN J CHEM, V73, P2021, DOI 10.1139/v95-250
   ZHOU Q, 1995, J AM CHEM SOC, V117, P7017, DOI 10.1021/ja00131a031
NR 26
TC 37
Z9 37
U1 2
U2 10
PU VCH PUBLISHERS INC
PI DEERFIELD BEACH
PA 303 NW 12TH AVE, DEERFIELD BEACH, FL 33442-1788
SN 0935-9648
J9 ADV MATER
JI Adv. Mater.
PD SEP
PY 1996
VL 8
IS 9
BP 768
EP &
DI 10.1002/adma.19960080916
PG 5
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA VG738
UT WOS:A1996VG73800015
DA 2018-10-20
ER

PT J
AU Sodhi, RNS
AF Sodhi, RNS
TI Application of surface analytical and modification techniques to
   biomaterial research
SO JOURNAL OF ELECTRON SPECTROSCOPY AND RELATED PHENOMENA
LA English
DT Article
DE adsorbate; biomaterial; plasma technique; SSIMS; surface modification;
   XPS
ID SCANNING-TUNNELING-MICROSCOPY; NEURONAL CELL ATTACHMENT; ATOMIC-FORCE
   MICROSCOPY; X-RAY PHOTOELECTRON; ADHESION; PLASMA;
   POLY(TETRAFLUOROETHYLENE); TEFLON; FILMS; POLYTETRAFLUOROETHYLENE
AB The development of suitable materials for biomedical applications requires a thorough understanding of the structure and chemistry of the solid-liquid interface when such a material is placed in the biological environment. The held is made complex by the diversity of materials used, the different applications one has to consider, and the complexity of the various biological environments the implanted material may find itself in. To understand the interactions which may occur, it is important to have information on the structure and composition of the top few atomic layers. Concepts from surface science, such as surface analysis and modification techniques prove to be valuable aids in the development of suitable biomaterials. These methods are not new or unique but are well established in other technologies. In this paper, several areas of surface modification techniques will be chosen to illustrate how they are being applied in the biomaterial field, stressing the interdisciplinary nature of the work as well as the surface analytical techniques involved.
RP Sodhi, RNS (reprint author), UNIV TORONTO,CTR BIOMAT,170 COLL ST,TORONTO,ON M5S 3E3,CANADA.
CR American Society for Testing and Materials (ASTM), 1992, ANN BOOK ASTM STAND, V11.04
   ANDERS PA, 1989, J APPL PHYS, V66, P3548
   Andrade J. D., 1985, SURFACE INTERFACIAL, V1, P105
   BAIER RE, 1984, J BIOMED MATER RES, V18, P337, DOI 10.1002/jbm.820180404
   Beamson G., 1992, HIGH RESOLUTION XPS
   Briggs D., 1989, HDB STATIC SECONDARY
   BROWNE M, 1994, BIOMATERIALS, V15, P894, DOI 10.1016/0142-9612(94)90113-9
   BUSSCHER HJ, 1991, CELL MATER, V1, P243
   CADMAN P, 1979, J MATER SCI, V14, P2672, DOI 10.1007/BF00610638
   CALLEN BW, 1995, J VAC SCI TECHNOL A, V13, P2023, DOI 10.1116/1.579647
   CALLEN BW, 1993, J BIOMED MATER RES, V27, P851, DOI 10.1002/jbm.820270703
   CALLEN BW, 1995, J BIOMED MATER RES, V29, P279, DOI 10.1002/jbm.820290302
   CALLEN BW, 1994, T 20 M SOC BIOM BOST, P342
   CASTNER DG, 1992, T 4 WORLD BIOM C BER, P194
   CHAKRABARTI N, 1988, MACROMOLECULES, V21, P3011, DOI 10.1021/ma00188a020
   CHANEY R, 1987, FRESEN Z ANAL CHEM, V329, P143, DOI 10.1007/BF00469126
   CHANG CA, 1987, APPL PHYS LETT, V51, P1236, DOI 10.1063/1.98741
   CLARK DT, 1986, J ELECTRON SPECTROSC, V41, P399, DOI 10.1016/0368-2048(86)85017-4
   CLARK DT, 1987, J POLYM SCI POL CHEM, V25, P2643, DOI 10.1002/pola.1987.080251002
   Clark DT, 1978, POLYM SURFACES, P185
   CURTIS ASG, 1986, J CELL SCI, V86, P9
   DAVIES M, 1996, J ELECT SPECTROSC RE, V81, P249
   DAVIES MC, 1990, CRIT REV BIOCOMPAT, V5, P297
   ERTEL SI, 1991, J BIOMAT SCI-POLYM E, V3, P63
   Formichi M J, 1988, Ann Vasc Surg, V2, P14, DOI 10.1016/S0890-5096(06)60773-5
   GJERMO P, 1989, J DENT RES, V68, P1602
   GOMBOTZ WR, 1989, J APPL POLYM SCI, V37, P91, DOI 10.1002/app.1989.070370108
   HANSMA PK, 1988, SCIENCE, V242, P209, DOI 10.1126/science.3051380
   HAQUE Y, 1986, J APPL POLYM SCI, V32, P4369, DOI 10.1002/app.1986.070320407
   JANSTA J, 1975, J APPL POLYM SCI, V19, P3201, DOI 10.1002/app.1975.070191206
   JOHANSSON C, 1989, J BIOMED ENG, V11, P3, DOI 10.1016/0141-5425(89)90158-1
   Johnston EE, 1996, J ELECTRON SPECTROSC, V81, P303, DOI 10.1016/0368-2048(95)02666-5
   KASEMO B, 1986, CRIT REV BIOCOMPAT, V2, P335
   KIAEI D, 1992, J BIOMAT SCI-POLYM E, V4, P35
   KNUTSON K, 1985, SURFACE INTERFACIAL, V1, P197
   Lausmaa J, 1996, J ELECTRON SPECTROSC, V81, P343, DOI 10.1016/0368-2048(95)02530-8
   LINDSAY SM, 1993, J VAC SCI TECHNOL A, V11, P808, DOI 10.1116/1.578309
   MAEUSLI PA, 1986, BIOL BIOMECHANICAL P, P57
   MCKEOWN NB, 1991, LANGMUIR, V7, P2146, DOI 10.1021/la00058a029
   MICHAEL R, 1986, J VAC SCI TECHNOL A, V4, P1861, DOI 10.1116/1.573778
   Morosoff N., 1990, PLASMA DEPOSITION TR, P1, DOI 10.1016/13978-0-12-200430-8.50007-5
   RANIERI JP, 1994, INT J DEV NEUROSCI, V12, P725, DOI 10.1016/0736-5748(94)90052-3
   RANIERI JP, 1995, J BIOMED MATER RES, V29, P779, DOI 10.1002/jbm.820290614
   RATNER BD, 1990, J VAC SCI TECHNOL A, V8, P2306, DOI 10.1116/1.576755
   RATNER BD, 1993, J BIOMED MATER RES, V27, P837, DOI 10.1002/jbm.820270702
   Ratner BD, 1990, PLASMA DEPOSITION TR, P463
   RATNR BD, 1987, J BIOMED MATER RES-A, V21, P59
   ROBERTS RF, 1976, J APPL POLYM SCI, V20, P255, DOI 10.1002/app.1976.070200121
   RYE RR, 1987, APPL SURF SCI, V29, P397, DOI 10.1016/0169-4332(87)90045-6
   RYE RR, 1990, LANGMUIR, V6, P338, DOI 10.1021/la00092a008
   Sabbatini L, 1996, J ELECTRON SPECTROSC, V81, P285, DOI 10.1016/0368-2048(95)02528-6
   SACHER E, 1988, SURFACE CHARACTERISA
   Sherwood PMA, 1996, J ELECTRON SPECTROSC, V81, P319, DOI 10.1016/0368-2048(95)02529-4
   SODHI RNS, 1992, J DENT RES, V71, P1493, DOI 10.1177/00220345920710080601
   SODHI RNS, 1992, T 4 WORLD BIOM C BER, P172
   VARGO TG, 1992, LANGMUIR, V8, P130, DOI 10.1021/la00037a025
   VARGO TG, 1995, J BIOMED MATER RES, V29, P767, DOI 10.1002/jbm.820290613
   VARGO TG, 1991, J POLYM SCI POL CHEM, V29, P555, DOI 10.1002/pola.1991.080290412
   WERTHEIMER MR, 1985, J VAC SCI TECHNOL A, V3, P2643, DOI 10.1116/1.572805
   ZHOU XL, 1990, J CHEM PHYS, V92, P5612, DOI 10.1063/1.458493
NR 60
TC 38
Z9 39
U1 0
U2 7
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0368-2048
J9 J ELECTRON SPECTROSC
JI J. Electron Spectrosc. Relat. Phenom.
PD SEP
PY 1996
VL 81
IS 3
BP 269
EP 284
DI 10.1016/0368-2048(95)02665-7
PG 16
WC Spectroscopy
SC Spectroscopy
GA VT919
UT WOS:A1996VT91900005
DA 2018-10-20
ER

PT J
AU Alonso, F
   Ugarte, JJ
   Sansom, D
   Viviente, JL
   Onate, JI
AF Alonso, F
   Ugarte, JJ
   Sansom, D
   Viviente, JL
   Onate, JI
TI Effects of ion implantation on Ti-6Al-4V on its frictional behaviour
   against UHMWPE
SO SURFACE & COATINGS TECHNOLOGY
LA English
DT Article; Proceedings Paper
CT 9th International Conference on Surface Modification of Metals by Ion
   Beams (SMMIB 95)
CY SEP 04-08, 1995
CL SAN SEBASTIAN, SPAIN
SP INASMET
DE carbon ion implantation; Ti-6Al-4V titanium alloy; hardness; friction
ID TITANIUM
AB The aim of this work was to study the effect of carbon ion implantation and a DLC coating on the friction response of Ti-6Al-4V/UHMWPE materials used for biomedical implants, and on the endurance of the protective oxide layer of the Ti alloy at increasing loads.
   Carbon implantation was carried out at doses ranging from 2 x 10(17) to 10 x 10(17) ions cm(-2) and energies from 75 to 180 keV. This implantation procedure produced a more than twofold improvement in hardness, as evaluated by a dynamic micro-indentation technique at increasing loads from 0.4 to 10 mN. Dry pin-on-disc tribological tests, using an UHMWPE pin, showed that some of the implantation treatments effectively protected the surface of the Ti alloy, without producing a break in the protective passive oxide layer and exhibited low friction values, similar to those obtained in DLC coatings. No direct correlation has been found, however, between the hardening induced by ion implantation and the improved tribological response. Formation of TiC precipitates could account for the hardening effect observed after carbon implantation and, in addition, implantation may cause stabilisation of the protective oxide layer on the titanium surface.
C1 UNIV BATH,SCH MAT SCI,BATH BA2 7AY,AVON,ENGLAND.
RP Alonso, F (reprint author), INASMET,CAMINO PORTUETXE 12,SAN SEBASTIAN 20009,SPAIN.
RI Onate, J. Ignacio/I-1555-2015
OI Onate de la Presa, Jose Ignacio/0000-0002-9078-4480
CR Alonso F, 1995, SURF COAT TECH, V74-75, P986, DOI 10.1016/0257-8972(95)08291-3
   BOLSTER RN, 1987, SURF COAT TECH, V33, P469, DOI 10.1016/0257-8972(87)90211-8
   CHEN A, 1991, WEAR MATERIALS, P667
   CLARKE LA, 1992, ASTM STP, V1144, P7
   Elder J. E., 1989, Surface Engineering, V5, P55
   HOHMUTH K, 1985, MATER SCI ENG, V69, P489, DOI 10.1016/0025-5416(85)90351-9
   Lausmaa J., 1991, Surface Engineering, V7, P311
   NASSER S, 1990, CLIN ORTHOPAEDICS, V261, P171
   OLIVER WC, 1984, METALL TRANS A, V15, P2221, DOI 10.1007/BF02647105
   ONATE JI, 1994, SURF COAT TECH, V65, P165, DOI 10.1016/S0257-8972(94)80025-1
   PIVIN JC, 1987, J MATER SCI, V22, P1087, DOI 10.1007/BF01103555
   RIEU J, 1992, SURFACE MODIFICATION, V5, P155
   SARITAS S, 1987, MATER SCI ENG, V90, P297, DOI 10.1016/0025-5416(87)90225-4
   SCHROER A, 1991, SURF COAT TECH, V47, P418, DOI 10.1016/0257-8972(91)90307-I
   SIOSHANSI P, 1987, NUCL INSTRUM METH B, V19-20, P204, DOI 10.1016/S0168-583X(87)80043-5
NR 15
TC 36
Z9 37
U1 0
U2 6
PU ELSEVIER SCIENCE SA LAUSANNE
PI LAUSANNE 1
PA PO BOX 564, 1001 LAUSANNE 1, SWITZERLAND
SN 0257-8972
J9 SURF COAT TECH
JI Surf. Coat. Technol.
PD SEP
PY 1996
VL 83
IS 1-3
BP 301
EP 306
DI 10.1016/0257-8972(96)02767-3
PG 6
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA VE213
UT WOS:A1996VE21300053
DA 2018-10-20
ER

PT J
AU Marshall, KG
AF Marshall, KG
TI Prevention. How much harm? How much benefit? .4. The ethics of informed
   consent for preventive screening programs
SO CANADIAN MEDICAL ASSOCIATION JOURNAL
LA English
DT Article
ID PATIENT-PHYSICIAN PARTNERSHIP; HEALTH-CARE MANAGEMENT; BREAST-CANCER;
   PROSTATE-CANCER; OLDER WOMEN; MEDICINE; INTERVENTIONS; INFORMATION;
   ATTENDANCE; GUIDELINES
AB Preventive interventions may have few or unproven benefits, or they may even be harmful. Since three of the fundamental precepts of Western biomedical ethics are beneficence, non-maleficence and respect for individual autonomy, failure to obtain truly informed consent for many current preventive interventions may be unethical. However, there are many impediments to obtaining such consent. Physicians-need to be aware of an immense amount of up-to-date, complex information. It may be difficult for patients to assimilate this information, and there is rarely time for physicians to become informed and to inform their patients. Clinical practice guidelines may be helpful, but not all are based on evidence, and recommendations are often conflicting. Medical institutions, as well as individual clinicians, can help solve these dilemmas. Authors and journal editors can make a:commit ment to report and publish wall-referenced evidence-based guidelines. Organizations such as the Canadian Task Force on the Periodic Health Examination and the,US Preventive Services Task Force can develop balanced, evidence-based patient-information material. Faculty at all levels of medical education can increase their emphasis on the ethics of prevention. Individual clinicians should avoid making clinical decisions on the basis of relative reductions of morbidity or mortality, should use evidence-based clinical practice guidelines rather than those based on authority whenever possible, should make use of patient-information material and, most important, should have a consistent policy of obtaining informed consent from: patients before they participate in potentially harmful preventive programs.
RP Marshall, KG (reprint author), MCGILL UNIV,DEPT FAMILY MED,517 PINE AVE W,MONTREAL,PQ H3Y 1Y8,CANADA.
CR ANGELL M, 1994, NEW ENGL J MED, V331, P189, DOI 10.1056/NEJM199407213310309
   ANNAS GJ, 1992, J GERONTOL, V47, P121
   BAINES CJ, 1992, CAN MED ASSOC J, V146, P2147
   BATTISTA RN, 1995, J CLIN EPIDEMIOL, V48, P875, DOI 10.1016/0895-4356(94)00199-Z
   BAUM M, 1995, BRIT MED J, V310, P1003, DOI 10.1136/bmj.310.6985.1003
   BEAUCHAMP TL, 1989, MED ETHICS, P173
   BEISECKER AE, 1990, MED CARE, V28, P19, DOI 10.1097/00005650-199001000-00004
   BLACK WC, 1995, J NATL CANCER I, V87, P720, DOI 10.1093/jnci/87.10.720
   BLACKHALL LJ, 1995, JAMA-J AM MED ASSOC, V274, P820, DOI 10.1001/jama.274.10.820
   BUTLER JA, 1993, J ROY SOC MED, V86, P341
   *CAN TASK FORC PER, 1994, CAN GUID CLIN PREV H
   *CAN TASK FORC PER, 1994, CAN GUID CLIN PREV H, P791
   CARRESE JA, 1995, JAMA-J AM MED ASSOC, V274, P826, DOI 10.1001/jama.274.10.826
   CASSEL CK, 1992, J GERONTOL, V47, P126
   COCHRANE AL, 1971, BRIT MED BULL, V27, P3, DOI 10.1093/oxfordjournals.bmb.a070810
   Collins J. H., 1995, J AM TAXATION ASS, V17, P1
   CONROY M, 1995, BRIT J GEN PRACT, V45, P371
   CSAJA R, 1994, ANN INTERN MED, V120, P602
   DEBER RB, 1994, CAN MED ASSOC J, V151, P423
   DEBER RB, 1994, CAN MED ASSOC J, V151, P171
   EDWARDS PJ, 1992, BMJ-BRIT MED J, V305, P267, DOI 10.1136/bmj.305.6848.267
   *FDN INF MED DEC M, 1994, PSA DEC WHAT YOU NEE
   FRENCH K, 1982, BRIT MED J, V285, P617, DOI 10.1136/bmj.285.6342.617
   GLODE LM, 1994, HOSP PRACT, V29, P10
   GOSTIN LO, 1995, JAMA-J AM MED ASSOC, V274, P844
   HAHN DL, 1993, J FAM PRACTICE, V37, P432
   HAYNES RB, 1993, ANN NY ACAD SCI, V703, P210, DOI 10.1111/j.1749-6632.1993.tb26350.x
   HOLLAND WW, 1993, BRIT MED J, V306, P1222, DOI 10.1136/bmj.306.6887.1222
   HUX JE, 1995, MED DECIS MAKING, V15, P152, DOI 10.1177/0272989X9501500208
   JEYAPRAGASAN M, 1878, CAN FAM PHYSICIAN, V39, P1878
   KRAHN M, 1991, ANN INTERN MED, V115, P248, DOI 10.7326/0003-4819-115-4-248
   LEE JM, 1993, NEW ENGL J MED, V328, P438, DOI 10.1056/NEJM199302113280613
   Lyon H. C.  Jr., 1989, Proceedings: The Thirteenth Annual Symposium on Computer Applications in Medical Care (Cat. No.89TH0286-5), P1043
   Mappes T. A., 1991, BIOMEDICAL ETHICS
   MARSHALL KG, 1993, CAN FAM PHYSICIAN, V39, P2385
   MCCORMICK J, 1988, LANCET, V2, P839
   MCCORMICK J, 1994, LANCET, V344, P390
   OHAGAN J, 1991, NZ MED J, V104, P122
   OXMAN AD, 1995, CAN MED ASSOC J, V153, P1423
   ROBERTS MM, 1989, BRIT MED J, V299, P1153, DOI 10.1136/bmj.299.6708.1153
   ROSE G, 1985, INT J EPIDEMIOL, V14, P32, DOI 10.1093/ije/14.1.32
   SCHAPIRA DV, 1993, CANCER, V71, P839, DOI 10.1002/1097-0142(19930201)71:3<839::AID-CNCR2820710329>3.0.CO;2-E
   SKRABANEK P, 1988, LANCET, V1, P1155
   SKRABANEK P, 1990, J MED ETHICS, V16, P187, DOI 10.1136/jme.16.4.187
   SKRABANEK P, 1994, DEATH HUMANE MED, P31
   SOX HC, 1994, NEW ENGL J MED, V330, P1589, DOI 10.1056/NEJM199406023302208
   STEPHENSON MJ, 1993, CAN FAM PHYSICIAN, V39, P745
   STRANDBERG TE, 1991, JAMA-J AM MED ASSOC, V266, P1225, DOI 10.1001/jama.266.9.1225
   *US PREV SERV TASK, 1989, ASS EFF 169 INT
   VEATCH RM, 1989, MED ETHICS
   Vevaina J R, 1993, Dis Mon, V39, P869
   WALDRON G, 1993, BRIT MED J, V307, P500, DOI 10.1136/bmj.307.6902.500-c
   WALSWORTHBELL JP, 1993, BRIT MED J, V307, P1495, DOI 10.1136/bmj.307.6917.1495-a
   WOOLF SH, 1995, NEW ENGL J MED, V333, P1401, DOI 10.1056/NEJM199511233332107
   WOOLF SH, 1993, ARCH INTERN MED, V153, P2646, DOI 10.1001/archinte.153.23.2646
   1994, BRIT MED J, V308, P313
   1994, BRIT MED J, V308, P308
NR 57
TC 27
Z9 27
U1 0
U2 1
PU CANADIAN MEDICAL ASSOCIATION
PI OTTAWA
PA 1867 ALTA VISTA DR, OTTAWA ON K1G 3Y6, CANADA
SN 0820-3946
J9 CAN MED ASSOC J
JI Can. Med. Assoc. J.
PD AUG 15
PY 1996
VL 155
IS 4
BP 377
EP 383
PG 7
WC Medicine, General & Internal
SC General & Internal Medicine
GA VC609
UT WOS:A1996VC60900020
PM 8752062
DA 2018-10-20
ER

PT J
AU Santin, M
   Huang, SJ
   Iannace, S
   Ambrosio, L
   Nicolais, L
   Peluso, G
AF Santin, M
   Huang, SJ
   Iannace, S
   Ambrosio, L
   Nicolais, L
   Peluso, G
TI Synthesis and characterization of a new interpenetrated
   poly(2-hydroxyethylmethacrylate)-gelatin composite polymer
SO BIOMATERIALS
LA English
DT Article
DE poly(2-hydroxyethylmethacrylate); gelatin; interpenetrating polymer
   network; biocompatibility; cell adhesion
ID IMPLANTATION; INVITRO; INVIVO
AB Poly(2-hydroxyethylmethacrylate) [poly(HEMA)] is a widely used biomaterial which does not allow cell adhesion and growth on its surface, limiting its use in biomedical applications in which cell cohesion is detrimental. We have prepared a poly(HEMA)-gelatin composite hydrogel using a sequential interpenetrating polymer network technique. The properties of this material were compared with poly(HEMA) freeze-dried sponges in terms of morphology, mechanical properties and biocompatibility. Moreover, in vivo biocompatibility experiments highlighted the occurrence of cellular interactions on the surface of the poly(HEMA)-gelatin interpenetrating polymer network, which are usually absent when unmodified poly(HEMA) hydrogels are implanted in the same host organism. These tests also showed a progressive gelatin degradation from the surface to the bulk of the poly(HEMA)-gelatin specimens during short-term (7 d) implantation. Finally, in vitro tests confirmed an improved ability of this composite to scaffold for the cells. (C) 1996 Elsevier Science Limited.
C1 CNR,INST PROT BIOCHEM & ENZYMOL,I-80072 ARCO,NAPLES,ITALY.
   UNIV CONNECTICUT,INST MAT SCI,STORRS,CT 06269.
   UNIV NAPLES,DEPT MAT & PROD ENGN,I-80125 NAPLES,ITALY.
OI AMBROSIO, LUIGI/0000-0002-8367-2405; Iannace,
   Salvatore/0000-0003-1487-4983
CR ALI SAM, 1993, BIOMATERIALS, V14, P648, DOI 10.1016/0142-9612(93)90063-8
   AMUDESWARI S, 1984, EUR POLYM J, V20, P91, DOI 10.1016/0014-3057(84)90230-1
   ANDERSON JM, 1988, ASAIO, V11
   BADWEY JA, 1980, ANNU REV BIOCHEM, V49, P695, DOI 10.1146/annurev.bi.49.070180.003403
   CHIRILA TV, 1993, BIOMATERIALS, V14, P26, DOI 10.1016/0142-9612(93)90072-A
   CIVERCHIAPEREZ L, 1980, P NATL ACAD SCI-BIOL, V77, P2064, DOI 10.1073/pnas.77.4.2064
   COLEMAN DL, 1974, J BIOMED MATER RES, V8, P65, DOI 10.1002/jbm.820080308
   COLEMAN DL, 1974, J BIOMED MATER RES, V8, P199, DOI 10.1002/jbm.820080503
   GORHAM SD, 1991, BIOMATERIALS NOVEL M
   JAYANTHI R, 1990, BIOMATERIALS, V11, P238
   KUMAR GS, 1981, J POLYM SCI POL CHEM, V9, P1265
   Pulapura S, 1992, J Biomater Appl, V6, P216, DOI 10.1177/088532829200600303
   RATNER BD, 1993, J BIOMED MATER RES, V27, P837, DOI 10.1002/jbm.820270702
   REMES A, 1992, BIOMATERIALS, V13, P731, DOI 10.1016/0142-9612(92)90010-L
   RICHES D, 1988, MOL CELLULAR BIOL WO
   SMETANA K, 1992, BIOMATERIALS, V13, P639, DOI 10.1016/0142-9612(92)90033-K
   Sperling L. H., 1981, INTERPENETRATING POL
   STOL M, 1991, BIOMATERIALS, V12, P454, DOI 10.1016/0142-9612(91)90142-W
   STOL M, 1985, BIOMATERIALS, V6, P193, DOI 10.1016/0142-9612(85)90009-2
   WOERLY S, 1990, BIOMATERIALS, V11, P97, DOI 10.1016/0142-9612(90)90123-8
   ZHAO QH, 1992, J BIOMED MATER RES, V26, P1019, DOI 10.1002/jbm.820260805
NR 21
TC 67
Z9 69
U1 0
U2 20
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD AUG
PY 1996
VL 17
IS 15
BP 1459
EP 1467
DI 10.1016/0142-9612(96)89769-9
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA UZ139
UT WOS:A1996UZ13900001
PM 8853115
DA 2018-10-20
ER

PT J
AU Mitura, S
   Niedzielski, P
   Jachowicz, D
   Langer, M
   Marciniak, J
   Stanishevsky, A
   Tochitsky, E
   Louda, P
   Couvrat, P
   Denis, M
   Lourdin, P
AF Mitura, S
   Niedzielski, P
   Jachowicz, D
   Langer, M
   Marciniak, J
   Stanishevsky, A
   Tochitsky, E
   Louda, P
   Couvrat, P
   Denis, M
   Lourdin, P
TI Influence of carbon coatings origin on the properties important for
   biomedical application
SO DIAMOND AND RELATED MATERIALS
LA English
DT Article
DE carbon coatings; plasma assisted CVD; biomaterials
ID RF DENSE-PLASMA; FILMS; DEPOSITION; CVD
AB The purpose of the present study was to investigate the properties of a carbon layer depending of the origin of applied methods. Quasiamorphous carbon coatings prepared by ion beam methane decomposition by RF dense plasma and vacuum pulsed are deposition were applied to stainless steel implants used in surgery. The studies of carbon films as coatings for implants in surgery were aimed on the investigations of biological resistance of implants, histopathological investigations using laboratory animals, tests of corrosion resistance, measurements of mechanical properties and a breakdown test in Tyrod solution.
   The comparison of the properties of the coating produced by these methods shows very good biotolerance and biocompatibility of all of the coatings. They are not corroded in physiological fluids. From the other side they have different properties, especially electrical and optical, and are not influenced on medical applications. The obtained results prove that the implants coated by all the methods mentioned are a very good material for medical use.
C1 SILESIAN TECH UNIV, INST MET, GLIWICE, POLAND.
   BELARUS ACAD SCI, PLASMOTEG ENGN CTR, MINSK 220141, BYELARUS.
   TECH UNIV LIBEREC, INST SCI MAT, LIBEREC 46117, CZECH REPUBLIC.
   ECOLE CATHOLIQUE ARTS MTIERS, F-69321 LYON 05, FRANCE.
RP Mitura, S (reprint author), TECH UNIV LODZ, INST MAT SCI & ENGN, STEFANOWSKIEGO 1, PL-90924 LODZ, POLAND.
RI Mitura, Stanislaw/L-6013-2014
OI Mitura, Stanislaw/0000-0001-9280-3748; Niedzielski,
   Piotr/0000-0002-6966-9154
CR ANGUS J, 1986, PLASMA DEPOSITED THI
   BUTTER R, 1995, DIAM RELAT MATER, V4, P857, DOI 10.1016/0925-9635(94)05280-8
   CHANDRA L, 1995, DIAM RELAT MATER, V4, P852, DOI 10.1016/0925-9635(94)05255-7
   COOPER CV, 1994, DIAM RELAT MATER, V3, P534, DOI 10.1016/0925-9635(94)90219-4
   COUVRAT P, 1995, DIAM RELAT MATER, V4, P1251, DOI 10.1016/0925-9635(95)00307-X
   GRANT DM, 1992, DIAM RELAT MATER, V1, P727, DOI 10.1016/0925-9635(92)90198-W
   GRILL A, 1993, DIAM RELAT MATER, V2, P597, DOI 10.1016/0925-9635(93)90190-D
   KCHOLODNY AK, 1995, COMMUNICATION
   LETTINGTON AH, 1992, DIAM RELAT MATER, V1, P805, DOI 10.1016/0925-9635(92)90104-V
   Marciniak J., 1992, BIOMATERIALY CHIRURG
   MITURA E, 1994, DIAM RELAT MATER, V3, P896, DOI 10.1016/0925-9635(94)90295-X
   MITURA S, 1991, SURF COAT TECH, V47, P106, DOI 10.1016/0257-8972(91)90273-Y
   MITURA S, 1995, DIAM RELAT MATER, V4, P302, DOI 10.1016/0925-9635(94)05203-4
   MITURA S, 1995, ADV SCI TECHNOLOGY, V6, P273
   OLBORSKA A, 1994, DIAM RELAT MATER, V3, P899, DOI 10.1016/0925-9635(94)90296-8
   TOCHITSKY EI, 1991, SURF COAT TECH, V47, P522, DOI 10.1016/0257-8972(91)90320-V
   TOCHITSKY EI, 1991, SURF COAT TECH, V47, P292, DOI 10.1016/0257-8972(91)90294-7
   WEI RH, 1993, DIAM RELAT MATER, V2, P898, DOI 10.1016/0925-9635(93)90247-Y
   WILLIAMS DF, 1973, IMPLANTS SURG
NR 19
TC 24
Z9 24
U1 1
U2 21
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0925-9635
EI 1879-0062
J9 DIAM RELAT MATER
JI Diam. Relat. Mat.
PD AUG
PY 1996
VL 5
IS 10
BP 1185
EP 1188
DI 10.1016/0925-9635(95)00525-0
PG 4
WC Materials Science, Multidisciplinary; Materials Science, Coatings &
   Films; Physics, Applied; Physics, Condensed Matter
SC Materials Science; Physics
GA VH527
UT WOS:A1996VH52700018
DA 2018-10-20
ER

PT J
AU Francois, P
   Vaudaux, P
   Foster, TJ
   Lew, DP
AF Francois, P
   Vaudaux, P
   Foster, TJ
   Lew, DP
TI Host-bacteria interactions in foreign body infections
SO INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
LA English
DT Article; Proceedings Paper
CT 4th International Conference on the Prevention of Infection (CIPI)
CY MAY 06-07, 1996
CL NICE, FRANCE
ID COAGULASE-NEGATIVE STAPHYLOCOCCI; FIBRONECTIN-BINDING-PROTEINS; AUREUS
   COLLAGEN ADHESIN; CLUMPING FACTOR; LIGAND-BINDING; NUCLEOTIDE-SEQUENCE;
   MOLECULAR CHARACTERIZATION; FIBRINOGEN RECEPTOR; BONE SIALOPROTEIN;
   SEPTIC ARTHRITIS
AB Persistent staphylococcal infections are a major medical problem, especially when they occur on implanted materials or intravascular catheters. This review describes some of the recently discovered molecular mechanisms of Staphylococcus aureus attachment to host proteins coating biomedical implants. These interactions involve specific surface proteins, called bacterial adhesins, that recognize specific domains of host proteins deposited on indwelling devices, such as fibronectin, fibrinogen, or fibrin. Elucidation of molecular mechanisms of S aureus adhesion to the different host proteins may lead to the development of specific inhibitors blocking attachment of S aureus, which may decrease the risk of bacterial colonization of indwelling devices.
C1 UNIV HOSP,DIV INFECT DIS,CH-1211 GENEVA 14,SWITZERLAND.
   UNIV GENEVA,APPL PHYS GRP,GENEVA,SWITZERLAND.
   TRINITY COLL DUBLIN,DEPT MICROBIOL,MOYNE INST,DUBLIN,IRELAND.
FU Wellcome Trust
CR BISNO AL, 1994, INFECT ASS INDWELLIN, P398
   BODEN MK, 1994, MOL MICROBIOL, V12, P599, DOI 10.1111/j.1365-2958.1994.tb01046.x
   BOUCHENAKI N, 1990, ANTIMICROB AGENTS CH, V34, P21, DOI 10.1128/AAC.34.1.21
   CHEUNG AI, 1995, INFECT IMMUN, V63, P1914
   CHEUNG AL, 1990, J INFECT DIS, V161, P1177, DOI 10.1093/infdis/161.6.1177
   CHHATWAL GS, 1987, INFECT IMMUN, V55, P1878
   Christensen Gordon D., 1994, P45
   CHUARD C, 1991, ANTIMICROB AGENTS CH, V35, P2611, DOI 10.1128/AAC.35.12.2611
   DELMI M, 1994, J ORTHOPAED RES, V12, P432, DOI 10.1002/jor.1100120316
   DICKINSON RB, 1995, INFECT IMMUN, V63, P3143
   FISCHER B, IN PRESS J ORTHOP RE
   FLOCK JI, 1987, EMBO J, V6, P2351, DOI 10.1002/j.1460-2075.1987.tb02511.x
   Foster T. J., 1994, P31
   FOSTER TJ, 1994, FEMS MICROBIOL LETT, V118, P199, DOI 10.1016/0378-1097(94)90504-5
   Francois P, 1996, BIOMATERIALS, V17, P667, DOI 10.1016/0142-9612(96)86736-6
   GREENE C, 1995, MOL MICROBIOL, V17, P1143, DOI 10.1111/j.1365-2958.1995.mmi_17061143.x
   GREENE C, IN PRESS MICROBIOLOG
   HERRMANN M, 1990, J CLIN INVEST, V86, P942
   HERRMANN M, 1991, INFECT IMMUN, V59, P279
   HERRMANN M, 1993, J INFECT DIS, V167, P312, DOI 10.1093/infdis/167.2.312
   HERRMANN M, 1988, J INFECT DIS, V158, P693, DOI 10.1093/infdis/158.4.693
   HOOK M, 1989, FIBRONECTIN, P295
   JONSSON K, 1991, EUR J BIOCHEM, V202, P1041, DOI 10.1111/j.1432-1033.1991.tb16468.x
   JONSSON K, 1995, J BIOL CHEM, V270, P21457, DOI 10.1074/jbc.270.37.21457
   KLOOS WE, 1994, CLIN MICROBIOL REV, V7, P117
   KUYPERS JM, 1989, INFECT IMMUN, V57, P2306
   LIANG OD, 1993, BIOCHIM BIOPHYS ACTA, V1225, P57, DOI 10.1016/0925-4439(93)90122-H
   LINDBERG M, 1990, MOL BIOL STAPHYLOCOC, P343
   LOPES JD, 1985, SCIENCE, V229, P275, DOI 10.1126/science.3160113
   LUCET JC, 1990, ANTIMICROB AGENTS CH, V34, P2312, DOI 10.1128/AAC.34.12.2312
   MCDEVITT D, 1995, MOL MICROBIOL, V16, P895, DOI 10.1111/j.1365-2958.1995.tb02316.x
   MCDEVITT D, 1994, MOL MICROBIOL, V11, P237, DOI 10.1111/j.1365-2958.1994.tb00304.x
   MCGAVIN MJ, 1993, J BIOL CHEM, V268, P23946
   MCGAVIN MJ, 1991, J BIOL CHEM, V266, P8343
   MOREILLON P, 1995, INFECT IMMUN, V63, P4738
   MULLER E, 1993, J INFECT DIS, V168, P1211, DOI 10.1093/infdis/168.5.1211
   PARK PW, 1991, J BIOL CHEM, V266, P23399
   PATTI JM, 1993, BIOCHEMISTRY-US, V32, P11428, DOI 10.1021/bi00093a021
   PATTI JM, 1995, J BIOL CHEM, V270, P12005, DOI 10.1074/jbc.270.20.12005
   PATTI JM, 1992, J BIOL CHEM, V267, P4766
   PATTI JM, 1994, INFECT IMMUN, V62, P152
   PITTET D, 1995, ARCH INTERN MED, V155, P1177, DOI 10.1001/archinte.155.11.1177
   PITTET D, 1994, JAMA-J AM MED ASSOC, V271, P1598, DOI 10.1001/jama.271.20.1598
   RAJA RH, 1990, INFECT IMMUN, V58, P2593
   ROZALSKA B, 1994, APMIS, V102, P1
   RUPP ME, 1994, CLIN INFECT DIS, V19, P231, DOI 10.1093/clinids/19.2.231
   RYDEN C, 1989, EUR J BIOCHEM, V184, P331, DOI 10.1111/j.1432-1033.1989.tb15023.x
   SCHAAD HJ, 1994, ANTIMICROB AGENTS CH, V38, P1703, DOI 10.1128/AAC.38.8.1703
   SHIRO H, 1994, J INFECT DIS, V169, P1042, DOI 10.1093/infdis/169.5.1042
   SIGNAS C, 1989, P NATL ACAD SCI USA, V86, P699, DOI 10.1073/pnas.86.2.699
   SWITALSKI LM, 1993, MOL MICROBIOL, V7, P99, DOI 10.1111/j.1365-2958.1993.tb01101.x
   VAUDAUX P, 1984, J INFECT DIS, V150, P546, DOI 10.1093/infdis/150.4.546
   VAUDAUX P, 1993, J INFECT DIS, V167, P633, DOI 10.1093/infdis/167.3.633
   VAUDAUX P, 1989, J INFECT DIS, V160, P865, DOI 10.1093/infdis/160.5.865
   VAUDAUX P, 1992, J INFECT DIS, V166, P58, DOI 10.1093/infdis/166.1.58
   VAUDAUX PE, 1984, INFECT IMMUN, V45, P768
   VAUDAUX PE, 1995, INFECT IMMUN, V63, P585
   Vaudaux Pierre E., 1994, P1
   WALDVOGEL FA, 1995, PRINCIPLES PRACTICE, P1754
   YACOUB A, 1994, EUR J BIOCHEM, V222, P919, DOI 10.1111/j.1432-1033.1994.tb18940.x
   ZIMMERLI W, 1984, J CLIN INVEST, V73, P1191, DOI 10.1172/JCI111305
   ZIMMERLI W, 1982, J INFECT DIS, V146, P487, DOI 10.1093/infdis/146.4.487
   ZIMMERLI W, 1984, INFECT IMMUN, V46, P625
NR 63
TC 65
Z9 65
U1 0
U2 7
PU SLACK INC
PI THOROFARE
PA 6900 GROVE RD, THOROFARE, NJ 08086
SN 0899-823X
J9 INFECT CONT HOSP EP
JI Infect. Control Hosp. Epidemiol.
PD AUG
PY 1996
VL 17
IS 8
BP 514
EP 520
PG 7
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA VE320
UT WOS:A1996VE32000008
PM 8875296
DA 2018-10-20
ER

PT J
AU Kato, K
   Matsumoto, G
   Karasawa, Y
   Niimura, N
   Matsubayashi, M
   Tsuruno, A
AF Kato, K
   Matsumoto, G
   Karasawa, Y
   Niimura, N
   Matsubayashi, M
   Tsuruno, A
TI Neutron radiography of thick hydrogenous materials with use of an
   imaging plate neutron detector
SO NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION A-ACCELERATORS
   SPECTROMETERS DETECTORS AND ASSOCIATED EQUIPMENT
LA English
DT Article; Proceedings Paper
CT 2nd International Topical Meeting on Neutron Radiography System Design
   and Characterization
CY NOV 12-18, 1995
CL RIKKYO UNIV, INST ATOM ENERGY, NAGASAKA, JAPAN
SP Inoue Fdn Sci, Atom Energy Soc Japan, Japanese Soc Non Destruct Inspect, Radiat Applicat Dev Assoc, Japan Atom Energy Res Inst, Tokai Estab, Rikkyo Univ, Inst Atom Energy
HO RIKKYO UNIV, INST ATOM ENERGY
DE neutron radiography; imaging plate; water; mouse
AB The value of the neutron mass attenuation coefficient of hydrogen being very high, it is extremely difficult to image normal size, living animals with neutron radiography. However, the authors suggest the possibility of applying neutron radiography for biomedical specimens. The organs in the breast, bones and cartilages in the extremities, and the tail of mice and rats were clearly imaged by neutron radiography with Gd foils as neutron converters and X-ray films. However, no contours of the organs in the mouse abdomen were visible with neutron radiography with an exposure time of 200 s.
   By adding Gd or Li compounds as neutron converters to imaging X-ray plates, imaging plates have been developed for neutron detectors. A trial using these imaging plates for neutron radiography of water-filled containers and the abdomen of mice was completed. The roundness of a 100 ml-beaker was imaged with a neutron exposure of 180 s. Obscure contours of the liver and kidneys of the mouse were imaged with a neutron exposure of 100 s.
C1 NAGOYA UNIV,FAC ENGN,NAGOYA,AICHI 460,JAPAN.
   JAPAN ATOM ENERGY RES INST,ADV SCI RES CTR,TOKAI,IBARAKI 31911,JAPAN.
   JAPAN ATOM ENERGY RES INST,RES REACTOR TECHNOL DEV DIV,TOKAI,IBARAKI 31911,JAPAN.
RP Kato, K (reprint author), INAZAWA CITY HOSP,INAZAWA,AICHI 492,JAPAN.
CR MATSUBAYASHI M, 1994, NEUTRON RADIOGRAPHY (4): INCLUDING RADIOSCOPY AND COMPLEMENTARY INSPECTION METHODS USING NEUTRONS, P415
   Matsumoto G., 1995, Medical Imaging Technology, V13, P885
   MATSUMOTO G, 1994, NEUTRON RADIOGRAPHY (4): INCLUDING RADIOSCOPY AND COMPLEMENTARY INSPECTION METHODS USING NEUTRONS, P333
   NIIMURA N, 1994, NUCL INSTRUM METH A, V349, P521, DOI 10.1016/0168-9002(94)91220-3
NR 4
TC 6
Z9 7
U1 0
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-9002
J9 NUCL INSTRUM METH A
JI Nucl. Instrum. Methods Phys. Res. Sect. A-Accel. Spectrom. Dect. Assoc.
   Equip.
PD JUL 21
PY 1996
VL 377
IS 1
BP 123
EP 125
DI 10.1016/0168-9002(96)00129-5
PG 3
WC Instruments & Instrumentation; Nuclear Science & Technology; Physics,
   Nuclear; Physics, Particles & Fields
SC Instruments & Instrumentation; Nuclear Science & Technology; Physics
GA UY527
UT WOS:A1996UY52700029
DA 2018-10-20
ER

PT J
AU Bruce, PG
AF Bruce, PG
TI Rechargeable lithium batteries
SO PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY A-MATHEMATICAL PHYSICAL
   AND ENGINEERING SCIENCES
LA English
DT Article
ID MANGANESE OXIDE CATHODE; INSERTION; LIMN2O4; EXTRACTION; SYSTEM
AB Much of materials electrochemistry represents a fusion of solid-state chemistry and electrochemistry. The commercial success of the world's first rechargeable lithium battery, introduced recently by Sony, is a triumph of materials electrochemistry. By developing radically new anodes, cathodes and electrolytes, a cell has been produced which can store three times the energy per unit weight and volume compared with conventional systems. This represents a revolution in battery technology. The Sony cell was developed in response to a demand from consumer electronic products such as camcorders. The future development of such products, e.g. mobile telephones and lap-top computers, of biomedical devices, such as the artificial heart, and of electric vehicles, is crucially dependent on developing advanced batteries. The markets for many of these devices are vast. The Sony cell is based on the rocking-chair concept and is composed of a carbon anode, LiCoO2 cathode and non-aqueous electrolyte. The advantages and disadvantages of the rocking-chair battery will be compared with those of the rechargeable lithium battery based on a lithium-metal anode. The Sony cell represents merely a first-generation lithium system. Future substantial improvements in performance will also rely on innovative materials electrochemistry. The search for new intercalation cathodes which can offer advantages compared with LiCoO2 are discussed. In particular, the development of new 3 and 4 V cathodes, based on LiMn2O4 spinel materials, is presented. These materials have a number of important advantages which make them attractive as the basis for a new generation of rechargeable lithium batteries. The new synthetic routes to the spinel materials are described, as are the structures, microstructures and electrochemical performance of these materials.
RP Bruce, PG (reprint author), UNIV ST ANDREWS, SCH CHEM, ST ANDREWS KY16 9ST, FIFE, SCOTLAND.
CR BARBOUX P, 1991, J SOLID STATE CHEM, V94, P185, DOI 10.1016/0022-4596(91)90231-6
   BRUCE PG, 1993, RSC 1 INT C MAT CHEM
   Dahn J. R., 1994, LITHIUM BATTERIES NE, P1
   DELMAS C, 1994, LITHIUM BATTERIES NE, P457
   GOODENOUGH JB, 1984, REV CHIM MINER, V21, P435
   HUANG HT, 1994, J ELECTROCHEM SOC, V141, pL76, DOI 10.1149/1.2055042
   HUANG HT, 1995, J POWER SOURCES, V54, P52, DOI 10.1016/0378-7753(94)02039-6
   HUANG HT, 1994, J ELECTROCHEM SOC, V141, pL106, DOI 10.1149/1.2055168
   Linden D., 1984, HDB BATTERIES FUEL C
   MIZUCHIMA K, 1980, MAT RES B, V17, P785
   MOMCHILOV A, 1993, J POWER SOURCES, V41, P305, DOI 10.1016/0378-7753(93)80048-T
   Nagaura T., 1990, 3 INT BATT SEM DEERF
   PISTOIA G, 1993, SOLID STATE IONICS, V66, P135, DOI 10.1016/0167-2738(93)90036-3
   TARASCON JM, 1993, ELECTROCHIM ACTA, V38, P1221, DOI 10.1016/0013-4686(93)80053-3
   THACKERAY MM, 1984, MATER RES BULL, V19, P179, DOI 10.1016/0025-5408(84)90088-6
   THACKERAY MM, 1992, J ELECTROCHEM SOC, V139, P363, DOI 10.1149/1.2069222
   THACKERAY MM, 1983, MATER RES BULL, V18, P461, DOI 10.1016/0025-5408(83)90138-1
   THOMAS MGS, 1985, SOLID STATE IONICS, V18, P794
   THOMAS MGSR, 1985, SOLID STATE IONICS, V17, P13, DOI 10.1016/0167-2738(85)90117-1
   Vetter K. J., 1966, ELECTROCHIM ACTA, V11, P401
NR 20
TC 40
Z9 40
U1 2
U2 15
PU ROYAL SOC
PI LONDON
PA 6-9 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND
SN 1364-503X
J9 PHILOS T R SOC A
JI Philos. Trans. R. Soc. A-Math. Phys. Eng. Sci.
PD JUL 15
PY 1996
VL 354
IS 1712
BP 1577
EP 1593
DI 10.1098/rsta.1996.0066
PG 17
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA UZ217
UT WOS:A1996UZ21700008
DA 2018-10-20
ER

PT J
AU Yamamoto, Y
   Sefton, MV
AF Yamamoto, Y
   Sefton, MV
TI Hofmann degradation of acrylamide copolymer: Synthesis of amine
   functionalized thermoplastic hydrogel
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
ID POLYMER LATEX
AB The amine functionalization of an acrylamide copolymer was achieved via Hofmann degradation. The starting material, poly(acrylamide-co-methyl methacrylate), was synthesized by radical precipitation polymerization. Using this copolymer, Hofmann degradation at 0 degrees C in a water-dioxane mixture was done using sodium hypochlorite and NaOH. The resulting hydrogel could be dissolved in water-tetrahydrofuran mixtures, and the cast film had a water content of 73%. It was found that the conversion to primary amine was lower, and the extent of a side reaction was higher, compared to those of an acrylamide homopolymer. This was presumed to be due to the lack of the neighboring group effect among acrylamide units since it was a random copolymer. Further modification of this polymer by reacting the amine group is considered to obtain the desired properties for biomedical applications. (C) 1996 John Wiley & Sons, Inc.
C1 UNIV TORONTO,DEPT CHEM ENGN & APPL CHEM,TORONTO,ON M5S 1A4,CANADA.
   UNIV TORONTO,CTR BIOMAT,TORONTO,ON M5S 1A4,CANADA.
CR Badesso R. J., 1993, P AM CHEM SOC DIV PO, V69, P251
   BAINES FC, 1968, J POLYM SCI A1, V6, P2433, DOI 10.1002/pol.1968.150060901
   DAWSON DJ, 1976, J AM CHEM SOC, V98, P5996, DOI 10.1021/ja00435a036
   GREENLEY RZ, 1980, J MACROMOL SCI CHEM, VA14, P445, DOI 10.1080/00222338008081032
   HARLAND RS, 1993, J CONTROL RELEASE, V26, P157, DOI 10.1016/0168-3659(93)90184-7
   KAWAGUCHI H, 1984, J COLLOID INTERF SCI, V97, P465, DOI 10.1016/0021-9797(84)90318-7
   KAWAGUCHI H, 1981, J APPL POLYM SCI, V26, P2015, DOI 10.1002/app.1981.070260624
   MARCH J, 1985, ADV ORG CHEM, P983
   OHTSUKA Y, 1981, ACS SYM SER, P145
   RADHAKRISHNA AS, 1979, J ORG CHEM, V44, P1746, DOI 10.1021/jo01324a048
   REYNOLDS DD, 1947, J AM CHEM SOC, V69, P911, DOI 10.1021/ja01196a052
   SAINI G, 1971, MAKROMOLEKUL CHEM, V144, P235
   SEFTON MV, 1992, J CONTROL RELEASE, V19, P289, DOI 10.1016/0168-3659(92)90084-5
   SMETANA KJ, 1993, J BIOMED MATER RES, V24, P463
   TABAL H, 1989, EUR POLYM J, V25, P31
   TANAKA H, 1978, J POLYM SCI POL LETT, V16, P87, DOI 10.1002/pol.1978.130160205
   TANAKA H, 1979, J POLYM SCI POL CHEM, V17, P1239, DOI 10.1002/pol.1979.170170427
   TANAKA K, 1976, THIN SOLID FILMS, V33, P309, DOI 10.1016/0040-6090(76)90100-0
   VYAVAHARE N, 1994, J POLYM SCI POL CHEM, V32, P1271, DOI 10.1002/pola.1994.080320708
NR 19
TC 19
Z9 22
U1 1
U2 7
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-8995
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD JUL 11
PY 1996
VL 61
IS 2
BP 351
EP 358
DI 10.1002/(SICI)1097-4628(19960711)61:2<351::AID-APP18>3.0.CO;2-6
PG 8
WC Polymer Science
SC Polymer Science
GA UR697
UT WOS:A1996UR69700018
DA 2018-10-20
ER

PT J
AU Goffeng, AR
   Holst, E
   Milsom, I
   Lindstedt, G
   Lundberg, PA
   Andersch, B
AF Goffeng, AR
   Holst, E
   Milsom, I
   Lindstedt, G
   Lundberg, PA
   Andersch, B
TI Fetal fibronectin and microorganisms in vaginal fluid of healthy
   pregnant women
SO ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA
LA English
DT Article
DE fetal fibronectin; bacterial vaginosis; hydrogen peroxide-producing
   lactobacilli
ID BACTERIAL VAGINOSIS; PRETERM DELIVERY; GRAM STAIN; LACTOBACILLI;
   MICROFLORA; PREDICTOR; BIRTH; FLORA
AB Objective. To determine fetal fibronectin in vaginal fluid from healthy women during uncomplicated pregnancy and to investigate possible relationships to gestational age and the vaginal microflora.
   Materials and methods. Samples of vaginal fluid were collected for fetal fibronectin determination and for quantitative aerobic and anaerobic microbiological culture from 22 women followed longitudinally at 12, 28 and 37 weeks gestation and cross-sectionally in women at 12 weeks (n=10), 28 weeks (n=10), 37 weeks (n=10), and 39 weeks (n=30) gestation, respectively. Fetal fibronectin was determined by a quantitative enzyme immunoassay (Adeza Biomedical).
   Results. There were no significant differences between the concentrations of fetal fibronectin in vaginal secretions at any of the four measurement points (12, 28, 37 and 39 weeks gestation). Women with elevated fetal fibronectin concentration (greater than or equal to 0.05 mg/L) had less often hydrogen peroxide-producing facultative lactobacilli (p<0.0001), and more often bacterial vaginosis (p<0.02) and Peptostreptococcus species (p<0.002). Bacterial vaginosis (p<0.01) and Candida albicans (p<0.01) were more frequently found in women lacking hydrogen peroxide-producing lactobacilli.
   Conclusion. Fetal fibronectin in vaginal fluid was more associated with the vaginal microflora than with the gestational age of the pregnancy. Presence of hydrogen peroxide-producing lactobacilli seems to be the most important factor for a stable vaginal microflora.
C1 LUND UNIV,DEPT MED MICROBIOL,LUND,SWEDEN.
   GOTHENBURG UNIV,SAHLGRENS UNIV HOSP,DEPT CLIN CHEM & TRANSFUS MED,GOTHENBURG,SWEDEN.
RP Goffeng, AR (reprint author), EAST HOSP,DEPT OBSTET & GYNECOL,S-41685 GOTHENBURG,SWEDEN.
CR EKMAN G, 1995, ACTA OBSTET GYN SCAN, V74, P698, DOI 10.3109/00016349509021177
   ESCHENBACH DA, 1989, J CLIN MICROBIOL, V27, P251
   FEINBERG RF, 1991, AM J PATHOL, V138, P537
   HAY PE, 1994, BRIT J OBSTET GYNAEC, V101, P1048, DOI 10.1111/j.1471-0528.1994.tb13580.x
   HILLIER SL, 1992, OBSTET GYNECOL, V79, P369, DOI 10.1097/00006250-199203000-00008
   HILLIER SL, 1992, AM J OBSTET GYNECOL, V166, P938, DOI 10.1016/0002-9378(92)91368-K
   HOLST E, 1994, J CLIN MICROBIOL, V32, P176
   KLEBANOFF SJ, 1991, J INFECT DIS, V164, P94, DOI 10.1093/infdis/164.1.94
   KURKI T, 1992, OBSTET GYNECOL, V80, P173
   LEESON S, 1993, BRIT J OBSTET GYNAEC, V100, P304, DOI 10.1111/j.1471-0528.1993.tb12968.x
   LOCKWOOD CJ, 1993, AM J OBSTET GYNECOL, V169, P798, DOI 10.1016/0002-9378(93)90008-7
   LOCKWOOD CJ, 1991, NEW ENGL J MED, V325, P669, DOI 10.1056/NEJM199109053251001
   MARTIUS J, 1988, OBSTET GYNECOL, V71, P89
   MCCARTHY PE, 1991, NEW ENGL J MED, V325, P727
   NAGEOTTE MP, 1994, AM J OBSTET GYNECOL, V170, P20
   REDONDOLOPEZ V, 1990, REV INFECT DIS, V12, P856
   SPIEGEL CA, 1983, J CLIN MICROBIOL, V18, P170
NR 17
TC 7
Z9 7
U1 0
U2 0
PU MUNKSGAARD INT PUBL LTD
PI COPENHAGEN
PA 35 NORRE SOGADE, PO BOX 2148, DK-1016 COPENHAGEN, DENMARK
SN 0001-6349
J9 ACTA OBSTET GYN SCAN
JI Acta Obstet. Gynecol. Scand.
PD JUL
PY 1996
VL 75
IS 6
BP 520
EP 525
DI 10.3109/00016349609054664
PG 6
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA UZ092
UT WOS:A1996UZ09200003
DA 2018-10-20
ER

PT J
AU Manner, I
   Alanen, A
   Komu, M
   Savunen, T
   Kantonen, I
   Ekfors, T
AF Manner, I
   Alanen, A
   Komu, M
   Savunen, T
   Kantonen, I
   Ekfors, T
TI MR imaging in the presence of small circular metallic implants -
   Assessment of thermal injuries
SO ACTA RADIOLOGICA
LA English
DT Article
DE MR; safety; foreign bodies; experimental
ID BIOMEDICAL IMPLANTS; POTENTIAL HAZARDS; DEVICES
AB Purpose: The thermal effects of MR imaging in the presence of circular nonferromagnetic metallic implants were studied in 6 rabbits.
   Material and Methods: A sternotomy was performed and fixed with stainless steel wires, and small titanium rings (diameter 3 mm) were placed on the surface of the ascending aorta and subcutaneous tissue of the thigh. Four of the rabbits were exposed to an imaging procedure with a 1.5 T scanner applying a T1-weighted spin-echo sequence and a gradient echo sequence. Two of the animals served as unexposed controls. Thirty-six hours after the exposure, tissues adjacent to the implants were examined histologically and compared with corresponding samples of the control animals.
   Results: In the area of the titanium rings, histologic analysis revealed slight inflammatory changes apparently caused by the operation. No evidence of thermal injury was found, suggesting that the presence of the rings does not contraindicate MR examinations. Necrosis was noted in all of the sternal specimens. This was probably postoperative, but it impaired the assessment of thermal injury in this area.
C1 TURKU UNIV,DEPT DIAGNOST RADIOL,FIN-20520 TURKU,FINLAND.
   TURKU UNIV,DEPT SURG,FIN-20520 TURKU,FINLAND.
   TURKU UNIV,DEPT PATHOL,FIN-20520 TURKU,FINLAND.
RP Manner, I (reprint author), TURKU UNIV HOSP,DIAGNOST IMAGING CTR,KIINAMYLLYNKATU 4-8,FIN-20520 TURKU,FINLAND.
CR BOTTOMLEY PA, 1985, MAGNET RESON MED, V2, P336, DOI 10.1002/mrm.1910020404
   BUDINGER TF, 1981, J COMPUT ASSIST TOMO, V5, P800, DOI 10.1097/00004728-198112000-00003
   DARSONVAL MA, 1993, ARCH PHYSL NORM PATH, V5, P401
   DAVIS PL, 1981, AM J ROENTGENOL, V137, P857, DOI 10.2214/ajr.137.4.857
   FISCHER H, 1989, RADIOLOGY, V173, P382
   GANGAROSA RE, 1987, MAGN RESON IMAGING, V5, P287, DOI 10.1016/0730-725X(87)90006-3
   HASSLER M, 1986, Journal de Radiologie (Paris), V67, P661
   KANAL E, 1990, RADIOLOGY, V176, P593, DOI 10.1148/radiology.176.3.2202008
   Kanal E., 1988, MAGN RESON IMAGIN S1, V7, P106
   MARK AS, 1987, RADIOLOGY, V162, P311, DOI 10.1148/radiology.162.2.3797642
   NEW PFJ, 1983, RADIOLOGY, V147, P139, DOI 10.1148/radiology.147.1.6828719
   Schaefer D.J., 1988, BIOMEDICAL MAGNETIC, P553
   SHELLOCK FG, 1991, RADIOLOGY, V180, P541, DOI 10.1148/radiology.180.2.2068325
   SHELLOCK FG, 1988, AM J ROENTGENOL, V151, P811, DOI 10.2214/ajr.151.4.811
   SHELLOCK FG, 1994, RADIOLOGY, V192, P865, DOI 10.1148/radiology.192.3.8058962
   SHELLOCK FG, 1988, AM J ROENTGENOL, V151, P389, DOI 10.2214/ajr.151.2.389
   SHELLOCK FG, 1987, RADIOLOGY, V163, P259, DOI 10.1148/radiology.163.1.3823445
   SHELLOCK FG, 1990, AM J ROENTGENOL, V154, P1229, DOI 10.2214/ajr.154.6.2110733
   SHELLOCK FG, 1987, RADIOLOGY, V167, P809
   Shellock FG, 1987, RADIOLOGY, V165, P150
   SOULEN RL, 1985, RADIOLOGY, V154, P705, DOI 10.1148/radiology.154.3.3969474
NR 21
TC 10
Z9 10
U1 0
U2 2
PU MUNKSGAARD INT PUBL LTD
PI COPENHAGEN
PA 35 NORRE SOGADE, PO BOX 2148, DK-1016 COPENHAGEN, DENMARK
SN 0284-1851
J9 ACTA RADIOL
JI Acta Radiol.
PD JUL
PY 1996
VL 37
IS 4
BP 551
EP 554
PG 4
WC Radiology, Nuclear Medicine & Medical Imaging
SC Radiology, Nuclear Medicine & Medical Imaging
GA VA958
UT WOS:A1996VA95800015
PM 8688241
DA 2018-10-20
ER

PT J
AU Kishida, A
   Kato, S
   Ohmura, K
   Sugimura, K
   Akashi, M
AF Kishida, A
   Kato, S
   Ohmura, K
   Sugimura, K
   Akashi, M
TI Evaluation of biological responses to polymeric biomaterials by RT-PCR
   analysis .1. Study of IL-1 beta mRNA expression
SO BIOMATERIALS
LA English
DT Article
DE biocompatibility; macrophage; IL-I beta; mRNA; RT-PCR
ID BIOMEDICAL POLYMERS; MONOCYTES MACROPHAGES
AB In this study, we introduce a novel research methodology, the evaluation of mRNA expression of cells contacting with polymeric materials using reverse transcription-polymerase chain reaction (RT-PCR) analysis HL-60 was used as a model of the macrophages. The expression of interleukin-1 beta (IL-1 beta) mRNA, a cytokine secreted by macrophages, was selected to estimate the extent of inflammation. The expression of IL-1 beta mRNA in the HL60 cells cultured on various substrates and in Various conditions was studied. Expression of IL-1 beta could be successfully determined by RT-PGR analysis. A 48 h incubation period was necessary to clarify the expression of IL-1 beta mRNA. It became clear that lipopolysaccharide stimulation was not necessary in this analysis because of the high sensitivity of RT-PCR analysis. It is concluded that RT-PCR analysis is a powerful tool for studying cell-polymer interaction, and is a complementary method for ELISA. (C) 1996 Elsevier Science Limited
RP Kishida, A (reprint author), KAGOSHIMA UNIV,FAC ENGN,DEPT APPL CHEM & CHEM ENGN,1-21-40 KORIMOTO,KAGOSHIMA 890,JAPAN.
CR BONFIELD TL, 1991, J BIOMED MATER RES, V25, P165, DOI 10.1002/jbm.820250204
   BONFIELD TL, 1992, J BIOMED MATER RES, V26, P837, DOI 10.1002/jbm.820260702
   BONFIELD TL, 1992, J BIOMED MATER RES, V26, P457, DOI 10.1002/jbm.820260404
   BONFIELD TL, 1993, J BIOMED MATER RES, V27, P1195, DOI 10.1002/jbm.820270910
   BONFIELD TL, 1989, J BIOMED MATER RES, V23, P535, DOI 10.1002/jbm.820230602
   CARDONA MA, 1992, J BIOMED MATER RES, V26, P851, DOI 10.1002/jbm.820260703
   FALCK P, 1995, BIOMATERIALS, V16, P61, DOI 10.1016/0142-9612(95)91097-I
   Ikada Y, 1986, J BIOACT COMPAT POL, V1, P32
   KISHIDA A, 1991, BIOMATERIALS, V12, P786, DOI 10.1016/0142-9612(91)90031-5
   MILLER KM, 1989, J BIOMED MATER RES, V23, P1007, DOI 10.1002/jbm.820230904
   MILLER KM, 1988, J BIOMED MATER RES, V22, P713, DOI 10.1002/jbm.820220805
   MILLER KM, 1989, J BIOMED MATER RES, V23, P911, DOI 10.1002/jbm.820230808
   NAGAHARA S, 1994, SOC POLYM SCI JAPAN, V23, P53
   NAKAJIMA T, 1993, J CLIN INVEST, V92, P186, DOI 10.1172/JCI116548
   TABATA Y, 1989, J COLLOID INTERF SCI, V127, P132, DOI 10.1016/0021-9797(89)90013-1
   TABATA Y, 1988, BIOMATERIALS, V9, P35
   TAMADA Y, 1986, POLYM MED, V2, P101
NR 17
TC 33
Z9 33
U1 0
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUL
PY 1996
VL 17
IS 13
BP 1301
EP 1305
DI 10.1016/0142-9612(96)88675-3
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA UT734
UT WOS:A1996UT73400006
PM 8805977
DA 2018-10-20
ER

PT J
AU Li, YJ
   Matthews, KH
   Chen, TM
   Wang, YF
   Kodama, M
   Nakaya, T
AF Li, YJ
   Matthews, KH
   Chen, TM
   Wang, YF
   Kodama, M
   Nakaya, T
TI Novel blood-compatible polyurethanes containing poly(butadiene) soft
   segments and phosphatidylcholine analogues for biomedical applications
SO CHEMISTRY OF MATERIALS
LA English
DT Article
ID PHOSPHOLIPID ANALOG; ALBUMIN ADSORPTION; SURFACE; CHAIN;
   PHOSPHORYLCHOLINE; BIOSTABILITY; COPOLYMERS; ADHESION; POLYMERS; BOND
AB New segmented polyurethanes (SPUs) based on stearyl and phosphatidylcholine analogues were synthesized. The soft segments used in this study were the poly(butadiene) (PBD) glycol, the hard segments of these SPUs were composed of 4,4'-methylenediphenyl diisocyanate (MDI), 2-[bis(2-hydroxyethyl)methylammonio]ethy stearylphosphate (BESP), and 1,4-butanediol (BD). The bulk and surface characterization was investigated by differential scanning calorimetry (DSC), X-ray diffraction, attenuated total reflectance Fourier transform infrared spectroscopy (ATR-FTIR), and contact angle measurements. The mechanical properties were investigated by dynamic viscoelasticity and tensile property experiments. The blood compatibilities of the new SPUs were evaluated by platelet-rich plasma (PRP) contact studies and viewed by scanning electron microscopy(SEM). The results show that this new material has good mechanical strength with an elongation at break of 252%, and the blood compatibilities of the SPUs have a great difference between the glass contact side and air-exposed side for the same cast films. The hot-pressed films, having same polyimide contact surface, show that the phospholipid SPU is a favorable surface in terms of platelet adhesion and that the morphology of adhered platelets undergoes a relatively low degree of variation. The clotting time of the cast films contacting with PRP was more than 240 s for the new polymers and 122 and 86 s for polystyrene and glass, respectively.
C1 OSAKA CITY UNIV,FAC ENGN,DEPT BIOAPPL CHEM,SUMIYOSHI KU,OSAKA 558,JAPAN.
   NATL INST ADV INTERDISCIPLINARY RES,BION DESIGN GRP,TSUKUBA,IBARAKI 305,JAPAN.
OI Matthews, Kerr/0000-0002-8503-7157
CR BORETOS JW, 1972, J BIOMED MATER RES, V6, P473, DOI 10.1002/jbm.820060513
   BORETOS JW, 1967, SCIENCE, V158, P1481, DOI 10.1126/science.158.3807.1481
   BORETOS JW, 1982, 8TH P ANN SOC BIOM, P24
   CHAPMAN D, 1984, Patent No. 199790
   Coury A J, 1988, J Biomater Appl, V3, P130, DOI 10.1177/088532828800300202
   COURY AJ, 1987, LIFE SUPPORT SYST, V5, P25
   COURY AJ, 1984, ADV URETHANE SCI TEC, V9, P130
   DEFIFE KM, 1995, J BIOMED MATER RES, V29, P431, DOI 10.1002/jbm.820290403
   DURANI AA, 1986, Patent No. 275293
   DURRANI AA, 1986, BIOMATERIALS, V7, P121, DOI 10.1016/0142-9612(86)90068-2
   EBERHART RC, 1987, ARTIF ORGANS, V11, P375
   ESTES GM, 1970, J MACROMOL SCI-REV M, VC  4, P313
   GRASEL TG, 1987, J BIOMED MATER RES, V21, P815, DOI 10.1002/jbm.820210702
   ISHIHARA K, 1995, BIOMATERIALS, V16, P873, DOI 10.1016/0142-9612(95)94150-J
   Lelah M. D., 1986, POLYURETHANES MED
   LETOURNEUR D, 1991, J POLYM SCI POL CHEM, V29, P1367, DOI 10.1002/pola.1991.080291001
   LI YJ, 1995, MACROMOL CHEM PHYSIC, V196, P3143, DOI 10.1002/macp.1995.021961006
   LI YJ, 1995, MACROMOL RAPID COMM, V16, P253, DOI 10.1002/marc.1995.030160404
   LI YJ, IN PRESS BIOMATERIAL
   LI YJ, IN PRESS J BIOMATER
   MARCONI W, 1995, BIOMATERIALS, V16, P449, DOI 10.1016/0142-9612(95)98817-X
   MARCONI W, 1994, MACROMOL CHEM PHYS, V195, P875, DOI 10.1002/macp.1994.021950306
   MCMILLIN CR, 1989, IEEE ENG MED BIO JUN, P30
   MUNRO MS, 1983, ASAIO J, V6, P65
   NAKAI S, 1977, MAKROMOL CHEM, V178, P2963
   NAKAYA T, 1987, KAGAKU, V42, P725
   NAKAYA T, 1986, Patent No. 207395
   OBRIEN DF, 1989, ENCY POLYM SCI ENG, V17, P108
   PITT WG, 1988, BIOMATERIALS, V9, P36, DOI 10.1016/0142-9612(88)90067-1
   Planck H, 1987, PROGR BIOMEDICAL ENG
   RAHMAN R, 1989, J POLYM SCI POL CHEM, V27, P2673, DOI 10.1002/pola.1989.080270815
   SAKURAI I, 1992, MACROMOLECULES, V25, P7256, DOI 10.1021/ma00052a029
   Saunders J. H., 1962, POLYURETHANES CHEM 1
   SHIN YC, 1994, J BIOMAT SCI-POLYM E, V6, P195
   STOKES K, 1990, Journal of Biomaterials Science Polymer Edition, V1, P207
   Stokes K, 1987, J Biomater Appl, V1, P411
   STOKES K, 1982, BIOMATERIALS, V3, P225, DOI 10.1016/0142-9612(82)90024-2
   Stokes K B, 1988, J Biomater Appl, V3, P228, DOI 10.1177/088532828800300205
   STRIZINAR I, 1992, J BIOMED MATER RES, V26, P577
   TAKAHARA A, 1991, BIOMATERIALS, V12, P324, DOI 10.1016/0142-9612(91)90042-9
   TAKAHARA A, 1991, J BIOMED MATER RES, V25, P341, DOI 10.1002/jbm.820250306
   TAKAHARA A, 1985, POLYMER, V26, P987, DOI 10.1016/0032-3861(85)90218-6
   TAKAHARA A, 1988, ARTIFICIAL HEART, V2, P19
   TSUCHIYA T, 1995, J BIOMED MATER RES, V29, P635
   UMEDA T, 1982, MAKROMOL CHEM-RAPID, V3, P457
   VALENCIA GP, 1985, Patent No. 247114
   YAMADA M, 1995, MACROMOL RAPID COMM, V16, P25, DOI 10.1002/marc.1995.030160105
   YAMADA M, 1995, J MACROMOL SCI PURE, VA32, P1235, DOI 10.1080/10601329508009351
   YAMADA M, 1985, 50 SPRING M JPN CHEM, V2, P1582
   YAMADA M, 1986, 52 SPRING M JPN CHEM, V2, P793
NR 50
TC 39
Z9 40
U1 1
U2 4
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036
SN 0897-4756
J9 CHEM MATER
JI Chem. Mat.
PD JUL
PY 1996
VL 8
IS 7
BP 1441
EP 1450
DI 10.1021/cm960014x
PG 10
WC Chemistry, Physical; Materials Science, Multidisciplinary
SC Chemistry; Materials Science
GA VA057
UT WOS:A1996VA05700018
DA 2018-10-20
ER

PT J
AU Thompson, JY
   Bayne, SC
   Swift, EJ
AF Thompson, JY
   Bayne, SC
   Swift, EJ
TI Dental materials citations .A. January to June 1996
SO DENTAL MATERIALS
LA English
DT Bibliography
AB Objective. A search was conducted to identify the denial materials publications that appeared in biomedical journals from January 1996 to June 1996 and to compare the frequency of citations among the different categories.
   Methods. The tables of contents of 16 primary journals and 48 secondary journals were examined to identify dental materials articles that were published from January to June 1996. These citations were divided into 17 categories and the numbers of citations in each category were compared. To assess the usefulness of the citation listing, a survey of Academy of Dental Materials subscribers was conducted (n= 153 of 382 or 40.1% have responded to date).
   Results. As in previous years, the greatest number of citations were found in categories of bonding (n=83) and resin-based restorative materials such as composites and resin-reinforced glass ionomers (n=80). Results of the reader survey indicated that 84.3% of the respondents have used the citations lists, and 95.4% feel that its publication should be continued.
   Significance. The literature compiled in this list serves to supplement the electronic indexing mechanisms so that academicians and researchers can have ready access to the current literature in the field of dental materials.
RP Thompson, JY (reprint author), UNIV N CAROLINA,SCH DENT,DEPT OPERAT DENT,CB 7450,BRAUER HALL,CHAPEL HILL,NC 27599, USA.
NR 0
TC 8
Z9 8
U1 0
U2 1
PU ACAD DENTAL MATERIALS
PI DALLAS
PA BAYLOR COLLEGE DENTISTRY, 3302 GASTON AVE, DALLAS, TX 75266-0677
SN 0109-5641
J9 DENT MATER
JI Dent. Mater.
PD JUL
PY 1996
VL 12
IS 4
BP 272
EP 286
DI 10.1016/S0109-5641(96)80034-0
PG 15
WC Dentistry, Oral Surgery & Medicine; Materials Science, Biomaterials
SC Dentistry, Oral Surgery & Medicine; Materials Science
GA VQ333
UT WOS:A1996VQ33300009
PM 9002846
DA 2018-10-20
ER

PT J
AU Mitura, E
   Niedzielska, A
   Niedzielski, P
   Klimek, L
   Rylski, A
   Mitura, S
   Moll, J
   Pietrzykowski, W
AF Mitura, E
   Niedzielska, A
   Niedzielski, P
   Klimek, L
   Rylski, A
   Mitura, S
   Moll, J
   Pietrzykowski, W
TI The properties of carbon layers deposited onto titanium substrates
SO DIAMOND AND RELATED MATERIALS
LA English
DT Article; Proceedings Paper
CT 6th European Conference on Diamond, Diamond-like and Related Materials
   (Diamond Films 95)
CY SEP 10-15, 1995
CL BARCELONA, SPAIN
DE amorphous carbon; adhesion; biomaterial; biomedical applications;
   interface
ID RF DENSE-PLASMA; COATINGS; FILMS
AB Thin, hard, amorphous carbon layers, deposited using a dense r.f. methane plasma onto titanium substrate, were investigated. This includes an examination of the interface between the carbon layer and the substrate and the optimization of the process and its application.
   The substrates coated with carbon layers were analysed by Auger electron spectroscopy (AES) and scanning electron microscopy (SEM). Results of AES studies show that the surface layer, several thousand angstroms thick, consists of carbon. The carbon film passes smoothly into a thick layer (about 1 mu m) consisting of titanium carbide. The composition varies across the transitional layer between carbon and carbide regions. This coating structure ensures a high mechanical strength and very good adhesion to Ti substrates. These coatings also protect metal implants against corrosion, and protect man from a serious illness, metallosis.
   Preliminary,investigations in vivo and in vitro confirm the biocompatibility of the C/TiC/Ti system and its biointegration. In addition, investigations of the mechanical, anticorrosive and structural properties of the coatings, deposited using a dense methane plasma excited in an r.f. electric field, show that this can be a very good material to apply in cardiovascular surgery.
   The r.f. decomposition of methane seems to be a very convenient method for the production of superhard carbon coatings on Ti substrates for medical applications.
C1 TECH UNIV LODZ,INST MAT SCI & ENGN,PL-90924 LODZ,POLAND.
   MED ACAD LODZ,PAEDIAT CARDIAC SURG DEPT,PL-93338 LODZ,POLAND.
RP Mitura, E (reprint author), TECH UNIV LODZ,FAC PROC & ENVIRONM ENGN,WOLCZANSKA 175,PL-90924 LODZ,POLAND.
RI Mitura, Stanislaw/L-6013-2014; Klimek, Leszek/K-5958-2015
OI Mitura, Stanislaw/0000-0001-9280-3748; Klimek,
   Leszek/0000-0003-3617-8225; Niedzielski, Piotr/0000-0002-6966-9154
CR ANGUS J, 1986, PLASMA DEPOSITED THI
   CHUAN CC, 1974, CHARACTERIZATION SOL, P534
   COOPER CV, 1994, DIAM RELAT MATER, V3, P534, DOI 10.1016/0925-9635(94)90219-4
   COUVRAT P, 1995, DIAM RELAT MATER, V4, P1251, DOI 10.1016/0925-9635(95)00307-X
   GRIL A, 1994, DIAM RELAT MATER, V2, P597
   LETTINGTON AH, 1992, DIAM RELAT MATER, V1, P805, DOI 10.1016/0925-9635(92)90104-V
   MITURA E, 1994, DIAM RELAT MATER, V3, P896, DOI 10.1016/0925-9635(94)90295-X
   MITURA S, 1991, SURF COAT TECH, V47, P106, DOI 10.1016/0257-8972(91)90273-Y
   MITURA S, 1995, DIAM RELAT MATER, V4, P302, DOI 10.1016/0925-9635(94)05203-4
   MITURA S, 1995, ADV SCI TECHNOLOGY, V6, P273
   OLBORSKA A, 1994, DIAM RELAT MATER, V3, P899, DOI 10.1016/0925-9635(94)90296-8
   WEI R, 1994, DIAM RELAT MATER, V2, P898
NR 12
TC 19
Z9 20
U1 1
U2 14
PU ELSEVIER SCIENCE SA LAUSANNE
PI LAUSANNE 1
PA PO BOX 564, 1001 LAUSANNE 1, SWITZERLAND
SN 0925-9635
J9 DIAM RELAT MATER
JI Diam. Relat. Mat.
PD JUL
PY 1996
VL 5
IS 9
BP 998
EP 1001
DI 10.1016/0925-9635(95)00469-6
PG 4
WC Materials Science, Multidisciplinary; Materials Science, Coatings &
   Films; Physics, Applied; Physics, Condensed Matter
SC Materials Science; Physics
GA VA325
UT WOS:A1996VA32500022
DA 2018-10-20
ER

PT J
AU Barnes, RM
AF Barnes, RM
TI Analytical plasma source mass spectrometry in biomedical research
SO FRESENIUS JOURNAL OF ANALYTICAL CHEMISTRY
LA English
DT Article; Proceedings Paper
CT 29th International Colloquium on Spectroscopy
CY AUG 27-SEP 01, 1995
CL LEIPZIG, GERMANY
ID ELEMENTAL SPECIATION; ANION-EXCHANGE; CHROMATOGRAPHY; LEAD;
   METALLOPORPHYRINS
AB The features of inductively coupled plasma-mass spectrometry (ICP-MS) that make it unique also make possible applications in biological chemistry and biomedical research that would be otherwise difficult or impossible. High sensitivity, characterized spectral interferences, rapid mass scanning, and individual isotope measurements are now combined with sophisticated sample preparation, separations, or stable isotope additions to achieve rapid semi-quantitative analysis, element speciation, and high accuracy. The semi-quantitative analysis of various materials, the separation and detection of macromolecules in blood and other tissues, and tracking of stable isotopes added either purposely or inadvertently to children are important applications of ICP-MS. Current functional limitations and obstacles and potential development areas also are examined.
RP Barnes, RM (reprint author), UNIV MASSACHUSETTS,LEDERLE GRAD RES CTR,DEPT CHEM,BOX 34510,AMHERST,MA 01003, USA.
CR ALLAIN P, 1992, BIOL MASS SPECTROM, V21, P141, DOI 10.1002/bms.1200210305
   AMARASIRIWARDEN.D, 1995, UNPUB APPL SPECTROSC
   ARAR EJ, 1992, ENVIRON SCI TECHNOL, V26, P1944, DOI 10.1021/es00034a010
   BACON JR, 1944, J ANAL ATOM SPECTROM, V9, pR267
   BARNES RM, 1993, ANAL CHIM ACTA, V283, P115, DOI 10.1016/0003-2670(93)85214-5
   BEARY ES, 1994, J ANAL ATOM SPECTROM, V9, P1363, DOI 10.1039/ja9940901363
   BEARY ES, 1994, ANAL CHEM, V66, P431, DOI 10.1021/ac00076a004
   BROWINS RJ, 1994, J ANAL ATOM SPECTROM, V9, P1233
   Cairns W. R. L., 1994, Analytical Proceedings, V31, P295, DOI 10.1039/ai9943100295
   CLELAND SL, 1994, J ANAL ATOM SPECTROM, V9, P975, DOI 10.1039/ja9940900975
   CORNELIS R, 1994, J ANAL ATOM SPECTROM, V9, P945, DOI 10.1039/ja9940900945
   CORNELIS R, 1993, ANAL CHIM ACTA, V283, P183, DOI 10.1016/0003-2670(93)85221-5
   CRESSER MS, 1995, J ANAL ATOM SPECTROM, V10, pR9, DOI 10.1039/ja995100009r
   CREWS HM, 1994, ANALYST, V119, P2491, DOI 10.1039/an9941902491
   CREWS HM, 1993, AM LAB, V25
   DAMS R, 1994, BIOL TRACE ELEM RES, V42, P539
   DAUVHY X, 1993, J CHROMATOGR SCI, V31, P416
   DEAN JR, 1994, J ANAL ATOM SPECTROM, V9, P615, DOI 10.1039/ja9940900615
   DEBIEVRE P, 1993, MASS SPECTROM REV, V12, P143, DOI 10.1002/mas.1280120302
   DEBIEVRE P, 1993, ANAL PROC, V30, P328
   DENOYER ER, 1995, ATOM SPECTROSC, V16, P1
   DONARD OFX, 1993, ENV ANAL TECHNIQUES, P549
   EVANS EH, 1993, J ANAL ATOM SPECTROM, V8, P1, DOI 10.1039/ja9930800001
   EVANS S, 1994, J ANAL ATOM SPECTROM, V9, P1249, DOI 10.1039/ja9940901249
   FELDMANN I, 1994, J ANAL ATOM SPECTROM, V9, P1007, DOI 10.1039/ja9940901007
   FORSTNER U, 1993, INT J ENVIRON AN CH, V51, P5, DOI 10.1080/03067319308027608
   GARCIAALONSO JI, 1993, ANAL CHIM ACTA, V283, P261, DOI 10.1016/0003-2670(93)85231-8
   GODLEWSKA B, 1993, CHEM ANAL-WARSAW, V38, P267
   GOOSSENS J, 1993, J ANAL ATOM SPECTROM, V8, P921, DOI 10.1039/ja9930800921
   GRAY AL, 1994, ANAL PROC, V31, P371
   GREGOIRE DC, 1994, J ANAL ATOM SPECTROM, V9, P393, DOI 10.1039/ja9940900393
   GRIEND CES, 1994, J CHROMATOGR A, V673, P299
   HALICZ L, 1994, SPECTROCHIM ACTA B, V49, P637, DOI 10.1016/0584-8547(94)80057-X
   HARALDSSON C, 1994, J ANAL ATOM SPECTROM, V9, P1229, DOI 10.1039/ja9940901229
   HEUMANN KG, 1994, J ANAL ATOM SPECTROM, V9, P1351, DOI 10.1039/ja9940901351
   HIGH KA, 1995, FRESEN J ANAL CHEM, V351, P393, DOI 10.1007/BF00322908
   HIGH KA, 1995, ANALYST, V120, P629, DOI 10.1039/an9952000629
   HILL SJ, 1993, J ANAL ATOM SPECTROM, V8, P499, DOI 10.1039/ja9930800499
   HOLLAND G, 1993, APPL PLASMA SOURCE M, V2
   HORLICK G, 1944, J ANAL ATOM SPECTROM, V9, P593
   HUANG CW, 1994, J ANAL ATOM SPECTROM, V9, P681
   INOUE Y, 1995, J ANAL ATOM SPECTROM, V10, P363, DOI 10.1039/ja9951000363
   JAKUBOWSKI N, 1994, J ANAL ATOM SPECTROM, V9, P193, DOI 10.1039/ja9940900193
   KRAUSE P, 1993, FRESEN J ANAL CHEM, V346, P324
   KUMAR U, 1994, J CHROMATOGR SCI, V32, P282, DOI 10.1093/chromsci/32.7.282
   LARSEN EH, 1994, J ANAL ATOM SPECTROM, V9, P1099, DOI 10.1039/ja9940901099
   LARSEN EH, 1993, J ANAL ATOM SPECTROM, V8, P1075, DOI 10.1039/ja9930801075
   LE SXC, 1994, ENVIRON SCI TECHNOL, V28, P1598, DOI 10.1021/es00058a010
   LIU Y, 1995, ANAL CHEM, V67, P2020, DOI 10.1021/ac00109a019
   LIU Y, 1993, HRC-J HIGH RES CHROM, V16, P717
   LORD CJ, 1994, J ANAL ATOM SPECTROM, V9, P599, DOI 10.1039/ja9940900599
   LU PL, 1993, ANAL CHIM ACTA, V284, P181, DOI 10.1016/0003-2670(93)80022-D
   LU QH, 1995, ANAL CHEM, V67, P2949, DOI 10.1021/ac00113a033
   MAURAS Y, 1993, CLIN CHIM ACTA, V218, P201, DOI 10.1016/0009-8981(93)90184-6
   MCKAY K, 1993, CANCER SURV, V17, P407
   MELLON FA, 1993, ANAL CHIM ACTA, V283, P190, DOI 10.1016/0003-2670(93)85222-6
   MOENS L, 1994, J ANAL ATOM SPECTROM, V9, P187, DOI 10.1039/ja9940900187
   MOENS L, 1994, J ANAL ATOM SPECTROM, V9, P1075, DOI 10.1039/ja9940901075
   MORITA M, 1994, ANAL CHEM, V66, P1588, DOI 10.1021/ac00081a038
   OLESIK JW, 1995, ANAL CHEM, V67, P1, DOI 10.1021/ac00097a003
   Pais Istvan, 1994, P73, DOI 10.1002/9783527615872.ch3
   Perry B. J., 1994, Analytical Proceedings, V31, P269, DOI 10.1039/ai9943100269
   PLATZNER I, 1994, J ANAL ATOM SPECTROM, V9, P719, DOI 10.1039/ja9940900719
   PRETORIUS W, 1993, HRC-J HIGH RES CHROM, V16, P157
   PRETORIUS WG, 1993, J CHROMATOGR, V646, P369, DOI 10.1016/0021-9673(93)83350-2
   REED NM, 1994, J ANAL ATOM SPECTROM, V9, P881, DOI 10.1039/ja9940900881
   ROTTMANN L, 1994, ANAL CHEM, V66, P3709, DOI 10.1021/ac00093a027
   ROTTMANN L, 1994, FRESEN J ANAL CHEM, V350, P221, DOI 10.1007/BF00322473
   SCHONEICH C, 1995, ANAL CHEM, V67, pR155, DOI 10.1021/ac00108a009
   SEUBERT A, 1994, FRESEN J ANAL CHEM, V350, P210, DOI 10.1007/BF00322472
   SHEPPARD BS, 1994, J ANAL ATOM SPECTROM, V9, P145, DOI 10.1039/ja9940900145
   SHUM SCK, 1993, ANAL CHEM, V65, P2972, DOI 10.1021/ac00069a006
   SMITH RD, 1993, ANAL CHEM, V65, pA574, DOI 10.1021/ac00061a001
   STROH A, 1993, ATOM SPECTROSC, V14, P141
   SUBRAMANIAN KNS, 1955, KINETIC MODELS TRACE
   TANNER SD, 1995, ATOM SPECTROSC, V16, P16
   TAYLOR A, 1994, J ANAL ATOM SPECTROM, V9, pR87, DOI 10.1039/ja994090087r
   TEMPLETON DM, 1994, SCI TOTAL ENVIRON, V148, P253, DOI 10.1016/0048-9697(94)90401-4
   THOMPSON JJ, 1993, J AOAC INT, V76, P1378
   THORMANN W, 1994, ELECTROPHORESIS, V15, P3, DOI 10.1002/elps.1150150103
   TITTES W, 1994, J ANAL ATOM SPECTROM, V9, P1015, DOI 10.1039/ja9940901015
   TOLG G, 1993, ANAL CHIM ACTA, V283, P3, DOI 10.1016/0003-2670(93)85206-Y
   TOMLINSON MJ, 1995, ANALYST, V120, P583, DOI 10.1039/an9952000583
   TOMLINSON MJ, 1994, J ANAL ATOM SPECTROM, V9, P657
   VANDECASTEELE C, 1993, J ANAL ATOM SPECTROM, V8, P781, DOI 10.1039/ja9930800781
   VANHOE H, 1993, J TRACE ELEM ELECT H, V7, P131
   VANHOE H, 1994, J ANAL ATOM SPECTROM, V9, P177, DOI 10.1039/ja9940900177
   VANHOE H, 1994, J ANAL ATOM SPECTROM, V9, P23, DOI 10.1039/ja9940900023
   VELA NP, 1993, ANAL CHEM, V65, pA585, DOI 10.1021/ac00061a002
   Vighi M, 1993, Ann Ist Super Sanita, V29, P209
   VOLLKOPF U, 1995, ATOM SPECTROSC, V16, P19
   WALDER AJ, 1993, ANAL SCI, V9, P675, DOI 10.2116/analsci.9.675
   WASTNEY ME, 1995, UNPUB AM J PHYSL
   WILLIAMS CA, 1995, ANALYST, V120, P341, DOI 10.1039/an9952000341
   WOLF RE, 1995, ATOM SPECTROSC, V16, P22
   XIAO G, 1994, J ANAL ATOM SPECTROM, V9, P509, DOI 10.1039/ja9940900509
   XU Y, 1995, ANAL CHEM, V67, pR436
   YAMASAKI S, 1994, MICROCHEM J, V49, P305, DOI 10.1006/mchj.1994.1042
   ZHAO Z, 1993, J CHROMATOGR-BIOMED, V615, P83, DOI 10.1016/0378-4347(93)80293-D
NR 99
TC 34
Z9 33
U1 0
U2 1
PU SPRINGER VERLAG
PI NEW YORK
PA 175 FIFTH AVE, NEW YORK, NY 10010
SN 0937-0633
J9 FRESEN J ANAL CHEM
JI Fresenius J. Anal. Chem.
PD JUL
PY 1996
VL 355
IS 5-6
BP 433
EP 441
PG 9
WC Chemistry, Analytical
SC Chemistry
GA UV610
UT WOS:A1996UV61000003
DA 2018-10-20
ER

PT J
AU Dang, MH
   Birchler, F
   Ruffieux, K
   Wintermantel, E
AF Dang, MH
   Birchler, F
   Ruffieux, K
   Wintermantel, E
TI Toxicity screening of biodegradable polymers .1. Selection and
   evaluation of cell culture test methods
SO JOURNAL OF ENVIRONMENTAL POLYMER DEGRADATION
LA English
DT Article
DE toxicity screening; biodegradable polymers; cell cultures; test with
   extract
AB A screening test method for potential toxicity of biodegradable plastics on humans and the environment was selected and evaluated with samples of cellulose acetate, Bionolle, polyhydroxybutyrate-co-valerate (Biopol), and polycaprolactone (Tone polymer). Among the standard in vitro tests using animal cell cultures for the evaluation of biomedical materials, the test by direct contact and the test with extract were examined. Qualitative and quantitative determinations of the cell viability and morphology indicate that the test with extracts can be easily performed, providing reproducible and comparable results for all materials. Using the cell culture test with the extract of sterile samples, an estimation of the toxicity of a new polymeric material can be obtained within a few weeks.
RP Dang, MH (reprint author), ETH ZURICH, CHAIR BIOCOMPATIBLE MAT SCI & ENGN, WAGISTR 23, SCHLIEREN, SWITZERLAND.
CR [Anonymous], ASTM STAND
   [Anonymous], ISO109935 5
   Matthews I. P., 1994, Clinical Materials, V15, P191, DOI 10.1016/0267-6605(94)90082-5
   Petitmermet M, 1995, BIOREMED SER, V3, P223
   WAN H, 1994, J MATER SCI-MATER M, V5, P154, DOI 10.1007/BF00053336
NR 5
TC 9
Z9 9
U1 0
U2 6
PU SPRINGER/PLENUM PUBLISHERS
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1064-7546
J9 J ENVIRON POLYM DEGR
JI J. Environ. Polym. Degrad.
PD JUL
PY 1996
VL 4
IS 3
BP 197
EP 203
DI 10.1007/BF02067453
PG 7
WC Engineering, Environmental; Polymer Science
SC Engineering; Polymer Science
GA VC286
UT WOS:A1996VC28600006
DA 2018-10-20
ER

PT J
AU Miller, JM
   Dunn, B
   Valentine, JS
   Zink, JI
AF Miller, JM
   Dunn, B
   Valentine, JS
   Zink, JI
TI Synthesis conditions for encapsulating cytochrome c and catalase in SiO2
   sol-gel materials
SO JOURNAL OF NON-CRYSTALLINE SOLIDS
LA English
DT Article
ID GLUCOSE BIOSENSOR; SILICA-GEL; GLASSES; ENZYMES; IMMOBILIZATION
AB The encapsulation of biological molecules in sol-gel materials has led to the development of a new class of chemical and biomedical sensors. The influence of sol-gel synthesis conditions on the stability, chemical function, and enzymatic reactivity for horse heart cytochrome c and bovine liver catalase encapsulated in silica sol-gel materials was studied. The effects of synthesis pH, alcohol/alkoxide ratio, and buffer type were examined using UV-Vis absorption spectroscopy for cytochrome c-doped materials and gasometric analysis for assays of catalase in gels. In general, the behavior of the proteins encapsulated in silica gels mirrored their behavior in solution suggesting that the stability limiting factor for encapsulating these biological molecules is determined by the solution stability of the protein. In the case of catalase, the results indicate that the silica gel stabilizes the encapsulated enzyme to higher methanol concentrations.
C1 UNIV CALIF LOS ANGELES,DEPT MAT SCI & ENGN,LOS ANGELES,CA 90095.
   UNIV CALIF LOS ANGELES,DEPT CHEM & BIOCHEM,LOS ANGELES,CA 90095.
RI Valentine, Joan/B-6665-2008
OI Valentine, Joan/0000-0002-7174-925X
CR Adar F., 1978, PORPHYRINS A, P167
   AUDEBERT P, 1993, CHEM MATER, V5, P911, DOI 10.1021/cm00031a005
   AVNIR D, 1992, ACS SYM SER, V499, P384
   BEERS RF, 1952, J BIOL CHEM, V195, P133
   BERNARDS TNM, 1991, J NON-CRYST SOLIDS, V134, P1, DOI 10.1016/0022-3093(91)90005-Q
   Bertini I., 1994, BIOINORG CHEM, P611
   BRAUN S, 1990, MATER LETT, V10, P1, DOI 10.1016/0167-577X(90)90002-4
   Brinker C. J., 1990, SOL GEL SCI PHYSICS, P97
   CHUNG KE, 1995, ANAL CHEM, V67, P1505, DOI 10.1021/ac00105a004
   DAVE BC, 1994, ANAL CHEM, V66, pA1120, DOI 10.1021/ac00094a001
   ELLERBY LM, 1992, SCIENCE, V255, P1113, DOI 10.1126/science.1312257
   GLEZER V, 1993, J AM CHEM SOC, V115, P2533, DOI 10.1021/ja00059a072
   KLEIN LC, 1985, ANNU REV MATER SCI, V15, P227
   KLEIN LC, 1984, J NON-CRYST SOLIDS, V63, P23, DOI 10.1016/0022-3093(84)90383-1
   KUROKAWA Y, 1994, CARBOHYD POLYM, V23, P1, DOI 10.1016/0144-8617(94)90083-3
   KUROKAWA Y, 1993, BIOTECHNOL BIOENG, V42, P394, DOI 10.1002/bit.260420318
   LAN E, 1994, THESIS UCLA
   Lapange S., 1978, PHYSICOCHEMICAL ASPE, P331
   MAEHLY AC, 1954, METHOD BIOCHEM ANAL, V1, P357
   NARANG U, 1994, CHEM MATER, V6, P1596, DOI 10.1021/cm00046a004
   NARANG U, 1994, ANAL CHEM, V66, P3139, DOI 10.1021/ac00091a023
   SCHONBAUM GR, 1976, OXIDATION REDUCTIO C, V13, P542
   TATSU Y, 1992, CHEM LETT, P1615, DOI 10.1246/cl.1992.1615
   Theorell H, 1941, J AM CHEM SOC, V63, P1804, DOI 10.1021/ja01852a005
   UNO T, 1984, BIOCHEMISTRY-US, V23, P6802, DOI 10.1021/bi00321a081
   Uo M., 1992, J CERAM SOC JPN, V100, P426
   VEGA AJ, 1989, J NON-CRYST SOLIDS, V111, P153, DOI 10.1016/0022-3093(89)90276-7
   VOET D, 1990, BIOCHEMISTRY
   WU SG, 1994, APPL BIOCHEM BIOTECH, V47, P11, DOI 10.1007/BF02788671
NR 29
TC 73
Z9 75
U1 1
U2 15
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0022-3093
J9 J NON-CRYST SOLIDS
JI J. Non-Cryst. Solids
PD JUL
PY 1996
VL 202
IS 3
BP 279
EP 289
DI 10.1016/0022-3093(96)00191-3
PG 11
WC Materials Science, Ceramics; Materials Science, Multidisciplinary
SC Materials Science
GA VF407
UT WOS:A1996VF40700010
DA 2018-10-20
ER

PT J
AU Hjelle, MA
   Bauer, MA
AF Hjelle, MA
   Bauer, MA
TI Characteristics of an ultrafiltered deionized water system used in the
   manufacture of implantable biomedical devices
SO JOURNAL OF THE INSTITUTE OF ENVIRONMENTAL SCIENCES
LA English
DT Article
DE ultrapure water; endotoxin; total oxidizable carbon (TOC); bacteria;
   deionized; ultrafilter (UF)
AB The purpose of this paper is to demonstrate the characteristics of an ultrafiltered deionized water system used in the manufacture of biomedical devices. The water system was designed to reduce product concerns with respect to ionic contamination, organic contamination, and microbial contamination. The goal of the system was to produce high-purity deionized water that exceeded the requirements of USP pure water and meet the manufacturing requirements of electronic device assembly. This goal was achieved by using a compact design, select materials of construction, and robust pretreatment to reduce the bur-den to the ultrafiltration system. Continuous supply is delivered to all points of use through balanced pressures within the system and without a bulk storage tank. System maintenance is reduced to routine daily monitoring and sanitization once per month. Detailed descriptions of the system design, system operating conditions, and variable data are included to demonstrate system performance.
RP Hjelle, MA (reprint author), MEDTRONIC INC,CHEM SERV,MINNEAPOLIS,MN, USA.
CR COLLENTRO WV, 1987, ULTRAPURE WATER, V4, P40
   LORCH W, 1981, HDB WATER PURIFICATI, P516
   1990, USP, V22
NR 3
TC 0
Z9 0
U1 0
U2 1
PU INST ENVIRONMENTAL SCI
PI MT PROSPECT
PA 940 E NORTHWEST HIGHWAY, MT PROSPECT, IL 60056
SN 1052-2883
J9 J INST ENVIRON SCI
JI J. Inst. Environ. Sci.
PD JUL-AUG
PY 1996
VL 39
IS 4
BP 40
EP 44
PG 5
WC Engineering, Environmental; Environmental Sciences; Instruments &
   Instrumentation
SC Engineering; Environmental Sciences & Ecology; Instruments &
   Instrumentation
GA VE846
UT WOS:A1996VE84600005
DA 2018-10-20
ER

PT J
AU Joziasse, CAP
   Veenstra, H
   Grijpma, DW
   Pennings, AJ
AF Joziasse, CAP
   Veenstra, H
   Grijpma, DW
   Pennings, AJ
TI On the chain stiffness of poly(lactide)s
SO MACROMOLECULAR CHEMISTRY AND PHYSICS
LA English
DT Article
ID RESORBABLE MATERIALS; CHEMICAL-STRUCTURE; MOLECULAR-WEIGHT;
   ENTANGLEMENT; POLYMERS; POLY(L-LACTIDE); POLYLACTIDE; DIMENSIONS;
   TRANSITION; FIXATION
AB Poly(lactide)s (PLAs) are well known hydrolytically degradable polymers, that are widely used for biomedical applications. However, the intrinsic brittle nature of poly(lactide)s is still poorly understood. The stiffness of a polymer chain, expressed as the characteristic ratio C-infinity plays an important role in the deformation mechanism of amorphous polymers. In order to investigate the effect of tacticity, high molecular weight poly(lactide) stereo-copolymers with D-lactide contents in the range 0-50 mol-% were synthesised. These polymers were used in light scattering and differential scanning calorimetry (DSC) experiments for the determination of the characteristic ratio C-infinity and glass transition temperature T-g. The results of the light scattering experiments in acetonitrile indicate that the characteristic ratio C-infinity for poly(lactide)s depends on the L/D-lactide ratio and increases with the tacticity of the polymer from 9.5 for racemic PDLLA to an estimated 11.8 for isotactic PLLA. These results are consistent with the observed brittle behaviour of poly(lactide) stereo-copolymers and agree well with predictions obtained from group contribution methods. The choice of the relevant bond length used for the calculation of the characteristic ratio from the scattering data is not as obvious as it may seem and remains a point of discussion. The tacticity of poly(lactide)s also influences the glass transition temperature, which varies from 54 degrees C for racemic to 63 degrees C for isotactic poly(lactide).
RP Joziasse, CAP (reprint author), UNIV GRONINGEN,DEPT POLYMER CHEM,NIJENBORGH 4,NL-9747 AG GRONINGEN,NETHERLANDS.
CR AHARONI SM, 1985, MACROMOLECULES, V18, P2624, DOI 10.1021/ma00154a045
   BAREISS RE, 1975, POLYM HDB
   BERSTED BH, 1979, J APPL POLYM SCI, V24, P37, DOI 10.1002/app.1979.070240105
   BOS RRM, 1989, INT J ORAL MAX SURG, V18, P365, DOI 10.1016/S0901-5027(89)80035-9
   BOYER RF, 1992, MACROMOLECULES, V25, P5326, DOI 10.1021/ma00046a034
   BRANT DA, 1969, MACROMOLECULES, V2, P228, DOI 10.1021/ma60009a003
   CUTRIGHT DE, 1971, J ORAL SURG, V29, P393
   FETTERS LJ, 1994, MACROMOLECULES, V27, P4639, DOI 10.1021/ma00095a001
   Flory PJ., 1969, STATISTICAL MECHANIC
   Freed KF, 1987, RENORMALIZATION GROU
   GENT AN, 1972, J POLYM SCI A2, V10, P571, DOI 10.1002/pol.1972.160100314
   GRIJPMA DW, 1994, POLYM ENG SCI, V34, P1674, DOI 10.1002/pen.760342205
   GRIJPMA DW, 1993, MAKROMOL CHEM-RAPID, V14, P155
   GRIJPMA DW, 1994, COLLOID POLYM SCI, V272, P1068, DOI 10.1007/BF00652375
   JOZIASSE CAP, 1994, POLYM BULL, V33, P599, DOI 10.1007/BF00296170
   KULKARNI R K, 1971, Journal of Biomedical Materials Research, V5, P169, DOI 10.1002/jbm.820050305
   LEENSLAG JW, 1987, BIOMATERIALS, V8, P70, DOI 10.1016/0142-9612(87)90034-2
   LEENSLAG JW, 1987, BIOMATERIALS, V8, P311, DOI 10.1016/0142-9612(87)90121-9
   LEENSLAG JW, 1984, J APPL POLYM SCI, V39, P2829
   OROFINO TA, 1957, J CHEM PHYS, V26, P1067, DOI 10.1063/1.1743472
   PIETILA LO, COMMUNICATION
   PORTER RS, 1966, CHEM REV, V66, P1, DOI 10.1021/cr60239a001
   SCHINDLER A, 1979, J POLYM SCI POL CHEM, V17, P2593, DOI 10.1002/pol.1979.170170831
   TONELLI AE, 1969, MACROMOLECULES, V2, P225, DOI 10.1021/ma60009a002
   TURNER DT, 1982, POLYMER, V23, P626, DOI 10.1016/0032-3861(82)90106-9
   Van Krevelen D. W., 1976, PROPERTIES POLYM
   VANDEWITTE P, 1994, THESIS TWENTE U ENSC
   WOOL RP, 1993, MACROMOLECULES, V26, P1564, DOI 10.1021/ma00059a012
   WU S, 1989, J POLYM SCI POL PHYS, V27, P723, DOI 10.1002/polb.1989.090270401
   WU SH, 1992, POLYM ENG SCI, V32, P823, DOI 10.1002/pen.760321209
   WU SH, 1992, POLYM INT, V29, P229, DOI 10.1002/pi.4990290313
   YAMAKAWA H, 1971, MODERN THEORY POLYM
NR 32
TC 65
Z9 65
U1 2
U2 24
PU HUTHIG & WEPF VERLAG
PI BASEL
PA AUF DEM WOLF 4 FX#001-41-61-317-94-11, CH-4052 BASEL, SWITZERLAND
SN 1022-1352
J9 MACROMOL CHEM PHYSIC
JI Macromol. Chem. Phys.
PD JUL
PY 1996
VL 197
IS 7
BP 2219
EP 2229
DI 10.1002/macp.1996.021970713
PG 11
WC Polymer Science
SC Polymer Science
GA VA040
UT WOS:A1996VA04000013
DA 2018-10-20
ER

PT J
AU Gallorini, M
   Apostoli, P
AF Gallorini, M
   Apostoli, P
TI Standard reference materials and data quality assurance in the
   biomedical analysis of trace elements
SO BIOLOGICAL TRACE ELEMENT RESEARCH
LA English
DT Article
DE biological standard reference materials; trace elements; human body
   fluids; quality assurance; biomarkers
ID EUROPEAN-COMMUNITY; REFERENCE VALUES; ITALIAN SUBJECTS; INHABITANTS;
   TISSUES; BLOOD
AB Accurate and precise analytical data of the concentrations of bio-analytes in bioclinical studies are of fundamental importance. Quality assurance procedures should always be performed to check the overall analytical work. This can be conveniently performed if appropriate standard reference materials with known concentrations of the analyte object of study are available. This paper underlines the key points related to the production and use of biological standard materials for trace element analysis. In particular, the present situation in the field of trace element determination in human biological fluids and the related problems are illustrated. The considerations given in this work may contribute to the preparation of the new biomarker standard materials.
C1 UNIV BRESCIA,INST OCCUPAT HLTH,BRESCIA,ITALY.
RP Gallorini, M (reprint author), UNIV PAVIA,CNR,CTR RADIOCHEM & ACTIVAT ANAL,PAVIA,ITALY.
CR Aitio A., 1981, QUALITY CONTROL OCCU
   [Anonymous], 1993, INT VOC BAS GEN TERM
   BUTTNER J, 1980, J CLIN CHEM CLIN BIO, V18, P855
   Buttner J., 1980, J CLIN CHEM CLIN BIO, V18, P69
   GLADNEY ES, 1982, NBS SPEC PUBL, P260
   IYENGAR GV, 1989, ELEMENTAL ANAL BIOL, V1
   MINOIA C, 1990, SCI TOTAL ENVIRON, V95, P89, DOI 10.1016/0048-9697(90)90055-Y
   MINOIA C, 1992, SCI TOTAL ENVIRON, V120, P63, DOI 10.1016/0048-9697(92)90216-F
   MURAMATSU Y, 1985, IAEARL128 INT AT EN
   *NIST STAND REF MA, 1991, SPECIAL PUBLICATION, V260
   Rennert O M, 1984, METABOLISM TRACE MET, VI
   RENNERT OM, 1984, METABOLISM TRACE MET, V2
   SABBIONI E, 1992, SCI TOTAL ENVIRON, V120, P39, DOI 10.1016/0048-9697(92)90215-E
   THOMPSON MB, 1986, MANAGING CONDUCT DAT, P199
   TORO EC, 1990, IAEA128 INT AT EN AG
   VERSIECK J, 1989, TRACE ELEMENTS HUMAN
   *WHO, 1984, PRINC PROC QUAL ASS
NR 17
TC 3
Z9 3
U1 0
U2 1
PU HUMANA PRESS INC
PI TOTOWA
PA 999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512
SN 0163-4984
J9 BIOL TRACE ELEM RES
JI Biol. Trace Elem. Res.
PD JUN
PY 1996
VL 52
IS 3
BP 263
EP 272
DI 10.1007/BF02789167
PG 10
WC Biochemistry & Molecular Biology; Endocrinology & Metabolism
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism
GA UV440
UT WOS:A1996UV44000005
PM 8811283
DA 2018-10-20
ER

PT J
AU Tirrell, JG
   Tirrell, DA
AF Tirrell, JG
   Tirrell, DA
TI Synthesis of biopolymers: Proteins, polyesters, polysaccharides and
   polynucleotides
SO CURRENT OPINION IN SOLID STATE & MATERIALS SCIENCE
LA English
DT Review
ID RECOMBINANT ESCHERICHIA-COLI; NEPHILA-CLAVIPES; CHEMOENZYMATIC
   SYNTHESIS; DRAGLINE SILK; CELLULOSE-II; DNA MOLECULE; BOMBYX-MORI;
   ACIDS; GENES; POLYPEPTIDES
AB The synthesis of proteins, polyesters, polysaccharides and polynucleotides can be adapted to produce new macromolecular materials. Proteins of designed sequence, and with specific chemical functions, conferred by the incorporation of unnatural amino acids, have been prepared in genetically engineered bacteria. Polyesters, useful as biodegradable thermoplastics, have been made in bacterial hosts, and more recently, in transgenic plants. Polysaccharides, made either chemically or enzymatically, are being explored for biomedical applications, and synthetic polynucleotides could eventually serve as scaffolds in the construction of nanoscale materials.
RP Tirrell, JG (reprint author), UNIV MASSACHUSETTS, DEPT POLYMER SCI & ENGN, AMHERST, MA 01003 USA.
CR ANDERSON AJ, 1990, MICROBIOL REV, V54, P450
   BECKER MA, 1994, ACS SYM SER, V544, P252
   BECKER MA, 1994, ACS SYM SER, V544, P185
   Bruno FF, 1995, MACROMOLECULES, V28, P8881, DOI 10.1021/ma00130a028
   CABALLERO KP, 1995, INT J BIOL MACROMOL, V17, P86, DOI 10.1016/0141-8130(95)93522-Y
   CASE ST, 1994, ACS SYM SER, V544, P80
   CASE ST, 1994, ACS SYM SER, V544, P243
   CHEN XM, 1994, MACROMOL CHEM PHYSIC, V195, P3567, DOI 10.1002/macp.1994.021951105
   CHEN XM, 1995, MACROMOLECULES, V28, P6014, DOI 10.1021/ma00122a005
   COLGIN MA, 1995, SPIDER SILK BIOMATER, P1009
   CUNNIFF PM, 1994, ACS SYM SER, V544, P234
   Curley JM, 1996, MACROMOLECULES, V29, P1762, DOI 10.1021/ma951185a
   DEGUCHI Y, 1994, J MACROMOL SCI PURE, VA31, P1691, DOI 10.1080/10601329408545877
   DEKONING G, 1995, CAN J MICROBIOL, V41, P303, DOI 10.1139/m95-201
   Deming TJ, 1996, MACROMOLECULES, V29, P1442, DOI 10.1021/ma9510698
   DOI Y, 1995, MACROMOL SYMP, V98, P585, DOI 10.1002/masy.19950980150
   DOUGHERTY MJ, 1993, MACROMOLECULES, V26, P1779, DOI 10.1021/ma00059a045
   DU SM, 1995, J AM CHEM SOC, V117, P1194, DOI 10.1021/ja00109a002
   DU SM, 1995, BIOCHEMISTRY-US, V34, P673, DOI 10.1021/bi00002a035
   EGGINK G, 1995, CAN J MICROBIOL, V41, P14, DOI 10.1139/m95-163
   FAVIER V, 1995, MACROMOLECULES, V28, P6365, DOI 10.1021/ma00122a053
   FLAPAN E, 1995, J CHEM SOC CHEM COMM, P2249, DOI 10.1039/c39950002249
   FURUIKE T, 1995, MACROMOLECULES, V28, P7241, DOI 10.1021/ma00125a029
   HINMAN MB, 1994, ACS SYM SER, V544, P222
   KALOUSEK S, 1995, CAN J MICROBIOL, V41, P216, DOI 10.1139/m95-190
   Kamitakahara H, 1996, MACROMOLECULES, V29, P1119, DOI 10.1021/ma951454x
   KANG CK, 1995, BIOTECHNOL LETT, V17, P583, DOI 10.1007/BF00129382
   KATSURAYA K, 1995, MACROMOLECULES, V28, P6697, DOI 10.1021/ma00124a001
   KIM OY, 1995, CAN J MICROBIOL, V41, P32, DOI 10.1139/m95-165
   Kobayashi S, 1996, MACROMOLECULES, V29, P2698, DOI 10.1021/ma951552i
   KOTHAKOTA S, 1995, J AM CHEM SOC, V117, P536, DOI 10.1021/ja00106a064
   KOTHAKOTA S, 1995, J POLYM SCI POL CHEM, V33, P1267, DOI 10.1002/pola.1995.080330809
   KOYAMA N, 1995, BIOTECHNOL LETT, V17, P281, DOI 10.1007/BF01190637
   KREJCHI MT, 1994, SCIENCE, V265, P1427, DOI 10.1126/science.8073284
   LEE EY, 1995, APPL MICROBIOL BIOT, V42, P901
   LEE SY, 1995, CAN J MICROBIOL, V41, P207, DOI 10.1139/m95-189
   MAHONEY DV, 1994, ACS SYM SER, V544, P196
   MCGRATH KP, 1992, J AM CHEM SOC, V114, P727, DOI 10.1021/ja00028a048
   NAKAMURA S, 1994, ACS SYM SER, V544, P211
   NAWRATH C, 1994, P NATL ACAD SCI USA, V91, P12760, DOI 10.1073/pnas.91.26.12760
   ORFANIDOU CC, 1995, INT J BIOL MACROMOL, V17, P93, DOI 10.1016/0141-8130(95)93523-Z
   POIRIER Y, 1995, INT J BIOL MACROMOL, V17, P7, DOI 10.1016/0141-8130(95)93511-U
   PRINCE JT, 1995, BIOCHEMISTRY-US, V34, P10879, DOI 10.1021/bi00034a022
   RAYMOND S, 1995, MACROMOLECULES, V28, P2096, DOI 10.1021/ma00110a051
   RAYMOND S, 1995, CARBOHYD RES, V277, P209, DOI 10.1016/0008-6215(95)00219-J
   RHIE HG, 1995, CAN J MICROBIOL, V41, P200, DOI 10.1139/m95-188
   RICH JO, 1995, BIOTECHNOL BIOENG, V45, P426, DOI 10.1002/bit.260450507
   SAMAIN E, 1995, CARBOHYD RES, V271, P217, DOI 10.1016/0008-6215(95)00022-L
   SMITH SV, 1993, MATER RES SOC SYMP P, V292, P93
   STUART ES, 1995, CAN J MICROBIOL, V41, P84, DOI 10.1139/m95-174
   WANG H, 1995, BIOCHEMISTRY-US, V34, P920, DOI 10.1021/bi00003a026
   YOSHIKAWA E, 1994, MACROMOLECULES, V27, P5471, DOI 10.1021/ma00097a029
NR 52
TC 5
Z9 5
U1 1
U2 15
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 1359-0286
EI 1879-0348
J9 CURR OPIN SOLID ST M
JI Curr. Opin. Solid State Mat. Sci.
PD JUN
PY 1996
VL 1
IS 3
BP 407
EP 411
DI 10.1016/S1359-0286(96)80033-7
PG 5
WC Materials Science, Multidisciplinary; Physics, Applied; Physics,
   Condensed Matter
SC Materials Science; Physics
GA VE415
UT WOS:A1996VE41500013
DA 2018-10-20
ER

PT J
AU Goodyer, PD
   Fothergill, JC
   Jones, NB
   Hanning, CD
AF Goodyer, PD
   Fothergill, JC
   Jones, NB
   Hanning, CD
TI The design of an optical fiber pressure transducer for use in the upper
   airways
SO IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING
LA English
DT Article
ID SENSORS
AB The development of an optical fiber transducer for use in biomedical applications has been presented. The design was targeted for use in the upper airways of patients with sleep disorders stemming from partial or total occlusion of the airway, The transducer's preliminary specification was suited for that of upper airway manometry: a resolution of 10 Pa over the range +/-5 kPa, a single transducer being less than 0.94 mm in diameter. Amplitude modulated optical fiber sensors are susceptible to loss due to bending of the fiber care and cladding. The design of the transducer uses a series of three optical fibers, one emitting and two receiving, the combination of the two receiving optical fibers is used to reduce effects of light loss: a bend radios of 50 mm is typical for the insertion into the naso-pharynx. The transducer transduction element is a silicone gel coated with reflective titanium dioxide, the meniscus deforms under pressure and modulates the intensity of tight reflected back into the receiving optical fibers. The main disadvantage of optical fiber pressure transducers is their susceptibility to temperature drift. Temperature in the airway rarely changes more than 17 degrees C. The frequency of breathing and the high thermal mass of the catheter means that:temperature drift in this application is not significant, and, will cause an insignificant error of 12 Pa. The transducer is inexpensive to produce, and may he deemed disposable: approximately $20 in material costs (using current manufacturing techniques this can be halved). The system has the added advantage of being electrically, magnetically, and chemically passive. The potential For miniaturization is limited only by the mechanical strength of the optical fibers as mechanical problems associated with fragile elastic membranes do not apply.
C1 UNIV LEICESTER,DEPT ANAESTHESIA,LEICESTER LE1 7RH,LEICS,ENGLAND.
RP Goodyer, PD (reprint author), UNIV LEICESTER,DEPT ENGN,UNIV RD,LEICESTER LE1 7RH,LEICS,ENGLAND.
CR BERTHOLD JW, 1994, P 10 OPT FIBR SENS C, P182
   BOCK WJ, 1992, IEEE T INSTRUM MEAS, V41, P68, DOI 10.1109/19.126634
   GOODYER P, 1995, THESIS U LEICESTER, pCH5
   GOODYER PD, IN PRESS MED BIOL EN
   GUILLEMINAULT C, 1990, OBSTRUCTIVE SLEEP AP, pCH1
   HUDGEL DA, 1993, ENT J, V71, P42
   KOHL C, 1990, J AEROSOL SCI, V21, P415
   LEKHOLM A, 1968, MED BIOL ENG, V7, P333
   LIBO Y, 1991, SENSOR ACTUAT A-PHYS, V29, P29
   PAPAGEORGIOU G, 1988, SENSOR REV IFS PUBLI, V8, P19
   SKATVEDT O, 1994, ARCH DIS CHILD, V71, P138, DOI 10.1136/adc.71.2.138
   SKATVEDT O, 1992, LARYNGOSCOPE, V102, P1275, DOI 10.1288/00005537-199211000-00014
   TRACEY PM, 1991, IEEE T IND APPL, V27, P96, DOI 10.1109/28.67537
   WOLTHUIS RA, 1991, IEEE T BIO-MED ENG, V38, P974, DOI 10.1109/10.88443
NR 14
TC 12
Z9 12
U1 0
U2 3
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017-2394
SN 0018-9294
J9 IEEE T BIO-MED ENG
JI IEEE Trans. Biomed. Eng.
PD JUN
PY 1996
VL 43
IS 6
BP 600
EP 606
DI 10.1109/10.495279
PG 7
WC Engineering, Biomedical
SC Engineering
GA UM669
UT WOS:A1996UM66900006
PM 8987264
DA 2018-10-20
ER

PT J
AU Arru, P
   Rinaldi, S
   Stacchino, C
   Vallana, F
AF Arru, P
   Rinaldi, S
   Stacchino, C
   Vallana, F
TI Wear assessment in bileaflet heart valves
SO JOURNAL OF HEART VALVE DISEASE
LA English
DT Article; Proceedings Paper
CT International Symposium on Wear in Mechanical Heart Valve Prostheses
CY SEP   29, 1995
CL AARHUUS UNIV HOSP, WERNER, DENMARK
HO AARHUUS UNIV HOSP
ID BIOMEDICAL DEVICES; PROSTHESIS; EXPERIENCE; DESIGN
AB Sorin Biomedica has accumulated 20 years of experience in designing and manufacturing heart valves as well as in the development of turbostratic carbons, both as bulk coating (pyrolytic carbon, PyC) and as a thin film (Carbofilm).
   In designing a bileaflet valve, where hinges represent the most critical elements since wear occurs mainly at these points, we took into account: a) theoretical considerations on the geometry (flat-to-flat vs. curved-to-flat) of the coupling elements undergoing impact wear; b) kinematic coupling (sliding, rotation, rolling) between the moving parts in relation to friction wear; c) experimental wear rates of different material couples (PyC/PyC, metal/PyC) assessed by paying attention to test artifacts due to particle contamination; and d) wear mechanisms involving brittle fracture mechanics for bulk PyC and ductile fracture mode for metals.
   On the basis of the above evaluations a Carbofilm coated titanium alloy housing and PyC leaflets were developed for the Sorin Bicarbon valve. A flat-to-flat coupling between hinge stops and mating pivot surfaces for reducing the impact wear and a rolling action aimed at minimizing the friction wear were designed for the hinge.
   The Bicarbon long term durability has been assessed by accelerated wear tests conducted in comparison with clinically accepted bileaflet prostheses (CarboMedics and St. Jude Medical).
   The main results for the Bicarbon valve were, wear rates slightly lower or comparable to those found in the reference valves and wear morphology free from microfractures, while deep cracks associated with higher stress concentrations were detected on the PyC components of the reference valves. No mechanical failure or loss of functionality occurred up to 2,100 million cycles (equivalent of 52.5 years).
C1 SORIN BIOMED SPA,I-13040 SALUGGIA,ITALY.
CR AEBISCHER P, 1988, BIOMATERIALS, V9, P80, DOI 10.1016/0142-9612(88)90075-0
   ARRU P, 1994, INT J ARTIF ORGANS, V17, P280
   Arru P, 1987, HIGH TECH CERAMICS, P117
   BOKROS JC, 1977, CARBON, V15, P355
   BOKROS JC, 1992, REPLACEMENT CARDIAC, P21
   Burwell J.T.  Jr., 1957, Wear, V1, P119, DOI 10.1016/0043-1648(57)90005-4
   DISALVO C, 1994, J CARDIOVASC SURG, V35, P199
   *FDA, 1994, DRAFT REPLACEMENT
   HAUBOLD AD, 1978, BIOCOMPATIBILITY CLI, V2, P341
   Juvinall R. C., 1967, ENG CONSIDERATION ST
   MILANO A, 1992, J THORAC CARDIOV SUR, V103, P267
   Paccagnella A, 1986, J ARTIF ORGANS, V9, P115
   RITCHIE RO, 1990, J BIOMED MATER RES, V24, P189, DOI 10.1002/jbm.820240206
   Ritchie RO, 1996, J HEART VALVE DIS, V5, pS9
   SBARBATI R, 1991, INT J ARTIF ORGANS, V14, P491
   Shim H S, 1974, Biomater Med Devices Artif Organs, V2, P103
   SHIM HS, 1977, J BIOENG, V1, P223
   SHIM HS, 1978, J BIOENG, V2, P341
   SHIM HS, 1976, J BIOENG, V1, P45
   Thiene G, 1989, Eur J Cardiothorac Surg, V3, P65, DOI 10.1016/1010-7940(89)90014-6
   VALLANA F, 1993, CERAM INT, V19, P169, DOI 10.1016/0272-8842(93)90038-S
   Vallana F, 1992, ASAIO J, V38, pM600, DOI 10.1097/00002480-199207000-00107
   VITALE E, 1995, INT J ARTIF ORGANS, V18, P775
   1987, CARBOMEDICS DATA PHY
   1995, ISODIS5840ISOTC150SC
   1994, J HEART VALVE DIS S1, V3, pS1
NR 26
TC 7
Z9 8
U1 0
U2 2
PU I C R PUBLISHERS
PI NORTHWOOD
PA CRISPIN HOUSE, 12/A SOUTH APPROACH, MOOR PARK, NORTHWOOD, ENGLAND HA6
   2ET
SN 0966-8519
J9 J HEART VALVE DIS
JI J. Heart Valve Dis.
PD JUN
PY 1996
VL 5
SU 1
BP S133
EP S143
PG 11
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA VH148
UT WOS:A1996VH14800020
PM 8803766
DA 2018-10-20
ER

PT J
AU Bergoc, RM
   Menossi, CA
   Caro, RA
AF Bergoc, RM
   Menossi, CA
   Caro, RA
TI Radioisotope methodology course: Radioprotection aspects
SO JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY-ARTICLES
LA English
DT Article; Proceedings Paper
CT International Conference on Isotopes
CY MAY 07-12, 1995
CL BEIJING, PEOPLES R CHINA
SP Amer Nucl Soc, Isotopes & Radiat Div, Brit Nucl Energy Soc, China Natl Nucl Corp, Chinese Chem Soc, European Nucl Soc, German Chem Soc, Nucl Chem Sect, Indian Nucl Soc, Int Isotope Soc, Japan Radioisotope Assoc, Korean Nucl Soc, Natl Nat Sci Fdn China, Nucl Soc Russia
AB Since 1962 a Radioisotopes Methodology Course is given annually at the School of Pharmacy and Biochemistry. Buenos Aires University, Argentina, where usually professionals of the biomedical area assists. The current program has 222 hours of training: 122 hours devoted to theoretical aspects and 100 hours to intensive practical work. The training in radioprotection include subjects as: definitions, dosimetrical magnitudes and units, dose rate, equivalent dose, effective dose, exposition, dosimetry of internal and external sources, shielding, classification of working conditions and areas, transportation of radioactive materials, instrumentation associated to radioprotection and many application excersises. A total of 1085 professionals have passed their examination. Percentage distribution according to different professions can be resumed as follows: 16.1 physicians, 65.1 biochemists, 0.7 engineers, 2.0 biologist and 16.1 from others professions such pharmacists, etc. The training in radioprotection throughout the whole program is oriented to consolidate the general knowledge on the subject independently from the previous universitary formation. We stress also the importance and differentiate the applications to biochemistry, principally those concerning the use of 125-I, as well as to nuclear medicine fundamentally through the utilisation of 99m-Tc generators.
C1 ARGENT NATL NUCL REGULATORY AUTHOR,BUENOS AIRES,DF,ARGENTINA.
RP Bergoc, RM (reprint author), UNIV BUENOS AIRES,SCH PHARM & BIOCHEM,RADIOISOTOPES LAB,BUENOS AIRES,DF,ARGENTINA.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU AKADEMIAI KIADO
PI BUDAPEST
PA PO BOX 245, H-1519 BUDAPEST, HUNGARY
SN 0236-5731
J9 J RADIOAN NUCL CH AR
JI J. Radioanal. Nucl. Chem.-Artic.
PD JUN
PY 1996
VL 206
IS 2
BP 257
EP 262
DI 10.1007/BF02039651
PG 6
WC Chemistry, Analytical; Chemistry, Inorganic & Nuclear; Nuclear Science &
   Technology
SC Chemistry; Nuclear Science & Technology
GA VD127
UT WOS:A1996VD12700010
DA 2018-10-20
ER

PT J
AU Barrett, R
   Gross, RS
AF Barrett, R
   Gross, RS
TI Super-active shape-memory alloy composites
SO SMART MATERIALS & STRUCTURES
LA English
DT Article
ID GELS
AB A new type of very-low-stiffness super-active composite material is presented. This laminate uses shape-memory alloy (SMA) filaments which are embedded within a low-hardness silicone matrix. The purpose is to develop an active composite in which the local strains within the SMA actuator material will be approximately 1%, while the laminate strains will be at least an order of magnitude larger. This type of laminate will be useful for biomimetic, biomedical, surgical and prosthetic applications in which the very high stiffness and actuation strength of conventional SMA filaments are too great for biological tissues. A modified form of moment and force-balance analysis is used to model the performance of the super-active shape-memory alloy composite (SASMAC). The analytical models are used to predict the performance of a SASMAC pull-pull actuator which uses 10 mil diameter Tinel alloy K actuators embedded in a 0.10'' thick, 25 Durometer silicone matrix. The results of testing demonstrate that the laminate is capable of straining up to 10% with theory and experiment in good agreement. Fatigue testing was conducted on the actuator for 1000 cycles. Because the local strains within the SMA were kept to less than 1%, the element showed no degradation in performance.
C1 AUBURN UNIV,DEPT AEROSP ENGN,AUBURN,AL 36849.
CR DOI M, 1992, MACROMOL J, V29, P5504
   DUERIG TW, 1989, MRS INT M ADV MATS, V9, P581
   OSADA Y, 1992, NATURE, V355, P242, DOI 10.1038/355242a0
   PEI QB, 1993, SMART MATER STRUCT, V2, P1
   *RAYCH CORP MET DI, 1989, RAYCHEM TINEL SHAPE
   Segalman D. J., 1992, Smart Materials and Structures, V1, P95, DOI 10.1088/0964-1726/1/1/015
   Shahinpoor M., 1994, Smart Materials and Structures, V3, P367, DOI 10.1088/0964-1726/3/3/012
   SHIGA T, 1990, J APPL POLYM SCI, V39, P2305, DOI 10.1002/app.1990.070391110
   *SWISSM ADV MAT TE, 1992, SHAP MEM ACT
NR 9
TC 30
Z9 31
U1 0
U2 3
PU IOP PUBLISHING LTD
PI BRISTOL
PA TECHNO HOUSE, REDCLIFFE WAY, BRISTOL, ENGLAND BS1 6NX
SN 0964-1726
J9 SMART MATER STRUCT
JI Smart Mater. Struct.
PD JUN
PY 1996
VL 5
IS 3
BP 255
EP 260
DI 10.1088/0964-1726/5/3/003
PG 6
WC Instruments & Instrumentation; Materials Science, Multidisciplinary
SC Instruments & Instrumentation; Materials Science
GA UW422
UT WOS:A1996UW42200003
DA 2018-10-20
ER

PT J
AU Stupar, J
   Dolinsek, F
AF Stupar, J
   Dolinsek, F
TI Determination of chromium, manganese, lead and cadmium in biological
   samples including hair using direct electrothermal atomic absorption
   spectrometry
SO SPECTROCHIMICA ACTA PART B-ATOMIC SPECTROSCOPY
LA English
DT Article
DE botanical samples; ETAAS; hair samples; slurry sampling; solid sampling
ID SLURRY ATOMIZATION; ENVIRONMENTAL-SAMPLES; MATRIX MODIFICATION; TANNERY
   WORKERS; PLANT MATERIALS; ERROR ANALYSIS; SCALP HAIR; FURNACE; COPPER;
   GFAAS
AB Direct analysis of solid samples employing a laboratory assembled electrothermal atomic absorption spectrometer is demonstrated to be a feasible approach for determination of trace elements in plant tissue and hair samples for special applications in plant physiology and biomedical research. As an example, the kinetics of Cr uptake by cabbage and its distribution have been measured as a function of chromium speciation in the nutrient solution. Further, longitudinal concentration gradients of Cr, Pb and Cd have been measured in hair of various population groups exposed to different levels of these elements in ambient and/or occupational environments. The techniques are validated for the determination of these trace elements by neutron activation analysis, dissolution atomic absorption spectrometry and by analysis of certified reference materials. Slurry sample introduction is found appropriate for routine trace element determination and in homogeneity testing. Direct sample introduction is indispensable in the analysis of very small (< 1 mg) tissue biopsy samples in the determination of trace element distributions.
RP Stupar, J (reprint author), JOZEF STEFAN INST,JAMOVA 39,LJUBLJANA 1111,SLOVENIA.
CR ALDER JF, 1976, ANAL CHIM ACTA, V587, P313
   BRADY DV, 1974, ATOM ABSORPT NEWSL, V13, P118
   CARRION N, 1988, J ANAL ATOM SPECTROM, V3, P479, DOI 10.1039/ja9880300479
   CHATTOPADHYAY A, 1974, TRACE SUBSTANCES ENV, V8, P31
   DOBROWOLSKI R, 1993, FRESEN J ANAL CHEM, V346, P1058, DOI 10.1007/BF00323716
   DOLINSEK F, 1991, J ANAL ATOM SPECTROM, V9, P653
   EBDON L, 1987, MICROCHEM J, V36, P207, DOI 10.1016/0026-265X(87)90155-X
   EBDON L, 1986, MICROCHEM J, V34, P340, DOI 10.1016/0026-265X(86)90129-3
   EBDON L, 1990, J ANAL ATOM SPECTROM, V5, P321, DOI 10.1039/ja9900500321
   EBDON L, 1987, J ANAL ATOM SPECTROM, V2, P317, DOI 10.1039/ja9870200317
   FAGIOLI F, 1986, ATOM SPECTROSC, V7, P49
   GARCIA IL, 1992, J ANAL ATOM SPECTROM, V7, P529, DOI 10.1039/ja9920700529
   HAMBIDGE KM, 1972, AM J CLIN NUTR, V25, P380
   HOENIG M, 1986, ANAL CHEM, V58, P2614, DOI 10.1021/ac00126a008
   HOLCOMBE JA, 1989, J ANAL ATOM SPECTROM, V4, P423, DOI 10.1039/ja9890400423
   JORDAN P, 1989, ATOM SPECTROSC, V10, P165
   KOPITO L, 1969, J AMER MED ASSOC, V209, P243, DOI 10.1001/jama.209.2.243
   KUMPULAINEN J, 1982, ANAL CHIM ACTA, V138, P361, DOI 10.1016/S0003-2670(01)85322-8
   LAHOUTI M, 1979, J SCI FOOD AGR, V30, P136, DOI 10.1002/jsfa.2740300207
   LVOV BV, 1988, J ANAL ATOM SPECTROM, V3, P9, DOI 10.1039/ja9880300009
   MAJIDI V, 1990, SPECTROCHIM ACTA B, V45, P753, DOI 10.1016/0584-8547(90)80054-M
   MILLERIHLI NJ, 1993, FRESEN J ANAL CHEM, V345, P482, DOI 10.1007/BF00326337
   MILLERIHLI NJ, 1994, J ANAL ATOM SPECTROM, V9, P1129, DOI 10.1039/ja9940901129
   MILLERIHLI NJ, 1992, ATOM SPECTROSC, V13, P1
   MILLERIHLI NJ, 1989, SPECTROCHIM ACTA B, V44, P1221, DOI 10.1016/0584-8547(89)80120-X
   MILLERIHLI NJ, 1990, FRESEN Z ANAL CHEM, V337, P771
   OLAYINKA KO, 1986, J ANAL ATOM SPECTROM, V1, P297, DOI 10.1039/ja9860100297
   RAMACHANDRAN V, 1980, J NUCL AGR BIOL, V9, P127
   RANDALL JA, 1989, BRIT J IND MED, V46, P171
   RENSHAW G D, 1973, Journal of Forensic Sciences, V18, P143
   RENSHAW GD, 1972, NATURE, V238, P162, DOI 10.1038/238162a0
   SANER G, 1984, BRIT J IND MED, V41, P263
   SHEWRY PR, 1974, J EXP BOT, V25, P785, DOI 10.1093/jxb/25.4.785
   SLAVIN W, 1989, TALANTA, V36, P171, DOI 10.1016/0039-9140(89)80092-X
   SLAVIN W, 1982, SPECTROCHIM ACTA B, V37, P955, DOI 10.1016/0584-8547(82)80113-4
   STAUBER JL, 1989, SCI TOTAL ENVIRON, V83, P85, DOI 10.1016/0048-9697(89)90007-7
NR 36
TC 37
Z9 37
U1 0
U2 12
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
SN 0584-8547
J9 SPECTROCHIM ACTA B
JI Spectroc. Acta Pt. B-Atom. Spectr.
PD JUN
PY 1996
VL 51
IS 7
BP 665
EP 683
DI 10.1016/0584-8547(96)01475-9
PG 19
WC Spectroscopy
SC Spectroscopy
GA UV738
UT WOS:A1996UV73800003
DA 2018-10-20
ER

PT J
AU Jen, AC
   Wake, MC
   Mikos, AG
AF Jen, AC
   Wake, MC
   Mikos, AG
TI Review: Hydrogels for cell immobilization
SO BIOTECHNOLOGY AND BIOENGINEERING
LA English
DT Review
DE hydrogel; cell immobilization; surface adhesion; matrix entrapment;
   microencapsulation; immunoisolation; bioartificial organs
ID LONG-TERM REVERSAL; MICROENCAPSULATED ISLETS; RAT ISLETS; HEPATOCYTE
   FUNCTION; TRANSPLANTATION; TISSUE; MICROCAPSULES; ALGINATE;
   XENOTRANSPLANTATION; PHOTOPOLYMERIZATION
AB Hydrogels are being investigated for mammalian cell immobilization. Their material properties can be engineered for biocompatibility, selective permeability, mechanical and chemical stability, and other requirements as specified by the application including uniform cell distribution and a given membrane thickness or mechanical strength. These aqueous gels are attractive for analytical and tissue engineering applications and can be used with immobilization in therapies for various diseases as well as to generate bioartificial organs. Recent advances have broadened the use of hydrogel cell immobilization in biomedical fields. To provide an overview of available technology, this review surveys the current developments in immobilization of mammalian cells in hydrogels. Discussions cover hydrogel requirements for use in adhesion, matrix entrapment, and microencapsulation, the respective processing methods, as well as current applications. (C) 1996 John Wiley & Sons, Inc.
C1 RICE UNIV,COX LAB BIOMED ENGN,DEPT CHEM ENGN,HOUSTON,TX 77251.
   RICE UNIV,INST BIOSCI & BIOENGN,HOUSTON,TX 77251.
CR Aebisher P, 1993, FUNDAMENTALS ANIMAL, P197
   ANDERSON JM, 1988, T AM SOC ART INT ORG, V34, P101
   AOMATSU Y, 1992, TRANSPLANT P, V24, P2922
   AUNG T, 1994, TRANSPLANT P, V26, P790
   Bell CL, 1995, ADV POLYM SCI, V122, P125
   BESSELINK GAJ, 1994, J BIOMAT SCI-POLYM E, V6, P675
   Chang T M, 1992, ASAIO J, V38, P128, DOI 10.1097/00002480-199204000-00013
   Christenson L, 1993, FUNDAMENTALS ANIMAL, P7
   CIMA L, 1994, ANN BIOMED ENG, V22, P184
   CORKHILL PH, 1993, J BIOMAT SCI-POLYM E, V4, P615, DOI 10.1163/156856293X00834
   DRUMHELLER PD, 1995, HDB BIOMEDICAL ENG, P1583
   FAN MY, 1990, DIABETES, V39, P519, DOI 10.2337/diabetes.39.4.519
   FRITSCHY WM, 1991, DIABETOLOGIA, V34, P542, DOI 10.1007/BF00400270
   Gibson LJ, 1988, CELLULAR SOLIDS STRU
   GOOSEN MFA, 1993, FUNDAMENTALS ANIMAL, P43
   GROBOILLOT A, 1994, CRIT REV BIOTECHNOL, V14, P75, DOI 10.3109/07388559409086963
   Kanda K, 1993, ASAIO J, V39, pM561
   KING G, 1993, FUNDAMENTALS ANIMAL, P1
   KOBAYASHI H, 1991, CURR EYE RES, V10, P899, DOI 10.3109/02713689109020325
   KOBAYASHI H, 1991, BIOMATERIALS, V12, P747, DOI 10.1016/0142-9612(91)90024-5
   KOEBE HG, 1994, XENOBIOTICA, V24, P95, DOI 10.3109/00498259409043224
   Kost J, 1986, HYDROGELS MED PHARM, V3, P95
   KRESTOW M, 1991, TRANSPLANTATION, V51, P651, DOI 10.1097/00007890-199103000-00021
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   LANZA RP, 1992, DIABETES, V41, P1503, DOI 10.2337/diabetes.41.12.1503
   LEE J, 1993, FASEB J, V7, P586
   LEVESQUE L, 1992, ENDOCRINOLOGY, V130, P644, DOI 10.1210/en.130.2.644
   LUM ZP, 1991, DIABETES, V40, P1511, DOI 10.2337/diabetes.40.11.1511
   LUM ZP, 1992, TRANSPLANTATION, V53, P1180, DOI 10.1097/00007890-199206000-00002
   LUNDBERG P, 1992, MAGN RESON MED, V25, P273, DOI 10.1002/mrm.1910250206
   MIKOS AG, 1994, BIOTECHNOL BIOENG, V43, P673, DOI 10.1002/bit.260430717
   Miwa H, 1993, ASAIO J, V39, pM273
   NYBERG SL, 1994, ANN SURG, V220, P59
   OXLEY HR, 1993, BIOMATERIALS, V14, P1064, DOI 10.1016/0142-9612(93)90207-I
   Park H., 1994, P INT S CONTR REL BI, V21, P21
   PARK K, 1993, BIODEGRADABLE HYDROG
   Park K., 1987, HYDROGELS MED PHARM, P151
   PATHAK CP, 1992, J AM CHEM SOC, V114, P8311, DOI 10.1021/ja00047a065
   Peppas N. A., 1986, HYDROGELS MED PHARM, P1
   PEPPAS NA, 1986, HYDROGELS MED PHARM, P57
   PLUNKETT ML, 1990, LAB INVEST, V62, P510
   PONCELET D, 1993, FUNDAMENTALS ANIMAL, P113
   RATNER B, 1986, HYDROGELS MED PHARM, P85
   Sato M, 1993, ASAIO J, V39, pM554
   SAWHNEY AS, 1993, BIOMATERIALS, V14, P1008, DOI 10.1016/0142-9612(93)90194-7
   SAWHNEY AS, 1992, BIOMATERIALS, V13, P863, DOI 10.1016/0142-9612(92)90180-V
   SAWHNEY AS, 1993, MACROMOLECULES, V26, P581, DOI 10.1021/ma00056a005
   SCHREZENMEIR J, 1992, TRANSPLANT P, V24, P2941
   SEFTON MV, 1993, ADV POLYM SCI, V107, P143
   SHATFORD RA, 1992, J SURG RES, V53, P549, DOI 10.1016/0022-4804(92)90253-V
   SMETANA K, 1993, BIOMATERIALS, V14, P1046, DOI 10.1016/0142-9612(93)90203-E
   SOONSHIONG P, 1992, TRANSPLANTATION, V54, P769, DOI 10.1097/00007890-199211000-00001
   SOONSHIONG P, 1993, P NATL ACAD SCI USA, V90, P5843, DOI 10.1073/pnas.90.12.5843
   SOONSHIONG P, 1992, TRANSPLANT P, V24, P2946
   SOONSHIONG P, 1994, T SOC BIOMATER, V17, P356
   Stevenson WTK, 1993, FUNDAMENTALS ANIMAL, P143
   Sun A M, 1992, ASAIO J, V38, P125, DOI 10.1097/00002480-199204000-00012
   Sun AM, 1992, MICROCAPSULES NANOPA, P315
   Thomson R.C., 1995, MOL BIOL BIOTECHNOLO, P717
   ULUDAG H, 1990, BIOMATERIALS, V11, P708, DOI 10.1016/0142-9612(90)90032-L
   ULUDAG H, 1993, J BIOMED MATER RES, V27, P1213, DOI 10.1002/jbm.820271002
   WELLS GDM, 1993, BIOMATERIALS, V14, P615, DOI 10.1016/0142-9612(93)90181-Z
   WOERLY S, 1993, BIOMATERIALS, V14, P1056, DOI 10.1016/0142-9612(93)90205-G
   WOERLY S, 1990, BIOMATERIALS, V11, P97, DOI 10.1016/0142-9612(90)90123-8
   Yannas IV, 1995, ADV POLYM SCI, V122, P219
   Yuet P., 1993, FUNDAMENTALS ANIMAL, P79
NR 66
TC 351
Z9 357
U1 3
U2 128
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0006-3592
J9 BIOTECHNOL BIOENG
JI Biotechnol. Bioeng.
PD MAY 20
PY 1996
VL 50
IS 4
BP 357
EP 364
DI 10.1002/(SICI)1097-0290(19960520)50:4<357::AID-BIT2>3.0.CO;2-K
PG 8
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA UG326
UT WOS:A1996UG32600003
PM 18626984
DA 2018-10-20
ER

PT J
AU Iannace, S
   Ambrosio, L
   DAmore, A
   Nicolais, L
AF Iannace, S
   Ambrosio, L
   DAmore, A
   Nicolais, L
TI Nonlinear viscoelasticity of Hydrothane(R)
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
AB The nonlinear viscoelastic behaviour of Hydrothane(R), a hydrophilic polyurethane used for biomedical applications, has been studied. The material has been tested in stress-relaxation experiments in a range of deformation up to 25%. Isochrone curves have been predicted by using the rubber elasticity theory and separating strain and time effect. Stress-strain curves obtained at different strain rates have been interpreted introducing strain rate dependent scaling factors.
C1 UNIV NAPLES FEDERICO II,INST COMPOSITE MAT TECHNOL,I-80125 NAPLES,ITALY.
RP Iannace, S (reprint author), UNIV NAPLES FEDERICO II,DEPT MAT & PROD ENGN,P TECCHIO 80,I-80125 NAPLES,ITALY.
OI AMBROSIO, LUIGI/0000-0002-8367-2405; Iannace,
   Salvatore/0000-0003-1487-4983
CR CHANG WV, 1977, J POLYM SCI POL PHYS, V15, P923, DOI 10.1002/pol.1977.180150601
   DOI M, 1986, THEORY POLYM DYNAMIC
   FERRY JD, 1980, VISCOELASTIC PROPERT
   Fung Y-C, 1993, BIOMECHANICS
   HAUT RC, 1972, J BIOMECH, V5, P423, DOI 10.1016/0021-9290(72)90001-2
   HAUT RC, 1993, ANTERIOR CRUCIATE LI
   IANNACE S, IN PRESS BIOMATERIAL
   LIN HC, 1987, ADV BIOENG, V3, P5
   Lodge A. S, 1964, ELASTIC LIQUIDS
   Matsuoka S., 1986, FAILURE PLASTICS
   OSAKI K, 1980, MACROMOLECULES, V13, P671, DOI 10.1021/ma60075a036
   RIVLIN RS, 1948, PHILOS TR R SOC S-A, V241, P379, DOI 10.1098/rsta.1948.0024
   ROLAND CM, 1989, RUBBER CHEM TECHNOL, V62, P880, DOI 10.5254/1.3536281
   SPERLING LH, 1986, INTRO PHYSICAL POLYM
   WAGNER MH, 1976, RHEOL ACTA, V15, P136, DOI 10.1007/BF01517505
   WILLIAMS G, 1970, T FARADAY SOC, V66, P80, DOI 10.1039/tf9706600080
   WOO SLY, 1981, J BIOMECH ENG-T ASME, V103, P293, DOI 10.1115/1.3138295
NR 17
TC 2
Z9 2
U1 0
U2 3
PU CHAPMAN HALL LTD
PI LONDON
PA 2-6 BOUNDARY ROW, LONDON, ENGLAND SE1 8HN
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD MAY
PY 1996
VL 7
IS 5
BP 305
EP 307
DI 10.1007/BF00058572
PG 3
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA UL308
UT WOS:A1996UL30800012
DA 2018-10-20
ER

PT J
AU Bennett, LH
   Wang, PS
   Donahue, MJ
AF Bennett, LH
   Wang, PS
   Donahue, MJ
TI Artifacts in magnetic resonance imaging from metals
SO JOURNAL OF APPLIED PHYSICS
LA English
DT Article; Proceedings Paper
CT 40th Annual Conference on Magnetism and Magnetic Materials
CY NOV 06-09, 1995
CL PHILADELPHIA, PA
SP Amer Inst Phys, IEEE, Magnet Soc, Minerals Met & Mat Soc, Amer Soc Testing & Mat, USN, Off Naval Res, Amer Ceram Soc
AB Metallic biomedical implants, such as aneurysm Clips, endoprostheses, and internal orthopedic devices give rise to artifacts in the magnetic resonance image (MRI) of patients. Such artifacts impair the information contained in the image in precisely the region of most interest, namely near the metallic device. Ferromagnetic materials are contraindicated because of the hazards associated with their movement during the MRI procedure. In less-magnetic metals, it has been suggested that the extent of the artifact is related to the magnetic susceptibility of the metal, but no systematic data appear to be available. When the susceptibility is sufficiently small, an additional artifact due to electrical conductivity is observed. We present an initial systematic study of MRI artifacts produced by two low susceptibility metals, titanium (relative permeability mu(r) approximate to 1.0002) and copper (mu(r) approximate to 0.99998), including experimental, theoretical, and computer simulation results. (C) 1996 American Institute of Physics.
RP Bennett, LH (reprint author), NATL INST STAND & TECHNOL,GAITHERSBURG,MD 20899, USA.
CR ALANEN A, 1995, ACTA RADIOL, V36, P92
   BRACEWELL RN, 1967, ASTROPHYS J, V150, P427, DOI 10.1086/149346
   CAMACHO CR, 1995, JMRI-J MAGN RESON IM, V5, P75, DOI 10.1002/jmri.1880050115
   LUCZNIK RP, 1993, RADIOLOGY, V187, P855
   Ludeke K M, 1985, Magn Reson Imaging, V3, P329, DOI 10.1016/0730-725X(85)90397-2
   MALKOI JA, 1989, RADIOLOGY, V143, P563
   PATTON JA, 1994, RADIOGRAPHICS, V14, P1083, DOI 10.1148/radiographics.14.5.7991815
   Wang P., UNPUB
   WANG PS, 1995, J MATER SCI, V30, P1069, DOI 10.1007/BF01178447
   WANG PS, 1995, J MATER SCI, V30, P1059, DOI 10.1007/BF01178445
NR 10
TC 37
Z9 37
U1 0
U2 18
PU AMER INST PHYSICS
PI WOODBURY
PA CIRCULATION FULFILLMENT DIV, 500 SUNNYSIDE BLVD, WOODBURY, NY 11797-2999
SN 0021-8979
J9 J APPL PHYS
JI J. Appl. Phys.
PD APR 15
PY 1996
VL 79
IS 8
BP 4712
EP 4714
DI 10.1063/1.361649
PN 2A
PG 3
WC Physics, Applied
SC Physics
GA UG877
UT WOS:A1996UG87700087
DA 2018-10-20
ER

PT J
AU DeAza, PN
   Luklinska, ZB
   Anseau, M
   Guitian, F
   DeAza, S
AF DeAza, PN
   Luklinska, ZB
   Anseau, M
   Guitian, F
   DeAza, S
TI Morphological studies of pseudowollastonite for biomedical application
SO JOURNAL OF MICROSCOPY-OXFORD
LA English
DT Article
DE wollastonite; bioactivity; electron microscopy
ID SIMULATED BODY-FLUID; GLASS-CERAMICS; APATITE
AB Pseudowollastonite ceramic (psW) composed of CaO . SiO2 was found to be bioactive in a simulated body fluid environment. The chemical reaction initiated at the material surface resulted in hydroxyapatite (HA) formation. These bone-bonding properties are essential for securing the necessary physico-chemical integration of the material with living bone. Materials behaving in this way can be considered for potential biomedical application as bone tissue substitute for a natural bone repair or replacement as implant.
   A mechanism of hydroxyapatite formation on pseudowollastonite ceramics surface was investigated during exposure to a simulated body fluid (SBF) for a period of 3 weeks. Morphology and structure of the surface product and its original substrate was examined by thin-film X-ray diffraction, scanning electron microscopy and high-resolution transmission electron microscopy. HA crystals were found to form on an amorphous silica intermediate layer. (100) lattice planes of IIA were resolved and identified.
   Concentration of ions in the SBF and pH of the SBF were monitored throughout the exposure. Additional pH measurements were made at the interface of psW with SBF. The HA formation occurred when there was a sudden increase of pH from 7.25 to 10.5 at the interface of psW with SBF as a result of ionic exchange between 2H(+) and Ca2+ within the psW network. This ionic exchange transformed the psW crystals into an amorphous silica phase. The appropriate pH and the ion concentrations were essential for partial dissolution of the amorphous silica phase and subsequent precipitation of a Ca-P rich phase which then transformed to HA.
C1 UNIV LONDON QUEEN MARY & WESTFIELD COLL,DEPT MAT,IRC,LONDON E1 4NS,ENGLAND.
   UNIV LONDON LONDON HOSP,IRC BIOMED MAT,COLL MED,LONDON E1 2AD,ENGLAND.
   CSIC,INST CERAM & VIDRIO,MADRID,SPAIN.
RP DeAza, PN (reprint author), UNIV SANTIAGO DE COMPOSTELA,INST CERAM,CAMPUS SUR,SANTIAGO,SPAIN.
RI De Aza, Piedad/A-7621-2015
OI De Aza, Piedad/0000-0001-9316-4407
CR DEAZA PN, 1994, SCRIPTA METALL MATER, V31, P1001, DOI 10.1016/0956-716X(94)90517-7
   DEAZA PN, 1995, MATERIALS CLIN APPL, P19
   EBISAWA Y, 1990, J MATER SCI-MATER M, V1, P239, DOI 10.1007/BF00701083
   Gamble J. E., 1967, CHEM ANATOMY PHYSL P
   GROSS U, 1985, J BIOMED MATER RES, V19, P251, DOI 10.1002/jbm.820190308
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   HENCH LL, 1984, SCIENCE, V226, P630, DOI 10.1126/science.6093253
   HENCH LL, 1990, HDB BIOACTIVE CERAMI, V1, P13
   HENCH LL, 1982, BIOMATERIALS INTERFA
   HENCH LL, 1971, J BIOMED MATER RES S, V2, P117, DOI DOI 10.1002/JBM.820050611
   KEREBEL B, 1976, J ULTRA MOL STRUCT R, V57, P266, DOI 10.1016/S0022-5320(76)80116-5
   KOKUBO T, 1985, J MATER SCI, V20, P2001, DOI 10.1007/BF01112282
   Kokubo T., 1982, Bulletin of the Institute for Chemical Research, Kyoto University, V60, P260
   KOKUBO T, 1986, J MATER SCI, V21, P536, DOI 10.1007/BF01145520
   KOKUBO T, 1987, J MATER SCI, V22, P4067, DOI 10.1007/BF01133359
   Kokubo T., 1993, INTRO BIOCERAMICS, P75
   KOKUBO T, 1986, 14 INT C GLASS, V2, P408
   KOKUBO T, 1987, YOGYO-KYOKAI-SHI, V95, P785
   LUKLINSKA ZB, 1992, BONE BONDING MAT, P73
   MERLOS A, 1991, P 5 C SENS THEIR APP, P127
   MIZUTANI S, 1970, SEDIMENTOLOGY, V15, P419, DOI 10.1111/j.1365-3091.1970.tb02193.x
   OHTSUKI C, 1992, J NON-CRYST SOLIDS, V143, P84, DOI 10.1016/S0022-3093(05)80556-3
   OHTSUKI C, 1992, BIOCERAMICS, V5, P79
   OHURA K, 1991, J BIOMED MATER RES, V25, P357, DOI 10.1002/jbm.820250307
   SPECTOR M, 1975, J MICROSC-OXFORD, V103, P55, DOI 10.1111/j.1365-2818.1975.tb04536.x
   Yamamuro T, 1988, Ann N Y Acad Sci, V523, P107, DOI 10.1111/j.1749-6632.1988.tb38505.x
   YAMAMURO T, 1990, BIOCERAMICS, V2, P361
   YAMAMURO T, 1989, BIOCERAMICS, V1, P175
   YOSHII S, 1988, J BIOMED MATER RES-A, V22, P327, DOI 10.1002/jbm.820221410
NR 29
TC 82
Z9 82
U1 0
U2 15
PU BLACKWELL SCIENCE LTD
PI OXFORD
PA OSNEY MEAD, OXFORD, OXON, ENGLAND OX2 0EL
SN 0022-2720
J9 J MICROSC-OXFORD
JI J. Microsc.-Oxf.
PD APR
PY 1996
VL 182
BP 24
EP 31
DI 10.1111/j.1365-2818.1996.tb04794.x
PN 1
PG 8
WC Microscopy
SC Microscopy
GA UG936
UT WOS:A1996UG93600003
PM 8632444
DA 2018-10-20
ER

PT J
AU Ektessabi, AM
   Otsuka, T
   Tsuboi, Y
   Horino, Y
   Mokuno, Y
   Fujii, K
   Albrektsson, T
   Sennerby, L
   Johansson, C
AF Ektessabi, AM
   Otsuka, T
   Tsuboi, Y
   Horino, Y
   Mokuno, Y
   Fujii, K
   Albrektsson, T
   Sennerby, L
   Johansson, C
TI Preliminary experimental results on mapping of the elemental
   distribution of the organic tissues surrounding titanium-alloy implants
SO NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION B-BEAM
   INTERACTIONS WITH MATERIALS AND ATOMS
LA English
DT Article; Proceedings Paper
CT VIIth International Conference on Particle Induced X-ray Emission and
   Its Analytical Applications
CY MAY 26-30, 1995
CL ABANO TERME, ITALY
SP Ist Nazl Fis Nucl, Italy, Univ Padova, Italy, Ruder Boskovic Inst, Croatia, Int Atom Energy Agcy, Austria
ID BIOMEDICAL APPLICATIONS; NUCLEAR MICROSCOPY
AB Titanium alloy (Ti-6Al-4V) is one of the most common materials which are used as orthopaedic and dental implants. In this paper, preliminary experimental results are presented on the measurement of distribution (mapping of X-ray intensities) of the constituent elements of the tissues as well as the released impurity elements in the organic tissues around a Ti-alloy implant. Micro-beam PIXE was carried out for the case of a Ti-6Al-4V implant which was inserted in tibial metaphysis of a rabbit for 12 weeks, using a Nissin high voltage accelerator. Maps of Ca and P clearly show the situation of bone formation and Ca concentration with respect to implant surface. The maps of K alpha intensities of Ti and Al are also obtained to investigate the possible release of these elements. In conclusion, application of micro-beam PIXE to mapping of the constituent and impurity elements around implants can be used as a powerful tool in clarifying the mechanism of osseo-integration, and release of impurity ions from the implants.
C1 KYOTO UNIV,FAC MED,KYOTO,JAPAN.
   AIST,OSAKA NATL RES INST,OSAKA,JAPAN.
   UNIV GOTHENBURG,INST SURG SCI,GOTHENBURG,SWEDEN.
RP Ektessabi, AM (reprint author), KYOTO UNIV,FAC ENGN,KYOTO,JAPAN.
CR CHOLEWA M, 1993, NUCL INSTRUM METH B, V77, P282, DOI 10.1016/0168-583X(93)95556-K
   EKTESSABI AM, 1994, INT J PIXE, V4, P81
   LINDH U, 1993, NUCL INSTRUM METH B, V77, P261, DOI 10.1016/0168-583X(93)95553-H
   MOKUNO Y, 1994, NUCL INSTRUM METH B, V85, P741, DOI 10.1016/0168-583X(94)95914-5
   MORETTO P, 1993, NUCL INSTRUM METH B, V77, P275, DOI 10.1016/0168-583X(93)95555-J
   VIS RD, 1988, SCANNING MICROSCOPY, V2, P977
   WATT F, 1993, NUCL INSTRUM METH B, V77, P249, DOI 10.1016/0168-583X(93)95552-G
NR 7
TC 24
Z9 24
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-583X
J9 NUCL INSTRUM METH B
JI Nucl. Instrum. Methods Phys. Res. Sect. B-Beam Interact. Mater. Atoms
PD APR
PY 1996
VL 109
BP 278
EP 283
DI 10.1016/0168-583X(95)00922-1
PG 6
WC Instruments & Instrumentation; Nuclear Science & Technology; Physics,
   Atomic, Molecular & Chemical; Physics, Nuclear
SC Instruments & Instrumentation; Nuclear Science & Technology; Physics
GA UV444
UT WOS:A1996UV44400054
DA 2018-10-20
ER

PT J
AU Laurent, A
   Beaujeux, R
   Wassef, M
   Rufenacht, D
   Boschetti, E
   Merland, JJ
AF Laurent, A
   Beaujeux, R
   Wassef, M
   Rufenacht, D
   Boschetti, E
   Merland, JJ
TI Trisacryl gelatin microspheres for therapeutic embolization .1.
   Development and in vitro evaluation
SO AMERICAN JOURNAL OF NEURORADIOLOGY
LA English
DT Article
DE interventional materials, particles and microspheres
ID POLYVINYL-ALCOHOL; MITOMYCIN-C; CELLS; INJECTION; HYDROGELS; PARTICLES;
   INVITRO; CULTURE; KIDNEY
AB PURPOSE: To develop a precisely calibrated, perfectly spherical, stainable, soft, and implantable but nonresorbable particulate embolization material. METHODS: Calibrated particles with a trisacryl gelatin polymer core and hydrophilic surface characteristics were obtained by reversed emulsion synthesis followed by application of a wet-sieving technique. Particles were suspended in saline, bottled, and sterilized. Quality control included analysis of particle diameters before and after sieving and of suspension sterility and apyrogenicity. Particles were subsequently tested to ascertain their compatibility with commercially available microcatheters. RESULTS: The resulting embolization material consisted of spherical, stainable microspheres of medical grade with diameters ranging from 130 mu m to 1200 mu m. Sieving the suspension produced particle groups of homogeneous size (accuracy, +/- 20-100 mu m). At injection, the particles showed no tendency to build aggregates or to obstruct the microcatheters. CONCLUSION: Precisely calibrated and easy-to-use microspheres were obtained that satisfied the biomedical requirements for implantation as an embolization material.
C1 UNIV PARIS,CLAUDE BERNARD RES ASSOC,LAB INTERVENT NEURORADIOL,F-75252 PARIS,FRANCE.
   HOP LARIBOISIERE,DEPT PATHOL,F-75475 PARIS,FRANCE.
   SOC SEPRACOR IBF,VILLENEUVE GARENN,FRANCE.
   CTR RECH INTERVENT IMAGING,JOUY EN JOSAS,FRANCE.
CR BENITA S, 1986, J PHARM SCI, V9, P847
   BERGETHON PR, 1989, J CELL SCI, V92, P111
   BERTA P, 1986, FEBS LETT, V200, P27, DOI 10.1016/0014-5793(86)80504-X
   BROWN NE, 1977, J CHROMATOGR, V150, P101
   CASTANEDAZUNIGA WR, 1978, RADIOLOGY, V126, P783, DOI 10.1148/126.3.783
   Co C S, 1983, Radiat Med, V1, P268
   CORY RN, 1986, EUR J PHARMACOL, V131, P153, DOI 10.1016/0014-2999(86)90531-5
   DION JE, 1986, RADIOLOGY, V160, P717, DOI 10.1148/radiology.160.3.2426727
   DOMAS L, 1993, INNOV TECH BIOL MED, V14, P436
   FLANDROY P, 1990, NEURORADIOLOGY, V32, P311, DOI 10.1007/BF00593051
   FORSBERG JO, 1978, ACTA CHIR SCAND, V144, P275
   FUJIMOTO S, 1985, CANCER, V56, P2404, DOI 10.1002/1097-0142(19851115)56:10<2404::AID-CNCR2820561011>3.0.CO;2-C
   GUYOMARD S, 1985, ANN INST PASTEUR MIC, V136B, P49, DOI 10.1016/S0769-2609(85)80005-3
   HECQUET B, 1986, ANTICANCER RES, V6, P65
   HORAK D, 1986, BIOMATERIALS, V7, P188, DOI 10.1016/0142-9612(86)90100-6
   JACK CR, 1985, AM J NEURORADIOL, V6, P595
   KATO T, 1981, CANCER, V48, P674, DOI 10.1002/1097-0142(19810801)48:3<674::AID-CNCR2820480303>3.0.CO;2-E
   KERBER CW, 1978, AM J ROENTGENOL, V130, P1193, DOI 10.2214/ajr.130.6.1193
   LAURENT A, 1989, INNOV TECH BIOL MED, V10, P357
   LONGACRE JJ, 1972, PLAST RECONSTR SURG, V50, P618, DOI 10.1097/00006534-197212000-00019
   LUESSENHOP AJ, 1960, JAMA-J AM MED ASSOC, V172, P1153, DOI 10.1001/jama.1960.63020110001009
   MADOULE P, 1981, J RADIOL, V62, P457
   MAISONNEURA, 1990, FRENCH PHARMACOPEIA, P1
   MAISONNEURE, 1980, EUROPEAN PHARMACOPEI
   MILLERFAURES A, 1985, DEV BIOL STAND, V60, P209
   OBRENOVITCH A, 1982, BIOL CELL, V46, P249
   PRINZMETAL M, 1947, AM HEART J, V33, P420, DOI 10.1016/0002-8703(47)90090-2
   RAO VRK, 1991, J NEURORADIOLOGY, V18, P61
   RAZIEL A, 1980, AM J ROENTGENOL, V134, P404, DOI 10.2214/ajr.134.2.404
   REPA I, 1989, RADIOLOGY, V170, P395, DOI 10.1148/radiology.170.2.2911663
   RUSSELL EJ, 1987, RADIOLOGY, V165, P631, DOI 10.1148/radiology.165.3.3685342
   SPENLEHAUER G, 1989, BIOMATERIALS, V10, P557, DOI 10.1016/0142-9612(89)90063-X
   STOL M, 1985, BIOMATERIALS, V6, P193, DOI 10.1016/0142-9612(85)90009-2
   STRIDBECK H, 1984, INVEST RADIOL, V19, P179
   WRIGHT KC, 1982, RADIOLOGY, V142, P351, DOI 10.1148/radiology.142.2.6172809
NR 35
TC 111
Z9 120
U1 2
U2 12
PU AMER SOC NEURORADIOLOGY
PI OAK BROOK
PA 2210 MIDWEST RD, OAK BROOK, IL 60521
SN 0195-6108
J9 AM J NEURORADIOL
JI Am. J. Neuroradiol.
PD MAR
PY 1996
VL 17
IS 3
BP 533
EP 540
PG 8
WC Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical
   Imaging
SC Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging
GA UB139
UT WOS:A1996UB13900022
PM 8881250
DA 2018-10-20
ER

PT J
AU Cheang, P
   Khor, KA
AF Cheang, P
   Khor, KA
TI Addressing processing problems associated with plasma spraying of
   hydroxyapatite coatings
SO BIOMATERIALS
LA English
DT Article
DE hydroxyapatite; plasma spraying; microstructure; powder properties;
   bioactive phases
ID CALCIUM-PHOSPHATE; TITANIUM IMPLANTS
AB Biomedical coatings generally have to satisfy specific requirements such as a high degree of crystallinity (for positive biological responses), good coating adhesion and optimal porosity. These are necessary to enhance biocompatibility, accelerate post-operative healing and improve fixation. Thermal spray processes have been frequently used to deposit functionally active biomedical coatings, such as hydroxyapatite (HA), onto prosthetic implants. The benefits of HA materials in coated implants have been widely acknowledged, but the occurrence of several poor performances has generated concerns over the consistency and reliability of thermally sprayed HA coatings. Recent investigations using HA coatings have shown that process related variability has significant influence on coating characteristics such as phase composition, structure and chemical composition and performance such as bioresorption, degradation and bone apposition. Variation in process parameters such as powder morphology can induce microstructural and mechanical inconsistencies that have an effect on the service performance of the coating. In order to reach some acceptable level of reliability, it may be necessary to control existing variability in commercially available HA feedstock. In addition, certain opposing factors severely constrain the means to achieve the necessary coating conditions via thermal spraying alone; therefore, creating the need to introduce other innovative or secondary treatment stages to attain the desired results. This paper highlights some of the problems associated with plasma spray coating of HA and suggests that tailoring the powder feedstock morphology and properties through suitable conditioning processes can aid the deposition efficiency and produce an acceptable coating structure.
C1 NANYANG TECHNOL UNIV,SCH MECH & PROD ENGN,SINGAPORE 2263,SINGAPORE.
   NANYANG TECHNOL UNIV,SCH APPL SCI,SINGAPORE 2263,SINGAPORE.
RI Khor, Khiam Aik/G-2827-2010; Khor, Khiam Aik (Michael)/B-6929-2009
OI KHOR, Khiam/0000-0003-1954-8423
CR CAHN RW, 1993, MAT SCI TECHNOLOGY M, V14, P278
   CHEANG P, 1989, THESIS MONASH U AUST
   CHEANG P, 1994, P 8 INT C BIOM ENG S, P531
   CHEN JY, 1994, BIOMATERIALS, V15, P396, DOI 10.1016/0142-9612(94)90253-4
   De Groot K., 1990, HDB BIOACTIVE CERAMI, P3
   DEGROOT K, 1982, BIOCERAMICS CALCIUM
   DUCHEYNE P, 1986, BIOMATERIALS, V7, P97, DOI 10.1016/0142-9612(86)90063-3
   Gerdeman D. A., 1972, ARC PLASMA TECHNOLOG
   GROSS KA, 1990, THESIS MONASH U AUST
   GROSS KA, 1993, CHARACTERISATION PER, P256
   HEIDE H, 1987, P INT C HOT IS PRESS, P423
   JACHO M, 1981, CLIN ORTHOP RELAT R, V157, P259
   KAY JF, 1992, DENTAL CLIN N AM, V38, P1
   Khor K. A., 1994, THERMAL SPRAY IND AP, P147
   KHOR KA, 1994, J THERM SPRAY TECHN, V3, P45, DOI 10.1007/BF02648998
   KHOR KA, 1994, P 8 INT C BIOM ENG S, P536
   KHOR KA, 1995, UNPUB J MAT P TECHNO
   KHOR KA, 1995, IN PRESS P 2 INT S A
   KLEIN CPAT, 1994, J BIOMED MATER RES, V28, P909, DOI 10.1002/jbm.820280810
   LACEFIELD WR, 1988, MAT CHARACTERIZATION, P72
   MALMBERG S, 1993, J THERM SPRAY TECHN, V2, P339
   MANLEY MT, 1987, 33RD T ANN M ORTH RE, V12, P214
   MAXIAN SH, 1993, J BIOMED MATER RES, V27, P717, DOI 10.1002/jbm.820270604
   RADIN SR, 1992, J MATER SCI-MATER M, V3, P33, DOI 10.1007/BF00702942
   RAVAGLIOLI A, 1992, BIOCERAMICS MAT PROP, P264
   RIVERO DP, 1988, J BIOMED MATER RES, V22, P191, DOI 10.1002/jbm.820220304
   Tagai H, 1980, MECH PROPERTIES BIOM
   VARDELLE M, 1983, 10 INT THERM SPRAYIN, V80, P88
   YIP CS, 1995, P INT C MECH SOL MAT, VA, P191
   ZYMAN Z, 1993, BIOMATERIALS, V14, P225, DOI 10.1016/0142-9612(93)90027-Y
   1983, Patent No. 109049
NR 31
TC 166
Z9 174
U1 4
U2 23
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAR
PY 1996
VL 17
IS 5
BP 537
EP 544
DI 10.1016/0142-9612(96)82729-3
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA TY590
UT WOS:A1996TY59000009
PM 8991486
DA 2018-10-20
ER

PT J
AU Swift, EJ
   Thompson, JY
   Bayne, SC
AF Swift, EJ
   Thompson, JY
   Bayne, SC
TI Review of dental materials citations .B. July to December 1995
SO DENTAL MATERIALS
LA English
DT Article
AB Objective: A lag of many months occurs between journal issue publication and updates to electronic databases. The objective of this literature analysis was to identify and categorize all of the dental materials citations in biomedical journals that were published from July 1995 through December 1995.
   Methods: Seventeen primary and 51 secondary journals were searched using their tables of contents to detect and record dental materials publications from July to December of 1995. Those journals that were typically rich in dental materials articles were classified as primary ones. Citations were categorized into 17 topics and divided into subsections. The review excluded case reports, most literature related primarily to dental implants, and most articles on biomedical materials used outside of the field of general dentistry.
   Results. The greatest number of citations was related to topics of dentin bonding and resin-based restorative filling materials (composites and glass ionomers). There was no major change in the number of dental materials publications per year reported from 1993 (n = 786) to 1995 (n = 751).
   Significance: This citation list provides a comprehensive resource for use by academicians and researchers to bridge the gap between initial publication and access to electronic searching methods for major databases.
RP Swift, EJ (reprint author), UNIV N CAROLINA,SCH DENT,DEPT OPERAT DENT,CHAPEL HILL,NC 27599, USA.
CR BAYNE SC, 1995, DENT MATER, V11, P281, DOI 10.1016/0109-5641(95)80064-6
   BAYNE SC, 1994, DENT MATER, V10, P59, DOI 10.1016/0109-5641(94)90023-X
   Christensen G J, 1995, J Esthet Dent, V7, P228, DOI 10.1111/j.1708-8240.1995.tb00584.x
   JENDRESEN MD, 1993, J PROSTHET DENT, V70, P44, DOI 10.1016/0022-3913(93)90036-N
   JENDRESEN MD, 1995, J PROSTHET DENT, V74, P60, DOI 10.1016/S0022-3913(05)80231-8
   JENDRESEN MD, 1994, J PROSTHET DENT, V72, P39, DOI 10.1016/0022-3913(94)90214-3
   LLOYD CH, 1995, J DENT, V23, P67, DOI 10.1016/0300-5712(95)98973-7
   SWIFT EJ, 1995, DENT MATER, V11, P52, DOI 10.1016/0109-5641(95)80009-3
   VANNOORT R, 1993, J DENT, V21, P5, DOI 10.1016/0300-5712(93)90046-S
   VANNOORT R, 1994, J DENT, V22, P5, DOI 10.1016/0300-5712(94)90139-2
   1995, CLIN RES ASS NEWSLET, V19, P1
NR 11
TC 3
Z9 3
U1 0
U2 2
PU ACAD DENTAL MATERIALS
PI DALLAS
PA BAYLOR COLLEGE DENTISTRY, 3302 GASTON AVE, DALLAS, TX 75266-0677
SN 0109-5641
J9 DENT MATER
JI Dent. Mater.
PD MAR
PY 1996
VL 12
IS 2
BP 127
EP 141
PG 15
WC Dentistry, Oral Surgery & Medicine; Materials Science, Biomaterials
SC Dentistry, Oral Surgery & Medicine; Materials Science
GA UD091
UT WOS:A1996UD09100009
PM 9002855
DA 2018-10-20
ER

PT J
AU Kaetsu, I
AF Kaetsu, I
TI Biomedical materials, devices and drug delivery systems by radiation
   techniques
SO RADIATION PHYSICS AND CHEMISTRY
LA English
DT Article; Proceedings Paper
CT 8th Tihany Symposium on Radiation Chemistry
CY 1994
CL BALATONSZEPLAK, HUNGARY
AB The study of radiation polymerization in a super-cooled state started in 1966 and has been applied to the immobilization of biofunctional materials since 1973. In the last twenty years, application has been concentrated to the immobilization of drugs and hormones for the purpose of drug delivery systems. Very recently, the author has proposed a concept of environmental signal responsive chemical delivery system, as a new generation of controlled release and delivery systems. The study and development of materials, devices and systems is described. The signal responsive delivery system consists of a sensor part and a controlled delivery part. Therefore, the use of immobilization techniques for the biochip sensor and the hydrogel actuator has been investigated. As a future goal, systems for the brain research are to be designed and studied.
RP Kaetsu, I (reprint author), KINKI UNIV,FAC SCI & TECHNOL,DEPT NUCL ENGN,KOWAKAE 3-4-1,OSAKA 577,JAPAN.
CR KAETSU I, 1993, ADV POLYM SCI, V105, P81
   KAETSU I, 1972, J POLYM SCI A1, V10, P2203, DOI 10.1002/pol.1972.150100801
   KAETSU I, 1988, DRUG DEV IND PHARM, V14, P2519, DOI 10.3109/03639048809152030
   YOSHIDA M, 1979, J PHARM SCI, V68, P628, DOI 10.1002/jps.2600680531
NR 4
TC 16
Z9 16
U1 0
U2 0
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
J9 RADIAT PHYS CHEM
JI Radiat. Phys. Chem.
PD MAR
PY 1996
VL 47
IS 3
BP 419
EP 424
DI 10.1016/0969-806X(95)00129-L
PG 6
WC Chemistry, Physical; Nuclear Science & Technology; Physics, Atomic,
   Molecular & Chemical
SC Chemistry; Nuclear Science & Technology; Physics
GA TN378
UT WOS:A1996TN37800022
DA 2018-10-20
ER

PT J
AU Ando, H
   Watanabe, S
   Mori, S
   Wada, Y
   Tanada, M
   Suzuki, H
   Takagi, S
   Nagaoka, S
   Matsumoto, K
   Suzuki, T
   Ogasawara, K
   Ogawa, K
   Tsumura, K
AF Ando, H
   Watanabe, S
   Mori, S
   Wada, Y
   Tanada, M
   Suzuki, H
   Takagi, S
   Nagaoka, S
   Matsumoto, K
   Suzuki, T
   Ogasawara, K
   Ogawa, K
   Tsumura, K
TI Intracellular recordings from Xenopus oocyte by using telescience
   technique
SO ACTA ASTRONAUTICA
LA English
DT Article; Proceedings Paper
CT 46th International-Astronautical-Federation Congress
CY OCT 02-06, 1995
CL OSLO, NORWAY
SP Int Astronaut Federat
AB By using telescience techniques, we developed and tested a system for remotely conducting intracellular recordings, an indispensable method for biomedical studies. As a representative experiment we chose to study on the adenosine-induced responses of Xenopus oocyte. Experimental materials were placed in a room simulating an orbital laboratory. The experiment was controlled and monitored by a principal investigator (PI) from another room simulating a ground control room. The two rooms were connected by a telecommunication simulator that could impose the communication delay and limit the data transfer rate. The PI inserted one or two microelectrodes into an oocyte using remote control on the micro-manipulators and on the platform of microscope with stereoscopic pictures observed through a head mounted display. By inserting one electrode, we could successfully study the adenosine responses at various concentrations. Then, we tried to perform the ''voltage clamp'' recordings by inserting two electrodes into one oocyte. Though insertion of two electrodes was troublesome, we finally succeeded the voltage clamp recordings. Result indicate the usefulness of the telescience for conducting intracellular recordings in space.
RP Ando, H (reprint author), KOBE UNIV,SCH MED,DEPT PHYSIOL,KOBE,JAPAN.
CR LOTAN I, 1985, MOL PHARMACOL, V28, P170
   WATANABE S, 1994, ACTA ASTRONAUT, V33, P189, DOI 10.1016/0094-5765(94)90124-4
NR 2
TC 0
Z9 0
U1 0
U2 0
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
SN 0094-5765
J9 ACTA ASTRONAUT
JI Acta Astronaut.
PD FEB-APR
PY 1996
VL 38
IS 4-8
BP 517
EP 523
DI 10.1016/0094-5765(96)00026-4
PG 7
WC Engineering, Aerospace
SC Engineering
GA VJ682
UT WOS:A1996VJ68200031
DA 2018-10-20
ER

PT J
AU DeLucas, LJ
AF DeLucas, LJ
TI International Space Station
SO ACTA ASTRONAUTICA
LA English
DT Article; Proceedings Paper
CT 46th International-Astronautical-Federation Congress
CY OCT 02-06, 1995
CL OSLO, NORWAY
SP Int Astronaut Federat
AB The International Space Station represents the largest scientific and technological cooperative program in history, drawing on the resources of thirteen nations. The early stages of construction will involve significant participation from the Russian Space Agency (RSA), numerous nations of the European Space Agency (ESA), and-the space agencies of Canada (CSA), Japan (NASDA) and the United States Space Agency (NASA). Its purpose is to place a unique, highly capable laboratory in lower orbit, where high value scientific research can be performed in microgravity; In addition to providing facilities where an international crew of six astronaut-scientists can live and work in space, it will provide important laboratory research facilities for performing basic research in life science, biomedical and material sciences, as well as space and engineering technology development which cannot be accomplished on Earth. The Space Station will be comprised of numerous interlocking components which are currently being constructed on Earth. Space Station will be assembled in orbit over a period of time and will provide several experimentation modules as well as habitation modules and interfaces for logistic modules. Including the four extensive solar rays from which it will draw electrical power, the Station will measure more than 300 feet wide by 200 feet long. This paper will present an overview of the various phases of construction of the Space Station and the planned science thought will be performed during the construction phase and after completion.
RP DeLucas, LJ (reprint author), UNIV ALABAMA,CTR MACROMOL CRYSTALLOG,BIRMINGHAM,AL 35294, USA.
NR 0
TC 5
Z9 5
U1 0
U2 5
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
SN 0094-5765
J9 ACTA ASTRONAUT
JI Acta Astronaut.
PD FEB-APR
PY 1996
VL 38
IS 4-8
BP 613
EP 619
DI 10.1016/0094-5765(96)00056-2
PG 7
WC Engineering, Aerospace
SC Engineering
GA VJ682
UT WOS:A1996VJ68200039
DA 2018-10-20
ER

PT J
AU Tangpasuthadol, V
   Shefer, A
   Hooper, KA
   Kohn, J
AF Tangpasuthadol, V
   Shefer, A
   Hooper, KA
   Kohn, J
TI Thermal properties and physical ageing behaviour of tyrosine-derived
   polycarbonates
SO BIOMATERIALS
LA English
DT Article
DE physical ageing; enthalpy relaxation kinetics; differential scanning
   calorimetry; tyrosine; polycarbonates
ID GLASS-TRANSITION TEMPERATURE; ENTHALPY RELAXATION; PSEUDO-POLY(AMINO
   ACIDS); AGING TEMPERATURE
AB Tyrosine-derived polycarbonates are new carbonate-amide copolymers. These materials have been suggested for use in medical applications, but their thermal properties and their enthalpy relaxation kinetics (physical ageing behaviour) have so far not been evaluated in detail. Since structure-property correlations involving enthalpy relaxation are rarely investigated for biomedical polymers, a series of four tyrosine-derived polycarbonates was used as a model system to study the effect of pendant chain length on the thermal properties and the enthalpy relaxation kinetics. The chemical structure of the test polymers was identical except for the length of their respective pendant chains. This feature facilitated the identification of structure-property correlations. Quantitative differential scanning calorimetry was utilized to determine the thermal properties and to measure enthalpy relaxation kinetics. The glass transition temperature of this family of polymers decreased from 93 to 52 degrees C when the length of the pendant chain was increased from two to eight carbon atoms. Successive additions of methylene groups to the pendant chain made a fairly constant contribution to lowering the glass transition temperature. For pendant chains of four or more methylene groups, the rate of enthalpy relaxation was independent of the number of methylene groups in the pendant chain. The enthalpy relaxation data were fitted to the Cowie-Ferguson model and the relaxation times obtained were about 90 min. Dynamic mechanical analysis was employed to study the viscoelastic properties. The available observations indicate that the polymers become more flexible with increasing length of the pendant chain. The results suggest that the length of the pendant chain can be used effectively to control important material properties in this series of polymers.
C1 RUTGERS STATE UNIV,DEPT CHEM,NEW BRUNSWICK,NJ 08903.
RI Tangpasuthadol, Varawut/F-9260-2010
FU NIGMS NIH HHS [GM39455]
CR ANDERSON JM, 1985, BIOCOMPATIBILITY TIS, V1, P67
   BAUWENSCROWET C, 1986, POLYMER, V27, P709, DOI 10.1016/0032-3861(86)90128-X
   Billmeyer FW, 1984, TXB POLYM SCI
   BRON S, 1993, POLYM MAT SCI ENG, V69, P37
   BRON S, 1993, IEEE 19 ANN NE BIOEN, P145
   CELLI A, 1992, POLYMER, V33, P2699, DOI 10.1016/0032-3861(92)90440-8
   CHENG SZD, 1991, POLYMER, V32, P2053, DOI 10.1016/0032-3861(91)90172-F
   CLARSON SJ, 1985, POLYMER, V26, P930, DOI 10.1016/0032-3861(85)90140-5
   COFFEY D, 1992, S POLYM DEL SYST SPR
   COWIE JMG, 1989, MACROMOLECULES, V22, P2312, DOI 10.1021/ma00195a054
   COWIE JMG, 1989, MACROMOLECULES, V22, P2307, DOI 10.1021/ma00195a053
   ERTEL SI, 1994, J BIOMED MATER RES, V28, P919, DOI 10.1002/jbm.820280811
   KOHN J, 1993, TRENDS POLYM SCI, V1, P206
   MONTSERRAT S, 1994, J POLYM SCI POL PHYS, V32, P509, DOI 10.1002/polb.1994.090320312
   PETHRICK RA, 1993, TRENDS POLYM SCI, V1, P226
   PULAPURA S, 1992, BIOPOLYMERS, V32, P411, DOI 10.1002/bip.360320418
   SHEFER A, 1992, MACROMOLECULES, V25, P4036, DOI 10.1021/ma00041a028
   SPATOLA AF, 1983, CHEM BIOCH AMINO ACI, V7, P267
   STRUIK LCE, 1978, PHYSICAL AGING AMORP
   YOSHIDA H, 1982, J MACROMOL SCI PHYS, VB21, P565, DOI 10.1080/00222348208215191
   ZHOU J, 1994, 20 ANN M SOC BIOM BO, P371
NR 21
TC 15
Z9 16
U1 0
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 1996
VL 17
IS 4
BP 463
EP 468
DI 10.1016/0142-9612(96)89665-7
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA TY460
UT WOS:A1996TY46000011
PM 8938243
DA 2018-10-20
ER

PT J
AU Ellis, RD
   Jankowski, TB
   Jasper, JE
   Abdul, A
AF Ellis, RD
   Jankowski, TB
   Jasper, JE
   Abdul, A
TI Gero-Informatics and the Internet: Locating gerontology information on
   the World Wide Web (WWW)
SO GERONTOLOGIST
LA English
DT Article
DE computer applications; electronic information; Internet; World Wide Web
AB The Internet, and in particular the World Wide Web (WWW), are growing at a tremendous rate. information useful to researchers and practitioners in gerontology is scattered and hard to locate, even for experts in the use of the WWW. In order to locate and organize access to this material, a WWW server was developed for gerontologists, using state-of-the-art Internet search techniques. This report provides background on the WWW, reasons for its growth, its potential usefulness to gerontologists, and the results of an exhaustive search of over 300 potential sites. Relevant information was discovered in 5 general categories of gerontology-related information: academic institutions, government agencies, biomedical and health research institutions, general interest sites and data archives.
C1 WAYNE STATE UNIV,DEPT IND & MFG ENGN,DETROIT,MI 48202.
RP Ellis, RD (reprint author), WAYNE STATE UNIV,INST GERONTOL,87 E FERRY,226 KNAPP BLDG,DETROIT,MI 48202, USA.
RI Ellis, Richard/A-5905-2009
OI Ellis, Richard/0000-0003-0435-8395
CR POST JA, 1995, AGEING INT, V22, P56
NR 1
TC 7
Z9 7
U1 0
U2 1
PU GERONTOLOGICAL SOCIETY AMER
PI WASHINGTON
PA 1275 K STREET NW SUITE 350, WASHINGTON, DC 20005-4006
SN 0016-9013
J9 GERONTOLOGIST
JI Gerontologist
PD FEB
PY 1996
VL 36
IS 1
BP 100
EP 105
DI 10.1093/geront/36.1.100
PG 6
WC Gerontology
SC Geriatrics & Gerontology
GA TV975
UT WOS:A1996TV97500018
PM 8932415
OA Bronze
DA 2018-10-20
ER

PT J
AU Xu, JW
   Gilson, DFR
   Butler, IS
   Stangel, I
AF Xu, JW
   Gilson, DFR
   Butler, IS
   Stangel, I
TI Effect of high external pressures on the vibrational spectra of
   biomedical materials: Calcium hydroxyapatite and calcium fluoroapatite
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
ID TRANSFORM INFRARED-SPECTROSCOPY; LITHIUM HYDROXIDE; PHOSPHATE IONS;
   EARLY DEPOSITS; SOLID-PHASE; PO4 DOMAIN; APATITES; ENVIRONMENT;
   EVOLUTION; ENAMEL
AB Infrared and Raman spectra of the principal mineral component of human hard tissue, calcium hydroxyapatite, Ca-10(PO4)(6)(OH)(2), or HAP, and the analogous calcium fluoroapatite, Ca-10(PO4)(6)F-2, or FAP, have been recorded, using a diamond-anvil cell, at pressures ranging from ambient to 30 kbar. For FAP, the absence of any discontinuities in the slopes of the nu (cm(-1)) versus P (kbar) plots for the observed bands indicates that no pressure-induced structural transition occurs in this material throughout the pressure range investigated. For the internal vibrational modes of HAP, however, there are distinct breaks at similar to 20 kbar in the nu versus P plots, suggesting the occurrence of a structural change at this pressure. The OH stretching mode of HAP shifts to higher wave numbers with increasing pressure while the associated OH librational mode shifts in the opposite direction. The pressure-induced structural transition in HAP is reversible and occurs at similar to 22 kbar upon decompression. Further evidence for a structural change taking place at similar to 20 kbar was provided by a parallel pressure-tuning Raman study. Hydrogen bonding does not occur, or is very weak, in HAP. (C) 1996 John Wiley & Sons, Inc.
C1 MCGILL UNIV,DEPT CHEM,MONTREAL,PQ H3A 2K6,CANADA.
   MCGILL UNIV,FAC DENT,MONTREAL,PQ H3A 1A4,CANADA.
CR ADAMS DM, 1991, J PHYS CHEM-US, V95, P7064, DOI 10.1021/j100171a063
   ADAMS DM, 1991, J PHYS-CONDENS MAT, V3, P9503, DOI 10.1088/0953-8984/3/47/022
   ANDRESVERGES M, 1983, SPECTROCHIM ACTA A, V39, P1077, DOI 10.1016/0584-8539(83)80128-7
   BADDIEL CB, 1966, SPECTROCHIM ACTA, V22, P1407, DOI 10.1016/0371-1951(66)80133-9
   BUSING WR, 1957, J CHEM PHYS, V26, P563, DOI 10.1063/1.1743345
   DASARATHY H, 1993, J BIOMED MATER RES, V27, P477, DOI 10.1002/jbm.820270408
   de Groot K, 1988, Ann N Y Acad Sci, V523, P272
   DEGROOT K, 1987, J BIOMED MATER RES, V21, P1375, DOI 10.1002/jbm.820211203
   DEGROOT K, 1980, BIOMATERIALS, V1, P47, DOI 10.1016/0142-9612(80)90059-9
   ELLIOTT JC, 1962, J DENT RES, V41, P1251
   ENGEL G, 1972, J SOLID STATE CHEM, V5, P28, DOI 10.1016/0022-4596(72)90004-7
   FOWLER BO, 1974, INORG CHEM, V13, P194, DOI 10.1021/ic50131a039
   GONZALEZDIAZ PF, 1977, J SOLID STATE CHEM, V22, P193, DOI 10.1016/0022-4596(77)90037-8
   HAMANN SD, 1975, AUST J CHEM, V28, P2567, DOI 10.1071/CH9752567
   IQBAL Z, 1977, J PHYS CHEM SOLIDS, V38, P923, DOI 10.1016/0022-3697(77)90132-9
   KAY MI, 1964, NATURE, V204, P1050, DOI 10.1038/2041050a0
   KLEE WE, 1970, J INORG NUCL CHEM, V32, P1837, DOI 10.1016/0022-1902(70)80590-5
   KLUG DD, 1983, REV SCI INSTRUM, V54, P1205, DOI 10.1063/1.1137551
   KROBOK MP, 1994, J PHYS-CONDENS MAT, V6, P9789, DOI 10.1088/0953-8984/6/45/028
   KRUGER MB, 1989, J CHEM PHYS, V91, P5910, DOI 10.1063/1.457460
   LEUNG YC, 1990, SPECTROCHIM ACTA A, V46, P1453, DOI 10.1016/0584-8539(90)80059-8
   LIPPINCOTT ER, 1955, J CHEM PHYS, V23, P1099, DOI 10.1063/1.1742196
   MOON SH, 1974, J CHEM PHYS, V61, P48, DOI 10.1063/1.1681669
   Naray-Szabo S, 1930, Z KRISTALLOGR, V75, P387
   NORDQUIST WD, 1973, CALC TISS RES, V12, P30, DOI 10.1007/BF02013719
   PIERMARINI GJ, 1975, J APPL PHYS, V46, P2774, DOI 10.1063/1.321957
   REY C, 1991, CALCIFIED TISSUE INT, V49, P383, DOI 10.1007/BF02555847
   REY C, 1990, CALCIFIED TISSUE INT, V46, P384, DOI 10.1007/BF02554969
   YOUNG R, 1974, CLIN ORTHOPAEDICS, V113, P249
NR 29
TC 20
Z9 20
U1 0
U2 13
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD FEB
PY 1996
VL 30
IS 2
BP 239
EP 244
DI 10.1002/(SICI)1097-4636(199602)30:2<239::AID-JBM14>3.0.CO;2-H
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA UD181
UT WOS:A1996UD18100015
PM 9019489
DA 2018-10-20
ER

PT J
AU Simpson, ML
   Miller, JC
   Lowndes, DH
AF Simpson, ML
   Miller, JC
   Lowndes, DH
TI Laser technology at the Oak Ridge National Laboratory
SO JOURNAL OF LASER APPLICATIONS
LA English
DT Article
DE laser technology research; exchange; laser industry interaction; Oak
   Ridge National Laboratory
ID SUPERCONDUCTING THIN-FILMS; RESONANCE IONIZATION SPECTROSCOPY; HIGH-TC;
   GROWTH; DEPOSITION; ABLATION
AB Researchers at the Department of Energy (DOE) facilities at Oak Ridge perform a variety of basic and applied research involving lasers and laser technology, One of the major strengths at Oak Ridge is the combination of core capabilities in optical materials, optical diagnostics, and sensors, Communities benefiting from these core capabilities include environmental, biomedical, and industrial sponsors, Industry can interact with Oak Ridge in a variety of ways: with Cooperative Research and Development Agreements (CRADAs), through Work for Others (WFO) programs, and as User Center participants, Oak Ridge is also active in sponsoring workshops and symposia for industrial participants like the Optical Diagnostics in Manufacturing and Process Control symposium held in December 1993. In this paper, an overview of a selection of laser technologies residing at Oak Ridge is provided, Examples of the application of these technologies are given as well as overviews of several on-going CRADAs with industrial partners.
RP Simpson, ML (reprint author), OAK RIDGE NATL LAB,POB 2008,OAK RIDGE,TN 37831, USA.
CR ALLISON SW, 1988, P ICALEO
   CHEN CH, 1992, INT J GENOME RES, V1, P25
   CHEN CH, 1984, APPL PHYS LETT, V44, P640, DOI 10.1063/1.94861
   CHEUNG JT, 1988, CRIT REV SOLID STATE, V15, P63, DOI 10.1080/10408438808244625
   COMPTON RN, 1989, LASER APPL PHYSICAL
   DESAI SR, 1994, J CHEM PHYS, V101
   FORK DK, 1991, APPL PHYS LETT, V58, P2294, DOI 10.1063/1.104903
   FORK DK, 1990, APPL PHYS LETT, V57, P2504, DOI 10.1063/1.104181
   GARSIDE BK, 1988, P SOC PHOTO-OPT INS, V954, P670
   HURST GS, 1979, REV MOD PHYS, V51, P767, DOI 10.1103/RevModPhys.51.767
   INAM A, 1988, APPL PHYS LETT, V53, P908, DOI 10.1063/1.100155
   Jellison G. E.  Jr., 1993, Optical Materials, V2, P105, DOI 10.1016/0925-3467(93)90035-Y
   JELLISON GE, 1990, APPL OPTICS, V29, P959, DOI 10.1364/AO.29.000959
   KANAI M, 1989, APPL PHYS LETT, V54, P1802, DOI 10.1063/1.101269
   KANAI M, 1991, APPL PHYS LETT, V58, P771, DOI 10.1063/1.104543
   KERCEL SW, 1993, 12383 ORNL
   KERCEL SW, ULTRAHIGH HIGH SPEED, P60
   LEE LP, 1991, APPL PHYS LETT, V59, P3051, DOI 10.1063/1.105790
   LOWNDES DH, 1994, MODERN TOPICS GROWTH
   MCCAMY JW, 1993, APPL PHYS LETT, V63, P3008, DOI 10.1063/1.110267
   MILLER JC, 1991, LECT NOTES PHYSICS, V389
   MILLER JC, 1982, J CHEM PHYS, V76, P2056
   MILLER JC, 1994, AIP C P, V288
   MUHS JD, 1992, PHOTONICS, V98
   NORTON DP, 1991, PHYS REV LETT, V66, P1537, DOI 10.1103/PhysRevLett.66.1537
   NORTON DP, 1993, APPL PHYS LETT, V62, P1679, DOI 10.1063/1.109574
   NORTON DP, 1994, IN PRESS SCIENCE
   STEVENSON CL, 1993, APPL SPECTROSC, V47, P430, DOI 10.1366/0003702934334967
   STOREY JME, 1994, SPECTROSCOPY     AUG
   VODINH T, 1994, IN PRESS LASERS SURG
   WATTS W, 1992, APPL SPECTROSC, V46, P1235, DOI 10.1366/0003702924123953
   WOOD RF, 1984, SEMICONDUCTORS SEMIM, V23
   WU XD, 1988, APPL PHYS LETT, V52, P754, DOI 10.1063/1.99337
   WU XD, 1990, APPL PHYS LETT, V56, P1481, DOI 10.1063/1.103209
NR 34
TC 0
Z9 0
U1 0
U2 0
PU LASER INST AMER
PI ORLANDO
PA 12424 RESEARCH PARKWAY SUITE 125, ORLANDO, FL 32826
SN 1042-346X
J9 J LASER APPL
JI J. Laser Appl.
PD FEB
PY 1996
VL 8
IS 1
BP 55
EP 60
DI 10.2351/1.4745405
PG 6
WC Materials Science, Multidisciplinary; Optics; Physics, Applied
SC Materials Science; Optics; Physics
GA UG055
UT WOS:A1996UG05500009
DA 2018-10-20
ER

PT J
AU Krajewski, A
   Ravaglioli, A
   Kirsch, M
   Biagini, G
   Solmi, R
   Belmonte, M
   Zucchini, C
   Gandolfi, MG
   Castaldini, C
   Rodriguez, L
   Giardino, R
   Mongiorgi, R
   Roncari, E
   Orlandi, L
AF Krajewski, A
   Ravaglioli, A
   Kirsch, M
   Biagini, G
   Solmi, R
   Belmonte, M
   Zucchini, C
   Gandolfi, MG
   Castaldini, C
   Rodriguez, L
   Giardino, R
   Mongiorgi, R
   Roncari, E
   Orlandi, L
TI Ceramic support for cell cultures
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID HUMAN-ENDOTHELIAL-CELLS
AB Research was carried out on the use of ceramics as supports to host mammalian cells. The research was part of a programme whose priority was to study the possibility of using ceramics in the non-traditional sector of the biomedical field. The aim of the study was also to verify the suitability of particular types of ceramics dealt with in the literature for these applications. Among the different samples tested the cordieritic one proved to be very interesting, at least in relation to the cellular cultures considered. The chemical composition of the material is not, however, the only important aspect, since other parameters concur to make the hosting of cells highly acceptable. Of particular importance is the rugosity and porosity of the surface and its flaking, not only externally, but also in the pores.
C1 WITE GMBH,BERLIN,GERMANY.
   UNIV ANCONA,INST NORMAL HUMAN MORPHOL,FAC MED,ANCONA,ITALY.
   UNIV BOLOGNA,INST HISTOL,FAC MED,BOLOGNA,ITALY.
   UNIV TURIN,DEPT MED,TURIN,ITALY.
   UNIV BOLOGNA,DIV ESPERIMENTAL SURG,ORTHOPAED INST RIZZOLI,BOLOGNA,ITALY.
   UNIV BOLOGNA,DEPT HEARTH SCI,BOLOGNA,ITALY.
   UNIV BOLOGNA,FAC PHARM,BOLOGNA,ITALY.
   NATL INST STUDY & TREATMENT TUMOURS ONCOL C,MILAN,ITALY.
RP Krajewski, A (reprint author), ITALIAN NATL RES COUNCIL,INST TECHNOL RES,FAENZA,ITALY.
RI Mattioli-Belmonte, Monica/J-5861-2012
OI Gandolfi, Maria Giovanna/0000-0001-7793-6227; SOLMI,
   ROSSELLA/0000-0001-9122-8243
CR BERG GJ, 1988, ANIMAL CELL BIOTECHN, P321
   DEKKER A, 1991, J MATER SCI-MATER M, V2, P227, DOI 10.1007/BF00703376
   DELGUERRA SS, 1993, BIOMATERALI, V1, P29
   DEWOOD MA, 1993, CLIN CARDIOL, V16, P302, DOI 10.1002/clc.4960160404
   DUKE PJ, 1993, J CELL BIOCHEM, V51, P274, DOI 10.1002/jcb.240510306
   GOMI K, 1993, BIOMATERIALS, V14, P91, DOI 10.1016/0142-9612(93)90216-O
   KOLLER MR, 1993, BLOOD, V82, P378
   Martinetti R, 1993, P ECERS 3 MADR, V3, P17
   ONEILL C, 1986, CELL, V44, P489, DOI 10.1016/0092-8674(86)90470-8
   PARULEKAR SJ, 1992, INT REV CYTOL, V142, P145, DOI 10.1016/S0074-7696(08)62076-8
   VANWACHEM PB, 1985, BIOMATERIALS, V6, P403, DOI 10.1016/0142-9612(85)90101-2
   VROUWENVELDER WCA, 1993, THESIS DRUKKERIJ SIN, P7
   WATSON PA, 1991, FASEB J, V5, P2013
   YAMAMOTO M, 1993, EXP CELL RES, V204, P121, DOI 10.1006/excr.1993.1016
NR 14
TC 4
Z9 5
U1 0
U2 1
PU CHAPMAN HALL LTD
PI LONDON
PA 2-6 BOUNDARY ROW, LONDON, ENGLAND SE1 8HN
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD FEB
PY 1996
VL 7
IS 2
BP 99
EP 102
DI 10.1007/BF00058720
PG 4
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA UA904
UT WOS:A1996UA90400006
DA 2018-10-20
ER

PT J
AU Ishihara, K
   Fujiike, A
   Iwasaki, Y
   Kurita, K
   Nakabayashi, N
AF Ishihara, K
   Fujiike, A
   Iwasaki, Y
   Kurita, K
   Nakabayashi, N
TI Synthesis of polymers having a phospholipid polar group connected to a
   poly(oxyethylene) chain and their protein adsorption-resistance
   properties
SO JOURNAL OF POLYMER SCIENCE PART A-POLYMER CHEMISTRY
LA English
DT Article
DE phospholipid polymer; biomaterials; hydrogel; protein adsorption;
   surface modification; blood compatibility
ID PHOSPHORYLCHOLINE MOIETY; PHOSPHATIDYLCHOLINES; MEMBRANES; SURFACES;
   LIPIDS; PLASMA
AB New methacrylates having a phospholipid polar group which was connected to various lengths of poly(oxyethylene) chains to form a polymerizable group (MEOnPC) were synthesized. The MEOnPC could polymerize with n-butyl methacrylate (BMA) in ethanol using a conventional radical polymerization technique. The unit mole fraction of MEOnPC in the polymer corresponded to that in the feed monomer solution. The MEOnPC polymers were soluble in ethanol, insoluble in water, but swelled in water and became hydrated. On the surface of a poly(BMA) membrane coated with MEOnPC, the phosphorylcholine groups of the MEOnPC unit present were determined by x-ray photoelectron spectroscopy. As a fundamental evaluation for biomedical materials, adsorption of one of the plasma proteins, fibrinogen, on acrylic beads coated with the MEOnPC polymers was evaluated. The amount of fibrinogen adsorbed on the MEOnPC polymer was smaller than that on the original acrylic beads, poly(BMA) and poly(2-hydroxyethyl methacrylate). The increase in the MEOnPC unit mole fraction in the polymer showed more effective protein adsorption-resistant properties. (C) 1996 John Wiley & Sons, Inc.
C1 NIHON UNIV,COLL SCI & TECHNOL,DEPT IND CHEM,CHIYODA KU,TOKYO 101,JAPAN.
RP Ishihara, K (reprint author), TOKYO MED & DENT UNIV,INST MED & DENT ENGN,CHIYODA KU,2-3-10 KANDA SURUGADAI,TOKYO 101,JAPAN.
RI Iwasaki, Yasuhiko/D-6870-2011
OI Iwasaki, Yasuhiko/0000-0003-1603-6174
CR BAMFORD CH, 1992, VROMAN EFFECT
   BASZKIN A, 1980, J BIOMED MATER RES, V14, P393, DOI 10.1002/jbm.820140406
   BERGSTROM K, 1992, J BIOMED MATER RES, V26, P779, DOI 10.1002/jbm.820260607
   BERGSTROM K, 1994, J BIOMAT SCI-POLYM E, V6, P123
   Brash JL, 1991, BLOOD COMPATIBLE MAT, P3
   CAMPBELL EJ, 1994, ASAIO J, P853
   EDMUNDSON RS, 1962, CHEM IND-LONDON, P1828
   GENNIS RB, 1989, BIOMEMBRANES MOL STR
   GROS L, 1981, ANGEW CHEM INT EDIT, V20, P305, DOI 10.1002/anie.198103051
   HALL B, 1989, BIOMATERIALS, V10, P219, DOI 10.1016/0142-9612(89)90096-3
   HUPFER B, 1981, MACROMOL CHEM PHYS, V182, P247
   ISHIHARA K, 1990, J BIOMED MATER RES, V24, P1069, DOI 10.1002/jbm.820240809
   ISHIHARA K, 1992, J BIOMED MATER RES, V26, P1543, DOI 10.1002/jbm.820261202
   ISHIHARA K, 1994, J BIOMED MATER RES, V28, P225, DOI 10.1002/jbm.820280213
   ISHIHARA K, 1993, J BIOMED MATER RES, V27, P1309, DOI 10.1002/jbm.820271011
   ISHIHARA K, 1991, J BIOMED MATER RES, V25, P1397, DOI 10.1002/jbm.820251107
   ISHIHARA K, 1990, POLYM J, V22, P355, DOI 10.1295/polymj.22.355
   ISHIHARA K, 1991, SEITAI ZAIRYO, V9, P243
   IWASAKI Y, 1994, J BIOMAT SCI-POLYM E, V6, P447, DOI 10.1163/156856294X00437
   KADOMA Y, 1978, KOBUNSHI RONBUNSHU, V35, P423, DOI 10.1295/koron.35.423
   KOJIMA M, 1991, BIOMATERIALS, V12, P121, DOI 10.1016/0142-9612(91)90189-H
   LAMPARSKI H, 1993, J AM CHEM SOC, V115, P8096, DOI 10.1021/ja00071a022
   REGEN SL, 1981, BIOCHEM BIOPH RES CO, V101, P131, DOI 10.1016/S0006-291X(81)80020-4
   SHEPPARD JI, 1994, J BIOMED MATER RES, V28, P1175, DOI 10.1002/jbm.820281008
   SLACK SM, 1992, J BIOMED MATER RES, V26, P1633, DOI 10.1002/jbm.820261208
   SOLTYS CE, 1993, BIOCHEMISTRY-US, V32, P9545, DOI 10.1021/bi00088a005
   SUGIYAMA K, 1994, POLYM J, V26, P561, DOI 10.1295/polymj.26.561
   TANAKA S, 1994, MACROMOL RAPID COMM, V15, P319, DOI 10.1002/marc.1994.030150404
   UEDA T, 1995, J BIOMED MATER RES, V29, P381, DOI 10.1002/jbm.820290313
   UEDA T, 1991, J BIOMAT SCI-POLYM E, V3, P185
   YU J, 1994, INT J ARTIF ORGANS, V17, P499
NR 31
TC 41
Z9 41
U1 0
U2 2
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0887-624X
J9 J POLYM SCI POL CHEM
JI J. Polym. Sci. Pol. Chem.
PD JAN 30
PY 1996
VL 34
IS 2
BP 199
EP 205
DI 10.1002/(SICI)1099-0518(19960130)34:2<199::AID-POLA6>3.0.CO;2-P
PG 7
WC Polymer Science
SC Polymer Science
GA TM426
UT WOS:A1996TM42600010
DA 2018-10-20
ER

PT J
AU Whitley, JQ
   Kusy, RP
AF Whitley, JQ
   Kusy, RP
TI Reutilizing and retesting of parallel plate sensors in dielectric
   thermal analysis
SO THERMOCHIMICA ACTA
LA English
DT Article; Proceedings Paper
CT 23rd North-American-Thermal-Analysis-Society Conference
CY SEP 25-28, 1994
CL TORONTO, CANADA
SP N Amer Thermal Anal Soc
DE DETA; membrane; quality assurance; poly(vinyl chloride); loss factor;
   permittivity
ID ELECTRODES
AB One of the advantages of dielectric thermal analysis (DETA) is that the parallel plate sensors are disposable, thereby eliminating potentially time-consuming clean-up procedures. Nonetheless, sometimes the reusing of parallel plate sensors is desirable, for example, when the test material is limited, further processing is intended, or cyclic testing is required. In this experiment, multiple-run and single-run methodologies were performed, the former without unloading the ram, and the latter after unloading the ram, removing the specimen, and cleaning the sensor. A dummy biomedical membrane was cast from a tetrahydrofuran solution of highly plasticized poly(vinyl chloride). After running each DETA experiment at a heating rate of 3 degrees C min(-1) from -20 to +80 degrees C at 1, 10, and 100 Hz, no significant differences were observed for permittivities, loss factors, tan deltas, ion conductivities, or the membrane thicknesses at room temperature. When calibrated, sensor areas varied by +/-1%, and thermistor values varied by +/-0.5%. From comparative graphs, box-plots, and statistical analyses, the data confirm that parallel plate sensors can be reutilized for retesting with these biomedical membranes.
C1 UNIV N CAROLINA,DENT RES CTR,CHAPEL HILL,NC 27599.
CR AMBROSIUS EE, 1966, MECHANICAL MEASUREME, P56
   CRAGGS A, 1974, J CHEM EDUC, V51, P541, DOI 10.1021/ed051p541
   JOHNSON TA, 1990, AM J PHYSIOL, V258, pH1224
   LINDNER E, 1994, J BIOMED MATER RES, V28, P591, DOI 10.1002/jbm.820280509
   MCCRUM NG, 1991, ANELASTIC DIELECTRIC, pCH7
   MOORE CYRIL, 1964, BIOCHEM BIOPHYS RES COMMUN, V15, P562, DOI 10.1016/0006-291X(64)90505-4
   POURNOOR K, 1991, POLYMER, V32, P445, DOI 10.1016/0032-3861(91)90448-R
   SIMON MA, 1993, POLYMER, V34, P5106, DOI 10.1016/0032-3861(93)90255-9
   SIMON MA, 1995, IN PRESS J BIOMED MA
   SIMPSON RJ, 1988, AM HEART J, V116, P1663, DOI 10.1016/0002-8703(88)90791-0
   TOTH K, 1986, ANAL CHEM, V58, P2741, DOI 10.1021/ac00126a035
NR 11
TC 1
Z9 1
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0040-6031
J9 THERMOCHIM ACTA
JI Thermochim. Acta
PD JAN 20
PY 1996
VL 272
BP 95
EP 103
DI 10.1016/0040-6031(95)02458-1
PG 9
WC Thermodynamics; Chemistry, Analytical; Chemistry, Physical
SC Thermodynamics; Chemistry
GA TW691
UT WOS:A1996TW69100011
DA 2018-10-20
ER

PT B
AU Tsuruta, T
AF Tsuruta, T
BE Ogata, N
   Kim, SW
   Feijen, J
   Okano, T
TI New polymeric materials design for biomedical applications
SO ADVANCED BIOMATERIALS IN BIOMEDICAL ENGINEERING AND DRUG DELIVERY
   SYSTEMS
LA English
DT Proceedings Paper
CT 5th Iketani Conference on Biomedical Polymers
CY APR 18-22, 1995
CL KAGOSHIMA UNIV, KAGOSHIMA, JAPAN
SP Iketani Sci & Technol Fdn
HO KAGOSHIMA UNIV
DE materials design; polyamine copolymers; microdomain structure;
   conformational transition; inert surface
C1 SCI UNIV TOKYO,FAC ENGN,DEPT IND CHEM,SHINJUKU KU,TOKYO 162,JAPAN.
NR 0
TC 2
Z9 2
U1 0
U2 0
PU SPRINGER-VERLAG
PI TOKYO
PA 37-3, HONGO 3-CHOME BONKYO-KU, TOKYO 113, JAPAN
BN 4-431-70163-X
PY 1996
BP 43
EP 47
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials; Pharmacology &
   Pharmacy
SC Engineering; Materials Science; Pharmacology & Pharmacy
GA BF14A
UT WOS:A1996BF14A00009
DA 2018-10-20
ER

PT B
AU Nakabayashi, N
AF Nakabayashi, N
BE Ogata, N
   Kim, SW
   Feijen, J
   Okano, T
TI Preparation of self-assembled biomimetic membranes and their functions
SO ADVANCED BIOMATERIALS IN BIOMEDICAL ENGINEERING AND DRUG DELIVERY
   SYSTEMS
LA English
DT Proceedings Paper
CT 5th Iketani Conference on Biomedical Polymers
CY APR 18-22, 1995
CL KAGOSHIMA UNIV, KAGOSHIMA, JAPAN
SP Iketani Sci & Technol Fdn
HO KAGOSHIMA UNIV
DE phospholipid; 2-Methacryloyloxyethyl phosphorylcholine;
   nonthrombogenicity; self-assembled biomimetic membrane; protein
   adsorption; hydrogel; biocompatibility; biomedical material
C1 TOKYO MED & DENT UNIV,INST MED & DENT ENGN,CHIYODA KU,TOKYO 101,JAPAN.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER-VERLAG
PI TOKYO
PA 37-3, HONGO 3-CHOME BONKYO-KU, TOKYO 113, JAPAN
BN 4-431-70163-X
PY 1996
BP 193
EP 197
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials; Pharmacology &
   Pharmacy
SC Engineering; Materials Science; Pharmacology & Pharmacy
GA BF14A
UT WOS:A1996BF14A00036
DA 2018-10-20
ER

PT B
AU Kobayashi, K
   Usui, T
   Akaike, T
AF Kobayashi, K
   Usui, T
   Akaike, T
BE Ogata, N
   Kim, SW
   Feijen, J
   Okano, T
TI Artificial glycoconjugate polymers: Cell-specific biomedical materials
   using carbohydrates as recognition signals
SO ADVANCED BIOMATERIALS IN BIOMEDICAL ENGINEERING AND DRUG DELIVERY
   SYSTEMS
LA English
DT Proceedings Paper
CT 5th Iketani Conference on Biomedical Polymers
CY APR 18-22, 1995
CL KAGOSHIMA UNIV, KAGOSHIMA, JAPAN
SP Iketani Sci & Technol Fdn
HO KAGOSHIMA UNIV
C1 NAGOYA UNIV, FAC AGR SCI, NAGOYA, AICHI 46401, JAPAN.
   NAGOYA UNIV, FAC AGR SCI, NAGOYA, AICHI 46401, JAPAN.
NR 0
TC 1
Z9 1
U1 0
U2 0
PU SPRINGER-VERLAG TOKYO
PI TOKYO
PA 37-3, HONGO 3-CHOME BONKYO-KU, TOKYO, 113, JAPAN
BN 4-431-70163-X
PY 1996
BP 215
EP 216
PG 2
WC Engineering, Biomedical; Materials Science, Biomaterials; Pharmacology &
   Pharmacy
SC Engineering; Materials Science; Pharmacology & Pharmacy
GA BF14A
UT WOS:A1996BF14A00043
DA 2018-10-20
ER

PT S
AU Zlatanovic, MD
   Kunosic, AM
   Belosevac, RB
   Popovic, NV
AF Zlatanovic, MD
   Kunosic, AM
   Belosevac, RB
   Popovic, NV
BE Uskokovic, DP
TI Plasma deposition of hard coatings - Duplex treatment
SO ADVANCED MATERIALS FOR HIGH TECHNOLOGY APPLICATIONS
SE Materials Science Forum
LA English
DT Article; Proceedings Paper
CT 1st Yugoslavian Advanced Materials Conference - Advanced Materials 95 on
   Challenges of Tomorrow
CY SEP 18-22, 1995
CL HERCEG NOVI, YUGOSLAVIA
DE hard coatings; plasma deposition; duplex treatment; plasma nitriding;
   TiN; TiAlN
ID COMPRESSIBILITY; TIN; STEEL
AB Various ion and plasma assisted techniques used for surface modification and formation of functional surface layers are extensively developed as a important part of plasma surface engineering (PSE), Besides many applications in electrical engineering, microelectronics, optoelectronics, optics, sensors and actuators, biomedical engineering and other fields for production of active surface elements, the use of plasma technique for synthesis of new materials and deposition of protective coatings on functional components is of increasing importance, In order to obtain various thermal and diffusion barriers, wear and corrosion resistant layers and surface structure with desired tribological properties, a wide range of materials in the form of coatings was obtained by using plasma technique. In many cases, wear resistant material was found to have high hardness so that a new class of surface protective layers known as hard coatings was developed. Further research in this field includes the formation of multicomponent, multilayer and composite structures, as well as superlattice with desired tribological properties. A composite surface: structure which consists of a hard coating deposited on plasma nitrided layer was considered and its principal properties analyzed.
C1 IMT, PLASMA TECHNOL CTR ETF, YU-11000 BELGRADE, YUGOSLAVIA.
   INST NUCL SCI, YU-11000 BELGRADE, YUGOSLAVIA.
RP Zlatanovic, MD (reprint author), FAC ELECT ENGN, BULEVAR REVOLUCIJE 73, YU-11000 BELGRADE, YUGOSLAVIA.
CR BARNETT SA, 1992, MAT PRECESSING, V7, P1
   COHEN ML, 1989, SCIENCE, V243, P547, DOI 10.1126/science.243.4890.547
   FELLA R, 1988, SURF COAT TECH, V36, P257, DOI 10.1016/0257-8972(88)90155-7
   GOBLE RJ, 1985, CAN MINERAL, V23, P273
   GREDIC T, 1993, THIN SOLID FILMS, V228, P261, DOI 10.1016/0040-6090(93)90612-S
   GREDIC T, 1993, SURF COAT TECH, V61, P338, DOI 10.1016/0257-8972(93)90249-N
   GREDIC T, 1992, SURF COAT TECH, V55, P502, DOI 10.1016/S0257-8972(07)80073-9
   HOLLECK H, 1990, SURF COAT TECH, V43-4, P245, DOI 10.1016/0257-8972(90)90078-Q
   HOLLECK H, 1989, METALL, V43, P614
   Holmberg K., 1994, COATING TRIBOLOGY
   HULTMANN L, 1993, ICMCTF 93 SAN DIEG
   KNITTLE E, 1989, NATURE, V337, P349, DOI 10.1038/337349a0
   LIU AY, 1990, PHYS REV B, V41, P10727, DOI 10.1103/PhysRevB.41.10727
   LIU AY, 1989, SCIENCE, V245, P841, DOI 10.1126/science.245.4920.841
   Matthews J. W., 1975, EPITAXIAL GROWTH
   ROBERTSON J, 1992, SURF COAT TECH, V50, P185, DOI 10.1016/0257-8972(92)90001-Q
   SHINN M, 1992, J MATER RES, V7, P901, DOI 10.1557/JMR.1992.0901
   SUN Y, 1991, MAT SCI ENG A-STRUCT, V140, P419, DOI 10.1016/0921-5093(91)90458-Y
   Zhogolev D. A., 1981, ZH STRUKT KHIM, V22, P46
   ZLATANOVIC M, 1994, SURF COAT TECH, V63, P35, DOI 10.1016/S0257-8972(05)80005-2
   ZLATANOVIC M, 1990, SURF COAT TECH, V41, P17, DOI 10.1016/0257-8972(90)90127-X
   ZLATANOVIC M, 1991, SURF COAT TECH, V48, P19, DOI 10.1016/0257-8972(91)90124-F
   ZLATANOVIC M, 1994, SURF COAT TECH, V64, P173, DOI 10.1016/0257-8972(94)90105-8
   ZLATANOVIC M, 1989, COAT TECH 89, P135
   ZLATANOVIC M, 1989, 2ND P ASM INT C ION, P99
   ZLATANOVIC M, 1991, 1 ASM HEAT TREAT SUR, P655
NR 26
TC 10
Z9 10
U1 0
U2 0
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 0255-5476
BN 0-87849-731-5
J9 MATER SCI FORUM
PY 1996
VL 214
BP 179
EP 188
DI 10.4028/www.scientific.net/MSF.214.179
PG 10
WC Chemistry, Physical; Electrochemistry; Materials Science,
   Multidisciplinary; Metallurgy & Metallurgical Engineering; Materials
   Science, Characterization & Testing; Materials Science, Coatings &
   Films; Optics; Polymer Science
SC Chemistry; Electrochemistry; Materials Science; Metallurgy &
   Metallurgical Engineering; Optics; Polymer Science
GA BG35S
UT WOS:A1996BG35S00022
DA 2018-10-20
ER

PT B
AU Robare, EW
   Bugle, CM
   Davidson, JA
   Daigle, KP
AF Robare, EW
   Bugle, CM
   Davidson, JA
   Daigle, KP
BE Weiss, I
   Srinivasan, R
   Bania, PJ
   Eylon, D
   Semiatin, SL
TI Development of processing methods for Ti-13Nb-13Zr
SO ADVANCES IN THE SCIENCE AND TECHNOLOGY OF TITANIUM ALLOY PROCESSING
LA English
DT Proceedings Paper
CT International Symposium on Advances in the Science and Technology of
   Titanium Alloy Processing at the 125th TMS Annual Meeting and Exhibition
CY FEB 05-08, 1996
CL ANAHEIM, CA
SP TMS Titanium & Shaping & Forming Comm
ID LOW-MODULUS; ALLOY
AB Ti-13Nb-13Zr (Ti-13-13(TM)) is a new titanium alloy which has a unique combination of properties that may make it an attractive choice for a variety of applications. Originally developed for use in biomedical implants, this alloy combines a low elastic modulus, high strength, excellent hot and cold workability, superior corrosion resistance, and the ability to be surface hardened to improve wear properties.
   Research on this age-hardenable alloy has shown that the mechanical properties can be controlled over a significant range through hot working, heat treatment and cold working. The elastic modulus of Ti-13-13 can be varied between approximately 41 and 83 GPa, and strengths as high as 1330 MPa have been achieved. Some typical combinations of properties are presented.
   Further, the material does not seem to exhibit some of the typical processing difficulties encountered in some age-hardenable beta Ti alloys. For example, in wire drawing trials, Ti-13-13 yielded exceptionally good surface finish in the "as-drawn" condition with over 85% cold work. Some examples of processing behavior are discussed.
C1 Dynamet Inc, Res & Dev, Washington, PA 15302 USA.
RP Robare, EW (reprint author), Dynamet Inc, Res & Dev, 195 Museum Rd, Washington, PA 15302 USA.
CR DAIGLE KP, 1994, P 1994 INT C TIT PRO
   DAVIDSON JA, 1994, BIO-MED MATER ENG, V4, P231
   GOODMAN SB, 1993, J APPL BIOMATER, V4, P331, DOI 10.1002/jab.770040407
   KOVACS P, 1995, ASTM STP, V1272
   MISHRA AK, 1995, ASTM STP, V1272
   POGGIE RA, 1996, MAT MANUFACTURING PR, V2
NR 6
TC 1
Z9 1
U1 0
U2 1
PU MINERALS, METALS & MATERIALS SOC
PI WARRENDALE
PA 184 THORN HILL RD, WARRENDALE, PA 15086-7514 USA
BN 0-87339-324-4
PY 1996
BP 283
EP 291
PG 9
WC Metallurgy & Metallurgical Engineering
SC Metallurgy & Metallurgical Engineering
GA BM47L
UT WOS:000078852200023
DA 2018-10-20
ER

PT J
AU Kanazawa, H
   Yamamoto, K
   Matsushima, Y
   Takai, N
   Kikuchi, A
   Sakurai, Y
   Okano, T
AF Kanazawa, H
   Yamamoto, K
   Matsushima, Y
   Takai, N
   Kikuchi, A
   Sakurai, Y
   Okano, T
TI Temperature-responsive chromatography using
   poly(N-isopropylacrylamide)-modified silica
SO ANALYTICAL CHEMISTRY
LA English
DT Article
ID CULTURED-CELLS; PERMEATION; RELEASE; MEMBRANES; POLYMERS; WATER
AB A new concept in chromatography is proposed that utilizes a temperature-responsive surface with a constant aqueous mobile phase. The surface of the silica stationary phase in high-performance liquid chromatography (HPLC) has been modified with temperature-responsive polymers to exhibit temperature-controlled hydrophilic/hydrophobic changes. Poly(N-isopropylacrylamide) (PIPAAm) was grafted onto (aminopropyl)silica using an activated esteramine coupling method. These grafted silica surfaces show hydrophilic properties at lower temperatures which, as temperature increases, transform to hydrophobic surface properties. The elution profile of five mixed steroids on an HPLC column packed with this material depends largely on the temperature of the aqueous mobile phase. Retention times increase with increasing temperature without any change in the eluent. Changes in the retention times of hydrophobic steroids were larger than those for hydrophilic steroids. The temperature-responsive interaction between PIPAAm-modified silica and these steroids is proposed to result from changes in the surface properties of the HPLC stationary phase by the transition of hydrophilic/hydrophobic surface-grafted IPAAm polymers. We demonstrate a novel and useful new chromatography system in which surface properties and the resulting function of the HPLC stationary phase are controlled by external temperature changes, This method should be effective in biological and biomedical separations of peptides and proteins using only aqueous mobile phases.
C1 TOKYO DENKI UNIV,FAC SCI & ENGN,SAITAMA 35003,JAPAN.
   TOKYO WOMENS MED COLL,INST BIOMED ENGN,SHINJUKU KU,TOKYO 162,JAPAN.
RP Kanazawa, H (reprint author), KYORITSU COLL PHARMACEUT SCI,MINATO KU,1-5-30 SHIBA KOEN,TOKYO 105,JAPAN.
RI Okano, Teruo/J-4028-2012
OI Kanazawa, Hideko/0000-0003-2550-470X
CR BAE YH, 1990, J POLYM SCI POL PHYS, V28, P923, DOI 10.1002/polb.1990.090280609
   BUCKMANN AF, 1981, MAKROMOL CHEM, V182, P1379
   FUJISHIGE S, 1989, J PHYS CHEM-US, V93, P3311, DOI 10.1021/j100345a085
   FUJISHIGE S, 1987, POLYM J, V19, P297, DOI 10.1295/polymj.19.297
   GAUR RK, 1989, ANAL BIOCHEM, V180, P253, DOI 10.1016/0003-2697(89)90426-0
   GEWEHR M, 1992, MAKROMOL CHEM, V193, P249
   Heskins M., 1968, J MACROMOL SCI CHEM, V2, P1441, DOI [10.1080/10601326808051910, DOI 10.1080/10601326808051910]
   HOSOYA K, 1994, MACROMOLECULES, V27, P3973, DOI 10.1021/ma00092a042
   ISHIHARA K, 1984, J APPL POLYM SCI, V29, P211, DOI 10.1002/app.1984.070290119
   KANAZAWA H, 1993, 1ST P INT C INT MAT, P415
   KOPECEK J, 1971, J POLYM SCI A1, V9, P2801, DOI 10.1002/pol.1971.150091005
   LINDSAY S, 1992, HIGH PERFORMANCE LIQ, P302
   MATSUKATA M, 1994, J BIOCHEM-TOKYO, V116, P682, DOI 10.1093/oxfordjournals.jbchem.a124580
   MIRON T, 1982, ANAL BIOCHEM, V126, P433, DOI 10.1016/0003-2697(82)90540-1
   OKAHATA Y, 1986, MACROMOLECULES, V19, P493, DOI 10.1021/ma00156a049
   OKANO T, 1978, J APPL POLYM SCI, V22, P369, DOI 10.1002/app.1978.070220206
   OKANO T, 1990, J CONTROL RELEASE, V11, P255, DOI 10.1016/0168-3659(90)90138-J
   OKANO T, 1993, J BIOMED MATER RES, V27, P1243, DOI 10.1002/jbm.820271005
   TAKEI YG, 1994, MACROMOLECULES, V27, P6163, DOI 10.1021/ma00099a035
   TAKEI YG, 1993, BIOCONJUGATE CHEM, V4, P42, DOI 10.1021/bc00019a006
   TAKEI YG, 1993, BIOCONJUGATE CHEM, V4, P341, DOI 10.1021/bc00023a006
   TANAKA T, 1982, SCIENCE, V218, P467, DOI 10.1126/science.218.4571.467
   YAMADA N, 1990, MAKROMOL CHEM-RAPID, V11, P571
   YOSHIDA R, 1995, NATURE, V374, P240, DOI 10.1038/374240a0
   YOSHIDA R, 1991, J BIOMAT SCI-POLYM E, V3, P155, DOI 10.1163/156856291X00250
NR 25
TC 320
Z9 326
U1 5
U2 80
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036
SN 0003-2700
J9 ANAL CHEM
JI Anal. Chem.
PD JAN 1
PY 1996
VL 68
IS 1
BP 100
EP 105
DI 10.1021/ac950359j
PG 6
WC Chemistry, Analytical
SC Chemistry
GA TN244
UT WOS:A1996TN24400018
PM 21619225
DA 2018-10-20
ER

PT J
AU Cosofret, VV
   Olson, WW
   Marzouk, SAM
   Erdosy, M
   Johnson, TA
   Buck, RP
AF Cosofret, VV
   Olson, WW
   Marzouk, SAM
   Erdosy, M
   Johnson, TA
   Buck, RP
TI Calcium selective polymeric membranes for microfabricated sensor arrays
SO ANALYTICAL LETTERS
LA English
DT Article
DE calcium planar microchemical sensor arrays; polymeric membranes;
   impedance analysis; blood interactions with sensor materials
ID PLASTICIZED POLYVINYL-CHLORIDE) PROPERTIES; VALINOMYCIN ELECTRODES; ION;
   FREQUENCY; ADHESION; MATRICES; LIFETIME
AB The potentiometric and impedance characteristics of various selective Ca2+ polymeric membranes are described and interpreted by theory and experiments for Ca2+ microfabricated sensor arrays. These are designed for further biomedical applications with an emphasis on potential in situ applications. The polymeric materials used in the present studies consist of either carboxylated PVC or aliphatic polyurethane. Both materials showed good adherence properties to the polyimide-coated Kapton substrate used in planar sensor fabrication. The impedance analysis, performed in the frequency range from 65,000 Hz to 0.1 Hz, revealed the bulk geometrical response at high frequencies. Measured R(bulk) corresponds to the unperturbed bulk resistance. That, in turn, depends on mobilities and concentrations of Ca2+ complex and mobile sites. Decreases in R(bulk) correlated well with sensor behavior during the preconditioning (hydration) period. Studies of blood interactions with these sensors proved that the main sensor characteristics (E(o), slope of the calibration curve, and reproducibility of response) are not significantly affected after 14 days of whole blood contact.
C1 UNIV N CAROLINA,DEPT MED,CHAPEL HILL,NC 27599.
RP Cosofret, VV (reprint author), UNIV N CAROLINA,DEPT CHEM,CHAPEL HILL,NC 27599, USA.
RI Marzouk, Sayed/C-6155-2011
CR BUCK RP, 1982, ION SEL ELECTRODE RE, V4, P3
   CHA GS, 1991, ANAL CHEM, V63, P1666, DOI 10.1021/ac00017a003
   COSOFRET VV, 1995, ANAL CHEM, V67, P1647, DOI 10.1021/ac00106a001
   COSOFRET VV, 1994, ANAL LETT, V27, P3039, DOI 10.1080/00032719408000310
   COSOFRET VV, 1994, ANAL CHEM, V66, P3592, DOI 10.1021/ac00093a010
   COSOFRET VV, 1994, ANALYST, V119, P2283, DOI 10.1039/an9941902283
   COSOFRET VV, 1994, TALANTA, V41, P931, DOI 10.1016/0039-9140(94)E0106-2
   COSOFRET VV, IN PRESS ANAL CHIM A
   COSOFRET VV, IN PRESS TALANTA
   COSOFRET VV, IN PRESS POLYMERIC M
   COSOFRET VV, 1994, POLYM MAT SCI ENG, V70, P137
   CUTLER SG, 1978, POLYM PREPRS AM CHEM, V19, P330
   DINTEN O, 1991, ANAL CHEM, V63, P596, DOI 10.1021/ac00006a009
   DORAZIO P, 1992, ELECTROLYTES BLOOD G, V14, P21
   DURSELEN LFJ, 1988, ANAL CHEM, V60, P1455, DOI 10.1021/ac00165a021
   Gettes LS, 1992, HEART CARDIOVASCULAR, P2021
   HARRISON DJ, 1988, J ELECTROCHEM SOC, V135, P2473, DOI 10.1149/1.2095361
   HORVAI G, 1986, ANAL CHEM, V58, P2735, DOI 10.1021/ac00126a034
   HORVAI G, 1989, ION SELECTIVE ELECTR, P397
   LADENSON JH, 1983, ANAL P, V20, P554
   LEWENSTAM A, 1991, Analytical Proceedings, V28, P106
   LI XZ, 1990, SENSOR ACTUAT B-CHEM, V1, P275, DOI 10.1016/0925-4005(90)80215-L
   LINDNER E, 1993, J CHEM SOC FARADAY T, V89, P361, DOI 10.1039/ft9938900361
   LINDNER E, 1994, J BIOMED MATER RES, V28, P591, DOI 10.1002/jbm.820280509
   LINDNER E, 1988, ANAL CHEM, V60, P295, DOI 10.1021/ac00155a004
   LINDNER E, 1993, FRESEN J ANAL CHEM, V346, P584, DOI 10.1007/BF00321250
   LIU D, 1993, ANAL CHIM ACTA, V274, P37, DOI 10.1016/0003-2670(93)80602-H
   LUNDBERG RD, 1978, POLYM PREPR AM CHEM, V19, P310
   MARCHANT RE, 1986, J BIOMED MATER RES, V20, P153, DOI 10.1002/jbm.820200205
   MEIER PC, 1980, LIQUID MEMBRANE ION, P13
   OESCH U, 1986, CLIN CHEM, V32, P1448
   PUNGOR E, 1994, PURE APPL CHEM, V51, P1913
   STATCHWILL T, 1986, J ELECTROANAL CHEM, V202, P75
   TOTH K, 1986, ANAL CHEM, V58, P2741, DOI 10.1021/ac00126a035
   TREASURE JL, 1985, CONTINUOUS MEASUREME, P297
NR 35
TC 5
Z9 5
U1 0
U2 1
PU MARCEL DEKKER INC
PI NEW YORK
PA 270 MADISON AVE, NEW YORK, NY 10016
SN 0003-2719
J9 ANAL LETT
JI Anal. Lett.
PY 1996
VL 29
IS 5
BP 725
EP 743
PG 19
WC Chemistry, Analytical
SC Chemistry
GA UC492
UT WOS:A1996UC49200006
DA 2018-10-20
ER

PT J
AU Elbert, DL
   Hubbell, JA
AF Elbert, DL
   Hubbell, JA
TI Surface treatments of polymers for biocompatibility
SO ANNUAL REVIEW OF MATERIALS SCIENCE
LA English
DT Review
DE biomaterial; peptide; saccharide; hydrogel; poly(ethylene glycol)
ID SELF-ASSEMBLED MONOLAYERS; MONOCLONAL-ANTIBODY BINDING; BLOOD-CONTACTING
   PROPERTIES; NEURONAL CELL ATTACHMENT; PROTEIN ADSORPTION; POLY(ETHYLENE
   GLYCOL); EXTRACELLULAR-MATRIX; POLYETHYLENE OXIDE; POLYURETHANE
   SURFACES; PHOSPHOLIPID POLYMERS
AB Biological recognition mediates cell and tissue interactions with biomaterials, be the materials employed in a biotechnical environment in vitro or a biomedical environment in vivo. These interactions are typically mediated by proteins that have adsorbed to the biomaterial surface. The principles of protein adsorption and biological recognition are described. Polymer surface modifications to reduce protein adsorption upon biomaterial surfaces are summarized, as are modifications to enhance the irreversible adsorption of proteins. Using these approaches, it may be possible to reduce the extent to which the biomaterial surface and the protein-biomaterial surface are recognized by cells and tissues. Polymer surface modifications to incorporate oligopeptide-, saccharide-, and oligosaccharide-based receptor-binding sequences are described to enable direct binding of cells with the polymer surface. With use of these approaches, it is possible to endow an entirely synthetic material with the biological recognition characteristics of biological macromolecules.
RP Elbert, DL (reprint author), CALTECH,DIV CHEM & CHEM ENGN,PASADENA,CA 91125, USA.
RI Hubbell, Jeffrey/A-9266-2008; Elbert, Donald/B-2040-2008
OI Hubbell, Jeffrey/0000-0003-0276-5456; Elbert, Donald/0000-0001-6480-9536
CR ADACHI N, 1994, J BIOMAT SCI-POLYM E, V6, P463
   AMIJI M, 1993, J BIOMAT SCI-POLYM E, V4, P217, DOI 10.1163/156856293X00537
   AMIJI M, 1993, J COLLOID INTERF SCI, V155, P251, DOI 10.1006/jcis.1993.1031
   AMIJI MM, 1994, J APPL POLYM SCI, V52, P539, DOI 10.1002/app.1994.070520409
   ANDRADE JD, 1986, ADV POLYM SCI, V79, P1
   BARRERA DA, 1993, J AM CHEM SOC, V115, P11010, DOI 10.1021/ja00076a077
   BARRERA DA, 1995, MACROMOLECULES, V28, P425, DOI 10.1021/ma00106a004
   BERGSTROM K, 1994, J BIOMAT SCI-POLYM E, V6, P123
   BROWN EJ, 1992, INFECT AGENT DIS, V1, P63
   BRUNSTEDT MR, 1993, J BIOMED MATER RES, V27, P367, DOI 10.1002/jbm.820270310
   BUCK CA, 1987, ANNU REV CELL BIOL, V3, P179, DOI 10.1146/annurev.cb.03.110187.001143
   BURNS NL, 1995, LANGMUIR, V11, P2768, DOI 10.1021/la00007a070
   BYUN Y, 1994, J BIOMAT SCI-POLYM E, V6, P1
   CARDIN AD, 1989, ARTERIOSCLEROSIS, V9, P21, DOI 10.1161/01.ATV.9.1.21
   CHAIKOF EL, 1992, J BIOMED MATER RES, V26, P1163, DOI 10.1002/jbm.820260906
   CHINN JA, 1992, J BIOMED MATER RES, V26, P757, DOI 10.1002/jbm.820260606
   CHO CS, 1993, J BIOMED MATER RES, V27, P199, DOI 10.1002/jbm.820270209
   CIMA LG, 1994, J CELL BIOCHEM, V56, P155, DOI 10.1002/jcb.240560206
   CINNI E, 1993, BIOMATERIALS, V14, P588
   CLAPPER DL, 1994, J CELL BIOCHEM     S, V18, P283
   DAI WG, 1994, BIO-TECHNOL, V12, P797, DOI 10.1038/nbt0894-797
   DESAI NP, 1994, ABSTR PAP AM CHEM S, V207, P8
   DIMILLA PA, 1994, J AM CHEM SOC, V116, P2225, DOI 10.1021/ja00084a105
   DRUMHELLER PD, 1994, J POLYM SCI POL CHEM, V32, P2715, DOI 10.1002/pola.1994.080321412
   DRUMHELLER PD, 1995, J BIOMED MATER RES, V29, P207, DOI 10.1002/jbm.820290211
   DRUMHELLER PD, 1994, ANAL BIOCHEM, V222, P380, DOI 10.1006/abio.1994.1506
   DRUMMOND RK, 1991, BIOMATERIALS, V12, P356, DOI 10.1016/0142-9612(91)90002-R
   ESMON CT, 1995, FASEB J, V9, P946
   FENG L, 1995, J BIOMAT SCI-POLYM E, V7, P439, DOI 10.1163/156856295X00445
   FERGUSON GS, 1993, MACROMOLECULES, V26, P5870, DOI 10.1021/ma00074a007
   FREIJLARSSON C, 1993, J APPL POLYM SCI, V50, P345, DOI 10.1002/app.1993.070500215
   FUJIMOTO K, 1993, BIOMATERIALS, V14, P442, DOI 10.1016/0142-9612(93)90147-T
   FUJIMOTO K, 1994, ACS SYM SER, V540, P228
   GEFFEN I, 1992, INT REV CYTOL, V137B, P181
   GOMBOTZ WR, 1991, J BIOMED MATER RES, V25, P1547, DOI 10.1002/jbm.820251211
   GRAF J, 1987, BIOCHEMISTRY-US, V26, P6896, DOI 10.1021/bi00396a004
   GRASEL TG, 1990, J BIOMED MATER RES, V24, P605, DOI 10.1002/jbm.820240507
   GU YJ, 1994, CELL TRANSPLANT, V3, pS19
   GUIRE PE, 1993, Patent No. 5263992
   GUTSCHE AT, 1994, BIOTECHNOL BIOENG, V43, P801, DOI 10.1002/bit.260430815
   HAN DK, 1993, J BIOMAT SCI-POLYM E, V4, P401
   Harris J.M., 1992, POLYETHYLENE GLYCOL
   HATANAKA K, 1993, MACROMOLECULES, V26, P1483, DOI 10.1021/ma00059a001
   HEALY KE, 1994, BIOTECHNOL BIOENG, V43, P792, DOI 10.1002/bit.260430814
   HORBETT TA, 1994, J BIOMAT SCI-POLYM E, V6, P15, DOI 10.1163/156856295X00724
   HUBBELL JA, 1993, CARDIOVASC PATHOL, V2, pS121
   HUBBELL JA, 1991, BIO-TECHNOL, V9, P568, DOI 10.1038/nbt0691-568
   HUBBELL JA, 1995, BIO-TECHNOL, V13, P565, DOI 10.1038/nbt0695-565
   HUBBELL JA, 1995, Patent No. 5462990
   HUMPHRIES MJ, 1990, J CELL SCI, V97, P585
   HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S
   INTVELD PJA, 1994, J POLYM SCI POL CHEM, V32, P1063, DOI 10.1002/pola.1994.080320608
   ISHIHARA K, 1995, BIOMATERIALS, V16, P873, DOI 10.1016/0142-9612(95)94150-J
   ISHIHARA K, 1994, J BIOMED MATER RES, V28, P1347, DOI 10.1002/jbm.820281113
   JACKSON RL, 1991, PHYSIOL REV, V71, P481
   JEON SI, 1991, J COLLOID INTERF SCI, V142, P159, DOI 10.1016/0021-9797(91)90044-9
   JEON SI, 1991, J COLLOID INTERF SCI, V142, P149, DOI 10.1016/0021-9797(91)90043-8
   JULIANO RL, 1993, J CELL BIOL, V120, P577, DOI 10.1083/jcb.120.3.577
   KIAEI D, 1995, J BIOMED MATER RES, V29, P729, DOI 10.1002/jbm.820290609
   KIAEI D, 1992, J BIOMAT SCI-POLYM E, V4, P35
   KIM YJ, 1994, J APPL POLYM SCI, V54, P1863, DOI 10.1002/app.1994.070541209
   KISHIDA A, 1994, BIOMATERIALS, V15, P1170, DOI 10.1016/0142-9612(94)90238-0
   KOBAYASHI K, 1994, METHOD ENZYMOL, V247, P409
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   LASIC DD, 1994, ANGEW CHEM INT EDIT, V33, P1685, DOI 10.1002/anie.199416851
   LASKY LA, 1992, SCIENCE, V258, P964, DOI 10.1126/science.1439808
   LEE JH, 1989, J BIOMED MATER RES, V23, P351, DOI 10.1002/jbm.820230306
   LEES WJ, 1994, J MED CHEM, V37, P3419, DOI 10.1021/jm00046a027
   LELLAH MD, 1986, POLYURETHANES MED
   LI S, 1995, ABSTR PAP AM CHEM S, V209, P305
   LIN HB, 1992, J BIOMAT SCI-POLYM E, V3, P217, DOI 10.1163/156856292X00132
   LLANOS GR, 1992, BIOMATERIALS, V13, P421, DOI 10.1016/0142-9612(92)90161-G
   LLANOS GR, 1993, J BIOMAT SCI-POLYM E, V4, P381
   LOFAS S, 1995, PURE APPL CHEM, V67, P829, DOI 10.1351/pac199567050829
   LOPEZ GP, 1992, J BIOMED MATER RES, V26, P415, DOI 10.1002/jbm.820260402
   LOPEZ GP, 1993, J AM CHEM SOC, V115, P5877, DOI 10.1021/ja00066a087
   MARCHANT RE, 1994, J BIOMAT SCI-POLYM E, V6, P549, DOI 10.1163/156856294X00509
   MASSIA SP, 1992, J BIOL CHEM, V267, P10133
   MASSIA SP, 1990, ANAL BIOCHEM, V187, P292, DOI 10.1016/0003-2697(90)90459-M
   MASSIA SP, 1991, J CELL BIOL, V114, P1089, DOI 10.1083/jcb.114.5.1089
   MATTHEWS KH, 1994, MAT SCI ENG C-BIOMIM, V2, P51, DOI 10.1016/0928-4931(94)90029-9
   MECHAM RP, 1991, ANNU REV CELL BIOL, V7, P71, DOI 10.1146/annurev.cellbio.7.1.71
   MERRILL EW, 1993, J BIOMAT SCI-POLYM E, V5, P1
   MOGHADDAM MJ, 1993, J POLYM SCI POL CHEM, V31, P1589, DOI 10.1002/pola.1993.080310629
   MOGHIMI SM, 1993, BIOCHIM BIOPHYS ACTA, V1179, P157, DOI 10.1016/0167-4889(93)90137-E
   MOSHER DF, 1993, CURR OPIN STRUC BIOL, V3, P214, DOI 10.1016/S0959-440X(05)80155-1
   NOJIRI C, 1992, J BIOMAT SCI-POLYM E, V4, P75
   NOMIZU M, 1995, FEBS LETT, V365, P227, DOI 10.1016/0014-5793(95)00475-O
   NORDE W, 1991, Journal of Biomaterials Science Polymer Edition, V2, P183
   OSHEA GM, 1986, DIABETES, V35, P943, DOI 10.2337/diabetes.35.8.943
   OSTERBERG E, 1995, J BIOMED MATER RES, V29, P741, DOI 10.1002/jbm.820290610
   PARK KD, 1992, J BIOMED MATER RES, V26, P739, DOI 10.1002/jbm.820260605
   PEPPAS NA, 1994, SCIENCE, V263, P1715, DOI 10.1126/science.8134835
   PLOW EF, 1995, FASEB J, V9, P939
   PRIME KL, 1993, J AM CHEM SOC, V115, P10714, DOI 10.1021/ja00076a032
   RANIERI JP, 1994, INT J DEV NEUROSCI, V12, P725, DOI 10.1016/0736-5748(94)90052-3
   RANIERI JP, 1993, J BIOMED MATER RES, V27, P917, DOI 10.1002/jbm.820270711
   REMES A, 1992, BIOMATERIALS, V13, P731, DOI 10.1016/0142-9612(92)90010-L
   REMPP P, 1991, POLYM PREPR-ACS, V32, P687
   RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619
   RUOSLAHTI E, 1986, Patent No. 4578079
   SAWHNEY AS, 1992, BIOMATERIALS, V13, P863, DOI 10.1016/0142-9612(92)90180-V
   SCHAKENRAAD JM, 1992, CELL MATER, V2, P193
   SHIN YC, 1994, J BIOMAT SCI-POLYM E, V6, P281
   SHOICHET MS, 1994, BIOTECHNOL BIOENG, V43, P563, DOI 10.1002/bit.260430705
   SILVER JH, 1995, J BIOMED MATER RES, V29, P535, DOI 10.1002/jbm.820290414
   SILVER JH, 1994, BIOMATERIALS, V15, P695, DOI 10.1016/0142-9612(94)90168-6
   SINGER II, 1988, J CELL BIOL, V106, P2171, DOI 10.1083/jcb.106.6.2171
   SINGER II, 1987, J CELL BIOL, V104, P573, DOI 10.1083/jcb.104.3.573
   SINGHVI R, 1994, SCIENCE, V264, P696, DOI 10.1126/science.8171320
   STAUFFER SR, 1992, POLYMER, V33, P3932, DOI 10.1016/0032-3861(92)90385-A
   TERLINGEN JGA, 1992, J BIOMAT SCI-POLYM E, V4, P31
   TINGEY KG, 1991, LANGMUIR, V7, P2471, DOI 10.1021/la00059a013
   TSENG YC, 1995, BIOMATERIALS, V16, P963, DOI 10.1016/0142-9612(95)94902-W
   UCHIDA E, 1994, LANGMUIR, V10, P481, DOI 10.1021/la00014a023
   UCHIDA M, 1991, MACROMOLECULES, V24, P3238, DOI 10.1021/ma00011a031
   VANALSTINE JM, 1993, COLLOID SURFACE A, V77, P149, DOI 10.1016/0927-7757(93)80111-Q
   VARKI A, 1994, P NATL ACAD SCI USA, V91, P7390, DOI 10.1073/pnas.91.16.7390
   WOJCIECHOWSKI P, 1991, Journal of Biomaterials Science Polymer Edition, V2, P203
   WOODHOUSE KA, 1994, J COLLOID INTERF SCI, V164, P40, DOI 10.1006/jcis.1994.1141
   WOODLE MC, 1992, BIOCHIM BIOPHYS ACTA, V1113, P171, DOI 10.1016/0304-4157(92)90038-C
   YAMADA KM, 1991, J BIOL CHEM, V266, P12809
   YANG Z, 1995, J AM CHEM SOC, V117, P4843, DOI 10.1021/ja00122a014
   YOON SC, 1990, MACROMOLECULES, V23, P4351, DOI 10.1021/ma00222a004
   YU XH, 1990, J APPL POLYM SCI, V41, P1777, DOI 10.1002/app.1990.070410734
NR 125
TC 389
Z9 392
U1 4
U2 152
PU ANNUAL REVIEWS INC
PI PALO ALTO
PA 4139 EL CAMINO WAY, PO BOX 10139, PALO ALTO, CA 94303-0139
SN 0084-6600
J9 ANNU REV MATER SCI
JI Annu. Rev. Mater. Sci.
PY 1996
VL 26
BP 365
EP 394
DI 10.1146/annurev.ms.26.080196.002053
PG 30
WC Materials Science, Multidisciplinary
SC Materials Science
GA VB465
UT WOS:A1996VB46500015
DA 2018-10-20
ER

PT J
AU Kalasinsky, VF
AF Kalasinsky, VF
TI Biomedical applications of infrared and Raman microscopy
SO APPLIED SPECTROSCOPY REVIEWS
LA English
DT Review
ID SINGLE LIVING CELLS; PYROPHOSPHATE DIHYDRATE DEPOSITION; FT-IR
   MICROSPECTROSCOPY; HUMAN BREAST TISSUES; SPECTROSCOPIC IDENTIFICATION;
   URINARY CALCULI; KIDNEY-STONE; SPATIAL-RESOLUTION; IMAGING MICROSCOPY;
   FOREIGN MATERIALS
RP Kalasinsky, VF (reprint author), ARMED FORCES INST PATHOL,DEPT ENVIRONM & TOXICOL PATHOL,WASHINGTON,DC 20306, USA.
CR ABRAHAM JL, 1979, SCIENCE, V206, P716, DOI 10.1126/science.493979
   ADAR F, 1988, MICROCHEM J, V38, P50, DOI 10.1016/0026-265X(88)90004-5
   ALBIN M, 1993, ANAL CHEM, V65, pA489, DOI 10.1021/ac00058a002
   ANDERSEN ME, 1981, ANAL CHEM, V53, P1772, DOI 10.1021/ac00235a013
   ASHER SA, 1993, ANAL CHEM, V65, pA59, DOI 10.1021/ac00052a715
   ASSELIN KJ, 1994, APPL SPECTROSC, V48, P699, DOI 10.1366/000370294774369009
   BAEK M, 1988, APPL SPECTROSC, V42, P1312, DOI 10.1366/0003702884430010
   BARAGA JJ, 1992, P NATL ACAD SCI USA, V89, P3473, DOI 10.1073/pnas.89.8.3473
   BARER R, 1949, NATURE, V163, P198, DOI 10.1038/163198a0
   BARRY B, 1982, J CELL BIOL, V94, P479, DOI 10.1083/jcb.94.2.479
   BARTICK EG, 1985, APPL SPECTROSC, V39, P885, DOI 10.1366/0003702854249961
   BENEDETTI E, 1986, APPL SPECTROSC, V40, P39, DOI 10.1366/0003702864815565
   BENEDETTI E, 1990, APPL SPECTROSC, V44, P1276, DOI 10.1366/000370290789619621
   BLAHA JJ, 1978, ANAL CHEM, V50, P892, DOI 10.1021/ac50029a018
   BLAHA JJ, 1981, VIB SPECTRA STRUCT, V10, P227
   BOT ACC, 1989, EXP EYE RES, V49, P161, DOI 10.1016/0014-4835(89)90086-9
   BROWN PR, 1990, ANAL CHEM, V62, pA995, DOI 10.1021/ac00218a001
   BUITEVELD H, 1984, APPL SPECTROSC, V38, P304, DOI 10.1366/0003702844555520
   CAI MZ, 1989, EXP EYE RES, V49, P531, DOI 10.1016/S0014-4835(89)80052-1
   CAMPION A, 1988, J AM CHEM SOC, V110, P408
   CASSIS LA, 1993, ANAL CHEM, V65, P1247, DOI 10.1021/ac00057a023
   CENTENO JA, 1993, APPL SPECTROSC, V47, P341, DOI 10.1366/0003702934066613
   CENTENO JA, 1992, LAB INVEST, V66, P123
   CENTENO JA, 1994, APPL SPECTROSC, V48, P569, DOI 10.1366/0003702944924745
   CENTENO JA, 1995, PLAST RECONSTR SURG, V20
   Chang RK, 1982, SURFACE ENHANCED RAM
   Chase DB, 1994, FOURIER TRANSFORM RA
   CHOO LP, 1993, BIOCHIM BIOPHYS ACTA, V1182, P333, DOI 10.1016/0925-4439(93)90078-F
   CLARK RJH, 1986, ADV INFRARED RAMAN S
   CLARKE RH, 1987, APPL OPTICS, V26, P3175, DOI 10.1364/AO.26.003175
   Coates V. J., 1953, J OPT SOC AM, V47, P984
   Colthup N. B., 1990, INTRO INFRARED RAMAN
   CRAMERS CA, 1988, CRIT REV ANAL CHEM, V20, P117, DOI 10.1080/00078988808048809
   DALTERIO RA, 1987, APPL SPECTROSC, V41, P241, DOI 10.1366/000370287774986732
   DALTERIO RA, 1986, APPL SPECTROSC, V40, P271, DOI 10.1366/0003702864509484
   DAUDON M, 1983, KIDNEY INT, V23, P842, DOI 10.1038/ki.1983.104
   DELAGE C, 1973, ARCH DERMATOL, V108, P104, DOI 10.1001/archderm.1973.01620220066018
   DELHAYE M, 1975, J RAMAN SPECTROSC, V3, P33, DOI 10.1002/jrs.1250030105
   DEMUL FFM, 1984, HUM PATHOL, V15, P1062, DOI 10.1016/S0046-8177(84)80250-6
   DHAMELINCOURT P, 1979, ANAL CHEM, V51, pA414, DOI 10.1021/ac50039a002
   DONG A, 1987, BIOCHEM BIOPH RES CO, V156, P752
   ETZ ES, 1979, SCANNING ELECTRON MI, V1, P67
   FABIAN H, 1993, APPL SPECTROSC, V47, P1513, DOI 10.1366/0003702934067469
   FABIAN H, 1993, VIB SPECTROSC, V4, P125, DOI 10.1016/0924-2031(93)87032-O
   FENTON JJ, 1995, ARCH PATHOL, V20
   FRANK CJ, 1994, ANAL CHEM, V66, P319, DOI 10.1021/ac00075a002
   FRANK CJ, 1993, APPL SPECTROSC, V47, P387, DOI 10.1366/0003702934334958
   FRICK R, 1973, BEITR PATHOL, V149, P39, DOI 10.1016/S0005-8165(73)80123-4
   GAYOU RM, 1979, PLAST RECONSTR SURG, V63, P700, DOI 10.1097/00006534-197905000-00015
   GERRARD DL, 1986, APPL SPECTROSC REV, V22, P251, DOI 10.1080/05704928608070179
   GERSON DJ, 1988, INFRARED MICROSPECTR, P73
   Grasselli J, 1981, CHEM APPL RAMAN SPEC
   Grasselli J. G., 1991, ANAL RAMAN SPECTROSC
   GRIFFITHS PR, 1986, FOURIER TRANSFORM IN
   HARDT NS, 1994, MODERN PATHOL, V7, P669
   HARTHCOCK MA, 1988, APPL SPECTROSC, V42, P449, DOI 10.1366/0003702884427780
   HARTHCOCK MA, 1988, INFRARED MICROSPECTR, P21
   HONG TDN, 1992, CLIN CHEM, V38, P292
   HUIZINGA A, 1989, EXP EYE RES, V48, P487, DOI 10.1016/0014-4835(89)90032-8
   Humecki H.J., 1995, PRACTICAL GUIDE INFR
   HUONG PV, 1991, ANAL RAMAN SPECTROSC, P397
   ISHIDA H, 1987, APPL SPECTROSC, V41, P407, DOI 10.1366/0003702874448779
   JOHNSON FR, UNPUB
   KALASINSKY KS, 1994, J ANAL TOXICOL, V18, P337, DOI 10.1093/jat/18.6.337
   KALASINSKY KS, 1993, FORENSIC SCI INT, V63, P253, DOI 10.1016/0379-0738(93)90278-I
   KATON JE, 1986, ANAL CHEM, V58, pA465, DOI 10.1021/ac00294a002
   KEEN CE, 1991, HISTOPATHOLOGY, V19, P529, DOI 10.1111/j.1365-2559.1991.tb01501.x
   KESSLER DA, 1992, NEW ENGL J MED, V326, P1713, DOI 10.1056/NEJM199206183262525
   KLUG DD, 1992, LASER SURG MED, V12, P13, DOI 10.1002/lsm.1900120105
   KODALI DR, 1991, APPL SPECTROSC, V45, P1310, DOI 10.1366/0003702914335878
   KODATI VR, 1990, APPL SPECTROSC, V44, P1134, DOI 10.1366/0003702904086470
   KODATI VR, 1993, APPL SPECTROSC, V47, P334, DOI 10.1366/0003702934066604
   KODATI VR, 1991, APPL SPECTROSC, V45, P581, DOI 10.1366/0003702914336859
   KODATI VR, 1990, APPL SPECTROSC, V44, P1408, DOI 10.1366/000370290789619405
   KODATI VR, 1990, APPL SPECTROSC, V44, P837, DOI 10.1366/0003702904087181
   KOSSOVSKY N, 1992, AM J CLIN PATHOL, V97, P34
   LEVIN IW, 1984, ADV INFRARED RAMAN S, V11, pCH1
   LEVINE SM, 1994, INT J DEV NEUROSCI, V12, P275, DOI 10.1016/0736-5748(94)90075-2
   LEVINE SM, 1994, AM J PATHOL, V145, P1041
   LEVINE SM, 1993, APPL SPECTROSC REV, V28, P385, DOI 10.1080/05704929308018117
   LEVINE SM, 1994, NEUROPROTOCOLS, V5, P63
   LEWIS EN, 1988, APPL SPECTROSC, V42, P1188, DOI 10.1366/0003702884429850
   LEWIS EN, 1995, APPL SPECTROSC, V49, P672, DOI 10.1366/0003702953964066
   LEWIS EN, 1988, ANAL CHEM, V60, P2658, DOI 10.1021/ac00175a002
   LOPPNOW GR, 1989, P NATL ACAD SCI USA, V86, P1515, DOI 10.1073/pnas.86.5.1515
   LUKE JL, UNPUB
   MARTOJA R, 1982, CR ACAD SCI III-VIE, V295, P369
   MARTOJA R, 1981, CR ACAD SCI III-VIE, V292, P857
   MAUGARS YM, 1994, J RHEUMATOL, V21, P573
   MCGILL N, 1991, LANCET, V337, P77, DOI 10.1016/0140-6736(91)90738-B
   MENDELSOHN R, 1989, CALCIFIED TISSUE INT, V44, P20, DOI 10.1007/BF02556236
   Messerschmidt R. G., 1988, INFRARED MICROSPECTR
   MESSERSCHMIDT RG, 1989, APPL SPECTROSC, V43, P11, DOI 10.1366/0003702894201761
   MESSERSCHMIDT RG, 1988, INFRARED MICROSPECTR, P1
   MORRIS HR, 1994, APPL SPECTROSC, V48, P857, DOI 10.1366/0003702944029820
   OLEARY TJ, 1989, APPL SPECTROSC, V43, P1095, DOI 10.1366/0003702894203994
   Osborne B. G., 1986, NEAR INFRARED SPECTR
   OZAKI Y, 1988, APPL SPECTROSC REV, V24, P259, DOI 10.1080/05704928808060459
   PALLISTER DM, 1994, APPL SPECTROSC, V48, P1277, DOI 10.1366/0003702944027480
   PELL RJ, 1993, APPL SPECTROSC, V47, P634, DOI 10.1366/0003702934067126
   PUPPELS GJ, 1991, EXP CELL RES, V195, P361, DOI 10.1016/0014-4827(91)90385-8
   PUPPELS GJ, 1991, BIOPHYS J, V60, P1046, DOI 10.1016/S0006-3495(91)82142-7
   PUPPELS GJ, 1993, APPL SPECTROSC, V47, P1256, DOI 10.1366/0003702934068017
   PUPPELS GJ, 1990, NATURE, V347, P301, DOI 10.1038/347301a0
   REDD DCB, 1993, APPL SPECTROSC, V47, P787, DOI 10.1366/0003702934067072
   REFFNER JA, 1995, REV SCI INSTRUM, V66, P1298, DOI 10.1063/1.1145958
   Rochow TG, 1994, INTRO MICROSCOPY MEA
   ROSASCO GJ, 1975, APPL SPECTROSC, V29, P396, DOI 10.1366/000370275774455752
   ROSASCO GJ, 1975, SCIENCE, V190, P557, DOI 10.1126/science.190.4214.557
   ROSASCO GT, 1981, ADV INFRARED RAMAN S, V7, P223
   SCHMID ED, 1988, SPECTROSCOPY BIOL MO
   SCHRADER B, 1973, ANGEW CHEM INT EDIT, V12, P884, DOI 10.1002/anie.197308841
   SCHWAB SD, 1984, ANAL CHEM, V56, P2199, DOI 10.1021/ac00276a049
   SHEARER JC, 1983, ANAL CHEM, V55, pA874, DOI 10.1021/ac00259a002
   SHUNSHIN GD, 1993, INVEST OPHTH VIS SCI, V34, P3489
   SIEBINGA I, 1991, EXP EYE RES, V53, P233, DOI 10.1016/0014-4835(91)90079-T
   SMAHEL J, 1979, BRIT J PLAST SURG, V32, P35, DOI 10.1016/0007-1226(79)90058-4
   SMAHEL J, 1978, MATER TECHNOL, V6, P51
   Smith A., 1979, APPL INFRARED SPECTR
   SOMMER AJ, 1991, APPL SPECTROSC, V45, P1633, DOI 10.1366/0003702914335229
   SUDLOW K, 1991, CLIN CHIM ACTA, V203, P387, DOI 10.1016/0009-8981(91)90313-2
   SUREAU F, 1990, APPL SPECTROSC, V44, P1047, DOI 10.1366/0003702904086920
   Thomas GJ, 1986, BIOMOLECULAR STEREOD, VIV, P227
   TODD EA, 1994, APPL SPECTROSC, V48, P545, DOI 10.1366/0003702944924790
   TOMAZIC BB, 1987, SCANNING MICROSCOPY, V1, P95
   TREADO PJ, 1990, APPL SPECTROSC, V44, P1, DOI 10.1366/0003702904085714
   TREADO PJ, 1992, APPL SPECTROSC, V46, P553, DOI 10.1366/0003702924125032
   TREADO PJ, 1994, APPL SPECTROSC, V48, P607, DOI 10.1366/0003702944924899
   TUNGOL MW, 1993, APPL SPECTROSC, V47, P1655, DOI 10.1366/0003702934334552
   WALLON J, 1994, APPL SPECTROSC, V48, P190, DOI 10.1366/0003702944028542
   Wetzel D. L., 1993, SPECTROSCOPY, V8, P40
   WISHNOK JS, 1992, ANAL CHEM, V64, pA1126, DOI 10.1021/ac00047a002
   WONG PTT, 1990, APPL SPECTROSC, V44, P1715, DOI 10.1366/0003702904417481
   WONG PTT, 1993, APPL SPECTROSC, V47, P1830, DOI 10.1366/0003702934065885
   WONG PTT, 1991, P NATL ACAD SCI USA, V88, P10988, DOI 10.1073/pnas.88.24.10988
   WONG PTT, 1993, APPL SPECTROSC, V47, P1058, DOI 10.1366/0003702934415291
   WOPENKA B, 1987, ANAL CHEM, V59, P2165, DOI 10.1021/ac00144a034
   WOPENKA B, 1986, APPL SPECTROSC, V40, P144, DOI 10.1366/0003702864509592
   ZHENG SD, 1987, APPL SPECTROSC, V41, P696, DOI 10.1366/0003702874448661
NR 139
TC 28
Z9 28
U1 1
U2 7
PU MARCEL DEKKER INC
PI NEW YORK
PA 270 MADISON AVE, NEW YORK, NY 10016
SN 0570-4928
J9 APPL SPECTROSC REV
JI Appl. Spectrosc. Rev.
PY 1996
VL 31
IS 3
BP 193
EP 249
DI 10.1080/05704929608000570
PG 57
WC Instruments & Instrumentation; Spectroscopy
SC Instruments & Instrumentation; Spectroscopy
GA VK885
UT WOS:A1996VK88500002
DA 2018-10-20
ER

PT B
AU Rubio, M
AF Rubio, M
BE Burattini, E
   Balerna, A
TI Trace and ultra trace element analysis in biomedical materials
SO BIOMEDICAL APPLICATIONS OF SYNCHROTRON RADIATION
SE PROCEEDINGS OF THE INTERNATIONAL SCHOOL OF PHYSICS ENRICO FERMI
LA English
DT Proceedings Paper
CT 128th Course of the International-School-of-Physics-Enrico-Fermi -
   Biomedical Applications of Synchrotron Radiation
CY JUL 12-22, 1994
CL VARENNA, ITALY
SP Italian Phys Soc
C1 NATL UNIV CORDOBA,FAC MATEMAT ASTRON & FIS,RA-5000 CORDOBA,ARGENTINA.
NR 0
TC 1
Z9 1
U1 0
U2 0
PU I O S PRESS
PI AMSTERDAM
PA VAN DIEMENSTRAAT 94, 1013 CN AMSTERDAM, NETHERLANDS
BN 90-5199-248-3
J9 P INT SCH PHYS
PY 1996
VL 128
BP 313
EP 332
PG 20
WC Physics, Condensed Matter; Radiology, Nuclear Medicine & Medical Imaging
SC Physics; Radiology, Nuclear Medicine & Medical Imaging
GA BF38L
UT WOS:A1996BF38L00018
DA 2018-10-20
ER

PT B
AU Denisov, NA
   Dets, SM
   Kravchenko, IV
AF Denisov, NA
   Dets, SM
   Kravchenko, IV
BE Croitoru, NI
   Frenz, M
   King, TA
   Pratesi, R
   Scheggi, AMV
   Seeger, S
   Wolfbeis, OS
   Katzir, A
TI Tapered fiber optics sensors for laser medicine
SO BIOMEDICAL SYSTEMS AND TECHNOLOGIES, PROCEEDINGS OF
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Conference on Biomedical Systems and Technologies
CY SEP 08-10, 1996
CL VIENNA, AUSTRIA
SP Laser Vis, European Laser Assoc, Int Biomed Opt Soc, European Opt Soc, Soc Photo Opt Instrumentat Engineers, Commiss European Communities, Directorate Gen Sci Res & Dev
DE fiber optics sensor; tapered tip; light collector; optical coupling
AB Biomedical science and practical medicine need special techniques for reliable real-time remote detection and determination information from human tissue. Most applications of these techniques in interior organs are based on optical fibers which should not only be able to deliver excitation light with minimal loss but provide effective light gathering from tissue being under the test. As emitted from tissue optical signal is often weak especially if autofluorescence spectroscopy is chosen for diagnostics, an efficient collection by fiber optics probe became essential. The main part of proposed fiber optics probes is specially designed tapered tip with one nat surface and another spherical one. This tip operates as a collector, transmitter and coupler to deliver light to the tissue and backward to the detector simultaneously. To find geometrical dimensions of tips optimized for these purposes calculating formulas have been adduced. These optimized tips could collect fluorescence signal from biological sites in wide angular aperture region and could transport light without leakage on tapered surface. When delivery fibers are placed at the focal plane of tip spherical surface an efficient optical coupling with them is achieved. Ray tracing of the tapered tips has been performed on sapphire and quartz tip materials in air and in saline to determine the best sensor design.
RP Denisov, NA (reprint author), NATL ACAD SCI UKRAINE,DEPT OPT ENGN,UA-252056 KIEV,UKRAINE.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU SPIE - INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA PO BOX 10, BELLINGHAM, WA 98227-0010
BN 0-8194-2330-0
J9 P SOC PHOTO-OPT INS
PY 1996
VL 2928
BP 165
EP 174
DI 10.1117/12.259958
PG 10
WC Biochemistry & Molecular Biology; Medicine, Research & Experimental;
   Optics
SC Biochemistry & Molecular Biology; Research & Experimental Medicine;
   Optics
GA BG97A
UT WOS:A1996BG97A00019
DA 2018-10-20
ER

PT S
AU Tsuruta, T
AF Tsuruta, T
TI Contemporary topics in polymeric materials for biomedical applications
SO BIOPOLYMERS LIQUID CRYSTALLINE POLYMERS PHASE EMULSION
SE Advances in Polymer Science
LA English
DT Review
ID POLY(2-HYDROXYETHYL METHACRYLATE) POLYAMINE; POLYETHER
   POLY(URETHANEUREA) ELASTOMERS; SULFONATE-CONTAINING POLYURETHANES;
   LACTOSE-CARRYING POLYSTYRENE; POLY(ETHER URETHANE UREAS);
   BLOCK-COPOLYMER SURFACES; CELL ATTACHMENT ACTIVITY; PHOSPHOLIPID POLAR
   GROUP; SOFT SEGMENT CHEMISTRY; RANDOM NETWORK MODEL
AB Contemporary topics in polymeric materials for biomedical applications are reviewed, with the emphasis on the modes of interaction of water soluble polymers as well as their conjugates, and those of microdomain-structured polymers with proteins and cells. The nature of biocompatibility of these polymer surfaces is discussed in terms of the random-network concept of water molecules on the polymer surface. Several recent studies on biohybridized and biomimicking materials are also reviewed.
RP Tsuruta, T (reprint author), SCI UNIV TOKYO, FAC ENGN, DEPT IND CHEM, SHINJUKU KU, 1-2 KAGURAZAKA, TOKYO 162, JAPAN.
CR AKAIKE T, 1993, GASTROENTEROL JPN, V28, P45
   AKAIKE T, 1993, NEW FUNCTIONALITY B, P303
   ALBERTSSON PA, 1986, PARTITION CELL PARTI
   AMIJI M, 1993, J BIOMAT SCI-POLYM E, V4, P217, DOI 10.1163/156856293X00537
   ANDRADE JD, 1979, J COLLOID INTERF SCI, V72, P488, DOI 10.1016/0021-9797(79)90350-3
   BAMFORD CH, 1989, J BIOMAT SCI-POLYM E, V1, P1
   BEER JH, 1992, BLOOD, V79, P117
   BELCH AC, 1983, J CHEM PHYS, V78, P4817, DOI 10.1063/1.445416
   BERG JC, 1993, WETTABILITY, V49, P75
   BERGSTROM K, 1992, J BIOMED MATER RES, V26, P779, DOI 10.1002/jbm.820260607
   BIGELOW JC, 1989, J IMMUNOL METHODS, V117, P289, DOI 10.1016/0022-1759(89)90152-X
   BRANDLEY BK, 1988, ANAL BIOCHEM, V172, P270, DOI 10.1016/0003-2697(88)90442-3
   BROWN EJ, 1988, J EXP MED, V167, P777, DOI 10.1084/jem.167.3.777
   BRUNSTEDT MR, 1993, J BIOMED MATER RES, V27, P255, DOI 10.1002/jbm.820270216
   BRUNSTEDT MR, 1993, J BIOMED MATER RES, V27, P367, DOI 10.1002/jbm.820270310
   CHAIKOF EL, 1992, J BIOMED MATER RES, V26, P1163, DOI 10.1002/jbm.820260906
   CHEN GH, 1994, J BIOMAT SCI-POLYM E, V5, P371
   COLE CA, 1988, T 3 WORLD BIOM C, V11, P299
   COSTELLO CA, 1987, MACROMOLECULES, V20, P2819, DOI 10.1021/ma00177a030
   DEDHAR S, 1987, J CELL BIOL, V104, P585, DOI 10.1083/jcb.104.3.585
   DEJANA E, 1988, J CELL BIOL, V107, P1215, DOI 10.1083/jcb.107.3.1215
   DESAI NP, 1991, J BIOMED MATER RES, V25, P829, DOI 10.1002/jbm.820250704
   DRAGO RS, 1987, INORG CHEM, V26, P9, DOI 10.1021/ic00248a003
   DRAGO RS, 1971, J AM CHEM SOC, V93, P6014, DOI 10.1021/ja00752a010
   DRUMHELLER PD, 1991, T 17 M SOC BIOM, V14, P239
   FABRIZIUSHOMAN DJ, 1991, J BIOMED MATER RES, V25, P953, DOI 10.1002/jbm.820250804
   FABRIZIUSHOMAN DJ, 1991, J BIOMAT SCI-POLYM E, V3, P27, DOI 10.1163/156856292X00060
   FOWKES FM, 1990, J ADHES SCI TECHNOL, V4, P669, DOI 10.1163/156856190X00595
   FUJIMOTO K, 1993, J BIOMED MATER RES, V27, P1559, DOI 10.1002/jbm.820271213
   GOODMAN SL, 1993, J BIOMED MATER RES, V27, P683, DOI 10.1002/jbm.820270516
   GOTO M, 1994, J CONTROL RELEASE, V28, P223
   GRAINGER DW, 1990, J BIOMED MATER RES, V24, P403, DOI 10.1002/jbm.820240402
   GREEN JL, 1986, J PHYS CHEM-US, V90, P3958, DOI 10.1021/j100408a027
   GREEN JL, 1987, J CHEM PHYS, V86, P1841, DOI 10.1063/1.452136
   GRESHAM HD, 1989, J CELL BIOL, V108, P1935, DOI 10.1083/jcb.108.5.1935
   HAN DK, 1993, J BIOMAT SCI-POLYM E, V4, P401
   HAN DK, 1993, J BIOMAT SCI-POLYM E, V4, P579
   HARE DE, 1992, J CHEM PHYS, V96, P13, DOI 10.1063/1.462852
   HAUTANEN A, 1989, J BIOL CHEM, V264, P1437
   HAYMAN EG, 1985, J CELL BIOL, V100, P1948, DOI 10.1083/jcb.100.6.1948
   HERRING M, 1978, SURGERY, V84, P498
   Heskins M., 1968, J MACROMOL SCI CHEM, V2, P1441, DOI [10.1080/10601326808051910, DOI 10.1080/10601326808051910]
   HIRANO Y, 1993, J BIOMAT SCI-POLYM E, V4, P235, DOI 10.1163/156856293X00546
   HIRANO Y, 1991, J BIOMED MATER RES, V25, P1523, DOI 10.1002/jbm.820251209
   HIRAO A, 1986, MACROMOLECULES, V19, P1294, DOI 10.1021/ma00159a002
   HOLMESFARLEY SR, 1988, LANGMUIR, V4, P921, DOI 10.1021/la00082a025
   Ikada Y., 1985, POLYM BIOMATERIALS, P135
   IMAI Y, 1972, KOBUNSHI, V21, P569
   IMAI Y, 1973, JPN J ARTIF ORGANS, V2, P95
   IMANISHI Y, 1988, J MACROMOL SCI CHEM, VA25, P555, DOI 10.1080/00222338808053384
   ISHIHARA K, 1992, J BIOMED MATER RES, V26, P1543, DOI 10.1002/jbm.820261202
   ISHIHARA K, 1994, J BIOMED MATER RES, V28, P225, DOI 10.1002/jbm.820280213
   ISHIHARA K, 1993, J BIOMED MATER RES, V27, P1309, DOI 10.1002/jbm.820271011
   ITO Y, 1991, J BIOMED MATER RES, V25, P1325, DOI 10.1002/jbm.820251102
   ITO Y, 1991, J BIOMED MATER RES, V25, P1347, DOI 10.1002/jbm.820251104
   JVAN S, 1991, J BIOMAT SCI-POLYM E, V2, P91
   KASUYA Y, 1993, J BIOMAT SCI-POLYM E, V4, P369, DOI 10.1163/156856293X00636
   KASUYA Y, 1994, J BIOMED MATER RES, V28, P397, DOI 10.1002/jbm.820280315
   KATAOKA K, 1980, J BIOMED MATER RES, V14, P817, DOI 10.1002/jbm.820140613
   KATAOKA K, 1988, BIOMATERIALS, V9, P218, DOI 10.1016/0142-9612(88)90087-7
   KATAOKA K, 1993, J CONTROL RELEASE, V24, P119
   KATAOKA K, 1982, BIOMATERIALS, V3, P237, DOI 10.1016/0142-9612(82)90026-6
   KATAOKA K, 1980, MAKROMOL CHEM, V181, P1363
   KATAOKA K, 1978, MAKROMOL CHEM, V179, P1121
   KATAOKA K, 1983, EUR POLYM J, V19, P979, DOI 10.1016/0014-3057(83)90060-5
   KATAOKA K, 1982, MAKROMOL CHEM-RAPID, V3, P275
   KATAOKA K, 1991, KOBUNSHI RONBUNSHU, V48, P201, DOI 10.1295/koron.48.201
   KIKUCHI A, 1993, J COLLOID INTERF SCI, V158, P10, DOI 10.1006/jcis.1993.1222
   KIKUCHI A, 1992, Japanese Journal of Artificial Organs, V21, P1212
   KIKUCHI A, 1992, J BIOMAT SCI-POLYM E, V3, P355, DOI 10.1163/156856292X00187
   KIKUCHI A, 1988, JPN J ARTIF ORGANS, V17, P487
   KIKUCHI A, 1991, POLYM ADVAN TECHNOL, V2, P245
   KIKUHCI A, 1993, ARTIFICIAL HEART, V4, P29
   KOBAYASHI A, 1994, J BIOMAT SCI-POLYM E, V6, P325, DOI 10.1163/156856295X00030
   KOBAYASHI A, 1992, J BIOMAT SCI-POLYM E, V3, P499, DOI 10.1163/156856292X00466
   Kobayashi Kazukiyo, 1994, P261
   KUGO K, 1994, J BIOMAT SCI-POLYM E, V5, P325, DOI 10.1163/156856294X00059
   KUGUMIYA T, 1992, J BIOACT COMPAT POL, V7, P337, DOI 10.1177/088391159200700403
   LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X
   LIN HB, 1994, J BIOMED MATER RES, V28, P329, DOI 10.1002/jbm.820280307
   LIN SC, 1991, J BIOMED MATER RES, V25, P791, DOI 10.1002/jbm.820250608
   LIU S Q, 1989, Journal of Biomaterials Science Polymer Edition, V1, P111
   LIU SQ, 1993, J BIOMED MATER RES, V27, P909, DOI 10.1002/jbm.820270710
   LLANOS GR, 1993, J BIOMAT SCI-POLYM E, V4, P381
   LYMAN DJ, 1972, T AM SOC ART INT ORG, V18, P19
   MAEDA T, 1991, P 11 TAN C POL RES K, P45
   MAEDA Y, 1993, J PHYS CHEM-US, V97, P13903, DOI 10.1021/j100153a073
   MALCOLM GN, 1957, T FARADAY SOC, V53, P921, DOI 10.1039/tf9575300921
   MARUYAMA A, 1986, MAKROMOL CHEM, V187, P1895
   MARUYAMA A, 1988, J BIOMED MATER RES, V22, P555, DOI 10.1002/jbm.820220610
   MARUYAMA A, 1988, BIOMATERIALS, V9, P471, DOI 10.1016/0142-9612(88)90041-5
   MARUYAMA A, 1989, BIOMATERIALS, V10, P291, DOI 10.1016/0142-9612(89)90068-9
   MARUYAMA A, 1987, MAKROMOL CHEM-RAPID, V8, P27
   MASSIA SP, 1990, ANN NY ACAD SCI, V589, P261, DOI 10.1111/j.1749-6632.1990.tb24251.x
   MASSIA SP, 1990, ANAL BIOCHEM, V187, P292, DOI 10.1016/0003-2697(90)90459-M
   MASSIA SP, 1991, J CELL BIOL, V114, P1089, DOI 10.1083/jcb.114.5.1089
   MASSIA SP, 1991, J BIOMED MATER RES, V25, P223, DOI 10.1002/jbm.820250209
   MASSIA SP, 1991, T 17 M SOC BIOM, V14, P238
   MATSUDA T, 1989, T AM SOC ART INT ORG, V35, P677
   MATSUO ES, 1988, J CHEM PHYS, V89, P1695, DOI 10.1063/1.455115
   MIYAMOTO M, 1989, VOX SANG, V57, P164, DOI 10.1111/j.1423-0410.1989.tb00815.x
   MONJI N, 1994, J BIOMAT SCI-POLYM E, V5, P407, DOI 10.1163/156856294X00112
   MONJI N, 1988, T 3 WORLD BIOMATER C, V11, P298
   NABESHIMA Y, 1989, Journal of Biomaterials Science Polymer Edition, V1, P85
   NABESHIMA Y, 1987, POLYM J, V19, P593, DOI 10.1295/polymj.19.593
   NICOL A, 1992, J BIOMED MATER RES, V26, P393, DOI 10.1002/jbm.820260309
   NICOL A, 1993, J BIOMED MATER RES, V27, P801, DOI 10.1002/jbm.820270613
   NILSSON K, 1981, BIOCHEM BIOPH RES CO, V102, P449, DOI 10.1016/0006-291X(81)91541-2
   NISHIMURA T, 1980, MAKROMOL CHEM-RAPID, V1, P573
   NISHIMURA T, 1982, MAKROMOL CHEM, V183, P29
   NISHIMURA T, 1988, T 3 WORLD BIOM C, V11, P481
   NITADORI Y, 1979, MAKROMOL CHEM, V180, P1877
   NOGUCHI Y, 1991, J IMMUNOL, V146, P3599
   NOJIRI C, 1990, J BIOMED MATER RES, V24, P1151, DOI 10.1002/jbm.820240903
   NOJIRI C, 1992, J BIOMAT SCI-POLYM E, V4, P75
   NOJIRI C, 1993, ARTIFICIAL HEART, P53
   OHGAWARA H, 1994, CELL TRANSPLANT, V3, P83
   OHLSON S, 1978, FEBS LETT, V93, P5, DOI 10.1016/0014-5793(78)80792-3
   OKANO T, 1993, J BIOMED MATER RES, V27, P1519, DOI 10.1002/jbm.820271208
   OKANO T, 1978, J APPL POLYM SCI, V22, P369, DOI 10.1002/app.1978.070220206
   OKANO T, 1981, J BIOMED MATER RES, V15, P393, DOI 10.1002/jbm.820150310
   OKANO T, 1977, NIPPON KAGAKU KAISHI, P88, DOI 10.1246/nikkashi.1977.88
   OKANO T, 1993, J BIOMED MATER RES, V27, P1243, DOI 10.1002/jbm.820271005
   OKANO T, 1979, JPN J ARTIF ORGANS, V8, P292
   OKANO T, 1994, JAPANESE TECHNOLOGY, V4, P67
   OKKEMA A Z, 1989, Journal of Biomaterials Science Polymer Edition, V1, P43, DOI 10.1163/156856289X00055
   OKKEMA AZ, 1991, J BIOMED MATER RES, V25, P1371, DOI 10.1002/jbm.820251106
   PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0
   PIERSCHBACHER MD, 1984, P NATL ACAD SCI-BIOL, V81, P5985, DOI 10.1073/pnas.81.19.5985
   PLOW EF, 1985, P NATL ACAD SCI USA, V82, P8057, DOI 10.1073/pnas.82.23.8057
   PYTELA R, 1985, P NATL ACAD SCI USA, V82, P5766, DOI 10.1073/pnas.82.17.5766
   RATNER BD, 1988, J BIOMED MATER RES, V22, P509, DOI 10.1002/jbm.820220607
   RENIER M, 1993, J BIOMAT SCI-POLYM E, V5, P231
   RICE SA, 1981, J PHYS CHEM-US, V85, P1108, DOI 10.1021/j150609a009
   RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619
   SANTERRE JP, 1992, J BIOMED MATER RES, V26, P39, DOI 10.1002/jbm.820260105
   SHAREFKIN JB, 1982, SURGERY, V92, P385
   SHIBATA S, 1990, DRUG DELIVERY SYSTEM, V7, P109
   SILVER JH, 1993, J BIOMED MATER RES, V27, P735, DOI 10.1002/jbm.820270606
   SILVER JH, 1993, J BIOMED MATER RES, V27, P1443, DOI 10.1002/jbm.820271111
   STANISLAWSKI L, 1993, J BIOMED MATER RES, V27, P619, DOI 10.1002/jbm.820270509
   STANLEY JC, 1982, SURGERY, V92, P994
   STEELE JG, 1992, J BIOMED MATER RES, V26, P861, DOI 10.1002/jbm.820260704
   STILLINGER FH, 1980, SCIENCE, V209, P451, DOI 10.1126/science.209.4455.451
   SUNAMOTO J, 1992, MACROMOLECULES, V25, P5665, DOI 10.1021/ma00047a017
   SUNAMOTO J, 1993, NEW FUNCTIONALITY MA, P203
   SUNG CSP, 1981, MACROMOLECULES, V14, P212, DOI 10.1021/ma50002a047
   Taira H., 1994, Japanese Journal of Artificial Organs, V23, P695
   TAKAHARA A, 1982, KOBUNSHI RONBUNSHU, V39, P203, DOI 10.1295/koron.39.203
   TAKAHARA A, 1991, J BIOMED MATER RES, V25, P341, DOI 10.1002/jbm.820250306
   TAKAHARA A, 1991, J BIOMED MATER RES, V25, P1095, DOI 10.1002/jbm.820250905
   TAKAHARA A, 1993, J BIOMAT SCI-POLYM E, V5, P183
   TAKAHARA A, 1992, J BIOMED MATER RES, V26, P801, DOI 10.1002/jbm.820260609
   TAKAHARA A, 1992, KOBUNSHI RONBUNSHU, V49, P275, DOI 10.1295/koron.49.275
   TAKAHARA A, 1991, ARTIFICIAL HEART, V3, P77
   TAKEI YG, 1994, J BIOMAT SCI-POLYM E, V6, P149
   TAMADA Y, 1993, J COLLOID INTERF SCI, V155, P334, DOI 10.1006/jcis.1993.1044
   TAMADA Y, 1993, POLYMER, V34, P2208, DOI 10.1016/0032-3861(93)90752-V
   TANAKA T, 1987, ENCY POLYM SCI ENG, V7, P514
   TANZAWA H, 1985, 1 JAP US WORKSH BIOM
   TANZAWA H, 1986, JPN J ARTIF ORGANS, V15, P16
   TERADA T, 1993, J PHYS CHEM-US, V97, P3619, DOI 10.1021/j100116a029
   TOBE S, 1992, BIOCHEM BIOPH RES CO, V184, P225, DOI 10.1016/0006-291X(92)91182-P
   TSURUTA T, 1990, MAKROMOL CHEM-M SYMP, V33, P243, DOI 10.1002/masy.19900330121
   TSURUTA T, 1987, MAKROMOL CHEM-M SYMP, V12, P323, DOI 10.1002/masy.19870120116
   TYLER BJ, 1993, J BIOMED MATER RES, V27, P327, DOI 10.1002/jbm.820270306
   TYLER BJ, 1992, J BIOMED MATER RES, V26, P273, DOI 10.1002/jbm.820260302
   UEDA Y, 1990, THESIS SCI U TOKYO, P34
   VANDERLEI B, 1989, THORAC CARDIOV SURG, V37, P337, DOI 10.1055/s-2007-1020349
   WALTER H, 1977, METHODS CELL SEPARAT, V1, P307
   WANG CB, 1983, MACROMOLECULES, V16, P775, DOI 10.1021/ma00239a014
   WATER H, 1985, PARTITIONING AQUEOUS
   WILDEVUUR CRH, 1987, BIOMATERIALS, V8, P418, DOI 10.1016/0142-9612(87)90076-7
   WILKES GL, 1981, MACROMOLECULES, V14, P456, DOI 10.1021/ma50003a045
   WILLIAMS SK, 1987, ANN NY ACAD SCI, V516, P145, DOI 10.1111/j.1749-6632.1987.tb33037.x
   WILLIAMS SK, 1994, J BIOMED MATER RES, V28, P203, DOI 10.1002/jbm.820280210
   YAMADA N, 1992, Japanese Journal of Artificial Organs, V21, P206
   YAMADANOSAKA A, 1990, J APPL POLYM SCI, V39, P2443, DOI 10.1002/app.1990.070391117
   YAMADANOSAKA A, 1991, J APPL POLYM SCI, V43, P1165, DOI 10.1002/app.1991.070430617
   YOKOYAMA M, 1991, CANCER RES, V51, P3229
   YOKOYAMA M, 1990, J CONTROL RELEASE, V11, P269
   YOKOYAMA M, 1992, BIOCONJUGATE CHEM, V3, P295, DOI 10.1021/bc00016a007
   YOKOYAMA M, 1990, CANCER RES, V50, P1693
   YOSHIDA R, 1991, J BIOMAT SCI-POLYM E, V3, P155, DOI 10.1163/156856291X00250
   YOSHIDA R, 1994, J BIOMAT SCI-POLYM E, V6, P585, DOI 10.1163/156856294X00536
   YUE X, 1988, SURGERY, V103, P206
   YUI N, 1986, MAKROMOL CHEM, V187, P943
   YUI N, 1988, BIOMATERIALS, V9, P225, DOI 10.1016/0142-9612(88)90088-9
   YUI N, 1984, POLYM J, V16, P119, DOI 10.1295/polymj.16.119
   YUI N, 1986, J BIOMED MATER RES, V20, P929, DOI 10.1002/jbm.820200708
   YUI N, 1991, ARTIFICIAL HEART, V3, P23
NR 191
TC 90
Z9 91
U1 0
U2 13
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
SN 0065-3195
BN 3-540-60484-7
J9 ADV POLYM SCI
JI Adv. Polym. Sci.
PY 1996
VL 126
BP 1
EP 51
PG 51
WC Polymer Science
SC Polymer Science
GA BF45K
UT WOS:A1996BF45K00001
DA 2018-10-20
ER

PT J
AU Hess, T
   Stepanow, B
   Knopp, MV
AF Hess, T
   Stepanow, B
   Knopp, MV
TI Safety of intrauterine contraceptive devices during MR imaging
SO EUROPEAN RADIOLOGY
LA English
DT Article
DE MR safety; intrauterine contraceptive device; MR compatibility;
   biomedical materials
ID BIOMEDICAL IMPLANTS; METALLIC IMPLANTS; POTENTIAL HAZARDS;
   MAGNETIC-FIELDS
AB Three intrauterine contraceptive devices (IUD) were examined in an experimental in vitro set-up to test their MR compatibility: Multiload CU375, Nova T (containing copper and silver), and Gyne T. The devices were fixed in a polyacrylamide gel and exposed to the magnetic field and the radiofrequency (RF) of standard MR sequences (spin-echo, turbo-spin-echo, turboFLASH, and magnetization transfer prepared FLASH). The RF power of a turbo-spin-echo sequence was increased by a factor of 5. Temperatures of the IUDs and the gel were measured during the MR examination. No deflection of the IUDs exposed to the magnetic field of 1.5 Tesla was detected. Under normal imaging conditions no temperature increase could be observed. Using an increased RF power, a maximal temperature rise of 0.4 degrees C per examination was seen. no differences between the gel and the IUDs were observed, indicating that there is no specific heating of the tested IUDs.
RP Hess, T (reprint author), GERMAN CANC RES CTR,RES PROGRAM RADIOL DIAGNOST & THERAPY,NEUENHEIMER FELD 280,D-69120 HEIDELBERG,GERMANY.
CR BROWN MA, 1987, MAGN RESON IMAGING, V5, P443, DOI 10.1016/0730-725X(87)90378-X
   DAVIS PL, 1981, AM J ROENTGENOL, V137, P857, DOI 10.2214/ajr.137.4.857
   GOLD JP, 1989, ANN THORAC SURG, V48, P643, DOI 10.1016/0003-4975(89)90780-7
   KAGETSU NJ, 1991, RADIOLOGY, V179, P505, DOI 10.1148/radiology.179.2.2014301
   KANAL E, 1990, RADIOLOGY, V176, P593, DOI 10.1148/radiology.176.3.2202008
   MARK AS, 1987, RADIOLOGY, V162, P311, DOI 10.1148/radiology.162.2.3797642
   MESGARZADEH M, 1985, SKELETAL RADIOL, V14, P205, DOI 10.1007/BF00355565
   NEW PFJ, 1983, RADIOLOGY, V147, P139, DOI 10.1148/radiology.147.1.6828719
   SHELLOCK FG, 1991, RADIOLOGY, V180, P541, DOI 10.1148/radiology.180.2.2068325
   SHELLOCK FG, 1988, AM J ROENTGENOL, V151, P811, DOI 10.2214/ajr.151.4.811
   SHELLOCK FG, 1988, AM J ROENTGENOL, V151, P389, DOI 10.2214/ajr.151.2.389
   SHELLOCK FG, 1993, RADIOLOGY, V189, P587, DOI 10.1148/radiology.189.2.8210394
   SHELLOCK FG, 1992, REV MAGN RESON IMAGI, V4, P21
NR 13
TC 13
Z9 13
U1 0
U2 1
PU SPRINGER VERLAG
PI NEW YORK
PA 175 FIFTH AVE, NEW YORK, NY 10010
SN 0938-7994
J9 EUR RADIOL
JI Eur. Radiol.
PY 1996
VL 6
IS 1
BP 66
EP 68
DI 10.1007/BF00619957
PG 3
WC Radiology, Nuclear Medicine & Medical Imaging
SC Radiology, Nuclear Medicine & Medical Imaging
GA TV240
UT WOS:A1996TV24000014
PM 8797953
DA 2018-10-20
ER

PT S
AU Fornaciari, G
   Capasso, L
AF Fornaciari, G
   Capasso, L
BE Spindler, K
   Wilfing, H
   RastbichlerZissernig, E
   zurNedden, D
   Nothdurfter, H
TI Natural and artificial 13th-19th century mummies in Italy
SO HUMAN MUMMIES: GLOBAL SURVEY OF THEIR STATUS AND THE TECHNIQUES OF
   CONSERVATION
SE MAN IN THE ICE
LA English
DT Proceedings Paper
CT International Mummy Symposium
CY SEP 15-17, 1993
CL INNSBRUCK, AUSTRIA
SP Univ Innsbruck, Inst Prehist & Early Hist, Univ Innsbruck, Inst Prehist Alpine Res
AB Numerous collections of mummies in Italy are unexpectedly distributed over che entire and in particular in the southern part of the country. Burials dare from medieval to modern times, with a higher incidence between the 17th and 19th centuries. The mummies are both artificial, chose submitted to the process of embalming and natural which represent che majority of the collections. Natural mummification was made easier by particular drainage methods of the cadaveric savage frequently used in the crypts of the churches, especially in southern Italy.
   The study of the natural mummies of the church of Santa Maria della Grazia in Comiso (Sicily, 18th-19th centuries) made possible the diagnosis of atherosclerosis, splenomegaly, tuberculosis, acariasis, colon diverticulosis, inguinal hernia and varicose ulcer.
   Examination of the natural and artificial mummies of he Abbey of S. Domenico Maggiore in Naples (15th-17th centuries) clarified the embalming methods of the Renaissance, allowing the diagnosis of two cases of infectious disease (smallpox and venereal syphilis) and two of neoplastic pathology (epithelioma and adenocarcinoma).
   The Italian mummies submitted to paleopathological studies have shown chat modern biomedical techniques, such as immunohistochemistry and electronmicroscopy, can be applied to this type of material, providing extremely interesting results for the history of diseases.
C1 UNIV PISA,SCH MED,INST PATHOL,I-56100 PISA,ITALY.
RI Wilfing, Harald/C-3918-2013
OI Wilfing, Harald/0000-0001-8591-2145
NR 0
TC 3
Z9 3
U1 0
U2 2
PU SPRINGER-VERLAG
PI VIENNA
PA MOLKERBASTEI 5, POSTFACH 367, A-1011 VIENNA, AUSTRIA
SN 0947-3483
BN 3-211-82659-9
J9 MAN IN ICE
PY 1996
VL 3
BP 195
EP 203
PG 9
WC Anthropology; Archaeology
SC Anthropology; Archaeology
GA BH13M
UT WOS:A1996BH13M00019
DA 2018-10-20
ER

PT S
AU Park, H
   Park, K
AF Park, H
   Park, K
BE Ottenbrite, RM
   Huang, SJ
   Park, K
TI Hydrogels in bioapplications
SO HYDROGELS AND BIODEGRADABLE POLYMERS FOR BIOAPPLICATIONS
SE ACS Symposium Series
LA English
DT Review
CT Symposium on Hydrogels and Biodegradable Polymers for Bioapplications,
   at the 208th National Meeting of the American-Chemical-Society
CY AUG 21-26, 1994
CL WASHINGTON, D.C.
SP Amer Chem Soc, Div Polym Chem Inc
ID PHASE-TRANSITION; DRUG DELIVERY; IMPLANT MATERIALS; GELS; GLUCOSE;
   MEMBRANES; IMMOBILIZATION; METHACRYLATE); TRANSPORT; BEHAVIOR
AB Research on hydrogels has been geared toward biomedical applications from the beginning due to their relatively high biocompatibility. Initially only the hydrophilic nature and the large swelling properties of hydrogels was explored. Continued research on hydrogels has resulted in the development of new types of hydrogels, such as environment-sensitive hydrogels, thermoplastic hydrogels, hydrogel foams, and sol-gel phase-reversible hydrogels. Application of hydrogels ranges from biomedical devices to solute separation. Examples of hydrogel applications in pharmaceutics, biomaterials, and biotechnology are briefly described.
C1 PURDUE UNIV, SCH PHARM, W LAFAYETTE, IN 47907 USA.
CR Aharoni S. M., 1992, SYNTHESIS CHARACTERI
   Albin G, 1990, PULSED SELF REGULATE, P159
   AMIYA T, 1987, MACROMOLECULES, V20, P1162, DOI 10.1021/ma00171a050
   BAE YH, 1991, PHARMACEUT RES, V8, P624, DOI 10.1023/A:1015860824953
   BRANNONPEPPAS L, 1991, CHEM ENG SCI, V46, P715, DOI 10.1016/0009-2509(91)80177-Z
   CAPOZZA RC, 1990, POLYM PREPRINTS, V31, P57
   CARLSON KH, 1993, J CATARACT REFR SURG, V19, P9, DOI 10.1016/S0886-3350(13)80272-6
   CHIRILA TV, 1993, BIOMATERIALS, V14, P26, DOI 10.1016/0142-9612(93)90072-A
   CONSTANCE J, 1991, MECH ENG, V113, P51
   CORKHILL PH, 1989, BIOMATERIALS, V10, P3, DOI 10.1016/0142-9612(89)90002-1
   DARSOW U, 1995, J ALLERGY CLIN IMMUN, V95, P677, DOI 10.1016/S0091-6749(95)70172-9
   DAVIES ML, 1992, BIOMATERIALS, V13, P991, DOI 10.1016/0142-9612(92)90149-I
   De Rossi D., 1992, Journal of Intelligent Material Systems and Structures, V3, P75, DOI 10.1177/1045389X9200300105
   DeRossi D., 1991, POLYM GELS FUNDAMENT
   DONG LC, 1990, J CONTROL RELEASE, V13, P21, DOI 10.1016/0168-3659(90)90071-Z
   DREXLER KE, 1992, NANOSYSTEMS MOL MACH
   FEIL H, 1991, J MEMBRANE SCI, V64, P283, DOI 10.1016/0376-7388(91)80099-R
   GEHRKE SH, 1986, CHEM ENG SCI, V41, P2153, DOI 10.1016/0009-2509(86)87131-7
   GRAIVER D, 1993, BIOMATERIALS, V14, P465, DOI 10.1016/0142-9612(93)90150-Z
   GUENET JMM, 1992, THERMOREVERSIBLE GEL
   HILLWEST JL, 1994, P NATL ACAD SCI USA, V91, P5967, DOI 10.1073/pnas.91.13.5967
   HOFFMAN A S, 1987, Journal of Controlled Release, V6, P297, DOI 10.1016/0168-3659(87)90083-6
   HOOPER HH, 1990, MACROMOLECULES, V23, P1096, DOI 10.1021/ma00206a031
   HU YX, 1993, MACROMOLECULES, V26, P1761, DOI 10.1021/ma00059a041
   INOMATA H, 1992, LANGMUIR, V8, P687, DOI 10.1021/la00038a064
   ISHIHARA K, 1983, MAKROMOL CHEM-RAPID, V4, P327
   KAETSU I, 1992, RADIAT PHYS CHEM, V40, P157
   KINDLER DD, 1990, J APPL PHYSIOL, V69, P373
   KITANO S, 1992, J CONTROL RELEASE, V19, P162
   KITANO S, 1993, P 1 INT C INT MAT, P383
   KLUMB LA, 1993, J CONTROL RELEASE, V27, P95, DOI 10.1016/0168-3659(93)90214-P
   Kost J., 1990, PULSED SELF REGULATE
   KWON IC, 1991, NATURE, V354, P291, DOI 10.1038/354291a0
   LACY PE, 1995, SCI AM, V273, P50, DOI 10.1038/scientificamerican0795-50
   LEE KK, 1990, CHEM ENG SCI, V45, P766, DOI 10.1016/0009-2509(90)87019-O
   LEE SJ, 1994, POLYM PREPRINTS, V35, P391
   LEE SJ, UNPUB J MOL REC
   LIU Y, 1994, EUR POLYM J, V30, P457, DOI 10.1016/0014-3057(94)90044-2
   MAMADA A, 1990, MACROMOLECULES, V23, P1517, DOI 10.1021/ma00207a046
   MARCHETTI M, 1989, SEPAR PURIF METHOD, V18, P177, DOI 10.1080/03602548908050923
   MAUBON AJ, 1994, RADIOLOGY, V193, P721, DOI 10.1148/radiology.193.3.7972813
   MIYAZAKI H, 1993, P 1 INT C INT MAT, P481
   MOLIN A, 1992, GYNECOL OBSTET INVES, V34, P12, DOI 10.1159/000292716
   MYERS RI, 1991, OPTOMETRY VISION SCI, V68, P776, DOI 10.1097/00006324-199110000-00003
   NETTI PA, 1993, BIOMATERIALS, V14, P1098, DOI 10.1016/0142-9612(93)90211-J
   NIGAM SC, 1988, BIOTECHNOL PROGR, V4, P166, DOI 10.1002/btpr.5420040307
   OHMINE I, 1982, J CHEM PHYS, V77, P5725, DOI 10.1063/1.443780
   OKUZAKI H, 1993, P 1 INT C INT MAT TE, P273
   Oxley H. R., 1993, Biomaterials, V14, P1065
   Park H., 1994, 20 ANN M SOC BIOM
   Park H., 1994, P INT S CONTR REL BI, V21, P21
   PARK K, 1993, BIODEGRADABLE HYDROG
   PARK TG, 1990, J BIOMED MATER RES, V24, P21, DOI 10.1002/jbm.820240104
   PARK TG, 1994, BIOTECHNOL PROGR, V10, P82, DOI 10.1021/bp00025a010
   Peppas N. A., 1987, HYDROGELS MED PHARM, V1-3
   PISHKO MV, 1991, ANAL CHEM, V63, P2268, DOI 10.1021/ac00020a014
   SAWAHATA K, 1990, J CONTROL RELEASE, V14, P253, DOI 10.1016/0168-3659(90)90165-P
   SHINO D, 1993, P 1 INT C INT MAT, P301
   SIEGEL RA, 1990, PULSED SELF REGULATE, pCH8
   STUDT T, 1995, R PLUS D MAGAZINE, P22
   STUDT T, 1992, R D MAG          APR, P55
   SUZUKI A, 1993, P 1 INT C INT MAT, P297
   SUZUKI M, 1989, KOBUNSHI RONBUNSHU, V46, P603, DOI 10.1295/koron.46.603
   TAKAGI T, 1993, P 1 INT C INT MAT
   TANAKA T, 1981, SCI AM, V244, P124, DOI 10.1038/scientificamerican0181-124
   TANAKA T, 1982, SCIENCE, V218, P467, DOI 10.1126/science.218.4571.467
   VASHEGHANIFARAHANI E, 1992, CHEM ENG SCI, V47, P31, DOI 10.1016/0009-2509(92)80197-K
   WICHTERLE O, 1960, NATURE, V185, P117, DOI 10.1038/185117a0
   YOSHIDA R, 1995, NATURE, V374, P240, DOI 10.1038/374240a0
NR 69
TC 38
Z9 40
U1 1
U2 8
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 SIXTEENTH ST NW, WASHINGTON, DC 20036 USA
SN 0097-6156
BN 0-8412-3400-0
J9 ACS SYM SER
JI ACS Symp. Ser.
PY 1996
VL 627
BP 2
EP 10
PG 9
WC Chemistry, Multidisciplinary; Mechanics
SC Chemistry; Mechanics
GA BF19C
UT WOS:A1996BF19C00001
DA 2018-10-20
ER

PT B
AU Petersen, K
AF Petersen, K
GP IEEE
TI Biomedical applications of MEMS
SO IEDM - INTERNATIONAL ELECTRON DEVICES MEETING, TECHNICAL DIGEST 1996
LA English
DT Proceedings Paper
CT 1996 International Electron Devices Meeting
CY DEC 08-11, 1996
CL SAN FRANCISCO, CA
SP IEEE Electron Devices Soc
AB Exploiting the materials and processing techniques developed for integrated circuits, silicon micromachining technology has been responsible for fundamental improvements in many, diverse fields of biomedicine. As blood pressure sensors, chemical sensors, micro-chemical reaction and analysis systems, and micro-fluidic control systems, the impact of micromachining on biomedical applications has already been impressive, but is only now poised for dramatic advances.
   This paper will review current state-of-the-art biomedical applications of micromachining technology such as pressure sensors and biochemical sensors. In addition, we will discuss significant new biomedical innovations on the horizon which make use of micromachining techniques and processes.
RP Petersen, K (reprint author), CEPHEID,SAN JOSE,CA, USA.
NR 0
TC 9
Z9 9
U1 0
U2 1
PU I E E E
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017
BN 0-7803-3394-2
PY 1996
BP 239
EP 242
DI 10.1109/IEDM.1996.553575
PG 4
WC Engineering, Electrical & Electronic
SC Engineering
GA BG98F
UT WOS:A1996BG98F00051
DA 2018-10-20
ER

PT J
AU Schimpf, PH
   Haynor, DR
   Kim, Y
AF Schimpf, PH
   Haynor, DR
   Kim, Y
TI Object-free adaptive meshing in highly heterogeneous 3-D domains
SO INTERNATIONAL JOURNAL OF BIO-MEDICAL COMPUTING
LA English
DT Article
DE numerical analysis; finite element; mesh generation; adaptive
ID FINITE-ELEMENT STRATEGY; REFINEMENT
AB Traditional approaches to the generation of finite element meshes are well suited for modeling the homogeneous or mildly heterogeneous domains presented by man-made objects, but are difficult to apply to the complex 3-D domains encountered in some biomedical applications. In this paper, we describe an adaptive algorithm that automates the modeling of these domains. The method differs from traditional approaches in that no explicit description is required of the boundaries between objects with dissimilar material properties. The algorithm uses images of the tissue class to build irregular meshes, and continuity is enforced by constraining the solution at irregular nodes. Local estimates of the error in the flux solution are used to refine the mesh. For an analytic problem with a rapid change along a spherical boundary, the adaptive method converges to a 1% voltage error using 25% of the degrees of freedom required by a uniform refinement, and to a 5% voltage gradient error using 11% of the degrees of freedom. For a defibrillation model in a pig thorax, the voltage gradient solution in the ventricles of the heart converges to within 5% of a uniform mesh solution using less than 8% of the memory and processing resources required by a uniform mesh, which has been the only practical alternative for subject-specific modeling.
C1 UNIV WASHINGTON,DEPT ELECT ENGN,SEATTLE,WA 98195.
   UNIV WASHINGTON,DEPT RADIOL,SEATTLE,WA 98195.
FU NHLBI NIH HHS [HL48814]
CR Axelsson O., 1984, FINITE ELEMENT SOLUT
   Bank R.E., 1983, SCI COMPUT, P3
   BATHE KJ, 1982, FINITE ELEMENT PROCE
   BESAG J, 1986, J ROY STAT SOC B MET, V48, P259
   BLILIE DE, 1991, P 13 C IEEE EMBS, V13, P772
   Burnett D., 1988, FINITE ELEMENT ANAL
   CAREY GF, 1988, INT J NUMER METH ENG, V26, P2607, DOI 10.1002/nme.1620261203
   DEMKOWICZ L, 1989, COMPUT METHOD APPL M, V77, P79, DOI 10.1016/0045-7825(89)90129-1
   DEMKOWICZ L, 1988, 8802 U TEX I COMP ME
   GEORGE P, 1991, AUTOMATIC MESH GENER
   HAGEMAN LA, 1981, APPLIED ITERATIVE ME, P138
   IMGRUND MC, 1991, P 3 INT C QUAL ASS S, P190
   Irons BM, 1972, MATH FDN FINITE ELEM, P557
   JORGENSON DB, 1995, IEEE T BIO-MED ENG, V42, P559, DOI 10.1109/10.387195
   JORGENSON DB, 1995, IEEE T BIO-MED ENG, V42, P172, DOI 10.1109/10.341830
   KELA A, 1987, ENG COMPUT, V4, P104
   KOCVARA M, 1993, INT J NUMER METH ENG, V36, P1703, DOI 10.1002/nme.1620361006
   MURAMATSU K, 1991, IEEE T MAGN, V27, P5211, DOI 10.1109/20.278790
   MURAMATSU K, 1993, IEEE T MAGN, V29, P1479, DOI 10.1109/20.250682
   ODEN JT, 1989, COMPUT METHOD APPL M, V77, P113, DOI 10.1016/0045-7825(89)90130-8
   RACHOWICZ W, 1989, COMPUT METHOD APPL M, V77, P181, DOI 10.1016/0045-7825(89)90131-X
   RHEINBOLDT WC, 1980, ACM T MATH SOFTWARE, V6, P166, DOI 10.1145/355887.355891
   SCHIMPF PH, 1995, MED BIOL ENG COMPUT, V33, P713, DOI 10.1007/BF02510792
   SHEPHARD MS, 1988, APPL MECH REV, V41, P169
   SHRINIDHI N, 1995, IN PRESS IEEE T BIOM
   STRANG G, 1972, MATH FDN FINITE ELEM, P689
   TAYLOR RL, 1986, INT J NUMER METH ENG, V22, P39, DOI 10.1002/nme.1620220105
   WHEELER MJ, 1989, P 2 INT C QUAL ASS S, P1
   Zienkiewicz O, 1989, FINITE ELEMENT METHO
   ZIENKIEWICZ OC, 1987, INT J NUMER METH ENG, V24, P337, DOI 10.1002/nme.1620240206
NR 30
TC 14
Z9 14
U1 0
U2 3
PU ELSEVIER SCI IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0020-7101
J9 INT J BIOMED COMPUT
JI Int. J. Bio-Med. Comput.
PD JAN
PY 1996
VL 40
IS 3
BP 209
EP 225
DI 10.1016/0020-7101(95)01146-3
PG 17
WC Computer Science, Interdisciplinary Applications; Computer Science,
   Theory & Methods; Engineering, Biomedical; Medical Informatics
SC Computer Science; Engineering; Medical Informatics
GA UB229
UT WOS:A1996UB22900006
PM 8666474
DA 2018-10-20
ER

PT S
AU Burg, KJL
   Shalaby, SW
AF Burg, KJL
   Shalaby, SW
BE Clough, RL
   Shalaby, SW
TI Radiation sterilization of medical devices and pharmaceuticals
SO IRRADIATION OF POLYMERS: FUNDAMENTALS AND TECHNOLOGICAL APPLICATIONS
SE ACS SYMPOSIUM SERIES
LA English
DT Article; Proceedings Paper
CT Symposium on Irradiation of Polymers, at the 208th National Meeting of
   the American-Chemical-Society
CY AUG 21-26, 1994
CL WASHINGTON, DC
SP Amer Chem Soc, Div Polym Chem Inc
ID TENDON ALLOGRAFTS
AB The advantages of ionizing irradiation over traditional sterilization methods are overviewed and recent developments in the field are described. The effect of irradiation on synthetic polymers, natural materials, and pharmaceuticals is discussed, along with the advantages and disadvantages of irradiation on each of these systems. Biomedical materials have the stringent requirement of maintaining their integrity during sterilization as well as displaying short and long-term biocompatibility in the biological environment. In effect, a biomedical device or pharmaceutical product should maintain its chemical and physical properties through different stages of processing including terminal sterilization. Sterilization is a sensitive, critical step in this process.
C1 POLY MED INC,CTR APPL TECHNOL,PENDLETON,SC 29670.
RP Burg, KJL (reprint author), CLEMSON UNIV,DEPT BIOENGN,RHODES ENGN RES CTR 301,CLEMSON,SC 29634, USA.
CR ARTANDI C, 1959, NUCLEONICS, V17, P86
   *ASS ADV MED INSTR, 1984, GUID GAMM RAD STER M
   *ASS ADV MED INSTR, 1992, ST321991 ANSIAAMI
   BELKOFF SM, 1992, J ORTHOPAED RES, V10, P461, DOI 10.1002/jor.1100100320
   BRUCK SD, 1988, J BIOMED MAT RES APP, V32, P133
   CHAPIRO A, 1962, RAD CHEM POLYM SYSTE, V15, P341
   CHRISTENSEN EA, 1992, PRINCIPLES PRACTICE, P558
   DEDEYNE P, 1991, CONNECT TISSUE RES, V27, P51
   DZIEDZICGOCLAWS.A, 1991, CLIN ORTHOP RELAT R, V272, P30
   HANSEN J, 1994, MED DEVICE DIAGN MAY, P218
   *INT AT EN AG, 1967, RADIOSTERILIZATION M
   JACOBS PT, 1995, ACS S SEIRES
   MOACANIN J, 1973, Biomaterials Medical Devices and Artificial Organs, V1, P183
   NAIR PD, 1988, BIOMATERIALS, V9, P335, DOI 10.1016/0142-9612(88)90029-4
   SHALABY SW, 1995, Patent No. 5422068
   STEINGER E, 1973, HDB DESINFEKTION STE, V2, P181
   VOLLAND C, 1994, J CONTROL RELEASE, V31, P293, DOI 10.1016/0168-3659(94)90012-4
NR 17
TC 7
Z9 7
U1 0
U2 3
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 SIXTEENTH ST NW, WASHINGTON, DC 20036
SN 0097-6156
BN 0-8412-3377-2
J9 ACS SYM SER
PY 1996
VL 620
BP 240
EP 245
PG 6
WC Chemistry, Multidisciplinary; Polymer Science
SC Chemistry; Polymer Science
GA BF03R
UT WOS:A1996BF03R00018
DA 2018-10-20
ER

PT J
AU Forstel, H
AF Forstel, H
TI Production and use of nitrogen-15 in German agricultural, biomedical and
   ecological research - A historical review
SO ISOTOPES IN ENVIRONMENTAL AND HEALTH STUDIES
LA English
DT Review
DE application; Germany; history; Leipzig; nitrogen 15; production; review
ID DIFFERENT COMPARTMENTS; ISOTOPE RATIOS
AB The history of production and application of the stable nitrogen isotope N-15 in Germany is mainly part of the history of the former Institute of Stable Isotopes, later a part of the Central Institute of Isotope and Radiation Research (Zentralinstitut fur Isotopen-und Strahlenforschung) in Leipzig. In 1956, after a relatively large fractionation during isotopic exchange in the system NO/HNO3, was reported by SPINDEL and TAYLOR, the construction of an isotope enrichment plant was planned and started work in 1958 on a laboratory scale. The prodution of N-15-labelled material in the institute started in 1960, followed in 1968 by the start of a separation plant in Wolfen as a branch of industrial fertilizer production. The economy was optimized by feeding back the N-15 decreased efflux to the fertilizer production line.
   The material produced was used for studies at home and abroad. Close contacts with the IAEA (International Atomic Energy Agency, Vienna) and the development of an easy-to-handle optical instrument for N-15 measurements were the basis for a wide application in agriculture and medicine.
   As a result of German reunification fertilizer production in Wolfen was stopped, and consequently the successful N-15 separation plant had to be closed. A broad spectrum of N-15-labelled compounds, however, is being produced also today in Berlin and is purchased by Chemotrade, Leipzig.
   In the Western part of the country stable isotopes were not produced, but could be purchased on the world market at prices far below the realistic economic costs. At that time research was not coordinated centrally, until the lack of common information was counteracted by the foundation of the Working Group on Stable Isotopes in Mainz in 1977. A similar group in Eastern Germany had been at work since 1959, but no direct contact between the two groups had existed for political reasons.
RP Forstel, H (reprint author), FORSCHUNGSZENTRUM JULICH, FORSCHUNGSZENTRUM, INST RADIOAGRON, POSTFACH 1913, D-52425 JULICH, GERMANY.
CR *ADL DDR, 1990, DAUERF
   *ADL DDR, 1987, FZ MUNCH METH ERG EI
   *ADL DDR, 1978, 155 ADL
   AMBERGER A, 1987, GEOCHIM COSMOCHIM AC, V51, P2699, DOI 10.1016/0016-7037(87)90150-5
   *ASTI, 1967, ARB STAB IS LEIPZ OC
   *ASTI, 1969, ARB STAB IS LEIPZ OC
   *ASTI, 1965, ARB STAB IS LEIPZ OC
   BIRKENFELD H, 1962, MASSENSPEKTROMETRISC
   BUCHMANN N, 1995, OECOLOGIA, V102, P361, DOI 10.1007/BF00329803
   DURKA W, 1994, NATURE, V372, P765, DOI 10.1038/372765a0
   FAUST H., 1962, Kernenergie, V5, P391
   FAUST H, 1993, ISOTOPENPRAXIS, V29, P289, DOI 10.1080/00211919308046699
   FAUST H, 1960, Z ANAL CHEM, V175, P9
   FAUST H, 1987, TAGUNGSBAND METHODEN, P3
   Faust H., 1981, ISOCOMMERZ GMBH BERL, V5, P1
   Faust H., 1981, METHODENKATALOG ZFI, V36, P1
   FAUST H, 1960, ISOTOPENTECHNIK, V1, P13
   FAUST H, 1964, ABH DTSCHN AKAD CGB, V7, P577
   FREYER HD, 1994, 1 RESULTS 15N 14N RA, P7
   GEBAUER G, 1994, PLANT SOIL, V164, P267, DOI 10.1007/BF00010079
   GEBAUER G, 1991, OECOLOGIA, V87, P198, DOI 10.1007/BF00325257
   GEBAUER G, 1993, ISOTOPENPRAXIS, V29, P35, DOI 10.1080/10256019308046133
   Hartig W., 1978, DDR MED REPORT, V7, P563
   HIRSCHBERG K, 1985, ZFL MITT LEIPZIG, V110, P4
   HUBNER G, 1970, ROLLE WASSERS BIOL S
   HUBNER H, 1976, STABILE ISOTOPE SCHR, V7, P1
   JONAS C, 1989, ZFL MITTEILUNGEN LEI, V150, P285
   JUNG K, 1985, EUR J NUCL MED, V11, P62
   KORSCHENS, 1992, DAUERFELDVERSUCHE NA
   KRELL E, 1958, HDB LABORATORIUMSDES
   KRELL E, 1976, ISOTOPENPRAXIS, V12, P188
   KRETZSCHMANN G, 1970, ISOTOPENPRAXIS, V6, P354
   KRUMBIEGEL P, 1985, EUR J NUCL MED, V11, P58
   KRUMBIEGEL P, 1991, Z KLIN MED, V46, P691
   KRUMBIEGEL P, 1992, STABLE ISOTOPE PHARM
   KRUMBIEGEL P, 1983, ISOCOMMERZ GMBH BERL, V13, P1
   KRUMBIEGEL P, 1970, ISOTOPIEEFFEKTE
   LATUS C, 1990, NATURWISSENSCHAFTEN, V77, P283, DOI 10.1007/BF01131225
   MEIER G, 1992, ISOTOPENPRAXIS, V28, P85, DOI 10.1080/00211919208050832
   REINHARDT R, 1983, ISOTOPENPRAXIS, V19, P208, DOI 10.1080/10256018308544887
   Schmidt H., 1989, P 5 WORK M IS NAT LE, P613
   SEGSCHNEIDER HJ, 1995, NEW PHYTOL, V131, P109, DOI 10.1111/j.1469-8137.1995.tb03060.x
   *TGL, 1990, 14466 DDR TGL
   *U BONN, 1991, 1 U BONN FAK BONN
   VOERKELIUS S, 1990, GESELLSCHAFT, V60, P361
   WETZEL H, 1989, ZFL MITT, V150
   1962, KERNENERGIE, V5, P208
   1995, ENV HLTH STUD, V31, P237
   1964, ABHANDL DTSCH AK CGB, P1
   1994, ISOT ENVIRON HEALT S, V30, P87
   1960, KERNENERGIE, V3, P815
   1993, ENV HLTH STUD, V29, P1
   1992, ISOT ENVIRON HEALT S, V28, P1
NR 53
TC 2
Z9 2
U1 0
U2 1
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 1025-6016
J9 ISOT ENVIRON HEALT S
JI Isot. Environ. Health Stud.
PY 1996
VL 32
IS 1
BP 1
EP 13
DI 10.1080/10256019608036288
PG 13
WC Chemistry, Inorganic & Nuclear; Environmental Sciences
SC Chemistry; Environmental Sciences & Ecology
GA UL241
UT WOS:A1996UL24100001
DA 2018-10-20
ER

PT J
AU Iwasaki, Y
   Kurita, K
   Ishihara, K
   Nakabayashi, N
AF Iwasaki, Y
   Kurita, K
   Ishihara, K
   Nakabayashi, N
TI Effect of reduced protein adsorption on platelet adhesion at the
   phospholipid polymer surfaces
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE phospholipid polymer; blood compatibility; protein adsorption; platelet
   adhesion; nonthrombogenicity; lipid adsorption; gold-colloid
   immunoassay; biomimetic membrane
ID HUMAN PLASMA-PROTEINS; BLOOD COMPATIBILITY; POLAR GROUP;
   PHOSPHORYLCHOLINE MOIETY; GRAFT-COPOLYMERS; VASCULAR GRAFTS;
   HEMOCOMPATIBILITY; BIOMATERIALS; POLYURETHANE; WATER
AB We prepared polymers having a phospholipid polar group, poly[omega-methacryloxyloxyalkyl phosphorylcholine (MAPC)-co-n-butyl methacrylate (BMA)], as new biomedical materials and evaluated their blood compatibility with attention to protein adsorption and platelet adhesion. The total amount of proteins adsorbed on the polymer surface from human plasma was determined, and the distribution of adsorbed proteins on the plasma-contacting surface was analyzed. The amount of proteins adsorbed on every poly(MAPC-co-BMA) was small compared with that observed on polymers without the phospholipid polar group. However, there was no significant difference in the amount of adsorbed proteins on the poly(MAPC-co-BMA) even when the methylene chain length between the phospholipid polar group and the backbone in the MAPC moiety was altered. Platelet adhesion on the polymer surface from a platelet suspension in a buffered solution was evaluated with and without plasma treatment on the surface. When a rabbit platelet suspension was brought into contact with the poly(BMA) surface after treatment with plasma, many platelets adhered and aggregated. However, a reduced amount of platelet adhered on the poly(BMA) was found in the case of direct contact with the platelet suspension. On the other hand, the poly(MAPC-co-BMA)s could inhibit platelet adhesion under both conditions. Based on these results, it can be concluded that the proteins adsorbed on the surface play an important role in determining the platelet adhesion and suppression of the protein adsorption on the surface, which is one of the most significant ways of inhibiting platelet adhesion.
C1 TOKYO MED & DENT UNIV,INST MED & DENT ENGN,CHIYODA KU,TOKYO 101,JAPAN.
   NIHON UNIV,COLL SCI & TECHNOL,DEPT IND CHEM,CHIYODA KU,TOKYO 101,JAPAN.
RI Iwasaki, Yasuhiko/D-6870-2011
OI Iwasaki, Yasuhiko/0000-0003-1603-6174
CR ANDRADE JD, 1973, T AM SOC ART INT ORG, V19, P1
   BAMFORD CH, 1992, VROMAN EFFECT
   Brash JL, 1987, ACS S SERIES, V343
   Brash JL, 1991, BLOOD COMPATIBLE MAT, P3
   CAMPBELL EJ, 1992, MATER RES SOC SYMP P, V252, P229
   CHOLAKIS CH, 1991, J BIOMED MATER RES, V25, P791
   GRASEL TG, 1987, J BIOMED MATER RES, V21, P815, DOI 10.1002/jbm.820210702
   HALL B, 1989, BIOMATERIALS, V10, P213
   HANSON SR, 1980, J LAB CLIN MED, V95, P289
   HAYWARD JA, 1984, BIOMATERIALS, V5, P135, DOI 10.1016/0142-9612(84)90047-4
   ISHIHARA K, 1992, J BIOMED MATER RES, V26, P1543, DOI 10.1002/jbm.820261202
   ISHIHARA K, 1994, J BIOMED MATER RES, V28, P225, DOI 10.1002/jbm.820280213
   ISHIHARA K, 1994, J POLYM SCI POL CHEM, V32, P859, DOI 10.1002/pola.1994.080320507
   ISHIHARA K, 1993, J BIOMED MATER RES, V27, P1309, DOI 10.1002/jbm.820271011
   ISHIHARA K, 1991, J BIOMED MATER RES, V25, P1397, DOI 10.1002/jbm.820251107
   ISHIHARA K, 1990, POLYM J, V22, P355, DOI 10.1295/polymj.22.355
   ISHIHARA K, 1993, NEW FUNCTIONALITY PO, VB, P233
   ISHIHARA K, 1991, SEITAI ZAIRYO, V9, P243
   ISHIHARA K, 1994, ACS SYM SER, V556, P353
   IWASAKI Y, 1994, J BIOMAT SCI-POLYM E, V6, P447, DOI 10.1163/156856294X00437
   KANO K, 1989, BIOMATERIALS, V10, P455
   KOJIMA M, 1991, BIOMATERIALS, V12, P121, DOI 10.1016/0142-9612(91)90189-H
   LYMAN DJ, 1970, THROMB DIATH HAEMO, V42, P109
   MOHAMMAD SF, 1986, T AM SOC ART INT ORG, V32, P323
   NAKABAYASHI N, 1991, POLYMERS AND BIOMATERIALS, P343
   NOJIRI C, 1990, J BIOMED MATER RES, V24, P1151, DOI 10.1002/jbm.820240903
   NOZAKI Y, 1984, JINKO ZOKI, V13, P1147
   OKANO T, 1978, POLYM J, V10, P233
   PANKOWSKY DA, 1990, J VASC SURG, V11, P599, DOI 10.1067/mva.1990.18272
   PARK K, 1986, J COLLOID INTERF SCI, V111, P197, DOI 10.1016/0021-9797(86)90019-6
   PEPPAS NA, 1987, HYDROGELS MED PHARM, V3
   Ratner BD, 1979, J POLYM SCI POLYM S, V66, P363
   SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7
   TSURUTA T, 1992, POLYM MAT BIOMEDICAL
   UEDA T, 1995, J BIOMED MATER RES, V29, P381, DOI 10.1002/jbm.820290313
   UEDA T, 1992, POLYM J, V24, P1259, DOI 10.1295/polymj.24.1259
   UEDA T, 1991, J BIOMAT SCI-POLYM E, V3, P185
   Yianni YP, 1992, STRUCTURAL DYNAMIC P, P187
   ZIATS NP, 1990, J LAB CLIN MED, V116, P687
   ZIATS NP, 1991, CELL MATER, V1, P73
NR 40
TC 48
Z9 50
U1 0
U2 9
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 1996
VL 8
IS 2
BP 151
EP 163
DI 10.1163/156856296X00228
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA VW644
UT WOS:A1996VW64400007
PM 8957711
DA 2018-10-20
ER

PT J
AU Kartvelishvili, T
   Kvintradze, A
   Katsarava, R
AF Kartvelishvili, T
   Kvintradze, A
   Katsarava, R
TI Amino acid based bioanalogous polymers. Synthesis of novel poly(urethane
   amide)s based on N,N'-(trimethylenedioxydicarbonyl)bis(phenylalanine)
SO MACROMOLECULAR CHEMISTRY AND PHYSICS
LA English
DT Article
ID DERIVATIVES; ESTERS; ALPHA
AB The feasibility of synthesizing high-molecular-weight amino acid based bioanalogous polymers (AABBPs)-poly(urethane amide)s (PUA) - via polycondensation (PC) of dip-nitrophenyl ester of N,N'-(trimethylenedioxydicarbonyl)bis(L-phenylalanine) (3) with diamines or their derivatives under mild conditions in organic solvents was studied for the first time. A regular PUA (eta(red) = 1,53 dL/g) was obtained by PC of 3 with hexamethylenediamine. A dipeptide (Phe-Phe) containing regular poly(ester urethane amide) (eta(red) = 0,58 dL/g) was synthesized by PC of 3 with p-toluenesulfonic acid salt of bis(L-phenylalanine) 1,4-butylene diester. A tripeptide (Phe-Lys-Phe) containing PUA (eta(red) = 0,38 dL/g) with pendent ester groups was prepared via PC of 3 with N,N-bis(trimethylsilyl)-L-lysine methyl ester. These novel AABBPs which may be considered as structural analogs of AB type bioanalogous polymers - conventional poly(amino acids) are of interest in enzymology, immunology, pharmacology, and biotechnology (as materials for biomedical applications).
RP Kartvelishvili, T (reprint author), GEORGIAN ACAD SCI,INST MOLEC BIOL & BIOPHYS,14 L GOTUA STR,TBILISI 380060,REP OF GEORGIA.
CR ARABULI N, 1994, MACROMOL CHEM PHYSIC, V195, P2279, DOI 10.1002/macp.1994.021950633
   CLEAVER CS, 1955, J AM CHEM SOC, V77, P1544, DOI 10.1021/ja01611a042
   GARKUSHABOZHKO IP, 1982, ZH ORG KHIM+, V18, P2340
   HORT U, 1976, CONDENSATION MONOMER, P206
   KATSARAVA RD, 1993, MAKROMOL CHEM, V194, P3209
   KATSARAVA RD, 1985, MAKROMOL CHEM, V186, P939
   KATSARAVA RD, 1985, ACTA POLYM, V36, P29
   KHARADZE DP, 1994, VYSOKOMOL SOEDIN, V36, P1462
   KHURGIN YI, 1962, DOKL AKAD NAUK SSSR, V143, P629
   KOHN J, 1987, J AM CHEM SOC, V109, P817, DOI 10.1021/ja00237a030
   LABSKY J, 1979, EUR POLYM J, V15, P167, DOI 10.1016/0014-3057(79)90203-9
   OLEINIK NM, 1980, ZH ORG KHIM+, V16, P1469
   SU CP, 1977, J POLYM SCI POL CHEM, V15, P185, DOI 10.1002/pol.1977.170150117
   SU CW, 1974, J AM CHEM SOC, V96, P1854, DOI 10.1021/ja00813a034
NR 14
TC 7
Z9 7
U1 0
U2 5
PU HUTHIG & WEPF VERLAG
PI BASEL
PA AUF DEM WOLF 4 FX#001-41-61-317-94-11, CH-4052 BASEL, SWITZERLAND
SN 1022-1352
J9 MACROMOL CHEM PHYSIC
JI Macromol. Chem. Phys.
PD JAN
PY 1996
VL 197
IS 1
BP 249
EP 257
DI 10.1002/macp.1996.021970119
PG 9
WC Polymer Science
SC Polymer Science
GA TP173
UT WOS:A1996TP17300019
DA 2018-10-20
ER

PT J
AU Tokura, S
   Nishimura, SI
   Sakairi, N
   Nishi, N
AF Tokura, S
   Nishimura, SI
   Sakairi, N
   Nishi, N
TI Biological activities of biodegradable polysaccharide
SO MACROMOLECULAR SYMPOSIA
LA English
DT Article; Proceedings Paper
CT 5th SPSC International Polymer Conference on Challenges in Polymer
   Science and Technology
CY NOV 28-DEC 02, 1994
CL SENRI LIFE SCI CTR, SENRI, JAPAN
SP Soc Polym Sci, Japan
HO SENRI LIFE SCI CTR
ID CHITIN DERIVATIVES; MICE
AB A low toxicity of chitin was demonstrated to be mostly due to biodegradability and the fast metabolization of hydrolysate in animal body. Chitosan, a deacetylated derivative of chitin, is also known to be a biocompatible polymer in spite of a slight immunoadjuvant activity in animal body. Chitosan is easily regenerated to fiber, film, beads and non woven fabrics owing to its high solubility toward diluted aqueous organic acids such as formic acid, acetic acid, glutamic acid and ascorbic acid. The regeneration of chitin was achieved into fibers, gels, porous foams and non woven fabrics following to dissolution of chitin with formic acid or calcium chloride dihydrate saturated methanol. Chitin and its derivatives have been applied as biomedical materials due to remarkable advantages such as antimicrobial activity, acceleration of epidermal cell assembly, low toxicity, and biodegradability.
C1 HOKKAIDO UNIV,GRAD SCH SCI,SAPPORO,HOKKAIDO 060,JAPAN.
RP Tokura, S (reprint author), HOKKAIDO UNIV,GRAD SCH ENVIRONM EARTH SCI,SAPPORO,HOKKAIDO 060,JAPAN.
CR DOMSZY JG, 1985, MAKROMOL CHEM, V186, P1671
   HACKMAN RH, 1954, AUST J BIOL SCI, V7, P168, DOI 10.1071/BI9540168
   HIRANO S, 1976, CARBOHYD RES, V47, P315, DOI 10.1016/S0008-6215(00)84198-1
   MINAMI S, 1991, ADV CHITIN CHITOSAN, P61
   NISHIMURA K, 1985, VACCINE, V3, P379, DOI 10.1016/0264-410X(85)90127-6
   NISHIMURA K, 1986, VACCINE, V4, P151, DOI 10.1016/0264-410X(86)90002-2
   OKAMOTO Y, 1993, J VET MED SCI, V55, P743, DOI 10.1292/jvms.55.743
   TOKURA S, 1983, POLYM J, V15, P485, DOI 10.1295/polymj.15.485
   TOKURA S, 1993, ACS SYM SER, V520, P351
   TOKURA S, 1979, POLYM J, V11, P781, DOI 10.1295/polymj.11.781
   TOKURA S, UNPUB CARBOHYDR POLY
   URAKI Y, 1993, CARBOHYD POLYM, V20, P139, DOI 10.1016/0144-8617(93)90089-M
   WATANABE K, 1992, CARBOHYD POLYM, V17, P29, DOI 10.1016/0144-8617(92)90020-Q
   YANO H, 1985, Mie Medical Journal, V35, P53
NR 14
TC 42
Z9 44
U1 0
U2 6
PU HUTHIG & WEPF VERLAG
PI BASEL
PA AUF DEM WOLF 4 FX#001-41-61-317-94-11, CH-4052 BASEL, SWITZERLAND
SN 1022-1360
J9 MACROMOL SYMP
JI Macromol. Symp.
PD JAN
PY 1996
VL 101
BP 389
EP 396
DI 10.1002/masy.19961010144
PG 8
WC Polymer Science
SC Polymer Science
GA TP172
UT WOS:A1996TP17200043
DA 2018-10-20
ER

PT J
AU Khor, KA
   Cheang, P
AF Khor, KA
   Cheang, P
TI Effects of feedstock and laser post-spray treatment on plasma sprayed
   bioceramic coatings
SO MATERIALS AND MANUFACTURING PROCESSES
LA English
DT Article
ID HYDROXYAPATITE COATINGS; PARAMETERS
AB Hydroxyapatite (HA) is a bioactive material with Ca to P ratio similar to that of natural bone. This can encourage early bonding between bony tissues and the implant surface. Plasma spraying is efficient in coating HA onto biomedical implants. However, the biocompatibility of hydroxyapatite (HA) changes after plasma spraying. This paper reports the preparation and characterization of HA coatings using different feedstocks; calcined HA (CHA) that has angular geometry, and spray dried HA (SDHA) that is predominantly spherical in shape. The results indicates that the state of the starting powder adversely influences the coating characteristics.;Both types of HA, calcined and crushed HA powders and spray dried HA powders, are plasma sprayed on steel substrates to produce HA coatings. The results indicate that particle cohesion, size range and thermal treatment during thermal spray processing alter the phase and structure of the as-sprayed coatings. Post-spray treatment by pulsed lasers is performed on the coatings to modify the surface characteristics and phase composition of the surface layer. This, in addition, may be necessary to produce a dense and well-bonded coating having the desired biocompatible properties. Laser treatments show overall melting of the HAcoating to yield a smooth surface. However, the presence of crack networks is undesirable.
C1 NANYANG TECHNOL UNIV,SCH MECH & PROD ENGN,SINGAPORE 639798,SINGAPORE.
   NANYANG TECHNOL UNIV,SCH APPL SCI,SINGAPORE 639798,SINGAPORE.
RI Khor, Khiam Aik/G-2827-2010; Khor, Khiam Aik (Michael)/B-6929-2009
OI KHOR, Khiam/0000-0003-1954-8423
CR ANTONIO JA, 1992, J BONE JOINT SURG AM, V74, P995
   BOSTMAN O, 1989, CLIN ORTHOPAEDICS, V238, P195
   BROWN SR, 1994, J MATER SCI-MATER M, V5, P756, DOI 10.1007/BF00120371
   CHEANG P, 1995, J MATER PROCESS TECH, V48, P429, DOI 10.1016/0924-0136(94)01679-U
   CHEANG P, 1995, HIGH TEMPERATURE SOC, V1, P181
   DEBRUIJN JD, 1995, J BIOMED MATER RES, V29, P89, DOI 10.1002/jbm.820290113
   DORFMAN MR, 1986, P ITSC 86 MONTR CAN, P241
   GEESINK RGT, 1995, J BONE JOINT SURG BR, V77B, P534
   JARCHO M, 1980, J BIOMEDICAL MAT RES, V14, P713
   JARCHO M, 1981, CLIN ORTHOPAEDICS, V285, P102
   KHOR KA, 1994, J THERM SPRAY TECHN, V3, P45, DOI 10.1007/BF02648998
   KOCH B, 1990, J BIOMED MATER RES, V24, P655, DOI 10.1002/jbm.820240603
   LUGSCHEIDER E, 1992, INT ADV COATINGS TEC, P967
   MCPHERSON R, 1995, J MATER SCI-MATER M, V6, P327, DOI 10.1007/BF00120300
   MURYAMA M, 1995, J BIOMEDICAL MAT RES, V29, P329
   RADIN SR, 1992, J MATER SCI-MATER M, V3, P33, DOI 10.1007/BF00702942
   VARDELLE M, 1993, J THERM SPRAY TECHN, V2, P79
   YAMASAKI H, 1992, BIOMATERIALS, V13, P308, DOI 10.1016/0142-9612(92)90054-R
   YANG CY, 1995, J MATER SCI-MATER M, V6, P249, DOI 10.1007/BF00120267
NR 19
TC 0
Z9 0
U1 0
U2 0
PU MARCEL DEKKER INC
PI NEW YORK
PA 270 MADISON AVE, NEW YORK, NY 10016
SN 1042-6914
J9 MATER MANUF PROCESS
JI Mater. Manuf. Process.
PY 1996
VL 11
IS 5
BP 869
EP 882
DI 10.1080/10426919608947533
PG 14
WC Engineering, Manufacturing; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA VP325
UT WOS:A1996VP32500010
DA 2018-10-20
ER

PT B
AU Serafetinides, AA
AF Serafetinides, AA
BE Atanasov, PA
TI Short pulse laser beam interactions with polymers biocompatible
   materials and tissue
SO NINTH INTERNATIONAL SCHOOL ON QUANTUM ELECTRONICS: LASERS-PHYSICS AND
   APPLICATIONS
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT 9th International School on Quantum Electronics - Lasers-Physics and
   Applications
CY SEP 16-20, 1996
CL VARNA, BULGARIA
SP Bulgarian Acad Sci, Inst Electr, Soc Photo Opt Instrumentat Engineers, Soc Photo Opt Instrumentat Engineers, Bulgaria Chapter, Int Sci Org Zond
DE ablation; tissue ablation; polymers ablation; picoseconds ablation;
   femtoseconds ablation
AB Pulsed laser beams, of very short duration, appear to be very promising tools for polymer surface processing. Recently we have studied the interaction of picosecond and femtosecond laser radiation in the visible region of the spectrum with synthetic polymer films and we have compared these studies with our similar studies nab nanosecond duration laser radiation.
   Biocompatible polymers have been extensively used for sutures, vascular grafts or bone and other hard tissue replacements. The use of surgical lasers for intervention on biocompatible material - tissue interfaces has attracted a great deal of interest, as both the high intensity, short pulse duration lasers and the prosthetic biomaterials are in increasing use. Our recent ablation studies, using ultrashort laser pulses, of biocompatible materials, are described in this article.
   Lasers were introduced in medical research in the early sixties but the laser beam ability to remove efficiently and safely soft or hard tissue, the lateral thermal damage and the final surface characteristics are still under investigation In the past few years, pulse mid-infrared lasers have attracted much attention because they operate at wavelengths where soft or hard tissue, try virtue of their water or water and hydroxyapatite content respectively, exhibit strong absorption restricting residual thermal damage to a relatively small zone. Recently we have investigated the interaction of short pulse laser radiation of picosecond and femtosecond duration with soft and hard tissue, as this unexplored field is expected to be a potential alternative in powerful laser processing of biomedical structures.
   The experimental results obtained, including ablation rates, ablation wavelength dependence, pulse duration dependence, fluence dependence, etc. are presented These results are discussed according to simple theoretical models of laser energy absorption and the possible mechanisms of ultrashort pulse laser ablation, which in some cases involves multiphoton photodissociation processes. Finally, the design characteristics of the lasers employed in our experiments, are stated briefly.
RP Serafetinides, AA (reprint author), NATL TECH UNIV ATHENS,DEPT PHYS,LASER & APPLICAT LAB,ZOGRAFOU CAMPUS,GR-15773 ATHENS,GREECE.
NR 0
TC 0
Z9 0
U1 0
U2 3
PU SPIE - INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA PO BOX 10, BELLINGHAM, WA 98227-0010
BN 0-8194-2466-8
J9 P SOC PHOTO-OPT INS
PY 1996
VL 3052
BP 111
EP 123
DI 10.1117/12.262907
PG 3
WC Optics; Physics, Applied
SC Optics; Physics
GA BH07B
UT WOS:A1996BH07B00010
DA 2018-10-20
ER

PT J
AU Shintani, H
AF Shintani, H
TI Formation and elution of toxic compounds from sterilized medical
   products: Toxic compound formation from irradiated products
SO RADIATION PHYSICS AND CHEMISTRY
LA English
DT Article
ID POLY(ETHER URETHANE UREA); BIOMEDICAL APPLICATIONS; GAMMA-RAY;
   POLYURETHANES; 4,4'-METHYLENEDIANILINE; DEGRADATION;
   4,4'-DIAMINODIPHENYLMETHANE; BIODEGRADATION; MUTAGENICITY
AB No formation of MDA was observed in chain-extended thermoplastic polyurethane (PU) when sterilized by autoclave or gamma-ray irradiation. No formation of MDA was observed in nonchain-extended thermoplastic PU when sterilized by gamma-ray irradiation. Less than 1 ppm MDA was produced in nonchain-extended thermoplastic PU sterilized by autoclave sterilization. Autoclave sterilization did not produce MDA in thermosetting PU potting material. MDA formation in potting material was promoted by gamma-ray irradiation and increased with increasing irradiation at a quadratic equation of regression. MDA formation at 100 kGy irradiation is a few ppm and <1 ppm at 25 kGy irradiation, therefore the potential risk to human recipients was not significant. The elution of compounds other than MDA from potting material was more problematic. Solvent extracts from potting material presented mutagenicity in the absence of metabolic activity. MDA presented mutagenicity in the presence of metabolic activity, therefore MDA was not the mutagenic trigger. The chemical and biological characteristics of the specific mutagens required to identify in a further study. Negative promotion of MDA formation and a lesser presence of mutagen in autoclave sterilized potting material indicated that autoclave sterilization was preferable.
RP Shintani, H (reprint author), NATL INST HLTH SCI,DEPT MED DEVICES,SETAGAYA KU,1-18-1 KAMIYOGA,TOKYO 158,JAPAN.
CR BRUCK SD, 1988, J BIOMED MATER RES-A, V22, P133, DOI 10.1002/jbm.820221306
   COCKER J, 1988, J ANAL TOXICOL, V12, P9, DOI 10.1093/jat/12.1.9
   Coury A J, 1988, J Biomater Appl, V3, P130, DOI 10.1177/088532828800300202
   CUNNINGHAM ML, 1990, CHEM RES TOXICOL, V3, P159
   DARBY TD, 1978, TOXICOL APPL PHARM, V46, P449, DOI 10.1016/0041-008X(78)90090-X
   DEICHMANN WB, 1978, TOXICOLOGY, V11, P185, DOI 10.1016/S0300-483X(78)91089-2
   ERNES DA, 1983, ANAL CHEM, V55, P408, DOI 10.1021/ac00253a062
   FROMMELT H, 1987, MAKROMOL CHEM-M SYMP, V12, P281, DOI 10.1002/masy.19870120114
   GOGOLEWSKI S, 1989, COLLOID POLYM SCI, V267, P757, DOI 10.1007/BF01410115
   Gogolewski S., 1991, TRENDS POLYM SCI, V1, P47
   GOHLKE R, 1974, INT ARCH ARBEITSMED, V32, P217, DOI 10.1007/BF00539338
   GOLBERG L, 1986, HAZARD ASSESSMENT ET
   GRIESSER HJ, 1991, POLYM DEGRAD STABIL, V33, P329, DOI 10.1016/0141-3910(91)90080-B
   HO T, 1979, ENVIRON MUTAGEN, V1, P167
   Hu C. B., 1980, AM CHEM SOC DIV POLY, V21, P156
   Huff J. E., 1983, PROGR CLIN BIOL RES, V141, P347
   KOPELMAN H, 1966, BMJ-BRIT MED J, V1, P514, DOI 10.1136/bmj.1.5486.514
   Kopelman H., 1966, Q J MED, V53, P553
   LAI YC, 1991, J APPL POLYM SCI, V42, P3173, DOI 10.1002/app.1991.070421210
   LAMB JC, 1986, J TOXICOL ENV HEALTH, V18, P325, DOI 10.1080/15287398609530874
   LELAH MD, 1987, POLYURETHANES MED
   MARCHANT RE, 1987, POLYMER, V28, P2032, DOI 10.1016/0032-3861(87)90037-1
   MAZZU AL, 1984, J BIOMED MATER RES, V18, P961, DOI 10.1002/jbm.820180810
   MCGILL DB, 1974, NEW ENGL J MED, V291, P278, DOI 10.1056/NEJM197408082910604
   Mizutani H., 1960, HDB PLASTIC MANUFACT
   NYSTROM B, 1991, AM J MED, V91, pS264, DOI 10.1016/0002-9343(91)90379-C
   O'Mara M. M., 1984, PROG BIOMED ENG, V1, P83
   OKAMURA S, 1969, RAD CHEM POLYM SYSTE, V15
   PETROVIC ZS, 1984, J APPL POLYM SCI, V29, P1031, DOI 10.1002/app.1984.070290401
   Phus S. K., 1987, J BIOMED MATER RES, V21, P231
   PLUDRO G, 1969, ACTA POL PHARM, V26, P353
   RAO TK, 1982, ARCH TOXICOL, V49, P185, DOI 10.1007/BF00347866
   Ratner B. D., 1983, PHYSICOCHEMICAL ASPE, P969
   RATNER BD, 1981, ACS SYM SER, V162, P371
   SHINTANI H, 1989, J ANAL TOXICOL, V13, P354, DOI 10.1093/jat/13.6.354
   SHINTANI H, 1990, J APPL POLYM SCI, V41, P661, DOI 10.1002/app.1990.070410316
   SHINTANI H, 1989, FRESEN Z ANAL CHEM, V333, P637, DOI 10.1007/BF00496937
   SHINTANI H, 1991, J BIOMED MATER RES, V25, P1275, DOI 10.1002/jbm.820251008
   SHINTANI H, 1995, J APPL POLYM SCI, V42, P1979
   Shintani H, 1994, OHIO SCI WORKBOOKS P
   SHINTANI H, 1995, IN PRESS J RAD STERI
   SMITH R, 1987, J BIOMED MATER RES, V21, P1149, DOI 10.1002/jbm.820210908
   STEINHOFF D, 1970, NATURWISSENSCHAFTEN, V57, P247, DOI 10.1007/BF01010277
   TAKAHARA A, 1991, BIOMATERIALS, V12, P324, DOI 10.1016/0142-9612(91)90042-9
   WALL LA, 1955, J POLYM SCI, V17, P141, DOI 10.1002/pol.1955.120178318
   Williams N., 1974, NEW ENGL J MED, V291, P1256
   YOSHII F, 1985, J APPL POLYM SCI, V30, P3339, DOI 10.1002/app.1985.070300816
   ZHAO Q, 1987, POLYMER, V28, P2040, DOI 10.1016/0032-3861(87)90038-3
NR 48
TC 8
Z9 8
U1 0
U2 2
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
J9 RADIAT PHYS CHEM
JI Radiat. Phys. Chem.
PD JAN
PY 1996
VL 47
IS 1
BP 139
EP 148
DI 10.1016/0969-806X(94)00135-7
PG 10
WC Chemistry, Physical; Nuclear Science & Technology; Physics, Atomic,
   Molecular & Chemical
SC Chemistry; Nuclear Science & Technology; Physics
GA TC695
UT WOS:A1996TC69500026
DA 2018-10-20
ER

PT J
AU Fareed, J
AF Fareed, J
TI Current trends in antithrombotic drug and device development
SO SEMINARS IN THROMBOSIS AND HEMOSTASIS
LA English
DT Article
DE antithrombotic drugs; heparin; hirudin; antiplatelet; biotechnology
ID MOLECULAR MARKERS; HEPARIN FRACTIONS; ANTICOAGULANT-THERAPY; VEIN
   THROMBOSIS; PERSPECTIVES; ACTIVATION; FRAGMENTS; HIRUDIN
AB During the past decade, many significant developments in the clinical management of thrombotic and vascular disorders have occurred. In particular, several newer approaches for the prophylactic and therapeutic management of such disorders as venous thrombosis, acute myocardial infarction, and stroke have been introduced. This has been possible because of the understanding of the molecular mechanisms involved in the thrombogenic process, which plays a key role in the pathophysiology of thrombotic and vascular disorders. With the increased knowledge of the pathophysiology of thrombosis have come advances in drug treatment possibilities. Advances in biotechnology and separation techniques have contributed to the development of many newer antithrombotic, anticoagulant, and thrombolytic drugs. Many new drugs and devices based on newer concepts are currently being tested in various clinical trials. Hirudin, hirulog, GPIIb/IIIa targeting antibodies, and tissue factor pathway inhibitor are some examples. From these current developments, it can be appreciated that antithrombotic drugs represent a wide spectrum of natural, synthetic, semisynthetic, and biotechnology-produced agents with marked differences in chemical composition, physicochemical properties, biochemical actions, and pharmacologic effects. The use of physical means to treat thrombotic disorders and advanced means of drug delivery add to the expanding nature of treatment, The endogenous actions of the antithrombotic drugs are quite complex. It is no longer valid to assume that an antithrombotic drug must produce an anticoagulant action in blood, as do the classical heparin and oral anticoagulants. Many of these new drugs do not produce any alteration of currently measurable blood-clotting parameters, yet they are effective therapeutic agents because of their interactions with the elements of the blood and the vasculature. Another perspective is that several of these agents require endogenous transformation to become active products. Therefore, it becomes important to rely on the pharmacodynamic actions of these agents rather than on other in vitro characteristics to assess potency or efficacy. Hematologic and vascular modulation play a key role in the mediation of the antithrombotic actions of these drugs, involving red cells, white cells, platelets, endothelial cells, and blood;proteins. Thus, an optimal antithrombotic drug approach will include the targeting of ail possible sites involved in thrombogenesis. Antithrombotic and anticoagulant drugs will also be useful in the development of such biomedical devices as stents and other vascular support material. Polytherapeutic approaches utilizing combinations of drugs may turn out to be the most effective in the management of thrombotic disorders.
C1 LOYOLA UNIV, MED CTR, DEPT PHARMACOL, MAYWOOD, IL 60153 USA.
RP Fareed, J (reprint author), LOYOLA UNIV, MED CTR, DEPT PATHOL, 2160 S 1ST AVE, MAYWOOD, IL 60153 USA.
CR FAREED J, 1985, SEMIN THROMB HEMOST, V11, P227, DOI 10.1055/s-2007-1004380
   FAREED J, 1980, CLIN CHEM, V26, P1380
   FAREED J, 1983, SEMIN THROMB HEMOST, V9, P355
   FAREED J, 1989, SEMIN THROMB HEMOST, V15, P230, DOI 10.1055/s-2007-1002710
   FAREED J, 1984, NOUV REV FR HEMATOL, V26, P267
   FAREED J, 1985, SEMIN THROMB HEMOST, V11, P1, DOI 10.1055/s-2007-1004350
   FAREED J, 1983, CLIN CHEM, V29, P1641
   FAREED J, 1986, SEMIN THROMB HEMOST, V12, P102, DOI 10.1055/s-2007-1003542
   FAREED J, 1986, MED J AUSTRALIA, V144, pHS21
   FAREED J, 1981, PERSPECTIVES HEMOSTA, P310
   FAREED J, 1983, SEMIN THROMB HEMOST, V9, P379
   FAREED J, 1986, THROMBOSIS HEMORRHAG, P83
   FAREED J, 1983, SEMIN THROMB HEMOST, V8, P288
   HULL R, 1983, ARCH INTERN MED, V143, P2061, DOI 10.1001/archinte.143.11.2061
   LAGERSTEDT CI, 1985, LANCET, V2, P515
   MARKWARDT F, 1986, ANN NY ACAD SCI, V485, P204, DOI 10.1111/j.1749-6632.1986.tb34582.x
   MARKWARDT F, 1985, BIOMED BIOCHIM ACTA, V44, P1007
   MARKWARDT F, 1988, PHARMAZIE, V43, P202
   MESSMORE HL, 1984, SEMIN THROMB HEMOST, V10, P264, DOI 10.1055/s-2007-1004431
   PETITTI DB, 1986, AM J MED, V81, P255, DOI 10.1016/0002-9343(86)90260-3
   SUAREZ CR, 1984, SEMIN THROMB HEMOST, V10, P280, DOI 10.1055/s-2007-1004433
   SUMMARIA L, 1988, AM SURGEON, V54, P156
   ULUTIN ON, 1986, THROMBOSIS HEMORRHAG, P101
   WALENGA JM, 1986, CRC CR REV CL LAB SC, V22, P361
   WALENGA JM, 1983, SEMIN THROMB HEMOST, V9, P346
   1988, LANCET, V13, P349
NR 26
TC 10
Z9 10
U1 1
U2 2
PU THIEME MEDICAL PUBL INC
PI NEW YORK
PA 333 SEVENTH AVE, NEW YORK, NY 10001 USA
SN 0094-6176
EI 1098-9064
J9 SEMIN THROMB HEMOST
JI Semin. Thromb. Hemost.
PY 1996
VL 22
SU 1
BP 3
EP 8
PG 6
WC Hematology; Peripheral Vascular Disease
SC Hematology; Cardiovascular System & Cardiology
GA UV124
UT WOS:A1996UV12400002
PM 8807721
DA 2018-10-20
ER

PT J
AU Chan, CM
   Ko, TM
   Hiraoka, H
AF Chan, CM
   Ko, TM
   Hiraoka, H
TI Polymer surface modification by plasmas and photons
SO SURFACE SCIENCE REPORTS
LA English
DT Review
ID GLOW-DISCHARGE POLYMERIZATION; AMMONIA GASEOUS PLASMA; EXCIMER LASER
   ABLATION; LOW-TEMPERATURE-PLASMA; ION MASS-SPECTROMETRY; OXYGEN PLASMA;
   PLATELET-ADHESION; POLY(METHYL METHACRYLATE); ENZYME-IMMOBILIZATION;
   INTRAOCULAR LENSES
AB Polymers have been applied successfully in fields such as adhesion, biomaterials, protective coatings, friction and wear, composites, microelectronic devices, and thin-film technology. In general, special surface properties with regard to chemical composition, hydrophilicity, roughness, crystallinity, conductivity, lubricity, and cross-linking density are required for the success of these applications. Polymers very often do not possess the surface properties needed for these applications. However, they have excellent bulk physical and chemical properties, are inexpensive, and are easy to process. For these reasons, surface modification techniques which can transform these inexpensive materials into highly valuable finished products have become an important part of the plastics and many other industries. In recent years, many advances have been made in developing surface treatments to alter the chemical and physical properties of polymer surfaces without affecting bulk properties. Common surface modification techniques include treatments by flame, corona, plasmas, photons, electron beams, ion beams, X-rays, and gamma-rays.
   Plasma treatment is probably the most versatile surface treatment technique. Different types of gases such as argon, oxygen, nitrogen, fluorine, carbon dioxide, and water can produce the unique surface properties required by various applications. For example, oxygen-plasma treatment can increase the surface energy of polymers, whereas fluorine-plasma treatment can decrease the surface energy and improve the chemical inertness. Cross-linking at a polymer surface can be introduced by an inert-gas plasma. Modification by plasma treatment is usually confined to the top several hundred angstroms and does not affect the bulk properties. The main disadvantage of this technique is that it requires a vacuum system, which increases the cost of operation.
   Thin polymer films with unique chemical and physical properties are produced by plasma polymerization. This technology is still in its infancy, and the plasma chemical process is not fully understood. The films are prepared by vapor phase deposition and can be formed on practically any substrate with good adhesion between the film and the substrate. These films, which are usually highly cross-linked and pinhole-free, have very good barrier properties. Such films find great potential in biomaterial applications and in the microelectronics industry.
   Very high-power microwave-driven mercury lamps are available, and they are used in UV-hardening of photoresist patterns for image stabilization at high temperatures. Other applications of UV irradiation include surface photo-oxidation, increase of hydrophilicity, and photocuring of paintings.
   Pulsed UV-lasers are used in surface modification in many areas. Pulsed UV-laser irradiation can produce submicron periodic linear and dot patterns on polymer surfaces without photomask. These interference patterns can be used to increase surface roughness of inert polymers for improved adhesion. These images can also be transferred to silicon surfaces by reactive ion etching. Pulsed laser beams can be applied to inert polymer surfaces for increased hydrophilicity and wettability. Polymer surfaces treated by pulsed UV-laser irradiation can be positively or negatively charged to enhance chemical reactivity and processability. Pulsed UV-laser exposures with high fluence give rise to photoablation with a clean wall profile. There are many other practical applications of laser photoablation, including via-hole fabrication, and diamond-film deposition. The present review discusses all these current applications, especially in the biomedical and microelectronics areas.
C1 HONG KONG UNIV SCI & TECHNOL, DEPT CHEM, KOWLOON, HONG KONG.
RP Chan, CM (reprint author), HONG KONG UNIV SCI & TECHNOL, DEPT CHEM ENGN, KOWLOON, HONG KONG.
CR ALLING E, 1985, P SOC PHOTO-OPT INST, V539, P194
   ASFARDJANI K, 1991, J APPL POLYM SCI, V43, P271, DOI 10.1002/app.1991.070430206
   BACHMANN F, 1990, EUR MAT RES SOC 1990
   BAIK KH, 1994, J PHOTOPOLYM SCI TEC, V7, P517
   BIEG KW, 1980, SOL ENERG MATER, V3, P301, DOI 10.1016/0165-1633(80)90068-4
   BIRCH AD, 1983, MICROELECTRON MANUF, V6, P20
   BLAIS PD, 1983, P SOC PHOTO-OPT INS, V333, P20
   BOLLE M, 1993, J APPL PHYS, V73, P3516, DOI 10.1063/1.352957
   BRADLEY A, 1975, ANAL CHEM, V47, P1838, DOI 10.1021/ac60361a044
   BRENNAN WJ, 1991, POLYMER, V32, P1527, DOI 10.1016/0032-3861(91)90436-M
   BRINEN JS, 1991, SURF INTERFACE ANAL, V17, P63, DOI 10.1002/sia.740170202
   Chan C. M, 1994, POLYM SURFACE MODIFI
   CHAPPELL PJC, 1991, SURF INTERFACE ANAL, V17, P143, DOI 10.1002/sia.740170305
   CHEN KS, 1982, J APPL POLYM SCI, V27, P4655, DOI 10.1002/app.1982.070271212
   CHO DL, 1990, J APPL POLYM SCI, V41, P1373, DOI 10.1002/app.1990.070410702
   CHO DL, 1988, J APPL POLYM SCI APP, V42, P139
   CHUANG TJ, 1988, APPL PHYS A-MATER, V45, P277, DOI 10.1007/BF00617932
   CLARK DT, 1979, J POLYM SCI POL CHEM, V17, P957, DOI 10.1002/pol.1979.170170404
   CLARK DT, 1975, J POLYM SCI POL CHEM, V13, P857, DOI 10.1002/pol.1975.170130408
   CLARK DT, 1979, J POLYM SCI POL CHEM, V17, P1317, DOI 10.1002/pol.1979.170170507
   CLARK DT, 1987, J POLYM SCI POL CHEM, V25, P2643, DOI 10.1002/pola.1987.080251002
   CLARK DT, 1980, J POLYM SCI POL CHEM, V18, P27, DOI 10.1002/pol.1980.170180103
   CLARK DT, 1977, J POLYM SCI POL CHEM, V15, P2321, DOI 10.1002/pol.1977.170151004
   CLARK DT, 1978, J POLYM SCI POL CHEM, V16, P911, DOI 10.1002/pol.1978.170160506
   Clark DT, 1978, POLYM SURFACES, P185
   COBURN JW, 1979, IBM J RES DEV, V23, P33, DOI 10.1147/rd.231.0033
   COLLINS GCS, 1973, EUR POLYM J, V9, P1173, DOI 10.1016/0014-3057(73)90120-1
   CORN S, 1991, J ADHES SCI TECHNOL, V5, P239, DOI 10.1163/156856191X00170
   d'Agostino R., 1990, PLASMA DEPOSITION TR, P95
   d'Agostino R, 1982, PLASMA CHEM PLASMA P, V2, P213
   DAGOSTINO R, 1983, J APPL PHYS, V54, P1284, DOI 10.1063/1.332193
   DAUTARTAS MF, 1987, J ELECTROANAL CHEM, V219, P71, DOI 10.1016/0022-0728(87)85032-5
   DEMURA M, 1992, BIOMATERIALS, V13, P276, DOI 10.1016/0142-9612(92)90050-X
   DONOHOE KG, 1979, J APPL POLYM SCI, V23, P2591, DOI 10.1002/app.1979.070230905
   EGITTO FD, 1990, PURE APPL CHEM, V62, P1699, DOI 10.1351/pac199062091699
   EPAILLARD F, 1989, J APPL POLYM SCI, V38, P887, DOI 10.1002/app.1989.070380510
   ERTEL SI, 1990, J BIOMED MATER RES, V24, P1637, DOI 10.1002/jbm.820241207
   Evans J.R.G., 1987, J ADHES SCI TECHNOL, V1, P291
   FAKES DW, 1988, SURF INTERFACE ANAL, V13, P233, DOI 10.1002/sia.740130411
   FOERCH R, 1991, J ADHES SCI TECHNOL, V5, P549, DOI 10.1163/156856191X00747
   FOERCH R, 1990, J APPL POLYM SCI, V40, P1903, DOI 10.1002/app.1990.070401109
   FOERCH R, 1990, J POLYM SCI POL CHEM, V28, P803, DOI 10.1002/pola.1990.080280409
   FUKUMURA H, 1991, APPL PHYS A-MATER, V53, P255, DOI 10.1007/BF00324261
   GARFINKLE AM, 1984, T AM SOC ART INT ORG, V30, P432
   GERENSER LJ, 1993, J ADHES SCI TECHNOL, V7, P10
   GEUSKENS G, 1978, EUR POLYM J, V14, P291, DOI 10.1016/0014-3057(78)90051-4
   GIROUX TA, 1991, J APPL POLYM SCI, V43, P145, DOI 10.1002/app.1991.070430112
   GOMBOTZ WR, 1988, J APPL POLYM SCI APP, V42, P285
   GRANT JL, 1988, J VAC SCI TECHNOL A, V6, P2213, DOI 10.1116/1.575013
   GRIFFING BF, 1983, P SOC PHOTO-OPT INS, V394, P33
   HANSEN RH, 1966, J POLYM SCI POL LETT, V4, P203, DOI 10.1002/pol.1966.110040309
   HASIRCI N, 1987, J APPL POLYM SCI, V34, P2457, DOI 10.1002/app.1987.070340710
   HASIRCI N, 1987, J APPL POLYM SCI, V34, P1135, DOI 10.1002/app.1987.070340322
   HETTLICH HJ, 1991, BIOMATERIALS, V12, P521, DOI 10.1016/0142-9612(91)90153-2
   HIRAOKA H, 1989, J VAC SCI TECHNOL B, V7, P1760, DOI 10.1116/1.584453
   HIRAOKA H, 1981, J ELECTROCHEM SOC, V128, P2645, DOI 10.1149/1.2127321
   HIRAOKA H, 1981, J VAC SCI TECHNOL, V19, P1132, DOI 10.1116/1.571183
   HIRAOKA H, 1994, APPL PHYS LETT, V64, P563, DOI 10.1063/1.111104
   Hiraoka H., 1987, Proceedings of the SPIE - The International Society for Optical Engineering, V771, P174
   Hiraoka H., 1987, Microelectronic Engineering, V6, P407, DOI 10.1016/0167-9317(87)90066-9
   HIRAOKA H, 1994, JPN J APPL PHYS 1, V33, P7135, DOI 10.1143/JJAP.33.7135
   HIRAOKA H, 1991, MATER RES SOC SYMP P, V227, P329, DOI 10.1557/PROC-227-329
   Hiraoka H, 1989, PHOTOCHEMISTRY SOLID, P448
   HIRAOKA H, 1994, MAT MANUF PROCESSES, V9, P467
   HIRAOKA H, UNPUB MICROGRAPH TAK
   HIRAOKA H, 1989, PHOTOCHEMISTRY SOLID
   HIRAOKA H, 1984, P 10 INT C EL ION BE, P171
   HIRAOKA H, 1987, 172 M EL SOC OCT 19
   HIRAOKA H, 1993, JPN J APPL PHYS, V32, P6182
   HIROTSU T, 1980, J ADHESION, V11, P57, DOI 10.1080/00218468008078904
   HO CP, 1988, J BIOMED MATER RES, V22, P919, DOI 10.1002/jbm.820221007
   HO CP, 1990, J APPL POLYM SCI, V39, P1541, DOI 10.1002/app.1990.070390712
   HOFFMAN AS, 1988, J APPL POLYM SCI APP, V42, P251
   HOLLAHAN JR, 1969, J APPL POLYM SCI, V13, P807, DOI 10.1002/app.1969.070130419
   HSIEH YL, 1989, J APPL POLYM SCI, V38, P1719, DOI 10.1002/app.1989.070380911
   HULT A, 1985, MACROMOLECULES, V18, P1804, DOI 10.1021/ma00152a003
   INAGAKI N, 1983, J APPL POLYM SCI, V28, P3629, DOI 10.1002/app.1983.070281204
   INAGAKI N, 1990, J ADHES SCI TECHNOL, V4, P99, DOI 10.1163/156856190X00126
   INAGAKI N, 1989, J ADHES SCI TECHNOL, V3, P637, DOI 10.1163/156856189X00461
   INAGAKI N, 1986, J POLYM SCI POL LETT, V24, P447, DOI 10.1002/pol.1986.140240903
   INAGAKI N, 1985, J APPL POLYM SCI, V30, P3385, DOI 10.1002/app.1985.070300821
   INAGAKI N, 1987, J POLYM SCI POL CHEM, V25, P1803, DOI 10.1002/pola.1987.080250709
   INAGAKI N, 1984, POLYM BULL, V12, P437
   Inagaki N., 1982, INT J ADHES ADHES, V2, P169
   INOUE H, 1990, J APPL POLYM SCI, V41, P1815, DOI 10.1002/app.1990.070410737
   INYAMA Y, 1988, J APPL POLYM SCI APP, V42, P97
   ISHIKAWA Y, 1985, MAKROMOL CHEM-RAPID, V6, P495
   ITO H, 1982, SPE REG TECH C ELL N
   KATNANI AD, 1989, J ADHES SCI TECHNOL, V3, P441, DOI 10.1163/156856189X00326
   KAWAKAMI M, 1988, BIOTECHNOL BIOENG, V32, P369, DOI 10.1002/bit.260320316
   KIAEI D, 1992, J BIOMAT SCI-POLYM E, V4, P35
   KIAEI D, 1992, RADIAT PHYS CHEM, V39, P463
   KNICKMEYER WW, 1974, J APPL POLYM SCI, V18, P301, DOI 10.1002/app.1974.070180126
   KNOP A, 1979, CHEM APPLICATION PHE
   KO TM, 1993, BIOMATERIALS, V14, P657
   KO TM, 1993, J APPL POLYM SCI, V47, P1601, DOI 10.1002/app.1993.070470908
   KO TM, 1993, J COLLOID INTERF SCI, V156, P207, DOI 10.1006/jcis.1993.1101
   KO TM, 1994, FRONTIERS OF POLYMERS AND ADVANCED MATERIALS, P439
   KO TM, 1991, THESIS U WISCONSIN M
   KUMAGAI H, 1993, J APPL PHYS, V73, P1971, DOI 10.1063/1.353161
   LAI JY, 1989, J APPL POLYM SCI, V37, P1465, DOI 10.1002/app.1989.070370603
   LAOHAROJANAPHAND P, 1990, J APPL POLYM SCI, V40, P369, DOI 10.1002/app.1990.070400306
   LATSCH S, 1994, MATER RES SOC S P, V312, P239
   LEE JH, 1991, BIOMATERIALS, V12, P443
   LIEPINS R, 1981, J VAC SCI TECHNOL, V18, P1218, DOI 10.1116/1.570897
   LOH IH, 1987, POLYM ENG SCI, V27, P861, DOI 10.1002/pen.760271115
   LUB J, 1989, J POLYM SCI POL CHEM, V27, P4035, DOI 10.1002/pola.1989.080271213
   LUB J, 1989, POLYMER, V30, P40, DOI 10.1016/0032-3861(89)90380-7
   LUB J, 1989, POLYMER, V30, P35
   MA WHL, 1980, Patent No. 4187331
   MACDONALD SA, 1985, P SPE REGIONAL TECHN, P177
   MARCHANT RE, 1988, J APPL POLYM SCI APP, V42, P125
   MATIENZO LJ, 1988, J VAC SCI TECHNOL A, V6, P950, DOI 10.1116/1.575037
   MATZAKIS M, 1980, MICR ENG P AMST, P439
   McColgin W. C., 1988, Proceedings of the SPIE - The International Society for Optical Engineering, V920, P260
   MOMOSE Y, 1988, J APPL POLYM SCI APP, V42, P49
   MORITA S, 1979, J POLYM SCI POL CHEM, V17, P2775, DOI 10.1002/pol.1979.170170914
   MORITA S, 1985, PURE APPL CHEM, V57, P1277, DOI 10.1351/pac198557091277
   MORITZ H, 1978, Patent No. 4104070
   MORRA M, 1989, J COLLOID INTERF SCI, V132, P504, DOI 10.1016/0021-9797(89)90264-6
   MORRA M, 1990, SURF INTERFACE ANAL, V16, P412, DOI 10.1002/sia.740160186
   MORRA M, 1990, J COLLOID INTERF SCI, V137, P11, DOI 10.1016/0021-9797(90)90038-P
   MOSHONOV A, 1980, J APPL POLYM SCI, V25, P771, DOI 10.1002/app.1980.070250506
   MUNRO HS, 1988, J COATING TECHNOL, V60, P41
   MUNRO HS, 1987, POLYM COMMUN, V28, P339
   MURATSUGU M, 1991, J COLLOID INTERF SCI, V147, P378, DOI 10.1016/0021-9797(91)90170-D
   MUTLU M, 1991, J MATER CHEM, V1, P447, DOI 10.1039/jm9910100447
   NAKAJIMA K, 1979, J APPL POLYM SCI, V23, P2627, DOI 10.1002/app.1979.070230908
   NAKAYAMA Y, 1988, J POLYM SCI POL CHEM, V26, P559, DOI 10.1002/pola.1988.080260219
   NIEHUIS E, 1989, SURF INTERFACE ANAL, V14, P135, DOI 10.1002/sia.740140307
   NIINO H, 1989, APPL PHYS LETT, V55, P510, DOI 10.1063/1.101863
   NIINO H, 1993, APPL PHYS LETT, V63, P3527, DOI 10.1063/1.110091
   NIINO H, 1989, APPL PHYS LETT, V54, P2159, DOI 10.1063/1.101154
   NIINO H, 1992, APPL PHYS LETT, V60, P2697, DOI 10.1063/1.106877
   OCCHIELLO E, 1988, POLYMER, V29, P2277, DOI 10.1016/0032-3861(88)90122-X
   OCCHIELLO E, 1989, J PHYS D APPL PHYS, V22, P983, DOI 10.1088/0022-3727/22/7/018
   OCCHIELLO E, 1991, J APPL POLYM SCI, V42, P2045, DOI 10.1002/app.1991.070420732
   OHKUBO J, 1990, J APPL POLYM SCI, V41, P349, DOI 10.1002/app.1990.070410127
   OKOSHI M, 1992, J MATER RES, V7, P1912, DOI 10.1557/JMR.1992.1912
   OSADA Y, 1987, THIN SOLID FILMS, V151, P71, DOI 10.1016/0040-6090(87)90010-1
   PETRAT FM, 1994, SURF INTERFACE ANAL, V21, P274, DOI 10.1002/sia.740210503
   PITTS J, 1964, PHOTOCHEMISTRY, P686
   PRATT KJ, 1989, J BIOMED MATER RES, V23, P1131, DOI 10.1002/jbm.820231004
   RENEKER DH, 1976, J MACROMOL SCI CHEM, VA 10, P599, DOI 10.1080/00222337608061202
   Roland B., 1987, Proceedings of the SPIE - The International Society for Optical Engineering, V771, P69
   Sanchez Urrutia M., 1988, J APPL POLYM SCI APP, V42, P305
   SCHONHORN H, 1967, J APPL POLYM SCI, V11, P1461, DOI 10.1002/app.1967.070110809
   SHAW JM, 1989, J VAC SCI TECHNOL B, V7, P1709, DOI 10.1116/1.584444
   SHEN M, 1979, ACS S SER, V108
   SHEN MS, 1992, J ADHES SCI TECHNOL, V6, P995
   SIMIONESCU BC, 1981, POLYM BULL, V4, P415, DOI 10.1007/BF00254973
   SIPEHIA R, 1988, J BIOMED MATER RES, V22, P417, DOI 10.1002/jbm.820220505
   SIPEHIA R, 1986, BIOMATERIALS, V7, P471, DOI 10.1016/0142-9612(86)90038-4
   SIPEHIA R, 1982, BIOMATER ARTIF CELL, V10, P229, DOI 10.3109/10731198209118783
   SOWELL RR, 1972, J ADHESION, V4, P15, DOI 10.1080/00218467208072207
   SPIERTZ E, 1984, MICROCIRCUIT WENG, V68, P1
   SRINIVASAN R, 1994, N-HOLLAND D, P137
   STERRETT TL, 1992, J MATER SCI-MATER M, V3, P402, DOI 10.1007/BF00701235
   STROBEL M, 1987, J POLYM SCI POL CHEM, V25, P1295, DOI 10.1002/pola.1987.080250508
   STROBEL M, 1987, J POLYM SCI POL CHEM, V25, P3343, DOI 10.1002/pola.1987.080251213
   STROBEL M, 1985, J POLYM SCI POL CHEM, V23, P1125, DOI 10.1002/pol.1985.170230417
   STROM DR, 1986, SEMICOND INT     MAY
   SUHR H, 1988, PLASMA CHEM PLASMA P, V8, P9, DOI 10.1007/BF01016927
   TANIGAWA S, 1991, J ADHES SCI TECHNOL, V5, P543, DOI 10.1163/156856191X00738
   TERLINGEN JGA, 1993, J COLLOID INTERF SCI, V155, P55, DOI 10.1006/jcis.1993.1009
   THOMPSON LF, 1972, J APPL POLYM SCI, V16, P1179, DOI 10.1002/app.1972.070160512
   THOMPSON LF, 1972, J APPL POLYM SCI, V16, P2317, DOI 10.1002/app.1972.070160912
   THOMPSON LF, 1972, J APPL POLYM SCI, V16, P2291, DOI 10.1002/app.1972.070160911
   TRAN CNB, 1989, J COLLOID INTERF SCI, V132, P373, DOI 10.1016/0021-9797(89)90252-X
   URY MG, 1983, OPTICAL MICROLITHOGR, V344, P241
   *USH EL, 1994, UER20172
   VANDERLAAN JS, 1991, INT J ARTIF ORGANS, V14, P661
   VARGO TG, 1989, J POLYM SCI POL CHEM, V27, P1267, DOI 10.1002/pola.1989.080270413
   VARGO TG, 1988, POLYM PREP-ACS, V2, P303
   VOLLENBROEK FA, 1983, POLYM ENG SCI, V23, P925, DOI 10.1002/pen.760231702
   WANG D, 1991, J APPL POLYM SCI, V42, P233, DOI 10.1002/app.1991.070420128
   WERTHEIMER MR, 1981, J APPL POLYM SCI, V26, P2087, DOI 10.1002/app.1981.070260630
   YADUSA H, 1977, J APPL POLYM, V21, P3167
   YAGI T, 1982, J APPL POLYM SCI, V27, P4019, DOI 10.1002/app.1982.070271032
   YAMAGISHI FG, 1981, THIN SOLID FILMS, V84, P427, DOI 10.1016/0040-6090(81)90183-8
   YAMAGISHI FG, 1991, THIN SOLID FILMS, V202, P39, DOI 10.1016/0040-6090(91)90539-A
   YAO YG, 1993, J ADHES SCI TECHNOL, V7, P63
   YASUDA H, 1977, J POLYM SCI POL CHEM, V15, P991, DOI 10.1002/pol.1977.170150420
   YASUDA H, 1978, J POLYM SCI POL CHEM, V16, P415, DOI 10.1002/pol.1978.170160212
   YASUDA H, 1977, J APPL POLYM SCI, V21, P3179, DOI 10.1002/app.1977.070211128
   YASUDA H, 1978, J POLYM SCI POL CHEM, V16, P313, DOI 10.1002/pol.1978.170160201
   YASUDA H, 1973, J APPL POLYM SCI, V17, P137, DOI 10.1002/app.1973.070170111
   YASUDA H, 1977, J APPL POLYM SCI, V21, P3139, DOI 10.1002/app.1977.070211124
   YASUDA H, 1978, J POLYM SCI POL CHEM, V16, P2587, DOI 10.1002/pol.1978.170161013
   Yasuda H., 1985, PLASMA POLYM
   YASUDA HK, 1990, PURE APPL CHEM, V63, P1689
   YASUDA T, 1988, J POLYM SCI POL PHYS, V26, P1781, DOI 10.1002/polb.1988.090260817
   YASUDA T, 1988, J POLYM SCI POL PHYS, V26, P2061, DOI 10.1002/polb.1988.090261004
   YEH YS, 1986, J POLYM SCI POL CHEM, V24, P3233, DOI 10.1002/pola.1986.080241208
   YEH YS, 1988, J BIOMED MATER RES, V22, P795, DOI 10.1002/jbm.820220904
   YOUNG JF, 1983, PHYS REV B, V27, P1155, DOI 10.1103/PhysRevB.27.1155
NR 196
TC 317
Z9 317
U1 16
U2 200
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-5729
J9 SURF SCI REP
JI Surf. Sci. Rep.
PY 1996
VL 24
IS 1-2
BP 3
EP 54
PG 52
WC Chemistry, Physical; Physics, Condensed Matter
SC Chemistry; Physics
GA UU393
UT WOS:A1996UU39300001
DA 2018-10-20
ER

PT J
AU Grosset, DG
   Georgiadis, D
   Kelman, AW
   Cowburn, P
   Stirling, S
   Lees, KR
   Faichney, A
   Mallinson, A
   Quin, R
   Bone, I
   Pettigrew, L
   Brodie, E
   MacKay, T
   Wheatley, DJ
AF Grosset, DG
   Georgiadis, D
   Kelman, AW
   Cowburn, P
   Stirling, S
   Lees, KR
   Faichney, A
   Mallinson, A
   Quin, R
   Bone, I
   Pettigrew, L
   Brodie, E
   MacKay, T
   Wheatley, DJ
TI Detection of microemboli by transcranial Doppler ultrasound
SO TEXAS HEART INSTITUTE JOURNAL
LA English
DT Article
DE cerebral arteries ultrasonography; cerebral embolism and thrombosis
   ultrasonography; heart valve prosthesis; ultrasonography, Doppler,
   transcranial
ID PROSTHETIC CARDIAC VALVES; ARTERY BYPASS-SURGERY; CARDIOPULMONARY
   BYPASS; INTRACRANIAL EMBOLI; CAROTID DISEASE; BJORK-SHILEY; SIGNALS
AB Doppler ultrasound detection of abnormally high-pitched signals within the arterial waveform offers a new method for diagnosis, and potentially for prediction, of embolic complications in at-risk patients. The nature of Doppler ''microembolic'' signals is of particular interest in patients with prosthetic heart valves, where a high prevalence of these signals is observed Monitoring the middle cerebral artery with 2-MHz transcranial Doppler ultrasound (TC-2000 Nicolet Biomedical; Warwick, UK), we looked for microemboli signals in 150 patients (95 women and 55 men), and found I or more signals during a 30-min recording in 89% of 70 patients with Bjork-Shiley valves (principally monostrut), 54% of 50 patients with Medtronic-Hall valves, and 50% of 30 patients with Carpentier-Edwards valves (p < 0.001, chi(2)). In the patients with Bjork-Shiley valves, the mean number of signals per hour was 59 (range, 42-86; 95% confidence interval), which was significantly higher than the mean in patients with Medtronic-Hall and Carpentier-Edwards valves (1.5 [range, 0.5-2.5] and 1 [range, 0-5.3], respectively; both p < 0.04, multiple comparisons, Bonferroni correction). In the patients undergoing serial pre- and postoperative studies, the causative role of the valve implant was emphasized. There was no correlation between the number of emboli signals and a prior history of neurologic deficit, cardiac rhythm, previous cardiac surgery, or the intensity of oral anticoagulation, in patients with prosthetic heart valves. In Bjork-Shiley patients, dual (mitral and aortic) valves were associated with more signals than were single valves. In Medtronic-Hall patients, the signal count was greater for valves in the aortic position than it was for valves in the mitral position. Comparative studies of Doppler emboli signals in other clinical settings suggest a difference in composition or size of the underlying material between prosthetic valve patients and patients with carotid stenosis. These studies also suggest that the signals are of gaseous origin in valve patients. The clinical significance of continuing microembolism remains to be determined.
RP Grosset, DG (reprint author), SO GEN HOSP,INST NEUROL SCI,DEPT NEUROL,GLASGOW G51 4TF,LANARK,SCOTLAND.
CR AASLID R, 1982, J NEUROSURG, V57, P769, DOI 10.3171/jns.1982.57.6.0769
   BLOOMFIELD P, 1986, CIRCULATION, V73, P1213, DOI 10.1161/01.CIR.73.6.1213
   Brown M M, 1994, J Heart Valve Dis, V3, P126
   CORTINA JM, 1986, J THORAC CARDIOV SUR, V91, P174
   DITULLIO M, 1993, STROKE, V24, P1020, DOI 10.1161/01.STR.24.7.1020
   GEORGIADIS D, 1993, STROKE, V24, P1664, DOI 10.1161/01.STR.24.11.1664
   GEORGIADIS D, 1994, STROKE, V25, P1211, DOI 10.1161/01.STR.25.6.1211
   GEORGIADIS D, 1994, EUR J VASCULAR SURG, V8, P309, DOI 10.1016/S0950-821X(05)80147-1
   GEORGIADIS D, 1994, STROKE, V25, P587, DOI 10.1161/01.STR.25.3.587
   GLEN SK, 1995, UNDERSEA HYPERBAR M, V22, P129
   Grosset D G, 1994, J Heart Valve Dis, V3, P128
   GROSSET DG, 1994, STROKE, V25, P382, DOI 10.1161/01.STR.25.2.382
   GROSSET DG, 1993, STROKE, V24, P1922, DOI 10.1161/01.STR.24.12.1922
   GROSSET DG, 1994, EUR J CARDIO-THORAC, V8, P63, DOI 10.1016/1010-7940(94)90092-2
   GROSSET DG, 1993, 5 M NEUR RES GROUP W
   GROSSET DG, 1995, 9 INT CER HEM S 1995
   HARRISON MJG, 1990, STROKE, V21, P1512, DOI 10.1161/str.21.10.1512a
   MacArthur K J, 1988, Eur J Cardiothorac Surg, V2, P143, DOI 10.1016/1010-7940(88)90062-0
   Mackay T G, 1995, J Heart Valve Dis, V4, P414
   MARKUS H, 1993, LANCET, V341, P784, DOI 10.1016/0140-6736(93)90561-T
   ORSINELLI DA, 1994, AM HEART J, V128, P990, DOI 10.1016/0002-8703(94)90599-1
   PADAYACHEE TS, 1987, ANN THORAC SURG, V44, P298, DOI 10.1016/S0003-4975(10)62077-2
   PUGSLEY W, 1994, STROKE, V25, P1393, DOI 10.1161/01.STR.25.7.1393
   PUGSLEY W, 1990, VASCULAR SURG, V24, P34, DOI 10.1177/153857449002400107
   SIEBLER M, 1993, BRAIN, V116, P1005, DOI 10.1093/brain/116.5.1005
   SIEBLER M, 1992, STROKE, V23, P1652, DOI 10.1161/01.STR.23.11.1652
   Spencer M P, 1969, Ann Thorac Surg, V8, P489
   SPENCER MP, 1969, JOM-J OCCUP MED, V11, P238
   SPENCER MP, 1992, TRANSCRANIAL DOPPLER, P215
   TEGELER CH, 1990, J CARDIOVASC TECHNOL, V9, P283
NR 30
TC 15
Z9 15
U1 0
U2 2
PU TEXAS HEART INST
PI HOUSTON
PA PO BOX 20345, HOUSTON, TX 77225-0345
SN 0730-2347
J9 TEX HEART I J
JI Tex. Heart Inst. J.
PY 1996
VL 23
IS 4
BP 289
EP 292
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA VY292
UT WOS:A1996VY29200009
PM 8969029
DA 2018-10-20
ER

PT B
AU Parthasarathi, S
   Tittmann, BR
AF Parthasarathi, S
   Tittmann, BR
BE Nair, CGK
   Raj, B
   Nurthy, CRL
   Jayakumar, T
TI Emerging applications of acoustic microscopy
SO TRENDS IN NDE SCIENCE AND TECHNOLOGY - PROCEEDINGS OF THE 14TH WORLD
   CONFERENCE ON NDT (14TH WCNDT), VOLS 1-5
LA English
DT Proceedings Paper
CT 14th World Conference on NDT - Trends in NDE Science and Technology
   (14th WCNDT)
CY DEC 08-13, 1996
CL NEW DELHI, INDIA
SP Int Comm NDT, Indian Soc Non Destruct Testing
DE acoustic microscopy; bond strength; coatings; films characterization
AB This paper reports on emerging applications of acoustic microscopy techniques for the quantitative characterization of coatings and films. Single and multi-layer films coatings are ideal materials in a variety of semiconductor, optical, display, biomedical and aerospace applications. As with any engineered structure, the properties of the coatings and their adhesion to each other and to the substrate are of critical importance. Theoretical models of wave propagation indicate the Rayleigh wave velocity at high frequencies are sensitive to the properties of coatings and their interface condition and could be used potentially to characterize the same.
RP Parthasarathi, S (reprint author), PENN STATE UNIV,DEPT ENGN SCI & MECH,227 HAMMOND BLDG,UNIVERSITY PK,PA 16802, USA.
NR 0
TC 1
Z9 1
U1 0
U2 0
PU A A BALKEMA
PI ROTTERDAM
PA PO BOX 1675, 3000 BR ROTTERDAM, NETHERLANDS
BN 90-5410-740-5
PY 1996
BP 227
EP 230
PG 4
WC Materials Science, Characterization & Testing
SC Materials Science
GA BH40Q
UT WOS:A1996BH40Q00039
DA 2018-10-20
ER

PT J
AU Causon, DM
AF Causon, DM
TI An efficient front-tracking algorithm for multi-component flow
   calculations with biomedical applications
SO ZEITSCHRIFT FUR ANGEWANDTE MATHEMATIK UND MECHANIK
LA English
DT Article; Proceedings Paper
CT 3rd International Congress on Industrial and Applied Mathematics (ICIAM
   95)
CY JUL 03-07, 1995
CL HAMBURG, GERMANY
SP Gesell Angew Math & Mech
ID SCHEMES; GODUNOV
AB A hybrid front-tracking algorithm has been developed for applications to shock wave propagation in gas/gas and gas/water media. The hybrid scheme resolves shock waves and rarefactions accurately and material fronts have aero width. The method is being used to study planar shock wave interaction with a gas bubble in water with applications to extracorporeal shock wave lithotripsy.
RP Causon, DM (reprint author), MANCHESTER METROPOLITAN UNIV,CTR MATH MODELING & FLOW ANAL,CHESTER ST,MANCHESTER M1 5GD,LANCS,ENGLAND.
RI Causon, Derek/H-4948-2012
CR GLIMM J, 1955, COMMUN PUR APPL MATH, P697
   HARTEN A, 1983, SIAM REV, V25, P35, DOI 10.1137/1025002
   KARNI S, 1994, J COMPUT PHYS, V112, P31, DOI 10.1006/jcph.1994.1080
   TAKAYAMA K, 1993, JPN J APPL PHYS 1, V32, P2192, DOI 10.1143/JJAP.32.2192
   VAN LEER B, 1984, SIAM J SCI STAT COMP, V5, P1, DOI 10.1137/0905001
NR 5
TC 4
Z9 4
U1 0
U2 1
PU AKADEMIE VERLAG GMBH
PI BERLIN
PA MUHLENSTRASSE 33-34, D-13187 BERLIN, GERMANY
SN 0044-2267
J9 Z ANGEW MATH MECH
JI Z. Angew. Math. Mech.
PY 1996
VL 76
SU 1
BP 371
EP 372
PG 2
WC Mathematics, Applied; Mechanics
SC Mathematics; Mechanics
GA VG254
UT WOS:A1996VG25400105
DA 2018-10-20
ER

PT J
AU Langer, R
AF Langer, R
TI Biomaterials and biomedical engineering
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article; Proceedings Paper
CT Symposium on Frontiers of Chemical Engineering Science, Commemorating
   the 50th Anniversary of Chemical Engineering Science
CY MAR 23-25, 1995
CL MIT, CAMBRIDGE, MA
SP Elsevier Sci Ltd, MIT, Dept Chem Engn
HO MIT
ID CONTROLLED-RELEASE POLYMER; DRUG-CARRIER MATRICES; BIOERODIBLE
   POLYANHYDRIDES; POLYSILOXANE NETWORKS; POLY(ETHYLENE OXIDE); POTENTIAL
   TREATMENT; HYDROGELS; DELIVERY; INVITRO; BLOOD
AB The current status and future prospects of biomaterials, in the context of chemical engineering science and biomedical engineering, is examined. Research on artificial organs, controlled drug delivery systems, tissue engineering, materials for minimally invasive surgery, medical contrast imaging agents, gene therapy, immobilized enzyme bioreactors, and biosensors is evaluated. Techniques for assessing the performance of biomaterials are considered. The role of new types of materials, not yet used in medicine, such as electrically conducting polymers, is discussed. Finally, an analysis of future educational and training issues in biomaterials in the context of chemical engineering is provided.
RP Langer, R (reprint author), MIT, DEPT CHEM ENGN, CAMBRIDGE, MA 02139 USA.
CR ANDERSON JL, 1978, J PHYS CHEM-US, V82, P608, DOI 10.1021/j100494a022
   BALLAL G, 1985, CHEM ENG SCI, V40, P1477, DOI 10.1016/0009-2509(85)80089-0
   BARRERA DA, 1993, J AM CHEM SOC, V115, P11010, DOI 10.1021/ja00076a077
   Bell CL, 1995, J CONTROL RELEASE, V37, P277, DOI 10.1016/0168-3659(95)00085-2
   BISSELL MJ, 1987, J CELL SCI, P327
   BRAZEL CS, 1994, MATER RES SOC SYMP P, V331, P211
   BREM H, 1991, J NEUROSURG, V74, P441, DOI 10.3171/jns.1991.74.3.0441
   BREM H, 1989, SELECT CANCER THER, V5, P55, DOI 10.1089/sct.1989.5.55
   BREM H, 1995, LANCET, V345, P1008, DOI 10.1016/S0140-6736(95)90755-6
   BREM H, 1988, AM ASS NEUROL SURG, P349
   Brenner H., 1993, MACROTRANSPORT PROCE
   BRITTON R A, 1968, Journal of Biomedical Materials Research, V2, P429, DOI 10.1002/jbm.820020403
   CHAIKOF EL, 1990, J COLLOID INTERF SCI, V137, P340, DOI 10.1016/0021-9797(90)90410-P
   CHANDRASAKARAN SK, J PHARM SCI, V71, P1399
   COHEN S, 1990, J AM CHEM SOC, V112, P7832, DOI 10.1021/ja00177a074
   COLTON C K, 1971, Journal of Biomedical Materials Research, V5, P459, DOI 10.1002/jbm.820050504
   COLTON C K, 1970, Chemical Engineering Progress Symposium Series, V66, P85
   Colton C. K., 1987, UREMIA THERAPY TECHN, P187
   COLTON CK, 1971, AICHE J, V17, P800, DOI 10.1002/aic.690170408
   COLTON CK, 1975, J LAB CLIN MED, V85, P355
   COLTON CK, 1981, KIDNEY, V2, P2425
   CONTARD P, 1993, J INVEST DERMATOL, V100, P35, DOI 10.1111/1523-1747.ep12349952
   CROOKS CA, 1990, J BIOMED MATER RES, V24, P1241, DOI 10.1002/jbm.820240908
   CUSSLER EL, 1983, CHEM ENG SCI, V38, P2027, DOI 10.1016/0009-2509(83)80106-7
   DACOSTA VS, 1980, J COLLOID INTERF SCI, V76, P594
   DEEN WM, 1994, P INT S COPNTROL REL, V21, P103
   DIMILLA PA, 1991, BIOPHYS J, V60, P15, DOI 10.1016/S0006-3495(91)82027-6
   DOMB AJ, 1988, MACROMOLECULES, V21, P1925, DOI 10.1021/ma00185a008
   DOMB AJ, 1987, J POLYM SCI POL CHEM, V25, P3373, DOI 10.1002/pola.1987.080251217
   DUNN JCY, 1992, J CELL BIOL, V116, P1043, DOI 10.1083/jcb.116.4.1043
   EDWARDS DA, 1994, J PHARM SCI, V83, P1315, DOI 10.1002/jps.2600830925
   FOLKMAN J, 1980, NATURE, V288, P551, DOI 10.1038/288551a0
   FREED LE, 1994, BIOTECHNOL BIOENG, V43, P605, DOI 10.1002/bit.260430710
   FREED LE, 1994, BIOTECHNOL BIOENG, V43, P597, DOI 10.1002/bit.260430709
   GIFFORD GH, 1976, J BIOMED MATER RES, V10, P857, DOI 10.1002/jbm.820100605
   GOTCH FA, 1972, NIH72103 DEP HLTH ED
   GREF R, 1994, SCIENCE, V263, P1600, DOI 10.1126/science.8128245
   Hansbrough John F., 1992, Journal of Burn Care and Rehabilitation, V13, P519, DOI 10.1097/00004630-199209000-00004
   HILLWEST JL, 1994, P NATL ACAD SCI USA, V91, P5967, DOI 10.1073/pnas.91.13.5967
   HILLWEST JL, 1994, OBSTET GYNECOL, V83, P59
   HSIEH DST, 1983, J PHARM SCI-US, V72, P17, DOI 10.1002/jps.2600720105
   HUBBELL JA, 1995, CHEM ENG NEWS, V73, P42, DOI 10.1021/cen-v073n011.p042
   KHARE AR, 1993, J BIOMAT SCI-POLYM E, V4, P275, DOI 10.1163/156856293X00564
   KLEIN E, 1977, J MEMBRANE SCI, V2, P349, DOI 10.1016/S0376-7388(00)83262-7
   KOST J, 1991, ADV DRUG DELIVER REV, V6, P19
   LABEQUE R, 1993, P NATL ACAD SCI USA, V90, P3476, DOI 10.1073/pnas.90.8.3476
   LANGER R, 1982, SCIENCE, V217, P261, DOI 10.1126/science.7089564
   LANGER R, 1990, SCIENCE, V249, P1527, DOI 10.1126/science.2218494
   LANGER R, 1976, NATURE, V263, P797, DOI 10.1038/263797a0
   Langer R, 1995, Tissue Eng, V1, P151, DOI 10.1089/ten.1995.1.151
   LANGER R, 1983, J MACROMOL SCI R M C, VC23, P61, DOI 10.1080/07366578308079439
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   LARSON RG, 1977, NATURE, V268, P409, DOI 10.1038/268409a0
   LAURENCIN CT, 1993, J ORTHOPAED RES, V11, P256, DOI 10.1002/jor.1100110213
   LAVIN A, 1985, SCIENCE, V230, P543, DOI 10.1126/science.4048947
   LEONARD EF, 1960, T AM SOC ART INT ORG, V6, P33
   LEONARD EF, 1974, 74605 DEP HLTH ED WE
   LEONARD EF, 1959, T NY ACAD SCI, V21, P585
   LEONG KW, 1986, J BIOMED MATER RES, V20, P51, DOI 10.1002/jbm.820200106
   LEONG KW, 1987, MACROMOLECULES, V20, P705, DOI 10.1021/ma00170a001
   LEONG KW, 1985, J BIOMED MATER RES, V19, P941, DOI 10.1002/jbm.820190806
   LIGHTFOOT EN, 1974, TRANSPORT PHENOMENA
   MCGRATH KP, 1992, J AM CHEM SOC, V114, P727, DOI 10.1021/ja00028a048
   MERRILL EW, 1970, J APPL PHYSIOL, V29, P723
   MERRILL EW, 1966, T AM SOC ART INT ORG, V12, P139
   MERRILL EW, 1992, POLYETHYLENE GLYCOL, P199
   MERRILL EW, 1982, J AM SOC ARTIF INT O, V6, P60
   MICHAELS A S, 1985, Journal of Controlled Release, V2, P405, DOI 10.1016/0168-3659(85)90062-8
   MICHAELS AS, 1975, AICHE J, V21, P985, DOI 10.1002/aic.690210522
   MICHAELS AS, 1976, PURE APPL CHEM, V46, P193, DOI 10.1351/pac197646020193
   PATHAK CP, 1992, J AM CHEM SOC, V114, P8311, DOI 10.1021/ja00047a065
   PEKALA RW, 1986, BIOMATERIALS, V7, P372, DOI 10.1016/0142-9612(86)90008-6
   PEPPAS NA, 1994, SCIENCE, V263, P1715, DOI 10.1126/science.8134835
   PISHKO MV, 1991, ANAL CHEM, V63, P2268, DOI 10.1021/ac00020a014
   POWELL EM, 1990, BRAIN RES, V515, P309, DOI 10.1016/0006-8993(90)90612-F
   PREIS I, 1979, J IMMUNOL METHODS, V28, P193, DOI 10.1016/0022-1759(79)90341-7
   RATNER BD, 1993, CARDIOVASC PATHOL, V2, pS87, DOI 10.1016/1054-8807(93)90049-8
   REMPP P, 1990, POLYM PREPR AM CHEM, V31, P215
   RHINE WD, 1980, CONTROLLED RELEASE B, P177
   RITGER P L, 1987, Journal of Controlled Release, V5, P23, DOI 10.1016/0168-3659(87)90034-4
   ROBERTSON C, ADV CHEM ENG, V16
   SALTZMAN WM, 1993, CRIT REV THER DRUG, V10, P111
   SAWHNEY AS, 1993, MACROMOLECULES, V26, P581, DOI 10.1021/ma00056a005
   SHAH N, 1986, CHEM ENG SCI, V41, P283, DOI 10.1016/0009-2509(86)87009-9
   SIMONS M, 1992, NATURE, V359, P67, DOI 10.1038/359067a0
   SULLIVAN SJ, 1991, SCIENCE, V252, P718, DOI 10.1126/science.2024124
   SUNG C, 1990, POLYMER, V31, P556, DOI 10.1016/0032-3861(90)90402-K
   SWEENEY LM, IN PRESS TOXIC VITRO
   TAMADA JA, 1993, P NATL ACAD SCI USA, V90, P552, DOI 10.1073/pnas.90.2.552
   TAMARGO RJ, 1989, J BIOMED MATER RES, V23, P253, DOI 10.1002/jbm.820230209
   VACANTI JP, 1988, J PEDIATR SURG, V23, P3, DOI 10.1016/S0022-3468(88)80529-3
   VUNJAKNOVAKOVIC G, IN PRESS AICHE J
   WHEATLEY MA, 1990, BIOMATERIALS, V11, P713, DOI 10.1016/0142-9612(90)90033-M
   WONG JY, 1994, P NATL ACAD SCI USA, V91, P3201, DOI 10.1073/pnas.91.8.3201
   YARMUSH ML, 1993, CRIT REV THER DRUG, V10, P197
   ZHOU XH, 1994, BBA-BIOMEMBRANES, V1189, P195, DOI 10.1016/0005-2736(94)90066-3
NR 96
TC 52
Z9 53
U1 0
U2 5
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD DEC
PY 1995
VL 50
IS 24
BP 4109
EP 4121
DI 10.1016/0009-2509(95)00226-X
PG 13
WC Engineering, Chemical
SC Engineering
GA TP497
UT WOS:A1995TP49700032
DA 2018-10-20
ER

PT J
AU Ciardelli, G
   Saad, B
   Hirt, T
   Keiser, O
   Neuenschwander, P
   Uhlschmid, GK
AF Ciardelli, G
   Saad, B
   Hirt, T
   Keiser, O
   Neuenschwander, P
   Uhlschmid, GK
TI Phagocytosis and biodegradation of short-chain poly[(R)-3-hydroxybutyric
   acid] particles in macrophage cell line
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article; Proceedings Paper
CT 12th European Conference on Biomaterials
CY SEP 10-13, 1995
CL OPORTO, PORTUGAL
ID HYDROXYBUTYRATE-HYDROXYVALERATE COPOLYMERS; DEGRADATION; INVIVO;
   POLY(EPSILON-CAPROLACTONE); POLY(3-HYDROXYBUTYRATE); PHB
AB The biocompatibility a nd the degradation mechanisms of block co-polyurethanes containing crystallizable telechelic poly [(R)-3-hydroxybutyric acid] (PHB) segments have found recently growing interest for the possible biomedical applications of these new materials. The random hydrolytic cleavage of the amorphous part of these polymers might result, in vivo, in the production of small crystalline particles of low molecular weight PHB that could then undergo phagocytosis and biodegradation inside phagosomes. To test this possibility, a fluorescent-labelled PHB segment was synthesized, precipitated in the form of crystalline particles, and used for an in vitro investigation of its interaction with macrophage cell line. Light and fluorescence microscopy performed in the present study clearly show that the fluorescent particles are well internalized in phagosomes already after 1 h of incubation. The number of phagocytized particles decreases notably after 8 days of incubation. A quantitative determination of the time dependence of the phagocytosis was obtained through laser cytometry and fluorescence-activated cell sorting (FAGS). Fluorescence spectroscopy and high-performance liquid chromatography (HPLC) analysis of extracts of cell supernatants revealed the presence of supposed degradation products of PHB after 8 days of incubation, suggesting that macrophages could degrade low molecular weight PHB.
C1 UNIV ZURICH HOSP,DEPT SURG,DIV RES,CH-8091 ZURICH,SWITZERLAND.
RP Ciardelli, G (reprint author), ETH ZURICH,INST POLYMERS,CH-8092 ZURICH,SWITZERLAND.
OI Ciardelli, Gianluca/0000-0003-0199-1427; Saad,
   Bashar/0000-0003-4052-2279
CR CIARDELLI G, UNPUB
   GIILDING DK, 1981, BIOCOMPATIBILITY CLI, V2, P209
   GOGOLEWSKI S, 1993, J BIOMED MATER RES, V27, P1135, DOI 10.1002/jbm.820270904
   HIRT T, UNPUB
   HOLLAND SJ, 1987, BIOMATERIALS, V8, P289, DOI 10.1016/0142-9612(87)90117-7
   KORSATKO W, 1983, PHARM IND, V45, P1004
   MILLER ND, 1987, BIOMATERIALS, V8, P129, DOI 10.1016/0142-9612(87)90102-5
   PITT CG, 1981, J APPL POLYM SCI, V26, P3779, DOI 10.1002/app.1981.070261124
   SAAD B, IN PRESS J MATER SCI
   SAITO T, 1991, BIOMATERIALS, V12, P309, DOI 10.1016/0142-9612(91)90039-D
   TABATA Y, 1988, J BIOMED MATER RES, V22, P837, DOI 10.1002/jbm.820221002
   TABATA Y, 1990, ADV POLYM SCI, V94, P108
   WOODWARD SC, 1985, J BIOMED MATER RES, V19, P437, DOI 10.1002/jbm.820190408
NR 13
TC 15
Z9 15
U1 1
U2 3
PU CHAPMAN HALL LTD
PI LONDON
PA 2-6 BOUNDARY ROW, LONDON, ENGLAND SE1 8HN
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD DEC
PY 1995
VL 6
IS 12
BP 725
EP 730
DI 10.1007/BF00134308
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA TM616
UT WOS:A1995TM61600011
DA 2018-10-20
ER

PT J
AU Ianno, NJ
   Dillon, RO
   Ali, A
   Ahmad, A
AF Ianno, NJ
   Dillon, RO
   Ali, A
   Ahmad, A
TI Deposition of diamond-like carbon on a titanium biomedical alloy
SO THIN SOLID FILMS
LA English
DT Article; Proceedings Paper
CT 22nd International Conference on Metallurgical Coatings and Thin Films
   (ICMCTF 1995)
CY APR 25-29, 1995
CL SAN DIEGO, CA
SP Amer Vacuum Soc, Vacuum Met & Thin Films Div
DE adhesion; carbon; physical vapour deposition; plasma processing and
   deposition
AB Much of the orthopedic community now believe that the long-term failure of total hip and knee prostheses is directly or indirectly due to the production of wear particles, particularly polyethylene wear particles which are produced at the articulating interface between the metal component and the high molecular weight plastic component. Therefore, a friction and wear reducing coating on the metal component, which is also biocompatible, should reduce the production of the polyethylene wear particles and dramatically extend hip-implant life. Diamondlike carbon (DLC), with its extreme smoothness, hardness, low coefficient of friction, and biocompatibility is an excellent candidate for such an application. One of the key issues that may limit the utility of DLC in this application is the adhesion of this material to common biomedical alloys. We will show that high adhesion strength between sputter-deposited DLC and a silicon-coated titanium biomedical alloy can be easily achieved.
RP Ianno, NJ (reprint author), UNIV NEBRASKA, DEPT ELECT ENGN, CTR MICROELECTR & OPT MAT RES, LINCOLN, NE 68588 USA.
CR BOX GEP, 1978, STATISTICS EXPT, P306
   Davies O. L., 1971, DESIGN ANAL IND EXPT
   FRANKS J, 1989, J VAC SCI TECHNOL A, V7, P2307, DOI 10.1116/1.575933
   GRILL A, 1990, IBM J RES DEV, V34, P849, DOI 10.1147/rd.346.0849
   HARRIS SJ, 1993, SURF COAT TECH, V62, P550, DOI 10.1016/0257-8972(93)90298-3
   HARRIS WH, 1994, ACTA ORTHOP SCAND, V65, P113, DOI 10.3109/17453679408993734
   LEE HJ, 1992, SURF COAT TECH, V55, P552, DOI 10.1016/S0257-8972(07)80081-8
   MAA JS, 1979, THIN SOLID FILMS, V64, P439, DOI 10.1016/0040-6090(79)90328-6
   MAKOVICKA T, 1993, F0863091C0047 WRIG L
   MIYOSHI K, 1992, SURF COAT TECH, V55, P428, DOI 10.1016/S0257-8972(07)80061-2
   MURARKA SP, 1983, SILICIDES VLSI APPLI, pCH4
   VANGURP GJ, 1979, J APPL PHYS, V50, P6915, DOI 10.1063/1.325843
NR 12
TC 37
Z9 38
U1 0
U2 4
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0040-6090
J9 THIN SOLID FILMS
JI Thin Solid Films
PD DEC 1
PY 1995
VL 270
IS 1-2
BP 275
EP 278
DI 10.1016/0040-6090(95)06710-8
PG 4
WC Materials Science, Multidisciplinary; Materials Science, Coatings &
   Films; Physics, Applied; Physics, Condensed Matter
SC Materials Science; Physics
GA TM187
UT WOS:A1995TM18700052
DA 2018-10-20
ER

PT J
AU KO, WH
AF KO, WH
TI PACKAGING OF MICROFABRICATED DEVICES AND SYSTEMS
SO MATERIALS CHEMISTRY AND PHYSICS
LA English
DT Review
DE PACKAGING; MICROSENSORS; MICROACTUATORS; MICROFABRICATED DEVICES;
   MICROSYSTEMS
ID SENSORS
AB All devices and systems need to be packaged for applications. For microfabricated devices or systems the packaging is an essential part of the design, not an after-thought. The functions of packaging are: (i) to protect the devices from the environment, and (ii) to protect the environment from the device operation. At present, there is no generally applicable packaging method for all microdevices, but there are basic principles useful in packaging design. This article outlines the fundamental requirements, design considerations, and packaging techniques for sensors and microsystems, with selected examples, and suggested references. The protection of the device includes: (i) electrical isolation and passivation of leads and device structures from the penetration of moisture and ions; sealing techniques and hermeticity measurements are important aspects; (ii) mechanical protection to ensure structural integrity and dimensional stability; (iii) thermal and optical isolation, and (iv) chemical and biological isolation and protection. It is also necessary to protect the environment from the device materials and device operation, so that no undesirable reaction with or contamination of the environment occurs. This is especially important for devices used in biomedical, pharmaceutical and food processing. Biocompatibility and contamination must be considered as factors in the design. Successful packaging design requires the integration of knowledge of materials, device characteristics, packaging and evaluation techniques. It remains as a challenge in the MEMS field for engineers.
C1 CASE WESTERN RESERVE UNIV,CTR ELECTR DESIGN,CLEVELAND,OH 44106.
RP KO, WH (reprint author), CASE WESTERN RESERVE UNIV,DEPT ELECT ENGN & APPL PHYS,EUCLID AVE,CLEVELAND,OH 44106, USA.
CR BARD AJ, 1992, PURE APPL CHEM, V64, P185, DOI 10.1351/pac199264020185
   CLINE HE, 1978, J APPL PHYS, V49, P2412, DOI 10.1063/1.325082
   EDEN JG, 1986, IEEE CIRCUITS DEVICE, V2, P18, DOI 10.1109/MCD.1986.6311766
   EHRLICH DJ, 1982, IEEE T COMPONENTS HY, V1, P520
   ESASHI M, 1990, SENSOR ACTUAT A-PHYS, V23, P1048, DOI 10.1016/0924-4247(90)87087-Y
   ESASHI M, 1990, SENSOR ACTUAT A-PHYS, V21, P931
   FUNG CD, 1985, MICROMACHINING MICRO
   HANNEBORG A, 1991, JAN IEEE WORKSH MICR, P92
   HOFFERINS HL, 1991, JUN TRANSD 91 SAN FR, P986
   Ko W.H., 1983, IEEE ENG MED BIO MAR, V2, P22
   Ko W. H., 1985, MICROMACHINING MICRO
   LEE YS, 1982, IEEE T ELECTRON DEV, V29, P42, DOI 10.1109/T-ED.1982.20656
   LEE YS, 1982, IEEE T ELECTRON DEV, V29, P48
   LESKY JB, 1985, DEC IEEE INT EL DEV, P684
   MATISOFF BS, 1990, HDB ELECTRONICS PACK
   NEUMAN MR, 1982, MED PROG TECHNOL, V9, P95
   REICHL H, 1991, SENSOR ACTUAT A-PHYS, V25, P63
   SENTURIA SD, 1989, ELECTRONIC DEVICE PA
   SERAPHIM DP, 1989, PRINCIPLES ELECTRONI
   SHLICHTA PJ, 1988, NASA TECH BRIEFS, V12, P84
   SMITH RL, 1989, FUNDAMENTALS GENERAL, V1, pCH4
   SOORIAJUMAR K, 1993, JUN TRANSD 93 YOK, P191
   Spiering V. L., 1991, TRANSDUCERS '91. 1991 International Conference on Solid-State Sensors and Actuators. Digest of Technical Papers (Cat. No.91CH2817-5), P982, DOI 10.1109/SENSOR.1991.149055
   TIEN Z, 1992, FARADAY DISCUSS, V94
   VANDENVLEKKERT HH, 1990, SENSOR ACTUAT B-CHEM, V1, P395, DOI 10.1016/0925-4005(90)80237-T
   VONGUTFELD RJ, 1982, APPL PHYS LETT, V40, P352, DOI 10.1063/1.93069
   WOLF S, 1990, SILICON PROCESSING V, V2, P176
   WONG ASH, 1985, THESIS CASE W RESERV
   ZIAIE B, 1993, JUN INT C SOL STAT S, P266
   1990, ENG MATERIALS HDB, V3
   1987, METHOD, V1014
   1988, JEDEC22A109 EL IND A
NR 32
TC 32
Z9 34
U1 1
U2 13
PU ELSEVIER SCIENCE SA LAUSANNE
PI LAUSANNE 1
PA PO BOX 564, 1001 LAUSANNE 1, SWITZERLAND
SN 0254-0584
J9 MATER CHEM PHYS
JI Mater. Chem. Phys.
PD NOV 30
PY 1995
VL 42
IS 3
BP 169
EP 175
DI 10.1016/0254-0584(95)01573-6
PG 7
WC Materials Science, Multidisciplinary
SC Materials Science
GA TF280
UT WOS:A1995TF28000003
DA 2018-10-20
ER

PT J
AU MASIULANIS, B
   CALUSINSKI, G
   MARJANSKI, W
   KOTSCHY, M
   JURKOWSKI, P
   GORALCZYK, B
   STANISZEWSKAKUS, J
   SOLSKI, L
   KRZEMIENDABROWSKA, A
AF MASIULANIS, B
   CALUSINSKI, G
   MARJANSKI, W
   KOTSCHY, M
   JURKOWSKI, P
   GORALCZYK, B
   STANISZEWSKAKUS, J
   SOLSKI, L
   KRZEMIENDABROWSKA, A
TI INVESTIGATION ON SUITABILITY OF POLY(URETHANEIMIDES) AS BIOMATERIALS
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
ID POLYIMIDE FILMS; WATER
AB The mechanical properties of poly(urethaneimides) (PUI) were compared with known biomedical polyurethanes. The resistance of PUI to extraction with hexane and water and to sterilization with ethylene oxide or water vapor was stated. Water sorption and the permeability of water vapor, oxygen, and carbon dioxide through PUI foils were investigated. In blood compatibility, the PUI foils were similar to cellulose material Cuprophane, used in dialysis. Preliminary in vivo testing of PUI implanted in rats indicated good biocompatibility of this polymer. (C) 1995 John Wiley & Sons, Inc.
C1 MED ACAD BYDGOSZCZ,DEPT PATHOPHYSIOL,PL-85094 BYDGOSZCZ,POLAND.
   MED ACAD WROCLAW,CHAIR SURG TRAUMATOL,DEPT EXPTL SURG & BIOMAT RES,PL-50326 WROCLAW,POLAND.
RP MASIULANIS, B (reprint author), GDANSK TECH UNIV,FAC CHEM,PL-80952 GDANSK,POLAND.
CR BAMFORD CH, 1992, POLYM MED, P57
   CHARLES HK, 1984, POLYIMIDES, V2, P1139
   EASTMOND GC, 1993, POLYMER, V34, P667, DOI 10.1016/0032-3861(93)90571-Q
   FREIJLARSSON C, 1993, J APPL POLYM SCI, V49, P815, DOI 10.1002/app.1993.070490507
   GOGOLEWSKI S, 1989, COLLOID POLYM SCI, V267, P757, DOI 10.1007/BF01410115
   GOSEY MT, 1985, POLYM PERMEABILITY, P309
   HABAL MB, 1987, ADV BIOMEDICAL PLYME, P27
   HACHISUKA H, 1991, J POLYM SCI POL PHYS, V29, P11, DOI 10.1002/polb.1991.090290103
   ILLINGER IL, 1974, PERMEABILITY PLASTIC, P183
   JURKOWSKI P, 1993, UNPUBLISHED REPORT
   KIM SW, 1990, POLIMERY, V11, P401
   KOMATSUZAKI S, 1992, J APPL POLYM SCI APP, V50, P309
   LAWANDY SN, 1980, ELASTOMERICS, V10, P43
   LIM BS, 1993, J POLYM SCI POL PHYS, V31, P545, DOI 10.1002/polb.1993.090310505
   MARJANSKI W, 1986, ZESZ NAUK POLITECHNI, V57
   MASIULANIS B, 1985, J APPL POLYM SCI, V30, P2731, DOI 10.1002/app.1985.070300702
   MASIULANIS B, 1987, J APPL POLYM SCI, V34, P1941, DOI 10.1002/app.1987.070340512
   MASIULANIS B, 1987, Patent No. 140428
   MASIULANIS B, 1993, POLIMERY, V8, P414
   MOYLAN CR, 1991, J POLYM SCI POL PHYS, V29, P87, DOI 10.1002/polb.1991.090290111
   OKANO T, 1992, J BIOMED MATER RES, V26, P801
   Rogers C. E., 1985, POLYM PERMEABILITY, P11, DOI DOI 10.1007/978-94-009-4858-72
   SAHER E, 1981, J APPL POLYM SCI, V26, P679
   STANISZEWSKAKUS J, 1994, UNPUBLISHED REPORT
   Tock R. W., 1983, ADV POLYM TECHNOL, V3, P223
   UKIBAYRAM K, 1992, POLYMER, V23, P2084
   ULRICH H, 1984, POLYURETHANES BIOMED, P175
   WARD RS, 1984, POLYURETHANES BIOMED, P191
   WROBLEWSKI DA, 1988, APPLIED BIOACTIVE PO, P281
NR 29
TC 5
Z9 5
U1 0
U2 2
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-8995
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD NOV 28
PY 1995
VL 58
IS 9
BP 1441
EP 1454
DI 10.1002/app.1995.070580905
PG 14
WC Polymer Science
SC Polymer Science
GA TB510
UT WOS:A1995TB51000005
DA 2018-10-20
ER

PT J
AU DELANGE, PJ
   MAHY, JWG
AF DELANGE, PJ
   MAHY, JWG
TI TOF-SIMS AND XPS INVESTIGATIONS OF FIBERS, COATINGS AND BIOMEDICAL
   MATERIALS
SO FRESENIUS JOURNAL OF ANALYTICAL CHEMISTRY
LA English
DT Article; Proceedings Paper
CT 8th Conference on Applied Surface Analysis
CY SEP 05-08, 1994
CL KAISERSLAUTERN, GERMANY
ID RAY PHOTOELECTRON-SPECTROSCOPY; WOOD
AB The use of ToF-SIMS and XPS in industrial research is demonstrated by a number of applications of surface analysis within Akzo Nobel: surface treatment of carbon fibers, adhesion activation of aramid fibers, weathering and protection of wood, surfactant adsorption on pigments, grafting of polypropylene with acrylic monomers and treatment of a perfluorinated membrane with an amphiphile. The examples illustrate the broad use of these techniques on non-conducting organic and polymeric materials.
RP DELANGE, PJ (reprint author), AKZO NOBEL CENT RES,DEPT ANALYT & ENVIRONM CHEM,POB 9300,6800 SB ARNHEM,NETHERLANDS.
CR ALEXANDER MR, 1994, CARBON, V32, P785, DOI 10.1016/0008-6223(94)90034-5
   AMEEN AP, 1993, POLYMER, V34, P1795, DOI 10.1016/0032-3861(93)90418-A
   ANDREWS MC, 1995, COMPOSITE INTERFACES
   DELANGE PJ, 1992, SURF INTERFACE ANAL, V19, P397, DOI 10.1002/sia.740190174
   DELANGE PJ, 1994, SURF INTERFACE ANAL, V22, P502, DOI 10.1002/sia.7402201106
   DELANGE PJ, 1993, I PHYS C SER, V130, P439
   DONNET JB, 1990, CARBON FIBRES
   Dorris GM, 1978, CELLUL CHEM TECHNOL, V12, P9
   FEIST WC, 1984, CHEM SOLID WOOD, pCH11
   GARTON A, 1985, J POLYM SCI POL CHEM, V23, P1031, DOI 10.1002/pol.1985.170230408
   HON DNS, 1984, J APPL POLYM SCI, V29, P2777, DOI 10.1002/app.1984.070290908
   MAHY J, 1994, SURF INTERFACE ANAL, V21, P1, DOI 10.1002/sia.740210102
   MAHY J, 1994, COMPOSITES, V25, P653, DOI 10.1016/0010-4361(94)90198-8
   MAHY JWG, 1991, INTERFACIAL PHENOMENA IN COMPOSITE MATERIALS 91, P45
   MUKHERJEE AK, 1983, J MACROMOL SCI CHEM, VA19, P1069, DOI 10.1080/00222338308081086
   MUKHERJEE AK, 1985, J APPL POLYM SCI, V30, P2655, DOI 10.1002/app.1985.070300628
   VANSTRAATENNIJE.WF, 1993, LANGMUIR, V9, P1657
   WAUGH AR, 1987, J PHYS-PARIS, V48, P577, DOI 10.1051/jphyscol:1987694
NR 18
TC 14
Z9 14
U1 0
U2 6
PU SPRINGER VERLAG
PI NEW YORK
PA 175 FIFTH AVE, NEW YORK, NY 10010
SN 0937-0633
J9 FRESEN J ANAL CHEM
JI Fresenius J. Anal. Chem.
PD NOV-DEC
PY 1995
VL 353
IS 5-8
BP 487
EP 493
DI 10.1007/BF00321308
PG 7
WC Chemistry, Analytical
SC Chemistry
GA TH385
UT WOS:A1995TH38500001
DA 2018-10-20
ER

PT J
AU Mammel, KA
   Kaplan, DW
AF Mammel, KA
   Kaplan, DW
TI Research consent by adolescent minors and Institutional Review Boards
SO JOURNAL OF ADOLESCENT HEALTH
LA English
DT Article
DE consent; confidentiality; Institutional Review Boards; adolescents;
   research
ID BIOMEDICAL-RESEARCH; CHILDREN
AB Purpose: A national survey of institutional review boards (IRBs) was conducted to determine: (1) the current practices of IRBs concerning consent for adolescent miners; and (2) the existence of support for changes in the federal regulations for research on adolescents.
   Methods: Six hundred surveys were mailed in two waves to all IRE chairs in the United States, with the exception of highly specialized institutions. The survey consisted of three sections. Section 1 assessed demographic data, such as institution type; presence of personnel trained in adolescent health; and number of protocols involving adolescents reviewed annually. Section 2 presented a series of twelve scenarios for which respondents stated whether their IRE would waive parental consent under present federal regulations. These scenarios varied the sensitivity of information and procedural invasiveness, and ranged from simple satisfaction surveys to experimental drug treatment for AIDS. Section 3 assessed whether respondents would recommend changes in current federal regulations that would enable adolescent miners to provide their own consent to research participation. To this end, respondents indicated whether minor consent alone is sufficient or if parental consent should be required for 10 general research categories that paralleled the level of invasiveness of the scenarios presented in Section 2.
   Results: Two hundred and thirty-three surveys (39%) were returned and 183 (30%) were fully scorable. Within group comparisons for IRBs were conducted using Chi-square statistics. Seventy percent of respondent IRBs required parental consent for all research on miners, and IRBs reviewing more than 10 adolescent protocols per year were less likely to require parental consent (p <.01). Responses did not differ by institution type or presence of personnel trained in adolescent health. Fifty-two percent of respondent IRBs required parental consent for a simple satisfaction survey, and only 29% of IRBs would waive parental consent for an anonymous HIV seroprevalence study. Over one-half of IRBs supported changes in regulations that would enable miners to provide informed self-consent for seven of 10 general research categories: anonymous surveys (supported by 93%), research involving sensitive material if nothing more than survey (89%) or venipuncture (53%) were involved, and research on diseases for which miners may consent to treatment including survey (93%), venipuncture (68%), or medication approved for use in pediatric patients (57%).
   Conclusion: Even though IRBs practice under the same federal regulations there is a broad spectrum of interpretation. Considerable support exists for changing the guidelines for certain categories of research involving adolescents. Federal regulations need to be clarified for meaningful and necessary research on adolescents to take place.
C1 UNIV COLORADO,CHILDRENS HOSP,HLTH SCI CTR,DEPT PEDIAT,ADOLESCENT MED SECT,DENVER,CO 80218.
CR BROOME ME, 1992, RES NURS HEALTH, V15, P147, DOI 10.1002/nur.4770150209
   *DHEW, 1977, OS770004 PUBL
   GRISSO T, 1992, SOCIAL RES CHILDREN
   GRODIN MA, 1988, PEDIATR CLIN N AM, V35, P1389
   Holder Angela R, 1981, IRB, V3, P5, DOI 10.2307/3563513
   MORRISSEY JM, 1986, CONSENT CONFIDENTIAL, P91
   MOSS HB, 1979, CANCER, V43, P1549
   MUNIR K, 1992, J AM ACAD CHILD PSY, V31, P408, DOI 10.1097/00004583-199205000-00005
   SCHULTZ AL, 1975, WESTERN J MED, V123, P76
   SEVERSON H, 1989, PREV MED, V18, P267, DOI 10.1016/0091-7435(89)90074-1
   SUSMAN EJ, 1992, J PEDIATR-US, V121, P547, DOI 10.1016/S0022-3476(05)81142-4
   TARNOWSKI KJ, 1990, PEDIATRICS, V85, P58
   THOMPSON RA, 1990, CHILD DEV, V61, P1
   Thurber F W, 1992, J Pediatr Nurs, V7, P165
   WEITHORN LA, 1982, CHILD DEV, V53, P1589, DOI 10.2307/1130087
   Weithorn Lois A, 1983, IRB, V5, P1, DOI 10.2307/3563792
NR 16
TC 42
Z9 42
U1 0
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010
SN 1054-139X
J9 J ADOLESCENT HEALTH
JI J. Adolesc. Health
PD NOV
PY 1995
VL 17
IS 5
BP 323
EP 330
DI 10.1016/1054-139X(95)00176-S
PG 8
WC Psychology, Developmental; Public, Environmental & Occupational Health;
   Pediatrics
SC Psychology; Public, Environmental & Occupational Health; Pediatrics
GA TK532
UT WOS:A1995TK53200010
PM 8924437
DA 2018-10-20
ER

PT J
AU SHAMES, B
   FOX, JG
   DEWHURST, F
   YAN, LL
   SHEN, ZL
   TAYLOR, NS
AF SHAMES, B
   FOX, JG
   DEWHURST, F
   YAN, LL
   SHEN, ZL
   TAYLOR, NS
TI IDENTIFICATION OF WIDESPREAD HELICOBACTER-HEPATICUS INFECTION IN FECES
   IN COMMERCIAL MOUSE COLONIES BY CULTURE AND PCR ASSAY
SO JOURNAL OF CLINICAL MICROBIOLOGY
LA English
DT Article
ID CAMPYLOBACTER-CINAEDI; DNA
AB The identification of a new murine pathogen, Helicobacter hepaticus, and its association with chronic active hepatitis and liver tumors prompted an evaluation of the prevalence of H, hepaticus in commercially available mice. Of the 28 different strains or stocks, totaling 160 mice from four major commercial vendors, cultured for H. hepaticus, 100% of mice from two outbred strains from one vendor were infected with H. hepaticus, whereas of 13 inbred mouse strains from another vendor were infected, This high prevalence of H, hepaticus established a need for a rapid and reproducible, noninvasive assay for the screening of colony-maintained mice being used for biomedical research. The culturing of fecal material by using 0.45-mu m-pore-size filtration for H. hepaticus consistently yielded reproducible results but required extended periods of time (1 to 3 weeks) to obtain a definitive answer. Although it is rapid, the use of a direct PCR-based detection assay with fecal specimens is restricted by inhibitory agents. To circumvent these inhibitory agents and to augment our H. hepaticus culture technique, we have developed a novel PCR system in which the bacteria are isolated from fecal material in the presence of polyvinylpyropyrollidone and lysed by treatment with Chelex 100. The PCR is performed with Tth polymerase supplemented with a polymerase enhancer. By this PCR method, 24 H. hepaticus culture-positive and 30 H. hepaticus culture-negative fecal samples were correctly identified, Moreover, two samples which were PCR positive and culture negative initially were positive by both methods upon retesting of fresh material, Southern blot hybridizations and sequencing of PCR products showed them to be H, hepaticus specific. A comparison of results obtained under identical conditions indicated a 100-fold increase in sensitivity with Tth polymerase over Tag polymerase. This PCR method can be used as a noninvasive means of rapidly screening large numbers of colony mice for H. hepaticus.
C1 MIT,DIV COMPARAT MED,CAMBRIDGE,MA 02139.
   FORSYTH DENT CTR,DEPT MOLEC GENET,BOSTON,MA 02115.
FU NCRR NIH HHS [RR07036, RR01046]; OFP OPHS HHS [RFPS 94-69]
CR ATLAS RM, 1993, HDB METHODS AQUATIC, P261
   BATTLES JK, 1995, J CLIN MICROBIOL, V33, P1344
   Bej Asim K., 1994, P219
   Bej Asim K., 1994, P327
   COVER TL, 1995, ASM NEWS, V61, P21
   DELAMBALLERIE X, 1992, RES MICROBIOL, V143, P785, DOI 10.1016/0923-2508(92)90107-Y
   FLORES BM, 1990, INFECT IMMUN, V58, P3947
   FOLTZ CJ, 1995, ANTIMICROB AGENTS CH, V39, P1292, DOI 10.1128/AAC.39.6.1292
   FOX JG, 1995, J CLIN MICROBIOL, V33, P445
   FOX JG, 1994, J CLIN MICROBIOL, V32, P1238
   FOX JG, 1993, BIOL CLIN PRACTICE, P407
   FOX JW, UNPUB
   GEBHART CJ, 1989, J CLIN MICROBIOL, V27, P1692
   Higuchi R, 1989, PCR TECHNOLOGY PRINC, P31
   HIU PJ, 1992, BIOTECHNOL GENET ENG, V10, P343
   JIANG X, 1992, Journal of Clinical Microbiology, V30, P2529
   LEE A, 1992, INT J SYST BACTERIOL, V42, P27, DOI 10.1099/00207713-42-1-27
   Mahbubani Meena H., 1994, P307
   OCHERT AS, 1994, PCR METH APPL, V3, P365
   PANACCIO M, 1991, NUCLEIC ACIDS RES, V19, P1151, DOI 10.1093/nar/19.5.1151
   Panaccio Michael, 1994, P151
   Poli F, 1993, PCR Methods Appl, V2, P356
   SAYLER GS, 1990, ANNU REV MICROBIOL, V44, P625
   SCHAUER DB, 1993, J CLIN MICROBIOL, V31, P2709
   SOLNICK JV, 1993, INFECT AG DIS, V1, P294
   STEFFAN RJ, 1988, APPL ENVIRON MICROB, V54, P2908
   VANZWET AA, 1994, J CLINMICROBIOL, V32, P1343
   WARD JM, 1994, JNCI-J NATL CANCER I, V86, P1222, DOI 10.1093/jnci/86.16.1222
   WIDJOJOATMODJO MN, 1992, J CLIN MICROBIOL, V30, P3195
NR 29
TC 151
Z9 160
U1 0
U2 2
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1325 MASSACHUSETTS AVENUE, NW, WASHINGTON, DC 20005-4171
SN 0095-1137
J9 J CLIN MICROBIOL
JI J. Clin. Microbiol.
PD NOV
PY 1995
VL 33
IS 11
BP 2968
EP 2972
PG 5
WC Microbiology
SC Microbiology
GA TA461
UT WOS:A1995TA46100033
PM 8576355
DA 2018-10-20
ER

PT J
AU Rosiak, JM
   Ulanski, P
   Rzeznicki, A
AF Rosiak, JM
   Ulanski, P
   Rzeznicki, A
TI Hydrogels for biomedical purposes
SO NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION B-BEAM
   INTERACTIONS WITH MATERIALS AND ATOMS
LA English
DT Article; Proceedings Paper
CT 1st International Symposium on Ionizing Radiation and Polymers (IRaP94)
CY NOV 14-19, 1994
CL QUADELOUPE, FRANCE
SP INSERM, Minist Def, Minist DOM TOM, Minist Enseignement Super & Rech, Minist Environm, Soc Francaise Phys, Soc Francaise Chim
ID CROSS-LINKING; POLYMERS
AB Medical advances that have prolonged the average life span have generated more needs for new materials that can be used as tissue and organ replacements, drug delivery systems or components of devices related to therapy and diagnosis. One of the most promising class of such materials seems to be hydrogels. Taking poly(ethylene oxide) - PEO as an example of hydrogel-forming polymers the mechanism of formation and decay of its macroradicals in aqueous solution was discussed. The influence of scavengers as well as concentration of PEO solution on the formation of gel has been shown. Short description of technologies of some hydrogel biomaterials obtained by means of radiation technique was given.
RP Rosiak, JM (reprint author), TECH UNIV LODZ,INST APPL RADIAT CHEM,WROBLEWSKIEGO 15,PL-93590 LODZ,POLAND.
RI Ulanski, Piotr/S-9103-2018
OI Ulanski, Piotr/0000-0002-4310-3574
CR BEHZADI A, 1970, BERICH BUNSEN GESELL, V74, P649
   BORGWARDT U, 1969, MAKROMOLEKUL CHEM, V127, P176
   INOUE K, 1992, PANCREAS, V7, P562, DOI 10.1097/00006676-199209000-00009
   MATHESON MS, 1973, J PHYS CHEM-US, V77, P2420, DOI 10.1021/j100639a011
   OLEJNICZAK J, 1991, RADIAT PHYS CHEM, V37, P499
   ROSIAK J, 1990, RADIAT PHYS CHEM, V36, P747
   Rosiak J, 1989, Polim Med, V19, P93
   Rosiak J., 1989, Patent, Patent No. [US 4871490, 4871490]
   ULANSKI P, 1994, J RADIOAN NUCL CH LE, V186, P315, DOI 10.1007/BF02162615
   ULANSKI P, 1994, MACROMOL CHEM PHYSIC, V195, P1443, DOI 10.1002/macp.1994.021950427
   ULANSKI P, 1994, IN PRESS RAD PHYS CH
NR 11
TC 40
Z9 41
U1 0
U2 7
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-583X
J9 NUCL INSTRUM METH B
JI Nucl. Instrum. Methods Phys. Res. Sect. B-Beam Interact. Mater. Atoms
PD NOV
PY 1995
VL 105
IS 1-4
BP 335
EP 339
DI 10.1016/0168-583X(95)00550-1
PG 5
WC Instruments & Instrumentation; Nuclear Science & Technology; Physics,
   Atomic, Molecular & Chemical; Physics, Nuclear
SC Instruments & Instrumentation; Nuclear Science & Technology; Physics
GA TM152
UT WOS:A1995TM15200070
DA 2018-10-20
ER

PT J
AU MATSUURA, Y
   ABEL, T
   HARRINGTON, JA
AF MATSUURA, Y
   ABEL, T
   HARRINGTON, JA
TI OPTICAL-PROPERTIES OF SMALL-BORE HOLLOW GLASS WAVE-GUIDES
SO APPLIED OPTICS
LA English
DT Article
DE HOLLOW WAVE-GUIDES; INFRARED FIBERS; BIOMEDICAL OPTICS
ID WAVE-GUIDES; TRANSMISSION; LOSSES; ATTENUATION; DELIVERY; FIBERS
AB Hollow glass waveguides with a 250-mu m i.d. have been fabricated with a liquid-phase deposition technique that uses silica tubing as a base material. The losses of the 250-mu m-bore guide measured at CO2 laser wavelengths are as low as 2.0 dB/m. The straight losses for the hollow guides are in good agreement with theoretically predicted losses as a result of the nearly ideal structure of the guides. It is also shown that the guides have low bending losses, a nearly pure-mode delivery, and good high-power laser transmission. By proper design of the dielectric thickness, the guide is also able to deliver Er:YAG laser energy with a low loss of 1.2 dB/m for the 320-mu m-bore waveguide. Because the hollow glass waveguide is very flexible and robust, it is quite suitable for medical applications.
RP MATSUURA, Y (reprint author), RUTGERS STATE UNIV,FIBER OPT MAT RES PROGRAM,BRETT & BOWSER RD,POB 909,PISCATAWAY,NJ 08855, USA.
RI matsuura, yuji/M-6457-2016
OI matsuura, yuji/0000-0002-4722-7654
CR ABE S, 1991, IEEE T MICROW THEORY, V39, P230, DOI 10.1109/22.102965
   ABEL T, 1994, OPT LETT, V19, P1034, DOI 10.1364/OL.19.001034
   CROITORU N, 1990, APPL OPTICS, V29, P1805, DOI 10.1364/AO.29.001805
   CROITORU N, 1990, Patent No. 4930863
   DAHAN R, 1992, MATER RES BULL, V27, P761, DOI 10.1016/0025-5408(92)90084-D
   DAHAN R, 1994, P SOC PHOTO-OPT INS, V2131, P35, DOI 10.1117/12.180762
   GANNOT I, 1994, P SOC PHOTO-OPT INS, V2084, P66
   GREGORY CC, 1993, APPL OPTICS, V32, P5302, DOI 10.1364/AO.32.005302
   HALL DR, 1977, J APPL PHYS, V48, P1212, DOI 10.1063/1.323761
   HARRINGTON JA, 1990, OPT LETT, V15, P541, DOI 10.1364/OL.15.000541
   HARRINGTON JA, 1990, SPIE MILESTONE SE MS, V9, P409
   HARRINGTON JA, 1990, SPIE MILESTONE SE MS, V9, P527
   KATO Y, 1993, P SOC PHOTO-OPT INST, V2131, P66
   MARCATILI EAJ, 1964, AT&T TECH J, V43, P1783, DOI 10.1002/j.1538-7305.1964.tb04108.x
   MATSUURA Y, 1994, ELECTRON LETT, V30, P1688, DOI 10.1049/el:19941124
   MATSUURA Y, 1989, J OPT SOC AM A, V6, P423, DOI 10.1364/JOSAA.6.000423
   MATSUURA Y, 1993, APPL OPTICS, V32, P6598, DOI 10.1364/AO.32.006598
   MIYAGI M, 1984, J LIGHTWAVE TECHNOL, V2, P116, DOI 10.1109/JLT.1984.1073590
   MIYAGI M, 1990, APPL OPTICS, V29, P367, DOI 10.1364/AO.29.000367
   MIYAGI M, 1981, APPL OPTICS, V20, P1221, DOI 10.1364/AO.20.001221
   Schweig B., 1973, MIRRORS GUIDE MANUFA
NR 21
TC 101
Z9 103
U1 3
U2 13
PU OPTICAL SOC AMER
PI WASHINGTON
PA 2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036
SN 0003-6935
J9 APPL OPTICS
JI Appl. Optics
PD OCT 20
PY 1995
VL 34
IS 30
BP 6842
EP 6847
DI 10.1364/AO.34.006842
PG 6
WC Optics
SC Optics
GA RZ268
UT WOS:A1995RZ26800008
PM 21060543
DA 2018-10-20
ER

PT J
AU COSOFRET, VV
   ERDOSY, M
   JOHNSON, TA
   BELLINGER, DA
   BUCK, RP
   ASH, RB
   NEUMAN, MR
AF COSOFRET, VV
   ERDOSY, M
   JOHNSON, TA
   BELLINGER, DA
   BUCK, RP
   ASH, RB
   NEUMAN, MR
TI ELECTROANALYTICAL AND SURFACE CHARACTERIZATION OF ENCAPSULATED
   IMPLANTABLE MEMBRANE PLANAR MICROSENSORS
SO ANALYTICA CHIMICA ACTA
LA English
DT Article
DE SENSORS; ENCAPSULATED POLYMERIC MEMBRANES; BIOCOMPATIBLE POLYMERS;
   IMPLANTABLE SENSORS
ID SOLVENT POLYMERIC MEMBRANES; ELECTROCHEMICAL DETECTOR; SYNTHETIC
   HYDROGELS; TRANSPORT PROCESSES; ELECTRODES; SENSORS
AB The selective polymeric membranes of planar microsensors sensitive to inorganic analytes of biomedical interest (e.g., H+, K+), fabricated on a flexible polyimide (Kapton(R) DuPont) substrate using a combination of thin-film, thick-film and packaging technologies, were encapsulated with a biocompatible polymeric material such as poly(2-hydroxyethylmethacrylate) (poly-HEMA), The electroanalytical characteristics pf these sensors (linear activity ranges, slopes of the calibration curves, response times, membrane resistances, and selectivities) are not significantly different when compared with those of non-coated membrane sensors. The encapsulated membrane electrodes show improved analytical characteristics after exposure to whole blood samples for specified periods of time. The long-term stability of the membranes for in vivo use was investigated by the cage implant system; the membrane biostability and cell adhesion, at 1, 3, 7, and 14 days of subcutaneous implantation in Sprague-Dawley rats, were evaluated by scanning electron microscopy.
C1 UNIV N CAROLINA,DEPT CHEM,CHAPEL HILL,NC 27599.
   UNIV N CAROLINA,SCH MED,CHAPEL HILL,NC 27599.
   N CAROLINA STATE UNIV,DEPT ELECT & COMP ENGN,RALEIGH,NC 27695.
   CASE WESTERN RESERVE UNIV,METROHLTH MED CTR,DEPT OBSTET GYNECOL,CLEVELAND,OH 44109.
CR AMMANN D, 1985, ANAL CHIM ACTA, V171, P119, DOI 10.1016/S0003-2670(00)84189-6
   BILBRUCK J, 1993, INT J PHARM, V99, P293, DOI 10.1016/0378-5173(93)90372-M
   CLARK LC, 1988, METHOD ENZYMOL, V137, P68
   COSOFRET VV, 1992, J ELECTROANAL CHEM, V327, P137, DOI 10.1016/0022-0728(92)80142-Q
   COSOFRET VV, 1995, ANAL CHEM, V67, P1647, DOI 10.1021/ac00106a001
   COSOFRET VV, 1993, J ELECTROANAL CHEM, V345, P169, DOI 10.1016/0022-0728(93)80477-Y
   COSOFRET VV, 1994, ANALYST, V119, P2283, DOI 10.1039/an9941902283
   COSOFRET VV, 1994, TALANTA, V41, P931, DOI 10.1016/0039-9140(94)E0106-2
   COSOFRET VV, IN PRESS POLYM MATER
   COSOFRET VV, 1994, ANAL LETT, V27, P15
   DAVIES ML, 1991, SELECT ELECTR REV, V13, P159
   DINTEN O, 1991, ANAL CHEM, V63, P596, DOI 10.1021/ac00006a009
   DURSELEN LFJ, 1988, ANAL CHEM, V60, P1455, DOI 10.1021/ac00165a021
   GADZEKPO VPY, 1986, ANALYST, V111, P567, DOI 10.1039/an9861100567
   HAMILTON CJ, 1988, POLYMER, V29, P1879, DOI 10.1016/0032-3861(88)90406-5
   ISHII K, 1993, CONCURRENT ENG AUTOM, P19
   KO WH, 1985, IMPLANTABLE SENSORS, P259
   KUSY RP, 1994, POLYMER, V35, P2141, DOI 10.1016/0032-3861(94)90241-0
   KUSY RP, 1994, J MATER SCI LETT, V13, P849, DOI 10.1007/BF00273227
   LINDNER E, 1993, J CHEM SOC FARADAY T, V89, P361, DOI 10.1039/ft9938900361
   LINDNER E, 1993, TALANTA, V40, P957, DOI 10.1016/0039-9140(93)80151-G
   LINDNER E, 1993, FRESEN J ANAL CHEM, V346, P584, DOI 10.1007/BF00321250
   LINDNER E, 1994, DIAGNOSTIC BIOSENSOR, P149
   MARCHANT RE, 1986, J BIOMED MATER RES, V20, P53
   MCKINLEY BA, 1981, CRIT CARE MED, V9, P333, DOI 10.1097/00003246-198104000-00011
   MEIER PC, 1980, MED BIOL APPLICATION, P13
   MURPHY SM, 1988, POLYMER, V29, P1887, DOI 10.1016/0032-3861(88)90407-7
   OESCH U, 1980, ANAL CHEM, V52, P692, DOI 10.1021/ac50054a024
   OESCH U, 1986, CLIN CHEM, V32, P1448
   POTJEKAMLOTH K, 1989, SENSOR ACTUATOR, V18, P415, DOI 10.1016/0250-6874(89)87047-7
   Pungor E., 1977, PURE APPL CHEM, V51, P1913
   REICHERT WM, 1992, MAT SCI TECHNOL, V14, P303
   SEPRAPHIM DP, 1989, PRINCIPLES ELECTRONI
   SHICHIRI M, 1987, GBF MONOGR, V10, P95
   SHIMADA K, 1980, MED BIOL ENG COMPUT, V18, P741, DOI 10.1007/BF02441899
   SITTAMPALAM G, 1983, ANAL CHEM, V55, P1608, DOI 10.1021/ac00260a039
   UEDA N, 1987, GBF MONOGR, V10, P265
   WANG J, 1985, ANAL CHEM, V57, P1536, DOI 10.1021/ac00285a010
NR 38
TC 12
Z9 12
U1 0
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0003-2670
J9 ANAL CHIM ACTA
JI Anal. Chim. Acta
PD OCT 10
PY 1995
VL 314
IS 1-2
BP 1
EP 11
DI 10.1016/0003-2670(95)00260-7
PG 11
WC Chemistry, Analytical
SC Chemistry
GA RZ263
UT WOS:A1995RZ26300001
DA 2018-10-20
ER

PT J
AU CHEN, LQ
   YUDE, Z
   DU, XQ
   WANG, QZ
   ZHANG, ZQ
AF CHEN, LQ
   YUDE, Z
   DU, XQ
   WANG, QZ
   ZHANG, ZQ
TI BIOMEDICAL MATERIAL FOR SUTURELESS ESOPHAGOGASTROSTOMY - ANALYSIS OF 31
   CASES
SO CHINESE MEDICAL JOURNAL
LA English
DT Article
AB The results of 31 cases of sutureless esophagogastrostomy by intraluminal elastic circular ligation (IECL) with the biodegradable supporting tube were reported. The fate of the supporting tube could be tracked satisfactorily by X-ray, The tube-dislodge time was 15.03 +/- 2.23 days and unaffected by the size of supporting tube or the site of anastomosis, The supporting tube could be safely absorbed or partially discharged through the alimentary tract. IECL, with the merits of saving time, anastomosing tightly and leaving no suture materials in the anastomotic site, can be expected to further reduce the incidence of anastomotic leakage and provide references for other gastrointestinal anastomosis.
RP CHEN, LQ (reprint author), HEBEI MED COLL,AFFILIATED HOSP 4,DEPT THORAC SURG,SHIJIAZHUANG 050011,PEOPLES R CHINA.
CR PING YM, 1982, CHINESE J ONCOL, V4, P36
   ZHANG X, 1988, CHIN J EXP SURG, V5, P170
   ZHANG YD, 1988, CHINESE J ONCOL, V10, P224
   ZHANG YD, 1982, CHINESE J ONCOL, V4, P5
   ZHANG YD, 1989, CHINESE J SURG, V27, P369
NR 5
TC 2
Z9 2
U1 0
U2 0
PU CHINESE MEDICAL ASSOCIATION
PI BEIJING
PA 42 DONGSI XIDAJIE, BEIJING 100710, PEOPLES R CHINA
SN 0366-6999
J9 CHINESE MED J-PEKING
JI Chin. Med. J.
PD OCT
PY 1995
VL 108
IS 10
BP 750
EP 753
PG 4
WC Medicine, General & Internal
SC General & Internal Medicine
GA TF113
UT WOS:A1995TF11300008
PM 8565660
DA 2018-10-20
ER

PT J
AU Nair, PD
AF Nair, PD
TI Currently practised sterilization methods - Some inadvertent
   consequences
SO JOURNAL OF BIOMATERIALS APPLICATIONS
LA English
DT Article
DE sterilization methods; biomedical polymers; polyesters; biocompatibility
ID ETHYLENE-OXIDE; DEGRADATION; PROSTHESES; INVITRO; GRAFTS
AB Currently used sterilization techniques such as ethylene oxide, gamma irradiation, and steam sterilization could introduce inadvertent consequences, especially in polymeric materials. These could have far-reaching effects on the biocompatibility of the materials. Some of these consequences are reviewed and a typical example of the effect of steam sterilization on the properties and biocompatibility of polyethylene terephthalate is discussed.
C1 SREE CHITRA TIRUNAL INST MED SCI & TECHNOL,TRIVANDRUM 695012,KERALA,INDIA.
CR BAQUEY C, 1987, BIOMATERIALS, V8, P185, DOI 10.1016/0142-9612(87)90061-5
   BERGER K, 1981, ANN SURG, V193, P477
   BRUCK S D, 1971, Journal of Biomedical Materials Research, V5, P139, DOI 10.1002/jbm.820050303
   Chapiro A., 1962, RAD CHEM POLYM SYSTE
   CHRISTENSEN EA, 1967, S RADIOSTERILIZATION
   CHU CC, 1983, J BIOMED MATER RES, V17, P1029, DOI 10.1002/jbm.820170612
   CLARKE CP, 1966, J SURG, P36
   CONWAY PF, 1979, BRIT J SURG, V66, P262, DOI 10.1002/bjs.1800660414
   Dempsey D J, 1989, J Biomater Appl, V3, P454
   EHLRENBERG L, 1974, MUTAT RES, V24, P84
   FREEMAN MAR, 1960, J HYG-CAMBRIDGE, P337
   GUIDOIN R, 1985, BIOMATERIALS, V6, P122, DOI 10.1016/0142-9612(85)90075-4
   GUMARGALIEVA KZ, 1982, BIOMATERIALS, V3, P177, DOI 10.1016/0142-9612(82)90008-4
   Habermann V, 1985, Arch Toxicol Suppl, V8, P458
   JAYABALAN M, 1986, ANGEW MAKROMOL CHEM, V142, P51, DOI 10.1002/apmc.1986.051420104
   JAYABALAN M, 1989, BIOMATERIALS, V10, P33, DOI 10.1016/0142-9612(89)90006-9
   JAYABALAN M, 1986, 5TH P SO BIOM ENG C, P344
   JAYABALAN M, 1991, BIOMED, V11, P7
   LUDWIG K, 1988, OPHTHALMIC RES, V20, P304, DOI 10.1159/000266732
   MARLOWE DE, 1987, J PHARM SCI, V76, P333, DOI 10.1002/jps.2600760414
   MAZZU AL, 1984, J BIOMED MATER RES, V18, P961, DOI 10.1002/jbm.820180810
   MELBERG SG, 1988, DIABETIC MED, V5, P243, DOI 10.1111/j.1464-5491.1988.tb00977.x
   NAIR P D, 1990, Clinical Materials, V5, P43, DOI 10.1016/0267-6605(90)90070-C
   NAIR PD, 1984, BIOMATERIALS, V5, P305, DOI 10.1016/0142-9612(84)90079-6
   NAIR PD, 1988, BIOMATERIALS, V9, P335, DOI 10.1016/0142-9612(88)90029-4
   NAIR PD, UNPUB STUDIES CYTOXI
   OLEARY RK, 1968, J PHARM SCI, V57, P12, DOI 10.1002/jps.2600570102
   REUTER A, 1969, APPL MICROBIOL, V18, P1057
   ROSE R M, 1984, Journal of Orthopaedic Research, V2, P393, DOI 10.1002/jor.1100020412
   SAWYER PN, 1979, J BIOMED MATER RES, V13, P937, DOI 10.1002/jbm.820130611
   SHINTANI H, 1989, J ANAL TOXICOL, V13, P354, DOI 10.1093/jat/13.6.354
   Shumnes E., 1984, CONTACT DERMATITIS, V10, P240
   SPENLEHAUER G, 1989, BIOMATERIALS, V10, P557, DOI 10.1016/0142-9612(89)90063-X
   Szycher M., 1991, BLOOD COMPATIBLE MAT, P87
   Takesawa S, 1987, Nephrol Dial Transplant, V1, P254
   TURNER DT, 1973, RAD CHEM MACROMOLECU, pCH8
   VINCE DG, 1991, BIOMATERIALS, V12, P731, DOI 10.1016/0142-9612(91)90021-2
   VINK P, 1986, BIOMATERIALS, V7, P225, DOI 10.1016/0142-9612(86)90108-0
   WALL LA, 1955, J POLYM SCI, V17, P141, DOI 10.1002/pol.1955.120178318
NR 39
TC 51
Z9 51
U1 1
U2 17
PU TECHNOMIC PUBL CO INC
PI LANCASTER
PA 851 NEW HOLLAND AVE, BOX 3535, LANCASTER, PA 17604
SN 0885-3282
J9 J BIOMATER APPL
JI J. Biomater. Appl.
PD OCT
PY 1995
VL 10
IS 2
BP 121
EP 135
DI 10.1177/088532829501000203
PG 15
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA TQ684
UT WOS:A1995TQ68400003
PM 8618206
DA 2018-10-20
ER

PT J
AU KAETSU, I
AF KAETSU, I
TI RADIATION SYNTHESIS AND FABRICATION FOR BIOMEDICAL APPLICATIONS
SO RADIATION PHYSICS AND CHEMISTRY
LA English
DT Article; Proceedings Paper
CT 9th International Meeting on Radiation Processing
CY SEP 11-16, 1994
CL ISTANBUL, TURKEY
DE RADIATION POLYMERIZATION; CROSS-LINKING; GRAFTING; IMMOBILIZATION;
   BIOMEDICAL MATERIALS; BIOMEDICAL APPLICATIONS; DRUG DELIVERY SYSTEMS;
   SIGNAL RESPONSIVE CHEMICAL DELIVERY SYSTEMS
ID IMMOBILIZATION
AB Radiation synthesis and fabrication techniques can make various specific forms and structures of materials enhancedly which are useful for biomedical applications, Those materials are a porous gel and membrane, an interpenetrating networked(IPN) hydrogel, a heterogeneous surface phase membrane,an ultra-thin membrane, a biofunctional laminate and an ultra-fine particle. Radiation techniques can attach various biofunctionalities to those materials effectively by means of immobilization of biofunctional components such as enzymes,proteins,hormones,drugs:,microbial cells and tissue cells, It is convenient that the immobilization can be finished at the same time as the synthesis and fabrication in many cases, The applications to bioreactors,biosensors, artificial organs, drug delivery systems and recently to signal responsive chemical delivery systems, have been studied and developed based on those techniques.
RP KAETSU, I (reprint author), KINKI UNIV,FAC SCI & TECHNOL,DEPT NUCL ENGN,KOWAKAE 3-4-1,OSAKA,OSAKA 577,JAPAN.
CR KAETSU I, 1993, ADV POLYM SCI, V105, P81
   KAETSU I, 1985, RADIAT PHYS CHEM, V25, P517, DOI 10.1016/0146-5724(85)90131-1
   KAETSU I, 1981, RADIAT PHYS CHEM, V18, P343, DOI 10.1016/0146-5724(81)90086-8
NR 3
TC 18
Z9 18
U1 0
U2 1
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
SN 0146-5724
J9 RADIAT PHYS CHEM
JI Radiat. Phys. Chem.
PD OCT-DEC
PY 1995
VL 46
IS 4-6
BP 1025
EP 1030
DI 10.1016/0969-806X(95)00314-N
PN 2
PG 6
WC Chemistry, Physical; Nuclear Science & Technology; Physics, Atomic,
   Molecular & Chemical
SC Chemistry; Nuclear Science & Technology; Physics
GA TD120
UT WOS:A1995TD12000021
DA 2018-10-20
ER

PT J
AU BURGESS, LW
AF BURGESS, LW
TI ABSORPTION-BASED SENSORS
SO SENSORS AND ACTUATORS B-CHEMICAL
LA English
DT Article; Proceedings Paper
CT 2nd European Conference on Optical Chemical Sensors and Biosensors
   (EUROPT(R)ODE II)
CY APR 19-21, 1994
CL FLORENCE, ITALY
DE ABSORPTION; CHEMICAL SENSORS
AB Many chemical sensors based on fiber optics and absorption spectroscopy have been reported in applications ranging from biomedical and environmental monitoring to industrial process control. In these diverse applications, the analyte can be probed directly, by measuring its intrinsic absorption, or by incorporating some transduction mechanism such as a reagent chemistry to enhance sensitivity and selectivity. Physical and performance requirements are placed on a device depending on its intended use. In applications such as chemical process monitoring, survivability and the assurance of the long-term quality of the analytical data are paramount. The above needs have resulted in devices that now employ multivariate data analysis, complex sampling interfaces, and reagent renewal mechanisms. The response from such systems can provide information not only about target analyte(s), but can also signal the presence of interferences, and may potentially be used to follow ser,sor degradation. Examples are given of devices currently being investigated along with a discussion of some of the remaining material, chemical, and optical challenges.
RP BURGESS, LW (reprint author), UNIV WASHINGTON,CTR PROC ANALYT CHEM,BG-10,SEATTLE,WA 98195, USA.
CR ANGEL S, 1989, SPIE P, V1172, P115
   BERMAN RJ, 1990, ANAL CHEM, V62, P2066, DOI 10.1021/ac00218a003
   BERMAN RJ, 1990, SPIE P, V1368, P45
   BERMAN RJ, 1989, SPIE P, V1172, P206
   HENSHAW JM, 1993, THESIS U WASHINGTON
   LIN ZH, 1994, ANAL CHEM, V66, P2552, DOI 10.1021/ac00087a021
   POLANYI ML, 1962, REV SCI INSTRUM, V33, P1050, DOI 10.1063/1.1717679
   Sanchez E., 1990, J CHEMOMETR, V4, P29, DOI DOI 10.1002/CEM.1180040105
   Sanchez E, 1988, J CHEMOMETR, V2, P265
   WEI W, 1992, ANAL CHEM, V64, P22
   Wilson B. E., 1989, J CHEMOMETR, V3, P493
NR 11
TC 13
Z9 13
U1 1
U2 1
PU ELSEVIER SCIENCE SA LAUSANNE
PI LAUSANNE 1
PA PO BOX 564, 1001 LAUSANNE 1, SWITZERLAND
SN 0925-4005
J9 SENSOR ACTUAT B-CHEM
JI Sens. Actuator B-Chem.
PD OCT
PY 1995
VL 29
IS 1-3
BP 10
EP 15
DI 10.1016/0925-4005(95)01657-0
PG 6
WC Chemistry, Analytical; Electrochemistry; Instruments & Instrumentation
SC Chemistry; Electrochemistry; Instruments & Instrumentation
GA TD753
UT WOS:A1995TD75300003
DA 2018-10-20
ER

PT J
AU WALSH, D
   MANN, S
AF WALSH, D
   MANN, S
TI FABRICATION OF HOLLOW POROUS SHELLS OF CALCIUM-CARBONATE FROM
   SELF-ORGANIZING MEDIA
SO NATURE
LA English
DT Article
AB A RICH variety of elaborate microscopic skeletal structures composed of inorganic materials are produced in nature(1). Such complex, three-dimensional structures, if produced synthetically, could find important applications as light-weight ceramics, catalyst supports, biomedical implants and robust membranes for high-temperature separation technology. Here we describe a method for synthesizing hollow porous shells of crystalline calcium carbonate (aragonite) that resemble the coccospheres of certain marine algae. We show that thin cellular frameworks of either mesoporous or macroporous aragonite can be formed from oil-water-surfactant microemulsions supersaturated with calcium bicarbonate, with the pore size determined by the relative concentrations of water and oil. Using micrometre-sized polystyrene beads as the substrate for the microemulsion, hollow spherical shells of the honeycomb architecture can be produced. We propose that these cellular frameworks originate from rapid mineralization of aragonite, with a self-organized foam of oil droplets acting as a structural template, and suggest that similar processes could be of general importance in materials chemistry.
C1 UNIV BATH,SCH CHEM,BATH BA2 7AY,AVON,ENGLAND.
RI Mann, Stephen/D-1332-2012
OI Mann, Stephen/0000-0003-3012-8964; Walsh, Dominic/0000-0002-8693-6808
CR KITANO Y, 1962, J GEOPHYS RES, V67, P4873, DOI 10.1029/JZ067i012p04873
   KRESGE CT, 1992, NATURE, V2359, P710
   SCHRIVEN LE, 1960, NATURE, V187, P186
   Sebba F., 1987, FOAMS BILIQUID FOAMS
   THOMPSON DW, 1952, GROWTH FORM, V2, P645
   WALSH D, 1994, SCIENCE, V264, P1576, DOI 10.1126/science.264.5165.1576
   WATZKE HJ, 1994, ADV COLLOID INTERFAC, V50, P1, DOI 10.1016/0001-8686(94)80021-9
   WIDAWSKI G, 1994, NATURE, V369, P387, DOI 10.1038/369387a0
   Winter A., 1994, COCCOLITHOPHORES
NR 9
TC 392
Z9 400
U1 7
U2 151
PU MACMILLAN MAGAZINES LTD
PI LONDON
PA 4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF
SN 0028-0836
J9 NATURE
JI Nature
PD SEP 28
PY 1995
VL 377
IS 6547
BP 320
EP 323
DI 10.1038/377320a0
PG 4
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA RX111
UT WOS:A1995RX11100049
DA 2018-10-20
ER

PT J
AU GROTH, T
   CAMPBELL, EJ
   HERRMANN, K
   SEIFERT, B
AF GROTH, T
   CAMPBELL, EJ
   HERRMANN, K
   SEIFERT, B
TI APPLICATION OF ENZYME IMMUNOASSAYS FOR TESTING HEMOCOMPATIBILITY OF
   BIOMEDICAL POLYMERS
SO BIOMATERIALS
LA English
DT Article
DE POLYMERS; PLATELET ADHESION ACTIVATION; FIBRINOGEN ADSORPTION;
   MONOCLONAL ANTIBODIES; ENZYME IMMUNOASSAY
ID INTEGRIN ALPHA-IIB-BETA-3; PLATELET ACTIVATION; MONOCLONAL-ANTIBODY;
   HUMAN-FIBRINOGEN; CELL-ADHESION; GAMMA-CHAIN; SURFACES; BLOOD
AB In this study enzyme immunoassays are presented for the assessment of platelet adhesion/activation and fibrinogen adsorption/conformation. The estimation of platelet adhesion and activation was performed with two enzyme immunoassays (EIAs) using monoclonal antibodies directed against CD42b (GP Ib) and CD 62 (GMP 140 or P-Selectin). The applicability of EIA was first demonstrated in microtitre plates coated with fibrinogen. The thrombogenic substrate showed that platelet adhesion and activation reached a plateau level within 30 min. The use of EIA for testing biomaterials was demonstrated with polymeric reference materials where a differentiation of materials with respect to adhesion and activation was achieved. To validate the EIA scanning electron microscopy was applied and confirmed the different extent of adhesion and activation of platelets on reference materials. In addition, polyurethaneureas, based on 4,4'-diphenylmethane diisocyanate and polytetramethylene glycols, with different hard segment content and composition were investigated. It was found that both adhesion and activation were not simply dependent on the hard segment content but also on the hard segment composition. To get more insight into the mechanism of this process, two EIAs for the binding of fibrinogen using polyclonal and monoclonal antibodies were developed. There it was shown that the adhesion and activation of platelets on polyurethaneureas was not simply dependent on the total amount of adsorbed fibrinogen but rather on its conformation, indicated by the binding of the monoclonal antibody directed vs the gamma-chain of fibrinogen.
C1 HUMBOLDT UNIV BERLIN,SCH DENT,D-10098 BERLIN,GERMANY.
   HUMBOLDT UNIV BERLIN,SCH MED,INST ROENTGENDIAGNOST INTERVENT RADIOL,D-10098 BERLIN,GERMANY.
   BIOCOMPATIBLES LTD,UXBRIDGE UB8 3PQ,MIDDX,ENGLAND.
RI Seifert, Barbara/K-7569-2012
OI Groth, Thomas/0000-0001-6647-9657
CR ABSOLOM DR, 1988, J BIOMED MATER RES, V22, P215, DOI 10.1002/jbm.820220306
   ALTANKOV G, 1990, HAEMATOLOGIA, V23, P239
   ANDRADE JD, 1986, ADV POLYM SCI, V79, P1
   CAMPBELL EJ, 1992, MRS S P TISSUE INDUC, P229
   CASTNER DG, 1992, REFERENCE MATERIALS, P173
   DU XP, 1991, CELL, V65, P409, DOI 10.1016/0092-8674(91)90458-B
   ELOY R, 1987, THROMB RES, V47, P223
   GEMMELL CH, 1992, 24TH T WORLD BIOM C, P470
   GENTRY PA, 1992, J COMP PATHOL, V107, P243, DOI 10.1016/0021-9975(92)90002-C
   GOODALL AH, 1991, BLOOD COAGUL FIBRIN, V2, P377, DOI 10.1097/00001721-199104000-00024
   GROTH T, 1992, J BIOMAT SCI-POLYM E, V3, P285, DOI 10.1163/156856292X00385
   GROTH T, 1992, BIOMATERIAL TISSUE I, V10, P247
   HAYCOX CL, 1993, J BIOMED MATER RES, V27, P1181, DOI 10.1002/jbm.820270909
   HSULIN SC, 1984, J BIOL CHEM, V259, P9121
   HYNES RO, 1991, THROMB HAEMOSTASIS, V66, P40
   KIEFFER N, 1993, ROLE OF PLATELETS IN BLOOD-BIOMATERIAL INTERACTIONS, P15
   KLOCZEWIAK M, 1984, BIOCHEMISTRY-US, V23, P1767, DOI 10.1021/bi00303a028
   LAMM W, 1993, REFERENCE MATERIALS
   LEMM W, 1992, REFERENCE MATERIALS OF THE EUROPEAN COMMUNITIES, P173
   MARMUR A, 1986, J COLLOID INTERF SCI, V114, P261, DOI 10.1016/0021-9797(86)90260-2
   MCEVER RP, 1984, J BIOL CHEM, V259, P9799
   MISSIRLIS Y, 1992, REFERENCE MATERIALS OF THE EUROPEAN COMMUNITIES, P157
   MOHRI H, 1993, THROMB HAEMOSTASIS, V69, P490
   MULVIHILL JN, 1993, ROLE OF PLATELETS IN BLOOD-BIOMATERIAL INTERACTIONS, P69
   MUSTARD JF, 1987, ANN NY ACAD SCI, V516, P12
   PODIAS A, 1994, J BIOMAT SCI-POLYM E, V6, P399
   POOT A, 1993, TEST PROCEDURES BLOO, P229
   SADACOSTA V, 1991, J COLLOID INTERF SCI, V80, P445
   SAKARIASSEN KS, 1988, THROMB HAEMOSTASIS, V60, P392
   SALZMAN EW, 1987, ANN NY ACAD SCI, V516, P184
   SALZMAN EW, 1987, HEMOSTASIS THROMBOSI, P1335
   SHATTIL SJ, 1993, THROMB HAEMOSTASIS, V70, P224
   SIXMA JJ, 1991, J BIOMAT SCI-POLYM E, V3, P17
   SREENIVASAN K, 1991, Clinical Materials, V7, P27, DOI 10.1016/0267-6605(91)90053-I
NR 34
TC 42
Z9 45
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD SEP
PY 1995
VL 16
IS 13
BP 1009
EP 1015
DI 10.1016/0142-9612(95)94909-5
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA RM797
UT WOS:A1995RM79700008
PM 8580253
DA 2018-10-20
ER

PT J
AU OKANO, T
   KIKUCHI, A
   SAKURAI, Y
   TAKEI, Y
   OGATA, N
AF OKANO, T
   KIKUCHI, A
   SAKURAI, Y
   TAKEI, Y
   OGATA, N
TI TEMPERATURE-RESPONSIVE POLY(N-ISOPROPYLACRYLAMIDE) AS A MODULATOR FOR
   ALTERATION OF HYDROPHILIC HYDROPHOBIC SURFACE-PROPERTIES TO CONTROL
   ACTIVATION INACTIVATION OF PLATELETS
SO JOURNAL OF CONTROLLED RELEASE
LA English
DT Article; Proceedings Paper
CT 3rd European Symposium on Controlled Drug Delivery
CY APR 04-06, 1994
CL NOORDWIJK, NETHERLANDS
SP 3M Medica GmbH, Germany, Astra Arcus AB, Sweden, Astra Hassle AB, Sweden, Ciba Geigy Ltd, US, Insutech Inc, US, Medisorb Technol Int LP, US, N V Organon Akzo Nobel, Netherlands, Pronova Biopolym a s, Norway, Rhone Poulenc Rorer SA, France, Sandoz Pharma Ltd, Switzerland, Yamanouchi Europe B V, Netherlands
DE POLY (N-ISOPROPYLACRYLAMIDE) (PIPAAM); PIPAAM-GRAFTED SURFACE; CONTACT
   ANGLE; TEMPERATURE-MODULATED SURFACE PROPERTY CHANGES; PLATELET
   ACTIVATION
ID DRUG PERMEATION; CULTURED-CELLS; SKIN LAYERS; POLYMER; HYDROGELS;
   SWITCHES; RELEASE; WATER; POLYSTYRENE; IMMUNOASSAY
AB Our research is directed toward development and fundamental studies of biomedically relevant modulation systems using the temperature-responsive polymer, poly(N-isopropylacrylamide) (PIPAAm) functionalized with a carboxyl end group, as the switching element. This material has been attached to both biomolecules and solid surfaces to create new, modified bioconjugates and grafted surfaces, respectively. PIPAAm was used to introduce a reversible switching function correlated to hydration-dehydration changes of polymer chains in response to changes in temperature, The introduction of PIPAAm chains onto polymer surfaces is intended to impart temperature-responsive surface property changes, These surfaces were prepared using either PIPAAm with a terminal carboxyl end group or random copolymers of IPAAm with acrylic acid. The effects of graft conformation on the dynamics of grafted PIPAAm species were investigated by means of aqueous dynamic contact angle measurement. Each PIPAAm-grafted surface showed completely hydrophilic nature below 20 degrees C, however, these surfaces become hydrophobic above their critical temperature. The extent of hydrophobic property for multipoint-grafted surfaces was small compared to that of the terminally grafted surface. These hydrophilic/hydrophobic surface property changes affect the platelet contact activation. The increase in cytoplasmic [Ca2+](i) in platelets was observed only when PIPAAm grafted surface become hydrophobic, The feasibility of cell activation/inactivation control by temperature-modulated surface changes is attractive as modulator for biomedical systems and this strategy may lead to development of new 'intelligent materials' with specific temperature-modulated surface properties.
C1 SOPHIA UNIV,FAC SCI & TECHNOL,DEPT CHEM,CHIYODA KU,TOKYO 102,JAPAN.
RP OKANO, T (reprint author), TOKYO WOMENS MED COLL,INST BIOMED ENGN,SHINJUKU KU,8-1 KAWADACHO,TOKYO 162,JAPAN.
RI Okano, Teruo/J-4028-2012
CR Andrade J. D., 1985, SURFACE INTERFACIAL, P249
   BAE YH, 1987, MAKROMOL CHEM-RAPID, V8, P481
   BAE YH, 1990, J POLYM SCI POL PHYS, V28, P923, DOI 10.1002/polb.1990.090280609
   CHEN JP, 1990, BIOMATERIALS, V11, P631, DOI 10.1016/0142-9612(90)90020-Q
   COLE CA, 1987, ACS SYM SER, V350, P245
   DETTRE RH, 1964, J PHYS CHEM-US, V69, P1507
   DONG L C, 1986, Journal of Controlled Release, V4, P223, DOI 10.1016/0168-3659(86)90006-4
   FREITAS RFS, 1987, CHEM ENG SCI, V42, P97, DOI 10.1016/0009-2509(87)80213-0
   GAUR RK, 1989, ANAL BIOCHEM, V180, P253, DOI 10.1016/0003-2697(89)90426-0
   GEHRKE SH, 1993, ADV POLYM SCI, V110, P81
   GRAINGER DW, 1989, J BIOMED MATER RES, V23, P979, DOI 10.1002/jbm.820230903
   GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440
   Heskins M., 1968, J MACROMOL SCI CHEM, V2, P1441, DOI [10.1080/10601326808051910, DOI 10.1080/10601326808051910]
   HOFFMAN A S, 1986, Journal of Controlled Release, V4, P213
   JOHNSON RE, 1964, J PHYS CHEM-US, V68, P1744, DOI 10.1021/j100789a012
   MATSUKATA M, 1994, J BIOCHEM-TOKYO, V116, P682, DOI 10.1093/oxfordjournals.jbchem.a124580
   MONJI N, 1987, APPL BIOCHEM BIOTECH, V14, P107, DOI 10.1007/BF02798429
   MONJI N, 1990, BIOCHEM BIOPH RES CO, V172, P652, DOI 10.1016/0006-291X(90)90724-2
   OKANO T, 1978, J APPL POLYM SCI, V22, P369, DOI 10.1002/app.1978.070220206
   OKANO T, 1990, J CONTROL RELEASE, V11, P255, DOI 10.1016/0168-3659(90)90138-J
   OKANO T, 1993, J BIOMED MATER RES, V27, P1243, DOI 10.1002/jbm.820271005
   OKANO T, 1990, PULSED SELF REGULATE, P17
   PARK KD, 1988, J BIOMED MATER RES, V22, P977, DOI 10.1002/jbm.820221103
   PARK TG, 1993, J BIOMAT SCI-POLYM E, V4, P493
   SMITH L, 1982, J APPL POLYM SCI, V26, P1269
   Starks C. M., 1974, FREE RADICAL TELOMER
   TAKEI YG, 1994, J BIOMAT SCI-POLYM E, V6, P149
   TAKEI YG, 1994, MACROMOLECULES, V27, P6163, DOI 10.1021/ma00099a035
   TAKEI YG, 1993, BIOCONJUGATE CHEM, V4, P42, DOI 10.1021/bc00019a006
   TAKEI YG, 1993, BIOCONJUGATE CHEM, V4, P341, DOI 10.1021/bc00023a006
   TAKEI YG, 1995, IN PRESS BIOMATERIAL
   WANG KL, 1993, ADV POLYM SCI, V110, P67
   YAMADA N, 1990, MAKROMOL CHEM-RAPID, V11, P571
   YOSHIDA R, 1991, J BIOMAT SCI-POLYM E, V3, P155, DOI 10.1163/156856291X00250
   YOSHIDA R, 1992, J BIOMAT SCI-POLYM E, V3, P243, DOI 10.1163/156856292X00150
   YUI N, 1993, J BIOMAT SCI-POLYM E, V4, P199, DOI 10.1163/156856293X00528
NR 36
TC 80
Z9 85
U1 0
U2 15
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-3659
J9 J CONTROL RELEASE
JI J. Control. Release
PD SEP
PY 1995
VL 36
IS 1-2
BP 125
EP 133
DI 10.1016/0168-3659(95)00054-C
PG 9
WC Chemistry, Multidisciplinary; Pharmacology & Pharmacy
SC Chemistry; Pharmacology & Pharmacy
GA RV908
UT WOS:A1995RV90800012
DA 2018-10-20
ER

PT J
AU ILZHOEFER, JR
   BROOM, BC
   NEPA, SM
   VOGLER, EA
   KHAN, SA
   SPONTAK, RJ
AF ILZHOEFER, JR
   BROOM, BC
   NEPA, SM
   VOGLER, EA
   KHAN, SA
   SPONTAK, RJ
TI EVIDENCE OF HIERARCHICAL ORDER IN AN AMPHIPHILIC GRAFT TERPOLYMER GEL
SO JOURNAL OF PHYSICAL CHEMISTRY
LA English
DT Letter
ID MICROPHASE SEPARATION; BLOCK-COPOLYMER; SUSPENSIONS; POLYMERS; GELATION;
   RHEOLOGY; MELTS; POINT
AB Graft terpolymers consist of a polymer backbone onto which are grafted two series of chemically dissimilar sidechains. Depending on monomer incompatibility, such terpolymers either order into periodic morphologies or remain microscopically mixed. Addition of a small quantity (<2 wt%) of dibenzylidene sorbitol, a small-molecule gelling agent which self-associates through hydrogen bonding, to a homogeneous (i.e., disordered) amphiphilic graft terpolymer results in a physical gel that exhibits two levels of structural organization. In this initial study, we report on the nature and evolution of such hierarchical order. Interactions between the gellant and terpolymer result in the formation of a fine percolation network comprised of fibrillar strands measuring 10-20 nm in diameter, as determined from scanning electron micrographs. Amorphous micrometer-size spherules, similar in appearance to crystalline spherulites, subsequently develop through nucleation. Dynamic theological measurements reveal that these two distinct levels of microstructural organization are (i) responsible for deformation mechanisms manifested at different strain levels and (ii) recoverable upon mechanical and thermal recycling. These polymer-rich gels constitute a new family of responsive materials which show promise in biomedical applications.
C1 N CAROLINA STATE UNIV, DEPT MAT SCI & ENGN, RALEIGH, NC 27695 USA.
   N CAROLINA STATE UNIV, DEPT CHEM ENGN, RALEIGH, NC 27695 USA.
   BECTON DICKINSON INC, DEPT POLYMER SCI & TECHNOL, RES TRIANGLE PK, NC 27709 USA.
CR ARANGUREN MI, 1992, J RHEOL, V36, P1165, DOI 10.1122/1.550306
   BATES FS, 1990, ANNU REV PHYS CHEM, V41, P525, DOI 10.1146/annurev.pc.41.100190.002521
   Bird R.B., 1987, DYNAMICS POLYM LIQUI, V1
   COVIELLO T, 1992, MACROMOLECULES, V25, P1011, DOI 10.1021/ma00028a082
   CUVELIER G, 1990, MAKROMOL CHEM-M SYMP, V40, P23, DOI 10.1002/masy.19900400105
   EISA T, 1993, BIOMATERIALS, V14, P755, DOI 10.1016/0142-9612(93)90040-9
   FRAAIJE JGEM, 1993, J CHEM PHYS, V99, P9202, DOI 10.1063/1.465536
   FREDRICKSON GH, 1987, J CHEM PHYS, V87, P697, DOI 10.1063/1.453566
   FREDRICKSON GH, 1992, PHYSICS POLYM SURFAC, pCH1
   GARBASSI F, 1994, POLYM SURFACES PHYSI, P285
   GIDO SP, 1993, MACROMOLECULES, V26, P2636, DOI 10.1021/ma00062a040
   HASHIMOTO T, 1989, SPRINGER SERIES CHEM, V51, P2
   HOLDEN G, 1987, THERMOPLASTIC ELASTO, P481
   ILZHOEFER JR, IN PRESS MICROSC RES
   ILZHOEFER JR, IN PRESS LANGMUIR
   KHAN SA, 1994, CHEM MATER, V6, P2359, DOI 10.1021/cm00048a023
   KHAN SA, 1993, J RHEOL, V37, P1225, DOI 10.1122/1.550378
   KHAN SA, 1992, RHEOL ACTA, V31, P151, DOI 10.1007/BF00373237
   KILPATRICK PK, 1994, ACS SYM SER, V578, P229
   KOBAYASHI T, 1989, HIHON REOROJI GAKKAI, V17, P155
   LAURER JH, UNPUB MACROMOLECULES
   LEIBLER L, 1980, MACROMOLECULES, V13, P1602, DOI 10.1021/ma60078a047
   MCCALL PC, 1988, Patent No. 86832092
   MITRA D, 1988, J APPL POLYM SCI, V36, P387, DOI 10.1002/app.1988.070360211
   MITRA D, 1988, POLYMER, V29, P1990, DOI 10.1016/0032-3861(88)90172-3
   MOGI Y, 1992, MACROMOLECULES, V25, P5408, DOI 10.1021/ma00046a043
   MULLER T, 1989, COLLOID POLYM SCI, V267, P230, DOI 10.1007/BF01410580
   PRUDHOMME RK, 1990, ELECTRONIC MATERIALS, P838
   RUSSELL TP, 1994, NATURE, V368, P729, DOI 10.1038/368729a0
   SHIBAYAMA M, 1982, MACROMOLECULES, V15, P274, DOI 10.1021/ma00230a015
   STADLER R, 1995, MACROMOLECULES, V28, P3080, DOI 10.1021/ma00113a010
   TENIJENHUIS K, 1989, MACROMOLECULES, V22, P411
   Thierry A., 1992, PROG COLLOID POLYM S, V87, P28
   TOHYAMA K, 1981, NATURE, V289, P813, DOI 10.1038/289813a0
   UTRACKI LA, 1990, POLYM ALLOYS BLENDS, P117
   WIDAWSKI G, 1994, NATURE, V369, P387, DOI 10.1038/369387a0
   YANG MC, 1986, J RHEOL, V30, P1015, DOI 10.1122/1.549892
NR 37
TC 21
Z9 21
U1 0
U2 7
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0022-3654
J9 J PHYS CHEM-US
JI J. Phys. Chem.
PD AUG 10
PY 1995
VL 99
IS 32
BP 12069
EP 12071
DI 10.1021/j100032a002
PG 3
WC Chemistry, Physical
SC Chemistry
GA RN706
UT WOS:A1995RN70600002
DA 2018-10-20
ER

PT J
AU BOOS, KS
   RUDOLPHI, A
   VIELHAUER, S
   WALFORT, A
   LUBDA, D
   EISENBEISS, F
AF BOOS, KS
   RUDOLPHI, A
   VIELHAUER, S
   WALFORT, A
   LUBDA, D
   EISENBEISS, F
TI ALKYL-DIOL SILICA (ADS) - RESTRICTED ACCESS PRECOLUMN PACKINGS FOR
   DIRECT-INJECTION AND COUPLED-COLUMN CHROMATOGRAPHY OF BIOFLUIDS
SO FRESENIUS JOURNAL OF ANALYTICAL CHEMISTRY
LA English
DT Article
ID PERFORMANCE LIQUID-CHROMATOGRAPHY; CLEANUP; HPLC
AB The direct and repetitive injection of untreated biological fluids (e.g. hemolyzed blood, plasma, serum, cell culture and tissue homogenates) onto an HPLC-system and the subsequent analysis of low-molecular weight compounds (e.g. drugs, xenobiotics, metabolites) is rendered possible by a coupled-column configuration and special precolumn packings. For this purpose a new family of chemically and enzymatically tailored reversed-phase packing materials have been prepared. The LC-integrated sample clean-up with these restricted access (bimodal) phases is based on the complete nonadsorptive size exclusion of macromolecules (e.g. proteins) and on the simultaneous dynamic partitioning of the target molecules, The bonded phase which exclusively covers the internal pore surface of a glyceryl-modified silica is a butyryl-(C-4), capryloyl-(C-8) or stearoyl-(C-18) moiety. These ligands allow a classical reversed-phase or ion-pair chromatography during the sample work-up step. The capacity of the n-alkyl phase is comparable with conventional silica based RP-materials. The broad hydrophobic retentive capability of these packings allows the extraction of a wide variety of compounds of biomedical interest. The electroneutral and hydrophilic particle exterior (glyceryl-residues) was generated using either soluble or immobilized enzymes (lipase, esterase) which cleave the fatty acid esters exclusively at the outer surface. Unwanted macromolecular components of a sample (e.g. proteins) are quantitatively eluted in the void volume due to the restricted access given by the pore size (6 nm) and the nonadsorptive external diol coverage. The lifetime of a precolumn (25 x 4 mm I.D.) packed with these novel bimodal, i.e. RP-SEC phases exceeds more than 200 injections of 500 mu l plasma. In addition to the synthesis, this paper describes an application of each of these Alkyl-Diol Silica (ADS) precolumn packings in fully automated coupled-column HPLC systems for the analysis of drugs and endogenous compounds in different biological matrices.
C1 E MERCK AG,D-64271 DARMSTADT,GERMANY.
RP BOOS, KS (reprint author), UNIV HOSP MUNICH,INST CLIN CHEM,POB 701260,D-81312 MUNICH,GERMANY.
CR ANDERSON DJ, 1993, ANAL CHEM, V65, pR434
   [Anonymous], 1980, ANAL CHEM, V52, P2242
   BOOS KS, 1988, J CHROMATOGR, V456, P93, DOI 10.1016/0021-9673(86)80009-7
   BOOS KS, 1991, Patent No. 4130475
   HAGINAKA J, 1991, TRAC-TREND ANAL CHEM, V10, P17, DOI 10.1016/0165-9936(91)85040-X
   HAGINAKA J, 1989, ANAL CHEM, V61, P2445, DOI 10.1021/ac00196a024
   HUBER JFK, 1973, J CHROMATOGR, V83, P267, DOI 10.1016/S0021-9673(00)97044-4
   IMAI H, 1989, ANAL SCI, V5, P389, DOI 10.2116/analsci.5.389
   KIMATA K, 1991, J CHROMATOGR, V558, P19, DOI 10.1016/0021-9673(91)80108-S
   MEISER BM, 1994, TRANSPLANTATION, V57, P563
   OOSTERKAMP AJ, 1994, J CHROMATOGR B, V653, P55, DOI 10.1016/0378-4347(93)E0405-F
   OOSTERKAMP AJ, 1994, ANAL CHEM, V66, P4295, DOI 10.1021/ac00095a028
   PINKERTON TC, 1991, J CHROMATOGR, V544, P13, DOI 10.1016/S0021-9673(01)83975-3
   RUDOLPHI A, 1995, J PHARMACEUT BIOMED, V13, P615, DOI 10.1016/0731-7085(95)01317-E
   SHIHABI ZK, 1988, J LIQ CHROMATOGR, V11, P1579, DOI 10.1080/01483918808076722
   UNGER KK, 1991, CHROMATOGRAPHIA, V31, P507, DOI 10.1007/BF02262398
   VIELHAUER S, 1995, J CHROMATOGR B, V666, P315, DOI 10.1016/0378-4347(94)00578-S
   WESTERLUND D, 1987, CHROMATOGRAPHIA, V24, P155, DOI 10.1007/BF02688478
   YU Z, 1994, 5TH INT S PHARM BIOM, P117
NR 19
TC 106
Z9 106
U1 0
U2 18
PU SPRINGER VERLAG
PI NEW YORK
PA 175 FIFTH AVE, NEW YORK, NY 10010
SN 0937-0633
J9 FRESEN J ANAL CHEM
JI Fresenius J. Anal. Chem.
PD AUG
PY 1995
VL 352
IS 7-8
BP 684
EP 690
DI 10.1007/BF00323048
PG 7
WC Chemistry, Analytical
SC Chemistry
GA RR550
UT WOS:A1995RR55000014
DA 2018-10-20
ER

PT J
AU KOBAYASHI, E
   MATSUMOTO, S
   DOI, H
   YONEYAMA, T
   HAMANAKA, H
AF KOBAYASHI, E
   MATSUMOTO, S
   DOI, H
   YONEYAMA, T
   HAMANAKA, H
TI MECHANICAL-PROPERTIES OF THE BINARY TITANIUM-ZIRCONIUM ALLOYS AND THEIR
   POTENTIAL FOR BIOMEDICAL MATERIALS
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
ID TI
AB Mechanical properties of titanium-zirconium binary alloys were investigated in order to reveal their possible use for new biomedical materials and to collect useful data for alloy design through a hardness test, a tensile test, and optical microscopy. The hardness of the alloy containing 50% zirconium was approximately 2.5 times as large as the hardness of pure titanium and pure zirconium. Tensile tests showed a similar tendency. No changes between hardness of as cast specimens and as homogenized specimens were observed, nor were changes in microstructures noted. Comparisons between the Ti-6Al-4V alloy and the Ti-Zr-6Al-4V alloy indicated that a titanium-zirconium alloy could provide a base material for a new biomedical alloy. From these results, it was concluded that new alloys for biomedical materials should be designed as titanium-zirconium base alloys. (C) 1995 John Wiley and Sons, Inc.
C1 TOKYO INST POLYTECH,DEPT IND CHEM,ATSUGI,KANAGAWA 24303,JAPAN.
RP KOBAYASHI, E (reprint author), TOKYO MED & DENT UNIV,INST MED & DENT ENGN,CHIYODA KU,2-3-10 KANDA SURUGADAI,TOKYO 101,JAPAN.
CR Douglass D.L, 1963, ATOM ENERGY REV, V3, P71
   ETCHU Y, 1992, J JPN SOC DENT MAT D, V11, P270
   FLEISCHER RL, 1963, ACTA METALL MATER, V11, P203, DOI 10.1016/0001-6160(63)90213-X
   FRIEDEL J, 1964, DISLOCATIONS, P351
   HAMANAKA H, 1989, J DENT RES, V68, P1529, DOI 10.1177/00220345890680111201
   IMGRAM AG, 1962, J LESS-COMMON MET, V4, P217, DOI 10.1016/0022-5088(62)90068-1
   MOTT NF, 1947, STRENGTH SOLIDS
   Murray J. L., 1987, PHASE DIAGRAMS BINAR, P340
   OKUNO O, 1985, J JPN SOC DENT MAT D, V4, P408
   SUZUKI T, 1967, PHYSICS STRENGTH PLA
   SUZUKI T, 1967, DISLOCATION DYNAMICS
   TAKAHASHI M, 1994, UNPUB
   Yamamoto Y., 1989, Shimadzu Review, V46, P63
   Yoneyama T, 1992, Dent Mater J, V11, P1
   YONEYAMA T, 1993, J BIOMED MATER RES, V27, P399, DOI 10.1002/jbm.820270313
   YONEYAMA T, 1994, J JPN DENT MAT DEVIC, V13, P213
   Yoneyama T, 1993, J JPN SOC BIOMATER, V11, P71
NR 17
TC 128
Z9 134
U1 2
U2 47
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD AUG
PY 1995
VL 29
IS 8
BP 943
EP 950
DI 10.1002/jbm.820290805
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA RL619
UT WOS:A1995RL61900004
PM 7593037
DA 2018-10-20
ER

PT J
AU BURNY, F
   DONKERWOLCKE, M
   MUSTER, D
AF BURNY, F
   DONKERWOLCKE, M
   MUSTER, D
TI BIOMATERIALS EDUCATION - A CHALLENGE FOR MEDICINE AND INDUSTRY IN THE
   LATE 1990S
SO MATERIALS SCIENCE AND ENGINEERING A-STRUCTURAL MATERIALS PROPERTIES
   MICROSTRUCTURE AND PROCESSING
LA English
DT Article; Proceedings Paper
CT 1st European-Material-Research-Society Symposium on Advanced Materials
   Education
CY MAY 24-26, 1994
CL STRASBOURG, FRANCE
SP European Mat Res Soc
DE BIOMATERIALS; EDUCATION; INDUSTRY; UNIVERSITY
AB To treat diseases or disabilities, medicine and surgery use drugs and/or biomaterials. Devices used in the biomedical sector are often classified as a single sector (biomedical devices) which in reality comprises different market niches requiring appropriate R&D approaches. Throughout Europe, many biomaterials experts participate in formal or informal networks and existing protocols in research. The networks were reinforced by the creation of national and European Meetings, the support of the EC in projects such as Brite Euram. The interdisciplinary nature of the teaching is critical; permanent education and in-job training are imperatives. University researchers in materials science should spin off ideas into campus companies or small industries. A proposal was made for a European Advanced Course on Biomaterials, leading to the degree of Master of Science. A cooperative effort must be chartered, in which leaders in business help the educational system produce the technically literate person that the 21st century will demand.
C1 UNIV STRASBOURG 1,CHRU,LEED BIOMAT,STRASBOURG,FRANCE.
RP BURNY, F (reprint author), FREE UNIV BRUSSELS,HOP ERASME,DEPT ORTHOPED & TRAUMATOL,BRUSSELS,BELGIUM.
CR BLACK J, 1992, J APPL BIOMATER, V3, P231, DOI 10.1002/jab.770030311
   BORETOS JW, 1984, CONT BIOMATERIAL
   DESAHAGUN, 1938, HIST GENERAL COSAS N
   GUIBAL P, 1903, THESIS PARIS
   HALL CW, 1971, J BIOMED MATER RES 1, V2, P1
   LAMBOTTE A, 1935, NOUVELLES MED ILLUST, V22, P1
   RICHE M, 1925, B MEM SOC CHIR PARIS, P11
   SUTTON NG, 1935, MED J AUSTRALIA, V2, P611
   WILLEMS, 1992, EUROPEAN MARKET BIOM
   Williams D. F., 1987, DEFINITIONS BIOMATER
   1982, CONSENSUS DEV C BETH
NR 11
TC 9
Z9 9
U1 0
U2 2
PU ELSEVIER SCIENCE SA LAUSANNE
PI LAUSANNE 1
PA PO BOX 564, 1001 LAUSANNE 1, SWITZERLAND
SN 0921-5093
J9 MAT SCI ENG A-STRUCT
JI Mater. Sci. Eng. A-Struct. Mater. Prop. Microstruct. Process.
PD AUG 1
PY 1995
VL 199
IS 1
BP 53
EP 59
DI 10.1016/0921-5093(95)09907-7
PG 7
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Metallurgy & Metallurgical Engineering
SC Science & Technology - Other Topics; Materials Science; Metallurgy &
   Metallurgical Engineering
GA RU806
UT WOS:A1995RU80600010
DA 2018-10-20
ER

PT J
AU TABATA, Y
   SATO, S
   OMICHI, H
AF TABATA, Y
   SATO, S
   OMICHI, H
TI 2ND INTERNATIONAL-SYMPOSIUM ON RADIATION TECHNOLOGY IN BIOMEDICAL
   MATERIALS - PREFACE
SO RADIATION PHYSICS AND CHEMISTRY
LA English
DT Editorial Material
NR 0
TC 3
Z9 3
U1 0
U2 0
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
SN 0146-5724
J9 RADIAT PHYS CHEM
JI Radiat. Phys. Chem.
PD AUG
PY 1995
VL 46
IS 2
BP 157
EP 157
DI 10.1016/0969-806X(95)90037-M
PG 1
WC Chemistry, Physical; Nuclear Science & Technology; Physics, Atomic,
   Molecular & Chemical
SC Chemistry; Nuclear Science & Technology; Physics
GA RK077
UT WOS:A1995RK07700001
DA 2018-10-20
ER

PT J
AU BAYNE, SC
   SWIFT, EJ
   THOMPSON, JY
AF BAYNE, SC
   SWIFT, EJ
   THOMPSON, JY
TI REVIEW OF DENTAL MATERIALS CITATIONS .A. JANUARY TO JUNE 1995
SO DENTAL MATERIALS
LA English
DT Review
AB Objective: Electronic databases are an excellent resource for identifying relevant references for research and education projects. However, these databases are not yet a substitute for direct inspection of the literature because: (a) there still is a lag of many months between journal issue publication and updates of the database, and (b) most databases selectively report a portion of the entire literature. The objective was to identify and categorize all the dental materials citations in biomedical journals that were published from January 1995 through June 1995.
   Methods: Seventeen primary and 56 secondary dental journals were manually searched via their tables of contents to detect dental materials publications from January to June of 1995. Denial materials citations were categorized into 17 major sections and further divided into several subsections. The review excluded case reports and literature primarily related to dental implants or biomedical materials outside of dentistry.
   Results: Three hundred-sixty-nine citations were identified. The greatest number of citations were associated with dentin bonding, composites, and glass ionomers. There was no significant increase in dental materials publications vs. the number reported for 1994.
   Significance: This list provides a comprehensive source for review by academicians and researchers to bridge the gap between initial publication and electronic citation.
RP BAYNE, SC (reprint author), UNIV N CAROLINA,SCH DENT,DEPT OPERAT DENT,CHAPEL HILL,NC 27599, USA.
CR AIDA M, 1995, J PROSTHET DENT, V73, P464, DOI 10.1016/S0022-3913(05)80076-9
   AKINMADE AO, 1995, BIOMATERIALS, V16, P149, DOI 10.1016/0142-9612(95)98279-N
   Al-Waheidi E M, 1995, Quintessence Int, V26, P385
   ANASTASSIADOU V, 1995, DENT MATER, V11, P182, DOI 10.1016/0109-5641(95)80015-8
   ANDERSSON OH, 1995, J MATER SCI-MATER M, V6, P242, DOI 10.1007/BF00146863
   ANDERSSONWENCKE.IE, 1995, ASDC J DENT CHILD, V62, P197
   ANUSAVICE KJ, 1995, DENT MATER, V11, P102, DOI 10.1016/0109-5641(95)80042-5
   ARIMA T, 1995, J PROSTHET DENT, V73, P55, DOI 10.1016/S0022-3913(05)80273-2
   ARITA IH, 1995, J MATER SCI MAT MED, V6, P9
   ASMUSSEN E, 1995, J DENT RES, V74, P715, DOI 10.1177/00220345950740021501
   BALES DJ, 1991, CURR OPIN DENT, V1, P253
   BALES DJ, 1992, CURR OPIN DENT, V2, P183
   BALES DJ, 1991, CURR OPIN DENT, V1, P245
   Balevi B, 1995, Oral Health, V85, P29
   BARNETT ML, 1995, J DENT RES, V74, P1129, DOI 10.1177/00220345950740041401
   BASKETTER D, 1995, CONTACT DERMATITIS, V32, P65, DOI 10.1111/j.1600-0536.1995.tb00748.x
   BAUMGARDNER KR, 1995, J AM DENT ASSOC, V126, P351, DOI 10.14219/jada.archive.1995.0180
   BAYNE SC, 1994, DENT MATER, V10, P59, DOI 10.1016/0109-5641(94)90023-X
   Beckett H, 1995, Quintessence Int, V26, P217
   BENAMAR A, 1995, J ORAL REHABIL, V22, P101, DOI 10.1111/j.1365-2842.1995.tb00242.x
   BERDOUSES E, 1995, J DENT RES, V74, P1185, DOI 10.1177/00220345950740050701
   BERRY TG, 1995, AM J DENT, V8, P122
   Berte J J, 1995, J Prosthodont, V4, P129, DOI 10.1111/j.1532-849X.1995.tb00328.x
   Bester S P, 1995, Int J Prosthodont, V8, P46
   BICHACHO N, 1995, OPER DENT, V20, P68
   Binon P P, 1995, Int J Prosthodont, V8, P162
   BISHARA SE, 1995, ANGLE ORTHOD, V65, P117
   Blight S J, 1995, Br J Orthod, V22, P35
   Bott B, 1995, J Esthet Dent, V7, P110, DOI 10.1111/j.1708-8240.1995.tb00727.x
   BRAEM MJA, 1995, DENT MATER, V11, P137, DOI 10.1016/0109-5641(95)80049-2
   BRANTLEY WA, 1995, DENT MATER, V11, P154, DOI 10.1016/0109-5641(95)80011-5
   Briseno B, 1995, Quintessence Int, V26, P361
   Bruce G J, 1995, Compend Contin Educ Dent, V16, P180
   BRUZE M, 1995, CONTACT DERMATITIS, V32, P156, DOI 10.1111/j.1600-0536.1995.tb00806.x
   Buch D, 1995, Int J Prosthodont, V8, P285
   Burke F J, 1995, Quintessence Int, V26, P293
   BURROW MF, 1995, J DENT, V23, P41, DOI 10.1016/0300-5712(95)90659-6
   CAFRUNY WA, 1995, AM J DENT, V8, P152
   CAMPS J, 1995, DENT MATER, V11, P177, DOI 10.1016/0109-5641(95)80014-X
   CARVALHO RM, 1995, AM J DENT, V8, P128
   CERNAVIN I, 1995, AUST DENT J, V40, P79, DOI 10.1111/j.1834-7819.1995.tb03120.x
   Chadwick S M, 1995, Br J Orthod, V22, P113
   Chadwick S M, 1995, Br J Orthod, V22, P29
   CHAI TI, 1995, J PROSTHET DENT, V73, P534, DOI 10.1016/S0022-3913(05)80112-X
   Chan DCN, 1995, QUINTESSENCE INT, V26, P57
   Chirtoc M, 1995, Int J Prosthodont, V8, P259
   Cho E, 1995, Quintessence Int, V26, P351
   CHO GC, 1995, J PROSTHET DENT, V73, P419, DOI 10.1016/S0022-3913(05)80068-X
   CHRISTENSEN GJ, 1995, J AM DENT ASSOC, V126, P781, DOI 10.14219/jada.archive.1995.0274
   CHRISTENSEN GJ, 1995, J AM DENT ASSOC, V126, P503, DOI 10.14219/jada.archive.1995.0215
   CIPRIANO TM, 1995, J PROSTHET DENT, V73, P8, DOI 10.1016/S0022-3913(05)80265-3
   Cohen B I, 1995, Oral Health, V85, P7
   Cohen B I, 1995, J Esthet Dent, V7, P174, DOI 10.1111/j.1708-8240.1995.tb00574.x
   Cohen B I, 1995, Compend Contin Educ Dent, V16, P630
   Cornell D F, 1995, J Esthet Dent, V7, P81, DOI 10.1111/j.1708-8240.1995.tb00566.x
   Counts A L, 1995, J Prosthodont, V4, P3, DOI 10.1111/j.1532-849X.1995.tb00306.x
   Croll T P, 1995, Quintessence Int, V26, P121
   Croll Theodore P., 1995, ASDC (American Society of Dentistry for Children) Journal of Dentistry for Children, V62, P17
   Cunningham J L, 1995, Int J Prosthodont, V8, P69
   CZERW RJ, 1995, OPER DENT, V20, P58
   DARIEL MP, 1995, DENT MATER, V11, P211
   DARR AH, 1995, J ORAL REHABIL, V22, P43, DOI 10.1111/j.1365-2842.1995.tb00209.x
   Davis B A, 1995, J Prosthodont, V4, P111, DOI 10.1111/j.1532-849X.1995.tb00325.x
   DEGROOD ME, 1995, J ENDODONT, V21, P65, DOI 10.1016/S0099-2399(06)81097-6
   DEHOFF PH, 1995, DENT MATER, V11, P126, DOI 10.1016/0109-5641(95)80047-6
   DENISSEN H, 1995, J MATER SCI-MATER M, V6, P35, DOI 10.1007/BF00121245
   DERAND T, 1995, DENT MATER, V11, P93, DOI 10.1016/0109-5641(95)80040-9
   DERHAMI K, 1995, OPER DENT, V20, P100
   DIAZARNOLD AM, 1995, AM J DENT, V8, P134
   DIAZARNOLD AM, 1995, DENT MATER, V11, P96, DOI 10.1016/0109-5641(95)80041-7
   Dietschi D, 1995, Quintessence Int, V26, P127
   DIXON DL, 1995, J PROSTHET DENT, V73, P510, DOI 10.1016/S0022-3913(05)80108-8
   Dominici J T, 1995, J Prosthodont, V4, P101, DOI 10.1111/j.1532-849X.1995.tb00324.x
   DONACHIE MA, 1995, J DENT, V23, P157, DOI 10.1016/0300-5712(95)93573-K
   Downing A, 1995, Br J Orthod, V22, P41
   DRIESSENS FCM, 1995, J MATER SCI-MATER M, V6, P272, DOI 10.1007/BF00120270
   DYSON JE, 1995, AUST DENT J, V40, P50, DOI 10.1111/j.1834-7819.1995.tb05615.x
   ECONOMIDES N, 1995, J ENDODONT, V21, P122, DOI 10.1016/S0099-2399(06)80436-X
   EICK JD, 1995, J DENT RES, V74, P1246, DOI 10.1177/00220345950740060201
   EIDE R, 1995, ACTA ODONTOL SCAND, V53, P12, DOI 10.3109/00016359509005937
   ELBADRAWY WA, 1995, J PROSTHET DENT, V73, P515, DOI 10.1016/S0022-3913(05)80109-X
   Ergas R P, 1995, Pediatr Dent, V17, P204
   Fanning D E, 1995, Gen Dent, V43, P256
   FEILZER AJ, 1995, DENT MATER, V11, P186, DOI 10.1016/0109-5641(95)80016-6
   FIELD MJ, 1995, J AM DENT ASSOC, V126, P191, DOI 10.14219/jada.archive.1995.0144
   FISCHMAN SL, 1995, J DENT RES, V74, P1117
   FISCHMAN SL, 1995, J DENT RES, V74, P1116
   FLINT GN, 1995, CONTACT DERMATITIS, V32, P218, DOI 10.1111/j.1600-0536.1995.tb00672.x
   FRANCHI M, 1995, J MATER SCI-MATER M, V6, P187, DOI 10.1007/BF00146853
   FRANCHI M, 1995, QUINTESSENCE INT, V26, P431
   FRIEDL KH, 1995, OPER DENT, V20, P34
   FRIEDL KH, 1995, OPER DENT, V20, P74
   FUJISHIMA A, 1995, DENT MATER, V11, P82, DOI 10.1016/0109-5641(95)80038-7
   Futatsuki M, 1995, J Clin Pediatr Dent, V19, P99
   Garcia-Godoy F, 1995, J Clin Pediatr Dent, V19, P181
   Gegauff A G, 1995, Int J Prosthodont, V8, P62
   GEMALMAZ D, 1995, J PROSTHET DENT, V73, P49
   GERZINA TM, 1995, J DENT RES, V74, P369, DOI 10.1177/00220345950740011301
   GILMOUR ASM, 1995, J PROSTHET DENT, V73, P569, DOI 10.1016/S0022-3913(05)80118-0
   GIORDANO RA, 1995, J PROSTHET DENT, V73, P411, DOI 10.1016/S0022-3913(05)80067-8
   GIRAY CB, 1995, AUST DENT J, V40, P43, DOI 10.1111/j.1834-7819.1995.tb05613.x
   GIVAN DA, 1995, J PROSTHET DENT, V73, P377
   GLUSKIN AH, 1995, J ENDODONT, V21, P33, DOI 10.1016/S0099-2399(06)80554-6
   Godder Benjamin, 1995, General Dentistry, V43, P252
   GOLDBERG M, 1995, J DENT, V23, P15, DOI 10.1016/0300-5712(95)90655-2
   GOLDSTEIN RE, 1995, J AM DENT ASSOC, V126, P761, DOI 10.14219/jada.archive.1995.0271
   GRANCHI D, 1995, ORAL SURG ORAL MED O, V79, P359, DOI 10.1016/S1079-2104(05)80230-6
   GRIPPO JO, 1995, J AM DENT ASSOC, V126, P619, DOI 10.14219/jada.archive.1995.0241
   GROSSMAN ES, 1995, J PROSTHET DENT, V73, P199, DOI 10.1016/S0022-3913(05)80162-3
   GROSSMAN ES, 1995, J PROSTHET DENT, V73, P290, DOI 10.1016/S0022-3913(05)80208-2
   Gruythuysen R. J. M., 1995, ASDC (American Society of Dentistry for Children) Journal of Dentistry for Children, V62, P22
   Guzman A, 1995, Int J Prosthodont, V8, P179
   GWINNETT AJ, 1995, AM J DENT, V8, P109
   HALBACH S, 1995, J DENT RES, V74, P1103, DOI 10.1177/00220345950740041101
   HARRINGTON E, 1995, J ORAL REHABIL, V22, P377, DOI 10.1111/j.1365-2842.1995.tb00788.x
   HASEGAWA T, 1995, J PROSTHET DENT, V73, P432, DOI 10.1016/S0022-3913(05)80071-X
   HATA G, 1995, J ENDODONT, V21, P167, DOI 10.1016/S0099-2399(06)80559-5
   Haug S P, 1995, J Prosthodont, V4, P11, DOI 10.1111/j.1532-849X.1995.tb00308.x
   HAUTANIEMI JA, 1995, J MATER SCI-MATER M, V6, P46, DOI 10.1007/BF00121247
   HAYAKAWA T, 1995, DENT MATER, V11, P221
   Hembree J H Jr, 1995, Quintessence Int, V26, P145
   Henderson B, 1995, J Can Dent Assoc, V61, P429
   HILL R, 1995, J MATER SCI-MATER M, V6, P311, DOI 10.1007/BF00120298
   HIMEL VT, 1995, J ENDODONT, V21, P142, DOI 10.1016/S0099-2399(06)80440-1
   HINOURA K, 1995, OPER DENT, V20, P30
   HISATSUNE K, 1995, J MATER SCI-MATER M, V6, P284, DOI 10.1007/BF00120272
   HOLTAN JR, 1995, OPER DENT, V20, P94
   HOLTAN JR, 1995, J AM DENT ASSOC, V126, P611, DOI 10.14219/jada.archive.1995.0240
   HONG YH, 1995, EUR J ORTHODONT, V17, P121, DOI 10.1093/ejo/17.2.121
   Hosoya Y, 1995, J Clin Pediatr Dent, V19, P185
   HOTTA M, 1995, J ORAL REHABIL, V22, P197, DOI 10.1111/j.1365-2842.1995.tb01564.x
   HOVAV S, 1995, OPER DENT, V20, P63
   HTANG A, 1995, DENT MATER, V11, P7, DOI 10.1016/0109-5641(95)80002-6
   HUNTER AR, 1995, OPER DENT, V20, P2
   Hurzeler M B, 1995, Int J Prosthodont, V8, P142
   HUTTON JE, 1995, J PROSTHET DENT, V73, P126, DOI 10.1016/S0022-3913(05)80150-7
   IMAZATO S, 1995, J DENT, V23, P177, DOI 10.1016/0300-5712(95)93576-N
   IMBERY TA, 1995, J AM DENT ASSOC, V126, P753, DOI 10.14219/jada.archive.1995.0270
   IMBERY TA, 1995, AM J DENT, V8, P117
   INDRANI DJ, 1995, DENT MATER, V11, P201, DOI 10.1016/0109-5641(95)80019-0
   INOKOSHI S, 1995, OPER DENT, V20, P111
   IVANOVSKI S, 1995, DENT MATER, V11, P19, DOI 10.1016/0109-5641(95)80004-2
   JACOBSEN T, 1995, DENT MATER, V11, P132, DOI 10.1016/0109-5641(95)80048-4
   JAGGER DC, 1995, J ORAL REHABIL, V22, P275, DOI 10.1111/j.1365-2842.1995.tb00086.x
   JAGGER DC, 1995, J ORAL REHABIL, V22, P349, DOI 10.1111/j.1365-2842.1995.tb00784.x
   JANDA R, 1995, BIOMATERIALS, V16, P209, DOI 10.1016/0142-9612(95)92119-Q
   JENDRESEN MD, 1993, J PROSTHET DENT, V70, P44, DOI 10.1016/0022-3913(93)90036-N
   JENDRESEN MD, 1995, J PROSTHET DENT, V74, P60, DOI 10.1016/S0022-3913(05)80231-8
   JENDRESEN MD, 1994, J PROSTHET DENT, V72, P39, DOI 10.1016/0022-3913(94)90214-3
   JEPSON NJA, 1995, J DENT, V23, P123, DOI 10.1016/0300-5712(95)98979-D
   JOHANSSON BI, 1995, DENT MATER, V11, P41, DOI 10.1016/0109-5641(95)80007-7
   Johnston W M, 1995, Int J Prosthodont, V8, P79
   JONTELL M, 1995, J DENT RES, V74, P1162, DOI 10.1177/00220345950740050401
   Jou G L, 1995, J Clin Orthod, V29, P184
   KALACHANDRA S, 1995, J MATER SCI-MATER M, V6, P218, DOI 10.1007/BF00146859
   KAPLOWITZ GJ, 1995, J AM DENT ASSOC, V126, P486, DOI 10.14219/jada.archive.1995.0212
   KARLSSON S, 1995, J ORAL REHABIL, V22, P9, DOI 10.1111/j.1365-2842.1995.tb00204.x
   KARLZENREUTERVI.G, 1995, ASDC J DENT CHILD, V62, P108
   KELLY JR, 1995, DENT MATER, V11, P103, DOI 10.1016/0109-5641(95)80043-3
   KELLY JR, 1995, J DENT RES, V74, P1253, DOI 10.1177/00220345950740060301
   KELSEY WP, 1995, QUINTESSENCE INT, V26, P15
   KERN M, 1995, J DENT, V23, P47, DOI 10.1016/0300-5712(95)90660-A
   KERN M, 1995, J PROSTHET DENT, V73, P240, DOI 10.1016/S0022-3913(05)80200-8
   Kern M, 1995, J Prosthodont, V4, P16, DOI 10.1111/j.1532-849X.1995.tb00309.x
   KEROSUO H, 1995, ANGLE ORTHOD, V65, P111
   Keyf Filiz, 1995, Journal of Nihon University School of Dentistry, V37, P1
   KINNEY JH, 1995, J DENT RES, V74, P1179, DOI 10.1177/00220345950740050601
   Kocadereli I, 1995, J Clin Pediatr Dent, V19, P127
   KONONEN M, 1995, J PROSTHET DENT, V73, P4, DOI 10.1016/S0022-3913(05)80264-1
   KOPPANG R, 1995, J PROSTHET DENT, V73, P486, DOI 10.1016/S0022-3913(05)80080-0
   KOTSIOMITI E, 1995, J ORAL REHABIL, V22, P135, DOI 10.1111/j.1365-2842.1995.tb00247.x
   KOVARIK RE, 1995, AM J DENT, V8, P145
   KREJCI I, 1995, DENT MATER, V11, P34, DOI 10.1016/0109-5641(95)80006-9
   KVAM K, 1995, BIOMATERIALS, V16, P73, DOI 10.1016/0142-9612(95)91099-K
   LANGER R, 1995, ANN BIOMED ENG, V23, P101, DOI 10.1007/BF02368317
   LARMOUR CJ, 1995, J DENT, V23, P37, DOI 10.1016/0300-5712(95)90658-5
   Laurell K A, 1995, Quintessence Int, V26, P139
   Lee Charles Q., 1995, General Dentistry, V43, P158
   LEE SY, 1995, J DENT, V23, P27, DOI 10.1016/0300-5712(95)90657-4
   LEEMPOEL PJB, 1995, J ORAL REHABIL, V22, P327, DOI 10.1111/j.1365-2842.1995.tb00780.x
   Lefebvre C A, 1995, Int J Prosthodont, V8, P122
   LEINFELDER KF, 1995, J AM DENT ASSOC, V126, P663, DOI 10.14219/jada.archive.1995.0247
   LENZ J, 1995, J APPL BIOMATER, V6, P55, DOI 10.1002/jab.770060108
   LEUNG YC, 1995, DENT MATER, V11, P191, DOI 10.1016/0109-5641(95)80017-4
   LIAO WM, 1995, J ORAL REHABIL, V22, P67
   LIBERMAN R, 1995, J ORAL REHABIL, V22, P445, DOI 10.1111/j.1365-2842.1995.tb00799.x
   Libman W J, 1995, Int J Prosthodont, V8, P155
   Liebenberg W H, 1995, J Esthet Dent, V7, P155, DOI 10.1111/j.1708-8240.1995.tb00572.x
   Liebenberg William H., 1995, General Dentistry, V43, P50
   Lim P F, 1995, Int J Prosthodont, V8, P117
   LIN JHC, 1995, J ORAL REHABIL, V22, P331, DOI 10.1111/j.1365-2842.1995.tb00781.x
   LLOYD CH, 1995, J DENT, V23, P67, DOI 10.1016/0300-5712(95)98973-7
   Loney R W, 1995, Int J Prosthodont, V8, P247
   LONNROTH EC, 1995, SWED DENT J, V19, P55
   LORSCHEIDER FL, 1995, FASEB J, V9, P504
   LUEBKE NH, 1995, J ENDODONT, V21, P259, DOI 10.1016/S0099-2399(06)80993-3
   LYGRE H, 1995, ACTA ODONTOL SCAND, V53, P75, DOI 10.3109/00016359509005950
   Lyzak W A, 1995, J Prosthodont, V4, P133, DOI 10.1111/j.1532-849X.1995.tb00329.x
   LYZAK WA, 1995, GEN DENT, V43, P49
   MACHIDA T, 1995, J ENDODONT, V21, P88, DOI 10.1016/S0099-2399(06)81102-7
   MACKERT JR, 1995, J DENT RES, V74, P1259, DOI 10.1177/00220345950740060401
   MACPHERSON LC, 1995, BRIT DENT J, V178, P341, DOI 10.1038/sj.bdj.4808760
   MAFFEZZOLI A, 1995, J MATER SCI-MATER M, V6, P155, DOI 10.1007/BF00120292
   MAFFEZZOLI A, 1995, J MATER SCI-MATER M, V6, P161, DOI 10.1007/BF00120293
   MAIR LH, 1995, J DENT, V23, P107, DOI 10.1016/0300-5712(95)98976-A
   Manga R K, 1995, Gen Dent, V43, P241
   MANTON DJ, 1995, AUST DENT J, V40, P22, DOI 10.1111/j.1834-7819.1995.tb05608.x
   Matasa C G, 1995, J Clin Orthod, V29, P16
   MATSUMURA H, 1995, J PROSTHET DENT, V73, P386, DOI 10.1016/S0022-3913(05)80336-1
   MATSUMURA H, 1995, J PROSTHET DENT, V73, P233, DOI 10.1016/S0022-3913(05)80199-4
   MAY KB, 1995, J PROSTHET DENT, V73, P428, DOI 10.1016/S0022-3913(05)80070-8
   Mazzeo N, 1995, Pediatr Dent, V17, P112
   McCracken MS, 1995, QUINTESSENCE INT, V26, P21
   McEvoy S A, 1995, J Esthet Dent, V7, P104, DOI 10.1111/j.1708-8240.1995.tb00726.x
   Mclean J W, 1995, J Esthet Dent, V7, P141, DOI 10.1111/j.1708-8240.1995.tb00570.x
   MECHOLSKY JJ, 1995, DENT MATER, V11, P113, DOI 10.1016/0109-5641(95)80045-X
   MECHOLSKY JJ, 1995, DENT MATER, V11, P111, DOI 10.1016/0109-5641(95)80044-1
   MEECHAN JG, 1995, J ORAL MAXIL SURG, V53, P284, DOI 10.1016/0278-2391(95)90226-0
   MEHTA S, 1995, BIOMATERIALS, V16, P97, DOI 10.1016/0142-9612(95)98269-K
   MEIARS JR, 1995, AM J DENT, V8, P80
   MEIJERING AC, 1995, J DENT, V23, P21, DOI 10.1016/0300-5712(95)90656-3
   MENG CL, 1995, ANGLE ORTHOD, V65, P209
   MERCURI LG, 1995, J ORAL MAXIL SURG, V53, P106, DOI 10.1016/0278-2391(95)90381-X
   MERTZFAIRHURST EJ, 1995, ASDC J DENT CHILD, V62, P97
   Meyenberg K H, 1995, J Esthet Dent, V7, P73, DOI 10.1111/j.1708-8240.1995.tb00565.x
   Millett D T, 1995, Br J Orthod, V22, P161
   Millstein P L, 1995, Int J Prosthodont, V8, P129
   MISERENDINO LJ, 1995, J ENDODONT, V21, P83, DOI 10.1016/S0099-2399(06)81101-5
   MITCHELL CA, 1995, BIOMATERIALS, V16, P11, DOI 10.1016/0142-9612(95)91090-L
   MIXSON JM, 1995, AM J DENT, V8, P5
   Mizrahi E, 1995, J Clin Orthod, V29, P268
   MOHSEN NM, 1995, J ORAL REHABIL, V22, P183, DOI 10.1111/j.1365-2842.1995.tb01562.x
   MOHSEN NM, 1995, J ORAL REHABIL, V22, P213, DOI 10.1111/j.1365-2842.1995.tb01566.x
   Moore B. Keith, 1995, General Dentistry, V43, P176
   Morand J M, 1995, Quintessence Int, V26, P389
   Moseley H C, 1995, Br J Orthod, V22, P23
   MOSHONOV J, 1995, ORAL SURG ORAL MED O, V79, P221, DOI 10.1016/S1079-2104(05)80287-2
   Mount G J, 1995, Int Dent J, V45, P135
   MUNKSGAARD EC, 1995, AM J DENT, V8, P137
   MUSIKANT BL, 1995, J ORAL REHABIL, V22, P435, DOI 10.1111/j.1365-2842.1995.tb00797.x
   NAKABAYASHI N, 1995, AM J DENT, V8, P37
   NERY S, 1995, J DENT, V23, P55, DOI 10.1016/0300-5712(95)90661-Z
   NIEMZ MH, 1995, J DENT RES, V74, P1194, DOI 10.1177/00220345950740050801
   Nikaido T, 1995, Quintessence Int, V26, P221
   NIKOLAI RJ, 1995, DENT MATER, V11, P169, DOI 10.1016/0109-5641(95)80013-1
   Noie F, 1995, Int J Prosthodont, V8, P51
   OCONNOR RP, 1995, J ENDODONT, V21, P74, DOI 10.1016/S0099-2399(06)81099-X
   Oda Yutaka, 1995, Bulletin of Tokyo Dental College, V36, P1
   Oesterle L J, 1995, J Clin Orthod, V29, P31
   OSBORNE JW, 1995, OPER DENT, V20, P26
   Owens B M, 1995, Compend Contin Educ Dent, V16, P557
   PAMEIJER CH, 1995, AM J DENT, V8, P140
   PAMEIJER CH, 1995, AM J DENT, V8, P43
   PANAGIOTOUNI E, 1995, J PROSTHET DENT, V73, P578, DOI 10.1016/S0022-3913(05)80120-9
   PANG IC, 1995, J PROSTHET DENT, V73, P17, DOI 10.1016/S0022-3913(05)80267-7
   PANITVISAI P, 1995, J ENDODONT, V21, P57
   PARKER HH, 1995, J DENT, V23, P113, DOI 10.1016/0300-5712(95)98977-B
   PASHLEY DH, 1995, DENT MATER, V11, P117, DOI 10.1016/0109-5641(95)80046-8
   PATERSON FM, 1995, J DENT, V23, P137, DOI 10.1016/0300-5712(95)93570-R
   Patton L L, 1995, Gen Dent, V43, P22
   PAULUZZI P, 1995, CONTACT DERMATITIS, V32, P123, DOI 10.1111/j.1600-0536.1995.tb00772.x
   PERCINOTO C, 1995, AM J DENT, V8, P20
   PEUTZFELDT A, 1995, ACTA ODONTOL SCAND, V53, P29, DOI 10.3109/00016359509005941
   Phoenix R D, 1995, Int J Prosthodont, V8, P187
   PIDAPARTI RMV, 1995, J BIOMED MATER RES, V29, P309, DOI 10.1002/jbm.820290305
   Piddock V, 1995, Int J Prosthodont, V8, P280
   POHL L, 1995, ACTA ODONTOL SCAND, V53, P44, DOI 10.3109/00016359509005944
   Polyzois G L, 1995, J Prosthodont, V4, P38, DOI 10.1111/j.1532-849X.1995.tb00313.x
   Polyzois G L, 1995, Int J Prosthodont, V8, P150
   Polyzois G L, 1995, Compend Contin Educ Dent, V16, P230
   POLYZOIS GL, 1995, J BIOMATER APPL, V9, P355, DOI 10.1177/088532829500900403
   POWELL LV, 1995, OPER DENT, V20, P7
   Powers J M, 1995, J Prosthodont, V4, P28, DOI 10.1111/j.1532-849X.1995.tb00311.x
   PRIEST G, 1995, INT J PERIODONT REST, V15, P239
   PRIYAWAN R, 1995, J MATER SCI-MATER M, V6, P1, DOI 10.1007/BF00121237
   PURK JH, 1995, J DENT, V8, P75
   RITTER JE, 1995, DENT MATER, V11, P147, DOI 10.1016/0109-5641(95)80051-4
   RITTER JE, 1995, DENT MATER, V11, P142, DOI 10.1016/0109-5641(95)80050-6
   ROSSOMANDO KJ, 1995, DENT MATER, V11, P47, DOI 10.1016/0109-5641(95)80008-5
   ROULET JF, 1995, J DENT RES, V74, P381, DOI 10.1177/00220345950740011501
   Rubinstein S, 1995, J Esthet Dent, V7, P167, DOI 10.1111/j.1708-8240.1995.tb00573.x
   SAMET N, 1995, J PROSTHET DENT, V73, P457, DOI 10.1016/S0022-3913(05)80075-7
   SANCHEZ E, 1995, J AM DENT ASSOC, V126, P359, DOI 10.14219/jada.archive.1995.0181
   SANO H, 1995, J DENT RES, V74, P1093, DOI 10.1177/00220345950740041001
   SANO H, 1995, OPER DENT, V20, P18
   Sato Y, 1995, Int J Prosthodont, V8, P73
   SCHMALZ G, 1995, J PROSTHET DENT, V73, P392, DOI 10.1016/S0022-3913(05)80337-3
   SCHMITT SM, 1995, J PROSTHET DENT, V73, P280, DOI 10.1016/S0022-3913(05)80206-9
   Seghi R R, 1995, Int J Prosthodont, V8, P239
   SEKA W, 1995, J DENT RES, V74, P1086, DOI 10.1177/00220345950740040901
   SENDA A, 1995, OPER DENT, V20, P51
   SEPPA L, 1995, EUR J ORAL SCI, V103, P182, DOI 10.1111/j.1600-0722.1995.tb00022.x
   Shanthala B M, 1995, J Clin Pediatr Dent, V19, P121
   SHINKAI K, 1995, AM J DENT, V8, P149
   SHORTALL AC, 1995, J ORAL REHABIL, V22, P337, DOI 10.1111/j.1365-2842.1995.tb00782.x
   SIDHU SK, 1995, AM J DENT, V8, P59
   Sinha P K, 1995, J Clin Orthod, V29, P97
   SIPAHIER M, 1995, QUINTESSENCE INT, V26, P37
   SIPAHIER M, 1995, QUINTESSENCE INT, V26, P43
   SJOGREN G, 1995, ACTA ODONTOL SCAND, V53, P24, DOI 10.3109/00016359509005940
   SMALES RJ, 1995, AUST DENT J, V40, P171, DOI 10.1111/j.1834-7819.1995.tb05632.x
   SMART ER, 1995, BRIT DENT J, V178, P108, DOI 10.1038/sj.bdj.4808663
   Sohmura T, 1995, Int J Prosthodont, V8, P252
   SORENSEN JA, 1995, EUR J ORAL SCI, V103, P186, DOI 10.1111/j.1600-0722.1995.tb00023.x
   SORENSEN JA, 1995, EUR J ORAL SCI, V103, P116, DOI 10.1111/j.1600-0722.1995.tb00128.x
   Spranger H, 1995, Quintessence Int, V26, P149
   Staninec M, 1995, Gen Dent, V43, P278
   Sterrett J, 1995, J Can Dent Assoc, V61, P412
   STRYDOM C, 1995, AM J DENT, V8, P93
   SULJAK JP, 1995, J DENT, V23, P171, DOI 10.1016/0300-5712(95)93575-M
   SUZUKI S, 1995, AM J DENT, V8, P83
   Swift E J Jr, 1995, Quintessence Int, V26, P95
   SWIFT EJ, 1995, DENT MATER, V11, P196, DOI 10.1016/0109-5641(95)80018-2
   SWIFT EJ, 1995, DENT MATER, V11, P52, DOI 10.1016/0109-5641(95)80009-3
   SYVERUD M, 1995, DENT MATER, V11, P14, DOI 10.1016/0109-5641(95)80003-4
   TAIRA M, 1995, J MATER SCI-MATER M, V6, P197, DOI 10.1007/BF00146855
   TAIRA M, 1995, J MATER SCI-MATER M, V6, P5, DOI 10.1007/BF00121238
   TAIRA M, 1995, J MATER SCI-MATER M, V6, P167, DOI 10.1007/BF00120294
   TAIRA Y, 1995, DENT MATER, V11, P2, DOI 10.1016/0109-5641(95)80001-8
   TAIRA Y, 1995, J ORAL REHABIL, V22, P409, DOI 10.1111/j.1365-2842.1995.tb00793.x
   Tay F.R., 1995, QUINTESSENCE INT, V26, P63
   TAY FR, 1995, J DENT RES, V74, P1168, DOI 10.1177/00220345950740050501
   TAY FR, 1995, AM J DENT, V8, P105
   Ten Cate J. M., 1995, Journal of Dental Research, V74, P1266
   TENBOSCH JJ, 1995, J DENT RES, V74, P374, DOI 10.1177/00220345950740011401
   THONEMANN B, 1995, DENT MATER, V11, P161, DOI 10.1016/0109-5641(95)80012-3
   Thordrup M, 1995, Int J Prosthodont, V8, P233
   TORABINEJAD M, 1995, J ENDODONT, V21, P109, DOI 10.1016/S0099-2399(06)80433-4
   TORABINEJAD M, 1995, J ENDODONT, V21, P295, DOI 10.1016/S0099-2399(06)81004-6
   TORBJORNER A, 1995, J PROSTHET DENT, V73, P439, DOI 10.1016/S0022-3913(05)80072-1
   TRIOLO PT, 1995, OPER DENT, V20, P46
   Tripodakis A P, 1995, Int J Prosthodont, V8, P265
   TUNTIPRAWON M, 1995, AUST DENT J, V40, P17, DOI 10.1111/j.1834-7819.1995.tb05607.x
   TYAS MJ, 1995, AUST DENT J, V40, P167, DOI 10.1111/j.1834-7819.1995.tb05631.x
   UNTERBRINK GL, 1995, J DENT, V23, P183, DOI 10.1016/0300-5712(95)93577-O
   UTER W, 1995, CONTACT DERMATITIS, V32, P135, DOI 10.1111/j.1600-0536.1995.tb00802.x
   Valderrama S, 1995, Int J Prosthodont, V8, P29
   VALLITTU PK, 1995, ACTA ODONTOL SCAND, V53, P99, DOI 10.3109/00016359509005954
   VALLITTU PK, 1995, J ORAL REHABIL, V22, P257, DOI 10.1111/j.1365-2842.1995.tb00083.x
   Van Zeghbroeck L, 1995, J Esthet Dent, V7, P49
   Van Zeghbroeck L, 1995, J Esthet Dent, V7, P59
   VANLANDUYT P, 1995, J MATER SCI-MATER M, V6, P8, DOI 10.1007/BF00121239
   VANMEERBEEK B, 1995, DENT MATER, V11, P87, DOI 10.1016/0109-5641(95)80039-5
   VANNOORT R, 1993, J DENT, V21, P5, DOI 10.1016/0300-5712(93)90046-S
   VANNOORT R, 1994, J DENT, V22, P5, DOI 10.1016/0300-5712(94)90139-2
   Vickery J M, 1995, Int J Prosthodont, V8, P221
   Waggoner W F, 1995, Pediatr Dent, V17, P36
   WAGNER WC, 1995, J PROSTHET DENT, V73, P471, DOI 10.1016/S0022-3913(05)80077-0
   WAKASA K, 1995, J ORAL REHABIL, V22, P371, DOI 10.1111/j.1365-2842.1995.tb00787.x
   WAKASA K, 1995, J MATER SCI-MATER M, V6, P29, DOI 10.1007/BF00121243
   WARD MT, 1995, OPER DENT, V20, P106
   WARFVINGE K, 1995, BRIT DENT J, V178, P149, DOI 10.1038/sj.bdj.4808684
   Wataha J C, 1995, Int J Prosthodont, V8, P9
   Wataha J C, 1995, Int J Prosthodont, V8, P228
   WATANABE I, 1995, J PROSTHET DENT, V73, P299, DOI 10.1016/S0022-3913(05)80209-4
   WATKINS JH, 1995, DENT MATER, V11, P24, DOI 10.1016/0109-5641(95)80005-0
   WATTS DC, 1995, AM J DENT, V8, P15
   Weesner B W Jr, 1995, Compendium, V16, P88
   WELLER RN, 1995, INT ENDOD J, V28, P86, DOI 10.1111/j.1365-2591.1995.tb00164.x
   WESTERHOFF B, 1995, J ORAL REHABIL, V22, P121, DOI 10.1111/j.1365-2842.1995.tb00245.x
   WHITE RR, 1995, DENT MATER, V11, P208
   WHITE SN, 1995, J ENDODONT, V21, P9, DOI 10.1016/S0099-2399(06)80549-2
   WHITEHEAD SA, 1995, J ORAL REHABIL, V22, P421, DOI 10.1111/j.1365-2842.1995.tb00795.x
   WHITTERS CJ, 1995, J DENT, V23, P145, DOI 10.1016/0300-5712(95)93571-I
   WILDERSMITH P, 1995, ORAL SURG ORAL MED O, V79, P685, DOI 10.1016/S1079-2104(05)80300-2
   Williamson R T, 1995, Quintessence Int, V26, P413
   WILLIAMSON RT, 1995, J PROSTHET DENT, V73, P400, DOI 10.1016/S0022-3913(05)80338-5
   WILSON NHF, 1995, AM J DENT, V8, P99
   WISCOVITCH JG, 1995, J ENDODONT, V21, P43, DOI 10.1016/S0099-2399(06)80556-X
   Wiskott H W, 1995, Int J Prosthodont, V8, P105
   YOKOI K, 1995, J DENT, V23, P117, DOI 10.1016/0300-5712(95)98978-C
   YOSHIMINE Y, 1995, ORAL SURG ORAL MED O, V79, P351, DOI 10.1016/S1079-2104(05)80229-X
   YU H, 1995, J DENT, V23, P101, DOI 10.1016/0300-5712(95)98975-9
   ZACHRISSON BU, 1995, ANGLE ORTHOD, V65, P35
   ZAKI HS, 1995, J PROSTHET DENT, V73, P1, DOI 10.1016/S0022-3913(05)80263-X
   Ziebert A J, 1995, J Prosthodont, V4, P33, DOI 10.1111/j.1532-849X.1995.tb00312.x
   ZWETCHKENBAUM S, 1995, J PROSTHET DENT, V73, P525, DOI 10.1016/S0022-3913(05)80110-6
   1995, J ENDODONT, V21, P13
NR 378
TC 4
Z9 4
U1 1
U2 3
PU ACAD DENTAL MATERIALS
PI DALLAS
PA BAYLOR COLLEGE DENTISTRY, 3302 GASTON AVE, DALLAS, TX 75266-0677
SN 0109-5641
J9 DENT MATER
JI Dent. Mater.
PD JUL
PY 1995
VL 11
IS 4
BP 281
EP 293
DI 10.1016/0109-5641(95)80064-6
PG 13
WC Dentistry, Oral Surgery & Medicine; Materials Science, Biomaterials
SC Dentistry, Oral Surgery & Medicine; Materials Science
GA TH837
UT WOS:A1995TH83700012
PM 8621053
DA 2018-10-20
ER

PT J
AU PARTY, E
   GERSHEY, EL
AF PARTY, E
   GERSHEY, EL
TI A REVIEW OF SOME AVAILABLE RADIOACTIVE AND NONRADIOACTIVE SUBSTITUTES
   FOR USE IN BIOMEDICAL-RESEARCH
SO HEALTH PHYSICS
LA English
DT Review
DE WASTE MANAGEMENT; WASTE DISPOSAL; S-35; BIOASSAY
AB The unavailability of disposal facilities for long-lived low-level radioactive waste (LLRW), expense associated with its disposal, and, for some generators, limitation of space to decay short half-life radioactive materials has prompted the search for alternatives to radiochemical techniques. Some of these alternatives are presented below.
RP PARTY, E (reprint author), ROCKEFELLER UNIV, 1230 YORK AVE, NEW YORK, NY 10021 USA.
CR BARINAGA M, 1993, SCIENCE, V260, P750, DOI 10.1126/science.8484114
   EVANS MR, 1992, NATURE, V358, P520, DOI 10.1038/358520a0
   HATFULL GF, 1994, ASM NEWS, V60, P255
   HOWARD GC, 1993, METHODS NONRADIOACTI
   PARTY E, 1989, HEALTH PHYS, V56, P571
   Stewart G. S. A. B., 1993, ASM News (Washington), V59, P241
   ZAGURSKY RJ, 1991, BIOTECHNIQUES, V11, P36
NR 7
TC 7
Z9 7
U1 1
U2 2
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0017-9078
EI 1538-5159
J9 HEALTH PHYS
JI Health Phys.
PD JUL
PY 1995
VL 69
IS 1
BP 1
EP 5
DI 10.1097/00004032-199507000-00001
PG 5
WC Environmental Sciences; Public, Environmental & Occupational Health;
   Nuclear Science & Technology; Radiology, Nuclear Medicine & Medical
   Imaging
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health; Nuclear Science & Technology; Radiology, Nuclear Medicine &
   Medical Imaging
GA RF830
UT WOS:A1995RF83000001
PM 7790201
DA 2018-10-20
ER

PT J
AU NAVARRO, A
   GARCIAGARDUNO, M
   VAZQUEZPOLO, G
   ALVAREZCASTILLO, A
   CASTANO, VM
   MARTINEZ, E
AF NAVARRO, A
   GARCIAGARDUNO, M
   VAZQUEZPOLO, G
   ALVAREZCASTILLO, A
   CASTANO, VM
   MARTINEZ, E
TI STUDIES ON THE STABILITY OF A STYRENE-BUTADIENE COPOLYMER FOR USE IN
   BIOMEDICAL APPLICATIONS
SO JOURNAL OF BIOACTIVE AND COMPATIBLE POLYMERS
LA English
DT Article
ID DEGRADATION
AB Two samples of commercially-available styrene-butadiene block copolymers (SBC) were tested for suitability for use in biomedical applications. A 30% sample and a 40% sample of styrene-containing polymers with very similar molecular weights (approximately 300,000) were characterized before and after being placed in a physiological serum for a period of six months. SEM, FTIR, and atomic absorption spectroscopy were used to characterize the polymers. Scanning and transmission electron micrographs showed that the SBC's morphology was clearly affected by the serum. A difference was observed with the higher styrene-containing polymer which showed no degradation of the elastomeric portion of the copolymer, whereas the 30% sample showed that considerable degradation occurred in this area. Atomic absorption results showed a clear difference in the capability of both materials to absorb K+, Na+ and Ca++ ions with a clear advantage for the 40% styrene-containing material. FTIR results indicate that both polymer samples degraded in the serum, showing loss of both the polystyrene and polybutadiene portions, as well as oxidation of the double bonds in the latter.
C1 UNIV NACL AUTONOMA MEXICO,INST FIS,MEXICO CITY 01000,DF,MEXICO.
   IND NEGROMEX SA CV,MEXICO CITY 11700,DF,MEXICO.
   UNIV NACL AUTONOMA MEXICO,FAC ODONTOL,UNIDAD INVEST & POSGRADO,MEXICO CITY 01000,DF,MEXICO.
RI Castano, Victor/C-1696-2018
CR BRANNONPEPPAS L, 1992, J CONTROL RELEASE, V20, P201, DOI 10.1016/0168-3659(92)90122-8
   BRANNONPEPPAS L, 1994, J BIOMAT SCI-POLYM E, V5, P339, DOI 10.1163/156856294X00068
   CASTANO VM, 1994, POLYM BULL, V32, P693, DOI 10.1007/BF00973921
   CASTANO VM, 1991, MATER LETT, V12, P199, DOI 10.1016/0167-577X(91)90174-5
   GROBE GL, 1986, MATER RES SOC S P, P55
   HENCH LL, 1980, SCIENCE, V208, P826, DOI 10.1126/science.6246576
   HSIVE GH, 1993, J BIOMAT SCI-POLYM E, V5, P205
   ISAACS PA, 1981, ELASTOMERICS     APR, P26
   MCGRATH JE, 1981, ACS POLYM S SER, V166
   MERRILL EW, 1993, J BIOMAT SCI-POLYM E, V5, P1
   Morton M., 1983, ANIONIC POLYM PRINCI
   RENIER M, 1993, J BIOMAT SCI-POLYM E, V5, P231
   RODRIGUEZ R, 1992, MATER LETT, V12, P448, DOI 10.1016/0167-577X(92)90212-3
   WILLIAMS JL, 1988, TPE, P203
   WU Y, 1992, J APPL POLYM SCI, V46, P201, DOI 10.1002/app.1992.070460202
NR 15
TC 1
Z9 1
U1 0
U2 1
PU TECHNOMIC PUBL CO INC
PI LANCASTER
PA 851 NEW HOLLAND AVE, BOX 3535, LANCASTER, PA 17604
SN 0883-9115
J9 J BIOACT COMPAT POL
JI J. Bioact. Compat. Polym.
PD JUL
PY 1995
VL 10
IS 3
BP 258
EP 272
DI 10.1177/088391159501000305
PG 15
WC Biotechnology & Applied Microbiology; Materials Science, Biomaterials;
   Polymer Science
SC Biotechnology & Applied Microbiology; Materials Science; Polymer Science
GA RN672
UT WOS:A1995RN67200005
DA 2018-10-20
ER

PT J
AU SHINTANI, H
AF SHINTANI, H
TI FORMATION AND ELUTION OF TOXIC COMPOUNDS FROM STERILIZED MEDICAL
   PRODUCTS - METHYLENEDIANILINE FORMATION IN POLYURETHANE
SO JOURNAL OF BIOMATERIALS APPLICATIONS
LA English
DT Article
DE MEDICAL DEVICE; POLYURETHANE; 4,4'-METHYLENEDIANILINE; MDA; GAMMA-RAY
   IRRADIATION; AUTOCLAVE STERILIZATION; MUTAGENICITY TEST
ID SOLID-PHASE EXTRACTION; POLY(ETHER URETHANE UREA); BIOMEDICAL
   APPLICATIONS; LIQUID-CHROMATOGRAPHY; DENTAL MATERIALS; HPLC ANALYSIS;
   GAMMA-RAY; 4,4'-METHYLENEDIANILINE; DEGRADATION;
   4,4'-DIAMINODIPHENYLMETHANE
AB The formation of a toxic and carcinogenic compound, methylenedianiline (MDA), in sterilized medical use polyurethane (PU) is discussed. Due to good biocompatibility and biostability, PU is widely used for blood-containing devices. There are two types of PU currently available for medical use. One is chain-extended thermoplastic PU the other is thermosetting PU used for potting material connecting fibers and modules in artificial dialyzers and plasma separators. Both gamma-ray irradiation and autoclave sterilization are predominantly used for the sterilization of these devices. MDA formation in sterilized PUs by gamma-ray irradiation and by autoclave treatment is compared. The Delany clause in the USA prohibits the manufacture of medical devices producing any toxic compound during fabrication and sterilization, therefore, the formation and elution of MDA and other toxic compounds should be seriously considered. Although MDA formation at a concentration of a few to a few hundred ppb in autoclaved chain-extended thermoplastic PU has been reported, there have been no papers describing MDA formation in autoclaved thermosetting PU potting material, or describing MDA and thermosetting PU. We elected to determine whether MDA was in fact produced in PUs sterilized by gamma-ray irradiation or by autoclave sterilization. Our objective was to estimate the risk factor to the human patients or recipient. Our conclusion is to confirm which sterilization of gamma-ray or autoclave is more appropriate. No formation of MDA was observed in autoclaved thermosetting PU potting material at 121 degrees C for 60 min. A few ppm of MDA was formed in irradiated potting material. MDA formation increased with increasing irradiation doses. MDA formed in irradiated potting material at 2.5 Mrad (less than one ppm) is not a significant risk to the recipient. The estimated cancer causing risk factor when absorbing one mg MDA/kg body weight/day is 0.29. Twenty-nine persons per 100 persons exhibit a cancer potential. More importantly, our experimental evidence indicated that serum extracts from irradiated potting material contained unknown compounds other than MDA, The presence of these compounds is considerably more significant and toxic. When tested, these compounds proved to be mutagenic in the absence of metabolic activity, thus promoting a need to identify and study further. Compounds indicating mutagenicity increased with increasing irradiation. Small amounts of mutagenic compounds were determined in extract from autoclaved potting material, smaller than that by gamma-ray irradiation. Therefore, autoclave sterilization is more appropriate, providing materials can withstand the process. Mutagenicity and cytotoxicity tests of the solvent extract from thermoplastic PU are also discussed, as is a pretreatment method of liquid-liquid extraction and the solid-phase extraction of serum MDA prior to HPLC analysis.
C1 NATL INST HLTH SCI,DEPT MED DEVICES,SETAGAYA KU,TOKYO 158,JAPAN.
CR BOWMAN MC, 1978, J ASSOC OFF ANA CHEM, V61, P1253
   BRUCK SD, 1988, J BIOMED MATER RES-A, V22, P133, DOI 10.1002/jbm.820221306
   COCKER J, 1988, J ANAL TOXICOL, V12, P9, DOI 10.1093/jat/12.1.9
   Coury A J, 1988, J Biomater Appl, V3, P130, DOI 10.1177/088532828800300202
   CUNNINGHAM ML, 1990, CHEM RES TOXICOL, V3, P157, DOI 10.1021/tx00014a012
   DARBY TD, 1978, TOXICOL APPL PHARM, V46, P449, DOI 10.1016/0041-008X(78)90090-X
   DEICHMANN WB, 1978, TOXICOLOGY, V11, P185, DOI 10.1016/S0300-483X(78)91089-2
   DYER E, 1964, J POLYM SCI A2, P1
   ERNES DA, 1983, ANAL CHEM, V55, P408, DOI 10.1021/ac00253a062
   FROMMELT H, 1987, MAKROMOL CHEM-M SYMP, V12, P281, DOI 10.1002/masy.19870120114
   FURUKAWA M, 1980, J CHROMATOGR, V198, P212, DOI 10.1016/S0021-9673(00)80113-2
   GARDNER J, 1986, INTRO STERILIZATION
   GOGOLEWSKI S, 1989, COLLOID POLYM SCI, V267, P757, DOI 10.1007/BF01410115
   Gogolewski S., 1991, TRENDS POLYM SCI, V1, P47
   GOHLKE R, 1974, INT ARCH ARBEITSMED, V32, P217, DOI 10.1007/BF00539338
   GOLDBERG L, 1986, HAZARD ASSESSMENT ET
   GRIESSER HJ, 1991, POLYM DEGRAD STABIL, V33, P329, DOI 10.1016/0141-3910(91)90080-B
   HO T, 1979, ENVIRON MUTAGEN, V1, P167
   Hu C. B., 1980, AM CHEM SOC DIV POLY, V21, P156
   Huff J. E., 1983, PROGR CLIN BIOL RES, V141, P347
   HUNTER SK, 1982, T AM SOC ART INT ORG, V28, P473
   KOPELMAN H, 1966, BMJ-BRIT MED J, V1, P514, DOI 10.1136/bmj.1.5486.514
   Kopelman H., 1966, Q J MED, V53, P553
   LAI YC, 1991, J APPL POLYM SCI, V42, P3173, DOI 10.1002/app.1991.070421210
   LAMB JC, 1986, J TOXICOL ENV HEALTH, V18, P325, DOI 10.1080/15287398609530874
   LELAH MD, 1987, POLYURETHANES MED
   MARCHANT RE, 1987, POLYMER, V28, P2032, DOI 10.1016/0032-3861(87)90037-1
   MAZZU AL, 1984, J BIOMED MATER RES, V18, P961, DOI 10.1002/jbm.820180810
   MCGILL DB, 1974, NEW ENGL J MED, V291, P278, DOI 10.1056/NEJM197408082910604
   MEEHAN E, 1990, MAR PITTSB C NEW YOR
   Mizutani H., 1960, HDB PLASTIC MANUFACT
   NYSTROM B, 1991, AM J MED, V91, pS264, DOI 10.1016/0002-9343(91)90379-C
   O'Mara M. M., 1984, PROG BIOMED ENG, V1, P83
   OKAMURA S, 1969, SERIES MONOGRAPHS SC, V15
   PETROVIC ZS, 1984, J APPL POLYM SCI, V29, P1031, DOI 10.1002/app.1984.070290401
   Phus S. K., 1987, J BIOMED MATER RES, V21, P231
   PLUDRO G, 1969, ACTA POL PHARM, V26, P353
   RAO TK, 1982, ARCH TOXICOL, V49, P185, DOI 10.1007/BF00347866
   Ratner B. D., 1983, PHYSICOCHEMICAL ASPE, P969
   RATNER BD, 1981, ACS SYM SER, V162, P371
   SHINTANI H, 1989, J ANAL TOXICOL, V13, P354, DOI 10.1093/jat/13.6.354
   SHINTANI H, 1991, J ANAL TOXICOL, V15, P198, DOI 10.1093/jat/15.4.198
   SHINTANI H, 1991, J APPL POLYM SCI, V42, P1979, DOI 10.1002/app.1991.070420723
   SHINTANI H, 1990, J APPL POLYM SCI, V41, P661, DOI 10.1002/app.1990.070410316
   SHINTANI H, 1992, J CHROMATOGR, V600, P93, DOI 10.1016/0021-9673(92)85442-V
   SHINTANI H, 1992, J LIQ CHROMATOGR, V15, P1315, DOI 10.1080/10826079208018290
   SHINTANI H, 1989, FRESEN Z ANAL CHEM, V333, P637, DOI 10.1007/BF00496937
   SHINTANI H, 1993, J ANAL TOXICOL, V17, P73, DOI 10.1093/jat/17.2.73
   SHINTANI H, 1991, J BIOMED MATER RES, V25, P1275, DOI 10.1002/jbm.820251008
   SHINTANI H, 1991, J RAD STERIL, V3, P92
   SHINTANI H, 1991, OHIO SCI WORKBOOKS P
   SHINTANI H, 1991, 8TH DAN S CHROM WARS
   SMITH R, 1987, J BIOMED MATER RES, V21, P1149, DOI 10.1002/jbm.820210908
   STEINHOFF D, 1970, NATURWISSENSCHAFTEN, V57, P247, DOI 10.1007/BF01010277
   TAKAHARA A, 1991, BIOMATERIALS, V12, P324, DOI 10.1016/0142-9612(91)90042-9
   TORTORETO M, 1983, J CHROMATOGR, V262, P367, DOI 10.1016/S0021-9673(01)88122-X
   WALL LA, 1955, J POLYM SCI, V17, P141, DOI 10.1002/pol.1955.120178318
   Williams N., 1974, NEW ENGL J MED, V291, P1256
   YOSHII F, 1985, J APPL POLYM SCI, V30, P3339, DOI 10.1002/app.1985.070300816
   ZHAO Q, 1987, POLYMER, V28, P2040, DOI 10.1016/0032-3861(87)90038-3
   1982, NTP81143 NAT TOX PRO
   1984, FED REGISTER, V49, P46293
NR 62
TC 26
Z9 26
U1 0
U2 4
PU TECHNOMIC PUBL CO INC
PI LANCASTER
PA 851 NEW HOLLAND AVE, BOX 3535, LANCASTER, PA 17604
SN 0885-3282
J9 J BIOMATER APPL
JI J. Biomater. Appl.
PD JUL
PY 1995
VL 10
IS 1
BP 23
EP 58
DI 10.1177/088532829501000102
PG 36
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA RN468
UT WOS:A1995RN46800001
PM 7473051
DA 2018-10-20
ER

PT J
AU FRIENDS, GD
   KUNZLER, JF
   OZARK, RM
AF FRIENDS, GD
   KUNZLER, JF
   OZARK, RM
TI RECENT ADVANCES IN THE DESIGN OF POLYMERS FOR CONTACT-LENSES
SO MACROMOLECULAR SYMPOSIA
LA English
DT Article; Proceedings Paper
CT 35th IUPAC International Symposium on Macromolecules (MACROAKRON 94)
CY JUL 11-19, 1994
CL UNIV AKRON, AKRON, OH
SP Int Union Pure & Appl Chem
HO UNIV AKRON
ID BIOMEDICAL APPLICATIONS; HYDROGELS
AB Three approaches for the design of polymers for extended wear contact lenses possessing high oxygen permeability are described. These approaches include the design of high strength, high water content hydrogels, the design of low water content fluorosilicone based materials and the design of hydrogels based on methacrylate end capped hydrophilic side chain siloxanes.
C1 BAUSCH & LOMB INC,DIV CONTACT LENS,DEPT CHEM & POLYMER DEV,ROCHESTER,NY 14692.
CR Boretos J W, 1971, J Biomed Mater Res, V5, P373, DOI 10.1002/jbm.820050408
   Brandrup J., 1989, POLYM HDB
   CHANG SH, 1980, Patent No. 4182822
   Chromecek RC, 1984, US Patent, Patent No. 4436887
   COX I, BAUSCH LOMB CLIN DAT
   DROBNIC J, 1977, USE POLYM MED B, V1
   DUNCAN R, 1983, BIOCHIM BIOPHYS ACTA, V755, P518, DOI 10.1016/0304-4165(83)90258-1
   FRIENDS G, 1994, ACS SYM SER, V540, P76
   FRIENDS G, 1992, J BIOMEDICAL MATERIA, V50, P59
   HART DE, 1986, OPHTHALMOLOGY, V93, P495
   Ho C. P., 1987, POLYM MAT SCI ENG, V56, P705
   HOLDEN BA, 1983, INVEST OPHTH VIS SCI, V24, P218
   HOLDEN BA, 1984, INVEST OPHTH VIS SCI, V25, P1161
   KAGANOV AL, 1976, J BIOMED MATER RES, V10, P1, DOI 10.1002/jbm.820100102
   Keogh P., 1981, U. S. Pat., Patent No. [4,260,725, 4260725]
   KEOGH PL, 1979, BIOMATER ARTIF CELL, V7, P307, DOI 10.3109/10731197909117586
   Kleiner E., 1979, US Patent, Patent No. [4,136,250, 4136250]
   KOPECEK J, 1982, MACROMOLECULES, P305
   KUDELA V, 1987, ENCY POLYM SCI ENG, V7, P783
   LAI Y, 1993, KIRKOTHMER ENCY CHEM, V7, P191
   LAI YC, 1991, J APPL POLYM SCI, V42, P3173, DOI 10.1002/app.1991.070421210
   MINARIK L, 1989, CLAO Journal, V15, P185
   MUELLER KF, 1986, Patent No. 4605712
   ORSBORN G N, 1988, CLAO Journal, V14, P81
   Peppas N A, 1981, Contact Intraocul Lens Med J, V7, P300
   RATNER B, 1988, COMPREHENSIVE POLYM, V7, P222
   RUSCIO DV, 1993, POLYM PREP AM CHEM S, V69, P221
   SARVER M, 1981, AM J OPTOM PHYSL OPT, V58, P387
   Schoessler JP, 1983, INT CONTACT LENS CLI, V10, P148
   TIGHE BJ, 1986, BRIT POLYM J, V18, P8, DOI 10.1002/pi.4980180104
NR 30
TC 22
Z9 22
U1 2
U2 11
PU HUTHIG & WEPF VERLAG
PI BASEL
PA AUF DEM WOLF 4 FX#001-41-61-317-94-11, CH-4052 BASEL, SWITZERLAND
SN 1022-1360
J9 MACROMOL SYMP
JI Macromol. Symp.
PD JUL
PY 1995
VL 98
BP 619
EP 631
DI 10.1002/masy.19950980153
PG 13
WC Polymer Science
SC Polymer Science
GA RZ124
UT WOS:A1995RZ12400042
DA 2018-10-20
ER

PT J
AU KIM, YD
   LEE, BK
   JEON, EJ
   SHIN, YC
   KIM, SC
AF KIM, YD
   LEE, BK
   JEON, EJ
   SHIN, YC
   KIM, SC
TI HYDROPHILIC-HYDROPHOBIC INTERPENETRATING POLYMER NETWORKS AND
   DICYANATE-BASED SEMI-IPN MATERIALS
SO MACROMOLECULAR SYMPOSIA
LA English
DT Article; Proceedings Paper
CT 35th IUPAC International Symposium on Macromolecules (MACROAKRON 94)
CY JUL 11-19, 1994
CL UNIV AKRON, AKRON, OH
SP Int Union Pure & Appl Chem
HO UNIV AKRON
AB Hydrophilic-hydrophobic IPN materials of poly(acrylic acid)poly(styrene-co-acrylonitrile) were synthesized and the pervaporation characteristics of the IPN membranes were evaluated for the separation of ethanol/water mixture. Hydrophilic-hydrophobic IPN materials of polyurethane-polystyrene were synthesized and the blood compatibility of the IPN's were measured for the biomedical application. Dicyanate-engineering plastics semi-IPN's were prepared and the morphology and mechanical properties were evaluated for the high temperature composite matrix materials.
C1 KOREA ADV INST SCI & TECHNOL,DEPT CHEM ENGN,TAEJON 305701,SOUTH KOREA.
CR JEON EJ, 1992, J MEMBRANE SCI, V70, P193, DOI 10.1016/0376-7388(92)80105-S
   SHIN YC, IN PRESS J BIOMATERI
   SHIN YC, 1992, POLYMER, V16, P520
NR 3
TC 2
Z9 2
U1 0
U2 2
PU HUTHIG & WEPF VERLAG
PI BASEL
PA AUF DEM WOLF 4 FX#001-41-61-317-94-11, CH-4052 BASEL, SWITZERLAND
SN 1022-1360
J9 MACROMOL SYMP
JI Macromol. Symp.
PD JUL
PY 1995
VL 98
BP 665
EP 672
DI 10.1002/masy.19950980157
PG 8
WC Polymer Science
SC Polymer Science
GA RZ124
UT WOS:A1995RZ12400045
DA 2018-10-20
ER

PT J
AU CHIELLINI, E
   SOLARO, R
AF CHIELLINI, E
   SOLARO, R
TI MULTIFUNCTIONAL BIOERODIBLE BIODEGRADABLE POLYMERIC MATERIALS
SO MACROMOLECULAR SYMPOSIA
LA English
DT Article; Proceedings Paper
CT 35th IUPAC International Symposium on Macromolecules (MACROAKRON 94)
CY JUL 11-19, 1994
CL UNIV AKRON, AKRON, OH
SP Int Union Pure & Appl Chem
HO UNIV AKRON
ID ALKYL VINYL ETHERS; CATIONIC POLYMERIZATION; CONTROLLED RELEASE;
   EPSILON-CAPROLACTONE; DELTA-VALEROLACTONE; POLYLACTONES; FORMULATION;
   MECHANISM
AB As a part of our continuing interest in the preparation of multifunctional polymeric materials and evaluation of their potential in biomedical and environmental field, a survey on new polymeric systems susceptible to bioerosion and/or biodegradation attack is presented. In particular attention has been focused on the preparation and characterization of the following classes of polymeric materials: 1) hydroxyl-containing polyesters; 2) functionalized cyclodextrins; 3) hydrophilic polymers containing carboxylic groups; 4) hydrogels for the release of phytodrugs; 5) hybrid polymeric materials; 6) synthetic and semisynthetic polyfunctional polymeric materials for the removal of uremic toxins. A few examples of the use of these polymers in the controlled release of drugs and as coadjuvants in the chronic renal failure treatment will be also presented.
RP CHIELLINI, E (reprint author), UNIV PISA,DEPT CHEM & IND CHEM,VIA RISORGIMENTO 35,I-56126 PISA,ITALY.
CR AKELAH A, 1985, J POLYM MATER, V2, P149
   ANDERSON JM, 1986, ADV DRUG DELIVERY SY
   BACCI L, 1995, THESIS U PISA
   Baer E, 1939, J BIOL CHEM, V128, P463
   BAILY WPJ, 1983, CHEM TECHNOLOGY WATE, P249
   BARSOTTI G, IN PRESS P IKETANI C
   BRAUNS U, 1985, Patent No. 149197
   BRAUNS U, 1985, Patent No. 3346123
   BRESCHI MC, 1995, 1ST S FRONT BIOM POL, P31
   CANTONI G, 1995, 3RD INT S POL ADV TE, P150
   CHIELLINI E, 1992, MAKROMOL CHEM-M SYMP, V54-5, P483, DOI 10.1002/masy.19920540136
   CHIELLINI E, 1992, J CONTROL RELEASE, V22, P273, DOI 10.1016/0168-3659(92)90102-W
   CHIELLINI E, 1992, J BIOACT COMPAT POL, V7, P161, DOI 10.1177/088391159200700204
   CHIELLINI E, 1994, J BIOACT COMPAT POL, V9, P152, DOI 10.1177/088391159400900203
   CHIELLINI E, 1995, 1ST S FRONT MED POL, P12
   CHIELLINI E, 1995, 3RD INT S POL ADV TE, P250
   CHIELLINI E, 1990, Patent No. 1242214
   CHIELLINI E, 1995, 1ST S FRONT BIOM POL, P30
   CHIELLINI E, 1991, Patent No. 8304858
   CHIELLINI E, 1991, Patent No. 830497
   CHIELLINI E, UNPUB J ENV POLYM DE
   CHIELLINI E, 1995, 3RD INT S POL ADV TE, P251
   CHIELLINI E, 1990, Patent No. 17714
   Chiellini E, 1990, J BIOACT COMPAT POLY, V5, P16
   CHIELLINI E, 1990, Patent No. 17713
   CHIELLINI E, 1989, POLYM MED SURGERY
   CHIELLINI E, 1991, Patent No. 260
   CHIELLINI E, 1992, Patent No. 830172
   CHIELLINI E, 1983, GEBEM MED, V1
   CHIELLINI EE, 1995, IKETANI C IKETANI, P73
   Ching C, 1993, BIODEGRADABLE POLYM
   DANTONE S, 1992, NEW POLYM MAT, V3, P223
   DeRossi D., 1991, POLYM GELS FUNDAMENT
   DOSSI E, 1994, GNOSEIS S, V1, P120
   DOSSI E, 1994, GNOSEIS S, V1, P118
   DOSSI E, 1993, BIOMATERIALI, V7, P111
   FINCH CA, 1985, CHEM TECHNOLOGY WATE
   FONTANILLE M, 1989, COMPREHENIVE POLYM S, V3, pCH25
   FRIEDMAN EA, 1974, 7TH P ANN CONTR C BE, P98
   GARDER DL, 1971, T AM SOC ART INT ORG, V17, P329
   GEBELEIN GC, 1985, BIOACTIVE POLYM SYST
   GIANNASI D, 1994, GNOSEIS, V1, P114
   GIORDANO C, 1974, 7TH P ANN CONTR C BE, P97
   Gregory J., 1983, CHEM TECHNOLOGY WATE, P307
   HALL HK, 1958, J AM CHEM SOC, V80, P6409, DOI 10.1021/ja01556a060
   HALSALL TG, 1947, J CHEM SOC, P1427, DOI 10.1039/jr9470001427
   INOUE S, 1972, J ORGANOMET CHEM, V39, P11, DOI 10.1016/S0022-328X(00)88899-3
   IRIE T, 1989, CARBOHYD RES, V192, P167, DOI 10.1016/0008-6215(89)85176-6
   ISSA R, 1991, J CONTROL RELEASE, V17, P113
   JEANES A, 1950, J AM CHEM SOC, V72, P2655, DOI 10.1021/ja01162a086
   JEDLINSKI Z, 1992, MAKROMOL CHEM-M SYMP, V60, P235, DOI 10.1002/masy.19920600121
   JING SB, 1950, CHEM EXPRESS, V72, P2655
   Jun Hae Sang, 1994, Journal of Environmental Polymer Degradation, V2, P9, DOI 10.1007/BF02073482
   KRICHELDORF HR, 1987, MACROMOLECULES, V20, P2050, DOI 10.1021/ma00175a002
   KRICHELDORF HR, 1986, MAKROMOL CHEM, V187, P1611
   KRICHELDORF HR, 1988, MAKROMOL CHEM, V189, P317
   KRICHELDORF HR, 1986, MAKROMOL CHEM, V187, P771
   KRICHELDORF HR, 1989, EUR POLYM J, V25, P585, DOI 10.1016/0014-3057(89)90010-4
   KYDONEUS AF, 1980, CONTROLLED RELEASE T
   MAYER JM, 1994, TRENDS POLYM SCI, V2, P227
   MORGANTII F, 1994, CNOSEIS S, V1, P116
   Napper D. H., 1983, CHEM TECHNOLOGY WATE, P233
   NIR MM, 1993, PLAST ENG, P75
   Peppas N. A., 1987, HYDROGELS MED PHARM, V2
   Peppas N. A., 1986, HYDROGELS MED PHARM, V1
   PEPPAS NA, 1987, HYDROGELS MED PHARM, V3
   PITHA J, 1990, CARBOHYD RES, V200, P429, DOI 10.1016/0008-6215(90)84208-C
   PITHA J, 1985, J PHARM SCI, V75, P987
   PITHA J, 1988, J BIOACT COMPAT POLY, V3, P157
   REHAB A, 1991, J BIOACT COMPAT POL, V6, P52, DOI 10.1177/088391159100600105
   REHAB A, 1990, J CONTROL RELEASE, V13, P1
   REPPE W, 1956, LIEBIGS ANN CHEM, V60, P84
   RUSSO PS, 1987, ACS S SER, V350
   SCHMIDT U, 1980, ANGEW CHEM INT EDIT, V19, P198, DOI 10.1002/anie.198001981
   SOLARO R, 1983, J APPL POLYM SCI, V28, P3651, DOI 10.1002/app.1983.070281206
   SOLARO R, 1991, REACT POLYM, V14, P21, DOI 10.1016/0923-1137(91)90244-I
   SOLARO R, 1993, J BIOACT COMPAT POL, V8, P236, DOI 10.1177/088391159300800303
   SOLARO R, UNPUB EUR POLYM J
   SOLARO R, 1991, SYNTHETIC POLYM DRUG, P71
   SOLARO R, 1993, CHIM IND-MILAN, V75, P535
   SPARKS RE, 1972, T AM SOC ART INT ORG, V18, P458
   Stahl G.A., 1986, WATER SOLUBLE POLYM
   TAYLOR GT, 1989, PHARMACEUT RES, V6, P641, DOI 10.1023/A:1015922019038
   TOKIWA Y, 1981, J APPL POLYM SCI, V26, P441, DOI 10.1002/app.1981.070260206
   TSUDA T, 1965, MAKROMOLEKUL CHEM, V86, P304
   TSURUTA T, 1989, COMPREHENSIVE POLYM, V3, pCH31
   YOUNG DM, 1956, ACS PREP, V16, P108
   1959, Patent No. 2914556
   1983, ISP2550029R INT SPEC
   1957, Patent No. 2809208
NR 90
TC 14
Z9 14
U1 2
U2 4
PU HUTHIG & WEPF VERLAG
PI BASEL
PA AUF DEM WOLF 4 FX#001-41-61-317-94-11, CH-4052 BASEL, SWITZERLAND
SN 1022-1360
J9 MACROMOL SYMP
JI Macromol. Symp.
PD JUL
PY 1995
VL 98
BP 803
EP 824
DI 10.1002/masy.19950980168
PG 22
WC Polymer Science
SC Polymer Science
GA RZ124
UT WOS:A1995RZ12400054
DA 2018-10-20
ER

PT J
AU RATNER, BD
AF RATNER, BD
TI ADVANCES IN THE ANALYSIS OF SURFACES OF BIOMEDICAL INTEREST
SO SURFACE AND INTERFACE ANALYSIS
LA English
DT Article
ID ION MASS-SPECTROMETRY; X-RAY PHOTOELECTRON; ANGLE-DEPENDENT XPS; POLYMER
   SURFACES; DEPTH PROFILES; POLY(METHYL METHACRYLATE); MULTIVARIATE DATA;
   ELECTRON-SPECTRA; SOLID-SURFACES; PROTEIN FILMS
AB Materials used in biomedical applications often function based upon their surface properties, Thus, understanding their surfaces is critical to the design and engineering of new biomaterials and medical devices, Modern surface analysis tools have been developed largely around the needs for the microelectronics and petrochemicals industries, where durable, inorganic surfaces are studied, This paper examines how surface analysis methods can be applied to biomaterials which are typically hydrated and fragile, In particular, vacuum compatibility, sample damage, the aqueous/solid interface; spatial information, buried interfaces, chemical complexity and correlation with bio-reactivity will be addressed,
C1 UNIV WASHINGTON,DEPT CHEM ENGN,SEATTLE,WA 98195.
RP RATNER, BD (reprint author), UNIV WASHINGTON,CTR BIOENGN,BF-10,SEATTLE,WA 98195, USA.
CR AKHTER S, 1988, APPL SURF SCI, V35, P241, DOI 10.1016/0169-4332(88)90053-0
   BEEBE KR, 1987, ANAL CHEM, V59, pA1007, DOI 10.1021/ac00144a725
   BELLARE JR, 1988, J ELECTRON MICR TECH, V10, P87, DOI 10.1002/jemt.1060100111
   BRIGGS D, 1986, SURF INTERFACE ANAL, V9, P391
   BRIGGS D, 1984, SURF INTERFACE ANAL, V6, P184, DOI 10.1002/sia.740060407
   BUCHWALTER LP, 1990, J VAC SCI TECHNOL A, V8, P781, DOI 10.1116/1.576917
   BUSSING TD, 1985, J VAC SCI TECHNOL A, V3, P1973, DOI 10.1116/1.572910
   CALDWELL SJ, 1990, THESIS U WASHINGTON
   CASTNER DG, 1988, SURFACE CHARACTERIZA, P65
   CHANEY R, 1987, FRESEN Z ANAL CHEM, V329, P143, DOI 10.1007/BF00469126
   CHANG SK, 1977, MED PROG TECHNOL, V5, P57
   CHANG SK, 1977, 51ST COLL SURF SCI S
   CHILKOTI A, 1992, SURF INTERFACE ANAL, V18, P604, DOI 10.1002/sia.740180807
   CHILKOTI A, 1993, ANAL CHEM, V65, P1736, DOI 10.1021/ac00061a017
   CHILKOTI A, IN PRESS ANAL CHEM
   CHRISTIE OHJ, 1987, CHEMOMETR INTELL LAB, V2, P53, DOI 10.1016/0169-7439(87)80085-0
   DAVIES MC, 1990, CRIT REV BIOCOMPAT, V5, P297
   FERRIS JP, 1992, SCIENCE, V257, P1387, DOI 10.1126/science.1529338
   FISHER KA, 1976, P NATL ACAD SCI USA, V73, P173, DOI 10.1073/pnas.73.1.173
   GELADI P, 1986, ANAL CHIM ACTA, V185
   Geladi P., 1988, J CHEMOMETR, V2, P231, DOI DOI 10.1002/CEM.1180020403
   GILDING DK, 1980, BIOMATERIALS, V1, P163, DOI 10.1016/0142-9612(80)90040-X
   HANSON SR, 1982, ADV BIOMATER, V3, P519
   HARKER LA, 1979, J CLIN INVEST, V64, P559, DOI 10.1172/JCI109494
   Hart Dean E., 1993, CLAO (Contact Lens Association of Ophthalmologists) Journal, V19, P169
   HEARN MJ, 1986, SURF INTERFACE ANAL, V9, P411
   HOOK KJ, 1987, MACROMOLECULES, V20, P2112, DOI 10.1021/ma00175a011
   JURS PC, 1986, SCIENCE, V232, P1219, DOI 10.1126/science.3704647
   KAELBLE DH, 1977, POLYMER, V18, P475, DOI 10.1016/0032-3861(77)90164-1
   KARGACIN ME, 1986, ANAL CHEM, V58, P2300, DOI 10.1021/ac00124a041
   KNOBLER CM, 1990, ADV CHEM PHYS, V77, P397, DOI 10.1002/9780470141267.ch7
   LAIBINIS PE, 1991, SCIENCE, V254, P981, DOI 10.1126/science.254.5034.981
   LEWIS KB, 1993, J COLLOID INTERF SCI, V158, P77
   LINNER JG, 1986, J HISTOCHEM CYTOCHEM, V34, P1123, DOI 10.1177/34.9.2426340
   MACKENZIE AP, 1972, SCANNING ELECTRON MI, P273
   MANTUS DS, 1993, ANAL CHEM, V65, P1431, DOI 10.1021/ac00058a021
   MELLINGER M, 1987, CHEMOMETR INTELL LAB, V2, P29, DOI 10.1016/0169-7439(87)80083-7
   MOHANDAS N, 1974, J BIOMED MATER RES, V8, P119, DOI 10.1002/jbm.820080203
   MOZES N, 1989, COLLOID SURFACE, V42, P313
   NAKAHAMA S, 1994, UNPUB
   NEUMANN AW, 1979, J POLY SCI        PS, V66, P391
   PAYNTER RW, 1981, SURF INTERFACE ANAL, V3, P186, DOI 10.1002/sia.740030410
   PAYNTER RW, 1984, J COLLOID INTERF SCI, V101, P233, DOI 10.1016/0021-9797(84)90023-7
   PAYNTER RW, 1985, SURFACE INTERFACIAL, V2, P189
   PEREZLUNA VH, 1994, J BIOMED MATER RES, V28, P1111, DOI 10.1002/jbm.820281002
   PEREZLUNA VH, 1993, 19TH T ANN M SOC BIO, P281
   RATNER BD, 1978, J APPL POLYM SCI, V22, P643, DOI 10.1002/app.1978.070220306
   RATNER BD, 1981, J COLLOID INTERF SCI, V83, P630, DOI 10.1016/0021-9797(81)90358-1
   RATNER BD, IN PRESS BIOMATERIAL
   ROBERTS GG, 1990, LANGMUIRBLODGETT FIL
   ROUXHET PG, 1994, COLLOID SURFACE, V2, P348
   RUGGIERO F, 1984, EUR J CELL BIOL, V35, P49
   SMITH GC, 1992, SURF INTERFACE ANAL, V19, P175, DOI 10.1002/sia.740190134
   STENGER DA, 1992, J AM CHEM SOC, V114, P8435, DOI 10.1021/ja00048a013
   STICKLE WF, 1990, J VAC SCI TECHNOL A, V8, P2217, DOI 10.1116/1.577040
   STICKLE WF, 1992, J VAC SCI TECHNOL A, V10, P2806, DOI 10.1116/1.577914
   THOMAS EV, 1994, ANAL CHEM, V66, pA795, DOI 10.1021/ac00087a002
   TYLER BJ, 1989, SURF INTERFACE ANAL, V14, P443, DOI 10.1002/sia.740140804
   VANDERVALK P, 1983, J BIOMED MATER RES, V17, P807, DOI 10.1002/jbm.820170508
   Vickerman J. C., 1989, SECONDARY ION MASS S
   VOGEL V, 1991, ANNU REV MATER SCI, V21, P515
   WILSON IH, 1989, J VAC SCI TECHNOL A, V7, P2840, DOI 10.1116/1.576155
   WOJCIECHOWSKI PW, 1993, COLLOID SURFACE B, V1, P107, DOI 10.1016/0927-7765(93)80041-V
   WOLD S, 1987, CHEMOMETR INTELL LAB, V2, P37, DOI 10.1016/0169-7439(87)80084-9
   YASUDA H, 1978, J BIOMED MATER RES, V12, P701, DOI 10.1002/jbm.820120510
   YIH RS, 1987, J ELECTRON SPECTROSC, V43, P61, DOI 10.1016/0368-2048(87)80019-1
   ZANDVLIET HJW, 1992, SECONDARY ION MASS S, P3
   ZASADZINSKI JAN, 1987, CHEM ENG COMMUN, V52, P283, DOI 10.1080/00986448708911873
NR 68
TC 43
Z9 44
U1 1
U2 12
PU JOHN WILEY & SONS LTD
PI CHICHESTER
PA THE ATRIUM, SOUTHERN GATE, CHICHESTER PO19 8SQ, W SUSSEX, ENGLAND
SN 0142-2421
J9 SURF INTERFACE ANAL
JI Surf. Interface Anal.
PD JUL
PY 1995
VL 23
IS 7-8
BP 521
EP 528
DI 10.1002/sia.740230712
PG 8
WC Chemistry, Physical
SC Chemistry
GA RH941
UT WOS:A1995RH94100011
DA 2018-10-20
ER

PT J
AU MIYATA, T
   MORIZANE, M
   NAKAMAE, K
   OKUMURA, M
   KINOMURA, K
AF MIYATA, T
   MORIZANE, M
   NAKAMAE, K
   OKUMURA, M
   KINOMURA, K
TI PROPERTIES OF BIOMEDICAL PRESSURE-SENSITIVE ADHESIVE COPOLYMER FILMS
   WITH PENDANT MONOSACCHARIDES
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
ID AMIDE TYPE; POLYMERS; POLY(VINYLSACCHARIDE)S; POLYMERIZATION
AB Glucosyloxyethyl methacrylate (GEMA) was copolymerized with butyl acrylate (BA) for the preparation of a biomedical pressure-sensitive adhesive with pendant monosaccharides, for possible use in medical applications. The measurements of 180 degrees peel strength, ball tack, and holding power for the GEMA-BA copolymer films revealed that the film at the GEMA content of 5 mol % has excellent pressure-sensitive adhesive properties. Protein adsorption onto the GEMA-BA copolymer film hardly occurred due to very low interfacial free energy between its surface and water. Release profiles of vitamin B-12 from the GEMA-BA copolymer film suggests that it is useful as a material for a transdermal therapeutic system. (C) 1995 John Wiley and Sons, Inc.
C1 KOBE UNIV,FAC ENGN,NADA KU,KOBE 657,JAPAN.
   NIPPON FINE CHEM CO LTD,TAKASAGO,HYOGO 676,JAPAN.
CR BLACK WAP, 1968, MAKROMOL CHEM, V117, P210
   CARPINO LA, 1976, MAKROMOL CHEM, V177, P1631
   Chien Y. W., 1987, CONTROLLED DRUG DELI, P523
   CHIEN YW, 1987, CONTROLLED RELEASE T, P281
   Chien YW., 1982, NOVEL DRUG DELIVERY, P149
   FOWKES FM, 1962, J PHYS CHEM-US, V66, P382, DOI 10.1021/j100808a524
   FOWKES FM, 1963, J PHYS CHEM-US, V67, P2538, DOI 10.1021/j100806a008
   GAINSLY M, 1954, ADHESION ADHESIVES F, P127
   HORI Y, 1980, SETTYAKU HDB
   IKADA Y, 1984, ADV POLYM SCI, V57, P103
   KITAZAWA S, 1990, CHEM LETT, P1733, DOI 10.1246/cl.1990.1733
   KLEIN J, 1987, MAKROMOL CHEM, V188, P1217
   KLEIN J, 1989, MAKROMOL CHEM, V190, P2527
   KLEIN J, 1985, MAKROMOL CHEM-RAPID, V6, P675
   KOBAYASHI A, 1986, MAKROMOL CHEM-RAPID, V7, P645
   KOBAYASHI K, 1987, NIPPON KAGAKU KAISHI, P575, DOI 10.1246/nikkashi.1987.575
   KOBAYASHI K, 1988, J MACROMOL SCI CHEM, VA25, P655, DOI 10.1080/00222338808053391
   KOBAYASHI K, 1985, KOBUNSHI RONBUNSHU, V42, P719, DOI 10.1295/koron.42.719
   MIYATA T, 1994, MACROMOL CHEM PHYSIC, V195, P3597, DOI 10.1002/macp.1994.021951107
   NAKAMAE K, 1994, MACROMOL CHEM PHYSIC, V195, P2663, DOI 10.1002/macp.1994.021950733
   NAKAMAE K, 1993, MAKROMOL CHEM-RAPID, V14, P413
   NAKAMAE K, 1994, MACROMOL CHEM PHYSIC, V195, P1953, DOI 10.1002/macp.1994.021950606
   NAKAMAE K, 1990, J ADHES SOC JPN, V26, P128
   NAKAMAE K, 1990, J ADHES SOC JPN, V26, P100
   OKUMURA M, 1990, 57H NAT M CHEM SOC J
   OWENS DK, 1969, J APPL POLYM SCI, V13, P1741, DOI 10.1002/app.1969.070130815
   PAYNTER RW, 1984, POLYM BIOMATERIALS, P121
   PAYNTER RW, 1985, SURFACE INTERFACIAL, V2, P189
   SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7
   TANIGAWA S, 1991, J ADHES SCI TECHNOL, V51, P543
   VIENTH WR, 1991, DIFFUSION POLYM PRIN, P215
   WHISTLER RL, 1950, J AM CHEM SOC, V72, P2299
   Z0237 JAP IND STAND
NR 33
TC 7
Z9 7
U1 1
U2 5
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-8995
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD JUN 20
PY 1995
VL 56
IS 12
BP 1615
EP 1623
DI 10.1002/app.1995.070561212
PG 9
WC Polymer Science
SC Polymer Science
GA QY973
UT WOS:A1995QY97300012
DA 2018-10-20
ER

PT J
AU DMITRIEV, SN
   OGANESSIAN, YT
   STARODUB, GY
   SHISHKIN, SV
   BUKLANOV, GV
   KHARITONOV, YP
   NOVGORODOV, AF
   YUSHKEVICH, YV
   NEWTON, D
   TALBOT, RJ
AF DMITRIEV, SN
   OGANESSIAN, YT
   STARODUB, GY
   SHISHKIN, SV
   BUKLANOV, GV
   KHARITONOV, YP
   NOVGORODOV, AF
   YUSHKEVICH, YV
   NEWTON, D
   TALBOT, RJ
TI ULTRA-PURE PU-236 AND PU-237 FOR ENVIRONMENTAL AND BIOMEDICAL-RESEARCH
SO APPLIED RADIATION AND ISOTOPES
LA English
DT Article
AB Isotopically pure Pu-236 (>99.999% by activity) has been produced by irradiating U (95% U-235) With He-4 ions and refining the product by electromagnetic mass separation. Further developments in the production of Pu-237 are also reported, giving material containing, by activity, only 3 x 10(-6)% Pu-236 and probably only similar to 10(-5)% Pu-238.
C1 AEA TECHNOL,BIOMED RES,DIDCOT OX11 0RA,OXON,ENGLAND.
RP DMITRIEV, SN (reprint author), DUBNA JOINT NUCL RES INST,DUBNA 141980,RUSSIA.
CR DMITRIEV SN, 1993, APPL RADIAT ISOTOPES, V44, P1097, DOI 10.1016/0969-8043(93)90112-N
   EFURD DW, 1991, RADIOCHIM ACTA, V54, P159
   ELLIS YA, 1979, PHYS REV C, V20, P799, DOI 10.1103/PhysRevC.20.799
   KALINNIKOV VG, 1992, NUCL INSTRUM METH B, V70, P62, DOI 10.1016/0168-583X(92)95910-J
   PERELYGIN VP, 1993, HEAVY ION PHYSICS, P375
   TALBOT RJ, 1994, APPL RADIAT ISOTOPES, V45, P743, DOI 10.1016/0969-8043(94)90123-6
   TALBOT RJ, 1993, HEALTH PHYS, V65, P41, DOI 10.1097/00004032-199307000-00006
   VANDENBOSCH R, 1958, PHYS REV, V111, P1358, DOI 10.1103/PhysRev.111.1358
   WARNER AJ, 1994, RADIAT PROT DOSIM, V55, P61, DOI 10.1093/oxfordjournals.rpd.a082376
   1983, ANN ICRP, V11, P13
   1982, IONIZING RAD SORUCES
NR 11
TC 13
Z9 13
U1 0
U2 1
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
SN 0969-8043
J9 APPL RADIAT ISOTOPES
JI Appl. Radiat. Isot.
PD MAY
PY 1995
VL 46
IS 5
BP 307
EP 309
DI 10.1016/0969-8043(94)00134-L
PG 3
WC Chemistry, Inorganic & Nuclear; Nuclear Science & Technology; Radiology,
   Nuclear Medicine & Medical Imaging
SC Chemistry; Nuclear Science & Technology; Radiology, Nuclear Medicine &
   Medical Imaging
GA RA525
UT WOS:A1995RA52500006
DA 2018-10-20
ER

PT J
AU ZHANG, LL
   XIONG, CD
   DENG, XM
AF ZHANG, LL
   XIONG, CD
   DENG, XM
TI BIODEGRADABLE POLYESTER BLENDS FOR BIOMEDICAL APPLICATION
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
ID HYDROXYBUTYRATE-HYDROXYVALERATE COPOLYMERS; PEO/PLA BLOCK COPOLYMERS;
   POLYMERS; DEGRADATION; ACID); POLY(EPSILON-CAPROLACTONE); SURGERY; PHB
AB A new family of bioabsorbable materials suitable for biomedical applications was designed and prepared by means of blending of some available polyesters to develop new biodegradable materials tailored for different requirements. Multiphase polymer blends containing poly(d, l-lactide) (PLA), poly(epsilon-caprolactone) (PCL), poly(d, l-lactide-co-poly(ethylene glycol) (PELA), poly(epsilon-caprolactone)-co-poly(ethylene glycol) (PECL), and poly(beta-hydroxybutyrate) (PHB), PLA/PCL, PELA/PECL, PHB/PLA, PHB/PELA, PHB/PCL, and PHB/PECL blends were respectively investigated. It was found that PLA/PCL, PHB, and PHB/PLA and PHB/PCL blends were seemingly immiscible, with their morphology and hydrolytic behavior were determined by the composition of the blends. On the other hand, the miscibility of PELA/PECL, PHB/PELA, and PHB/PECL blends was improved by using PELA and/or PECL block copolymers that contained poly(ethylene glycol) (PEG) as compatibilizer. The blends showed to a certain extent miscibility, fine phase morphology, and fast hydrolysis. (C) 1995 John Wiley and Sons, Inc.
C1 ACAD SINICA,CHENGDU INST ORGAN CHEM,CHENGDU 610041,PEOPLES R CHINA.
CR CHA Y, 1990, BIOMATERIALS, V11, P108, DOI 10.1016/0142-9612(90)90124-9
   CHANG R-K, 1986, Pharmaceutical Technology, V10, P32
   COHN D, 1988, J BIOMED MATER RES, V22, P993, DOI 10.1002/jbm.820221104
   DAVE P, 1990, POLYM MATER SCI ENG, V63, P726
   DENG XM, 1990, J POLYM SCI POL LETT, V28, P411, DOI 10.1002/pol.1990.140281303
   DOLLINGER HM, 1990, ACS POLYM PREPR, V31, P429
   FRAZZA E J, 1971, Journal of Biomedical Materials Research Biomedical Materials Symposium, V1, P43
   GILDING DK, 1979, POLYMER, V20, P1459, DOI 10.1016/0032-3861(79)90009-0
   GRECO P, 1989, POLYMER, V30, P1475, DOI 10.1016/0032-3861(89)90219-X
   HELLER J, 1989, ADV BIOMED POLYM WOR, P31
   HOLLAND S J, 1986, Journal of Controlled Release, V4, P155, DOI 10.1016/0168-3659(86)90001-5
   HOLLINGER JO, 1983, J BIOMED MATER RES, V17, P71, DOI 10.1002/jbm.820170107
   HOLMES PA, 1985, PHYS TECHNOL, V16, P32, DOI 10.1088/0305-4624/16/1/305
   KULKARNI R K, 1971, Journal of Biomedical Materials Research, V5, P169, DOI 10.1002/jbm.820050305
   KULKARNI RK, 1966, ARCH SURG-CHICAGO, V93, P839
   Lisuardi A., 1992, POLYM MATER SCI ENG, V67, P298
   MILLER ND, 1987, BIOMATERIALS, V8, P129, DOI 10.1016/0142-9612(87)90102-5
   PITT CG, 1979, J BIOMED MATER RES, V13, P497, DOI 10.1002/jbm.820130313
   PITT CG, 1981, BIOMATERIALS, V2, P215
   REED AM, 1981, POLYMER, V22, P494, DOI 10.1016/0032-3861(81)90168-3
   VAINIONPAA S, 1989, PROG POLYM SCI, V14, P679, DOI 10.1016/0079-6700(89)90013-0
   XU RP, 1991, POLYM BIOMATERIALS, V3, P285
   YASIN M, 1989, BIOMATERIALS, V10, P400, DOI 10.1016/0142-9612(89)90132-4
   YOUNES H, 1987, J BIOMED MATER RES, V21, P1301, DOI 10.1002/jbm.820211103
   ZHANG LL, 1992, AUG NAT S POL CHANGC, P1013
NR 25
TC 89
Z9 96
U1 0
U2 27
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-8995
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD APR 4
PY 1995
VL 56
IS 1
BP 103
EP 112
DI 10.1002/app.1995.070560114
PG 10
WC Polymer Science
SC Polymer Science
GA QL998
UT WOS:A1995QL99800014
DA 2018-10-20
ER

PT J
AU TANG, LP
   EATON, JW
AF TANG, LP
   EATON, JW
TI INFLAMMATORY RESPONSES TO BIOMATERIALS
SO AMERICAN JOURNAL OF CLINICAL PATHOLOGY
LA English
DT Review
DE BIOMATERIALS; FIBRINOGEN; INFLAMMATION
ID TOTAL HIP-REPLACEMENT; SYNOVIAL-LIKE MEMBRANE; BONE-CEMENT INTERFACE;
   GEL BREAST IMPLANTS; 10-YEAR FOLLOW-UP; COMPLEMENT ACTIVATION;
   SILICONE-GEL; INVIVO BIOCOMPATIBILITY; POLYMERIC BIOMATERIALS; PROTEIN
   ADSORPTION
AB Implanted biomedical devices are of increasing importance in modern medical care. However, surprisingly little is known of the factors that determine biocompatibility of the materials used in these devices. These materials, although generally inert and non-toxic, can mediate a variety of adverse reactions, including inflammation, fibrosis, coagulation, and infection. This brief review focuses on the inflammatory responses (including fibrosis) that commonly occur around implanted biomaterials. Host proteins that spontaneously associate with implant surfaces are important determinants of the acute inflammatory response. In this regard, adsorbed fibrinogen appears particularly pro-inflammatory. Chronic inflammatory processes, in many cases in response to fragments of implanted biomaterials, may cause implant failure. In the case of silicone-filled mammary prostheses, the extravasation of silicone gel has been held responsible for a number of complications, including silicone granuloma, synovitis, connective-tissue disease, and lymphadenopathy. In some instances, material-mediated inflammatory responses may even cause degradation of the material itself (via oxidative products released by implant-associated inflammatory cells). Overall, there is insufficient knowledge of the determinants and mechanisms of host: implant responses. A clear understanding of tissue:biomaterial interactions will be required both to explain the pathogenesis of many implant-mediated complications and to aid in the development of more biocompatible materials for implantable devices.
C1 ALBANY MED COLL,DEPT PATHOL & LAB MED,DIV EXPTL PATHOL,ALBANY,NY 12208.
CR ANDRADE JD, 1987, ANN NY ACAD SCI, V516, P158
   ASPLUND O, 1984, PLAST RECONSTR SURG, V73, P270, DOI 10.1097/00006534-198402000-00022
   ATHANASOU NA, 1992, J BONE JOINT SURG BR, V74, P57
   Baier R E, 1969, J Biomed Mater Res, V3, P191, DOI 10.1002/jbm.820030115
   BAKER JL, 1982, PLAST RECONSTR SURG, V69, P56, DOI 10.1097/00006534-198269010-00008
   BARKER DE, 1978, PLAST RECONSTR SURG, V61, P836, DOI 10.1097/00006534-197861060-00002
   BENJAMIN E, 1982, DIAGN HISTOPATHOL, V5, P133
   BENOIT FM, 1993, J BIOMED MATER RES, V27, P1341, DOI 10.1002/jbm.820271014
   BLOEBAUM RD, 1993, J ARTHROPLASTY, V8, P195
   BLOEBAUM RD, 1994, CLIN ORTHOPAEDICS, V298, P19
   BOMMER J, 1981, LANCET, V1, P1314
   BOMMER J, 1981, NEW ENGL J MED, V305, P1077, DOI 10.1056/NEJM198110293051809
   BRODY GS, 1977, PLAST RECONSTR SURG, V60, P615, DOI 10.1097/00006534-197710000-00020
   CAPOZZI A, 1981, PLAST RECONSTR SURG, V68, P512, DOI 10.1097/00006534-198110000-00006
   CAPOZZI A, 1978, PLAST RECONSTR SURG, V62, P302, DOI 10.1097/00006534-197808000-00038
   CHAN SC, 1991, CLIN CHEM, V37, P756
   CHENOWETH DE, 1984, ARTIF ORGANS, V8, P281, DOI 10.1111/j.1525-1594.1984.tb04291.x
   CHEUNG AK, 1989, KIDNEY INT, V36, P257, DOI 10.1038/ki.1989.188
   CHINN JA, 1992, J BIOMED MATER RES, V16, P757
   CHRISTIE AJ, 1977, JAMA-J AM MED ASSOC, V237, P1463, DOI 10.1001/jama.237.14.1463
   CHUANG HYK, 1980, THROMB RES, V19, P1, DOI 10.1016/0049-3848(80)90398-9
   CRADDOCK PR, 1977, J CLIN INVEST, V59, P879, DOI 10.1172/JCI108710
   DAYER JM, 1979, J CLIN INVEST, V64, P1386, DOI 10.1172/JCI109596
   DIGBY JM, 1982, HAND, V14, P326, DOI 10.1016/S0072-968X(82)80069-7
   DOMANSKIS EJ, 1976, PLAST RECONSTR SURG, V58, P689, DOI 10.1097/00006534-197612000-00006
   DOOR LD, 1990, CLIN ORTHOP RELAT R, V261, P82
   EDMOND JA, 1980, PLAST RECONSTR SURG, V66, P478
   EHRLICH HP, 1983, J CELL PHYSIOL, V116, P345, DOI 10.1002/jcp.1041160312
   EISENBERG HV, 1977, PLAST RECONSTR SURG, V59, P849, DOI 10.1097/00006534-197706000-00024
   ENDO LP, 1987, SEMIN ARTHRITIS RHEU, V17, P112, DOI 10.1016/0049-0172(87)90033-3
   EYSSEN JE, 1984, PLAST RECONSTR SURG, V73, P415, DOI 10.1097/00006534-198403000-00013
   GABRIELSE, 1994, NEW ENGL J MED, V330, P1697
   GOLDRING S R, 1985, Arthritis and Rheumatism, V28, pS36
   GOLDRING SR, 1983, J BONE JOINT SURG AM, V65, P575, DOI 10.2106/00004623-198365050-00001
   GOLDRING SR, 1986, ARTHRITIS RHEUM-US, V29, P836, DOI 10.1002/art.1780290704
   GOLDRING SR, 1988, NONCEMENTED TOTAL HI, P35
   GORDON M, 1982, J BONE JOINT SURG AM, V64, P574, DOI 10.2106/00004623-198264040-00013
   GUIDOIN R, 1984, ANN THORAC SURG, V37, P457, DOI 10.1016/S0003-4975(10)61131-9
   HANDEL N, 1991, PLAST RECONSTR SURG, V88, P475, DOI 10.1097/00006534-199109000-00015
   HENSON PM, 1975, J CLIN INVEST, V56, P1053, DOI 10.1172/JCI108152
   HERZLINGER GA, 1980, T AM SOC ART INT ORG, V26, P165
   HOGQUIST KA, 1991, J IMMUNOL, V147, P2181
   HOLTROP ME, 1982, CALCIFIED TISSUE INT, V34, P488, DOI 10.1007/BF02411290
   HOWIE DW, 1992, T ORTHOP RES SOC, V17, P344
   HUANG TT, 1978, PLAST RECONSTR SURG, V61, P277, DOI 10.1097/00006534-197802000-00026
   ITO N, 1969, CANCER RES, V29, P1137
   JASTY M, 1990, J BONE JOINT SURG BR, V72, P63
   JASTY M, 1991, J BONE JOINT SURG BR, V73, P551
   JASTY M, 1993, J APPL BIOMATER, V4, P273, DOI 10.1002/jab.770040310
   JASTY M, 1992, CLIN ORTHOP RELAT R, V285, P116
   JENNINGS DA, 1991, ANN PLAS SURG, V27, P553, DOI 10.1097/00000637-199112000-00007
   KAUFMAN RL, 1985, J RHEUMATOL, V12, P1066
   KOSSOVSKY N, 1994, ARCH PATHOL LAB MED, V118, P686
   KOTTKEMARCHANT K, 1987, J BIOMED MATER RES, V21, P379, DOI 10.1002/jbm.820210310
   KOTTKEMARCHANT K, 1989, BIOMATERIALS, V10, P147, DOI 10.1016/0142-9612(89)90017-3
   LEONG ASY, 1982, NEW ENGL J MED, V306, P135, DOI 10.1056/NEJM198201213060303
   LEONG ASY, 1981, LANCET, V1, P889
   LEONG ASY, 1981, LANCET, V2, P210
   LOMBARDI AV, 1989, J BONE JOINT SURG AM, V71A, P1337, DOI 10.2106/00004623-198971090-00009
   MARCHANT RE, 1984, J BIOMED MATER RES, V18, P1169, DOI 10.1002/jbm.820180917
   MARCHANT RE, 1986, J BIOMED MATER RES, V20, P37, DOI 10.1002/jbm.820200105
   MASON J, 1981, ARCH DERMATOL, V117, P366
   MATHIESEN EB, 1991, J BONE JOINT SURG BR, V73, P569
   MCCAULEY RL, 1990, J SURG RES, V49, P103, DOI 10.1016/0022-4804(90)90118-L
   MCDONALD MD, 1995, J BIOMED MATER RES, V29, P1, DOI 10.1002/jbm.820290102
   MELMED EP, 1988, PLAST RECONSTR SURG, V82, P285, DOI 10.1097/00006534-198808000-00013
   MONTANDOND, 1979, PLAST RECONSTR SURG, V63, P719
   MULROY RD, 1990, J BONE JOINT SURG BR, V72, P757
   MUNDY GR, 1977, SCIENCE, V196, P1109
   MURRAY DW, 1990, J BONE JOINT SURG BR, V72, P988
   PANKOWSKY DA, 1990, J VASC SURG, V11, P599, DOI 10.1067/mva.1990.18272
   PARFREY PS, 1981, LANCET, V1, P1101
   PHUA SK, 1987, J BIOMED MATER RES, V21, P231, DOI 10.1002/jbm.820210207
   PICHA GJ, 1990, PLAST RECONSTR SURG, V85, P903, DOI 10.1097/00006534-199006000-00011
   PITT WG, 1986, J COLLOID INTERF SCI, V111, P343, DOI 10.1016/0021-9797(86)90039-1
   ROSTOKER W, 1978, J BIOMED MATER RES, V12, P317, DOI 10.1002/jbm.820120306
   Rudolph R, 1980, Ann Plast Surg, V4, P14
   SCHMALZRIED TP, 1991, CLIN ORTHOP RELAT R, V274, P60
   SEDEL L, 1992, ARCH ORTHOP TRAUM SU, V111, P255, DOI 10.1007/BF00571519
   SEVASTIANOV VI, 1988, CRIT REV BIOCOMPAT, V4, P109
   SHEPARD AD, 1984, J VASC SURG, V1, P829, DOI 10.1067/mva.1984.avs0010829
   SILVER RM, 1993, ARCH DERMATOL, V129, P63, DOI 10.1001/archderm.129.1.63
   SODERQUIST ME, 1980, J COLLOID INTERF SCI, V75, P386, DOI 10.1016/0021-9797(80)90463-4
   SPILIZEWSKI K L, 1985, Journal of Controlled Release, V2, P197, DOI 10.1016/0168-3659(85)90045-8
   STAUFFER RN, 1982, J BONE JOINT SURG AM, V64, P983, DOI 10.2106/00004623-198264070-00003
   STEINBACH BG, 1993, RADIOGRAPHICS, V13, P95, DOI 10.1148/radiographics.13.1.8426939
   SUTHERLAND CJ, 1982, J BONE JOINT SURG AM, V64, P970
   SUTHERLAND K, 1993, J CLIN INVEST, V92, P2360, DOI 10.1172/JCI116841
   TANG L, 1995, IN PRESS 21ST ANN M
   TANG LP, 1993, J LAB CLIN MED, V122, P292
   TANG LP, 1993, J EXP MED, V178, P2147, DOI 10.1084/jem.178.6.2147
   TRAVIS WD, 1985, HUM PATHOL, V16, P19, DOI 10.1016/S0046-8177(85)80209-4
   VARGA J, 1989, ANN INTERN MED, V111, P377, DOI 10.7326/0003-4819-111-5-377
   VISTNES LM, 1977, PLAST RECONSTR SURG, V59, P31, DOI 10.1097/00006534-197701000-00005
   WICKHAM MG, 1978, SCIENCE, V199, P437, DOI 10.1126/science.619466
   WILLERT HG, 1977, J BIOMED MATER RES, V11, P157, DOI 10.1002/jbm.820110202
   WINDING O, 1988, SCAND J PLAST RECONS, V22, P127, DOI 10.3109/02844318809072383
   WOLF CF, 1981, INT J ARTIF ORGANS, V5, P277
   WORSING RA, 1982, J BONE JOINT SURG AM, V64, P581, DOI 10.2106/00004623-198264040-00014
   ZHAO Q, 1990, J BIOMED MATER RES, V24, P621, DOI 10.1002/jbm.820240508
NR 100
TC 289
Z9 295
U1 1
U2 83
PU LIPPINCOTT-RAVEN PUBL
PI PHILADELPHIA
PA 227 EAST WASHINGTON SQUARE, PHILADELPHIA, PA 19106
SN 0002-9173
J9 AM J CLIN PATHOL
JI Am. J. Clin. Pathol.
PD APR
PY 1995
VL 103
IS 4
BP 466
EP 471
PG 6
WC Pathology
SC Pathology
GA QQ628
UT WOS:A1995QQ62800018
PM 7726145
DA 2018-10-20
ER

PT J
AU WANG, IW
   ANDERSON, JM
   JACOBS, MR
   MARCHANT, RE
AF WANG, IW
   ANDERSON, JM
   JACOBS, MR
   MARCHANT, RE
TI ADHESION OF STAPHYLOCOCCUS-EPIDERMIDIS TO BIOMEDICAL POLYMERS -
   CONTRIBUTIONS OF SURFACE THERMODYNAMICS AND HEMODYNAMIC SHEAR CONDITIONS
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
ID PROSTHETIC VASCULAR GRAFTS; PLASMA-PROTEINS; ADHERENCE; BIOMATERIALS;
   FIBRONECTIN; FIBRINOGEN; PRINCIPLES; ADSORPTION; ALBUMIN
AB Adhesion studies of Staphylococcus epidermidis RP62A were conducted using a rotating disk system to determine the roles of surface physicochemistry and topographies under physiologic shear conditions. Six materials were investigated: biomedical reference polyethylene and polydimethylsiloxane; argon plasma-treated reference polyethylene (Ar-PE); Silastic(R); expanded polytetrafluoroethylene; and woven Dacron. All of the polymers except Dacron demonstrated reduced bacterial adhesion with increasing shear stress. Argon plasma treatment of polyethylene reduced the level of staphylococcal adhesion. Adsorption of human plasma proteins effected significantly lower numbers of adherent bacteria. The lowest adhesion was observed for Ar-PE in 1% human plasma protein solution, whereas Dacron had the highest number of adherent bacteria. The high adhesion on Dacron was attributed to increased bacterial flux caused by topography-induced turbulent flow and physical entrapment of the bacteria in the fiber interstices. The results indicate that the driving force for S. epidermidis adhesion is strongly influenced by substrate physicochemistry, but this may be dominated by physical forces such as shear and turbulence. (C) 1995 John Wiley & Sons, Inc.
C1 CASE WESTERN RESERVE UNIV,DEPT BIOMED ENGN,CLEVELAND,OH 44106.
   CASE WESTERN RESERVE UNIV,DEPT MACROMOLEC SCI,CLEVELAND,OH 44106.
   CASE WESTERN RESERVE UNIV,INST PATHOL,CLEVELAND,OH 44106.
FU NHLBI NIH HHS [HL-47300]
CR ABSOLOM DR, 1983, APPL ENVIRON MICROB, V46, P90
   ANDRADE JD, 1985, INTERFACIAL ASPECTS
   BENTON ER, 1966, J FLUID MECH, V24, P781, DOI 10.1017/S0022112066001009
   BRUNSTEDT MR, 1994, 20TH ANN M SOC BIOM
   COTTONARO CN, 1981, ASAIO T, V27, P391
   DAILY JW, 1960, T ASME             D, V82, P217
   DANILICH MJ, 1992, J BIOMAT SCI-POLYM E, V3, P195, DOI 10.1163/156856292X00123
   EASMON CSF, 1990, PRINCIPLES BACTERIOL, V2, P161
   FABRIZIUSHOMAN DJ, 1991, J BIOMED MATER RES, V25, P953, DOI 10.1002/jbm.820250804
   FERREIROS CM, 1989, FEMS MICROBIOL LETT, V160, P89
   FLETCHER M, 1982, APPL ENVIRON MICROB, V44, P184
   GILBERT P, 1991, J APPL BACTERIOL, V71, P72
   GOLDSMITH HL, 1986, THROMB HAEMOSTASIS, V55, P415
   GRIESLER HP, 1991, NEW BIOL SYNTHETIC V
   HERRMANN M, 1988, J INFECT DIS, V158, P693, DOI 10.1093/infdis/158.4.693
   HOGT AH, 1985, J GEN MICROBIOL, V131, P2485
   HORBETT TA, 1993, CARDIOVASC PATHOL, V2, pS137
   LEVICH VG, 1962, PHYSICOCHEMICAL HYDR
   LOCCI R, 1980, ZENTRALBL BAKTERIO B, V173, P300
   LUDWICKA A, 1984, POLYM BIOMATERIALS, P241
   MALANGONI MA, 1993, J SURG RES, V54, P168, DOI 10.1006/jsre.1993.1027
   MARCHANT RE, 1989, J POLYM SCI POL CHEM, V27, P881, DOI 10.1002/pola.1989.080270314
   MULLER E, 1991, INFECT IMMUN, V59, P3323
   NORDE W, 1991, Journal of Biomaterials Science Polymer Edition, V2, P183
   OBRIEN T, 1992, BRIT J SURG, V79, P1262, DOI 10.1002/bjs.1800791205
   RATNER BD, 1993, CARDIOVASC PATHOL, V2, pS87, DOI 10.1016/1054-8807(93)90049-8
   SCHMITT DD, 1986, J VASC SURG, V3, P732, DOI 10.1067/mva.1986.avs0030732
   Schoen F.J., 1987, T AM SOC ART INT ORG, V33, P8
   SIVERHUS DJ, 1990, SURGERY, V107, P613
   SNOOKS SJ, 1988, J VASC SURG, V7, P538, DOI 10.1067/mva.1988.avs0070538
   SUGARMAN B, 1982, INFECTION, V10, P9, DOI 10.1007/BF01640828
   SZYCHER M, 1991, HIGH PERFORMANCE BIO, P1
   TENNEKES H, 1972, 1ST COURSE TURBULENC
   TIMMERMAN CP, 1991, INFECT IMMUN, V59, P187
   TOJO M, 1988, J INFECT DIS, V157, P713, DOI 10.1093/infdis/157.4.713
   WANG IW, 1993, J INFECT DIS, V167, P329, DOI 10.1093/infdis/167.2.329
   WHEAT RW, 1992, ZINSSER MICROBIOLOGY, P8
   YATES SG, 1978, ANN SURG, V188, P611, DOI 10.1097/00000658-197811000-00005
   ZIATS NP, 1990, J LAB CLIN MED, V116, P687
NR 39
TC 47
Z9 47
U1 1
U2 8
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD APR
PY 1995
VL 29
IS 4
BP 485
EP 493
DI 10.1002/jbm.820290408
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA QP943
UT WOS:A1995QP94300007
PM 7622533
DA 2018-10-20
ER

PT J
AU GREIL, P
AF GREIL, P
TI ACTIVE-FILLER-CONTROLLED PYROLYSIS OF PRECERAMIC POLYMERS
SO JOURNAL OF THE AMERICAN CERAMIC SOCIETY
LA English
DT Article
ID SILICON-CARBIDE FIBER; HIGH-TENSILE STRENGTH; CERAMIC FIBERS; OXYCARBIDE
   GLASSES; ORGANOMETALLIC POLYMERS; POLYCARBOSILANE FIBER; SIC FIBER;
   PRECURSOR; NITRIDE; CONVERSION
AB Manufacturing of bulk ceramic components from materials in the system Si-Me-C-N-O (Me Ti, Cr, V, Mo, Si, B, CrSi2, MoSi2, etc.) from preceramic organosilicon polymers-such as poly(carbosilanes), poly(silazanes), or poly(siloxanes)-has become possible by incorporating reactive filler particles into the liquid or solid polymer precursor. During pyrolytic decomposition of the polymer matrix, the filler particles react with carbon from the polymer precursor or nitrogen from the reaction gas atmosphere to form new (oxy)carbide or (oxy)nitride phases embedded in a nanocrystalline SI-O-C(-N) matrix. The selective expansion encountered in the filler phase reaction can be used to compensate for the polymer shrinkage upon pyrolytic conversion. The formation of a transient pore network between 400 degrees and 1000 degrees C is governed by the polymer decomposition as well as the filler particle reaction kinetics, Thus, the properties of the oxycarbonitride composite materials can be tailored by controlling the microstructures of the polymer-derived matrix phase, the filler network, and the residual porosity. Near-net-shape forming of bulk ceramic components, even with complex geometry, is possible, making novel applications of polymer-derived bulk materials in biomedical, electrical, and mechanical fields highly interesting.
RP GREIL, P (reprint author), UNIV ERLANGEN NURNBERG,DEPT MAT SCI GLASS & CERAM,D-91058 ERLANGEN,GERMANY.
CR Ainger FW, 1960, SPECIAL CERAMICS, V661, P168
   ATWELL WH, 1991, INORGANIC AND ORGANOMETALLIC OLIGOMERS AND POLYMERS, P147
   AYLETT BJ, 1968, ORGANOMET CHEM REV A, V3, P151
   BABONNEAU F, 1990, J MATER SCI, V25, P3664, DOI 10.1007/BF00575402
   BALDUS HP, 1992, MATER RES SOC SYMP P, V271, P821, DOI 10.1557/PROC-271-821
   BANEY RH, 1979, Patent No. 2021545
   BANEY RH, 1982, Patent No. 4310651
   BARIN I., 1989, THERMOCHEMICAL DATA
   BELOT V, 1992, J POLYM SCI POL CHEM, V30, P613, DOI 10.1002/pola.1992.080300413
   BLUM YD, 1989, J MATER SCI, V24, P1707, DOI 10.1007/BF01105695
   BOUILLON E, 1991, J MATER SCI, V26, P1517, DOI 10.1007/BF00544661
   BOULLION E, 1991, J MATER SCI, V26, P1333
   BURNS GT, 1989, J AM CERAM SOC, V72, P333, DOI 10.1111/j.1151-2916.1989.tb06129.x
   Chantrell PG, 1965, SPECIAL CERAMICS, V67
   COOKE TF, 1991, J AM CERAM SOC, V74, P2959, DOI 10.1111/j.1151-2916.1991.tb04289.x
   CZEKAJ CL, 1990, J AM CERAM SOC, V73, P352, DOI 10.1111/j.1151-2916.1990.tb06518.x
   Emsley R. J. P., 1990, British Ceramic Proceedings, P139
   ERNY T, 1993, J AM CERAM SOC, V76, P207, DOI 10.1111/j.1151-2916.1993.tb03709.x
   FRITZ G, 1956, Z ANORG ALLG CHEM, V286, P149, DOI 10.1002/zaac.19562860307
   GALASSO F, 1966, APPL PHYS LETT, V9, P37, DOI 10.1063/1.1754590
   GERMAN RM, 1987, INT J POWDER METALL, V23, P237
   GREIL P, 1992, MATER RES SOC SYMP P, V274, P155, DOI 10.1557/PROC-274-155
   Greil P., 1990, Journal of the European Ceramic Society, V6, P53, DOI 10.1016/0955-2219(90)90035-E
   GREIL P, 1991, J MATER SCI, V27, P1053
   GREIL P, 1991, CERAMIC T, V19, P43
   HASEGAWA Y, 1983, J MATER SCI, V18, P3633, DOI 10.1007/BF00540736
   HASEGAWA Y, 1980, J MATER SCI, V15, P720, DOI 10.1007/BF00551739
   HASEGAWA Y, 1989, J MATER SCI, V24, P1177
   HASEGAWA Y, 1986, J MATER SCI, V21, P321, DOI 10.1007/BF01144739
   HATAKEYAMA F, 1990, J AM CERAM SOC, V73, P2107, DOI 10.1111/j.1151-2916.1990.tb05278.x
   HURWITZ FI, 1993, J MATER SCI, V28, P6622, DOI 10.1007/BF00356406
   HURWITZ FI, 1989, CERAM ENG SCI P, V10, P750
   ICHIKAWA H, 1987, J MATER SCI LETT, V6, P420, DOI 10.1007/BF01756783
   ISHIKAWA T, 1992, J MATER SCI, V27, P6627, DOI 10.1007/BF01165946
   JAMET J, 1984, CERAM ENG SCI P, V5, P677
   JOHNSON SM, 1988, J AM CERAM SOC, V71, pC132
   KOMEYA K, 1986, J NONCRYST SOLIDS, V83, P208
   LAFFON C, 1989, J MATER SCI, V24, P1503, DOI 10.1007/BF02397093
   LAINE RM, 1987, POLYM PREPR, V28, P393
   Lavedrine A., 1991, Journal of the European Ceramic Society, V8, P221, DOI 10.1016/0955-2219(91)90098-K
   LEGROW GE, 1987, AM CERAM SOC BULL, V66, P363
   Levenspiel O., 1972, CHEM REACTION ENG
   LIPOWITZ J, 1991, AM CERAM SOC BULL, V70, P1888
   LIPOWITZ J, 1990, J MATER SCI, V25, P2118, DOI 10.1007/BF01045776
   PEUCKERT M, 1990, ADV MATER, V2, P398, DOI 10.1002/adma.19900020903
   PORTE L, 1989, J MATER SCI, V24, P271, DOI 10.1007/BF00660966
   POUSKOULELI G, 1989, CERAM INT, V15, P213, DOI 10.1016/0272-8842(89)90041-2
   RAHN JA, 1990, MATER RES SOC SYMP P, V171, P31
   RENLUND GM, 1991, J MATER RES, V6, P2723, DOI 10.1557/JMR.1991.2723
   RENLUND GM, 1991, J MATER RES, V6, P2716, DOI 10.1557/JMR.1991.2716
   RENLUND GM, 1989, THESIS RENSSELAER PO
   RICE RW, 1983, AM CERAM SOC BULL, V62, P889
   RIEDEL R, 1992, NATURE, V355, P355
   SASAKI Y, 1987, J MATER SCI, V22, P443, DOI 10.1007/BF01160751
   SAWYER LC, 1987, J AM CERAM SOC, V70, P798, DOI 10.1111/j.1151-2916.1987.tb05631.x
   SCHWARTZ KB, 1988, ADV CERAM MATER, V3, P320
   SCHWARTZ KB, 1986, MATER RES SOC S P, V73, P407
   Seibold M., 1993, Journal of the European Ceramic Society, V11, P105, DOI 10.1016/0955-2219(93)90041-O
   SEIBOLD M, 1990, ADV MATER PROCESS, V1, P641
   SEYFERTH D, 1992, J AM CERAM SOC, V75, P1300, DOI 10.1111/j.1151-2916.1992.tb05578.x
   SEYFERTH D, 1991, J AM CERAM SOC, V74, P2687, DOI 10.1111/j.1151-2916.1991.tb06824.x
   SEYFERTH D, 1990, J AM CERAM SOC, V73, P2131, DOI 10.1111/j.1151-2916.1990.tb05286.x
   SEYFERTH D, 1983, J AM CERAM SOC, V66, pC13
   SEYFERTH D, 1984, J AM CERAM SOC, V67, pC132
   SEYFERTH D, 1986, SCI CERAMIC CHEM PRO, P354
   SEYFERTH D, 1987, ACS SYM SER, V360, P143
   SHELDON BW, 1992, J AM CERAM SOC, V75, P677, DOI 10.1111/j.1151-2916.1992.tb07858.x
   SHILLING CL, 1983, AM CERAM SOC B, V62, P912
   SINCLAIR RA, 1984, MATER RES SOC S P, V32, P387
   SINGH AK, 1992, MATER RES SOC SYMP P, V271, P795, DOI 10.1557/PROC-271-795
   SIRIEIX F, 1990, COMPOS SCI TECHNOL, V37, P7, DOI 10.1016/0266-3538(90)90089-N
   SONG YC, 1988, J MATER SCI, V23, P1911, DOI 10.1007/BF01115750
   SORARU GD, 1990, J MATER SCI, V25, P3886, DOI 10.1007/BF00582455
   SUTTOR D, 1995, CERAMIC T, V51, P211
   TAKI T, 1988, J MATER SCI LETT, V7, P209, DOI 10.1007/BF01730172
   TAKI T, 1987, J MATER SCI LETT, V6, P826, DOI 10.1007/BF01729026
   TAWANCY HM, 1992, J MATER SCI, V27, P1061, DOI 10.1007/BF01197661
   Toreki W., 1992, CERAM ENG SCI P, V13, P198
   Verbeek W, 1974, Ger Pat, Patent No. 2236078
   Verbeek W, 1974, U.S. Patent, Patent No. 3853567
   Verbeek W., 1973, Ger. Pat, Patent No. 2218960
   WALKER BE, 1983, AM CERAM SOC BULL, V62, P916
   WEST R, 1983, AM CERAM SOC BULL, V62, P899
   WEST R, 1984, ULTRASTRUCTURE PROCE, P235
   WHITE DA, 1987, ADV CERAM MATER, V2, P45
   WILLS RR, 1983, AM CERAM SOC BULL, V62, P904
   WINTER G, 1975, Patent No. 3892583
   Winter G, 1974, Ger Pat, Patent No. 2243527
   WU MJ, 1992, MACROMOLECULES, V25, P1840
   WYNNE KJ, 1984, ANNU REV MATER SCI, V14, P297, DOI 10.1146/annurev.ms.14.080184.001501
   YAJIMA S, 1978, NATURE, V273, P525, DOI 10.1038/273525a0
   YAJIMA S, 1981, AM CERAM SOC BULL, V60, P253
   YAJIMA S, 1981, J MATER SCI, V16, P1349, DOI 10.1007/BF01033851
   YAJIMA S, 1976, NATURE, V261, P683, DOI 10.1038/261683a0
   YAJIMA S, 1977, NATURE, V266, P521, DOI 10.1038/266521a0
   YAJIMA S, 1978, J MATER SCI, V13, P2569, DOI 10.1007/BF02402743
   YAJIMA S, 1983, AM CERAM SOC BULL, V62, P893
   YAJIMA S, 1957, CHEM LETT, V9, P931
   YU YF, 1986, MATER RES SOC S P, V73, P559
   ZHANG H, 1990, J AM CERAM SOC, V73, P958, DOI 10.1111/j.1151-2916.1990.tb05143.x
NR 100
TC 307
Z9 326
U1 2
U2 65
PU AMER CERAMIC SOC 735 CERAMIC PLACE
PI WESTERVILLE
PA PO BOX 6136, WESTERVILLE, OH 43081-6136
SN 0002-7820
J9 J AM CERAM SOC
JI J. Am. Ceram. Soc.
PD APR
PY 1995
VL 78
IS 4
BP 835
EP 848
DI 10.1111/j.1151-2916.1995.tb08404.x
PG 14
WC Materials Science, Ceramics
SC Materials Science
GA QT907
UT WOS:A1995QT90700001
DA 2018-10-20
ER

PT J
AU CALLEN, BW
   LOWENBERG, BF
   LUGOWSKI, S
   SODHI, RNS
   DAVIES, JE
AF CALLEN, BW
   LOWENBERG, BF
   LUGOWSKI, S
   SODHI, RNS
   DAVIES, JE
TI NITRIC-ACID PASSIVATION OF TI6AL4V REDUCES THICKNESS OF SURFACE OXIDE
   LAYER AND INCREASES TRACE-ELEMENT RELEASE
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
ID DENTAL IMPLANT MATERIALS; PREPARATIVE PROCEDURES; CITRIC-ACID;
   WHOLE-BLOOD; ALUMINUM; TITANIUM; BRAIN; BONE; ABSORPTION; INHIBITION
AB Passivation of Ti6Al4V and cpTi implants using methods based on the ASTM-F86 nitric acid protocol are used with the intention of reducing their surface reactivity, and consequently the corrosion potential, in the highly corrosive biologic milieu. The ASTM-F86 passivation protocol was originally developed for surgical implants made of stainless steel and chrome cobalt alloy. Using X-ray photoelectron spectroscopy (XPS) to examine the effect of nitric acid passivation on the surface oxide layer of mill-annealed Ti6Al4V and cpTi, we have found that such treatment actually reduced the oxide thickness on the alloy while having no significant effect on the pure metal. These results correlated with observations obtained using graphite furnace atomic absorption spectrophotometry (GFAAS) to detect trace element release from solid, mill-annealed, Ti6Al4V and cpTi into serum-containing culture medium. We detected significantly greater levels of Ti, Al, and V in the presence of passivated compared to nonpassivated Ti6Al4V. In contrast, nitric acid passivation did not influence Ti release from mill-annealed cpTi. These results, derived from two mill-annealed Ti-based metals, would indicate that reexamination of ASTM-F86-based passivation protocols with respect to Ti6Al4V should be considered in view of the widespread use of this alloy for biomedical devices. (C) 1995 John Wiley & Sons, Inc.
RP CALLEN, BW (reprint author), UNIV TORONTO,CTR BIOMAT,170 COLL ST,TORONTO,ON M5S 1A1,CANADA.
CR ALFREY AC, 1976, NEW ENGL J MED, V294, P184, DOI 10.1056/NEJM197601222940402
   ASK M, 1988, APPL SURF SCI, V35, P283
   BIANCO PD, 1993, 19TH ANN M SOC BIOM
   BLUMENTHAL NC, 1984, CALCIFIED TISSUE INT, V36, P439, DOI 10.1007/BF02405357
   BLUMENTHAL NC, 1989, J BIOMED MATER RES-A, V23, P13, DOI 10.1002/jbm.820231305
   BRUNEEL N, 1988, J BIOMED MATER RES, V22, P203, DOI 10.1002/jbm.820220305
   DUCHEYNE P, 1984, J BIOMED MATER RES, V18, P293, DOI 10.1002/jbm.820180306
   FLENDRIG JA, 1976, LANCET, V1, P1235
   JACOBS JJ, 1991, J BONE JOINT SURG AM, V73A, P1475, DOI 10.2106/00004623-199173100-00005
   JACOBS JJ, 1993, 19TH ANN M SOC BIOM
   JERVIS TR, 1993, METALL TRANS A, V24, P215, DOI 10.1007/BF02669618
   Johansson CB, 1992, EUR J EXP MUSCULOSKE, V1, P161
   KIRSCHBAUM BB, 1989, AM J MED SCI, V279, P9
   LAUSMAA J, 1985, BIOMATERIALS, V6, P23, DOI 10.1016/0142-9612(85)90033-X
   LAUSMAA J, 1986, MAT RES S P, V35, P351
   LOWENBERG BF, 1994, J MATER SCI-MATER M, V5, P467, DOI 10.1007/BF00058985
   LUGOWSKI S, 1987, J BIOMED MATER RES, V21, P657, DOI 10.1002/jbm.820210510
   LUGOWSKI S, 1987, TRACE ELEM MED, V4, P28
   MAEUSLI PA, 1986, BIOL BIOMECHANICAL P, P57
   MASSEY RC, 1989, ALUMINUM FOOD ENV
   MURALEEDHARAN TM, 1992, THIN SOLID FILMS, V221, P104, DOI 10.1016/0040-6090(92)90802-I
   OSBORN JF, 1990, CLIN IMPLANT MAT, P73
   PILLIAR RM, 1987, J BIOMED MATER RES-A, V21, P1
   ROSTOKER W, 1974, J BIOMED MATER RES, V8, P407, DOI 10.1002/jbm.820080609
   SHAM TK, 1979, CHEM PHYS LETT, V68, P426, DOI 10.1016/0009-2614(79)87231-0
   SLANINA P, 1985, ACTA PHARMACOL TOX, V56, P331
   SLANINA P, 1984, FOOD CHEM TOXICOL, V22, P391, DOI 10.1016/0278-6915(84)90369-7
   SMITH DC, 1991, J BIOMED MATER RES, V25, P1045, DOI 10.1002/jbm.820250902
   SMITH DC, 1991, J BIOMED MATER RES, V25, P1069, DOI 10.1002/jbm.820250903
   SMITH DC, 1989, ORAL IMPLANTOLOGY BI, P185
   SMITH GK, 1981, SYSTEMIC ASPECTS BIO, V2, P1
   SODHI RNS, 1994, J VAC SCI TECHNOL A, V12, P267, DOI 10.1116/1.578899
   SODHI RNS, 1991, J VAC SCI TECHNOL A, V9, P1329, DOI 10.1116/1.577621
   SOLAR RJ, 1978, ASTM684 SPEC TECHN P
   VANATTEKUM PMTM, 1977, J ELECTRON SPECTROSC, V11, P363, DOI 10.1016/0368-2048(77)80013-3
   VANDERVOET GB, 1991, HISTO CYTOCHEMISTRY, P235
   VANGINKEL MF, 1993, J LAB CLIN MED, V121, P453
   WILLS MR, 1983, LANCET, V2, P49
   WROBEL K, 1993, TRACE ELEM MED, V10, P97
   1992, ANN BOOK ASTM STANDA
NR 40
TC 71
Z9 71
U1 1
U2 18
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD MAR
PY 1995
VL 29
IS 3
BP 279
EP 290
DI 10.1002/jbm.820290302
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA QJ437
UT WOS:A1995QJ43700001
PM 7615579
DA 2018-10-20
ER

PT J
AU HOLCOMB, WF
AF HOLCOMB, WF
TI RADIATION SAFETY TRAINING-PROGRAM AT THE NATIONAL-INSTITUTES-OF-HEALTH
SO MILITARY MEDICINE
LA English
DT Article
AB At the U.S. Public Health Service's National Institutes of Health (NIH), one of the world's largest biomedical and clinical research institutions, 70 to 80% of all research is performed using radiation or radioactive materials. To maintain a safe environment and minimize risks to the health and safety of the employees, patients, visitors, and the surrounding community, a radiation protection program is required. Under U.S. Nuclear Regulatory Commission licenses and NIH policies, the Radiation Safety Branch (RSB), Division of Safety, administers a comprehensive radiation safety program covering over 3,500 NIH laboratories and some 7,000 laboratory and ancillary staff workers. The NIH radiation protection program provides for the effective supervision, control, and monitoring of all radioactive materials and radiation sources at NIH, This includes activities such as radiation exposure monitoring, laboratory inspections, waste management, consulting, environmental monitoring, and training, Training is considered an integral part of the radiation safety program, RSB offers an extensive training program with over 20 different training courses each year, For example, in 1993 some 6,700 employees attended 243 classes.
RP HOLCOMB, WF (reprint author), NIH,DIV SAFETY,RADIAT SAFETY BRANCH,BLDG 10,BETHESDA,MD 20892, USA.
NR 0
TC 1
Z9 1
U1 0
U2 2
PU ASSN MILITARY SURG US
PI BETHESDA
PA 9320 OLD GEORGETOWN RD, BETHESDA, MD 20814
SN 0026-4075
J9 MIL MED
JI Milit. Med.
PD MAR
PY 1995
VL 160
IS 3
BP 115
EP 120
PG 6
WC Medicine, General & Internal
SC General & Internal Medicine
GA QY950
UT WOS:A1995QY95000006
PM 7783932
DA 2018-10-20
ER

PT J
AU DILL, A
   BROWN, P
   CIAMBRONE, D
   RAKOWSKI, W
AF DILL, A
   BROWN, P
   CIAMBRONE, D
   RAKOWSKI, W
TI THE MEANING AND PRACTICE OF SELF-CARE BY OLDER ADULTS - A QUALITATIVE
   ASSESSMENT
SO RESEARCH ON AGING
LA English
DT Article
ID SYMPTOMS; ILLNESS; BEHAVIOR; CULTURE; PEOPLE
AB Drawing on material from qualitative interviews, this article examines self-care as a response to physical symptoms commonly experienced by older people.  The analysis indicates that older persons approach, interpret, and treat their symptoms within both biomedical and psychosocial frameworks.  Self-care responses appear to be learned early in life, reinforced throughout the life cycle, and formed in consultation with professional as well as lay persons.  Symptom responses reflect and reinforce the meaning of social relations in individuals' lives, providing a symbolic medium for the assessment of present and past relationships, cross-generational connections, and past troubles and issues of personal identity.  Findings suggest that categorizing sources of care into professional, informal, or self overly simplifies the symptom experience of older adults.  Self-care goes beyond the acknowledgement of discomfort and subsequent treatment of symptoms; it involves the representation and interpretation of the self.
C1 BROWN UNIV,DEPT COMMUNITY HLTH,PROVIDENCE,RI 02912.
   BROWN UNIV,CTR GERONTOL & HLTH CARE RES,PROVIDENCE,RI 02912.
RP DILL, A (reprint author), BROWN UNIV,DEPT SOCIOL,BOX 1916,PROVIDENCE,RI 02912, USA.
CR BRODY EM, 1981, J AM GERIATR SOC, V29, P442, DOI 10.1111/j.1532-5415.1981.tb01746.x
   BURY M, 1991, SOCIOL HEALTH ILL, V13, P451, DOI 10.1111/j.1467-9566.1991.tb00522.x
   Chappell N L, 1988, Compr Gerontol B, V2, P92
   CHAPPELL NL, 1987, HLTH AGING SOCIOLOGI, P159
   Charmaz K., 1991, GOOD DAYS BAD DAYS S
   DEAN K, 1981, SOC SCI MED-MED SOC, V15, P673, DOI 10.1016/0271-7123(81)90091-2
   DEAN K, 1986, SOC SCI MED, V22, P275, DOI 10.1016/0277-9536(86)90076-6
   Dean K., 1992, AGING HLTH BEHAV, P27
   EWING KP, 1990, ETHOS, V18, P251, DOI 10.1525/eth.1990.18.3.02a00020
   Fitzpatrick R., 1984, EXPERIENCE ILLNESS, P11
   Gergen K., 1983, STUDIES SOCIAL IDENT, P254
   Gochman DS, 1988, HLTH BEHAV EMERGING, P149
   HAUG M, 1984, NOV ANN M GER SOC AM
   HAUG MR, 1989, SOC SCI MED, V29, P171, DOI 10.1016/0277-9536(89)90165-2
   HENNESSY CH, 1989, J AGING STUD, V3, P39, DOI 10.1016/0890-4065(89)90024-8
   KLEINMAN A, 1988, ILLNESS NARRATIVES
   LEVENTHAL EA, 1986, J AM GERIATR SOC, V34, P185
   Levin LS, 1976, SELF CARE LAY INITIA
   LUBORSKY MR, 1993, GERONTOLOGIST, V33, P445, DOI 10.1093/geront/33.4.445
   Mishler E., 1981, SOCIAL CONTEXTS HLTH
   PROHASKA TR, 1987, HEALTH PSYCHOL, V6, P495, DOI 10.1037//0278-6133.6.6.495
   Register C., 1987, LIVING CHRONIC ILLNE
   SEGALL A, 1989, SOC SCI MED, V29, P153, DOI 10.1016/0277-9536(89)90163-9
   SEGALL A, 1991, ADV MED SOCIOLOGY, V2, P115
   Starr P, 1982, SOCIAL TRANSFORMATIO
   VERBRUGGE LM, 1987, MED CARE, V25, P539, DOI 10.1097/00005650-198706000-00008
   WILLIAMS G, 1984, SOCIOLOGY HLTH ILLNE, V6, P176
   Young K, 1989, TEXTS IDENTITY, P152
   ZOLA IK, 1973, SOC SCI MED, V7, P677, DOI 10.1016/0037-7856(73)90002-4
NR 29
TC 22
Z9 22
U1 0
U2 2
PU SAGE PUBL INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320
SN 0164-0275
J9 RES AGING
JI Res. Aging
PD MAR
PY 1995
VL 17
IS 1
BP 8
EP 41
DI 10.1177/0164027595171002
PG 34
WC Gerontology
SC Geriatrics & Gerontology
GA QH650
UT WOS:A1995QH65000002
DA 2018-10-20
ER

PT J
AU POGHOSSIAN, AS
AF POGHOSSIAN, AS
TI USING THE SITE-BINDING MODEL FOR AN EXPLANATION OF THE BLOOD
   COMPATIBILITY OF SOME MATERIALS USED IN BIOMEDICAL SENSORS
SO SENSORS AND ACTUATORS B-CHEMICAL
LA English
DT Article; Proceedings Paper
CT 5th International Meeting on Chemical Sensors
CY JUL 11-14, 1994
CL ROME, ITALY
DE BIOMEDICAL SENSORS; BLOOD COMPATIBILITY; SITE-BINDING MODEL
ID INTERFACE; OPERATION; SYSTEM
AB Blood clotting time is the most obvious indication of the biological incompatibility of materials that are in contact with blood. The results of the investigation of blood clotting time are presented for 12 different materials that are widely used in biomedical chemical-sensor technology. The most important factors that define the antithrombogenic properties of materials are the surface-state charges and electrochemical phenomena taking place at the solid-state-blood interface. Using the site-binding model, a mechanism that can explain the high antithrombogenic properties of some materials is proposed and discussed.
RP POGHOSSIAN, AS (reprint author), STATE ENGN UNIV ARMENIA,TERIAN 105,YEREVAN 375009,ARMENIA.
CR BOUSSE L, 1983, IEEE T ELECTRON DEV, V30, P1263, DOI 10.1109/T-ED.1983.21284
   KOBLOV LF, 1975, METHODS APPARATUS IN, P96
   MANEBU C, 1982, POLYM MED APPLICATIO, P248
   MATSUO T, 1979, IEEE T ELECTRON DEV, V26, P1856, DOI 10.1109/T-ED.1979.19780
   MEIXNER LK, 1992, SENSOR ACTUAT B-CHEM, V6, P315, DOI 10.1016/0925-4005(92)80077-B
   SIU WM, 1979, IEEE T ELECTRON DEV, V26, P1805, DOI 10.1109/T-ED.1979.19690
   TORBICZ W, 1992, SENSOR ACTUAT B-CHEM, V7, P565, DOI 10.1016/0925-4005(92)80365-5
   VANKERKHOF JC, 1994, SENSOR ACTUAT B-CHEM, V18, P56, DOI 10.1016/0925-4005(94)87056-X
   WILLIAMS DF, 1978, IMPLANT SURGERY, P552
   YATES DE, 1974, J CHEM SOC FARAD T 1, V70, P1807, DOI 10.1039/f19747001807
NR 10
TC 1
Z9 1
U1 0
U2 0
PU ELSEVIER SCIENCE SA LAUSANNE
PI LAUSANNE 1
PA PO BOX 564, 1001 LAUSANNE 1, SWITZERLAND
SN 0925-4005
J9 SENSOR ACTUAT B-CHEM
JI Sens. Actuator B-Chem.
PD MAR
PY 1995
VL 24
IS 1-3
BP 159
EP 161
DI 10.1016/0925-4005(95)85034-1
PG 3
WC Chemistry, Analytical; Electrochemistry; Instruments & Instrumentation
SC Chemistry; Electrochemistry; Instruments & Instrumentation
GA RM959
UT WOS:A1995RM95900032
DA 2018-10-20
ER

PT J
AU SUK, WA
AF SUK, WA
TI THE NIEHS SUPERFUND BASIC RESEARCH-PROGRAM - OVERVIEW AND AREAS OF
   FUTURE-RESEARCH DIRECTIONS
SO ENVIRONMENTAL HEALTH PERSPECTIVES
LA English
DT Article; Proceedings Paper
CT Joint US/Mexico Conference on Fate, Transport and Interactions of Metals
CY APR 14-16, 1993
CL TUCSON, AZ
DE NIEHS; HAZARDOUS SUBSTANCES; INTERDISCIPLINARY; BASIC RESEARCH; BIOLOGIC
   MARKERS; METALS; MIXTURES OF CHEMICALS; TECHNOLOGY TRANSFER
AB The National Institute of Environmental Health Sciences' Superfund Basic Research Program is currently funding 142 separate research projects within 18 programs encompassing 29 universities and institutions around the United States. The research under this program covers a wide range of interdisciplinary science from both the biomedical and nonbiomedical perspectives. This is a unique program of technology-driven research. Nonetheless, there are some areas of research that should be investigated or investigated further, should funds become available. Environmental health risk posed by the location of Superfund sites may be distributed inequitably across socioeconomic status and racial groups. Since one in five children now lives below the poverty line, an important aspect of environmental equity must be the investigation of the health effects of environmental factors on children. The multidisciplinary investigation of the effects of hazardous substance exposure on children is an area that needs much research due to the fact that most of the toxicologic data available are based on adults and animals. This program is funding 27 projects on ecologic damage posed by hazardous wastes. Much more research is needed in the investigation of toxic effects on natural succession of ecosystems as well as on their effects on biodiversity to further our understanding of the food web in the role of bioavailability in human health, and to examine the bioaccumulation of these chemicals as it relates to their fate and transport. This program is researching and developing many innovative technologies for detecting, assessing, and reducing toxic materials in the environment. As these products are developed through basic research, it becomes necessary to design a technology-transfer strategy for this program to handle the unique problems associated with transferring multidisciplinary technology from basic research to applied research and eventually to technology demonstrations and commercialization. Two areas of prime consideration are biologically based risk assessment and bioremediation. Presently, more than half of hazardous waste remediation is done via incineration. Additional funding will allow for investigating innovative technologies in incineration, to augment studies on the health effects of exposure to toxic combustion by-products, and to develop real-time monitors for hazardous waste incinerator emissions. From a public health perspective, this technology may allow for the destruction of environmental hazardous wastes such that potential human health effects are ameliorated, or indeed prevented, specifically by reducing the amount and toxicity of hazardous substances.
RP SUK, WA (reprint author), NIEHS, POB 12233, RES TRIANGLE PK, NC 27709 USA.
NR 0
TC 2
Z9 2
U1 1
U2 6
PU US DEPT HEALTH HUMAN SCIENCES PUBLIC HEALTH SCIENCE
PI RES TRIANGLE PK
PA NATL INST HEALTH, NATL INST ENVIRONMENTAL HEALTH SCIENCES, PO BOX 12233,
   RES TRIANGLE PK, NC 27709-2233 USA
SN 0091-6765
EI 1552-9924
J9 ENVIRON HEALTH PERSP
JI Environ. Health Perspect.
PD FEB
PY 1995
VL 103
SU 1
BP 3
EP 5
DI 10.2307/3432001
PG 3
WC Environmental Sciences; Public, Environmental & Occupational Health;
   Toxicology
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health; Toxicology
GA QP391
UT WOS:A1995QP39100001
PM 7621795
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU BOZSAI, G
   MELEGH, M
AF BOZSAI, G
   MELEGH, M
TI APPLICATION OF THE TRANSVERSELY HEATED GRAPHITE ATOMIZER TO THE
   DETERMINATION OF TRACE-METALS IN ENVIRONMENTAL AND BIOMEDICAL SAMPLES
SO MICROCHEMICAL JOURNAL
LA English
DT Article; Proceedings Paper
CT 6th Hungaro/Italian Symposium on Spectrochemistry: Advances in
   Environmental Sciences
CY AUG 23-27, 1993
CL LILLAFURED, HUNGARY
SP EOTVOS LORAND TUDOMANYEGYETEM, BUDAPEST, IST SUPER SANITA, ROME
ID ABSORPTION SPECTROMETRY; FURNACE; INTERFERENCE; SELENIUM
AB A transversely heated graphite atomizer (THGA) with longitudinal Zeeman background correction was used for the determination of silver, nickel, cobalt, and chromium in water and human urine samples. The performance of the new type furnace was compared with that of a conventional ''Massmann''-type atomizer. The gas phase and covolatilization interferences of chloride and sulfate matrices in the determination of silver in water observed in the conventional furnace were successfully eliminated using the THGA technique. Detection limits for nickel, cobalt, and chromium were significantly improved using the new atomizer. The results of the determination of trace elements in standard reference materials showed good agreement with the certified or informative values. (C) 1995 Academic Press, Inc.
C1 INST ENVIRONM MANAGEMENT,H-1518 BUDAPEST,HUNGARY.
RP BOZSAI, G (reprint author), NATL INST HYG,POB 64,H-1966 BUDAPEST,HUNGARY.
CR BOZSAI G, 1990, TALANTA, V37, P545, DOI 10.1016/0039-9140(90)80195-L
   DELOOSVOLLEBREG.MT, 1988, SPECTROCHIM ACTA B, V43, P1147
   FRECH W, 1982, SPECTROCHIM ACTA B, V37, P1021, DOI 10.1016/0584-8547(82)80031-1
   FRECH W, 1985, PROG ANAL ATOM SPECT, V8, P257
   FRECH W, 1986, ANAL CHEM, V58, P1973, DOI 10.1021/ac00122a013
   MINOIA C, 1992, APPLICATION ZEEMAN G
   SHUTTLER I, 1992, ATOM SPECTROSC, V13, P174
   WELZ B, 1992, J ANAL ATOM SPECTROM, V7, P505, DOI 10.1039/ja9920700505
NR 8
TC 9
Z9 9
U1 0
U2 0
PU ACADEMIC PRESS INC JNL-COMP SUBSCRIPTIONS
PI SAN DIEGO
PA 525B STREET, SUITE 1900, SAN DIEGO, CA 92101-4495
SN 0026-265X
J9 MICROCHEM J
JI Microchem J.
PD FEB-APR
PY 1995
VL 51
IS 1-2
BP 39
EP 45
DI 10.1006/mchj.1995.1007
PG 7
WC Chemistry, Analytical
SC Chemistry
GA QK537
UT WOS:A1995QK53700006
DA 2018-10-20
ER

PT J
AU ALI, SAM
   HOURSTON, DJ
   MANZOOR, K
   WILLIAMS, DF
AF ALI, SAM
   HOURSTON, DJ
   MANZOOR, K
   WILLIAMS, DF
TI THE STABILITY OF POLY(ETHER URETHANE) POLYDIMETHYLSILOXANE
   INTERPENETRATING POLYMER NETWORKS
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
ID IMPLANTABLE DEVICES; DEGRADATION; MECHANISMS
AB Interpenetrating polymer networks (IPNs) are a special type of polymer blend consisting of two polymer networks synthesized and/or cross-linked independently within each other. One potential approach for the preparation of composite materials from polymers having desirable physical characteristics obtained by modifying their surfaces with physiologically acceptable polymers involves IPN technology. An IPN based on a poly(ether urethane) and polydimethylsiloxane has been synthesized and characterized using optical microscopy, dynamic mechanical analysis, and scanning electron microscopy. The stability of poly(ether urethane)/polydimethylsiloxane composites were studied in hydroxyl radical aqueous solutions over 30 weeks. The data suggest that these composites have good potential for biomedical applications. (C) 1995 John Wiley & Sons, Inc.
C1 ROYAL LIVERPOOL UNIV HOSP,DEPT CLIN ENGN,LIVERPOOL L69 3BX,MERSEYSIDE,ENGLAND.
   LOUGHBOROUGH UNIV TECHNOL,INST POLYMER TECHNOL & MAT ENGN,LOUGHBOROUGH LE11 3TU,LEICS,ENGLAND.
   UNIV LANCASTER,CTR POLYMER,LANCASTER LA1 4YA,ENGLAND.
CR ALI SAM, 1993, BIOMATERIALS, V14, P648, DOI 10.1016/0142-9612(93)90063-8
   ALI SAM, 1994, J APPL POLYM SCI, V51, P1389, DOI 10.1002/app.1994.070510805
   ALI SAM, 1993, J BIOMED MATER RES, V27, P1409, DOI 10.1002/jbm.820271108
   ALI SAM, 1994, BIOMATERIALS, V15, P779, DOI 10.1016/0142-9612(94)90032-9
   ARKLES BC, 1983, MED DEVICE DIAGN IND, V5, P66
   ARKLES BC, 1983, POLYM MAT SCI ENG, V49, P6
   Baier R., 1977, ANN NY ACAD SCI, V17, P283
   DWIGHT DW, 1979, POLYM PREPR AM CHEM, V20, P702
   EBDIB HR, 1988, POLYMER, V29, P1079
   EBDON JR, 1984, POLYMER, V25, P1633, DOI 10.1016/0032-3861(84)90159-9
   EBDON JR, 1986, POLYMER, V27, P1807, DOI 10.1016/0032-3861(86)90280-6
   EBDON JR, 1986, ADV CHEM SERIES, V211
   HELMER JD, 1969, J APPL POLYM SCI, V13, P2112
   KLEIN PG, 1982, THESIS LANCASTER U L
   LEE CL, 1969, POLYM PREPR AM CHEM, V10, P1311
   LEGRAND DG, 1970, POLYM PREPR AM CHEM, V11, P442
   MANZOOR K, 1994, THESIS LANCASTER U L
   OMALLY JJ, 1977, POLYM PREPR, V18, P11
   WARD RS, 1980, ORG COAT PLAST CHEM, V42, P227
NR 19
TC 8
Z9 9
U1 0
U2 1
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-8995
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD JAN 31
PY 1995
VL 55
IS 5
BP 733
EP 740
DI 10.1002/app.1995.070550509
PG 8
WC Polymer Science
SC Polymer Science
GA QC555
UT WOS:A1995QC55500009
DA 2018-10-20
ER

PT S
AU Piel, H
AF Piel, H
BE DewHughes, D
TI Future prospects of applied superconductivity in Europe
SO APPLIED SUPERCONDUCTIVITY 1995, VOLS. 1 AND 2: VOL 1: PLENARY TALKS AND
   HIGH CURRENT APPLICATIONS; VOL 2: SMALL SCALE APPLICATIONS
SE INSTITUTE OF PHYSICS CONFERENCE SERIES
LA English
DT Article; Proceedings Paper
CT 2nd European Conference on Applied Superconductivity (EUCAS 1995)
CY JUL 03-06, 1995
CL EDINBURGH, SCOTLAND
SP Ansaldo Energia, BICC Cent Tech Unit, City Edinburgh Dist Council, Cookson, Dept Trade & Ind, European Mat Res Soc, Engn & Phys Sci Res Council, GEC Alsthom NV, Lothian & Edinburgh Enterprise Ltd, Merck Ind Chem, NKT Res Ctr, Oxford Instruments, Quantum Design, Natl Grid Co plc, Royal Soc, Royal Soc Edinburgh, Brit Cryogen Council, Inst Elect Engn
AB This contribution is a personal view of the current state and the future evolution of applied superconductivity with a specific focus on the European scene. It is approached by giving some examples from the history of applied superconductivity and by sketching the present market for products using superconducting components. Today's superconducting NMR, MRI and SQUID systems and the large scale projects of the near future, especially in the field of particle accelerators and energy technology, are exclusively based on metallic superconductors. The High Temperature Superconductors (HTS) still have a long way to go before they will have a noticeable impact on the superconductivity market, but quite a few practical uses of high Tc components are beginning to take shape. HTS bulk materials in the form of current leads are the first products which are used in commercial systems. The fabrication and application of HTS Josephson junctions is progressing and may find uses in the fields of biomedical research and non destructive evaluation. ITS wires and tapes are being tested in cryogen free or very high field magnets and in energy technology. One particular application area which is carrying much hope for the introduction of HTS materials to present technology will be described in more detail. It is the practical use of superconductors in high frequency fields. Epitaxial HTS films are expected to have their first wide spread use in mobile communication and rf signal sensing. In closing the early activities of a new European organization called CONECTUS are introduced. Tn this context an updated forecast of the size of the future superconductivity world market will be given.
RP Piel, H (reprint author), BERG UNIV GESAMTHSCH WUPPERTAL,INST SCI MAT,D-42097 WUPPERTAL,GERMANY.
CR Cavallari G., 1994, P EPAC 94, P2042
   ELIAS LR, 1976, PHYS REV LETT, V36, P71
   FAIRBANK WM, 1949, PHYS REV, V76, P1106, DOI 10.1103/PhysRev.76.1106
   FOLTYN SR, 1995, P INT WORKSHOP SUPER
   GRUNDER H, COMMUNICATION
   HEINRICHS H, 1995, APPLIED SUPERCONDUCT, V1, P627
   IJIMA Y, 1993, J APPL PHYS, V74, P1905
   KOMAREK P, 1995, APPLIED SUPERCONDUCT, V1, P9
   LEROY D, P ASC 94
   London H, 1934, NATURE, V133, P497, DOI 10.1038/133497b0
   MATTHIAS BT, 1954, PHYS REV, V95, P1435, DOI 10.1103/PhysRev.95.1435
   MAXWELL E, 1948, PHYS REV, V74, P1234
   PIPPARD AB, 1947, P ROY SOC LOND A MAT, V191, P371
   ROSNER CH, COMMUNICATION
   SATO KI, 1995, UNPUB PHYSICA B
   SCHWETTMANN HA, 1988, NEAR ZERO, P376
   WOOD M, P ASC 94
NR 17
TC 5
Z9 5
U1 0
U2 7
PU IOP PUBLISHING LTD
PI BRISTOL
PA TECHNO HOUSE, REDCLIFFE WAY, BRISTOL, ENGLAND BS1 6NX
SN 0951-3248
BN 0-7503-0348-4
J9 INST PHYS CONF SER
PY 1995
VL 148
BP 1
EP 8
PG 8
WC Physics, Applied; Physics, Condensed Matter
SC Physics
GA BE67G
UT WOS:A1995BE67G00001
DA 2018-10-20
ER

PT J
AU LABOW, RS
   ERFLE, DJ
   SANTERRE, JP
AF LABOW, RS
   ERFLE, DJ
   SANTERRE, JP
TI NEUTROPHIL-MEDIATED DEGRADATION OF SEGMENTED POLYURETHANES
SO BIOMATERIALS
LA English
DT Article
DE NEUTROPHILS; CELL CULTURE; ELASTASE; POLYURETHANES; DEGRADATION
ID BIOMATERIALS; ACTIVATION
AB The biostability of polyurethanes was evaluated using a human neutrophil cell culture. The polymers were synthesized with C-14 radiolabelled components incorporated into the polyurethane chain and the amount of radiolabel released during exposure to cells and medium was used as a marker for material degradation. The effect of diisocyanate, soft segment and chain extender chemistry on the susceptibility of polymer degradation was examined. All polymers showed a release of material into the tissue culture medium which was unrelated to the cells. A significant cell-dependent release of radiolabel-containing material was found from one of the polymers (a polyester urea-urethane, TDI/ PCL/ED) which increased linearly up to 96 h. The polyether-containing polyurethanes showed no significant cell-mediated degradation under similar conditions as measured by radiolabel release. Scanning electron microscopy (SEM) showed that the cells adhered to the different polyurethanes. However, no effect of neutrophils on polymer structure could be detected by this technique. The cellular response to each polymer was evaluated by measuring release of elastase-like activity (ELA) into the tissue culture media. After 24 h TDI/PCL/ED showed the highest levels of ELA in the tissue culture medium. When TDI/PCL/ED was incubated with commercial elastase in vitro, a significant release of radiolabel was found which was comparable to the amount of radiolabelled material released from this polymer in contact with the neutrophils in culture. No significant amount of radiolabel was released from the corresponding polyether material (TDI/PTMO/ED) under similar conditions. This study has identified one enzymatic activity (elastase) as a possible contributor to the deterioration of biomedical implants in vivo in that the polymer which elicited the greatest response of ELA also showed release of radiolabel when incubated with elastase in vitro. The use of a live cell culture system to assess the susceptibility of polyurethanes to degradation has provided a significant step forward in understanding the mechanism of biodegradation.
C1 UNIV OTTAWA,DEPT BIOCHEM,OTTAWA,ON,CANADA.
RP LABOW, RS (reprint author), UNIV OTTAWA,OTTAWA CIVIC HOSP,INST HEART,DIV CARDIOVASC DIVICES,1053 CARLING AVE,OTTAWA,ON K1Y 4E9,CANADA.
CR BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77
   FAYMONVILLE ME, 1991, J THORAC CARDIOV SUR, V102, P309
   GRIESSER HJ, 1991, POLYM DEGRAD STABIL, V33, P329, DOI 10.1016/0141-3910(91)90080-B
   JANOFF A, 1969, BIOCHEM J, V114, P157, DOI 10.1042/bj1140157
   KELLEY JL, 1987, EXP MOL PATHOL, V46, P266, DOI 10.1016/0014-4800(87)90049-9
   KRAUSE TJ, 1993, J BIOMED MATER RES, V27, P65, DOI 10.1002/jbm.820270109
   LABOW RS, 1994, J BIOMAT SCI-POLYM E, V6, P169, DOI 10.1163/156856294X00293
   Lelah M. D., 1986, POLYURETHANES MED
   PAPATHEOFANIS FJ, 1991, J BIOMED MATER RES, V25, P761, DOI 10.1002/jbm.820250606
   REMES A, 1992, BIOMATERIALS, V13, P731, DOI 10.1016/0142-9612(92)90010-L
   RIGDON RH, 1975, CRIT REV FOOD SCI NU, V7, P435
   ROULIS M, 1990, ARTERIOSCLEROSIS, V10, P246
   SALTHOUSE TN, 1976, J BIOMED MATER RES, V10, P197, DOI 10.1002/jbm.820100204
   SANTERRE JP, 1993, J BIOMED MATER RES, V27, P97, DOI 10.1002/jbm.820270113
   SANTERRE JP, 1994, IN PRESS J BIOMED MA, V28
   SCHMIDT JA, 1992, BIOMATERIALS, V13, P1059, DOI 10.1016/0142-9612(92)90138-E
   SUTHERLAND K, 1993, J CLIN INVEST, V92, P2360, DOI 10.1172/JCI116841
   Szycher M, 1988, J Biomater Appl, V3, P297, DOI 10.1177/088532828800300207
   Thoma R J, 1987, J Biomater Appl, V1, P449
   WACHTFOGEL YT, 1987, BLOOD, V69, P324
NR 20
TC 47
Z9 48
U1 1
U2 6
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 1995
VL 16
IS 1
BP 51
EP 59
DI 10.1016/0142-9612(95)91096-H
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA QB054
UT WOS:A1995QB05400008
PM 7718693
DA 2018-10-20
ER

PT S
AU Scranton, AB
   Rangarajan, B
   Klier, J
AF Scranton, AB
   Rangarajan, B
   Klier, J
BE Peppas, NA
   Langer, RS
TI Biomedical applications of polyelectrolytes
SO BIOPOLYMERS II
SE Advances in Polymer Science
LA English
DT Review
ID GLASS-IONOMER CEMENTS; MODEL MEMBRANE SYSTEMS; SHEAR BOND STRENGTH;
   POLY(METHACRYLIC ACID) GELS; POLY-ELECTROLYTE COMPLEXES; CONTROLLED DRUG
   DELIVERY; PHOSPHOLIPID VESICLE MEMBRANES; GLUCOSE-SENSITIVE MEMBRANES;
   WATER-SOLUBLE COPOLYMERS; PRE-IRRADIATION METHOD
AB Polyelectrolytes are used in a variety of biomedical systems, including dental adhesives and restorations; controlled release devices; polymeric drugs, prodrugs, and adjuvants; and biocompatible materials. This article provides a review of biomedical applications of polyelectrolytes with emphasis on recent developments. For completeness, an overview of the methods for polyelectrolyte synthesis is provided along with a description of the unique properties of polyelectrolyte solutions, gels, and complexes which make them useful in biomedical applications. The discussion of dental materials focuses on the recent developments in glass-ionomer cements and novel organic polyelectrolyte adhesives since these materials are replacing the traditional zinc carboxylates. The section on controlled release applications includes a brief overview of recent developments in the mature areas of coatings, matrices and binders; and provides more in-depth discussions of the advanced responsive, bioadhesive, and liposomal systems that have emerged in recent years. Finally, descriptions of the recent work in polyelectrolytes as biocompatible materials as well as drugs or prodrugs are provided.
C1 DOW CHEM CO USA, CENT RES, ADV POLYMER SYST LAB, MIDLAND, MI 48640 USA.
RP Scranton, AB (reprint author), MICHIGAN STATE UNIV, DEPT CHEM ENGN, E LANSING, MI 48824 USA.
CR AGABEYOGLU IT, 1986, DRUG DEV IND PHARM, V12, P569, DOI 10.3109/03639048609048029
   AKASHI M, 1990, ADV POLYM SCI, V97, P107
   Akelah A., 1990, FUNCTIONALIZED POLYM
   ALBIN G, 1985, Journal of Controlled Release, V2, P153, DOI 10.1016/0168-3659(85)90041-0
   Albin G, 1990, PULSED SELF REGULATE, P159
   ALBIN G W, 1987, Journal of Controlled Release, V6, P267, DOI 10.1016/0168-3659(87)90081-2
   ALEKSEEV KV, 1991, NOVEL DRUG FORMULATI, P59
   ALEXANDROWICZ Z, 1963, J POLYM SCI PART A, V1, P3231, DOI 10.1002/pol.1963.100011017
   ALEYAMMA AJ, 1990, BIOMIMETIC POLYMERS, P191
   ALEYAMMA AJ, 1988, POLYM MATER SCI ENG, V59, P692
   ALHAIQUE F, 1985, J PHARM PHARMACOL, V37, P310, DOI 10.1111/j.2042-7158.1985.tb05072.x
   ALICO KV, 1984, MAKROMOL CHEM-RAPID, V5, P345
   Amsel L.P., 1984, PHARM TECH, V8, P28
   ANBAR M, 1971, J DENT RES, V50, P778, DOI 10.1177/00220345710500033801
   ANBAR M, 1974, J DENT RES, V53, P879, DOI 10.1177/00220345740530041901
   ANDERSON JM, 1985, CRC CRITICAL REV BIO, P111
   ANDRADE JK, 1987, T AM SOC ART INT ORG, V83, P75
   ARMSTRONG RW, 1969, ENCYCLOPEDIA POLYMER, V10, P781
   ARTURSSON P, 1989, Advanced Drug Delivery Reviews, V3, P165, DOI 10.1016/0169-409X(89)90009-4
   ASMUSSEN E, 1991, J DENT RES, V70, P1290, DOI 10.1177/00220345910700091101
   ASMUSSEN E, 1993, J DENT RES, V72, P558, DOI 10.1177/00220345930720030101
   AZORI M, 1986, MAKROMOL CHEM, V187, P303
   AZZUOLI G, 1987, BIOMATERIALS, V8, P61, DOI 10.1016/0142-9612(87)90032-9
   BABA M, 1990, ANTIMICROB AGENTS CH, V34, P134, DOI 10.1128/AAC.34.1.134
   BAJORAS G, 1986, POLYM J, V18, P955, DOI 10.1295/polymj.18.955
   BAMFORD CH, 1983, EUR POLYM J, V19, P1027, DOI 10.1016/0014-3057(83)90068-X
   BANSLEBEN DA, 1985, POLYM PREPRINTS, V26, P106
   BARBUCCI R, 1991, J CONTROL RELEASE, V17, P79, DOI 10.1016/0168-3659(91)90133-X
   BARBUCCI R, 1987, ADV BIOMEDICAL POLYM, P259
   BARKHORDAR R A, 1988, Journal of Dental Research, V67, P263
   BARRY TI, 1979, J DENT RES, V58, P1072, DOI 10.1177/00220345790580030801
   BARTELS T, 1981, J POLYM SCI POL CHEM, V19, P127, DOI 10.1002/pol.1981.170190113
   BAUDUIN G, 1981, MAKROMOL CHEM, V182, P773
   Bayne S C, 1992, Adv Dent Res, V6, P65
   BEKTUROV E, 1980, ADV POLYM SCI, V41, P100
   Ben-Amar A, 1989, Am J Dent, V2, P175
   BENOIT H, 1954, J PHYS CHEM-US, V57, P958
   BENVENUTI M, 1989, DEV HEMATOL, V23, P259
   BERG HJ, 1988, J DENT RES, V67, P280
   BILLINGTON RW, 1990, BRIT DENT J, V169, P164, DOI 10.1038/sj.bdj.4807311
   Billmeyer FW, 1984, TXB POLYM SCI
   BLAGOJEVIC B, 1989, AUST DENT J, V33, P320
   BLANCHON S, 1991, INT J PHARM, V72, P1, DOI 10.1016/0378-5173(91)90374-W
   BODDE HE, 1990, J CONTROL RELEASE, V13, P225, DOI 10.1016/0168-3659(90)90012-I
   BORDEN KA, 1988, MACROMOLECULES, V21, P2649, DOI 10.1021/ma00186a059
   BORDEN KA, 1987, MACROMOLECULES, V20, P454, DOI 10.1021/ma00168a046
   BORUE VY, 1988, MACROMOLECULES, V21, P3240
   BOTTENBERG P, 1991, J PHARM PHARMACOL, V43, P457, DOI 10.1111/j.2042-7158.1991.tb03514.x
   BOUSSOUIRA B, 1987, J MACROMOL SCI CHEM, VA24, P137, DOI 10.1080/00222338708068127
   Bowen R L, 1992, Adv Dent Res, V6, P44
   Bowen R L, 1987, Int Dent J, V37, P158
   BOWEN RL, 1985, INT DENT J, V35, P155
   BOWEN RL, 1984, IND ENG CHEM PROD RD, V23, P78, DOI 10.1021/i300013a015
   BRACKETT WW, 1992, J PROSTHET DENT, V67, P59, DOI 10.1016/0022-3913(92)90050-K
   BRACKETT WW, 1989, J PROSTHET DENT, V62, P261, DOI 10.1016/0022-3913(89)90328-4
   BRADY JE, 1984, J AM CHEM SOC, V106, P4279, DOI 10.1021/ja00327a044
   Brannon-Peppas L., 1990, ABSORBENT POLYM TECH, V8, P45, DOI DOI 10.1016/B978-0-444-88654-5.50008-X
   BRANNONPEPPAS L, 1989, J CONTROL RELEASE, V8, P267, DOI 10.1016/0168-3659(89)90048-5
   BREMECKER KD, 1984, J PHARM SCI, V73, P548, DOI 10.1002/jps.2600730429
   BROOK I M, 1991, Clinical Materials, V7, P295, DOI 10.1016/0267-6605(91)90073-O
   BROOK IM, 1992, BIOMATERIALS, V13, P721, DOI 10.1016/0142-9612(92)90134-A
   BRUCK SD, 1988, CRIT REV THER DRUG, V5, P171
   BRUNE D, 1982, SCAND J DENT RES, V90, P409
   BRUNE D, 1984, SCAND J DENT RES, V92, P156
   BRYDSON JA, 1982, PLASTIC MATERIALS
   BUCHHOLZ FL, 1990, ABSORBENT POLYM TECH, P23
   BURAIE AN, 1991, ALEXANDRIA J PHARM S, V5, P37
   BURGESS DJ, 1991, POLYM PREPR, V32, P600
   BUTLER GB, 1991, ACS SYM SER, V467, P25
   BUTTON GL, 1985, J PROSTHET DENT, V53, P34, DOI 10.1016/0022-3913(85)90060-5
   CANDAU F, 1986, COLLOID POLYM SCI, V264, P676, DOI 10.1007/BF01469528
   CAPAN Y, 1989, PHARM IND, V51, P443
   CARRALE CE, 1982, ACS S SER, V186
   Chang R K, 1988, J Biomater Appl, V3, P80, DOI 10.1177/088532828800300104
   CHANG R-K, 1987, Pharmaceutical Technology, V11, P64
   CHANG RK, 1990, PHARM TECH, V14, P62
   CHEN RS, 1989, J ADHES SCI TECHNOL, V3, P49, DOI 10.1163/156856189X00047
   CHIEN YW, 1990, MED RES REV, V10, P477, DOI 10.1002/med.2610100405
   CHIEN YW, 1983, DRUG DEV IND PHARM, V9, P497, DOI 10.3109/03639048309044691
   CHIGIRA H, 1991, DENT MATER, V7, P103, DOI 10.1016/0109-5641(91)90054-3
   CHIGIRA H, 1988, JPN J CONSERV DENT, V31, P667
   CHITNIS VS, 1991, DRUG DEV IND PHARM, V17, P879, DOI 10.3109/03639049109040824
   CHOULIS NH, 1975, J PHARM SCI, V64, P1033, DOI 10.1002/jps.2600640634
   CHUNG DW, 1986, J AM CHEM SOC, V108, P5823, DOI 10.1021/ja00279a026
   COLOMBO P, 1993, ADV DRUG DELIVER REV, V11, P37, DOI 10.1016/0169-409X(93)90026-Z
   COOK WD, 1982, BIOMATERIALS, V3, P232, DOI 10.1016/0142-9612(82)90025-4
   COOK WD, 1983, BIOMATERIALS, V4, P85, DOI 10.1016/0142-9612(83)90045-5
   COOLEY RL, 1991, J PROSTHET DENT, V66, P773, DOI 10.1016/0022-3913(91)90413-Q
   CRAIG DQM, 1992, P INT S CONTROL REL, V19, P260
   CRAIG RG, 1983, DENTAL MATERIALS PRO
   CRANFIELD M, 1982, J DENT, V10, P333, DOI 10.1016/0300-5712(82)90028-8
   Crim G A, 1993, Am J Dent, V6, P192
   CRIM GA, 1993, J PROSTHET DENT, V69, P561, DOI 10.1016/0022-3913(93)90281-R
   CRISP S, 1974, J DENT RES, V53, P1414, DOI 10.1177/00220345740530062001
   CRISP S, 1979, J DENT, V7, P304, DOI 10.1016/0300-5712(79)90143-X
   CRISP S, 1974, J DENT RES, V53, P1408, DOI 10.1177/00220345740530061901
   CRISP S, 1976, J DENT RES, V55, P1023, DOI 10.1177/00220345760550060401
   CULBERTSON BM, 1985, ENCY POLYM SCI ENG, V11, P740
   Davis E L, 1993, Am J Dent, V6, P127
   DAVIS M, 1986, INT J PHARM, V28, P157, DOI 10.1016/0378-5173(86)90241-3
   DAVIS MB, 1986, DRUG DEV IND PHARM, V12, P1419, DOI 10.3109/03639048609065869
   DAVIS RM, 1984, THESIS PRINCETON U P
   Davison CJ, 1990, J BIOACT COMPAT POL, V5, P267, DOI 10.1177/088391159000500303
   De Moor C.P., 1989, P INT S CONTROLLED R, V16, P157
   DEGROOT K, 1980, J DENT RES, V59, P1493, DOI 10.1177/00220345800590090601
   DeSchepper E J, 1989, Am J Dent, V2, P51
   DEVLIN BP, 1986, MACROMOLECULES, V19, P2465, DOI 10.1021/ma00163a028
   DEVLIN BP, 1987, POLYM PREPRINTS, V28
   DEVRIES ME, 1988, J BIOMED MATER RES, V22, P1023, DOI 10.1002/jbm.820221106
   DILTS WE, 1985, J PROSTHET DENT, V53, P505, DOI 10.1016/0022-3913(85)90635-3
   DOMINQUEZ L, 1987, MAKROMOL CHEM-RAPID, V8, P151
   DONARUMA LG, 1980, ANIONIC POLYM DRUGS, V1
   DONG C, 1991, J CONTROL RELEASE, V17, P217, DOI 10.1016/0168-3659(91)90140-9
   DRAGAN S, 1981, J POLYM SCI POL CHEM, V19, P2869, DOI 10.1002/pol.1981.170191120
   DRAGAN S, 1991, POLYM BULL, V27, P17, DOI 10.1007/BF00296319
   DUMITRIU S, 1992, POLYM MED, P115
   Dumitriu S, 1990, J BIOACT COMPAT POL, V5, P310, DOI 10.1177/088391159000500307
   DUNN RL, 1991, ACS SYM SER, V469, P11
   DURRANI MJ, 1992, P INT S CONTROL REL, V19, P811
   Eick J D, 1992, Quintessence Int, V23, P43
   ELLIS J, 1991, POLYM INT, V24, P221, DOI 10.1002/pi.4990240404
   ELLIS J, 1990, J MATER SCI LETT, V9, P1058, DOI 10.1007/BF00727876
   ELLIS J, 1991, Clinical Materials, V7, P341, DOI 10.1016/0267-6605(91)90079-U
   EUM KM, 1989, MACROMOLECULES, V22, P2755, DOI 10.1021/ma00196a038
   FERRITTO MS, 1988, MACROMOLECULES, V21, P3117, DOI 10.1021/ma00188a036
   FERRUTI P, 1985, POLYMER, V26, P1336, DOI 10.1016/0032-3861(85)90309-X
   FERRUTI P, 1984, ADV POLYM SCI, V58, P55
   FINI A, 1987, MAKROMOL CHEM, V188, P1959
   FIRESTONE BA, 1988, POLYM COMMUN, V29, P204
   FIXMAN M, 1978, MACROMOLECULES, V11, P863, DOI 10.1021/ma60065a004
   FIXMAN M, 1982, J CHEM PHYS, V76, P6346, DOI 10.1063/1.443039
   FORSS H, 1990, SCAND J DENT RES, V98, P173
   FORSTEN L, 1977, SCAND J DENT RES, V85, P503
   FORSTEN L, 1991, SCAND J DENT RES, V99, P241
   FOUGNOT C, 1984, BIOMATERIALS, V5, P94, DOI 10.1016/0142-9612(84)90008-5
   FOUGNOT C, 1979, ANN BIOMED ENG, V7, P441, DOI 10.1007/BF02364220
   FOUGNOT C, 1979, ANN BIOMED ENG, V7, P429, DOI 10.1007/BF02364219
   FUKUMORI Y, 1988, CHEM PHARM BULL, V36, P4927
   Garcia-Godoy F, 1988, Am J Dent, V1, P97
   Garcia-Godoy F, 1991, Am J Dent, V4, P223
   Garcia-Godoy F, 1992, Am J Dent, V5, P283
   Gebelein C.G., 1987, ADV BIOMEDICAL POLYM, P277
   GEKKO K, 1981, J BIOCHEM-TOKYO, V90, P39, DOI 10.1093/oxfordjournals.jbchem.a133468
   GEKKO K, 1981, BIOCHEMISTRY-US, V20, P4667, DOI 10.1021/bi00519a023
   GHANEM A, 1980, PHARM ACTA HELV, V55, P61
   GIESELMAN MB, 1992, MACROMOLECULES, V25, P4832, DOI 10.1021/ma00044a056
   GLASS JE, 1989, ACS DIVISION POLYM C, V30, P387
   GOETHALS EJ, 1980, POLYM AMINES AMMONIU
   GRAHAM NB, 1986, NATO ASI SERIES E, V106, P170
   GRASEL TG, 1989, J BIOMED MATER RES, V23, P311, DOI 10.1002/jbm.820230304
   GREENLEY RZ, 1991, ACS SYM SER, V469, P213
   GREENWALD HL, 1980, HDB WATER SOLUBLE GU, P17
   GRIGNON J, 1980, J APPL POLYM SCI, V25, P2829, DOI 10.1002/app.1980.070251215
   Grodzinsky AJ, 1990, PULSED SELF REGULATE, P47
   GROSS JR, 1990, ABSORBENT POLYM TECH, P3
   Gross L., 1966, CHEM PHYSICS IONIC S, P361
   GUMOWSKI F, 1987, Pharmaceutical Technology, V11, P28
   GURNY R, 1987, Journal of Controlled Release, V6, P367, DOI 10.1016/0168-3659(87)90090-3
   Haddad D, 1992, Am J Dent, V5, P286
   HAN DK, 1991, J BIOMED MATER RES, V25, P561, DOI 10.1002/jbm.820250502
   HARADA J, 1992, ACS SYM SER, V480, P80
   HARIHARAN D, 1992, P INT S CONTR REL BI, V19, P367
   HARRIS D, 1990, BIOMATERIALS, V11, P652, DOI 10.1016/0142-9612(90)90023-J
   HARRIS D, 1990, J CONTROL RELEASE, V12, P55, DOI 10.1016/0168-3659(90)90183-T
   HARRIS D, 1990, J CONTROL RELEASE, V12, P45, DOI 10.1016/0168-3659(90)90182-S
   HASA J, 1975, J POLYM SCI POL PHYS, V13, P263, DOI 10.1002/pol.1975.180130204
   HASA J, 1975, J POLYM SCI POL PHYS, V13, P253, DOI 10.1002/pol.1975.180130203
   HASEGAWA T, 1989, DENT MATER, V5, P150, DOI 10.1016/0109-5641(89)90002-X
   HASSAN RM, 1993, J APPL POLYM SCI, V47, P1649, DOI 10.1002/app.1993.070470912
   HATIBOVICKOFMAN S, 1991, SWED DENT J, V15, P253
   Hayakawa T, 1988, Dent Mater J, V7, P19
   HELLER J, 1993, CRIT REV THER DRUG, V10, P253
   HELMUS MN, 1984, J BIOMED MATER RES, V18, P165, DOI 10.1002/jbm.820180207
   HERMANS JJ, 1948, RECL TRAV CHIM PAY B, V67, P761
   HEWLETT ER, 1991, J PROSTHET DENT, V66, P767, DOI 10.1016/0022-3913(91)90412-P
   HEYS RJ, 1991, J DENT RES, V70, P55, DOI 10.1177/00220345910700010901
   Hicks M J, 1986, Quintessence Int, V17, P527
   Hicks M J, 1992, Am J Dent, V5, P329
   HIGUCHI S, 1986, MACROMOLECULES, V19, P2263, DOI 10.1021/ma00162a026
   HILL RG, 1988, J DENT RES, V67, P1446, DOI 10.1177/00220345880670120101
   HILL RG, 1989, J MATER SCI, V24, P363, DOI 10.1007/BF00660982
   HILL RG, 1991, J MATER SCI, V26, P67, DOI 10.1007/BF00576034
   HINOURA K, 1991, J DENT RES, V70, P1542, DOI 10.1177/00220345910700121301
   HIRANO S, 1987, ADV BIOMEDICAL POLYM, P285
   HODD KA, 1976, BRIT POLYM J, V8, P131, DOI 10.1002/pi.4980080405
   Horbett T.A., 1984, POLYM BIOMATERIALS, P193
   HORBETT TA, 1983, POLYM PREPR-ACS, V24, P34
   HSU YG, 1991, MAKROMOL CHEM, V192, P999
   HUNKELER D, 1992, ACS SYM SER, V480, P24
   IDOL WK, 1986, J MEMBRANE SCI, V28, P269, DOI 10.1016/S0376-7388(00)82039-6
   IHATA J, 1988, J POLYM SCI POL CHEM, V26, P167, DOI 10.1002/pola.1988.080260116
   IHATA J, 1988, J POLYM SCI POL CHEM, V26, P177, DOI 10.1002/pola.1988.080260117
   IHATA J, 1988, J POLYM SCI POL CHEM, V26, P187, DOI 10.1002/pola.1988.080260118
   Iioka A, 1989, Dent Mater J, V8, P236
   Ikada Y., 1984, POLYM BIOMATERIALS, P135
   IMAI Y, 1991, J DENT RES, V70, P1088, DOI 10.1177/00220345910700071401
   IMENSON AP, 1983, 2ND GUMS STAB FOOD I, V2, P189
   ISHIGAKI I, 1982, J APPL POLYM SCI, V27, P1033, DOI 10.1002/app.1982.070270322
   ISHIGAKI I, 1982, J APPL POLYM SCI, V27, P1043, DOI 10.1002/app.1982.070270323
   ISHIHARA K, 1992, J BIOMED MATER RES, V26, P937, DOI 10.1002/jbm.820260708
   ISHIHARA K, 1984, POLYM J, V16, P647, DOI 10.1295/polymj.16.647
   ISHIHARA K, 1986, J POLYM SCI POL LETT, V24, P413, DOI 10.1002/pol.1986.140240809
   ISHIHARA K, 1984, POLYM J, V16, P625, DOI 10.1295/polymj.16.625
   ISHIHARA K, 1989, J BIOMED MATER RES, V23, P1475, DOI 10.1002/jbm.820231209
   ISHIHARA K, 1983, MAKROMOL CHEM-RAPID, V4, P327
   Ishihara K., 1988, P INT S CONTROLLED R, V15, P168
   ITO H, 1986, J APPL POLYM SCI, V31, P2491, DOI 10.1002/app.1986.070310810
   ITO Y, 1986, J BIOMED MATER RES, V20, P1157, DOI 10.1002/jbm.820200808
   ITO Y, 1989, J CONTROL RELEASE, V10, P195, DOI 10.1016/0168-3659(89)90063-1
   ITO Y, 1990, POLYMER, V31, P2157, DOI 10.1016/0032-3861(90)90090-L
   ITO Y, 1986, J BIOMED MATER RES, V20, P1139, DOI 10.1002/jbm.820200807
   ITO Y, 1986, J BIOMED MATER RES, V20, P1017, DOI 10.1002/jbm.820200715
   ITO Y, 1992, SYNTHESIS BIOCOMPOSI, P137
   ITO Y, 1984, POLYM PREPAR JPN, V33, P2163
   IWATA H, 1988, J MEMBRANE SCI, V38, P185, DOI 10.1016/S0376-7388(00)80879-0
   Iwata H., 1988, P INT S CONTR REL BI, V15, P170
   JOHNSON M, 1985, EUR POLYM J, V21, P147, DOI 10.1016/0014-3057(85)90045-X
   JOHNSTON AD, 1989, J DENT RES, V68, P1337, DOI 10.1177/00220345890680091001
   JONCK L M, 1992, Clinical Materials, V9, P85, DOI 10.1016/0267-6605(92)90053-V
   JONCK LM, 1989, CLIN MATER, V4, P85
   JOZEFOWICZ M, 1985, AM SOC ARTIF INTERN, V8, P218
   Kabanov V., 1984, MACROMOL CHEM S, P259
   KABANOV VA, 1986, MAKROMOL CHEM-M SYMP, V1, P101, DOI 10.1002/masy.19860010110
   KABRA B, 1989, POLYM PREPR, V30, P490
   KATAOKA K, 1979, MAKROMOL CHEM, V180, P65
   KATAOKA K, 1980, MAKROMOL CHEM, V181, P1363
   Katchalsky A., 1966, CHEM PHYSICS IONIC S, P295
   KATO A, 1983, BIORHEOLOGY, V20, P593
   Kato A, 1984, J Microencapsul, V1, P105, DOI 10.3109/02652048409038514
   KATO A, 1985, POLYM MATER SCI ENG, V53, P654
   KATO A, 1987, ADV BIOMEDICAL POLYM, P285
   KATO A, 1987, POLYM SCI TECHNOL, V35, P299
   KAWASHIMA Y, 1991, INT J PHARM, V75, P25, DOI 10.1016/0378-5173(91)90247-L
   KAWASHIMA Y, 1985, J PHARM SCI, V74, P264, DOI 10.1002/jps.2600740308
   KAZANSKII KS, 1992, ADV POLYM SCI, V104, P97
   KHOKHLOV AR, 1982, POLYMER, V23, P1742, DOI 10.1016/0032-3861(82)90116-1
   KHOKHLOV AR, 1980, J PHYS A-MATH GEN, V13, P979, DOI 10.1088/0305-4470/13/3/030
   KHOSLA R, 1987, J PHARM PHARMACOL, V39, P47, DOI 10.1111/j.2042-7158.1987.tb07161.x
   KIKUCHI Y, 1988, B CHEM SOC JPN, V61, P2943, DOI 10.1246/bcsj.61.2943
   KIKUCHI Y, 1988, J APPL POLYM SCI, V35, P259, DOI 10.1002/app.1988.070350119
   KIKUCHI Y, 1980, MAKROMOL CHEM-RAPID, V1, P253
   KIM S W, 1985, Critical Reviews in Biocompatibility, V1, P229
   KIMBALL GE, 1957, J PHYS CHEM-US, V56, P47
   KINOSHITA T, 1983, J MACROMOL SCI PHYS, VB22, P1, DOI 10.1080/00222348308215489
   KISLALIOGLU MS, 1991, J PHARM SCI, V80, P799, DOI 10.1002/jps.2600800820
   KIYOMURA M, 1987, J JPN DENT MATER, V6, P719
   KLIER J, 1990, MACROMOLECULES, V23, P4944, DOI 10.1021/ma00225a011
   KOBAYASHI S, 1983, MAKROMOL CHEM, V184, P793
   KOKUBO T, 1991, J CONTROL RELEASE, V17, P69
   KONAK C, 1989, POLYMER, V30, P677, DOI 10.1016/0032-3861(89)90154-7
   KONO K, 1990, J MEMBRANE SCI, V50, P85, DOI 10.1016/S0376-7388(00)80888-1
   KONO K, 1990, BIOCHEMISTRY-US, V29, P3631, DOI 10.1021/bi00467a007
   KORSHAK VV, 1985, ENVIRON PROT ENG, V11, P103
   KOST J, 1985, J BIOMED MATER RES, V19, P1117, DOI 10.1002/jbm.820190920
   KOST J, 1991, ADV DRUG DELIVER REV, V6, P19
   KOTIN L, 1961, J AM CHEM SOC, V83, P1026, DOI 10.1021/ja01466a003
   KOTZ J, 1992, ACTA POLYM, V43, P193, DOI 10.1002/actp.1992.010430401
   KOTZ J, 1991, ACTA POLYM, V42, P28, DOI 10.1002/actp.1991.010420109
   KOTZ J, 1993, MAKROMOL CHEM, V194, P397
   KOU JH, 1988, PHARMACEUT RES, V5, P592, DOI 10.1023/A:1015998131160
   KRABBENDAM CA, 1987, J DENT, V15, P77, DOI 10.1016/0300-5712(87)90004-2
   KUDO S, 1992, MAKROMOL CHEM-RAPID, V13, P545
   KULKARNI PV, 1990, J MACROMOL SCI R M C, V30, P364
   KWON GS, 1991, J COLLOID INTERF SCI, V143, P501, DOI 10.1016/0021-9797(91)90283-E
   KWON IC, 1991, J CONTROL RELEASE, V17, P149, DOI 10.1016/0168-3659(91)90054-H
   KWON IC, 1991, NATURE, V354, P291, DOI 10.1038/354291a0
   LEHMANN K, 1984, ACTA PHARM FENN, V93, P55
   LEHMANN K, 1989, CHEM APPL PROPERTIES, P153
   LEHMANN K, 1985, P INT S CONTROLLED R, V12, P361
   Leung S. H., 1988, J CONTROL RELEASE, V5, P223
   LEVI M, 1989, POLYM THEIR PROPERTI, P379
   LI FM, 1991, J BIOACT COMPAT POL, V6, P142, DOI 10.1177/088391159100600203
   LI SP, 1991, DRUG DEV IND PHARM, V17, P1655
   LIFSON S, 1957, J CHEM PHYS, V27, P700, DOI 10.1063/1.1743817
   LIN A, 1992, J DENT RES, V71, P1836, DOI 10.1177/00220345920710111401
   LIN SY, 1991, PHARMACEUT RES, V8, P1137, DOI 10.1023/A:1015850301214
   LINAKIS JG, 1992, PHARMACOL TOXICOL, V70, P38, DOI 10.1111/j.1600-0773.1992.tb00422.x
   Lindeque B. G. P., 1993, Clinical Materials, V14, P49, DOI 10.1016/0267-6605(93)90047-B
   LIPPMAN N, 1988, Journal of Dental Research, V67, P263
   LONGER MA, 1985, J PHARM SCI, V74, P406, DOI 10.1002/jps.2600740408
   Lynch E, 1989, J Ir Dent Assoc, V35, P66
   MACHIDA Y, 1979, CHEM PHARM BULL, V27, P93
   MAEDA M, 1991, ANN NY ACAD SCI, V618, P362, DOI 10.1111/j.1749-6632.1991.tb27256.x
   MAEDA M, 1988, J AM CHEM SOC, V110, P7455, DOI 10.1021/ja00230a028
   MAEDA M, 1984, J AM CHEM SOC, V106, P250, DOI 10.1021/ja00313a049
   MAKSIMENKO OO, 1990, VYSOKOMOL SOEDIN A+, V32, P2362
   MALAVASIC T, 1986, J MACROMOL SCI CHEM, VA23, P853, DOI 10.1080/00222338608069477
   MALLEY I, 1987, DRUG DEV IND PHARM, V13, P67, DOI 10.3109/03639048709040156
   MANDEL M, 1984, ANGEW MAKROMOL CHEM, V123, P63, DOI 10.1002/apmc.1984.051230103
   MANDEL M, 1988, ENCY POLYM SCI ENG, V11, P739
   MANNING GS, 1972, ANNU REV PHYS CHEM, V23, P117, DOI 10.1146/annurev.pc.23.100172.001001
   MANNING GS, 1969, J CHEM PHYS, V51, P934, DOI 10.1063/1.1672158
   MANNING GS, 1965, J CHEM PHYS, V43, P4250, DOI 10.1063/1.1696682
   MANNING GS, 1969, J CHEM PHYS, V51, P924, DOI 10.1063/1.1672157
   MANNING MC, 1989, PHARM RES-DORDR, V6, P903, DOI 10.1023/A:1015929109894
   MANSEN AE, 1981, CANCER RES, V16, P329
   MARCOS BP, 1991, J CONTROL RELEASE, V17, P267
   MARGAU M, 1981, 3RD P MISAO, V5, P504
   MAUZAC M, 1984, BIOMATERIALS, V5, P301, DOI 10.1016/0142-9612(84)90078-4
   MAUZAC M, 1982, BIOMATERIALS, V3, P221, DOI 10.1016/0142-9612(82)90023-0
   MAYS JW, 1990, POLYM COMMUN, V31, P170
   MCCAGHREN RA, 1990, J DENT RES, V69, P40, DOI 10.1177/00220345900690010601
   MCCOMB D, 1987, J DENT RES, V66, P1025, DOI 10.1177/00220345870660050601
   MCCORMICK CL, 1991, ACS SYM SER, V467, P2
   MCCORMICK CL, 1992, MACROMOLECULES, V25, P1201, DOI 10.1021/ma00030a001
   MCGINTY JW, 1989, AQUEOUS POLYM COATIN, P317
   MCLEAN JW, 1985, BRIT DENT J, V158, P410, DOI 10.1038/sj.bdj.4805621
   MERRILL EW, 1987, ANN NY ACAD SCI, V516, P196, DOI 10.1111/j.1749-6632.1987.tb33041.x
   MERYON SD, 1984, INT ENDOD J, V17, P16, DOI 10.1111/j.1365-2591.1984.tb00373.x
   MESHALI MM, 1993, INT J PHARM, V89, P177, DOI 10.1016/0378-5173(93)90241-7
   MIDDLETON JC, 1989, POLYM PREPR AM CHEM, V30, P348
   MILLER RM, 1985, ESAO P, V12, P466
   MISRA DN, 1988, LANGMUIR, V4, P953, DOI 10.1021/la00082a029
   MISRA DN, 1989, J DENT RES, V68, P42, DOI 10.1177/00220345890680010601
   MISRA DN, 1987, J BIOMED MATER RES, V21, P1329, DOI 10.1002/jbm.820211105
   MITRA SB, 1991, J DENT RES, V70, P72, DOI 10.1177/00220345910700011201
   MITRA SB, 1991, J DENT RES, V70, P75, DOI 10.1177/00220345910700011301
   MOJON P, 1992, J DENT RES, V71, P1633, DOI 10.1177/00220345920710091701
   MORA M, 1992, J CONTROL RELEASE, V18, P153, DOI 10.1016/0168-3659(92)90184-S
   MORIMOTO K, 1987, J PHARMACOBIO-DYNAM, V10, P85, DOI 10.1248/bpb1978.10.85
   MORIMOTO K, 1985, J PHARM PHARMACOL, V37, P134, DOI 10.1111/j.2042-7158.1985.tb05024.x
   MORIMOTO K, 1982, INT J PHARM, V12, P107
   MORIMOTO Y, 1992, J CONTROL RELEASE, V18, P113
   MORTNY KS, 1988, J BIOMATERIALS APPLI, V3
   MUNKSGAARD EC, 1985, J DENT RES, V64, P1409, DOI 10.1177/00220345850640121801
   MUQBILL R, 1979, J POLYM SCI POL LETT, V17, P369, DOI 10.1002/pol.1979.130170607
   MURAMATSU N, 1983, J BIOMED MATER RES, V17, P959, DOI 10.1002/jbm.820170607
   MURTHY K S, 1986, Pharmaceutical Technology, V10, P46
   NAGAI T, 1993, ADV DRUG DELIVER REV, V11, P179, DOI 10.1016/0169-409X(93)90032-Y
   NAKABAYASHI N, 1982, J BIOMED MATER RES, V16, P265, DOI 10.1002/jbm.820160307
   NAKABAYASHI N, 1988, KOBUNSHI RONBUNSHU, V45, P91, DOI 10.1295/koron.45.91
   NAKABAYASHI N, 1984, CRIT REV BIOCOMPAT, V1, P25
   NAKABAYASHI N, 1981, REP I MED DENT ENG, V15, P37
   NAKANO M, 1980, INT J PHARM, V4, P291
   NAVARRO A, 1991, STP HARM SCI, V1, P151
   NEMEC JW, 1988, ENCY POLYM SCI ENG, P211
   Neve A D, 1993, Clin Mater, V12, P113, DOI 10.1016/0267-6605(93)90059-G
   Neve A D, 1992, Clin Mater, V9, P13, DOI 10.1016/0267-6605(92)90005-E
   NEVE AD, 1992, CLIN MATER, V9, P21
   Nicholson J.W., 1991, CLIN MATER, V7, P289, DOI 10.1016/0267-6605(91)90072-N
   NICHOLSON JW, 1988, J DENT RES, V67, P1451, DOI 10.1177/00220345880670120201
   NICOLAI T, 1989, MACROMOLECULES, V22, P438, DOI 10.1021/ma00191a080
   ODIAN G, 1991, PRINCIPLES POLYM
   ODIJK T, 1978, J POLYM SCI POL PHYS, V16, P627, DOI 10.1002/pol.1978.180160405
   ODIJK T, 1977, J POLYM SCI POL PHYS, V15, P477, DOI 10.1002/pol.1977.180150307
   Oilo G, 1992, Adv Dent Res, V6, P50
   OKAHATA Y, 1984, J CHEM SOC CHEM COMM, P519, DOI 10.1039/c39840000519
   OKAHATA Y, 1987, MACROMOLECULES, V20, P15, DOI 10.1021/ma00167a004
   OKKEMA AZ, 1991, BIOMATERIALS, V12, P668, DOI 10.1016/0142-9612(91)90115-Q
   OKKEMA AZ, 1988, MATER RES SOC S P, V110, P91
   OKOR RS, 1991, J CONTROL RELEASE, V16, P349, DOI 10.1016/0168-3659(91)90012-3
   OMICHI H, 1986, J APPL POLYM SCI, V32, P4827, DOI 10.1002/app.1986.070320505
   ORACESKA B, 1992, P INT S CONTROL REL, V19, P198
   OSADA Y, 1981, J POLYM SCI POL LETT, V19, P303, DOI 10.1002/pol.1981.130190605
   OSADA Y, 1993, PROG POLYM SCI, V18, P187, DOI 10.1016/0079-6700(93)90025-8
   OSADA Y, 1991, J MACROMOL SCI CHEM, VA28, P1189, DOI 10.1080/00222339108054092
   OSADA Y, 1986, J MEMBRANE SCI, V27, P327, DOI 10.1016/0376-7388(86)80003-5
   OSADA Y, 1987, ADV POLYM SCI, V82, P1
   OSADA Y, 1994, TRENDS POLYM SCI, V2, P61
   OSAWA F, 1954, J POLYM SCI, V13, P93, DOI 10.1002/pol.1954.120136808
   Osborne J W, 1990, Am J Dent, V3, P40
   OSBORNE JW, 1986, DENT MATER, V2, P147, DOI 10.1016/S0109-5641(86)80023-9
   OSTERWALD HP, 1985, PHARM RES-DORDR, V1, P14
   OTTENBRITE RM, 1985, ANN NY ACAD SCI, V446, P160, DOI 10.1111/j.1749-6632.1985.tb18398.x
   OTTENBRITE RM, 1985, BIOACTIVE POLYM SYST, P514
   OTTENBRITE RM, 1983, POLYM SCI TECHNOL PO, V23, P3
   OTTENBRITE RM, 1978, POLYM DRUGS, P263
   OTTENBRITE RM, 1984, ANTICANCER INTERFERO, P247
   OZTURK SS, 1988, PHARMACEUT RES, V5, P550, DOI 10.1023/A:1015937912504
   Panarin E. F., 1985, MAKROMOL CHEM S, V9, P25, DOI [10.1002/macp.1985.020091985104, DOI 10.1002/MACP.1985.020091985104]
   PARK H, 1985, Journal of Controlled Release, V2, P47, DOI 10.1016/0168-3659(85)90032-X
   PARK K, 1984, INT J PHARM, V19, P107, DOI 10.1016/0378-5173(84)90154-6
   Park K., 1984, RECENT ADV DRUG DELI, P163
   PEARSON G J, 1991, Clinical Materials, V7, P325, DOI 10.1016/0267-6605(91)90076-R
   PEARSON GJ, 1987, DENT MATER, V3, P275, DOI 10.1016/S0109-5641(87)80087-8
   PEARSON GJ, 1989, DENT MATER, V5, P10, DOI 10.1016/0109-5641(89)90084-5
   PEFFERKORN E, 1982, BIOPOLYMERS, V21, P1451, DOI 10.1002/bip.360210713
   PEPPAS N A, 1985, Journal of Controlled Release, V2, P257, DOI 10.1016/0168-3659(85)90050-1
   Peppas N. A., 1986, HYDROGELS MED PHARM, VI, P1
   PEPPAS NA, 1993, ADV DRUG DELIVER REV, V11, P1, DOI 10.1016/0169-409X(93)90025-Y
   PERNER T, 1987, BRIT POLYM J, V19, P181, DOI 10.1002/pi.4980190210
   Petrak K, 1986, J BIOACT COMPAT POL, V1, P202
   PHILIPP B, 1989, PROG POLYM SCI, V14, P91, DOI 10.1016/0079-6700(89)90018-X
   PHILIPP B, 1991, POLYM NEWS, V16, P106
   PHILIPP B, 1980, ACTA POLYM, V31, P654
   PHILIPP B, 1980, ACTA POLYM, V31, P592
   PHILLIPS RW, 1982, SKINNERS SCI DENTAL
   PITT CG, 1986, PHARM INT, V88
   POWIS DR, 1982, J DENT RES, V61, P1416, DOI 10.1177/00220345820610120801
   PRADNY M, 1986, POLYM BULL, V16, P195, DOI 10.1007/BF00955491
   PRADNY M, 1990, MAKROMOL CHEM, V191, P1887
   PRATI C, 1992, DENT MATER, V8, P21, DOI 10.1016/0109-5641(92)90048-H
   PRATI C, 1991, Clinical Materials, V8, P137, DOI 10.1016/0267-6605(91)90022-8
   PROSSER HJ, 1982, J BIOMED MATER RES, V16, P431, DOI 10.1002/jbm.820160411
   PRUDHOMME RK, 1993, P ACS POLYM MATERIAL, V69, P527
   PUJOLFORTIN ML, 1991, MACROMOLECULES, V24, P4523, DOI 10.1021/ma00016a007
   RAGHUNATHAN Y, 1981, J PHARM SCI, V70, P379, DOI 10.1002/jps.2600700409
   RATH NC, 1984, CHEM-BIOL INTERACT, V48, P339, DOI 10.1016/0009-2797(84)90144-3
   RATNR BD, 1987, J BIOMED MATER RES-A, V21, P59
   REGEN SL, 1984, J AM CHEM SOC, V106, P2446, DOI 10.1021/ja00320a043
   RETIEF DH, 1984, CARIES RES, V18, P250, DOI 10.1159/000260773
   RODRIGUES F, 1982, PRINCIPLES POLYM SYS
   ROZIER A, 1989, INT J PHARM, V57, P163, DOI 10.1016/0378-5173(89)90305-0
   RUBINSTEIN A, 1992, INT J PHARM, V84, P141, DOI 10.1016/0378-5173(92)90054-6
   RUSSEL WB, 1982, J POLYM SCI POL PHYS, V20, P1233, DOI 10.1002/pol.1982.180200710
   RYSER HJP, 1980, CANCER, V45, P1207, DOI 10.1002/1097-0142(19800315)45:5+<1207::AID-CNCR2820451327>3.0.CO;2-M
   RYTTING JH, 1991, P PROGRAM INT S CONT, V18, P115
   SALAMONE JC, 1980, J POLYM SCI POL CHEM, V18, P2983, DOI 10.1002/pol.1980.170181008
   SALAMONE JC, 1978, POLYMER, V19, P1157, DOI 10.1016/0032-3861(78)90064-2
   SALAMONE JC, 1982, POLYMER, V23, P843, DOI 10.1016/0032-3861(82)90144-6
   SALAMONE JC, 1985, J POLYM SCI POL LETT, V23, P655, DOI 10.1002/pol.1985.130231210
   SALAMONE JC, 1986, J POLYM SCI POL SYM, P187
   SALAMONE JC, 1974, J POLYM SCI POL SYM, P51
   SALAMONE JC, 1991, J MACROMOL SCI CHEM, VA28, P225, DOI 10.1080/00222339108052097
   SALAMONE JC, 1988, WATER SOLUBLE POLYM, P181
   SALIB N, 1983, PHARM IND, V45, P902
   SAMSONOV GV, 1992, ADV POLYM SCI, V104, P1
   SANADA T, 1986, J BIOMED MATER RES, V20, P1179, DOI 10.1002/jbm.820200809
   SANTERRE JP, 1992, J BIOMED MATER RES, V26, P1003, DOI 10.1002/jbm.820260804
   SANTERRE JP, 1992, J BIOMED MATER RES, V26, P39, DOI 10.1002/jbm.820260105
   SARAI K, 1991, ANTICANCER RES, V11, P957
   SATO T, 1986, J BIOACT COMP POLYM, V1, P445
   SAWAHATA K, 1990, J CONTROL RELEASE, V14, P253, DOI 10.1016/0168-3659(90)90165-P
   SAWYER PN, SURFACE CHARGE THROM, V416, P561
   SCHERER W, 1989, OPER DENT, V14, P82
   Scherer W, 1989, Am J Dent, V2, P355
   SCHOO HFM, 1992, MACROMOLECULES, V25, P1633, DOI 10.1021/ma00032a002
   SCHOSSELER F, 1991, MACROMOLECULES, V24, P225, DOI 10.1021/ma00001a035
   SCHROEDER UKO, 1989, MACROMOLECULES, V22, P765, DOI 10.1021/ma00192a042
   SCHULZ RC, 1989, MAKROMOL CHEM-M SYMP, V26, P221, DOI 10.1002/masy.19890260123
   SEDEREL LC, 1981, J BIOMED MATER RES, V15, P819, DOI 10.1002/jbm.820150606
   SEDEREL LC, 1983, BIOMATERIALS, V4, P210, DOI 10.1016/0142-9612(83)90013-3
   SEKI K, 1984, MACROMOLECULES, V17, P1692, DOI 10.1021/ma00139a009
   SHATAYEVA LK, 1979, J APPL POLYM SCI, V23, P2245, DOI 10.1002/app.1979.070230803
   SHIBUTA R, 1986, J BIOMED MATER RES, V20, P971, DOI 10.1002/jbm.820200712
   SIEGEL RA, 1988, J CONTROL RELEASE, V8, P179, DOI 10.1016/0168-3659(88)90044-2
   SIEGEL RA, 1988, MACROMOLECULES, V21, P3254, DOI 10.1021/ma00189a021
   SIEGEL RA, 1988, P INT S CONTROLLED R, V15, P164
   SIEGEL RA, 1990, PULSED SELF REGULATE, P129
   SILVER J, 1990, POLYM PREPR, V31, P222
   SKORODINSKAYA AM, 1984, KHIM FARM ZH+, V18, P283
   SMART JD, 1989, INT J PHARM, V53, P79, DOI 10.1016/0378-5173(89)90365-7
   Smith D C, 1968, Br Dent J, V124, P381
   SOUTO C, 1992, 6TH C INT TECHN PHAR, V3, P349
   SOUTO C, 1991, INT J PHARMACEUT, V67, P113
   Stanley H R, 1992, Adv Dent Res, V6, P55
   STIGTER D, 1975, J COLLOID INTERF SCI, V53, P296, DOI 10.1016/0021-9797(75)90016-8
   STRAUSS UP, 1959, J AM CHEM SOC, V81, P5295, DOI 10.1021/ja01529a012
   SUMAMOTO J, 1983, POLYM MED, P157
   SUMAMOTO J, 1985, CRC CRIT R THER DRUG, V2, P117
   SUNAMOTO J, 1988, CHEM LETT, P1781, DOI 10.1246/cl.1988.1781
   SUZUKI M, 1991, J DENT RES, V70, P1092, DOI 10.1177/00220345910700071501
   SUZUKI M, 1987, J RAMAN SPECTROSC, V18, P315, DOI 10.1002/jrs.1250180503
   SUZUKI S, 1990, J BIOMED MATER RES, V24, P1091, DOI 10.1002/jbm.820240811
   SWARTZ ML, 1984, J DENT RES, V63, P158, DOI 10.1177/00220345840630021301
   SWIFT EJ, 1989, AM J DENT, V2, P358
   Tagami J, 1987, Dent Mater J, V6, P201
   TAKAHATA H, 1990, CHEM PHARM BULL, V38, P2556
   Takeyama M, 1978, J JPN SOC DENT APPAR, V19, P179
   TAKIGAWA DY, 1985, MACROMOLECULES, V18, P338, DOI 10.1021/ma00145a006
   TALUKDAR MM, 1991, P INT S CONTROL REL, V18, P247
   TANAKA T, 1988, J DENT RES, V67, P1376, DOI 10.1177/00220345880670110301
   TANAKA T, 1988, J PROSTHET DENT, V60, P271, DOI 10.1016/0022-3913(88)90267-3
   TANI N, 1980, CONTROLLED RELEASE P, P79
   TAYLOR LD, 1986, J POLYM SCI POL LETT, V24, P287, DOI 10.1002/pol.1986.140240609
   TIRRELL DA, 1985, MACROMOLECULES, V18, P1512, DOI 10.1021/ma00149a027
   TIRRELL DA, 1990, PULSED SELF REGULATE, P109
   TJAN AHL, 1991, J PROSTHET DENT, V66, P602, DOI 10.1016/0022-3913(91)90437-2
   TOBIAS RS, 1985, INT ENDOD J, V18, P161, DOI 10.1111/j.1365-2591.1985.tb00435.x
   TOUMBA KJ, 1993, CARIES RES, V27, P43, DOI 10.1159/000261601
   TRIJASSON P, 1990, MAKROMOL CHEM-M SYMP, V35-6, P141, DOI 10.1002/masy.19900350111
   TSAI MF, 1984, J POLYM SCI POL CHEM, V22, P2523, DOI 10.1002/pol.1984.170221019
   TSAI MF, 1984, ION EXCH TECHNOL, P533
   TSUCHIDA E, 1982, ADV POLYM SCI, V45, P1
   TUMOKO U, 1991, KONBUNSHI RONBUNSHU, V48, P289
   UCHIDA K, 1992, P INT S CONTROL REL, V19, P381
   Um C M, 1992, Quintessence Int, V23, P209
   URYO T, 1991, POLYM SCI SER C, V2, P989
   VALENTINE JR, 1982, POLYM PREPR, V29, P446
   VANDERDOES L, 1980, J POLYM SCI POL LETT, V18, P53, DOI 10.1002/pol.1980.130180110
   VANDERDOES L, 1986, DEV HEMATOL IMMUNOL, V14, P215
   VANMEERBEEK B, 1993, J DENT RES, V72, P495, DOI 10.1177/00220345930720020501
   VENZ S, 1993, J DENT RES, V72, P582, DOI 10.1177/00220345930720030501
   VERBEECK RMH, 1993, J DENT RES, V72, P577, DOI 10.1177/00220345930720030401
   VINK H, 1981, MACROMOL CHEM PHYS, V182, P279
   WALLES WE, 1990, ACS SYM SER, V423, P266
   WANDREY C, 1985, ACTA POLYM, V36, P100, DOI 10.1002/actp.1985.010360209
   WANG T, 1991, J DENT RES, V70, P59, DOI 10.1177/00220345910700011001
   Wasson E A, 1993, Clin Mater, V12, P181, DOI 10.1016/0267-6605(93)90070-N
   WASSON EA, 1990, BRIT POLYM J, V23, P179, DOI 10.1002/pi.4980230129
   WASSON EA, 1993, J DENT RES, V72, P481, DOI 10.1177/00220345930720020201
   WATANABE F, 1988, J DENT RES, V67, P479, DOI 10.1177/00220345880670020901
   WEBB RE, 1991, J DENT RES, V70, P211, DOI 10.1177/00220345910700031101
   WEISS AM, 1986, AICHE S SER 82, V250, P85
   WEN S, 1991, J APPL POLYM SCI, V42, P1399, DOI 10.1002/app.1991.070420524
   WEN S, 1991, J APPL POLYM SCI, V43, P205, DOI 10.1002/app.1991.070430119
   WHITE SN, 1992, J PROSTHET DENT, V67, P156, DOI 10.1016/0022-3913(92)90447-I
   WILLIAMS JA, 1989, J ORAL REHABIL, V16, P475, DOI 10.1111/j.1365-2842.1989.tb01368.x
   WILSON AD, 1973, Patent No. 1316129
   WILLIAMS JA, 1991, J ORAL REHABIL, V18, P163, DOI 10.1111/j.1365-2842.1991.tb00044.x
   Wilson A D, 1990, Int J Prosthodont, V3, P425
   WILSON A D, 1991, Clinical Materials, V7, P275, DOI 10.1016/0267-6605(91)90070-V
   WILSON AD, 1983, J DENT RES, V62, P590, DOI 10.1177/00220345830620051801
   WILSON AD, 1985, BIOMATERIALS, V6, P431, DOI 10.1016/0142-9612(85)90107-3
   WILSON AD, 1980, IND ENG CHEM PROD RD, V19, P263, DOI 10.1021/i360074a027
   WILSON AD, 1978, CHEM SOC REV, V7, P265, DOI 10.1039/cs9780700265
   WILSON AD, 1977, J DENT, V5, P117, DOI 10.1016/0300-5712(77)90070-7
   WILSON AD, 1984, BRIT DENT J, V157, P449, DOI 10.1038/sj.bdj.4805517
   WILSON AD, 1988, GLASS IONOMER CEMENT, P134
   WILSON C, 1988, INT J PANCREATOL, V3, P273
   Wilson M A, 1991, Clin Mater, V7, P15, DOI 10.1016/0267-6605(91)90051-G
   WOOD D, 1991, Clinical Materials, V7, P301, DOI 10.1016/0267-6605(91)90074-P
   WOOD D, 1991, BIOMATERIALS, V12, P164, DOI 10.1016/0142-9612(91)90195-G
   XI T, 1991, Clinical Materials, V8, P43
   XI T, 1990, C MRS INT S P, V3, P483
   YAMAKAWA H, 1971, MODERN THEORY POLYM
   Yamauchi J., 1986, J JPN DENT MATER, V5, P144
   YANG YJ, 1991, J ORG CHEM, V56, P4300, DOI 10.1021/jo00013a043
   YIN YL, 1992, ACS SYM SER, V480, P91
   YOSHIDA M, 1991, RADIAT PHYS CHEM, V38, P7
   ZIDAN O, 1987, J DENT RES, V66, P716, DOI 10.1177/00220345870660030201
   ZUELLIGSINGER R, 1992, J DENT RES, V71, P1842, DOI 10.1177/00220345920710111501
NR 523
TC 57
Z9 57
U1 1
U2 24
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
SN 0065-3195
BN 3-540-58788-8
J9 ADV POLYM SCI
JI Adv. Polym. Sci.
PY 1995
VL 122
BP 1
EP 54
PG 54
WC Materials Science, Biomaterials; Polymer Science
SC Materials Science; Polymer Science
GA BE58P
UT WOS:A1995BE58P00001
DA 2018-10-20
ER

PT S
AU Bell, CL
   Peppas, NA
AF Bell, CL
   Peppas, NA
BE Peppas, NA
   Langer, RS
TI Biomedical membranes from hydrogels and interpolymer complexes
SO BIOPOLYMERS II
SE Advances in Polymer Science
LA English
DT Review
ID TEMPERATURE-SENSITIVE GELS; INTERPENETRATING POLYMER NETWORKS; BLENDS
   INVOLVING POLYMERS; EQUILIBRIUM SWELLING BEHAVIOR; LABELED POLY(ETHYLENE
   GLYCOL); VOLUME-PHASE-TRANSITIONS; POLY(ACRYLIC ACID); POLY(METHACRYLIC
   ACID); SOLUTE DIFFUSION; POLYELECTROLYTE COMPLEXES
AB Biomedical applications of hydrogel membranes require understanding of their structural characteristics and diffusive behavior. Thus, the subject of this review is the analysis of the response of such biomembranes to their surrounding environment. This responsive behavior may be due to the presence of certain functional groups along the polymer chains or specific interactions between polymer chains (complexation). This behavior is particularly important in the use of these physiologically responsive materials in membrane applications. We begin with an introduction to the structural characteristics and behavior of hydrogel membranes followed by a discussion of the types of environmentally responsive behavior seen with hydrogels. The subject of interpolymer complexation is then treated with emphasis on complexation due to hydrogen bonding and how this type of behavior may be used to produce responsive membranes. Finally, the theories of transport in membranes are reviewed.
C1 PURDUE UNIV, SCH CHEM ENGN, W LAFAYETTE, IN 47907 USA.
CR ADACHI H, 1982, POLYM J, V14, P985, DOI 10.1295/polymj.14.985
   ANDERSON JL, 1974, BIOPHYS J, V14, P130, DOI 10.1016/S0006-3495(74)70005-4
   ANNAKA M, 1992, MACROMOLECULES, V25, P4826, DOI 10.1021/ma00044a054
   ANTIPINA AD, 1972, VYSOKOMOL SOEDIN A, V14, P941
   BAE YH, 1989, J CONTROL RELEASE, V9, P271, DOI 10.1016/0168-3659(89)90096-5
   BAILEY FE, 1964, J POLYM SCI PART A, V2, P845, DOI 10.1002/pol.1964.100020221
   BARANOVSKY V, 1991, EUR POLYM J, V27, P643, DOI 10.1016/0014-3057(91)90149-I
   BEKTUROV EA, 1981, ADV POLYM SCI, V41, P99
   BELL CL, 1994, THESIS PURDUE U
   BELTRAN S, 1990, J CHEM PHYS, V92, P2061, DOI 10.1063/1.458039
   BELTRAN S, 1991, MACROMOLECULES, V24, P549, DOI 10.1021/ma00002a032
   BIMENDINA LA, 1974, VYSOKOMOL SOEDIN A+, V16, P2810
   BOKIAS G, 1994, MACROMOLECULES, V27, P427, DOI 10.1021/ma00080a016
   BORDEN KA, 1987, MACROMOLECULES, V20, P454, DOI 10.1021/ma00168a046
   Brannon-Peppas L., 1990, ABSORBENT POLYM TECH, V8, P45, DOI DOI 10.1016/B978-0-444-88654-5.50008-X
   BRANNONPEPPAS L, 1991, CHEM ENG SCI, V46, P715, DOI 10.1016/0009-2509(91)80177-Z
   BRANNONPEPPAS L, 1989, J CONTROL RELEASE, V8, P267, DOI 10.1016/0168-3659(89)90048-5
   BRANNONPEPPAS L, 1991, INT J PHARM, V70, P53, DOI 10.1016/0378-5173(91)90163-I
   BRANNONPEPPAS L, 1991, J CONTROL RELEASE, V16, P319, DOI 10.1016/0168-3659(91)90009-3
   BRANNONPEPPAS L, 1988, POLYM BULL, V20, P285
   BRANNONPEPPAS L, 1990, ABSORBENT POLYM TECH, P67
   BRENNER H, 1977, J COLLOID INTERF SCI, V58, P312, DOI 10.1016/0021-9797(77)90147-3
   BROMBERG LE, 1991, J MEMBRANE SCI, V62, P117, DOI 10.1016/0376-7388(91)80056-C
   BROMBERG LE, 1991, J MEMBRANE SCI, V62, P131, DOI 10.1016/0376-7388(91)80057-D
   BURZAK K, 1994, BIOMATERIALS, V15, P231
   CHATTERJEE SK, 1991, POLYM COMMUN, V32, P473
   CHATTERJEE SK, 1989, J POLYM SCI POL CHEM, V27, P3855, DOI 10.1002/pola.1989.080271125
   CHATTERJEE SK, 1991, POLYM COMMUN, V32, P220
   CHEN HL, 1982, MACROMOLECULES, V15, P1445, DOI 10.1021/ma00233a047
   CHUNG DJ, 1992, J CONTROL RELEASE, V18, P45
   COLE CA, 1987, ACS SYM SER, V350, P245
   Crank J., 1975, MATH DIFFUSION
   DAOUST H, 1990, POLYMER, V31, P1946, DOI 10.1016/0032-3861(90)90021-P
   DEEN WM, 1987, AICHE J, V33, P1409, DOI 10.1002/aic.690330902
   DOI M, 1992, MACROMOLECULES, V25, P5504, DOI 10.1021/ma00046a058
   DONG LC, 1992, J CONTROL RELEASE, V19, P171
   DONG LC, 1982, ACS S SERIES REVERSI, P237
   DRUMMOND RK, 1989, MACROMOLECULES, V22, P3816, DOI 10.1021/ma00199a059
   DUBIN SB, 1967, P NATL ACAD SCI USA, V57, P1164, DOI 10.1073/pnas.57.5.1164
   DUBROVSKII SA, 1992, POLYM BULL, V29, P587, DOI 10.1007/BF00296722
   FEIL H, 1992, MACROMOLECULES, V25, P5528, DOI 10.1021/ma00046a063
   FEIL H, 1991, J MEMBRANE SCI, V64, P283, DOI 10.1016/0376-7388(91)80099-R
   FERGUSON J, 1968, EUR POLYM J, V4, P343, DOI 10.1016/0014-3057(68)90022-0
   FIRESTONE BA, 1988, POLYM COMMUN, V29, P204
   Flory P. J. E., 1956, PRINCIPLES POLYM CHE
   Flory PJ, 1943, J CHEM PHYS, V11, P521, DOI 10.1063/1.1723792
   FLYNN GL, 1974, J PHARM SCI-US, V63, P479, DOI 10.1002/jps.2600630403
   FREITAS RFS, 1987, CHEM ENG SCI, V42, P97, DOI 10.1016/0009-2509(87)80213-0
   GALLI AJ, 1983, J CHEM PHYS, V79, P2411, DOI 10.1063/1.446048
   GEHRKE SH, 1989, CHEM ENG SCI, V44, P559, DOI 10.1016/0009-2509(89)85032-8
   GLADDEN JK, 1953, J AM CHEM SOC, V75, P3900, DOI 10.1021/ja01112a008
   GUTOWSKA A, 1992, J CONTROL RELEASE, V22, P95, DOI 10.1016/0168-3659(92)90194-V
   HARIHARAN D, 1993, THESIS PURDUE U W LA
   HARLAND RS, 1987, POLYM BULL, V18, P553
   HELLER J, 1990, J CONTROL RELEASE, V13, P295, DOI 10.1016/0168-3659(90)90019-P
   HEMKER DJ, 1990, MACROMOLECULES, V23, P4411, DOI 10.1021/ma00222a014
   HEMKER DJ, 1987, MACROMOLECULES, V23, P4404
   HIROTSU S, 1987, J CHEM PHYS, V87, P1392, DOI 10.1063/1.453267
   HOFFMAN A S, 1986, Journal of Controlled Release, V4, P213
   HOOPER HH, 1990, MACROMOLECULES, V23, P1096, DOI 10.1021/ma00206a031
   HORBETT TA, 1984, RECENT ADV DRUG DELI, P209
   HORSKY J, 1987, POLYM COMMUN, V29, P110
   IRIE M, 1986, MACROMOLECULES, V19, P2476, DOI 10.1021/ma00164a003
   IRIE M, 1986, MACROMOLECULES, V19, P2890, DOI 10.1021/ma00165a040
   ISHIHARA K, 1984, POLYM J, V16, P647, DOI 10.1295/polymj.16.647
   ISHIHARA K, 1986, J POLYM SCI POL LETT, V24, P413, DOI 10.1002/pol.1986.140240809
   ISHIHARA K, 1984, POLYM J, V16, P625, DOI 10.1295/polymj.16.625
   ITO Y, 1992, MACROMOLECULES, V25, P7313, DOI 10.1021/ma00052a037
   ITO Y, 1989, J CONTROL RELEASE, V10, P195, DOI 10.1016/0168-3659(89)90063-1
   JEON SH, 1988, J POLYM SCI POL CHEM, V26, P1419, DOI 10.1002/pola.1988.080260514
   JEUN SH, 1989, J POLYM SCI C, V27, P161
   KABRA BG, 1991, POLYM COMMUN, V32, P322
   KALYUZHNAYA RI, 1976, VYSOKOMOL SOEDIN A+, V18, P71
   KALYUZHNAYA RI, 1975, VYSOKOMOL SOEDIN A+, V17, P2786
   KATCHALSKY A, 1949, EXPERIENTIA, V5, P319, DOI 10.1007/BF02172636
   KATCHALSKY A, 1950, J POLYM SCI, V5, P283, DOI 10.1002/pol.1950.120050302
   KATCHALSKY A, 1955, J POLYM SCI, V15, P68
   KATCHALSKY A, 1949, J POLYM SCI, V4, P393
   Khare A. R., 1991, POLYM NEWS, V16, P230
   KHARE AR, 1993, POLYMER, V34, P4736, DOI 10.1016/0032-3861(93)90710-R
   KHOKHLOV AR, 1993, MAKROMOL CHEM-THEOR, V2, P169
   KHOKHLOV AR, 1992, MACROMOLECULES, V25, P4779, DOI 10.1021/ma00044a045
   KIM JT, 1991, IND ENG CHEM RES, V29, P1008
   KIM OK, 1993, MACROMOLECULES, V26, P379, DOI 10.1021/ma00054a018
   KIM S W, 1990, Journal of Controlled Release, V11, P193
   KIM SW, 1990, WATER POLYM, P347
   KLIER J, 1990, MACROMOLECULES, V23, P4944, DOI 10.1021/ma00225a011
   KOKUFUTA E, 1991, MACROMOLECULES, V24, P1605, DOI 10.1021/ma00007a024
   KONAK C, 1989, POLYMER, V30, P677, DOI 10.1016/0032-3861(89)90154-7
   KONO K, 1993, J MEMBRANE SCI, V76, P233, DOI 10.1016/0376-7388(93)85220-Q
   KOPYLOVA YM, 1987, VYSOKOMOL SOEDIN A+, V29, P517
   KOVAC J, 1978, MACROMOLECULES, V11, P362, DOI 10.1021/ma60062a016
   KUDELA V, 1985, ENCY POLYM SCI TECHN, P783
   KUHN W, 1950, NATURE, V165, P514, DOI 10.1038/165514a0
   LEE JY, 1988, MACROMOLECULES, V21, P346, DOI 10.1021/ma00180a011
   LEE JY, 1988, MACROMOLECULES, V21, P954, DOI 10.1021/ma00182a019
   LICHKUS AM, 1988, MACROMOLECULES, V21, P2636, DOI 10.1021/ma00186a054
   LIU GJ, 1991, MACROMOLECULES, V24, P68, DOI 10.1021/ma00001a011
   MALONE DM, 1978, CHEM ENG SCI, V33, P1429, DOI 10.1016/0009-2509(78)85192-6
   MARCHETTI M, 1990, MACROMOLECULES, V23, P1760, DOI 10.1021/ma00208a034
   MATUSZEWSKACZERWIK J, 1988, POLYM BULL, V19, P149, DOI 10.1007/BF00257008
   NICOLI D, 1983, MACROMOLECULES, V16, P887, DOI 10.1021/ma00240a011
   NIELSEN LE, 1974, MECHANICAL PROPERTIE, V1, P39
   NISHI S, 1985, MACROMOLECULES, V18, P1519, DOI 10.1021/ma00150a001
   NISHI S, 1989, POLYM J, V21, P393, DOI 10.1295/polymj.21.393
   OHMINE I, 1982, J CHEM PHYS, V77, P5725, DOI 10.1063/1.443780
   OHNO H, 1978, MAKROMOL CHEM, V179, P755
   OKANO T, 1990, J CONTROL RELEASE, V11, P255, DOI 10.1016/0168-3659(90)90138-J
   OPPERMANN W, 1992, ACS SYM SER, V480, P159
   OSADA Y, 1981, J POLYM SCI POL LETT, V19, P303, DOI 10.1002/pol.1981.130190605
   OSADA Y, 1979, J POLYM SCI POL CHEM, V17, P3485, DOI 10.1002/pol.1979.170171107
   OSADA Y, 1986, J MEMBRANE SCI, V27, P327, DOI 10.1016/0376-7388(86)80003-5
   OSADA Y, 1976, J POLYM SCI POL LETT, V14, P129, DOI 10.1002/pol.1976.130140302
   OSADA Y, 1980, J POLYM SCI POL LETT, V18, P281, DOI 10.1002/pol.1980.130180407
   OSADA Y, 1987, ADV POLYM SCI, V82, P2
   OTAKE K, 1989, J CHEM PHYS, V91, P1345, DOI 10.1063/1.457157
   OYAMA HT, 1987, MACROMOLECULES, V20, P474, DOI 10.1021/ma00169a002
   OYAMA HT, 1987, MACROMOLECULES, V20, P1839, DOI 10.1021/ma00174a024
   PAPISOV IM, 1974, VYSOKOMOL SOEDIN A+, V16, P1133
   PARK SM, 1989, J POLYM SCI POL CHEM, V27, P4109, DOI 10.1002/pola.1989.080271218
   PARK TG, 1992, J APPL POLYM SCI, V46, P659, DOI 10.1002/app.1992.070460413
   PEIFFER DG, 1985, POLYMER, V26, P1058, DOI 10.1016/0032-3861(85)90229-0
   PEPPAS NA, 1985, J APPL POLYM SCI, V30, P2589, DOI 10.1002/app.1985.070300623
   PEPPAS NA, 1991, J BIOACT COMPAT POL, V6, P241, DOI 10.1177/088391159100600303
   PEPPAS NA, 1991, J CONTROL RELEASE, V16, P203, DOI 10.1016/0168-3659(91)90044-E
   PEPPAS NA, 1993, ADV DRUG DELIVER REV, V11, P1, DOI 10.1016/0169-409X(93)90025-Y
   PEPPAS NA, 1983, J MEMBRANE SCI, V15, P275, DOI 10.1016/S0376-7388(00)82304-2
   PEPPAS NA, 1983, J MEMBRANE SCI, V16, P361, DOI 10.1016/S0376-7388(00)81321-6
   PEPPAS NA, 1994, J APPL POLYM SCI, V52, P763, DOI 10.1002/app.1994.070520606
   PEPPAS NA, 1986, HYDROGELS MED PHARM, V1, P28
   Peppas NA, 1984, CHEM ENG COMMUN, V30, P291, DOI 10.1080/00986448408911134
   REINHART CT, 1984, J MEMBRANE SCI, V18, P227, DOI 10.1016/S0376-7388(00)85036-X
   SAMSONOV GV, 1979, VYSOKOMOL SOEDIN A+, V21, P723
   SATOMATSUO E, 1992, NATURE, V358, P482
   SCRANTON AB, 1991, J POLYM SCI B
   SHIGA T, 1993, J APPL POLYM SCI, V47, P113, DOI 10.1002/app.1993.070470114
   SHINKAI S, 1981, J AM CHEM SOC, V103, P111, DOI 10.1021/ja00391a021
   SIEGEL RA, 1988, MACROMOLECULES, V21, P3254, DOI 10.1021/ma00189a021
   SIEGEL RA, 1990, PULSED SELF REGULATE, P129
   SIEGEL RA, 1988, J CONTROL RELEASE, V8, P79
   SMITH FG, 1980, J COLLOID INTERF SCI, V78, P444, DOI 10.1016/0021-9797(80)90584-6
   SOUTAR I, 1990, MACROMOLECULES, V23, P5170, DOI 10.1021/ma00226a027
   STAIKOS G, 1991, MAKROMOL CHEM, V192, P2649
   STEINBERG IZ, 1966, NATURE, V210, P568, DOI 10.1038/210568a0
   TANAKA T, 1979, POLYMER, V20, P1404, DOI 10.1016/0032-3861(79)90281-7
   TIRRELL D A, 1987, Journal of Controlled Release, V6, P15, DOI 10.1016/0168-3659(87)90060-5
   TRANK SJ, 1987, CHEM ENG SCI, V42, P381, DOI 10.1016/0009-2509(87)85070-4
   TRELOAR LRG, 1975, PHYSICS RUBBER ELAST
   TSUCHIDA E, 1982, ADV POLYM SCI, V45, P1
   VANDEGRAMPEL HT, 1992, J POLYM SCI POL CHEM, V30, P787, DOI 10.1002/pola.1992.080300508
   YASUDA H, 1971, J MACROMOL SCI PHYS, VB  5, P111, DOI 10.1080/00222347108212523
   YASUDA H, 1969, MAKROMOLEKUL CHEM, V125, P108
   YASUDA H, 1968, MAKROMOL CHEM, V118, P19
   YASUDA H, 1969, MAKROMOLEKUL CHEM, V126, P177
   YOSHIDA R, 1992, J BIOMAT SCI-POLYM E, V3, P243, DOI 10.1163/156856292X00150
   ZRINYI M, 1987, POLYMER, V28, P1139, DOI 10.1016/0032-3861(87)90256-4
NR 156
TC 134
Z9 137
U1 0
U2 29
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
SN 0065-3195
BN 3-540-58788-8
J9 ADV POLYM SCI
JI Adv. Polym. Sci.
PY 1995
VL 122
BP 125
EP 175
PG 51
WC Materials Science, Biomaterials; Polymer Science
SC Materials Science; Polymer Science
GA BE58P
UT WOS:A1995BE58P00003
DA 2018-10-20
ER

PT J
AU TRELOAR, PH
   CHRISTIE, IM
   VADGAMA, PM
AF TRELOAR, PH
   CHRISTIE, IM
   VADGAMA, PM
TI ENGINEERING THE RIGHT MEMBRANES FOR ELECTRODES AT THE BIOLOGICAL
   INTERFACE - SOLVENT-CAST AND ELECTROPOLYMERIZED
SO BIOSENSORS & BIOELECTRONICS
LA English
DT Article; Proceedings Paper
CT 2nd CEC Workshop on Bioelectronics: Interfacing Biology with Electronics
CY NOV, 1993
CL FRANKFURT, GERMANY
SP COMMISS EUROPEAN COMMUNITIES
DE AMPEROMETRY; ENZYME ELECTRODE; MEMBRANE; PERMSELECTIVE; BIOCOMPATIBLE;
   DIAMOND-LIKE CARBON; CELLULOSE ACETATE; POLYVINYL CHLORIDE; PHENOL
ID GLUCOSE ENZYME ELECTRODE; SELECTIVITY; BIOSENSORS; BARRIER; PHENOLS;
   BLOOD
AB A generic approach to adapting many sensors to the rigours of biomedical measurement is to protect appropriate components with selective solute discriminating membrane layers. Our work has utilised external barrier membranes for mass transport control to enzyme electrodes in order to adapt their behaviour to requisite clinical ranges; these membranes have had the additional important effect of reducing surface deposition of colloid and other material on electrode surfaces. Internal membranes, especially those interposed between the enzyme layer and the working electrode of an amperometric sensor, have been found by us to be remarkably important in determining sensor operational stability. This paper will review such membrane materials, including coating technologies, and suggest appropriate directions for future work.
RP TRELOAR, PH (reprint author), UNIV MANCHESTER,HOPE HOSP,DEPT MED,CLIN BIOCHEM SECT,ECCLES OLD RD,SALFORD M6 8HD,LANCS,ENGLAND.
CR BLUM LJ, 1991, BIOSENSORS PRINCIPLE
   BORESTOS JW, 1973, CONCISE GUIDE BIOMED, P11
   CHRISTIE I, 1993, ANAL CHIM ACTA, V272, P145, DOI 10.1016/0003-2670(93)80386-Y
   CHRISTIE IM, 1993, ANAL CHIM ACTA, V274, P191, DOI 10.1016/0003-2670(93)80465-W
   CHRISTIE IM, 1992, ANAL CHIM ACTA, V269, P65, DOI 10.1016/0003-2670(92)85134-R
   CHRISTIE IM, 1991, Patent No. 91054064
   CHURCHOUSE SJ, 1986, BIOSENSORS, V2, P325, DOI 10.1016/0265-928X(86)85022-2
   CLARK LC, 1962, ANN NY ACAD SCI, V102, P29, DOI 10.1111/j.1749-6632.1962.tb13623.x
   DESAI MA, 1993, SCAND J CLIN LAB INV, V53, P53, DOI 10.3109/00365519309090679
   EVANS AC, 1991, SURF COAT TECH, V47, P662, DOI 10.1016/0257-8972(91)90338-W
   FRANKS J, 1989, J VAC SCI TECHNOL A, V7, P2307, DOI 10.1116/1.575933
   GORTON L, 1990, ANAL CHIM ACTA, V223, P23
   HIGSON SPJ, 1993, ANAL CHIM ACTA, V271, P125, DOI 10.1016/0003-2670(93)80559-4
   KAMIZAWA C, 1972, B CHEM SOC JPN, V45, P2964, DOI 10.1246/bcsj.45.2964
   KHEDR MGA, 1979, CHEM-ING-TECH, V51, P756, DOI 10.1002/cite.330510719
   KOOCHAKI Z, 1991, J MEMBRANE SCI, V57, P83, DOI 10.1016/S0376-7388(00)81164-3
   MATSUURA T, 1971, J APPL POLYM SCI, V15, P2905, DOI 10.1002/app.1971.070151202
   MULLEN WH, 1986, ANAL CHIM ACTA, V183, P59, DOI 10.1016/0003-2670(86)80074-5
   PALLESCHI G, 1986, ANAL BIOCHEM, V159, P114, DOI 10.1016/0003-2697(86)90315-5
   REYNOLDS ER, 1992, BIOSENSORS CHEM SENS, P186
   ROFF WJ, 1971, FIBRES FILMS PLASTIC, P463
   TANG LX, 1990, ANAL CHIM ACTA, V232, P357, DOI 10.1016/S0003-2670(00)81254-4
   THEWS G, 1960, ARCH GES PHYSIOL, V271, P227
   THOMSON LA, 1991, BIOMATERIALS, V12, P37
   Turner A. P. F., 1987, BIOSENSORS FUNDAMENT
NR 25
TC 25
Z9 25
U1 0
U2 7
PU ELSEVIER ADVANCED TECHNOLOGY
PI OXFORD
PA OXFORD FULFILLMENT CENTRE THE BOULEVARD, LANGFORD LANE, KIDLINGTON,
   OXFORD, OXON, ENGLAND OX5 1GB
SN 0956-5663
J9 BIOSENS BIOELECTRON
JI Biosens. Bioelectron.
PY 1995
VL 10
IS 1-2
BP 195
EP 201
DI 10.1016/0956-5663(95)96806-A
PG 7
WC Biophysics; Biotechnology & Applied Microbiology; Chemistry, Analytical;
   Electrochemistry; Nanoscience & Nanotechnology
SC Biophysics; Biotechnology & Applied Microbiology; Chemistry;
   Electrochemistry; Science & Technology - Other Topics
GA QK937
UT WOS:A1995QK93700019
PM 7734119
DA 2018-10-20
ER

PT J
AU Kohn, DH
AF Kohn, DH
TI Acoustic emission and nondestructive evaluation of biomaterials and
   tissues
SO CRITICAL REVIEWS IN BIOMEDICAL ENGINEERING
LA English
DT Review
DE acoustic emission; biomaterials; bone; implants; fatigue; damage; damage
   accumulation; wave
ID QUANTITATIVE COMPUTED-TOMOGRAPHY; ULTRASONIC WAVE-PROPAGATION; VIBRATION
   TESTING INSITU; X-RAY ABSORPTIOMETRY; HUMAN CORTICAL BONE; SINGLE
   PHOTON-ABSORPTIOMETRY; FATIGUE DAMAGE ACCUMULATION; TI-6AL-4V IMPLANT
   ALLOY; EMBEDDED OPTICAL FIBER; POROUS COATED IMPLANTS
AB Acoustic emission (AE) is an acoustic wave generated by the release of energy from localized sources in a material subjected to an externally applied stimulus. This technique may be used nondestructively to analyze tissues, materials, and biomaterial/tissue interfaces. Applications of AE include use as an early warning tool for detecting tissue and material defects and incipient failure, monitoring damage progression, predicting failure, characterizing failure mechanisms, and serving as a tool to aid in understanding material properties and structure-function relations. All these applications may be performed in real time.
   This review discusses general principles of AE monitoring and the use of the technique in 3 areas of importance to biomedical engineering: (1) analysis of biomaterials, (2) analysis of tissues, and (3) analysis of tissue/biomaterial interfaces. Focus in these areas is on detection sensitivity, methods of signal analysis in both the time and frequency domains, the relationship between acoustic signals and microstructural phenomena, and the uses of the technique in establishing a relationship between signals and failure mechanisms.
C1 UNIV MICHIGAN, BIOENGN PROGRAM, ANN ARBOR, MI 48109 USA.
RP Kohn, DH (reprint author), UNIV MICHIGAN, SCH DENT, DEPT BIOL & MAT SCI, ANN ARBOR, MI 48109 USA.
RI CHEN, Jiangang/A-1549-2011
FU NIAMS NIH HHS [5-P60-AR20557]; NCRR NIH HHS [2-SO7-RR05321]
CR ABDELSALAM S, 1990, INT J FRACTURE, V45, P311, DOI 10.1007/BF00036274
   ABENDSCHEIN W, 1970, CLIN ORTHOP RELAT R, P294
   ABENDSCHEIN WF, 1972, J TRAUM, V12, P297, DOI 10.1097/00005373-197204000-00005
   ALREJA V, 1985, P 5 INT C TIT DTSCH, P933
   AN HS, 1994, SPINE, V19, P2358, DOI 10.1097/00007632-199410150-00019
   ANAST G T, 1958, Am J Phys Med, V37, P157
   ASHMAN RB, 1990, J BIOMECH, V23, P941, DOI 10.1016/0021-9290(90)90359-B
   ASHMAN RB, 1987, J BIOMECH, V20, P979, DOI 10.1016/0021-9290(87)90327-7
   ASHMAN RB, 1988, J BIOMECH, V21, P177, DOI 10.1016/0021-9290(88)90167-4
   ASHMAN RB, 1984, J BIOMECH, V17, P349, DOI 10.1016/0021-9290(84)90029-0
   AWERBUCH J, 1988, ASTM STP, V964, P121
   BACHMANN V, 1976, J TEST EVAL, V4, P257
   BAKUCKAS JG, 1987, ISTFA ADV MAT S ASM, P33
   BARAN DT, 1988, CALCIFIED TISSUE INT, V43, P138, DOI 10.1007/BF02571310
   BARTLETT ML, 1987, C P FAT, P87
   BASSIM NM, 1981, ACOUSTIC EMISSION, P139
   BAXTER WJ, 1990, J TEST EVAL, V18, P430
   BAXTER WJ, 1977, RES TECHNIQUES NONDE, V3, P395
   Beattie AG., 1983, J ACOUSTIC EMISSION, V2, P95
   BEHIRI JC, 1980, J MATER SCI, V15, P1841, DOI 10.1007/BF00550605
   BENTZEN SM, 1987, J BIOMECH, V20, P743, DOI 10.1016/0021-9290(87)90053-4
   Bereiter-Hahn J., 1989, Acoustical Imaging. Vol.17, P27
   BERNDT CC, 1985, J ENG GAS TURB POWER, V107, P142, DOI 10.1115/1.3239674
   BERNDT CC, 1984, ULTRASTRUCTURE PROCE, P524
   BILGRAM R, 1985, P 5 INT C TIT DTSCH, P955
   BONFIELD W, 1982, J BIOMED ENG, V4, P23, DOI 10.1016/0141-5425(82)90022-X
   BONFIELD W, 1976, J BIOMECH, V9, P131, DOI 10.1016/0021-9290(76)90151-2
   BONSE U, 1991, J MATER SCI, V26, P4076
   BOWLES CO, 1992, J MATER SCI, V27, P5756
   BRASSOW F, 1982, EUR J RADIOL, V2, P99
   BRIGGS GAD, 1985, INTRO SCANNING ACOUS
   BRIGHTON CT, 1979, ELECTRICAL PROPERTIE
   Broek D., 1984, ELEMENTARY ENG FRACT
   Buck O., 1989, MRS Bulletin, V14, P44
   BURR DB, 1985, J BIOMECH, V18, P189, DOI 10.1016/0021-9290(85)90204-0
   CALER WE, 1989, J BIOMECH, V22, P625, DOI 10.1016/0021-9290(89)90013-4
   Callaghan J J, 1992, J Arthroplasty, V7, P495, DOI 10.1016/S0883-5403(05)80223-2
   CANN CE, 1985, BONE, V6, P1, DOI 10.1016/8756-3282(85)90399-0
   CARTER DR, 1976, J BIOMECH, V9, P27, DOI 10.1016/0021-9290(76)90136-6
   CARTER DR, 1981, J BIOMECH, V14, P461, DOI 10.1016/0021-9290(81)90096-8
   CARTER DR, 1981, ACTA ORTHOP SCAND, V52, P481, DOI 10.3109/17453678108992136
   CARTER DR, 1976, J BIOMECH, V9, P211, DOI 10.1016/0021-9290(76)90006-3
   CARTER DR, 1977, J BIOMECH, V10, P325, DOI 10.1016/0021-9290(77)90005-7
   CAZENEUVE C, 1990, J MATER SCI, V25, P1902, DOI 10.1007/BF01045740
   CHANCY G, 1985, P 5 INT C TIT DTSCH, P1891
   CHEN IIH, 1987, J BIOMECH, V20, P523, DOI 10.1016/0021-9290(87)90252-1
   CHEN PS, 1984, EXP MECH, V24, P342
   CHRISTEL P, 1989, J BIOMED MATER RES, V23, P45, DOI 10.1002/jbm.820230105
   CHRISTENSEN AB, 1986, J BIOMECH, V19, P53, DOI 10.1016/0021-9290(86)90108-9
   CODY DD, 1991, SPINE, V16, P146
   COGNARD J, 1990, J ADHESION, V32, P45, DOI 10.1080/00218469008030179
   COLLIER RJ, 1982, J BIOMECH, V15, P545, DOI 10.1016/0021-9290(82)90067-7
   CORNELISSEN M, 1987, J BIOMECH, V20, P333, DOI 10.1016/0021-9290(87)90041-8
   CORNELISSEN P, 1986, J BIOMECH, V19, P551, DOI 10.1016/0021-9290(86)90128-4
   CRAIG RG, 1993, RESTORATIVE DENTAL M
   CULNANE AH, 1991, J MATER SCI LETT, V10, P333, DOI 10.1007/BF00719700
   CURREY J, 1984, MECHANICAL ADAPTATIO
   CURTIS GJ, 1975, NON-DESTRUCT TEST, V8, P249, DOI 10.1016/0029-1021(75)90045-6
   DAI YZ, 1991, INT J FATIGUE, V13, P227, DOI 10.1016/0142-1123(91)90246-U
   DANIEL BL, 1994, INVEST RADIOL, V29, P933, DOI 10.1097/00004424-199410000-00012
   DAVIES JP, 1993, T SOC BIOMAT, V19, P244
   DELAVEAUX R, 1991, MATER EVAL, V49, P1042
   DOHERTY WP, 1974, J BIOMECH, V7, P559, DOI 10.1016/0021-9290(74)90090-6
   DOWLING NE, 1985, ASTM STAND NEWS, V13, P44
   DROUILLAR TF, 1983, 1 INT S AC EM REINF, P1
   DROUILLARD TF, 1988, MATER EVAL, V46, P174
   DROUILLARD TF, 1990, J ACOUSTIC EMISSION, V9, P45
   DROUILLARD TF, 1986, J ACOUSTIC EMISSION, V5, P120
   DUNEGAN HL, 1971, MATER RES STANDARD, V11, P21
   DURAY SJ, 1995, J DENT RES, V74, P184
   ELIAS JJ, 1993, 1993 BIOENG C LA BED, V24, P327
   ESSES SI, 1989, J BONE MINER RES, V4, P715
   EYRES KS, 1993, J BONE JOINT SURG BR, V75, P358
   FAH D, 1988, J BIOMECH, V21, P975, DOI 10.1016/0021-9290(88)90136-4
   FARAH JW, 1973, J BIOMECH, V6, P511, DOI 10.1016/0021-9290(73)90009-2
   FEINSTEIN L, 1975, P 10 S NDE, P143
   FELDKAMP LA, 1989, J BONE MINER RES, V4, P3, DOI 10.1002/jbmr.5650040103
   FIG LM, 1990, ARCH OTOLARYNGOL, V116, P191
   FILIAGGI MJ, 1991, J BIOMED MATER RES, V25, P1211, DOI 10.1002/jbm.820251004
   FIROOZNIA H, 1986, RADIOLOGY, V159, P737, DOI 10.1148/radiology.159.3.3704152
   FIROOZNIA H, 1984, CT-J COMPUT TOMOGR, V8, P99
   FISCHER RA, 1986, J BIOMECH, V19, P119, DOI 10.1016/0021-9290(86)90142-9
   FLORIANI LP, 1967, SURG FORUM, V18, P48
   FRANK EH, 1991, T ORTHOP RES SOC, V16, P74
   FRIESEL M, 1984, METALL TRANS A, V15, P1849, DOI 10.1007/BF02664898
   FRIESEL MA, 1984, MATER SCI ENG, V68, P107, DOI 10.1016/0025-5416(84)90248-9
   Frost H.M., 1960, H FORD HOSP B, V8, P25
   FROST HM, 1966, BONE DYNAMICS OSTEOP
   FUHRMANN J, 1993, J APPL POLYM SCI, V48, P2123, DOI 10.1002/app.1993.070481207
   FUJII Y, 1994, BONE MINER, V25, P93, DOI 10.1016/S0169-6009(08)80251-6
   GALLAGHER C, 1985, J COMPUT ASSIST TOMO, V9, P634, DOI 10.1097/00004728-198505000-00075
   GAO XJ, 1988, PROGR ACOUSTIC EMISS, V4, P201
   GAO XJ, 1986, PROGR ACOUSTIC EMISS, V3, P263
   GARDNER TN, 1992, J BIOMECH, V25, P1265, DOI 10.1016/0021-9290(92)90282-6
   GEORGE TF, 1992, J APPL BIOMATER, V3, P29, DOI 10.1002/jab.770030106
   GERLANC M, 1975, CLIN ORTHOP RELAT R, V111, P175
   GOLDRING SR, 1983, J BONE JOINT SURG AM, V65, P575, DOI 10.2106/00004623-198365050-00001
   GREENFIELD GB, 1991, RADIOGRAPHICS, V11, P611, DOI 10.1148/radiographics.11.4.1887116
   GREENFIELD MA, 1992, MED PHYS, V19, P1349, DOI 10.1118/1.596769
   HAMSTAD MA, 1986, EXP MECH, V26, P7, DOI 10.1007/BF02319949
   HANAGUD S, 1977, P IEEE ULTR S, P242
   HANAGUD S, 1974, P IEEE ULTR S, P77
   HARP JH, 1994, CLIN ORTHOP RELAT R, V301, P42
   HARRIS DO, 1974, EXP MECH, V14, P71, DOI 10.1007/BF02323130
   HARRIS DO, 1971, ASTM STP, V505, P238
   Hartbower C. E., 1973, Engineering Fracture Mechanics, V5, P765, DOI 10.1016/0013-7944(73)90050-7
   HASEGAWA K, 1993, BONE, V14, P737, DOI 10.1016/8756-3282(93)90205-O
   HAWORTH WL, 1979, FATIGUE ENG MATER, V1, P351, DOI 10.1111/j.1460-2695.1979.tb00392.x
   HAYES WC, 1991, RADIOL CLIN N AM, V29, P1
   HEANEY RP, 1989, JAMA-J AM MED ASSOC, V261, P2986, DOI 10.1001/jama.261.20.2986
   HEIPLE CR, 1981, ACOUSTIC EMISSION, P14
   HEROUX P, 1994, ANN BIOMED ENG, V22, P328, DOI 10.1007/BF02368239
   HIGHT TK, 1980, J BIOMECH, V13, P139, DOI 10.1016/0021-9290(80)90188-8
   HONEYCOMBE RWK, 1988, PLASTIC DEFORMATION
   HORN CA, 1965, J COLL RADIOL AUSTRA, V9, P165
   HOWIE DW, 1988, J BONE JOINT SURG AM, V70A, P257, DOI 10.2106/00004623-198870020-00015
   HVID I, 1989, J BIOMECH, V22, P837, DOI 10.1016/0021-9290(89)90067-5
   Irwin G. R, 1957, J APPL MECH, V24, P361, DOI DOI 10.1111/J.1460-2695.2012.01707.X
   JACKSON P, 1990, J MATER SCI LETT, V9, P1165, DOI 10.1007/BF00721878
   JANES GC, 1993, J BONE JOINT SURG BR, V75, P914
   JASTY M, 1991, J BONE JOINT SURG BR, V73, P551
   JASTY MJ, 1986, J BONE JOINT SURG AM, V68A, P912, DOI 10.2106/00004623-198668060-00014
   JEE WSS, 1990, ANAT REC, V227, P418, DOI 10.1002/ar.1092270405
   JENG JS, 1989, J ACOUSTIC EMISSION, V8, pS268
   JONSSON U, 1984, ACTA ORTHOP SCAND, V55, P441, DOI 10.3109/17453678408992391
   JURIST JM, 1970, PHYS MED BIOL, V15, P417, DOI 10.1088/0031-9155/15/3/002
   JURIST JM, 1973, J BIOMECH, V6, P331, DOI 10.1016/0021-9290(73)90093-6
   KANEKO T, 1986, J BIOMED MATER RES, V20, P169, DOI 10.1002/jbm.820200206
   KANEKO T, 1991, BIOMATERIALS, V12, P555, DOI 10.1016/0142-9612(91)90050-K
   KANNATEYASIBU E, 1987, J MECH SYS SIG P, V1, P333
   KATZ JL, 1993, J BIOMECH ENG-T ASME, V115, P543, DOI 10.1115/1.2895537
   KATZ Y, 1970, INT J FRACT MECH, V6, P219
   KAUFMAN JJ, 1993, J BONE MINER RES, V8, P517
   KENNEDY JR, 1982, SCRIPTA METALL MATER, V16, P525, DOI 10.1016/0036-9748(82)90263-0
   KEYAK JH, 1994, J BIOMED MATER RES, V28, P1329, DOI 10.1002/jbm.820281111
   KHALIL TB, 1981, J SOUND VIB, V75, P417, DOI 10.1016/0022-460X(81)90387-4
   KIM HC, 1994, J MAT RES, V9
   KIM KH, 1994, J DENT RES, V73, P499, DOI 10.1177/00220345940730020301
   KIM KH, 1991, ENG FRACT MECH, V40, P811, DOI 10.1016/0013-7944(91)90238-V
   KISHI T, 1980, TITANIUM 80 SCI TECH, P1709
   KISHI T, 1985, TITANIUM SCI TECHNOL, P2039
   KISHI T, 1984, PROGR ACOUSTIC EMISS, V2, P547
   KLINE RA, 1990, J ENG MATER-T ASME, V112, P218, DOI 10.1115/1.2903310
   KNETS LV, 1975, MEKH POLIM, V4, P685
   KNODO S, 1985, DENT MATER J, V4, P81
   KOENEMAN J, 1990, J APPL BIOMATER, V1, P79, DOI 10.1002/jab.770010110
   KOHLES SS, 1994, J BIOMECH, V27, P137, DOI 10.1016/0021-9290(94)90202-X
   KOHN DH, 1992, J BIOMED MATER RES, V26, P19, DOI 10.1002/jbm.820260104
   KOHN DH, 1990, J BIOMED MATER RES, V24, P1483, DOI 10.1002/jbm.820241106
   KOHN DH, 1992, J MATER SCI, V27, P3133, DOI 10.1007/BF01116003
   KOHN DH, 1994, MED PROG TECHNOL, V20, P169
   KOHN DH, 1992, J MATER SCI, V27, P1633, DOI 10.1007/BF00542927
   KOHN DH, 1992, 1992 ADV BIOENGINEER, V27, P297
   KOHN DH, 1995, HDB ADV MAT TESTING, P593
   KOHN DH, 1989, TITANIUM SCI TECHNOL, P789
   KONDO S, 1992, J DENT RES, V71, P558
   KONONEN M, 1991, DENT MATER, V7, P211, DOI 10.1016/0109-5641(91)90046-2
   KRASNOW AZ, 1987, J NUCL MED, V28, P1268
   KRAUYA UE, 1978, MEKH POLIM, V7, P109
   KROGER H, 1995, ACTA ORTHOP SCAND, V66, P47, DOI 10.3109/17453679508994639
   KUPPERMAN DS, 1990, J ENG MATER-T ASME, V112, P198, DOI 10.1115/1.2903307
   Kushibiki J., 1987, IEEE 1987 Ultrasonics Symposium Proceedings (Cat. No.87CH2492-7), P837
   KWON OY, 1990, J ACOUSTIC EMISSION, V9, P123
   KWON SJ, 1985, P IEEE ULTR S, P864
   LAKES R, 1986, J BIOMED ENG, V8, P143, DOI 10.1016/0141-5425(86)90049-X
   LANG SB, 1970, IEEE T BIO-MED ENG, VBM17, P101, DOI 10.1109/TBME.1970.4502706
   LANG SM, 1988, J BONE JOINT SURG AM, V70A, P1531, DOI 10.2106/00004623-198870100-00013
   LANKFORD J, 1991, J MATER SCI, V26, P1131
   LAWRENCE JM, 1991, T ORTHOP RES SOC, V16, P518
   LAYTON MW, 1988, ARTHRITIS RHEUM, V31, P1400, DOI 10.1002/art.1780311109
   LEAITY GP, 1984, FAT FRACT ENG MAT ST, V12, P271
   LEE SY, 1995, J DENT RES, V74, P184
   LEICHTER I, 1992, BIOMATERIALS, V13, P478, DOI 10.1016/0142-9612(92)90170-S
   LEWIS JL, 1975, J BIOMECH, V8, P17, DOI 10.1016/0021-9290(75)90039-1
   LEWIS JL, 1975, J BONE JOINT SURG AM, V57, P576
   LI SX, 1984, MATER EVAL, V42, P1020
   LI XJ, 1990, ANAT REC, V227, P12, DOI 10.1002/ar.1092270103
   LICHT T, 1979, 2 TECH REV
   LIEBETRAU R, 1993, J OTOLARYNGOL, V22, P249
   LINGARD S, 1993, WEAR, V162, P597, DOI 10.1016/0043-1648(93)90548-Z
   LINGARD S, 1984, WEAR, V96, P75, DOI 10.1016/0043-1648(84)90105-4
   LOTZ JC, 1990, J COMPUT ASSIST TOMO, V14, P107, DOI 10.1097/00004728-199001000-00020
   LOWET G, 1993, J BIOMECH, V26, P689, DOI 10.1016/0021-9290(93)90032-A
   MA BT, 1990, POLYM COMPOSITE, V11, P211, DOI 10.1002/pc.750110403
   MAISL M, 1990, J ENG MATER-T ASME, V112, P223, DOI 10.1115/1.2903311
   MARGOLIN H, 1980, TITANIUM 80 SCI TECH, P169
   MARKEL MD, 1992, AM J VET RES, V53, P2105
   MARKEL MD, 1990, ACTA ORTHOP SCAND, V61, P487, DOI 10.3109/17453679008993569
   MARTIN B, 1992, J ORTHOP RES, V10, P818, DOI 10.1002/jor.1100100611
   MARTIN RB, 1982, J BIOMECH, V15, P137
   MARTIN RB, 1989, STRUCTURE FUNCTION A
   MASLOUHI A, 1989, J ACOUSTIC EMISSION, V8, pS292
   MATTHEWS JR, 1981, ACOUSTIC EMISSION
   MAZESS RB, 1989, ANN BIOMED ENG, V17, P177, DOI 10.1007/BF02368026
   MCBROOM RJ, 1985, J BONE JOINT SURG AM, V67A, P1206, DOI 10.2106/00004623-198567080-00010
   MCCABE F, 1991, J BONE MINER RES, V6, P53
   MCCARTHY RN, 1990, J BIOMECH, V23, P1139, DOI 10.1016/0021-9290(90)90006-O
   MCGUIRE SM, 1993, J MATER RES, V8, P2216, DOI 10.1557/JMR.1993.2216
   MCKELVIE ML, 1991, PHYS MED BIOL, V36, P1331, DOI 10.1088/0031-9155/36/10/003
   MEDRANO RE, 1993, REV SCI INSTRUM, V64, P250, DOI 10.1063/1.1144446
   MELANITIS N, 1990, J MATER SCI, V25, P5081, DOI 10.1007/BF00580133
   MELTON LJ, 1993, J BONE MINER RES, V8, P1227
   MEUNIER A, 1988, J ORTHOPAED RES, V6, P770, DOI 10.1002/jor.1100060521
   Mielke W., 1990, Journal of Acoustic Emission, V9, P103
   MOORTHY V, 1991, FAT FRACT STEEL CONC
   MORRIS RA, 1975, P 10 S NDE, P90
   MOSEKILDE L, 1989, BONE, V10, P465, DOI 10.1016/8756-3282(89)90080-X
   MURPHY KA, 1992, APPL OPTICS, V31, P431, DOI 10.1364/AO.31.000431
   MURRAY IPC, 1989, SKELETAL RADIOL, V18, P493, DOI 10.1007/BF00351747
   MYERS ER, 1991, CALCIFIED TISSUE INT, V49, P292, DOI 10.1007/BF02556221
   *NASA, 1992, NASA TECH BRIEFS
   *NASA, 1993, NASA TECH BRIEFS, V17, P22
   *NASA, 1992, YASA TECH BRIEFS, V16, P62
   NETRAVALI AN, 1989, COMPOS SCI TECHNOL, V34, P289, DOI 10.1016/0266-3538(89)90001-8
   NETRAVALI AN, 1989, COMPOS SCI TECHNOL, V35, P13, DOI 10.1016/0266-3538(89)90068-7
   NETZ P, 1979, ACTA ORTHOP SCAND S, V176
   NICHOLLS PJ, 1981, MED BIOL ENG COMPUT, V19, P416, DOI 10.1007/BF02441305
   OBRIEN WJ, 1977, DENTAL MATERIALS REV, P123
   OCCHIELLO E, 1989, COMPOS SCI TECHNOL, V36, P133, DOI 10.1016/0266-3538(89)90084-5
   OHIRA T, 1980, 5TH P INT AE S, P137
   OHTA A, 1977, INT J FRACTURE, V13, P289
   OHTA A, 1977, ENG FRACT MECH, V9, P307
   OKAWAI H, 1989, ACOUST IMAGING, P192
   ONO K, 1979, FUNDAMENTALS ACOUSTI, P167
   ORTOFT G, 1993, BONE, V14, P667, DOI 10.1016/8756-3282(93)90090-W
   OVERGAARD K, 1992, CALCIFIED TISSUE INT, V50, P30, DOI 10.1007/BF00297294
   PAPAZLAN JM, 1992, J ENG MAT TECH, V114, P399
   PECK SD, 1989, J DENT RES, V68, P107, DOI 10.1177/00220345890680020201
   PELKER RR, 1985, J BIOMECH, V18, P745, DOI 10.1016/0021-9290(85)90049-1
   PELKER RR, 1983, J BIOMECH, V16, P481, DOI 10.1016/0021-9290(83)90062-3
   PETERS A, 1982, MED BIOL ENG COMPUT, V20, pN8
   POLEKSIC L, 1993, SKELETAL RADIOL, V22, P577
   POLIAKOFF SJ, 1989, T ORTHOP RES SOC, V14, P483
   POLLOCK AA, 1981, INT ADV NONDESTRUCTI, V7, P215
   PULS MP, 1991, METALL TRANS A, V22, P2327, DOI 10.1007/BF02664999
   PUSKAR A, 1993, ULTRASONICS, V31, P61, DOI 10.1016/0041-624X(93)90034-W
   QUINTEN A, 1989, MAT SCI ENG A-STRUCT, V122, P15, DOI 10.1016/0921-5093(89)90764-8
   RAGHAVENDRO MN, 1989, J ACOUSTIC EMISSION, V8, pS284
   RAJAN DS, 1989, J ACSOUSTIC EMISSION, V8, pS297
   RAYMAKERS JA, 1986, SKELETAL RADIOL, V15, P191, DOI 10.1007/BF00354059
   ROSENQVIST R, 1986, J BONE JOINT SURG AM, V68A, P538, DOI 10.2106/00004623-198668040-00009
   RUBIN CT, 1987, J BIOMECH, V20, P723, DOI 10.1016/0021-9290(87)90038-8
   SACHSE W, 1991, ASTM STP, V1077
   SAFAI S, 1979, AM CERAM SOC BULL, V58, P624
   SAFAI S, 1980, 9 INT THERM SPRAY C, P129
   SAHA S, 1977, IEEE T BIO-MED ENG, V24, P508, DOI 10.1109/TBME.1977.326161
   SAHA S, 1977, J BIOMECH, V10, P393, DOI 10.1016/0021-9290(77)90015-X
   SCHAFFLER MB, 1990, BONE, V11, P321, DOI 10.1016/8756-3282(90)90087-F
   SCHAFFLER MB, 1989, BONE, V10, P207, DOI 10.1016/8756-3282(89)90055-0
   SCHAFFLER MB, 1994, BONE, V15, P483, DOI 10.1016/8756-3282(94)90271-2
   SCHMIDT J, 1994, MED BIOL ENG COMPUT, V32, P258, DOI 10.1007/BF02512520
   SCHUBIGER O, 1986, NEURORADIOLOGY, V28, P93, DOI 10.1007/BF00327878
   SCHUSTER J, 1990, J COMPOS TECH RES, V12, P52
   SEITZ P, 1987, J BONE JOINT SURG BR, V69, P407
   SHANKAR NR, 1982, CERAM ENG SCI P, V3, P772
   SHANKAR NR, 1983, 10 INT THERM SPRAYIN, P41
   SHIMAISHIN OA, 1976, MAT EVOL, V34, P137
   Sklarczyk C., 1992, Journal of the European Ceramic Society, V9, P427, DOI 10.1016/0955-2219(92)90103-K
   SMITH MD, 1992, CLIN ORTHOPAEDICS, V283, P244
   SMITH PA, 1990, COMPOS SCI TECHNOL, V38, P85, DOI 10.1016/0266-3538(90)90073-E
   SNYDER SM, 1991, J ORTHOPAED RES, V9, P422, DOI 10.1002/jor.1100090315
   SONSTEGARD DA, 1976, J BIOMECH, V9, P689, DOI 10.1016/0021-9290(76)90170-6
   SPIEGL PV, 1975, J BIOMECH, V8, P213, DOI 10.1016/0021-9290(75)90027-5
   SRIKANTH V, 1994, J MATER SCI, V29, P3363, DOI 10.1007/BF00356686
   STEELE CR, 1988, J BIOMECH ENG-T ASME, V110, P87, DOI 10.1115/1.3108423
   STEPHENS RR, 1988, REV SCI INSTRUM, V59, P1412, DOI 10.1063/1.1139679
   STEWART A, 1994, CALCIFIED TISSUE INT, V54, P466, DOI 10.1007/BF00334324
   SUGIYAMA H, 1989, CLIN ORTHOP RELAT R, V249, P122
   SULIMAN AA, 1993, J DENT RES, V72, P1532, DOI 10.1177/00220345930720111201
   SUNDARESAN MJ, 1994, J COMPOS TECH RES, V16, P127
   TANAKA H, 1975, SCRIPTA METALL MATER, V9, P777, DOI 10.1016/0036-9748(75)90239-2
   TATENTO H, 1989, ACOUST IMAGING, P125
   TAVAKOLI MB, 1991, PHYS MED BIOL, V36, P1529, DOI 10.1088/0031-9155/36/11/012
   THOMAS RA, 1977, P IEEE ULTR S, P237
   THOMPSN DO, 1986, REV PROGR NONDESTRUC
   THOMPSON RB, 1975, P 10 S NDE, P98
   THOMPSON RB, 1990, J TEST EVAL, V18, P421
   THOMSEN JJ, 1990, J BIOMECH, V23, P215, DOI 10.1016/0021-9290(90)90013-S
   Tiitto K., 1989, Nondestructive Testing Communications, V5, P27, DOI 10.1080/02780898908952952
   TSURUTA H, 1980, P 5 INT AE S JAP SOC, P175
   TURNER CH, 1991, CALCIFIED TISSUE INT, V49, P116, DOI 10.1007/BF02565132
   ULREN L, 1990, J ADHESION, V31, P117, DOI 10.1080/00218469008048220
   VANBERKUM FNR, 1989, J BONE MINER RES, V4, P679
   VANBUSKIRK WC, 1986, J MATER SCI, V21, P2759, DOI 10.1007/BF00551484
   VANBUSKIRK WC, 1981, J BIOMECH ENG-T ASME, V103, P67, DOI 10.1115/1.3138262
   VANDERPERRE G, 1983, J BIOMECH ENG-T ASME, V105, P244, DOI 10.1115/1.3138412
   VANDERSCHUEREN D, 1993, CALCIFIED TISSUE INT, V53, P342, DOI 10.1007/BF01351841
   VANROERMUND PM, 1987, SKELETAL RADIOL, V16, P52, DOI 10.1007/BF00349929
   VARY A, 1991, MATER EVAL, V49, P581
   VARY A, 1991, AM SOC TEST MATER, V1077, P95, DOI 10.1520/STP19087S
   VERPOEST I, 1981, FATIGUE ENG MATER ST, V3, P203
   VIANO D, 1976, J BIOMECH, V9, P703, DOI 10.1016/0021-9290(76)90172-X
   VIKSTROM M, 1989, COMPOS STRUCT, V13, P49, DOI 10.1016/0263-8223(89)90072-X
   Wadley H. N. G., 1980, International Metals Reviews, V25, P41
   WAGNER L, 1989, TITANIUM SCI TECHNOL
   WAITE SR, 1990, COMPOSITES, V21, P148, DOI 10.1016/0010-4361(90)90007-J
   WAITE SR, 1990, COMPOSITES, V21, P225, DOI 10.1016/0010-4361(90)90237-Q
   WAKAYAMA S, 1985, P 2 INT C AC EM, pS278
   WALKER D, 1991, IEEE ENG MED BIOL C, V13, P2107
   WALTER A, 1984, BIOMATERIALS BIOMECH, P55
   WALTER A, 1986, MATER RES SOC S P, V55, P181
   WEHRLI FW, 1993, CALCIFIED TISSUE INT, V53, pS162, DOI 10.1007/BF01673429
   WEI RP, 1981, ASTM STP, V738, P103
   WELLS JG, 1985, BIOMATERIALS, V6, P218, DOI 10.1016/0142-9612(85)90016-X
   WEVERS M, 1991, AM SOC TEST MATER, V1077, P416, DOI 10.1520/STP19111S
   WHITE SP, 1989, PROSTHETIC HIP JOINT
   WILLERT HG, 1977, J BIOMED MATER RES, V11, P157, DOI 10.1002/jbm.820110202
   WILLERT HG, 1990, CLIN ORTHOP RELAT R, V258, P108
   WIOLAND M, 1993, J NUCL MED, V34, P1410
   WISHART JM, 1993, BRIT J RADIOL, V66, P435, DOI 10.1259/0007-1285-66-785-435
   WOLFARTH D, 1990, J APPL BIOMATER, V1, P3, DOI 10.1002/jab.770010103
   WOLTERS J, 1986, 2 INT S AC EM REINF, P29
   WONG ATC, 1976, J BIOMECH, V9, P813, DOI 10.1016/0021-9290(76)90189-5
   WONG FY, 1983, J BIOMECH, V16, P849, DOI 10.1016/0021-9290(83)90009-X
   WOOH SC, 1990, J ENG MATER-T ASME, V112, P175, DOI 10.1115/1.2903304
   WRIGHT TM, 1983, J BIOMECH ENG-T ASME, V105, P20, DOI 10.1115/1.3138379
   WRIGHT TM, 1976, J BIOMED MATER RES, V10, P637, DOI 10.1002/jbm.820100420
   WRIGHT TM, 1981, J BIOMECH, V14, P405, DOI 10.1016/0021-9290(81)90058-0
   WRIGHT TM, 1977, J BIOMECH, V10, P419, DOI 10.1016/0021-9290(77)90019-7
   WRIGHT TM, 1978, MATER EVAL, P37
   WRIGHT TM, 1981, 1981 BIOM S ASME NEW, P237
   WRIGHT TM, 1988, NONDESTRUCTIVE TESTI, V5, P447
   YAMAGUCHI K, 1991, AM SOC TEST MATER, V1077, P123, DOI 10.1520/STP19089S
   YAMAKI T, 1986, SURG NEUROL, V26, P551, DOI 10.1016/0090-3019(86)90338-1
   YAMAMOTO S, 1992, J MATER RES, V7, P2240, DOI 10.1557/JMR.1992.2240
   YEE BGW, 1973, TITANIUM SCI TECHNOL, P707
   YOON HS, 1976, J BIOMECH, V9, P459, DOI 10.1016/0021-9290(76)90089-0
   YOON HS, 1976, J BIOMECH, V9, P407, DOI 10.1016/0021-9290(76)90118-4
   YOON HS, 1980, P IEEE ULTR S, P1067
   YUYAMA S, 1982, PROGR ACOUSTIC EMISS, P126
   ZHU ZM, 1982, PROGR ACOUSTIC EMISS, P366
   ZIMMERMAN MC, 1989, J ORTHOP RES, V7, P607, DOI 10.1002/jor.1100070420
   ZIMMERMAN MC, 1990, IEEE T BIO-MED ENG, V37, P433, DOI 10.1109/10.55634
   ZIMMERMAN MC, 1994, J BIOMED MATER RES, V28, P931, DOI 10.1002/jbm.820280812
   ZIMMERMAN RA, 1987, NEURORADIOLOGY, V29, P246, DOI 10.1007/BF00451761
   ZIOUPOS P, 1994, J MATER SCI, V29, P978, DOI 10.1007/BF00351420
   ZIOUPOS P, 1994, MED ENG PHYS, V16, P203, DOI 10.1016/1350-4533(94)90039-6
   ZUMING Z, 1984, PROGR ACOUSTIC EMISS, V2, P218
   1983, 1 INT S AC EM REINF
   1976, 2 INT S AC EM REINF
NR 340
TC 9
Z9 9
U1 1
U2 14
PU BEGELL HOUSE INC
PI DANBURY
PA 50 NORTH ST, DANBURY, CT 06810 USA
SN 0278-940X
EI 1943-619X
J9 CRIT REV BIOMED ENG
JI Crit. Rev. Biomed. Eng.
PY 1995
VL 23
IS 3-4
BP 221
EP 306
DI 10.1615/CritRevBiomedEng.v23.i3-4.20
PG 86
WC Engineering, Biomedical
SC Engineering
GA VA999
UT WOS:A1995VA99900002
PM 8853951
DA 2018-10-20
ER

PT J
AU SWIFT, EJ
   BAYNE, SC
   MARKER, VA
   FORD, KY
AF SWIFT, EJ
   BAYNE, SC
   MARKER, VA
   FORD, KY
TI REVIEW OF THE 1994 DENTAL MATERIALS LITERATURE
SO DENTAL MATERIALS
LA English
DT Review
AB Objectives. Electronic databases provide strong support for research and education literature searches. However, there is still some lag in time between publication and updates of the database. The objective of this summary was to identify and categorize the 1994 dental materials scientific literature that dealt with restorative dentistry.
   Methods. Seventeen primary journals were manually searched via the Tables of Contents and 88 secondary journals were manually or electronically searched. Dental materials citations were categorized into 15 major sections and several subsections, excluding case reports and literature primarily related to dental implants or biomedical materials outside of dentistry.
   Results. Nearly twelve hundred citations were identified, the largest number being associated with composites and glass ionomers.
   Significance. This list provides a comprehensive source for review by academicians and researchers to bridge the gap between initial publication and electronic citation.
C1 BAYLOR COLL DENT, DEPT BIOMAT SCI, DALLAS, TX 75246 USA.
RP SWIFT, EJ (reprint author), UNIV N CAROLINA, SCH DENT, DEPT OPERAT DENT, CHAPEL HILL, NC 27599 USA.
CR Abdullah H., 1994, Clinical Materials, V16, P15, DOI 10.1016/0267-6605(94)90087-6
   Abuasi H A, 1994, Eur J Prosthodont Restor Dent, V2, P117
   Adair Steven M., 1994, Pediatric Dentistry, V16, P410
   ADAMS AM, 1994, INT ENDOD J, V27, P171, DOI 10.1111/j.1365-2591.1994.tb00250.x
   Adams D, 1994, Adv Dent Res, V8, P291
   ALBERT K, 1994, BIO-MED MATER ENG, V4, P199
   ALBERT MS, 1994, NATURE, V370, P199, DOI 10.1038/370199a0
   ALBERTS B, 1994, SCIENCE, V266, P1660, DOI 10.1126/science.7992048
   Aldana L, 1994, Int J Prosthodont, V7, P473
   ALHADAINY HA, 1994, J ENDODONT, V20, P449, DOI 10.1016/S0099-2399(06)80036-1
   Allen W R, 1994, J Dent Assoc S Afr, V49, P331
   ALLENBY CF, 1994, CONTACT DERMATITIS, V30, P135, DOI 10.1111/j.1600-0536.1994.tb00693.x
   Almajed I, 1994, J Clin Pediatr Dent, V19, P19
   ALPER J, 1994, SCIENCE, V263, P324, DOI 10.1126/science.8278805
   ALTIERI JV, 1994, J PROSTHET DENT, V71, P16, DOI 10.1016/0022-3913(94)90249-6
   AMBJORNSEN E, 1994, DENT MATER, V10, P107, DOI 10.1016/0109-5641(94)90049-3
   AMORY C, 1994, DENT MATER, V10, P203, DOI 10.1016/0109-5641(94)90033-7
   ANDERSSON B, 1994, INT J ORAL MAXILLOF, V9, P665
   ANDERSSON L, 1994, SWED DENT J S, V56
   ANDERSSON OH, 1994, BIOMATERIALS, V15, P882, DOI 10.1016/0142-9612(94)90111-2
   ANDREOPOULOS AG, 1994, J PROSTHET DENT, V72, P462, DOI 10.1016/0022-3913(94)90115-5
   Andrews P B, 1994, J Can Dent Assoc, V60, P976
   Angmar-Mansson B, 1994, Adv Dent Res, V8, P75
   ANSELME K, 1994, CELL MATER, V4, P113
   ANUSAVICE KJ, 1994, DENT MATER, V10, P141, DOI 10.1016/0109-5641(94)90055-8
   ANUSAVICE KJ, 1994, DENT MATER, V10, P230, DOI 10.1016/0109-5641(94)90066-3
   Aoba T, 1994, Adv Dent Res, V8, P66
   APPLETON J, 1994, SCANNING MICROSCOPY, V8, P711
   ARAKI K, 1994, J ENDODONT, V20, P67, DOI 10.1016/S0099-2399(06)81183-0
   Arnold T J, 1994, Compendium, V15, P780
   ARTACHOPERULA E, 1994, J MICROSC-OXFORD, V173, P73, DOI 10.1111/j.1365-2818.1994.tb03429.x
   ARVIER JF, 1994, BRIT J ORAL MAX SURG, V32, P276, DOI 10.1016/0266-4356(94)90046-9
   ASAOKA K, 1994, J DENT RES, V73, P1539, DOI 10.1177/00220345940730090901
   ASSAEL LA, 1994, J ORAL MAXIL SURG, V52, P757, DOI 10.1016/0278-2391(94)90495-2
   ASSIF D, 1994, J PROSTHET DENT, V71, P565, DOI 10.1016/0022-3913(94)90438-3
   ATCHISON WD, 1994, FASEB J, V8, P622
   ATTAL JP, 1994, DENT MATER, V10, P259, DOI 10.1016/0109-5641(94)90071-X
   ATTIN T, 1994, OPER DENT, V19, P110
   AVOURIS P, 1994, SCIENCE, V264, P942, DOI 10.1126/science.264.5161.942
   Awad M A, 1994, J Can Dent Assoc, V60, P318
   BAGLEY A, 1994, OPER DENT, V19, P97
   Bahn S L, 1994, Compendium, V15, P825
   BALES DJ, 1991, CURR OPIN DENT, V1, P253
   BALES DJ, 1992, CURR OPIN DENT, V2, P183
   BALES DJ, 1991, CURR OPIN DENT, V1, P245
   BALL P, 1994, NATURE, V367, P323, DOI 10.1038/367323a0
   BANKS PA, 1994, EUR J ORTHODONT, V16, P19, DOI 10.1093/ejo/16.1.19
   BAPNA MS, 1994, J ORAL REHABIL, V21, P577, DOI 10.1111/j.1365-2842.1994.tb01172.x
   BARAN G, 1994, J DENT RES, V73, P1450, DOI 10.1177/00220345940730080901
   Baratieri L N, 1994, Quintessence Int, V25, P749
   Barber H D, 1994, Compendium, V15, P1392
   BARBOSA SV, 1994, J ENDODONT, V20, P6, DOI 10.1016/S0099-2399(06)80018-X
   Barclay C W, 1994, Eur J Prosthodont Restor Dent, V3, P5
   Barkmeier W W, 1994, Am J Dent, V7, P175
   Barkmeier W W, 1994, Am J Dent, V7, P239
   BARNES DM, 1994, OPER DENT, V19, P133
   Barreto L C, 1994, J Clin Pediatr Dent, V19, P31
   Barsby M J, 1994, J Can Dent Assoc, V60, P435
   BASSI G, 1994, BRIT DENT J, V177, P248, DOI 10.1038/sj.bdj.4808576
   Basson N J, 1994, J Dent Assoc S Afr, V49, P339
   BAUMBERGER T, 1994, NATURE, V367, P544, DOI 10.1038/367544a0
   BAYNE SC, 1994, DENT MATER, V10, P11, DOI 10.1016/0109-5641(94)90016-7
   BAYNE SC, 1994, J AM DENT ASSOC, V125, P687, DOI 10.14219/jada.archive.1994.0113
   BAYNE SC, 1994, DENT MATER, V10, P59, DOI 10.1016/0109-5641(94)90023-X
   BEAN TA, 1994, J BIOMED MATER RES, V28, P59, DOI 10.1002/jbm.820280108
   Bearn D R, 1994, Quintessence Int, V25, P321
   Bebermeyer R D, 1994, Quintessence Int, V25, P209
   Becker W, 1994, Int J Oral Maxillofac Implants, V9, P31
   BECKER W, 1994, INT J ORAL MAXILLOF, V9, P305
   Bell R B, 1994, J Esthet Dent, V6, P129, DOI 10.1111/j.1708-8240.1994.tb00846.x
   BELVEDERE PC, 1994, NW DENT          MAR, P19
   Ben-Amar A, 1994, Am J Dent, V7, P141
   BENBASSAT H, 1994, CELL MATER, V4, P37
   BERGLUND A, 1992, SWED DENT J S, V85
   BERGMAN B, 1994, SWED DENT J, V18, P25
   BERKSUN S, 1994, J PROSTHET DENT, V71, P423, DOI 10.1016/0022-3913(94)90109-0
   Berry E A, 1994, J Prosthodont, V3, P126, DOI 10.1111/j.1532-849X.1994.tb00141.x
   BERRY EA, 1994, OPER DENT, V19, P122
   BERRY FA, 1994, AM J DENT, V7, P333
   BERRY TG, 1994, J AM DENT ASSOC, V125, P392, DOI 10.14219/jada.archive.1994.0053
   BEUF O, 1994, DENT MATER, V10, P265, DOI 10.1016/0109-5641(94)90072-8
   Beyerle M P, 1994, Int J Prosthodont, V7, P234
   BILLAS IML, 1994, SCIENCE, V265, P1682, DOI 10.1126/science.265.5179.1682
   BISHARA SE, 1994, ANGLE ORTHOD, V64, P277
   BLOCK MS, 1994, J ORAL MAXIL SURG, V52, P937, DOI 10.1016/S0278-2391(10)80074-6
   BLOOM NS, 1994, NATURE, V367, P694, DOI 10.1038/367694a0
   Blumenthal N M, 1994, Ill Dent J, V63, P35
   BLUMENTHAL NM, 1994, DENT J, V63, P35
   Blunden R E, 1994, Br J Orthod, V21, P125
   BOGERT TR, 1994, ORAL HLTH, V84, P35
   Borem L M, 1994, Quintessence Int, V25, P283
   Botha C T, 1994, J Dent Assoc S Afr, V49, P201
   BOTTON G, 1994, J MICROSC-OXFORD, V173, P9, DOI 10.1111/j.1365-2818.1994.tb03424.x
   BOURKE AM, 1994, J DENT, V22, P242, DOI 10.1016/0300-5712(94)90123-6
   BOUVIER M, 1994, CELL MATER, V4, P135
   BOWEN WH, 1994, J DENT RES, V73, P1773, DOI 10.1177/00220345940730111501
   BOYD KS, 1994, INT ENDOD J, V27, P330, DOI 10.1111/j.1365-2591.1994.tb00278.x
   Boyd R L, 1994, Int Dent J, V44, P119
   BOYEN PJ, 1994, ORAL IMPLANTOLOGY, V20, P227
   Boyer D B, 1994, Am J Dent, V7, P91
   Brackett W W, 1994, Int J Prosthodont, V7, P13
   BRACKETT WW, 1994, OPER DENT, V19, P106
   BRAEM M, 1994, J DENT, V22, P97, DOI 10.1016/0300-5712(94)90010-8
   BRAEM MJA, 1994, J BIOMED MATER RES, V28, P1397, DOI 10.1002/jbm.820281203
   BREEDING LC, 1994, J PROSTHET DENT, V71, P31, DOI 10.1016/0022-3913(94)90252-6
   BRIDGEMAN AM, 1994, AUST DENT J, V39, P279, DOI 10.1111/j.1834-7819.1994.tb05562.x
   Briggs P, 1994, Eur J Prosthodont Restor Dent, V3, P51
   BROCKHURST PJ, 1994, AUST DENT J, V39, P33, DOI 10.1111/j.1834-7819.1994.tb05544.x
   BROWN RC, 1994, J ENDODONT, V20, P288, DOI 10.1016/S0099-2399(06)80818-6
   Brown Ronald S., 1994, General Dentistry, V42, P242
   BROWNE RM, 1994, J DENT, V22, pS21, DOI 10.1016/0300-5712(94)90035-3
   Browning G C, 1994, Quintessence Int, V25, P787
   Bryant A W, 1994, J Prosthodont, V3, P96, DOI 10.1111/j.1532-849X.1994.tb00135.x
   BRYANT RW, 1994, AUST DENT J, V39, P77, DOI 10.1111/j.1834-7819.1994.tb01377.x
   BUNKER BC, 1994, SCIENCE, V264, P48, DOI 10.1126/science.264.5155.48
   Burgess J, 1994, J Esthet Dent, V6, P207, DOI 10.1111/j.1708-8240.1994.tb00861.x
   Burke F J, 1994, Quintessence Int, V25, P335
   Burke F J, 1994, Quintessence Int, V25, P269
   Burke F J, 1994, Int Dent J, V44, P195
   BURKE FJT, 1994, BRIT DENT J, V176, P251, DOI 10.1038/sj.bdj.4808428
   BURKE FM, 1994, J DENT, V22, P283, DOI 10.1016/0300-5712(94)90061-2
   BURNS T, 1994, J DENT, V22, P273, DOI 10.1016/0300-5712(94)90056-6
   BURROW MF, 1994, J DENT RES, V73, P522, DOI 10.1177/00220345940730020701
   BURROW MF, 1994, DENT MATER, V10, P241, DOI 10.1016/0109-5641(94)90068-X
   BUSH AI, 1994, SCIENCE, V265, P1464, DOI 10.1126/science.8073293
   BUTTERMANN GR, 1994, J BIOMECH, V27, P1087, DOI 10.1016/0021-9290(94)90225-9
   Buyukyilmaz S, 1994, Int J Prosthodont, V7, P372
   CAI H, 1994, SCIENCE, V266, P1551, DOI 10.1126/science.266.5190.1551
   CALISKAN MK, 1994, INT ENDOD J, V27, P163, DOI 10.1111/j.1365-2591.1994.tb00247.x
   CALLIS PD, 1994, J ENDODONT, V20, P555, DOI 10.1016/S0099-2399(06)80072-5
   CALVERT P, 1994, NATURE, V367, P119, DOI 10.1038/367119a0
   CAMPS J, 1994, DENT MATER, V10, P210, DOI 10.1016/0109-5641(94)90034-5
   Cardoso A C, 1994, Quintessence Int, V25, P835
   CARMAN JE, 1994, J ENDODONT, V20, P571, DOI 10.1016/S0099-2399(06)80078-6
   Cassidy M, 1994, Dent Update, V21, P196
   CASSINELLI C, 1994, J BIOMED MATER RES, V28, P1427, DOI 10.1002/jbm.820281207
   CASTANO P, 1994, J MICROSC-OXFORD, V175, P229, DOI 10.1111/j.1365-2818.1994.tb03489.x
   Castellani D, 1994, Int J Prosthodont, V7, P149
   CASTELLANI D, 1994, J PROSTHET DENT, V72, P360, DOI 10.1016/0022-3913(94)90554-1
   CASTRO GW, 1994, OPER DENT, V19, P194
   CATTANILORENTE MA, 1994, DENT MATER, V10, P37, DOI 10.1016/0109-5641(94)90020-5
   Cavicchia F., 1994, INT J ORAL MAXILLOF, V9, P711
   CERNAVIN I, 1994, AUST DENT J, V39, P28, DOI 10.1111/j.1834-7819.1994.tb05543.x
   CHADWICK RG, 1994, BRIT DENT J, V176, P17, DOI 10.1038/sj.bdj.4808350
   CHADWICK RG, 1994, J DENT, V22, P364, DOI 10.1016/0300-5712(94)90090-6
   CHADWICK RG, 1994, J ORAL REHABIL, V21, P533, DOI 10.1111/j.1365-2842.1994.tb01167.x
   Chai J, 1994, J Prosthodont, V3, P134, DOI 10.1111/j.1532-849X.1994.tb00143.x
   Chai J, 1994, Int J Prosthodont, V7, P155
   Chain M C, 1994, Am J Dent, V7, P195
   CHAN DCN, 1994, AM J DENT, V7, P322
   CHAN KC, 1994, J PROSTHET DENT, V72, P420, DOI 10.1016/0022-3913(94)90563-0
   CHAN MFWY, 1994, J DENT, V22, P292, DOI 10.1016/0300-5712(94)90062-0
   CHANDLER JE, 1994, J DENT RES, V73, P1554, DOI 10.1177/00220345940730091101
   Chappell R P, 1994, Quintessence Int, V25, P359
   Chappell R P, 1994, Quintessence Int, V25, P851
   CHAPPELL RP, 1994, J PROSTHET DENT, V72, P183, DOI 10.1016/0022-3913(94)90078-7
   Charlton D G, 1994, Am J Dent, V7, P47
   CHARLTON DG, 1994, OPER DENT, V19, P154
   Checchi L, 1994, Quintessence Int, V25, P647
   CHEN JY, 1994, BIOMATERIALS, V15, P396, DOI 10.1016/0142-9612(94)90253-4
   CHENG AC, 1994, J PROSTHET DENT, V72, P8, DOI 10.1016/0022-3913(94)90208-9
   CHENG PT, 1994, CELL MATER, V4, P299
   CHESTNUTT IG, 1994, BRIT DENT J, V177, P125, DOI 10.1038/sj.bdj.4808525
   CHEUNG LK, 1994, J ORAL MAXIL SURG, V52, P373, DOI 10.1016/0278-2391(94)90440-5
   Chiche G J, 1994, Compendium, V15, P328
   CHIGIRA H, 1994, J DENT RES, V73, P1088, DOI 10.1177/00220345940730051101
   CHIGIRA H, 1994, DENT MATER, V10, P363, DOI 10.1016/0109-5641(94)90060-4
   CHRISTENSEN GJ, 1994, J AM DENT ASSOC, V125, P193, DOI 10.14219/jada.archive.1994.0269
   CHRISTENSEN GJ, 1994, J AM DENT ASSOC, V125, P1257, DOI 10.14219/jada.archive.1994.0156
   CHRISTENSEN GJ, 1994, ORAL HLTH, V84, P43
   CHRISTENSEN GJ, 1994, J AM DENT ASSOC, V125, P305
   CHRISTENSEN GJ, 1994, ORAL HLTH, V84, P47
   CHRISTERSSON C, 1991, SWED DENT J, V77
   CHUNG KH, 1994, DENT MATER, V10, P325, DOI 10.1016/0109-5641(94)90041-8
   Ciamponi A L, 1994, Quintessence Int, V25, P599
   CIEPLAK M, 1994, SCIENCE, V265, P1209, DOI 10.1126/science.265.5176.1209
   Clark D C, 1994, J Can Dent Assoc, V60, P711
   Cobo J M, 1994, J Clin Orthod, V28, P600
   Cochran David, 1994, Int J Oral Maxillofac Implants, V9, P289
   Cohen B D, 1994, Dent Update, V21, P57
   Cohen B I, 1994, J Prosthodont, V3, P53, DOI 10.1111/j.1532-849X.1994.tb00126.x
   Cohen B I, 1994, Oral Health, V84, P7
   COHEN J, 1994, SCIENCE, V264, P1534, DOI 10.1126/science.8202707
   COLLETT AR, 1994, AUST DENT J, V39, P298, DOI 10.1111/j.1834-7819.1994.tb05566.x
   CONCEICAO EN, 1994, J PROSTHET DENT, V71, P303, DOI 10.1016/0022-3913(94)90472-3
   Cooney P V, 1994, J Can Dent Assoc, V60, P140
   CORBIN SB, 1994, J AM DENT ASSOC, V125, P381, DOI 10.14219/jada.archive.1994.0055
   COX CF, 1994, J AM DENT ASSOC, V125, P823, DOI 10.14219/jada.archive.1994.0205
   Coyne B M, 1994, Eur J Prosthodont Restor Dent, V3, P87
   CRAIG RG, 1994, OPER DENT, V19, P138
   Crawford P R, 1994, N Y State Dent J, V60, P80
   Crim G A, 1994, Quintessence Int, V25, P781
   Crispin B J, 1994, Compendium, V15, P294
   CROLL TP, 1994, J DENT CHILD, V61, P246
   CROLL TP, 1994, ORAL HLTH, V84, P45
   CROLL TP, 1994, J CLIN ORTHOD, V28, P265
   CSERNA A, 1994, J PROSTHET DENT, V71, P387, DOI 10.1016/0022-3913(94)90100-7
   DACULSI G, 1994, CELL MATER, V4, P63
   Dahl B L, 1994, Quintessence Int, V25, P561
   DANIN J, 1994, INT ENDOD J, V27, P257, DOI 10.1111/j.1365-2591.1994.tb00265.x
   DARBAR UR, 1994, J DENT, V22, P259, DOI 10.1016/0300-5712(94)90054-X
   DARDICK I, 1994, MICROSC RES TECHNIQ, V27, P46, DOI 10.1002/jemt.1070270104
   DARLING M, 1994, BIOMATERIALS, V15, P299, DOI 10.1016/0142-9612(94)90055-8
   DAUTELMORAZIN A, 1994, J ENDODONT, V20, P531, DOI 10.1016/S0099-2399(06)80066-X
   David A T, 1994, Indian J Dent Res, V5, P101
   David S B, 1994, Compendium, V15, P810
   Davidson C L, 1994, J Esthet Dent, V6, P223, DOI 10.1111/j.1708-8240.1994.tb00863.x
   Davidson C L, 1994, Am J Dent, V7, P111
   Davidson D F, 1994, J Can Dent Assoc, V60, P301
   Davis B A, 1994, J Prosthodont, V3, P31, DOI 10.1111/j.1532-849X.1994.tb00122.x
   Davis B K, 1994, Int J Prosthodont, V7, P227
   Davis D M, 1994, Dent Update, V21, P15
   de Freitas A R, 1994, Quintessence Int, V25, P419
   DEGEE AJ, 1994, INT ENDOD J, V27, P239
   DEGROOT K, 1994, ORAL IMPLANTOLOGY, V20, P232
   DEHOFF PH, 1994, DENT MATER, V10, P178, DOI 10.1016/0109-5641(94)90029-9
   DEKKER A, 1994, CELL MATER, V4, P101
   DELCOURT MO, 1994, SCANNING MICROSCOPY, V8, P449
   DELLABONA A, 1994, J DENT, V22, P103, DOI 10.1016/0300-5712(94)90012-4
   DEMENEZES LFS, 1994, ANGLE ORTHOD, V64, P383
   DESAEYTIJD C, 1994, EUR J ORTHODONT, V16, P541, DOI 10.1093/ejo/16.6.541
   Devlin H., 1994, Clinical Materials, V16, P111, DOI 10.1016/0267-6605(94)90105-8
   DEWALD JP, 1994, J PROSTHET DENT, V71, P394, DOI 10.1016/0022-3913(94)90102-3
   DHUMMARUNGRONG S, 1994, J DENT CHILD, V61, P17
   DICKENSVENZ SH, 1994, DENT MATER, V10, P100, DOI 10.1016/0109-5641(94)90048-5
   Dickerson W G, 1994, J Can Dent Assoc, V60, P687
   Dietschi D, 1994, Quintessence Int, V25, P659
   DIETSCHI D, 1994, DENT MATER, V10, P353, DOI 10.1016/0109-5641(94)90059-0
   DIJKMAN GEHM, 1994, SCAND J DENT RES, V102, P144
   DIONYSOPOULOS P, 1994, OPER DENT, V19, P183
   DISHMAN MV, 1994, DENT MATER, V10, P33, DOI 10.1016/0109-5641(94)90019-1
   Dixon D L, 1994, Int J Prosthodont, V7, P129
   DIXON DL, 1994, J PROSTHET DENT, V72, P457, DOI 10.1016/0022-3913(94)90114-7
   DIXON DL, 1994, J PROSTHET DENT, V71, P316, DOI 10.1016/0022-3913(94)90474-X
   Donly K, 1994, Quintessence Int, V25, P355
   Donly K J, 1994, Am J Dent, V7, P275
   DOOTZ ER, 1994, J PROSTHET DENT, V71, P379, DOI 10.1016/0022-3913(94)90098-1
   DORNEY B, 1994, AUST DENT J, V39, P372, DOI 10.1111/j.1834-7819.1994.tb03109.x
   DORTMANS LJMG, 1994, J BIOMECH ENG-T ASME, V116, P373, DOI 10.1115/1.2895746
   dos Santos J Jr, 1994, Compendium, V15, P230
   Douglas C W, 1994, Adv Dent Res, V8, P254
   DOYLE RJ, 1994, CELL MATER, V4, P91
   DRORY MD, 1994, SCIENCE, V263, P1753, DOI 10.1126/science.263.5154.1753
   du Preez I C, 1994, J Dent Assoc S Afr, V49, P61
   Duckworth R M, 1994, Adv Dent Res, V8, P202
   Duke E S, 1994, Compendium, V15, P864
   DUKE ES, 1994, AM J DENT, V7, P307
   DUNN J, 1994, J CALIF DENT ASS APR, P73
   DUPOIRIEUX L, 1994, INT J ORAL MAX SURG, V23, P395, DOI 10.1016/S0901-5027(05)80028-1
   EAKLE WS, 1994, J PROSTHET DENT, V72, P351, DOI 10.1016/0022-3913(94)90552-5
   EBERHART M, 1994, SCIENCE, V265, P332, DOI 10.1126/science.265.5170.332
   EDELMANN L, 1994, SCANNING MICROSCOPY, V8, P551
   Edgar W M, 1994, Adv Dent Res, V8, P239
   Edge M J, 1994, J Prosthodont, V3, P130, DOI 10.1111/j.1532-849X.1994.tb00142.x
   EHRNFORD LE, 1994, SWED DENT J, V18, P207
   EHUDIN DZ, 1994, J PROSTHET DENT, V71, P165, DOI 10.1016/0022-3913(94)90026-4
   EIDE R, 1994, SCAND J DENT RES, V102, P76
   Eidenbenz S, 1994, Int J Prosthodont, V7, P134
   EKFELDT A, 1989, SWED DENT J S, V65
   ELCHARKAWI HG, 1994, J PROSTHET DENT, V72, P614, DOI 10.1016/0022-3913(94)90294-1
   Elhabashy A, 1994, Am J Dent, V7, P50
   ELIADES G, 1994, J DENT, V22, P73, DOI 10.1016/0300-5712(94)90004-3
   Ellwood R, 1994, Int Dent J, V44, P628
   ELMOWAFY OM, 1994, OPER DENT, V19, P11
   ELMOWAFY OM, 1994, J DENT, V22, P33
   ELMOWAFY OM, 1994, OPER DENT, V19, P176
   Endo K, 1994, Dent Mater J, V13, P228
   ENG JH, 1994, J DENT RES, V73, P1050
   ENGLUND GS, 1994, J DENT RES, V73, P620
   ENTWISTLE A, 1994, J MICROSC-OXFORD, V175, P238, DOI 10.1111/j.1365-2818.1994.tb03490.x
   EPSTEIN J, 1994, ORAL SURG ORAL MED O, V77, P242, DOI 10.1016/0030-4220(94)90292-5
   Erickson R L, 1994, Am J Dent, V7, P279
   Erickson R L, 1994, J Esthet Dent, V6, P227, DOI 10.1111/j.1708-8240.1994.tb00864.x
   ERICSON D, 1994, SCAND J DENT RES, V102, P244
   EUFINGER H, 1994, INT J ORAL MAX SURG, V23, P399
   FAIST J, 1994, SCIENCE, V264, P553, DOI 10.1126/science.264.5158.553
   FARINA M, 1994, J MICROSC-OXFORD, V173, P1, DOI 10.1111/j.1365-2818.1994.tb03423.x
   FARNAN I, 1994, SCIENCE, V265, P1206, DOI 10.1126/science.265.5176.1206
   FAVA LRG, 1994, INT ENDOD J, V27, P47, DOI 10.1111/j.1365-2591.1994.tb00229.x
   Fehling A W, 1994, J Prosthodont, V3, P256, DOI 10.1111/j.1532-849X.1994.tb00164.x
   FEIFEL H, 1994, INT J ORAL MAX SURG, V23, P104, DOI 10.1016/S0901-5027(05)80603-4
   FEJERESKOV O, 1994, INT DENT J, V44, P169
   Fejerskov O, 1994, Int Dent J, V44, P139
   FEJERSKOV O, 1994, ADV DENT RES, V5, P15
   Feldens E G, 1994, J Clin Pediatr Dent, V18, P187
   Fernandez E., 1994, Clinical Materials, V16, P99, DOI 10.1016/0267-6605(94)90103-1
   Ferracane J L, 1994, Am J Dent, V7, P103
   FERRACANE JL, 1994, J ORAL REHABIL, V21, P441, DOI 10.1111/j.1365-2842.1994.tb01158.x
   FERRACANE JL, 1994, DENT MATER, V10, P92, DOI 10.1016/0109-5641(94)90047-7
   Ferrari M, 1994, Quintessence Int, V25, P861
   FERRARI M, 1994, J PROSTHET DENT, V71, P404, DOI 10.1016/0022-3913(94)90104-X
   Ferrari M, 1994, Quintessence Int, V25, P621
   Ferrari M, 1994, Am J Dent, V7, P217
   FERRARI M, 1994, INT J PERIODONT REST, V14, P273
   FERRO KJ, 1994, J PROSTHET DENT, V71, P462, DOI 10.1016/0022-3913(94)90183-X
   Fettig R H, 1994, J Oral Implantol, V20, P42
   Filler S J, 1994, Am J Dent, V7, P85
   Finger W J, 1994, Am J Dent, V7, P35
   Fischman Steven A., 1994, Pediatric Dentistry, V16, P368
   Fitchie James G., 1994, General Dentistry, V42, P54
   FITTING HJ, 1994, SCANNING MICROSCOPY, V8, P165
   FLAITZ CM, 1994, J DENT CHILD, V61, P21
   FLAM F, 1994, SCIENCE, V266, P215, DOI 10.1126/science.266.5183.215
   FLORES DA, 1994, ANGLE ORTHOD, V64, P283
   FORD TRP, 1994, J ENDODONT, V20, P381
   FOREMAN FJ, 1994, J AM DENT ASSOC, V125, P182, DOI 10.14219/jada.archive.1994.0270
   FORSTEN L, 1994, AUST DENT J, V39, P339, DOI 10.1111/j.1834-7819.1994.tb03102.x
   Forsten L, 1994, J Esthet Dent, V6, P216, DOI 10.1111/j.1708-8240.1994.tb00862.x
   FORTIN D, 1994, DENT MATER, V10, P253, DOI 10.1016/0109-5641(94)90070-1
   FORTIN D, 1994, AM J DENT, V7, P315
   Forward G C, 1994, Adv Dent Res, V8, P208
   FOSTER LV, 1994, BRIT DENT J, V177, P89, DOI 10.1038/sj.bdj.4808518
   FOWLER CS, 1994, OPER DENT, V19, P47
   Fox N A, 1994, Br J Orthod, V21, P33
   Franchi M, 1994, Quintessence Int, V25, P577
   FRANKEL MS, 1994, J DENT RES, V73, P1759, DOI 10.1177/00220345940730111301
   Freedman G, 1994, J Can Dent Assoc, V60, P695
   FRIEDL KH, 1994, OPER DENT, V19, P228
   FRISBIE CD, 1994, SCIENCE, V265, P2071, DOI 10.1126/science.265.5181.2071
   FROST HM, 1994, ANGLE ORTHOD, V64, P175
   Fujisawa S, 1994, Dent Mater J, V13, P251
   FURUZONO T, 1993, J BIOMAT SCI-POLYM E, V5, P89
   Futatsuki M, 1994, J Clin Pediatr Dent, V18, P191
   Gaffar A, 1994, Int Dent J, V44, P63
   Gagnon F, 1994, J Prosthodont, V3, P228, DOI 10.1111/j.1532-849X.1994.tb00160.x
   Gaintantzopoulou M D, 1994, Am J Dent, V7, P39
   Galan D, 1994, J Can Dent Assoc, V60, P422
   GALE MS, 1994, J DENT, V22, P370, DOI 10.1016/0300-5712(94)90091-4
   GALUN EA, 1994, J PROSTHET DENT, V72, P424, DOI 10.1016/0022-3913(94)90564-9
   GALVAN DA, 1994, J ENDODONT, V20, P83, DOI 10.1016/S0099-2399(06)81187-8
   Garberoglio P, 1994, Quintessence Int, V25, P49
   GARCIABARBERO AE, 1994, DENT MATER, V10, P83, DOI 10.1016/0109-5641(94)90045-0
   GAREY DJ, 1994, J PROSTHET DENT, V71, P124, DOI 10.1016/0022-3913(94)90019-1
   Garg A K, 1994, Implant Soc, V5, P11
   GAULKER IA, 1994, INT J PROSTHODONT, V7, P258
   GAYLE FW, 1994, SCIENCE, V266, P1015, DOI 10.1126/science.266.5187.1015
   GEISGERSTORFER J, 1994, J DENT, V22, P247, DOI 10.1016/0300-5712(94)90124-4
   GELBARD S, 1994, J PROSTHET DENT, V71, P1, DOI 10.1016/0022-3913(94)90246-1
   GEORGOPOULOU M, 1994, INT ENDOD J, V27, P139, DOI 10.1111/j.1365-2591.1994.tb00243.x
   GERSCHMAN JA, 1994, AUST DENT J, V39, P353, DOI 10.1111/j.1834-7819.1994.tb03105.x
   GERZINA TM, 1994, J ORAL REHABIL, V21, P463, DOI 10.1111/j.1365-2842.1994.tb01160.x
   GEWIRTH AA, 1994, MICROS RES TECH, V27, P268
   Ghalichebaf M, 1994, Compendium, V15, P473
   GHANI F, 1994, J ORAL REHABIL, V21, P631
   Ghani S H, 1994, Br J Orthod, V21, P239
   Ghani S H, 1994, Br J Orthod, V21, P375
   GHAZALI SE, 1989, SWED DENT J S, V59
   GILBERT JL, 1994, DENT MATER, V10, P134, DOI 10.1016/0109-5641(94)90054-X
   GILHEANY PA, 1994, J ENDODONT, V20, P22, DOI 10.1016/S0099-2399(06)80022-1
   GILLETT GR, 1994, J DENT RES, V73, P1766, DOI 10.1177/00220345940730111401
   Gilpatrick R O, 1994, Quintessence Int, V25, P573
   GIORDANO RA, 1994, J PROSTHET DENT, V71, P468, DOI 10.1016/0022-3913(94)90184-8
   GLASSMAN GD, 1994, ORAL HLTH, V84, P13
   Godder B, 1994, Am J Dent, V7, P74
   GOLDBERG M, 1994, J DENT, V22, pS25, DOI 10.1016/0300-5712(94)90036-1
   GOLDSTEIN RE, 1994, J AM DENT ASSOC, V125, P1447, DOI 10.14219/jada.archive.1994.0215
   GOLDSTEIN RE, 1994, J AM DENT ASSOC, V125, P551, DOI 10.14219/jada.archive.1994.0077
   GOLDSTEIN RE, 1994, J CALIF DENT ASS SEP, P23
   Goracci G, 1994, Quintessence Int, V25, P627
   Gough M, 1994, Dent Update, V21, P203
   Granstrom G, 1994, INT J ORAL MAXILLOF, V9, P653
   Graves S L, 1994, Aust Prosthodont J, V8, P31
   Gray G B, 1994, Eur J Prosthodont Restor Dent, V2, P131
   GREER AL, 1994, NATURE, V368, P688, DOI 10.1038/368688a0
   GRIGGS JA, 1994, DENT MATER, V10, P314, DOI 10.1016/0109-5641(94)90039-6
   Grobler S R, 1994, J Dent Assoc S Afr, V49, P67
   Grogono A L, 1994, Am J Dent, V7, P89
   GRYNPAS MD, 1994, CELL MATER, V4, P287
   GUBA CJ, 1994, OPER DENT, V19, P146
   GUCKENBERGER R, 1994, SCIENCE, V266, P1538, DOI 10.1126/science.7985024
   Gugushe T S, 1994, J Dent Assoc S Afr, V49, P209
   Gwinnett A J, 1994, Am J Dent, V7, P144
   Gwinnett A J, 1994, Quintessence Int, V25, P687
   Gwinnett A J, 1994, Quintessence Int, V25, P215
   Gwinnett A J, 1994, Am J Dent, V7, P243
   Gwinnett A J, 1994, Am J Dent, V7, P57
   GWINNETT AJ, 1994, DENT MATER, V10, P150
   GWINNETT AJ, 1994, AM J DENT, V7, P312
   HADAVI F, 1994, J PROSTHET DENT, V72, P250, DOI 10.1016/0022-3913(94)90337-9
   HALL G, 1994, SWED DENT J, V18, P29
   Hall H D, 1994, J Okla Dent Assoc, V85, P20
   HALLETT KB, 1994, AUST DENT J, V39, P292, DOI 10.1111/j.1834-7819.1994.tb05565.x
   Hallgren A, 1994, Br J Orthod, V21, P23
   HAMULA W, 1994, ORAL HLTH, V84, P43
   HAN CH, 1994, INT J ORAL MAXILLOF, V9, P698
   Hanawa T, 1994, Dent Mater J, V13, P164
   HANKINSON JA, 1994, INT J PERIODONT REST, V14, P139
   HANKS CT, 1994, J ORAL REHABIL, V21, P475, DOI 10.1111/j.1365-2842.1994.tb01162.x
   HARDEE MW, 1994, J ENDODONT, V20, P377, DOI 10.1016/S0099-2399(06)80294-3
   HARKIN T, 1994, FASEB J, V8, P1215
   Harnick D J, 1994, J Gen Orthod, V5, P11
   HARRIGAN TP, 1994, J BIOMECH, V27, P323, DOI 10.1016/0021-9290(94)90008-6
   HARRIS DE, 1994, NATURE, V367, P713, DOI 10.1038/367713a0
   Harris I R, 1994, Int J Prosthodont, V7, P348
   HASE JC, 1993, SWED DENT J S, V89
   Hasegawa T, 1994, Am J Dent, V7, P212
   HATTON JF, 1994, J ENDODONT, V20, P580, DOI 10.1016/S0099-2399(06)80080-4
   HAUDRECHY P, 1994, CONTACT DERMATITIS, V31, P249, DOI 10.1111/j.1600-0536.1994.tb01997.x
   Haveman C W, 1994, Am J Dent, V7, P247
   Hayakawa I, 1994, Int J Prosthodont, V7, P339
   Hayakawa Tohru, 1994, Journal of Nihon University School of Dentistry, V36, P52
   HAYASHI Y, 1994, ORAL SURG ORAL MED O, V77, P623, DOI 10.1016/0030-4220(94)90323-9
   HEIFETZ SB, 1994, J CALIF DENT ASS MAR, P49
   HEINZ DL, 1994, SCIENCE, V264, P279, DOI 10.1126/science.264.5156.279
   HELLGREN K, 1994, SWED DENT J, V18, P9
   HELSINGEN AL, 1994, INT J ORAL MAXILLOF, V9, P422
   HENG YM, 1994, J MICROSC-OXFORD, V173, P79, DOI 10.1111/j.1365-2818.1994.tb03430.x
   HENNEQUIN M, 1994, J ENDODONT, V20, P551, DOI 10.1016/S0099-2399(06)80071-3
   HERO H, 1994, CELL MATER, V4, P409
   HIDAKA S, 1994, J BIOMED MATER RES, V28, P175, DOI 10.1002/jbm.820280206
   HIGA RK, 1994, INT ENDOD J, V27, P252, DOI 10.1111/j.1365-2591.1994.tb00264.x
   Hilton T J, 1994, Int J Prosthodont, V7, P424
   Hirano S, 1994, Dent Mater J, V13, P214
   HO MH, 1994, J PROSTHET DENT, V72, P367, DOI 10.1016/0022-3913(94)90555-X
   Hoad-Reddick G, 1994, Eur J Prosthodont Restor Dent, V3, P61
   HOGLUND AC, 1994, ACTA ODONTOL SCAND, V52, P140
   HOLGER SKM, 1994, INT J ORAL MAXILLOF, V9, P689
   Holt R D, 1994, Int Dent J, V44, P331
   HOLTAN JR, 1994, OPER DENT, V19, P189
   HOLTAN JR, 1994, J DENT, V22, P92, DOI 10.1016/0300-5712(94)90008-6
   Hondrum S O, 1994, Int J Prosthodont, V7, P517
   HORSTEDBINDSLEV P, 1994, J DENT, V22, pS29, DOI 10.1016/0300-5712(94)90037-X
   Hosoya Y, 1994, J Clin Pediatr Dent, V18, P115
   Hosseini A, 1994, Quintessence Int, V25, P567
   HOTTA M, 1994, J ORAL REHABIL, V21, P679
   HOTTA M, 1994, OPER DENT, V19, P42
   HOTZ G, 1994, INT J ORAL MAX SURG, V23, P413, DOI 10.1016/S0901-5027(05)80033-5
   Houpt M, 1994, Quintessence Int, V25, P155
   Hulterstrom M, 1994, INT J ORAL MAXILLOF, V9, P449
   Hum S K, 1994, Oral Health, V84, P9
   HUME WR, 1994, J ORAL REHABIL, V21, P469, DOI 10.1111/j.1365-2842.1994.tb01161.x
   HUMMEL SK, 1994, J PROSTHODONT, V3, P107
   HUNT PR, 1994, J ESTHET DENT, V6, P191
   HYON SH, 1994, J BIOMAT SCI-POLYM E, V5, P397, DOI 10.1163/156856294X00103
   Iimuro F T, 1994, Dent Mater J, V13, P76
   Ikemi T, 1994, Dent Mater J, V13, P1
   ILBAY SG, 1994, J ORAL REHABIL, V21, P103, DOI 10.1111/j.1365-2842.1994.tb01129.x
   IMAI Y, 1994, DENT MATER, V10, P275, DOI 10.1016/0109-5641(94)90074-4
   Imai Y, 1994, Dent Mater J, V13, P190
   Imai Y, 1994, Dent Mater J, V13, P66
   IMAZATO S, 1994, J DENT RES, V73, P1641, DOI 10.1177/00220345940730100901
   IMFELD K, 1994, ADV DENT RES, V8, P225
   Ingram G S, 1994, Adv Dent Res, V8, P158
   Inoue M, 1994, Am J Dent, V7, P161
   IRELAND AJ, 1994, EUR J ORTHODONT, V16, P27, DOI 10.1093/ejo/16.1.27
   ISAKSSON S, 1992, SWED DENT J S, V84
   ISHIKAWA K, 1994, DENT MATER, V10, P26, DOI 10.1016/0109-5641(94)90018-3
   ISHIKAWA K, 1994, J DENT RES, V73, P1197, DOI 10.1177/00220345940730061101
   Ishikawa K, 1994, Dent Mater J, V13, P182
   Ishikawa-Nagai S, 1994, Int J Prosthodont, V7, P50
   ITO K, 1994, SCIENCE, V263, P66, DOI 10.1126/science.263.5143.66
   Itoh H, 1994, Dent Mater J, V13, P25
   Jackley G A, 1994, J Prosthodont, V3, P16, DOI 10.1111/j.1532-849X.1994.tb00119.x
   JAGGER DC, 1994, J PROSTHET DENT, V72, P320, DOI 10.1016/0022-3913(94)90347-6
   JAMALUDDIN A, 1994, J ORAL REHABIL, V21, P649
   JEANSONNE MJ, 1994, J ENDODONT, V20, P276, DOI 10.1016/S0099-2399(06)80815-0
   JENDRESEN MD, 1993, J PROSTHET DENT, V70, P44, DOI 10.1016/0022-3913(93)90036-N
   JENDRESEN MD, 1994, J PROSTHET DENT, V72, P39, DOI 10.1016/0022-3913(94)90214-3
   JENKINS WMM, 1994, J DENT, V22, P108, DOI 10.1016/0300-5712(94)90013-2
   JEPSON NJA, 1994, BRIT DENT J, V177, P11, DOI 10.1038/sj.bdj.4808489
   JIN CM, 1994, SCIENCE, V263, P68, DOI 10.1126/science.263.5143.68
   Johansson P, 1994, INT J ORAL MAXILLOF, V9, P279
   Johnson A, 1994, Int J Prosthodont, V7, P35
   JOHNSON ME, 1994, OPER DENT, V19, P205
   JOKSTAD A, 1994, ACTA ODONTOL SCAND, V52, P234, DOI 10.3109/00016359409029052
   Jokstad A, 1994, Quintessence Int, V25, P101
   JONES DW, 1994, BRIT DENT J, V177, P159
   Jones M L, 1994, Br J Orthod, V21, P133
   Joyston-Bechal S., 1994, DENT UPDATE, V21, P366
   JUNIPER RP, 1994, BRIT J ORAL MAX SURG, V32, P71, DOI 10.1016/0266-4356(94)90130-9
   JUSKAITIS R, 1994, J MICROSC-OXFORD, V176, P188, DOI 10.1111/j.1365-2818.1994.tb03514.x
   KAISER J, 1994, SCIENCE, V265, P1365, DOI 10.1126/science.8073269
   KAISER J, 1994, SCIENCE, V265, P2010, DOI 10.1126/science.265.5181.2010
   KALFAS S, 1989, SWED DENT J S, V63
   Kamegai Akihide, 1994, Bio-Medical Materials and Engineering, V4, P291
   KAMPOSIORA P, 1994, J PROSTHET DENT, V71, P435, DOI 10.1016/0022-3913(94)90179-1
   Kanca J 3rd, 1994, J Esthet Dent, V6, P286
   KANERVA L, 1994, CONTACT DERMATITIS, V31, P299, DOI 10.1111/j.1600-0536.1994.tb02023.x
   KANIWA MA, 1994, CONTACT DERMATITIS, V30, P20, DOI 10.1111/j.1600-0536.1994.tb00723.x
   KANIWA MA, 1994, CONTACT DERMATITIS, V30, P26, DOI 10.1111/j.1600-0536.1994.tb00724.x
   KAPLAN BA, 1994, J PROSTHET DENT, V71, P603, DOI 10.1016/0022-3913(94)90445-6
   KAPLOWITZ GJ, 1994, J ENDODONT, V20, P109, DOI 10.1016/S0099-2399(06)80052-X
   1994, PEDIATR DENT, V16, P56
   1994, J DENT ASSOC S AFR, V49, P358
   1994, ORAL HLTH, V84, P47
   1994, PEDIATR DENT, V16, P25
   1994, ORTHOD REV       SEP, P7
   1994, CINCINNATI DENT SOC, V63, P30
   1994, ORTHOD REV       JUL, P8
   1994, J DENT EDUC, V58, P433
   1994, ORAL REV         MAR, P10
   1994, ORAL HLTH, V84, P45
   1994, ORTHOD REV       MAR, P10
   1994, ORTHOD REV       JAN, P11
   1994, CINCINNATI DENT SCH, V63, P30
   1994, J DENT EDUC, V58, P424
   1994, J AM DENT ASSOC, V125, P1591
   1994, PEDIATR DENT, V16, P31
   1994, J DENT EDUC, V58, P26
   1994, J DENT EDUC, V58, P261
   FORTIN D, 1995, AM J DENT, V8, P201
   Karkazis H C, 1994, Eur J Prosthodont Restor Dent, V2, P109
   KARLSSON S, 1994, ACTA ODONTOL SCAND, V52, P290, DOI 10.3109/00016359409029041
   KATONA TR, 1994, J DENT RES, V73, P1470, DOI 10.1177/00220345940730081201
   KATSIKAS NG, 1994, DENT MATER, V10, P2, DOI 10.1016/0109-5641(94)90014-0
   KAWAGUCHI M, 1994, J DENT RES, V73, P516, DOI 10.1177/00220345940730020601
   KAWAHARA LK, 1994, J CALIF DENT ASS JUN, P55
   Kawai K, 1994, Quintessence Int, V25, P53
   Kawakami M, 1994, Am J Dent, V7, P53
   KAWANO F, 1994, J PROSTHET DENT, V72, P599, DOI 10.1016/0022-3913(94)90292-5
   KAWANO F, 1994, J PROSTHET DENT, V72, P393, DOI 10.1016/0022-3913(94)90559-2
   KAWASAKI M, 1994, SCIENCE, V266, P1540, DOI 10.1126/science.266.5190.1540
   KELLER EE, 1994, J ORAL MAXIL SURG, V52, P438, DOI 10.1016/0278-2391(94)90335-2
   KELLETT M, 1994, J DENT, V22, P208, DOI 10.1016/0300-5712(94)90108-2
   KENDALL K, 1994, SCIENCE, V263, P1720, DOI 10.1126/science.263.5154.1720
   KENR M, 1994, J PROSTHET DENT, V71, P453
   KENYON CM, 1994, J MICROSC-OXFORD, V176, P152, DOI 10.1111/j.1365-2818.1994.tb03509.x
   KERN M, 1994, DENT MATER, V10, P19, DOI 10.1016/0109-5641(94)90017-5
   KERN M, 1994, J DENT, V22, P300, DOI 10.1016/0300-5712(94)90067-1
   KERN M, 1994, J PROSTHET DENT, V71, P251, DOI 10.1016/0022-3913(94)90463-4
   Kidd E A, 1994, Dent Update, V21, P323
   KILDAL KK, 1994, ACTA ODONTOL SCAND, V52, P315, DOI 10.3109/00016359409029044
   KILPATRICK NM, 1994, J DENT, V22, P182, DOI 10.1016/0300-5712(94)90203-8
   KIM HJ, 1994, BIO-MED MATER ENG, V4, P171
   KIM KH, 1994, J DENT RES, V73, P499, DOI 10.1177/00220345940730020301
   King A W, 1994, Northwest Dent Res, V4, P11
   KING AWC, 1994, J PROSTHET DENT, V72, P314, DOI 10.1016/0022-3913(94)90346-8
   King B B, 1994, J Prosthodont, V3, P219, DOI 10.1111/j.1532-849X.1994.tb00159.x
   Kingman A, 1994, Adv Dent Res, V8, P56
   KINNEY JH, 1994, SCANNING MICROSCOPY, V8, P197
   Kjaerheim V, 1994, Adv Dent Res, V8, P302
   Kleerekoper M, 1994, Adv Dent Res, V8, P32
   Knight G M, 1994, Quintessence Int, V25, P97
   KNOBLER CM, 1994, NATURE, V369, P15, DOI 10.1038/369015a0
   Knoernschild K L, 1994, Int J Prosthodont, V7, P22
   Kobayashi S, 1994, Int Dent J, V44, P641
   KOMATSU H, 1994, J AM DENT ASSOC, V125, P543, DOI 10.14219/jada.archive.1994.0082
   KOMORI T, 1994, J ORAL MAXIL SURG, V52, P516, DOI 10.1016/0278-2391(94)90356-5
   Kon M, 1994, Dent Mater J, V13, P47
   Kon M, 1994, Dent Mater J, V13, P138
   KONONEN M, 1994, J BIOMED MATER RES, V28, P1027, DOI 10.1002/jbm.820280907
   Koroluk Lorne, 1994, Pediatric Dentistry, V16, P276
   KOTSIOMITI E, 1994, J PROSTHET DENT, V71, P511, DOI 10.1016/0022-3913(94)90192-9
   Koutsi V., 1994, Pediatric Dentistry, V16, P29
   KRAFFT T, 1994, INT J ORAL MAX SURG, V23, P418, DOI 10.1016/S0901-5027(05)80034-7
   Kraut J M, 1994, J Clin Orthod, V28, P50
   KREJCI I, 1994, J PROSTHET DENT, V72, P233, DOI 10.1016/0022-3913(94)90335-2
   Krejci I, 1994, Quintessence Int, V25, P403
   KREJCI I, 1994, J DENT RES, V73, P1228, DOI 10.1177/00220345940730061501
   Krejci I, 1994, Quintessence Int, V25, P199
   Krejci I, 1994, Am J Dent, V7, P27
   KREJCI I, 1994, DENT MATER, V10, P331, DOI 10.1016/0109-5641(94)90042-6
   KREULEN CM, 1994, J DENT CHILD, V61, P29
   KREULEN CM, 1994, J DENT CHILD, V61, P192
   KRUFT MAB, 1994, J BIOMED MATER RES, V28, P1259, DOI 10.1002/jbm.820281103
   Kupietzky Ari, 1994, Pediatric Dentistry, V16, P340
   Kuroe K, 1994, J Clin Orthod, V28, P347
   KURTZ KS, 1994, J DENT RES, V73, P1130, DOI 10.1177/00220345940730060101
   Kutay O, 1994, Eur J Prosthodont Restor Dent, V2, P123
   KUTAY O, 1994, J PROSTHET DENT, V71, P525, DOI 10.1016/0022-3913(94)90194-5
   Ladizesky N H, 1994, Int J Prosthodont, V7, P307
   LAFONT J, 1994, CELL MATER, V4, P219
   Lagerlof F, 1994, Adv Dent Res, V8, P229
   LAIBLE JP, 1994, J BIOMECH ENG-T ASME, V116, P19, DOI 10.1115/1.2895699
   LAND MF, 1994, J PROSTHET DENT, V72, P4, DOI 10.1016/0022-3913(94)90207-0
   Laney W R, 1994, Int J Oral Maxillofac Implants, V9, P49
   LANOUE KF, 1994, FASEB J, V8, P132
   LARSON TD, 1994, NW DENT          JUL, P21
   LARSSON KS, 1994, J DENT, V22, pS12
   LATTA MA, 1994, J PROSTHET DENT, V72, P189, DOI 10.1016/0022-3913(94)90079-5
   Laufer B Z, 1994, Int J Prosthodont, V7, P247
   LAVERGNE JL, 1994, J MICROSC-OXFORD, V174, P195, DOI 10.1111/j.1365-2818.1994.tb03467.x
   Lavigne S E, 1994, Int J Oral Maxillofac Implants, V9, P156
   LAWLER A, 1994, SCIENCE, V266, P1315, DOI 10.1126/science.7973716
   LAWN BR, 1994, SCIENCE, V263, P1114, DOI 10.1126/science.263.5150.1114
   Leake J L, 1994, J Can Dent Assoc, V60, P1066
   LEE SY, 1994, J DENT, V22, P352, DOI 10.1016/0300-5712(94)90088-4
   LEE SY, 1994, J DENT, V22, P175, DOI 10.1016/0300-5712(94)90202-X
   LEFEBVRE CA, 1994, J PROSTHET DENT, V72, P644, DOI 10.1016/0022-3913(94)90298-4
   LEFEBVRE CA, 1994, J PROSTHET DENT, V71, P178, DOI 10.1016/0022-3913(94)90028-0
   Legnani P, 1994, Quintessence Int, V25, P435
   Leinfelder K F, 1994, J Esthet Dent, V6, P177, DOI 10.1111/j.1708-8240.1994.tb00855.x
   Leinfelder K F, 1994, Compendium, V15, P1398
   LEINFELDER KF, 1994, J AM DENT ASSOC, V125, P292, DOI 10.14219/jada.archive.1994.0029
   LEINFELDER KF, 1994, J AM DENT ASSOC, V125, P586, DOI 10.14219/jada.archive.1994.0066
   LEINFELDER KF, 1994, J AM DENT ASSOC, V125, P65, DOI 10.14219/jada.archive.1994.0016
   LEINFELDER KF, 1994, ORAL HLTH, V84, P31
   Leong D, 1994, Int J Prosthodont, V7, P440
   LESOT H, 1994, CELL MATER, V4, P199
   LEUNG SF, 1994, INT ENDOD J, V27, P39, DOI 10.1111/j.1365-2591.1994.tb00227.x
   LEVARTOVSKY S, 1994, J PROSTHET DENT, V72, P481, DOI 10.1016/0022-3913(94)90118-X
   LEVI E, 1994, J MED STATE DENT ASS, V37, P11
   Levine R A, 1994, Compendium, V15, P528
   LEVITCH LC, 1994, J DENT, V22, P195, DOI 10.1016/0300-5712(94)90107-4
   LEW D, 1994, J ORAL MAXIL SURG, V52, P952, DOI 10.1016/S0278-2391(10)80078-3
   LEWINSTEIN I, 1994, J ENDODONT, V20, P61, DOI 10.1016/S0099-2399(06)81181-7
   Lewis D W, 1994, J Can Dent Assoc, V60, P1050
   LI JG, 1994, ACTA ODONTOL SCAND, V52, P209, DOI 10.3109/00016359409029048
   LIBERMAN R, 1994, J ORAL REHABIL, V21, P87, DOI 10.1111/j.1365-2842.1994.tb01127.x
   Liebenberg W H, 1994, J Can Dent Assoc, V60, P289
   Liebenberg W H, 1994, J Can Dent Assoc, V60, P701
   LIN CP, 1994, J DENT RES, V73, P1072, DOI 10.1177/00220345940730050901
   LIN CP, 1994, J BIOMECH, V27, P1037, DOI 10.1016/0021-9290(94)90220-8
   LINDBERG NE, 1994, ACTA ODONTOL SCAND, V52, P219, DOI 10.3109/00016359409029050
   Linden J J, 1994, Am J Dent, V7, P31
   Linehan A D, 1994, J Prosthodont, V3, P88, DOI 10.1111/j.1532-849X.1994.tb00134.x
   LIPHARDT M, 1994, SCIENCE, V263, P367, DOI 10.1126/science.263.5145.367
   LLOYD CH, 1994, DENT MATER, V10, P128, DOI 10.1016/0109-5641(94)90053-1
   Loney R W, 1994, Int J Prosthodont, V7, P362
   LONG DKM, 1994, NW DENT RES, V4, P13
   LoPresti J T, 1994, N Y State Dent J, V60, P39
   LOS SA, 1994, OPER DENT, V19, P169
   Low D, 1994, Dent Mater J, V13, P103
   Loyola-Rodriguez Juan P., 1994, Pediatric Dentistry, V16, P346
   LOZADA JL, 1994, ORAL IMPLANTOLOGY, V20, P315
   Lui J L, 1994, Quintessence Int, V25, P313
   LUI JL, 1994, OPER DENT, V19, P165
   LUMLEY PJ, 1994, J DENT, V22, P376, DOI 10.1016/0300-5712(94)90093-0
   Lund P S, 1994, J Prosthodont, V3, P2, DOI 10.1111/j.1532-849X.1994.tb00116.x
   LUNDIN S, 1990, SWED DENT J S, V73
   LUOMANEN M, 1994, SCAND J DENT RES, V102, P223
   Lygidakis N A, 1994, J Clin Pediatr Dent, V19, P23
   LYGRE H, 1994, ACTA ODONTOL SCAND, V52, P150, DOI 10.3109/00016359409027589
   LYMAN CE, 1994, J MICROSC-OXFORD, V176, P85, DOI 10.1111/j.1365-2818.1994.tb03503.x
   LYNCH A, 1994, J DENT RES, V73, P1778, DOI 10.1177/00220345940730111601
   MACDONALD A, 1994, J ENDODONT, V20, P598, DOI 10.1016/S0099-2399(06)80085-3
   MACKERT JR, 1994, J DENT RES, V73, P1221, DOI 10.1177/00220345940730061401
   Mackie I C, 1994, Dent Update, V21, P192
   MacPherson Jeff R., 1994, General Dentistry, V42, P310
   Maeda Y, 1994, Int J Prosthodont, V7, P17
   MAHARAJ G, 1994, BIO-MED MATER ENG, V4, P193
   MAHLER DB, 1994, J DENT RES, V73, P1663, DOI 10.1177/00220345940730101201
   MAHLER DB, 1994, J AM DENT ASSOC, V125, P282, DOI 10.14219/jada.archive.1994.0038
   MAHMOOD S, 1994, AUST DENT J, V39, P15, DOI 10.1111/j.1834-7819.1994.tb05539.x
   MAIR LH, 1994, BR J ORAL MAXILLO SU, V32, P91
   Mangum Frank I. Jr., 1994, General Dentistry, V42, P304
   Margolis Maureen Quirk, 1994, Pediatric Dentistry, V16, P200
   MARIANI T, 1994, J MICROSC-OXFORD, V176, P121, DOI 10.1111/j.1365-2818.1994.tb03506.x
   MARINI E, 1994, CELL MATER, V4, P231
   Marks R G, 1994, Int Dent J, V44, P275
   Marlin G M, 1994, Compendium, V15, P628
   MARSHALL E, 1994, SCIENCE, V265, P20, DOI 10.1126/science.8016650
   MARSHALL E, 1994, SCIENCE, V265, P314, DOI 10.1126/science.8023150
   MARSHALL E, 1994, SCIENCE, V265, P1651, DOI 10.1126/science.265.5179.1651
   MARSHALL E, 1994, SCIENCE, V265, P467, DOI 10.1126/science.8036487
   MARSHALL E, 1994, SCIENCE, V263, P747
   Mason P N, 1994, Quintessence Int, V25, P499
   MATSUI Y, 1994, INT J ORAL MAXILLOF, V9, P397
   MATSUKAWA S, 1994, DENT MATER, V10, P343, DOI 10.1016/0109-5641(94)90057-4
   Matsumura H, 1994, Quintessence Int, V25, P425
   MATSUYA Y, 1994, BIOMATERIALS, V15, P307, DOI 10.1016/0142-9612(94)90056-6
   MATTHEW IR, 1994, ORAL SURG ORAL MED O, V77, P456, DOI 10.1016/0030-4220(94)90223-2
   Mattie P A, 1994, J Prosthodont, V3, P213, DOI 10.1111/j.1532-849X.1994.tb00158.x
   MATTSSON U, 1994, ACTA ODONTOL SCAND, V52, P86, DOI 10.3109/00016359409029060
   MAYWALD M, 1994, SCANNING MICROSCOPY, V8, P181
   MCCABE JF, 1994, BRIT DENT J, V176, P333, DOI 10.1038/sj.bdj.4808447
   MCCOMB D, 1994, J PROSTHET DENT, V72, P517, DOI 10.1016/0022-3913(94)90125-2
   McConnell R J, 1994, J Can Dent Assoc, V60, P49
   MCCONNELL RJ, 1994, J IR DENT ASS, V40, P2
   MCCORD JF, 1994, AUST DENT J, V39, P365, DOI 10.1111/j.1834-7819.1994.tb03107.x
   McGuckin R S, 1994, Quintessence Int, V25, P791
   McIntyre F M, 1994, Int J Prosthodont, V7, P461
   MCKINLEY IB, 1994, J ENDODONT, V20, P558, DOI 10.1016/S0099-2399(06)80073-7
   McLean J W, 1994, Quintessence Int, V25, P587
   McLean J W, 1994, J Esthet Dent, V6, P195, DOI 10.1111/j.1708-8240.1994.tb00860.x
   MEADE C, 1994, SCIENCE, V264, P1558, DOI 10.1126/science.264.5165.1558
   MEECHAN JG, 1994, BRIT J ORAL MAX SURG, V32, P91, DOI 10.1016/0266-4356(94)90135-X
   MELSEN B, 1994, EUR J ORTHODONT, V16, P531, DOI 10.1093/ejo/16.6.531
   MENDOZA DB, 1994, J PROSTHET DENT, V72, P591, DOI 10.1016/0022-3913(94)90290-9
   MERICSKESTERN R, 1994, CLIN ORAL IMPLAN RES, V5, P9, DOI 10.1034/j.1600-0501.1994.050102.x
   MERRILL EW, 1993, J BIOMAT SCI-POLYM E, V5, P1
   MERVIS J, 1994, SCIENCE, V265, P731, DOI 10.1126/science.265.5173.731-a
   MERVIS J, 1994, SCIENCE, V263, P165, DOI 10.1126/science.263.5144.165
   Mesaros A J Jr, 1994, Am J Dent, V7, P137
   MESKIN LH, 1994, J AM DENT ASSOC, V125, P234, DOI 10.14219/jada.archive.1994.0044
   METZ JE, 1994, J PROSTHET DENT, V71, P13, DOI 10.1016/0022-3913(94)90248-8
   METZ JE, 1994, ORAL HLTH, V84, P27
   MEYER JM, 1994, J DENT, V22, P131, DOI 10.1016/0300-5712(94)90195-3
   MILES DA, 1994, J ENDODONT, V20, P538, DOI 10.1016/S0099-2399(06)80068-3
   Miles P G, 1994, J Clin Orthod, V28, P74
   MILLER RG, 1994, J DENT RES, V73, P1457, DOI 10.1177/00220345940730081001
   Miller S, 1994, Int Dent J, V44, P83
   MILLETT DT, 1994, EUR J ORTHODONT, V16, P203, DOI 10.1093/ejo/16.3.203
   MILLSTEIN PL, 1994, J PROSTHET DENT, V71, P400, DOI 10.1016/0022-3913(94)90103-1
   MISCH C, 1994, J MICHIGAN DENT ASS, V76, P40
   Misch C E, 1994, Compendium, V15, P1344
   Misch C E, 1994, J Oral Implantol, V20, P100
   MISCH CM, 1994, ORAL HLTH, V84, P29
   MITCHELL CA, 1994, DENT MATER, V10, P88, DOI 10.1016/0109-5641(94)90046-9
   Mitchell L, 1994, Br J Orthod, V21, P79
   Mitchem J C, 1994, Am J Dent, V7, P232
   MITRA SB, 1994, DENT MATER, V10, P78, DOI 10.1016/0109-5641(94)90044-2
   Miyazaki K, 1994, Dent Mater J, V13, P9
   MJOR IA, 1994, J DENT, V22, pS3, DOI 10.1016/0300-5712(94)90031-0
   Mohite U H, 1994, Int J Prosthodont, V7, P479
   MOLIN M, 1990, SWED DENT J S, V71
   MOLINARI JA, 1994, KY DENT J, V45, P13
   MOMOI Y, 1994, BRIT DENT J, V176, P91, DOI 10.1038/sj.bdj.4808379
   MONGKOLNAM P, 1994, DENT MATER, V10, P196, DOI 10.1016/0109-5641(94)90032-9
   MOORHEAD JE, 1994, DENT MATER, V10, P45, DOI 10.1016/0109-5641(94)90021-3
   MORA GP, 1994, J BIOMED MATER RES, V28, P189, DOI 10.1002/jbm.820280208
   MORFIS A, 1994, ORAL SURG ORAL MED O, V77, P172, DOI 10.1016/0030-4220(94)90281-X
   MORI T, 1994, AUST DENT J, V39, P348, DOI 10.1111/j.1834-7819.1994.tb03104.x
   MOSELEY JP, 1994, J PROSTHET DENT, V71, P532, DOI 10.1016/0022-3913(94)90195-3
   MOSHONOV J, 1994, J ENDODONT, V20, P90, DOI 10.1016/S0099-2399(06)81189-1
   MOSS JP, 1994, DENT UPDATE, V21, P386
   MOSSINGHOFF GJ, 1994, FASEB J, V8, P1214
   Mount G J, 1994, Am J Dent, V7, P286
   MOUNT GJ, 1994, J OKLAHOMA DENT ASS, V85, P26
   MUELLER HJ, 1994, J ORAL REHABIL, V21, P699
   MULDER FM, 1994, NATURE, V367, P716, DOI 10.1038/367716a0
   Murakami S, 1994, Dent Mater J, V13, P240
   MURALI SR, 1994, CELL MATER, V4, P337
   MURATA H, 1994, J ORAL REHABIL, V21, P145, DOI 10.1111/j.1365-2842.1994.tb01133.x
   MUTLU G, 1994, J PROSTHET DENT, V71, P186, DOI 10.1016/0022-3913(94)90029-9
   MYERS JL, 1994, J PROSTHODONT, V3, P149
   Myers M L, 1994, Int J Prosthodont, V7, P549
   Myers M L, 1994, Int J Prosthodont, V7, P253
   MYERS TD, 1994, J CALIF DENT ASS SEP, P41
   Nagahara K, 1994, Int J Oral Maxillofac Implants, V9, P41
   NAKAYAMA M, 1994, BIO-MED MATER ENG, V4, P105
   NANCI A, 1994, CELL MATER, V4, P1
   Nancollas G H, 1994, Adv Dent Res, V8, P307
   NANCOLLAS GH, 1994, ORAL IMPLANTOLOGY, V20, P221
   Nasman Margareta, 1994, Pediatric Dentistry, V16, P217
   NATHANSON D, 1994, J AM DENT ASSOC, V125, P421, DOI 10.14219/jada.archive.1994.0052
   NAVAZESH M, 1994, J CALIF DENT ASS MAR, P62
   Nel J C, 1994, J Esthet Dent, V6, P282, DOI 10.1111/j.1708-8240.1994.tb00870.x
   NEL JC, 1994, J DENT ASSOC S AFR, V49, P143
   Nelson Linda P., 1994, Pediatric Dentistry, V16, P18
   Newman G V, 1994, J Clin Orthod, V28, P396
   NEWMAN RC, 1994, SCIENCE, V263, P1708, DOI 10.1126/science.263.5154.1708
   NICOUD JF, 1994, SCIENCE, V263, P636, DOI 10.1126/science.263.5147.636
   NIE SM, 1994, SCIENCE, V266, P1018, DOI 10.1126/science.7973650
   NIEDERAUER GG, 1994, BIOMATERIALS, V15, P342, DOI 10.1016/0142-9612(94)90246-1
   NIKAWA H, 1994, J PROSTHET DENT, V72, P657, DOI 10.1016/0022-3913(94)90300-X
   Nilson H, 1994, Int J Prosthodont, V7, P115
   NISHIHARA K, 1994, BIO-MED MATER ENG, V4, P151
   Nomoto R, 1994, Dent Mater J, V13, P198
   NORDBO H, 1994, J DENT, V22, P342, DOI 10.1016/0300-5712(94)90085-X
   Nordstrom E. G., 1994, Bio-Medical Materials and Engineering, V4, P309
   NORTHEAST SE, 1994, J DENT, V22, P252, DOI 10.1016/0300-5712(94)90126-0
   Nuckles D B, 1994, Quintessence Int, V25, P829
   Nunn J H, 1994, Int Dent J, V44, P165
   O'Brien W J, 1994, Int J Prosthodont, V7, P56
   O'Mullane D M, 1994, Int Dent J, V44, P257
   O'Mullane D M, 1994, Adv Dent Res, V8, P181
   OBERG S, 1994, INT J ORAL MAX SURG, V23, P110, DOI 10.1016/S0901-5027(05)80604-6
   OBRIEN WJ, 1994, J PROSTHET DENT, V72, P414, DOI 10.1016/0022-3913(94)90562-2
   Ochi S, 1994, Implant Dent, V3, P159, DOI 10.1097/00008505-199409000-00003
   OGAARD B, 1994, ADV DENT RES, V8, P1900
   OHMOTO K, 1994, J PROSTHET DENT, V71, P319, DOI 10.1016/0022-3913(94)90475-8
   OKABE T, 1994, J DENT RES, V73, P1711, DOI 10.1177/00220345940730110601
   OKAMOTO Y, 1994, J BIOMED MATER RES, V28, P1403, DOI 10.1002/jbm.820281204
   OKUZAKI H, 1994, J BIOMAT SCI-POLYM E, V5, P485, DOI 10.1163/156856294X00167
   OLIN PS, 1994, J PROSTHET DENT, V71, P625, DOI 10.1016/0022-3913(94)90449-9
   OLSEN FK, 1994, J ENDODONT, V20, P389, DOI 10.1016/S0099-2399(06)80297-9
   OLSSON S, 1994, J DENT RES, V73, P33, DOI 10.1177/00220345940730010501
   OLVERA N, 1994, DENT MATER, V10, P122, DOI 10.1016/0109-5641(94)90052-3
   Ophaug R, 1994, Adv Dent Res, V8, P87
   OSBORNE JW, 1994, AM J DENT, V7, P337
   OSTMAN PO, 1994, SCAND J DENT RES, V102, P172
   Otogoto Jun-Ichi, 1994, Journal of Nihon University School of Dentistry, V36, P209
   OWADALLY ID, 1994, INT ENDOD J, V27, P227, DOI 10.1111/j.1365-2591.1994.tb00260.x
   Ozata F, 1994, Quintessence Int, V25, P181
   OZDEN AN, 1994, J PROSTHET DENT, V72, P85
   PALMQVIST S, 1994, J PROSTHET DENT, V71, P245, DOI 10.1016/0022-3913(94)90462-6
   Palomo F, 1994, Int Dent J, V44, P75
   PAMEIJER CH, 1994, SWED DENT J, V18, P59
   PAMEIJER CH, 1991, SWED DENT J S, V80
   Pang I C, 1994, Northwest Dent Res, V4, P15
   PANG IC, 1994, J PROSTHET DENT, V72, P177, DOI 10.1016/0022-3913(94)90077-9
   Papathanasiou A G, 1994, Pediatr Dent, V16, P282
   PARISSIS N, 1994, AUST DENT J, V39, P184, DOI 10.1111/j.1834-7819.1994.tb03090.x
   PARSELL DE, 1994, DENT MATER, V10, P167, DOI 10.1016/0109-5641(94)90027-2
   Pascoe L., 1994, Pediatric Dentistry, V16, P193
   Paulillo L A, 1994, Am J Dent, V7, P153
   PAULILLO LAM, 1994, AM J DENT, V7, P345
   PEPPAS NA, 1994, SCIENCE, V263, P1715, DOI 10.1126/science.8134835
   PERA P, 1994, J PROSTHET DENT, V72, P585, DOI 10.1016/0022-3913(94)90289-5
   Perdigao J, 1994, Am J Dent, V7, P149
   Perdigao J, 1994, Quintessence Int, V25, P327
   Perdigao J, 1994, Int Dent J, V44, P349
   PERDIGAO J, 1994, J DENT RES, V73, P44, DOI 10.1177/00220345940730010601
   Perdigao J, 1994, Am J Dent, V7, P81
   Perrin C, 1994, Quintessence Int, V25, P603
   PETERSSON LG, 1994, SWED DENT J, V18, P69
   PEUTZFELDT A, 1994, SCAND J DENT RES, V102, P73
   PEUTZFELDT A, 1994, J DENT RES, V73, P511, DOI 10.1177/00220345940730020501
   PEUTZFELDT A, 1994, ACTA ODONTOL SCAND, V52, P51, DOI 10.3109/00016359409096376
   PEUTZFELDT A, 1994, J DENT RES, V73, P1657, DOI 10.1177/00220345940730101101
   Philip D S, 1994, J Can Dent Assoc, V60, P682
   Phillips KM, 1994, INT J ORAL MAXILLOF, V9, P533
   Piattelli A, 1994, Int J Oral Maxillofac Implants, V9, P163
   PICHE PW, 1994, J BIOMED MATER RES, V28, P603, DOI 10.1002/jbm.820280510
   PIERPONT WF, 1994, OPER DENT, V19, P211
   PIGNO MA, 1994, J PROSTHET DENT, V71, P295, DOI 10.1016/0022-3913(94)90470-7
   PILO R, 1994, DENT MATER, V10, P338, DOI 10.1016/0109-5641(94)90056-6
   PIMIENTA C, 1994, CELL MATER, V4, P379
   PINHOLT EM, 1994, CLIN ORAL IMPLAN RES, V5, P213, DOI 10.1034/j.1600-0501.1994.050404.x
   PISKIN E, 1994, J BIOMAT SCI-POLYM E, V5, P451, DOI 10.1163/156856294X00149
   Pissiotis A, 1994, Eur J Prosthodont Restor Dent, V3, P55
   PISSIOTIS E, 1994, J ENDODONT, V20, P118, DOI 10.1016/S0099-2399(06)80055-5
   Pizzoferrato Arturo, 1994, Clinical Materials, V15, P173, DOI 10.1016/0267-6605(94)90081-7
   Polyzois G. L., 1994, Clinical Materials, V16, P21, DOI 10.1016/0267-6605(94)90088-4
   Polyzois G L, 1994, Spec Care Dentist, V14, P26, DOI 10.1111/j.1754-4505.1994.tb01092.x
   POLYZOIS GL, 1994, J PROSTHET DENT, V71, P500, DOI 10.1016/0022-3913(94)90190-2
   POLYZOIS GL, 1994, J PROSTHET DENT, V71, P505, DOI 10.1016/0022-3913(94)90191-0
   Poolthong S, 1994, Dent Mater J, V13, P220
   POWELL LV, 1994, OPER DENT, V19, P70
   POWERS MP, 1994, J ORAL MAXIL SURG, V52, P904, DOI 10.1016/S0278-2391(10)80064-3
   PRADO C, 1994, AM J DENT, V7, P304
   PRATI C, 1994, J ENDODONT, V20, P174, DOI 10.1016/S0099-2399(06)80330-4
   PRATI C, 1994, J DENT, V22, P49, DOI 10.1016/0300-5712(94)90147-3
   PRATI C, 1994, J DENT, V22, P83, DOI 10.1016/0300-5712(94)90005-1
   PRESTON JD, 1994, INT J PROSTHODONT, V7, P399
   Price C A, 1994, Aust Prosthodont J, V8, P47
   PROMBONAS A, 1994, J PROSTHET DENT, V72, P95, DOI 10.1016/0022-3913(94)90218-6
   Proskin Howard M., 1994, Journal of Clinical Dentistry, V5, P19
   PSARRAS V, 1994, SWED DENT J, V18, P15
   QUEGUINER I, 1994, ORAL SURG ORAL MED O, V77, P90, DOI 10.1016/S0030-4220(06)80114-3
   Quirynen M, 1994, Int J Oral Maxillofac Implants, V9, P71
   Rankin K. Vendrell, 1994, Pediatric Dentistry, V16, P117
   RATLEDGE DK, 1994, J PROSTHET DENT, V72, P194, DOI 10.1016/0022-3913(94)90080-9
   RAVISHANKARA AR, 1994, SCIENCE, V263, P71, DOI 10.1126/science.263.5143.71
   RAVNHOLT G, 1994, J DENT, V22, P169, DOI 10.1016/0300-5712(94)90201-1
   RAZZOOG ME, 1994, J PROSTHET DENT, V72, P453, DOI 10.1016/0022-3913(94)90113-9
   RECLARU L, 1994, J DENT, V22, P159, DOI 10.1016/0300-5712(94)90200-3
   REEH ES, 1994, DENT MATER, V10, P247, DOI 10.1016/0109-5641(94)90069-8
   REID JS, 1994, J DENT CHILD, V61, P255
   REINHARDT JW, 1994, OPER DENT, V19, P217
   Retief D H, 1994, Int Dent J, V44, P19
   RETIEF DH, 1994, AM J DENT, V7, P43
   Rix A M, 1994, Am J Dent, V7, P131
   Rizoiu I M, 1994, Compendium, V15, P110
   ROBINSON PB, 1994, J PROSTHET DENT, V71, P390, DOI 10.1016/0022-3913(94)90101-5
   Rolla G, 1994, Int Dent J, V44, P99
   Rolla G, 1994, Adv Dent Res, V8, P272
   Rosen S, 1994, J Dent Educ, V58, P836
   Rossmann J A, 1994, Tex Dent J, V111, P17
   ROZAJZL WF, 1994, AM J DENT, V7, P319
   Rozier R G, 1994, Adv Dent Res, V8, P39
   RUBIE DC, 1994, SCIENCE, V264, P1445, DOI 10.1126/science.264.5164.1445
   Rueggeberg F A, 1994, Int J Prosthodont, V7, P159
   RUEGGEBERG FA, 1994, OPER DENT, V19, P26
   RUEGGEBERG FA, 1994, J PROSTHET DENT, V72, P406, DOI 10.1016/0022-3913(94)90561-4
   RUEGGEBERG FA, 1994, DENT MATER, V10, P282, DOI 10.1016/0109-5641(94)90076-0
   Russell D A, 1994, Int J Prosthodont, V7, P7
   Russell R R, 1994, Adv Dent Res, V8, P285
   RYDEN H, 1994, SWED DENT J, V18, P35
   SADAMORI S, 1994, J PROSTHET DENT, V72, P19, DOI 10.1016/0022-3913(94)90210-0
   SADOUN M, 1994, DENT MATER, V10, P185, DOI 10.1016/0109-5641(94)90030-2
   Sain D R, 1994, J Clin Orthod, V28, P522
   SAKAKI T, 1994, J PROSTHET DENT, V71, P552, DOI 10.1016/0022-3913(94)90436-7
   Salama F S, 1994, J Clin Pediatr Dent, V19, P35
   Salama Fouad S., 1994, Pediatric Dentistry, V16, P424
   SALONGA JP, 1994, J PROSTHET DENT, V72, P582, DOI 10.1016/0022-3913(94)90288-7
   SANO H, 1994, J DENT RES, V73, P1205, DOI 10.1177/00220345940730061201
   SANO H, 1994, DENT MATER, V10, P236, DOI 10.1016/0109-5641(94)90067-1
   SANO H, 1994, OPER DENT, V19, P59
   SANTOS AC, 1994, OPER DENT, V19, P2
   SARRETT DC, 1994, DENT MATER, V10, P6, DOI 10.1016/0109-5641(94)90015-9
   Satoh Y, 1994, J Nihon Univ Sch Dent, V36, P40
   SAUNDERS WP, 1994, J ENDODONT, V20, P155, DOI 10.1016/S0099-2399(06)80325-0
   SAUTIER JM, 1994, CELL MATER, V4, P357
   Scannapieco F A, 1994, J Dent Educ, V58, P843
   Scheie A A, 1994, Adv Dent Res, V8, P246
   SCHERRER SS, 1994, DENT MATER, V10, P172, DOI 10.1016/0109-5641(94)90028-0
   SCHLIEPHAKE H, 1994, INT J ORAL MAX SURG, V23, P300, DOI 10.1016/S0901-5027(05)80115-8
   SCHMALZ G, 1994, J ENDODONT, V20, P592, DOI 10.1016/S0099-2399(06)80083-X
   SCHMALZ G, 1994, J DENT, V22, pS6, DOI 10.1016/0300-5712(94)90032-9
   SCHMALZ G, 1994, DENT MATER, V10, P304, DOI 10.1016/0109-5641(94)90038-8
   Schulein T M, 1994, J Dent Educ, V58, P411
   Schultz J S, 1994, Adv Dent Res, V8, P100
   Schwabacher W B, 1994, J Prosthodont, V3, P188, DOI 10.1111/j.1532-849X.1994.tb00153.x
   Schwartz R S, 1994, Int J Prosthodont, V7, P418
   SCULLY MO, 1994, SCIENCE, V263, P337, DOI 10.1126/science.263.5145.337
   SCURRIA MS, 1994, J PROSTHET DENT, V71, P174, DOI 10.1016/0022-3913(94)90027-2
   SEACHRIST L, 1994, SCIENCE, V264, P499, DOI 10.1126/science.8160006
   SEATON P, 1994, J PROSTHET DENT, V71, P237, DOI 10.1016/0022-3913(94)90461-8
   Sekiya K, 1994, Dent Mater J, V13, P36
   Serra M C, 1994, Am J Dent, V7, P203
   SERVICE RF, 1994, SCIENCE, V264, P1532, DOI 10.1126/science.264.5165.1532
   SERVICE RF, 1994, SCIENCE, V264, P510, DOI 10.1126/science.264.5158.510
   Sethi A, 1994, Dent Update, V21, P52
   SHACKLETON JL, 1994, J PROSTHET DENT, V71, P23, DOI 10.1016/0022-3913(94)90250-X
   SHAH RM, 1994, J DENT RES, V73, P1783, DOI 10.1177/00220345940730111701
   Shapira J, 1994, Spec Care Dentist, V14, P158, DOI 10.1111/j.1754-4505.1994.tb01124.x
   Shazad N, 1994, Eur J Prosthodont Restor Dent, V3, P33
   Shearer A C, 1994, Int J Prosthodont, V7, P167
   Shellis R P, 1994, Int Dent J, V44, P263
   SHEN CY, 1994, DENT MATER, V10, P190, DOI 10.1016/0109-5641(94)90031-0
   Shinkai K, 1994, Quintessence Int, V25, P767
   SHINKAI K, 1994, J AM DENT ASSOC, V125, P1467, DOI 10.14219/jada.archive.1994.0214
   SHIROTA T, 1994, ORAL IMPLANTOLOGY, V20, P307
   Sidhu S K, 1994, Am J Dent, V7, P115
   Sidhu S K, 1994, Quintessence Int, V25, P797
   Siervo S, 1994, Quintessence Int, V25, P773
   Siervo S, 1994, Int J Prosthodont, V7, P434
   SIM C, 1994, DENT MATER, V10, P278, DOI 10.1016/0109-5641(94)90075-2
   Sim T P, 1994, Quintessence Int, V25, P505
   Simonsen R J, 1994, J Dent Educ, V58, P855
   SMALES RJ, 1994, AUST DENT J, V39, P344, DOI 10.1111/j.1834-7819.1994.tb03103.x
   SMITH DC, 1994, J DENT, V22, P121, DOI 10.1016/0300-5712(94)90017-5
   Smith I, 1994, Int Dent J, V44, P71
   SMITH MA, 1994, J ENDODONT, V20, P18, DOI 10.1016/S0099-2399(06)80021-X
   Smith T B, 1994, J Prosthodont, V3, P138, DOI 10.1111/j.1532-849X.1994.tb00144.x
   SOH G, 1994, J ORAL REHABIL, V21, P411, DOI 10.1111/j.1365-2842.1994.tb01155.x
   SOHOEL H, 1994, SCAND J DENT RES, V102, P126
   Sonis A L, 1994, J Clin Orthod, V28, P93
   Sonis A L, 1994, J Clin Orthod, V28, P293
   SOUSA JP, 1994, BIOMATERIALS, V15, P821, DOI 10.1016/0142-9612(94)90037-X
   Souto M, 1994, Am J Dent, V7, P122
   Souza M H, 1994, Am J Dent, V7, P67
   Spieler E L, 1994, Compendium, V15, P310
   STACKHOUSE JA, 1994, J PROSTHET DENT, V71, P209, DOI 10.1016/0022-3913(94)90035-3
   STAMWESTERVELD EB, 1994, CONTACT DERMATITIS, V31, P1, DOI 10.1111/j.1600-0536.1994.tb01894.x
   STASSEN LFA, 1994, BRIT J ORAL MAX SURG, V32, P83, DOI 10.1016/0266-4356(94)90133-3
   STEA S, 1994, J BIOMED MATER RES, V28, P319, DOI 10.1002/jbm.820280306
   STEELE JG, 1993, J BIOMAT SCI-POLYM E, V5, P245
   Steflik D E, 1994, J Oral Implantol, V20, P8
   STEFLIK DE, 1994, ORAL IMPLANTOLOGY, V20, P201
   STEFLIK DE, 1994, ORAL IMPLANTOLOGY, V20, P198
   STEIN JM, 1994, ANGLE ORTHOD, V64, P291
   Stephen K W, 1994, Adv Dent Res, V8, P185
   Stephen K W, 1994, Int Dent J, V44, P287
   STEVENS BH, 1994, J ENDODONT, V20, P246, DOI 10.1016/S0099-2399(06)80287-6
   STONE R, 1994, SCIENCE, V264, P204, DOI 10.1126/science.8146648
   STORIE DJ, 1994, ANGLE ORTHOD, V64, P199
   STRUTZ JM, 1994, J PROSTHET DENT, V72, P128, DOI 10.1016/0022-3913(94)90068-X
   SULIMAN AH, 1994, J PROSTHET DENT, V71, P7, DOI 10.1016/0022-3913(94)90247-X
   Summitt J B, 1994, Quintessence Int, V25, P251
   SUTOW EJ, 1994, J ORAL REHABIL, V21, P553, DOI 10.1111/j.1365-2842.1994.tb01169.x
   SUTTER F, 1994, CLIN ORAL IMPLAN RES, V5, P164, DOI 10.1034/j.1600-0501.1994.050307.x
   Suzuki S, 1994, Quintessence Int, V25, P59
   Swartz M L, 1994, J Clin Orthod, V28, P208
   Swift E J Jr, 1994, Int J Prosthodont, V7, P356
   SWITZER JA, 1994, SCIENCE, V264, P1573, DOI 10.1126/science.264.5165.1573
   Taira Y, 1994, Dent Mater J, V13, P155
   Tajima K, 1994, Dent Mater J, V13, P206
   TAM LE, 1994, J DENT RES, V73, P607, DOI 10.1177/00220345940730030601
   TAM LE, 1994, J DENT RES, V73, P1530, DOI 10.1177/00220345940730090801
   TAMARESELVY K, 1994, DENT MATER, V10, P290, DOI 10.1016/0109-5641(94)90036-1
   Tanaka Hajime, 1994, Journal of Nihon University School of Dentistry, V36, P135
   Tanaka J, 1994, Dent Mater J, V13, P55
   TANG LP, 1994, CELL MATER, V4, P429
   Tani C, 1994, Dent Mater J, V13, P131
   Tani Y, 1994, Dent Mater J, V13, P174
   TAY FR, 1994, J DENT RES, V73, P629, DOI 10.1177/00220345940730030801
   TAY FR, 1994, CELL MATER, V4, P317
   TAYAPONGSAK P, 1994, J ORAL MAXIL SURG, V52, P161, DOI 10.1016/0278-2391(94)90401-4
   Taylor D F, 1994, Am J Dent, V7, P167
   ten Cate J M, 1994, Adv Dent Res, V8, P125
   TENHUISEN KS, 1994, J DENT RES, V73, P598, DOI 10.1177/00220345940730030501
   Terata R, 1994, Dent Mater J, V13, P148
   THOMPSON GA, 1994, J PROSTHET DENT, V72, P651, DOI 10.1016/0022-3913(94)90299-2
   THOMPSON JY, 1994, J DENT RES, V73, P505, DOI 10.1177/00220345940730020401
   Thoms L M, 1994, Int J Prosthodont, V7, P403
   THORDRUP M, 1994, SCAND J DENT RES, V102, P186
   THORDRUP M, 1994, J DENT, V22, P147, DOI 10.1016/0300-5712(94)90198-8
   Thrash W J, 1994, Int Dent J, V44, P107
   THURMOND JW, 1994, J PROSTHET DENT, V72, P355, DOI 10.1016/0022-3913(94)90553-3
   Thylstrup A, 1994, Adv Dent Res, V8, P144
   Thyne Gerard M., 1994, New Zealand Dental Journal, V90, P56
   Tipton D F, 1994, J Clin Orthod, V28, P718
   TITLEY K, 1995, AM J DENT, V8, P224
   Titley K, 1994, Am J Dent, V7, P190
   TITLEY K, 1994, ORAL HLTH, V84, P3
   Toledano M, 1994, AM J DENT, V7, P328
   TONNER RIM, 1994, EUR J ORTHODONT, V16, P409, DOI 10.1093/ejo/16.5.409
   TONNER RIM, 1994, EUR J ORTHODONT, V16, P421, DOI 10.1093/ejo/16.5.421
   TORABINEJAD M, 1994, J ENDODONT, V20, P159, DOI 10.1016/S0099-2399(06)80326-2
   TORONTALI M, 1994, CELL MATER, V4, P125
   Touyz L Z, 1994, J Can Dent Assoc, V60, P454
   Triana R, 1994, Am J Dent, V7, P252
   Triana R T, 1994, J Clin Pediatr Dent, V18, P109
   TRUHLAR MR, 1994, J PROSTHET DENT, V71, P517, DOI 10.1016/0022-3913(94)90193-7
   TSCHAKALOFF A, 1994, INT J ORAL MAX SURG, V23, P443, DOI 10.1016/S0901-5027(05)80043-8
   TSU R, 1994, NATURE, V369, P442, DOI 10.1038/369442a0
   TSUCHIYA H, 1994, J PROSTHET DENT, V71, P618, DOI 10.1016/0022-3913(94)90448-0
   Tsujimoto Y, 1994, J Nihon Univ Sch Dent, V36, P199
   TSUMIMOTO Y, 1994, J NIHON U SCH DENT, V36, P199
   TUOVINEN V, 1994, J ORAL MAXIL SURG, V52, P931, DOI 10.1016/S0278-2391(10)80072-2
   TURNER CH, 1994, FASEB J, V8, P875
   Tyas M J, 1994, Int Dent J, V44, P303
   Tyas M J, 1994, Am J Dent, V7, P77
   TYAS MJ, 1994, AUST DENT J, V39, P220, DOI 10.1111/j.1834-7819.1994.tb04780.x
   TYAS MJ, 1994, AUST DENT J, V39, P188, DOI 10.1111/j.1834-7819.1994.tb03091.x
   TYLER MW, 1994, OPER DENT, V19, P116
   TYLKA DF, 1994, J PROSTHET DENT, V72, P121, DOI 10.1016/0022-3913(94)90067-1
   UCTASLI S, 1994, J ORAL REHABIL, V21, P565, DOI 10.1111/j.1365-2842.1994.tb01171.x
   Ulukapi Isin, 1994, Journal of Nihon University School of Dentistry, V36, P266
   UNGERSBOCK A, 1994, BIOMED MATER ENG, V4, P347
   Uno S, 1994, Dent Mater J, V13, P19
   UNSAL E, 1994, CELL MATER, V4, P309
   VALENZUELA VS, 1994, OPER DENT, V19, P91
   VALLITTU PK, 1994, J PROSTHET DENT, V72, P639, DOI 10.1016/0022-3913(94)90297-6
   VALLITTU PK, 1994, J PROSTHET DENT, V71, P613, DOI 10.1016/0022-3913(94)90447-2
   VALLITTU PK, 1994, J PROSTHET DENT, V71, P607, DOI 10.1016/0022-3913(94)90446-4
   VALLITTU PK, 1994, DENT MATER, V10, P116, DOI 10.1016/0109-5641(94)90051-5
   VALLITTU PK, 1994, J PROSTHET DENT, V72, P289, DOI 10.1016/0022-3913(94)90342-5
   van der Merwe W J, 1994, J Dent Assoc S Afr, V49, P11
   van der Vyver P J, 1994, J Dent Assoc S Afr, V49, P355
   van Putten M C Jr, 1994, J Prosthodont, V3, P79
   van Rensburg S D, 1994, J Dent Assoc S Afr, V49, P127
   VANDERSTEEN AFW, 1994, J MICROSC-OXFORD, V175, P21
   Vandewalle K S, 1994, Int J Prosthodont, V7, P315
   VANDIJKEN JWV, 1994, ACTA ODONTOL SCAND, V52, P368, DOI 10.3109/00016359409029034
   VANDIJKEN JWV, 1994, J DENT, V22, P265, DOI 10.1016/0300-5712(94)90055-8
   VANDIJKEN JWV, 1994, DENT MATER, V10, P319, DOI 10.1016/0109-5641(94)90040-X
   VANDKJKEN JWV, 1994, 6 YEAR EVALUATION DI
   VANKEKEN PE, 1994, SCIENCE, V264, P1437, DOI 10.1126/science.264.5164.1437
   VANKIJKEN JWV, 1994, J DENT, V22, P265
   VANMEERBEEK B, 1994, J ORAL REHABIL, V21, P57
   VANMEERBEEK B, 1994, J DENT, V22, P141, DOI 10.1016/0300-5712(94)90197-X
   VANMEERBEEK B, 1994, J DENT RES, V73, P1690, DOI 10.1177/00220345940730110401
   VANNOORT R, 1993, J DENT, V21, P5, DOI 10.1016/0300-5712(93)90046-S
   VANNOORT R, 1994, J DENT, V22, P5, DOI 10.1016/0300-5712(94)90139-2
   Vargas M A, 1994, Am J Dent, V7, P187
   VARGAS MA, 1994, OPER DENT, V19, P224
   VARGAS MA, 1994, AM J DENT, V7, P325
   Varpio M., 1994, Pediatric Dentistry, V16, P107
   VEIEN NK, 1994, CONTACT DERMATITIS, V30, P210, DOI 10.1111/j.1600-0536.1994.tb00645.x
   VEIGA MM, 1994, NATURE, V368, P816, DOI 10.1038/368816a0
   Venezie Ronald D., 1994, Pediatric Dentistry, V16, P433
   VENHOVEN BAM, 1994, BIOMATERIALS, V15, P1152, DOI 10.1016/0142-9612(94)90235-6
   Venkateswarlu P, 1994, Adv Dent Res, V8, P80
   VERDE MARL, 1994, J PROSTHET DENT, V71, P339
   VERZIJDEN CWGJM, 1994, J DENT, V22, P29, DOI 10.1016/0300-5712(94)90140-6
   VERZIJDEN CWGJM, 1994, J DENT RES, V73, P529, DOI 10.1177/00220345940730020801
   VIGUIE G, 1994, J PROSTHET DENT, V72, P245, DOI 10.1016/0022-3913(94)90336-0
   VIJAYARAGHAVAN TV, 1994, FLEXURAL BEHAVIOR VI
   VIVORY JL, 1994, SCIENCE, V264, P112
   von Fraunhofer J A, 1994, Int J Prosthodont, V7, P120
   Wakabayashi Y, 1994, Int J Prosthodont, V7, P302
   WALIVAARA B, 1994, BIOMATERIALS, V15, P827, DOI 10.1016/0142-9612(94)90038-8
   WALSH LJ, 1994, DENT MATER, V10, P162, DOI 10.1016/0109-5641(94)90026-4
   WALSHAW PR, 1994, J DENT RES, V73, P1079, DOI 10.1177/00220345940730051001
   WALTER M, 1994, J DENT, V22, P346, DOI 10.1016/0300-5712(94)90086-8
   WALTON JN, 1994, J PROSTHET DENT, V71, P283, DOI 10.1016/0022-3913(94)90468-5
   Wang R, 1994, Int J Prosthodont, V7, P43
   WANG WN, 1994, ANGLE ORTHOD, V64, P377
   WANG XA, 1994, INT J ORAL MAX SURG, V23, P115
   WARFVINGE G, 1994, J DENT, V22, pS16, DOI 10.1016/0300-5712(94)90034-5
   WARFVINGE G, 1994, SCAND J DENT RES, V102, P34
   WASSELL RW, 1994, J DENT RES, V73, P1546, DOI 10.1177/00220345940730091001
   WATAHA JC, 1994, J ORAL REHABIL, V21, P453, DOI 10.1111/j.1365-2842.1994.tb01159.x
   WATAHA JC, 1994, DENT MATER, V10, P298, DOI 10.1016/0109-5641(94)90037-X
   WATAHA JC, 1994, DENT MATER, V10, P156, DOI 10.1016/0109-5641(94)90025-6
   WATANABE I, 1994, J DENT, V22, P67, DOI 10.1016/0300-5712(94)90001-9
   WATANABE I, 1994, DENT MATER, V10, P369, DOI 10.1016/0109-5641(94)90061-2
   WATANABE I, 1994, BONDING GROUND DENTI, P1212
   Watson R M, 1994, Dent Update, V21, P8
   WATSON TF, 1994, BRIT DENT J, V176, P227, DOI 10.1038/sj.bdj.4808410
   Watts A, 1994, Eur J Prosthodont Restor Dent, V3, P27
   WATTS DC, 1994, J DENT, V22, P154, DOI 10.1016/0300-5712(94)90199-6
   WATTS DC, 1994, J DENT, V22, P112, DOI 10.1016/0300-5712(94)90014-0
   WELLER RN, 1994, INT ENDOD J, V27, P299, DOI 10.1111/j.1365-2591.1994.tb00272.x
   Wendt S L Jr, 1994, Am J Dent, V7, P207
   WENKING A, 1994, INT J PROSTHODONT, V7, P532
   White D J, 1994, Adv Dent Res, V8, P166
   WHITE JM, 1994, J DENT RES, V73, P1560, DOI 10.1177/00220345940730091201
   White K C, 1994, Quintessence Int, V25, P259
   White S N, 1994, J Esthet Dent, V6, P267, DOI 10.1111/j.1708-8240.1994.tb00868.x
   WHITE SN, 1994, J PROSTHET DENT, V71, P333, DOI 10.1016/0022-3913(94)90090-6
   WHITE SN, 1994, J PROSTHET DENT, V71, P257, DOI 10.1016/0022-3913(94)90464-2
   WHITE SN, 1994, DENT MATER, V10, P52, DOI 10.1016/0109-5641(94)90022-1
   WHITE SN, 1994, J CALIF DENT ASS MAR, P55
   WHITE SN, 1994, J CALIF DENT ASS AUG, P39
   Whitford G M, 1994, Adv Dent Res, V8, P5
   WIDSTROM E, 1994, SWED DENT J, V18, P1
   WILLIAMS JA, 1994, BIOMATERIALS, V15, P1008, DOI 10.1016/0142-9612(94)90082-5
   Williams P, 1994, J Can Dent Assoc, V60, P299
   WILLIAMS RM, 1994, FASEB J, V8, P804
   Williams V D, 1994, Am J Dent, V7, P184
   WILLIAMSON DL, 1994, J PROSTHET DENT, V72, P635, DOI 10.1016/0022-3913(94)90296-8
   Wilson J, 1994, Eur J Prosthodont Restor Dent, V2, P137
   WILSON PR, 1994, J PROSTHET DENT, V71, P560, DOI 10.1016/0022-3913(94)90437-5
   WILSON T, 1994, J MICROSC-OXFORD, V175, P1, DOI 10.1111/j.1365-2818.1994.tb04782.x
   Wilson T G Jr, 1994, Tex Dent J, V111, P7
   WINKLER MM, 1994, DENT MATER, V10, P222, DOI 10.1016/0109-5641(94)90065-5
   WISKOTT HWA, 1994, DENT MATER, V10, P215
   WONG WS, 1994, J ENDODONT, V20, P595, DOI 10.1016/S0099-2399(06)80084-1
   WOOLFORD MJ, 1994, J DENT, V22, P360, DOI 10.1016/0300-5712(94)90089-2
   WRANGSJO K, 1994, CONTACT DERMATITIS, V30, P102, DOI 10.1111/j.1600-0536.1994.tb00572.x
   WRANGSJO K, 1994, CONTACT DERMATITIS, V30, P139, DOI 10.1111/j.1600-0536.1994.tb00694.x
   Wright Kelly J., 1994, Pediatric Dentistry, V16, P102
   WRIGHT RS, 1994, ORAL HLTH, V84, P11
   Wu J C, 1994, Int J Prosthodont, V7, P209
   Wu J C, 1994, Aust Prosthodont J, V8, P55
   WU MK, 1994, INT ENDOD J, V27, P304, DOI 10.1111/j.1365-2591.1994.tb00273.x
   WYLIE SG, 1994, J DENT RES, V73, P1684, DOI 10.1177/00220345940730110301
   XU S, 1994, J MICROSC-OXFORD, V173, P199, DOI 10.1111/j.1365-2818.1994.tb03442.x
   XU W, 1994, SCANNING MICROSCOPY, V8, P499
   YAMADA S, 1994, CELL MATER, V4, P347
   Yan J, 1994, J Prosthet Dent, V71, P289, DOI 10.1016/0022-3913(94)90469-3
   YANAGA M, 1994, DENT MATER J, V13, P89
   Yanagawa T, 1994, Am J Dent, V7, P157
   YGUELHENRY S, 1994, J ENDODONT, V20, P367, DOI 10.1016/S0099-2399(06)80292-X
   YOSHIDA K, 1994, J DENT, V22, P296, DOI 10.1016/0300-5712(94)90064-7
   YOSHIDA K, 1994, J DENT, V22, P57, DOI 10.1016/0300-5712(94)90149-X
   YOSHIDA K, 1994, INT J ORAL MAXILLOF, V9, P719
   Yoshinari M, 1994, Int J Prosthodont, V7, P329
   YOU ZH, 1994, J ORAL MAXIL SURG, V52, P1293, DOI 10.1016/0278-2391(94)90052-3
   YOUNG L, 1994, J PROSTHET DENT, V71, P575, DOI 10.1016/0022-3913(94)90440-5
   Youngs G, 1994, Spec Care Dentist, V14, P68, DOI 10.1111/j.1754-4505.1994.tb01104.x
   YUNUS N, 1994, J ORAL REHABIL, V21, P641
   ZIOUPOS P, 1994, J BIOMECH, V27, P993, DOI 10.1016/0021-9290(94)90272-0
   Zografakis M A, 1994, Eur J Prosthodont Restor Dent, V2, P101
NR 1109
TC 5
Z9 5
U1 0
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0109-5641
EI 1879-0097
J9 DENT MATER
JI Dent. Mater.
PD JAN
PY 1995
VL 11
IS 1
BP 52
EP 77
DI 10.1016/0109-5641(95)80009-3
PG 26
WC Dentistry, Oral Surgery & Medicine; Materials Science, Biomaterials
SC Dentistry, Oral Surgery & Medicine; Materials Science
GA RV700
UT WOS:A1995RV70000009
PM 7498609
DA 2018-10-20
ER

PT J
AU ANDERSON, JM
   ZIATS, NP
   AZEEZ, A
   BRUNSTEDT, MR
   STACK, S
   BONFIELD, TL
AF ANDERSON, JM
   ZIATS, NP
   AZEEZ, A
   BRUNSTEDT, MR
   STACK, S
   BONFIELD, TL
TI PROTEIN ADSORPTION AND MACROPHAGE ACTIVATION ON POLYDIMETHYLSILOXANE AND
   SILICONE-RUBBER
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE BIOCOMPATIBILITY; POLYDIMETHYLSILOXANE; SILICONE RUBBER; PROTEIN
   ADSORPTION; MONOCYTE MACROPHAGE ACTIVATION
ID CONNECTIVE-TISSUE DISEASE; HUMAN PLASMA-PROTEINS; BIO-MEDICAL POLYMERS;
   BIOMEDICAL POLYMERS; INTERLEUKIN-1 GENERATION; MONOCYTES MACROPHAGES;
   BREAST IMPLANTS; VASCULAR GRAFTS; FACTOR-XII; STIMULATION
AB Static and dynamic human blood adsorption studies on polydimethylsiloxane, PDMS, and silicone rubber show that these materials are similar, but not identical, in their protein adsorption behavior. Fibrinogen, immunoglobulin G, and albumin were the predominant proteins identified on the material surfaces with fibronectin, Hageman factor (factor XII), and factor VIII/vWF adsorbing at intermediate levels. While the protein adsorption characteristics for the two materials were similar, higher levels of the respective proteins were identified on silicone rubber compared to PDMS. Monocytes/macrophages incubated on PDMS, silicone rubber and low density polyethylene, LDPE, with or without protein adsorption produced variable levels of IL-I beta, IL-6 and TNF-alpha dependent on the polymer and adsorbed protein. PDMS showed lower levels of the cytokines when compared to the polystyrene control and polyethylene. Protein preadsorption on the PDMS, polystyrene, and LDPE surfaces showed lower levels of cytokines when compared to the respective quantities produced with no protein adsorption suggesting a passivating effect by the protein adsorption phenomenon on monocyte/macrophage activation. Preadsorption of IgG, fibrinogen or fibronectin decreased the quantitative expression of IL-1 beta but increased the functional activity in the thymocyte proliferation assay indicating the presence of monocyte/macrophage activation products which either downregulated the activity of IL-1 beta or upregulated thymocyte proliferation in an independent fashion.
RP ANDERSON, JM (reprint author), CASE WESTERN RESERVE UNIV,INST PATHOL,2085 ADELBERT RD,CLEVELAND,OH 44106, USA.
FU NHLBI NIH HHS [HL-33849, HL-48771]
CR BONFIELD TL, 1991, J BIOMED MATER RES, V25, P165, DOI 10.1002/jbm.820250204
   BONFIELD TL, 1992, J BIOMED MATER RES, V26, P837, DOI 10.1002/jbm.820260702
   BONFIELD TL, 1992, J BIOMED MATER RES, V26, P457, DOI 10.1002/jbm.820260404
   BONFIELD TL, 1993, J BIOMED MATER RES, V27, P1195, DOI 10.1002/jbm.820270910
   BONFIELD TL, 1989, J BIOMED MATER RES, V23, P525
   BRASH JL, 1988, BLOOD, V71, P932
   Brash JL, 1991, BLOOD COMPATIBLE MAT, P3
   DUNN KW, 1992, BRIT J PLAST SURG, V45, P315, DOI 10.1016/0007-1226(92)90060-B
   FENSKE NA, 1993, ARCH DERMATOL, V129, P97, DOI 10.1001/archderm.129.1.97
   HORBETT TA, 1993, CARDIOVASC PATHOL S, V2, P173
   HORBETT TA, 1986, TECHNIQUES BIOCOMPAT, P183
   KOSSOVSKY N, 1987, CRIT REV BIOCOMPAT, V3, P53
   KRANE SM, 1985, COLLAGEN REL RES, V5, P99
   LEVIER RR, 1993, PLAST RECONSTR SURG, V92, P163
   MILLER KM, 1989, BIOMATERIALS, V10, P187, DOI 10.1016/0142-9612(89)90023-9
   MILLER KM, 1989, J BIOMED MATER RES, V23, P1007, DOI 10.1002/jbm.820230904
   MILLER KM, 1988, J BIOMED MATER RES, V22, P713, DOI 10.1002/jbm.820220805
   MILLER KM, 1989, J BIOMED MATER RES, V23, P911, DOI 10.1002/jbm.820230808
   NEMECEK JAR, 1993, SOUTH MED J, V86, P932
   NERAD JL, 1992, J LEUK BIOL, V52
   PANKOWSKY DA, 1990, J VASC SURG, V11, P599, DOI 10.1067/mva.1990.18272
   SCALCH L, 1991, BIOCHEM BIOPH RES CO, V174, P885
   SILVER RM, 1993, ARCH DERMATOL, V129, P63, DOI 10.1001/archderm.129.1.63
   SPILIZEWSKI KL, 1987, BIOMATERIALS, V8, P12, DOI 10.1016/0142-9612(87)90021-4
   VROMAN L, 1988, B NEW YORK ACAD MED, V64, P352
   VROMAN L, 1987, SEMIN THROMB HEMOST, V13, P79, DOI 10.1055/s-2007-1003477
   VROMAN L, 1980, BLOOD, V55, P156
   VROMAN L, 1971, FED PROC, V30, P1494
   WAHL SM, 1988, J IMMUNOL, V140, P3026
   ZIATS NP, 1990, J LAB CLIN MED, V116, P687
   ZIATS NP, 1991, CELL MATER, V1, P73
NR 31
TC 77
Z9 77
U1 0
U2 16
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 1995
VL 7
IS 2
BP 159
EP 169
DI 10.1163/156856295X00670
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA QZ524
UT WOS:A1995QZ52400007
PM 7654630
DA 2018-10-20
ER

PT J
AU KASUGA, T
   INOUE, T
   TSUJI, K
   OTA, Y
   ABE, Y
AF KASUGA, T
   INOUE, T
   TSUJI, K
   OTA, Y
   ABE, Y
TI PREPARATION OF POROUS CERAMICS WITH CALCIUM METAPHOSPHATE FIBER SKELETON
   FOR BIOMEDICAL USE
SO JOURNAL OF THE AMERICAN CERAMIC SOCIETY
LA English
DT Note
ID PHOSPHATE GLASS-CERAMICS; INTERFACE; BONE
AB High-strength calcium metaphosphate fibers for biomedical applications are extracted from crystallized products of calcium ultraphosphate glasses by aqueous leaching. In the present work, new types of porous ceramics with a skeleton composed of the crystalline fibers are prepared by heating the fibrous products extracted. The fibers in the ceramic are interlinked to each other by glassy phases formed during the heating. This porous material has a large porosity of >60%. The surface of the skeleton can be successfully converted into new calcium phosphate phases such as apatite by heating the porous material treated with a molten salt mixture of CaCl2Ca(NO3)(2).
C1 YABASHI IND CO LTD,OGAKI,GIFU 50322,JAPAN.
RP KASUGA, T (reprint author), NAGOYA INST TECHNOL,DEPT MAT SCI & ENGN,NAGOYA,AICHI 466,JAPAN.
CR ABE Y, 1982, J AM CERAM SOC, V65, pC189
   ABE Y, 1987, PHOSPHORUS SULFUR, V30, P337, DOI 10.1080/03086648708080589
   ABE Y, 1984, J AM CERAM SOC, V67, pC142
   ABE Y, 1983, ORTHOPAED CERAM IMPL, V3, P49
   ABE Y, 1990, HDB BIOACTIVE CERAMI, V1, P109
   De Groot K., 1990, HDB BIOACTIVE CERAMI, P3
   HULBERT SF, 1972, J BIOMED MATER RES, V6, P347, DOI 10.1002/jbm.820060505
   KASUGA T, 1992, NIPPON SERAM KYO GAK, V100, P1088
   KASUGA T, 1993, PHOSPHORUS SULFUR, V76, P247
   KASUGA T, 1992, PHOSPHORUS RES B, V2, P17
   KLEIN CPAT, 1987, BIOMATERIALS, V8, P234, DOI 10.1016/0142-9612(87)90071-8
   KLEIN CPAT, 1984, BIOMATERIALS, V5, P362, DOI 10.1016/0142-9612(84)90036-X
   NAGASE M, 1992, BIOMATERIALS, V13, P172, DOI 10.1016/0142-9612(92)90067-X
   Ota Y., UNPUB
   WHITTINGHAM S, 1975, TISSUE ANTIGENS, V6, P23
NR 15
TC 18
Z9 18
U1 0
U2 0
PU AMER CERAMIC SOC 735 CERAMIC PLACE
PI WESTERVILLE
PA PO BOX 6136, WESTERVILLE, OH 43081-6136
SN 0002-7820
J9 J AM CERAM SOC
JI J. Am. Ceram. Soc.
PD JAN
PY 1995
VL 78
IS 1
BP 245
EP 247
PG 3
WC Materials Science, Ceramics
SC Materials Science
GA QD720
UT WOS:A1995QD72000042
DA 2018-10-20
ER

PT J
AU Bruns, M
   Schlesinger, R
   KleweNebenius, H
   Baumann, H
   Becht, R
   Ache, HJ
AF Bruns, M
   Schlesinger, R
   KleweNebenius, H
   Baumann, H
   Becht, R
   Ache, HJ
TI Development of Na+-sensitive membranes based on sputtered Na-Al-Si
   glasses
SO MIKROCHIMICA ACTA
LA English
DT Article
DE Na-sensitive glass membranes; RF magnetron sputtering; surface analysis;
   depth profiles; capacitance
ID ISFETS
AB Na+-sensitive microdevices are of increasing interest for integration in microanalytical systems e.g. for biomedical applications or for industrial process control. In order to produce ultra thin Na+-sensitive layers with fixed and reproducible composition and, in particular, defined Na concentration by means of RF sputtering, an off-axis geometry of a magnetron with cylindrical target was chosen for minimizing back-sputtering effects from the already deposited material. With this inverted cylindrical magnetron (ICM) it was possible to obtain reproducible and controllable sodium aluminosilicate glass layers on semiconductor substrates. Several surface and thin layer analytical techniques were applied for characterization of the membranes and for stoichiometry control. Especially by the non-destructive nuclear reaction analysis method a constant Na profile throughout the glass layer and - together with AES depth profiles the diffusion barrier effect of an Si3N4 interface layer could be verified. Electrochemical measurements proved Nernstian sensitivity down to 10(-4) M Na+ in solutions of pH 7, supporting sufficient stability and reproducibility of the sputtered Na+-sensitive layers.
C1 UNIV FRANKFURT,INST KERNPHYS,D-60486 FRANKFURT,GERMANY.
RP Bruns, M (reprint author), KERNFORSCHUNGSZENTRUM KARLSRUHE GMBH,INST RADIOCHEM,POB 3640,D-76021 KARLSRUHE,GERMANY.
RI Bruns, Michael/K-9073-2013
OI Bruns, Michael/0000-0002-0462-3948
CR ABE H, 1979, IEEE T ELECTRON DEV, V26, P1939, DOI 10.1109/T-ED.1979.19799
   BERGVELD P, 1988, ANAL BIOMEDICAL APPL, P91
   BYCHKOV E, 1994, SOLID STATE IONICS, V74, P165, DOI 10.1016/0167-2738(94)90207-0
   CRENS R, 1992, SOLID STATE IONICS 1, V53, P641
   DAVIES LE, 1978, HDB AUGER ELECTRON S
   EISENMAN G, 1967, GLASS ELECT HYDROGEN, pCH9
   ENDT PM, 1967, NUCL PHYS A, V105, P139
   ENDT PM, 1967, NUCL PHYS A, V105, P53
   Geerk J., 1989, Material Science Reports, V4, P193, DOI 10.1016/S0920-2307(89)80003-9
   HOFFMANN W, 1994, P MU TAS 94 WORKSHOP, P215
   ITO T, 1988, IEEE T ELECTRON DEV, V35, P56, DOI 10.1109/16.2415
   KLEIN M, 1989, SENSOR ACTUATOR, V17, P203, DOI 10.1016/0250-6874(89)80081-2
   LANFORD WA, 1979, J NON-CRYST SOLIDS, V33, P249, DOI 10.1016/0022-3093(79)90053-X
   MACDONALD JR, 1987, IMPEDANCE SPECTROSCO, P243
   MCCAUGHAN DV, 1974, P IEEE, V62, P1237
   PHAM MT, 1993, SENSOR ACTUAT B-CHEM, V13, P746
   SCHADE K, 1981, HALBLEITERTECHNOLOGI, V1, pCH13
   SCHLESINGER R, 1995, UNPUB J ANAL CHE JUL
   SCOFIELD JH, 1976, J ELECTRON SPECTROSC, V8, P129, DOI 10.1016/0368-2048(76)80015-1
   SMETS BMJ, 1983, FRESEN Z ANAL CHEM, V314, P285, DOI 10.1007/BF00516821
   WAGNER CD, 1982, J VAC SCI TECHNOL, V21, P933, DOI 10.1116/1.571870
NR 21
TC 1
Z9 1
U1 0
U2 3
PU SPRINGER-VERLAG WIEN
PI VIENNA
PA SACHSENPLATZ 4-6, PO BOX 89, A-1201 VIENNA, AUSTRIA
SN 0026-3672
J9 MIKROCHIM ACTA
JI Mikrochim. Acta
PY 1995
VL 121
IS 1-4
BP 73
EP 85
DI 10.1007/BF01248242
PG 13
WC Chemistry, Analytical
SC Chemistry
GA TN601
UT WOS:A1995TN60100006
DA 2018-10-20
ER

PT B
AU Tandon, RP
AF Tandon, RP
GP IEEE
TI Materials in biomedical engineering: Potential and issues
SO PROCEEDING OF THE FIRST REGIONAL CONFERENCE - IEEE ENGINEERING IN
   MEDICINE & BIOLOGY SOCIETY AND 14TH CONFERENCE OF THE BIOMEDICAL
   ENGINEERING SOCIETY OF INDIA
LA English
DT Proceedings Paper
CT 1st Regional Conference of the IEEE
   Engineering-in-Medicine-and-Biology-Society/14th Conference of the
   Biomedical-Engineering-Society-of-India
CY FEB 15-18, 1995
CL NEW DELHI, INDIA
SP IEEE, Engn Med & Biol Soc, Biomed Engn Soc India
C1 NATL PHYS LAB,NEW DELHI 110012,INDIA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU I E E E
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017
BN 0-7803-2711-X
PY 1995
BP 417
EP 418
PG 2
WC Engineering, Biomedical
SC Engineering
GA BG01B
UT WOS:A1995BG01B00204
DA 2018-10-20
ER

PT J
AU REID, G
   BUSSCHER, HJ
   SHARMA, S
   MITTELMAN, MW
   MCINTYRE, S
AF REID, G
   BUSSCHER, HJ
   SHARMA, S
   MITTELMAN, MW
   MCINTYRE, S
TI SURFACE-PROPERTIES OF CATHETERS, STENTS AND BACTERIA ASSOCIATED WITH
   URINARY-TRACT INFECTIONS
SO SURFACE SCIENCE REPORTS
LA English
DT Review
ID COAGULASE-NEGATIVE STAPHYLOCOCCI; TRANSFORM INFRARED-SPECTROSCOPY; HUMAN
   UROEPITHELIAL CELLS; ESCHERICHIA-COLI STRAINS; ACETYL-D-GLUCOSAMINE;
   TOXIC SHOCK SYNDROME; HYDROPHOBIC PROPERTIES; COMPETITIVE-EXCLUSION;
   POULTRY LACTOBACILLI; MICROBIAL ADHESION
AB Applications of surface and physico-chemical techniques to the clinical setting, in particular related to the urogenital tract, have been sporadic, often concentrating on aspects of biocompatibility and interactions of blood cells with materials.  In an era where billions of such devices are implanted annually, it is important to utilize such techniques to improve our understanding of material-host interactions.  In an effort to encourage further such interactive investigations, this review will illustrate some practical biomedical examples where utilization of sophisticated surface-science techniques has provided valuable insight into interfacial events between host components, micro-organisms and material surfaces.  Techniques to reduce bacterial infection and encrustations will be discussed, and suggestions given for future lines of enquiry.
C1 UNIV GRONINGEN,MAT TECH LAB,9700 AB GRONINGEN,NETHERLANDS.
   UNIV WESTERN ONTARIO,DEPT MICROBIOL & IMMUNOL,LONDON,ON N6A 3K7,CANADA.
   UNIV WESTERN ONTARIO,DIV UROL,LONDON,ON N6A 3K7,CANADA.
   UNIV WESTERN ONTARIO,DEPT CHEM,LONDON,ON N6A 3K7,CANADA.
   UNIV TORONTO HOSP,CTR INFECT & BIOMAT RES,TORONTO,ON,CANADA.
CR BATICH C, 1984, T ANN M SOC BIOMATER, P31
   BEAVERS EM, 1985, Patent No. 791021
   BERKLEY SF, 1987, JAMA-J AM MED ASSOC, V258, P917, DOI 10.1001/jama.258.7.917
   BIALKOWSKAHOBRZ.H, 1990, J CLIN MICROBIOL, V28, P269
   BOSKEY AL, 1992, CELL MATER, V2, P209
   Bremer P. J., 1991, Biofouling, V3, P89
   BRINKMAN E, 1991, BIOMATERIALS, V12, P63, DOI 10.1016/0142-9612(91)90134-V
   BRUCE AW, 1974, CAN MED ASSOC J, V111, P238
   BRUCE AW, 1988, CAN J MICROBIOL, V34, P339, DOI 10.1139/m88-062
   BRUCE AW, 1973, CAN MED ASSOC J, V108, P973
   Bruce AW, 1992, INT UROGYNECOL J, V3, P22, DOI DOI 10.1007/BF00372644
   BUSSCHER HJ, 1994, COLLOID SURFACE B, V2, P73, DOI 10.1016/0927-7765(94)80020-0
   BUSSCHER HJ, 1990, SURF INTERFACE ANAL, V15, P344, DOI 10.1002/sia.740150508
   CHAN RCY, 1985, INFECT IMMUN, V47, P84
   CHAN RCY, 1984, J UROLOGY, V131, P596, DOI 10.1016/S0022-5347(17)50512-1
   CHRISTENSEN GD, 1989, INFECT ASS INDWELLIN, P59
   COOK RL, 1988, CURR MICROBIOL, V17, P159, DOI 10.1007/BF01573472
   COSTERTON JW, 1992, INT BIODETER BIODEGR, V30, P123
   COSTERTON JW, 1987, ANNU REV MICROBIOL, V41, P435, DOI 10.1146/annurev.mi.41.100187.002251
   COX AJ, 1989, UROL RES, V17, P353, DOI 10.1007/BF00510524
   COX AJ, 1988, BRIT J UROL, V61, P156, DOI 10.1111/j.1464-410X.1988.tb05067.x
   COX AJ, 1987, BIOMATERIALS, V8, P500, DOI 10.1016/0142-9612(87)90089-5
   CUPERUS PL, 1993, J COLLOID INTERF SCI, V156, P319, DOI 10.1006/jcis.1993.1118
   CUPERUS PL, 1994, UNPUB J ANTIMICROB C
   DANKERT J, 1986, CRIT REV BIOCOMPAT, V2, P219
   DAVIES MC, 1989, SURF INTERFACE ANAL, V14, P115, DOI 10.1002/sia.740140304
   DUGUID IG, 1992, J ANTIMICROB CHEMOTH, V30, P791, DOI 10.1093/jac/30.6.791
   Duncan-Hewitt W., 1990, MICROBIAL CELL SURFA, P39
   EISEN A, 1989, MICROBIAL ECOL, V17, P17, DOI 10.1007/BF02025590
   Fleer A, 1989, J Invest Surg, V2, P391, DOI 10.3109/08941938909018264
   Fletcher M., 1985, BACTERIAL ADHESION M, P339
   FOERCH R, 1990, J POLYM SCI POL CHEM, V28, P193, DOI 10.1002/pola.1990.080280114
   GEERTSEMADOORNB.GI, 1994, J MICROBIOL METH, V19, P269
   GRIFFITH PR, 1986, FOURIER TRANSFORM IN
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   HACKER J, 1985, INFECT IMMUN, V47, P434
   HAGBERG L, 1981, INFECT IMMUN, V31, P564
   HEARN MJ, 1987, SURF INTERFACE ANAL, V10, P384, DOI 10.1002/sia.740100803
   HOBOT JA, 1991, MICROBIAL CELL SURFA, P127
   HULTGREN SJ, 1985, INFECT IMMUN, V50, P370
   IP WF, 1989, BIOMATERIALS, V10, P313, DOI 10.1016/0142-9612(89)90071-9
   JACOBSON SH, 1989, J INFECTION, V19, P17, DOI 10.1016/S0163-4453(89)94746-4
   JAMES AM, 1991, MICROBIAL CELL SURFA, P221
   KALLENIUS G, 1980, FEMS MICROBIOL LETT, V9, P297
   KIST ML, 1990, INFECT IMMUN, V58, P695
   Klotz SA, 1990, MICROBIAL CELL SURFA, P107
   KORHONEN TK, 1984, J BACTERIOL, V159, P762
   Kunin CM, 1987, DETECTION PREVENTION, P245
   LATRACHE H, 1994, COLLOID SURFACE B, V2, P47, DOI 10.1016/0927-7765(94)80017-0
   Marshall K.C., 1985, BACTERIAL ADHESION M, P133
   MCGROARTY J A, 1988, Microbial Ecology in Health and Disease, V1, P215
   MCGROARTY JA, 1988, CAN J MICROBIOL, V34, P974, DOI 10.1139/m88-171
   MCLEAN RJC, 1988, CRC CR REV MICROBIOL, V16, P37, DOI 10.3109/10408418809104467
   MCLEAN RJC, 1985, INFECT IMMUN, V49, P805
   MCMURDO MET, 1992, J EPIDEMIOL COMMUN H, V46, P222, DOI 10.1136/jech.46.3.222
   MILLSAP K, 1994, APPL ENVIRON MICROB, V60, P1867
   MITTELMAN MW, 1990, MICROBIAL ECOL, V19, P269, DOI 10.1007/BF02017171
   NAGAOKA S, 1990, BIOMATERIALS, V11, P419, DOI 10.1016/0142-9612(90)90098-B
   Naumann D., 1992, MODERN TECHNIQUES RA, P43
   NIVENS DE, 1993, J MICROBIOL METH, V17, P199, DOI 10.1016/0167-7012(93)90047-L
   PERE A, 1985, J GEN MICROBIOL, V131, P1705
   RATNER BD, 1980, J BIOMED MATER RES, V14, P665, DOI 10.1002/jbm.820140512
   RATNER BD, 1994, COLLOID SURFACE B, V2, P333, DOI 10.1016/0927-7765(94)80048-0
   RATNER BD, 1988, PROG BIOMED ENG, V5, P87
   REID G, 1994, ANTIMICROB AGENTS CH, V38, P1490, DOI 10.1128/AAC.38.7.1490
   REID G, 1985, INFECT IMMUN, V49, P320
   REID G, 1989, COLLOID SURFACE, V42, P299
   REID G, 1992, CELL MATER, V2, P253
   REID G, 1988, MICROBIAL ECOL, V16, P241, DOI 10.1007/BF02011698
   REID G, 1990, CLIN MICROBIOL REV, V3, P335
   REID G, 1984, NEW ZEAL MED J, V97, P439
   REID G, 1994, PARAPLEGIA, V32, P468, DOI 10.1038/sc.1994.74
   REID G, 1992, APPL ENVIRON MICROB, V58, P1549
   REID G, 1987, J UROLOGY, V138, P330, DOI 10.1016/S0022-5347(17)43137-5
   REID G, 1993, COLLOID SURFACE B, V1, P9, DOI 10.1016/0927-7765(93)80012-N
   REID G, 1987, REV INFECT DIS, V9, P470
   REID G, 1994, J BIOMED MATER RES, V28, P731, DOI 10.1002/jbm.820280610
   REID G, 1993, J MATER SCI-MATER M, V4, P17, DOI 10.1007/BF00122972
   REID G, 1988, CAN J MICROBIOL, V34, P344, DOI 10.1139/m88-063
   REID G, 1988, CURR MICROBIOL, V17, P151, DOI 10.1007/BF01573471
   REID G, 1993, CELL MATER, V3, P171
   REID G, 1994, SURF INTERFACE ANAL, V21, P581, DOI 10.1002/sia.740210812
   REID G, 1994, LANCET, V244, P1229
   REID G, 1995, IN PRESS MICROECOL T
   REID G, 1994, BIOINTERFACES, V2, P377
   RHEN M, 1986, J BACTERIOL, V168, P1234, DOI 10.1128/jb.168.3.1234-1242.1986
   ROBERTS JA, 1990, J UROLOGY, V144, P264, DOI 10.1016/S0022-5347(17)39428-4
   ROSENBERG M, 1986, ADV MICROB ECOL, V9, P353
   SCHAKENRAAD JM, 1989, BIOFOULING, V1, P193
   SCHAMBERGER PC, 1994, COLLOID SURFACE B, V2, P209, DOI 10.1016/0927-7765(94)80036-7
   STEADMAN R, 1989, BIOCHIM BIOPHYS ACTA, V1013, P21, DOI 10.1016/0167-4889(89)90122-5
   STICKLER D, 1991, EUR J CLIN MICROBIOL, V10, P157, DOI 10.1007/BF01964448
   SUCI PA, 1994, ANTIMICROB AGENTS CH, V38, P2125, DOI 10.1128/AAC.38.9.2125
   TIERNO PM, 1989, REV INFECT DIS, V11, pS182, DOI 10.1093/clinids/11.Supplement_1.S182
   TIERNO PM, 1985, CONTRACEPTION, V31, P185, DOI 10.1016/0010-7824(85)90033-2
   TOMECZEK L, 1992, FEMS MICROBIOL LETT, V94, P101
   TRAORE R, 1994, COLLOID SURFACE B, V2, P111, DOI 10.1016/0927-7765(94)80025-1
   UYAMA Y, 1991, BIOMATERIALS, V12, P71, DOI 10.1016/0142-9612(91)90135-W
   VAISANEN V, 1982, LANCET, V1, P1192
   VAISANENRHEN V, 1983, FEBS LETT, V159, P233, DOI 10.1016/0014-5793(83)80453-0
   VANDERMEI HC, 1989, BIOCHIM BIOPHYS ACTA, V991, P395, DOI 10.1016/0304-4165(89)90063-9
   VANDERMEI HC, 1988, COLLOID SURFACE, V32, P297, DOI 10.1016/0166-6622(88)80024-6
   VANDERMEI HC, 1987, J MICROBIOL METH, V6, P277, DOI 10.1016/0167-7012(87)90065-0
   VANDERMEI HC, 1989, APPL ENVIRON MICROB, V55, P2806
   VANDERWALL E, 1992, LANCET, V339, P946
   Wadstrom T., 1990, MICROBIAL CELL SURFA, P315
   WICKEN AJ, 1985, BACTERIAL ADHESION M, P45
NR 107
TC 23
Z9 23
U1 2
U2 8
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-5729
J9 SURF SCI REP
JI Surf. Sci. Rep.
PY 1995
VL 21
IS 7
BP 251
EP 273
DI 10.1016/0167-5729(94)00006-9
PG 23
WC Chemistry, Physical; Physics, Condensed Matter
SC Chemistry; Physics
GA QK685
UT WOS:A1995QK68500001
DA 2018-10-20
ER

PT J
AU AMBROSIO, L
   NICHOLAIS, L
AF AMBROSIO, L
   NICHOLAIS, L
TI PAPERS PRESENTED AT THE INTERNATIONAL-CONFERENCE ON MATERIALS FOR
   BIOMEDICAL APPLICATIONS, CAPRI, NAPLES, ITALY, 6-11-JUNE-1993
SO BIOMATERIALS
LA English
DT Editorial Material
C1 UNIV NAPLES,DEPT MAT & PROD ENGN,I-80125 NAPLES,ITALY.
   UNIV LECCE,DEPT MAT SCI,I-73100 LECCE,ITALY.
   UNIV NAPLES,INTERDISCIPLINARY RES CTR BIOMED MAT,I-80125 NAPLES,ITALY.
RP AMBROSIO, L (reprint author), CNR,INST COMPOSITE MAT TECHNOL,P TECHIO,NAPLES,ITALY.
OI AMBROSIO, LUIGI/0000-0002-8367-2405
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD DEC
PY 1994
VL 15
IS 15
BP 1195
EP 1195
DI 10.1016/0142-9612(94)90268-2
PG 1
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA PY723
UT WOS:A1994PY72300001
DA 2018-10-20
ER

PT J
AU GIUSTI, P
   LAZZERI, L
   DEPETRIS, S
   PALLA, M
   CASCONE, MG
AF GIUSTI, P
   LAZZERI, L
   DEPETRIS, S
   PALLA, M
   CASCONE, MG
TI COLLAGEN-BASED NEW BIOARTIFICIAL POLYMERIC MATERIALS
SO BIOMATERIALS
LA English
DT Article; Proceedings Paper
CT International Conference on Materials for Biomedical Applications
CY JUN 06-11, 1993
CL CAPRI, ITALY
SP ASSING SPA, CNR, EASTMAN CHEM EUROPE, ITALPRO SPA, MTS SYST, UNIV NAPLES FEDERICO II
DE BIOMATERIALS; COLLAGEN; POLY(VINYL ALCOHOL); POLY(ACRYLIC ACID); POLYMER
   BLENDS; THERMOMECHANICAL CHARACTERIZATION
AB Bioartificial polymeric materials, based on blends of biological and synthetic polymers, have been proposed as new materials for applications in the biomedical field. They should usefully combine the biocompatibility of the biological component with the physical and mechanical properties of the synthetic component. Blends of collagen with either poly(vinyl alcohol) or poly(acrylic acid) have been prepared by mixing aqueous solutions of the two polymers. Differential scanning calorimetry and dynamic mechanical thermal analysis has been carried out to investigate the miscibility properties of the polymers and the mechanical behaviour of the blends.
C1 CNR,CTR STUDIES ION POLYMERIZAT,I-56126 PISA,ITALY.
RP GIUSTI, P (reprint author), UNIV PISA,DEPT CHEM ENGN,VIA DIOTISALVI 2,I-56126 PISA,ITALY.
CR BARBER JM, 1992, J ENVIRON PERMITTING, V1, P59
   GIUSTI P, IN PRESS MAKROMOL CH
   GIUSTI P, 1991, 4TH EUR S BIOM IND R, P31
   GIUSTI P, 1989, 1ST P MED SCH SCI TE, P715
   GIUSTI P, 1991, 2ND JOINT SOV UN IT, P37
   GIUSTI P, 1989, 1ST P PAC POL C MAU, P137
   GIUSTI P, 1991, FEB INT S POL MAT AU, P491
   JOOS U, 1978, 71ST BES SCI M 3RD C
   PARKANY M, 1984, MACROMOLECULAR BIOMA, P911
   Paul D. R., 1988, ENCY POLYMER SCI ENG, V12, P399
   PUHL W, 1978, 71ST BES SCI M 3RD C
   SARTI B, 1992, THESIS U BOLOGNA ITA
   SHINODA K, 1976, POLYM J, V8, P202, DOI 10.1295/polymj.8.202
NR 13
TC 69
Z9 74
U1 0
U2 5
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD DEC
PY 1994
VL 15
IS 15
BP 1229
EP 1233
DI 10.1016/0142-9612(94)90274-7
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA PY723
UT WOS:A1994PY72300007
PM 7703319
DA 2018-10-20
ER

PT J
AU LAZZERI, L
   BARBANI, N
   CASCONE, MG
   LUPINACCI, D
   GIUSTI, P
   LAUS, M
AF LAZZERI, L
   BARBANI, N
   CASCONE, MG
   LUPINACCI, D
   GIUSTI, P
   LAUS, M
TI PHYSICOCHEMICAL AND MECHANICAL CHARACTERIZATION OF HYDROGELS OF
   POLY(VINYL ALCOHOL) AND HYALURONIC-ACID
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
AB Hydrogels are three-dimensional polymeric networks very similar to biological tissues and potentially useful as soft tissue substitutes and drug delivery systems.  Many synthetic polymers can be used to make hydrogels:  poly(vinyl alcohol) is widely employed to make hydrogels for biomedical applications.  Improvements in the biocompatibility characteristics of synthetic materials could be achieved by the addition of biological macromolecules.  The resulting materials named ''bioartifical polymeric materials'' could possess the good mechanical properties of the synthetic component and adequate biocompatibility due to the biological component.  We have used poly(vinyl alcohol) to make hydrogels containing various amounts of hyaluronic acid.  These bioartificial materials were studied to investigate the effect of the presence of the hyaluronic acid on the structural properties of the hydrogels.  Thermal, mechanical, morphological and X-ray analyses were performed.  A close correspondence between the network consistency and the degree of crystallinity developed in the matrix suggested that the hyaluronic acid, when its content is about 20%, could provide heterogeneous crystallization nuclei for poly(vinyl alcohol) thus increasing the crystallization degree, and consequently, the storage modulus.
C1 UNIV BOLOGNA,DIPARTIMENTO CHIM IND & MAT,I-40136 BOLOGNA,ITALY.
RP LAZZERI, L (reprint author), UNIV PISA,DIPARTIMENTO INGN CHIM,VIA DIOTISALVI 2,I-56126 PISA,ITALY.
OI Laus, Michele/0000-0002-4296-3732
CR GIUSTI P, 1993, TRENDS POLYM SCI, V1, P261
   GUISTI P, 1993, J MATER SCI-MATER M, V4, P538
   LAZZERI L, 1992, 4TH P WORLD BIOM C B, P462
   Nambu M, 1982, Japanese Patent Kokai, Patent No. [57/130543, 130543]
   PEPPAS NA, 1986, HYDROGELS MED PHARM, V3, P109
   SBARBATI R, IN PRESS J MATER SCI
   SWANN DA, 1991, BIOMATERIALS NOVEL M, pCH6
NR 7
TC 31
Z9 31
U1 0
U2 3
PU CHAPMAN HALL LTD
PI LONDON
PA 2-6 BOUNDARY ROW, LONDON, ENGLAND SE1 8HN
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD DEC
PY 1994
VL 5
IS 12
BP 862
EP 867
DI 10.1007/BF01172026
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA QB102
UT WOS:A1994QB10200006
DA 2018-10-20
ER

PT J
AU BOER, GJ
AF BOER, GJ
TI ETHICAL GUIDELINES FOR THE USE OF HUMAN EMBRYONIC OR FETAL TISSUE FOR
   EXPERIMENTAL AND CLINICAL NEUROTRANSPLANTATION AND RESEARCH
SO JOURNAL OF NEUROLOGY
LA English
DT Article
DE NECTAR; ETHICAL GUIDELINES; HUMAN FETAL TISSUE; NEUROTRANSPLANTATION
ID ADRENAL-MEDULLARY TRANSPLANTATION; ADVANCED PARKINSONS-DISEASE; RIGHT
   CAUDATE-NUCLEUS; DOPAMINE NEURONS; NEURAL TRANSPLANTATION; BRAIN; ISSUES
AB Recently a Network of European CNS Transplantation And Restoration (NECTAR) has been founded, aimed at a concerted effort to develop efficient, reliable, safe and ethically acceptable transplantation therapies for neurodegenerative diseases, in particular Parkinson's and Huntington's disease. Owing to the use of human fetal brain tissue in such studies, usually obtained from elective abortions, ethical concerns have been focused on the relation ship between abortion and transplantation activities. There is no uniform code on the retrieval and use of human embryonal or fetal material for experimental and clinical research or application in Europe, NECTAR has therefore formulated self-restraining ethical guidelines for its European member groups. These guidelines consist of a series of restrictions intended to-prevent the use of grafts from encouraging induced abortions and to maintain high standards of respect for life and human dignity. In order to support applications for human embryonal or fetal neurotransplantation studies of NECTAR member groups to local or national medico-ethical committees, and to stimulate the goal of obtaining European legislation on this issue, the guidelines are here presented. They are followed by extensive explanatory notes. Only in this public manner can the lines of thought behind these NECTAR guidelines be addressed critically by those working in the fields of biomedical ethics and legislation as well by politicians and the general public.
C1 NETHERLANDS INST BRAIN RES,GRAD SCH NEUROSCI AMSTERDAM,1105 AZ AMSTERDAM,NETHERLANDS.
CR ALLEN GS, 1989, ARCH NEUROL-CHICAGO, V46, P487, DOI 10.1001/archneur.1989.00520410021016
   BACKLUND EO, 1985, FERNSTROM F SERIES, P551
   BEAUCHAMP TL, 1989, PRINCIPLES BIOMEDICA
   BJORKLUND A, 1983, ACTA PHYSL SCAND S, V522, P1
   BOER GJ, 1991, NOTES DISCUSSION ETH
   BOPP J, 1988, REPORT HUMAN FETAL T, V1, P45
   BRUNDIN P, 1986, EXP BRAIN RES, V65, P235
   BURNELL GM, 1987, J PSYCHOL, V121, P71, DOI 10.1080/00223980.1987.9712645
   Burtchaell James Tunstead, 1988, IRB, V10, P7, DOI 10.2307/3564625
   CAPRON AM, 1976, BIOMEDICAL ETHICS LA, P489
   FARIA G, 1985, SOC WORK HEALTH CARE, V11, P85, DOI 10.1300/J010v11n01_06
   FRANKOWSKI SJ, 1987, ABORTION PROTECTION
   FREED CR, 1992, NEW ENGL J MED, V327, P1549, DOI 10.1056/NEJM199211263272202
   GARRY DJ, 1992, NEW ENGL J MED, V327, P1592, DOI 10.1056/NEJM199211263272211
   GASH DM, 1985, NEUROBIOL AGING, V6, P131, DOI 10.1016/0197-4580(85)90031-4
   GOETZ CG, 1989, NEW ENGL J MED, V320, P337, DOI 10.1056/NEJM198902093200601
   GREELY HT, 1989, NEW ENGL J MED, V320, P1093, DOI 10.1056/NEJM198904203201624
   HANSEN JT, 1989, SCIENCE, V246, P775, DOI 10.1126/science.2683082
   HENDERSON BTH, 1991, ARCH NEUROL-CHICAGO, V48, P822, DOI 10.1001/archneur.1991.00530200062020
   HOFFER BJ, 1991, TRENDS NEUROSCI, V14, P384, DOI 10.1016/0166-2236(91)90168-T
   ISACSON O, 1991, INTRACEREBRAL TRANSP, P245
   JACOBSON M, 1991, DEV NEUROBIOLOGY
   JIANG N, 1987, ACTA ACAD MED SHANGH, V14, P1
   Jones D Gareth, 1991, Bioethics, V5, P23, DOI 10.1111/j.1467-8519.1991.tb00142.x
   KING P, 1988, CLIN RES, V36, P205
   KOLARIK J, 1988, ACTIV NERV SUPER, V30, P155
   KOLLER WC, 1987, HDB PARKINSONS DISEA
   LAWLER SD, 1981, J CLIN PATHOL, V34, P240, DOI 10.1136/jcp.34.3.240
   LENNETTE EH, 1988, LABORATORY DIAGNOSIS, V2
   LINDVALL O, 1990, SCIENCE, V247, P574, DOI 10.1126/science.2105529
   LINDVALL O, 1992, ANN NEUROL, V31, P155, DOI 10.1002/ana.410310206
   LOZANO JJL, 1991, RESTOR NEUROL, V4, P87
   MACDONALD AS, 1990, TRANSPLANT P, V22, P1030
   MADRAZO I, 1987, NEW ENGL J MED, V316, P831, DOI 10.1056/NEJM198704023161402
   MADRAZO I, 1991, INTRACEREBRAL TRANSP, V4, P123
   MAHOWALD MB, 1988, CLIN RES, V36, P220
   MAY WF, 1990, TRANSPLANT P, V22, P985
   MCCULLAGH PM, 1987, FOETUS TRANSPLANT DO
   MCLAREN A, 1989, CAHBIREF1 COUNC EUR
   MOLINA H, 1991, RES NEUROL, V4, P99
   MOLLISON PL, 1987, BLOOD TRANSFUSION CL, P764
   NOLAN K, 1990, TRANSPLANT P, V22, P1028
   O'Rahilly R., 1987, DEV STAGES HUMAN EMB
   OLSON L, 1988, DISCUSSION NEUROSCIE, V5
   RALPH MR, 1990, SCIENCE, V247, P975, DOI 10.1126/science.2305266
   ROBERTSON JA, 1990, TRANSPLANT P, V22, P1025
   ROBERTSON JA, 1988, 6 HAST CTR REP
   SLADEK JR, 1988, SCIENCE, V240, P1386, DOI 10.1126/science.3375820
   SPENCER DD, 1992, NEW ENGL J MED, V327, P1541, DOI 10.1056/NEJM199211263272201
   WALTERS L, 1988, CLIN RES, V36, P209
   WARREN MA, 1975, TODAYS MORAL PROBLEM, P120
   WIDNER H, 1992, NEW ENGL J MED, V327, P1556, DOI 10.1056/NEJM199211263272203
   WOODS L, 1993, DIAGNOSTIC PATHOLOGY, P573
   YEZZI R, 1980, MED ETHICS THINKING
   1990, B WORLD MED ASS  FEB, P8
   1984, RECOMMENDATION USE E
   1972, USE FETUSES FETAL MA
   1988, REPORT HUMAN FETAL T
   1988, REPORT SCI RES RELAT
   1984, ADVICE DONATION USES
   1986, USE HUMAN EMBRYOS FO
   1993, NEW PROGRAM NECTAR N
   1989, REPORT USE HUMAN EMB
   1990, STATEMENT INTRACEREB
   1989, CM762
   1988, LANCET, V1, P1119
   1992, 1ST REPORT
   1993, 1991 1992 DUTCH COMM
   1990, JAMA-J AM MED ASSOC, V263, P565
   1989, USE HUMAN EMBRYOS FO
NR 70
TC 85
Z9 86
U1 1
U2 7
PU SPRINGER VERLAG
PI NEW YORK
PA 175 FIFTH AVE, NEW YORK, NY 10010
SN 0340-5354
J9 J NEUROL
JI J. Neurol.
PD DEC
PY 1994
VL 242
IS 1
BP 1
EP 13
DI 10.1007/BF00920568
PG 13
WC Clinical Neurology
SC Neurosciences & Neurology
GA PU855
UT WOS:A1994PU85500001
PM 7897446
DA 2018-10-20
ER

PT J
AU BRON, WE
AF BRON, WE
TI FROM COLOR-CENTERS TO COHERENT PHONON STATES
SO JOURNAL OF PHYSICS AND CHEMISTRY OF SOLIDS
LA English
DT Article
DE SEMICONDUCTORS; RAMAN SPECTROSCOPY; COLOR CENTERS; PHONONS
ID DIFFUSION; DYNAMICS
AB I trace the progression of scientific steps which start with color centers in alkali halides and end with my current research on the coherent generation and dephasing of vibrations in solids. It was Art Nowick who started me off along a series of ever more sophisticated experimental methods with which it has become possible to understand the temporal, spectral, and spatial response of insulators, semiconductors, superconductors, metals and biomedical tissues, to various forms of excitations. Among the observed phenomena are crystal field splitting of atomic states in ionic materials; localized and extended phonon states in alkaline-earth halides, and other insulators; spectral, spatial and temporally resolved phonon transport in various materials, the generation of coherent phonon and polariton states in semiconductors, and the dephasing of the coherent states and the observations of a long sought after long-lived phonon state.
RP BRON, WE (reprint author), UNIV CALIF IRVINE,DEPT PHYS,IRVINE,CA 92717, USA.
CR BILZ H, 1979, PHONON DISPERSION RE, P104
   BRON WE, 1965, PHYS REV, V139, pA233, DOI 10.1103/PhysRev.139.A233
   BRON WE, 1982, PHYS REV LETT, V49, P209, DOI 10.1103/PhysRevLett.49.209
   BRON WE, 1978, PHYS REV LETT, V40, P1459, DOI 10.1103/PhysRevLett.40.1459
   BRON WE, 1992, ULTRASHORT PROCESSES, P101
   DIPPOLITO JP, 1973, THESIS INDIANA U BLO
   FOURIER J, 1822, THEORIE ANAL CHALEUR
   KAZAKOVTSEV DV, 1978, JETP LETT+, V27, P181
   KAZAKOVTSEV DV, 1979, PHYS STATUS SOLIDI B, V96, P117, DOI 10.1002/pssb.2220960109
   KAZAKOVTSEV DV, 1981, J LOW TEMP PHYS, V45, P49, DOI 10.1007/BF00661142
   KAZAKOVTZEV DV, PISMA ESKP TEOR FIZ, V27, P194
   KLEMENS PG, 1966, PHYS REV, V38, P4573
   MARIS HJ, 1970, J ACOUST SOC AM, V50, P812
   MAUL MK, 1969, J APPL PHYS, V40, P2822, DOI 10.1063/1.1658082
   Orbach R., 1964, Physics, V1, P91
   Placzek G., 1934, HDB RADIOLOGIE
   QU J, 1993, PHYS REV B, V48, P6720, DOI 10.1103/PhysRevB.48.6720
   RHEE BK, 1986, PHYS REV B, V34, P7107, DOI 10.1103/PhysRevB.34.7107
   VONGUTFIELD RJ, 1964, PHYS REV LETT, V12, P641, DOI 10.1103/PhysRevLett.12.641
NR 19
TC 0
Z9 0
U1 0
U2 2
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
SN 0022-3697
J9 J PHYS CHEM SOLIDS
JI J. Phys. Chem. Solids
PD DEC
PY 1994
VL 55
IS 12
BP 1381
EP 1391
DI 10.1016/0022-3697(94)90565-7
PG 11
WC Chemistry, Multidisciplinary; Physics, Condensed Matter
SC Chemistry; Physics
GA QL009
UT WOS:A1994QL00900003
DA 2018-10-20
ER

PT J
AU SCHWERTNER, HA
AF SCHWERTNER, HA
TI PATENTING MEDICAL INVENTIONS
SO MILITARY MEDICINE
LA English
DT Article
AB Medical, dental, nursing, and biomedical personnel often perform critical research that can lead to patents.  Similarly, patentable discoveries can be made during the normal course of medical practice, e.g., the development of new biocompatible polymers, improved dental materials, new or modified catheters, new laboratory diagnostic tests, and improved medical devices.  Many inventions may not be patented in federal organizations due to the lack of information available on the patenting process.  In this article, the financial benefits that can be derived from patenting inventions are discussed, as well as the different types of patents that can be obtained, the conditions for patentability, bars or restrictions to obtaining a patent, the importance of proper record keeping, and the steps to take toward getting an invention patented.
RP SCHWERTNER, HA (reprint author), WILFORD HALL USAF MED CTR,RDL,CLIN INVEST DIRECTORATE,1255 WILFORD HALL LOOP,LACKLAND AFB,TX 78236, USA.
NR 0
TC 0
Z9 0
U1 1
U2 2
PU ASSN MILITARY SURG US
PI BETHESDA
PA 9320 OLD GEORGETOWN RD, BETHESDA, MD 20814
SN 0026-4075
J9 MIL MED
JI Milit. Med.
PD DEC
PY 1994
VL 159
IS 12
BP 729
EP 732
PG 4
WC Medicine, General & Internal
SC General & Internal Medicine
GA QK573
UT WOS:A1994QK57300002
PM 7723995
DA 2018-10-20
ER

PT J
AU KWIATEK, WM
AF KWIATEK, WM
TI BIOMEDICAL APPLICATIONS OF SYNCHROTRON X-RAY-FLUORESCENCE
SO ACTA PHYSICA POLONICA A
LA English
DT Article; Proceedings Paper
CT 2nd International School and Symposium on Synchrotron Radiation in
   Natural Science
CY MAY 18-26, 1994
CL JASZOWIEC, POLAND
SP COMMISS EUROPEAN COMMUNITIES, STATE COMM SCI RES, POLISH ACAD SCI, INST PHYS, JAGIELONIAN UNIV, INST PHYS, POLISH ACAD SCI, COMM PHYS, POLISH ACAD SCI, COMM CRYSTALLOG, POLISH ACAD SCI, INST PHYS CHEM, REG LAB PHYSICOCHEM ANAL, JAGIELLONIAN UNIV, RES, DOCTORQ CO, APRIL BUSINESS COMP CO
ID RADIATION; SRIXE
AB Since the exact role of trace elements in living organisms is still not very well known, it is a need of a careful analysis and study on trace element distributions in various bio-medical materials. The conventional techniques such as X-ray fluorescence, proton-induced X-ray emission, atomic absorption spectrophotometry do not always give precise determination, especially in microstructures areas. Since synchrotron radiation is very powerful and gives the opportunity to work with micro-beams the synchrotron radiation induced X-ray emission technique has been recently developed. Due to many properties of synchrotron radiation it becomes a very useful tool in science. In this paper a characterization of different apparatus for a trace element analysis as well as several applications are described to show the usefulness of the synchrotron radiation induced X-ray emission.
RP KWIATEK, WM (reprint author), H NIEWODNICZANSKI INST NUCL PHYS,RADZIKOWSKIEGO 152,PL-31342 KRAKOW,POLAND.
CR BAKIR F, 1976, B WORLD HEALTH ORGAN, V53, P87
   BUTTKEWITZ A, 1990, HASYLAB PROGR REPORT, P577
   IYENGAR GV, 1978, ELEMENTAL COMPOSITIO
   JAKSIC M, 1991, NUCL INSTRUM METH B, V56-7, P699, DOI 10.1016/0168-583X(91)95007-Z
   JONES KW, 1992, HDB XRAY SPECTROMETR, P441
   KWIATEK WM, 1990, NUCL INSTRUM METH B, V50, P347, DOI 10.1016/0168-583X(90)90380-D
   KWIATEK WM, 1992, NUCL INSTRUM METH B, V68, P122, DOI 10.1016/0168-583X(92)96062-4
   KWIATEK WM, 1992, ACTA PHYS POL A, V82, P263, DOI 10.12693/APhysPolA.82.263
   MURAKAMI M, 1973, Nature (London), V245, P153, DOI 10.1038/245153a0
   PROHASKA JR, 1987, PHYSIOL REV, V67, P858
   ROSE J, 1983, TRACE ELEMNTS HLTH
   SCOTT R, 1980, UROL RES, V8, P167
   VALKOVIC V, 1990, IAEA300 TECH DOC
NR 13
TC 10
Z9 10
U1 0
U2 2
PU POLISH ACAD SCIENCES INST PHYSICS
PI WARSAW
PA AL LOTNIKOW 32-46, 02-668 WARSAW, POLAND
SN 0587-4246
J9 ACTA PHYS POL A
JI Acta Phys. Pol. A
PD NOV
PY 1994
VL 86
IS 5
BP 695
EP 703
DI 10.12693/APhysPolA.86.695
PG 9
WC Physics, Multidisciplinary
SC Physics
GA PR749
UT WOS:A1994PR74900004
OA Bronze
DA 2018-10-20
ER

PT J
AU GRIJPMA, DW
   VANHOFSLOT, RDA
   SUPER, H
   NIJENHUIS, AJ
   PENNINGS, AJ
AF GRIJPMA, DW
   VANHOFSLOT, RDA
   SUPER, H
   NIJENHUIS, AJ
   PENNINGS, AJ
TI RUBBER TOUGHENING OF POLY(LACTIDE) BY BLENDING AND BLOCK
   COPOLYMERIZATION
SO POLYMER ENGINEERING AND SCIENCE
LA English
DT Article
ID POLY(L-LACTIC ACID); RESORBABLE MATERIALS; FRACTURE FIXATION; L-LACTIDE;
   POLYLACTIDE; PLATES; SCREWS; POLYMERIZATION; DEGRADATION
AB Copolymers of L-lactide with 15 or more mole % D-lactide are amorphous, noncrystallizable hydrolytically degradable materials. These glassy materials are brittle in tension and bending. To make these materials suitable for use as load-bearing devices in biomedical applications, toughness has to be enhanced. This is effectively accomplished by introducing a separate degradable rubber phase in the amorphous matrix. Several approaches have been explored: solution blending and coprecipitation of trimethylene carbonate and epsilon-caprolactone rubbers and poly(lactide), preparation of ABA triblock copolymers and blending of ABA block copolymers with the amorphous poly(lactide) matrix. In all cases very tough materials could be prepared. These materials are easily processable by compression molding at relatively low temperatures.
C1 UNIV GRONINGEN,DEPT POLYMER CHEM,9747 AG GRONINGEN,NETHERLANDS.
CR AGRAWAL CM, 1992, BIOMATERIALS, V13, P176, DOI 10.1016/0142-9612(92)90068-Y
   BOS RRM, 1987, J ORAL MAXIL SURG, V45, P751, DOI 10.1016/0278-2391(87)90194-7
   BOS RRM, 1989, INT J ORAL MAX SURG, V18, P365, DOI 10.1016/S0901-5027(89)80035-9
   BOYLE WJ, 1988, Patent No. 5664
   BRANDRUP J, POLYM HDB
   BRODE GL, 1972, J MACROMOL SCI CHEM, VA  6, P1109, DOI 10.1080/10601327208056888
   Bucknall C. B., 1977, TOUGHENED PLASTICS
   Carothers WH, 1930, J AM CHEM SOC, V52, P314, DOI 10.1021/ja01364a045
   CELLI A, 1992, POLYMER, V33, P2699, DOI 10.1016/0032-3861(92)90440-8
   CHA Y, 1990, BIOMATERIALS, V11, P108, DOI 10.1016/0142-9612(90)90124-9
   COHN D, 1989, BIOMATERIALS, V10, P466
   GORDA KR, 1991, POLYM COMMUN, V23, P25
   GRIJPMA DW, 1991, POLYM BULL, V25, P335, DOI 10.1007/BF00316903
   GRIJPMA DW, IN PRESS MAKROMOL CH
   GRIJPMA DW, 1991, POLYM B, V29, P571
   KINLOCH AJ, 1983, FRACTURE BEHAVIOUR P
   KRICHELDORF HR, 1987, J MACROMOL SCI CHEM, VA24, P1345, DOI 10.1080/00222338708076950
   KULKARNI R K, 1971, Journal of Biomedical Materials Research, V5, P169, DOI 10.1002/jbm.820050305
   LEENSLAG JW, 1987, BIOMATERIALS, V8, P70, DOI 10.1016/0142-9612(87)90034-2
   LEENSLAG JW, 1987, BIOMATERIALS, V8, P311, DOI 10.1016/0142-9612(87)90121-9
   LEENSLAG JW, 1987, MAKROMOL CHEM, V188, P1809
   LI SM, 1990, J MATER SCI-MATER M, V1, P198, DOI 10.1007/BF00701077
   LIPINSKY ES, 1986, CHEM ENG PROG, V82, P26
   MAJOLA A, 1992, J MATER SCI-MATER M, V3, P43, DOI 10.1007/BF00702943
   Manson J. A., 1976, POLYM BLENDS COMPOSI
   MARK HF, 1988, ENCY POLYM SCI TECHN, V1, P648
   MIGLIARESI C, 1991, J APPL POLYM SCI, V43, P83, DOI 10.1002/app.1991.070430109
   NAKAMURA T, 1989, J BIOMED MATER RES, V23, P1115, DOI 10.1002/jbm.820231003
   NIJENHUIS AJ, 1992, MACROMOLECULES, V25, P6419, DOI 10.1021/ma00050a006
   NIJENHUIS AJ, 1991, POLYM BULL, V26, P71, DOI 10.1007/BF00299350
   ROZEMA FR, 1991, THESIS U GRONINGEN N
   SCHINDLER A, 1979, J POLYM SCI POL CHEM, V17, P2593, DOI 10.1002/pol.1979.170170831
   SCHINDLER A, 1982, J POLYM SCI POL CHEM, V20, P319, DOI 10.1002/pol.1982.170200206
   Schindler A, 1977, CONT TOPICS POLYM SC, V2, P251
   Sinclair R. G., 1977, US Patent, Patent No. [4057537, 4 057 537]
   SINCLAIR RG, 1977, Patent No. 4045418
   SINCLAIR RG, 1989, Patent No. 1521
   Van Krevelen D. W., 1976, PROPERTIES POLYM
   VERT M, 1981, MAKROMOL CHEM S, V5, P30, DOI DOI 10.1002/MACP.1981.020051981103
   ZHU KJ, 1990, J APPL POLYM SCI, V39, P1, DOI 10.1002/app.1990.070390101
   ZHU KJ, 1991, MACROMOLECULES, V24, P1736, DOI 10.1021/ma00008a008
   1971, HDB CHEM PHYSICS, pC765
NR 42
TC 119
Z9 120
U1 2
U2 27
PU SOC PLASTICS ENG INC
PI BROOKFIELD CENTER
PA 14 FAIRFIELD DR, BROOKFIELD CENTER, CT 06804-0403
SN 0032-3888
J9 POLYM ENG SCI
JI Polym. Eng. Sci.
PD NOV
PY 1994
VL 34
IS 22
BP 1674
EP 1684
DI 10.1002/pen.760342205
PG 11
WC Engineering, Chemical; Polymer Science
SC Engineering; Polymer Science
GA PU107
UT WOS:A1994PU10700004
DA 2018-10-20
ER

PT J
AU AITON, JF
AF AITON, JF
TI THE WORLDWIDE WEB - AN INTERFACE BETWEEN RESEARCH AND TEACHING IN
   BIOINFORMATICS
SO DISEASE MARKERS
LA English
DT Review
AB The rapid expansion occurring in World-Wide Web activity is beginning to make the concepts of 'global hypermedia' and 'universal document readership' realistic objectives of the new revolution in information technology. One consequence of this increase in usage is that educators and students are becoming more aware of the diversity of the knowledge base which can be accessed via the Internet. Although computerised databases and information services have long played a key role in bioinformatics these same resources can also be used to provide core materials for teaching and learning. The large datasets and archives that have been compiled for biomedical research can be enhanced with the addition of a variety of multimedia elements (images, digital videos, animation etc.). The use of this digitally stored information in structured and self-directed learning environments is likely to increase as activity across World-Wide Web increases.
RP AITON, JF (reprint author), UNIV ST ANDREWS,SCH BIOL & MED SCI,ST ANDREWS KY16 9TS,FIFE,SCOTLAND.
NR 0
TC 7
Z9 8
U1 0
U2 0
PU ASFRA
PI EDAM
PA VOORHAVEN 33, 1135 BL EDAM, NETHERLANDS
SN 0278-0240
J9 DIS MARKERS
JI Dis. Markers
PD OCT
PY 1994
VL 12
IS 1
BP 3
EP 10
DI 10.1155/1994/412976
PG 8
WC Biotechnology & Applied Microbiology; Genetics & Heredity; Medicine,
   Research & Experimental; Pathology
SC Biotechnology & Applied Microbiology; Genetics & Heredity; Research &
   Experimental Medicine; Pathology
GA PN077
UT WOS:A1994PN07700001
PM 7842629
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU KASEMO, B
   LAUSMAA, J
AF KASEMO, B
   LAUSMAA, J
TI MATERIAL-TISSUE INTERFACES - THE ROLE OF SURFACE-PROPERTIES AND
   PROCESSES
SO ENVIRONMENTAL HEALTH PERSPECTIVES
LA English
DT Article; Proceedings Paper
CT Workshop on Biopersistence of Respirable Synthetic Fibers and Minerals
CY SEP 07-09, 1992
CL LYON, FRANCE
SP INT AGCY RES CANC, INSERM, CNRS
DE SURFACE; INTERFACE; METAL OXIDE; BIOMOLECULES; WATER; IONS; CELL
   MEMBRANE; BIOMATERIALS
ID IMPLANT MATERIALS; OXIDE-FILMS; TITANIUM; BIOMATERIAL; ADSORPTION
AB The introduction of a foreign material into living tissue-intentionally as in biomedical applications (implants, protheses, drugs) or unintentionally as when minerals or fibers are inhaled-results in the creation of interfaces between the material and the surrounding tissue. This article identifies and discusses the possible role of material surface properties and molecular processes occurring at such interfaces. For kinetic and thermodynamic reasons, surfaces are different from the corresponding bulk of the material, and contain reactive (unsaturated) bonds, which in turn lead to the formation of surface reactive layers (e.g., surface oxides on metals) and adsorbed contamination layers. The encounter with the biological environment leads to further surface reactions modifying the surface, and to the adsorption of water, ions, and biomolecules, which are continuously exchanged. The exact nature of the dynamic, adsorbed water, ions, and biomolecule coating in turn influences the behavior of cells approaching the material surface, and hence the tissue response.
RP KASEMO, B (reprint author), CHALMERS UNIV TECHNOL,DEPT APPL PHYS,S-41296 GOTHENBURG,SWEDEN.
CR ANDRADE JD, 1985, PROTEIN ADSORPTION S, V2
   ASK M, 1990, J MATER RES, V5, P1662, DOI 10.1557/JMR.1990.1662
   ASK M, 1988, APPL SURF SCI, V35, P283
   Branemark PI, 1985, TISSUE INTEGRATED PR
   HEALY KE, 1992, BIOMATERIALS, V13, P553, DOI 10.1016/0142-9612(92)90108-Z
   HEALY KE, 1992, J BIOMED MATER RES, V26, P319, DOI 10.1002/jbm.820260305
   IVARSSON B, 1986, CRIT REV BIOCOMPAT, V2, P1
   JACOBS JJ, 1991, J BONE JOINT SURG AM, V73A, P1475, DOI 10.2106/00004623-199173100-00005
   KASEMO B, 1986, CRIT REV BIOCOMPAT, V2, P335
   KASEMO B, 1991, BONE-BIOMATERIAL INTERFACE, P19
   Kasemo B, 1988, Int J Oral Maxillofac Implants, V3, P247
   KASEMO B, 1988, J BIOMED MATER RES-A, V22, P145, DOI 10.1002/jbm.820221307
   KASEMO B, 1988, SURFACE CHARACTERIZA, P1
   KING DA, 1983, CHEM PHYSICS HETEROG, V1
   LAUSMAA J, 1990, APPL SURF SCI, V45, P189, DOI 10.1016/0169-4332(90)90002-H
   LAUSMAA J, 1990, APPL SURF SCI, V44, P133, DOI 10.1016/0169-4332(90)90100-E
   LAUSMAA J, 1991, THESIS GOTHENBURG
   Luckey H. A., 1983, ASTM SPECIAL TECHNIC, V796
   LUNDSTROM I, 1985, ORAL INTERACTIONS RE, P9
   MAEUSLI PA, 1986, BIOL BIOMECHANICAL P, P57
   McQueen D, 1982, CLIN APPLICATIONS BI, P179
   RADEGRAN G, 1991, J ELECTRON MICR TECH, V19, P99, DOI 10.1002/jemt.1060190110
   SMITH DC, 1991, J BIOMED MATER RES, V25, P1069, DOI 10.1002/jbm.820250903
   SUNDGREN JE, 1986, J COLLOID INTERF SCI, V110, P9, DOI 10.1016/0021-9797(86)90348-6
   TENGVALL P, 1992, Clinical Materials, V9, P115, DOI 10.1016/0267-6605(92)90056-Y
   WILLIAMS DF, 1977, J MED ENG TECHNOL, V1, P266, DOI 10.3109/03091907709162192
   WOODMAN J L, 1984, Journal of Orthopaedic Research, V1, P421
NR 27
TC 114
Z9 116
U1 0
U2 9
PU NATL INST ENVIRON HEALTH SCI
PI RES TRIANGLE PK
PA PO BOX 12233, RES TRIANGLE PK, NC 27709
SN 0091-6765
J9 ENVIRON HEALTH PERSP
JI Environ. Health Perspect.
PD OCT
PY 1994
VL 102
SU 5
BP 41
EP 45
DI 10.2307/3432057
PG 5
WC Environmental Sciences; Public, Environmental & Occupational Health;
   Toxicology
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health; Toxicology
GA PT108
UT WOS:A1994PT10800009
PM 7882954
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU CUBEDDU, R
   MUSOLINO, M
   PIFFERI, A
   TARONI, P
   VALENTINI, G
AF CUBEDDU, R
   MUSOLINO, M
   PIFFERI, A
   TARONI, P
   VALENTINI, G
TI TIME-RESOLVED REFLECTANCE - A SYSTEMATIC STUDY FOR APPLICATION TO THE
   OPTICAL CHARACTERIZATION OF TISSUES
SO IEEE JOURNAL OF QUANTUM ELECTRONICS
LA English
DT Article
ID ULTRASHORT LASER-PULSES; RANDOM-MEDIA; LIGHT-SCATTERING; TURBID TISSUES;
   TRANSMITTANCE; SPECTROSCOPY; PROPAGATION; PROFILES; DESCRIBE; PHANTOM
AB In principle, the measurement of the time-resolved diffuse reflectance, as interpreted on the basis of the diffusion theory, allows us to determine the optical properties (absorption coefficient mu(a) and transport scattering coefficient mu's) of biological materials noninvasively.  A system for time-resolved reflectance measurements and its performances are described in detail.  An extensive experimental work and a computer simulation characterized the influence of mu(a), mu's, and observation distance on the measurement, and allowed to determine the ranges of mu(a) and mu's which can be measured reliably (and which include most of the values of interest in biomedical applications).  Moreover, on the basis of the experimental and computer work, the optimal experimental parameters can be determined in various situations.  The results presented are general and can be extended to different systems of measurement.
RP CUBEDDU, R (reprint author), POLITECN MILAN,CEQSE,CNR,PIAZZA L DA VINCI 32,I-20133 MILAN,ITALY.
RI Pifferi, Antonio/C-4688-2012; Taroni, Paola/C-4709-2012
OI Pifferi, Antonio/0000-0002-2261-2089; Taroni, Paola/0000-0001-7486-0001;
   Valentini, Gianluca/0000-0002-6340-3021
CR ARNFIELD MR, 1990, PHOTOCHEM PHOTOBIOL, V51, P667
   Berne B. J., 1975, DYNAMIC LIGHT SCATTE
   DUDERSTADT JJ, 1976, NUCL REACTOR ANAL, P140
   FERRARI M, 1992, J PHOTOCH PHOTOBIO B, V16, P141, DOI 10.1016/1011-1344(92)80005-G
   FLOCK ST, 1992, LASER SURG MED, V12, P510, DOI 10.1002/lsm.1900120510
   ISHIMARU A, 1978, WAVE PROPAGATION SCA, P175
   JACQUES SL, 1989, APPL OPTICS, V28, P2223, DOI 10.1364/AO.28.002223
   JACQUES SL, 1989, IEEE T BIO-MED ENG, V36, P1155, DOI 10.1109/10.42109
   LIU F, 1993, OPT LETT, V18, P432, DOI 10.1364/OL.18.000432
   MADSEN SJ, 1992, APPL OPTICS, V31, P3509, DOI 10.1364/AO.31.003509
   MADSEN SJ, 1992, PHYS MED BIOL, V37, P985, DOI 10.1088/0031-9155/37/4/012
   PATTERSON MS, 1989, APPL OPTICS, V28, P2331, DOI 10.1364/AO.28.002331
   PREUSS L E, 1986, Photochemistry and Photobiology, V43, p32S
   VANSTAVEREN HJ, 1991, APPL OPTICS, V30, P4507, DOI 10.1364/AO.30.004507
   WHITEHURST C, 1990, Lasers in Medical Science, V5, P395, DOI 10.1007/BF02032597
   WILSON BC, 1990, IEEE J QUANTUM ELECT, V26, P2186, DOI 10.1109/3.64355
   WILSON BC, 1987, PHOTOCHEM PHOTOBIOL, V46, P601, DOI 10.1111/j.1751-1097.1987.tb04820.x
   WILSON BC, 1985, PHOTOCHEM PHOTOBIOL, V42, P153, DOI 10.1111/j.1751-1097.1985.tb01554.x
   WILSON BC, 1988, PHOTON MIGRATION TIS, P25
   YOO KM, 1990, PHYS REV LETT, V65, P2210, DOI 10.1103/PhysRevLett.65.2210
   YOO KM, 1990, J OPT SOC AM B, V7, P1685, DOI 10.1364/JOSAB.7.001685
   YOO KM, 1989, APPL OPTICS, V28, P2343, DOI 10.1364/AO.28.002343
   YOO KM, 1990, PHYS REV LETT, V64, P2647, DOI 10.1103/PhysRevLett.64.2647
NR 23
TC 56
Z9 56
U1 0
U2 4
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017-2394
SN 0018-9197
J9 IEEE J QUANTUM ELECT
JI IEEE J. Quantum Electron.
PD OCT
PY 1994
VL 30
IS 10
BP 2421
EP 2430
DI 10.1109/3.328616
PG 10
WC Engineering, Electrical & Electronic; Optics; Physics, Applied
SC Engineering; Optics; Physics
GA PM813
UT WOS:A1994PM81300030
DA 2018-10-20
ER

PT J
AU RUDOLPH, AS
AF RUDOLPH, AS
TI BIOMATERIAL BIOTECHNOLOGY USING SELF-ASSEMBLED LIPID MICROSTRUCTURES
SO JOURNAL OF CELLULAR BIOCHEMISTRY
LA English
DT Article
DE SELF-ASSEMBLY; LIPIDS; BLOOD SUBSTITUTES; CONTROLLED RELEASE; MONOLAYER
   FORMATION
ID LIPOSOME-ENCAPSULATED HEMOGLOBIN; BLOOD SUBSTITUTE
AB Lipids are a class of molecules which self-assemble into a variety of phase-dependent morphologies. We have employed self-assembled lipid microstructures in the development of a number of biomedical material applications. The blood substitute, liposome encapsulated hemoglobin, is being investigated for the in vivo delivery of hemoglobin without many of the inherent toxicities associated with the delivery of free hemoglobin. This investigation is currently focused on demonstrations of efficacy in stressed animal models and on the safety of administering this material in models of sepsis. The synthetic modification of phospholipids to include photopolymerizable moieties such as diacetylenes has resulted in the spontaneous self-assembly of a hollow microcylinder which we are investigating for the controlled release of growth factors in soft tissue regeneration. Self-assembled monolayers are also being explored for the ability to surface modify biomaterials for improved cell adhesion. Photolithographic techniques have been combined with monolayer deposition to fabricate coplanar patterns of cell adhesion and inhibiting moieties. This results in the ability to spatially control the adhesion of cells to biomaterial surfaces. These cell patterns can form the basis for understanding two- and three-dimensional cellular events on the biomaterial surface and for the fabrication of improved cell-based biocompatible surfaces. The spontaneous self-assembly of lipids to form structures of biotechnological interest presents a unique opportunity to exploit this class of molecules for biomaterial applications. (C) 1994 Wiley-Liss, Inc.(*)
RP RUDOLPH, AS (reprint author), USN,RES LAB,CTR BIOMOLEC SCI & ENGN,CODE 6900,WASHINGTON,DC 20375, USA.
CR ALLEN T, 1992, LIPOSOME TECHNOLOGY, V3, P59
   Bangham A. D., 1983, LIPOSOME LETT
   JULIANO RL, 1980, LIPOSOMES IMMUNOBIOL, P49
   KLEINFELD D, 1988, J NEUROSCI, V8, P4098
   LINDBLOM G, 1989, BIOCHIM BIOPHYS ACTA, V988, P221, DOI 10.1016/0304-4157(89)90020-8
   LUZATTI V, 1968, NATURE, V73, P7304
   OSTRO MJ, 1989, AM J HOSP PHARM, V46, P1576
   OSTRO MJ, 1987, LIPOSOMES BIOPHYSICS
   PRICE RR, 1993, J MICROENCAPSUL, V10, P215, DOI 10.3109/02652049309104387
   RABINOVICI R, 1993, J TRAUMA, V35, P121, DOI 10.1097/00005373-199307000-00019
   RUDOLPH AS, 1991, P NATL ACAD SCI USA, V88, P10976, DOI 10.1073/pnas.88.23.10976
   RUDOLPH AS, 1992, BIOMATERIALS, V13, P1085, DOI 10.1016/0142-9612(92)90141-A
   RUDOLPH AS, 1991, NATURE, V352, P52, DOI 10.1038/352052a0
   RUDOLPH AS, 1988, CRYOBIOLOGY, V25, P277, DOI 10.1016/0011-2240(88)90036-3
   RUDOLPH AS, 1989, BIOTECHNOLOGICAL APP, V110, P305
   SCHNUR JM, 1987, THIN SOLID FILMS, V152, P181, DOI 10.1016/0040-6090(87)90416-0
   SPARGO BJ, 1992, MATER RES SOC SYMP P, V252, P285
   Tanford C., 1980, HYDROPHOBIC EFFECT
   YAGER P, 1984, MOL CRYST LIQ CRYST, V106, P371, DOI 10.1080/00268948408071454
NR 19
TC 25
Z9 27
U1 0
U2 9
PU WILEY-LISS
PI NEW YORK
PA DIV JOHN WILEY & SONS INC 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0730-2312
J9 J CELL BIOCHEM
JI J. Cell. Biochem.
PD OCT
PY 1994
VL 56
IS 2
BP 183
EP 187
DI 10.1002/jcb.240560211
PG 5
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA PJ445
UT WOS:A1994PJ44500010
PM 7829578
DA 2018-10-20
ER

PT J
AU ANDREOPOULOS, AG
   THEOPHANIDES, T
AF ANDREOPOULOS, AG
   THEOPHANIDES, T
TI DEGRADABLE PLASTICS - A SMART APPROACH TO VARIOUS APPLICATIONS
SO JOURNAL OF ELASTOMERS AND PLASTICS
LA English
DT Review
DE ATR-FT-IR; BIODEGRADATION; BIOMEDICAL POLYMERS; FT-IR; PHOTODEGRADATION;
   SPECTROPHOTOMETRY
ID LOW-MOLECULAR-WEIGHT; FUNCTIONAL-GROUP FORMATION; ULTRA-VIOLET
   DEGRADATION; LACTIC-ACID OLIGOMER; PHOTO-OXIDATION; RESORBABLE
   MATERIALS; INVITRO DEGRADATION; POLY(L-LACTIC ACID); POLYETHYLENE FILMS;
   SURFACE-LAYER
AB The suitability of photodegradation and biodegradation technologies for specialty applications is discussed. The research on degradable polymers is reviewed with emphasis on the processes of photooxidation, photostabilization and photosensitization. The degradation mechanisms, reaction products, analytical procedures and additives are discussed. Also, recent developments on biodegradable materials are reported, including composites of commodity plastics with starch, polymers of alpha-hydroxyacids, etc. Biomedical plastic based on lactic acid homopolymers or copolymers are another important field because of their versatility, which allows for successful product design. Typical applications are screws and plates used as implants for bone fixation or drug carriers. After the completion of a certain treatment, these materials degrade in the human body and do not require surgical retrieval.
C1 NATL TECH UNIV ATHENS, DEPT CHEM ENGN, RADIAT CHEM & BIOSPECT LAB, GR-15780 ATHENS, GREECE.
RP ANDREOPOULOS, AG (reprint author), NATL TECH UNIV ATHENS, DEPT CHEM ENGN, SPECIAL CHEM TECHNOL LAB, 9 IROON POLYTECH STR, GR-15780 ATHENS, GREECE.
CR ADAM C, 1990, POLYM DEGRAD STABIL, V27, P85, DOI 10.1016/0141-3910(90)90099-S
   ALBERTSSON AC, 1988, ACTA POLYM, V39, P95, DOI 10.1002/actp.1988.010390118
   ALBERTSSON AC, 1990, PROG POLYM SCI, V15, P177, DOI 10.1016/0079-6700(90)90027-X
   AMINABHAVI TM, 1990, POLYM-PLAST TECHNOL, V29, P235, DOI 10.1080/03602559008049843
   ANDRADY AL, 1990, J APPL POLYM SCI, V39, P363, DOI 10.1002/app.1990.070390213
   ANDREOPOULOS AG, 1993, IN PRESS POLYM TESTI
   ANDREOPOULOS AG, IN PRESS CLIN MATERI
   ANGIVTSEVA TG, 1990, INT POLYM SCI TECHN, V17, P55
   AVGOUSTAKIS K, 1991, INT J PHARM, V70, P77, DOI 10.1016/0378-5173(91)90166-L
   BARTUS J, 1989, POLYM DEGRAD STABIL, V26, P43, DOI 10.1016/0141-3910(89)90027-X
   BECK LR, 1979, NEW LONG ACTING INJE, V5, P545
   BELLENGER V, 1990, POLYM DEGRAD STABIL, V28, P53, DOI 10.1016/0141-3910(90)90051-8
   BODMEIER R, 1989, INT J PHARM, V51, P1, DOI 10.1016/0378-5173(89)90068-9
   BODMEIER R, 1989, J PHARM SCI, V78, P819, DOI 10.1002/jps.2600781008
   BOSE AK, 1989, 1989 POL LAM COAT C, P427
   BOTTENBERG P, 1991, P INT CONTROL REL BI, V18, P631
   BOUSQUET JA, 1987, POLYM DEGRAD STABIL, V18, P163, DOI 10.1016/0141-3910(87)90029-2
   BOUVIER M, 1991, J BIOMED MATER RES, V25, P773, DOI 10.1002/jbm.820250607
   BRUHN BW, 1991, P INT CONTROL REL BI, V18, P668
   BURFIELD DR, 1988, MAKROMOL CHEM, V189, P523
   CACIARI I, 1990, MACPLAS, V15, P54
   CARLSSON DJ, 1987, J APPL POLYM SCI, V33, P875, DOI 10.1002/app.1987.070330316
   CASTELEYN PP, 1992, J BONE JOINT SURG BR, V74, P858
   CASTILLO F, 1990, POLYM DEGRAD STABIL, V27, P1, DOI 10.1016/0141-3910(90)90092-L
   CHANDRA R, 1990, J MACROMOL SCI R M C, VC30, P155
   COFFIN MD, 1992, PHARMACEUT RES, V9, P200, DOI 10.1023/A:1018981222092
   COGHLAN A, 1990, NEW SCI, V125, P36
   CORDONNIER M, 1987, PLAST RUB PROC APPL, V8, P23
   DEMIRDERE A, 1991, EUR J PHARM BIOPHARM, V37, P42
   DO CH, 1987, J POLYM SCI POL CHEM, V25, P2301, DOI 10.1002/pola.1987.080250826
   DOI Y, 1990, MACROMOLECULES, V23, P26, DOI 10.1021/ma00203a006
   DUNN RL, 1991, P INT CONTROL REL BI, V18, P465
   EBI GC, 1990, J POLYM SCI POL CHEM, V28, P3533, DOI 10.1002/pola.1990.080281301
   ELING B, 1982, POLYMER, V23, P1587, DOI 10.1016/0032-3861(82)90176-8
   FERNANDI MJ, 1989, FEB P SPE REG TECHN, P525
   FRASER RK, 1992, J BONE JOINT SURG BR, V74, P929
   FUKUZAKI H, 1990, EUR POLYM J, V26, P1273, DOI 10.1016/0014-3057(90)90139-U
   FUZESSERY S, 1990, C P, P151
   GAUVIN P, 1987, MAKROMOL CHEM, V188, P1815
   GENTA I, 1991, P INT CONTROL REL BI, V18, P676
   GEORGE DI, 1988, MAY POL PROC APPL BU, P271
   GOHEEN SM, 1991, J APPL POLYM SCI, V42, P2691, DOI 10.1002/app.1991.070421007
   GRECO P, 1989, POLYMER, V30, P1475, DOI 10.1016/0032-3861(89)90219-X
   GUGUMUS F, 1990, ANGEW MAKROMOL CHEM, V182, P111, DOI 10.1002/apmc.1990.051820108
   GUGUMUS F, 1990, ANGEW MAKROMOL CHEM, V182, P85, DOI 10.1002/apmc.1990.051820107
   GUGUMUS F, 1990, ANGEW MAKROMOL CHEM, V176, P27, DOI 10.1002/apmc.1990.051760102
   GUILLET JE, 1973, 3RD TECHN C PHOT
   HON DNS, 1986, POLYM PHOTOCHEM, V7, P299, DOI 10.1016/0144-2880(86)90057-6
   Huang Jan-Chan, 1990, ADV POLYM TECHNOL, V10, P23
   IMASAKA K, 1990, MAKROMOL CHEM, V191, P2077
   Jian L., 1991, POLYM DEGRAD STABIL, V31, P1
   JIAN L, 1991, POLYM DEGRADAT STABI, V28, P335
   JOUAN X, 1991, J POLYM SCI POL CHEM, V29, P685, DOI 10.1002/pola.1991.080290510
   KABOTA H, 1990, POLYM DEGRADAT STABI, V29, P207
   KANESAWA Y, 1990, MAKROMOL CHEM-RAPID, V11, P679
   KISHIDA A, 1990, J CONTROL RELEASE, V13, P83, DOI 10.1016/0168-3659(90)90077-7
   KLEMCHUK PP, 1990, POLYM DEGRAD STABIL, V27, P183, DOI 10.1016/0141-3910(90)90108-J
   KOMITOV P, 1989, POLYM DEGRADAT STABI, V4, P303
   Labana S. S., 1976, ULTRAVIOLET LIGHT IN
   LACOSTE J, 1988, MAKROMOL CHEM, V189, P651
   LEENSLAG JW, 1987, BIOMATERIALS, V8, P70, DOI 10.1016/0142-9612(87)90034-2
   LEENSLAG JW, 1987, BIOMATERIALS, V8, P311, DOI 10.1016/0142-9612(87)90121-9
   LEENSLAG JW, 1987, MAKROMOL CHEM, V188, P1809
   LEENSLAG JW, 1987, POLYM COMMUN, V28, P92
   Lenz R W, 1989, Chinese Journal of Polymer Science, V7, P289
   LUCAS PC, 1989, POLYM DEGRAD STABIL, V26, P203, DOI 10.1016/0141-3910(89)90073-6
   LUCAS PC, 1988, POLYM DEGRAD STABIL, V22, P175, DOI 10.1016/0141-3910(88)90040-7
   LUCKI J, 1986, POLYMER, V27, P1193, DOI 10.1016/0032-3861(86)90007-8
   LUOMA GA, 1986, J APPL POLYM SCI, V32, P577
   MAJORANA P, 1991, C P
   MCCANN B, 1990, PLAST NEWS, V2, P7
   MEAD D, 1988, MAY POL PROC APPL BU, P291
   MIMELAUT VJ, 1988, C P, P333
   Mingbo H., 1987, POLYM DEGRAD STABIL, V18, P321
   MONTGOMERY M, 1991, MAT EDGE, V27, P6
   NAZARI G, 1989, POLIPLASTI PLAST RIN, V37, P46
   OMELCZUK MO, 1992, PHARMACEUT RES, V9, P26, DOI 10.1023/A:1018967424392
   OSAWA Z, 1986, POLYM PHOTOCHEM, V7, P337, DOI 10.1016/0144-2880(86)90002-3
   OTAKE Y, 1991, NIPPON GOMU KYAKAISH, V64, P688
   PARK TG, 1992, PHARMACEUT RES, V9, P37, DOI 10.1023/A:1018971525301
   PERRONE C, 1989, POLIPLASTI PLAST RIN, V37, P38
   PFEIL A, 1991, INT POLYM SCI TECHN, V18, P1
   PFEIL A, 1990, GUMMI FAS KUNST, V43, P180
   PHILAJAMAKI O, 1992, J BONE JOINT SURG BR, V74, P853
   PHILIPPART JL, 1990, MAKROMOL CHEM, V190, P413
   PHUA SK, 1987, J BIOMED MATER RES, V21, P231, DOI 10.1002/jbm.820210207
   PIELICHOWSKI J, 1988, MUANYAG GUMI, V25, P190
   PITT CG, 1981, BIOMATERIALS, V2, P215
   PRAMANICK D, 1987, POLYM BULL, V18, P311
   QURESHI FS, 1990, J POLYM ENG, V9, P302
   Ranby BG, 1975, PHOTODEGRADATION PHO
   REDPATH AE, 1988, MAY POL PROC APPL BU, P305
   REK V, 1989, POLYM DEGRAD STABIL, V24, P399, DOI 10.1016/0141-3910(89)90051-7
   REK V, 1986, POLYM PHOTOCHEM, V7, P273, DOI 10.1016/0144-2880(86)90055-2
   ROOM R, 1985, NEW TRENDS PHOTOCHEM, P147
   SACHAROW S, 1991, PAPER FILM FOIL CONV, V65, P58
   SASTRE R, 1990, J POLYM SCI POL CHEM, V28, P3661, DOI 10.1002/pola.1990.080281312
   SCHOOLENBERG GE, 1991, POLYMER, V32, P438, DOI 10.1016/0032-3861(91)90447-Q
   SCHOOLENBERG GE, 1991, POLYMER, V32, P432, DOI 10.1016/0032-3861(91)90446-P
   SEVERINI F, 1988, POLYM DEGRAD STABIL, V22, P185, DOI 10.1016/0141-3910(88)90041-9
   SEVERINI F, 1988, POLYM DEGRADAT STABI, V22, P79
   SHIH C, 1984, BIOMATERIALS, V5, P237, DOI 10.1016/0142-9612(84)90022-X
   SUBOCZ J, 1989, POLYM DEGRAD STABIL, V24, P335, DOI 10.1016/0141-3910(89)90044-X
   Szycher M, 1988, J Biomater Appl, V3, P297, DOI 10.1177/088532828800300207
   THAYER A, 1990, CHEM ENG NEWS, V68, P7, DOI 10.1021/cen-v068n026.p007
   THOMAS RH, 1990, POLYM NEWS, V15, P246
   TICE TR, 1991, P INT CONTROL REL BI, V18, P467
   TORIKAI A, 1990, J APPL POLYM SCI, V40, P1673
   TROJAN M, 1990, POLYM DEGRAD STABIL, V28, P275, DOI 10.1016/0141-3910(90)90068-I
   VAIDERGORIN EYL, 1987, POLYM DEGRAD STABIL, V18, P329, DOI 10.1016/0141-3910(87)90019-X
   WADA R, 1990, J PHARM SCI, V79, P919, DOI 10.1002/jps.2600791016
   WASSERBAUER R, 1990, BIOMATERIALS, V11, P36, DOI 10.1016/0142-9612(90)90049-V
   WASSERBAUER R, 1987, PLASTY KAUC, V24, P169
   WEI GX, 1991, J BONE JOINT SURG BR, V73, P246
   WELCH WF, 1987, APPL SPECTROSC, V41, P853, DOI 10.1366/0003702874448201
   WELLAND EL, 1989, POLYM COMMUN, V30, P302
   WOOTTON AB, 1988, PIGM RESIN TECHNOL, V17, P4
   YASSIN AA, 1990, J MACROMOL SCI R M C, VC30, P491, DOI 10.1080/07366579008050916
   ZWIERS RJM, 1983, POLYMER, V24, P167, DOI 10.1016/0032-3861(83)90128-3
   1989, EUROPEAN PLASTICS NE, V38
   1971, Patent No. 2119855
   1990, MPI, V134
   1991, NEW MAT JAP      APR, P10
   1968, Patent No. 1128793
   1971, Patent No. 2120336
NR 125
TC 17
Z9 17
U1 3
U2 24
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0095-2443
EI 1530-8006
J9 J ELASTOM PLAST
JI J. Elastomer Plast.
PD OCT
PY 1994
VL 26
IS 4
BP 308
EP 326
DI 10.1177/009524439402600401
PG 19
WC Materials Science, Multidisciplinary; Polymer Science
SC Materials Science; Polymer Science
GA PJ420
UT WOS:A1994PJ42000001
DA 2018-10-20
ER

PT J
AU DRUM, DA
   BULLEY, M
AF DRUM, DA
   BULLEY, M
TI MEDICAL WASTE-DISPOSAL
SO JOURNAL OF THE AIR & WASTE MANAGEMENT ASSOCIATION
LA English
DT Article
AB Medical (biomedical) wastes pose numerous potential health and safety hazards.  In addition to their infectious and toxic characteristics, the highly variable and inconsistent nature of medical waste streams has increased public concern about storage, treatment, transportation, and ultimate disposal.
   In recent years, techniques have been developed to reduce human exposure to the toxic and infectious components of medical wastes.  The most commonly used techniques include internal segregation, containment, and incineration.  Other common techniques include grinding, shredding, and disinfection, e.g., autoclaving and chemical treatment followed by landfilling.
   Of all the available technologies for medical waste treatment and disposal, incineration has been found to be the most effective method overall for destroying infectious and toxic material, volume reduction, and weight reduction in the medical waste stream.  Incineration destroys the broadest variety of medical waste constituents and can recover energy from the medical waste stream.  Incineration also is an appropriate alternative to burial of human pathological remains.
C1 AUCKLAND EPA LTD,AUCKLAND,NEW ZEALAND.
RP DRUM, DA (reprint author), BUUTLER CTY COMMUNITY COLL,BUTLER,PA 16003, USA.
CR BARTHOLOMEW P, 1994, 87TH ANN M EXH AIR W
   BOROWSKY AR, 1993, 86TH ANN M EXH AIR W
   CHANG TJ, 1991, 84TH ANN M EXH AIR W
   CROSS FL, 1993, 86TH ANN M EXH AIR W
   CROSS FL, 1990, INFECTIOUS WASTE MAN
   DRUM DA, 1993, REGULATORY ANAL MED
   GLASSER H, 1991, J AIR WASTE MANAGE, V41, P1180, DOI 10.1080/10473289.1991.10466913
   GREEN A, 1993, 86TH ANN M EXH AIR W
   HASSELRIIS F, 1994, 87TH ANN M EXH AIR W
   HASSELRIIS F, 1991, 84TH ANN M AIR WAST
   HASSELRIIS F, 1992, ASME NATIONAL WASTE
   HYLAND RG, 1994, 87TH ANN M EXH AIR W
   HYLAND RG, 1993, 86TH ANN M EXH AIR W
   JORDAN JW, 1994, 87TH ANN M EXH AIR W
   KONHEIM CS, 1994, 87TH ANN M EXH AIR W
   KONHEIM CS, 1993, 86TH ANN M EXH AIR W
   LAUBER JD, 1990, 83RD ANN M EXH AIR W
   LEE CC, 1991, 84TH ANN M EXH AIR W
   LERNER BJ, 1993, 86TH ANN M EXH AIR W
   LINDSEY WB, 1992, 85TH ANN M EXH AIR W
   MARRACK D, 1994, 87TH ANN M EXH AIR W
   1990, FINDING PRESCRIPTION
   1990, US EPA530SW90087A
   1992, STUDY NONBURN TECHNO
   1991, REPORT ASSESSMENT OP
   1990, EPA530SW90051A OFF W
   EPA625491030, P10
   1993, SOLID WASTE MANAGEME, pD207
NR 28
TC 11
Z9 11
U1 0
U2 9
PU AIR & WASTE MANAGEMENT ASSOC
PI PITTSBURGH
PA PO BOX 2861, PITTSBURGH, PA 15230
SN 1047-3289
J9 J AIR WASTE MANAGE
JI J. Air Waste Manage. Assoc.
PD OCT
PY 1994
VL 44
IS 10
BP 1176
EP 1179
PG 4
WC Engineering, Environmental; Environmental Sciences; Meteorology &
   Atmospheric Sciences
SC Engineering; Environmental Sciences & Ecology; Meteorology & Atmospheric
   Sciences
GA PP907
UT WOS:A1994PP90700002
DA 2018-10-20
ER

PT J
AU SULLIVAN, PK
   SMITH, JF
   ROZZELLE, AA
AF SULLIVAN, PK
   SMITH, JF
   ROZZELLE, AA
TI CRANIO-ORBITAL RECONSTRUCTION - SAFETY AND IMAGE QUALITY OF METALLIC
   IMPLANTS ON CT AND MRI SCANNING
SO PLASTIC AND RECONSTRUCTIVE SURGERY
LA English
DT Article
ID BIOMEDICAL IMPLANTS; FRACTURES; MANAGEMENT; FIXATION
AB A study was undertaken to evaluate the safety of magnetic resonance imaging (MRI) of metallic implants used in cranio-orbital reconstruction (stainless steel wire and titanium and Vitallium plates) and also to compare the degree of artifact created on computed tomographic (CT) scanning and MRI by each material.
   Samples of each material were tested for deflection (movement) in a 1.5-T MRI field and for temperature change under conditions simulating a clinical MRI scan. None of the materials exhibited any deflection, and none exhibited any significant temperature change compared with water.
   Standardized bars of each material and commonly used, commercially available titanium and Vitallium implants (plates, mesh) were evaluated for artifact. On blinded evaluation by three radiologists and on quantitative computer analysis of the CT images, the stainless steel produced the most artifact on both CT scan and MRI, followed by the Vitallium, with the least artifact caused by titanium. All the titanium images were felt to be acceptable to detect orbital pathology, while only the images with the thinnest Vitallium (micromesh) implant were acceptable.
C1 RHODE ISL HOSP,PROVIDENCE,RI 02902.
RP SULLIVAN, PK (reprint author), BROWN UNIV,SCH MED,DIV PLAST SURG,235 PLAIN ST,SUITE 502,PROVIDENCE,RI 02905, USA.
CR ANTONYSHYN O, 1989, ANN PLAS SURG, V22, P220, DOI 10.1097/00000637-198903000-00009
   DUJOVNY M, 1985, NEUROSURGERY, V17, P543, DOI 10.1227/00006123-198510000-00002
   GLASSMAN RD, 1990, PLAST RECONSTR SURG, V86, P1103, DOI 10.1097/00006534-199012000-00009
   JACKSON IT, 1989, CLIN PLAST SURG, V16, P77
   LEIPZIGER LS, 1992, CLIN PLAST SURG, V19, P167
   NGUYEN PN, 1992, CLIN PLAST SURG, V19, P87
   PHILLIPS JH, 1988, PLAST RECONSTR SURG, V82, P872, DOI 10.1097/00006534-198811000-00023
   ROHRICH RJ, 1992, CLIN PLAST SURG, V19, P149
   SARGENT LA, 1991, PLAST RECONSTR SURG, V88, P31, DOI 10.1097/00006534-199107000-00006
   SHELLOCK FG, 1991, RADIOLOGY, V180, P541, DOI 10.1148/radiology.180.2.2068325
   SHELLOCK FG, 1988, AM J ROENTGENOL, V151, P811, DOI 10.2214/ajr.151.4.811
   SHELLOCK FG, 1988, AM J ROENTGENOL, V151, P389, DOI 10.2214/ajr.151.2.389
   Shellock FG, 1987, RADIOLOGY, V165, P150
   SILVERMAN PM, 1986, COMPUT RADIOL, V10, P37, DOI 10.1016/0730-4862(86)90017-X
   SOULEN RL, 1985, RADIOLOGY, V154, P705, DOI 10.1148/radiology.154.3.3969474
   YAREMCHUK MJ, 1992, CLIN PLAST SURG, V19, P113
NR 16
TC 62
Z9 65
U1 0
U2 2
PU WILLIAMS & WILKINS
PI BALTIMORE
PA 351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436
SN 0032-1052
J9 PLAST RECONSTR SURG
JI Plast. Reconstr. Surg.
PD OCT
PY 1994
VL 94
IS 5
BP 589
EP 596
DI 10.1097/00006534-199410000-00004
PG 8
WC Surgery
SC Surgery
GA PK556
UT WOS:A1994PK55600004
PM 7938281
DA 2018-10-20
ER

PT J
AU ALLCOCK, HR
AF ALLCOCK, HR
TI CROSS-LINKING REACTIONS FOR THE CONVERSION OF POLYPHOSPHAZENES INTO
   USEFUL MATERIALS
SO CHEMISTRY OF MATERIALS
LA English
DT Article
ID INTERPENETRATING POLYMER NETWORKS; PHOSPHORUS-NITROGEN COMPOUNDS;
   THERMAL TRANSITION BEHAVIOR; SIDE GROUPS; LINKABLE POLYPHOSPHAZENE;
   CYCLIC PHOSPHAZENES; CARRIER MOLECULES; BOND-CLEAVAGE; HYDROGELS;
   POLY<BIS(TRIFLUOROETHOXY)PHOSPHAZENE>
AB The conversion of phosphazene high polymers to useful materials depends on the development of methods to cross-link the macromolecular chains. A number of crosslinking routes have been used including chemical, photochemical, and high-energy radiation techniques. The relationship of the cross-linking processes to electrochemical, electrooptical, elastomer, structural, membrane, surface, and biomedical properties is discussed.
RP ALLCOCK, HR (reprint author), PENN STATE UNIV,DEPT CHEM,UNIVERSITY PK,PA 16802, USA.
CR Allcock H. R., 1990, CONT POLYM CHEM
   ALLCOCK HR, 1993, MACROMOLECULES, V26, P11, DOI 10.1021/ma00053a002
   ALLCOCK HR, 1972, INORG CHEM, V11, P2584, DOI 10.1021/ic50117a003
   ALLCOCK HR, 1989, MACROMOLECULES, V22, P4179, DOI 10.1021/ma00201a008
   ALLCOCK HR, 1980, POLYMER, V21, P673, DOI 10.1016/0032-3861(80)90327-4
   ALLCOCK HR, 1992, BIOMATERIALS, V13, P857, DOI 10.1016/0142-9612(92)90179-R
   ALLCOCK HR, 1977, J AM CHEM SOC, V99, P3984, DOI 10.1021/ja00454a016
   ALLCOCK HR, 1992, MACROMOLECULES, V25, P5573, DOI 10.1021/ma00047a002
   ALLCOCK HR, 1988, BIOMATERIALS, V9, P509, DOI 10.1016/0142-9612(88)90046-4
   ALLCOCK HR, 1986, MACROMOLECULES, V19, P1508, DOI 10.1021/ma00160a003
   ALLCOCK HR, 1980, MACROMOLECULES, V13, P1332, DOI 10.1021/ma60078a002
   ALLCOCK HR, 1989, MACROMOLECULES, V22, P75, DOI 10.1021/ma00191a015
   ALLCOCK HR, 1992, CHEM MATER, V4, P296, DOI 10.1021/cm00020a015
   ALLCOCK HR, 1985, MACROMOLECULES, V18, P1330, DOI 10.1021/ma00148a050
   ALLCOCK HR, 1988, ACS SYM SER, V360, P250
   ALLCOCK HR, 1966, INORG CHEM, V5, P1716, DOI 10.1021/ic50044a017
   ALLCOCK HR, 1966, INORG CHEM, V5, P1709, DOI 10.1021/ic50044a016
   ALLCOCK HR, 1990, CHEM MATER, V2, P425, DOI 10.1021/cm00010a021
   ALLCOCK HR, 1977, INORG CHEM, V16, P3362, DOI 10.1021/ic50178a081
   ALLCOCK HR, 1993, CHEM MATER, V5, P1307, DOI 10.1021/cm00033a021
   ALLCOCK HR, 1974, MACROMOLECULES, V7, P284, DOI 10.1021/ma60039a006
   ALLCOCK HR, 1992, CHEM MATER, V4, P775, DOI 10.1021/cm00022a007
   ALLCOCK HR, 1972, MACROMOLECULES, V5, P231, DOI 10.1021/ma60026a026
   ALLCOCK HR, 1985, INORG CHEM, V24, P2656, DOI 10.1021/ic00211a015
   ALLCOCK HR, 1983, ORGANOMETALLICS, V2, P267, DOI 10.1021/om00074a011
   ALLCOCK HR, 1991, MACROMOLECULES, V24, P1000, DOI 10.1021/ma00005a006
   ALLCOCK HR, 1965, J AM CHEM SOC, V87, P4216, DOI 10.1021/ja01096a056
   ALLCOCK HR, 1975, MACROMOLECULES, V8, P377, DOI 10.1021/ma60046a001
   ALLCOCK HR, 1991, CHEM MATER, V3, P442, DOI 10.1021/cm00015a017
   ALLCOCK HR, 1985, CHEM ENG NEWS, V63, P22, DOI 10.1021/cen-v063n011.p022
   ALLCOCK HR, 1991, MACROMOLECULES, V24, P993, DOI 10.1021/ma00005a005
   ALLCOCK HR, 1979, J AM CHEM SOC, V101, P606, DOI 10.1021/ja00497a021
   ALLCOCK HR, 1992, CHEM MATER, V4, P769, DOI 10.1021/cm00022a006
   ALLCOCK HR, 1994, MACROMOLECULES, V27, P3131, DOI 10.1021/ma00090a003
   ALLCOCK HR, 1985, MACROMOLECULES, V18, P1340, DOI 10.1021/ma00148a051
   ALLCOCK HR, 1991, CHEM MATER, V3, P1120, DOI 10.1021/cm00018a032
   ALLCOCK HR, 1994, BIOMATERIALS, V15, P502, DOI 10.1016/0142-9612(94)90015-9
   ALLCOCK HR, 1988, BIOMATERIALS, V9, P500, DOI 10.1016/0142-9612(88)90045-2
   ALLCOCK HR, 1974, MACROMOLECULES, V7, P571, DOI 10.1021/ma60041a007
   ALLCOCK HR, 1991, MACROMOLECULES, V24, P2024, DOI 10.1021/ma00008a048
   ALLCOCK HR, 1994, MACROMOLECULES, V27, P3125, DOI 10.1021/ma00090a002
   ALLCOCK HR, 1993, MACROMOLECULES, V26, P1493, DOI 10.1021/ma00059a003
   ALLCOCK HR, 1992, J INORG ORGANOMET P, V2, P197
   ALLCOCK HR, 1992, RING OPENING POLYM, P217
   ALLCOCKI HR, 1994, ADV MATER, V6, P101
   ANDRIANOV AK, 1993, J CONTROL RELEASE, V27, P69, DOI 10.1016/0168-3659(93)90058-D
   ANDRIANOV AK, 1993, POLYM PREPR AM CHEM, V34, P233
   ARMAND MB, 1986, ANNU REV MATER SCI, V16, P245, DOI 10.1146/annurev.ms.16.080186.001333
   BABIC D, 1986, RADIAT PHYS CHEM, V28, P169
   BANO MC, 1991, BIO-TECHNOL, V9, P468, DOI 10.1038/nbt0591-468
   BENNETT JL, 1989, CHEM MATER, V1, P14
   BLONSKY PM, 1986, SOLID STATE IONICS, V18-9, P258, DOI 10.1016/0167-2738(86)90123-2
   BLONSKY PM, 1984, J AM CHEM SOC, V106, P6854, DOI 10.1021/ja00334a071
   COHEN S, 1990, J AM CHEM SOC, V112, P7832, DOI 10.1021/ja00177a074
   COHEN S, 1992, PCT INT APPL, P45
   DEGENNES PG, 1983, PHYS TODAY       JUN, P33
   DEMBEK AA, 1990, CHEM MATER, V2, P97, DOI 10.1021/cm00008a005
   DESPER CR, 1976, MACROMOLECULES, V9, P424, DOI 10.1021/ma60051a008
   DHALLUM G, 1992, MACROMOLECULES, V625, P1254
   DODGE JA, 1990, J AM CHEM SOC, V112, P1268, DOI 10.1021/ja00159a070
   DUBOIS RA, 1986, ORGANOMETALLICS, V5, P460, DOI 10.1021/om00134a012
   DUBOIS RA, 1984, ORGANOMETALLICS, V3, P649, DOI 10.1021/om00082a032
   Fieldhouse J. W., 1980, U.S. Patent, Patent No. [4,226,840, 4226840]
   FLINDT EP, 1977, Z ANORG ALLG CHEM, V428, P204, DOI 10.1002/zaac.19774280125
   Flory P.J., 1969, PRINCIPLES POLYM CHE
   FRANZ U, 1993, MACROMOLECULES, V26, P3723, DOI 10.1021/ma00066a036
   GETTLEMAN L, 1985, POLYM MAT SCI ENG, V53, P770
   HABER CM, 1960, P CHEM SOC LONDON, P219
   HERRING DL, 1960, CHEM IND-LONDON, P717
   KOJIMA M, 1989, POLYMER, V30, P1856, DOI 10.1016/0032-3861(89)90358-3
   KOJIMA M, 1989, POLYMER, V30, P579, DOI 10.1016/0032-3861(89)90138-9
   MANNERS I, 1989, J AM CHEM SOC, V111, P5478, DOI 10.1021/ja00196a071
   MANNERS I, 1989, J AM CHEM SOC, V111, P3067, DOI 10.1021/ja00190a052
   Mark J. E., 1992, INORGANIC POLYM, P272
   MONTAGUE RA, 1990, J AM CHEM SOC, V112, P6721, DOI 10.1021/ja00174a047
   NAPIERALA M, 1994, WORK CARRIED OUT PEN
   NEILSON RH, 1988, CHEM REV, V88, P541, DOI 10.1021/cr00085a005
   NEILSON RH, 1987, MACROMOLECULES, V20, P910, DOI 10.1021/ma00171a002
   NELSON CE, UNPUB
   NELSON CJ, 1991, CHEM MATER, V3, P786, DOI 10.1021/cm00017a010
   OBRIEN JP, 1979, MACROMOLECULES, V12, P108, DOI 10.1021/ma60067a023
   PACIOREK RH, 1965, INORG CHEM, V4, P1767
   PENTON HR, 1986, KAUT GUMMI KUNSTST, V39, P301
   ROSE SH, 1968, J POLYM SCI POL LETT, V6, P837, DOI 10.1002/pol.1968.110061203
   SCHNEIDER NS, 1978, ORG POL S NEW ORL 19, P271
   SENNETT MS, 1983, POLYM MAT SCI ENG, V49, P297
   SHRIVER DF, 1985, CHEM ENG NEWS, V63, P20
   SINGLER RE, 1982, ACS SYM SER, V193, P229
   Sperling L. H., 1981, INTERPENETRATING POL
   SPERLING LH, 1988, CHEMTECH, V18, P104
   Tate D.P., 1974, J POLYM SCI POLYM S, V48, P33
   TONGE JS, 1987, P S LITHIUM BATTERIE, V1, P533
   VISSCHER KB, 1990, MACROMOLECULES, V23, P4885, DOI 10.1021/ma00224a022
   WELKER MF, 1994, ACS SYM SER, V537, P293
   Wright P. V., 1975, British Polymer Journal, V7, P319, DOI 10.1002/pi.4980070505
   WRIGHT PV, 1976, J POLYM SCI POL PHYS, V14, P955, DOI 10.1002/pol.1976.180140516
   1985, ECNY POLYM SCI ENG, V1
NR 97
TC 98
Z9 100
U1 2
U2 12
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036
SN 0897-4756
J9 CHEM MATER
JI Chem. Mat.
PD SEP
PY 1994
VL 6
IS 9
BP 1476
EP 1491
DI 10.1021/cm00045a003
PG 16
WC Chemistry, Physical; Materials Science, Multidisciplinary
SC Chemistry; Materials Science
GA PG435
UT WOS:A1994PG43500003
DA 2018-10-20
ER

PT J
AU YAPARPALVI, R
   LOYALKA, SK
   TOMPSON, RV
AF YAPARPALVI, R
   LOYALKA, SK
   TOMPSON, RV
TI PRODUCTION OF SPHERICAL ZRO2-Y2O3 AND ZNO PARTICLES
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
ID SPRAY PYROLYSIS METHOD; EVAPORATIVE DECOMPOSITION; POWDER; BIOCERAMICS;
   CERAMICS
AB In recent years substantial effort has been focused on the use of engineered ceramics for biomedical applications. To produce ceramic components with reliable and reproducible properties for such speciality applications, it is necessary to use high-purity raw material powders with specific properties. Fine ceramic particles having specific shapes and sizes are also required for conducting biocompatibility experiments. This article reports on the laboratory scale production, in an aerosol reactor, of spherical, submicron zirconia (partially stabilized by yttria; ZrO2-Y2O3) and zinc oxide (ZnO) particles by the thermal decomposition of mists generated from aqueous solutions of inorganic metal salt precursors. The particles produced were characterized by scanning electron microscopy, X-ray diffraction, and Fourier transform infrared spectroscopy. (C) 1994 John Wiley and Sons, Inc.
C1 UNIV MISSOURI,COLL ENGN,PARTICULATE SYST RES CTR,COLUMBIA,MO 65211.
CR Brook R., 1984, NEW SCI, P13
   CHRISTEL P, 1991, ANN NY ACAD SCI, V523, P235
   DION I, 1993, BIOMATERIALS, V14, P107, DOI 10.1016/0142-9612(93)90218-Q
   DOREMUS RH, 1992, J MATER SCI, V27, P285, DOI 10.1007/BF00543915
   GARDNER TJ, 1984, AM CERAM SOC BULL, V63, P1498
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   ISHIZAWA H, 1986, AM CERAM SOC BULL, V65, P1399
   JOHNSON DW, 1981, AM CERAM SOC BULL, V60, P221
   LANGE FF, 1989, J AM CERAM SOC, V72, P3, DOI 10.1111/j.1151-2916.1989.tb05945.x
   MATIJEVIC E, 1985, ANNU REV MATER SCI, V15, P483
   NONMAN RD, 1964, J DENT RES, V43, P252
   PRATSINIS SE, 1989, CHEM ENG PROG    MAY, P62
   RICE RW, 1990, AICHE J, V36, P481, DOI 10.1002/aic.690360402
   SPROSON DW, 1986, CERAM INT, V12, P3, DOI 10.1016/S0272-8842(86)80003-7
   STJOHN KR, 1992, ASTM PUBLICATION STP, V1144
   TAKIGAWA K, 1990, BRIT CERAM TRANS J, V89, P82
   VINCENZINI P, 1982, 2ND P INT S BIOC LIG
   WILLIAMS DF, 1987, J MATER SCI, V22, P3421, DOI 10.1007/BF01161439
   1987, POWDER DIFFRACTION F
NR 19
TC 13
Z9 13
U1 0
U2 3
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD SEP
PY 1994
VL 28
IS 9
BP 1087
EP 1093
DI 10.1002/jbm.820280914
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA PE101
UT WOS:A1994PE10100013
PM 7814436
DA 2018-10-20
ER

PT J
AU VANWACHEM, PB
   VANLUYN, MJA
   BLAAUW, EH
   RAATJES, D
   CAHALAN, PT
   HENDRIKS, M
AF VANWACHEM, PB
   VANLUYN, MJA
   BLAAUW, EH
   RAATJES, D
   CAHALAN, PT
   HENDRIKS, M
TI INCIDENCE OF INFECTION IN IMPLANTED POLYURETHANE TUBING SEGMENTS
   SERIALLY INJECTED WITH STAPHYLOCOCCI
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID FOREIGN-BODY INFECTION; BACTERIAL ADHERENCE; PATHOGENESIS; ADHESION;
   POLYMERS; THERAPY
AB One of the major clinical complications in the biomedical application of synthetic materials is the incidence of implant-associated infections. Such infections are very often induced by Staphylococcus aureus. To obtain information on tissue reactions and minimal bacterial challenge needed to create an infection related to untreated implant surfaces, we injected polyurethane tubing segments with a series of Staphylococcus aureus. The segments were subcutaneously implanted in rats. Implantation periods varied from 2, 5 and 10 days to 3 weeks. Specimen were evaluated using light and transmission electron microscopy. At least 0.25 x 10(4) of Staphylococci aureus were needed to clearly recognize that bacteria had been injected in the polyurethane tubing segments. The evidence was indirect, showing high infiltration and activation of neutrophils and macrophages, but not bacteria. Furthermore, 0.25 x 10(6) S. aureus were needed to induce a persistent specific inflammatory reaction with high concentrations of lymphocytes, i.e. mainly plasma-cells, at 3 weeks. The results indicate that this model functioned well to obtain the wanted information. Results are discussed with respect to (a-) specific inflammatory reactions occurring with (bacterial-challenged) biomaterials. Ultimately, our goal is to develop infection-resistant materials, for which the in vivo model developed may be used to qualify the processed materials
C1 UNIV GRONINGEN HOSP,DEPT HOSP EPIDEMIOL,9713 EZ GRONINGEN,NETHERLANDS.
   MEDTRON BAKKEN RES CTR BV,6201 MP MAASTRICHT,NETHERLANDS.
RP VANWACHEM, PB (reprint author), UNIV GRONINGEN,CELL BIOL & ELECTRON MICROSCOPY LAB,OOSTERSINGEL 69-2,9713 EZ GRONINGEN,NETHERLANDS.
CR ABBAS AK, 1991, CELLULAR MOL IMMUNOL
   ANDERSON JM, 1993, CARDIOVASC PATHOL, V2, pS33
   ANWAR H, 1992, ANTIMICROB AGENTS CH, V36, P1347, DOI 10.1128/AAC.36.7.1347
   BISNO AL, 1989, INFECTIONS ASS INDWE
   BLACK J, 1992, BIOL PERFORMANCE MAT
   Brostoff J., 1991, CLIN IMMUNOLOGY
   CHRISTENSEN GD, 1987, ZBL BAKT S, V16, P103
   COLOMB G, 1991, J BIOMED MATER RES, V25, P937
   COSTERTON JW, 1984, REV INFECT DIS, V6, pS608, DOI 10.1093/clinids/6.Supplement_3.S608
   CRISTINA AG, 1987, BIOMATERIALS, V8, P423
   DANKERT J, 1986, CRIT REV BIOCOMPAT, V2, P219
   ELEK SD, 1957, BRIT J EXP PATHOL, V38, P573
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   HOGT AH, 1986, J BIOMED MATER RES, V20, P533, DOI 10.1002/jbm.820200409
   JANSEN B, 1990, PROGRESS IN BIOMEDICAL POLYMERS, P347
   JANSEN B, 1990, ADV BIOMAT, V9, P117
   JOHNSON GM, 1987, ZENTRALBLATT BAKTE S, V16, P33
   PLANCK H, 1984, POLYURETHANES BIOMED
   REED WP, 1978, J CHRON DIS, V31, P67, DOI 10.1016/0021-9681(78)90091-7
   Schoen F.J., 1987, T AM SOC ART INT ORG, V33, P8
   SHETH NK, 1985, LANCET, V2, P1266
   SHETH NK, 1987, ZBL BAKT S, V16, P177
   VANDERMEER JB, 1992, NETH J MED, V40, P244
   von Recum A F, 1989, J Invest Surg, V2, P351, DOI 10.3109/08941938909018260
   WALDVOGEL FA, 1990, PRINCIPLES PRACTICE, P1489
   ZIMMERLI W, 1984, J CLIN INVEST, V73, P1191, DOI 10.1172/JCI111305
   ZIMMERLI W, 1982, J INFECT DIS, V146, P487, DOI 10.1093/infdis/146.4.487
NR 27
TC 7
Z9 7
U1 0
U2 1
PU CHAPMAN HALL LTD
PI LONDON
PA 2-6 BOUNDARY ROW, LONDON, ENGLAND SE1 8HN
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD SEP-OCT
PY 1994
VL 5
IS 9-10
BP 628
EP 634
DI 10.1007/BF00120344
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA PU255
UT WOS:A1994PU25500013
DA 2018-10-20
ER

PT J
AU SALOMONI, A
   TUCCI, A
   ESPOSITO, L
   STAMENKOVIC, I
AF SALOMONI, A
   TUCCI, A
   ESPOSITO, L
   STAMENKOVIC, I
TI FORMING AND SINTERING OF MULTIPHASE BIOCERAMICS
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
AB Composite bioceramic materials could find use in a wide range of biomedical applications; however, their processing technologies are quite complex or not sufficiently developed. In order to eliminate deleterious influences of powder inhomogeneities and to reduce the machining time of final components, a novel procedure for multiphase powders using wet pretreatment and direct forming of green bodies having the desired geometries was studied. During the experimental work alumina, yttria-stabilized zirconia, and their mixtures were used. The forming of discs and femoral heads was done by pressure casting of aqueous suspensions of powders. The measurements of physical, mechanical and tribological properties of sintered samples were performed; the results obtained showed the effectiveness of the process since the property values approached those of similar materials actually on the market, while requiring less machining labour.
RP SALOMONI, A (reprint author), CTR CERAM,VIA MARTELLI 26,I-40138 BOLOGNA,ITALY.
CR ESPOSITO L, 1993, 3RD P EUR CER C, V3, P301
   NIIHARA K, 1982, J MATER SCI LETT, V1, P13, DOI 10.1007/BF00724706
   SALOMONI A, 1992, CERAMIC T, V26, P178
   TSUKUMA K, 1985, J AM CERAM SOC, V68, pC4
   1992, MAY P INT S HIP PROS
NR 5
TC 19
Z9 19
U1 0
U2 4
PU CHAPMAN HALL LTD
PI LONDON
PA 2-6 BOUNDARY ROW, LONDON, ENGLAND SE1 8HN
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD SEP-OCT
PY 1994
VL 5
IS 9-10
BP 651
EP 653
DI 10.1007/BF00120349
PG 3
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA PU255
UT WOS:A1994PU25500018
DA 2018-10-20
ER

PT J
AU TANZI, MC
   MANTERO, S
   FREDDI, G
   MOTTA, A
   SADA, A
   PELUSO, G
AF TANZI, MC
   MANTERO, S
   FREDDI, G
   MOTTA, A
   SADA, A
   PELUSO, G
TI CYTOCOMPATIBILITY OF 2 SEGMENTED BIOMEDICAL POLYURETHANES
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
AB In this work the proliferation of mitogen-activated human T lymphocytes, and human endothelial cells (HEC) adhesion and growth have been evaluated in vitro with two segmented polyurethanes (SPUs) having different chemical structure: Pellethane 2363-80A, a poly-ether-urethane, and Corethane 55D, a polycarbonate-urethane. The effect of the two SPUs on phytohemoagglutinin (PHA)-induced T-cells proliferation was analysed by evaluating both morphological changes of the lympho-monocyte system with scanning electron microscopy (SEM), and the perturbation of cell cycle progression with a cytofluorimetric technique. Results showed that, although the PHA stimulation of T-cells cultured on Corethane was sufficient to induce entry into the cell cycle, as evidenced by an increase in RNA content, the DNA synthesis appeared similar to that of unstimulated cultures. On the other hand, there was a significant increase of the DNA and RNA content in the culture performed in the presence of Pellethane, as in the case of PHA-stimulated control cultures. Moreover, in comparison with Pellethane, a strong decrease in monocyte attachment and spreading was observed on Corethane; with lymphocytes scattered around the monocytes, and not attached to them as in the case of Pellethane. In the experiment with HEC, the cells were directly seeded on the materials, and the number of cells attached after 4 and 72 h culture was then evaluated, the former reading being a measure for cell adhesion, the latter indicating the capacity of the cells to proliferate. Although both SPUs allowed a HEC adhesion lower than the positive control, it was possible to confirm that Pellethane well supports cell proliferation, whereas Corethane is less prone to promote cell growth
C1 STN SPERIMENTALE SETA,I-20133 MILAN,ITALY.
   CNR,INST BIOCHIM PROT ENZIMOL,I-80100 ARCO,ITALY.
RP TANZI, MC (reprint author), POLITECN MILAN,DIPARTIMENTO BIOINGN,PZZA L VINCI 32,I-20133 MILAN,ITALY.
RI Mantero, Sara/F-6587-2013; Tanzi, Maria Cristina/I-4620-2013
OI Tanzi, Maria Cristina/0000-0002-4913-6633; MANTERO,
   SARA/0000-0002-1264-0465; Motta, Antonella/0000-0003-4893-6863
CR Lelah M. D., 1986, POLYURETHANES MED
   MERRITT K, 1986, TECHNIQUES BIOCOMPAT, V2, P123
   MOLLER G, 1989, IMMUNOL REV, V11, P1
   PINCHUK L, 1993, 19TH T ANN M SOC BIO, V16, P22
   Stokes K B, 1988, J Biomater Appl, V3, P228, DOI 10.1177/088532828800300205
   SZYCHER M, 1991, BLOOD COMPATIBLE MAT, P42
   Tanzi M. C., 1993, Clinical Materials, V12, P17, DOI 10.1016/0267-6605(93)90023-Z
   TERADA N, 1991, J IMMUNOL, V147, P698
   WILLIAMS DF, 1986, TECHNIQUES BIOCOMPAT, V2, pCH4
   ZHAO Q, 1991, J BIOMED MATER RES, V25, P177, DOI 10.1002/jbm.820250205
NR 10
TC 2
Z9 2
U1 0
U2 5
PU CHAPMAN HALL LTD
PI LONDON
PA 2-6 BOUNDARY ROW, LONDON, ENGLAND SE1 8HN
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD SEP-OCT
PY 1994
VL 5
IS 9-10
BP 705
EP 710
DI 10.1007/BF00120361
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA PU255
UT WOS:A1994PU25500030
DA 2018-10-20
ER

PT J
AU WITTWER, C
   DEVLIN, AJ
   HATTON, PV
   BROOK, IM
   DOWNES, S
AF WITTWER, C
   DEVLIN, AJ
   HATTON, PV
   BROOK, IM
   DOWNES, S
TI THE RELEASE OF SERUM-PROTEINS AND DYE FROM GLASS-IONOMER (POLYALKENOATE)
   AND ACRYLIC CEMENTS - A PILOT-STUDY
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID OTOLOGIC SURGERY; INVITRO
AB Glass ionomer cements (GICs) are composite materials with the potential for use as improved bone substitutes and cements. The hydrophilic nature of the GIC matrix may confer the ability to release therapeutic agents after surgical implantation which would aid the development of GICs for wider biomedical application. Acrylic and GIC were loaded (5% w/w> with either a model dye or high molecular weight proteins and eluted in vitro over 84 days to study simulated drug release. Serum proteins were also adsorbed on to the surface of acrylic and two different GICs and desorption measured over six days. GIC was a suitable matrix for simple dye and protein release, protein release being greater from the GIC than from the acrylic cement. Selective desorption from the two different GICs studied was noted indicating GICs may be formulated to release specific drugs or proteins.
C1 ROYAL NATL ORTHOPAED HOSP,INST ORTHOPAED,IRC BIOMED MAT,STANMORE HA7 4LP,MIDDX,ENGLAND.
RP WITTWER, C (reprint author), UNIV SHEFFIELD,SCH CLIN DENT,BIOMAT GRP,CLAREMONT CRESCENT,SHEFFIELD S10 2TA,S YORKSHIRE,ENGLAND.
OI Hatton, Paul/0000-0001-5234-1104
CR BABIGHIAN G, 1992, J LARYNGOL OTOL, V106, P954, DOI 10.1017/S0022215100121450
   BAKER AS, 1988, J BONE JOINT SURG AM, V70A, P1551, DOI 10.2106/00004623-198870100-00015
   Barnes C, 1934, PHYSICS-J GEN APPL P, V5, P4, DOI 10.1063/1.1745209
   BROOK IM, 1985, BIOMATERIALS, V6, P281, DOI 10.1016/0142-9612(85)90027-4
   BROOK IM, 1992, BIOMATERIALS, V13, P721, DOI 10.1016/0142-9612(92)90134-A
   BROOK IM, 1986, BIOL BIOMECHANICAL P, V6, P251
   BUCHOLZ HW, 1979, RECENT ADV ORTHOPAED, V3, P61
   Crank J., 1975, MATH DIFFUSION, P238
   DOWNES S, 1991, Clinical Materials, V7, P227, DOI 10.1016/0267-6605(91)90063-L
   DOWNES S, 1989, CLIN MATER, V4, P109
   DOWNES S, 1990, CLIN ORTHOP REL, V252, P293
   HATTON PV, 1992, BRIT DENT J, V173, P275, DOI 10.1038/sj.bdj.4808026
   HATTON PV, 1992, ADV BIOMAT, V10, P331
   JONCK L M, 1990, Clinical Materials, V6, P323, DOI 10.1016/0267-6605(90)90052-W
   JOSEFSSON G, CLIN ORTHOP RELAT R, V253, P174
   RAMSDEN RT, 1992, J LARYNGOL OTOL, V106, P949, DOI 10.1017/S0022215100121449
NR 16
TC 4
Z9 4
U1 0
U2 0
PU CHAPMAN HALL LTD
PI LONDON
PA 2-6 BOUNDARY ROW, LONDON, ENGLAND SE1 8HN
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD SEP-OCT
PY 1994
VL 5
IS 9-10
BP 711
EP 714
DI 10.1007/BF00120362
PG 4
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA PU255
UT WOS:A1994PU25500031
DA 2018-10-20
ER

PT J
AU PELUSO, G
   PETILLO, O
   AMBROSIO, L
   NICOLAIS, L
AF PELUSO, G
   PETILLO, O
   AMBROSIO, L
   NICOLAIS, L
TI POLYETHERIMIDE AS BIOMATERIAL - PRELIMINARY IN-VITRO AND IN-VIVO
   BIOCOMPATIBILITY TESTING
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID NYLON WOOL; PATHOGENESIS; FIBER
AB During the last few years, on the basis of their physico-chemical characteristics, thermoplastic materials, already used in several advanced industries, have become very attractive candidates for biomedical applications as matrix for composite femoral stems and bone plates. In the present study, the biocompatibility of a thermoplastic material, polyetherimide (PEI), was investigated both in vivo, and in vitro. Our results show that PEI did not elicit any toxic response in cell culture testing. It was possible to grow on PEI surfaces not only 3T3 fibroblasts but also human endothelial cells (HEC) from human umbilical cord, with no apparent deleterious effects on the cell viability. The attachment, spreading, and growth of cells on PEI material was followed with respect to time. Both the number of adhering HEC, and the spreading area of individual cells, increased as a function of time. The hydrogen peroxide-sensitive dye DCFH-DA was used to examine the functional activity of cells adherent to PEI or control material implants. PEI material did not induce significant DCFH oxidation until day 14, when levels of DCFH oxidation were significantly higher than observed with PDMS negative control, but lower than those observed on Pellethane positive control.
C1 UNIV NAPLES FEDERICO II,DEPT MAT & PROD ENGN,I-80125 NAPLES,ITALY.
   UNIV NAPLES FEDERICO II,CNR,INST COMPOSITE MAT TECHNOL,I-80125 NAPLES,ITALY.
RP PELUSO, G (reprint author), CNR,INST PROT BIOCHEM & ENZYMOL,VIA TOIANO 6,I-80072 ARCO,ITALY.
OI AMBROSIO, LUIGI/0000-0002-8367-2405
CR BASS DA, 1983, J IMMUNOL, V130, P1910
   HAGGERTY HS, 1989, ACTA OTO-LARYNGOL, V107, P13, DOI 10.3109/00016488909127474
   JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470
   KESTON AS, 1965, ANAL BIOCHEM, V11, P1, DOI 10.1016/0003-2697(65)90034-5
   KLOCK JC, 1977, J CLIN INVEST, V60, P1183, DOI 10.1172/JCI108871
   KLOCK JC, 1976, BLOOD, V48, P149
   PELUSO G, 1991, BIOMATERIALS, V12, P231, DOI 10.1016/0142-9612(91)90205-O
   PELUSO G, 1991, Clinical Materials, V8, P99, DOI 10.1016/0267-6605(91)90016-9
   RICHARDSON RR, 1993, BIOMATERIALS, V14, P627, DOI 10.1016/0142-9612(93)90183-3
   ROBINSON JP, 1988, J LEUKOCYTE BIOL, V43, P304
   STRAIT LH, 1991, MAY T SOC BIOM SCOOT
   WENZ LM, 1990, J BIOMED MATER RES, V24, P207, DOI 10.1002/jbm.820240207
   ZIATS NP, 1989, BIOMATERIALS, V9, P5
   ZIMMERLI W, 1984, J CLIN INVEST, V73, P1191, DOI 10.1172/JCI111305
NR 14
TC 31
Z9 31
U1 1
U2 12
PU CHAPMAN HALL LTD
PI LONDON
PA 2-6 BOUNDARY ROW, LONDON, ENGLAND SE1 8HN
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD SEP-OCT
PY 1994
VL 5
IS 9-10
BP 738
EP 742
DI 10.1007/BF00120367
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA PU255
UT WOS:A1994PU25500036
DA 2018-10-20
ER

PT J
AU KISHIDA, A
   UENO, Y
   FUKUDOME, N
   YASHIMA, E
   MARUYAMA, I
   AKASHI, M
AF KISHIDA, A
   UENO, Y
   FUKUDOME, N
   YASHIMA, E
   MARUYAMA, I
   AKASHI, M
TI IMMOBILIZATION OF HUMAN THROMBOMODULIN ONTO POLY(ETHER URETHANE UREA)
   FOR DEVELOPING ANTITHROMBOGENIC BLOOD-CONTACTING MATERIALS
SO BIOMATERIALS
LA English
DT Article; Proceedings Paper
CT 4th International Conference on Molecular Aspects of Biomaterials
   (BIOINTERACTIONS 93)
CY AUG 29-SEP 01, 1993
CL NOORDWIJKERHOUT, NETHERLANDS
DE THROMBOMODULIN; POLY(ETHER URETHANE UREA); IMMOBILIZATION;
   ANTITHROMBOGENICITY; PLATELET ADHESION
ID ANTICOAGULANT ACTIVITY; HEPARIN; COPOLYMERS
AB Thrombomodulin (TM) is a newly described endothelial cell-associated protein that functions as a potent natural anticoagulant by converting thrombin from a procoagulant protease to an anticoagulant. In this study, focussing on the application of TM for biomedical materials, recombinant human TM (hTM) was immobilized onto the polymers for medical use, and the evaluation of their antithrombogenicity and the interaction with platelets were investigated. As the base polymer for immobilization reaction, poly(ether urethane urea)(PEUU), which was reported to have good blood compatibility, was used. hTM-immobilized PEUU showed superior antithrombogenic activity, such as the prolongation of plasma recalcification time and the inhibition of thrombin-induced platelet aggregation, though the amount of immobilized hTM was very small (i.e. less than 1 mu g/cm(2)). Platelet adhesions onto hTM-immobilized PEUU were not observed. These results show that the immobilization of hTM does not change the native good blood compatibility of PEUU, but provides excellent anticoagulant activity.
C1 KAGOSHIMA UNIV,FAC ENGN,DEPT APPL CHEM & CHEM ENGN,KAGOSHIMA 890,JAPAN.
   NATL COLL TECHNOL,DEPT IND CHEM,MIYAKONOJO,MIYAZAKI,JAPAN.
   KAGOSHIMA UNIV,FAC MED,DEPT CLIN LAB MED,KAGOSHIMA 890,JAPAN.
RI Yashima, Eiji/H-5380-2011
OI Yashima, Eiji/0000-0001-6307-198X
CR AKASHI M, 1992, BIOCONJUGATE CHEM, V3, P363, DOI 10.1021/bc00017a002
   AKASHI M, 1989, J BIOACT COMPAT POL, V4, P4
   CLARKE JH, 1993, J BIOL CHEM, V268, P6309
   EBERT CD, 1982, J BIOMED MATER RES, V16, P629, DOI 10.1002/jbm.820160510
   ISHIHARA K, 1993, BIOMEDICAL APPL POLY, P89
   ITO Y, 1986, J BIOMED MATER RES, V20, P1157, DOI 10.1002/jbm.820200808
   ITO Y, 1986, J BIOMED MATER RES, V20, P1017, DOI 10.1002/jbm.820200715
   JOHANSSON AC, 1974, BIOCHIM BIOPHYS ACTA, V370, P339, DOI 10.1016/0005-2744(74)90094-1
   KAWAUCHI H, 1969, J BIOCHEM-TOKYO, V66, P783, DOI 10.1093/oxfordjournals.jbchem.a129208
   KITANO H, 1982, J APPL BIOCHEM, V4, P434
   KULIK EA, 1993, BIOMATERIALS, V14, P763, DOI 10.1016/0142-9612(93)90041-Y
   LOK BK, 1983, J COLLOID INTERF SCI, V91, P87, DOI 10.1016/0021-9797(83)90316-8
   MORI Y, 1978, T AM SOC ART INT ORG, V24, P736
   OSHIRO T, 1980, ARTIF ORGANS, V4, P58
   OSHIRO T, 1988, METHOD ENZYMOL, V137, P529
   SALEM HH, 1984, J BIOL CHEM, V259, P2246
   SENATORE F, 1986, J BIOMED MATER RES, V20, P177, DOI 10.1002/jbm.820200207
   SHIRAI T, 1988, J BIOCHEM-TOKYO, V103, P281, DOI 10.1093/oxfordjournals.jbchem.a122261
   VULIC I, 1988, J POLYM SCI POL CHEM, V26, P381, DOI 10.1002/pola.1988.080260204
   YAGI K, 1989, CHEM PHARM BULL, V37, P732
   YAMADA H, 1981, BIOCHEMISTRY-US, V20, P4836, DOI 10.1021/bi00520a005
   ZUSHI M, 1989, J BIOL CHEM, V264, P10351
NR 22
TC 42
Z9 43
U1 1
U2 5
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD AUG
PY 1994
VL 15
IS 10
BP 848
EP 852
DI 10.1016/0142-9612(94)90041-8
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA PC347
UT WOS:A1994PC34700018
PM 7986950
DA 2018-10-20
ER

PT J
AU DIEDERICH, F
   ISAACS, L
   PHILP, D
AF DIEDERICH, F
   ISAACS, L
   PHILP, D
TI SYNTHESES, STRUCTURES, AND PROPERTIES OF METHANOFULLERENES
SO CHEMICAL SOCIETY REVIEWS
LA English
DT Review
ID BUCKMINSTERFULLERENE C60; FULLERENE DERIVATIVES; VALENCE TAUTOMERISM;
   C-60; CHEMISTRY; FULLEROIDS; SPECTROSCOPY; INHIBITION; EPOXIDE; ADDUCTS
AB The chemistry of the fullerenes has been extensively explored - this review focuses specifically on the methanofullerenes. A comprehensive coverage of the known methanofullerene syntheses is presented. This is followed by a discussion of the electronic structure of the methanofullerenes which is based on experimental and computational studies. Lastly, we discuss the further functionalization of the methanofullerenes and their possible applications in materials and biomedical sciences.
RP DIEDERICH, F (reprint author), ETH ZURICH,ORGAN CHEM LAB,UNIV STR 16,CH-8092 ZURICH,SWITZERLAND.
RI Isaacs, Lyle/B-4472-2009
OI Isaacs, Lyle/0000-0002-4079-332X
CR AN YZ, 1994, J ORG CHEM, V59, P2927, DOI 10.1021/jo00090a006
   ANDERSON HL, 1994, IN PRESS ANGEW CHEM, V33
   ARBOGAST JW, 1991, J PHYS CHEM-US, V95, P11, DOI 10.1021/j100154a006
   ARNZ R, 1991, ANGEW CHEM INT EDIT, V30, P683, DOI 10.1002/anie.199106831
   BALCH AL, 1991, INORG CHEM, V30, P3980, DOI 10.1021/ic00021a003
   Billups W. E., 1993, BUCKMINSTERFULLERENE
   BINGEL C, 1993, CHEM BER-RECL, V126, P1957, DOI 10.1002/cber.19931260829
   CREEGAN KM, 1992, J AM CHEM SOC, V114, P1103, DOI 10.1021/ja00029a058
   DIEDERICH F, 1992, ACCOUNTS CHEM RES, V25, P119, DOI 10.1021/ar00015a004
   DIEDERICH F, 1991, SCIENCE, V252, P548, DOI 10.1126/science.252.5005.548
   DIEDERICH F, 1994, J CHEM SOC PERK T 2, P391, DOI 10.1039/p29940000391
   DIEDERICH F, 1994, NATURE, V369, P199, DOI 10.1038/369199a0
   DIXON DA, 1992, J PHYS CHEM-US, V96, P6107, DOI 10.1021/j100194a001
   ELEMES Y, 1992, ANGEW CHEM INT EDIT, V31, P351, DOI 10.1002/anie.199203511
   FAGAN PJ, 1991, SCIENCE, V252, P1160, DOI 10.1126/science.252.5009.1160
   FRIEDMAN SH, 1993, J AM CHEM SOC, V115, P6506, DOI 10.1021/ja00068a005
   FRYDMAN L, 1990, J AM CHEM SOC, V112, P6472, DOI 10.1021/ja00174a003
   GUNTHER H, 1973, ANGEW CHEM INT EDIT, V12, P570, DOI 10.1002/anie.197305701
   GUNTHER H, 1975, PURE APPL CHEM, V44, P807, DOI 10.1351/pac197544040807
   GUNTHER H, 1970, TETRAHEDRON LETT, P5173
   HADDON RC, 1993, SCIENCE, V261, P1545, DOI 10.1126/science.261.5128.1545
   HAWKINS JM, 1990, J ORG CHEM, V55, P6250, DOI 10.1021/jo00313a009
   HIRSCH A, 1994, ANGEW CHEM INT EDIT, V33, P437, DOI 10.1002/anie.199404371
   HIRSCH A, 1993, ANGEW CHEM INT EDIT, V32, P1138, DOI 10.1002/anie.199311381
   HOFFMANN R, 1970, TETRAHEDRON LETT, P2907
   ISAACS L, 1993, HELV CHIM ACTA, V76, P1231, DOI 10.1002/hlca.19930760310
   ISAACS L, 1993, HELV CHIM ACTA, V76, P2454, DOI 10.1002/hlca.19930760705
   KRATSCHMER W, 1990, NATURE, V347, P354, DOI 10.1038/347354a0
   KROTO HW, 1987, NATURE, V329, P529, DOI 10.1038/329529a0
   KROTO HW, 1985, NATURE, V318, P162, DOI 10.1038/318162a0
   MATSUZAWA N, 1992, J PHYS CHEM-US, V96, P7594, DOI 10.1021/j100198a021
   NALWA HS, 1993, ADV MATER, V5, P341, DOI 10.1002/adma.19930050504
   OSTERODT J, 1993, CHEM BER-RECL, V126, P2331, DOI 10.1002/cber.19931261023
   PRATO M, 1993, J AM CHEM SOC, V115, P7876, DOI 10.1021/ja00070a043
   PRATO M, 1993, J ORG CHEM, V58, P5578, DOI 10.1021/jo00073a004
   PRATO M, 1993, J AM CHEM SOC, V115, P8479, DOI 10.1021/ja00071a080
   RAGHAVACHARI K, 1993, CHEM PHYS LETT, V209, P223, DOI 10.1016/0009-2614(93)80097-9
   SHI S, 1992, J AM CHEM SOC, V114, P10656, DOI 10.1021/ja00052a083
   SIJBESMA R, 1993, J AM CHEM SOC, V115, P6510, DOI 10.1021/ja00068a006
   SKIEBE A, 1994, J CHEM SOC CHEM COMM, P335, DOI 10.1039/c39940000335
   SMITH AB, 1993, J AM CHEM SOC, V115, P5829, DOI 10.1021/ja00066a063
   SUZUKI T, 1992, J AM CHEM SOC, V114, P7301, DOI 10.1021/ja00044a055
   SUZUKI T, 1992, J AM CHEM SOC, V114, P7300, DOI 10.1021/ja00044a054
   SUZUKI T, 1991, SCIENCE, V254, P1186, DOI 10.1126/science.254.5035.1186
   TAYLOR R, 1992, J CHEM SOC PERK T 2, P3, DOI 10.1039/p29920000003
   TAYLOR R, 1993, NATURE, V363, P685, DOI 10.1038/363685a0
   TAYLOR R, 1991, TETRAHEDRON LETT, V32, P3731, DOI 10.1016/S0040-4039(00)79780-2
   TAYLOR R, 1993, PHILOS T ROY SOC A, V343, P87, DOI 10.1098/rsta.1993.0043
   TOKUYAMA H, 1993, J AM CHEM SOC, V115, P7918, DOI 10.1021/ja00070a064
   TOKUYAMA H, 1993, TETRAHEDRON LETT, V34, P7429, DOI 10.1016/S0040-4039(00)60144-2
   TSUDA M, 1993, TETRAHEDRON LETT, V34, P6911, DOI 10.1016/S0040-4039(00)91828-8
   VASELLA A, 1992, ANGEW CHEM INT EDIT, V31, P1388, DOI 10.1002/anie.199213881
   VOGEL E, 1980, ISRAEL J CHEM, V20, P215
   VOGEL E, 1993, PURE APPL CHEM, V65, P143, DOI 10.1351/pac199365010143
   VOGEL E, 1982, ANGEW CHEM S, P1882
   VOGEL E, 1969, PURE APPL CHEM, V20, P237
   VOGEL E, 1967, SPEC PUBL CHEM SOC, V21, P113
   WILSON SR, 1993, J CHEM SOC CHEM COMM, P784, DOI 10.1039/c39930000784
   WOOLEY KL, 1993, J AM CHEM SOC, V115, P9836, DOI 10.1021/ja00074a075
   WUDL F, 1992, ACCOUNTS CHEM RES, V25, P157, DOI 10.1021/ar00015a009
NR 60
TC 181
Z9 181
U1 0
U2 39
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK MILTON ROAD, CAMBRIDGE, CAMBS, ENGLAND
   CB4 4WF
SN 0306-0012
J9 CHEM SOC REV
JI Chem. Soc. Rev.
PD AUG
PY 1994
VL 23
IS 4
BP 243
EP 255
DI 10.1039/cs9942300243
PG 13
WC Chemistry, Multidisciplinary
SC Chemistry
GA PH102
UT WOS:A1994PH10200003
DA 2018-10-20
ER

PT J
AU KENNEDY, JP
AF KENNEDY, JP
TI NEW BIOMATERIALS BY CARBOCATIONIC PROCESSES
SO MACROMOLECULAR SYMPOSIA
LA English
DT Article; Proceedings Paper
CT 11th International Symposium on Cationic Polymerization and Related
   Ionic Processes
CY JUL 05-08, 1993
CL BOROVETS, BULGARIA
SP INT UNION PURE & APPL CHEM, BULGARIAN ACAD SCI, INST POLYM, NATL SCI FDN USA, TECHNOL UNIV, BOURGAS, NEFTOCHIM CO, BOURGAS, NEOCHIM, DIMITROVGRAD, BANK ECON PROJECTS MINERALBANK, ENGN PLAST EVSTATIEV, SOFIA
ID TOUGHENED POLY(METHYL METHACRYLATE); L-PIB NETWORKS
AB Well-defined macromolecular composites have been prepared by living carbocationic polymerization of isobutylene in combination with other conventional techniques.  The products were designed for biomedical uses as 1) intervertebral disc replacement, 2) improved impact- and fatigue- resistant bone cements, 3) delayed drug release reservoirs, and 4) small diameter nonthrombogenic vascular grafts.  The syntheses are out-lined, and the novelty, main characteristics and properties of these unique materials are summarized.  The era of designed biomaterials is upon us.
RP KENNEDY, JP (reprint author), UNIV AKRON,INST POLYMER SCI,AKRON,OH 44325, USA.
CR ANDERSON JM, 1991, ARTIFICIAL HEART, P45
   CHEN D, 1988, J MACROMOL SCI CHEM, VA25, P389, DOI 10.1080/00222338808053376
   CHEN D, 1989, J BIOMED MATER RES, V23, P1327, DOI 10.1002/jbm.820231109
   Cooper SL, 1982, ADV CHEM SER, V199
   ISHIHARA K, 1984, POLYM J, V16, P625, DOI 10.1295/polymj.16.625
   IVAN B, 1990, POLYM PREPRINTS, V31, P215
   IVAN B, 1990, POLYM PREPR, V31, P217
   Kennedy J. P., 1992, DESIGNED POLYM CARBO
   KENNEDY JP, 1991, J MACROMOL SCI CHEM, VA28, P209, DOI 10.1080/00222339108052096
   KENNEDY JP, 1993, MACROMOLECULES, V26, P567, DOI 10.1021/ma00056a002
   KENNEDY JP, 1983, POLYM BULL, V10, P146
   KENNEDY JP, 1993, J BIOMAT SCI-POLYM E, V4, P1
   KENNEDY JP, 1993, Patent No. 7854421
   KESZLER B, 1993, UNPUB
   KESZLER B, 1992, UNPUB
   KESZLER B, 1992, POLYM B, V29, P689
   KESZLER B, IN PRESS J CONTROLLE
   Kost J, 1986, HYDROGELS MED PHARM, V3, P95
   KYU T, 1993, MACROMOLECULES, V26, P572, DOI 10.1021/ma00056a003
   LANDER LM, 1993, POLYM PREPR, V34, P606
   MACKEY PW, 1991, THESISU AKRON
   Merril EW, 1987, HYDROGELS MED PHARM, V3, P1
   PAPPAS NA, 1987, HYDROGELS MED PHARM, V3, P109
   REFOJO MF, 1980, SYNTHETIC BIOMEDICAL, P171
   SHALABY SW, 1986, POLYM BIOMATERIALS, P323
   STANLEY JC, 1991, VASCULAR SURGERY COM, P275
   Tighe B.J., 1987, HYDROGELS MED PHARM, P53
   VOGLER EA, 1992, LANGMUIR, V8, P2013, DOI 10.1021/la00044a023
   WICHTERLE O, 1960, NATURE, V185, P117, DOI 10.1038/185117a0
   ZIATS NP, 1988, BIOMATERIALS, V9, P5, DOI 10.1016/0142-9612(88)90063-4
NR 30
TC 14
Z9 14
U1 0
U2 0
PU HUTHIG & WEPF VERLAG
PI BASEL
PA AUF DEM WOLF 4 FX#001-41-61-317-94-11, CH-4052 BASEL, SWITZERLAND
SN 1022-1360
J9 MACROMOL SYMP
JI Macromol. Symp.
PD AUG
PY 1994
VL 85
BP 79
EP 96
DI 10.1002/masy.19940850107
PG 18
WC Polymer Science
SC Polymer Science
GA PF834
UT WOS:A1994PF83400006
DA 2018-10-20
ER

PT J
AU LIN, JC
   WANG, YL
   HARIMAN, RJ
AF LIN, JC
   WANG, YL
   HARIMAN, RJ
TI COMPARISON OF POWER DEPOSITION PATTERNS PRODUCED BY MICROWAVE AND
   RADIO-FREQUENCY CARDIAC ABLATION CATHETERS
SO ELECTRONICS LETTERS
LA English
DT Article
DE SAR (BIOLOGICAL); BIOMEDICAL ELECTRONICS
AB Transcatheter microwave and radio frequency (RF) electrodes are used for the ablative treatment of cardiac arrhythmias. The authors compare the power deposition patterns of microwave antennas and RF electrodes in saline phantoms of biological material. The decrease in power deposition as a function of distance away from the electrode is nearly exponential for RF and is considerably steeper than microwave antennas. These results suggest that microwave antennas are capable of heating a larger volume and thus creating a greater lesion than RF.
C1 EDWARD HINES VET ADM MED CTR,DEPT MED,HINES,IL 60141.
RP LIN, JC (reprint author), UNIV ILLINOIS,DEPT ELECT ENGN,M-C 154,851 S MORGAN ST,CHICAGO,IL 60607, USA.
CR HOYT RH, 1986, J APPL CARDIOL, V1, P469
   HUANG SK, 1987, J AM COLL CARDIOL, V9, P349, DOI 10.1016/S0735-1097(87)80388-1
   LANGBERG JJ, 1991, PACE, V4, P2105
   LANGBERG JJ, 1990, PACE, V13, P1241
   Lin J. C., 1993, Chinese Journal of Medical and Biological Engineering, V13, P293
   LIN JC, 1990, EMERGING ELECTROMAGN, P125
NR 6
TC 19
Z9 20
U1 0
U2 2
PU IEE-INST ELEC ENG
PI HERTFORD
PA MICHAEL FARADAY HOUSE SIX HILLS WAY STEVENAGE, HERTFORD, ENGLAND SG1 2AY
SN 0013-5194
J9 ELECTRON LETT
JI Electron. Lett.
PD JUN 9
PY 1994
VL 30
IS 12
BP 922
EP 923
DI 10.1049/el:19940682
PG 2
WC Engineering, Electrical & Electronic
SC Engineering
GA NV160
UT WOS:A1994NV16000002
DA 2018-10-20
ER

PT J
AU PARKER, TL
   PARKER, KL
   MCCOLL, IR
   GRANT, DM
   WOOD, JV
AF PARKER, TL
   PARKER, KL
   MCCOLL, IR
   GRANT, DM
   WOOD, JV
TI THE BIOCOMPATIBILITY OF LOW-TEMPERATURE DIAMOND-LIKE CARBON-FILMS - A
   TRANSMISSION ELECTRON-MICROSCOPY, SCANNING ELECTRON-MICROSCOPY AND
   CYTOTOXICITY STUDY
SO DIAMOND AND RELATED MATERIALS
LA English
DT Article; Proceedings Paper
CT Diamond Films 93
CY SEP 20-24, 1993
CL ALBUFEIRA, SPAIN
AB Preliminary studies have shown that diamond-like carbon (DLC) coatings can be adherent on a range of substrate materials, resistant to wear and non-toxic to cells in vitro. This has led to the question of the possible biomedical application of DLC-coated materials, particularly in the field of implantation surgery. Assessment of the biocompatibility of implanted material requires two questions to be addressed: (1) is the implanted material toxic to cell growth, and (2) what is the nature of the cell-DLC layer interaction? In this study we show, by the Kenacid Blue cytotoxicity test, that cells grown on DLC-coated PCF membranes exhibit an initial increased attachment to the carbon substrate, and thereafter exhibit a normal growth rate over the 3-day test periods compared with cells grown on uncoated polystyrene. Scanning electron microscopy shows these cells possess characteristics typical of normal cell attachment and growth. Cells were grown on DLC-coated PCF membranes to facilitate examination of the cell-DLC coating interface by transmission electron microscopy. These results show that cells grown on both DLC-coated and non-coated membranes presented normal morphological characteristics of attachment and growth. These findings indicate that the DLC coating is non-toxic in vitro and sustains normal cell growth.
C1 UNIV NOTTINGHAM,DEPT MAT ENGN & MAT DESIGN,NOTTINGHAM NG7 2RD,ENGLAND.
RP PARKER, TL (reprint author), UNIV NOTTINGHAM,DEPT HUMAN MORPHOL,UNIV PK,NOTTINGHAM NG7 2RD,ENGLAND.
OI Grant, David/0000-0002-6786-7720
CR CLOTHIER R H, 1987, Molecular Toxicology, V1, P571
   MCCOLL IR, 1993, DIAM RELAT MATER, V3, P83
NR 2
TC 45
Z9 46
U1 0
U2 2
PU ELSEVIER SCIENCE SA LAUSANNE
PI LAUSANNE 1
PA PO BOX 564, 1001 LAUSANNE 1, SWITZERLAND
SN 0925-9635
J9 DIAM RELAT MATER
JI Diam. Relat. Mat.
PD JUN
PY 1994
VL 3
IS 8
BP 1120
EP 1123
DI 10.1016/0925-9635(94)90104-X
PG 4
WC Materials Science, Multidisciplinary; Materials Science, Coatings &
   Films; Physics, Applied; Physics, Condensed Matter
SC Materials Science; Physics
GA NR554
UT WOS:A1994NR55400008
DA 2018-10-20
ER

PT J
AU TU, R
   SHEN, SH
   LIN, D
   HATA, C
   THYAGARAJAN, K
   NOISHIKI, Y
   QUIJANO, RC
AF TU, R
   SHEN, SH
   LIN, D
   HATA, C
   THYAGARAJAN, K
   NOISHIKI, Y
   QUIJANO, RC
TI FIXATION OF BIOPROSTHETIC TISSUES WITH MONOFUNCTIONAL AND
   MULTIFUNCTIONAL POLYEPOXY COMPOUNDS
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
ID COLLAGEN; GRAFT
AB Collagen from a native tissue is fixed with a polyepoxy compound (PC) for use as a new biologic prosthetic material. Prior studies have shown that this biomaterial has comparable properties with collagen fixed with glutaraldehyde (GA), and thus has great promise for biomedical applications. A prior kinetic study indicated that the reaction between the functional groups of collagen and the multifunctional epoxy EX-313 is a 2.5th-order reaction. The purpose of this study was to understand the mechanism of the amino acid-PC reactions in a fixation process. Bovine arteries were fixed with a monofunctional PC (EX-131) and a multifunctional PC (EX-313) as a function of fixation time. A sequential fixation with a second fixative was used to identify the available remaining reactive sites from a prior fixation. The denaturation temperature (T-d) was measured on each sample. Because the denaturation temperature is a direct indication of crosslinking of individual amino acids with the fixative, the increase in T-d of a subsequent fixation may be indicative of the available remaining amino acids. The fixation index was measured on each sample to reflect the increase of fixation completion in a sequential fixation process. The fixation index and crosslink data also revealed that the reactive amino acids for EX-131 and EX-313 may not be exactly the same. The data in this study suggest that a monofunctional fixative can pre-react with the amino acids of collagen to effectively block further fixation of collagen with a second fixative. This amino acid masking may be associated with collagen branching. Collagen branching and its effect on denaturation temperature are described. (C) 1994 John Wiley & Sons, Inc.
C1 BAXTER EDWARDS CVS DIV,IRVINE,CA.
   YOKOHAMA CITY UNIV,YOKOHAMA 236,JAPAN.
RP TU, R (reprint author), TU BIOSCI LAB,2151 PALERMO,TUSTIN,CA 92680, USA.
CR CARPENTIER A, 1969, J THORAC CARDIOV SUR, V58, P467
   DARDIK H, 1976, ANN SURG, V183, P252, DOI 10.1097/00000658-197603000-00006
   EYRE DR, 1984, ANNU REV BIOCHEM, V53, P717, DOI 10.1146/annurev.bi.53.070184.003441
   HATA C, 1992, ARTIF ORGANS, V16, P263, DOI 10.1111/j.1525-1594.1992.tb00307.x
   Hata C., 1992, International Journal of Artificial Organs, V15, P562
   IMAMURA E, 1988, JPN J ARTIF ORGANS, V17, P1101
   LEE JM, 1991, ARTIF ORGANS, V15, P303
   LOHRE J, 1991, ARTIF ORGANS, V15, P124
   MARCH J, 1985, ADV ORGANIC CHEM REA, P368
   MASUOKA M, 1985, LEATHER CHEM, V30, P223
   MCINTYRE J, 1991, T SOC BIOMATERIALS, V14, P119
   MCINTYRE J, 1992, ABSTR ASAIO, V21, P122
   MORRISON RT, 1986, ORGANIC CHEM, P548
   MURAYAMA Y, 1988, T AM SOC ART INT ORG, V34, P546
   NIMNI ME, 1988, COLLAGEN, V1, P1
   Nimni ME, 1988, COLLAGEN, VIII, P1
   NOIJIRI C, 1987, J THORAC CARDIOVASC, V93, P867
   NOISHIKI Y, 1986, T AM SOC ART INT ORG, V32, P114
   Noishiki Y, 1989, U. S. Patent, Patent No. [4,806,595, 4806595]
   Rosenberg D., 1978, VASCULAR GRAFTS, P261
   SABATINI DD, 1963, J CELL BIOL, V17, P19, DOI 10.1083/jcb.17.1.19
   SAWYER PN, 1983, VASCULAR GRAFTING CL, P331
   SHECHTER L, 1956, IND ENG CHEM, V48, P86, DOI 10.1021/ie50553a028
   SUMA H, 1990, TEX HEART I J, V17, P103
   Sung H. W., 1992, International Journal of Artificial Organs, V15, P562
   SUNG HW, 1992, ARTIF ORGANS, V16, P485, DOI 10.1111/j.1525-1594.1992.tb00328.x
   Tanzer M. L., 1976, BIOCH COLLAGEN, P137
   TU R, 1993, J BIOMED MATER RES, V27, P3, DOI 10.1002/jbm.820270103
   TU R, 1993, JUL ESAO ISAO M AMST
   TU R, 1991, 17TH T ANN M SOC BIO, P163
   TU R, 1991, ABSTR ASAIO, V114
   TU R, 1991, T AM SOC ART INT ORG, V37, P470
   Tu Roger, 1992, International Journal of Artificial Organs, V15, P548
   WAITE JH, 1981, CRC HDB BIOCH AGING
   Yamauchi M., 1988, COLLAGEN, P157
NR 35
TC 55
Z9 57
U1 3
U2 5
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD JUN
PY 1994
VL 28
IS 6
BP 677
EP 684
DI 10.1002/jbm.820280604
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA NL112
UT WOS:A1994NL11200003
PM 8071378
DA 2018-10-20
ER

PT J
AU CERRAI, P
   TRICOLI, M
   LELLI, L
   GUERRA, GD
   DELGUERRA, RS
   CASCONE, MG
   GIUSTI, P
AF CERRAI, P
   TRICOLI, M
   LELLI, L
   GUERRA, GD
   DELGUERRA, RS
   CASCONE, MG
   GIUSTI, P
TI BLOCK-COPOLYMERS OF L-LACTIDE AND POLY(ETHYLENE GLYCOL) FOR BIOMEDICAL
   APPLICATIONS
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article; Proceedings Paper
CT 1993 Conference of the European-Society-for-Biomaterials
CY 1993
CL DAVOS, SWITZERLAND
SP EUROPEAN SOC BIOMAT
ID EPSILON-CAPROLACTONE; POLYMERIZATION
AB Poly (L-lactide)-poly (oxyethylene)-poly (L-lactide) block copolymers obtained in bulk, by a ring opening mechanism, from poly(ethylene glycol)s (PEG)s and L-lactide (LA), at 120-140 degrees C, in the absence of added catalysts are described. By using PEGs with different molecular masses, 3000 and 35 000, respectively, and varying the initial molar ratio LA to PEG, two series of copolymers with different molecular masses, relative length of blocks and hydrophilicity were obtained. Physico-chemical characterization of the copolymers had been previously performed. The morphological characteristics of the copolymers were investigated by means of X-ray diffractometry, optical and scanning electron microscopy. The biological properties of the materials were determined by evaluating their cytotoxicity, cytocompatibility, hemocompatibility and degradability using different standard tests. The results obtained indicate that the block copolymers synthesized may be useful for biomedical applications, in particular as resorbable drug vehicles. The materials are brittle and their mechanical properties are not appropriate for implant devices.
C1 CNR,IST FISIOL CLIN,I-56126 PISA,ITALY.
   UNIV PISA,DIPARTIMENTO INGN CHIM,I-56126 PISA,ITALY.
RP CERRAI, P (reprint author), CNR,CTR STUDI PROC IONICI POLIMERIZZAZIONE & PROP FIS,VIA DIOTISALVI 2,I-56126 PISA,ITALY.
CR CERRAI P, 1989, POLYMER, V30, P338, DOI 10.1016/0032-3861(89)90126-2
   CERRAI P, 1993, MAKROMOL CHEM-RAPID, V14, P529
   CERRAI P, 1993, J MATER SCI-MATER M, V5, P33
   CHRISTENSEN U, 1980, THROMB HAEMOSTASIS, V43, P169
   DELGUERRA RS, 1993, ALTERNATIVES LABORAT, V21, P907
   DENG XM, 1990, J POLYM SCI POL LETT, V28, P411, DOI 10.1002/pol.1990.140281303
   GIUSTI P, 1988, PROGR BIOMED ENG, V5, P51
   GUERRA GD, 1993, J BIOMAT SCI-POLYM E, V4, P643, DOI 10.1163/156856293X00852
   JEDLINSKI Z, 1993, MAKROMOL CHEM, V194, P1681
   KIMURA Y, 1989, POLYMER, V30, P1342, DOI 10.1016/0032-3861(89)90058-X
   KRICHELDORF HR, 1993, MAKROMOL CHEM, V194, P463
   ROZENBERG BA, 1992, MAKROMOL CHEM-M SYMP, V60, P177, DOI 10.1002/masy.19920600116
   ZHU KJ, 1990, J APPL POLYM SCI, V39, P1, DOI 10.1002/app.1990.070390101
NR 13
TC 73
Z9 74
U1 4
U2 11
PU CHAPMAN HALL LTD
PI LONDON
PA 2-6 BOUNDARY ROW, LONDON, ENGLAND SE1 8HN
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JUN-JUL
PY 1994
VL 5
IS 6-7
BP 308
EP 313
DI 10.1007/BF00058953
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA PL066
UT WOS:A1994PL06600002
DA 2018-10-20
ER

PT J
AU TANZI, MC
   VERDERIO, P
   LAMPUGNANI, MG
   RESNATI, M
   DEJANA, E
   STURANI, E
AF TANZI, MC
   VERDERIO, P
   LAMPUGNANI, MG
   RESNATI, M
   DEJANA, E
   STURANI, E
TI CYTOTOXICITY OF SOME CATALYSTS COMMONLY USED IN THE SYNTHESIS OF
   COPOLYMERS FOR BIOMEDICAL USE
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article; Proceedings Paper
CT 1993 Conference of the European-Society-for-Biomaterials
CY 1993
CL DAVOS, SWITZERLAND
SP EUROPEAN SOC BIOMAT
AB The cytotoxicity of four catalysts commonly used for the synthesis of copolymers for biomedical use, such as segmented polyurethanes, was evaluated towards two types of cells, the first being the well-characterized cell line Swiss 3T3 mouse fibroblasts, the second the actual living system that faces any device in contact with blood, i.e. human endothelial cells (HEC). The catalysts were two tertiary aliphatic amines: TMBDA (tetramethylbutanediamine), and DABCO (1-4 diazo (2,2,2) octane); two alkyl tin compounds: DBTDL (dibutyl-tindilaurate), and SnOct (stannous octoate). Cytotoxicity tests were carried out by adding to the culture medium, after cell adhesion, different concentrations of each catalyst in dimethylsulphoxide, and keeping them in contact with the monolayer for 72 h. All the catalysts proved to be cytotoxic, although at different extent (in the order: DABCO < TMBDA < SnOct < DBTDL); their dose inhibiting 50% of cell growth (IC50) came out to be lower for 3T3 fibroblasts than for HEC, with the exception of DBTDL, which showed a similar toxicity for both the cell fines. As an example, the cytotoxicity of a polyurethane-amide, laboratory synthesized with DBTDL as catalysts, was checked with fibroblasts. By using both the method of the extract, and that of the direct contact (through a microporous membrane), a moderate to severe cell growth inhibition, related to the Sn content in the material, was observed.
C1 IST RIC FARMACOL MARIO NEGRI,MILAN,ITALY.
   UNIV MILAN,DIPARTIMENTO FISIOL & BIOCHIM GEN,MILAN,ITALY.
RP TANZI, MC (reprint author), POLITECN MILAN,DIPARTIMENTO BIOINGN,I-20133 MILAN,ITALY.
RI Verderio, Paolo/B-5034-2017; Tanzi, Maria Cristina/I-4620-2013
OI Verderio, Paolo/0000-0002-9231-1281; Tanzi, Maria
   Cristina/0000-0002-4913-6633; Lampugnani, Maria
   Grazia/0000-0002-4802-7064
CR BRAMBILLA R, 1991, BIOCHEM J, V278, P447, DOI 10.1042/bj2780447
   COHN D, 1990, CLIN IMPLANT MATER, V9, P473
   HAYES WJ, 1980, HDB PESTICIDE TOXICO, V2, P537
   LELAH M, 1986, POLYURETHANES MED, P24
   Reegen SL, 1971, ADV URETHANE SCI TEC, V1, P1
   Sax N. I., 1989, DANGEROUS PROPERTIES, V3
   TANZI MC, 1992, BIOMATERIALS, V13, P425, DOI 10.1016/0142-9612(92)90162-H
   TANZI MC, 1991, 17TH P ANN M SOC BIO, P127
NR 8
TC 115
Z9 117
U1 0
U2 24
PU CHAPMAN HALL LTD
PI LONDON
PA 2-6 BOUNDARY ROW, LONDON, ENGLAND SE1 8HN
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JUN-JUL
PY 1994
VL 5
IS 6-7
BP 393
EP 396
DI 10.1007/BF00058971
PG 4
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA PL066
UT WOS:A1994PL06600020
DA 2018-10-20
ER

PT J
AU PETILLO, O
   PELUSO, G
   AMBROSIO, L
   NICOLAIS, L
   KAO, WJ
   ANDERSON, JM
AF PETILLO, O
   PELUSO, G
   AMBROSIO, L
   NICOLAIS, L
   KAO, WJ
   ANDERSON, JM
TI IN-VIVO INDUCTION OF MACROPHAGE IA-ANTIGEN (MHC CLASS-II) EXPRESSION BY
   BIOMEDICAL POLYMERS IN THE CAGE IMPLANT SYSTEM
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
ID ADJUVANT ACTIVITY; IMMUNE-RESPONSE; SURFACTANTS; LIPOPOLYSACCHARIDE;
   INVIVO; BIOCOMPATIBILITY; INFLAMMATION; FORMULATION; INVOLVEMENT;
   ANTIBODIES
AB Examination of the cellular components in the inflammatory exudate, which infiltrates subcutaneous cages, can be used to monitor the progress of an inflammatory response to an implanted material. Of particular interest is the study monocyte/macrophage infiltration into the implanted cages containing biomaterials, as macrophages may initiate a wide spectrum of responses upon interaction with a foreign material. In this study, the authors propose a technique using subcutaneous tissue cages in conjunction with cytofluorimetric analysis of exudate leukocytes to evaluate the monocyte/macrophage cell activation in response to different materials. The studies reported here used several materials (thermoplastic and elastomeric polymers) as the challenging agent, to demonstrate whether polymers, chemically different from each other, could differentially activate macrophages to carry out their proinflammatory role more effectively. The materials tested included: poly(etherurethane ureas) (PEUU A'), poly(etherurethane ureas) with a surface active additive, Methacrol(R), (PEUU C'), polymethylsiloxane (PDMS), polyetherimide, (PEI), and polyetheretherketone, (PEEK). For all the tested materials, the maximum numbers of exudate cells and of Ia-positive macrophages were found on day 7, although the entity of the cell increase was associated with the material used for the implant. Similarly, the percentage of Ia-positive macrophages varied according to the specific polymer present in the cages after 7 days. By day 14 the percentage of Ia-positive macrophages decreased with individual exudates showing 19-32% Ia-positive cells depending on the different type of material. Only in the case of PDMS did the percentage of Ia-positive macrophages remain the same as compared with control empty cage macrophages. (C) 1994 John Wiley and Sons, Inc.
C1 ARCO FELICE,CNR,INST PROT BIOCHEM & ENZYMOL,I-80072 NAPLES,ITALY.
   UNIV NAPLES,DEPT MAT & PROD ENGN,I-80125 NAPLES,ITALY.
   CNR,INST COMPOSITE MAT TECHNOL,I-80125 NAPLES,ITALY.
   CASE WESTERN RESERVE UNIV,INST PATHOL,CLEVELAND,OH 44106.
OI AMBROSIO, LUIGI/0000-0002-8367-2405
FU NHLBI NIH HHS [HL-25239, HL-33849]
CR ALLISON AC, 1986, J IMMUNOL METHODS, V95, P157, DOI 10.1016/0022-1759(86)90402-3
   ANDERSON JM, 1988, ASAIO, V11, P101
   BEHBEHANI K, 1985, J IMMUNOL, V134, P2047
   BEHBEHANI K, 1981, CLIN IMMUNOL IMMUNOP, V198, P190
   BELLER DI, 1980, J IMMUNOL, V124, P1426
   BRUNSTEDT MR, 1993, J BIOMED MATER RES, V27, P255, DOI 10.1002/jbm.820270216
   BRUNSTEDT MR, 1993, J BIOMED MATER RES, V27, P367, DOI 10.1002/jbm.820270310
   BYARS NE, 1987, VACCINE, V5, P223, DOI 10.1016/0264-410X(87)90105-8
   DIJKSTRA CD, 1985, IMMUNOLOGY, V54, P589
   EZEKOWITZ RAB, 1981, J EXP MED, V154, P60, DOI 10.1084/jem.154.1.60
   FUKUMOTO T, 1982, EUR J IMMUNOL, V12, P237, DOI 10.1002/eji.1830120313
   HAMILTON TA, 1987, IMMUNOL TODAY, V8, P151, DOI 10.1016/0167-5699(87)90145-9
   HUNTER R, 1981, J IMMUNOL, V127, P1244
   HUNTER RL, 1984, J IMMUNOL, V133, P3167
   HUNTER RL, 1986, SCAND J IMMUNOL, V23, P287, DOI 10.1111/j.1365-3083.1986.tb01970.x
   JOHNSTON RB, 1988, NEW ENGL J MED, V318, P747, DOI 10.1056/NEJM198803243181205
   KADAR L, 1986, J IMMUNOL, V136, P3166
   KASAMA T, 1992, INT ARCH ALLERGY IMM, V97, P130, DOI 10.1159/000236108
   MARCHANT R, 1983, J BIOMED MATER RES, V17, P301, DOI 10.1002/jbm.820170209
   MATIS LA, 1983, P NATL ACAD SCI-BIOL, V80, P6019, DOI 10.1073/pnas.80.19.6019
   NATION JL, 1983, STAIN TECHNOL, V58, P347, DOI 10.3109/10520298309066811
   PELUSO G, 1991, J BIOMED MATER RES, V25, P637, DOI 10.1002/jbm.820250507
   REMES A, 1992, BIOMATERIALS, V13, P731, DOI 10.1016/0142-9612(92)90010-L
   REMICK DG, 1988, AM J PATHOL, V131, P298
   ROBEY WG, 1986, P NATL ACAD SCI USA, V83, P7023, DOI 10.1073/pnas.83.18.7023
   SNIPPE H, 1981, INT ARCH ALLER A IMM, V65, P390, DOI 10.1159/000232780
   STRASSMANN G, 1985, CELL IMMUNOL, V94, P65
   UNANUE ER, 1984, ANNU REV IMMUNOL, V2, P395, DOI 10.1146/annurev.immunol.2.1.395
   UNANUE ER, 1987, SCIENCE, V236, P551, DOI 10.1126/science.2437650
   VONRECUM AF, 1986, HDB BIOMATERIALS EVA
   WARREN KS, 1976, ANN NY ACAD SCI, V278, P7, DOI 10.1111/j.1749-6632.1976.tb47011.x
   WENTWORTH PA, 1989, INFECT IMMUN, V57, P2028
   WU Y, 1991, J BIOMED MATER RES, V25, P725, DOI 10.1002/jbm.820250604
   ZIATS NP, 1988, BIOMATERIALS, V9, P5, DOI 10.1016/0142-9612(88)90063-4
   ZIEGLER HK, 1984, J IMMUNOL, V133, P1825
   ZIGTERMAN GJWJ, 1987, J IMMUNOL, V138, P220
NR 36
TC 43
Z9 43
U1 1
U2 15
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD MAY
PY 1994
VL 28
IS 5
BP 635
EP 646
DI 10.1002/jbm.820280514
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA NG210
UT WOS:A1994NG21000013
PM 8027104
DA 2018-10-20
ER

PT J
AU BRINKMAN, UAT
AF BRINKMAN, UAT
TI ONLINE SAMPLE TREATMENT FOR OR VIA COLUMN LIQUID-CHROMATOGRAPHY
SO JOURNAL OF CHROMATOGRAPHY A
LA English
DT Article; Proceedings Paper
CT 6th International Symposium on Handling of Environmental and Biological
   Samples in Chromatography
CY JUL 19-21, 1993
CL UNIV SURREY, GUILDFORD, ENGLAND
SP INT ASSOC ENVIRONM ANAL CHEM, CHROMATOG SOC
HO UNIV SURREY
ID POLYCYCLIC AROMATIC-HYDROCARBONS; CAPILLARY GAS-CHROMATOGRAPHY;
   TREATMENT COUPLED ONLINE; TRACE ENRICHMENT; PRE-COLUMN; BIOLOGICAL
   SAMPLES; MASS-SPECTROMETRY; PACKING MATERIALS; AMINO-ACIDS; PHASE
AB It is generally recognized that sample treatment often is the bottleneck in trace-lever organic analysis. As far as column liquid chromatography (LC) is concerned, the design, and commercialization, of on-line and fully automated precolumn/analytical column LC systems with diode-array UV or mass spectrometric detection is a distinct step towards solving the existing problems. Small precolumns that can be packed with sorbents of divergent selectivity, and also on-line (electro)dialysis modules, have been shown to perform well in many environmental and biomedical applications. In addition, it is noteworthy that LC or rather, LC-type, trace enrichment and clean-up on such precolumns are increasingly being used as an on-line treatment step for aqueous samples prior to capillary gas chromatographic analysis.
RP BRINKMAN, UAT (reprint author), FREE UNIV AMSTERDAM,DEPT ANALYT CHEM,DE BOELELAAN 1083,1081 HV AMSTERDAM,NETHERLANDS.
CR AERTS MML, 1988, J CHROMATOGR, V435, P97, DOI 10.1016/S0021-9673(01)82166-X
   AERTS MML, 1990, J CHROMATOGR, V500, P453, DOI 10.1016/S0021-9673(00)96085-0
   AGASOSTER T, 1991, J CHROMATOGR-BIOMED, V570, P99, DOI 10.1016/0378-4347(91)80204-P
   BAGHERI H, 1992, ANALUSIS, V20, P475
   BOOS KS, 1992, J CHROMATOGR, V600, P189, DOI 10.1016/0021-9673(92)85547-7
   BOURQUE AJ, 1991, J CHROMATOGR, V537, P123, DOI 10.1016/S0021-9673(01)88891-9
   BRINKMAN UAT, 1989, J CHROMATOGR-BIOMED, V492, P251, DOI 10.1016/S0378-4347(00)84471-0
   BRINKMAN UAT, 1987, CHROMATOGRAPHIA, V24, P190, DOI 10.1007/BF02688480
   BROUWER ER, 1990, CHROMATOGRAPHIA, V29, P415, DOI 10.1007/BF02261387
   BUCK RH, 1984, J CHROMATOGR, V315, P279, DOI 10.1016/S0021-9673(01)90745-9
   BULTERMAN AJ, 1993, HRC-J HIGH RES CHROM, V16, P397
   DEBETS AJJ, 1992, J CHROMATOGR, V600, P163, DOI 10.1016/0021-9673(92)85544-4
   DEBETS AJJ, 1990, CHROMATOGRAPHIA, V30, P361, DOI 10.1007/BF02328498
   DEKOK A, 1992, J CHROMATOGR, V623, P265
   DERUITER C, 1988, CHROMATOGRAPHIA, V26, P267, DOI 10.1007/BF02268165
   FARJAM A, 1988, J CHROMATOGR, V452, P419, DOI 10.1016/S0021-9673(01)81465-5
   FARJAM A, 1991, ANAL CHEM, V63, P2481, DOI 10.1021/ac00021a017
   FARJAM A, 1992, J CHROMATOGR, V589, P141, DOI 10.1016/0021-9673(92)80015-M
   FARJAM A, 1991, THESIS VRIJE U AMSTE, pCH1
   GAO C X, 1989, Biochromatography, V4, P224
   Grob K., 1991, LINE COUPLED LC GC
   HAGEN DF, 1990, ANAL CHIM ACTA, V236, P157, DOI 10.1016/S0003-2670(00)83309-7
   HOGENDOORN EA, 1993, J CHROMATOGR, V644, P307, DOI 10.1016/0021-9673(93)80713-I
   HOGENDOORN EA, 1993, THESIS FREE U AMSTER
   IRTH H, 1989, J CHROMATOGR-BIOMED, V491, P321, DOI 10.1016/S0378-4347(00)82850-9
   Kamp R.M., 1991, LC GC EUR, V4, P40
   Krull I.S., 1986, REACTION DETECTION L
   KWAKMAN PJM, 1992, CHROMATOGRAPHIA, V34, P4147
   LAI F, 1993, J PHARMACEUT BIOMED, V11, P117, DOI 10.1016/0731-7085(93)80131-J
   LOW KS, 1984, ANAL LETT, V17, P915
   MARIS FA, 1988, J CHROMATOGR, V445, P129, DOI 10.1016/S0021-9673(01)84514-3
   NIELEN MWF, 1985, ANAL CHEM, V57, P806, DOI 10.1021/ac00281a008
   NONDEK L, 1983, J CHROMATOGR, V282, P141, DOI 10.1016/S0021-9673(00)91598-X
   PINKERTON TC, 1991, J CHROMATOGR, V544, P13, DOI 10.1016/S0021-9673(01)83975-3
   SCHUSTER R, 1988, J CHROMATOGR-BIOMED, V431, P271, DOI 10.1016/S0378-4347(00)83096-0
   SIGVARDSON KW, 1984, J CHROMATOGR, V316, P507, DOI 10.1016/S0021-9673(00)96179-X
   SLOBODNIK J, 1993, J CHROMATOGR, V642, P359, DOI 10.1016/0021-9673(93)80099-T
   SLOBODNIK J, 1992, ANAL CHIM ACTA, V268, P55, DOI 10.1016/0003-2670(92)85248-5
   UNGER KK, 1991, CHROMATOGRAPHIA, V31, P507, DOI 10.1007/BF02262398
   VANDEMERBEL NC, 1993, J CHROMATOGR, V634, P1, DOI 10.1016/0021-9673(93)80308-U
   VANDERHORST FAL, 1990, J CHROMATOGR, V500, P443, DOI 10.1016/S0021-9673(00)96084-9
   VANHOUT PJM, 1993, EUROPEAN WATER POLLU, V3, P29
   VANZOONEN P, 1990, HRC-J HIGH RES CHROM, V13, P483
   VARGA GM, 1990, J CHROMATOGR, V523, P173
   VREULS JJ, 1991, CHROMATOGRAPHIA, V31, P113, DOI 10.1007/BF02274556
   VREULS JJ, IN PRESS J ASS OFFIC
   VREULS JJ, 1993, THESIS FREE U AMSTER
   WERKHOVENGOEWIE CE, 1981, ANAL CHEM, V53, P2072, DOI 10.1021/ac00236a029
   ZECH K, 1986, J CHROMATOGR, V353, P351, DOI 10.1016/S0021-9673(01)87105-3
   ZHOU FX, IN PRESS J CHROMATOG
NR 50
TC 61
Z9 61
U1 0
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0021-9673
J9 J CHROMATOGR A
JI J. Chromatogr. A
PD APR 15
PY 1994
VL 665
IS 2
BP 217
EP 231
DI 10.1016/0021-9673(94)85052-6
PG 15
WC Biochemical Research Methods; Chemistry, Analytical
SC Biochemistry & Molecular Biology; Chemistry
GA NH281
UT WOS:A1994NH28100002
PM 8205231
DA 2018-10-20
ER

PT J
AU DEFFONTAINESFOUREZ, M
   DEFFONTAINES, B
   CHICOT, D
   IOST, A
AF DEFFONTAINESFOUREZ, M
   DEFFONTAINES, B
   CHICOT, D
   IOST, A
TI MICROHARDNESS AND SPECTROSCOPY STUDIES OF SURFACE MODIFICATION OF
   TITANIUM-ALLOYS BY MELTED METAPHOSPHATES
SO THIN SOLID FILMS
LA English
DT Article; Proceedings Paper
CT Symposium on Ion Beam, Plasma, Laser and Thermally-Stimulated Deposition
   Processes, at the European-Materials-Research-Society 1993 Spring
   Conference
CY MAY 04-07, 1993
CL STRASBOURG, FRANCE
SP EUROPEAN MAT RES SOC
ID COATINGS; HARDNESS
AB A new method is proposed in order to improve the surface properties of titanium alloys used in biomedical applications. This paper considers the surface modification that appears after the reaction between metaphosphate glasses and titanium alloys (TA6V). The structural characterization of this material has been realized by several spectroscopic methods of investigation such as scanning electron microscopy, energy-dispersive X-ray analysis and wavelength-dispersive spectroscopy. Measurements of Vickers microhardness exhibit a correlation between the phosphorus profile and the evolution of hardness of the modified titanium alloy surface. The relative increase in the Vickers microhardness is about 65%. By application of the composite model, the absolute hardness of the coating was found to be HV0 = 550.
C1 ECOLE NATL SUPER ARTS & METIERS,CER LILLE,F-59046 LILLE,FRANCE.
RP DEFFONTAINESFOUREZ, M (reprint author), UNIV LITTORAL,CTR UNIV CITADELLE,CTR RECH ENVIRONNEMENT IND DUNKERQUE,BP 5526,F-59379 DUNKERQUE,FRANCE.
RI IOST, alain/D-8909-2011
OI IOST, alain/0000-0003-2185-4673; DEFFONTAINES,
   Benoit/0000-0001-5104-8264; Chicot, Didier/0000-0002-5203-3168
CR DEFFONTAINES B, 1992, P INT C RAMAN SPECTR
   DEFFONTAINES B, UNPUB
   DEFFONTAINES B, 1992, P INT S PHOSPHATES C
   DEGROOT K, 1987, CLIN RELAT RES, V225, P147
   DUCHEYNE P, 1985, J BIOMED MATER RES, V19, P273, DOI 10.1002/jbm.820190309
   DUCHEYNE P, 1990, BIOMATERIALS, V11, P244, DOI 10.1016/0142-9612(90)90005-B
   FARGES G, 1989, THIN SOLID FILMS, V181, P365, DOI 10.1016/0040-6090(89)90505-1
   JONSSON B, 1984, THIN SOLID FILMS, V114, P257, DOI 10.1016/0040-6090(84)90123-8
   RIVIERE JP, 1990, SURF COAT TECH, V42, P81, DOI 10.1016/0257-8972(90)90116-T
   Tabor D., 1986, ASTM STP, V889, P129
   Thomas A., 1987, Surface Engineering, V3, P117
   Vingsbo O., 1986, ASTM SPEC TECH PUBL, V889, P257
NR 12
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCIENCE SA LAUSANNE
PI LAUSANNE 1
PA PO BOX 564, 1001 LAUSANNE 1, SWITZERLAND
SN 0040-6090
J9 THIN SOLID FILMS
JI Thin Solid Films
PD APR 1
PY 1994
VL 241
IS 1-2
BP 230
EP 233
DI 10.1016/0040-6090(94)90431-6
PG 4
WC Materials Science, Multidisciplinary; Materials Science, Coatings &
   Films; Physics, Applied; Physics, Condensed Matter
SC Materials Science; Physics
GA NG663
UT WOS:A1994NG66300049
DA 2018-10-20
ER

PT J
AU ALLCOCK, HR
   PUCHER, SR
   SCOPELIANOS, AG
AF ALLCOCK, HR
   PUCHER, SR
   SCOPELIANOS, AG
TI POLY[(AMINO-ACID-ESTER)PHOSPHAZENES] - SYNTHESIS, CRYSTALLINITY, AND
   HYDROLYTIC SENSITIVITY IN SOLUTION AND THE SOLID-STATE
SO MACROMOLECULES
LA English
DT Article
ID POLYPHOSPHAZENES
AB Fifteen different poly[(amino acid ester)phosphazenes] were synthesized to study their crystalline character and hydrolysis behavior in the solution and solid states. The polyphosphazenes synthesized were poly[bis(methyl glycinat-N-yl)phosphazene], poly[bis(ethyl glycinat-N-yl)phosphazene], poly[bis(tert-butyl glycinat-N-yl)phosphazene], poly[bis(benzyl glycinat-N-yl)phosphazene], poly[bis(methyl alaninat-N-yl)phosphazene], poly[bis(ethyl alaninat-N-yl)phosphazene], poly[bis(tert-butyl alaninat-N-yl)phos-phazene], poly[bis(benzyl alaninat-N-yl)phosphazene], poly[bis(methyl valinat-N-yl)phosphazene], poly-[bis(ethyl valinat-N-yl)phosphazene], poly[bis(tert-butyl valinat-N-yl)phosphazene],poly[bis(benzyl valinat-N-yl)phosphazene], poly[bis(methyl phenylalaninat-N-yl)phosphazene], poly[bis(ethyl phenylalaninat-N-yl)phosphazene], and poly[bis(tert-butyl phenylalaninat-N-yl)phosphazene]. The fully-substituted polymers were obtained by treatment of poly(dichlorophosphazene) with a large excess of the appropriate amino acid ester. Several of these polymers were crystalline as measured by differential scanning calorimetry and by polarized optical microscopy. Hydrolysis studies were performed to estimate the rates of decomposition of the polymers and the duration over which the polymers maintained their structural integrity. The polymers are potential biomedical materials.
C1 ETHICON INC,A JOHNSON & JOHNSON CO,SOMERVILLE,NJ 08876.
RP ALLCOCK, HR (reprint author), PENN STATE UNIV,DEPT CHEM,UNIV PK,PA 16801, USA.
CR ALLCOCK HR, 1991, MACROMOLECULES, V24, P23, DOI 10.1021/ma00001a005
   ALLCOCK HR, 1977, MACROMOLECULES, V10, P824, DOI 10.1021/ma60058a020
   ALLCOCK HR, 1965, J AM CHEM SOC, V87, P4216, DOI 10.1021/ja01096a056
   ALLCOCK HR, 1985, CHEM ENG NEWS, V63, P22, DOI 10.1021/cen-v063n011.p022
   ALLCOCK HR, 1982, INORG CHEM, V21, P515, DOI 10.1021/ic00132a009
   ALLCOCK HR, 1988, MACROMOLECULES, V21, P1980, DOI 10.1021/ma00185a015
   DOMB AJ, 1990, J POLYM SCI, V21, P973
   ELEMA H, 1990, COLLOID POLYM SCI, V268, P1082, DOI 10.1007/BF01410673
   GROLLEMAN C W J, 1986, Journal of Controlled Release, V3, P143, DOI 10.1016/0168-3659(86)90075-1
   HOSKINS IA, 1991, SURG GYNECOL OBSTET, V172, P108
   LAURENCIN CT, 1987, J BIOMED MATER RES, V21, P1231, DOI 10.1002/jbm.820211006
   LAURENCIN CT, UNPUB J BIOM MAT RES
NR 12
TC 144
Z9 158
U1 0
U2 12
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036
SN 0024-9297
J9 MACROMOLECULES
JI Macromolecules
PD FEB 28
PY 1994
VL 27
IS 5
BP 1071
EP 1075
DI 10.1021/ma00083a001
PG 5
WC Polymer Science
SC Polymer Science
GA MZ653
UT WOS:A1994MZ65300001
DA 2018-10-20
ER

PT J
AU WU, HM
   OLIER, R
   JAFFREZICRENAULT, N
   CLECHET, P
   NYAMSI, A
   MARTELET, C
AF WU, HM
   OLIER, R
   JAFFREZICRENAULT, N
   CLECHET, P
   NYAMSI, A
   MARTELET, C
TI COVALENT IMMOBILIZATION OF GLUCOSE-OXIDASE ONTO GRAPHITIC ELECTRODES
SO ELECTROCHIMICA ACTA
LA English
DT Article
DE CARBON FIBER; GRAPHITE; CARBONACEOUS MATERIALS; ENZYME MODIFIED
   ELECTRODE; BIOSENSOR
ID CARBON ELECTRODES; ACTIVATED CARBON; ENZYME ELECTRODE; GLASSY-CARBON;
   CODEPOSITION; FIBERS
AB Graphitic substrates (plates and carbon fibre 7 mu m in diameter) have been used and characterized in order to obtain glucose sensitive electrodes. Preparation of such electrodes before enzymatic sensitization and after cleaning involves a specific electrochemical pretreatment of oxidation at +2.3 V/sce. Further covalent immobilization of glucose oxidase proceeds through a grafting between surface carboxyl group and a carbodiimide reagent Performances of enzymatic electrodes such as their stability up to two months make them well suited for further application in the biomedical field.
C1 ECOLE CENT LYON,PHYSICOCHIM INTERFACES LAB,CNRS,URA 404,F-69131 ECULLY,FRANCE.
   LAB TRIBOL & DYNAM SYST,CNRS,URA 855,F-69131 ECULLY,FRANCE.
CR BARBIER B, 1990, J ELECTROCHEM SOC, V137, P1757, DOI 10.1149/1.2086794
   Bardeletti G., 1991, BIOSENSOR PRINCIPLES, P7
   BARTON SS, 1975, CARBON, V13, P283, DOI 10.1016/0008-6223(75)90029-9
   BIANCO P, 1990, J ELECTROANAL CHEM, V293, P151, DOI 10.1016/0022-0728(90)80059-F
   BOURDILLON C, 1980, J AM CHEM SOC, V102, P4231, DOI 10.1021/ja00532a040
   BOWLING R, 1989, LANGMUIR, V5, P683, DOI 10.1021/la00087a022
   CESPUGLIO R, 1992, 14TH ANN INT C IEEE, P181
   CHO YK, 1979, BIOTECHNOL BIOENG, V21, P461, DOI 10.1002/bit.260210308
   CHO YK, 1978, BIOTECHNOL BIOENG, V20, P1651, DOI 10.1002/bit.260201011
   CHUN BW, 1992, CARBON, V30, P177, DOI 10.1016/0008-6223(92)90078-B
   CSOREGI E, 1993, ANAL CHIM ACTA, V273, P59, DOI 10.1016/0003-2670(93)80145-B
   DONG SJ, 1989, ELECTROANAL, V1, P99, DOI 10.1002/elan.1140010203
   ELLIOTT CM, 1976, ANAL CHEM, V48, P1247, DOI 10.1021/ac50002a046
   FITZER E, 1991, J ADHESION, V36, P139, DOI 10.1080/00218469108027068
   GREEN MJ, 1986, J CHEM SOC FARAD T 1, V82, P1237, DOI 10.1039/f19868201237
   GUILBAULT GG, 1973, ANAL CHIM ACTA, V64, P439, DOI 10.1016/S0003-2670(01)82476-4
   GUNASINGHAM H, 1989, ELECTROANAL, V1, P223, DOI 10.1002/elan.1140010306
   HENDJI AN, 1993, SENSOR ACTUAT B-CHEM, V15, P127
   PISHKO MV, 1991, ANAL CHEM, V63, P2268, DOI 10.1021/ac00020a014
   WANG J, 1992, ANAL CHEM, V64, P456, DOI 10.1021/ac00028a023
   WANG J, 1989, ELECTROANAL, V1, P151, DOI 10.1002/elan.1140010210
NR 21
TC 22
Z9 22
U1 1
U2 5
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
SN 0013-4686
J9 ELECTROCHIM ACTA
JI Electrochim. Acta
PD FEB
PY 1994
VL 39
IS 3
BP 327
EP 331
DI 10.1016/0013-4686(94)80070-7
PG 5
WC Electrochemistry
SC Electrochemistry
GA MU762
UT WOS:A1994MU76200002
DA 2018-10-20
ER

PT J
AU ISHIHARA, K
   TSUJI, T
   KUROSAKI, T
   NAKABAYASHI, N
AF ISHIHARA, K
   TSUJI, T
   KUROSAKI, T
   NAKABAYASHI, N
TI HEMOCOMPATIBILITY ON GRAFT-COPOLYMERS COMPOSED OF
   POLY(2-METHACRYLOYLOXYETHYL PHOSPHORYLCHOLINE) SIDE-CHAIN AND
   POLY(N-BUTYL METHACRYLATE) BACKBONE
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
ID PROTEIN ADSORPTION; 2-METHACRYLOYLOXYETHYL PHOSPHORYLCHOLINE;
   PHOSPHOLIPID POLYMERS; ALKYL METHACRYLATES; BLOOD COMPATIBILITY; HUMAN
   PLASMA; SURFACES; MEMBRANE
AB To improve the hemocompatibility on hydrophobic biomedical materials by a simple coating technique, graft: copolymers composed of a hydrophilic side chain with phospholipid polar groups and a hydrophobic backbone were synthesized. The hydrophilic chain had phospholipid polar groups, poly[2-methacryloyloxyethyl phosphorylcholine (MPC)], and the hydrophobic backbone was poly[n-butyl methacrylate (BMA)]. Because the graft copolymers obtained could dissolve in ethanol, they could be used as a coating material. When the poly(MPC-graft-BMA) was coated onto a poly(BMA) membrane, the composition of the MPC units on the surface was maintained in the bulk graft copolymer even after immersion in water. Protein adsorption on the membrane coated with the graft copolymer from human plasma detected by a gold-colloid labeled immunoassay was drastically decreased compared with that on glass and the original membrane. Moreover, blood cell adhesion, activation, and aggregation on the membrane after contact with human citrated whole blood were suppressed by the coating of the graft copolymer. These results clearly show that the poly(MPC-graft-BMA) is a suitable material for improving hemocompatibility on the biomedical devices because of its protein adsorption and cell adhesion resistant properties. (C) 1994 John Wiley and Sons, Inc.
C1 TOKYO INST POLYTECH,FAC ENGN,ATSUGI,KANAGAWA 24302,JAPAN.
RP ISHIHARA, K (reprint author), TOKYO MED & DENT UNIV,INST MED & DENT ENGN,CHIYODA KU,2-3-10 KANDA SURUGADAI,TOKYO,TOKYO 101,JAPAN.
CR AKISAWA T, 1989, T AM SOC ART INT ORG, V35, P333
   BAMFORD CH, 1992, VROMAN EFFECT
   Brash JL, 1991, BLOOD COMPATIBLE MAT, P3
   FUKUMOTO K, 1992, BIOMATERIALS, V13, P235
   HAYASHI K, 1985, KOBUNSHI RONBUNSHU, V42, P77, DOI 10.1295/koron.42.77
   IDE F, 1987, SURFACE MODIFICATION
   ISHIHARA K, 1989, KOBUNSHI RONBUNSHU, V46, P591, DOI 10.1295/koron.46.591
   ISHIHARA K, 1990, J BIOMED MATER RES, V24, P1069, DOI 10.1002/jbm.820240809
   ISHIHARA K, 1992, J BIOMED MATER RES, V26, P1543, DOI 10.1002/jbm.820261202
   ISHIHARA K, 1992, BIOMATERIALS, V13, P145, DOI 10.1016/0142-9612(92)90062-S
   ISHIHARA K, 1991, J BIOMED MATER RES, V25, P1397, DOI 10.1002/jbm.820251107
   ISHIHARA K, 1990, POLYM J, V22, P355, DOI 10.1295/polymj.22.355
   ISHIHARA K, IN PRESS J POLYM S A
   ISHIHARA K, 1991, SEITAI ZAIRYO, V9, P243
   LEE JH, 1989, J BIOMED MATER RES, V23, P351, DOI 10.1002/jbm.820230306
   LEE JH, 1990, BIOMATERIALS, V11, P455, DOI 10.1016/0142-9612(90)90058-X
   Ratner BD, 1979, J POLYM SCI POLYM S, V66, P363
   REMPP PF, 1984, ADV POLYM SCI, V58, P1
   Tsuruta T., 1989, MULTIPHASE BIOMEDICA
   UEDA T, 1992, POLYM J, V24, P1259, DOI 10.1295/polymj.24.1259
   UEDA T, 1991, J BIOMAT SCI-POLYM E, V3, P185
   YASUDA H, 1982, BIOMATERIALS, V3, P68, DOI 10.1016/0142-9612(82)90036-9
   ZIATS NP, 1990, J LAB CLIN MED, V116, P687
   ZIATS NP, 1991, CELL MATER, V1, P73
NR 24
TC 107
Z9 108
U1 1
U2 15
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD FEB
PY 1994
VL 28
IS 2
BP 225
EP 232
DI 10.1002/jbm.820280213
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA MT018
UT WOS:A1994MT01800012
PM 8207035
DA 2018-10-20
ER

PT J
AU HA, HF
AF HA, HF
TI AN OVERVIEW ON STUDY OF IMMOBILIZATION OF BIOACTIVE SPECIES AND DDS BY
   MEANS OF RADIATION TECHNOLOGY IN CHINA
SO JOURNAL OF CONTROLLED RELEASE
LA English
DT Article
DE RADIATION TECHNOLOGY; IMMOBILIZATION OF BIOACTIVE SPECIES; BIOMEDICAL
   APPLICATION; DRUG DELIVERY SYSTEM (DDS)
AB The present paper gives an overview on the research and application of immobilization of bioactive species and DDS by means of radiation technology that have been carried out in China recently. The following three parts are included in this paper: (1) radiation preparation of biomedical materials; (2) radiation immobilization of bioactive species; (3) DDS.
RP HA, HF (reprint author), BEIJING UNIV,DEPT TECH PHYS,BEIJING 100871,PEOPLES R CHINA.
CR COA J, 1991, J RAD RES RAD PROCES, V9, P219
   DU C, 1984, J RAD RES RAD PROCES, V2, P27
   GU JH, 1990, J RAD RES RAD PROCES, V8, P163
   HA HF, 1985, RADIAT PHYS CHEM, V25, P501
   HA HF, 1991, SINOJAPANESE BILATER
   HA HF, 1990, J RAD RES RAD PROCES, V8, P25
   HA HF, 1977, RADIAT PHYS CHEM, V31, P761
   HA HF, 1989, J RAD RES RAD PROCES, V7, P30
   HA HG, 1992, J RAD RES RAD PROCES, V10, P7
   HA JF, 1988, ACTA POLYM SINICA, V3, P219
   HU W, 1986, 3RD P NAT C RAD PROC, P142
   JIN C, 1988, J RAD RES RAD PROCES, V6, P49
   LI XM, 1991, J RAD RES RAD PROCES, V9, P2
   LI XM, 1988, J CHINA U SCI TECHNO, V18, P319
   LI XM, 1989, ACTA POLYM SINICA, V5, P524
   LI XM, 1989, J RAD RES RAD PROCES, V1, P36
   LI XM, 1982, J CHINA U SCI TECHNO, V12, P4
   LIU PF, IN PRESS
   LIU RZ, 1990, J BIOMED ENG, V8, P308
   LIU YM, 1987, RADIAT PHYS CHEM, V30, P215
   LIU YM, 1988, J RAD RES READ PROCE, V6, P44
   LIU ZM, 1987, J SHANGHAI U SCI TEC, V3, P3
   LU XH, 1991, J RAD RES RAD PROCES, V9, P233
   MA ZT, 1986, J SHANGHAI U SCI TEC, V4, P1
   MA ZT, 1984, J SHANGHAI U SCI TEC, V2, P27
   SHAN J, 1992, IMRP8, P9
   TEH MR, 1986, ACTA CHIM SINICA, V44, P850
   WANG GH, 1988, RADIAT PHYS CHEM, V31, P705
   YAN Q, 1988, J SHANGHAI U SCI TEC, V4
   YANG Y, 1986, 3RD P NAT C RD PROC, P139
   YANG YG, 1986, POLYM COMMUN, V2, P81
   YU U, 1990, J RAD RES RAD PROCES, V8, P168
   ZHAI M, 1992, IMRP8
   ZHANG ZH, 1982, J CHINA U SCI TECHNO, V12
   ZHENG JY, 1990, J ISOTOPES, V3, P242
   孙以实, 1991, Chinese Journal of Polymer Science, V9, P353
NR 36
TC 1
Z9 1
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-3659
J9 J CONTROL RELEASE
JI J. Control. Release
PD FEB
PY 1994
VL 29
IS 1-2
BP 195
EP 199
DI 10.1016/0168-3659(94)90136-8
PG 5
WC Chemistry, Multidisciplinary; Pharmacology & Pharmacy
SC Chemistry; Pharmacology & Pharmacy
GA NE024
UT WOS:A1994NE02400021
DA 2018-10-20
ER

PT J
AU LIU, YF
   GUO, ZY
   LIU, XQ
   QU, T
   XIE, JL
AF LIU, YF
   GUO, ZY
   LIU, XQ
   QU, T
   XIE, JL
TI APPLICATIONS OF ACCELERATOR MASS-SPECTROMETRY IN ANALYSIS OF TRACE
   ISOTOPES AND ELEMENTS
SO PURE AND APPLIED CHEMISTRY
LA English
DT Article
ID ATOMIC-ABSORPTION SPECTROMETRY; BIO-MEDICAL SCIENCES; HALF-LIFE;
   CROSS-SECTIONS; ATMOSPHERIC TRANSPORT; INSITU PRODUCTION; COSMOGENIC
   BE-10; NUCLEAR-PHYSICS; SOLAR NEUTRINOS; STRIPA GRANITE
AB Accelerator mass spectrometry (AMS) is mainly employed to measure very low concentrations of a number of long-lived radioisotopes and stable isotopes with very high sensitivities. The predominant application of AMS is in the field of geosciences and is based on chronological evaluations and dating principles. This paper deals with AMS applications other than dating problems, aiming at the analytical aspects of the trace isotopes and trace elements. It addresses non-dating applications in the fields of nuclear physics, geology, hydrology, environmental sciences, material sciences and, in recent years, biomedical sciences which have received increasing attention. Comparison of AMS with other analytical techniques with respect to detection limits and other functions is also discussed.
C1 BEIJING UNIV, INST HEAVY ION PHYS, BEIJING 100871, PEOPLES R CHINA.
RP LIU, YF (reprint author), BEIJING UNIV, DEPT TECH PHYS, BEIJING 100871, PEOPLES R CHINA.
CR ALBURGER DE, 1986, EARTH PLANET SC LETT, V78, P168, DOI 10.1016/0012-821X(86)90058-0
   ALFREY AC, 1976, NEW ENGL J MED, V294, P184, DOI 10.1056/NEJM197601222940402
   ALFREY AC, 1987, TOXICOLOGY METALS CL, P201
   ALLEGRE CJ, 1980, EARTH PLANET SC LETT, V48, P148, DOI 10.1016/0012-821X(80)90177-6
   Alvarez LW, 1939, PHYS REV, V56, P613, DOI 10.1103/PhysRev.56.613
   ALVAREZ LW, 1980, SCIENCE, V208, P1095, DOI 10.1126/science.208.4448.1095
   Alvarez LW, 1939, PHYS REV, V56, P379, DOI 10.1103/PhysRev.56.379.2
   ANDREWS JN, 1989, GEOCHIM COSMOCHIM AC, V53, P1803, DOI 10.1016/0016-7037(89)90301-3
   ANNEGARN HJ, 1990, NUCL INSTRUM METH B, V49, P264, DOI 10.1016/0168-583X(90)90258-V
   ANTHONY JM, 1987, NUCL INSTRUM METH B, V29, P77, DOI 10.1016/0168-583X(87)90208-4
   ANTHONY JM, 1989, NUCL INSTRUM METH B, V40-1, P731, DOI 10.1016/0168-583X(89)90465-5
   ANTHONY JM, 1983, NUCL INSTRUM METHODS, V218, P463, DOI 10.1016/0167-5087(83)91022-0
   ANTHONY JM, 1985, NUCL INSTRUM METH B, V10-1, P498, DOI 10.1016/0168-583X(85)90295-2
   ANTHONY JM, 1990, NUCL INSTRUM METH B, V52, P493, DOI 10.1016/0168-583X(90)90464-6
   BAHCALL JN, 1982, REV MOD PHYS, V54, P767, DOI 10.1103/RevModPhys.54.767
   BARD E, 1987, NUCL INSTRUM METH B, V29, P297, DOI 10.1016/0168-583X(87)90253-9
   BARKER J, 1990, NUCL INSTRUM METH B, V52, P540, DOI 10.1016/0168-583X(90)90473-8
   BEER J, 1988, NATURE, V331, P675, DOI 10.1038/331675a0
   BEER J, 1983, RADIOCARBON, V25, P269
   Bennett C L, 1977, Science, V198, P508
   BENNINGHOVEN A, 1986, SECONDARY ION MASS S
   BENTLY HW, 1986, HDB ENV ISOTOPE GEOC, V2, P429
   BROWN L, 1984, ANNU REV EARTH PL SC, V12, P39, DOI 10.1146/annurev.ea.12.050184.000351
   BROWN L, 1989, GEOCHIM COSMOCHIM AC, V53, P135, DOI 10.1016/0016-7037(89)90280-9
   BROWN L, 1987, PHILOS T R SOC A, V323, P75, DOI 10.1098/rsta.1987.0073
   CARROLL BH, 1980, PHOTOGR SCI ENG, V24, P265
   CHANG KH, 1984, THESIS U TORONTO CAN
   CHEW SH, 1984, NUCL INSTRUM METH B, V5, P179, DOI 10.1016/0168-583X(84)90506-8
   CLAUSEN HB, 1973, J GLACIOL, V12, P411
   CREASER RA, 1991, GEOCHIM COSMOCHIM AC, V55, P397, DOI 10.1016/0016-7037(91)90427-7
   CURRIE LA, 1991, RADIOCARBON, V33, P189
   DEMASTER DJ, 1980, EARTH PLANET SC LETT, V48, P209, DOI 10.1016/0012-821X(80)90182-X
   DITTRICH B, 1990, NUCL INSTRUM METH B, V52, P588, DOI 10.1016/0168-583X(90)90481-9
   DONAHUE DJ, 1990, P BEIJING INT WORKSH
   ELMORE D, 1984, NUCL INSTRUM METH B, V5, P109, DOI 10.1016/0168-583X(84)90492-0
   ELMORE D, 1985, NUCL INSTRUM METH B, V10-1, P738, DOI 10.1016/0168-583X(85)90096-5
   ELMORE D, 1987, SCIENCE, V236, P543, DOI 10.1126/science.236.4801.543
   ELMORE D, 1987, BIOL TRACE ELEM RES, V12, P231, DOI 10.1007/BF02796683
   ELMORE D, 1990, NUCL INSTRUM METH B, V52, P531, DOI 10.1016/0168-583X(90)90471-6
   ELMORE D, 1980, PHYS REV LETT, V45, P589, DOI 10.1103/PhysRevLett.45.589
   EMERY JF, 1972, NUCL SCI ENG, V48, P319, DOI 10.13182/NSE72-A22489
   ERDTMANN G, 1986, TREATISE ANAL CHEM 1, V14
   ERNST H, 1984, NUCL INSTRUM METH B, V5, P426, DOI 10.1016/0168-583X(84)90554-8
   FABRYKAMARTIN J, 1987, NUCL INSTRUM METH B, V29, P361, DOI 10.1016/0168-583X(87)90265-5
   FABRYKAMARTIN JT, 1989, GEOCHIM COSMOCHIM AC, V53, P1817, DOI 10.1016/0016-7037(89)90302-5
   FABRYKAMARTIN JT, 1987, P S NATURAL ANALOGUE
   FEHN U, 1986, NATURE, V323, P707, DOI 10.1038/323707a0
   FELTON JS, 1990, NUCL INSTRUM METH B, V52, P517, DOI 10.1016/0168-583X(90)90469-B
   FINK D, 1990, NUCL INSTRUM METH B, V52, P601, DOI 10.1016/0168-583X(90)90483-B
   FINKEL RC, 1991, IN PRESS ADV ANAL GE
   FINKEL RC, 1988, UCAR1006288 ANN REP, P94
   FREEDMAN MS, 1976, SCIENCE, V193, P1117, DOI 10.1126/science.193.4258.1117
   FREEMAN SPHT, 1990, NUCL INSTRUM METH B, V52, P405, DOI 10.1016/0168-583X(90)90446-2
   FREKERS D, 1983, PHYS REV C, V28, P1756, DOI 10.1103/PhysRevC.28.1756
   GOVE HE, 1990, NUCL INSTRUM METH B, V52, P502, DOI 10.1016/0168-583X(90)90466-8
   GOVE HE, 1987, NUCL INSTRUM METH B, V29, pR7, DOI 10.1016/0168-583X(87)90190-X
   GOVE HE, 1978, 1ST P RAD DAT ACC RO, P1
   GRASSERBAUER M, 1988, J RES NAT BUR STAND, V93, P510, DOI 10.6028/jres.093.140
   GRASSERBAUER M, 1987, ANAL CHIM ACTA, V195, P1, DOI 10.1016/S0003-2670(00)85646-9
   GRIME GW, 1991, NUCL INSTRUM METH B, V54, P52, DOI 10.1016/0168-583X(91)95490-5
   HEMMICK TK, 1987, NUCL INSTRUM METH B, V29, P389, DOI 10.1016/0168-583X(87)90271-0
   HENNING W, 1981, 1981 P INT S ACC MAS, P1
   Henning W., 1985, AIP C P, V126, P203
   HENNING W, 1984, P C SOLAR NEUTRINOS
   Heumann K. G, 1988, INORGANIC MASS SPECT, P301
   HOCKETT RS, 1989, APPL PHYS LETT, V54, P1793, DOI 10.1063/1.101266
   HOFFMAN DC, 1971, NATURE, V234, P132, DOI 10.1038/234132a0
   HOFMANN HJ, 1990, NUCL INSTRUM METH B, V52, P544, DOI 10.1016/0168-583X(90)90474-9
   HOFMANN HJ, 1987, NUCL INSTRUM METH B, V29, P32, DOI 10.1016/0168-583X(87)90198-4
   HOFMEIJER GK, 1987, NUCL INSTRUM METH B, V29, P166, DOI 10.1016/0168-583X(87)90229-1
   HUANG DF, 1991, J CHINESE MASS SPECT, V12, P94
   HURST GS, 1988, SPECTROCHIM ACTA B, V43, P715, DOI 10.1016/0584-8547(88)80104-6
   HURST GS, 1988, PRINCIPLES APPLICATI
   IMAMURA M, 1990, NUCL INSTRUM METH B, V52, P595, DOI 10.1016/0168-583X(90)90482-A
   JIANG SS, 1990, NUCL INSTRUM METH B, V52, P608, DOI 10.1016/0168-583X(90)90484-C
   JOHNSSON SAE, 1988, PIXE NOVAL TECHNIQUE
   JONES GA, 1990, NUCL INSTRUM METH B, V52, P278, DOI 10.1016/0168-583X(90)90421-P
   KEILSON J, 1978, 1ST P C RAD DAT ACC, P391
   KLEIN J, 1981, ANLPHY811 REP, P136
   KLEIN J, 1990, BEIJING INT WORKSHOP
   KLEIN J, 1991, IN PRESS EARTH PLANE
   KLOUDA GA, 1984, NUCL INSTRUM METH B, V5, P265, DOI 10.1016/0168-583X(84)90524-X
   KORSCHINEK G, 1990, NUCL INSTRUM METH B, V52, P498, DOI 10.1016/0168-583X(90)90465-7
   KRUCK TPA, 1988, MET IONS BIOL SYST, V24, P285
   KUSAKABE M, 1982, NATURE, V299, P712, DOI 10.1038/299712a0
   KUTSCHERA W, 1988, NUCL INSTRUM METH A, V268, P552, DOI 10.1016/0168-9002(88)90578-5
   KUTSCHERA W, 1984, NUCL INSTRUM METH B, V5, P420, DOI 10.1016/0168-583X(84)90553-6
   KUTSCHERA W, 1986, NUCL INSTRUM METH B, V17, P377, DOI 10.1016/0168-583X(86)90167-9
   KUTSCHERA W, 1984, NUCL INSTRUM METH B, V5, P430, DOI 10.1016/0168-583X(84)90555-X
   KUTSCHERA W, 1990, ANNU REV NUCL PART S, V40, P411
   KUTSCHERA W, 1990, NUCL INSTRUM METH B, V50, P252, DOI 10.1016/0168-583X(90)90364-Z
   KUTSCHERA W, 1989, RADIOCARBON, V31, P311
   KUTSCHERA W, 1980, PHYS REV LETT, V45, P592, DOI 10.1103/PhysRevLett.45.592
   KUTSCHERA W, 1991, RADIOCARBON, V33, P218
   LARUE GS, 1977, PHYS REV LETT, V38, P1011, DOI 10.1103/PhysRevLett.38.1011
   LINDSAY NM, 1988, NUCL INSTRUM METH B, V35, P358, DOI 10.1016/0168-583X(88)90296-0
   LIU XQ, 1991, NAGARA9107 TECHN REP
   LOWE DC, 1987, NUCL INSTRUM METH B, V29, P291, DOI 10.1016/0168-583X(87)90252-7
   LUCK JM, 1983, SCIENCE, V222, P613, DOI 10.1126/science.222.4624.613
   LVOV BV, 1986, SPECTROCHIM ACTA B, V41, P1043, DOI 10.1016/0584-8547(86)80125-2
   LVOV BV, 1990, SPECTROCHIM ACTA B, V45, P633, DOI 10.1016/0584-8547(90)80046-L
   MABUCHI H, 1974, J INORG NUCL CHEM, V36, P1687, DOI 10.1016/0022-1902(74)80493-8
   MAENHAUT W, 1990, NUCL INSTRUM METH B, V49, P518, DOI 10.1016/0168-583X(90)90304-D
   MAGEE CW, 1988, J RES NAT BUR STAND, V93, P390, DOI 10.6028/jres.093.088
   MAKINO T, 1975, SHITSURYO BUNSEKI, V23, P33
   MARTIN FW, 1991, NUCL INSTRUM METH B, V54, P64, DOI 10.1016/0168-583X(91)95491-U
   MEIRAV O, 1990, NUCL INSTRUM METH B, V52, P536, DOI 10.1016/0168-583X(90)90472-7
   MIDDLETON R, 1987, PHILOS T R SOC A, V323, P121, DOI 10.1098/rsta.1987.0077
   MIDDLETON R, 1979, PHYS REV LETT, V43, P429, DOI 10.1103/PhysRevLett.43.429
   MIDDLETON R, 1989, RADIOCARBON, V31, P305
   MILNER RG, 1985, PHYS REV LETT, V54, P1472, DOI 10.1103/PhysRevLett.54.1472
   MONAGHAN MC, 1986, EARTH PLANET SC LETT, V76, P279, DOI 10.1016/0012-821X(86)90079-8
   MORELAND PE, 1965, J INORG NUCL CHEM, V27, P493, DOI 10.1016/0022-1902(65)80252-4
   MULLER RA, 1977, SCIENCE, V196, P521, DOI 10.1126/science.196.4289.521
   MULLER RA, 1977, SCIENCE, V196, P489, DOI 10.1126/science.196.4289.489
   NAKAMURA T, 1987, NUCL INSTRUM METH B, V29, P355, DOI 10.1016/0168-583X(87)90264-3
   NELSON DE, 1977, SCIENCE, V198, P507, DOI 10.1126/science.198.4316.507
   OSTLUND HG, 1987, NUCL INSTRUM METH B, V29, P286, DOI 10.1016/0168-583X(87)90251-5
   PAUL M, 1986, NATURE, V321, P511, DOI 10.1038/321511a0
   PAUL M, 1980, PHYS LETT B, V94, P303, DOI 10.1016/0370-2693(80)90883-7
   PAUL M, 1987, NUCL INSTRUM METH B, V29, P341, DOI 10.1016/0168-583X(87)90262-X
   PAVICH MJ, 1985, GEOLOGY, V13, P39, DOI 10.1130/0091-7613(1985)13<39:BAOAQW>2.0.CO;2
   PERL DP, 1988, MET IONS BIOL SYST, V24, P259
   PHILLIPS FM, 1984, P S TECH U, V1, P47
   PRZYBYLOWICZ W, 1990, NUCL INSTRUM METH B, V49, P509, DOI 10.1016/0168-583X(90)90302-B
   PURDY CB, 1987, NUCL INSTRUM METH B, V29, P372, DOI 10.1016/0168-583X(87)90266-7
   PURSER KH, 1977, REV PHYS APPL, V12, P1487, DOI 10.1051/rphysap:0197700120100148700
   RAISBECK GM, 1985, NATURE, V315, P315, DOI 10.1038/315315a0
   RAISBECK GM, 1981, GEOPHYS RES LETT, V8, P1015, DOI 10.1029/GL008i009p01015
   RAISBECK GM, 1981, NATURE, V292, P825, DOI 10.1038/292825a0
   RAISBECK GM, 1990, NUCL INSTRUM METH B, V52, P211
   RAISBECK GM, 1981, ANLPHY811 REP, P458
   RODHE H, 1990, SCIENCE, V248, P1217, DOI 10.1126/science.248.4960.1217
   ROWLEY JK, 1985, AIP C P, V126, P1
   ROY JC, 1957, CAN J PHYS, V35, P649, DOI 10.1139/p57-069
   RUCKLIDGE JC, 1990, NUCL INSTRUM METH B, V52, P507, DOI 10.1016/0168-583X(90)90467-9
   RUCKLIDGE JC, 1981, NUCL INSTRUM METHODS, V191, P1, DOI 10.1016/0029-554X(81)90973-3
   RUCKLIDGE JC, 1982, CAN MINERAL, V20, P111
   RUCKLIDGE JC, 1987, J TRACE MICROPROBE T, V5, P23
   SCANLON BR, 1987, NUCL INSTRUM METH B, V29, P291
   SCHIFFER JP, 1981, ANLPHY811 REP, P154
   SCHNEIDER RJ, 1987, NUCL INSTRUM METH B, V29, P271, DOI 10.1016/0168-583X(87)90248-5
   SCHWARZSCHILD AZ, 1977, B AM PHYS SOC, V22, P94
   SCHWEIKERT EA, 1989, ANALYST, V114, P269, DOI 10.1039/an9891400269
   SHEU YD, 1986, J ELECTROCHEM SOC, V133, P2136, DOI 10.1149/1.2108356
   SLAVIN W, 1984, GRAPHITE FURNACE AAS, P18
   STEPHENS W, 1980, PHYS REV C, V21, P1664, DOI 10.1103/PhysRevC.21.1664
   STRAUME T, 1990, NUCL INSTRUM METH B, V52, P552, DOI 10.1016/0168-583X(90)90475-A
   SYNAL HA, 1990, NUCL INSTRUM METH B, V52, P483, DOI 10.1016/0168-583X(90)90462-4
   TAKACS S, 1990, NUCL INSTRUM METH B, V49, P195, DOI 10.1016/0168-583X(90)90241-L
   TAYLOR RE, 1987, NUCL INSTRUM METH B, V29, P159, DOI 10.1016/0168-583X(87)90227-8
   TENG RTD, 1987, NUCL INSTRUM METH B, V29, P281, DOI 10.1016/0168-583X(87)90250-3
   TERA F, 1983, METEORITICS, V18, P405
   VALETTESILVER JN, 1986, EARTH PLANET SC LETT, V80, P82, DOI 10.1016/0012-821X(86)90021-X
   VOGEL JS, 1990, NUCL INSTRUM METH B, V52, P524, DOI 10.1016/0168-583X(90)90470-F
   VOGEL JS, 1990, RADIOCARBON, V32, P81
   VOURVOPOULOS G, 1990, NUCL INSTRUM METH B, V52, P451, DOI 10.1016/0168-583X(90)90456-5
   WAHLEN M, 1989, SCIENCE, V245, P286, DOI 10.1126/science.245.4915.286
   WAHLEN M, 1983, EOS T AM GEOPHYS UN, V64, P282
   WANG YA, 1988, J CHINESE MASS SPECT, V9, P3
   WATSON EE, MIRDOSE CODE 1988 VE
   WELZ B, 1985, ATOMIC ABSORPTION SP
   WENDORF F, 1987, NUCL INSTRUM METH B, V29, P155, DOI 10.1016/0168-583X(87)90226-6
   WILHARTITZ P, 1987, FRESEN Z ANAL CHEM, V329, P228, DOI 10.1007/BF00469146
   WING J, 1965, J INORG NUCL CHEM, V27, P487, DOI 10.1016/0022-1902(65)80251-2
   WOLFLI W, 1987, NUCL INSTRUM METH B, V29, P1, DOI 10.1016/0168-583X(87)90193-5
   WOLFLI W, 1984, NUCL INSTRUM METH B, V5, pR5, DOI 10.1016/0168-583X(84)90487-7
   YIOU F, 1972, PHYS REV LETT, V29, P372, DOI 10.1103/PhysRevLett.29.372
NR 168
TC 18
Z9 22
U1 1
U2 2
PU WALTER DE GRUYTER GMBH
PI BERLIN
PA GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY
SN 0033-4545
EI 1365-3075
J9 PURE APPL CHEM
JI Pure Appl. Chem.
PD FEB
PY 1994
VL 66
IS 2
BP 305
EP 334
DI 10.1351/pac199466020305
PG 30
WC Chemistry, Multidisciplinary
SC Chemistry
GA NE479
UT WOS:A1994NE47900010
OA Bronze
DA 2018-10-20
ER

PT J
AU ALLCOCK, HR
   PUCHER, SR
   SCOPELIANOS, AG
AF ALLCOCK, HR
   PUCHER, SR
   SCOPELIANOS, AG
TI SYNTHESIS OF POLY(ORGANOPHOSPHAZENES) WITH GLYCOLIC ACID ESTER AND
   LACTIC-ACID ESTER SIDE-GROUPS - PROTOTYPES FOR NEW BIOERODIBLE POLYMERS
SO MACROMOLECULES
LA English
DT Article
ID HYDROLYSIS-SENSITIVE POLY<(ORGANO)PHOSPHAZENES>; BIODEGRADABLE POLYMERS;
   POLYPHOSPHAZENES
AB Four different poly(organophosphazenes) bearing esters of glycolic or lactic acid as side groups have been synthesized in order to investigate their stability in aqueous media. The polymers are poly[bis-(ethyl glycolato)phosphazene],poly[bis(ethyl lactato)phosphazene],poly[bis(benzyl glycolato)phosphazene], and poly[bis(benzyl lactato)phosphazene]. The benzyl esters of glycolic and lactic acid were prepared by the base-catalyzed transesterification of their ethyl esters with benzyl alcohol at 90 degrees C. Poly(dichlorophosphazene) was treated with a large excess of the appropriate sodium acid ester at 50 degrees C to yield the fully-substituted polymer. To avoid unwanted molecular weight decline, these polymers were stored-under nitrogen or in vacuum. Hydrolytic decomposition profiles in aqueous media were monitored by P-31 NMR spectroscopy and by gel permeation chromatography (GPC). The possible utility of these polymers as biomedical materials is discussed.
C1 ETHICON INC,SOMERVILLE,NJ 08876.
RP ALLCOCK, HR (reprint author), PENN STATE UNIV,DEPT CHEM,UNIV PK,PA 16802, USA.
CR ALLCOCK HR, 1991, MACROMOLECULES, V24, P23, DOI 10.1021/ma00001a005
   ALLCOCK HR, 1977, MACROMOLECULES, V10, P824, DOI 10.1021/ma60058a020
   ALLCOCK HR, 1965, J AM CHEM SOC, V87, P4216, DOI 10.1021/ja01096a056
   ALLCOCK HR, 1982, INORG CHEM, V21, P515, DOI 10.1021/ic00132a009
   ALLCOCK HR, 1988, MACROMOLECULES, V21, P1980, DOI 10.1021/ma00185a015
   ALLCOCK HR, UNPUB
   CROMMEN JHL, 1992, BIOMATERIALS, V13, P511, DOI 10.1016/0142-9612(92)90102-T
   CROMMEN JHL, 1992, BIOMATERIALS, V13, P601, DOI 10.1016/0142-9612(92)90028-M
   HOSKINS IA, 1991, SURG GYNECOL OBSTET, V172, P108
   LAURENCIN C, 1992, PMSE, V66, P33
   LAURENCIN CT, 1987, J BIOMED MATER RES, V21, P1231, DOI 10.1002/jbm.820211006
   LAURENCIN CT, 1993, J BIOMED MATER RES, V27, P963, DOI 10.1002/jbm.820270716
   MCCALDIN DJ, 1960, CHEM REV, V60, P39, DOI 10.1021/cr60203a004
NR 13
TC 56
Z9 65
U1 1
U2 11
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036
SN 0024-9297
J9 MACROMOLECULES
JI Macromolecules
PD JAN 3
PY 1994
VL 27
IS 1
BP 1
EP 4
DI 10.1021/ma00079a001
PG 4
WC Polymer Science
SC Polymer Science
GA MQ385
UT WOS:A1994MQ38500001
DA 2018-10-20
ER

PT J
AU VRIJENHOEK, RC
AF VRIJENHOEK, RC
TI UNISEXUAL FISH - MODEL SYSTEMS FOR STUDYING ECOLOGY AND EVOLUTION
SO ANNUAL REVIEW OF ECOLOGY AND SYSTEMATICS
LA English
DT Review
DE SEX; ASEXUALITY; CLONES; COEXISTENCE; CONSERVATION
ID POECILIOPSIS PISCES-POECILIIDAE; LIZARDS GENUS CNEMIDOPHORUS; CLONALLY
   INHERITED GENOMES; MITOCHONDRIAL-DNA ANALYSES; RED QUEEN;
   DROSOPHILA-MELANOGASTER; GENETIC DISSECTION; CELL-PROLIFERATION;
   GYNOGENETIC FISH; LINKAGE ANALYSIS
AB Since their discovery in 1932, all-female ''species'' of fish have provided rich material for ecological and evolutionary studies. The significance of these rare organisms lies in the perspective they provide on what is considered normal (i.e. biparental sexuality). Study of these fish and their sexual relatives has contributed to our understanding of: (i) the origins and evolution of asexuality; (ii) the ecology of hybrids; (iii) genotypic and environmental effects on ecologically relevant traits; and (iv) the maintenance of sex in higher organisms. A consistent message emerging from these studies is the significance of genetic diversity for survival in spatially and temporally heterogeneous environments. Consequently, unisexual fish also serve as useful models for studying the role of genetic variation in the survival of small endangered populations. Finally, unisexual fish serve as genetically uniform systems for environmental and biomedical studies. The purpose of this review is to bring wider attention to the range of biological problems that can be attacked with these remarkable organisms.
RP VRIJENHOEK, RC (reprint author), RUTGERS STATE UNIV,CTR THEORET & APPL GENET,NEW BRUNSWICK,NJ 08903, USA.
CR ANGUS RA, 1979, EVOLUTION, V33, P27, DOI 10.1111/j.1558-5646.1979.tb04659.x
   AVISE JC, 1989, EVOLUTION, V43, P1192, DOI 10.1111/j.1558-5646.1989.tb02568.x
   AVISE JC, 1992, EVOL BIOL, V26, P225
   BALSANO JS, 1985, ENVIRON BIOL FISH, V12, P251, DOI 10.1007/BF00005456
   Bell G., 1982, MASTERPIECE NATURE
   BROWN WM, 1979, P NATL ACAD SCI USA, V76, P1967, DOI 10.1073/pnas.76.4.1967
   BULGER AJ, 1979, EVOLUTION, V33, P848, DOI 10.1111/j.1558-5646.1979.tb04739.x
   BULGER AJ, 1982, EVOLUTION, V36, P1041, DOI 10.1111/j.1558-5646.1982.tb05472.x
   CASE TJ, 1986, EVOLUTION, V40, P366, DOI 10.1111/j.1558-5646.1986.tb00478.x
   CASE TJ, 1990, OECOLOGIA, V83, P220, DOI 10.1007/BF00317756
   CHARLESWORTH D, 1993, J HERED, V84, P321, DOI 10.1093/oxfordjournals.jhered.a111351
   CIMINO MC, 1972, EVOLUTION, V26, P294, DOI 10.1111/j.1558-5646.1972.tb00195.x
   CLANTON WESLEY, 1934, OCC PAPERS MUS ZOOL UNIV MICH, V290, P1
   COLE CJ, 1985, SYST ZOOL, V34, P359, DOI 10.2307/2413153
   CRADDOCK C, 1993, TRENDS ECOL EVOL, V8, P458, DOI 10.1016/0169-5347(93)90011-D
   CUELLAR O, 1977, SCIENCE, V197, P837, DOI 10.1126/science.887925
   Darlington C. D., 1939, EVOLUTION GENETIC SY
   Dawley Robert M., 1989, New York State Museum Bulletin, V466, P1
   DENSMORE LD, 1989, EVOLUTION, V43, P969, DOI 10.1111/j.1558-5646.1989.tb02543.x
   DROSOPOULOS S, 1978, EVOLUTION, V32, P916, DOI 10.1111/j.1558-5646.1978.tb04645.x
   ECHELLE AA, 1990, SYST ZOOL, V39, P70, DOI 10.2307/2992209
   ECHELLE AA, 1983, EVOLUTION, V37, P722
   Frankel OH, 1981, CONSERVATION EVOLUTI
   FROST DR, 1988, SYST ZOOL, V37, P200, DOI 10.2307/2992277
   Ghiselin MT, 1974, EC NATURE EVOLUTION
   Graf Jean-Daniel, 1989, New York State Museum Bulletin, V466, P289
   HAIGH J, 1978, THEOR POPUL BIOL, V14, P251, DOI 10.1016/0040-5809(78)90027-8
   Hamilton W. D., 1982, Population biology of infectious diseases. (Report of the Dahlem Workshop on Population Biology of Infectious Disease Agents, Berlin, 1982, March 14-19.) (Life Sciences Research Report, 25), P269
   HEDGES SB, 1992, NATURE, V356, P708, DOI 10.1038/356708a0
   HILLIS DM, 1991, SCIENCE, V251, P308, DOI 10.1126/science.1987647
   HOTZ H, 1985, J EXP ZOOL, V236, P199, DOI 10.1002/jez.1402360210
   Hubbs C., 1964, Bulletin of the Texas Memorial Museum, VNo. 8, P1
   Hubbs CL, 1932, SCIENCE, V76, P628, DOI 10.1126/science.76.1983.628
   KEEGANROGERS V, 1984, ANIM BEHAV, V32, P1040, DOI 10.1016/S0003-3472(84)80219-5
   KEEGANROGERS V, 1988, AM NAT, V132, P846, DOI 10.1086/284893
   KIDWELL MG, 1977, GENETICS, V86, P813
   KIRKENDALL LR, 1990, EVOLUTION, V44, P698, DOI 10.1111/j.1558-5646.1990.tb05949.x
   KONDRASHOV AS, 1988, NATURE, V336, P435, DOI 10.1038/336435a0
   KRAUS F, 1990, P NATL ACAD SCI USA, V87, P2235, DOI 10.1073/pnas.87.6.2235
   LADLE RJ, 1992, TRENDS ECOL EVOL, V7, P405, DOI 10.1016/0169-5347(92)90021-3
   LESLIE JF, 1980, EVOLUTION, V34, P1105, DOI 10.1111/j.1558-5646.1980.tb04051.x
   LESLIE JF, 1978, GENETICS, V90, P801
   LESLIE JF, 1982, J HERED, V73, P19, DOI 10.1093/oxfordjournals.jhered.a109568
   LIMA NRW, 1993, THESIS FEDERAL U SAO
   LIVELY CM, 1990, NATURE, V344, P864, DOI 10.1038/344864a0
   LYNCH M, 1984, Q REV BIOL, V59, P257, DOI 10.1086/413902
   LYNCH M, 1990, EVOLUTION, V44, P1725, DOI 10.1111/j.1558-5646.1990.tb05244.x
   MASLIN TP, 1968, SYST ZOOL, V17, P219, DOI 10.2307/2412001
   MASLIN TP, 1971, AM ZOOL, V11, P361
   MCKAY FE, 1971, ECOLOGY, V52, P778, DOI 10.2307/1936025
   MICHOD R. E, 1988, EVOLUTION SEX EXAMIN
   MJD White, 1978, MODES SPECIATION
   MONTOVANI B, 1992, EVOLUTION, V46, P783
   Moore W.S., 1984, P329
   MOORE WS, 1971, ECOLOGY, V52, P791, DOI 10.2307/1936026
   MOORE WS, 1975, ECOLOGY, V56, P791, DOI 10.2307/1936292
   MORITZ C, 1991, P ROY SOC B-BIOL SCI, V244, P145, DOI 10.1098/rspb.1991.0063
   Moritz C, 1989, B NEW YORK STATE MUS, V466, P87
   MORITZ CC, 1989, EVOLUTION, V43, P958, DOI 10.1111/j.1558-5646.1989.tb02542.x
   MUKAI T, 1972, GENETICS, V72, P335
   MULLER HJ, 1964, MUTAT RES, V1, P2, DOI 10.1016/0027-5107(64)90047-8
   NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771
   NEI M, 1970, AM NAT, V104, P211
   PARKER ED, 1979, EVOLUTION, V33, P1150, DOI 10.1111/j.1558-5646.1979.tb04769.x
   PARKER ED, 1977, EVOLUTION, V31, P836, DOI 10.1111/j.1558-5646.1977.tb01076.x
   QUATTRO JM, 1992, P NATL ACAD SCI USA, V89, P348, DOI 10.1073/pnas.89.1.348
   QUATTRO JM, 1992, GENETICS, V130, P621
   QUATTRO JM, 1989, SCIENCE, V245, P976, DOI 10.1126/science.2772650
   QUATTRO JM, 1991, GENETICS, V127, P391
   RICE WR, 1994, SCIENCE, V263, P230, DOI 10.1126/science.8284674
   ROSENZWEIG ML, 1978, BIOL J LINN SOC, V10, P275, DOI 10.1111/j.1095-8312.1978.tb00016.x
   ROUGHGARDEN J, 1972, AM NAT, V106, P683, DOI 10.1086/282807
   SCHENCK RA, 1986, EVOLUTION, V40, P1060, DOI 10.1111/j.1558-5646.1986.tb00573.x
   SCHENCK RA, 1989, B NEW YORK STATE MUS, V466, P39
   SCHLUPP I, 1994, SCIENCE, V263, P373, DOI 10.1126/science.8278809
   SCHULTZ ME, 1989, ENVIRON RES, V48, P248, DOI 10.1016/S0013-9351(89)80038-6
   SCHULTZ ME, 1982, ENVIRON RES, V27, P337, DOI 10.1016/0013-9351(82)90089-5
   SCHULTZ ME, 1985, EXP MOL PATHOL, V42, P320, DOI 10.1016/0014-4800(85)90082-6
   SCHULTZ ME, 1982, J HERED, V73, P43, DOI 10.1093/oxfordjournals.jhered.a109573
   Schultz R. J., 1977, Evolutionary Biol, V10, P277
   Schultz R.J., 1982, P103
   Schultz R.J., 1973, P207
   SCHULTZ RJ, 1971, AM ZOOL, V11, P351
   SCHULTZ RJ, 1966, BIOL BULL, V130, P415, DOI 10.2307/1539747
   SCHULTZ RJ, 1973, SCIENCE, V179, P180, DOI 10.1126/science.179.4069.180
   SCHULTZ RJ, 1969, AM NAT, V103, P605, DOI 10.1086/282629
   SCHULTZ RJ, 1993, ENVIRON BIOL FISH, V36, P83, DOI 10.1007/BF00005982
   SCHULTZ RJ, 1989, B NEW YORK STAT MUSE, V466, P32
   SIMMONS MJ, 1977, ANNU REV GENET, V11, P49, DOI 10.1146/annurev.ge.11.120177.000405
   SMITH JM, 1986, NATURE, V324, P300
   SMITH JM, 1966, AM NAT, V100, P637, DOI 10.1086/282457
   SMITH JM, 1992, NATURE, V356, P661, DOI 10.1038/356661a0
   SMITH JM, 1978, EVOLUTION SEX
   SPIELMAN D, 1992, ZOO BIOL, V11, P343, DOI 10.1002/zoo.1430110506
   SPINELLA DG, 1982, GENETICS, V100, P279
   SPOLSKY CM, 1992, NATURE, V356, P706, DOI 10.1038/356706a0
   STANLEY SM, 1975, SCIENCE, V190, P382, DOI 10.1126/science.1179215
   STEARNS SC, 1986, EVOLUTION, V40, P893, DOI 10.1111/j.1558-5646.1986.tb00560.x
   STENSETH NC, 1985, EVOLUTION, V39, P294, DOI 10.1111/j.1558-5646.1985.tb05667.x
   SUOMALAINEN E, 1987, CYTOLOGY EVOLUTION P
   Templeton A.R., 1982, P75
   TUNNER HG, 1979, NATURWISSENSCHAFTEN, V66, P268, DOI 10.1007/BF00571614
   Turner B.J., 1982, Progress in Clinical and Biological Research, V96, P265
   TURNER BJ, 1983, EVOLUTION, V37, P798, DOI 10.1111/j.1558-5646.1983.tb05601.x
   TURNER BJ, 1980, EVOLUTION, V34, P917, DOI 10.1111/j.1558-5646.1980.tb04029.x
   UZZELL T, 1975, P ACAD NAT SCI PHILA, V127, P13
   UZZELL T, 1970, AM NAT, V104, P433, DOI 10.1086/282678
   Vrijenhoek R.C., 1984, P399
   Vrijenhoek R.C., 1990, P175
   Vrijenhoek R. C, 1984, POPULATION BIOL EVOL, P217, DOI 10.1007/978-3-642-69646-6_18
   VRIJENHOEK RC, 1978, SCIENCE, V199, P549, DOI 10.1126/science.199.4328.549
   VRIJENHOEK RC, 1978, AM NAT, V112, P41, DOI 10.1086/283251
   VRIJENHOEK RC, 1979, AM NAT, V113, P17, DOI 10.1086/283362
   VRIJENHOEK RC, 1985, SCIENCE, V229, P400, DOI 10.1126/science.229.4711.400
   VRIJENHOEK RC, 1992, EVOLUTION, V46, P1642, DOI 10.1111/j.1558-5646.1992.tb01159.x
   VRIJENHOEK RC, 1979, AM ZOOL, V19, P787
   VRIJENHOEK RC, 1982, EVOLUTION, V36, P768, DOI 10.1111/j.1558-5646.1982.tb05443.x
   VRIJENHOEK RC, 1974, EVOLUTION, V28, P205
   VRIJENHOEK RC, 1989, EVOLUTION, V43, P24
   Vrijenhoek RC., 1994, CONSERVATION GENETIC
   Vrijenhoek Robert C., 1989, New York State Museum Bulletin, V466, P19
   WEEKS SC, 1993, AM NAT, V141, P409, DOI 10.1086/285481
   WEEKS SC, 1992, BEHAV ECOL SOCIOBIOL, V30, P1
   WEEKS SC, 1991, THESIS RUTGERS U NJ
   Wetherington J.D., 1989, P259
   WETHERINGTON JD, 1987, EVOLUTION, V41, P721, DOI 10.1111/j.1558-5646.1987.tb05848.x
   WETHERINGTON JD, 1989, EVOLUTION, V43, P635, DOI 10.1111/j.1558-5646.1989.tb04258.x
   WHITE CN, 1994, MOL BIOL EVOL, V11, P106
   White MJD, 1973, ANIMAL CYTOLOGY EVOL
   WILLIAMS GC, 1975, SEX EVOLUTION
   WILSON DS, 1989, SPECIATION ITS CONSE, P366
   WRIGHT JW, 1968, COPEIA, P128
   1983, GILA YAQUI TOPMINNOW
NR 133
TC 146
Z9 150
U1 1
U2 20
PU ANNUAL REVIEWS INC
PI PALO ALTO
PA 4139 EL CAMINO WAY, PO BOX 10139, PALO ALTO, CA 94303-0139
SN 0066-4162
J9 ANNU REV ECOL SYST
JI Annu. Rev. Ecol. Syst.
PY 1994
VL 25
BP 71
EP 96
DI 10.1146/annurev.es.25.110194.000443
PG 26
WC Ecology; Evolutionary Biology
SC Environmental Sciences & Ecology; Evolutionary Biology
GA PU883
UT WOS:A1994PU88300004
DA 2018-10-20
ER

PT S
AU BELL, CL
   PEPPAS, NA
AF BELL, CL
   PEPPAS, NA
BE Mikos, AG
   Murphy, RM
   Bernstein, H
   Peppas, NA
TI POLY(METHACRYLIC ACID-G-ETHYLENE GLYCOL) HYDROGELS AS PH-RESPONSIVE
   BIOMEDICAL MATERIALS
SO BIOMATERIALS FOR DRUG AND CELL DELIVERY
SE MATERIALS RESEARCH SOCIETY SYMPOSIUM PROCEEDINGS
LA English
DT Proceedings Paper
CT Symposium on Biomaterials for Drug and Cell Delivery
CY NOV 29-DEC 01, 1993
CL BOSTON, MA
SP MAT RES SOC
C1 PURDUE UNIV,SCH CHEM ENGN,W LAFAYETTE,IN 47907.
NR 0
TC 10
Z9 10
U1 0
U2 1
PU MATERIALS RESEARCH SOC
PI PITTSBURGH
PA 9800 MCKNIGHT RD, SUITE 327, PITTSBURGH, PA 15237
SN 0272-9172
BN 1-55899-230-8
J9 MATER RES SOC SYMP P
PY 1994
VL 331
BP 199
EP 204
PG 6
WC Materials Science, Multidisciplinary; Pharmacology & Pharmacy
SC Materials Science; Pharmacology & Pharmacy
GA BA69J
UT WOS:A1994BA69J00030
DA 2018-10-20
ER

PT J
AU BAYNE, SC
   SWIFT, EJ
AF BAYNE, SC
   SWIFT, EJ
TI REVIEW OF THE 1993 DENTAL MATERIALS LITERATURE
SO DENTAL MATERIALS
LA English
DT Review
ID GLASS-IONOMER CEMENTS; COMPOSITE RESIN RESTORATIONS; SHEAR BOND
   STRENGTH; OCCLUSAL TOOTH WEAR; SCANNING ELECTRON-MICROSCOPE; 3-YEAR
   FOLLOW-UP; ND-YAG LASER; IRREVERSIBLE HYDROCOLLOID IMPRESSIONS;
   PERFORMANCE POLYETHYLENE FIBER; ALLERGIC CONTACT-DERMATITIS
AB Objectives. Electronic databases are not sufficiently up to date to provide comprehensive notation of the most recent literature for reference in developing scientific papers. The objective of this summary was to identify and categorize the 1993 dental materials scientific literature that dealt with restorative dentistry.
   Methods. 17 primary journals were manually searched via the tables of contents, and 101 secondary journals were manually or electronically searched. Dental materials citations were categorized into 15 major sections and several subsections, excluding case reports and all the literature primarily related to dental implants or biomedical materials outside of dentistry.
   Results. This study identified 786 citations, the largest number being associated with glass ionomers and composites.
   Significance. This citation list provides a comprehensive source for review by academicians and researchers that bridges the gap between initial publication and electronic citation.
RP BAYNE, SC (reprint author), UNIV N CAROLINA, SCH DENT, DEPT OPERAT DENT, CHAPEL HILL, NC 27599 USA.
CR AASRUM E, 1993, AM J ORTHOD DENTOFAC, V104, P48, DOI 10.1016/0889-5406(93)70026-K
   Abdalla A I, 1993, Am J Dent, V6, P295
   ABDALLA AI, 1993, J DENT, V21, P158, DOI 10.1016/0300-5712(93)90026-M
   ABDALLA AI, 1993, J ORAL REHABIL, V20, P257, DOI 10.1111/j.1365-2842.1993.tb01608.x
   ABERER W, 1993, CONTACT DERMATITIS, V28, P163, DOI 10.1111/j.1600-0536.1993.tb03379.x
   ABUASI HA, 1993, J DENT, V21, P360, DOI 10.1016/0300-5712(93)90013-G
   AKERBOOM HBM, 1993, J PROSTHET DENT, V70, P351, DOI 10.1016/0022-3913(93)90221-9
   AKTENER BO, 1993, INT ENDOD J, V26, P137, DOI 10.1111/j.1365-2591.1993.tb00556.x
   AKTENER BO, 1993, J ENDODONT, V19, P228, DOI 10.1016/S0099-2399(06)81296-3
   ALAJAM ADK, 1993, J ENDODONT, V19, P353, DOI 10.1016/S0099-2399(06)81362-2
   ALDUWAIRI Y, 1993, J PROSTHET DENT, V69, P138, DOI 10.1016/0022-3913(93)90130-G
   Alexander J C, 1993, J Clin Orthod, V27, P207
   ALFAWAZ A, 1993, J ENDODONT, V19, P219, DOI 10.1016/S0099-2399(06)81294-X
   Ali S M, 1993, Dent Mater J, V12, P45
   ALMOAYAD M, 1993, BRIT DENT J, V175, P363
   Ambus C, 1993, Am J Dent, V6, P35
   AMDITIS C, 1993, AUST DENT J, V38, P22, DOI 10.1111/j.1834-7819.1993.tb05447.x
   ANAGNOSTOPOULOS T, 1993, DENT MATER, V9, P182, DOI 10.1016/0109-5641(93)90118-A
   Anderson M H, 1993, Dent Clin North Am, V37, P419
   ANDERSON RJ, 1993, J PROSTHET DENT, V69, P1, DOI 10.1016/0022-3913(93)90230-L
   ANDERSSON M, 1993, ACTA ODONTOL SCAND, V51, P59, DOI 10.3109/00016359309041149
   ANDERSSON OH, 1993, BIOMATERIALS, V14, P317, DOI 10.1016/0142-9612(93)90125-L
   ANDERSSON OH, 1993, J BIOMED MATER RES, V27, P941, DOI 10.1002/jbm.820270713
   ANDERSSON OH, 1992, BIOMATERIALS, V13, P172
   ANIC I, 1993, INT ENDOD J, V26, P284, DOI 10.1111/j.1365-2591.1993.tb00573.x
   APPELDOORN RE, 1993, J PROSTHET DENT, V70, P6, DOI 10.1016/0022-3913(93)90029-N
   ARCORIA CJ, 1993, J ORAL REHABIL, V20, P213, DOI 10.1111/j.1365-2842.1993.tb01603.x
   ARCURI MR, 1993, J PROSTHET DENT, V69, P483, DOI 10.1016/0022-3913(93)90157-J
   ARENA CA, 1993, J PROSTHET DENT, V70, P126, DOI 10.1016/0022-3913(93)90006-A
   ARO T, 1993, CONTACT DERMATITIS, V28, P276, DOI 10.1111/j.1600-0536.1993.tb03431.x
   Asad Tehmina, 1993, International Journal of Prosthodontics, V6, P9
   ASMUSSEN E, 1993, J DENT RES, V72, P558, DOI 10.1177/00220345930720030101
   ASMUSSEN E, 1993, ACTA ODONTOL SCAND, V51, P235, DOI 10.3109/00016359309040572
   AZOUKA A, 1993, J ORAL REHABIL, V20, P393, DOI 10.1111/j.1365-2842.1993.tb01623.x
   BAGAMBISA FB, 1993, J BIOMED MATER RES, V27, P1047, DOI 10.1002/jbm.820270810
   BAGAMBISA FB, 1993, CELL MATER, V3, P93
   Bagheri J, 1993, Iowa Dent J, V79, P13
   Bahannan S, 1993, Int J Prosthodont, V6, P502
   Bahcall James K., 1993, General Dentistry, V41, P45
   Baker P S, 1993, Int J Prosthodont, V6, P291
   BALES DJ, 1991, CURR OPIN DENT, V1, P253
   BALES DJ, 1992, CURR OPIN DENT, V2, P183
   BALES DJ, 1991, CURR OPIN DENT, V1, P245
   Ban S, 1993, Dent Mater J, V12, P106
   BAPNA MS, 1993, DENT MATER, V9, P51, DOI 10.1016/0109-5641(93)90106-Z
   BARNES DM, 1993, OPER DENT, V18, P237
   Barrack G, 1993, Quintessence Int, V24, P701
   Barrack G, 1993, Int J Prosthodont, V6, P428
   BARRETT RD, 1993, AM J ORTHOD DENTOFAC, V103, P8, DOI 10.1016/0889-5406(93)70098-9
   Barron D J, 1993, Int J Prosthodont, V6, P495
   BASS JK, 1993, AM J ORTHOD DENTOFAC, V103, P280, DOI 10.1016/0889-5406(93)70009-D
   BEATTY MW, 1993, BIOMATERIALS, V14, P999, DOI 10.1016/0142-9612(93)90192-5
   BEATTY MW, 1993, J BIOMED MATER RES, V27, P403, DOI 10.1002/jbm.820270314
   BECKHAM BM, 1993, J ENDODONT, V19, P388, DOI 10.1016/S0099-2399(06)81501-3
   Beemer R L, 1993, Pediatr Dent, V15, P408
   Ben-Amar A, 1993, Am J Dent, V6, P65
   BEREKALLY TL, 1993, AUST DENT J, V38, P85, DOI 10.1111/j.1834-7819.1993.tb05468.x
   BEREKALLY TL, 1993, AUST DENT J, V38, P229, DOI 10.1111/j.1834-7819.1993.tb03070.x
   BERGENHOLTZ G, 1993, J DENT, V21, P220, DOI 10.1016/0300-5712(93)90133-B
   BERGLUND A, 1993, J DENT RES, V72, P939, DOI 10.1177/00220345930720051601
   Bernal G, 1993, Int J Prosthodont, V6, P286
   Berrong J M, 1993, J Prosthodont, V2, P24, DOI 10.1111/j.1532-849X.1993.tb00377.x
   BERTE JJ, 1993, J PROSTHET DENT, V69, P347, DOI 10.1016/0022-3913(93)90122-5
   BESIMO C, 1993, J PROSTHET DENT, V69, P144, DOI 10.1016/0022-3913(93)90132-8
   BEVENIUS J, 1993, J ORAL REHABIL, V20, P1, DOI 10.1111/j.1365-2842.1993.tb01509.x
   BEZZON OL, 1993, J PROSTHET DENT, V69, P243, DOI 10.1016/0022-3913(93)90098-9
   BIRCHER AJ, 1993, CONTACT DERMATITIS, V29, P275, DOI 10.1111/j.1600-0536.1993.tb03568.x
   BISHARA SE, 1993, AM J ORTHOD DENTOFAC, V103, P115, DOI 10.1016/S0889-5406(05)81760-3
   BISHARA SE, 1993, AM J ORTHOD DENTOFAC, V104, P444, DOI 10.1016/0889-5406(93)70070-5
   BISHARA SE, 1993, AM J ORTHOD DENTOFAC, V104, P170, DOI 10.1016/S0889-5406(05)81007-8
   Blair K F, 1993, Int J Prosthodont, V6, P579
   Blixt M, 1993, Quintessence Int, V24, P203
   BLUNCK U, 1993, ACTA ODONTOL SCAND, V51, P353, DOI 10.3109/00016359309040586
   BOHNE W, 1993, CELL MATER, V3, P377
   Boksman L, 1993, Quintessence Int, V24, P131
   BOUVIER D, 1993, DENT MATER, V9, P365, DOI 10.1016/0109-5641(93)90058-X
   Bowen R L, 1993, J Calif Dent Assoc, V21, P19
   BOWEN RL, 1993, DENT MATER, V9, P290, DOI 10.1016/0109-5641(93)90045-R
   BOYER DB, 1993, J DENT RES, V72, P1244, DOI 10.1177/00220345930720081401
   BOYLE JJ, 1993, J PROSTHET DENT, V69, P19, DOI 10.1016/0022-3913(93)90234-F
   BRAEM MJA, 1993, DENT MATER, V9, P23, DOI 10.1016/0109-5641(93)90100-5
   Brandt R L, 1993, Gen Dent, V41, P157
   BRANTLEY WA, 1993, CELL MATER, V3, P103
   BRANTLEY WA, 1993, J ORAL REHABIL, V20, P61, DOI 10.1111/j.1365-2842.1993.tb01515.x
   BRES EF, 1993, J MICROSC-OXFORD, V170, P147, DOI 10.1111/j.1365-2818.1993.tb03334.x
   Bridgeport D A, 1993, J Prosthodont, V2, P144, DOI 10.1111/j.1532-849X.1993.tb00398.x
   Brouns E M, 1993, Eur J Orthod, V15, P115
   Brown I H, 1993, Am J Dent, V6, P255
   BROWN KB, 1993, OPER DENT, V18, P17
   BUMGARDNER JD, 1993, DENT MATER, V9, P85, DOI 10.1016/0109-5641(93)90080-A
   BUMGARDNER JD, 1993, DENT MATER, V9, P252, DOI 10.1016/0109-5641(93)90070-7
   Burgess J O, 1993, Am J Dent, V6, P137
   Burgess John O., 1993, General Dentistry, V41, P301
   Burke F J, 1993, Dent Update, V20, P109
   Burke F J, 1993, Quintessence Int, V24, P875
   BURKE FJ, 1993, DENT UPDATE, V20, P112
   BURR DB, 1993, J BIOMECH, V26, P613, DOI 10.1016/0021-9290(93)90023-8
   Burrow M F, 1993, Dent Mater J, V12, P97
   BURTSCHER P, 1993, DENT MATER, V9, P218, DOI 10.1016/0109-5641(93)90064-W
   Butson T J, 1993, Int J Prosthodont, V6, P468
   CARDASH HS, 1993, J PROSTHET DENT, V69, P620, DOI 10.1016/0022-3913(93)90293-W
   Carr A B, 1993, Int J Prosthodont, V6, P233
   CARROTTE PV, 1993, BRIT DENT J, V174, P235, DOI 10.1038/sj.bdj.4808129
   CARSTENSEN W, 1993, ANGLE ORTHOD, V63, P221
   CATHERS SJ, 1993, ORAL SURG ORAL MED O, V76, P343, DOI 10.1016/0030-4220(93)90265-6
   CATTANILORENTE MA, 1993, DENT MATER, V9, P57, DOI 10.1016/0109-5641(93)90107-2
   CATTERLIN RK, 1993, J PROSTHET DENT, V69, P57, DOI 10.1016/0022-3913(93)90241-F
   CAUSTO BE, 1993, DENT MATER, V9, P309
   CHADWICK RG, 1993, J DENT, V21, P111, DOI 10.1016/0300-5712(93)90158-M
   Chai J, 1993, J Prosthodont, V2, P167, DOI 10.1111/j.1532-849X.1993.tb00402.x
   Chalker S A, 1993, Eur J Prosthodont Restor Dent, V1, P151
   CHAN FW, 1993, AUST DENT J, V38, P39, DOI 10.1111/j.1834-7819.1993.tb05449.x
   Chan M F, 1993, Eur J Prosthodont Restor Dent, V2, P23
   Chang J C, 1993, J Prosthodont, V2, P110, DOI 10.1111/j.1532-849X.1993.tb00391.x
   Chang J C, 1993, Am J Dent, V6, P53
   Chen L H, 1993, Int J Prosthodont, V6, P573
   CHEN ZP, 1993, J BIOMECH ENG-T ASME, V115, P119, DOI 10.1115/1.2895458
   Cheng A C, 1993, J Prosthodont, V2, P103, DOI 10.1111/j.1532-849X.1993.tb00390.x
   CHENG YY, 1993, BIOMATERIALS, V14, P775, DOI 10.1016/0142-9612(93)90043-2
   Chew C L, 1993, Int J Prosthodont, V6, P528
   CHONG BS, 1993, INT ENDOD J, V26, P218, DOI 10.1111/j.1365-2591.1993.tb00562.x
   CHONG YH, 1993, J ORAL REHABIL, V20, P631, DOI 10.1111/j.1365-2842.1993.tb01651.x
   CHOW TW, 1993, J DENT, V21, P367, DOI 10.1016/0300-5712(93)90014-H
   CHRISTENSEN GJ, 1993, J AM DENT ASSOC, V124, P248, DOI 10.14219/jada.archive.1993.0270
   CHUNG KH, 1993, J ORAL REHABIL, V20, P79, DOI 10.1111/j.1365-2842.1993.tb01517.x
   COLI P, 1993, OPER DENT, V18, P33
   Coli P, 1993, Quintessence Int, V24, P583
   Collis J, 1993, Int J Prosthodont, V6, P440
   COOGAN MM, 1993, INT ENDOD J, V26, P355, DOI 10.1111/j.1365-2591.1993.tb00769.x
   Cooper R B, 1993, J Clin Orthod, V27, P164
   Cortes O, 1993, Am J Dent, V6, P299
   COWIN SC, 1993, J BIOMECH ENG-T ASME, V115, P528, DOI 10.1115/1.2895535
   Cox C J, 1993, Eur J Prosthodont Restor Dent, V1, P179
   CRAIG RG, 1993, J ORAL REHABIL, V20, P483, DOI 10.1111/j.1365-2842.1993.tb01634.x
   CREUGERS NHJ, 1993, J DENT, V21, P281, DOI 10.1016/0300-5712(93)90108-3
   Crim G A, 1993, Am J Dent, V6, P192
   Crim G A, 1993, Am J Dent, V6, P142
   CRIM GA, 1993, J PROSTHET DENT, V69, P561, DOI 10.1016/0022-3913(93)90281-R
   CROLET JM, 1993, J BIOMECH, V26, P677, DOI 10.1016/0021-9290(93)90031-9
   Cua-Benward Gracia B., 1993, Pediatric Dentistry, V15, P353
   CUNNINGHAM JL, 1993, J DENT, V21, P274, DOI 10.1016/0300-5712(93)90106-Z
   Curtis S R, 1993, Int J Prosthodont, V6, P553
   CUSANO F, 1993, CONTACT DERMATITIS, V28, P127, DOI 10.1111/j.1600-0536.1993.tb03369.x
   DAHL BL, 1993, ACTA ODONTOL SCAND, V51, P299, DOI 10.3109/00016359309040581
   DALLOROLOGIO GD, 1993, AM J DENT, V6, P283
   Darbar U R, 1993, Eur J Prosthodont Restor Dent, V1, P117
   Davenport J C, 1993, Dent Update, V20, P221
   Davidson C L, 1993, Am J Dent, V6, P39
   DAVIDSON CL, 1993, J ORAL REHABIL, V20, P291, DOI 10.1111/j.1365-2842.1993.tb01611.x
   DAVIES EH, 1993, BIOMATERIALS, V14, P636, DOI 10.1016/0142-9612(93)90184-4
   Davies Jeffrey P., 1993, Clinical Materials, V12, P121, DOI 10.1016/0267-6605(93)90061-B
   Davis D R, 1993, Clin Mater, V12, P83, DOI 10.1016/0267-6605(93)90054-B
   Davis E L, 1993, Am J Dent, V6, P127
   DAVIS SJ, 1993, PROTEIN ENG, V6, P229, DOI 10.1093/protein/6.2.229
   DECAMARGO LM, 1993, J PROSTHET DENT, V70, P114, DOI 10.1016/0022-3913(93)90003-7
   DEDERICH DN, 1993, J AM DENT ASSOC, V124, P57, DOI 10.14219/jada.archive.1993.0036
   DEGEE AJ, 1993, DENT MATER, V9, P11, DOI 10.1016/0109-5641(93)90097-A
   DEJOU J, 1993, J BIOMED MATER RES, V27, P877, DOI 10.1002/jbm.820270706
   DENISSEN HW, 1993, J PROSTHET DENT, V69, P464, DOI 10.1016/0022-3913(93)90154-G
   DENRY IL, 1993, J DENT RES, V72, P1429, DOI 10.1177/00220345930720101301
   DENRY IL, 1993, J DENT RES, V72, P572, DOI 10.1177/00220345930720030301
   DeSchepper E J, 1993, Am J Dent, V6, P235
   Devlin H, 1993, Dent Update, V20, P21
   DHARMAR S, 1993, J PROSTHET DENT, V69, P369, DOI 10.1016/0022-3913(93)90182-N
   Diaz-Arnold A M, 1993, Am J Dent, V6, P291
   Diaz-Arnold A M, 1993, J Prosthodont, V2, P215, DOI 10.1111/j.1532-849X.1993.tb00412.x
   Dickinson G L, 1993, Am J Dent, V6, P85
   DICKINSON GL, 1993, J AM DENT ASSOC, V124, P68, DOI 10.14219/jada.archive.1993.0265
   DION I, 1993, BIOMATERIALS, V14, P122, DOI 10.1016/0142-9612(93)90222-N
   DITSCHI D, 1993, QUINTESSENCE INT, V24, P281
   Diwan R, 1993, Clin Mater, V12, P117, DOI 10.1016/0267-6605(93)90060-K
   Dixon D L, 1993, Int J Prosthodont, V6, P303
   Donovan T E, 1993, Dent Clin North Am, V37, P433
   DOOTZ ER, 1993, J PROSTHET DENT, V69, P114, DOI 10.1016/0022-3913(93)90250-R
   DOUGHERTY HL, 1993, AM J ORTHOD DENTOFAC, V104, pA23, DOI 10.1016/S0889-5406(05)80999-0
   Douglas W H, 1993, J Clin Dent, V4, P43
   DRAPAL S, 1993, J DENT RES, V72, P587, DOI 10.1177/00220345930720030601
   Driessen C. H., 1993, International Journal of Prosthodontics, V6, P31
   Drummond B. K., 1993, New Zealand Dental Journal, V89, P92
   DRUMMOND JL, 1993, DENT MATER, V9, P68, DOI 10.1016/0109-5641(93)90109-4
   DRUMMOND JL, 1993, DENT MATER, V9, P214, DOI 10.1016/0109-5641(93)90123-8
   Duke E S, 1993, Dent Clin North Am, V37, P329
   DUNNE SM, 1993, BRIT DENT J, V174, P405, DOI 10.1038/sj.bdj.4808186
   Duret F, 1993, J Can Dent Assoc, V59, P445
   DUTTON FB, 1993, J DENT, V21, P52, DOI 10.1016/0300-5712(93)90052-R
   EDGERTON M, 1993, J PROSTHET DENT, V69, P406, DOI 10.1016/0022-3913(93)90190-Y
   Edmunds D H, 1993, Dent Update, V20, P14
   EDMUNDS DH, 1993, DENT UPDATE, V20, P18
   Eick J D, 1993, Quintessence Int, V24, P571
   Eick J D, 1993, Quintessence Int, V24, P632
   EICK JD, 1993, DENT MATER, V9, P123, DOI 10.1016/0109-5641(93)90088-8
   EIDE R, 1993, SCAND J DENT RES, V101, P1
   EKFELDT A, 1993, ACTA ODONTOL SCAND, V51, P99, DOI 10.3109/00016359309041154
   EKSTRAND K, 1993, J PROSTHET DENT, V69, P314, DOI 10.1016/0022-3913(93)90112-2
   ELBADRAWY WAG, 1993, DENT MATER, V9, P63, DOI 10.1016/0109-5641(93)90108-3
   Eldiwany M, 1993, Am J Dent, V6, P222
   ELEY BM, 1993, BRIT DENT J, V175, P355, DOI 10.1038/sj.bdj.4808325
   ELEY BM, 1993, BRIT DENT J, V175, P161
   Elhabashy A, 1993, Am J Dent, V6, P123
   ELIADES G, 1993, DENT MATER, V9, P198, DOI 10.1016/0109-5641(93)90120-F
   ELIADES T, 1993, AM J ORTHOD DENTOFAC, V104, P21, DOI 10.1016/S0889-5406(08)80120-5
   Elkins C J, 1993, Quintessence Int, V24, P271
   Emilson C G, 1993, Quintessence Int, V24, P511
   ERICSON D, 1993, J PROSTHET DENT, V70, P219, DOI 10.1016/0022-3913(93)90055-S
   FAIRHURST CW, 1993, DENT MATER, V9, P269, DOI 10.1016/0109-5641(93)90073-Y
   FEILZER AJ, 1993, DENT MATER, V9, P2, DOI 10.1016/0109-5641(93)90095-8
   FERNANDES CP, 1993, J PROSTHET DENT, V70, P457, DOI 10.1016/0022-3913(93)90085-3
   FERRACANE JL, 1993, DENT MATER, V9, P300, DOI 10.1016/0109-5641(93)90047-T
   Ferrari M, 1993, Quintessence Int, V24, P861
   Ferrari M, 1993, Quintessence Int, V24, P735
   FERRARI M, 1993, J PROSTHET DENT, V70, P465, DOI 10.1016/0022-3913(93)90086-4
   Fischer G M, 1993, Am J Dent, V6, P173
   Fitchie J G, 1993, Quintessence Int, V24, P65
   FITCHIE JG, 1993, DENT MATER, V9, P28, DOI 10.1016/0109-5641(93)90101-U
   FORSS H, 1993, J DENT RES, V72, P1257, DOI 10.1177/00220345930720081601
   FORSTEN L, 1993, ACTA ODONTOL SCAND, V51, P195, DOI 10.3109/00016359309040567
   FOSTER KH, 1993, J ENDODONT, V19, P136, DOI 10.1016/S0099-2399(06)80508-X
   Frangou M J, 1993, Eur J Prosthodont Restor Dent, V1, P111
   Franklin S, 1993, J Clin Orthod, V27, P83
   FRAYSSINET P, 1993, CELL MATER, V3, P383
   FREEDMAN G, 1993, AM J DENT, V6, P55
   Fujisawa S, 1993, Dent Mater J, V12, P69
   FULL CA, 1993, J DENT CHILD, V60, P52
   FULL CA, 1993, J DENT CHILD, V60, P48
   FULL CA, 1993, J DENT CHILD, V60, P57
   Fusayama T, 1993, Quintessence Int, V24, P225
   FYHRIE DP, 1993, J BIOMECH, V26, P955, DOI 10.1016/0021-9290(93)90057-L
   Galan D, 1993, J Ir Dent Assoc, V39, P104
   GANGLER P, 1993, SCAND J DENT RES, V101, P345
   Garcia-Godoy F, 1993, J Clin Pediatr Dent, V17, P83
   Garcia-Godoy F, 1993, Gen Dent, V41, P557
   Garcia-Godoy Franklin, 1993, Pediatric Dentistry, V15, P272
   GARCIAGODOY F, 1993, OPER DENT, V18, P144
   GATES WD, 1993, J PROSTHET DENT, V69, P12, DOI 10.1016/0022-3913(93)90232-D
   GATTI AM, 1993, CELL MATER, V3, P283
   GEE D, 1993, BRIT DENT J, V174, P65, DOI 10.1038/sj.bdj.4808079
   GEERTS GAVM, 1993, J PROSTHET DENT, V70, P406, DOI 10.1016/0022-3913(93)90075-Y
   GEIGER SB, 1993, DENT MATER, V9, P33, DOI 10.1016/0109-5641(93)90102-V
   GEISGERSTORFER J, 1993, DENT MATER, V9, P177, DOI 10.1016/0109-5641(93)90117-9
   Gerbo L R, 1993, Am J Dent, V6, P96
   GERBO LR, 1993, AM J ORTHOD DENTOFAC, V103, P71, DOI 10.1016/0889-5406(93)70109-2
   GERLACH A, 1993, BIOMATERIALS, V14, P770, DOI 10.1016/0142-9612(93)90042-Z
   GILBERT JL, 1993, J BIOMED MATER RES, V27, P1357, DOI 10.1002/jbm.820271103
   GILBERT LC, 1993, MICROSC RES TECHNIQ, V25, P419, DOI 10.1002/jemt.1070250511
   Gilmour A S, 1993, Dent Update, V20, P167
   Gilmour AS, 1993, DENT UPDATE, V20, P171
   GOLDSTEIN GR, 1993, J PROSTHET DENT, V69, P616, DOI 10.1016/0022-3913(93)90292-V
   GOODIS HE, 1993, DENT MATER, V9, P146, DOI 10.1016/0109-5641(93)90111-3
   GOODIS HE, 1993, DENT MATER, V9, P79, DOI 10.1016/0109-5641(93)90079-6
   GOODIS HE, 1993, SCANNING MICROSCOPY, V7, P979
   GREY NJA, 1993, J DENT, V21, P47, DOI 10.1016/0300-5712(93)90051-Q
   GREY NJA, 1993, J DENT, V21, P185, DOI 10.1016/0300-5712(93)90031-K
   GRIEVE AR, 1993, J ORAL REHABIL, V20, P11, DOI 10.1111/j.1365-2842.1993.tb01510.x
   GRIMSDOTTIR MR, 1993, SCAND J DENT RES, V101, P229
   GROSSMAN ES, 1993, J PROSTHET DENT, V69, P469, DOI 10.1016/0022-3913(93)90155-H
   GUERRA L, 1993, CONTACT DERMATITIS, V28, P101, DOI 10.1111/j.1600-0536.1993.tb03351.x
   GUNDLER A, 1993, SCAND J DENT RES, V101, P252
   Gutmann M S, 1993, Am J Dent, V6, P99
   Gutteridge D L, 1993, Clin Mater, V12, P137, DOI 10.1016/0267-6605(93)90064-E
   Gwinnett A J, 1993, Am J Dent, V6, P7
   GWINNETT AJ, 1993, AM J DENT, V6, P207
   HABERMAN AL, 1993, CONTACT DERMATITIS, V28, P157, DOI 10.1111/j.1600-0536.1993.tb03378.x
   HADAVI F, 1993, OPER DENT, V18, P61
   HADAVI F, 1993, OPER DENT, V18, P2
   Hadavi F, 1993, Gen Dent, V41, P49
   Hager T S, 1993, J Prosthodont, V2, P56, DOI 10.1111/j.1532-849X.1993.tb00382.x
   HAHN R, 1993, DENT MATER, V9, P312, DOI 10.1016/0109-5641(93)90049-V
   HALL LHS, 1993, OPER DENT, V18, P246
   HALLER B, 1993, DENT MATER, V9, P191, DOI 10.1016/0109-5641(93)90119-B
   HALLETT KB, 1993, DENT MATER, V9, P306, DOI 10.1016/0109-5641(93)90048-U
   HALLSTROM U, 1993, J DENT CHILD, V60, P143
   HAM HJ, 1993, DENT MATER J SNU, V3, P83
   HAN S, 1993, ANGLE ORTHOD, V63, P67
   Hanawa T, 1993, Dent Mater J, V12, P118
   HANDLEY J, 1993, CONTACT DERMATITIS, V29, P258
   HANSEN EK, 1993, SCAND J DENT RES, V101, P115
   HANSEN EK, 1993, ACTA ODONTOL SCAND, V51, P73, DOI 10.3109/00016359309041151
   HANSEN EK, 1993, SCAND J DENT RES, V101, P62
   HANSEN EK, 1993, SCAND J DENT RES, V101, P176
   HANSSON O, 1993, SCAND J DENT RES, V101, P243
   HARNIRATTISAI C, 1993, OPER DENT, V18, P138
   Harper C, 1993, Br J Orthod, V20, P155
   HARRINGTON E, 1993, J DENT, V21, P305, DOI 10.1016/0300-5712(93)90114-6
   HASEGAWA T, 1993, DENT MATER, V9, P114, DOI 10.1016/0109-5641(93)90086-6
   HAYASHI Y, 1993, J ELECTRON MICROSC, V42, P141
   HAYASHI Y, 1993, J ELECTRON MICROSC, V42, P415
   HAYASHI Y, 1993, J ELECTRON MICROSC, V42, P342
   HEATH JR, 1993, J ORAL REHABIL, V20, P45, DOI 10.1111/j.1365-2842.1993.tb01513.x
   HEATH JR, 1993, J ORAL REHABIL, V20, P517, DOI 10.1111/j.1365-2842.1993.tb01638.x
   HEATH JR, 1993, J ORAL REHABIL, V20, P627, DOI 10.1111/j.1365-2842.1993.tb01650.x
   HEGARTY AM, 1993, BIOMATERIALS, V14, P349, DOI 10.1016/0142-9612(93)90053-5
   HERO H, 1993, DENT MATER, V9, P15, DOI 10.1016/0109-5641(93)90098-B
   HERRSTROM P, 1993, SCAND J DENT RES, V101, P232
   HEYMANN HO, 1993, J AM DENT ASSOC, V124, P27
   Hickham J H, 1993, J Clin Orthod, V27, P215
   Hicks M J, 1993, Am J Dent, V6, P176
   HICKS MJ, 1993, J DENT CHILD, V60, P201
   Hinoura K, 1993, Am J Dent, V6, P69
   Hinoura K, 1993, Int J Prosthodont, V6, P255
   Hirabayashi S, 1993, Dent Mater J, V12, P159
   Hirota Kazushi, 1993, Bio-Medical Materials and Engineering, V3, P147
   Hisatsune K, 1993, Dent Mater J, V12, P233
   Hoard R J, 1993, Oral Health, V83, P15
   HOARD RJ, 1993, ORAL HLTH, V83, P18
   HOJJATIE B, 1993, J DENT RES, V72, P566, DOI 10.1177/00220345930720030201
   HOLLAND RI, 1993, DENT MATER, V9, P99, DOI 10.1016/0109-5641(93)90083-3
   HOLMES J, 1993, AM J ORTHOD DENTOFAC, V104, P188, DOI 10.1016/S0889-5406(05)81009-1
   HUBSCH PF, 1993, J BIOMED ENG, V15, P401, DOI 10.1016/0141-5425(93)90077-C
   Huget E F, 1993, J Tenn Dent Assoc, V73, P16
   HULTERSTROM AK, 1993, ACTA ODONTOL SCAND, V51, P229, DOI 10.3109/00016359309040571
   Hummert T W, 1993, Am J Dent, V6, P305
   HUNG CM, 1993, J PROSTHET DENT, V69, P573, DOI 10.1016/0022-3913(93)90284-U
   HUNT JA, 1993, J BIOMED ENG, V15, P39, DOI 10.1016/0141-5425(93)90091-C
   HUTTON JE, 1993, J PROSTHET DENT, V70, P121, DOI 10.1016/0022-3913(93)90005-9
   HUYSMANS MCDNJM, 1993, J DENT, V21, P57, DOI 10.1016/0300-5712(93)90054-T
   HUYSMANS MCDNJM, 1993, INT ENDOD J, V26, P294, DOI 10.1111/j.1365-2591.1993.tb00574.x
   HUYSMANS MCDNJM, 1993, J DENT, V21, P190
   Ianzano J A, 1993, Am J Dent, V6, P10
   Ibrahim W M, 1993, J Nihon Univ Sch Dent, V35, P225
   Iimuro F T, 1993, Dent Mater J, V12, P136
   Imai Yohji, 1993, Clinical Materials, V12, P107, DOI 10.1016/0267-6605(93)90058-F
   Imbery T A, 1993, Int J Prosthodont, V6, P55
   INOKOSHI S, 1993, OPER DENT, V18, P8
   Inoue M, 1993, Am J Dent, V6, P243
   Inoue T, 1993, J Nihon Univ Sch Dent, V35, P252
   Ironside J G, 1993, Quintessence Int, V24, P867
   ISAKSSON M, 1993, SCAND J DENT RES, V101, P49
   Ishigami K, 1993, J Nihon Univ Sch Dent, V35, P36
   Ishikawa-Nagai S, 1993, Int J Prosthodont, V6, P522
   JAARDA MJ, 1993, J PROSTHET DENT, V69, P416, DOI 10.1016/0022-3913(93)90191-P
   Jacobi R, 1993, Dent Clin North Am, V37, P367
   JACOBSEN T, 1993, J DENT, V21, P150, DOI 10.1016/0300-5712(93)90025-L
   JAMESON MW, 1993, J BIOMECH, V26, P1055, DOI 10.1016/S0021-9290(05)80005-3
   JEAN AH, 1993, CELL MATER, V3, P193
   Jendresen M D, 1993, Quintessence Int, V24, P659
   JENDRESEN MD, 1993, J PROSTHET DENT, V70, P44, DOI 10.1016/0022-3913(93)90036-N
   JEPSON NJA, 1993, J DENT, V21, P163, DOI 10.1016/0300-5712(93)90027-N
   JEPSON NJA, 1993, J DENT, V21, P171, DOI 10.1016/0300-5712(93)90028-O
   JEPSON NJA, 1993, J DENT, V21, P244, DOI 10.1016/0300-5712(93)90137-F
   JOHANNSEN G, 1993, SWED DENT J, V17, P117
   JOHANSSON A, 1993, SCAND J DENT RES, V101, P407
   JOHANSSON A, 1993, J ORAL REHABIL, V20, P463, DOI 10.1111/j.1365-2842.1993.tb01632.x
   JOHANSSON A, 1993, J ORAL REHABIL, V20, P125, DOI 10.1111/j.1365-2842.1993.tb01596.x
   JOHANSSON A, 1993, SCAND J DENT RES, V101, P398
   JOHANSSON G, 1993, SCAND J DENT RES, V101, P78
   JOHNSON GH, 1993, J AM DENT ASSOC, V124, P39
   JOHNSON WW, 1993, DENT MATER, V9, P95, DOI 10.1016/0109-5641(93)90082-2
   JONAS J, 1993, J BIOMECH, V26, P271, DOI 10.1016/0021-9290(93)90365-L
   Jones D W, 1993, J Can Dent Assoc, V59, P155
   JORDAN RE, 1993, J AM DENT ASSOC, V124, P71, DOI 10.14219/jada.archive.1993.0229
   Kanca J, 1993, Am J Dent, V6, P287
   KANERVA L, 1993, CONTACT DERMATITIS, V28, P26, DOI 10.1111/j.1600-0536.1993.tb03319.x
   KANERVA L, 1993, CONTACT DERMATITIS, V28, P268, DOI 10.1111/j.1600-0536.1993.tb03430.x
   Kaplan I, 1993, J Tenn Dent Assoc, V73, P24
   KARLSSON S, 1993, ACTA ODONTOL SCAND, V51, P129, DOI 10.3109/00016359309041158
   KATZ JL, 1993, J BIOMECH ENG-T ASME, V115, P543, DOI 10.1115/1.2895537
   KAWAHARA D, 1993, CONTACT DERMATITIS, V28, P114, DOI 10.1111/j.1600-0536.1993.tb03357.x
   KAWAI K, 1993, DENT MATER, V9, P108, DOI 10.1016/0109-5641(93)90085-5
   Kawano Fumiaki, 1993, International Journal of Prosthodontics, V6, P43
   KEAVENY TM, 1993, J BIOMECH, V26, P991, DOI 10.1016/0021-9290(93)90059-N
   KEAVENY TM, 1993, J BIOMECH ENG-T ASME, V115, P534, DOI 10.1115/1.2895536
   Keith O, 1993, Br J Orthod, V20, P109
   KENNEDY JP, 1993, J BIOMAT SCI-POLYM E, V4, P445
   Kerber L J, 1993, Am J Dent, V6, P216
   KERN M, 1993, J PROSTHET DENT, V70, P449, DOI 10.1016/0022-3913(93)90084-2
   Kern M, 1993, Int J Prosthodont, V6, P585
   KERN M, 1993, DENT MATER, V9, P155, DOI 10.1016/0109-5641(93)90113-5
   KERN M, 1993, J DENT, V21, P185, DOI 10.1016/0300-5712(93)90030-T
   KERN M, 1993, J DENT, V21, P117, DOI 10.1016/0300-5712(93)90160-R
   KERN M, 1993, J DENT, V21, P47
   KEYAK JH, 1993, J BIOMED ENG, V15, P505, DOI 10.1016/0141-5425(93)90066-8
   KHAN AM, 1993, J ORAL REHABIL, V20, P605, DOI 10.1111/j.1365-2842.1993.tb01647.x
   Kidd E A, 1993, Dent Update, V20, P174
   KILPATRICK NM, 1993, J DENT, V21, P67, DOI 10.1016/0300-5712(93)90148-J
   KIM CW, 1993, DENT MATER J SNU, V3, P143
   KIM CW, 1993, DENT MATER J SNU, V3, P121
   KIM CW, 1993, DENT MATER J SNU, V3, P9
   KIM MW, 1993, DENT MATER J SNU, V3, P1
   KLINGE RF, 1993, ACTA ODONTOL SCAND, V51, P223, DOI 10.3109/00016359309040570
   Knight G T, 1993, Int J Prosthodont, V6, P475
   KNOWLES JC, 1993, J BIOMED MATER RES, V27, P1591, DOI 10.1002/jbm.820271217
   KODAKA T, 1993, SCANNING MICROSCOPY, V7, P247
   KODAKA T, 1993, MICROSC RES TECHNIQ, V24, P429, DOI 10.1002/jemt.1070240508
   KOHRI M, 1993, BIOMATERIALS, V14, P299, DOI 10.1016/0142-9612(93)90122-I
   KOLODNEY H, 1993, J PROSTHET DENT, V70, P474, DOI 10.1016/0022-3913(93)90088-6
   Kon M, 1993, Dent Mater J, V12, P12
   KOVARIK RE, 1993, J PROSTHET DENT, V69, P557, DOI 10.1016/0022-3913(93)90280-2
   KOVARIK RE, 1993, DENT MATER, V9, P222, DOI 10.1016/0109-5641(93)90065-X
   KREJCI I, 1993, J PROSTHET DENT, V69, P425, DOI 10.1016/0022-3913(93)90192-Q
   KREJCI I, 1993, J DENT, V21, P39, DOI 10.1016/0300-5712(93)90048-U
   KREJCI I, 1993, J DENT RES, V72, P490, DOI 10.1177/00220345930720020401
   KREULEN CM, 1993, J DENT CHILD, V60, P310
   KREULEN CM, 1993, J DENT CHILD, V60, P95
   KREULEN CM, 1993, J DENT CHILD, V60, P304
   Krishnan V K, 1993, Clin Mater, V12, P149
   Kurata S, 1993, Dent Mater J, V12, P127
   KUTSCH VKM, 1993, J AM DENT ASSOC, V124, P49, DOI 10.14219/jada.archive.1993.0038
   LADIZESKY NH, 1993, AUST DENT J, V38, P28, DOI 10.1111/j.1834-7819.1993.tb05448.x
   LADIZESKY NH, 1993, DENT MATER, V9, P128, DOI 10.1016/0109-5641(93)90089-9
   LAI JH, 1993, DENT MATER, V9, P139, DOI 10.1016/0109-5641(93)90091-4
   LARMAS MA, 1993, SCAND J DENT RES, V101, P185
   LATTA GH, 1993, J PROSTHET DENT, V70, P109, DOI 10.1016/0022-3913(93)90001-5
   Lautenschlager E P, 1993, Int Dent J, V43, P245
   LEAVOR RO, 1993, BRIT DENT J, V175, P400, DOI 10.1038/sj.bdj.4808338
   LEE SY, 1993, J DENT, V21, P373, DOI 10.1016/0300-5712(93)90015-I
   LEE YK, 1993, DENT MATER J SNU, V3, P49
   LEE YK, 1993, DENT MATER J SNU, V3, P103
   Leinfelder K F, 1993, Dent Clin North Am, V37, P411
   LEINFELDER KF, 1993, J AM DENT ASSOC, V124, P40, DOI 10.14219/jada.archive.1993.0129
   LEINFELDER KF, 1993, J AM DENT ASSOC, V124, P62, DOI 10.14219/jada.archive.1993.0180
   Lew Kenneth K. K., 1993, Clinical Materials, V12, P89, DOI 10.1016/0267-6605(93)90055-C
   LEWINSTEIN I, 1993, J ORAL REHABIL, V20, P107, DOI 10.1111/j.1365-2842.1993.tb01520.x
   Lewis Gladius, 1993, Bio-Medical Materials and Engineering, V3, P167
   LI JG, 1993, BIOMATERIALS, V14, P1186, DOI 10.1016/0142-9612(93)90165-X
   LI JG, 1993, BIOMATERIALS, V14, P229, DOI 10.1016/0142-9612(93)90028-Z
   Lidums A, 1993, Am J Dent, V6, P185
   Liebenberg W H, 1993, Quintessence Int, V24, P881
   LIN FH, 1993, J BIOMED ENG, V15, P481, DOI 10.1016/0141-5425(93)90063-5
   LIN JHC, 1993, DENT MATER, V9, P286
   LINDE F, 1993, J BIOMECH, V26, P1249, DOI 10.1016/0021-9290(93)90072-M
   Liou A D, 1993, Int J Prosthodont, V6, P377
   Liu C C, 1993, Int J Prosthodont, V6, P60
   LIU CC, 1993, DENT MATER, V9, P37, DOI 10.1016/0109-5641(93)90103-W
   LIU PR, 1993, J AM DENT ASSOC, V124, P59, DOI 10.14219/jada.archive.1993.0089
   LOCARDI B, 1993, BIOMATERIALS, V14, P437, DOI 10.1016/0142-9612(93)90146-S
   Loiacono Carla, 1993, General Dentistry, V41, P378
   Loney R W, 1993, Int J Prosthodont, V6, P390
   Lorey R E, 1993, J Prosthodont, V2, P151, DOI 10.1111/j.1532-849X.1993.tb00399.x
   LORSCHEIDER FL, 1993, FASEB J, V7, P1432
   LOVE WC, 1993, OPER DENT, V18, P195
   LU GH, 1993, J DENT, V21, P289, DOI 10.1016/0300-5712(93)90111-3
   LYGRE H, 1993, ACTA ODONTOL SCAND, V51, P45, DOI 10.3109/00016359309041147
   LYTTLE HA, 1993, J DENT RES, V72, P1320, DOI 10.1177/00220345930720091101
   MAHLER DB, 1993, DENT MATER, V9, P162, DOI 10.1016/0109-5641(93)90114-6
   MAMMONE JF, 1993, J BIOMECH, V26, P439, DOI 10.1016/0021-9290(93)90007-2
   MANABE A, 1993, J DENT, V21, P344, DOI 10.1016/0300-5712(93)90009-F
   Mandras R S, 1993, Am J Dent, V6, P119
   Mandras Rozalia S., 1993, General Dentistry, V41, P133
   Mangum Frank I. Jr., 1993, General Dentistry, V41, P139
   MANTE F, 1993, DENT MATER, V9, P325, DOI 10.1016/0109-5641(93)90051-Q
   Mante F K, 1993, Int J Prosthodont, V6, P546
   MARCUSHAMER M, 1993, J DENT CHILD, V60, P300
   MAREK M, 1993, J DENT RES, V72, P1315, DOI 10.1177/00220345930720091001
   MARKS LW, 1993, J BIOMED ENG, V15, P474, DOI 10.1016/0141-5425(93)90061-3
   MARQUEZ F, 1993, BIOMATERIALS, V14, P313, DOI 10.1016/0142-9612(93)90124-K
   Marshall G W Jr, 1993, Quintessence Int, V24, P606
   MARSHALL GW, 1993, DENT MATER, V9, P265, DOI 10.1016/0109-5641(93)90072-X
   MARTIN FE, 1993, AUST DENT J, V38, P102, DOI 10.1111/j.1834-7819.1993.tb05470.x
   MASH LK, 1993, J DENT, V21, P350, DOI 10.1016/0300-5712(93)90010-N
   MASUMI S, 1993, J ORAL REHABIL, V20, P97, DOI 10.1111/j.1365-2842.1993.tb01519.x
   MATSUMURA H, 1993, J PROSTHET DENT, V70, P296, DOI 10.1016/0022-3913(93)90211-6
   MATSUMURA H, 1993, J PROSTHET DENT, V70, P207, DOI 10.1016/0022-3913(93)90053-Q
   Matsumura H, 1993, Am J Dent, V6, P43
   MAY KB, 1993, J PROSTHET DENT, V70, P410, DOI 10.1016/0022-3913(93)90076-Z
   MCALARNEY ME, 1993, AM J ORTHOD DENTOFAC, V104, P575, DOI 10.1016/S0889-5406(05)80441-X
   MCALOON J, 1993, AUST DENT J, V38, P306, DOI 10.1111/j.1834-7819.1993.tb05503.x
   McCaughey A D, 1993, Dent Update, V20, P153
   McConnell R J, 1993, J Calif Dent Assoc, V21, P38
   McCormick J T, 1993, Quintessence Int, V24, P405
   MCINTYRE FM, 1993, J PROSTHET DENT, V69, P564, DOI 10.1016/0022-3913(93)90282-S
   MCKEE MD, 1993, J DENT RES, V72, P1406, DOI 10.1177/00220345930720101001
   MELVIN JW, 1993, J BIOMECH ENG-T ASME, V115, P549, DOI 10.1115/1.2895538
   MENTINK AGB, 1993, J ORAL REHABIL, V20, P455, DOI 10.1111/j.1365-2842.1993.tb01631.x
   MENTINK AGB, 1993, J ORAL REHABIL, V20, P577, DOI 10.1111/j.1365-2842.1993.tb01645.x
   MERMSEN RJ, 1993, DENT MATER, V9, P332
   MEYER RD, 1993, J PROSTHET DENT, V69, P141, DOI 10.1016/0022-3913(93)90131-7
   MICHEL MC, 1993, J BIOMECH, V26, P453, DOI 10.1016/0021-9290(93)90009-4
   MILLER M, 1993, J AM DENT ASSOC, V124, P32, DOI 10.14219/jada.archive.1993.0034
   Miller T E, 1993, Compendium, V14, P802
   MILLER TE, 1993, COMPENDIUM, V14, P806
   MILLER TE, 1993, COMPENDIUM, V14, P802
   Millett D, 1993, Br J Orthod, V20, P117
   MILLS CM, 1993, DRUG SAFETY, V9, P280, DOI 10.2165/00002018-199309040-00006
   MILLS RW, 1993, OPER DENT, V18, P148
   Milosevic A, 1993, Eur J Prosthodont Restor Dent, V1, P173
   MILOSEVIC A, 1993, INT ENDOD J, V26, P106, DOI 10.1111/j.1365-2591.1993.tb00551.x
   MINIOTIS NJ, 1993, J DENT RES, V72, P1045, DOI 10.1177/00220345930720060901
   MISRA DN, 1993, J DENT RES, V72, P1418, DOI 10.1177/00220345930720101101
   Miura H, 1993, Dent Mater J, V12, P209
   Mixson J M, 1993, Am J Dent, V6, P72
   Miyakawa O, 1993, Dent Mater J, V12, P171
   MIYAWAKI H, 1993, J ORAL REHABIL, V20, P653, DOI 10.1111/j.1365-2842.1993.tb01653.x
   Miyawaki H, 1993, Dent Mater J, V12, P62
   MIYAZAKI K, 1993, DENT MATER, V9, P46, DOI 10.1016/0109-5641(93)90105-Y
   MIYAZAKI K, 1993, DENT MATER, V9, P41, DOI 10.1016/0109-5641(93)90104-X
   MJOR IA, 1993, J DENT, V21, P338, DOI 10.1016/0300-5712(93)90006-C
   MJOR IA, 1993, OPER DENT, V18, P82
   MJOR IA, 1993, QUINTESSENCE INT, V242, P343
   MJOR IA, 1993, INT DENT J, V46, P466
   MOLIN M, 1993, ACTA ODONTOL SCAND, V51, P201, DOI 10.3109/00016359309040568
   MOLONEY LG, 1993, J ENDODONT, V19, P59, DOI 10.1016/S0099-2399(06)81195-7
   MOMOI Y, 1993, DENT MATER, V9, P151, DOI 10.1016/0109-5641(93)90112-4
   MONSENEGO G, 1993, J PROSTHET DENT, V69, P106, DOI 10.1016/0022-3913(93)90249-N
   MORGANO SM, 1993, J PROSTHET DENT, V70, P11, DOI 10.1016/0022-3913(93)90030-R
   MORI T, 1993, AUST DENT J, V38, P220, DOI 10.1111/j.1834-7819.1993.tb03068.x
   MORRA M, 1993, DENT MATER, V9, P375, DOI 10.1016/0109-5641(93)90060-4
   Mount G J, 1993, Quintessence Int, V24, P99
   MUELLER HJ, 1993, CELLS MATERIALS, V3, P23
   MURATA H, 1993, J ORAL REHABIL, V20, P177, DOI 10.1111/j.1365-2842.1993.tb01600.x
   1993, AM J DENT, V6, P320
   Murphy D G, 1993, J Mich Dent Assoc, V75, P42
   Myers M L, 1993, Am J Dent, V6, P77
   NAGASE M, 1993, BIOMATERIALS, V14, P1039, DOI 10.1016/0142-9612(93)90199-C
   NAKABAYASHI N, 1993, DENT MATER J SNU, V3, P35
   Neve A D, 1993, Clin Mater, V12, P113, DOI 10.1016/0267-6605(93)90059-G
   NORDBO H, 1993, J PROSTHET DENT, V69, P155, DOI 10.1016/0022-3913(93)90134-A
   O'Kane C, 1993, Br J Orthod, V20, P297
   O'Keefe K L, 1993, Int J Prosthodont, V6, P558
   OBRIEN WJ, 1993, DENT MATER, V9, P242, DOI 10.1016/0109-5641(93)90068-2
   OGUNTEBI B, 1993, J DENT RES, V72, P484, DOI 10.1177/00220345930720020301
   OILO G, 1993, ACTA ODONTOL SCAND, V51, P263, DOI 10.3109/00016359309040576
   Okamoto A, 1993, Dent Mater J, V12, P225
   Okamoto A, 1993, Dent Mater J, V12, P54
   OLSSON S, 1993, SCAND J DENT RES, V101, P180
   ONEAL SJ, 1993, J AM DENT ASSOC, V124, P48, DOI 10.14219/jada.archive.1993.0253
   OOMENS CWJ, 1993, J BIOMECH, V26, P617, DOI 10.1016/0021-9290(93)90024-9
   Osborne J W, 1993, J Ala Dent Assoc, V77, P12
   OSHIDA Y, 1993, DENT MATER, V9, P234, DOI 10.1016/0109-5641(93)90067-Z
   Oshida Yoshiki, 1993, Bio-Medical Materials and Engineering, V3, P117
   Oshida Yoshiki, 1993, Bio-Medical Materials and Engineering, V3, P185
   OSMAN YI, 1993, J PROSTHET DENT, V70, P94, DOI 10.1016/0022-3913(93)90038-P
   OSTMANANDERSSON E, 1993, SWED DENT J, V17, P139
   Owen C P, 1993, Int J Prosthodont, V6, P480
   OWEN DH, 1993, J ANDROL, V14, P210
   Owens B M, 1993, Compendium, V14, P1306
   OWENS BM, 1993, COMPENDIUM, V14, P214
   OWENS BM, 1993, COMPENDIUM, V14, P1304
   OWENS BM, 1993, COMPENDIUM, V14, P212
   OWENS BM, 1993, COMPENDIUM, V14, P1306
   OZATA F, 1993, INT ENDOD J, V26, P241, DOI 10.1111/j.1365-2591.1993.tb00565.x
   PAGE AE, 1993, J BIOMECH, V26, P571, DOI 10.1016/0021-9290(93)90018-A
   PAGHDIWALA AF, 1993, SCANNING MICROSCOPY, V7, P989
   PAGNIANO RP, 1993, J PROSTHET DENT, V70, P214, DOI 10.1016/0022-3913(93)90054-R
   PALLAV P, 1993, J DENT RES, V72, P56, DOI 10.1177/00220345930720010801
   Palmqvist S, 1993, Int J Prosthodont, V6, P279
   PANIGHI M, 1993, J BIOMED MATER RES, V27, P975, DOI 10.1002/jbm.820270802
   Papa J, 1993, Quintessence Int, V24, P93
   Papa J, 1993, Quintessence Int, V24, P715
   PAPADOGIANNIS Y, 1993, DENT MATER, V9, P118, DOI 10.1016/0109-5641(93)90087-7
   PAPAZOGLOU E, 1993, J PROSTHET DENT, V70, P386, DOI 10.1016/0022-3913(93)90072-V
   Park Kitae, 1993, Pediatric Dentistry, V15, P418
   Pashley E L, 1993, Am J Dent, V6, P189
   Pashley E L, 1993, Am J Dent, V6, P116
   PASHLEY EL, 1993, DENT MATER, V9, P19, DOI 10.1016/0109-5641(93)90099-C
   PASHLEY EL, 1993, QUINTESSENCE INT, V24, P618
   Paul S J, 1993, J Esthet Dent, V5, P179, DOI 10.1111/j.1708-8240.1993.tb00775.x
   Paul S J, 1993, J Esthet Dent, V5, P5, DOI 10.1111/j.1708-8240.1993.tb00737.x
   Paul S J, 1993, J Esthet Dent, V5, P51, DOI 10.1111/j.1708-8240.1993.tb00748.x
   Pearson G. J., 1993, Clinical Materials, V12, P77, DOI 10.1016/0267-6605(93)90053-A
   Perdigao J, 1993, Am J Dent, V6, P61
   PETERS MCRB, 1993, J DENT RES, V72, P1537, DOI 10.1177/00220345930720111301
   PEZZOLI M, 1993, J DENT, V21, P312, DOI 10.1016/0300-5712(93)90115-7
   Pick R M, 1993, Dent Clin North Am, V37, P281
   PICK RM, 1993, J AM DENT ASSOC, V124, P37, DOI 10.14219/jada.archive.1993.0027
   Pilcher E S, 1993, J Prosthodont, V2, P174, DOI 10.1111/j.1532-849X.1993.tb00403.x
   PINHEIRO ALB, 1993, BRIT J ORAL MAX SURG, V31, P239, DOI 10.1016/0266-4356(93)90147-O
   Pires J A, 1993, Quintessence Int, V24, P517
   PLASMANS PJJM, 1993, J ORAL REHABIL, V20, P561, DOI 10.1111/j.1365-2842.1993.tb01643.x
   PLASMANS PJJM, 1993, J DENT, V21, P228, DOI 10.1016/0300-5712(93)90134-C
   PLASMANS PJJM, 1993, OPER DENT, V18, P66
   Polyzois G L, 1993, Eur J Prosthodont Restor Dent, V2, P41
   POLYZOIS GL, 1993, J PROSTHET DENT, V70, P26, DOI 10.1016/0022-3913(93)90033-K
   POLYZOIS GL, 1993, J PROSTHET DENT, V69, P374, DOI 10.1016/0022-3913(93)90183-O
   Potoky J R, 1993, Gen Dent, V41, P550
   POUMARAT G, 1993, BIOMATERIALS, V14, P337, DOI 10.1016/0142-9612(93)90051-3
   Powell Tammy L., 1993, Pediatric Dentistry, V15, P104
   Powers J M, 1993, Am J Dent, V6, P232
   PRATI C, 1993, DENT MATER, V9, P338, DOI 10.1016/0109-5641(93)90053-S
   Probster L, 1993, Int J Prosthodont, V6, P259
   PUY MCL, 1993, QUINTESSENCE INT, V24, P429
   QUALTROUGH AJE, 1993, BRIT DENT J, V174, P450, DOI 10.1038/sj.bdj.4808196
   QVIST V, 1993, ACTA ODONTOL SCAND, V51, P253, DOI 10.3109/00016359309040575
   RABBE LM, 1994, CLIN MATER, V15, P221, DOI 10.1016/0267-6605(94)90049-3
   RABCHINSKY J, 1993, DENT MATER, V9, P378
   Rada R E, 1993, Quintessence Int, V24, P793
   RADFORD DR, 1993, INT J PROSTHODONT, V60, P50
   RAFTOPOULOS D, 1993, J BIOMED ENG, V15, P60, DOI 10.1016/0141-5425(93)90095-G
   RAGAIN JC, 1993, OPER DENT, V18, P218
   Ramer M S, 1993, J Prosthodont, V2, P156, DOI 10.1111/j.1532-849X.1993.tb00400.x
   RAMMELSBERG P, 1993, J PROSTHET DENT, V70, P300, DOI 10.1016/0022-3913(93)90212-7
   RANDOW K, 1993, ACTA ODONTOL SCAND, V51, P153, DOI 10.3109/00016359309041161
   RANDOW K, 1993, ACTA ODONTOL SCAND, V51, P333, DOI 10.3109/00016359309040584
   RATHINAM K, 1993, BIOMAT ARTIF CELL IM, V21, P91, DOI 10.3109/10731199309118300
   RATNER BD, 1993, J BIOMED MATER RES, V27, P837, DOI 10.1002/jbm.820270702
   Ray N J, 1993, J Ir Dent Assoc, V39, P30
   RAY NJ, 1993, J IR DENT ASS, V39, P63
   RAY NJ, 1993, J IR DENT ASS, V38, P89
   Razavi R, 1993, J Prosthodont, V2, P224, DOI 10.1111/j.1532-849X.1993.tb00414.x
   Reagan S E, 1993, Am J Dent, V6, P225
   Rebitski G, 1993, Am J Dent, V6, P204
   Regan D, 1993, Eur J Orthod, V15, P125
   Reid J S, 1993, Am J Dent, V6, P81
   REINHARDT JW, 1993, OPER DENT, V18, P56
   Retief D H, 1993, Am J Dent, V6, P17
   RHO JY, 1993, J BIOMECH, V26, P111, DOI 10.1016/0021-9290(93)90042-D
   RICHARDS JM, 1993, AM J ORTHOD DENTOFAC, V104, P224, DOI 10.1016/S0889-5406(05)81723-8
   RICHARDS ND, 1993, DENT MATER, V9, P91, DOI 10.1016/0109-5641(93)90081-Z
   RIMNAC CM, 1993, J BIOMECH, V26, P219, DOI 10.1016/0021-9290(93)90360-Q
   ROBINSON JG, 1993, DENT MATER, V9, P355, DOI 10.1016/0109-5641(93)90056-V
   RODFORD RA, 1993, BIOMATERIALS, V14, P781, DOI 10.1016/0142-9612(93)90044-3
   ROGGENSACK M, 1993, DENT MATER, V9, P104, DOI 10.1016/0109-5641(93)90084-4
   Rosenstiel S F, 1993, Int J Prosthodont, V6, P298
   ROSENSTIEL SF, 1993, J BIOMED MATER RES, V27, P415, DOI 10.1002/jbm.820270315
   ROSENSTIEL SF, 1993, DENT MATER, V9, P274, DOI 10.1016/0109-5641(93)90074-Z
   RUBBI E, 1993, DENT MATER, V9, P361, DOI 10.1016/0109-5641(93)90057-W
   Rueggeberg F A, 1993, Quintessence Int, V24, P391
   Rueggeberg F A, 1993, Am J Dent, V6, P91
   Rueggeberg F A, 1993, Int J Prosthodont, V6, P364
   RUEGGEBERG FA, 1993, OPER DENT, V18, P48
   SADEGH AM, 1993, J BIOMECH, V26, P167, DOI 10.1016/0021-9290(93)90047-I
   SAIKU JM, 1993, OPER DENT, V18, P172
   Sam W H, 1993, Br J Orthod, V20, P225
   SASAKI N, 1993, J BIOMECH, V26, P77, DOI 10.1016/0021-9290(93)90615-L
   SASAKI N, 1993, J BIOMECH, V26, P1369, DOI 10.1016/0021-9290(93)90088-V
   SASANALUCKIT P, 1993, BIOMATERIALS, V14, P906, DOI 10.1016/0142-9612(93)90132-L
   Satoh Y, 1993, J Nihon Univ Sch Dent, V35, P49
   Satoh Y, 1993, J NIHON U SCH DENT, V35, P192
   Scherrer S S, 1993, Int J Prosthodont, V6, P462
   SEGURA A, 1993, J ORAL REHABIL, V20, P495, DOI 10.1111/j.1365-2842.1993.tb01636.x
   Sekiya K, 1993, Dent Mater J, V12, P145
   SEPPA L, 1993, J DENT RES, V72, P1310, DOI 10.1177/00220345930720090901
   Settembrini Leonard, 1993, Journal of Clinical Dentistry, V4, P55
   SHALABY SW, 1993, CELL MATER, V3, P419
   SHAREEF MY, 1993, BIOMATERIALS, V14, P69, DOI 10.1016/0142-9612(93)90078-G
   SHEARER AC, 1993, J DENT, V21, P302, DOI 10.1016/0300-5712(93)90113-5
   SHEEN DH, 1993, ANGLE ORTHOD, V63, P225
   SHIAU JY, 1993, ANGLE ORTHOD, V63, P213
   SHIAU JY, 1993, J DENT RES, V72, P1291, DOI 10.1177/00220345930720090601
   SHIMIZU K, 1993, J BIOMED MATER RES, V27, P729, DOI 10.1002/jbm.820270605
   SHIN WS, 1993, DENT MATER, V9, P317, DOI 10.1016/0109-5641(93)90050-Z
   Shortall A C, 1993, Eur J Prosthodont Restor Dent, V1, P185
   Sidhu S K, 1993, Quintessence Int, V24, P553
   Sidhu S K, 1993, Clin Mater, V12, P11, DOI 10.1016/0267-6605(93)90022-Y
   Sikri V K, 1993, Indian J Dent Res, V4, P13
   Sim C, 1993, Int J Prosthodont, V6, P36
   SMALES RJ, 1993, J DENT, V21, P147, DOI 10.1016/0300-5712(93)90024-K
   SMALES RJ, 1993, OPER DENT, V18, P130
   Smith R M, 1993, Am J Dent, V6, P111
   SMITH RT, 1993, AM J ORTHOD DENTOFAC, V103, P448, DOI 10.1016/S0889-5406(05)81795-0
   SODERHOLM KJM, 1993, J DENT RES, V72, P1050, DOI 10.1177/00220345930720061001
   SOH G, 1993, CLIN MATER, V12, P73
   Sohmura T, 1993, Dent Mater J, V12, P190
   SOUZA MHS, 1983, AM J DENT, V6, P148
   SPEARS IR, 1993, J DENT RES, V72, P1526, DOI 10.1177/00220345930720111101
   STACEY GD, 1993, J PROSTHET DENT, V70, P395, DOI 10.1016/0022-3913(93)90073-W
   STAGGERS JA, 1993, ANGLE ORTHOD, V63, P141
   STANINEC M, 1993, DENT MATER, V9, P204, DOI 10.1016/0109-5641(93)90121-6
   Stanley H R, 1993, J Esthet Dent, V5, P208, DOI 10.1111/j.1708-8240.1993.tb00782.x
   STANLEY HR, 1993, J AM DENT ASSOC, V124, P76, DOI 10.14219/jada.archive.1993.0199
   STANLEY HR, 1993, J DENT RES, V72, P1362, DOI 10.1177/00220345930720100101
   STASTNY K, 1993, BIOMATERIALS, V14, P1105, DOI 10.1016/0142-9612(93)90212-K
   STENBERG R, 1993, ACTA ODONTOL SCAND, V51, P91, DOI 10.3109/00016359309041153
   STOKES AN, 1993, DENT MATER, V9, P370, DOI 10.1016/0109-5641(93)90059-Y
   STOKES AN, 1993, J ORAL REHABIL, V20, P89, DOI 10.1111/j.1365-2842.1993.tb01518.x
   Stol M, 1993, J Biomater Appl, V7, P224, DOI 10.1177/088532829300700302
   STUPP SI, 1993, J BIOMED MATER RES, V27, P289, DOI 10.1002/jbm.820270303
   STUPP SI, 1993, J BIOMED MATER RES, V27, P301, DOI 10.1002/jbm.820270304
   SULIMAN AA, 1993, DENT MATER, V9, P6, DOI 10.1016/0109-5641(93)90096-9
   SULIMAN AA, 1993, J DENT RES, V72, P1532, DOI 10.1177/00220345930720111201
   SULIMAN AHA, 1993, J PROSTHET DENT, V70, P118, DOI 10.1016/0022-3913(93)90004-8
   SUMMITT JB, 1993, OPER DENT, V18, P88
   SUMMITT JB, 1993, OPER DENT, V18, P209
   SUMMITT JB, 1993, OPER DENT, V18, P42
   SUMMITT JB, 1993, OPER DENT, V18, P37
   Sutherland J K, 1993, J Can Dent Assoc, V59, P430
   SUTHERLAND JK, 1993, J CAN DENT ASSOC, V59, P163
   SUTHERLAND JK, 1993, J CAN DENT ASSOC, V59, P155
   Suzuki S, 1993, Quintessence Int, V24, P885
   Suzuki S, 1993, Am J Dent, V6, P199
   Swift E J Jr, 1993, Am J Dent, V6, P88
   Swift E J Jr, 1993, Am J Dent, V6, P162
   SYDISKIS RJ, 1993, J PROSTHET DENT, V69, P431, DOI 10.1016/0022-3913(93)90193-R
   Syu J Z, 1993, Int J Prosthodont, V6, P25
   Tagami J, 1993, Am J Dent, V6, P145
   TAIRA M, 1993, DENT MATER, V9, P167, DOI 10.1016/0109-5641(93)90115-7
   TAKAHASHI H, 1993, J PROSTHET DENT, V70, P261, DOI 10.1016/0022-3913(93)90062-S
   Takahashi J, 1993, Dent Mater J, V12, P245
   Takahashi J, 1993, Dent Mater J, V12, P238
   TAKAHASHI K, 1993, DENT MATER, V9, P350, DOI 10.1016/0109-5641(93)90055-U
   TAKEMORI T, 1993, DENT MATER, V9, P136, DOI 10.1016/0109-5641(93)90090-D
   TAM LE, 1993, J DENT RES, V72, P953, DOI 10.1177/00220345930720051801
   TAMBURIC SD, 1993, INT ENDOD J, V26, P125, DOI 10.1111/j.1365-2591.1993.tb00554.x
   TAN HK, 1993, J PROSTHET DENT, V69, P250, DOI 10.1016/0022-3913(93)90101-S
   TAN HK, 1993, J PROSTHET DENT, V70, P532, DOI 10.1016/0022-3913(93)90267-R
   Tanaka J, 1993, Dent Mater J, V12, P1
   Tanaka J, 1993, Dent Mater J, V12, P196
   Tani C, 1993, Dent Mater J, V12, P219
   Tani Y, 1993, Dent Mater J, V12, P182
   Tate W H, 1993, Am J Dent, V6, P195
   TAYLOR MJ, 1993, J DENT, V21, P265, DOI 10.1016/0300-5712(93)90104-X
   Terata R, 1993, Dent Mater J, V12, P18
   TEWFIK HM, 1993, J ENDODONT, V19, P492, DOI 10.1016/S0099-2399(06)81489-5
   Thayer K E, 1993, Int J Prosthodont, V6, P264
   TISELIUS HG, 1993, SCANNING MICROSCOPY, V7, P381
   Tjan A H, 1993, Quintessence Int, V24, P211
   TOCCHIO RM, 1993, AM J ORTHOD DENTOFAC, V103, P155, DOI 10.1016/S0889-5406(05)81765-2
   TORRES V, 1993, CONTACT DERMATITIS, V29, P102, DOI 10.1111/j.1600-0536.1993.tb03499.x
   TOUATI B, 1993, J ESTHET DENT, V5, P10
   TOYOOKA H, 1993, J ORAL REHABIL, V20, P615, DOI 10.1111/j.1365-2842.1993.tb01648.x
   Triolo P T Jr, 1993, Am J Dent, V6, P302
   Tsuchiya H, 1993, Dent Mater J, V12, P253
   TSUCHIYA H, 1993, J DENT, V21, P240, DOI 10.1016/0300-5712(93)90136-E
   TUNCER N, 1993, J PROSTHET DENT, V69, P333, DOI 10.1016/0022-3913(93)90116-6
   TUNG MS, 1993, J ENDODONT, V19, P383, DOI 10.1016/S0099-2399(06)81500-1
   TURCK MD, 1993, J PROSTHET DENT, V69, P340, DOI 10.1016/0022-3913(93)90117-7
   TURNER CW, 1993, OPER DENT, V18, P187
   Turner P J, 1993, Br J Orthod, V20, P307
   TYAS MJ, 1993, AUST DENT J, V38, P46, DOI 10.1111/j.1834-7819.1993.tb05450.x
   TYAS MJ, 1993, AUST DENT J, V38, P294, DOI 10.1111/j.1834-7819.1993.tb05501.x
   TYAS MJ, 1993, AUST DENT J, V38, P225, DOI 10.1111/j.1834-7819.1993.tb03069.x
   UCTASLI S, 1993, J ORAL REHABIL, V20, P423, DOI 10.1111/j.1365-2842.1993.tb01626.x
   UMENMOTO K, 1993, DENT MATER J, V12, P29
   USAMI Y, 1993, DENT MATER, V9, P344, DOI 10.1016/0109-5641(93)90054-T
   VALLITTU PK, 1993, J ORAL REHABIL, V20, P533, DOI 10.1111/j.1365-2842.1993.tb01640.x
   VALLITTU PK, 1993, ACTA ODONTOL SCAND, V51, P363, DOI 10.3109/00016359309040587
   VALLITTU PK, 1993, J ORAL REHABIL, V20, P241, DOI 10.1111/j.1365-2842.1993.tb01606.x
   van der Zel J M, 1993, Quintessence Int, V24, P769
   VANDERVARST PGT, 1993, J DENT RES, V72, P1249, DOI 10.1177/00220345930720081501
   VANHOLDER R, 1993, BIOMATERIALS, V14, P737, DOI 10.1016/0142-9612(93)90037-3
   VANMEERBEEK B, 1993, J DENT RES, V72, P1423, DOI 10.1177/00220345930720101201
   VANMEERBEEK B, 1993, J DENT, V21, P195, DOI 10.1016/0300-5712(93)90126-B
   VANMEERBEEK B, 1993, J DENT RES, V72, P1434, DOI 10.1177/00220345930720101401
   VANMEERBEEK B, 1993, J DENT RES, V72, P495, DOI 10.1177/00220345930720020501
   VANMEERBEEK B, 1993, J PROSTHET DENT, V70, P308, DOI 10.1016/0022-3913(93)90213-8
   VANNOORT R, 1993, J DENT, V21, P5, DOI 10.1016/0300-5712(93)90046-S
   VANNOORT R, 1993, J DENT, V21, P209, DOI 10.1016/0300-5712(93)90128-D
   Vassilakos N, 1993, Eur J Prosthodont Restor Dent, V2, P29
   VASSILAKOS N, 1993, J DENT, V21, P297, DOI 10.1016/0300-5712(93)90112-4
   VENHOVEN BAM, 1993, BIOMATERIALS, V14, P871, DOI 10.1016/0142-9612(93)90010-Y
   VENZ S, 1993, J DENT RES, V72, P582, DOI 10.1177/00220345930720030501
   VERBEECK RMH, 1993, J DENT RES, V72, P577, DOI 10.1177/00220345930720030401
   VIAZIS AD, 1993, AM J ORTHOD DENTOFAC, V103, P537, DOI 10.1016/0889-5406(93)70094-5
   Vieira A C, 1993, J Clin Pediatr Dent, V18, P7
   VONBEETZEN M, 1993, OPER DENT, V18, P103
   VONFRAUNHOFER JA, 1993, ANGLE ORTHOD, V63, P73
   VONGSAVAN N, 1993, INT ENDOD J, V26, P10, DOI 10.1111/j.1365-2591.1993.tb00532.x
   VOSS A, 1993, ANGLE ORTHOD, V63, P149
   WAGNER WC, 1993, J BIOMED MATER RES, V27, P531, DOI 10.1002/jbm.820270414
   WAHLE JJ, 1993, J PROSTHET DENT, V69, P160, DOI 10.1016/0022-3913(93)90135-B
   WAKABAYASHI H, 1993, INT ENDOD J, V26, P153
   WALKER EB, 1993, J PROSTHET DENT, V70, P553, DOI 10.1016/0022-3913(93)90275-S
   Walsh W. R., 1993, Bio-Medical Materials and Engineering, V3, P75
   WANG BC, 1993, J BIOMED MATER RES, V27, P1315, DOI 10.1002/jbm.820271012
   WANG WN, 1993, AM J ORTHOD DENTOFAC, V104, P251, DOI 10.1016/S0889-5406(05)81726-3
   WANIS TM, 1993, J ORAL REHABIL, V20, P379, DOI 10.1111/j.1365-2842.1993.tb01621.x
   Wasson E A, 1993, Clin Mater, V12, P181, DOI 10.1016/0267-6605(93)90070-N
   WASSON EA, 1993, J DENT RES, V72, P481, DOI 10.1177/00220345930720020201
   WASSON EA, 1993, J DENT, V21, P122, DOI 10.1016/0300-5712(93)90161-I
   WATAHA JC, 1993, DENT MATER, V9, P172, DOI 10.1016/0109-5641(93)90116-8
   Watanabe I, 1993, Quintessence Int, V24, P335
   WATSON TF, 1993, INT ENDOD J, V26, P11, DOI 10.1111/j.1365-2591.1993.tb00533.x
   WATTS DC, 1993, DENT MATER, V9, P74, DOI 10.1016/0109-5641(93)90078-5
   WEBER H, 1993, J PROSTHET DENT, V69, P222, DOI 10.1016/0022-3913(93)90144-D
   Weinstein A R, 1993, Dent Clin North Am, V37, P391
   WENDT SL, 1993, ORAL SURG ORAL MED O, V75, P353, DOI 10.1016/0030-4220(93)90150-3
   WESTERGAARD J, 1993, SCAND J DENT RES, V101, P265
   WHITE JM, 1993, J AM DENT ASSOC, V124, P45, DOI 10.14219/jada.archive.1993.0273
   WHITE JM, 1993, SCANNING MICROSCOPY, V7, P239
   White S N, 1993, J Calif Dent Assoc, V21, P30
   White S N, 1993, Int J Prosthodont, V6, P384
   White S N, 1993, Int J Prosthodont, V6, P248
   WHITE SN, 1993, J PROSTHET DENT, V69, P568, DOI 10.1016/0022-3913(93)90283-T
   WHITE SN, 1993, DENT MATER, V9, P260, DOI 10.1016/0109-5641(93)90071-W
   WHITE SN, 1993, J PROSTHET DENT, V69, P28, DOI 10.1016/0022-3913(93)90235-G
   WIDSTROM E, 1993, SCAND J DENT RES, V101, P238
   WIESMANN HP, 1993, SCANNING MICROSCOPY, V7, P711
   WIGDOR H, 1993, J AM DENT ASSOC, V124, P65, DOI 10.14219/jada.archive.1993.0041
   Wilkie R, 1993, Am J Dent, V6, P181
   WILLEMS G, 1993, J DENT, V21, P74, DOI 10.1016/0300-5712(93)90149-K
   WILLEMS G, 1993, J BIOMED MATER RES, V27, P747, DOI 10.1002/jbm.820270607
   Willems G, 1993, Quintessence Int, V24, P641
   WILLEMS G, 1993, J DENT, V21, P79, DOI 10.1016/0300-5712(93)90150-O
   WILLIAMS JA, 1993, BIOMATERIALS, V14, P551, DOI 10.1016/0142-9612(93)90245-W
   Williams P T, 1993, J Can Dent Assoc, V59, P538
   Williamson R T, 1993, J Prosthodont, V2, P115, DOI 10.1111/j.1532-849X.1993.tb00392.x
   Wilson A D, 1993, Am J Dent, V6, P280
   WILSON J, 1993, OPER DENT, V18, P155
   WILSON J, 1993, INT DENT J, V43, P25
   Wilson P R, 1993, Int J Prosthodont, V6, P397
   WILSON PR, 1993, AUST DENT J, V38, P97, DOI 10.1111/j.1834-7819.1993.tb05469.x
   Wolf D M, 1993, Am J Dent, V6, P155
   WOLINSKY LE, 1993, J DENT RES, V72, P72, DOI 10.1177/00220345930720011101
   Wood M, 1993, Dent Clin North Am, V37, P445
   WOOD RE, 1993, OPER DENT, V18, P94
   Wood W E, 1993, J Prosthodont, V2, P13, DOI 10.1111/j.1532-849X.1993.tb00375.x
   WOODS PW, 1993, J AM DENT ASSOC, V124, P60, DOI 10.14219/jada.archive.1993.0108
   WOOLFORD M, 1993, J DENT, V21, P379, DOI 10.1016/0300-5712(93)90017-K
   WOOLFORD MJ, 1993, J ORAL REHABIL, V20, P249, DOI 10.1111/j.1365-2842.1993.tb01607.x
   WOZNIAK WT, 1993, DENT MATER, V9, P229, DOI 10.1016/0109-5641(93)90066-Y
   Wright G. Z., 1993, Pediatric Dentistry, V15, P425
   XIE J, 1993, DENT MATER, V9, P295, DOI 10.1016/0109-5641(93)90046-S
   Yamada K, 1993, Int J Prosthodont, V6, P242
   Yamaga M, 1993, Dent Mater J, V12, P36
   YAMAGISHI T, 1993, J PROSTHET DENT, V70, P264, DOI 10.1016/0022-3913(93)90063-T
   YEN TW, 1993, J PROSTHET DENT, V70, P224, DOI 10.1016/0022-3913(93)90056-T
   YONEYAMA T, 1993, J BIOMED MATER RES, V27, P399, DOI 10.1002/jbm.820270313
   YORK AK, 1993, OPER DENT, V18, P203
   Yoshida K, 1993, Am J Dent, V6, P13
   YOSHIDA K, 1993, J PROSTHET DENT, V69, P357, DOI 10.1016/0022-3913(93)90180-V
   Yu X Y, 1993, J Calif Dent Assoc, V21, P23
   Yubao L, 1993, Biomaterials, V14, P969
   ZAKARIASEN KL, 1993, J AM DENT ASSOC, V124, P30, DOI 10.14219/jada.archive.1993.0046
   ZENAROLA P, 1993, CONTACT DERMATITIS, V29, P157, DOI 10.1111/j.1600-0536.1993.tb03518.x
   Zenkner J E, 1993, Quintessence Int, V24, P783
NR 805
TC 6
Z9 6
U1 0
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0109-5641
EI 1879-0097
J9 DENT MATER
JI Dent. Mater.
PD JAN
PY 1994
VL 10
IS 1
BP 59
EP 76
DI 10.1016/0109-5641(94)90023-X
PG 18
WC Dentistry, Oral Surgery & Medicine; Materials Science, Biomaterials
SC Dentistry, Oral Surgery & Medicine; Materials Science
GA PG946
UT WOS:A1994PG94600010
PM 7995478
DA 2018-10-20
ER

PT S
AU ALLCOCK, HR
AF ALLCOCK, HR
BE WisianNeilson, P
   Allcock, HR
   Wynne, KJ
TI MACROMOLECULAR AND MATERIALS DESIGN USING POLYPHOSPHAZENES
SO INORGANIC AND ORGANOMETALLIC POLYMERS II: ADVANCED MATERIALS AND
   INTERMEDIATES
SE ACS SYMPOSIUM SERIES
LA English
DT Article; Proceedings Paper
CT Symposium on Inorganic and Organometallic Polymers II - Advanced
   Materials and Intermediates, at the 205th National Meeting of the
   American-Chemical-Society
CY MAR 28-APR 02, 1993
CL DENVER, CO
SP AMER CHEM SOC, DIV POLYM CHEM INC
ID LIQUID-CRYSTALLINE POLY(ORGANOPHOSPHAZENE); CROSS-LINKABLE
   POLYPHOSPHAZENE; THERMAL TRANSITION BEHAVIOR; SIDE GROUPS;
   SMALL-MOLECULE; PHOSPHAZENES; POLYMERS; LINKING;
   POLY<BIS(TRIFLUOROETHOXY)PHOSPHAZENE>; HYDROGELS
AB Polyphosphazenes are among the most versatile of all polymers. This is a consequence of the unique properties of the phosphorus-nitrogen backbone and the ease with which a wide range of different side groups can be introduced mainly by macromolecular substitution, but also by the polymerization of different ''monomers''. This field has reached a stage where the fundamental chemistry now allows the design and synthesis of a broad range of new materials that are valuable for properties such as elasticity, high refractive index, liquid crystallinity, ferroelectric-, NLO-, and photochromic attributes, and for uses as solid ionic conductors, biomedical microencapsulation polymers, and materials with controlled surface properties.
RP ALLCOCK, HR (reprint author), PENN STATE UNIV,DEPT CHEM,152 DAVEY LAB,UNIVERSITY PK,PA 16802, USA.
CR ALLCOCK HR, 1993, MACROMOLECULES, V26, P11, DOI 10.1021/ma00053a002
   ALLCOCK HR, 1989, MACROMOLECULES, V22, P4179, DOI 10.1021/ma00201a008
   ALLCOCK HR, 1992, MACROMOLECULES, V25, P5573, DOI 10.1021/ma00047a002
   ALLCOCK HR, 1988, BIOMATERIALS, V9, P509, DOI 10.1016/0142-9612(88)90046-4
   ALLCOCK HR, 1986, MACROMOLECULES, V19, P1508, DOI 10.1021/ma00160a003
   ALLCOCK HR, 1989, MACROMOLECULES, V22, P75, DOI 10.1021/ma00191a015
   ALLCOCK HR, 1992, CHEM MATER, V4, P296, DOI 10.1021/cm00020a015
   ALLCOCK HR, 1991, MACROMOLECULES, V24, P2841, DOI 10.1021/ma00010a031
   ALLCOCK HR, 1991, MACROMOLECULES, V24, P2846, DOI 10.1021/ma00010a032
   ALLCOCK HR, 1966, INORG CHEM, V5, P1716, DOI 10.1021/ic50044a017
   ALLCOCK HR, 1966, INORG CHEM, V5, P1709, DOI 10.1021/ic50044a016
   ALLCOCK HR, 1990, CHEM MATER, V2, P425, DOI 10.1021/cm00010a021
   ALLCOCK HR, 1977, INORG CHEM, V16, P3362, DOI 10.1021/ic50178a081
   ALLCOCK HR, 1972, MACROMOLECULES, V5, P231, DOI 10.1021/ma60026a026
   ALLCOCK HR, 1965, J AM CHEM SOC, V87, P4216, DOI 10.1021/ja01096a056
   ALLCOCK HR, 1991, CHEM MATER, V3, P442, DOI 10.1021/cm00015a017
   ALLCOCK HR, 1991, CHEM MATER, V3, P450, DOI 10.1021/cm00015a018
   ALLCOCK HR, 1992, CHEM MATER, V4, P769, DOI 10.1021/cm00022a006
   ALLCOCK HR, 1991, CHEM MATER, V3, P1120, DOI 10.1021/cm00018a032
   ALLCOCK HR, 1988, BIOMATERIALS, V9, P500, DOI 10.1016/0142-9612(88)90045-2
   ALLCOCK HR, 1991, MACROMOLECULES, V24, P2024, DOI 10.1021/ma00008a048
   ALLCOCK HR, 1990, MACROMOLECULES, V23, P3881, DOI 10.1021/ma00219a003
   ALLCOCK HR, 1989, MACROMOLECULES, V22, P2596, DOI 10.1021/ma00196a009
   ALLCOCK HR, 1992, CHEM PROCESSING ADV, P704
   ALLCOCK HR, 1993, UNPUB
   ALLCOCK HR, 1994, UNPUB
   ALLCOCK HR, 1992, INORGANIC POLYM, P61
   ALLCOCK HR, 1992, CHEMMATER, V4, P75
   ALLCOCK HR, 1987, POLYM PREPR, V28, P321
   ANDRIANOV AK, 1993, POLYM PREPR AM CHEM, V34, P233
   BANO MC, 1991, BIO-TECHNOL, V9, P468, DOI 10.1038/nbt0591-468
   BENNETT JL, 1989, CHEM MATER, V1, P14
   BENNETT JL, 1989, POLYM PREPR AM CHEM, V30, P437
   BLONSKY PM, 1984, J AM CHEM SOC, V106, P6854, DOI 10.1021/ja00334a071
   BLONSKY PM, 1985, POLYM MATER SCI ENG, V53, P118
   BLONSKY PM, 1986, SOLID STATE IONICS, V19, P258
   COHEN S, 1990, J AM CHEM SOC, V112, P7832, DOI 10.1021/ja00177a074
   COHEN S, 1993, CLIN MATER, V13, P3, DOI 10.1016/0267-6605(93)90082-I
   DEMBEK AA, 1990, CHEM MATER, V2, P97, DOI 10.1021/cm00008a005
   DEMBEK AA, 1991, ACS SYM SER, V455, P258
   FLINDT EP, 1977, Z ANORG ALLG CHEM, V428, P204, DOI 10.1002/zaac.19774280125
   KIM C, 1987, MACROMOLECULES, V20, P1726, DOI 10.1021/ma00173a050
   LERNER MM, 1991, CHEM MATER, V3, P1117, DOI 10.1021/cm00018a031
   LIANG M, 1991, J AM CHEM SOC, V113, P4044, DOI 10.1021/ja00010a085
   MONTAGUE RA, 1990, J AM CHEM SOC, V112, P6721, DOI 10.1021/ja00174a047
   NEILSON RH, 1988, CHEM REV, V88, P541, DOI 10.1021/cr00085a005
   NELSON CJ, 1991, CHEM MATER, V3, P786, DOI 10.1021/cm00017a010
   SENNETT MS, 1983, POLYM MAT SCI ENG, V49, P297
   SHRIVER DF, 1987, POLYM PREPR, V28, P438
   SINGLER RE, 1990, ACS SYM SER, V435, P185
   SINGLER RE, 1991, MACROMOLECULES, V24, P510, DOI 10.1021/ma00002a026
   SINGLER RE, 1987, MACROMOLECULES, V20, P1727, DOI 10.1021/ma00173a051
   SINGLER RE, 1975, POLYM ENG SCI, V15, P321, DOI 10.1002/pen.760150502
   SINGLER RE, 1987, POLYM PREPR, V28, P448
   Tate D.P., 1974, J POLYM SCI POLYM S, V48, P33
   WELKER MF, 1994, ACS SYM SER, V537, P293
   WISIANNEILSON P, 1980, J AM CHEM SOC, V102, P2848, DOI 10.1021/ja00528a060
NR 57
TC 24
Z9 24
U1 0
U2 1
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 SIXTEENTH ST NW, WASHINGTON, DC 20036
SN 0097-6156
BN 0-8412-3036-6
J9 ACS SYM SER
PY 1994
VL 572
BP 208
EP 231
PG 24
WC Chemistry, Multidisciplinary; Chemistry, Inorganic & Nuclear; Polymer
   Science
SC Chemistry; Polymer Science
GA BC69C
UT WOS:A1994BC69C00017
DA 2018-10-20
ER

PT J
AU KHODZHAEVA, ID
   KISLINOVSKAJA, NV
   SMUROVA, EV
AF KHODZHAEVA, ID
   KISLINOVSKAJA, NV
   SMUROVA, EV
TI STABILITY OF CIS-1,4-POLYISOPRENE AND ITS VULCANIZATES IN AQUEOUS AND
   BIOLOGICALLY-ACTIVE MEDIA
SO INTERNATIONAL JOURNAL OF POLYMERIC MATERIALS
LA English
DT Article; Proceedings Paper
CT International Conference on Regulation of Polymeric Materials Stability
CY OCT 12-15, 1992
CL INST CHEM PHYS, MOSCOW, RUSSIA
SP WESTERN CO NETHERLANDS, CIBA GEIGY SWITZERLAND, UNIROYAL CHEM & KISER RES USA, AMC SPREA & MONTEDISON ITALY
HO INST CHEM PHYS
DE BIOLOGICAL STABILITY; ELASTOMERS; CIS-1,4-POLYISOPRENE; VULCANIZED
   ELASTOMERS
AB The biological stability of natural and synthetic cis-1,4-polyisoprene is investigated with the objective to develop new highly elastic materials for biomedical applications.
C1 MV LOMONOSOV FINE CHEM TECHNOL INST,MOSCOW 117571,RUSSIA.
   AN BAKULEV CARDIOVASC SURG INST,MOSCOW,RUSSIA.
CR BEHIZI J, 1989, BIOMED MATER, V4, P2
   BRALEY SA, 1971, RUBBER CHEM TECH, V44, P363
   BRISTOW BM, 1985, NR TECHNOL, V16, P29
   Cunneen J. I., 1968, RUBBER REV, V41, P182
   DAVIES BJ, 1989, MECHANICAL INCORPORA, V1, P91
   GORTON ADT, 1977, NR TECHNOL, V8, P79
   IMAI Y, 1970, T AM SOC ART INT ORG, V16, P17
   KHILKO VA, 1982, VNUTRISOSUDISTAYA NE
   KISLINOVSKAJA NV, 1992, IN PRESS INT J POLYM
   PORTER M, 1989, P INT POLYM LATEX C
   SMUROVA EV, 1984, POLYM MED BIOL, P15
   Southern E, 1980, ACS SYM SER, V127, P375
   THOMAS AG, 1987, POLYMER, V28, P408, DOI 10.1016/0032-3861(87)90193-5
NR 13
TC 2
Z9 2
U1 0
U2 0
PU GORDON BREACH SCI PUBL LTD
PI READING
PA C/O STBS LTD PO BOX 90, READING, BERKS, ENGLAND RG1 8JL
SN 0091-4037
J9 INT J POLYM MATER
JI Int. J. Polym. Mater.
PY 1994
VL 25
IS 1-2
BP 107
EP 115
DI 10.1080/00914039408028582
PG 9
WC Polymer Science
SC Polymer Science
GA PZ142
UT WOS:A1994PZ14200011
DA 2018-10-20
ER

PT J
AU KAO, WYJ
   ZHAO, QH
   HILTNER, A
   ANDERSON, JM
AF KAO, WYJ
   ZHAO, QH
   HILTNER, A
   ANDERSON, JM
TI THEORETICAL-ANALYSIS OF IN-VIVO MACROPHAGE ADHESION AND FOREIGN-BODY
   GIANT-CELL FORMATION ON POLYDIMETHYLSILOXANE, LOW-DENSITY POLYETHYLENE,
   AND POLYETHERURETHANES
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
ID INVIVO; POLYURETHANE; BIOCOMPATIBILITY; BIOSTABILITY; MONOCYTES;
   CRACKING; KINETICS; INVITRO; FUSION; UREA)
AB Quantitative description of foreign body giant cell (FBGC) formation on implanted polymer surfaces as a function of time can conceivably correlate cell adhesion with polymer properties and possibly predict the behavior of the polymer in vivo. In the present study, the formation of FBGCs on various biomedical polymers was quantified by two parameters: the density of adherent macrophages present initially that participate in FBGC formation (d(o)) and the rate constant for cell fusion (k); both kinetic parameters were used to calculate the time-dependent FBGC density (d(fc)).
   The materials used were: three Pellethane poly(etherurethanes) (PEUs) varying in weight percent of hard segment, one poly(etherurethane urea) (PEUU), and NHLBI-DTB primary reference materials: low density polyethylene (LDPE), silica-free polydimethylsiloxane (PDMS). The results indicated that up to 5 weeks of implantation, FBGCs were formed from the fusion of one population of adherent macrophages present by 3 days post-implantation. Furthermore, only a small fraction (<8%) of this initial adherent macrophage population participated in FBGC formation. Based on the results of previous studies and the current study, it was concluded that increase in PEU hard segment weight percent, surface hardness and hydrophobicity increased total protein adsorption and effectively increased d(o) and d(fc). No further correlations between the material properties of all polymers and the cell kinetics can be made at this time. However, this study demonstrated that macrophage adhesion and FBGC formation can be quantified with the cell fusion model, and are modulated by various polymer properties. (C) 1994 John Wiley and Sons, Inc.
C1 CASE WESTERN RESERVE UNIV,INST PATHOL,CLEVELAND,OH 44106.
   CASE WESTERN RESERVE UNIV,DEPT MACROMOLEC SCI,CLEVELAND,OH 44106.
FU NHLBI NIH HHS [HL-25239, HL-33849, HL-47300]
CR ABE E, 1987, ENDOCRINOLOGY, V121, P271, DOI 10.1210/endo-121-1-271
   ANDERSON JM, 1984, BIOMATERIALS, V5, P5, DOI 10.1016/0142-9612(84)90060-7
   ANDERSON JM, 1988, ASAIO, V11, P101
   BONFIELD TL, 1992, J BIOMED MATER RES, V26, P837, DOI 10.1002/jbm.820260702
   BRUNSTEDT MR, 1993, J BIOMED MATER RES, V27, P255, DOI 10.1002/jbm.820270216
   BRUNSTEDT MR, 1993, J BIOMED MATER RES, V27, P367, DOI 10.1002/jbm.820270310
   BRUNSTEDT MR, 1990, BIOMATERIALS, V11, P8
   FLORY PJ, 1953, PRINCIPLES POLYMER C, pCH7
   HASSAN NF, 1989, J IMMUNOL, V143, P2179
   KAO WJ, UNPUB J BIOMED MATER
   Lambert RA, 1912, J EXP MED, V15, P510, DOI 10.1084/jem.15.5.510
   MARCHANT R, 1983, J BIOMED MATER RES, V17, P301, DOI 10.1002/jbm.820170209
   MOHANTY M, 1992, BIOMATERIALS, V13, P651, DOI 10.1016/0142-9612(92)90123-6
   MURCH AR, 1982, J PATHOL, V137, P177, DOI 10.1002/path.1711370302
   OGHISO Y, 1992, J LEUKOCYTE BIOL, V52, P421
   PAPADIMITRIOU JM, 1973, AM J PATHOL, V73, P349
   PAPADIMITRIOU JM, 1978, MEMBRANE FUSION, P181
   SMETANA K, 1987, EXP MOL PATHOL, V46, P258, DOI 10.1016/0014-4800(87)90048-7
   Szycher M, 1991, J Biomater Appl, V6, P110, DOI 10.1177/088532829100600202
   SZYCHER M, 1992, MED DEVICE TECHNOL, V11, P41
   WU Y, 1991, J BIOMED MATER RES, V25, P725, DOI 10.1002/jbm.820250604
   ZHAO Q, 1990, J BIOMED MATER RES, V24, P621, DOI 10.1002/jbm.820240508
   ZHAO Q, 1987, POLYMER, V28, P2040, DOI 10.1016/0032-3861(87)90038-3
   ZHAO Q, 1991, J BIOMED MATER RES, V25, P177, DOI 10.1002/jbm.820250205
   ZHAO QH, 1992, J BIOMED MATER RES, V26, P1019, DOI 10.1002/jbm.820260805
NR 25
TC 57
Z9 57
U1 0
U2 2
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD JAN
PY 1994
VL 28
IS 1
BP 73
EP 79
DI 10.1002/jbm.820280110
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA MM133
UT WOS:A1994MM13300009
PM 8126032
DA 2018-10-20
ER

PT J
AU ZEZIN, AB
   ROGACHEVA, VB
   KABANOV, VA
AF ZEZIN, AB
   ROGACHEVA, VB
   KABANOV, VA
TI INTERPOLYMER COMPLEXES FORMED BY POLYELECTROLYTE GELS
SO JOURNAL OF INTELLIGENT MATERIAL SYSTEMS AND STRUCTURES
LA English
DT Note
ID POLY-ELECTROLYTE NETWORKS; ACTIVE-TRANSPORT; LINEAR POLYIONS
AB The approaches to synthesis and modification of polymers based on the assembly of chemically complementary macromolecules have been recently widely developed. Interpoly-electrolyte complexes (IPEC) are more common polymers of this type. They are the products of interaction between oppositely charged polyelectrolytes (Bixler and Michaels, 1969; Tsushida and Abe, 1982). IPEC are of special interest as the effective adhesives for solving ecological, biomedical and agrotechnological problems due to their unique structure (Zezin and Baranovskii, 1983; Zezin et al., 1987). The utilization of cross-linked polyelectrolytes gives new opportunities for the construction of polycomplex substances and materials. These opportunities are based on the phenomenon of active transport of linear polyelectrolytes into oppositely charged networks (Rogacheva et al., 1988; Kabanov et al., 1988; Kabanov et al., 1989). The driving force of this transport and the mechanism of transport of linear polyions in polyelectrolyte gels are directly connected with the interpolyelectrolyte reaction (IPR) which proceeds between polyions and gel. Slightly cross-linked polyelectrolytes absorb oppositely charged linear polyions from aqueous solutions. This gradual uptake is followed by production of small counter ions of linear and cross-linked polyelectrolytes. For example, the reaction between slightly cross-linked poly(2-dimethylaminoethyl methacrylate) (PDMA) and linear poly(acrylic acid) (PAA) is presented in Scheme (I).
RP ZEZIN, AB (reprint author), MOSCOW MV LOMONOSOV STATE UNIV,FAC CHEM,DEPT POLYMER SCI,MOSCOW,RUSSIA.
RI Zezin, Aleksandr/D-2638-2015
OI Zezin, Aleksandr/0000-0002-6268-1927
CR Bixler HJ, 1969, ENCYCLOPEDIA POLYMER, V10, P765
   KABANOV VA, 1985, MAKROMOL CHEM, P137
   KABANOV VA, 1990, VYSOKOMOL SOEDIN B, V32, P83
   KABANOV VA, 1988, DOKL AKAD NAUK SSSR+, V303, P399
   KABANOV VA, 1989, MAKROMOL CHEM, V190, P2211
   KABANOV VA, 1990, MAKROMOL CHEM-M SYMP, V39, P155, DOI 10.1002/masy.19900390114
   ROGACHEVA VB, 1988, VYSOKOMOL SOEDIN A+, V30, P2120
   TANAKA T, 1978, PHYS REV LETT, V40, P820, DOI 10.1103/PhysRevLett.40.820
   TSUCHIDA E, 1982, ADV POLYM SCI, V45, P1
   ZEZIN AB, 1972, VYSOKOMOL SOEDIN A, V14, P772
   ZEZIN AB, 1987, KHIM FARM ZH, V7, P788
   ZEZIN AB, 1983, KHIMYA ZHIZN, V3, P22
   ZEZIN AB, 1989, FRONTIERS MACROMOLEC, P219
NR 13
TC 9
Z9 10
U1 1
U2 5
PU TECHNOMIC PUBL CO INC
PI LANCASTER
PA 851 NEW HOLLAND AVE, BOX 3535, LANCASTER, PA 17604
SN 1045-389X
J9 J INTEL MAT SYST STR
JI J. Intell. Mater. Syst. Struct.
PD JAN
PY 1994
VL 5
IS 1
BP 144
EP 146
DI 10.1177/1045389X9400500119
PG 3
WC Materials Science, Multidisciplinary
SC Materials Science
GA NC276
UT WOS:A1994NC27600019
DA 2018-10-20
ER

PT J
AU HEYDORN, K
AF HEYDORN, K
TI ANALYTICAL TECHNIQUES AND QUALITY-CONTROL IN BIOMEDICAL TRACE-ELEMENT
   RESEARCH
SO JOURNAL OF TRACE ELEMENTS IN EXPERIMENTAL MEDICINE
LA English
DT Article
DE CHORION VILLI; CONTAMINATION CONTROL; INTERFERENCE CONTROL; REFERENCE
   MATERIALS; TRACEABILITY
AB The small number of analytical results in trace element research calls for special methods of quality control. It is shown that when the analytical methods are in statistical control, only small numbers of duplicate or replicate results are needed to ascertain the absence of systematic errors caused by sample contamination or interference from other elements. The distribution of determinations of Cu in chorion villi from normal pregnant women is used as an example, and after screening it proved to be closely approximated by a logarithmic normal distribution with a mean value of 0.6 mg/kg. Measurement compatibility is obtained by control of traceability to certified reference materials, (C) 1994 Wiley-Liss, Inc.
RP HEYDORN, K (reprint author), RISO NATL LAB,DIV ISOTOPE,POB 49,DK-4000 ROSKILDE,DENMARK.
CR ANGLOV T, 1990, FRESEN J ANAL CHEM, V338, P530, DOI 10.1007/BF00322531
   HEYDORN K, 1973, TALANTA, V20, P835, DOI 10.1016/0039-9140(73)80199-7
   HEYDRON K, 1984, NEUTRON ACTIVATION A, V2, P44
   HORN N, 1992, Journal of Trace Elements in Experimental Medicine, V5, P115
NR 4
TC 3
Z9 3
U1 0
U2 0
PU WILEY-LISS
PI NEW YORK
PA DIV JOHN WILEY & SONS INC 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0896-548X
J9 J TRACE ELEM EXP MED
JI J. Trace Elem. Exp. Med.
PY 1994
VL 7
IS 1
BP 33
EP 38
PG 6
WC Biochemistry & Molecular Biology; Endocrinology & Metabolism
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism
GA NW929
UT WOS:A1994NW92900004
DA 2018-10-20
ER

PT B
AU AMBROSIO, L
   IANNACE, S
   MENSITIERI, M
   NETTI, PA
   NICOLAIS, L
AF AMBROSIO, L
   IANNACE, S
   MENSITIERI, M
   NETTI, PA
   NICOLAIS, L
BE Drake, K
   Bauer, J
   Serafini, T
   Cheng, P
TI STRUCTURAL MATERIALS FOR BIOMEDICAL APPLICATIONS
SO MOVING FORWARD WITH 50 YEARS OF LEADERSHIP IN ADVANCED MATERIALS - 39TH
   INTERNATIONAL SAMPE SYMPOSIUM AND EXHIBITION, VOL 39, BOOKS 1 AND 2
LA English
DT Proceedings Paper
CT 39th International SAMPE Symposium and Exhibition: Moving Forward With
   50 Years of Leadership in Advanced Materials
CY APR 11-14, 1994
CL ANAHEIM, CA
SP Soc Adv Mat & Proc Engn
DE APPLICATIONS, MEDICAL; BIOMATERIALS; COMPOSITES
C1 UNIV NAPLES FEDERICO 2,DEPT MAT & PROD ENGN,NAPLES,ITALY.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU SOC ADVANCEMENT MATERIAL & PROCESS ENGINEERING
PI COVINA
PA 843 W GLENTANA ST, PO BOX 2459, COVINA, CA 91722
BN 0-938994-69-7
PY 1994
BP 979
EP 988
PG 10
WC Materials Science, Multidisciplinary
SC Materials Science
GA BB69T
UT WOS:A1994BB69T00091
DA 2018-10-20
ER

PT J
AU SAKURAI, S
   NOKUWA, S
   MORIMOTO, M
   SHIBAYAMA, M
   NOMURA, S
AF SAKURAI, S
   NOKUWA, S
   MORIMOTO, M
   SHIBAYAMA, M
   NOMURA, S
TI CHANGES IN STRUCTURE AND PROPERTIES DUE TO MECHANICAL FATIGUE FOR
   POLYURETHANES CONTAINING POLY(DIMETHYL SILOXANE)
SO POLYMER
LA English
DT Article
DE POLYURETHANES; MECHANICAL FATIGUE; MICRODOMAINS
ID MICROPHASE SEPARATED STRUCTURE; X-RAY-SCATTERING; SEGMENTED
   POLY(URETHANEUREA)S; HARD SEGMENT; ORIENTATIONAL BEHAVIOR; BLOOD
   COMPATIBILITY; ELASTOMERS; COMPONENTS
AB Changes in structure and properties due to mechanical fatigue for segmented polyurethanes containing a block segment of poly(ethylene oxide)-block-poly(dimethyl siloxane)-block-poly(ethylene oxide) (PES) were investigated by mechanical and thermal analyses and a small-angle X-ray scattering (SAXS) technique. Six types of specimens designated KP-x-y were studied, where x and y denote, respectively, the fraction of PES component (x = 0 or 13 wt%) and the molecular weight of the soft-segment block, poly(tetramethylene glycol) (PTMG) (y = 1000, 2000 or 3000). The SAXS experiments revealed that dissociation of the hard-segment microdomains was induced by mechanical fatigue. The changes in the mechanical properties due to fatigue were discussed in relation to the PTMG soft-segment crystallization which can be triggered by the dissociation of the hard-segment microdomains. As already reported, KP-13-2000 has better antithrombogenicity and more suitable viscoelastic properties for use as a biomedical material than any of the others. It was found in this study that KP-13-2000 has strong resistance against mechanical fatigue as well, which is one of the most important characteristics required for biomedical materials. Although the microdomain structure was fractured by fatigue, the mechanical property of KP-13-2000 was not changed because the PES component prevents the PTMG soft segments from crystallizing.
RP SAKURAI, S (reprint author), KYOTO INST TECHNOL,DEPT POLYMER SCI & ENGN,SAKYO KU,KYOTO 606,JAPAN.
RI Shibayama, Mitsuhiro/E-1646-2015
OI Shibayama, Mitsuhiro/0000-0002-8683-5070
CR CLOGH SB, 1968, J MACROMOL SCI PHY B, V2, P553
   FAKIROV S, 1991, POLYMER, V32, P1173, DOI 10.1016/0032-3861(91)90218-8
   HOFFMANN K, 1983, MAKROMOL CHEM, V184, P1529
   HUH DS, 1971, POLYM ENG SCI, V11, P36
   ISHIHARA H, 1984, J MACROMOL SCI PHYS, VB22, P713, DOI 10.1080/00222348308215209
   KAJIYAMA T, 1969, MACROMOLECULES, V2, P254, DOI 10.1021/ma60009a009
   KAWANO S, 1990, REP PROG POLYM PHYS, V33, P319
   KIMURA I, 1974, MACROMOLECULES, V7, P355, DOI 10.1021/ma60039a018
   KIRA K, 1983, J JPN SOC BIOMATER, V1, P29
   KOBERSTEIN JT, 1983, J POLYM SCI POL PHYS, V21, P1439, DOI 10.1002/pol.1983.180210814
   Lelah M. D., 1986, POLYURETHANES MED
   LI C, 1990, POLYMER, V31, P3, DOI 10.1016/0032-3861(90)90339-Z
   MCKENNA LW, 1969, MACROMOLECULES, V2, P58, DOI 10.1021/ma60007a011
   MILLER JA, 1985, MACROMOLECULES, V18, P32, DOI 10.1021/ma00143a005
   PLANCK H, 1984, POLYURETHANES BIOMED
   SHIBAYAMA M, 1991, MACROMOLECULES, V24, P6254, DOI 10.1021/ma00023a031
   SHIBAYAMA M, 1990, POLYMER, V31, P749, DOI 10.1016/0032-3861(90)90299-E
   SHIBAYAMA M, 1987, POLYM J, V19, P1067, DOI 10.1295/polymj.19.1067
   SHIBAYAMA M, 1986, POLYM J, V18, P719, DOI 10.1295/polymj.18.719
   TAKAHARA A, 1985, KOBUNSHI RONBUNSHU, V42, P793, DOI 10.1295/koron.42.793
   TAKAHARA A, 1982, KOBUNSHI RONBUNSHU, V39, P203, DOI 10.1295/koron.39.203
   TAKAHARA A, 1985, POLYMER, V26, P978, DOI 10.1016/0032-3861(85)90217-4
   TAKAHARA A, 1985, POLYMER, V26, P987, DOI 10.1016/0032-3861(85)90218-6
   TRANCONG Q, IN PRESS POLYMER
   UEKI T, 1985, BIOPHYS CHEM, V23, P115, DOI 10.1016/0301-4622(85)80069-7
   YAMAMOTO T, 1989, POLYM J, V21, P895, DOI 10.1295/polymj.21.895
NR 26
TC 21
Z9 21
U1 1
U2 9
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0032-3861
J9 POLYMER
JI Polymer
PY 1994
VL 35
IS 3
BP 532
EP 539
DI 10.1016/0032-3861(94)90507-X
PG 8
WC Polymer Science
SC Polymer Science
GA MV153
UT WOS:A1994MV15300012
DA 2018-10-20
ER

PT S
AU TOMIHATA, K
   BURCZAK, K
   SHIRAKI, K
   IKADA, Y
AF TOMIHATA, K
   BURCZAK, K
   SHIRAKI, K
   IKADA, Y
BE Shalaby, SW
   Ikada, Y
   Langer, R
   Williams, J
TI CROSS-LINKING AND BIODEGRADATION OF NATIVE AND DENATURED COLLAGEN
SO POLYMERS OF BIOLOGICAL AND BIOMEDICAL SIGNIFICANCE
SE ACS SYMPOSIUM SERIES
LA English
DT Article; Proceedings Paper
CT Symposium on Polymers of Biological and Biomedical Significance, at the
   204th National Meeting of the American Chemical Society
CY AUG 24-28, 1992
CL WASHINGTON, DC
SP AMER CHEM SOC, DIV POLYM CHEM INC
ID FIBERS
AB Collagens are known to have wide biomedical applications. They are for hemostatic agent, blood vessel, heart valve, tendon and ligament, burn dressing, intradermal augmentation, drug delivery systems and so on (1). The denatured type collagen, gelatin, has also been used in medicine as plasma expander, wound dressing, adhesives, and absorbent pad for surgical use (2). Recently it has been reported that both collagen and gelatin can be effectively used as materials for nerve conduits (3,4). Furthermore, it should be noted that crosslinked gelatin has been long used as a material for embolization in endovascular surgery (5). The biodegradation rate of collagen-based implants is known to be strongly affected by the crosslinking density (6-8). Crosslinking can also improve the tensile properties of the materials to such a level as they are handled and sutured with ease. The purpose of this work is to compare different methods for crosslinking of native collagen and denatured gelatin. The crosslinking agents to be employed in this study include glutaraldehyde, water-soluble carbodiimide, bisepoxy compounds, UV radiation, and dehydrothermal treatment.
RP TOMIHATA, K (reprint author), KYOTO UNIV,BIOMED ENGN RES CTR,SAKYO KU,53 KAWAHARA CHO,SHOGO-IN,KYOTO 606,JAPAN.
CR CHVAPIL M, 1977, J BIOMED MATER RES, V11, P297, DOI 10.1002/jbm.820110213
   EYBL E, 1989, J BIOMED MATER RES, V23, P1355, DOI 10.1002/jbm.820231111
   IKADA Y, 1992, NEUROSURGEONS, V11, P236
   KATO YP, 1989, BIOMATERIALS, V10, P38, DOI 10.1016/0142-9612(89)90007-0
   LAW JK, 1989, J BIOMED MATER RES, V23, P961, DOI 10.1002/jbm.820230902
   LEE G, 1992, 30TH ANN M JAP SOC A, P93
   LI ST, 1991, BIOTECHNOLOGY AND POLYMERS, P281
   MILTHORPE BK, 1990, ADV BIOMAT, V9, P1
   PIAO DS, 1982, POLYM PREPRINTS JPN, V31, P2609
   PIEZ KA, 1989, ENCY POLYM SCI ENG, V3, P699
   Rose PJ, 1989, ENCY POLYM SCI ENG, V7, P488
   SPEER DP, 1980, J BIOMED MATER RES, V14, P753, DOI 10.1002/jbm.820140607
   VANLUYN MJA, 1992, BIOMATERIALS, V13, P1017, DOI 10.1016/0142-9612(92)90153-F
   WEADOCK K, 1983, BIOMATER ARTIF CELL, V11, P293, DOI 10.3109/10731198309118815
   Wong S. S., 1991, CHEM PROTEIN CONJUGA, P195
NR 15
TC 13
Z9 13
U1 0
U2 17
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 SIXTEENTH ST NW, WASHINGTON, DC 20036
SN 0097-6156
BN 0-8412-2732-2
J9 ACS SYM SER
PY 1994
VL 540
BP 275
EP 286
PG 12
WC Chemistry, Multidisciplinary; Medicine, Research & Experimental; Polymer
   Science
SC Chemistry; Research & Experimental Medicine; Polymer Science
GA BZ58M
UT WOS:A1994BZ58M00025
DA 2018-10-20
ER

PT J
AU MACRINA, FL
   MUNRO, CL
AF MACRINA, FL
   MUNRO, CL
TI GRADUATE TEACHING IN PRINCIPLES OF SCIENTIFIC INTEGRITY
SO ACADEMIC MEDICINE
LA English
DT Article
AB Training in the responsible conduct of research in the biomedical sciences is on its way to being a standard component in the graduate biomedical curriculum. Emphasis in this area has been catalyzed by certain requirements for such training imposed by the National Institutes of Health and by an increased awareness of relevant issues created by the publicity and discussion of incidents of scientific misconduct. The authors describe the development and formalization of a course about the responsible conduct of science for students in the biomedical disciplines at Virginia Commonwealth University. In addition, they discuss general considerations of course content important in teaching scientific integrity; examine the use of published resource materials and documents from professional societies, institutions, states, and the federal government as teaching tools; and describe the importance of case studies as vehicles for teaching scientific integrity.
C1 VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT MED SURG NURSING,RICHMOND,VA 23298.
RP MACRINA, FL (reprint author), VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT MICROBIOL & IMMUNOL,POB 678 MCV,RICHMOND,VA 23298, USA.
CR MARTIN RG, UNPUB STAMPEDE ZEBRA
NR 1
TC 8
Z9 8
U1 0
U2 4
PU HANLEY & BELFUS INC
PI PHILADELPHIA
PA 210 S 13TH ST, PHILADELPHIA, PA 19107
SN 1040-2446
J9 ACAD MED
JI Acad. Med.
PD DEC
PY 1993
VL 68
IS 12
BP 879
EP 884
DI 10.1097/00001888-199312000-00003
PG 6
WC Education, Scientific Disciplines; Health Care Sciences & Services
SC Education & Educational Research; Health Care Sciences & Services
GA MM253
UT WOS:A1993MM25300003
PM 8259956
OA Bronze
DA 2018-10-20
ER

PT J
AU FANO, V
   MA, WY
   ORTALLI, I
   POZELA, K
AF FANO, V
   MA, WY
   ORTALLI, I
   POZELA, K
TI THERMAL CONTRACTION OF SILICONE-BASED IMPRESSION MATERIALS
SO NUOVO CIMENTO DELLA SOCIETA ITALIANA DI FISICA D-CONDENSED MATTER ATOMIC
   MOLECULAR AND CHEMICAL PHYSICS FLUIDS PLASMAS BIOPHYSICS
LA English
DT Article
DE OTHER TOPICS IN BIOPHYSICS, MEDICAL PHYSICS, AND BIOMEDICAL ENGINEERING;
   MATERIALS TESTING; THEORETICAL EXPANSION AND THERMOMECHANICAL EFFECTS
ID DIMENSIONAL STABILITY
AB Linear thermal contraction of impression materials has been measured in the 40-18-degrees-C temperature range immediately after the polymerization shrinkage. Samples of 2 em in length have been analysed by a scanned laser beam micrometer and the coefficient of thermal contraction has been calculated. Silicone-based specimens of different viscosities have been tested. The temperature-induced shrinkage has been compared with the time-dependent shrinkage.
RP FANO, V (reprint author), UNIV PARMA,IST SCI FIS,I-43100 PARMA,ITALY.
CR BURDAIRON G, 1984, BIOMATERIALI DENTARI, P173
   CANCY JM, 1983, J ORAL REHABIL, V10, P325
   FANO V, 1992, DENT MATER, V8, P105, DOI 10.1016/0109-5641(92)90064-J
   FANO V, 1992, 6 MED C MED BIOL ENG, P119
   MANSFIELD MA, 1975, BRIT DENT J, V139, P267, DOI 10.1038/sj.bdj.4803587
   MCCAULEY JW, 1988, MTLTR8830 NTIS, P22
   SIMIONATO F, 1985, TECNOLOGIE MATERIALI, P1
   WILLIAMS PT, 1984, J PROSTHET DENT, V52, P120, DOI 10.1016/0022-3913(84)90194-X
   WILSON H, 1991, MATERIALI DENTARI LO
NR 9
TC 0
Z9 0
U1 0
U2 1
PU EDITRICE COMPOSITORI BOLOGNA
PI BOLOGNA
PA VIA STALINGRADO 97/2, I-40128 BOLOGNA, ITALY
SN 0392-6737
J9 NUOVO CIMENTO D
JI Nuovo Cimento Soc. Ital. Fis. D-Condens. Matter At. Mol. Chem. Phys.
   Fluids Plasmas Biophys.
PD DEC
PY 1993
VL 15
IS 12
BP 1533
EP 1538
DI 10.1007/BF02451944
PG 6
WC Physics, Multidisciplinary
SC Physics
GA NB558
UT WOS:A1993NB55800006
DA 2018-10-20
ER

PT J
AU OXLEY, HR
   CORKHILL, PH
   FITTON, JH
   TIGHE, BJ
AF OXLEY, HR
   CORKHILL, PH
   FITTON, JH
   TIGHE, BJ
TI MACROPOROUS HYDROGELS FOR BIOMEDICAL APPLICATIONS - METHODOLOGY AND
   MORPHOLOGY
SO BIOMATERIALS
LA English
DT Article
DE HYDROGELS; MEMBRANES; POLYMERIZATION; POROSITY
AB Macroporous hydrogel membranes have been fabricated using two complementary techniques, both involving the polymerization of a solution of monomers around a crystalline matrix which is subsequently removed. The first of these is the freeze-thaw technique, in which aqueous systems are used to form ice-based crystalline matrices. Whereas in the second, the porosigen technique, a crystalline compound (e.g. sucrose) is dispersed in the monomer solution prior to polymerization. Both copolymer composition and the polymerization conditions were found to influence membrane morphology and the limitations in the range of morphologies attainable using each technique are discussed. Careful choice of technique and polymerization conditions enables macroporous hydrogels with a wide range of morphologies to be fabricated, which are potentially valuable in a variety of biomedical applications. The suitability of these techniques described for the production of materials for use in affinity chromatography, as cell separation substrates and as synthetic articular cartilage as well as more general areas of biomedicine, is discussed.
C1 ASTON UNIV, DEPT CHEM ENGN & APPL CHEM, SPECIALTY MAT RES GRP, BIRMINGHAM B4 7ET, W MIDLANDS, ENGLAND.
CR ATKINS TW, 1992, J BIOMAT SCI-POLYM E, V3, P261, DOI 10.1163/156856292X00178
   CORKHILL PH, IN PRESS J BIOMATER
   FITTON JH, 1992, 4TH P WORLD BIOM C B, P670
   Haldon R.A., 1972, BR POLYM J, V4, P491
   KON M, 1981, PLAST RECONSTR SURG, V67, P289, DOI 10.1097/00006534-198103000-00002
   KRAUCH CH, 1968, NATURWISSENSCHAFTEN, V55, P539, DOI 10.1007/BF00660126
   MCCUTCHEN CW, 1969, LUBRICATION WEAR JOI, P117
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   MURPHY SM, 1992, J MATER CHEM, V2, P1007, DOI 10.1039/jm9920201007
   ONEILL C, 1990, J CELL SCI, V95, P577
   SKELLY PJ, 1979, POLYMER, V20, P1051, DOI 10.1016/0032-3861(79)90289-1
NR 11
TC 110
Z9 112
U1 2
U2 26
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD NOV
PY 1993
VL 14
IS 14
BP 1064
EP 1072
DI 10.1016/0142-9612(93)90207-I
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA MH266
UT WOS:A1993MH26600007
PM 8312461
DA 2018-10-20
ER

PT J
AU UGELSTAD, J
   STENSTAD, P
   KILAAS, L
   PRESTVIK, WS
   HERJE, R
   BERGE, A
   HORNES, E
AF UGELSTAD, J
   STENSTAD, P
   KILAAS, L
   PRESTVIK, WS
   HERJE, R
   BERGE, A
   HORNES, E
TI MONODISPERSE MAGNETIC POLYMER PARTICLES - NEW BIOCHEMICAL AND BIOMEDICAL
   APPLICATIONS
SO BLOOD PURIFICATION
LA English
DT Review
DE MONODISPERSE PARTICLES; MAGNETIC PARTICLES; CELL SEPARATION;
   MICROBIOLOGY; MOLECULAR BIOLOGY
AB The method of activated swelling of polymer particles developed by the authors allows the preparation of monodisperse spherical beads of predictable size from 1 to 100 mu m in diameter. The polymer particles may be prepared from a number of different monomeric materials and with various morphologies including macroporous structures. The porous beads form the basis for magnetizable monodisperse polymer particles which have magnetic iron oxides distributed as small grains all through the volume of the beads. The magnetic particles are being used extensively for selective cell separation and for Cell separation immunomagnetic separation within microbiology and molecular biology. A review of recent work within these fields is given. New methods for positive cell separation are announced.
C1 UNIV TRONDHEIM,IND CHEM LAB,TRONDHEIM,NORWAY.
   NORWEGIAN COLL VET MED,OSLO,NORWAY.
   DYNAL AS,OSLO,NORWAY.
RP UGELSTAD, J (reprint author), SINTEF,APPL CHEM,N-7034 TRONDHEIM,NORWAY.
NR 0
TC 96
Z9 105
U1 3
U2 41
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0253-5068
J9 BLOOD PURIFICAT
JI Blood Purif.
PD NOV-DEC
PY 1993
VL 11
IS 6
BP 349
EP 369
DI 10.1159/000170129
PG 21
WC Hematology; Urology & Nephrology
SC Hematology; Urology & Nephrology
GA NR865
UT WOS:A1993NR86500002
PM 8043257
DA 2018-10-20
ER

PT J
AU SHELLOCK, FG
   MORISOLI, S
   KANAL, E
AF SHELLOCK, FG
   MORISOLI, S
   KANAL, E
TI MR PROCEDURES AND BIOMEDICAL IMPLANTS, MATERIALS, AND DEVICES - 1993
   UPDATE
SO RADIOLOGY
LA English
DT Article
DE MAGNETIC RESONANCE (MR), SAFETY
ID HIGH-FIELD-STRENGTH; METALLIC BALLISTIC FRAGMENTS; IMAGING ARTIFACTS;
   DENTAL MATERIALS; POTENTIAL HAZARDS; MAGNETIC-FIELDS; SURGICAL CLIPS;
   RETINAL TACKS; FERROMAGNETISM; SAFETY
AB PURPOSE: To provide information on ferromagnetic metallic implants, materials, and devices that may be exposed to static magnetic fields during magnetic resonance (MR) imaging or spectroscopy.
   MATERIALS AND METHODS: An updated compilation of the results of more than 80 studies lists the specific object tested, the material used to construct the object, whether the object was deflected or moved during exposure to the static magnetic field, and the highest field strength used for testing the object (range, 0.147-4.7 T).
   RESULTS: The ferromagnetic qualities of 338 objects (32 aneurysm and hemostatic clips; six biopsy needles; five carotid artery vascular clamps; 18 dental devices or materials; 11 halo vests; 29 heart valve prostheses; 20 intravascular coils, filters, and stents; 22 ocular implants; 30 orthopedic implants, materials, and devices; 62 otologic implants; 23 pellets and bullets; 13 penile implants; 38 vascular access ports; and 29 miscellaneous objects) are reported.
   CONCLUSION: MR imaging or spectroscopy may be contraindicated in patients with such objects because of the risk of movement or dislodgment of the object.
C1 TOWER IMAGING, LOS ANGELES, CA 90048 USA.
   ST JOHNS HOSP, DEPT MED IMAGING, SANTA MONICA, CA USA.
   UNIV PITTSBURGH, DEPT RADIOL, PITTSBURGH, PA 15260 USA.
   PITTSBURGH NMR INST, PITTSBURGH, PA USA.
RP SHELLOCK, FG (reprint author), UNIV CALIF LOS ANGELES, SCH MED, DEPT RADIOL SCI, LOS ANGELES, CA USA.
FU NCI NIH HHS [1 R01 CA44014-05]
CR ALBERT DW, 1990, ARCH OPHTHALMOL-CHIC, V108, P320, DOI 10.1001/archopht.1990.01070050018007
   APPLEBAUM EL, 1990, ANN OTO RHINOL LARYN, V99, P801, DOI 10.1177/000348949009901009
   APPLEBAUM EL, 1985, ARCH OTOLARYNGOL, V111, P820
   BALLOCK RT, 1989, J BONE JOINT SURG AM, V71A, P431, DOI 10.2106/00004623-198971030-00020
   BARRAFATO D, 1984, CAN J SURG, V27, P509
   BECKER RL, 1988, AM J NEURORADIOL, V9, P885
   BELLON EM, 1984, MAGN RESON IMAGING, V2, P41
   BERNARDINO ME, 1986, RADIOLOGY, V158, P57, DOI 10.1148/radiology.158.1.3940398
   BROWN MA, 1987, MAGN RESON IMAGING, V5, P443, DOI 10.1016/0730-725X(87)90378-X
   CLAYMAN DA, 1990, AM J NEURORADIOL, V11, P385
   DAVIS PL, 1981, AM J ROENTGENOL, V137, P857, DOI 10.2214/ajr.137.4.857
   DEKEIZER RJ, 1984, DOC OPHTHALMOL, V61, P281
   DUJOVNY M, 1985, NEUROSURGERY, V17, P543, DOI 10.1227/00006123-198510000-00002
   DUPUY DE, 1993, AM J ROENTGENOL, V160, P893, DOI 10.2214/ajr.160.4.8456685
   FACHE JS, 1987, AM J NEURORADIOL, V8, P837
   FINN EJ, 1985, RADIOLOGY, V156, P139, DOI 10.1148/radiology.156.1.4001400
   GEGAUFF AG, 1990, J ORAL REHABIL, V17, P403, DOI 10.1111/j.1365-2842.1990.tb01411.x
   GILLINGS B R D, 1990, Dental Clinics of North America, V34, P683
   GO KG, 1989, CLIN NEUROL NEUROSUR, V91, P109, DOI 10.1016/S0303-8467(89)80030-7
   GOLD JP, 1989, ANN THORAC SURG, V48, P643, DOI 10.1016/0003-4975(89)90780-7
   Grassi C J, 1992, J Vasc Interv Radiol, V3, P535, DOI 10.1016/S1051-0443(92)72008-9
   HASSLER M, 1986, Journal de Radiologie (Paris), V67, P661
   HATHOUT G, 1992, JMRI-J MAGN RESON IM, V2, P93, DOI 10.1002/jmri.1880020117
   HINSHAW DB, 1988, RADIOLOGY, V166, P777, DOI 10.1148/radiology.166.3.3340777
   KAGETSU NJ, 1991, RADIOLOGY, V179, P505, DOI 10.1148/radiology.179.2.2014301
   KANAL E, 1990, RADIOLOGY, V176, P593, DOI 10.1148/radiology.176.3.2202008
   KANAL E, 1993, RADIOLOGY, V187, P612, DOI 10.1148/radiology.187.3.8497603
   KELLY WM, 1986, AM J NEURORADIOL, V7, P243
   KELSEY CA, 1991, RADIOLOGY, V180, P282, DOI 10.1148/radiology.180.1.2052711
   KLUCZNIK RP, 1993, RADIOLOGY, V187, P855, DOI 10.1148/radiology.187.3.8497645
   KUETHE DO, 1991, INVEST RADIOL, V26, P1, DOI 10.1097/00004424-199101000-00001
   LAAKMAN RW, 1985, AJR, V8, P837
   LEIBMAN CE, 1988, AJR, V150, P1174
   LEMMENS JAM, 1986, FORTSCHR RONTG NEUEN, V145, P311
   LEON JA, 1987, MAGN RESON IMAGING, V5, P405, DOI 10.1016/0730-725X(87)90130-5
   LIANG MD, 1989, MAGN RESON IMAGING, V7, P541, DOI 10.1016/0730-725X(89)90407-4
   LISSAC M, 1991, INVEST RADIOL, V26, P40, DOI 10.1097/00004424-199101000-00008
   LUFKIN R, 1988, AM J NEURORADIOL, V9, P953
   LYONS CJ, 1989, SPINE, V14, P670, DOI 10.1097/00007632-198907000-00004
   MARK AS, 1987, RADIOLOGY, V162, P311, DOI 10.1148/radiology.162.2.3797642
   MARSHALL MW, 1991, CARDIOVASC INTER RAD, V14, P163, DOI 10.1007/BF02577720
   MATSUMOTO AH, 1989, RADIOLOGY, V170, P753, DOI 10.1148/radiology.170.3.2916029
   MATTUCCI KF, 1986, OTOLARYNG HEAD NECK, V94, P441, DOI 10.1177/019459988609400407
   MECHLIN M, 1984, AM J ROENTGENOL, V143, P1281, DOI 10.2214/ajr.143.6.1281
   MESGARZADEH M, 1985, SKELETAL RADIOL, V14, P205, DOI 10.1007/BF00355565
   NEW PFJ, 1983, RADIOLOGY, V147, P139, DOI 10.1148/radiology.147.1.6828719
   POHOST GM, 1992, ANN NY ACAD SCI, V649, P302, DOI 10.1111/j.1749-6632.1992.tb49618.x
   POWER W, 1988, LANCET, V2, P227
   Pusey E, 1986, Radiographics, V6, P891
   RANDALL PA, 1988, AM J CARDIOL, V62, P973, DOI 10.1016/0002-9149(88)90907-1
   ROBERTS CW, 1990, ARCH OPHTHALMOL-CHIC, V108, P320
   SEIFF SR, 1991, ARCH OPHTHALMOL-CHIC, V109, P319, DOI 10.1001/archopht.1991.01080030021014
   SHELLOCK F G, 1989, Magnetic Resonance Quarterly, V5, P243
   SHELLOCK FG, 1992, JMRI-J MAGN RESON IM, V2, P225, DOI 10.1002/jmri.1880020217
   SHELLOCK FG, 1991, RADIOLOGY, V180, P541, DOI 10.1148/radiology.180.2.2068325
   SHELLOCK FG, 1988, AM J ROENTGENOL, V151, P811, DOI 10.2214/ajr.151.4.811
   SHELLOCK FG, 1988, AM J ROENTGENOL, V151, P389, DOI 10.2214/ajr.151.2.389
   SHELLOCK FG, 1990, AM J ROENTGENOL, V154, P631, DOI 10.2214/ajr.154.3.2106233
   SHELLOCK FG, 1991, JMRI-J MAGN RESON IM, V1, P97, DOI 10.1002/jmri.1880010114
   SHELLOCK FG, 1991, AM J NEURORADIOL, V12, P279
   SHELLOCK FG, 1992, RADIOLOGY, V185, P288
   SHELLOCK FG, 1992, APPL RADIOL      NOV, P44
   SHELLOCK FG, 1987, BOOK ABSTRACTS SOC M, P915
   SHELLOCK FG, 1990, RADIOLOGY P, V177, P271
   SHELLOCK FG, 1992, REV MAGN RESON IMAGI, V4, P21
   SHELLOCK FG, 1989, MAGN RESON IMAGIN S1, V7, P38
   SHELLOCK FG, 1988, MRI DECISIONS, V2, P25
   Shellock FG, 1987, RADIOLOGY, V165, P150
   SHELLOCK FG, IN PRESS MAGNETIC RE
   SHELLOCK FG, IN PRESS CURRENT PRA
   SHELLOCK FG, 1991, JMRI-J MAGN RESON IM, V1, P243
   SOULEN RL, 1985, RADIOLOGY, V154, P705, DOI 10.1148/radiology.154.3.3969474
   SOULEN RL, 1986, RADIOLOGY, V158, P279
   TEITELBAUM GP, 1990, RADIOLOGY, V175, P855, DOI 10.1148/radiology.175.3.2343136
   TEITELBAUM GP, 1988, RADIOLOGY, V168, P713, DOI 10.1148/radiology.168.3.3406402
   TEITELBAUM GP, 1990, RADIOLOGY, V177, P883, DOI 10.1148/radiology.177.3.2244005
   TEITELBAUM GP, 1989, CARDIOVASC INTER RAD, V12, P125, DOI 10.1007/BF02577374
   TEITELBAUM GP, 1988, RADIOLOGY, V166, P657, DOI 10.1148/radiology.166.3.3340759
   TEITELBAUM GP, 1990, AM J NEURORADIOL, V11, P267
   TO SYC, 1989, COMPUT MED IMAG GRAP, V13, P469, DOI 10.1016/0895-6111(89)90288-7
   VONROEMELING R, 1991, JMRI-J MAGN RESON IM, V1, P77
   WATANABE AT, 1990, RADIOLOGY, V177, P578, DOI 10.1148/radiology.177.2.2217801
   WHITE DW, 1987, AM J OTOL, V8, P290
   WILLIAMSON MR, 1988, ANGIOLOGY, V12, P1022
   YUH WTC, 1991, JMRI-J MAGN RESON IM, V1, P711, DOI 10.1002/jmri.1880010617
   ZHEUTLIN JD, 1987, AM J OPHTHALMOL, V103, P831, DOI 10.1016/S0002-9394(14)74404-6
   1988, HTLH DEVICES ALERT, V1
   1988, PREMARKET NOTIFICATI
   1993, MED DEVICES B, P1
NR 89
TC 118
Z9 121
U1 1
U2 5
PU RADIOLOGICAL SOC NORTH AMERICA
PI OAK BROOK
PA 820 JORIE BLVD, OAK BROOK, IL 60523 USA
SN 0033-8419
J9 RADIOLOGY
JI Radiology
PD NOV
PY 1993
VL 189
IS 2
BP 587
EP 599
DI 10.1148/radiology.189.2.8210394
PG 13
WC Radiology, Nuclear Medicine & Medical Imaging
SC Radiology, Nuclear Medicine & Medical Imaging
GA MD563
UT WOS:A1993MD56300043
PM 8210394
DA 2018-10-20
ER

PT J
AU GARG, AN
   WEGINWAR, RG
   CHUTKE, NL
AF GARG, AN
   WEGINWAR, RG
   CHUTKE, NL
TI RADIOCHEMICAL NEUTRON-ACTIVATION ANALYSIS OF FE, CO, ZN, SB AND SE IN
   BIOMEDICAL AND ENVIRONMENTAL-SAMPLES
SO SCIENCE OF THE TOTAL ENVIRONMENT
LA English
DT Article
DE RADIOCHEMICAL NAA; IRON; COBALT; ZINC; ANTIMONY; SELENIUM; ENVIRONMENTAL
   SAMPLES
ID TRACE-ELEMENTS; BIOLOGICAL-MATERIALS; SEPARATION; SELENIUM; METALS;
   FOODS
AB A radiochemical neutron activation method has been developed for the simultaneous determination of Fe, Co, Zn, Sb and Se levels in cancerous breast tissue, milk samples and fugitive cement dust particulates. Various Standard Reference Materials from NIST, USA (Bovine Liver 1577a, Milk Powder 1549, Coal Fly Ash 1633a and Urban Particulate Matter 1648), IAEA Vienna (Animal Muscle H-4, Milk powder A-11 and Soil-5) and NIES Japan (Pond Sediment) were also analysed for quality control. Samples together with standards were irradiated at a thermal neutron fluence of 10(13) ncm-2 s-1 for 2 weeks. After dissolution/fusion together with carriers, the Fe was first separated by extracting with diethyl ether followed by extraction with cupferron in chloroform. From the aqueous phase Co and Zn were extracted using alpha-nitroso-beta-naphthol in chloroform and 2-thenoyltrifluoroacetone in isobutylmethyl ketone, respectively. From another aliquot, Se was first complexed with o-phenylenediamine and extracted in benzene. Later Sb was extracted using KI and 4-(2-pyridylazo)-resorcinol (PAR) in benzene. The method yields reasonably accurate data for monitoring of trace elements in biomedical and environmental specimens.
RP GARG, AN (reprint author), NAGPUR UNIV, DEPT CHEM, NAGPUR 440010, MAHARASHTRA, INDIA.
CR ADEPETU JA, 1988, J RADIOAN NUCL CH AR, V121, P141, DOI 10.1007/BF02041455
   ALJABORI SM, 1990, J RADIOANAL NUCL CHE, V144, P229
   ANGERER J, 1990, FRESEN J ANAL CHEM, V337, P589, DOI 10.1007/BF00323093
   ARUNACHALAM J, 1979, NUCL ACTIVATION TECH, P499
   Berman E, 1980, TOXIC METALS THEIR A
   BHAT KR, 1982, SCI TOTAL ENVIRON, V22, P169, DOI 10.1016/0048-9697(82)90033-X
   BOGEN J, 1973, ATMOS ENVIRON, V7, P1117, DOI 10.1016/0004-6981(73)90220-5
   BYRNE AR, 1987, FRESEN Z ANAL CHEM, V326, P723, DOI 10.1007/BF00473540
   Chatt A., 1980, HAIR TRACE ELEMENTS, P46
   CHEEMA MN, 1981, RADIOCHIM ACTA, V28, P149
   CUNNINGHAM WC, 1987, J RADIOAN NUCL CH AR, V113, P423, DOI 10.1007/BF02050516
   DANG HS, 1984, J RADIOANAL NUCL CH, V84, P177, DOI 10.1007/BF02038194
   DEBSKI B, 1987, AM I NUTR, P1091
   DERMELJ M, 1986, J RADIOAN NUCL CH LE, V106, P91, DOI 10.1007/BF02162554
   EHMANN WD, 1989, CRC CR REV ANAL CHEM, V20, P405, DOI 10.1080/10408348908050073
   FOSTER HD, 1988, J NUTR, V118, P237
   FRANSSON GB, 1983, PEDIATR RES, V17, P912, DOI 10.1203/00006450-198311000-00015
   GANTHER HE, 1984, TRACE ELEMENT ANAL C, V3, P3
   GARG AN, 1990, BIOL TRACE ELEM RES, V26-7, P485, DOI 10.1007/BF02992704
   HAAS HF, 1986, FRESEN Z ANAL CHEM, V324, P13, DOI 10.1007/BF00469626
   IYENGAR GV, 1987, J RADIOAN NUCL CH AR, V110, P503, DOI 10.1007/BF02035540
   KALOUSKOVA J, 1989, J RADIOAN NUCL CH AR, V129, P59, DOI 10.1007/BF02037568
   KOSTA L, 1986, FRESEN Z ANAL CHEM, V324, P649, DOI 10.1007/BF00468374
   LEE RE, 1990, BIOL TRACE ELEM RES, V26-7, P321, DOI 10.1007/BF02992686
   LEVINSON AA, 1978, INVEST UROL, V15, P270
   MEYER BS, 1965, PLANT PHYSIOL, P473
   MORRISON GH, 1979, CRC CR REV ANAL CHEM, V8, P287, DOI 10.1080/10408347908085594
   PIETRA R, 1986, J RADIOAN NUCL CH AR, V102, P69, DOI 10.1007/BF02037950
   SAMUDRALWAR DL, 1987, J RADIOAN NUCL CH AR, V109, P363, DOI 10.1007/BF02037879
   SARMANI S, 1990, BIOL TRACE ELEM RES, V26-7, P497, DOI 10.1007/BF02992705
   Underwood E, 1977, TRACE ELEMENTS HUMAN
   WEGINWAR RG, 1990, OCT INT C ACT AN ITS, P261
   WILLIAMS RJP, 1987, POLYHEDRON, V6, P61, DOI 10.1016/S0277-5387(00)81239-5
   WU CY, 1987, J RADIOAN NUCL CH AR, V112, P133, DOI 10.1007/BF02037284
   XILEI L, 1988, ANAL CHIM ACTA, V211, P231, DOI 10.1016/S0003-2670(00)83683-1
   1989, REPORT JOINT WHO IAE
NR 36
TC 10
Z9 10
U1 0
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0048-9697
J9 SCI TOTAL ENVIRON
JI Sci. Total Environ.
PD NOV 1
PY 1993
VL 140
BP 421
EP 430
PG 10
WC Environmental Sciences
SC Environmental Sciences & Ecology
GA MH628
UT WOS:A1993MH62800037
PM 8272847
DA 2018-10-20
ER

PT J
AU STEYNBERG, S
   ROSSOUW, SF
AF STEYNBERG, S
   ROSSOUW, SF
TI THE AVAILABILITY OF RESEARCH JOURNALS IN SOUTH-AFRICAN ACADEMIC
   MEDICAL-LIBRARIES
SO SOUTH AFRICAN MEDICAL JOURNAL
LA English
DT Article
AB Biomedical researchers depend on the journals of science as a primary source of information. The spiralling cost of journals threatens the ability of libraries to provide their users' information needs. In this study the availability of a representative sample of journals used by South African biomedical researchers was determined at each of the seven medical faculty libraries. The application of a standardised document delivery test is described and the results are interpreted in terms of. (i) the capability index, which includes material obtainable through inter-library loans; and (ii) an availability index, or measure of the probability that a user will find an item without delay in his/her own library. The current status of availability of biomedical journals was found to be high at all the libraries; indeed, the scores compare favourably with results obtained at academic libraries overseas. There is, however, real concern that the financial crisis in tertiary education will cause the situation to deteriorate. Repetition of this test is recommended to monitor the (probably declining) level of journal availability. The information would support efforts to rationalise and subsequently strengthen academic medical libraries' collective holdings as a strategic national resource.
C1 CAPE TECHNIKON,SCH BUSINESS INFORMAT,CAPE TOWN,SOUTH AFRICA.
RP STEYNBERG, S (reprint author), UNIV CAPE TOWN,UNIV LIB,CAPE TOWN,SOUTH AFRICA.
CR Braun T., 1985, SCIENTOMETRIC INDICA
   Cronin B., 1984, CITATION PROCESS
   KANTOR P, 1984, OBJECTIVE PERFORMANC
   MANSBRIDGE J, 1986, LIBR INF SCI REV, V6, P299
   ORR RH, 1964, FED PROC, V23, P1310
   ORR RH, 1964, FED PROC, V23, P1297
   ORR RH, 1968, B MED LIBR ASSOC, V56, P241
   PROZESKY OW, 1990, BACKGROUND INFORMATI, P40
   VANHEERDEN PDR, 1992, S AFR MED J, V81, P243
NR 9
TC 4
Z9 4
U1 0
U2 1
PU MED ASSOC S AFRICA
PI JOHANNESBURG
PA MED HOUSE CENTRAL SQ 7430 PINELANDS JOHANNESBURG, SOUTH AFRICA
SN 0038-2469
J9 S AFR MED J
JI S. Afr. Med. J.
PD NOV
PY 1993
VL 83
IS 11
BP 837
EP 839
PG 3
WC Medicine, General & Internal
SC General & Internal Medicine
GA MG631
UT WOS:A1993MG63100011
PM 7839215
DA 2018-10-20
ER

PT J
AU CALDWELL, G
   NEUSE, EW
   STEPHANOU, A
AF CALDWELL, G
   NEUSE, EW
   STEPHANOU, A
TI SYNTHESIS OF WATER-SOLUBLE POLYAMIDOAMINES FOR BIOMEDICAL APPLICATIONS
   .2. POLYMERS POSSESSING INTRACHAIN-TYPE SECONDARY AMINO-GROUPS SUITABLE
   FOR SIDE-CHAIN ATTACHMENT
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
AB As part of a program to synthesize water-soluble polymeric carriers suitable for drug binding, the polyaddition reaction of methylenebisacrylamide with comonomers containing two primary amino groups is investigated. The copolymerization of the bisacrylamide with equimolar quantities of primary diamines under properly controlled experimental conditions is found to proceed in a linear propagation, giving rise to the formation of polyamides comprising two or more secondary amino groups in the recurring unit. Selected diamine monomers include ethylenediamine, diethylenetriamine, triethylenetetramine, 1,2-bis(3-aminopropylamino) ethane, and three 0,0'-bis-(2-aminopropyl) derivatives of poly(ethylene glycol) of different chain length, the last three monomers being chosen because of their outstanding hydrosolubilizing properties. Use of two different diamines in the proper stoichiometry leads to corresponding copolymers. The reactions are conducted in aqueous phase over periods of 1-3 days at 65-degrees-C, and the polymeric products, possessing the linear polyamidoamine structures 1 and 2, are fractionated by dialysis in membrane tubing with 12000-14000 molecular-mass cutoff and are isolated by freeze-drying as solid or resinous materials possessing complete solubility in water. Inherent viscosities are in the range of 8-40 mL g-1. Microanalytical and spectroscopic data confirm the proposed structures. The suitability of the intrachain secondary amine functions for side chain attachment and drug coupling is demonstrated in model reactions involving N-substitution. (C) 1993 John Wiley & Sons, Inc.
C1 UNIV WITWATERSRAND,DEPT CHEM,JOHANNESBURG 2050,SOUTH AFRICA.
CR BADER H, 1984, ANGEW MAKROMOL CHEM, V123, P457, DOI 10.1002/apmc.1984.051230121
   BARBUCCI R, 1981, J CHEM SOC DALTON, P2559, DOI 10.1039/dt9810002559
   CALDWELL G, 1992, S AFR J CHEM-S-AFR T, V45, P93
   DANUSSO F, 1970, POLYMER, V11, P88, DOI 10.1016/0032-3861(70)90029-7
   FERRUTI P, 1985, POLYMER, V26, P1336, DOI 10.1016/0032-3861(85)90309-X
   FERRUTI P, 1982, J APPL POLYM SCI, V27, P2239, DOI 10.1002/app.1982.070270633
   FERRUTI P, 1981, BIOMEDICAL APPLICATI, P39
   FERRUTI P, 1982, ADV POLYM SCI, V58, P55
   HARRIS JM, 1991, WATER SOLUBLE POLYM, P419
   MOLINEUX P, 1983, WATER SOLUBLE POLYM, V1, P19
NR 10
TC 24
Z9 26
U1 0
U2 5
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-8995
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD OCT 15
PY 1993
VL 50
IS 3
BP 393
EP 401
DI 10.1002/app.1993.070500303
PG 9
WC Polymer Science
SC Polymer Science
GA LZ134
UT WOS:A1993LZ13400003
DA 2018-10-20
ER

PT J
AU SWINWOOD, JF
   FRASER, FM
AF SWINWOOD, JF
   FRASER, FM
TI ENVIRONMENTAL APPLICATION OF GAMMA-TECHNOLOGY - UPDATE ON THE CANADIAN
   SLUDGE IRRADIATOR
SO RADIATION PHYSICS AND CHEMISTRY
LA English
DT Article; Proceedings Paper
CT 8TH INTERNATIONAL MEETING ON RADIATION PROCESSING
CY SEP 13-18, 1992
CL BEIJING, PEOPLES R CHINA
DE SLUDGE; DISINFECTION; RECYCLING; WASTE IRRADIATION
AB Waste treatment and disposal technologies have recently been subjected to increasing public and regulatory scrutiny. Concern for the environment and a heightened awareness of potential health hazards that could result from insufficient or inappropriate waste handling methods have combined to push waste generators in their search for new treatment alternatives. Gamma technology can offer a new option for the treatment of potentially infectious wastes, including municipal sewage sludge.
   Sewage sludge contains beneficial plant nutrients and a high organic component that make it ideal as a soil conditioning agent or fertilizer bulking material. It also carries potentially infectious microorganisms which limit opportunities for beneficial recycling of sludges. Gamma irradiation-disinfection of these sludges offers a reliable, fast and efficient method for safe sludge recycling.
   Nordion International's Market Development Division was created in 1987 as part of a broad corporate reorganization. It was given an exclusive mandate to develop new applications of gamma irradiation technology and markets for these new applications. Nordion has since explored and developed opportunities in food irradiation, pharmaceutical/cosmetic products irradiation, biomedical waste sterilization, airline waste disinfection, and sludge disinfection for recycling. This paper focuses on the last of these -a proposed sludge recycling facility that incorporates a cobalt 60 sludge irradiator.
RP SWINWOOD, JF (reprint author), NORDION INT INC,POB 13500,KANATA K2K 1X8,ON,CANADA.
NR 0
TC 8
Z9 8
U1 0
U2 2
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
SN 0146-5724
J9 RADIAT PHYS CHEM
JI Radiat. Phys. Chem.
PD OCT-DEC
PY 1993
VL 42
IS 4-6
BP 683
EP 687
DI 10.1016/0969-806X(93)90352-U
PG 5
WC Chemistry, Physical; Nuclear Science & Technology; Physics, Atomic,
   Molecular & Chemical
SC Chemistry; Nuclear Science & Technology; Physics
GA LK325
UT WOS:A1993LK32500026
DA 2018-10-20
ER

PT J
AU ALLCOCK, HR
   KLINGENBERG, EH
   WELKER, MF
AF ALLCOCK, HR
   KLINGENBERG, EH
   WELKER, MF
TI ALKANESULFONATION OF CYCLIC AND HIGH POLYMERIC PHOSPHAZENES
SO MACROMOLECULES
LA English
DT Article
ID ZWITTERIONIC SURFACTANTS; SIDE GROUPS; POLYPHOSPHAZENE; SULFONATES;
   SULTONES
AB A method for sulfonating aminophosphazenes with the use of 1,3-propanesultone is described. The alkanesulfonation reactions were first developed with small molecule phosphazene cyclic trimers as models for high polymeric phosphazenes. High molecular weight poly(aminophosphazenes) were then sulfonated using similar techniques. The structure and properties of the alkanesulfonated polymers were examined by DSC, intrinsic viscosity, and P-31, C-13, and H-1 NMR spectroscopy. This synthetic approach to sulfonated polymers is valuable for the development of new biomedical materials, membranes, reversibly cross-linkable polymers, surfactants, and polyelectrolytes.
RP ALLCOCK, HR (reprint author), PENN STATE UNIV,DEPT CHEM,UNIV PK,PA 16802, USA.
CR ALLCOCK HR, 1969, J AM CHEM SOC, V91, P5452, DOI 10.1021/ja01048a009
   ALLCOCK HR, 1989, MACROMOLECULES, V22, P75, DOI 10.1021/ma00191a015
   ALLCOCK HR, 1966, INORG CHEM, V5, P1709, DOI 10.1021/ic50044a016
   ALLCOCK HR, 1991, MACROMOLECULES, V24, P993, DOI 10.1021/ma00005a005
   ALLCOCK HR, 1991, CHEM MATER, V3, P1120, DOI 10.1021/cm00018a032
   ALLCOCK HR, 1964, J AM CHEM SOC, V86, P2591, DOI 10.1021/ja01067a015
   ALLCOCK HR, 1991, ORGANOMETALLICS, V10, P677, DOI 10.1021/om00049a029
   ALLEN CW, 1968, INORG CHEM, V7, P2183, DOI 10.1021/ic50069a002
   BECKEGOEHRING M, 1959, Z ANORG ALLG CHEM, V302, P103, DOI 10.1002/zaac.19593020110
   BIKALES NM, 1973, WATER SOLUBLE POLYM
   BRUNEL S, 1989, TETRAHEDRON, V45, P3363, DOI 10.1016/S0040-4020(01)81015-2
   CHAPMAN AC, 1960, J CHEM SOC, P3608, DOI 10.1039/jr9600003608
   CHITTENDEN RA, 1966, SPECTROCHIM ACTA, V22, P1449, DOI 10.1016/0371-1951(66)80138-8
   de Ficquelmont AM, 1939, ANN CHIM FRANCE, V12, P169
   DELL D, 1965, J CHEM SOC, P4070, DOI 10.1039/jr9650004070
   EISENBERG A, 1980, ADV CHEM SERIES, V187
   FEAKINS D, 1964, J CHEM SOC, P1735
   FEISTEL G, 1970, INORG CHEM, V9, P1401
   FEISTEL GR, 1967, J INORG NUCL CHEM, V29, P2731, DOI 10.1016/0022-1902(67)80011-3
   FISCHER RF, 1964, IND ENG CHEM, V56, P41, DOI 10.1021/ie50651a008
   FITZSIMMONS BW, 1964, J CHEM SOC, P1735, DOI 10.1039/jr9640001735
   FITZSIMMONS BW, 1961, CHEM IND-LONDON, P109
   GANAPATHIAPPAN S, 1988, MACROMOLECULES, V21, P2299, DOI 10.1021/ma00185a075
   GOLDSCHMIDT BM, 1974, J HETEROCYCLIC CHEM, V11, P719, DOI 10.1002/jhet.5570110510
   GREGOR HP, 1975, POLYM SCI TECHNOL, V7, P51
   HELBERGER JH, 1949, LIEBIGS ANN CHEM, V565, P22
   HELBERGER JH, 1954, LIEBIGS ANN CHEM, V586, P147
   HIGUCHI A, 1988, J APPL POLYM SCI, V36, P1753, DOI 10.1002/app.1988.070360804
   KEAT R, 1965, J CHEM SOC, P2215, DOI 10.1039/jr9650002215
   KEAT R, 1965, J CHEM SOC, P7193, DOI 10.1039/jr9650007193
   KING JF, 1988, J CHEM SOC CHEM COMM, P415, DOI 10.1039/c39880000415
   LASCHEWSKY A, 1991, POLYMER, V32, P2070, DOI 10.1016/0032-3861(91)90175-I
   LASCHEWSKY A, 1991, POLYMER, V32, P208
   LEHR W, 1967, Z ANORG ALLG CHEM, V350, P18, DOI 10.1002/zaac.19673500104
   MANI NV, 1969, J CHEM SOC, P51
   MCBEE ET, 1966, INORG CHEM, V5, P450, DOI 10.1021/ic50037a026
   MCBEE ET, 1959, AD209666
   MCBEE ET, 1991, AD254984
   MCBEE ET, 1959, AD209669
   MCGEACHIN HM, 1960, CHEM IND-LONDON, P1131
   MOLYNEUX P, 1983, WATER SOLUBLE POLYM, V1
   MONOTONERI E, 1989, MACROMOL CHEM, V190, P191
   MONOTONERI E, 1989, J MACROMOL SCI CHEM, V26, P645
   NICHOLS GM, 1961, ASD612 TECH REP
   PAETZOLD E, 1987, J PRAKT CHEM, V329, P725, DOI 10.1002/prac.19873290423
   PULAY P, 1969, ZS ACTA CHIM ACAD SC, V60, P333
   RATZ R, 1960, J INORG NUCL CHEM, V16, P60, DOI 10.1016/0022-1902(60)80087-5
   RATZ RFW, 1959, Patent No. 2876247
   RAY SK, 1961, J CHEM SOC, P872, DOI 10.1039/jr9610000872
   RAY SK, 1959, CHEM IND-LONDON, P53
   ROBERTS DW, 1987, TETRAHEDRON, V43, P1027, DOI 10.1016/S0040-4020(01)90041-9
   ROESKY HW, 1971, CHEM BER-RECL, V104, P653, DOI 10.1002/cber.19711040232
   ROESKY HW, 1968, INORG NUCL CHEM LETT, V4, P463
   SEEL F, 1958, Z ANORG ALLG CHEM, V295, P316, DOI 10.1002/zaac.19582950506
   UCHIDA M, 1989, MACROMOLECULES, V22, P2381, DOI 10.1021/ma00195a065
   1984, Patent No. 49099979
   1980, Patent No. 55139347
   1987, Patent No. 63112564
NR 58
TC 24
Z9 24
U1 0
U2 3
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036
SN 0024-9297
J9 MACROMOLECULES
JI Macromolecules
PD SEP 27
PY 1993
VL 26
IS 20
BP 5512
EP 5519
DI 10.1021/ma00072a032
PG 8
WC Polymer Science
SC Polymer Science
GA LZ505
UT WOS:A1993LZ50500032
DA 2018-10-20
ER

PT J
AU BOCQUET, B
   AITABDELMALEK, R
   LEROY, Y
AF BOCQUET, B
   AITABDELMALEK, R
   LEROY, Y
TI DECONVOLUTION AND WIENER FILTERING OF SHORT-RANGE RADIOMETRIC IMAGES
SO ELECTRONICS LETTERS
LA English
DT Article
DE BIOMEDICAL ELECTRONICS; IMAGE PROCESSING
ID MICROWAVE RADIOMETRY; THERMAL STRUCTURES
AB A radiometric probe positioned at different points on the surface of a lossy medium can detect the presence of a subsurface thermal noise source. Radiometric images are obtained by a combination of measured data and calculated weighting functions of the probe associated with the underlying lossy materials. The Letter shows that the quality of these images and their spatial resolution can be greatly improved by Wiener filtering deconvolution of their corresponding data.
RP BOCQUET, B (reprint author), UNIV SCI & TECHNOL LILLE,INST ELECTR & MICROELECTR NORD,DEPT HYPERFREQUENCES & SEMICOND,CNRS,F-59655 VILLENEUVE DASCQ,FRANCE.
CR BARDATI F, 1991, JUL P PIERS CAMBR
   BOCQUET B, 1986, ELECTRON LETT, V22, P120, DOI 10.1049/el:19860084
   CAMPBELL AM, 1992, PHYS MED BIOL, V37, P193, DOI 10.1088/0031-9155/37/1/014
   ENEL L, 1984, ELECTRON LETT, V20, P293, DOI 10.1049/el:19840200
   Kafadar K, 1986, IEEE T INSTRUM MEAS, V35, P492
   Leroy Y., 1987, Automedica, V8, P181
   MAMOUNI A, 1991, IEEE T MICROW THEORY, V39, P124, DOI 10.1109/22.64615
   MIZUSHINA S, 1991, JUL P PIERS CAMBR
   Pratt WK, 1978, DIGITAL IMAGE PROCES
   SOMLO PI, 1979, IEEE T MICROW THEORY, V27, P128, DOI 10.1109/TMTT.1979.1129573
NR 10
TC 10
Z9 11
U1 0
U2 1
PU IEE-INST ELEC ENG
PI HERTFORD
PA MICHAEL FARADAY HOUSE SIX HILLS WAY STEVENAGE, HERTFORD, ENGLAND SG1 2AY
SN 0013-5194
J9 ELECTRON LETT
JI Electron. Lett.
PD SEP 2
PY 1993
VL 29
IS 18
BP 1628
EP 1629
DI 10.1049/el:19931084
PG 2
WC Engineering, Electrical & Electronic
SC Engineering
GA MG407
UT WOS:A1993MG40700024
DA 2018-10-20
ER

PT J
AU KUPILARANTALA, T
   HYVONENDABEK, M
   RAISANEN, J
AF KUPILARANTALA, T
   HYVONENDABEK, M
   RAISANEN, J
TI EFFECTS OF PREPARATION METHODS OF BIOMEDICAL SAMPLES ON PIXE MEASUREMENT
   SENSITIVITY
SO APPLIED RADIATION AND ISOTOPES
LA English
DT Article
ID X-RAY-EMISSION; TRACE-ELEMENT ANALYSIS; EXTERNAL BEAM PIXE; PROTON-BEAM;
   TISSUES; TUMORS
AB Instrumental sample preparation techniques for PIXE measurements of human blood serum and bovine muscle were investigated. The techniques studied were direct measurement of a drop, drying on a foil and on an Al cup, lyophilization on a foil, pellet pressing of dried material, microtome sectioning and biopsy preparation. The same serum and muscle were used in each procedure allowing the comparison of detection limits between different methods. The most beneficial technique for both samples was lyophilization and pellet pressing.
RP KUPILARANTALA, T (reprint author), UNIV HELSINKI,DEPT PHYS,POB 9,SF-00014 HELSINKI,FINLAND.
CR AARNIO P, 1990, SAMP90
   ANDERSSON M, 1990, NUCL INSTRUM METH B, V49, P198, DOI 10.1016/0168-583X(90)90242-M
   ANTTILA A, 1985, NUCL INSTRUM METH B, V12, P245, DOI 10.1016/0168-583X(85)90058-8
   BARNES BK, 1975, ADV XRAY ANAL, V18, P343
   BEARSE RC, 1974, ANAL CHEM, V46, P499, DOI 10.1021/ac60340a028
   CAMPBELL JL, 1985, NUCL INSTRUM METH B, V6, P551, DOI 10.1016/0168-583X(85)90017-5
   CAMPBELL JL, 1975, ANAL CHEM, V47, P1542, DOI 10.1021/ac60359a006
   CAMPBELL JL, 1973, ADV XRAY ANALYSIS, V17, P457
   DECONNINCK G, 1977, NUCL INSTRUM METHODS, V142, P275, DOI 10.1016/0029-554X(77)90838-2
   DUREK K, 1983, IEEE T NUCL SCI, V30, P1310, DOI 10.1109/TNS.1983.4332517
   GALUSZKA J, 1984, NUCL INSTRUM METH B, V3, P141, DOI 10.1016/0168-583X(84)90351-3
   HECK D, 1983, IEEE T NUCL SCI, V30, P1220, DOI 10.1109/TNS.1983.4332493
   HYVONENDABEK M, 1984, CLIN CHEM, V30, P529
   HYVONENDABEK M, 1981, J RADIOANAL CHEM, V63, P163, DOI 10.1007/BF02518418
   JOHANSSON E, 1987, NUCL INSTRUM METH B, V22, P179, DOI 10.1016/0168-583X(87)90321-1
   KHAN AH, 1979, NUCL INSTRUM METHODS, V165, P253, DOI 10.1016/0029-554X(79)90279-9
   KIVITS HPM, 1979, NUCL INSTRUM METHODS, V164, P225, DOI 10.1016/0029-554X(79)90239-8
   LAPATTO R, 1989, BIOL TRACE ELEM RES, V19, P161, DOI 10.1007/BF02924293
   MAENHAUT W, 1987, NUCL INSTRUM METH B, V22, P138, DOI 10.1016/0168-583X(87)90311-9
   MAENHAUT W, 1980, NUCL INSTRUM METHODS, V168, P557, DOI 10.1016/0029-554X(80)91310-5
   MAENHAUT W, 1984, NUCL INSTRUM METH B, V3, P135, DOI 10.1016/0168-583X(84)90350-1
   MANGELSON NF, 1977, NUCL INSTRUM METHODS, V142, P133, DOI 10.1016/0029-554X(77)90821-7
   PALLON J, 1981, NUCL INSTRUM METHODS, V181, P71, DOI 10.1016/0029-554X(81)90583-8
   RAISANEN J, 1981, INT J APPL RADIAT IS, V32, P165, DOI 10.1016/0020-708X(81)90108-3
   RAISANEN J, 1982, NUCL INSTRUM METHODS, V196, P489, DOI 10.1016/0029-554X(82)90119-7
   ROBAYE G, 1980, NUCL INSTRUM METHODS, V172, P535, DOI 10.1016/0029-554X(80)90346-8
   SHAO HR, 1990, NUCL INSTRUM METH B, V49, P238, DOI 10.1016/0168-583X(90)90252-P
   TANAKA M, 1987, NUCL INSTRUM METH B, V22, P152, DOI 10.1016/0168-583X(87)90314-4
   TAPPER UAS, 1987, NUCL INSTRUM METH B, V22, P176, DOI 10.1016/0168-583X(87)90320-X
   WALTER RL, 1974, ANAL CHEM, V46, P843, DOI 10.1021/ac60343a038
NR 30
TC 2
Z9 2
U1 0
U2 0
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
SN 0969-8043
J9 APPL RADIAT ISOTOPES
JI Appl. Radiat. Isot.
PD SEP
PY 1993
VL 44
IS 9
BP 1177
EP 1182
DI 10.1016/0969-8043(93)90061-E
PG 6
WC Chemistry, Inorganic & Nuclear; Nuclear Science & Technology; Radiology,
   Nuclear Medicine & Medical Imaging
SC Chemistry; Nuclear Science & Technology; Radiology, Nuclear Medicine &
   Medical Imaging
GA LV300
UT WOS:A1993LV30000003
PM 8401448
DA 2018-10-20
ER

PT J
AU HELSEN, JA
   JAECQUES, SV
   VANHUMBEECK, J
   SIMON, JP
AF HELSEN, JA
   JAECQUES, SV
   VANHUMBEECK, J
   SIMON, JP
TI EVALUATION OF AN ELASTOMER FOR BIOMEDICAL USE IN LOAD-BEARING
   APPLICATIONS .1. IN-VITRO FATIGUE TESTING
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
AB The fatigue behaviour of a medical-grade thermoplastic polyolefin (TPO) was investigated with the objective of using TPOs for endoprosthetical aims in dental and orthopaedic applications. For this purpose, a TPO was subjected to the combined action of shear and compression fatigue while in contact with Hanks' solution. Cyclic loading between 150 and 1500 kPa shear stress and a number of cycles up to 9 x 10(6) was applied. The potential fatigue damage was assessed by in-fatigue-recording of the mechanical hysteresis curves and, after fatigue, by swelling tests in acetic acid solutions, dynamic mechanical thermal analysis, Fourier transform infrared spectroscopy, X-ray diffraction and scanning electron microscopy. The combined and critical application of these techniques allowed us to conclude that this material exhibits a very satisfactory fatigue behaviour under the loads investigated, making this material potentially useful for endoprostheses. Moreover, biomedical prescreening tests (according to USP Class VI) were all negative, stimulating continued research on this type of material.
C1 KATHOLIEKE UNIV LEUVEN,HOSP ORTHOPAED,DEPT ORTHOPAED SURG,B-3212 PELLENBERG,BELGIUM.
RP HELSEN, JA (reprint author), KATHOLIEKE UNIV LEUVEN,DEPT MET & MAT ENGN,CROYLAAN 2,B-3001 LOUVAIN,BELGIUM.
CR ALEXANDER LE, 1979, XRAY DIFFRACTION MET, P176
   EISELE U, 1990, INTRO POLYM PHYSICS, P40
   Engel L, 1981, ATLAS POLYM DAMAGE
   FUYIYAMA M, 1980, J POLYM SCI POL LETT, V18, P105
   MAST F, 1992, 4TH WORLD BIOM C BER, P692
   MURAYAMA T, 1978, DYNAMIC MECHANICAL A
   Rader C. P., 1990, THERMOPLASTIC ELASTO, P159
   REISCH MS, 1992, CHEM ENG NEWS   0504, P29
   Turley J. W., 1965, XRAY DIFFRACTION PAT
   VONCK CG, 1989, XRAY SCATTERING SYNT
   WEAST RC, 1991, CRC HDB CHEM PHYSICS
   1986, ANN BOOK ASTM STANDA, V15, P329
   1980, US PHARMACOPEIA, V20, P950
NR 13
TC 4
Z9 4
U1 0
U2 2
PU CHAPMAN HALL LTD
PI LONDON
PA 2-6 BOUNDARY ROW, LONDON, ENGLAND SE1 8HN
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD SEP
PY 1993
VL 4
IS 5
BP 471
EP 480
DI 10.1007/BF00120127
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA MG125
UT WOS:A1993MG12500006
DA 2018-10-20
ER

PT J
AU FOSCHI, D
   CASTOLDI, L
   LESMA, A
   MUSAZZI, M
   BENEVENTO, A
   TRABUCCHI, E
AF FOSCHI, D
   CASTOLDI, L
   LESMA, A
   MUSAZZI, M
   BENEVENTO, A
   TRABUCCHI, E
TI EFFECTS OF ISCHEMIA AND REPERFUSION ON LIVER-REGENERATION IN RATS
SO EUROPEAN JOURNAL OF SURGERY
LA English
DT Article
DE LIVER REGENERATION; HEPATECTOMY; OXYGEN FREE RADICALS; LIPID
   PEROXIDATION
ID HEPATOCYTE GROWTH-FACTOR; LIPID-PEROXIDATION; FREE-RADICALS;
   SUPEROXIDE-DISMUTASE; HEPATIC-INJURY; DAMAGE; PRESERVATION; PREVENTION;
   ISCHEMIA; OXIDASE
AB Objective: To assess the effects of oxygen free radicals on liver regeneration in rats after 80% hepatectomy.
   Design: Open laboratory study.
   Setting: Institute of Biomedical Sciences, University of Milan, Italy.
   Material. Female Sprague-Dawley rats.
   Interventions: After laparotomy 122 rats had ischaemia induced by clamping of the portal vein and hepatic artery, and 93 rats had manipulation of the vessels only. They were then allowed to recover before 80% hepatectomy was done. Absolute controls (n = 16) did not have a laparotomy. Mortality was recorded, and surviving rats were killed one, three, five, and seven days after operation. A further 10 rats had 80% hepatectomies and then underwent a 10 minute period of ischaemia 24 hours later. These animals were killed after three days. In yet more experiments 38 rats underwent 80% hepatectomies and were then divided into four groups: 8 were given allopurinol 50 mg/kg/day starting three days before operation; 8 were given superoxide dismutase 4.16 mg/kg intraperitoneally 30 minutes before induction of ischaemia; 12 were given verapamil 0.1 mg/kg 30 minutes before induction of ischaemia; and 10 were given saline (controls).
   Main outcome measures: Incorporation of tritiated thymidine into DNA, differences in liver weights, and lipid peroxide concentrations.
   Results: 43 rats died after ischaemia/reperfusion and 19 after hepatectomy alone. Ischaemia/reperfusion caused a significant reduction in the incorporation of tritiated thymidine into DNA 24 hours after hepatectomy (p < 0.01), and significant inhibition of recovery of liver weight three (p < 0.01) and five (p < 0.05) days after hepatectomy. These effects were associated with high lipid peroxide concentrations at three days. Allopurinol (p < 0.01, p < 0.05), superoxide dismutase (p < 0.01, p < 0.01) and verapamil (p < 0.01, N.S.) reduced the effects of ischaemia/ reperfusion on liver weights or lipid peroxide concentrations three days after hepatectomy.
   Conclusion: A 10 minute period of ischaemia followed by reperfusion temporarily reduces liver regeneration after 80% hepatectomy in rats.
C1 UNIV MILAN,INST BIOMED SCI L SACCO,DEPT SURG,I-20122 MILAN,ITALY.
   UNIV PAVIA,DEPT SURG,I-27100 PAVIA,ITALY.
RP FOSCHI, D (reprint author), UNIV MILAN,OSPED MAGGIORE,DEPT SURG & SURG THERAPEUT 1,I-20122 MILAN,ITALY.
OI Foschi, Diego/0000-0002-7702-8226
CR ADKISON D, 1986, ACTA PHYSL SCAND S, V548, P101
   ARTHUR MJP, 1985, GASTROENTEROLOGY, V89, P1114, DOI 10.1016/0016-5085(85)90218-5
   BACON BR, 1989, CHEM-BIOL INTERACT, V70, P183, DOI 10.1016/0009-2797(89)90045-8
   BECKER FF, 1963, AM J PATHOL, V43, P497
   BURTON K, 1956, BIOCHEM J, V62, P315, DOI 10.1042/bj0620315
   CHIEN KR, 1977, AM J PATHOL, V88, P539
   COCKERILL MJ, 1983, BIOCHIM BIOPHYS ACTA, V75, P208
   COMPORTI M, 1985, LAB INVEST, V53, P599
   DELMAESTRO RF, 1980, ACTA PHYSL SCAND S, V492, P153
   ENGERSON TD, 1987, J CLIN INVEST, V79, P1564, DOI 10.1172/JCI112990
   FLEIG WE, 1988, SCAND J GASTROENTERO, V23, P31, DOI 10.3109/00365528809095911
   FREEMAN BA, 1982, LAB INVEST, V47, P412
   Higgins GM, 1931, ARCH PATHOL, V12, P186
   JENNISCHE E, 1984, ACTA PATH MICRO IM A, V92, P55
   KAWAMOTO S, 1989, TRANSPLANT P, V21, P1287
   LINDROOS PM, 1991, HEPATOLOGY, V13, P743, DOI 10.1002/hep.1840130422
   MACKENZIE RJ, 1975, BRIT J SURG, V62, P431, DOI 10.1002/bjs.1800620603
   MARUBAYASHI S, 1982, SURGERY, V91, P631
   MARUBAYASHI S, 1986, SURGERY, V99, P184
   MCCORD JM, 1987, FASEB J, V46, P2402
   MCCORD JM, 1983, SURGERY, V94, P412
   MCKELVEY TG, 1988, AM J PHYSIOL, V254, pG753
   MICHALOPOULOS GK, 1992, HEPATOLOGY, V15, P149, DOI 10.1002/hep.1840150125
   NAUTA RJ, 1991, ANN SURG, V213, P137, DOI 10.1097/00000658-199102000-00008
   NORDSTROM G, 1985, SURGERY, V97, P679
   OBERLEY LW, 1979, CANCER RES, V39, P1141
   ONTELL SJ, 1989, ANN SURG, V209, P200, DOI 10.1097/00000658-198902000-00011
   PLACER ZA, 1966, ANAL BIOCHEM, V16, P359, DOI 10.1016/0003-2697(66)90167-9
   PLAYER TJ, 1977, BIOCHEM BIOPH RES CO, V78, P1397, DOI 10.1016/0006-291X(77)91447-4
   SITUNAYAKE RD, 1990, GUT, V31, P1311, DOI 10.1136/gut.31.11.1311
   SOBCZAK J, 1986, BIOCHIMIE, V68, P957, DOI 10.1016/S0300-9084(86)80039-6
   SOBCZAK J, 1989, ONCOGENE, V4, P1503
   SOMIMOTO K, 1987, SURGERY, V102, P821
   SOUTHARD JH, 1987, SURGERY, V101, P566
NR 34
TC 40
Z9 41
U1 0
U2 0
PU SCANDINAVIAN UNIVERSITY PRESS
PI OSLO
PA PO BOX 2959 TOYEN, JOURNAL DIVISION CUSTOMER SERVICE, N-0608 OSLO,
   NORWAY
SN 1102-4151
J9 EUR J SURG
JI Eur. J. Surg.
PD AUG
PY 1993
VL 159
IS 8
BP 393
EP 398
PG 6
WC Surgery
SC Surgery
GA LU761
UT WOS:A1993LU76100002
PM 8218549
DA 2018-10-20
ER

PT J
AU SHIH, CY
   LAI, JY
AF SHIH, CY
   LAI, JY
TI POLYVINYL-ALCOHOL PLASMA-DEPOSITED NYLON-4 MEMBRANE FOR HEMODIALYSIS
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
ID BIOMEDICAL APPLICATIONS; POLYMERIZATION; SURFACES
AB Polyvinyl alcohol (PVA) is a hydrophilic and blood compatible material, but it is easily hydrolyzed in aqueous solution. Various methods, including chemical crosslinking and gamma-ray irradiation, have been investigated by many researchers for overcoming the instability of PVA in aqueous solution. This study suggests a new hemodialysis membrane, which is prepared by plasma depositing vinylacetate (VAc) onto annealled nylon 4 membrane, followed by hydrolysis treatment. This improves the blood compatibility of nylon 4 and overcomes the hydrolysis problem of PVA. In addition to conventional plasma deposition, the plasma initiated interpenetrating network (IPN) method is also investigated.
   The new hemodialysis membranes prepared by both conventional plasma deposited VAc onto nylon 4 (PPVA/N4) and IPN polymer of plasma initiated VAc onto nylon 4 (PIPVA/N4 IPN) show significant improvement in blood compatibility. However, the solute permeabilities of PIPVA/N4 IPN membranes are higher than those of PPVA/N4 membranes. The permeabilities of NaCl, vitamin B12, and albumin for membranes prepared by IPN at 80 W, 30 sec plasma deposited conditions, i.e., the optimized conditions, are 3.614, 0.070, and 0.000 X 10(-5) cm2 /min, respectively. The mole ratio of adsorbed fibrinogen to adsorbed albumin (the mole ratio F/A) for this membrane is 0.20, and it also shows excellent blood compatibility in this study. (C) 1993 John Wiley & Sons, Inc.
C1 CHUNG YUAN CHRISTIAN UNIV,DEPT CHEM ENGN,CHUNGLI 32023,TAIWAN.
   CHENGSHIU JR COLL TECHNOL & COMMERCE,DEPT CHEM ENGN,KAOHSIUNG,TAIWAN.
CR ABSOLOM DR, 1987, J BIOMED MATER RES, V21, P161, DOI 10.1002/jbm.820210202
   COOPES IH, 1982, J MACROMOL SCI CHEM, VA17, P217, DOI 10.1080/00222338208063256
   HUANG RYM, 1981, J APPL POLYM SCI, V26, P1907, DOI 10.1002/app.1981.070260615
   HUANG RYM, 1981, J APPL POLYM SCI, V26, P1135, DOI 10.1002/app.1981.070260407
   JONG A, 1988, J APPL POLYM SCI, V36, P87, DOI 10.1002/app.1988.070360108
   KAIFU K, 1982, J BIOMED MATER RES, V16, P757, DOI 10.1002/jbm.820160602
   KARAKELLE M, 1989, J MEMBRANE SCI, V41, P305, DOI 10.1016/S0376-7388(00)82410-2
   LAI JY, 1992, J MEMBRANE SCI, V66, P169, DOI 10.1016/0376-7388(92)87007-K
   LAI JY, 1990, J APPL POLYM SCI, V39, P2293, DOI 10.1002/app.1990.070391109
   LAI JY, 1989, J APPL POLYM SCI, V37, P1465, DOI 10.1002/app.1989.070370603
   LAI JY, 1986, J APPL POLYM SCI, V32, P4709, DOI 10.1002/app.1986.070320435
   LAI JY, 1991, J APPL POLYM SCI, V43, P1431, DOI 10.1002/app.1991.070430804
   YASUDA H, 1982, BIOMATERIALS, V3, P68, DOI 10.1016/0142-9612(82)90036-9
   YEH YS, 1988, J BIOMED MATER RES, V22, P795, DOI 10.1002/jbm.820220904
   YOON SC, 1982, J APPL POLYM SCI, V27, P3133, DOI 10.1002/app.1982.070270834
NR 15
TC 16
Z9 16
U1 0
U2 9
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD AUG
PY 1993
VL 27
IS 8
BP 983
EP 989
DI 10.1002/jbm.820270803
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA LM052
UT WOS:A1993LM05200002
PM 8408126
DA 2018-10-20
ER

PT J
AU BARRETT, B
AF BARRETT, B
TI HEALTH-CARE BEHAVIOR ON NICARAGUA ATLANTIC COAST
SO SOCIAL SCIENCE & MEDICINE
LA English
DT Article
DE NICARAGUA; CENTRAL AMERICA; HEALTH BEHAVIOR; ETHNOMEDICINE; TRADITIONAL
   MEDICINE; WESTERN MEDICINE
ID WAR; POLITICS; SERVICES
AB Survey methods are used to investigate health behavior in five communities on Nicaragua's Atlantic Coast. Eighteen health behaviors classified as 'biomedical' or 'traditional' are analyzed according to the ethnicity and educational level of the respondent. Household location (urban vs rural) and material wealth are also analyzed as predictors of health care behavior. Traditional behaviors are found to vary considerably among the six ethnic groups and among the various socioeconomic groupings. Biomedical behaviors are not found to be clearly related to ethnicity, wealth, or education.
RP BARRETT, B (reprint author), JOHNS HOPKINS UNIV,INST NUTR CENT AMER & PANAMA,APARTADO 1188,GUATEMALA CITY,GUATEMALA.
CR AMADOR M, 1991, RAMA WANGKI, V2, P27
   ARAUZ R, 1991, LANCET, V337, P1290, DOI 10.1016/0140-6736(91)92960-A
   Baer Hans A., 1987, ENCOUNTERS BIOMEDICI
   BENT BK, 1991, TRABAJO MONOGRAFICO
   BENTLEY ME, 1988, SOC SCI MED, V27, P75, DOI 10.1016/0277-9536(88)90165-7
   BOSSERT T, 1982, MED ANTHROPOL Q, V15, P773
   BRAVEMAN P, 1987, INT J HEALTH SERV, V17, P169, DOI 10.2190/DB43-MWPL-2V12-WGXY
   BRAVEMAN P, 1985, WORLD HLTH FORUM, V6, P369
   BROWNER CH, 1991, MED ANTHROPOL Q, V5, P99, DOI 10.1525/maq.1991.5.2.02a00010
   *COMM HLTH RIGHTS, 1991, CRIT COND HLTH CAR N
   COREIL J, 1983, CULT MED PSYCHIAT, V7, P131, DOI 10.1007/BF00051846
   COSMINSKY S, 1977, SOC SCI MED, V11, P325, DOI 10.1016/0037-7856(77)90190-1
   *CTR INV DOC COST, 1989, EST ZON ESP II
   *CTR INV DOC COST, 1987, ETHN GROUPS NAT STAT
   DONAHUE J, 1986, NICARAGUAN REVOLUTIO
   DONAHUE JM, 1983, HUM ORGAN, V42, P264, DOI 10.17730/humo.42.3.x737h47hqw3r2785
   ELLSBERG MC, 1982, REV CENTROAM CIENCIA, V23, P145
   ELLSBERG MC, 1983, SCI PEOPLE, V15, P14
   ESCUDERO JC, 1980, INT J HEALTH SERV, V10, P647, DOI 10.2190/NT2B-0K80-EK76-26MV
   Garfield R., 1989, HLTH REVOLUTION NICA
   GARFIELD R, 1987, INT Q COMMUNITY HLTH, V7, P123
   GARFIELD RM, 1989, SOC SCI MED, V28, P669, DOI 10.1016/0277-9536(89)90214-1
   GARFIELD RM, 1987, AM J PUBLIC HEALTH, V77, P615, DOI 10.2105/AJPH.77.5.615
   GARFIELD RM, 1984, AM J PUBLIC HEALTH, V74, P1138, DOI 10.2105/AJPH.74.10.1138
   HALPERIN D, 1982, NEW ENGL J MED, V306, P308
   HEIBY JR, 1981, AM J PUBLIC HEALTH, V71, P514, DOI 10.2105/AJPH.71.5.514
   HELMS M, 1971, ASANG ADAPTIONS CULT
   HHELMS M, 1969, ANNTHR Q, V42, P325
   HODGSON R, 1967, THESIS FACULTAD CIEN
   KLEINMAN A, 1978, AM ANTHROPOL, V80, P661, DOI 10.1525/aa.1978.80.3.02a00170
   Lazarus E. S., 1986, MED ANTHROPOL Q, V17, P136
   LEFTON D, 1984, CAN MED ASSOC J, V130, P781
   LIUISER V, 1985, TE VOY AYUDAR NADA M
   LOEVINSOHN B, 1986, LANCET          0706, P1314
   LOEVINSOHN BP, 1987, AM J PUBLIC HEALTH, V77, P1407, DOI 10.2105/AJPH.77.11.1407
   *NAT CENTR AM HLTH, 1991, UNC PROGN HLTH SOL
   NELSON H, 1983, NATIONS HLTH     OCT
   *NICAR MIN SAL, 1991, PLAN TRIEN SAL 1991
   *NICAR MIN SAL REG, 1989, AN EV DIV DOC INV
   *NICAR MIN SAL REG, 1989, INF AN REG 1989
   NIETSCHMANN B, 1972, HUM ECOL, V1, P41, DOI 10.1007/BF01791280
   NIETSCHMANN B, 1969, THESIS U WISCONSIN
   PIJOAN M, 1946, Am Indig, V6, P157
   PIJOAN M, 1946, Am Indig, V6, ppassim
   PIJOAN M, 1944, AM INDIGENA, V4, P255
   RAMNUCCIROSS L, 1969, J HEALTH SOC BEHAV, V10, P201
   SANDIFORD P, 1991, AM J PUBLIC HEALTH, V81, P30, DOI 10.2105/AJPH.81.1.30
   Singer M, 1990, Med Anthropol, V12, P289
   VIISSAINEN K, 1991, REVOLUTION COUNTERRE
   WELLER SC, 1991, MED ANTHR, V13, P57
   *WHO, 1990, HLTH COND AM, P212
   *WHO, 1978, REP INT C PRIM HLTH
   1991, J PUBL HLTH POLICY, V12, P119
NR 53
TC 10
Z9 10
U1 0
U2 6
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
SN 0277-9536
J9 SOC SCI MED
JI Soc. Sci. Med.
PD AUG
PY 1993
VL 37
IS 3
BP 355
EP 368
DI 10.1016/0277-9536(93)90266-7
PG 14
WC Public, Environmental & Occupational Health; Social Sciences, Biomedical
SC Public, Environmental & Occupational Health; Biomedical Social Sciences
GA LM907
UT WOS:A1993LM90700008
PM 8356484
DA 2018-10-20
ER

PT J
AU PETERSEN, DR
AF PETERSEN, DR
TI REVIEWS AND COMMENTS ON ALCOHOL RESEARCH
SO ALCOHOL
LA English
DT Editorial Material
ID ACETALDEHYDE; BREATH; ASSAY
AB This section of the journal is designed to provide readers with reviews of recent literature, and to stimulate research on questions that are important in the treatment and prevention of alcohol addiction. Research can provide insight into the causes of alcohol abuse and addiction, as well as answers to questions concerning the biomedical and psychological consequences of alcohol consumption. The ideas and critique expressed in this department are those of the author and do not necessarily represent the views of the editor, editorial board, or publisher of Alcohol. Reference to the original articles is recommended before quoting any of this material in scientific publications.
C1 UNIV COLORADO,HLTH SCI CTR,HEPATOBILIARY RES CTR,DENVER,CO 80262.
RP PETERSEN, DR (reprint author), UNIV COLORADO,HLTH SCI CTR,ALCOHOL RES CTR,DENVER,CO 80262, USA.
CR DANNECKER JR, 1981, ANAL BIOCHEM, V114, P1, DOI 10.1016/0003-2697(81)90442-5
   PHILLIPS M, 1984, ALCOHOL CLIN EXP RES, V8, P293, DOI 10.1111/j.1530-0277.1984.tb05514.x
   STOWELL AR, 1980, BIOCHEM PHARMACOL, V29, P783, DOI 10.1016/0006-2952(80)90557-2
NR 3
TC 0
Z9 0
U1 0
U2 0
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
SN 0741-8329
J9 ALCOHOL
JI Alcohol
PD JUL-AUG
PY 1993
VL 10
IS 4
BP 323
EP 323
DI 10.1016/0741-8329(93)90013-E
PG 1
WC Substance Abuse; Pharmacology & Pharmacy; Toxicology
SC Substance Abuse; Pharmacology & Pharmacy; Toxicology
GA LL114
UT WOS:A1993LL11400013
DA 2018-10-20
ER

PT J
AU MOSHER, DF
AF MOSHER, DF
TI ADHESIVE PROTEINS AND THEIR CELLULAR RECEPTORS
SO CARDIOVASCULAR PATHOLOGY
LA English
DT Article
ID GLYCOPROTEIN-IIB-IIIA; PLATELET ACTIVATION; CYTOPLASMIC DOMAIN;
   ENDOTHELIAL-CELLS; INTRACELLULAR PH; VITRONECTIN; SURFACES; INTEGRINS;
   PLASMA; PHOSPHORYLATION
AB Many, and perhaps most, important cell adhesion receptors and ligands have been identified and characterized. The reagents, systems, and technologies are therefore available for a ''reductionist'' approach to the roles of cell adhesion in processes such as the interaction of blood with biomedical materials. Key to the success of this approach is the recognition that the same molecules or families of molecules are responsible for many different processes in organisms that have evolved over hundreds of millions of years. For instance, the alpha(IIb)beta3 integrin receptor that mediates platelet adhesion and aggregation and is defective in Glanzmann thrombasthenia in humans is very similar to the receptor that mediates muscle attachment and is defective in fruitflies with the myospheriod phenotype. The challenges to the field of cell adhesion are to understand the events that control the activities of adhesion receptors and ligands, the signals that emanate from ligated receptors, and how the signals are processed to influence behavior when cells encounter surfaces or other cells. To exemplify these issues, this chapter focuses on the alpha(v)beta3 integrin receptor, an adhesive ligand for the receptor, vitronectin; and modulation of cellular adhesion to vitronectin by high-molecular-weight kininogen. Platelet adhesion to biomaterials is contrasted with the more complex phenomenon of neutrophil adhesion to vascular endothelial cells.
RP MOSHER, DF (reprint author), UNIV WISCONSIN, SCH MED, DIV HEMATOL, MADISON, WI 53706 USA.
CR ALBRECHT RM, 1989, AM J ANAT, V185, P149, DOI 10.1002/aja.1001850208
   ANDRADE JD, 1987, ANN NY ACAD SCI, V516, P158, DOI 10.1111/j.1749-6632.1987.tb33038.x
   ASAKURA S, 1992, J CELL BIOL, V116, P465, DOI 10.1083/jcb.116.2.465
   BALE MD, 1989, BLOOD, V74, P2698
   BRASH JL, 1988, BLOOD, V71, P932
   BUTCHER EC, 1991, CELL, V67, P1033, DOI 10.1016/0092-8674(91)90279-8
   COLLINS WE, 1987, ANN NY ACAD SCI, V516, P291, DOI 10.1111/j.1749-6632.1987.tb33049.x
   Engel J, 1991, CURR OPIN CELL BIOL, V3, P779, DOI 10.1016/0955-0674(91)90050-9
   FABRIZIUSHOMAN DJ, 1992, THROMB HAEMOSTASIS, V68, P194
   FABRIZIUSHOMAN DJ, 1991, J BIOMAT SCI-POLYM E, V3, P27, DOI 10.1163/156856292X00060
   FERRELL JE, 1989, P NATL ACAD SCI USA, V86, P2234, DOI 10.1073/pnas.86.7.2234
   GOLDEN A, 1990, J CELL BIOL, V111, P3117, DOI 10.1083/jcb.111.6.3117
   Grinnell F, 1978, Int Rev Cytol, V53, P65
   HAYMAN EG, 1983, P NATL ACAD SCI-BIOL, V80, P4003, DOI 10.1073/pnas.80.13.4003
   HIBBS ML, 1991, SCIENCE, V251, P1611, DOI 10.1126/science.1672776
   HUANG MM, 1991, P NATL ACAD SCI USA, V88, P7844, DOI 10.1073/pnas.88.17.7844
   HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S
   HYNES RO, 1992, CELL, V68, P303, DOI 10.1016/0092-8674(92)90472-O
   INGBER DE, 1990, J CELL BIOL, V110, P1803, DOI 10.1083/jcb.110.5.1803
   KNAPP W, 1989, LEUCOCYTE TYPING, V4
   KORCGRODZICKI B, 1988, BIOCHEM BIOPH RES CO, V157, P1131
   LAWRENCE MB, 1991, CELL, V65, P859, DOI 10.1016/0092-8674(91)90393-D
   MANNING DR, 1991, THROMB HAEMOSTASIS, V66, P393
   MCGUIRE EA, 1988, J BIOL CHEM, V263, P1942
   OTOOLE TE, 1991, SCIENCE, V254, P845, DOI 10.1126/science.1948065
   PREISSNER KT, 1991, ANNU REV CELL BIOL, V7, P275, DOI 10.1146/annurev.cb.07.110191.001423
   RUOSLAHTI E, 1991, J CLIN INVEST, V87, P1, DOI 10.1172/JCI114957
   SANE DC, 1991, BIOCHEM BIOPH RES CO, V174, P465, DOI 10.1016/0006-291X(91)91439-J
   SCHWARTZ MA, 1991, P NATL ACAD SCI USA, V88, P7849, DOI 10.1073/pnas.88.17.7849
   SCHWARTZ MA, 1991, EXP CELL RES, V195, P533, DOI 10.1016/0014-4827(91)90407-L
   SELIGSOHN U, IN PRESS METABOLIC B
   Shattil SJ, 1991, CURR OPIN CELL BIOL, V3, P869, DOI 10.1016/0955-0674(91)90062-4
   SHIMIZU Y, 1991, FASEB J, V5, P2292
   TAMKUN JW, 1986, CELL, V46, P271, DOI 10.1016/0092-8674(86)90744-0
   Tomasini B R, 1991, Prog Hemost Thromb, V10, P269
   VROMAN L, 1987, ANN NY ACAD SCI, V516, P300, DOI 10.1111/j.1749-6632.1987.tb33050.x
   VROMAN L, 1977, ANN NY ACAD SCI, V283, P557, DOI 10.1111/j.1749-6632.1977.tb41799.x
   YAMADA KM, 1991, J BIOL CHEM, V266, P12809
NR 38
TC 3
Z9 3
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1054-8807
EI 1879-1336
J9 CARDIOVASC PATHOL
JI Cardiovasc. Pathol.
PD JUL-SEP
PY 1993
VL 2
IS 3
SU S
BP S149
EP S155
PG 7
WC Cardiac & Cardiovascular Systems; Pathology
SC Cardiovascular System & Cardiology; Pathology
GA MA485
UT WOS:A1993MA48500015
DA 2018-10-20
ER

PT J
AU WANG, TLD
   LYMAN, DJ
AF WANG, TLD
   LYMAN, DJ
TI MORPHOLOGY OF BLOCK COPOLYURETHANES .4. EFFECT OF SYNTHETIC PROCEDURE ON
   CHAIN STRUCTURE
SO JOURNAL OF POLYMER SCIENCE PART A-POLYMER CHEMISTRY
LA English
DT Article
DE COPOLYURETHANES; COPOLYETHER-URETHANE-UREAS; SYNTHESIS; MORPHOLOGY;
   INFRARED SPECTRA
ID LENGTH DISTRIBUTION; BLOOD-PLATELETS; COPOLYMERS; POLYMER
AB Analysis of products formed in the end-capping step during the synthesis of two block copolyurethanes being studied as biomedical materials has shown the presence of dimeric soft segments and free diisocyanate. In this standard two-step synthesis, the presence of these compounds lead to block copolyether-urethane-ureas containing sizeable amounts of dimeric hard and soft segments. These standard copolymers are compared in terms of IR spectra, stress-strain properties, and dynamic mechanical properties to their pure analogs which contain no dimeric segments.
C1 UNIV UTAH,DEPT MAT SCI & ENGN,SALT LAKE CITY,UT 84112.
CR EISENBACH CD, 1986, ADV ELASTOMERS RUBBE, P51
   ESTES GM, 1970, J MACROMOL SCI-REV M, VC  4, P313
   GOWER LA, UNPUB
   KATAOKA K, 1978, MAKROMOL CHEM, V179, P1121
   KNUTSON K, 1981, BIOMEDICAL DENTAL AP, P173
   LEGGE NR, 1987, ELASTOMERS COMPREHEN, P13
   LYMAN DJ, 1971, T AM SOC ART INT ORG, V17, P456
   LYMAN DJ, 1975, T AM SOC ART INT ORG, V21, P49
   LYMAN DJ, 1974, T AM SOC ART INT ORG, VB 20, P474
   LYMAN DJ, 1972, KINETICS MECHANISMS, V3, pCH3
   LYMAN DJ, 1981, STRUCTURAL ORDER POL, P205
   MILLER JA, 1985, MACROMOLECULES, V18, P32, DOI 10.1021/ma00143a005
   MORBITZER L, 1972, J APPL POLYM SCI, V16, P2697, DOI 10.1002/app.1972.070161022
   OKANO T, 1981, J BIOMED MATER RES, V15, P393, DOI 10.1002/jbm.820150310
   PEEBLES LH, 1974, MACROMOLECULES, V7, P872, DOI 10.1021/ma60042a034
   TAKAHARA A, 1985, POLYMER, V26, P987, DOI 10.1016/0032-3861(85)90218-6
   THOMPSON CM, 1990, J POLYM SCI POL CHEM, V28, P333, DOI 10.1002/pola.1990.080280209
   VANBOGART JWC, 1983, J POLYM SCI POL PHYS, V21, P65, DOI 10.1002/pol.1983.180210106
   WANG CB, 1983, MACROMOLECULES, V16, P775, DOI 10.1021/ma00239a014
NR 19
TC 25
Z9 25
U1 0
U2 1
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0887-624X
J9 J POLYM SCI POL CHEM
JI J. Polym. Sci. Pol. Chem.
PD JUL
PY 1993
VL 31
IS 8
BP 1983
EP 1995
DI 10.1002/pola.1993.080310806
PG 13
WC Polymer Science
SC Polymer Science
GA LG759
UT WOS:A1993LG75900006
DA 2018-10-20
ER

PT J
AU AUSTRIAN, R
AF AUSTRIAN, R
TI THE PNEUMOCOCCUS AND SOME MEN WHO CAME TO YALE
SO YALE JOURNAL OF BIOLOGY AND MEDICINE
LA English
DT Article
ID PROTECTIVE EFFICACY; VACCINE
AB Yale has been fortunate indeed to have had Dorothy Horstmann as a member of its faculty for all but one of the last 50 years. It has had also the wisdom to take cognizance of her value as an individual and of her contributions to biomedical science and human welfare on two occasions in recent years. Her studies of poliomyelitis, hepatitis, and rubella, executed with perceptiveness, rigor and modesty, have benefited countless numbers; and for her many achievements all are in her debt. I am beholden to her colleagues for this opportunity to pay tribute to a wise and gracious friend.
   In casting about for a subject befitting this occasion, the thought occurred that it might be of interest to examine the contributions of some former and present members of Yale's faculty to the subject of a group of infections still endemic in all human societies, namely those caused by Streptococcus pneumoniae or the pneumococcus. The list is doubtless not exhaustive but includes such notables as Winternitz, Blake, Paul, Trask, Eaton, and Beeson of former days. as well as reflecting ongoing investigations today by Eugene Shapiro and his colleagues. In reviewing some of this earlier work, it will be my endeavor to place it in the context of contemporary understanding. In the interest of some semblance of order, the material will be examined in topical rather than in chronological order, dealing with bacteriologic and immunologic, pathogenctic, therapeutic, and prophylactic considerations in that sequence.
RP AUSTRIAN, R (reprint author), UNIV PENN,SCH MED,JOHN HERR MUSSER DEPT RES MED,PHILADELPHIA,PA 19104, USA.
CR AUSTRIAN R, 1959, J EXP MED, V110, P585, DOI 10.1084/jem.110.4.585
   AUSTRIAN R, 1976, MT SINAI J MED, V43, P699
   AUSTRIAN R, 1960, BACTERIOL REV, V24, P261
   AUSTRIAN R, 1979, JOHNS HOPKINS MED J, V144, P192
   AUSTRIAN R, 1953, J EXP MED, V98, P21, DOI 10.1084/jem.98.1.21
   AUSTRIAN R, 1977, T AM CLIN CLIMAT ASS, V39, P141
   Beeson PB, 1938, P SOC EXP BIOL MED, V38, P160
   Beeson PB, 1940, J IMMUNOL, V38, P231
   Beeson PB, 1939, J EXP MED, V70, P239, DOI 10.1084/jem.70.3.239
   Blake FG, 1936, MEDICINE, V15, P1, DOI 10.1097/00005792-193602000-00001
   Blake FG, 1938, J AMER MED ASSOC, V111, P581, DOI 10.1001/jama.1938.02790330001001
   Blake FG, 1920, J EXP MED, V31, P499, DOI 10.1084/jem.31.5.499
   Blake FG, 1920, J EXP MED, V31, P445, DOI 10.1084/jem.31.4.445
   Blake FG, 1917, J EXP MED, V26, P67, DOI 10.1084/jem.26.1.67
   Blake FG, 1933, J BACTERIOL, V25, P289
   Blake FG, 1920, J EXP MED, V31, P403, DOI 10.1084/jem.31.4.403
   BLAKE FG, 1917, ARCH INTERN MED, V26, P779
   Cecil RL, 1918, J EXP MED, V28, P19, DOI 10.1084/jem.28.1.19
   Cecil RL, 1919, J EXP MED, V29, P457, DOI 10.1084/jem.29.5.457
   Cecil RL, 1920, J EXP MED, V32, P1, DOI 10.1084/jem.32.1.1
   Cecil RL, 1920, J EXP MED, V31, P685, DOI 10.1084/jem.31.6.685
   Cecil RL, 1920, J EXP MED, V31, P657, DOI 10.1084/jem.31.6.657
   Cecil RL, 1920, J EXP MED, V31, P519, DOI 10.1084/jem.31.5.519
   CLEMENS JD, 1984, REV INFECT DIS, V6, P589
   Eaton MD, 1935, J BACTERIOL, V30, P119
   Eaton MD, 1934, J BACTERIOL, V27, P271
   Frisch AW, 1942, J EXP MED, V76, P505, DOI 10.1084/jem.76.6.505
   Goebel WF, 1939, J BIOL CHEM, V129, P455
   Greenwood M, 1913, LANCET, V1, P158
   Hirschfelder AD, 1913, J EXP MED, V17, P666, DOI 10.1084/jem.17.6.666
   HORSTMANN DM, 1975, BIOGRAPHICAL MEMOIRS, V47, P323
   KAPLAN MH, 1950, J EXP MED, V91, P15
   Kline BS, 1915, J EXP MED, V21, P311, DOI 10.1084/jem.21.4.311
   Kline BS, 1913, J EXP MED, V18, P61, DOI 10.1084/jem.18.1.61
   Kline BS, 1915, J EXP MED, V21, P304, DOI 10.1084/jem.21.4.304
   Kline BS, 1913, J EXP MED, V18, P50, DOI 10.1084/jem.18.1.50
   MACLEOD CM, 1945, J EXP MED, V82, P445, DOI 10.1084/jem.82.6.445
   MacLeod CM, 1938, J CLIN INVEST, V17, P739, DOI 10.1172/JCI101002
   Paul JR, 1934, J BACTERIOL, V28, P45
   PAUL JR, 1972, YALE J BIOL MED, V45, P22
   PAUL JR, 1970, YALE J BIOL MED, V43, P110
   Paul JR, 1927, J EXP MED, V46, P807, DOI 10.1084/jem.46.5.807
   Paul JR, 1927, J EXP MED, V46, P793, DOI 10.1084/jem.46.5.793
   Paul JR, 1934, J BACTERIOL, V28, P69
   PAUL JR, 1952, YALE J BIOL MED, V24, P436
   Petersdorf R G, 1973, Trans Assoc Am Physicians, V86, P46
   POMALESLEBRON A, 1949, P SOC EXP BIOL MED, V70, P612
   SCHIEMANN O., 1927, ZEITSCHR HYG U INFEKTIONSKRANKH, V108, P220, DOI 10.1007/BF02176583
   SCHIFFMAN G, 1980, J IMMUNOL METHODS, V33, P133, DOI 10.1016/S0022-1759(80)80004-4
   SHAPIRO ED, 1991, NEW ENGL J MED, V325, P1453, DOI 10.1056/NEJM199111213252101
   SHAPIRO ED, 1984, ANN INTERN MED, V101, P325, DOI 10.7326/0003-4819-101-3-325
   SIBER GR, 1982, ANN INTERN MED, V96, P580, DOI 10.7326/0003-4819-96-5-580
   Winternitz MC, 1913, J EXP MED, V17, P657, DOI 10.1084/jem.17.6.657
   Winternitz MC, 1915, J EXP MED, V21, P320, DOI 10.1084/jem.21.4.320
   Winternitz MC, 1920, B JOHNS HOPKINS HOSP, V31, P63
   WINTERNITZ MC, 1913, J EXP MED, V17, P662
   WINTERNITZ MC, 1913, J EXP MED, V17, P660
   Yurchak A M, 1966, Trans Assoc Am Physicians, V79, P368
   1952, YALE J BIOL MED, V24, P444
NR 59
TC 0
Z9 0
U1 0
U2 1
PU YALE J BIOL MED INC
PI NEW HAVEN
PA 333 CEDAR ST, NEW HAVEN, CT 06510
SN 0044-0086
J9 YALE J BIOL MED
JI Yale J. Biol. Med.
PD JUL-AUG
PY 1993
VL 66
IS 4
BP 315
EP 324
PG 10
WC Biology; Medicine, General & Internal; Medicine, Research & Experimental
SC Life Sciences & Biomedicine - Other Topics; General & Internal Medicine;
   Research & Experimental Medicine
GA ND096
UT WOS:A1993ND09600002
PM 8209563
DA 2018-10-20
ER

PT J
AU LOPEZ, GP
   RATNER, BD
   RAPOZA, RJ
   HORBETT, TA
AF LOPEZ, GP
   RATNER, BD
   RAPOZA, RJ
   HORBETT, TA
TI PLASMA DEPOSITION OF ULTRATHIN FILMS OF POLY(2-HYDROXYETHYL
   METHACRYLATE) - SURFACE-ANALYSIS AND PROTEIN ADSORPTION MEASUREMENTS
SO MACROMOLECULES
LA English
DT Article
ID POLYMER SURFACES; HYDROXYETHYL METHACRYLATE; STATIC SIMS; COPOLYMER;
   FIBRINOGEN; XPS; MICROENCAPSULATION; ELUTABILITY; HYDROGELS; MEMBRANES
AB A method for the preparation of ultrathin films of poly(2-hydroxyethyl methacrylate) (PHEMA) by simultaneous condensation and RF plasma deposition of 2-hydroxyethyl methacrylate (HEMA) is described. Interactions of proteins with plasma-deposited and model PHEMA surfaces (spin-cast PHEMA, radiation-grafted PHEMA, and bulk PHEMA gels) were examined. Films prepared by conventional plasma deposition (i.e., without enhancing HEMA condensation by substrate temperature reduction) were also studied. I-125-radiolabeled fibrinogen was used to study the protein adsorption and retention characteristics of these materials. Kinetic protein adsorption and free iodide uptake studies were performed. In addition, gravimetric analysis, X-ray photoelectron spectroscopy, static secondary ion mass spectrometry, and water contact angle measurements were made to compare physical and chemical properties of the various hydrogel specimens and to gain insight into the reasons for their different protein interactions. Results demonstrate that plasma deposition of HEMA on substrates at low substrate temperatures is a viable method for preparing ultrathin, hydrogel films for biomedical applications.
C1 UNIV WASHINGTON,CTR BIOENGN,BF-10,SEATTLE,WA 98195.
   UNIV WASHINGTON,DEPT CHEM ENGN,SEATTLE,WA 98195.
CR ALBIN G, 1985, Journal of Controlled Release, V2, P153, DOI 10.1016/0168-3659(85)90041-0
   ARICA Y, 1987, BIOMATERIALS, V8, P489, DOI 10.1016/0142-9612(87)90087-1
   BOHNERT JL, 1986, J COLLOID INTERF SCI, V111, P363, DOI 10.1016/0021-9797(86)90040-8
   BRIGGS D, 1986, SURF INTERFACE ANAL, V9, P391
   BROWN A, 1986, SURF INTERFACE ANAL, V8, P75, DOI 10.1002/sia.740080207
   CASTNER DG, 1990, SURF INTERFACE ANAL, V15, P479, DOI 10.1002/sia.740150807
   CASTNER DG, 1988, SURFACE CHARACTERIZA
   CHILKOTI A, IN PRESS MACROMOLECU
   CHIRILA TV, 1989, J CATARACT REFR SURG, V15, P504, DOI 10.1016/S0886-3350(89)80106-3
   COHN D, 1984, J APPL POLYM SCI, V29, P2645, DOI 10.1002/app.1984.070290819
   COLLINS WE, 1987, SCANNING MICROSCOPY, V1, P1669
   DAWSON RM, 1987, BIOMATERIALS, V8, P360, DOI 10.1016/0142-9612(87)90006-8
   DENIZLI A, 1988, BIOMATERIALS, V9, P363, DOI 10.1016/0142-9612(88)90034-8
   DILKS A, 1981, ELECTRON SPECTROSCOP
   FISCHER JP, 1977, 17TH IUPAC PRAG MICR
   GOURLAY SJ, 1975, T AM SOC ART INT ORG, V21, P28
   HAQUE Y, 1986, J APPL POLYM SCI, V32, P4369, DOI 10.1002/app.1986.070320407
   HAYASHI K, 1985, KOBUNSHI RONBUNSHU, V42, P77, DOI 10.1295/koron.42.77
   HEARN MJ, 1988, SURF INTERFACE ANAL, V11, P198, DOI 10.1002/sia.740110405
   HEARN MJ, 1986, SURF INTERFACE ANAL, V9, P411
   HOFFMAN AS, 1983, RADIAT PHYS CHEM, V22, P267, DOI 10.1016/0146-5724(83)90211-X
   HOFFMAN AS, 1982, T SOC BIOMATERIALS, V5, P36
   HOLLY FJ, 1975, J BIOMED MATER RES, V9, P315, DOI 10.1002/jbm.820090307
   HORBETT TA, 1986, HYDROGELS MED PHARM
   HORBETT TA, 1980, ADHESION ADSORPTION
   HORBETT TA, 1982, ADV BIOMATERIALS
   JANSEN B, 1984, BIOMATERIALS BIOMECH
   KATAOKA K, 1988, BIOMATERIALS, V9, P218, DOI 10.1016/0142-9612(88)90087-7
   KATAOKA K, 1988, CRIT REV BIOCOMPAT, V4, P341
   KATAOKA K, 1988, ARTIF ORGANS, V12, P505
   KORBELAR P, 1988, J BIOMED MATER RES, V22, P751, DOI 10.1002/jbm.820220902
   KRESA Z, 1988, OTOLARYNG HEAD NECK, V98, P242, DOI 10.1177/019459988809800312
   LOPEZ GG, UNPUB
   LOPEZ GP, 1992, J POLYM SCI POL CHEM, V30, P2415, DOI 10.1002/pola.1992.080301116
   LOPEZ GP, 1991, SURF INTERFACE ANAL, V17, P267, DOI 10.1002/sia.740170508
   LOPEZ GP, 1992, J POLYM SCI POL CHEM, V30, P2427, DOI 10.1002/pola.1992.080301117
   LOPEZ GP, 1991, LANGMUIR, V7, P766, DOI 10.1021/la00052a027
   LOPEZ GP, 1990, J APPL POLYM SCI APP, V46, P493
   MARGULES GS, 1987, J BIOMED ENG, V9, P21, DOI 10.1016/0141-5425(87)90095-1
   MARUYAMA A, 1989, BIOMATERIALS, V10, P393, DOI 10.1016/0142-9612(89)90131-2
   MATEO NB, 1989, INVEST OPHTH VIS SCI, V30, P853
   MEABURN GM, 1978, INT J APPL RADIAT IS, V29, P233, DOI 10.1016/0020-708X(78)90047-9
   Peppas N A, 1981, Contact Intraocul Lens Med J, V7, P300
   PIJPERS AP, 1985, J POLYM SCI POL CHEM, V23, P453, DOI 10.1002/pol.1985.170230219
   RAPOZA RJ, 1990, J COLLOID INTERF SCI, V136, P480, DOI 10.1016/0021-9797(90)90395-5
   RATNER BD, 1972, J POLYM SCI A1, V10, P2425, DOI 10.1002/pol.1972.150100818
   RATNER BD, 1981, BIOCOMPATIBILITY CLI
   RATNER BD, IN PRESS SURFACE ANA
   Ratner BD, 1990, PLASMA DEPOSITION TR
   RATNER BD, 1976, ACS S SERIES
   ROBERT C C R, 1987, Journal of Controlled Release, V5, P151, DOI 10.1016/0168-3659(87)90006-X
   SEFTON MV, 1980, J PHARM SCI, V69, P208, DOI 10.1002/jps.2600690225
   SMETANA K, 1987, J BIOMED MATER RES, V21, P1247, DOI 10.1002/jbm.820211007
   STEVENSON WTK, 1987, BIOMATERIALS, V8, P449, DOI 10.1016/0142-9612(87)90081-0
   STEVENSON WTK, 1988, BIOMATER ARTIF CELL, V16, P747, DOI 10.3109/10731198809117567
   WARD CA, 1979, ANN BIOMED ENG, V7, P451, DOI 10.1007/BF02364221
   WARD CA, 1986, J COLLOID INTERF SCI, V114, P323, DOI 10.1016/0021-9797(86)90418-2
   WINTERS HF, 1985, MATER SCI ENG, V70, P53, DOI 10.1016/0025-5416(85)90268-X
   Yasuda H., 1981, Journal of Polymer Science, Polymer Physics Edition, V19, P1285, DOI 10.1002/pol.1981.180190901
   YASUDA H, 1985, PLASMAS POLYM, P345
   YOSHIDA M, 1987, BIOMATERIALS, V8, P124, DOI 10.1016/0142-9612(87)90101-3
   Yuee F, 1988, J MEMBRANE SCI, V39, P1
NR 62
TC 69
Z9 69
U1 0
U2 8
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036
SN 0024-9297
J9 MACROMOLECULES
JI Macromolecules
PD JUN 21
PY 1993
VL 26
IS 13
BP 3247
EP 3253
DI 10.1021/ma00065a001
PG 7
WC Polymer Science
SC Polymer Science
GA LJ088
UT WOS:A1993LJ08800001
DA 2018-10-20
ER

PT J
AU GIDDINGS, JC
AF GIDDINGS, JC
TI FIELD-FLOW FRACTIONATION - ANALYSIS OF MACROMOLECULAR, COLLOIDAL, AND
   PARTICULATE MATERIALS
SO SCIENCE
LA English
DT Review
ID MOLECULAR-WEIGHT DISTRIBUTIONS; SIZE CHARACTERIZATION;
   THERMAL-DIFFUSION; PARTICLE-SIZE; RIVER WATER; SEDIMENTATION;
   SEPARATION; CELLS; CHROMATOGRAPHY; PROTEINS
AB Field-flow fractionation (FFF) is a family of flexible elution techniques capable of simultaneous separation and measurement. Its sample domain extends across a broad macromolecular-colloidal-particulate continuum from about 1 nanometer to more than 100 micrometers and incorporates both simple and complex macromaterials of biological, biomedical, industrial, and environmental relevance. Complex materials are separated into components to simplify measurement. Component properties measurable by FFF include mass, size, density, charge, diffusivity, and thickness of adsorbed layers. When characterization by these properties is inadequate, other measurement tools can be readily coupled to FFF, either off-line or on-line, by virtue of its flow-elution operation. This article describes the principles and major subtechniques of the FFF family along with application of its measurement and separative capabilities.
RP GIDDINGS, JC (reprint author), UNIV UTAH, DEPT CHEM, FIELD FLOW FRACTIONAT RES CTR, SALT LAKE CITY, UT 84112 USA.
FU NIGMS NIH HHS [GM10851-36]
CR ARLAUSKAS RA, 1993, ACS SYM SER, V521, P2
   ARNER EC, 1989, BIOCHIM BIOPHYS ACTA, V993, P100, DOI 10.1016/0304-4165(89)90148-7
   BARMAN BN, 1989, POWDER TECHNOL, V59, P53, DOI 10.1016/0032-5910(89)80095-6
   BARMAN BN, 1992, LANGMUIR, V8, P51, DOI 10.1021/la00037a012
   BARMAN BN, IN PRESS ANAL BIOCH
   BECKETT R, 1987, ENVIRON TECHNOL LETT, V8, P339, DOI 10.1080/09593338709384493
   BECKETT R, 1987, ENVIRON SCI TECHNOL, V21, P289, DOI 10.1021/es00157a010
   BECKETT R, 1988, WATER RES, V22, P1535, DOI 10.1016/0043-1354(88)90166-2
   BECKETT R, 1990, J CHROMATOGR, V517, P435, DOI 10.1016/S0021-9673(01)95739-5
   BECKETT R, 1991, LANGMUIR, V7, P2040, DOI 10.1021/la00058a013
   BECKETT R, IN PRESS ENV TECHNOL
   BECKETT R, 1989, ACS SYM SER, V219, P65
   BECKETT R, 1993, ENV PARTICLES, V2, P157
   BENINCASA MA, 1992, ANAL CHEM, V64, P790, DOI 10.1021/ac00031a016
   BIGELOW JC, 1991, ACS SYM SER, V464, P146
   CALDWELL KD, 1988, ANAL CHEM, V60, pA959, DOI 10.1021/ac00168a001
   CALDWELL KD, 1972, SCIENCE, V176, P296, DOI 10.1126/science.176.4032.296
   CALDWELL KD, 1981, J PHARM SCI, V70, P1350, DOI 10.1002/jps.2600701216
   CALDWELL KD, 1981, COLLOID SURFACE, V3, P233, DOI 10.1016/0166-6622(81)80040-6
   CALDWELL KD, 1989, J COLLOID INTERF SCI, V132, P256, DOI 10.1016/0021-9797(89)90235-X
   CALDWELL KD, 1984, INVEST OPHTH VIS SCI, V25, P153
   CALDWELL KD, 1992, J CHROMATOGR, V604, P63, DOI 10.1016/0021-9673(92)85529-3
   CALDWELL KD, 1981, J CHROMATOGR, V215, P323, DOI 10.1016/S0021-9673(00)81411-9
   CALDWELL KD, 1980, J VIROL METHODS, V1, P241, DOI 10.1016/0166-0934(80)90022-1
   CALDWELL KD, 1984, CELL BIOPHYS, V6, P233, DOI 10.1007/BF02788630
   CALDWELL KD, IN PRESS ANAL CHEM
   CARDOT PJP, 1991, J CHROMATOGR-BIOMED, V568, P93, DOI 10.1016/0378-4347(91)80343-B
   CHASE MW, 1985, J PHYS CHEM REF DATA, V14, P1
   CHITTLEBOROUGH DJ, 1992, SOIL SCI, V153, P341, DOI 10.1097/00010694-199205000-00001
   Cox R. G., 1977, International Journal of Multiphase Flow, V3, P201, DOI 10.1016/0301-9322(77)90001-5
   COX RG, 1968, CHEM ENG SCI, V23, P147, DOI 10.1016/0009-2509(68)87059-9
   DAVIS JM, 1991, ANAL CHIM ACTA, V246, P161, DOI 10.1016/S0003-2670(00)80673-X
   Giddings J. C., 1966, SEPARATION SCI, V1, P123, DOI DOI 10.1080/01496396608049439
   GIDDINGS JC, 1981, SEPAR SCI TECHNOL, V16, P549, DOI 10.1080/01496398108058117
   GIDDINGS JC, 1981, ANAL CHEM, V53, P1170, DOI 10.1021/ac00234a001
   GIDDINGS JC, 1983, J COLLOID INTERF SCI, V92, P66, DOI 10.1016/0021-9797(83)90117-0
   GIDDINGS JC, 1991, ACS SYM SER, V472, P198
   GIDDINGS JC, 1991, ACS SYM SER, V464, P128
   GIDDINGS JC, 1988, CHEM ENG NEWS, V66, P34, DOI 10.1021/cen-v066n041.p034
   GIDDINGS JC, 1976, SCIENCE, V193, P1244, DOI 10.1126/science.959835
   GIDDINGS JC, 1987, J CHROMATOGR, V395, P19, DOI 10.1016/S0021-9673(01)94097-X
   GIDDINGS JC, 1989, J CHROMATOGR, V480, P21, DOI 10.1016/S0021-9673(01)84277-1
   GIDDINGS JC, 1979, SEPAR SCI TECHNOL, V14, P611, DOI 10.1080/01496397908057159
   GIDDINGS JC, 1977, ANAL BIOCHEM, V81, P395, DOI 10.1016/0003-2697(77)90710-2
   GIDDINGS JC, 1979, PURE APPL CHEM, V51, P1459, DOI 10.1351/pac197951071459
   GIDDINGS JC, 1991, ANAL CHEM, V63, P2869, DOI 10.1021/ac00024a013
   GIDDINGS JC, 1981, SEPAR SCI TECHNOL, V16, P607, DOI 10.1080/01496398108058119
   GIDDINGS JC, 1974, ANAL CHEM, V46, P1917, DOI 10.1021/ac60349a046
   GIDDINGS JC, 1976, J CHROMATOGR, V125, P3, DOI 10.1016/S0021-9673(00)93808-1
   GIDDINGS JC, 1978, SEPAR SCI TECHNOL, V13, P637, DOI 10.1080/01496397808057119
   GIDDINGS JC, 1977, J VIROL, V21, P131
   GIDDINGS JC, 1975, SEPAR SCI, V10, P133, DOI 10.1080/00372367508058996
   Giddings JC, 1991, KONA, V9, P200
   GIDDINGS JC, 1989, PHYSICAL METHODS C B, V3, P867
   GIDDINGS JC, 1991, UNIFIED SEPARATION S
   GILBART J, 1987, J CHROMATOGR, V387, P428, DOI 10.1016/S0021-9673(01)94548-0
   GRUSHKA E, 1973, SEPAR PURIF METHOD, V2, P127, DOI 10.1080/03602547408068793
   GUNDERSON JJ, 1984, SEPAR SCI TECHNOL, V19, P667, DOI 10.1080/01496398408060668
   HO BP, 1974, J FLUID MECH, V65, P365, DOI 10.1017/S0022112074001431
   HOFFSTETTERKUHN S, 1992, ANAL BIOCHEM, V206, P300, DOI 10.1016/0003-2697(92)90370-M
   JANCA J, 1983, TRAC-TREND ANAL CHEM, V2, P278, DOI 10.1016/0165-9936(83)87054-X
   JONSSON JA, 1989, ANAL CHEM, V61, P11
   KARAISKAKIS G, 1982, INT J ENVIRON AN CH, V12, P1, DOI 10.1080/03067318208071566
   KIRKLAND JJ, 1983, J CHROMATOGR, V255, P255, DOI 10.1016/S0021-9673(01)88289-3
   KIRKLAND JJ, 1992, J CHROMATOGR, V593, P339, DOI 10.1016/0021-9673(92)80303-C
   KIRKLAND JJ, 1988, ANAL CHEM, V60, P610, DOI 10.1021/ac00158a002
   LANGWOST B, 1992, CHROMATOGRAPHIA, V34, P317, DOI 10.1007/BF02268362
   LEVIN S, 1991, BIOMED CHROMATOGR, V5, P133, DOI 10.1002/bmc.1130050308
   LI JT, 1991, LANGMUIR, V7, P2034, DOI 10.1021/la00058a012
   LITZEN A, 1989, J CHROMATOGR, V476, P413, DOI 10.1016/S0021-9673(01)93885-3
   LITZEN A, UNPUB
   LIU G, 1992, CHROMATOGRAPHIA, V34, P483, DOI 10.1007/BF02290241
   Liu M., UNPUB
   LIU MK, IN PRESS MACROMOLECU
   LOU J, UNPUB
   MARTIN M, 1992, NATO ADV SCI INST SE, V383, P513
   MARTIN M, 1980, ANAL CHEM, V52, P2293, DOI 10.1021/ac50064a014
   MARTIN M, 1993, ANAL CHEM, V65, pA315, DOI 10.1021/ac00054a722
   MARTIN M, 1987, PARTICLE SIZE ANAL 1, P65
   MCCARTHY JF, 1989, ENVIRON SCI TECHNOL, V23, P496, DOI 10.1021/es00063a602
   MERINODUGAY A, 1992, J CHROMATOGR-BIOMED, V579, P73, DOI 10.1016/0378-4347(92)80364-V
   MOON MH, 1992, ANAL CHEM, V64, P3029, DOI 10.1021/ac00047a027
   MOON MH, IN PRESS J PHARM BIO
   MOZERSKY SM, 1988, ANAL BIOCHEM, V172, P113, DOI 10.1016/0003-2697(88)90419-8
   MYERS MN, 1982, ANAL CHEM, V54, P2284, DOI 10.1021/ac00250a032
   MYERS MN, 1993, ACS SYM SER, V521, P47
   MYERS MN, 1974, SEPAR SCI, V9, P47, DOI 10.1080/01496397408080043
   RATANATHANAWONG SK, UNPUB
   RATANATHANAWONGS SK, 1992, ANAL CHEM, V64, P6, DOI 10.1021/ac00025a003
   RATANATHANAWONGS SK, 1991, ACS SYM SER, V472, P229
   RATANATHANAWONGS SK, 1993, ACS SYM SER, V521, P13
   SCHALLINGER LE, 1984, SCIENCE, V225, P434, DOI 10.1126/science.6377495
   SCHIMPF ME, 1989, J POLYM SCI POL PHYS, V27, P1317, DOI 10.1002/polb.1989.090270610
   SCHIMPF ME, 1993, ACS SYM SER, V521, P63
   SCHIMPF ME, 1990, J POLYM SCI POL PHYS, V28, P2673, DOI 10.1002/polb.1990.090281313
   SCHIMPF ME, 1993, AM LAB SHELTON   FEB, P21
   SGIDDINGS JC, 1970, J PHYS CHEM-US, V74, P4291
   SHARMA RV, IN PRESS APPL ENV MI
   SHIUNDU PM, UNPUB
   SINCLAIR P, 1989, HYDROBIOLOGIA, V176, P239, DOI 10.1007/BF00026559
   SKLAVIADIS T, 1992, VIRUS RES, V26, P241, DOI 10.1016/0168-1702(92)90016-3
   TAYLOR HE, 1992, ANAL CHEM, V64, P2036, DOI 10.1021/ac00042a005
   WAHLUND KG, 1989, J CHROMATOGR, V461, P73, DOI 10.1016/S0021-9673(00)94276-6
   WILLIAMS PS, 1992, CHEM ENG COMMUN, V111, P121, DOI 10.1080/00986449208935984
   WILLIAMS PS, 1987, ANAL CHEM, V59, P2038, DOI 10.1021/ac00144a007
   YANG FJ, 1974, ANAL CHEM, V46, P1924, DOI 10.1021/ac60349a009
   YANG FS, 1983, J COLLOID INTERF SCI, V93, P115, DOI 10.1016/0021-9797(83)90391-0
   YANG FS, 1984, ANAL BIOCHEM, V138, P488, DOI 10.1016/0003-2697(84)90844-3
   YONKER CR, 1985, J VIROL METHODS, V11, P145, DOI 10.1016/0166-0934(85)90038-2
NR 109
TC 859
Z9 868
U1 13
U2 199
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 0036-8075
EI 1095-9203
J9 SCIENCE
JI Science
PD JUN 4
PY 1993
VL 260
IS 5113
BP 1456
EP 1465
DI 10.1126/science.8502990
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA LF058
UT WOS:A1993LF05800027
PM 8502990
DA 2018-10-20
ER

PT J
AU ALCALA, JR
   YU, C
   YEH, GJ
AF ALCALA, JR
   YU, C
   YEH, GJ
TI DIGITAL PHOSPHORIMETER WITH FREQUENCY-DOMAIN SIGNAL-PROCESSING -
   APPLICATION TO REAL-TIME FIBEROPTIC OXYGEN SENSING
SO REVIEW OF SCIENTIFIC INSTRUMENTS
LA English
DT Article
ID FLUORESCENCE LIFETIME DISTRIBUTIONS; PARALLEL ACQUISITION; PHASE;
   FLUOROMETER; KINETICS; PROTEINS
AB An instrument to measure the excited-state lifetimes of phosphorescent materials in real time is described. This apparatus uses pulsed and frequency-doubled Nd:YAG solid-state laser for excitation, sampler for data acquisition, and frequency domain methods for data fitting. The instrument amplifies the ac components of the detector output and band limits the signal to 25 kHz. The fundamental frequency of the excitation is then set to obtain a desired number of harmonics. This band limited signal is sampled and averaged over few thousand cycles in the time domain. The frequency domain representation of the data is obtained by employing fast Fourier transform algorithms. The phase delay and the modulation ratio of each sampled harmonic is then computed. Ten to a hundred values of the phase and modulations are averaged before computing the sensor lifetime. The instrument is capable of measuring precise and accurate excited-state lifetimes from subpicowatt luminescent signals in 100 mum optical fibers. To monitor oxygen for biomedical applications the response time of the system is decreased by collecting only 8 or 16 harmonics. A least-squares fit yields the lifetimes of single exponentials. A component of zero lifetime is introduced to account for the backscatter excitation. The phosphorescence lifetimes measured reproducibly to three parts in a thousand are used to monitor oxygen. Oxygen concentrations are computed employing empirical polynomials. The system drift is less than 1% over 100 h of continuous operation. This instrument is used to measure oxygen concentrations in vitro and in vivo with 2 s update times and 90 s full response times. Examples of measurements in saline solutions and in dogs are presented.
C1 BOC GRP INC,MURRAY HILL,NJ 07974.
RP ALCALA, JR (reprint author), CASE WESTERN RESERVE UNIV,DEPT BIOMED ENGN,CLEVELAND,OH 44106, USA.
CR ALCALA JR, 1987, BIOPHYS J, V51, P925, DOI 10.1016/S0006-3495(87)83420-3
   ALCALA JR, 1987, BIOPHYS J, V51, P597, DOI 10.1016/S0006-3495(87)83384-2
   ALCALA JR, 1987, BIOPHYS J, V51, P587, DOI 10.1016/S0006-3495(87)83383-0
   ALCALA JR, 1985, ANAL INSTRUM, V14, P225
   ALCALA JR, 1991, REV SCI INSTRUM, V62, P1672, DOI 10.1063/1.1142528
   ALCALA JR, 1987, THESIS U ILLINOIS UR
   Bagnich S. A., 1990, Optics and Spectroscopy, V69, P833
   FEDDERSEN BA, 1989, REV SCI INSTRUM, V60, P2929, DOI 10.1063/1.1140629
   GRATTAN KTV, 1988, REV SCI INSTRUM, V59, P1328, DOI 10.1063/1.1140257
   GRATTON E, 1983, BIOPHYS J, V44, P315, DOI 10.1016/S0006-3495(83)84305-7
   GRATTON E, 1984, REV SCI INSTRUM, V55, P486, DOI 10.1063/1.1137777
   JAMES DR, 1985, CHEM PHYS LETT, V120, P455, DOI 10.1016/0009-2614(85)85640-2
   LAKOWICZ JR, 1981, J BIOCHEM BIOPH METH, V5, P131, DOI 10.1016/0165-022X(81)90012-9
   LAKOWICZ JR, 1986, REV SCI INSTRUM, V57, P2499, DOI 10.1063/1.1139215
   LAKOWICZ JR, 1992, LASER FOCUS WORL MAY, P60
   MASUMO K, 1985, B CHEM SOC JPN, V58, P2451, DOI 10.1246/bcsj.58.2451
   MORANTZ DJ, 1985, POLYM COMMUN, V26, P170
   NEWHOUSE EI, 1988, CHEM PHYS LETT, V143, P106, DOI 10.1016/0009-2614(88)87020-9
   OCONNOR DV, 1984, TIME CORRELATED SING
   OCONNOR DV, 1984, TIME CORRELATED SING, P170
   PAPKOVSKY DB, 1992, BIOSENS BIOELECTRON, V7, P199, DOI 10.1016/0956-5663(92)87016-I
   Press WH, 1988, NUMERICAL RECIPIES
   SPENCER RD, 1969, ANN NY ACAD SCI, V158, P361, DOI 10.1111/j.1749-6632.1969.tb56231.x
   WEBER G, 1981, J PHYS CHEM-US, V85, P949, DOI 10.1021/j150608a006
   WILD UP, 1977, REV SCI INSTRUM, V48, P1621, DOI 10.1063/1.1134962
   ZHANG ZY, 1992, REV SCI INSTRUM, V63, P3869, DOI 10.1063/1.1143285
   1985, LAB TENDER INSTALLAT
NR 27
TC 18
Z9 18
U1 1
U2 3
PU AMER INST PHYSICS
PI WOODBURY
PA CIRCULATION FULFILLMENT DIV, 500 SUNNYSIDE BLVD, WOODBURY, NY 11797-2999
SN 0034-6748
J9 REV SCI INSTRUM
JI Rev. Sci. Instrum.
PD JUN
PY 1993
VL 64
IS 6
BP 1554
EP 1560
DI 10.1063/1.1144026
PG 7
WC Instruments & Instrumentation; Physics, Applied
SC Instruments & Instrumentation; Physics
GA LF965
UT WOS:A1993LF96500034
DA 2018-10-20
ER

PT J
AU CROMMEN, J
   VANDORPE, J
   SCHACHT, E
AF CROMMEN, J
   VANDORPE, J
   SCHACHT, E
TI DEGRADABLE POLYPHOSPHAZENES FOR BIOMEDICAL APPLICATIONS
SO JOURNAL OF CONTROLLED RELEASE
LA English
DT Article; Proceedings Paper
CT 2ND EUROPEAN SYMP ON CONTROLLED DRUG DELIVERY
CY APR 01-03, 1992
CL NOORDWIJK AAN ZEE, NETHERLANDS
SP DUTCH EXECUT AGCY TECHNOL POLICY, ORGANON INT, SANDOZ PHARMA, DUPHAR, SCHWARZ PHARMA, THERATECH, HOFFMANN LA ROCHE, MEDISOB TECHNOL, THREE M MEDICA
DE DEGRADABLE POLYPHOSPHAZENE; HYDROLYTIC DEGRADATION
ID POLY(ORGANOPHOSPHAZENES)
AB Polyphosphazene derivatives having amino acid ester side groups were prepared by reaction of poly (dichloro phosphazene) with ethyl esters of amino acids and dipeptides. In vitro degradation studies demonstrated that the rate of degradation depends on the nature of the amino acids. Introducing small amounts of depsipeptide ester co-substituents resulted in a drastic increase of the degradation. The rate of hydrolytic degradation of the polyphosphazene materials could be controlled by the content of the depsipeptide ester side groups or by blending poly[amino acid ester) phosphazenes] with poly [ (amino acid ester) -co- (depsipeptide ester) phosphazenes ]. A more detailed study of the degradation process indicated that in the initial stage of polymer degradation the amino acid ethyl ester is released, with subsequent formation of amino acid, ethanol and polymer backbone cleavage. Polyphosphazenes substituted with ethyl glycinate (D.S.>99%) are partially crystalline. D.S.C. experiments demonstrated that the degree of crystallinity and the morphology of the crystalline phase depends on the storage conditions.
C1 STATE UNIV GHENT,ORGAN CHEM LAB,AFDELING POLYMEERCHEM,KRIJGSLAAN 281-S4,B-9000 GHENT,BELGIUM.
   STATE UNIV GHENT,POLYMER CHEM LAB,B-9000 GHENT,BELGIUM.
CR Allcock H.R., 1979, CONT TOPICS POLYM SC, V3, P55
   ALLCOCK HR, 1986, MAKROMOL CHEM-M SYMP, V6, P101, DOI 10.1002/masy.19860060112
   ALLCOCK HR, 1972, CHEM REV, V72, P315, DOI 10.1021/cr60278a002
   ALLCOCK HR, 1983, MACROMOLECULES, V16, P715, DOI 10.1021/ma00239a001
   ALLCOCK HR, 1977, MACROMOLECULES, V10, P824, DOI 10.1021/ma60058a020
   ALLCOCK HR, 1982, INORG CHEM, V21, P515, DOI 10.1021/ic00132a009
   ALLCOCK HR, 1983, MACROMOLECULES, V16, P1401, DOI 10.1021/ma00243a001
   CROMMEN JHL, 1992, BIOMATERIALS, V13, P511, DOI 10.1016/0142-9612(92)90102-T
   CROMMEN JHL, 1992, BIOMATERIALS, V13, P601, DOI 10.1016/0142-9612(92)90028-M
   ENGELBERG I, 1991, BIOMATERIALS, V12, P292, DOI 10.1016/0142-9612(91)90037-B
   GOEDEMOED JH, 1991, J CONTROL RELEASE, V17, P245, DOI 10.1016/0168-3659(91)90143-2
   GOEDEMOED JH, 1990, POLYPHOSPHAZENE DRUG, pCH1
   GOEDEMOED JH, 1990, POLYPHOSPHAZENE DRUG, pCH7
   GROLLEMAN C W J, 1986, Journal of Controlled Release, V4, P119, DOI 10.1016/0168-3659(86)90047-7
   INTVELD PJ, 1990, MAKROMOL CHEM, V191, P1831
   LAURENCIN CT, 1987, J BIOMED MATER RES, V21, P1231, DOI 10.1002/jbm.820211006
   Lewis DH, 1990, BIODEGRADABLE POLYM, V45, P1
   MASARU Y, 1990, MAKROMOL CHEM-RAPID, V11, P337
   Schindler A, 1977, CONT TOPICS POLYM SC, V2, P251
   SCHWYZER R, 1955, HELV CHIM ACTA, V18, P69
   WERMUTH CG, 1980, CHEM IND, V7, P433
NR 21
TC 70
Z9 71
U1 0
U2 6
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-3659
J9 J CONTROL RELEASE
JI J. Control. Release
PD MAY 1
PY 1993
VL 24
IS 1-3
BP 167
EP 180
DI 10.1016/0168-3659(93)90176-6
PG 14
WC Chemistry, Multidisciplinary; Pharmacology & Pharmacy
SC Chemistry; Pharmacology & Pharmacy
GA LF865
UT WOS:A1993LF86500014
DA 2018-10-20
ER

PT J
AU TUDOR, AM
   MELIA, CD
   DAVIES, MC
   ANDERSON, D
   HASTINGS, G
   MORREY, S
   DOMINGOSSANDOS, J
   BARBOSA, M
AF TUDOR, AM
   MELIA, CD
   DAVIES, MC
   ANDERSON, D
   HASTINGS, G
   MORREY, S
   DOMINGOSSANDOS, J
   BARBOSA, M
TI THE ANALYSIS OF BIOMEDICAL HYDROXYAPATITE POWDERS AND HYDROXYAPATITE
   COATINGS ON METALLIC MEDICAL IMPLANTS BY NEAR-IR FOURIER-TRANSFORM
   RAMAN-SPECTROSCOPY
SO SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY
LA English
DT Article
AB In this paper we discuss the application of Fourier transform Raman (FM) spectroscopy to the in situ analysis of the inorganic bioceramic hydroxyapatite in both powder form and as a thermally sprayed hydroxyapatite coating on metals currently employed in medical implants for orthopaedic surgery. The derivation of the FTR spectrum of hydroxyapatite is attempted by the analysis of the pure powders of its known constituents. The FTR spectra of hydroxyapatite powders sintered up to 1300-degrees-C suggest significant structural changes in the region of 1250-degrees-C. The FTR spectra of coated metal systems clearly distinguish between samples of differing crystallinity and provide some information on the effect of the coating process on the hydroxyapatite material. The preliminary examination of hydroxyapatite coated dental screws shows a change in the nature of the hydroxyapatite coating on recovery after clinical use.
C1 UNIV NOTTINGHAM, DEPT PHARMACEUT SCI, NOTTINGHAM NG7 2RD, ENGLAND.
   PLASMA BIOTAL, TIDESWELL SK17 8DY, DERBY, ENGLAND.
   UNIV LONDON QUEEN MARY COLL, DEPT MAT, LONDON E1 4NS, ENGLAND.
   UNIV PORTO, DEPT ENGN & MET, P-4099 OPORTO, PORTUGAL.
RI Barbosa, Mario/F-5964-2011
OI Barbosa, Mario/0000-0003-3568-7482; Santos, Jose
   Domingos/0000-0002-6871-9850; Davies, Martyn/0000-0001-7695-0596
CR ARENDS J, 1982, J BIOL BUCCALE, V10, P125
   BIGI A, 1980, BIOMATERIALS, V1, P140, DOI 10.1016/0142-9612(80)90036-8
   BRES EF, 1990, J MICROSC-OXFORD, V160, P183, DOI 10.1111/j.1365-2818.1990.tb03057.x
   COOK SD, 1988, CLIN ORTHOP RELAT R, P303
   GEESINK RGT, 1987, CLIN ORTHOP RELAT R, P147
   HENCH LL, 1991, MRS B            SEP, P62
   LEMONS JE, 1988, CLIN ORTHOP RELAT R, P220
   NELSON DGA, 1981, J DENT RES, V60, P1621, DOI 10.1177/002203458106000312011
   NIE S, 1991, SPECTROSC INT, V3, P20
   OONISHI H, 1991, BIOMATERIALS, V12, P171, DOI 10.1016/0142-9612(91)90196-H
   TUDOR AM, 1991, SPECTROCHIM ACTA A, V47, P1389, DOI 10.1016/0584-8539(91)80229-C
   TUDOR AM, 1990, J PHARMACEUT BIOMED, V8, P717, DOI 10.1016/0731-7085(90)80109-3
   TUDOR AM, 1991, ANALYST, V114, P1061
   WALTERS MA, 1990, J INORG BIOCHEM, V39, P193, DOI 10.1016/0162-0134(90)84002-7
   WATTS PJ, 1991, PHARMACEUT RES, V8, P1323, DOI 10.1023/A:1015872300730
NR 15
TC 30
Z9 30
U1 1
U2 10
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
SN 0584-8539
J9 SPECTROCHIM ACTA A
JI Spectroc. Acta Pt. A-Molec. Biomolec. Spectr.
PD MAY-JUN
PY 1993
VL 49
IS 5-6
BP 675
EP 680
DI 10.1016/0584-8539(93)80089-S
PG 6
WC Spectroscopy
SC Spectroscopy
GA LB910
UT WOS:A1993LB91000008
DA 2018-10-20
ER

PT J
AU BOLLINI, D
   CERVELLERA, F
   EGENI, GP
   MAZZOLDI, P
   MOSCHINI, G
   ROSSI, P
   RUDELLO, V
AF BOLLINI, D
   CERVELLERA, F
   EGENI, GP
   MAZZOLDI, P
   MOSCHINI, G
   ROSSI, P
   RUDELLO, V
TI THE MICROBEAM FACILITY OF THE AN-2000 ACCELERATOR OF THE
   LABORATORI-NAZIONALI-DI-LEGNARO
SO NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION A-ACCELERATORS
   SPECTROMETERS DETECTORS AND ASSOCIATED EQUIPMENT
LA English
DT Article; Proceedings Paper
CT 6TH INTERNATIONAL CONF ON ELECTROSTATIC ACCELERATORS AND ASSOCIATED
   BOOSTERS
CY JUN 01-05, 1992
CL MONTEGROTTO TERME, ITALY
SP IST NAZL FIS NUCL, UNIV PADOVA, EUROPEAN PHYS SOC, MUNICIPAL ABANO TERME, MUNICIPAL MONTEGROTTO TERME, BRUKER SPECTROSPIN ITALIANA, DEPRETTO ESCHER WYSS, E ZANON
AB The setting-up of a nuclear microprobe facility (LPM) is described. The facility makes use of the dedicated AN-2000 accelerator of the Laboratori Nazionali di Legnaro, and therefore emphasis is placed on reliable and precise performance of the individual components, and thereby on on- and off-line data acquisition and processing. For the investigation of biomedical and material microstructures, the LPM is demonstrated to be an ideal example of the potentialities and limits of a nuclear microprobe system.
C1 INFN,LAB NAZL LEGNARO,LEGNANO,ITALY.
   INFN,SEZIONE PADOVA,PADUA,ITALY.
   UNIV BOLOGNA,DIPARTIMENTO FIS,I-40126 BOLOGNA,ITALY.
   UNIV PADUA,DIPARTIMENTO FIS,I-35100 PADUA,ITALY.
RP BOLLINI, D (reprint author), INFN,SEZIONE BOLOGNA,BOLOGNA,ITALY.
CR GRIME GW, 1991, NUCL INSTRUM METH B, V54, P52, DOI 10.1016/0168-583X(91)95490-5
   JAMIESON DN, 1989, NUCL INSTRUM METH B, V40-1, P669, DOI 10.1016/0168-583X(89)91072-0
   JOHANSSON TB, 1970, NUCL INSTRUM METHODS, V84, P141, DOI 10.1016/0029-554X(70)90751-2
NR 3
TC 22
Z9 22
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-9002
J9 NUCL INSTRUM METH A
JI Nucl. Instrum. Methods Phys. Res. Sect. A-Accel. Spectrom. Dect. Assoc.
   Equip.
PD APR 15
PY 1993
VL 328
IS 1-2
BP 173
EP 176
DI 10.1016/0168-9002(93)90621-N
PG 4
WC Instruments & Instrumentation; Nuclear Science & Technology; Physics,
   Nuclear; Physics, Particles & Fields
SC Instruments & Instrumentation; Nuclear Science & Technology; Physics
GA KW190
UT WOS:A1993KW19000031
DA 2018-10-20
ER

PT J
AU PAUL, M
AF PAUL, M
TI NEW DEVELOPMENTS AND CHALLENGES IN ACCELERATOR MASS-SPECTROMETRY
SO NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION A-ACCELERATORS
   SPECTROMETERS DETECTORS AND ASSOCIATED EQUIPMENT
LA English
DT Article; Proceedings Paper
CT 6TH INTERNATIONAL CONF ON ELECTROSTATIC ACCELERATORS AND ASSOCIATED
   BOOSTERS
CY JUN 01-05, 1992
CL MONTEGROTTO TERME, ITALY
SP IST NAZL FIS NUCL, UNIV PADOVA, EUROPEAN PHYS SOC, MUNICIPAL ABANO TERME, MUNICIPAL MONTEGROTTO TERME, BRUKER SPECTROSPIN ITALIANA, DEPRETTO ESCHER WYSS, E ZANON
ID BIO-MEDICAL SCIENCES; NEGATIVE-IONS; TANDEM ACCELERATOR; CA-41
AB The paper reviews the basic concepts of accelerator mass spectrometry and presents new areas of research investigated in various disciplines. Recent biomedical studies are described. Measurements of cosmogenic Ni-59 in samples of extra-terrestrial material at different AMS facilities equipped with large-size accelerators are reviewed. Comparison is made between the different experimental methods used for Ni-59 detection. Exploratory experiments in accelerator mass spectrometry combined with selective excitation of ions by a laser are described.
RP PAUL, M (reprint author), HEBREW UNIV JERUSALEM,RACAH INST PHYS,IL-91904 JERUSALEM,ISRAEL.
CR BENTE B, 1991, 9091 BESCHL U MUENCH
   BERKOVITS D, 1989, NUCL INSTRUM METH A, V281, P663, DOI 10.1016/0168-9002(89)91507-6
   BERKOVITS D, 1990, NUCL INSTRUM METH B, V52, P378, DOI 10.1016/0168-583X(90)90441-V
   BERKOVITS D, 1992, REV SCI INSTRUM, V63, P2825, DOI 10.1063/1.1142818
   BOARETTO E, 1992, UNPUB 203RD AM CHEM
   BONANI G, P INT S ARGR ALP DER
   ELMORE D, 1987, SCIENCE, V236, P543, DOI 10.1126/science.236.4801.543
   ELMORE D, 1987, BIOL TRACE ELEM RES, V12, P231, DOI 10.1007/BF02796683
   ELMORE D, 1990, NUCL INSTRUM METH B, V52, P531, DOI 10.1016/0168-583X(90)90471-6
   FAESTERMANN H, 1990, NUCL INSTRUM METH B, V50, P275, DOI 10.1016/0168-583X(90)90368-5
   FELTON JS, 1990, NUCL INSTRUM METH B, V52, P517, DOI 10.1016/0168-583X(90)90469-B
   FIFIELD LK, 1990, NUCL INSTRUM METH B, V52, P233, DOI 10.1016/0168-583X(90)90412-N
   FINK D, 1991, EARTH PLANET SC LETT, V107, P115, DOI 10.1016/0012-821X(91)90048-M
   GARWAN MA, 1990, NUCL INSTRUM METH B, V52, P512, DOI 10.1016/0168-583X(90)90468-A
   HEANEY RP, 1958, J CLIN ENDOCR METAB, V18, P1246, DOI 10.1210/jcem-18-11-1246
   HENNING W, 1981, 2ND P INT S ACC MASS, P320
   HONDA M, 1961, J GEOPHYS RES, V66, P3541, DOI 10.1029/JZ066i010p03541
   HONDA M, 1967, HDB PHYSIK, V46, P613
   HOTOP H, 1985, J PHYS CHEM REF DATA, V14, P731, DOI 10.1063/1.555735
   KILIUS LR, 1991, NUCL INSTRUM METH B, V56, P868
   KORSCHINEK G, 1987, NUCL INSTRUM METH B, V29, P67, DOI 10.1016/0168-583X(87)90206-0
   KUTSCHERA W, 1990, ANNU REV NUCL PART S, V40, P411
   KUTSCHERA W, IN PRESS NUCL INSTR
   LANZEROTTI LJ, 1972, SCIENCE, V179, P1232
   LITHERLAND AE, 1980, ANNU REV NUCL PART S, V30, P437, DOI 10.1146/annurev.ns.30.120180.002253
   MEIRAV O, 1991, AM J PHYSIOL, V260, pF466
   MEIRAV O, 1990, NUCL INSTRUM METH B, V52, P536, DOI 10.1016/0168-583X(90)90472-7
   MUELLER D, 1992, NUCL INSTRUM METH B, V68, P313
   NISHIIZUMI K, 1981, RADIOCHIM ACTA, V29, P113
   PAUL M, 1989, NUCL INSTRUM METH A, V277, P418, DOI 10.1016/0168-9002(89)90771-7
   PAUL ML, UNPUB
   RAISBECK GM, 1980, REV ARCHEOMETRIE, V4, P121
   REEDY RC, 1990, P LUNAR PLANET SCI, V21, P1003
   REEDY RC, 1991, SUN TIME
   SPERGEL MS, 1986, J GEOPHYS RES-SOLID, V91, pD483, DOI 10.1029/JB091iB04p0D483
   STEINHOF A, 1987, NUCL INSTRUM METH B, V29, P59, DOI 10.1016/0168-583X(87)90204-7
   SUTER M, 1990, NUCL INSTRUM METH B, V52, P211, DOI 10.1016/0168-583X(90)90409-N
   TRAVERS MJ, UNPPUB
   VOGEL JS, 1990, NUCL INSTRUM METH B, V52, P524, DOI 10.1016/0168-583X(90)90470-F
   1970, GEOCHIM COSMOCHIM S1, V2, P1503
   1982, PUBLICATION INT CO S, V30
NR 41
TC 11
Z9 11
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-9002
J9 NUCL INSTRUM METH A
JI Nucl. Instrum. Methods Phys. Res. Sect. A-Accel. Spectrom. Dect. Assoc.
   Equip.
PD APR 15
PY 1993
VL 328
IS 1-2
BP 330
EP 337
DI 10.1016/0168-9002(93)90649-3
PG 8
WC Instruments & Instrumentation; Nuclear Science & Technology; Physics,
   Nuclear; Physics, Particles & Fields
SC Instruments & Instrumentation; Nuclear Science & Technology; Physics
GA KW190
UT WOS:A1993KW19000059
DA 2018-10-20
ER

PT J
AU CLYMAN, JI
   POWSNER, SM
   PATON, JA
   MILLER, PL
AF CLYMAN, JI
   POWSNER, SM
   PATON, JA
   MILLER, PL
TI USING A NETWORK MENU AND THE UMLS INFORMATION-SOURCES MAP TO FACILITATE
   ACCESS TO ONLINE REFERENCE MATERIALS
SO BULLETIN OF THE MEDICAL LIBRARY ASSOCIATION
LA English
DT Article
AB As computer technology advances, clinicians and biomedical researchers are becoming more dependent upon information from online databases and information systems. By using specially configured computer workstations and high-speed computer networks, it is now possible to access this information in a rapid and straightforward manner. To empower users by providing these capabilities, the authors are assembling a variety of network workstations to be located throughout Yale-New Haven Medical Center. At the heart of the workstation is NetMenu, a program designed to help users connect to a number of important online information systems, including a hospital order entry and results reporting system, a drug reference, bibliographic retrieval systems, and educational programs. In addition, as part of the National Library of Medicine's Unified Medical Language System(TM) (UMLS(R)) project, the authors have developed a local prototype of the UMLS Information Sources Map (ISM) and a companion query assistant program to complement the NetMenu in helping users select and connect automatically to information services relevant to a particular question. The ISM query assistant draws from a listing of many online information sources accessible via local and international networks.
C1 YALE UNIV,SCH MED,DEPT PSYCHIAT,NEW HAVEN,CT 06510.
   YALE UNIV,SCH MED,OFF ACAD COMP,NEW HAVEN,CT 06510.
   YALE UNIV,SCH MED,CTR MED INFORMAT,DEPT ANESTHESIOL,NEW HAVEN,CT 06510.
RP CLYMAN, JI (reprint author), YALE UNIV,SCH MED,DEPT ANESTHESIOL MED INFORMAT,NEW HAVEN,CT 06510, USA.
CR CLAYTON PD, 1992, 15TH P ANN S COMP AP, P109
   CLYMAN JI, 1992, AM MED INFORMATICS A
   HUMPHREYS BL, 1992, 7TH P WORLD C MED IN, P1495
   KAHLE B, 1991, ONLINE, V15, P56
   LEVITT J, 1990, UNIX TODAY       OCT
   MASYS DR, 1992, 7TH P WORLD C MED IN, P151
   MASYS DR, 1992, 16TH P ANN S COMP AP
   MILLER PL, MEDINFO 92
   *NAT INF STAND ORG, 1988, ANSIZ3950
   Paton J. A., 1990, Fourteenth Annual Symposium on Computer Applications in Medical Care. Standards in Medical Informatics. A Conference of the American Medical Informatics Association, P709
   PATON JA, 1992, IN PRESS 16TH P ANN
   STAIR TO, 1990, ACAD MED, V65, P20, DOI 10.1097/00001888-199001000-00005
   STEINER JG, 1988, PROJECT ATHENA
   Tuttle M. S., 1992, MEDINFO 92. Proceedings of the Seventh World Congress on Medical Informatics, P1506
   1988, DIRECTORY ONLINE DAT
NR 15
TC 6
Z9 6
U1 0
U2 0
PU MED LIBRARY ASSN
PI CHICAGO
PA SUITE 300 6 N MICHIGAN AVE, CHICAGO, IL 60602
SN 0025-7338
J9 B MED LIBR ASSOC
JI Bull. Med. Libr. Assoc.
PD APR
PY 1993
VL 81
IS 2
BP 207
EP 216
PG 10
WC Information Science & Library Science
SC Information Science & Library Science
GA KX031
UT WOS:A1993KX03100009
PM 8472006
DA 2018-10-20
ER

PT J
AU SOBOL, WT
AF SOBOL, WT
TI LABORATORY INFORMATION-SYSTEM FOR NUCLEAR-MAGNETIC-RESONANCE RELAXOMETRY
   IN BIOMEDICAL MATERIALS (NMR LIS) .1. DATA-ACQUISITION AND EXPERIMENT
   CONTROL
SO COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE
LA English
DT Article
DE NUCLEAR MAGNETIC RESONANCE; COMPUTER CONTROL; LABORATORY EQUIPMENT
   INTERFACES
AB A large and comprehensive Laboratory Information System (LIS) was developed for a laboratory that specializes in the studies of nuclear magnetic resonance (NMR) relaxation behavior in biomedical materials. Several programs have been developed (data acquisition and hardware control, data analysis, theoretical modeling, utilities like plotting, FFT, and peak fitting), and several other are under development (data postprocessing, database management, linkage to other systems). This paper describes a software module that was developed to control the hardware (to communicate with the NMR spectrometer pulse programmer, magnet power supply, temperature controller), to achieve efficient data acquisition through a parallel interface to the ADC devices, and to provide a user friendly interface to a complex laboratory system.
RP SOBOL, WT (reprint author), UNIV ALABAMA,DEPT RADIOL,619 S 19TH ST,BIRMINGHAM,AL 35233, USA.
CR CARR HY, 1954, PHYS REV, V94, P630, DOI 10.1103/PhysRev.94.630
   FARRAR TC, 1971, PULSE FOURIER TRANSF
   Fukushima E., 1981, EXPT PULSE NMR NUTS
   HAHN EL, 1950, PHYS REV, V80, P580, DOI 10.1103/PhysRev.80.580
   MEIBOOM S, 1958, REV SCI INSTRUM, V29, P688, DOI 10.1063/1.1716296
   PEEMOELLER H, 1980, J MAGN RESON, V41, P358, DOI 10.1016/0022-2364(80)90085-2
   VOLD RL, 1968, J CHEM PHYS, V48, P3831, DOI 10.1063/1.1669699
NR 7
TC 0
Z9 0
U1 0
U2 4
PU ELSEVIER SCI IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0169-2607
J9 COMPUT METH PROG BIO
JI Comput. Meth. Programs Biomed.
PD APR
PY 1993
VL 39
IS 3-4
BP 225
EP 232
DI 10.1016/0169-2607(93)90025-G
PG 8
WC Computer Science, Interdisciplinary Applications; Computer Science,
   Theory & Methods; Engineering, Biomedical; Medical Informatics
SC Computer Science; Engineering; Medical Informatics
GA LF237
UT WOS:A1993LF23700009
PM 8334875
DA 2018-10-20
ER

PT J
AU SOBOL, WT
AF SOBOL, WT
TI LABORATORY INFORMATION-SYSTEM FOR NUCLEAR-MAGNETIC-RESONANCE RELAXOMETRY
   IN BIOMEDICAL MATERIALS (NMR LIS) .2. DATA-ANALYSIS
SO COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE
LA English
DT Article
DE NUCLEAR MAGNETIC RESONANCE; COMPUTER CONTROL; LABORATORY EQUIPMENT
   INTERFACES
ID PROGRAM; MODELS; DECAY
AB Data analysis modules for Nuclear Magnetic Resonance Relaxometry LIS are described. Since the experimental NMR results from biomedical samples often exhibit complex structure that arises from complexity of tissue, the analysis methods focus on search, investigation, and evaluation of complex multiexponential relaxation features. Two algorithms have been implemented: an enhanced spin grouping method that is based on a multiexponential curve stripping algorithm, and an eigenvalue decomposition method, implemented as modified DISCRETE program.
RP SOBOL, WT (reprint author), UNIV ALABAMA,DEPT RADIOL,619 S 19TH ST,BIRMINGHAM,AL 35233, USA.
CR DISTEFANO JJ, 1984, AM J PHYSIOL, V246, pR651
   DUNNE A, 1986, J PHARM PHARMACOL, V38, P97, DOI 10.1111/j.2042-7158.1986.tb04519.x
   GARDNER DG, 1959, J CHEM PHYS, V31, P978, DOI 10.1063/1.1730560
   GARFINKEL D, 1984, AM J PHYSIOL, V246, pR641
   GUARDABASSO V, 1988, COMPUT METH PROG BIO, V27, P55, DOI 10.1016/0169-2607(88)90103-4
   JENNRICH RI, 1979, ANNU REV BIOPHYS BIO, V8, P195, DOI 10.1146/annurev.bb.08.060179.001211
   Kirkup L., 1988, Computers in Physics, V2, P64
   LANDAHL HD, 1963, ANN NY ACAD SCI, V108, P331, DOI 10.1111/j.1749-6632.1963.tb13384.x
   LANDAW EM, 1984, AM J PHYSIOL, V246, pR665
   PECK CC, 1979, J PHARMACOKINET BIOP, V7, P537, DOI 10.1007/BF01062394
   PEDERSEN PV, 1977, J PHARMACOKINET BIOP, V5, P513, DOI 10.1007/BF01061732
   PEEMOELLER H, 1980, J MAGN RESON, V41, P358, DOI 10.1016/0022-2364(80)90085-2
   Provencher S. W., 1976, Journal of Chemical Physics, V64, P2772, DOI 10.1063/1.432601
   PROVENCHER SW, 1976, BIOPHYS J, V16, P27, DOI 10.1016/S0006-3495(76)85660-3
   SEDMAN AJ, 1976, J PHARM SCI, V65, P1006, DOI 10.1002/jps.2600650713
   SMITH MR, 1976, TECHNOMETRICS, V18, P467, DOI 10.2307/1268663
   SOBOL WT, 1987, MAGNET RESON MED, V4, P537, DOI 10.1002/mrm.1910040605
   SOBOL WT, 1989, B MAGN RESON, V11, P69
   SOBOL WT, COMPUT METHODS PROGR
   YAMAOKA K, 1978, J PHARMACOKINET BIOP, V6, P165, DOI 10.1007/BF01117450
   ZIERLER K, 1981, ANNU REV BIOPHYS BIO, V10, P531, DOI 10.1146/annurev.bb.10.060181.002531
NR 21
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCI IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0169-2607
J9 COMPUT METH PROG BIO
JI Comput. Meth. Programs Biomed.
PD APR
PY 1993
VL 39
IS 3-4
BP 233
EP 241
DI 10.1016/0169-2607(93)90026-H
PG 9
WC Computer Science, Interdisciplinary Applications; Computer Science,
   Theory & Methods; Engineering, Biomedical; Medical Informatics
SC Computer Science; Engineering; Medical Informatics
GA LF237
UT WOS:A1993LF23700010
PM 8334876
DA 2018-10-20
ER

PT J
AU ROATH, S
AF ROATH, S
TI BIOLOGICAL AND BIOMEDICAL ASPECTS OF MAGNETIC FLUID TECHNOLOGY
SO JOURNAL OF MAGNETISM AND MAGNETIC MATERIALS
LA English
DT Article; Proceedings Paper
CT 6TH INTERNATIONAL CONF ON MAGNETIC FLUIDS ( ICMF 6 )
CY JUL 20-24, 1992
CL PARIS, FRANCE
SP FRENCH MINIST RES & TECHNOL, FRENCH GEN DIRECT ARMAMENT, UNIV PIERRE & MARIE CURIE, UNIV PARIS 7, UNESCO, LAB GUERBET, JAPAN SOC MAGNET FLUID RES, EXXON, FERROFLUIDICS, BIOL & IND
ID ASSEMBLIES; SEPARATION; ANTIBODY; BLOOD
AB Magnetic fluid technology has undergone study and development in its biological and biomedical aspects, principally in image enhancement and in the use of a variety of Separation techniques in the purification of biological materials or in the identification of very small amounts of organisms, cells, or genomic material. Many of these processes are already applied to small scale laboratory processing or manufacturing. A variety of magnetic materials are used; no standard technique has yet been consolidated but efficiency of separation especially is rapidly increasing. Clinical applications may be related both to diagnosis in areas of low level infection or contamination and also in ex-vivo processing of materials such as human bone marrow or peripheral blood where specific cell populations can be extracted. This may be a valuable tool in human bone marrow processing and in the coming field of gene transfer technology, as well as in the purification of genomic material.
RP ROATH, S (reprint author), UNIV SOUTHAMPTON,SOUTHAMPTON GEN HOSP,LEVEL F,S ACAD BLOCK,SOUTHAMPTON S09 4XY,ENGLAND.
CR CHARLES SW, 1990, J MAGN MAGN MATER, V85, P277, DOI 10.1016/0304-8853(90)90066-Y
   GABARIELSEN OS, 1989, NUCLEAR ACIDS RES, V17, P6253
   GEE AP, 1991, BONE MARROW PURGING
   GLUCKSMAN MJ, 1986, SCIENCE, V231, P1273, DOI 10.1126/science.3945822
   HORNES E, 1993, IN PRESS GENETIC ANA
   HORTON JK, 1991, MAGNETIC SEPARATION, P107
   JACKSON CJ, 1990, J CELL SCI, V96, P257
   JAKOBSON KS, 1990, NUCLEIC ACIDS RES, V12, P18
   KARLSSON GB, 1991, ANAL BIOCHEM, V199, P219, DOI 10.1016/0003-2697(91)90093-9
   KEMPSHEAD JT, 1990, PROGR CLIN RES, V333
   LAUFFER RB, 1987, CHEM REV, V87, P901, DOI 10.1021/cr00081a003
   LONNEMARK M, 1988, ACTA RADIOL, V29, P599, DOI 10.3109/02841858809171945
   LONNEMARK M, 1988, ACTA RADIOL, V29, P232
   OWEN CS, 1981, CELL BIOPHYS, V3, P141, DOI 10.1007/BF02788130
   Patel PD, 1991, MAGNETIC SEPARATION, P93
   PAUL F, 1978, BRIT J HAEMATOL, V38, P273, DOI 10.1111/j.1365-2141.1978.tb01043.x
   PAUL F, 1981, LANCET
   ROATH S, 1990, J MAGN MAGN MATER, V85, P285, DOI 10.1016/0304-8853(90)90067-Z
   ROATH S, 1992, ADV BONE MARROW PURG, P239
   ROATH S, 1980, AIME S FINE PARTICLE, P1287
   RUUGE EK, 1993, J MAGN MAGN MATER, V122, P335, DOI 10.1016/0304-8853(93)91104-F
   SAMBROOK J, 1989, MOL CLONING LABORATO, V1, pCH7
   STRAUSS LC, 1991, AM J PEDIAT HEMATOL, V13, P217
   WILKSTROM M, 1992, ACTA RADIOL S, V33, P292
NR 24
TC 39
Z9 40
U1 1
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0304-8853
J9 J MAGN MAGN MATER
JI J. Magn. Magn. Mater.
PD APR
PY 1993
VL 122
IS 1-3
BP 329
EP 334
DI 10.1016/0304-8853(93)91103-E
PG 6
WC Materials Science, Multidisciplinary; Physics, Condensed Matter
SC Materials Science; Physics
GA LD485
UT WOS:A1993LD48500079
DA 2018-10-20
ER

PT J
AU LIU, NQ
   ZHOU, CN
   YAN, LN
   LI, XJ
   CHAO, ZY
   REN, ZG
   ZHOU, SJ
AF LIU, NQ
   ZHOU, CN
   YAN, LN
   LI, XJ
   CHAO, ZY
   REN, ZG
   ZHOU, SJ
TI A PRELIMINARY-STUDY ON THE POSITIONAL DISTRIBUTION OF CISPLATIN AND
   OTHER ELEMENTS IN THE LIVER OF NORMAL MICE
SO NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION B-BEAM
   INTERACTIONS WITH MATERIALS AND ATOMS
LA English
DT Article; Proceedings Paper
CT 6TH INTERNATIONAL CONF ON PIXE ( PARTICLE INDUCED X-RAY EMISSION ) AND
   ITS ANALYTICAL APPLICATIONS
CY JUL 20-24, 1992
CL WASADEA UNIV CONF HALL, TOKYO, JAPAN
SP WASEDA UNIV, COMMEMORAT ASSOC JAPAN WORLD EXPOSIT, INOUE FDN SCI, KAJIMA FDN, MURATA SCI FDN, NIPPON SHEET GLASS FDN MAT SCI
HO WASADEA UNIV CONF HALL
ID MICROPROBE
AB In the BEPC 4W1A station, synchrotron radiation has been used to induce X-ray fluorescence for measuring the concentration of elements in various materials, including biomedical samples. In this paper we present the 2D distribution map of platinum in liver slices of normal mice after Cisplatin treatment, and the correlation of the concentrations of the measured elements by mini-SXRF. The results show a positive correlation of the Fe concentration to those of Zn and Cu, and a positive relation of P to S in different points (150 x 150 mum2)  of the liver slice. In order to obtain more information, the same sample has also been measured by micro-PIXE at Fudan University. The possibilities and limitations of the two probes for analyzing biomedical samples are discussed.
C1 CHINESE ACAD MED SCI,INST CANC,ELECTRON MICROSCOPE LAB,BEIJING 100021,PEOPLES R CHINA.
   FUDAN UNIV,DEPT PHYS 2,SHANGHAI 200433,PEOPLES R CHINA.
RP LIU, NQ (reprint author), ACAD SINICA,INST HIGH ENERGY PHYS,POB 2732,BEIJING 100080,PEOPLES R CHINA.
CR BMAN J, 1988, TRACE ELEMENT ANAL C, P304
   GORDON BM, 1990, NUCL INSTRUM METH B, V45, P527, DOI 10.1016/0168-583X(90)90892-X
   LINDH U, 1990, NUCL INSTRUM METH B, V49, P451, DOI 10.1016/0168-583X(90)90292-3
   MUTSAERS PHA, 1990, NUCL INSTRUM METH B, V45, P557, DOI 10.1016/0168-583X(90)90899-6
   Ren Chigang, 1991, Nuclear Science and Techniques, V2, P13
NR 5
TC 4
Z9 10
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-583X
J9 NUCL INSTRUM METH B
JI Nucl. Instrum. Methods Phys. Res. Sect. B-Beam Interact. Mater. Atoms
PD APR
PY 1993
VL 75
IS 1-4
BP 571
EP 575
PG 5
WC Instruments & Instrumentation; Nuclear Science & Technology; Physics,
   Atomic, Molecular & Chemical; Physics, Nuclear
SC Instruments & Instrumentation; Nuclear Science & Technology; Physics
GA KY498
UT WOS:A1993KY49800120
DA 2018-10-20
ER

PT J
AU SLIERENDREGT, BL
   OTTING, N
   JONKER, M
   BONTROP, RE
AF SLIERENDREGT, BL
   OTTING, N
   JONKER, M
   BONTROP, RE
TI MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-II DQ DIVERSITY IN RHESUS
   MACAQUES
SO TISSUE ANTIGENS
LA English
DT Article
DE MHC; MHCMAMU; RFLP; RHESUS MACAQUE
ID HLA-DQ; BETA-CHAIN; RFLP ANALYSIS; ALPHA-CHAIN; DNA; POLYMORPHISM;
   SEQUENCE; PRIMATES; ANTIGENS; CLONING
AB By the use of restriction fragment length polymorphism analysis 10 Taq I fragments could be identified for the MhcMamu-DQA1 region. A strong correlation exists between the occurrence of Mamu-DQA1/Taq I fragments and Mamu-DAQ1 allelic sequence variation. Most restriction fragments correspond with a unique Mamu-DQA1 allele, with one exception being the Taq I 4.5 kb fragment that is associated with two Mamu-DQA1 alleles. The RFLP technique allowed the identification of 15 Mamu-DQB1/Taq I restriction fragments, whereas sequence analysis has permitted the characterization of at least 20 different Mamu-DQB1 alleles. In this communication two unpublished Mamu-DQB1 sequences are described. For Mamu-DQB1, on only four occasions was it possible to demonstrate a correlation between a certain fragment and an allelic sequence. These analyses, performed on material from truly homozygous animals, allowed us to define which combinations of Mamu-DQA1 and - DQB1 molecules form heterodimers at the cell surface. In addition, these studies are helpful in typing non-human primate species that are used in biomedical research.
RP SLIERENDREGT, BL (reprint author), TNO,INST APPL RADIOBIOL & IMMUNOL,DEPT CHRON & INFECT DIS,LANGE KLEIWEG 151,2288 GJ RIJSWIJK,NETHERLANDS.
RI Bontrop, Ronald/J-3628-2012
OI Bontrop, Ronald/0000-0003-0874-6467
CR AUFFRAY C, 1982, P NATL ACAD SCI-BIOL, V79, P6337, DOI 10.1073/pnas.79.20.6337
   BAKKER NPM, 1992, J EXP MED, V175, P933, DOI 10.1084/jem.175.4.933
   BELL J, 1986, LANCET, V1, P1058
   BONTROP RE, 1987, IMMUNOGENETICS, V25, P305, DOI 10.1007/BF00404423
   BONTROP RE, 1989, IMMUNOGENETICS, V30, P432, DOI 10.1007/BF02421175
   BONTROP RE, 1987, IMMUNOBIOLOGY HLA, V1, P815
   CHARRON DJ, 1984, NATURE, V312, P157, DOI 10.1038/312157a0
   GYLLENSTEN UB, 1989, P NATL ACAD SCI USA, V86, P9986, DOI 10.1073/pnas.86.24.9986
   GYLLENSTEN UB, 1988, P NATL ACAD SCI USA, V85, P7652, DOI 10.1073/pnas.85.20.7652
   JONKER M, 1991, HUM IMMUNOL, V32, P31, DOI 10.1016/0198-8859(91)90114-O
   KAPPES D, 1988, ANNU REV BIOCHEM, V57, P991, DOI 10.1146/annurev.bi.57.070188.005015
   KENTER M, 1992, IMMUNOGENETICS, V36, P71, DOI 10.1007/BF00215282
   KIENY MP, 1983, GENE, V26, P91, DOI 10.1016/0378-1119(83)90039-2
   KLEIN J, 1990, IMMUNOGENETICS, V31, P217
   KWOK WW, 1989, J IMMUNOL, V143, P3598
   KWOK WW, 1988, J IMMUNOL, V141, P3123
   LARHAMMAR D, 1982, P NATL ACAD SCI-BIOL, V79, P3687, DOI 10.1073/pnas.79.12.3687
   LETVIN NL, 1985, SCIENCE, V230, P71, DOI 10.1126/science.2412295
   LIPOING Y, 1991, J IMMUNOL, V147, P4393
   LONG EO, 1982, P NATL ACAD SCI-BIOL, V79, P7465, DOI 10.1073/pnas.79.23.7465
   MARCADET A, 1987, IMMUNOBIOLOGY HLA, V1, P553
   MARSH SGE, 1991, TISSUE ANTIGENS, V37, P181, DOI 10.1111/j.1399-0039.1991.tb01870.x
   OTTING N, 1992, J IMMUNOL, V149, P461
   RIEB O, 1990, IMMUNOGENETICS, V32, P110
   ROEP BO, 1988, HUM IMMUNOL, V23, P271, DOI 10.1016/0198-8859(88)90062-6
   SAIKI RK, 1986, NATURE, V324, P163, DOI 10.1038/324163a0
   SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463
   SCHARF SJ, 1986, SCIENCE, V233, P1076, DOI 10.1126/science.3461561
   SLIERENDREGT BL, 1991, HUM IMMUNOL, V30, P11, DOI 10.1016/0198-8859(91)90064-G
   SLIERENDREGT BL, 1992, HUM IMMUNOL, V35, P29, DOI 10.1016/0198-8859(92)90092-2
   SO AKL, 1988, ARTHRITIS RHEUM, V31, P990
NR 31
TC 11
Z9 11
U1 0
U2 0
PU MUNKSGAARD INT PUBL LTD
PI COPENHAGEN
PA 35 NORRE SOGADE, PO BOX 2148, DK-1016 COPENHAGEN, DENMARK
SN 0001-2815
J9 TISSUE ANTIGENS
JI Tissue Antigens
PD APR
PY 1993
VL 41
IS 4
BP 178
EP 185
DI 10.1111/j.1399-0039.1993.tb01999.x
PG 8
WC Cell Biology; Immunology; Pathology
SC Cell Biology; Immunology; Pathology
GA LG606
UT WOS:A1993LG60600003
PM 8103245
DA 2018-10-20
ER

PT J
AU QUEVAUVILLER, P
AF QUEVAUVILLER, P
TI IMPACT OF REFERENCE MATERIALS ON THE QUALITY OF CHEMICAL MEASUREMENTS
SO ANALUSIS
LA English
DT Article
AB Many analyses are performed every year for a multitude of purposes, including reports on the quality of goods and food, the state of the environment and the health of patients. That these results are accurate is a prerequisite for the interpretation of the data obtained. One of the most powerful tools for quality control of the analysis is to use reference materials (RMs) and certified reference materials (CRMs). These materials are necessary for processes including the following: method validation (CRM), monitoring of statistical control (RM), use of samples in intercomparisons (RMs). This contribution describes what is required of RMs and CRMs in chemical analyses and how they are used, and gives some examples of materials currently used in environmental, food and biomedical analysis.
RP QUEVAUVILLER, P (reprint author), COMMISS EUROPEAN COMMUNITIES,PROGRAMME MEASUREMENTS & TESTING BCR,200 RUE LOI,B-1049 BRUSSELS,BELGIUM.
CR ALLEN DW, 1989, APPL ORGANOMET CHEM, V1, P311
   BELLIARDO JJ, 1988, FRESEN Z ANAL CHEM, V332, P533, DOI 10.1007/BF00472637
   CAMPBELL MJ, 1992, J ANAL ATOM SPECTROM, V7, P617, DOI 10.1039/ja9920700617
   CANTILLO AY, 1992, STANDARD REFERENCE M
   COLINET E, IN PRESS MICROCHEM J
   CORNELIS R, 1992, FOOD CHEM, V43, P307, DOI 10.1016/0308-8146(92)90218-Q
   GRIEPINK B, 1991, FRESEN J ANAL CHEM, V339, P599, DOI 10.1007/BF00325544
   GRIEPINK B, 1990, FRESEN J ANAL CHEM, V338, P360, DOI 10.1007/BF00322493
   GRIEPINK B, 1992, HAZARDOUS METALS ENV, V17, P517
   HARTLEY TH, COMPUTERIZED QUALITY
   MAIER EA, 1991, TRAC-TREND ANAL CHEM, V10, P340, DOI 10.1016/0165-9936(91)87011-T
   MAIER EA, IN PRESS ANAL CHIM A
   MOOIJMAN KA, 1992, EUR14375EN CEC REP
   QUEVAUVILLER P, 1992, FRESEN J ANAL CHEM, V343, P335, DOI 10.1007/BF00322865
   QUEVAUVILLER P, 1992, MAR POLLUT BULL, V24, P601, DOI 10.1016/0025-326X(92)90280-J
   TAYLOR JK, 1985, NBS SPECIAL PUBL, V260
   TORO EC, 1990, IAEARL128 INT AT EN
   WELLS DE, IN P RESS MAR POLLUT
   1990, MARINE SEDIMENT REFE
   1976, PURE APPL CHEM, V48, P503
   1992, BCR REFERENCE MATERI
   1985, ISO IEC351985 INT OR
NR 22
TC 14
Z9 14
U1 0
U2 0
PU EDITIONS SCIENTIFIQUES ELSEVIER
PI PARIS CEDEX 15
PA 141 RUE JAVEL, 75747 PARIS CEDEX 15, FRANCE
SN 0365-4877
J9 ANALUSIS
JI Analusis
PD MAR
PY 1993
VL 21
IS 2
BP M47
EP M53
PG 7
WC Chemistry, Analytical
SC Chemistry
GA KQ284
UT WOS:A1993KQ28400011
DA 2018-10-20
ER

PT J
AU Muck, M
AF Mueck, Michael
TI PROGRESS IN RF-SQUIDS
SO IEEE TRANSACTIONS ON APPLIED SUPERCONDUCTIVITY
LA English
DT Article
AB At present, dc-SQUIDS made of conventional superconductors are recognised as the most sensitive devices for measuring magnetic flux. The growing interest in high-Tc superconducting electronics, however, has also increased the interest in rf-SQUIDS again. Here, rf-SQUIDS offer several advantages like the requirement for only one single Josephson junction and a low l/f noise. With relatively high bias frequencies (> 100 MHz) it is possible to obtain values of the white flux noise comparable to dc-SQUIDS. Starting from bulk material devices with relatively high flux noise levels, at preseat, the best high-Tc rf-SQUIDS offer a field sensitivily of less than 200 fT/root Hz (@ 1Hz). This is already sufficient for a number of biomedical applications. This paper reviews recent developments towards practical rf-SQUIDs made of high-Tc as well as conventional superconductors.
C1 [Mueck, Michael] Forschungszentrum Julich GmbH KFA, Inst Schicht & Ionentech, POB 1913,W 5170, Julich, Germany.
RP Muck, M (reprint author), Forschungszentrum Julich GmbH KFA, Inst Schicht & Ionentech, POB 1913,W 5170, Julich, Germany.
CR Ahola H., 1979, Journal of Low Temperature Physics, V35, P313, DOI 10.1007/BF00115582
   Behm W., 1985, THESIS TU BRAUNSCHWE
   BELOHOUBEK E, 1975, IEEE T MICROW THEORY, VMT23, P522, DOI 10.1109/TMTT.1975.1128615
   BETTS K, 1989, IEEE T MAGN, V25, P965
   Buhrman R. A., 1979, IEEE T MAG, V13, P879
   CAVALLERI A, 1992, SPRINGER PROG PHYS, V64, P252
   COLCLOUGH MS, 1987, NATURE, V328, P47, DOI 10.1038/328047a0
   Cui G., 1991, SUPERCOND SCI TECH, V4, P130
   DALY KP, 1991, IEEE T MAGN, V27, P3066, DOI 10.1109/20.133857
   DALY KP, 1991, APPL PHYS LETT, V58, P543, DOI 10.1063/1.104581
   Erne S., 1980, SQUID 80 SUPERCONDUC, P955
   Gaerttner M. R., 1974, PUBL IEEE, V74 CHO 852-4-MAG
   HERRMAN K, 1991, SUPERCOND SCI TECH, V4, P583, DOI 10.1088/0953-2048/4/11/007
   HOLLENHORST JN, 1979, IEEE T MAGN, V15, P474, DOI 10.1109/TMAG.1979.1060170
   JACKEL LD, 1975, J LOW TEMP PHYS, V19, P201, DOI 10.1007/BF00116178
   JACKEL LD, 1978, J APPL PHYS, V49, P471, DOI 10.1063/1.324366
   KAMPER RA, 1972, APPL PHYS LETT, V20, P270, DOI 10.1063/1.1654144
   KANTER H, 1977, IEEE T MAGN, V13, P389, DOI 10.1109/TMAG.1977.1059461
   KURKIJARVI J, 1973, J APPL PHYS, V44, P3729, DOI 10.1063/1.1662830
   Kurkijarvi J., 1972, IEEE PUB, VCHO 682-5-TABSC, P581
   LIKHACHEV AG, 1990, SUPERCOND SCI TECH, V3, P148, DOI 10.1088/0953-2048/3/3/009
   LONG AP, 1980, SQUID 80 SUPERCONDUC, P207
   McAvoy B. R., 1987, IEEE T MAG, VMAG-25, P389
   Miick M., 1992, APPL PH IN PRESS SEP
   MUCK M, 1992, APPL PHYS A-MATER, V54, P475, DOI 10.1007/BF00324323
   MUCK M, 1992, REV SCI INSTRUM, V63, P2268
   PIERCE JM, 1974, IEEE T MAGN, VMA10, P599, DOI 10.1109/TMAG.1974.1058427
   Rogalla H., 1976, SQUID SUPERCONDUCTIN, P339
   ROGALLA H, 1985, SQUID 85 SUPERCONDUC, P671
   Shnyrkov V. I., 1991, Modern Physics Letters B, V5, P1281, DOI 10.1142/S0217984991001568
   SMITH AD, 1987, IEEE T MAGN, V23, P1079, DOI 10.1109/TMAG.1987.1064875
   Tavrin Y., CRYOGENICS UNPUB
   TINCHEV SS, 1989, ELECTRON LETT, V25, P1579, DOI 10.1049/el:19891060
   WHEELER HA, 1965, IEEE T MICROW THEORY, VMT13, P172, DOI 10.1109/TMTT.1965.1125962
   ZAKOSARENKO VM, 1989, IEEE T MAGN, V25, P946, DOI 10.1109/20.92444
   ZANI MJ, 1991, IEEE T MAGN, V27, P2557, DOI 10.1109/20.133738
   ZHANG Y, 1992, APPL PHYS LETT, V60, P645, DOI 10.1063/1.106580
   ZHANG Y, 1992, APPL PHYS LETT, V60, P2303, DOI 10.1063/1.107011
   Zhang Y., 1990, APPL PHYS LETT, V56, P1597
   Zhang Y., CLIN PHYS PHYS UNPUB
   ZIMMERMAN JE, 1987, APPL PHYS LETT, V51, P617, DOI 10.1063/1.98365
NR 41
TC 16
Z9 16
U1 0
U2 2
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI PISCATAWAY
PA 445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA
SN 1051-8223
EI 1558-2515
J9 IEEE T APPL SUPERCON
JI IEEE Trans. Appl. Supercond.
PD MAR
PY 1993
VL 3
IS 1
BP 2003
EP 2010
DI 10.1109/77.233463
PN 4
PG 8
WC Engineering, Electrical & Electronic; Physics, Applied
SC Engineering; Physics
GA V43TI
UT WOS:000209703300052
DA 2018-10-20
ER

PT J
AU JOHANSSON, CB
   LAUSMAA, J
   ROSTLUND, T
   THOMSEN, P
AF JOHANSSON, CB
   LAUSMAA, J
   ROSTLUND, T
   THOMSEN, P
TI COMMERCIALLY PURE TITANIUM AND TI6AL4V IMPLANTS WITH AND WITHOUT
   NITROGEN-ION IMPLANTATION - SURFACE CHARACTERIZATION AND QUANTITATIVE
   STUDIES IN RABBIT CORTICAL BONE
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID SPECTROSCOPIC CHARACTERIZATION; TISSUE-RESPONSE; OXIDE-FILMS; WEAR;
   TI-6AL-4V
AB Nitrogen-ion implantation is a surface modification of interest for biomedical materials. In this study screw-shaped commercially pure titanium and Ti6Al4V alloy implants were nitrogen-ion implanted and analysed by scanning electron microscopy (SEM) and scanning Auger electron spectroscopy (AES). The surface topography was essentially similar for treated and non-treated samples. AES survey spectra showed an incorporation of nitrogen into the surface of the nitrogen-ion treated commercially pure titanium and Ti6Al4V implants, as judged by the ratio between the intensities of the peaks at 390 and 420 eV. AES depth profiles revealed a similar oxide thickness (7.5 nm) for the nitrogen-ion implanted and the non-treated samples. In nitrogen-ion implanted screws nitrogen was detected up to depths of about 150 nm below the surface, with a maximum nitrogen concentration at about 50 nm. Light microscopic examination of the 10 mum-thick ground sections 3 months after the insertion of nitrogen-ion implanted and non-treated commercially pure titanium and Ti6Al4V screws in the proximal tibial methaphysis of rabbits showed that bone filled a large portion of the area within the threads. A fibrous capsule was not observed. Light microscopic morphometry did not reveal any statistically significant differences in bone metal contact or bone area within the threads of nitrogen-ion treated and non-treated implants. The ''mirror-image'' analysis showed that for all implants examined significantly more bone was present immediately outside than inside the threads. The results from this study indicate that nitrogen-ion implanted, screw-shaped, commercially pure titanium and Ti6Al4V implants heal as well in cortical bone as non-treated samples.
C1 UNIV GOTEBORG,DEPT ANAT,S-41390 GOTHENBURG,SWEDEN.
   GOTHENBURG UNIV,CHALMERS UNIV TECHNOL,DEPT PHYS,S-41296 GOTHENBURG,SWEDEN.
RP JOHANSSON, CB (reprint author), UNIV GOTEBORG,DEPT HANDICAP RES,BRUNNSGATAN 2,S-41312 GOTHENBURG,SWEDEN.
OI Thomsen, Peter/0000-0003-3910-6665
CR ASK M, 1990, J MATER RES, V5, P1662, DOI 10.1557/JMR.1990.1662
   ASK M, 1988, APPL SURF SCI, V35, P283
   BAIER RE, 1982, BIOMATERIALS, V3, P21
   COOK SD, 1991, CLIN ORTHOP RELAT R, V264, P209
   DAVIS LE, 1978, HDB AUGER ELECTRON S
   DAWSON PT, 1985, SURF SCI, V149, P105, DOI 10.1016/S0039-6028(85)80016-9
   Dearnaley G., 1986, Surface Engineering, V2, P213
   Donath K., 1988, PRAPARATOR, V34, P197
   JOHANSSON C, 1991, THESIS U GOTEBORG
   LALOR PA, 1991, J BONE JOINT SURG BR, V73, P25
   LAUSMAA J, 1990, SURF INTERFACE ANAL, V15, P328, DOI 10.1002/sia.740150506
   LAUSMAA J, 1990, APPL SURF SCI, V44, P133, DOI 10.1016/0169-4332(90)90100-E
   LENNOX DW, 1987, CLIN ORTHOP RELAT R, V225, P171
   NASSER S, 1990, CLIN ORTHOPAEDICS, V261, P171
   OLIVER WC, 1984, METALL TRANS A, V15, P2221, DOI 10.1007/BF02647105
   RIEU J, 1991, BIOMATERIALS, V12, P139, DOI 10.1016/0142-9612(91)90192-D
   ROSTLUND T, 1990, J BIOMED MATER RES, V24, P847, DOI 10.1002/jbm.820240705
   SCALES JT, 1991, J BONE JOINT SURG BR, V73, P534
   SIOSHANSI P, 1987, NUCL INSTRUM METH B, V19-20, P204, DOI 10.1016/S0168-583X(87)80043-5
   WITT JD, 1991, J BONE JOINT SURG BR, V73, P559
NR 20
TC 39
Z9 39
U1 0
U2 1
PU CHAPMAN HALL LTD
PI LONDON
PA 2-6 BOUNDARY ROW, LONDON, ENGLAND SE1 8HN
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD MAR
PY 1993
VL 4
IS 2
BP 132
EP 141
DI 10.1007/BF00120382
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA LB029
UT WOS:A1993LB02900007
DA 2018-10-20
ER

PT J
AU KALMAN, PG
   ROTSTEIN, OD
   NIVEN, J
   GLYNN, MFX
   ROMASCHIN, AD
AF KALMAN, PG
   ROTSTEIN, OD
   NIVEN, J
   GLYNN, MFX
   ROMASCHIN, AD
TI DIFFERENTIAL STIMULATION OF MACROPHAGE PROCOAGULANT ACTIVITY BY VASCULAR
   GRAFTS
SO JOURNAL OF VASCULAR SURGERY
LA English
DT Article
ID TISSUE FACTOR GENERATION; HUMAN-MONOCYTES; POLYTETRAFLUOROETHYLENE
   GRAFTS; INTERLEUKIN-1 GENERATION; THROMBOPLASTIN ACTIVITY; COMPLEMENT
   ACTIVATION; FIBRINOLYTIC-ACTIVITY; PLATELET-AGGREGATION; BIOMEDICAL
   POLYMERS; MONONUCLEAR-CELLS
AB Purpose: The mechanism by which some graft materials are more thrombogenic than others is poorly understood. We hypothesized that differential induction of macrophage procoagulant activity (PCA) by various materials may contribute to variable thrombogenicity.
   Methods: Thioglycollate-elicited murine peritoneal macrophages were added to disks of Dacron and expanded polytetrafluoroethylene (ePTFE). After adherence, macrophages were incubated with and without endotoxin (lipopolysaccharide) and then recovered by sonication for determination of PCA with a one-step clotting bioassay.
   Results: PCA was significantly higher in cells after incubation on Dacron compared with ePTFE both in the absence of lipopolysaccharide (243 +/- 76 vs 68 +/- 39 mU, n = 4) and after stimulation with lipopolysaccharide (491 +/- 137 vs 139 +/- 41 mU, n = 4) (p < 0.01, analysis of variance). Using factor-deficient plasmas, we found that this PCA was consistent with tissue factor. This differential induction of PCA was related to increased macrophage adherence to Dacron compared to that to ePTFE (9374 +/- 1158 vs 2111 +/- 330 cells/mm2; n = 4; p < 0.01, analysis of variance).
   Conclusions: The thrombogenic nature of Dacron correlates with its ability to adhere macrophages and induce PCA. Strategies aimed at modulating these effects may reduce the thrombogenicity of vascular grafts and therefore potentially the incidence of graft thrombosis.
C1 UNIV TORONTO, DEPT SURG, TORONTO M5S 1A1, ONTARIO, CANADA.
   INST MED SCI, TORONTO, ON, CANADA.
RP KALMAN, PG (reprint author), TORONTO GEN HOSP, DIV VASC SURG, 9 EATON N, ROOM 215, 200 ELIZABETH ST, TORONTO M5G 2C4, ON, CANADA.
CR BONFIELD TL, 1989, J BIOMED MATER RES, V23, P535, DOI 10.1002/jbm.820230602
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999
   CHAPMAN HA, 1982, CELL, V28, P653, DOI 10.1016/0092-8674(82)90220-3
   CHAPMAN HA, 1983, J IMMUNOL, V130, P261
   DEAN RT, 1984, HAEMOSTASIS, V14, P412
   DUNN CJ, 1981, LYMPHOKINES, V4, P231
   EDWARDS RL, 1980, J IMMUNOL, V125, P606
   FAN ST, 1991, J CLIN INVEST, V87, P50, DOI 10.1172/JCI115000
   Greisler H, 1988, ASAIO Trans, V34, P1051
   Greisler H P, 1990, Ann Vasc Surg, V4, P98, DOI 10.1007/BF02042699
   GREISLER HP, 1989, J VASC SURG, V9, P588, DOI 10.1067/mva.1989.vs0090588
   HAMLIN GW, 1978, BRIT J SURG, V65, P272, DOI 10.1002/bjs.1800650416
   HARTUNG HP, 1983, AGENTS ACTIONS, V13, P415, DOI 10.1007/BF02176404
   JANCO RL, 1985, BLOOD, V65, P545
   KALMAN PG, 1990, J VASC SURG, V11, P591, DOI 10.1067/mva.1990.18048
   LENTZ AJ, 1985, J BIOMED MATER RES, V19, P1101, DOI 10.1002/jbm.820190919
   LYBERG T, 1981, BIOCHEM J, V194, P699, DOI 10.1042/bj1940699
   MILLER KM, 1989, BIOMATERIALS, V10, P187, DOI 10.1016/0142-9612(89)90023-9
   MILLER KM, 1988, J BIOMED MATER RES, V22, P713, DOI 10.1002/jbm.820220805
   MUHLFELDER TW, 1979, J CLIN INVEST, V63, P147, DOI 10.1172/JCI109269
   PRYDZ H, 1978, THROMB HAEMOSTASIS, V39, P582
   RICKLES FR, 1977, J LAB CLIN MED, V89, P792
   ROOHK HV, 1976, T AM SOC ART INT ORG, V22, P1
   ROSENTHAL GA, 1989, INFECT IMMUN, V57, P338
   SALTHOUSE TN, 1984, J BIOMED MATER RES, V18, P395, DOI 10.1002/jbm.820180407
   SAPSFORD RN, 1981, J THORAC CARDIOV SUR, V81, P860
   SCHWARTZ BS, 1986, J CLIN INVEST, V78, P1136, DOI 10.1172/JCI112693
   THAKUR ML, 1977, J NUCL MED, V18, P1014
   UNIYAL S, 1982, THROMB HAEMOSTASIS, V47, P285
   VANGINKEL CJW, 1977, BRIT J HAEMATOL, V37, P35
   VEITH FJ, 1986, J VASC SURG, V3, P104
   WARD CA, 1989, MED PROG TECHNOL, V15, P63
   WHITTEMORE AD, 1989, J VASC SURG, V10, P299, DOI 10.1067/mva.1989.14116
   YEAGER A, 1988, T AM SOC ART INT ORG, V34, P88
   ZIATS NP, 1988, BIOMATERIALS, V9, P5, DOI 10.1016/0142-9612(88)90063-4
   ZIATS NP, 1990, J LAB CLIN MED, V116, P687
NR 36
TC 20
Z9 20
U1 0
U2 0
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0741-5214
J9 J VASC SURG
JI J. Vasc. Surg.
PD MAR
PY 1993
VL 17
IS 3
BP 531
EP 537
DI 10.1016/0741-5214(93)90154-E
PG 7
WC Surgery; Peripheral Vascular Disease
SC Surgery; Cardiovascular System & Cardiology
GA KR851
UT WOS:A1993KR85100010
PM 8445749
DA 2018-10-20
ER

PT J
AU COSOFRET, VV
   LINDNER, E
   BUCK, RP
   KUSY, RP
   WHITLEY, JQ
AF COSOFRET, VV
   LINDNER, E
   BUCK, RP
   KUSY, RP
   WHITLEY, JQ
TI DESIGN OF IONOPHORE-FREE H+-SELECTIVE SOLVENT POLYMERIC MEMBRANES FOR
   FURTHER BIOMEDICAL APPLICATIONS
SO JOURNAL OF ELECTROANALYTICAL CHEMISTRY
LA English
DT Article
ID NEUTRAL-CARRIER; ELECTRODES; LIFETIME
AB Ionophore-free H+-selective solvent polymeric membrane electrodes based on aminated poly(vinyl chloride) (PVC-NH2) are studied. Among the large number of amino-PVC derivatives, the electrodes fabricated from piperazine-modified PVC show the best analytical performances. The new pH electrodes exhibit a Nernstian response between pH 4 and pH 12, and their selectivity coefficients toward biologically interesting cations match the corresponding values of H+ electrodes based on TDDA or ETH 5294. The.new membrane material offers additional prospects for ion-selective electrode fabrication with technologies used in microelectronic device development.
C1 UNIV N CAROLINA,DEPT CHEM,CHAPEL HILL,NC 27599.
   UNIV N CAROLINA,DEPT ORTHODONT,CHAPEL HILL,NC 27599.
CR AMMANN D, 1985, ANAL CHIM ACTA, V171, P119, DOI 10.1016/S0003-2670(00)84189-6
   AMMANN D, 1981, ANAL CHEM, V53, P2267, DOI 10.1021/ac00237a031
   AMMANN D, 1986, ION SELECTIVE MICROE, pCH18
   BAILEY PL, 1980, ANAL ION SELECTIVE E, P49
   Bergveld P., 1988, COMPREHENSIVE ANAL C, VXXIII
   BUCK RP, 1992, BIOSENSORS CHEM SENS
   CHAO P, 1988, PFLUG ARCH EUR J PHY, V411, P216, DOI 10.1007/BF00582318
   CHENG PS, 1980, NATL SCI COUN MONOGR, V8, P313
   CHOJNACKI J, 1990, J ELECTROANAL CHEM, V277, P159, DOI 10.1016/0022-0728(90)85098-P
   COSOFRET VV, 1992, J ELECTROANAL CHEM, V327, P137, DOI 10.1016/0022-0728(92)80142-Q
   COSOFRET VV, 1985, J PHARMACEUT BIOMED, V3, P123, DOI 10.1016/0731-7085(85)80015-7
   DINTEN O, 1991, ANAL CHEM, V63, P596, DOI 10.1021/ac00006a009
   EGOROV VV, 1990, TALANTA, V37, P461, DOI 10.1016/0039-9140(90)80071-M
   ERNE D, 1979, CHIMIA, V33, P88
   HARAME DL, 1987, IEEE T ELECTRON DEV, V34, P1700, DOI 10.1109/T-ED.1987.23140
   HARRISON DJ, 1988, J ELECTROCHEM SOC, V135, P2473, DOI 10.1149/1.2095361
   HUSER M, 1991, ANAL CHEM, V63, P1380, DOI 10.1021/ac00014a009
   KUSY RP, UNPUB
   LINDNER E, 1988, ANAL CHEM, V60, P295, DOI 10.1021/ac00155a004
   Lindner E., 1988, DYNAMIC CHARACTERIST
   MA SC, 1990, MIKROCHIM ACTA, V1, P197
   MA SC, 1988, ANAL CHEM, V60, P2293, DOI 10.1021/ac00171a027
   MOODY GJ, 1970, ANALYST, V95, P910, DOI 10.1039/an9709500910
   OESCH U, 1986, ANAL CHEM, V58, P2285, DOI 10.1021/ac00124a037
   PURVES RD, 1981, BIOL TECHNIQUE SERIE, V6
   SCHULTHESS P, 1981, ANAL CHIM ACTA, V131, P111, DOI 10.1016/S0003-2670(01)93540-8
   STACHWILL T, 1986, J ELECTROANAL CHEM, V202, P75
   TOTH K, 1989, ION SELECTIVE ELECTR, V5, P181
   WU HL, 1987, TALANTA, V34, P577, DOI 10.1016/0039-9140(87)80193-5
NR 29
TC 39
Z9 39
U1 0
U2 2
PU ELSEVIER SCIENCE SA LAUSANNE
PI LAUSANNE 1
PA PO BOX 564, 1001 LAUSANNE 1, SWITZERLAND
SN 0022-0728
J9 J ELECTROANAL CHEM
JI J. Electroanal. Chem.
PD FEB 15
PY 1993
VL 345
IS 1-2
BP 169
EP 181
DI 10.1016/0022-0728(93)80477-Y
PG 13
WC Chemistry, Analytical; Electrochemistry
SC Chemistry; Electrochemistry
GA KP533
UT WOS:A1993KP53300013
DA 2018-10-20
ER

PT J
AU SAWHNEY, AS
   PATHAK, CP
   HUBBELL, JA
AF SAWHNEY, AS
   PATHAK, CP
   HUBBELL, JA
TI BIOERODIBLE HYDROGELS BASED ON PHOTOPOLYMERIZED POLY(ETHYLENE
   GLYCOL)-CO-POLY(ALPHA-HYDROXY ACID) DIACRYLATE MACROMERS
SO MACROMOLECULES
LA English
DT Article
ID POLYETHYLENE OXIDE; DRUG DELIVERY; DEGRADATION; POLYMERS; WATER;
   COPOLYMERS; POLYESTERS; SURFACES; RELEASE; SYSTEMS
AB Macromers having a poly(ethylene glycol) central block, extended with oligomers of alpha-hydroxy acids such as oligo(dl-lactic acid) or oligo(glycolic acid) and terminated with acrylate groups, were synthesized and characterized with the goal of obtaining a bioerodible hydrogel that could be formed in direct contact with tissues or proteins by photopolymerization of aqueous solutions of the macromer. It was determined that the PEG component of these macromers must be greater than approximately 55 mol % to provide water solubility. The amphiphilic nature of the macromers causes them to assume a micellar conformation, which enables them to undergo rapid photopolymerization. Due to the multifunctionality of the macromers, polymerization results in the formation of cross-linked gels. These gels degrade upon hydrolysis of the oligo(alpha-hydroxy acid) regions into poly(ethylene glycol), the alpha-hydroxy acid, and oligo(acrylic acid). The degradation rates of these gels can be tailored by appropriate choice of the oligo(alpha-hydroxy acid) from less than 1 day to up to 4 months. Using non toxic photoinitiators, the macromers can be rapidly photopolymerized with visible light in direct contact with tissues without excess heating or local toxicity. If polymerized in contact with tissues, the gels adhere to the tissues, presumably by interpenetration; if polymerized prior to contact with tissues, the gels are very nonadhesive, presumably by possession of a large amount of free water which is not hydrogen bonded with the ether linkages of the ethylene glycol mers. These novel materials are suitable for a number of biomedical applications and show potential for use in macromolecular drug delivery.
C1 UNIV TEXAS,DEPT CHEM ENGN,AUSTIN,TX 78712.
RI Hubbell, Jeffrey/A-9266-2008
OI Hubbell, Jeffrey/0000-0003-0276-5456
CR ALLMER K, 1990, J POLYM SCI POL CHEM, V28, P173, DOI 10.1002/pola.1990.080280112
   ANDINI S, 1988, MAKROMOL CHEM-RAPID, V9, P119
   BARBUCCI IR, 1992, 4TH WORLD BIOM C, P461
   BRONDSTED H, 1991, BIOMATERIALS, V12, P584, DOI 10.1016/0142-9612(91)90056-G
   BRUIN P, 1988, MAKROMOL CHEM-RAPID, V9, P584
   BUCK CA, 1987, ANNU REV CELL BIOL, V3, P179, DOI 10.1146/annurev.cb.03.110187.001143
   BURNS JW, 1991, J T SOC BIOMATER, V14, P251
   CHURCHILL JR, 1985, Patent No. 4526938
   COHEN D, 1988, J BIOMED MATER RES, V22, P993
   DELLAVALLE F, 1990, Patent No. 4957744
   DENG XM, 1990, J POLYM SCI POL LETT, V28, P411, DOI 10.1002/pol.1990.140281303
   DESAI NP, 1991, BIOMATERIALS, V12, P144, DOI 10.1016/0142-9612(91)90193-E
   DESAI NP, 1991, J BIOMED MATER RES, V25, P829, DOI 10.1002/jbm.820250704
   DOMB AJ, 1989, MACROMOLECULES, V22, P3200, DOI 10.1021/ma00198a002
   DOMB AJ, 1991, J POLYM SCI POL CHEM, V29, P571, DOI 10.1002/pola.1991.080290413
   FUERTGES F, 1990, J CONTROL RELEASE, V11, P139, DOI 10.1016/0168-3659(90)90127-F
   GOMBOTZ WR, 1989, J APPL POLYM SCI, V37, P91, DOI 10.1002/app.1989.070370108
   HELLER J, 1991, BOIDEGRADABLE POLYM, P121
   HOLLAND S J, 1986, Journal of Controlled Release, V4, P155, DOI 10.1016/0168-3659(86)90001-5
   HUNT JA, 1990, J CONTROL RELEASE, V12, P159, DOI 10.1016/0168-3659(90)90092-8
   HUTCHINSON FG, 1990, J CONTROL RELEASE, V13, P279, DOI 10.1016/0168-3659(90)90018-O
   ISHIHARA K, 1989, J BIOMED MATER RES, V23, P1475, DOI 10.1002/jbm.820231209
   ITO K, 1991, MACROMOLECULES, V24, P2348, DOI 10.1021/ma00009a035
   KIM SW, 1992, PHARMACEUT RES, V9, P283, DOI 10.1023/A:1015887213431
   KISSEL T, 1991, J CONTROL RELEASE, V16, P27, DOI 10.1016/0168-3659(91)90028-C
   KOBAYASHI H, 1991, J BIOMED MATER RES, V25, P1481, DOI 10.1002/jbm.820251206
   KULKARNI RK, 1966, ARCH SURG-CHICAGO, V93, P839
   LANGER R, 1990, SCIENCE, V249, P1527, DOI 10.1126/science.2218494
   LEWIS DH, 1991, BIODEGRADABLE POLYM, P1
   MILLER RA, 1977, J BIOMED MATER RES, V11, P711, DOI 10.1002/jbm.820110507
   PATHAK CP, 1992, J AM CHEM SOC, V114, P8311, DOI 10.1021/ja00047a065
   PITT CG, 1981, BIOMATERIALS, V2, P215
   REED AM, 1981, POLYMER, V22, P494, DOI 10.1016/0032-3861(81)90168-3
   SAWHNEY AS, 1990, J BIOMED MATER RES, V24, P1397, DOI 10.1002/jbm.820241011
   SAWHNEY AS, UNPUB
   SMITH CR, 1988, Patent No. 4741337
   STOREY RF, 1991, J POLYM SCI POL CHEM, V29, P1759, DOI 10.1002/pola.1991.080291209
   TAMADA J, 1992, J BIOMAT SCI-POLYM E, V3, P315, DOI 10.1163/156856292X00402
   THOMPSON DF, 1988, DRUG INTEL CLIN PHAR, V22, P946, DOI 10.1177/106002808802201203
   TSENG YC, 1990, BIOMATERIALS, V11, P73, DOI 10.1016/0142-9612(90)90055-U
   VALDESAGUILERA O, 1992, MACROMOLECULES, V25, P541, DOI 10.1021/ma00028a008
   WELZ MM, 1992, J PHARM SCI-US, V81, P85, DOI 10.1002/jps.2600810117
   YAMAOKA T, 1992, 4TH WORLD BIOM C, P79
   YOKOYAMA M, 1991, CANCER RES, V51, P3229
   YOSHIKAWA M, 1989, NEW POLYM MATER, V1, P223
   1987, Patent No. 4716203
NR 46
TC 744
Z9 762
U1 8
U2 220
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036
SN 0024-9297
J9 MACROMOLECULES
JI Macromolecules
PD FEB 15
PY 1993
VL 26
IS 4
BP 581
EP 587
DI 10.1021/ma00056a005
PG 7
WC Polymer Science
SC Polymer Science
GA KM623
UT WOS:A1993KM62300005
DA 2018-10-20
ER

PT J
AU METHE, BM
AF METHE, BM
TI MANAGING RADIOACTIVELY CONTAMINATED INFECTIOUS WASTE AT A LARGE
   BIOMEDICAL FACILITY
SO HEALTH PHYSICS
LA English
DT Article
DE CONTAMINATION; WASTE MANAGEMENT; SCREENING MEASUREMENTS; RADIOACTIVE
   MATERIALS
AB Proper management of infectious waste containing radioactive material depends on three program elements. First, screening methods are required to identify medical waste containing radioactive material. Second, a means of managing the volume of waste identified has to be developed. Management includes identifying the radioisotopes, dealing with the physical requirements of the waste (e.g., the need for cold storage), and treating the material as a mixed waste. Finally, methods to limit production of waste at its source must be implemented. This includes educating the radioactive material users, enabling them with the means of reducing waste volume, and giving them feedback on how well they are implementing the waste reduction practices.
RP METHE, BM (reprint author), ALBANY MED CTR, ALBANY, NY 12208 USA.
CR MILLER K, 1990, RAD PROTECT MGT, V7, P30
   PENNOCK RE, 1980, MED HLTH PHYSICS, P5
   VANDERLICK C, 1980, MED HLTH PHYSICS, P17
NR 3
TC 3
Z9 3
U1 1
U2 4
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0017-9078
EI 1538-5159
J9 HEALTH PHYS
JI Health Phys.
PD FEB
PY 1993
VL 64
IS 2
BP 187
EP 191
DI 10.1097/00004032-199302000-00010
PG 5
WC Environmental Sciences; Public, Environmental & Occupational Health;
   Nuclear Science & Technology; Radiology, Nuclear Medicine & Medical
   Imaging
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health; Nuclear Science & Technology; Radiology, Nuclear Medicine &
   Medical Imaging
GA KH695
UT WOS:A1993KH69500011
PM 8449714
DA 2018-10-20
ER

PT J
AU ODONOVAN, TL
   CONTLA, PA
   DASGUPTA, DK
AF ODONOVAN, TL
   CONTLA, PA
   DASGUPTA, DK
TI APPLICATION OF GOLAY CODES AND PIEZOELECTRIC ULTRASOUND TRANSDUCERS TO
   BIOMEDICAL NONINVASIVE MEASUREMENT
SO IEEE TRANSACTIONS ON ELECTRICAL INSULATION
LA English
DT Article; Proceedings Paper
CT 7TH INTERNATIONAL SYMP ON ELECTRETS
CY SEP 25-27, 1991
CL BERLIN, GERMANY
AB Golay codes posses the property that combining the products of the two individual codes of the pair causes the self-induced noise to cancel out. This gives significant improvements in the signal to noise ratio obtained with short codes in signal to noise ratio enhancement systems, making the codes useful in biomedical Doppler applications. Present work combines these codes with an experimental piezoelectric ultrasound transducer in a water bath. It is shown that the signal to noise ratio improvements resulting from this are greatest when the input signal to noise ratio is greater than unity and the target is obscured by clutter. Further, it is shown that this system can be used to send multiple codes, with code-identification after detection, to extend the range-velocity limit in medical Doppler systems. It is also shown that pulse shape integrity is important in these systems, and that the required bandwidth is large. Transducers using polar polymeric (i.e. polyvinylidene fluoride, PVDF) sensor material are shown to give increased pulse integrity and bandwidth in comparison with the conventional ceramic (PZT) sensor material.
RP ODONOVAN, TL (reprint author), UNIV COLL N WALES,SCH ELECT ENGN SCI,BANGOR LL57 2UW,GWYNEDD,WALES.
CR CATHIGNOL DJ, 1980, IEEE T BIO-MED ENG, V27, P30, DOI 10.1109/TBME.1980.326688
   GOLAY MJE, 1961, IRE T INFORM THEOR, V7, P82, DOI 10.1109/TIT.1961.1057620
   GORFU Y, 1986, P IEEE ULTRASONICS S, V1, P573
   LAL R, 1989, THESIS U WALES BANGO
   LEE BB, 1983, ULTRASONICS, V21, P153, DOI 10.1016/0041-624X(83)90070-7
   Swartz R.G., 1980, ACOUST IMAGING, V8, P69
   SWARTZ RG, 1979, IEEE T ELECTRON DEV, V26, P1921, DOI 10.1109/T-ED.1979.19797
   TAKEUCHI Y, 1979, ULTRASONICS, V17, P125
NR 8
TC 5
Z9 5
U1 1
U2 3
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017-2394
SN 0018-9367
J9 IEEE T ELECTR INSUL
PD FEB
PY 1993
VL 28
IS 1
BP 93
EP 100
DI 10.1109/14.192244
PG 8
WC Engineering, Electrical & Electronic
SC Engineering
GA KL634
UT WOS:A1993KL63400011
DA 2018-10-20
ER

PT J
AU NEO, M
   KOTANI, S
   NAKAMURA, T
   YAMAMURO, T
   OHTSUKI, C
   KOKUBO, T
   BANDO, Y
AF NEO, M
   KOTANI, S
   NAKAMURA, T
   YAMAMURO, T
   OHTSUKI, C
   KOKUBO, T
   BANDO, Y
TI A COMPARATIVE-STUDY OF ULTRASTRUCTURES OF THE INTERFACES BETWEEN 4 KINDS
   OF SURFACE-ACTIVE CERAMIC AND BONE (JOURNAL OF BIOMEDICAL MATERIALS RES,
   VOL 26, PG 1419, 1992)
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Correction, Addition
C1 KYOTO UNIV,INST CHEM RES,UJI,KYOTO 611,JAPAN.
   NATL INST RES INORGAN MAT,TSUKUBA 305,JAPAN.
RP NEO, M (reprint author), KYOTO UNIV,FAC MED,DEPT ORTHOPED SURG,54 KAWAHARA CHO,SAKYO KU,KYOTO 606,JAPAN.
RI Ohtsuki, Chikara/E-4973-2010
OI Ohtsuki, Chikara/0000-0002-6474-1540
CR NEO M, 1992, J BIOMED MATER RES, V26, P1419, DOI 10.1002/jbm.820261103
NR 1
TC 1
Z9 1
U1 0
U2 1
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD FEB
PY 1993
VL 27
IS 2
BP 281
EP 281
DI 10.1002/jbm.820270219
PG 1
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA KG410
UT WOS:A1993KG41000018
OA Bronze
DA 2018-10-20
ER

PT J
AU APRIL, GV
   BOUCHARD, M
   DOUCET, M
AF APRIL, GV
   BOUCHARD, M
   DOUCET, M
TI SURFACE-ROUGHNESS CHARACTERIZATION OF DENTAL FILLINGS - A DIFFRACTIVE
   ANALYSIS
SO OPTICAL ENGINEERING
LA English
DT Article
DE BIOMEDICAL OPTICS; COMPOSITE RESINS; SURFACE ROUGHNESS; SPECKLE;
   STATISTICAL OPTICS
ID COMPOSITE RESINS
AB The large number of new materials such as amalgams and the variety of techniques for finishing and polishing in operative dentistry has stimulated interest in simple, nondestructive methods of surface roughness evaluation. We studied an optical method based on the scattering of reflected coherent light on prepared samples of composite resins submitted to different surface treatments. The method should be able to measure the degree of flatness of the samples, thus enabling a classification procedure according to a figure of merit to be defined. The diffraction properties of such moderately rough surfaces has been correlated with mechanical profilometer measurements of the residual granular structure after polishing. Different surface treatments of composite resins result in distinctive levels of surface flatness, and it is shown that a relation between the intensity of the normalized specular reflection of a beam of coherent light and the rms surface roughness can be established for characterization purposes.
RP APRIL, GV (reprint author), UNIV LAVAL,CTR OPT PHOTON & LASER,ST FOY G1K 7P4,PQ,CANADA.
CR ALLARDYCE KJ, 1988, APPL OPTICS, V26, P2364
   Beckmann P., 1963, SCATTERING ELECTROMA
   BENNETT HE, 1961, J OPT SOC AM, V51, P123, DOI 10.1364/JOSA.51.000123
   Bennett J. M., 1989, INTRO SURFACE ROUGHN
   CHEN RCS, 1988, J PROSTHET DENT, V59, P292, DOI 10.1016/0022-3913(88)90175-8
   FUJII H, 1976, OPT COMMUN, V16, P68, DOI 10.1016/0030-4018(76)90052-3
   Goodman J. W., 1975, Laser speckle and related phenomena, P9
   GROENHUIS RAJ, 1980, CARIES RES, V14, P333, DOI 10.1159/000260472
   Konishi R N, 1985, Dent Mater, V1, P55, DOI 10.1016/S0109-5641(85)80025-7
   LUTZ F, 1983, J AM DENT ASSOC, V107, P575, DOI 10.14219/jada.archive.1983.0300
   OHTSUBO J, 1978, OPT COMMUN, V25, P315, DOI 10.1016/0030-4018(78)90136-0
   REDMALM G, 1986, SWED DENT J, V10, P243
   REINHARDT JW, 1983, J PROSTHET DENT, V49, P485, DOI 10.1016/0022-3913(83)90308-6
   RUSS JC, 1986, J MICROSC-OXFORD, V144, P329, DOI 10.1111/j.1365-2818.1986.tb02810.x
   ULUSOY N, 1987, J PROSTHET DENT, V57, P286, DOI 10.1016/0022-3913(87)90299-X
NR 15
TC 1
Z9 1
U1 0
U2 2
PU SOC PHOTO-OPT INSTRUM ENG
PI BELLINGHAM
PA PO BOX 10, BELLINGHAM, WA 98227-0010
SN 0091-3286
J9 OPT ENG
JI Opt. Eng.
PD FEB
PY 1993
VL 32
IS 2
BP 334
EP 341
DI 10.1117/12.60748
PG 8
WC Optics
SC Optics
GA KL365
UT WOS:A1993KL36500020
DA 2018-10-20
ER

PT J
AU SMITH, RW
AF SMITH, RW
TI REACTIVE PLASMA SPRAY FORMING FOR ADVANCED MATERIALS SYNTHESIS
SO POWDER METALLURGY INTERNATIONAL
LA English
DT Article
ID POWDERS
AB The economic production of wear-resistant materials and advanced composite structural materials is of growing importance. Fiber, particulate, or intermetallic reinforced metal or ceramic matrices are all proposed for use in many varied applications, ranging from aircraft components, biomedical implants, to automotive engines. The acceptance of such hard materials or composites with Ni3Al or TiAl with SiC or Al2O3 fibers or particles, titanium alloys with carbide reinforcement, alumina or zirconia with SiAlON fibers, phase toughened MoSi2 with SiC dispersions, or aluminum alloys with ceramic particulate reinforcement all depend on viable and economic production methods. Reactive plasma spray processing is being investigated as a method by which to produce such materials and is already finding application in the production of wear-resistant materials, advanced composites, diamond, and high T(c) oxide superconductors. In these processes, the reactive thermal plasma state produces new phases, even as reinforcements in matrix materials, starting with particulates, liquids, and/or gases. This paper reviews recent investigations into the production of intermetallic alloys, composite materials such as TiAl, Ti/TiC, Ti/TiN, Mo/MoSi2, MoSi2/SiC, and Al2O3/SiAlON by reactive plasma spraying in controlled atmospheres. Research on diamond and high T(c) oxide superconductors is also discussed. In addition, the advantages, limitations, and research needs for this emerging technology are presented.
C1 RHEIN WESTFAL TH AACHEN,LEHR & FORSCH GEBIET WERKSTOFFWISSENSCH,W-5100 AACHEN,GERMANY.
RP SMITH, RW (reprint author), DREXEL UNIV,DEPT MAT ENGN,CTR PLASMA PROC MAT,PHILADELPHIA,PA 19104, USA.
CR ARSENAULT B, 1990, 3RD P NAT THERM SPRA
   CASTRO R, 1991, THESIS DREXEL U PHIL
   INAL OT, 1982, THIN SOLID FILMS, V95, P195, DOI 10.1016/0040-6090(82)90242-5
   ISHIZAKI K, 1989, J MATER SCI, V24, P3553, DOI 10.1007/BF02385739
   JAEGER DA, 1992, C P ITSC 92, P69
   KOBASHI K, 1987, 8TH P INT S PLASM CH, V4, P2475
   KONG PC, 1983, 6TH P INT S PLASM CH, V1, P219
   MATSUMOTO S, 1987, 8TH P INT S PLASM CH, V4, P2458
   MEYER TN, 1987, 8TH P INT S PLASM CH, P2006
   MITROFANOV B, 1981, MATER SCI ENG, V48, P21, DOI 10.1016/0025-5416(81)90062-8
   MUEHLBERGER E, 1974, 7TH P INT THERM SPRA, P245
   MULLER U, 1992, 3RD P INT C NEW DIAM
   MUTASIM ZZ, 1991, 4TH P NATL THERM SPR, P273
   OHMORI A, 1992, C P ITSC 92, P201
   PEHLIVANTURK NY, 1986, ION NITRIDING, P179
   SAMPATH S, 1989, 11TH P INT THERM SPR
   SMITH RW, 1989, J PLASMA CHEM, V9
   SMITH RW, 1993, IN PRESS
   SMITH RW, 1984, PLASMA PROCESSING SY, P30
   SMITH RW, 1991, POWDER METALLURGY IN, V23
   SMITH RW, 1981, J MET, V33, P23
   SMITH RW, 1989, 9TH P INT UN PUR APP
   SMITH RW, 1992, J THERM SPRAY TECHN, V1, P57
   TANAKA K, 1987, J MATER SCI, V22, P2192, DOI 10.1007/BF01132959
   THORPE M, 1991, CHEM ENG         NOV, P54
   Toth L. E., 1971, TRANSITIONAL METAL C
   TSAI C, 1992, 3RD P INT C NEW DIAM
   TSANTRIZOS PG, 1992, INT ADV COATING TECH, P195
   ZHU H, 1991, MAT SCI ENG A-STRUCT, V139, P352
   1989, MATERIALS SCI ENG 19
NR 30
TC 40
Z9 44
U1 0
U2 4
PU VERLAG SCHMID GMBH
PI FREIBURG
PA PO BOX 6609, D-79042 FREIBURG, GERMANY
SN 0048-5012
J9 POWDER METALL INT
PD FEB
PY 1993
VL 25
IS 1
BP 9
EP 16
PG 8
WC Metallurgy & Metallurgical Engineering
SC Metallurgy & Metallurgical Engineering
GA KU976
UT WOS:A1993KU97600001
DA 2018-10-20
ER

PT J
AU KAETSU, I
AF KAETSU, I
TI RADIATION SYNTHESIS OF POLYMERIC MATERIALS FOR BIOMEDICAL AND
   BIOCHEMICAL APPLICATIONS
SO ADVANCES IN POLYMER SCIENCE
LA English
DT Review
ID GLASS-FORMING MONOMERS; LOW-TEMPERATURES; 2-HYDROXYETHYL METHACRYLATE;
   ENZYME IMMOBILIZATION; CELL-CULTURE; HYDROGELS; CELLULASE; SURFACES;
   RELEASE
AB The study of Radiation Induced Polymerization in the supercooled state is reviewed. This polymerization has remarkable characteristics owing to a rapid increase of viscosity, such as a large polymerization rate at low temperatures and a maximum rate at temperatures above the glass transition temperature (T(g)).
   Applications of polymerization in a supercooled state to the immobilization of various biofunctional components is reviewed. Those applications show advantages because in the low temperature biofunctional components such as proteins, drugs and cells are entrapped or adhered effectively in the polymerized matrix. The immobilized composites are used for biomedical and biochemical systems and processes, such as immuno-diagnosis, artificial organs, drug delivery systems and cell cultures.
RP KAETSU, I (reprint author), KINKI UNIV,FAC SCI & TECHNOL,DEPT NUCL REACTOR ENGN,KOWAKAE 3-4-1,OSAKA,OSAKA 577,JAPAN.
CR ASANO M, 1985, KOBUNSHI RONBUNSHU, V42, P783, DOI 10.1295/koron.42.783
   ASANO M, 1982, POLYM PREPR-JAPAN, V39, P612
   ASANO M, 1985, BIOMATERIALS JAPAN, V3, P85
   ASANO M, 1982, POLYM PREPR-JAPAN, V39, P327
   ASANO M, 1983, POLYM PREPR-JAPAN, V40, P525
   ASANO M, 1982, J BIOACTIVE BIOCOMPA, V39, P333
   BARKALOV IM, 1962, DOKL AKAD NAUK SSSR+, V147, P395
   BEDDOWS CG, 1981, BIOTECHNOL BIOENG, V23, P2885, DOI 10.1002/bit.260231222
   BOCCU E, 1981, BIOTECHNOL BIOENG, V15, P1
   CATTK, 1967, J LAP CLIN MED, V70, P820
   CHAPIRO A, 1967, CR ACAD SCI C CHIM, V264, P285
   CHAPIRO A, 1967, J POLYM SCI C, V16, P767
   DOBO J, 1970, ACTA CHIM HUNG, V63, P435
   DUVAL D, 1987, IAEATECDOC486, P129
   FUJIMURA T, 1980, Z NATURFORSCH C, V35, P477
   FUJIMURA T, 1981, Z NATURFORSCH C, V37, P102
   GAO DY, 1988, EUR POLYM J, V24, P1037
   HA HF, 1985, IAEA4065RB PROGR REP
   HARDY G, 1962, 1962 P TIH S RAD CHE, P205
   HOFFMAN A S, 1986, Journal of Controlled Release, V4, P213
   HOFFMAN AS, 1972, T AM SOC ART INT ORG, V18, P10
   HOFFMAN AS, 1986, RADIAT PHYS CHEM, V25, P375
   IMAI K, 1986, PROSTATE, V8, P325, DOI 10.1002/pros.2990080404
   IRIE M, 1990, ADV POLYM SCI, V94, P28
   ISHIHARA K, 1984, POLYM J, V16, P625, DOI 10.1295/polymj.16.625
   KAESU I, 1983, Z NATURFORSCH C, V38, P821
   KAETSU I, 1980, J BIOMED MATER RES, V14, P185, DOI 10.1002/jbm.820140302
   KAETSU I, 1973, J POLYM SCI POL CHEM, V11, P1811, DOI 10.1002/pol.1973.170110803
   KAETSU I, 1980, J BIOMED MATER RES, V14, P199, DOI 10.1002/jbm.820140303
   KAETSU I, 1979, BIOTECHNOL BIOENG, V21, P847, DOI 10.1002/bit.260210508
   KAETSU I, 1972, J POLYM SCI A1, V10, P2203, DOI 10.1002/pol.1972.150100801
   KAETSU I, 1988, DRUG DEV IND PHARM, V14, P2519, DOI 10.3109/03639048809152030
   KAETSU I, 1985, RADIAT PHYS CHEM, V25, P517, DOI 10.1016/0146-5724(85)90131-1
   KAETSU I, 1981, RADIAT PHYS CHEM, V18, P343, DOI 10.1016/0146-5724(81)90086-8
   KAETSU I, 1985, RADIAT PHYS CHEM, V25, P879, DOI 10.1016/0146-5724(85)90169-4
   KAETSU I, 1969, J MACROMOL SCI CHEM, VA  3, P1509, DOI 10.1080/10601326908051949
   KAETSU I, 1972, J POLYM SCI A1, V10, P2661, DOI 10.1002/pol.1972.150100913
   KAETSU I, 1986, RADIAT PHYS CHEM, V27, P245
   KAETSU I, 1972, J POLYM SCI A1, V10, P2215, DOI 10.1002/pol.1972.150100802
   KAETSU I, 1967, J POLYM SCI A1, V5, P1899, DOI 10.1002/pol.1967.150050808
   KAETSU I, 1980, BIOMATERIALS, V1, P17, DOI 10.1016/0142-9612(80)90052-6
   KAETSU I, 1987, RADIAT PHYS CHEM, V29, P191
   KAETSU I, 1973, J POLYM SCI POL CHEM, V11, P1149, DOI 10.1002/pol.1973.170110603
   KAETSU I, 1979, BIOTECHNOL BIOENG, V21, P863, DOI 10.1002/bit.260210509
   KAETSU I, 1975, POLYM PREPRINT, V16, P465
   KAETSU I, 1990, INT J ARTIF ORGANS, V85, P75
   KAETSU I, 1988, J CONTROL RELEASE, V6, P249
   KARGIN V, 1967, J POLYM SCI C, V4, P767
   KAWASHIMA K, 1974, BIOTECHNOL BIOENG, V16, P609, DOI 10.1002/bit.260160505
   KRAETSU I, 1989, 16TH INT S CONTR REL
   KUMAKURA M, 1984, BIOTECHNOL BIOENG, V26, P17, DOI 10.1002/bit.260260105
   KUMAKURA M, 1984, ACTA CHIM HUNG, V116, P345
   KUMAKURA M, 1984, INT J APPL RADIAT IS, V35, P471, DOI 10.1016/0020-708X(84)90166-2
   KUMAKURA M, 1984, ANAL CHIM ACTA, V161, P109, DOI 10.1016/S0003-2670(00)85782-7
   KUMAKURA M, 1983, APPL BIOCHEM BIOTECH, V8, P87, DOI 10.1007/BF02778089
   KUMAKURA M, 1984, IMMUNOL COMM, V13, P199
   LANDO JB, 1964, J POLYM SCI C, V4, P789
   LEININGER RI, 1966, SCIENCE, V152, P1625, DOI 10.1126/science.152.3729.1625
   LEININGER RI, 1980, SCIENCE, V1, P17
   LIDDY JM, 1975, J POLYM S, V49, P109
   MAEDA H, 1973, BIOTECHNOL BIOENG, V15, P872
   NAKAMURA M, 1980, GAN TO KAGAKURYOHO, V7, P1824
   PEKALA W, 1986, RADIAT PHYS CHEM, V27, P275
   REMBAUM A, 1976, MACROMOLECULES, V9, P328, DOI 10.1021/ma60050a030
   TAMADA M, 1986, BIOTECHNOL BIOENG, V28, P1227, DOI 10.1002/bit.260280814
   TAMADA M, 1987, J FERMENT TECHNOL, V65, P73
   TANAKA T, 1982, SCIENCE, V218, P467, DOI 10.1126/science.218.4571.467
   YAMANAKA H, 1986, HORMONES CLIN, V34, P95
   YOSHIDA M, 1987, BIOMATERIALS, V8, P124, DOI 10.1016/0142-9612(87)90101-3
   YOSHII F, 1983, APPL BIOCHEM BIOTECH, V8, P115, DOI 10.1007/BF02778092
   YOSHII F, 1983, APPL BIOCHEM BIOTECH, V8, P505, DOI 10.1007/BF02780383
   YOSHII F, 1978, J APPLIED POLYM SCI, V22, P289
NR 72
TC 37
Z9 37
U1 0
U2 5
PU SPRINGER VERLAG
PI NEW YORK
PA 175 FIFTH AVE, NEW YORK, NY 10010
SN 0065-3195
J9 ADV POLYM SCI
JI Adv. Polym. Sci.
PY 1993
VL 105
BP 81
EP 97
PG 17
WC Polymer Science
SC Polymer Science
GA MB983
UT WOS:A1993MB98300004
DA 2018-10-20
ER

PT J
AU STACHOWICZ, W
   BURLINSKA, G
   MICHALIK, J
   DZIEDZICGOCLAWSKA, A
   OSTROWSKI, K
AF STACHOWICZ, W
   BURLINSKA, G
   MICHALIK, J
   DZIEDZICGOCLAWSKA, A
   OSTROWSKI, K
TI APPLICATIONS OF EPR SPECTROSCOPY TO RADIATION TREATED MATERIALS IN
   MEDICINE, DOSIMETRY, AND AGRICULTURE
SO APPLIED RADIATION AND ISOTOPES
LA English
DT Article; Proceedings Paper
CT 3RD INTERNATIONAL SYMP ON ESR ( ELECTRON SPIN RESONANCE ) DOSIMETRY AND
   APPLICATIONS
CY OCT 14-18, 1991
CL NIST, GAITHERSBURG, MD
SP US DEPT COMMERCE, US DEF NUCL AGCY, US DOE
HO NIST
DE EPR; IRRADIATION; PARAMAGNETIC CENTERS; BONE; MINERALIZED TISSUES; FOOD;
   DOSIMETRY
ID RESONANCE
AB Survey is given of the EPR studies on irradiated bone mineral referred to transplantology, physiology, pathology, dosimetry and to the detection of irradiated food. Stability, dose-dependency and nature of radiation-induced EPR signal in bone mineral (hydroxyapatite) are discussed. Paramagnetic centers produced by radiation as ''labels'' as applied to biomedical experiments and dosimetry are evaluated. Results on the detection of irradiated fruits, vegetables, and other dry food products are presented.
C1 SCH MED WARSZAWA,PL-02004 WARSAW,POLAND.
RP STACHOWICZ, W (reprint author), INST NUCL CHEM & TECHNOL,DORODNA 16,PL-03195 WARSAW,POLAND.
CR ASCENZI A, 1977, CALC TISS RES, V23, P7, DOI 10.1007/BF02012760
   CEVC P, 1972, RADIAT RES, V51, P581, DOI 10.2307/3573626
   DESROSIERS MF, 1991, HEALTH PHYS, V61, P859, DOI 10.1097/00004032-199112000-00018
   DODD NJF, 1985, RADIAT PHYS CHEM, V26, P451, DOI 10.1016/0146-5724(85)90234-1
   DZIEDZICGOCLAWS.A, 1991, CLIN ORTHOP RELAT R, V272, P30
   DZIEDZICGOCLAWSKA A, 1984, BASIC APPL HISTOCHEM, V28, P21
   HENNING GH, 1980, NATURE, V292, P533
   MOENS P, 1991, J CHEM SOC FARADAY T, V87, P3137, DOI 10.1039/ft9918703137
   OSTROWSKI K, 1971, CALC TISS RES, V7, P58, DOI 10.1007/BF02062593
   OSTROWSKI K, 1980, CALCIFIED TISSUE INT, V30, P179, DOI 10.1007/BF02408625
   OSTROWSKI K, 1972, HISTOCHEMISTRY, V32, P342
   OSTROWSKI K, 1991, CLIN ORTHOP RELAT R, V272, P21
   OSTROWSKI K, 1975, NUKLEONIKA, V20, P876
   Ostrowski K, 1980, FREE RADICAL BIO MED, V4, P321
   Raffi J.J., 1989, ANN FALSIF EXPERT CH, V82, P279
   SLAGER UT, 1964, RADIAT RES, V22, P556, DOI 10.2307/3571741
   Stachowicz W., 1970, PANEL P SERIES IAEA, P15
   SWARTZ HM, 1965, RADIAT RES, V24, P579, DOI 10.2307/3571876
NR 18
TC 12
Z9 12
U1 0
U2 3
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
SN 0969-8043
J9 APPL RADIAT ISOTOPES
JI Appl. Radiat. Isot.
PD JAN-FEB
PY 1993
VL 44
IS 1-2
BP 423
EP 427
DI 10.1016/0969-8043(93)90260-H
PG 5
WC Chemistry, Inorganic & Nuclear; Nuclear Science & Technology; Radiology,
   Nuclear Medicine & Medical Imaging
SC Chemistry; Nuclear Science & Technology; Radiology, Nuclear Medicine &
   Medical Imaging
GA KP625
UT WOS:A1993KP62500075
PM 8386048
DA 2018-10-20
ER

PT J
AU MAROM, G
   REUVENI, A
   COHN, D
AF MAROM, G
   REUVENI, A
   COHN, D
TI STIFFNESS VARIABILITY AND STRESS-DEPENDENT ELASTIC RESPONSE OF SYNTHETIC
   FIBER-REINFORCED COMPOSITES FOR BIOMEDICAL APPLICATIONS
SO BIOMATERIALS
LA English
DT Article
DE MECHANICAL PROPERTIES; COMPOSITE MATERIALS; SYNTHETIC FIBER; YOUNG
   MODULUS
AB A major design requirement of biomaterial prostheses is to match their elastic properties with those of the natural host tissue. Composite materials address this requirement because their elastic properties can be altered accurately through composition and directionality parameters, and they can be designed to match closely the elastic properties of the biological tissues, in isocompliance, modulus gradient and anisotropy. This adds to a range of advantages of synthetic composite materials with respect to potential biomedical applications, which draw on their heterogeneity and anisotropy. This paper focuses on the elastic properties of synthetic fibre-reinforced composite materials that pertain to biomedical applications, and demonstrates the range of stiffnesses obtainable through selection of constituents and by choice of angle of reinforcement.
RP MAROM, G (reprint author), HEBREW UNIV JERUSALEM,GRAD SCH APPL SCI & TECHNOL,CASALI INST APPL CHEM,IL-91904 JERUSALEM,ISRAEL.
CR AGARWLA BD, 1990, ANAL PEFORMANCE COMP
   Chou TW, 1992, MICROSTRUCTURAL DESI
   COHN D, 1992, J BIOMED MATER RES, V26, P1185, DOI 10.1002/jbm.820260909
   GERSHON B, 1990, Clinical Materials, V5, P13, DOI 10.1016/0267-6605(90)90068-7
   GERSHON B, 1990, BIOMATERIALS, V11, P548, DOI 10.1016/0142-9612(90)90076-3
   GERSHON B, 1982, BIOMATERIALS, V13, P38
   SCHEER W, 1981, PROCESSING USES CARB, P251
NR 7
TC 10
Z9 10
U1 1
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PY 1993
VL 14
IS 2
BP 127
EP 131
DI 10.1016/0142-9612(93)90224-P
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA KK595
UT WOS:A1993KK59500008
PM 8435456
DA 2018-10-20
ER

PT J
AU ANTICH, PP
   REEVE
AF ANTICH, PP
   REEVE
TI ULTRASOUND STUDY OF BONE IN-VITRO
SO CALCIFIED TISSUE INTERNATIONAL
LA English
DT Article
DE ULTRASOUND; BIOMECHANICAL COMPETENCE; BONE STRENGTH; OSTEOPOROSIS
ID VIBRATION TESTING INSITU; CORTICAL BONE; ELASTIC PROPERTIES; TIBIAL
   STIFFNESS; CANCELLOUS BONE; TRABECULAR BONE; MINERAL DENSITY; STRENGTH;
   VELOCITY; QUALITY
AB Ultrasound has been investigated as a tool for characterizing the biomechanical competence of bone. The rationale for using ultrasound rests on two points. First, its interaction with tissues can be used to measure their density, velocity, and structure, and thus to characterize the elasticity and to infer the strength of bone. Second, ultrasound may be used to characterize tissue properties over a wide range of spatial dimensions and organizational levels, ranging from its constituents (e.g., trabeculae for cancellous bone) to the entire organ' Different ultrasound techniques can be used to investigate diverse bone properties, but two techniques have emerged as having the potential for providing useful information on problems of current biomedical interest. These measure two parameters, density and velocity, which correlate with the elastic and ultimate properties of bone. In particular, the elasticity E is formally related to the product of density and velocity squared, E = rhov2. Moreover, it has been shown by mechanical testing that there is a single linear correlation between elasticity and strength at all orientations, both in cortical and in cancellous bone, materials with a strong intrinsic anisotropy. At the tissue level, it may therefore be expected that the ultrasound parameters will prove to be useful predictors of bone strength and of its dependence on orientation. In vitro ultrasound studies have shown that these properties can be measured specifically and quantitatively, and that they vary under different physiological conditions.
C1 UNIV TEXAS, SW MED CTR, CTR MINERAL METAB & CLIN RES, DALLAS, TX 75235 USA.
RP ANTICH, PP (reprint author), UNIV TEXAS, SW MED CTR, DEPT RADIOL, DALLAS, TX 75235 USA.
CR ABENDSCHEIN W, 1970, CLIN ORTHOP RELAT R, P294
   ANAST G T, 1958, Am J Phys Med, V37, P157
   ANTICH PP, 1991, J BONE MINER RES, V6, P417
   ANTICH PP, 1993, J BONE MINER RES, V8, P301
   ANTICH PP, 1992, J BONE MINER RES, V7, pS198
   ASHMAN RB, 1987, J BIOMECH, V20, P979, DOI 10.1016/0021-9290(87)90327-7
   ASHMAN RB, 1988, J BIOMECH, V21, P177, DOI 10.1016/0021-9290(88)90167-4
   ASHMAN RB, 1984, J BIOMECH, V17, P349, DOI 10.1016/0021-9290(84)90029-0
   CHANDRA K, 1990, ANN INT C IEEE ENG M, V12, P1400
   CHRISTENSEN AB, 1986, J BIOMECH, V19, P53, DOI 10.1016/0021-9290(86)90108-9
   CORNELISSEN M, 1987, J BIOMECH, V20, P333, DOI 10.1016/0021-9290(87)90041-8
   CORNELISSEN P, 1986, J BIOMECH, V19, P551, DOI 10.1016/0021-9290(86)90128-4
   CURREY JD, 1970, CLIN ORTHOP RELAT R, P210
   GEUSENS P, 1992, J BONE MINER RES, V7, P599
   GOSS SA, 1978, J ACOUST SOC AM, V64, P423, DOI 10.1121/1.382016
   HAYES WC, 1985, BONE MINERAL RES
   HEANEY RP, 1989, BONE MINER, V6, P1, DOI 10.1016/0169-6009(89)90018-4
   HEANEY RP, 1989, JAMA-J AM MED ASSOC, V261, P2986, DOI 10.1001/jama.261.20.2986
   JEFFCOTT LB, 1985, VET REC, V116, P337, DOI 10.1136/vr.116.13.337
   KATZ JL, 1987, J BIOMECH, V20, P1063, DOI 10.1016/0021-9290(87)90024-8
   LAKES R, 1986, J BIOMED ENG, V8, P143, DOI 10.1016/0141-5425(86)90049-X
   Langton C M, 1984, Eng Med, V13, P89
   LEES S, 1992, CALCIFIED TISSUE INT, V50, P88, DOI 10.1007/BF00297303
   LEES S, 1979, J ACOUST SOC AM, V66, P641, DOI 10.1121/1.383689
   LEES S, 1986, TISSUE CHARACTERIZAT, V2, P207
   MCCLOSKEY EV, 1990, CLIN SCI, V78, P221, DOI 10.1042/cs0780221
   MCKELVIE ML, 1989, BONE, V10, P101, DOI 10.1016/8756-3282(89)90005-7
   RICE JC, 1988, J BIOMECH, V21, P155, DOI 10.1016/0021-9290(88)90008-5
   THEISMANN H, 1949, Strahlentherapie, V80, P607
   TURNER CH, 1991, CALCIFIED TISSUE INT, V49, P116, DOI 10.1007/BF02565132
   TURNER CH, 1992, J ORTHOPAED RES, V10, P581, DOI 10.1002/jor.1100100413
   WHITING JF, 1977, ULTRASOUND MED, P1629
   WRIGHT LL, 1987, PEDIATR RES, V22, P541, DOI 10.1203/00006450-198711000-00014
   YOON HS, 1976, J BIOMECH, V9, P459, DOI 10.1016/0021-9290(76)90089-0
   ZERWEKH JE, 1991, J BONE MINER RES, V6, P239
   ZERWEKH JE, 1992, BONE MINER, V18, P65, DOI 10.1016/0169-6009(92)90800-S
   ZIMMERMAN MC, 1989, J ORTHOP RES, V7, P607, DOI 10.1002/jor.1100070420
   ZIMMERMAN MC, 1990, IEEE T BIO-MED ENG, V37, P433, DOI 10.1109/10.55634
NR 38
TC 21
Z9 21
U1 0
U2 2
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0171-967X
EI 1432-0827
J9 CALCIFIED TISSUE INT
JI Calcif. Tissue Int.
PY 1993
VL 53
SU 1
BP S157
EP S161
DI 10.1007/BF01673428
PG 5
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA LW987
UT WOS:A1993LW98700032
PM 8275372
DA 2018-10-20
ER

PT J
AU VALLANA, F
   PASQUINO, E
   RINALDI, S
   GALLONI, M
   GATTI, AM
   MODICA, F
   BENECH, A
AF VALLANA, F
   PASQUINO, E
   RINALDI, S
   GALLONI, M
   GATTI, AM
   MODICA, F
   BENECH, A
TI CARBOFILM(TM) - PRESENT AND FUTURE APPLICATIONS IN BIOMEDICAL DEVICES
SO CERAMICS INTERNATIONAL
LA English
DT Article
ID IMPLANTS; CARBON
AB Carbofilm is a thin film of pyrolytic carbon that can be deposited on materials, such as polymers and metals, suitable for implantable-prosthesis production. In this way, the coated material acquires the well-known biocompatibility characteristics of pyrolytic carbon.
C1 UNIV TURIN,SCH VET MED,DEPT MORPHOPHYSIOL,TURIN,ITALY.
   UNIV MODENA,SCH MED,BIOMAT LAB,MODENA,ITALY.
   UNIV TURIN,SCH MED,DEPT MAXILLOFACIAL SURG,TURIN,ITALY.
RP VALLANA, F (reprint author), SORIN BIOMED SPA,DIV CARDIOVASC,SALUGGIA,ITALY.
OI Modica, Fabio/0000-0002-1704-8081; BENECH, Arnaldo/0000-0003-1905-1089
CR AEBISCHER P, 1988, BIOMATERIALS, V9, P80, DOI 10.1016/0142-9612(88)90075-0
   AEBISHER P, 1986, 12TH ANN M SOC BIOM
   AISENBERG S, 1971, J APPL PHYS, V42, P2953, DOI 10.1063/1.1660654
   BERNEX F, 1992, 38TH ANN M AM SOC AR
   BOCCHIOTTI G, 1993, PLAST RECONSTR SURG, V19, P80
   BOCCHIOTTI G, 1989, 38TH C NAZ SOC IT CH
   BOKROS JC, 1977, CARBON, V15, P355
   CHIU TH, 1976, T AM SOC ART INT ORG, V22, P498
   CHU WK, 1978, BACKSCATTERING SPECT
   CZANDERNA AW, 1975, METHODS SURFACE ANAL, pCH4
   DONATH K, 1990, EXACT
   FENG L, 1991, J BIOMED MATER RES
   HAUBOLD AD, 1983, ASAIO J, V29, P88
   HAUBOLD AD, 1981, BIOCOMPATIBILITY CLI, V2
   KELLER JC, 1987, J BIOMED MATER RES, V21, P305, DOI 10.1002/jbm.820210304
   MARINKOVIC Z, 1976, CARBON, V14, P329, DOI 10.1016/0008-6223(76)90005-1
   MONDIERE CM, 1990, ANN VASC SURG, V4, P52
   NOERA G, 1989, CHIR TORAC, V42, P401
   PACCAGNELLA A, 1986, 6 SAT S WORLD C HIGH
   Paccagnella A, 1986, J ARTIF ORGANS, V9, P115
   PILLIAR RM, 1987, J BIOMED MATER RES-A, V21, P1
   RAMELLO A, 1985, COMMUNICATION
   RIVERO DP, 1988, J BIOMED MATER RES, V22, P191, DOI 10.1002/jbm.820220304
   ROSSI C, 1988, 17 WORLD C INT SOC C
   SBARBATI R, 1991, INT J ARTIF ORGANS, V14, P491
   SHIM HS, 1978, J BIOENG, V2, P341
   SHIM HS, 1976, J BIOENG, V1, P45
NR 27
TC 12
Z9 12
U1 1
U2 5
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0272-8842
J9 CERAM INT
JI Ceram. Int.
PY 1993
VL 19
IS 3
BP 169
EP 179
DI 10.1016/0272-8842(93)90038-S
PG 11
WC Materials Science, Ceramics
SC Materials Science
GA MF763
UT WOS:A1993MF76300005
DA 2018-10-20
ER

PT J
AU RAO, BR
   DAMARAJU, CV
   ALHUMOUD, JM
AF RAO, BR
   DAMARAJU, CV
   ALHUMOUD, JM
TI COVARIATE EFFECT ON THE LIFE EXPECTANCY AND PERCENTILE RESIDUAL LIFE
   FUNCTIONS UNDER THE PROPORTIONAL HAZARDS AND THE ACCELERATED LIFE MODELS
SO COMMUNICATIONS IN STATISTICS-THEORY AND METHODS
LA English
DT Article
DE HAZARD RATE; SURVIVAL FUNCTION; WEIBULL AND GOMPERTZ DISTRIBUTIONS;
   CANCER RISK ASSESSMENT
ID ZERO PROPERTY; CLOCK BACK; TIME; TUMOR
AB The present paper is concerned with statistical models for the dependence of survival time or time to occurrence of an event, such as time to tumor, on a vector X of covariates or prognostic variables such as age, sex, blood pressure, length of exposure to a toxic material, etc., measured on a group of individuals in biomedical investigations. It is assumed that the covariates influence the distribution of time to tumor only through a linear predictor eta = beta'X.
   The object of our paper is to investigate the effect due to the covariates on the Life Expectancy and the Percentile Residual Life (PRL) function of a family of organisms under the proportional hazards and the accelerated life models. The key result is that the families of survival distributions under these models have the 'setting the clock back to zero' property if the family of baseline survival distributions does. This property is a generalization of the lack of memory property of the exponential distribution. Simple examples of the members of this family are the linear hazard exponential, Pareto and Gompertz life distributions.
   As a simple application of the main results obtained in the present paper, we have considered a stochastic survival model recently proposed by Chiang and Conforti (1989) for the time-to-tumor distribution in the context of a large-scale serial sacrifice experiment by the National Center of Toxicological Research (NCTR). This involves some mice that were fed 2-AAF from infancy and those that developed bladder and/or liver neoplasms, see Farmer et al (1980). It is shown that their stochastic model for tumor incidence intensity at time t leads to a family of survival models that has the setting the clock back to zero property. The survival functions and the effect of the vector X of covariates on the PRL and the tumor-free life expectancies are evaluated for the proportional hazards and accelerated life models.
C1 UNIV PITTSBURGH, GRAD SCH PUBL HLTH, DEPT BIOSTAT, PITTSBURGH, PA 15261 USA.
   UNIV PITTSBURGH, DEPT CIVIL ENGN, PITTSBURGH, PA 15261 USA.
CR BAIN LJ, 1978, STATISTICAL ANAL REL
   BARLOW R, 1975, STATISTICAL THEORY R
   CHIANG CL, 1989, MATH BIOSCI, V94, P1, DOI 10.1016/0025-5564(89)90070-9
   CHIANG CL, 1968, INTRO STOCHASTIC PRO
   COX DR, 1972, J R STAT SOC B, V34, P187
   FARMER JH, 1980, J ENVIRON PATHOL TOX, V3, P55
   FEIGL P, 1965, BIOMETRICS, V21, P826, DOI 10.2307/2528247
   GARG ML, 1970, APPLIED STATISTICS, V19, P152
   GLASSER M, 1967, J AM STAT ASSOC, V62, P561, DOI 10.2307/2283983
   HAINES AL, 1984, RELIABILITY BIOMETRY
   KARLIN S, 1966, 1ST COURSE STOCHASTI
   LAIRD AK, 1965, GROWTH, V29, P233
   LITTLEFIELD NA, 1980, J ENVIRON PATHOL TOX, V3, P17
   MCCULLAGH P, 1983, GENERALIZED LINEAR M
   OAKES D, 1991, STATISTICAL THEORY M
   RAO BR, 1989, MATH BIOSCI, V96, P95
   RAO BR, 1990, J STAT PLAN INFER, V24, P347, DOI 10.1016/0378-3758(90)90053-W
   RAO BR, 1990, COMMUN STAT-THEOR M, V19, P583
   ZIPPIN C, 1966, BIOMETRICS, V22, P665, DOI 10.2307/2528067
NR 19
TC 1
Z9 1
U1 0
U2 1
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 0361-0926
EI 1532-415X
J9 COMMUN STAT-THEOR M
JI Commun. Stat.-Theory Methods
PY 1993
VL 22
IS 1
BP 257
EP 281
PG 25
WC Statistics & Probability
SC Mathematics
GA KD981
UT WOS:A1993KD98100016
DA 2018-10-20
ER

PT J
AU CASCONE, MG
   TRICOLI, M
   CERRAI, P
   DELGUERRA, RS
AF CASCONE, MG
   TRICOLI, M
   CERRAI, P
   DELGUERRA, RS
TI CELL-CULTURES IN THE BIOCOMPATIBILITY STUDY OF SYNTHETIC MATERIALS
SO CYTOTECHNOLOGY
LA English
DT Article; Proceedings Paper
CT 12TH NATIONAL CONGRESS OF THE ITALIAN CELL CULTURE ASSOC
CY DEC 09-11, 1992
CL GENOA, ITALY
SP ITALIAN CELL CULTURE ASSOC
AB In vitro cytotoxicity (Neutral Red uptake, Kenacid Blue and MTT) and cytocompatibility (cell adhesion and proliferation) tests were applied to the biocompatibility study of a series of poly(ester-ether-ester) block copolymers of potential interest as biomaterials. Our results indicate that the copolymer extracts after 72 hours incubation with a 3T3 mouse fibroblast cell line do not induce significant toxic effects. Furthermore, human umbilical vein endothelial cells seeded on thin copolymer films show a normal pattern            of growth. We conclude that the in vitro tests used are a valid instrument to evaluate the potential toxic action of synthetic materials on different cell compartments and that the tested materials seem to be promising for future applications in the field of biomedical devices.
C1 CNR,INST CLIN PHYS,I-56127 PISA,ITALY.
   CNR,CTR STUDI PROC IONICI,I-56126 PISA,ITALY.
RP CASCONE, MG (reprint author), DEPT CHEM ENGN,VIA DIOTISALVI 2,I-56126 PISA,ITALY.
CR SBARBATIDELGUER.R, 1993, IN PRESS IN VITRO VA
   Williams D. F., 1987, DEFINITIONS BIOMATER
   FOUND REPLACEMENT AN
NR 3
TC 8
Z9 8
U1 0
U2 0
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA SPUIBOULEVARD 50, PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
SN 0920-9069
J9 CYTOTECHNOLOGY
JI Cytotechnology
PY 1993
VL 11
SU 1
BP 137
EP 139
PG 3
WC Biotechnology & Applied Microbiology; Cell Biology
SC Biotechnology & Applied Microbiology; Cell Biology
GA LF815
UT WOS:A1993LF81500042
PM 22358679
DA 2018-10-20
ER

PT J
AU BERNDT, CC
   LIN, CK
AF BERNDT, CC
   LIN, CK
TI MEASUREMENT OF ADHESION FOR THERMALLY SPRAYED MATERIALS
SO JOURNAL OF ADHESION SCIENCE AND TECHNOLOGY
LA English
DT Review
DE ACOUSTIC EMISSION; ADHESION; ADHESION MEASUREMENT; COATING FAILURE;
   DEGRADATION; DOUBLE CANTILEVER BEAM TEST; FRACTURE MECHANICS;
   INDENTATION; LIFETIME MODELING; SCRATCH TEST; THERMALLY SPRAYED COATINGS
ID STABILIZED ZIRCONIA COATINGS; CERAMIC COATINGS; SCRATCH ADHESION;
   BARRIER COATINGS; FRACTURE-TOUGHNESS; SUBSTRATE ADHESION; PLASMA;
   INDENTATION; ENERGY
AB Thermally sprayed coatings have a distinctive microstructure which can be described as 'a three-dimensional layered structure of discs which are interlaced to form a material of composite nature'. The coatings are normally greater than 25 mu m in thickness and can thus be described as bulk coatings. The minimum microstructural detail would be a single splat (often described as a lamella), which is about 5 mu m in thickness and up to 80 mu m in diameter. This paper focuses on methods used to define and measure; the adhesion of coatings or deposits formed by thermal spray technology. The properties distinguished include those of strength and toughness. Measurements such as the tensile adhesion (according to ASTM C633) and double cantilever beam (DCB) tests will be addressed to illustrate the relevance (if any) of such methods to present industrial practice. Acoustic emission studies have also assessed a function termed as the 'crack density function', i.e. a product of the number of cracks and crack size. Other measuring methods applied to this technology include microhardness and scratch testing. The former technique has demonstrated that the material properties of coatings are anisotropic, and the latter method is being considered within the biomedical industry to assess the adhesion of hydroxyapatite to orthopedic prostheses. These techniques, among others, may be used for both fundamental understanding of coating performance (i.e. life prediction and cracking mechanisms)and as tests for quality control.
RP BERNDT, CC (reprint author), SUNY STONY BROOK,DEPT MAT SCI & ENGN,THERMAL SPRAY LAB,STONY BROOK,NY 11794, USA.
CR ANDERSON CW, 1992, 1992 P INT THERM SPR, P695
   APPS RL, 1974, CHEM ENG, V292, P769
   BASCOM WD, 1977, J MATER SCI, V12, P1401, DOI 10.1007/BF00540854
   BECHER PF, 1977, J MATER SCI, V12, P90, DOI 10.1007/BF00738474
   BECHER PF, 1978, FRACTURE MECHANICS C, V3, P463
   BELASHCHENKO VE, 1992, 1992 INT THERM SPRAY, P433
   BELTZUNG F, 1989, THIN SOLID FILMS, V181, P407, DOI 10.1016/0040-6090(89)90509-9
   BENJAMIN P, 1960, PROC R SOC LON SER-A, V254, P163, DOI 10.1098/rspa.1960.0012
   Berndt C.C., 1981, T INT ENG, V6, P53
   BERNDT CC, 1989, J MATER SCI, V24, P3511, DOI 10.1007/BF02385733
   BERNDT CC, 1984, THIN SOLID FILMS, V119, P173, DOI 10.1016/0040-6090(84)90532-7
   BERNDT CC, 1992, 1991 NAT THERM SPRAY, P199
   BERNDT CC, 1980, THESIS MONASH U AUST
   BERNDT CC, 1985, MAY THERM BARR COAT, P127
   BERNDT CC, 1984, ADV FRACTURE RES, V4, P2545
   BERNDT CC, 1992, 1992 INT THERM SPRAY
   BERNDT CC, 1992, 1992 INT THERM SPRAY, P941
   BERNECKI TF, 1992, 1991 NAT THERM SPRAY
   BESHISH GK, 1993, J THERM SPRAY TECHN, V2, P35
   BINNER JGP, 1984, BRIT CERAM TRANS J, V83, P168
   BISGAARD S, 1991, 1990 NAT THERM SPRAY, P661
   BLUMSANDMEIER S, 1991, 2ND PLASM TECHN S P
   BORDEAUX F, 1992, SURF COAT TECH, V54, P70, DOI 10.1016/0257-8972(92)90142-W
   BOX G, 1988, TECHNOMETRICS, V30, P1, DOI 10.2307/1270311
   BULL SJ, 1988, SURF COAT TECH, V36, P503, DOI 10.1016/0257-8972(88)90178-8
   BULL SJ, 1991, SURF COAT TECH, V50, P25, DOI 10.1016/0257-8972(91)90188-3
   BULL SJ, 1989, BRIT CERAM TRANS J, V88, P177
   BURNETT PJ, 1987, THIN SOLID FILMS, V154, P403, DOI 10.1016/0040-6090(87)90382-8
   CHALKER PR, 1991, MAT SCI ENG A-STRUCT, V140, P583, DOI 10.1016/0921-5093(91)90482-3
   CHANG GC, 1987, SURF COAT TECH, V30, P13, DOI 10.1016/0257-8972(87)90004-1
   COMYN J, 1990, INT J ADHES ADHES, V10, P161, DOI 10.1016/0143-7496(90)90099-J
   COX LC, 1988, SURF COAT TECH, V36, P807, DOI 10.1016/0257-8972(88)90021-7
   DALMASCHIO R, 1992, 1992 INT THERM SPRAY, P947
   DAS DK, 1991, SURF COAT TECH, V46, P331, DOI 10.1016/0257-8972(91)90175-V
   DEMASI JT, 1991, NASA CR182230 FIN RE
   DUNEGAN HL, 1975, PREVENTION STRUCTURA, P86
   FILAGGI MJ, 1991, J MATER SCI, V26, P5383
   FURUKUBO K, 1992, 1992 INT THERM SPRAY, P705
   GRISAFFE SJ, 1965, NASA TN D3113
   GRUTZNER H, 1991, SURF COAT TECH, V45, P317, DOI 10.1016/0257-8972(91)90238-R
   GUGDE M, 1991, 1990 NAT THERM SPRAY, P331
   HEINTZE GN, 1988, SURF COAT TECH, V36, P125, DOI 10.1016/0257-8972(88)90142-9
   HEINTZE GN, 1988, SURF COAT TECH, V34, P15, DOI 10.1016/0257-8972(88)90084-9
   HEINTZE GN, 1988, 1987 NAT THERM SPRAY, P271
   HENDRICKS RC, 1981, NASA TM81743
   HERMAN H, 1989, SCI AM, V256, P112
   HILLERY RV, 1987, NASA CR180807 FIN RE
   HOWARD SJ, 1991, SURF COAT TECH, V45, P333, DOI 10.1016/0257-8972(91)90240-W
   IWAMOT N, 1992, 1992 INT THERM SPRAY, P259
   Jones T.N.R., 1990, SURF COAT TECH, V43-44, P402
   JULIASCHMUTZ C, 1991, SURF COAT TECH, V48, P1, DOI 10.1016/0257-8972(91)90121-C
   KIES JA, 1969, FRACTURE 1969
   LAWN B, 1975, J MATER SCI, V10, P1049, DOI 10.1007/BF00823224
   LAWN BR, 1975, FRACTURE BRITTLE SOL
   LIN CK, 1993, 1993 NAT THERM SPRAY, P561
   LOPEZ E, 1989, J MATER SCI LETT, V8, P346, DOI 10.1007/BF00725519
   LUGSCHEIDER E, 1992, 1992 INT THERM SPRAY, P647
   LYASHENKO BA, 1969, SOV POWDER METALL, V8, P331
   MATTHEWS JR, 1983, ACOUSTIC EMISSION
   MATTING A, 1963, METALLWISS TECH, V17, P905
   MATTING A, 1963, METALLWISS TECH, V17, P583
   MATTING A, 1963, METALL, V17, P1213
   MAYURAM MM, 1992, 1992 INT THERM SPRAY, P711
   MCPHERSON R, 1989, SURF COAT TECH, V39, P173, DOI 10.1016/0257-8972(89)90052-2
   MEIER SM, 1991, NASA CR18911 FIN REP
   MILLER RA, 1984, J AM CERAM SOC, V67, P517, DOI 10.1111/j.1151-2916.1984.tb19162.x
   MILLER RA, 1987, SURF COAT TECH, V30, P1, DOI 10.1016/0257-8972(87)90003-X
   MILLER RA, 1989, J ENG GAS TURB POWER, V11, P301
   Mittal K. L., 1987, Journal of Adhesion Science and Technology, V1, P247, DOI 10.1163/156856187X00265
   MITTAL KL, 1978, ASTM STP, V640
   MOSTOVOY S, 1967, J MATER, V2, P661
   NAKAHIRA H, 1992, 1992 INT THERM SPRAY, P519
   NAYEBHASHEMI H, 1991, EXP MECH, P366
   NERZ TC, 1992, 1992 INT THERM SPRAY, P405
   NEUFUSS K, 1992, AUSTCERAM 1992, P124
   NOONE MJ, 1974, FRACTURE MECHANICS C, V1, P201
   OSTOJIC P, 1988, J AM CERAM SOC, V71, P891, DOI 10.1111/j.1151-2916.1988.tb07542.x
   OSTOJIC P, 1986, THESIS MONASH U AUST
   OUTWATER JO, 1969, J ADHESION, V1, P290, DOI 10.1080/00218466908072191
   PATRICK RL, 1967, TREATISE ADHESION AD, V1
   PERRY AJ, 1988, SURF COAT TECH, V36, P559, DOI 10.1016/0257-8972(88)90182-X
   RICHARD C, 1992, 1992 P INT THERM SPR, P11
   RICKERBY DS, 1988, SURF COAT TECH, V36, P541, DOI 10.1016/0257-8972(88)90181-8
   RYKALIN NN, 1976, PURE APPL CHEM, V48, P179, DOI 10.1351/pac197648020179
   SCHWEITZER KK, 1991, SURF COAT TECH, V48, P103, DOI 10.1016/0257-8972(91)90133-H
   SCOTT KT, 1991, ADV SURFACE COATINGS, P217
   SCOTT LG, 1991, BASIC ACOUSTIC EMISS
   SEKLER J, 1988, SURF COAT TECH, V36, P519, DOI 10.1016/0257-8972(88)90179-X
   STANTON WE, 1973, 7TH P INT MET SPRAYI, P157
   STEEPER TJ, 1992, 1992 INT THERM SPRAY, P415
   STEFFENS HD, 1987, SURF COAT TECH, V32, P327, DOI 10.1016/0257-8972(87)90117-4
   STRANGMAN TE, 1987, NASA CR179648 FIN RE
   SUHARA T, 1973, 7TH P INT MET SPRAYI, P179
   Taguchi G, 1987, TAGUCHI METHODS ORTH
   Thouless M.D., 1988, MATER RES SOC S P, V119, P51
   TOSS P, 1988, TAGUCHI TECHNIQUES Q
   TSURU T, 1987, CORROSION, V43, P703, DOI 10.5006/1.3583853
   WEISS LE, 1992, J THERM SPRAY TECHN, V1, P231
   WILMS V, 1976, THIN SOLID FILMS, V39, P251, DOI 10.1016/0040-6090(76)90643-X
   ZAKHAROV BM, 1970, SOV POWDER METALL, V9, P925
   ZATT JH, 1983, ANNU REV MATER SCI, V13, P9
   1985, P THERMAL BARRIER CO
   1991, D90791B AM SOC TEST
   1972, STP AM SOC TESTING M, V505
NR 104
TC 39
Z9 40
U1 1
U2 15
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 0169-4243
J9 J ADHES SCI TECHNOL
JI J. Adhes. Sci. Technol.
PY 1993
VL 7
IS 12
BP 1235
EP 1264
DI 10.1163/156856193X00088
PG 30
WC Engineering, Chemical; Materials Science, Multidisciplinary; Mechanics
SC Engineering; Materials Science; Mechanics
GA MQ145
UT WOS:A1993MQ14500001
DA 2018-10-20
ER

PT J
AU MERRILL, EW
AF MERRILL, EW
TI POLY(ETHYLENE OXIDE) STAR MOLECULES - SYNTHESIS, CHARACTERIZATION, AND
   APPLICATIONS IN MEDICINE AND BIOLOGY
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
AB It was an honor to be invited to honor Allan Hoffman on the occasion of his 60th birthday. It seems like yesterday that Allan and I shared an office in old Building 12 on the M.I.T. campus. At that time Allan had lost a bout with a snow covered mountain while on skis, and consequently moved about awkwardly in our already small room on crutches with a heavy cast. Despite these impediments, he carried on his classroom activities with typical energy. It was even earlier that at M.I.T., under the supervision of Ed Gilliland and myself, he carried out his doctoral research on the radiation grafting of styrene to polyethylene. Both he and I have dabbled in radiation chemistry on and off since then-he far more than I. Neither of us at that epoch had much idea about biomaterials or medical applications of materials-at least I did not-perhaps Allan had it in the back of his mind.
   The University of Washington, Seattle, is recognized as one of the great centers of biomedical engineering in the world, both in scope and in depth, and Allan has played a stellar role in the evolution of Seattle's reputation. He has also developed a reputation for outstanding work in biomaterials and is one of the most visible and internationally recognized leaders in the field.
RP MERRILL, EW (reprint author), MIT,DEPT CHEM ENGN,CAMBRIDGE,MA 02139, USA.
CR BAUER BJ, 1989, MACROMOLECULES, V22, P2337, DOI 10.1021/ma00195a058
   FRANCOIS J, 1985, EUR POLYM J, V21, P165, DOI 10.1016/0014-3057(85)90049-7
   GNANOU Y, 1988, MAKROMOL CHEM, V189, P2885
   Harris J.M., 1992, POLYETHYLENE GLYCOL
   LUTZ P, 1988, MAKROMOL CHEM, V189, P1051
   LUTZ P, 1991, COMMUNICATION
   MERRILL EW, 1992, Patent No. 5171264
   MERRILL EW, 1990, SOC BIOMATERIALS P
   REMPP P, 1990, POLYM PREPR AM CHEM, V31, P215
   REMPP P, 1991, POLYM PREPR-ACS, V32, P687
NR 10
TC 49
Z9 51
U1 0
U2 10
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 1993
VL 5
IS 1-2
BP 1
EP 11
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA MG099
UT WOS:A1993MG09900001
PM 8297822
DA 2018-10-20
ER

PT J
AU GRIJPMA, DW
   KROEZE, E
   NIJENHUIS, AJ
   PENNINGS, AJ
AF GRIJPMA, DW
   KROEZE, E
   NIJENHUIS, AJ
   PENNINGS, AJ
TI POLY(L-LACTIDE) CROSS-LINKED WITH SPIRO-BIS-DIMETHYLENE-CARBONATE
SO POLYMER
LA English
DT Article
DE POLY(L-LACTIDE); POLY(LACTONES); CROSS-LINKING; BICYCLIC BISCARBONATE;
   SWELLING BEHAVIOR; MECHANICAL PROPERTIES; THERMAL PROPERTIES
ID MOLECULAR-WEIGHT; L-LACTIDE; AMORPHOUS POLYMERS; INTERNAL-FIXATION;
   PLATES; SCREWS; COPOLYMERS; FRACTURES; NETWORKS; STRENGTH
AB Poly(L-lactide) and other poly(lactones) can be crosslinked by ring opening polymerization of the corresponding cyclic esters in the presence of a tetrafunctional bicyclic biscarbonate. Spiro-bis-dimethylene-carbonate was synthesized from pentaerythritol and diethylene-carbonate and used to prepare polyester networks for use in biomedical applications. Bulk copolymerization Of L-lactide with only small amounts of this crosslinker leads to networks with very high gel percentages of up to 100%. The initial crystallinity of these crosslinked poly(L-lactides), as well as the melting temperature, is very much reduced when compared with the homo poly(L-lactide). The degradation of the polymer in vivo is therefore expected to be enhanced and more benign at longer durations. Tensile strength and impact resistance are also greatly influenced by copolymerization with spiro-bis-dimethylene-carbonate.  Much tougher and stronger materials can be obtained in this way. These favourable properties allow the material to be used in the preparation of degradable implants such as fracture fixation devices.
C1 UNIV GRONINGEN,DEPT POLYMER SCI,NIJENBORGH 4,9747 AG GRONINGEN,NETHERLANDS.
CR BERLOW E, 1958, ACS MONOGRAPH SERIES, V136
   BERSTED BH, 1990, J APPL POLYM SCI, V39, P499, DOI 10.1002/app.1990.070390302
   BERSTED BH, 1979, J APPL POLYM SCI, V24, P37, DOI 10.1002/app.1979.070240105
   BOS RRM, 1987, J ORAL MAXIL SURG, V45, P751, DOI 10.1016/0278-2391(87)90194-7
   BOS RRM, 1989, INT J ORAL MAX SURG, V18, P365, DOI 10.1016/S0901-5027(89)80035-9
   BOS RRM, 1989, BRIT J ORAL MAX SURG, V27, P467, DOI 10.1016/S0266-4356(89)80004-X
   BRANT DA, 1969, MACROMOLECULES, V2, P228, DOI 10.1021/ma60009a003
   Carothers WH, 1930, J AM CHEM SOC, V52, P314, DOI 10.1021/ja01364a045
   DANIELS AU, 1990, J APPL BIOMATER, V1, P57, DOI 10.1002/jab.770010109
   deGennes PG, 1979, SCALING CONCEPTS POL
   DONALD AM, 1982, J POLYM SCI POL PHYS, V20, P899, DOI 10.1002/pol.1982.180200512
   FERRY JD, 1980, VISCOELASTIC PROPERT
   FISCHER EW, 1973, KOLLOID Z Z POLYM, V251, P980, DOI 10.1007/BF01498927
   FLORY PJ, 1979, MACROMOLECULES, V12, P119, DOI 10.1021/ma60067a025
   FLORY PJ, 1953, PRINCIPLES POLYM CHE
   GRIJPMA DW, 1990, POLYMER, V31, P2201, DOI 10.1016/0032-3861(90)90096-H
   GRIJPMA DW, 1991, POLYM BULL, V25, P335, DOI 10.1007/BF00316903
   GRIJPMA DW, 1992, POLYM BULL, V29, P571, DOI 10.1007/BF00296720
   GRIJPMA DW, IN PRESS
   Kausch H. H., 1987, POLYM FRACTURE
   KRIMM H, 1984, Patent No. 57360
   LEENSLAG JW, 1987, BIOMATERIALS, V8, P70, DOI 10.1016/0142-9612(87)90034-2
   LEENSLAG JW, 1987, MAKROMOL CHEM, V188, P1809
   LEENSLAG JW, 1987, POLYM COMMUN, V28, P92
   LLORENTE MA, 1979, J CHEM PHYS, V71, P682, DOI 10.1063/1.438354
   Mark J.E., 1988, RUBBERLIKE ELASTICIT
   MARK JE, 1982, RUBBER CHEM TECHNOL, V55, P762, DOI 10.5254/1.3535902
   MARK JE, 1981, PURE APPL CHEM, V53, P1495, DOI 10.1351/pac198153081495
   Mullins L., 1959, J APPL POLYM SCI, V2, P1
   NAKAMURA T, 1989, J BIOMED MATER RES, V23, P1115, DOI 10.1002/jbm.820231003
   NIJENHUIS AJ, IN PRESS
   ORWOLL RA, 1977, RUBBER CHEM TECHNOL, V50, P451, DOI 10.5254/1.3535155
   PENNINGS AJ, 1990, COLLOID POLYM SCI, V268, P2, DOI 10.1007/BF01410416
   PENNINGS AJ, 1968, PUBLICATION NATIONAL, V1573
   Pitt CG, 1984, J CONTROL RELEASE, V1, P3
   ROZEMA FR, UNPUB J BIOMED MATER
   ROZEMA FR, 1991, THESIS U GRONINGEN
   SCHULTZ JM, 1984, POLYM ENG SCI, V24, P770, DOI 10.1002/pen.760241007
   TRELOAR LRG, 1975, PHYSICS RUBBER ELAST
   TUNC D, 1988, Patent No. 321176
   TUNC D, 1990, Patent No. 4905680
   Vert M., 1984, MACROMOLECULAR BIOMA, P120
   ZHU KJ, 1991, MACROMOLECULES, V24, P1736, DOI 10.1021/ma00008a008
NR 43
TC 38
Z9 40
U1 0
U2 15
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0032-3861
J9 POLYMER
JI Polymer
PY 1993
VL 34
IS 7
BP 1496
EP 1503
DI 10.1016/0032-3861(93)90868-B
PG 8
WC Polymer Science
SC Polymer Science
GA KW744
UT WOS:A1993KW74400025
DA 2018-10-20
ER

PT J
AU HOSAKA, S
   MURAO, Y
   TAMAKI, H
   MASUKO, S
   MIURA, K
   KAWABATA, Y
AF HOSAKA, S
   MURAO, Y
   TAMAKI, H
   MASUKO, S
   MIURA, K
   KAWABATA, Y
TI MONODISPERSE MICROSPHERES OF COPOLYMERS OF GLYCIDYL METHACRYLATE AND ITS
   DERIVATIVES AS MATERIALS FOR BIOMEDICAL APPLICATION
SO POLYMER INTERNATIONAL
LA English
DT Article; Proceedings Paper
CT INTERNATIONAL SYMP ON POLYMERIC MICROSPHERES
CY OCT 23-26, 1991
CL FUKUI, JAPAN
SP HOKURIKU IND ADVANCE CTR, KUSAKABE GRIFFITH ACAD & CULTURE EXCHANGE FDN, CIBA GEIGY FDN JAPAN PROMOT SCI, YOSHIDA FDN SCI & TECHNOL, FUKUI MUNICIPAL GOVT
DE MONODISPERSE MICROSPHERES; POLYMER MICROSPHERES; GLYCIDYL METHACRYLATE;
   HYDROXYLATION; AMINATION
ID LUMINOL-BINDING MICROSPHERES; POLYMER PARTICLES; OXYGEN
AB Monodisperse microspheres of copolymers of glycidyl methacrylate were prepared by dispersion polymerization in organic media. The microsphere diameter could be adjusted in the range from 0.5 mum to 5 mum by changing the monomer concentration, the type of dispersion medium and the content of the comonomers' Terpolymers of glycidyl methacrylate, 2-hydroxyethyl methacrylate and tri(ethylene glycol) dimethacrylate were analysed by thermal decomposition gas chromatography and the compositions of the polymers agreed well with those of the monomer mixtures. The epoxide of the polymer microspheres was hydrolysed to alpha,beta-diol with dilute sulphuric acid without side reactions except the slight formation of sulphate. It was confirmed by the C-13 FT-NMR spectrum that the main structure of the hydrolysate was that of poly(glyceryl methacrylate). In the reaction of the epoxide with ammonia, the predominant production of tertiary amine was presumed by the relationship between the conversion of the epoxide and the nitrogen content of the reaction product. The amination of the epoxide with secondary amines resulted in the quantitative formation of the corresponding tertiary amines.
RP HOSAKA, S (reprint author), TORAY INDUSTRIES LTD,BASIC RES LABS,1111 TEBIRO,KAMAKURA,KANAGAWA 248,JAPAN.
CR HOSAKA S, 1983, IMMUNOL COMMUN, V12, P509, DOI 10.3109/08820138309051968
   KAWAGUCHI H, 1991, POLYM J, V23, P955, DOI 10.1295/polymj.23.955
   KOHASHI O, 1988, JPN J INFLAM, V8, P41
   MASUKO S, 1991, ARTIF ORGANS TODAY, V1, P245
   MATSUMOTO S, 1986, CHEM PHARM BULL, V34, P4775
   PAINE AJ, 1990, J POLYM SCI A, V28, P1485
   SUDOL ED, 1986, J POLYM SCI POL CHEM, V24, P3499, DOI 10.1002/pola.1986.080241230
   SUZUKI K, 1986, J LEUKOCYTE BIOL, V39, P475
   SUZUKI K, 1985, IGAKU AYUMI, V13, P741
   TAKEUCHI A, 1988, INT J TISSUE REACT, V10, P169
   TSENG CM, 1986, J POLYM SCI POL CHEM, V24, P2995, DOI 10.1002/pola.1986.080241126
   UCHIDA T, 1985, BIOCHEM BIOPH RES CO, V127, P584, DOI 10.1016/S0006-291X(85)80200-X
   UCHIDA T, 1982, IMMUNOL COMMUN, V11, P467, DOI 10.3109/08820138209050743
   UCHIDA T, 1985, J IMMUNOL METHODS, V77, P55, DOI 10.1016/0022-1759(85)90183-8
   UCHIDA T, 1986, J BIOACTIVE BIOCOMPA, V1, P172
   UCHIDA T, 1986, POLYM MED, P149
   UCHIDA T, 1988, ACTA HAMETOL JAPAN, V51, P579
   UCHIDA T, 1986, MACROPHAGE BIOL, P545
   UGELSTAD J, 1980, ADV COLLOID INTERFAC, V13, P101, DOI 10.1016/0001-8686(80)87003-5
   Vanderhoff JW, 1986, POLYM MATER SCI ENG, V54, P587
   YAMAMOTO H, 1986, Japanese Journal of Alcohol Studies and Drug Dependence, V21, P183
   YOKOO T, 1987, IGAKU NO AYUMI, V142, P349
NR 22
TC 8
Z9 8
U1 0
U2 3
PU JOHN WILEY & SONS LTD
PI W SUSSEX
PA BAFFINS LANE CHICHESTER, W SUSSEX, ENGLAND PO19 1UD
SN 0959-8103
J9 POLYM INT
JI Polym. Int.
PY 1993
VL 30
IS 4
BP 505
EP 511
DI 10.1002/pi.4990300414
PG 7
WC Polymer Science
SC Polymer Science
GA KM097
UT WOS:A1993KM09700013
DA 2018-10-20
ER

PT J
AU BIDE, M
   PHANEUF, M
   OZAKI, C
   ALESSI, J
   QUIST, W
   LOGERFO, F
AF BIDE, M
   PHANEUF, M
   OZAKI, C
   ALESSI, J
   QUIST, W
   LOGERFO, F
TI THE USE OF DYEING TECHNOLOGY IN BIOMEDICAL APPLICATIONS
SO TEXTILE CHEMIST AND COLORIST
LA English
DT Article
DE ANTIBIOTICS; ARTERIAL GRAFTS; BIOMEDICAL TEXTILES; KNITTED DACRON
   GRAFTS; TEXTILES IN MEDICINE
ID RELEASE SYSTEM; POLYTETRAFLUOROETHYLENE; ANTIBIOTICS; PROSTHESES;
   DACRON; GRAFT
AB Prosthetic arterial grafts of knitted polyester are widely used to replace blocked or damaged arteries. Despite all precautions, some grafts fail, proving incompatible with the body or succumbing to infection. Efforts to modify grafts to eliminate these failures have yet to be commercially successful, but co-operation between the disparate worlds of textile chemistry and cardiovascular surgery has led to some novel approaches to the problem.
   A series of experiments used common textile products and procedures such as alkali treatment, nonionic surfactants, dyes and soil release finishes to modify the surface of the graft and allow binding of anticlotting proteins. Dyes were also examined for antibiotic activity, and antibiotics were modified and applied using both exhaust and pad-heat procedures to provide infection resistant grafts.
   In a detailed study, two antibiotics were applied to polyester. The treated material was tested both in vitro and in vivo for long term antibiotic activity. The treated products are said to have great promise, and to represent a significant advance.
C1 HARVARD UNIV,NEW ENGLAND DEACONESS HOSP,SCH MED,BOSTON,MA 02215.
CR BENVENISTY AI, SURG FORUM, P433
   BENVENISTY AI, 1987, SURG GYNECOL OBSTET, V164, P143
   CHERVU A, 1991, J VASC SURG, V13, P897
   CHERVU A, 1991, J VASC SURG, V14, P521, DOI 10.1016/0741-5214(91)90246-Q
   CHRISTINA AG, 1987, SCIENCE, V237, P1588
   Golan J F, 1989, Infect Dis Clin North Am, V3, P247
   GROHE, 1992, CHEM BRIT, V28, P34
   GUIDOIN R, 1989, BIOMATERIALS, V10, P156, DOI 10.1016/0142-9612(89)90018-5
   GUIDOIN R, 1984, ANN THORAC SURG, V37, P457, DOI 10.1016/S0003-4975(10)61131-9
   HARVEY RA, 1981, ANN SURG, V194, P642, DOI 10.1097/00000658-198111000-00015
   HARVEY RA, 1984, AM J SURG, V147, P205, DOI 10.1016/0002-9610(84)90089-8
   HARVEY RA, 1982, SURGERY, V92, P504
   HARVEY RA, 1988, J VASC SURG, V8, P600
   HARVEY RA, 1985, ARCH SURG-CHICAGO, V120, P71
   HARVEY RA, 1980, SURG FORUM, V31, P29
   HAVERICH A, 1992, J VASC SURG, V15, P187, DOI 10.1016/0741-5214(92)70027-I
   ITO R, 1990, CARDIOVASCULAR SCI T
   ITO RK, 1991, BLOOD COAGUL FIBRIN, V2, P77, DOI 10.1097/00001721-199102000-00012
   JOKLEK W, 1984, ZINSSER MICROBIOLOGY, pCH9
   KISSA E, 1983, HDB FIBER SCI TECHNO, V2, pCH3
   MOORE W, 1991, VASCULAR SURG COMPRE, pCH16
   ROBERTS H, 1992, HOSPITAL PRACTI 0115, P73
   RUMISEK J, 1989, SURGERY, V10, P654
   Sugarman B, 1989, Infect Dis Clin North Am, V3, P187
   WOOD MJ, 1988, BRIT J CLIN PRACT, V42, P469
NR 25
TC 11
Z9 11
U1 0
U2 1
PU AMER ASSN TEXT CHEM COLOR
PI RES TRIANGLE PK
PA PO BOX 12215, RES TRIANGLE PK, NC 27709
SN 0040-490X
J9 TEXT CHEM COLOR
JI Text. Chem. Color.
PD JAN
PY 1993
VL 25
IS 1
BP 15
EP 19
PG 5
WC Materials Science, Textiles
SC Materials Science
GA KH658
UT WOS:A1993KH65800001
DA 2018-10-20
ER

PT J
AU MARTIN, BD
   AMPOFO, SA
   LINHARDT, RJ
   DORDICK, JS
AF MARTIN, BD
   AMPOFO, SA
   LINHARDT, RJ
   DORDICK, JS
TI BIOCATALYTIC SYNTHESIS OF SUGAR-CONTAINING POLY(ACRYLATE)-BASED
   HYDROGELS
SO MACROMOLECULES
LA English
DT Article
ID CHEMOENZYMATIC SYNTHESIS; ENZYMATIC-SYNTHESIS; ORGANIC-SOLVENTS;
   POLYMERS; DERIVATIVES; ESTERS
AB A chemoenzymatic approach has been developed to prepare monosaccharide-based poly-(acrylate)s. The lipase from Pseudomonas cepacia catalyzed the transesterification of a variety of monosaccharides with vinyl acrylate in pyridine to give the 6-acryloyl esters. The acrylate esters were polymerized in DMF with AIBN to give the poly(acrylate) products. Such a synthetic strategy has led to the synthesis of poly(methyl 6-acryloyl-beta-galactoside) with M(w) = 135 000 and M(n) = 58 000 for a polydispersity of 2.3. The overall yield from methyl beta-galactoside was 56 %. The polymer was highly water soluble and soluble in polar organic solvents. Replacing the methyl aglycon with phenyl or 2-nitrophenyl moieties resulted in polymers with poor water solubilities and improved organic solvent solubilities. In the case of the phenyl aglycon the polymer was prepared in 40 % isolated yield from phenyl beta-galactoside. The poly(phenyl 6-acryloyl-beta-galactoside) had an M(w) = 52 700 and an M(n) = 28 900 for a polydispersity of 1.8. Addition of ethylene glycol dimethacrylate as a cross-linker during AIBN-catalyzed polymerization in DMF resulted in water-insoluble polymers that swelled in aqueous solution. In the presence of 0.3 % cross-linker, a poly(methyl 6-acryloyl-beta-galactoside-hema) copolymer swelled to contain 98 % water and, hence, hold nearly 50-fold its weight in water. Such materials may be useful as biocompatible hydrogels for biomedical and membrane applications.
C1 UNIV IOWA,DEPT CHEM & BIOCHEM ENGN,IOWA CITY,IA 52242.
   UNIV IOWA,DEPT MED & NAT PROD CHEM,IOWA CITY,IA 52242.
CR ALLCOCK HR, 1991, MACROMOLECULES, V24, P23, DOI 10.1021/ma00001a005
   ALLCOCK HR, 1983, MACROMOLECULES, V16, P715, DOI 10.1021/ma00239a001
   BALLARD JM, 1980, CARBOHYD RES, V83, P138, DOI 10.1016/S0008-6215(00)85374-4
   BEDNARSKI MD, 1991, APPLIED BIOCATALYSIS, P87
   CARREA G, 1989, J CHEM SOC PERK T 1, P1057, DOI 10.1039/p19890001057
   DELINCK DL, 1990, TETRAHEDRON LETT, V31, P3093, DOI 10.1016/S0040-4039(00)94703-8
   DORDICK JS, 1989, ENZYME MICROB TECH, V11, P194, DOI 10.1016/0141-0229(89)90094-X
   GHOGARE A, 1990, J CHEM SOC CHEM COMM, P134, DOI 10.1039/c39900000134
   GLASS JE, 1990, ACS SYM SER, P443
   HAINES AH, 1981, ADV CARBOHYD CHEM BI, V39, P13
   HODGE P, 1988, SYNTHESIS SEPARATION, P43
   HOUGH L, 1975, CARBOHYD RES, V44, P37, DOI 10.1016/S0008-6215(00)84333-5
   KLIBANOV AM, 1990, ACCOUNTS CHEM RES, V23, P114, DOI 10.1021/ar00172a004
   Kondo K., 1987, FUNCTIONAL MONOMERS, P47
   MARGOLIN AL, 1991, J AM CHEM SOC, V113, P4693, DOI 10.1021/ja00012a055
   MARGOLIN AL, 1990, J AM CHEM SOC, V112, P2849, DOI 10.1021/ja00164a001
   MURPHY SM, 1988, POLYMER, V29, P1887, DOI 10.1016/0032-3861(88)90407-7
   OTAKE T, 1972, B CHEM SOC JPN, V43, P3199
   PALCIC MM, 1989, CARBOHYD RES, V190, P1, DOI 10.1016/0008-6215(89)84141-2
   PATIL DR, 1991, MACROMOLECULES, V24, P3462, DOI 10.1021/ma00011a068
   PATIL DR, 1991, BIOTECHNOL BIOENG, V37, P639, DOI 10.1002/bit.260370706
   Ratner B. D., 1976, ACS SYM SER, V31, P1, DOI [DOI 10.1021/SYMPOSIUM, 10.1021/bk-1976-0031.ch001]
   RIVA S, 1988, J AM CHEM SOC, V110, P584, DOI 10.1021/ja00210a045
   ROBYT JF, 1982, BIOORG CHEM, V11, P115, DOI 10.1016/0045-2068(82)90024-4
   Selegny E, 1979, OPTICALLY ACTIVE POL
   SIMON ES, 1988, J AM CHEM SOC, V110, P7159, DOI 10.1021/ja00229a033
   THERISOD M, 1986, J AM CHEM SOC, V108, P5638, DOI 10.1021/ja00278a053
   WANG YF, 1988, J AM CHEM SOC, V110, P7200, DOI 10.1021/ja00229a041
   Whitesides G.M., 1983, ALDRICHIM ACTA, V16, P27
NR 29
TC 99
Z9 104
U1 0
U2 12
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036
SN 0024-9297
J9 MACROMOLECULES
JI Macromolecules
PD DEC 21
PY 1992
VL 25
IS 26
BP 7081
EP 7085
DI 10.1021/ma00052a001
PG 5
WC Polymer Science
SC Polymer Science
GA KE277
UT WOS:A1992KE27700001
DA 2018-10-20
ER

PT J
AU LIOU, FJ
   NIU, GCC
   WANG, YJ
AF LIOU, FJ
   NIU, GCC
   WANG, YJ
TI PREPARATION AND CHARACTERIZATION OF 2 HEMA/PVA COPOLYMERS -
   POLY[HEMA-CO-(PVA-AA)] AND POLY[HEMA-CO-(PVA-MA)]
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
AB The copolymers of poly [HEMA-co-(PVA-AA)] and poly[HEMA-co-(PVA-MA)] were synthesized and characterized. The presence of PVA-AA in the copolymer increased the mechanical strength but decreased the water content of the material. The presence of PVA-MA, on the other hand, caused a decrease of mechanical strength and an increase of water content. The ionization of acidic group in poly [HEMA-co-(PVA-MA)] resulted in the swelling of the copolymer, and the swelling extent was controlled by the change of pH. Both copolymers have great potential in biomedical application.
C1 NATL YANG MING MED COLL,INST BIOMED ENGN,TAIPEI,TAIWAN.
CR BRUCK S D, 1973, Biomaterials Medical Devices and Artificial Organs, V1, P79
   CHIANG CT, 1990, J APPL BIOMATER, V1, P321, DOI 10.1002/jab.770010408
   CHIANG WY, 1985, J APPL POLYM SCI, V30, P3895, DOI 10.1002/app.1985.070300928
   GEBELEIN CG, 1984, POLYM MATERIALS MED
   HIRAI T, 1989, J APPL POLYM SCI, V38, P491, DOI 10.1002/app.1989.070380309
   HOFFMAN AS, 1974, J BIOMED MATER RES S, V5, P77
   JOHN MS, 1973, J BIOMED MATER RES, V7, P509
   MOLYNEUX P, 1983, WATER SOLUBLE SYNTHE, V1, pCH4
   NATHAN P, 1976, T AM SOC ART INT ORG, V22, P30
   Pedley DG, 1980, BRIT POLYM J, V12, P99
   PEPPAS NA, 1987, HYDROGELS MED PHARM, V2, pCH1
   RATNER BD, 1979, J POLYM SCI POLYM S, V66, P313
   WICHTERLE O, 1960, NATURE, V185, P117, DOI 10.1038/185117a0
NR 13
TC 13
Z9 13
U1 0
U2 2
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-8995
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD DEC 15
PY 1992
VL 46
IS 11
BP 1967
EP 1972
DI 10.1002/app.1992.070461109
PG 6
WC Polymer Science
SC Polymer Science
GA JX763
UT WOS:A1992JX76300009
DA 2018-10-20
ER

PT J
AU CAMBROSIO, A
   KEATING, P
AF CAMBROSIO, A
   KEATING, P
TI A MATTER OF FACS - CONSTITUTING NOVEL ENTITIES IN IMMUNOLOGY
SO MEDICAL ANTHROPOLOGY QUARTERLY
LA English
DT Article
ID ACTIVATED CELL SORTER; CANCER-RESEARCH; ANTIBODY; ANTIGENS;
   DIFFERENTIATION; ANTHROPOLOGY
AB This article contributes to the development of an anthropology of biomedicine that takes as its subject matter the content of biomedical knowledge and practices. It offers an ethnographic account of the establishment of the international classification of white blood cells, known as the "CD nomenclature, " and goes beyond the assertion that biomedical knowledge is "socially constructed, " providing a fine-textured analysis of how, in this specific case, knowledge was constituted. The CD nomenclature found its way into newspapers and daily medical practice mainly through the involvement of the CD4 subclass of lymphocytes (white blood cells) in AIDS definition and diagnosis. The establishment of the CD nomenclature is thus part of the recent movement of immunology to the center stage of the biomedical sciences. This study analyzes the articulation of the elements (institutions, tools, concepts) that made the classification possible. By focusing on the material practices of immunologists, the analysis shows that the present-day classification of lymphocytes has as its precondition the constitution of a network for the establishment of identities between immunological reagents produced by different laboratories. Furthermore, it is argued that the standards by which identities are established are inseparable from the entities (lymphocyte subsets) that are classified. Finally, it is claimed that an ethnography of the practices by which such a network comes into being provides an adequate analysis of the constitution of knowledge, specifically, of scientific information about the entities known as lymphocyte subsets.
C1 UNIV QUEBEC,DEPT HIST,MONTREAL H3C 3P8,QUEBEC,CANADA.
RP CAMBROSIO, A (reprint author), MCGILL UNIV,DEPT HUMANITIES & SOCIAL STUDIES MED,MONTREAL H3A 2T5,QUEBEC,CANADA.
CR ABBAS AK, 1991, CELULAR MOL IMMUNOLO
   Akrich M., 1992, SHAPING TECHNOLOGY B, P205
   Bernard A., 1984, LEUCOCYTE TYPING
   Callon M., 1991, FIGURES IRREVERSIBIL, P195
   CAMBROSIO A, 1992, J HIST BIOL, V25, P175, DOI 10.1007/BF00162840
   CANTOR H, 1975, CELL IMMUNOL, V15, P180, DOI 10.1016/0008-8749(75)90174-4
   CHARVOLIN F, 1991, 24TH ANN M SOC SOC S
   CHESS L, 1976, MANUAL CLIN IMMUNOLO, P77
   Clarke A., 1992, RIGHT TOOLS JOB WORK, P3
   Collins HM, 1985, CHANGING ORDER REPLI
   COLVIN RB, 1983, TRANSPLANT P, V15, P1166
   DAUSSET J, 1984, LEUCOCYTE TYPING HUM, P2
   DOWNEY GL, 1992, IN PRESS KNOWLEDGE S, V9
   EDELMAN GM, 1975, MOL APPROACHES IMMUN, P23
   FATHMAN CG, 1975, CELL IMMUNOL, V15, P109, DOI 10.1016/0008-8749(75)90169-0
   Fleck L., 1979, GENESIS DEV SCI FACT
   Ford WL., 1980, BLOOD PURE ELOQUENT, P457
   FORSYTHE DE, 1990, CS908 U PITTSB COMP
   FUJIMURA JH, 1987, SOC STUD SCI, V17, P257, DOI 10.1177/030631287017002003
   FUJIMURA JH, 1988, SOC PROBL, V35, P261, DOI 10.1525/sp.1988.35.3.03a00050
   FUJIMURA JH, 1992, SCI PRACTICE CULTURE, P169
   GOSSEL PP, 1992, RIGHT TOOLS JOB WORK, P287
   HACKING I, 1991, CRIT INQUIRY, V17, P253, DOI 10.1086/448583
   HARAWAY D, 1989, DIFFERENCES, V1, P3
   HAYNES BF, 1985, LEUCOCYTE TYPING, V1, P3
   HERZENBERG LA, 1979, MOL BASIS IMMUNE CEL, P315
   HERZENBERG LA, 1975, GM173670711 NIH GRAN
   HULETT HR, 1969, SCIENCE, V166, P747, DOI 10.1126/science.166.3906.747
   HULETT HR, 1973, CLIN CHEM, V19, P813
   JACOBI D, 1990, LANGAGES, V98, P103
   JULIUS MH, 1975, MAMMALIAN CELLS PROB, P107
   KARUSH F, 1989, IMMUNOLOGY, P73
   KEATING P, 1992, UNPUB SCI INSTRUMENT
   KNORRCETINA KD, 1981, MANUFACTURE KNOWLEDG
   KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0
   LATOUR B, 1990, STUD HIST PHILOS SCI, V21, P145, DOI 10.1016/0039-3681(90)90018-4
   LATOUR B, 1986, LABORATORY LIFE SOCI
   LATOUR B, 1987, SCI ACTION
   Latour Bruno, 1986, KNOWLEDGE SOC STUDIE, V6, P1
   LOCK M, KNOWLEDGE POWER PRAC
   LOKEN MR, 1975, ANN NY ACAD SCI, V254, P163, DOI 10.1111/j.1749-6632.1975.tb29166.x
   Lowy I, 1986, Int J Technol Assess Health Care, V2, P195
   LOWY I, 1990, HIST STUD PHYS BIOL, V21, P87
   LOWY I, 1987, MINERVA, V25, P171, DOI 10.1007/BF01096863
   LYNCH M, 1985, ART ARTIFACT LABORAT
   MARTIN E, 1990, MED ANTHROPOL Q, V4, P410, DOI 10.1525/maq.1990.4.4.02a00030
   MILSTEIN C, 1986, SCIENCE, V231, P1261, DOI 10.1126/science.3080810
   MILSTEIN C, 1987, LEUCOCYTE TYPING, V3, P1
   MILSTEIN C, 1989, LEUCOCYTE TYPING, V4, P1
   MOLLER G, 1988, SCAND J IMMUNOL, V27, P247, DOI 10.1111/j.1365-3083.1988.tb02344.x
   Moulin A. M, 1991, DERNIER LANGAGE MED
   NANNICOSTA A, 1987, TRANSPLANT P, V19, P1600
   *NAT COMM CLIN LAB, 1989, H42P DOC
   NAVARRO M, 1991, NY TIMES        0808, pD21
   OUDSHOORN N, 1990, B HIST MED, V64, P243
   PANEM S, 1984, INTERFERON CRUSADE
   Pickering A., 1992, SCI PRACTICE CULTURE, P1
   PINCH T, 1985, SOC STUD SCI, V15, P3, DOI 10.1177/030631285015001001
   RABINOW P, 1991, UNPUB SOCIOBIOLOGY B
   ROITT I, 1989, IMMUNOLOGY
   SHAW S, 1987, IMMUNOL TODAY, V8, P1, DOI 10.1016/0167-5699(87)90816-4
   Silverstein AM, 1989, HIST IMMUNOLOGY
   STILLWELL CR, 1991, UNPUB IMMUNOLOGY SIF
   TRAWEEK S, 1908, BEAMTIMES LIFETIMES
   YELTON DE, 1980, AM SCI, V68, P510
   YELTON DE, 1981, ANNU REV BIOCHEM, V50, P657, DOI 10.1146/annurev.bi.50.070181.003301
   YOUNG A, 1991, MAR ANN M AM ASS ADV
   ZOLA H, 1982, MONOCLONAL HYBRIDOMA, P1
NR 68
TC 22
Z9 22
U1 0
U2 1
PU AMER ANTHROPOLOGICAL ASSOC
PI ARLINGTON
PA 4350 NORTH FAIRFAX DRIVE SUITE 640, ARLINGTON, VA 22203
SN 0745-5194
J9 MED ANTHROPOL Q
JI Med. Anthropol. Q.
PD DEC
PY 1992
VL 6
IS 4
BP 362
EP 384
DI 10.1525/maq.1992.6.4.02a00040
PG 23
WC Anthropology; Public, Environmental & Occupational Health; Social
   Sciences, Biomedical
SC Anthropology; Public, Environmental & Occupational Health; Biomedical
   Social Sciences
GA KB915
UT WOS:A1992KB91500003
DA 2018-10-20
ER

PT J
AU PUTTERS, JLM
   SUKUL, DMKSK
   DEZEEUW, GR
   BIJMA, A
   BESSELINK, PA
AF PUTTERS, JLM
   SUKUL, DMKSK
   DEZEEUW, GR
   BIJMA, A
   BESSELINK, PA
TI COMPARATIVE CELL-CULTURE EFFECTS OF SHAPE MEMORY METAL (NITINOL(R)),
   NICKEL AND TITANIUM - A BIOCOMPATIBILITY ESTIMATION
SO EUROPEAN SURGICAL RESEARCH
LA English
DT Article
DE BIOCOMPATIBILITY; CELL CULTURES; MITOSIS INHIBITION TEST; NICKEL;
   NITINOL(R); TITANIUM
ID TISSUE
AB Nitinol(R) is an equiatomic alloy of nickel and titanium which has been attracting increasing interest in the field of biomedical engineering. To quantify toxicity as a preliminary evaluation of biocompatibility, inhibition of mitosis in human fibroblasts in tissue cultures exposed to test materials is an accepted screening method, although a dose-effect relationship had never been investigated. In this experiment, the effect of an increasing dose exposure to Nitinol, nickel or titanium on human fibroblasts in cell cultures was tested in subgroups in comparison with a control group. The results showed that nickel induces a significant (p less-than-or-equal-to 0.05) inhibition of mitosis in human fibroblasts, whereas no significant effects of this kind were found for titanium or Nitinol. According to the results of these studies, Nitinol is to be considered in this respect biocompatible and comparable to titanium, which would seem to justify application as a surgical implant.
C1 UNIV ROTTERDAM,HOSP DIJKZIGT,DEPT TRAUMATOL GEN SURG,DR MOLEWATERPLEIN 40,3015 GD ROTTERDAM,NETHERLANDS.
   ERASMUS UNIV,EXPTL SURG LAB,3000 DR ROTTERDAM,NETHERLANDS.
   MEM MET HOLLAND,ENSCHEDE,NETHERLANDS.
CR BENSMANN G, 1982, TECH MITT KRUPP FORS, V40, P123
   BUEHLER WJ, 1963, J APPL PHYS, V34, P1475, DOI 10.1063/1.1729603
   Castleman L. S., 1981, BIOCOMPATIBILITY CLI, V1, P129
   CASTLEMAN LS, 1976, J BIOMED MATER RES, V10, P695, DOI 10.1002/jbm.820100505
   CUTRIGHT DE, 1973, ORAL SURG ORAL MED O, V35, P578, DOI 10.1016/0030-4220(73)90017-0
   DAI KR, 1986, 1986 P ICOMAT NAR, P6430
   FERGUSON AB, 1960, J BONE JOINT SURG AM, V42, P77, DOI 10.2106/00004623-196042010-00007
   GRAY BA, 1987, AM J MED GENET, V28, P521, DOI 10.1002/ajmg.1320280236
   Kuo P P, 1989, Orthopedics, V12, P111
   LAING PATRICK G., 1967, J BIOMED MAT RES, V1, P135, DOI 10.1002/jbm.820010113
   PAPPAS AM, 1986, J BONE JOINT SURG AM, V50, P535
   TURNER JE, 1973, J BIOMED MATER RES, V7, P39, DOI 10.1002/jbm.820070104
   VINCENTINI B, 1986, 1986 P SHAP MEM ALL, P447
   WILLIAMS DF, 1974, P BIOMED ENG EXHIBIT, P207
   WOOD NK, 1970, J BIOMED MATER RES, P1
   ZUFENG Z, 1986, 1986 P ICOMAT NARA, P416
NR 16
TC 91
Z9 93
U1 2
U2 13
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0014-312X
J9 EUR SURG RES
JI Eur. Surg. Res.
PD NOV-DEC
PY 1992
VL 24
IS 6
BP 378
EP 382
DI 10.1159/000129231
PG 5
WC Surgery
SC Surgery
GA KK236
UT WOS:A1992KK23600008
PM 1292941
DA 2018-10-20
ER

PT J
AU ALLCOCK, HR
   PUCHER, SR
   TURNER, ML
   FITZPATRICK, RJ
AF ALLCOCK, HR
   PUCHER, SR
   TURNER, ML
   FITZPATRICK, RJ
TI POLY(ORGANOPHOSPHAZENES) WITH POLY(ALKYL ETHER) SIDE GROUPS - A STUDY OF
   THEIR WATER SOLUBILITY AND THE SWELLING CHARACTERISTICS OF THEIR
   HYDROGELS
SO MACROMOLECULES
LA English
DT Article
AB Five different poly[(alkyl ether)phosphazenes] were synthesized for studies of their water solubility as well as the swellabilities of their corresponding hydrogels in aqueous media. They are poly-[bis(methoxyethoxy)phosphazene], poly[bis[(aminoethoxy)ethoxy]phosphazene], poly[bis[(methoxyethoxy)ethoxy] phosphazene], poly[bis[(ethoxyethoxy)ethoxy]phosphazene], and poly[bis[(butoxyethoxy)ethoxy]phosphazene]. Lower critical solution temperatures (LCST) were detected for four of the polymers. This phenomenon was independent of polymer concentration. However, poly[bis[(aminoethoxy)ethoxy]phosphazene] possessed no LCST in aqueous media and remained fully soluble at all polymer concentrations. Hydrogels of these polymers were prepared by subjecting them to gamma radiation (1, 5, and 10 Mrad). The cross-linked polyphosphazenes behaved in a manner similar to that of their soluble counterparts. As the temperature of the aqueous media was increased, the hydrogels became opaque and released water. During these experiments, the percentage of water lost by the hydrogels was independent of both the pH of the aqueous media and the radiation dose received by the gels. No detectable decomposition of the soluble polymers was found nor was any loss of integrity of the hydrogels detected through several heating and cooling cycles. This solubility phenomenon was characteristic only of the interaction with water and was not detected in organic solvents. The potential biomedical applications of these materials are discussed.
RP ALLCOCK, HR (reprint author), PENN STATE UNIV,DEPT CHEM,UNIV PK,PA 16802, USA.
RI Turner, Michael/B-9217-2018
OI Turner, Michael/0000-0003-2853-5632
CR ALLCOCK HR, 1986, MACROMOLECULES, V19, P1508, DOI 10.1021/ma00160a003
   ALLCOCK HR, 1988, MACROMOLECULES, V21, P1, DOI 10.1021/ma00179a001
   ALLCOCK HR, 1965, J AM CHEM SOC, V87, P4216, DOI 10.1021/ja01096a056
   ALLCOCK HR, 1991, MACROMOLECULES, V24, P993, DOI 10.1021/ma00005a005
   ALLCOCK HR, 1988, BIOMATERIALS, V19, P509
   ALLCOCK HR, 1988, BIOMATERIALS, V19, P500
   BENNETT JL, 1989, CHEM MATER, V1, P14
   BLONSKY PM, 1984, J AM CHEM SOC, V106, P6854, DOI 10.1021/ja00334a071
   DONG LC, 1987, ACS SYM SER, V350, P236
   EAGLAND D, 1991, EUR POLYM J, V27, P299, DOI 10.1016/0014-3057(91)90109-2
   FLORY PJ, 1953, PRINCIPLES POLYM CHE
   Heskins M., 1968, J MACROMOL SCI CHEM, V2, P1441, DOI [10.1080/10601326808051910, DOI 10.1080/10601326808051910]
   KINIEDA H, 1975, ACS SYM SER, V9, P278
   MALCOLM GN, 1957, T FARADAY SOC, V53, P921, DOI 10.1039/tf9575300921
   TANIGAMI T, 1989, MACROMOLECULES, V22, P1397, DOI 10.1021/ma00193a065
NR 15
TC 65
Z9 67
U1 2
U2 6
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036
SN 0024-9297
J9 MACROMOLECULES
JI Macromolecules
PD OCT 12
PY 1992
VL 25
IS 21
BP 5573
EP 5577
DI 10.1021/ma00047a002
PG 5
WC Polymer Science
SC Polymer Science
GA JT846
UT WOS:A1992JT84600002
DA 2018-10-20
ER

PT J
AU SHIGEMASA, Y
   SASHIWA, H
   TANIOKA, S
   SAIMITO, H
   TANIGAWA, T
   TANAKA, Y
AF SHIGEMASA, Y
   SASHIWA, H
   TANIOKA, S
   SAIMITO, H
   TANIGAWA, T
   TANAKA, Y
TI BEHAVIOR OF MOUSE MACROPHAGE CELL-LINE AND MOUSE FIBROBLAST ON
   COPOLYMERS CONTAINING CELLULOSE TRIACETATE
SO INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
LA English
DT Article
DE COPOLYMER; CELLULOSE TRIACETATE; DIPHENYLMETHANE DIISOCYANATE; MOUSE
   MACROPHAGE; MOUSE FIBROBLAST
ID POLYMERS
AB Copolymers containing cellulose triacetate were prepared under various conditions. A bacteriological plastic dish was coated with the copolymer (HCTA-MDI copolymer) composed of hydrolysed cellulose triacetate (HCTA) and diphenylmethane diisocyanate (MDI). The deacetylated copolymer (DA-copolymer) was prepared by the deacetylation of HCTA-MDI copolymer. The behaviour of animal cells such as a mouse macrophage cell line (A640-BB-2 cells) and a mouse fibroblast (3T6 cells) on prepared dishes was investigated morphologically. A640-BB-2 cells showed good adhesion and smooth spreading, and 3T6 cells also showed good adhesion and sufficient cell growth on the dish coated with HCTA-MDI copolymer. These results suggest that these copolymers are useful for biomedical materials.
C1 TOTTORI UNIV,FAC MED,DEPT BACTERIOL,YONAGO,TOTTORI 683,JAPAN.
RP SHIGEMASA, Y (reprint author), TOTTORI UNIV,FAC ENGN,DEPT MAT SCI,TOTTORI 680,JAPAN.
CR AARONSON SA, 1968, J CELL PHYSIOL, V72, P141, DOI 10.1002/jcp.1040720208
   AMICK R, 1980, POLYMER, V21, P648, DOI 10.1016/0032-3861(80)90322-5
   IMAI Y, 1978, KAGAKU SOSETSU, P55
   IMANISHI Y, 1986, IYO KOBUNSHI ZAIRYO
   KATSUMOTO T, 1978, J ELECTRON MICROSC, V27, P275
   KIM S, 1973, J POLYM SCI POL LETT, V11, P731, DOI 10.1002/pol.1973.130111201
   KOBAYASHI A, 1986, MAKROMOL CHEM-RAPID, V7, P645
   OTSU T, 1972, KOBUNSHI GOSEI JIKKE, P299
   SHARON N, 1984, TRENDS BIOCHEM SCI, V9, P198, DOI 10.1016/0968-0004(84)90139-7
   STEINMANN HW, 1970, POLYMER PREPRINTS, V11, P285
   TAKAYAMA H, 1986, BIOMED RES-TOKYO, V7, P11, DOI 10.2220/biomedres.7.11
   TANIGAWA T, 1983, J CELL PHYSIOL, V116, P303, DOI 10.1002/jcp.1041160307
NR 12
TC 7
Z9 7
U1 0
U2 2
PU BUTTERWORTH-HEINEMANN LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0141-8130
J9 INT J BIOL MACROMOL
JI Int. J. Biol. Macromol.
PD OCT
PY 1992
VL 14
IS 5
BP 274
EP 278
DI 10.1016/S0141-8130(05)80040-6
PG 5
WC Biochemistry & Molecular Biology; Chemistry, Applied; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA JU802
UT WOS:A1992JU80200005
PM 1419965
DA 2018-10-20
ER

PT J
AU CARPENTER, JF
   HANSEN, TN
AF CARPENTER, JF
   HANSEN, TN
TI ANTIFREEZE PROTEIN MODULATES CELL-SURVIVAL DURING CRYOPRESERVATION -
   MEDIATION THROUGH INFLUENCE ON ICE CRYSTAL-GROWTH
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
ID RECRYSTALLIZATION; INHIBITION; FISHES
AB Antifreeze proteins (AFPs) are extremely efficient at inhibiting ice recrystallization in frozen solutions. Knight and Duman [Knight, C. A. & Duman, J. G. (1986) Cryobiology 23, 256-263] have proposed that this may be an important function of the proteins in freeze-tolerant organisms. We have tested this proposal in vitro by characterizing the influence of AFP on the recovery of cryopreserved cells, which often can survive cooling and yet subsequently be damaged by ice crystal growth during warming. Relatively low concentrations (e.g., 5-150 mug/ml) of winter flounder (Pseudopleuronectes americanus) AFP enhance survival of red blood cells cryopreserved in hydroxyethyl starch solutions. This effect is most apparent in samples warmed at suboptimal rates, i.e., where ice recrystallization would be exaggerated. Cryomicroscopy demonstrates that AFP inhibits ice recrystallization in the extracellular regions during the latter stages of the warming cycle. AFP concentrations that enhance survival of red cells confer partial inhibition of recrystallization. Relatively high concentrations of AFP (e.g., 1.54 mg/ml) are much more effective at inhibiting extracellular recrystallization. However, extensive growth of ice around the cell, and concomitant cell damage, is noted. The mechanism for this AFP-induced ice growth is unknown. We propose that there is a delicate balance between AFP-induced enhancement of cell preservation and AFP-induced enhancement of cell damage and that this balance hinges on the degrees of inhibition of ice recrystallization and of preferential growth of ice around the cells. We conclude that, under appropriate conditions, one of the proposed functions of AFPs in nature can be emulated, and perhaps have application, in cryopreservation of materials of biomedical interest.
RP CARPENTER, JF (reprint author), CRYOLIFE INC,2211 NEW MARKET PKWY,SUITE 142,MARIETTA,GA 30067, USA.
CR DAVIES PL, 1990, FASEB J, V4, P2460
   DEVRIES AL, 1982, COMP BIOCHEM PHYS A, V73, P627, DOI 10.1016/0300-9629(82)90270-5
   DEVRIES AL, 1984, PHILOS T R SOC B, V304, P575
   DUMAN J, 1983, ANNU REV PHYSIOL, V45, P261, DOI 10.1146/annurev.ph.45.030183.001401
   Duman J.G., 1991, P94
   DUMAN JG, 1974, NATURE, V247, P237, DOI 10.1038/247237a0
   DUMAN JG, 1984, J EXP ZOOL, V230, P355, DOI 10.1002/jez.1402300304
   FAHY GM, 1987, CRYOBIOLOGY, V24, P196, DOI 10.1016/0011-2240(87)90023-X
   FEENEY RE, 1973, NATURE, V243, P357, DOI 10.1038/243357a0
   KNIGHT CA, 1986, CRYOBIOLOGY, V23, P256, DOI 10.1016/0011-2240(86)90051-9
   KNIGHT CA, 1988, CRYOBIOLOGY, V25, P55, DOI 10.1016/0011-2240(88)90020-X
   KNIGHT CA, 1984, NATURE, V308, P295, DOI 10.1038/308295a0
   LIONETTI FJ, 1976, CRYOBIOLOGY, V13, P489, DOI 10.1016/0011-2240(76)90142-5
   MacFarlane DR, 1987, BIOPHYSICS ORGAN CRY, P237
   MAZUR P, 1984, AM J PHYSIOL, V247, pC125
   MAZUR P, 1970, SCIENCE, V168, P939, DOI 10.1126/science.168.3934.939
   PEGG DE, 1984, CRYOBIOLOGY, V21, P491, DOI 10.1016/0011-2240(84)90047-6
   RUBINSKY B, 1992, CRYOBIOLOGY, V29, P69, DOI 10.1016/0011-2240(92)90006-N
   RUBINSKY B, 1989, Cryobiology, V26, P580, DOI 10.1016/0011-2240(89)90207-1
   SPUTTEK A, 1991, CLIN APPL CRYOBIOLOG, P95
   THEEDE H, 1976, MAR BIOL, V36, P183, DOI 10.1007/BF00388441
   URRUTIA ME, 1992, BIOCHIM BIOPHYS ACTA, V1121, P199, DOI 10.1016/0167-4838(92)90355-H
   WILLIAMS RJ, 1970, CRYOBIOLOGY, V20, P521
NR 23
TC 110
Z9 115
U1 3
U2 34
PU NATL ACAD PRESS
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD OCT 1
PY 1992
VL 89
IS 19
BP 8953
EP 8957
DI 10.1073/pnas.89.19.8953
PG 5
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA JQ934
UT WOS:A1992JQ93400020
PM 1409591
OA Green Published, Bronze
DA 2018-10-20
ER

PT J
AU ARNDT, KA
AF ARNDT, KA
TI INFORMATION EXCESS IN MEDICINE - OVERVIEW, RELEVANCE TO DERMATOLOGY, AND
   STRATEGIES FOR COPING
SO ARCHIVES OF DERMATOLOGY
LA English
DT Article
ID CONSENSUS; PHYSICIANS; KNOWLEDGE; AMERICAN; JOURNALS; TRENDS
AB Background.-The amount of biomedical information contained in scientific journals has grown to the point that complete coverage of this material is impossible. The number of articles and journals being published has been growing at an exponential rate since 1750. Thirty-four thousand references from 4000 journals are added each month to the National Library of Medicine MEDLINE database from among the more than 100 000 scientific journals now published. This increase in scientific literature reflects not greater productivity but simply a larger number of scientists at work. Most articles written are eventually published in the medical literature, but a large number of scientific articles are of less than optimal quality, and most scientific articles that are published are never cited. Articles of higher quality and usefulness cluster in a few journals that enjoy great use in medical libraries and high scores on bibliometric scores such as the Science Citation Index.
   Observations.-To assess the reading habits of dermatologic trainees and evaluate how they cope with this information excess, a survey was distributed to 36 residents in three training programs. The average number of medical journal reading hours per month was 17; the number of hours devoted to reading issues of the Archives of Dermatology, the Journal of the American Academy of Dermatology, and the Journal of Investigative Dermatology were 3.2, 5.0, and 1.4, respectively; and the average resident read seven peer-reviewed journals, two to four dermatologic tabloids, and four peer-reviewed medical journals.
   Conclusions.-Critically and consistently reading a limited number of high-quality peer-reviewed journals as well as taking advantage of information available through computer networks and bibliographic and full-text databases is the best approach to coping with the volume of medical literature. Translating this information into a change in attitude and modification of physician behavior is best accomplished when local role models incorporate new ideas into their practice and teaching. Modifications that would, in fact, bring about truly useful changes, such as decreasing the number of new publications, melding journals already present into smaller numbers of publications rather than instituting new journals, altering the "publish-or-perish" rules, and writing more comprehensive articles rather than multiple small contributions, all await fundamental alterations in long-accepted policies in medicine.
RP ARNDT, KA (reprint author), BETH ISRAEL HOSP,DEPT DERMATOL,330 BROOKLINE AVE,BOSTON,MA 02215, USA.
CR ABT HA, 1981, PUBL ASTRON SOC PAC, V93, P269, DOI 10.1086/130820
   ARNDT KA, 1992, ARCH DERMATOL, V128, P101, DOI 10.1001/archderm.128.1.101
   BRADFORD SC, 1946, COMPLETE DOCUMENTATI, P729
   BRANSCOMB LM, 1968, SCI RES, V31, P49
   DOBROV GM, 1971, WISSENSCHAFTSORGANIS
   DOSZKOCS TE, 1980, SCIENCE, V208, P25, DOI 10.1126/science.6987735
   DURACK DT, 1978, NEW ENGL J MED, V298, P773, DOI 10.1056/NEJM197804062981405
   FYE WB, 1990, ANN INTERN MED, V113, P317, DOI 10.7326/0003-4819-113-4-317
   GARFIELD E, 1986, ANN INTERN MED, V105, P313, DOI 10.7326/0003-4819-105-2-313
   GARFIELD E, 1978, COPING BIOMEDICAL LI, P68
   GARVEY WD, 1979, COMMUNICATION ESSENC, P85
   GLANTZ SA, 1980, CIRCULATION, V61, P1, DOI 10.1161/01.CIR.61.1.1
   GOFFMAN W, 1970, SCI INFORMATION SYST, V226, P922
   Greer A L, 1988, Int J Technol Assess Health Care, V4, P5
   GREER AL, 1987, JAMA-J AM MED ASSOC, V258, P2739, DOI 10.1001/jama.258.19.2739
   HARRIS WE, 1983, PUBL ASTRON SOC PAC, V95, P989, DOI 10.1086/131278
   HEALY B, 1988, NEW ENGL J MED, V319, P1058, DOI 10.1056/NEJM198810203191605
   JONAS HS, 1989, JAMA-J AM MED ASSOC, V262, P1011, DOI 10.1001/jama.262.8.1011
   KOSECOFF J, 1987, JAMA-J AM MED ASSOC, V258, P2708, DOI 10.1001/jama.258.19.2708
   KRYSTAL A, 1989, NY TIMES BOOK R 0326, V1, P22
   LEBEDEV GA, 1975, NAUCNO TECHNISCESKAJ, V1, P3
   Lock SP, 1989, CBE VIEWS, V12, P57
   LOMAS J, 1989, NEW ENGL J MED, V321, P1306, DOI 10.1056/NEJM198911093211906
   Lundberg G. D., 1992, JAMA B MED LIB ASS, V80, P110
   MIHAJLOV AL, 1972, RIV INFORMAZIONE, V31, P74
   MORTON LT, 1972, USE MED LIT
   PRICE DD, 1975, SCI BABYLON, P165
   PRICE DJD, 1981, COPITN BIOMEDICAL LI
   QUINE WV, 1974, DAEDALUS, V103, P38
   RABINOWITZ HK, 1987, J MED EDUC, V62, P58
   REIDENBERG MM, 1989, CLIN PHARMACOL THER, V45, P337, DOI 10.1038/clpt.1989.38
   RENNIE D, 1986, JAMA-J AM MED ASSOC, V256, P2391, DOI 10.1001/jama.256.17.2391
   Rescher Nicholas, 1982, WISSENSCHAFTLICHER F
   RIORDAN PJ, 1981, B MED LIBR ASSOC, V69, P387
   SHELLEY WB, 1988, ARCH DERMATOL, V124, P1119, DOI 10.1001/archderm.124.7.1119
   SHULKIN DJ, 1990, JAMA-J AM MED ASSOC, V264, P453, DOI 10.1001/jama.1990.03450040041020
   STEINBROOK R, 1990, JAMA-J AM MED ASSOC, V263, P2078, DOI 10.1001/jama.263.15.2078
   STROSS JK, 1989, JAMA-J AM MED ASSOC, V262, P2721, DOI 10.1001/jama.262.19.2721
   TENNER E, 1988, HARVARD MAGAZINE APR, P23
   TRIMBLE V, 1984, NATURE, V310, P542, DOI 10.1038/310542a0
   WAKSMAN BH, 1980, J IMMUNOL, V124, P1009
   WARREN KS, 1981, COPING BIOMEDICAL LI, P19
   WARREN KS, 1978, COPING BIOMEDICAL LI
   WEISS P, 1986, HLTH BIOMEDICAL INFO
   ZUCKERMAN H, 1971, MINERVA, V9, P66, DOI 10.1007/BF01553188
   1990, SPECIALTY J READERSH
   1987, ANN INTERN MED, V106, P598
NR 47
TC 52
Z9 53
U1 0
U2 4
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 515 N STATE ST, CHICAGO, IL 60610
SN 0003-987X
J9 ARCH DERMATOL
JI Arch. Dermatol.
PD SEP
PY 1992
VL 128
IS 9
BP 1249
EP 1256
DI 10.1001/archderm.128.9.1249
PG 8
WC Dermatology
SC Dermatology
GA JM059
UT WOS:A1992JM05900012
PM 1519941
DA 2018-10-20
ER

PT J
AU KLINGER, T
   PFUTZNER, H
   SCHONHUBER, P
   HOFFMANN, K
   BACHL, N
AF KLINGER, T
   PFUTZNER, H
   SCHONHUBER, P
   HOFFMANN, K
   BACHL, N
TI MAGNETOSTRICTIVE AMORPHOUS SENSOR FOR BIOMEDICAL MONITORING
SO IEEE TRANSACTIONS ON MAGNETICS
LA English
DT Article; Proceedings Paper
CT 1992 INTERNATIONAL MAGNETICS CONF ( INTERMAG 92 ) - MAGNETIC RECORDING
   HEADS : INDUCTIVE THIN FILM AND LAMINATED
CY APR 13-16, 1992
CL ST LOUIS, MO
SP ALLEGHENY LUDLUM, ALLIED SIGNAL, APPL MAGNET, BASF MAGNET, BOHLMAN TACHNET, CRUCIBLE MAGNET, EASTMAN KODAK, F G JONES ASSOC, FUJITSU, GEC
AB A new sensor, very simple and inexpensive to manufacture, and with adjustable sensitivity, was developed for the monitoring of articular movements and lung ventilation. This sensor makes use of the change in permeability with respect to mechanical stress or strain. If an amorphous ribbon is glued on a plastic ribbon which shows considerably higher thickness, bending this compound sensor will cause plain tensile stress or compression in the amorphous magnetostrictive material. In the same way, using a pre-bent plastic ribbon yields an effective sensor for elongation in the connecting line of the sandwich ends.
C1 UNIV TECHNOL VIENNA,INST BASIC ENGN & MECH HANDLING,A-1040 VIENNA,AUSTRIA.
   UNIV VIENNA,INST SPORT SCI,A-1150 VIENNA,AUSTRIA.
RP KLINGER, T (reprint author), UNIV TECHNOL VIENNA,INST FUNDAMENTALS & THEORY ELECTROTECH,DIV BIOELECT & MAGNETISM,A-1040 VIENNA,AUSTRIA.
CR MEYDAN T, 1981, IEEE T MAGN, V17, P3376, DOI 10.1109/TMAG.1981.1061661
   MOHRI K, 1987, IEEE T MAGN, V23, P2212, DOI 10.1109/TMAG.1987.1065639
   PFUTZNER H, 1990, Frontiers of Medical and Biological Engineering, V2, P53
NR 3
TC 14
Z9 15
U1 0
U2 0
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017-2394
SN 0018-9464
J9 IEEE T MAGN
JI IEEE Trans. Magn.
PD SEP
PY 1992
VL 28
IS 5
BP 2400
EP 2402
DI 10.1109/20.179505
PN 2
PG 3
WC Engineering, Electrical & Electronic; Physics, Applied
SC Engineering; Physics
GA JN877
UT WOS:A1992JN87700099
DA 2018-10-20
ER

PT J
AU WABERS, HD
   HERGENROTHER, RW
   COURY, AJ
   COOPER, SL
AF WABERS, HD
   HERGENROTHER, RW
   COURY, AJ
   COOPER, SL
TI THROMBUS DEPOSITION ON POLYURETHANES DESIGNED FOR BIOMEDICAL
   APPLICATIONS
SO JOURNAL OF APPLIED BIOMATERIALS
LA English
DT Article
ID EXVIVO BLOOD COMPATIBILITY; SEGMENTED POLYURETHANES; SURFACES; INVITRO;
   BIOSTABILITY; OXIDATION; PROPERTY
AB Thrombogenicity was assessed by measuring the amount of In-111-platelets and I-125-fibrinogen deposited on the inner luminal surface of six polyurethanes for up to 60 min of blood contact in a canine ex-vivo shunt model. Commercial and laboratory synthesized polymers were examined. Two of the commercially synthesized polyurethanes (Biostable PURs) do not contain ether linkages in the polymer backbone and have previously shown resistance to oxidative and hydrolytic degradation. Static contact angle measurements, dynamic contact angle measurements, and ESCA were used to characterize the surfaces of these polyurethanes. The effectiveness of an acetone extraction used to remove extrusion waxes from Pellethane 2363-80A was similarly studied. Both Pellethane 2363-80A and the ether-free materials had relatively nonthrombogenic surfaces, as indicated by low platelet and fibrinogen deposition, making them potentially good candidates for biomedical applications.
C1 UNIV WISCONSIN,DEPT CHEM ENGN,MADISON,WI 53706.
FU NHLBI NIH HHS [HL-21001, HL-24046]
CR Andrade J. D., 1985, SURFACE INTERFACIAL, P249
   ANDRADE JD, 1986, SURF INTERFACE ANAL, V8, P253, DOI 10.1002/sia.740080606
   BOUVIER M, 1991, J BIOMED MATER RES, V25, P773, DOI 10.1002/jbm.820250607
   Coury A J, 1988, J Biomater Appl, V3, P130, DOI 10.1177/088532828800300202
   COURY AJ, 1987, LIFE SUPPORT SYST, V5, P25
   GRASEL TG, 1989, J BIOMED MATER RES, V23, P311, DOI 10.1002/jbm.820230304
   GRASEL TG, 1987, THESIS U WISCONSIN
   GREGONIS DE, 1981, ACS ORG COATINGS, V45, P347
   HAMILTON WC, 1972, J COLLOID INTERF SCI, V40, P219, DOI 10.1016/0021-9797(72)90011-2
   LARSSON N, 1990, J MATER SCI MATER ME, P157
   Lelah M. D., 1986, POLYURETHANES MED
   LELAH MD, 1984, J BIOMED MATER RES, V18, P475, DOI 10.1002/jbm.820180503
   LELAH MD, 1985, J COLLOID INTERF SCI, V104, P422, DOI 10.1016/0021-9797(85)90051-7
   LELAH MD, 1983, J BIOMED MATER RES, V17, P1, DOI 10.1002/jbm.820170102
   LELAH MD, 1985, J BIOMED MATER RES, V19, P1011, DOI 10.1002/jbm.820190913
   MCGRATH JE, 1987, THERMOPLASTIC ELASTO, P470
   OKKEMA A Z, 1989, Journal of Biomaterials Science Polymer Edition, V1, P43, DOI 10.1163/156856289X00055
   OKKEMA AZ, 1991, BIOMATERIALS, V12, P668, DOI 10.1016/0142-9612(91)90115-Q
   RATNER BD, 1988, J BIOMED MATER RES, V22, P509, DOI 10.1002/jbm.820220607
   STOKES K, 1987, POLYURETHANES BIOMED, V2, P109
   STOKES K, 1984, POLYURETHANES BIOMED, P243
   TAKAHARA A, 1991, BIOMATERIALS, V12, P324, DOI 10.1016/0142-9612(91)90042-9
   TAKAHARA A, 1991, J BIOMED MATER RES, V25, P341, DOI 10.1002/jbm.820250306
   TAKAHARA A, 1990, ARTIFICIAL HEART, V3
   THOMA RJ, 1987, J BIOMED MATER RES, V21, P525, DOI 10.1002/jbm.820210411
   TINGEY KG, 1988, POLYM SURFACE DYNAMI, P153
   ZHAO Q, 1987, POLYMER, V28, P2040, DOI 10.1016/0032-3861(87)90038-3
NR 27
TC 5
Z9 5
U1 0
U2 5
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 1045-4861
J9 J APPL BIOMATER
JI J. Appl. Biomater.
PD FAL
PY 1992
VL 3
IS 3
BP 167
EP 176
DI 10.1002/jab.770030302
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA JH983
UT WOS:A1992JH98300001
PM 10147713
DA 2018-10-20
ER

PT J
AU ELSON, ML
AF ELSON, ML
TI SOFT-TISSUE AUGMENTATION OF PERIORBITAL FINE LINES AND THE ORBITAL
   GROOVE WITH ZYDERM-I AND FINE-GAUGE NEEDLES
SO JOURNAL OF DERMATOLOGIC SURGERY AND ONCOLOGY
LA English
DT Article
ID INJECTABLE COLLAGEN
AB A new procedure utilizing Zyderm-I (Collagen Biomedical, Palo Alto, CA)and a 32-gauge needle for augmentation of the periorbital fine lines and the orbital groove is described. This advanced soft tissue augmentation technique is described in detail in 30 patients with before, after, and 1-week post-augmentation photographs presented by the author. This technique requires familiarity with soft tissue augmentation and the use of collagen injectable materials as well as specific training on a one-to-one basis with someone experienced with this particular technique.
RP ELSON, ML (reprint author), DERMATOL CTR INC,4535 HARDING RD,SUITE 300,NASHVILLE,TN 37205, USA.
CR CUCIN RL, 1983, PLAST RECONSTR SURG, V71, P731, DOI 10.1097/00006534-198305000-00032
   ELSON ML, 1989, J DERMATOL SURG ONC, V15, P301, DOI 10.1111/j.1524-4725.1989.tb03163.x
   ELSON ML, 1988, J AM ACAD DERMATOL, V18, P707, DOI 10.1016/S0190-9622(88)70094-8
   ELSON ML, 1987, SEMIN DERMATOL, V6, P77
   ELSON ML, 1991, COSMET DERMATOL, V4, P8
   ELSON ML, 1990, COSM DERMATOL, V3, P16
   HANKE CW, 1991, J AM ACAD DERMATOL, V25, P319, DOI 10.1016/0190-9622(91)70200-L
   KLEIN AW, 1983, J AM ACAD DERMATOL, V9, P224, DOI 10.1016/S0190-9622(83)70133-7
NR 8
TC 4
Z9 5
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010
SN 0148-0812
J9 J DERMATOL SURG ONC
PD SEP
PY 1992
VL 18
IS 9
BP 779
EP 782
DI 10.1111/j.1524-4725.1992.tb03035.x
PG 4
WC Oncology; Dermatology; Surgery
SC Oncology; Dermatology; Surgery
GA JL730
UT WOS:A1992JL73000002
PM 1512310
DA 2018-10-20
ER

PT J
AU ABE, M
   ITOH, T
   TAMAURA, Y
AF ABE, M
   ITOH, T
   TAMAURA, Y
TI MAGNETIC AND BIOMAGNETIC FILMS OBTAINED BY FERRITE PLATING IN
   AQUEOUS-SOLUTION
SO THIN SOLID FILMS
LA English
DT Article; Proceedings Paper
CT 1ST INTERNATIONAL WORKSHOP ON THE SCIENCE AND TECHNOLOGY OF THIN FILMS
   FOR THE 21ST-CENTURY
CY JUL 28-AUG 02, 1991
CL NORTHWESTERN UNIV, EVANSTON, IL
SP NATL SCI FDN, NORTHWESTERN UNIV, MAT RES SOC, INT UNION MAT RES SOC
HO NORTHWESTERN UNIV
ID THIN-FILM
AB Ferrite plating enables crystalline spinel ferrite films to be formed in an aqueous solution at low temperatures (less than 100-degrees-C). This technique allows the fabrication of new ferrite film devices on non-heat-resistant substrate materials such as plastics, GaAs integrated circuits etc. Ferrite-plated films prepared from aqueous solution exhibit strong compatibility with water and organic compounds which enable the films to be used in biomedical applications as biosensors and immunoassays.
   The low temperature synthesis of magnetite in ferrite plating bears a close analogy to the biological synthesis of magnetite in organisms such as magnetotactic bacteria and chitons.
C1 TOKYO INST TECHNOL,DEPT CHEM,MEGURO KU,TOKYO 152,JAPAN.
RP ABE, M (reprint author), TOKYO INST TECHNOL,DEPT PHYS ELECTR,O OKAYAMA,MEGURO KU,TOKYO 152,JAPAN.
CR ABE M, 1987, IEEE T MAGN, V23, P3432, DOI 10.1109/TMAG.1987.1065550
   ABE M, 1983, JPN J APPL PHYS 2, V22, pL511, DOI 10.1143/JJAP.22.L511
   ABE M, 1987, IEEE T MAGN, V23, P3736, DOI 10.1109/TMAG.1987.1065205
   ABE M, 1984, J APPL PHYS, V55, P2614, DOI 10.1063/1.333254
   ABE M, 1990, 5TH P INT C FERR BOM, P1131
   ABE M, 1985, ADV CERAM, V5, P639
   ABE M, 1991, UNPUB
   ABE M, 1991, IN PRESS SPR P MRS M
   BLAKEMORE RP, 1980, NATURE, V286, P384, DOI 10.1038/286384a0
   HORI S, UNPUB JPN J APPL PHY
   IBATA A, 1989, 13TH ANN C MAGN SOC, P251
   ISHIKAWA K, 1987, APR DIG INT C TOK
   ITOH T, 1991, J APPL PHYS, V69, P5911, DOI 10.1063/1.347837
   ITOH T, 1989, IEEE T MAGN, V25, P4230, DOI 10.1109/20.42578
   ITOH T, 1990, JPN J APPL PHYS 2, V29, pL1458, DOI 10.1143/JJAP.29.L1458
   ITOH T, UNPUB JPN J APPL PHY
   ITOH T, 1989, J MAGN SOC JPN, V13, P869
   LOWENSTAM HA, 1967, SCIENCE, P1371
   MINAKAWA H, 1990, CLIN CHEM, V36, P1090
   SAITO T, 1989, J METAL FINISHING SO, V40, P42
   TALISA SH, 1988, J APPL PHYS, V64, P5819, DOI 10.1063/1.342217
   TAMAURA Y, 1983, J CHEM SOC DALTON, P189, DOI 10.1039/dt9830000189
NR 22
TC 50
Z9 50
U1 2
U2 8
PU ELSEVIER SCIENCE SA LAUSANNE
PI LAUSANNE 1
PA PO BOX 564, 1001 LAUSANNE 1, SWITZERLAND
SN 0040-6090
J9 THIN SOLID FILMS
JI Thin Solid Films
PD AUG 28
PY 1992
VL 216
IS 1
BP 155
EP 161
DI 10.1016/0040-6090(92)90887-H
PG 7
WC Materials Science, Multidisciplinary; Materials Science, Coatings &
   Films; Physics, Applied; Physics, Condensed Matter
SC Materials Science; Physics
GA JK300
UT WOS:A1992JK30000032
DA 2018-10-20
ER

PT J
AU VANLUYN, MJA
   VANWACHEM, PB
   DAMINK, LO
   DIJKSTRA, PJ
   FEIJEN, J
   NIEUWENHUIS, P
AF VANLUYN, MJA
   VANWACHEM, PB
   DAMINK, LO
   DIJKSTRA, PJ
   FEIJEN, J
   NIEUWENHUIS, P
TI RELATIONS BETWEEN INVITRO CYTOTOXICITY AND CROSS-LINKED DERMAL SHEEP
   COLLAGENS
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
ID FIXED PERICARDIUM; GLUTARALDEHYDE; BIOMATERIALS; TOXICITY; DEGRADATION;
   CELLS; RAT
AB Collagen-based biomaterials have found various applications in the biomedical field.  However, collagen-based biomaterials may induce cytotoxic effects.  This study evaluated possible cytotoxic effects of (crosslinked) dermal sheep collagen (DSC) using a 7-d-methylcellulose cell culture with human skin fibroblasts.  Noncrosslinked DSC (NDSC), hexamethylene-diisocyanate-crosslinked DSC (HDSC), and glutaraldehyde-crosslinked DSC (GDSC), their extracts (1 x 10 d to 4 x 10 d extracts), or the corresponding extracted DSC samples were tested.  Cell growth was evaluated by cell counting, while cell morphology was assessed by light microscopy and transmission-electron microscopy.  Both GDSC and, to a lesser extent, HDSC, induced cytotoxicity, observed as inhibited cell growth and deviant cell morphology.  The deviant morphology consisted of extensive accumulations of lipid, reduction in the amount and dilatation of rough endoplasmatic reticulum, increased inclusions of cell remnants, and relatively rounded cell membranes.  With HDSC, both primary cytotoxicity, due to extractable products from the material, and secondary cytotoxicity, possibly due to a release of cytotoxic products resulting from enzymatic cell-biomaterial interactions, could be discriminated.  With GDSC, however, no clear distinction between primary and secondary cytotoxicity could be made.  With NDSC, only primary cytotoxicity, measured as low inhibition of cell proliferation, but without deviant morphology, was observed.  These remarkable differences in cytotoxicity are discussed in relation to residual agents and specific crosslinks present in DSCs as a consequence of processing and the crosslinking agents used.  The residual agents and the specific crosslinks give rise to differences in direct release of products and in sensitivity to hydrolysis and enzymatic breakdown.
C1 TWENTE UNIV,DEPT CHEM TECHNOL,7500 AE ENSCHEDE,NETHERLANDS.
RP VANLUYN, MJA (reprint author), UNIV GRONINGEN,DEPT HISTOL & CELL BIOL,BIOMAT RES SECT,OOSTERSINGEL 69-2,9713 EZ GRONINGEN,NETHERLANDS.
RI Dijkstra, Pieter/N-9328-2013
CR BAJPAI PK, 1980, IRCS MED SCI-BIOCHEM, V8, P642
   BERODE M, 1988, BIOCH INT, V17, P1
   BROWN WE, 1982, TOXICOL APPL PHARM, V63, P45, DOI 10.1016/0041-008X(82)90025-4
   CHANG KC, 1984, CLIN ALLERGY, V14, P329, DOI 10.1111/j.1365-2222.1984.tb02213.x
   Chvapil M, 1973, Int Rev Connect Tissue Res, V6, P1
   CHVAPIL M, 1983, J SURG RES, V35, P402, DOI 10.1016/0022-4804(83)90029-X
   CHVAPIL M, 1982, J BIOMED MATER RES, V16, P245, DOI 10.1002/jbm.820160306
   COOKE A, 1983, BRIT J EXP PATHOL, V64, P172
   EVERTS V, 1987, THESIS U AMSTERDAM N
   EYBL E, 1989, J BIOMED MATER RES, V23, P1355, DOI 10.1002/jbm.820231111
   GENDLER E, 1984, J BIOMED MATER RES, V18, P727, DOI 10.1002/jbm.820180703
   HUANGLEE LLH, 1990, J BIOMED MATER RES, V24, P1185, DOI 10.1002/jbm.820240905
   HUC A, 1985, J AM LEATHER CHEM AS, V80, P195
   HULSTAERT CE, 1983, HISTOCHEMISTRY, V78, P71, DOI 10.1007/BF00491113
   ISCOVE NN, 1979, IMMUNOLOGICAL METHOD, P379
   JOHANNSEN FR, 1987, J APPL TOXICOL, V7, P259, DOI 10.1002/jat.2550070407
   KENNEDY GL, 1986, J APPL TOXICOL, V6, P145, DOI 10.1002/jat.2550060302
   KLEINMAN HK, 1981, J CELL BIOL, V88, P473, DOI 10.1083/jcb.88.3.473
   LAZARUS SL, 1969, J INVEST DERMATOL, V52, P6
   MURPHY G, 1985, BIOESSAYS, V2, P55, DOI 10.1002/bies.950020204
   NIMNI ME, 1987, J BIOMED MATER RES, V21, P741, DOI 10.1002/jbm.820210606
   NIMNI ME, 1988, COLLAGEN, V1, P1
   PHARRISS BB, 1980, J AM LEATHER CHEM AS, V75, P474
   SHUBIK VM, 1978, J HYG EPID MICROB IM, V22, P408
   SPEER DP, 1980, J BIOMED MATER RES, V14, P753, DOI 10.1002/jbm.820140607
   SPEER DP, 1981, J BIOMED MATER RES, V15, P913
   TRAUBEL H, 1977, LEDER, P150
   TRAUBEL H, 1977, LEDER, P181
   ULREICH JB, 1981, J BIOMED MATER RES, V15, P913, DOI 10.1002/jbm.820150615
   VANGULIK TM, 1987, NETH J SURG, V39, P90
   VANGULIK TM, 1981, THESIS U AMSTERDAM
   VANLUYN MJA, 1991, J MATER SCI-MATER M, V2, P142, DOI 10.1007/BF00692972
   VANWACHEM PB, 1991, BIOMATERIALS, V12, P215, DOI 10.1016/0142-9612(91)90203-M
   VANWACHEM PB, IN PRESS CELLS MATER
   WOODROOF EA, 1978, J BIOENG, V2, P1
   Woolley D. E., 1984, EXTRACELLULAR MATRIX, P119
   YAJIMA T, 1986, CELL TISSUE RES, V245, P253
   YANO E, 1981, Japanese Journal of Industrial Health, V23, P537
NR 38
TC 112
Z9 112
U1 0
U2 12
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD AUG
PY 1992
VL 26
IS 8
BP 1091
EP 1110
DI 10.1002/jbm.820260810
PG 20
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA JD962
UT WOS:A1992JD96200009
PM 1429758
DA 2018-10-20
ER

PT J
AU ALLCOCK, HR
   FITZPATRICK, RJ
   VISSCHER, K
   SALVATI, L
AF ALLCOCK, HR
   FITZPATRICK, RJ
   VISSCHER, K
   SALVATI, L
TI THIN-LAYER GRAFTS OF POLY[BIS((METHOXYETHOXY)ETHOXY)PHOSPHAZENE] ON
   ORGANIC POLYMER SURFACES
SO CHEMISTRY OF MATERIALS
LA English
DT Article
ID POLY<BIS(TRIFLUOROETHOXY)PHOSPHAZENE>; POLY(ORGANOPHOSPHAZENES);
   POLYPHOSPHAZENES; INTERFACE
AB Poly[bis((methoxyethoxy)ethoxy)phosphazene] (1) was covalently bonded and cross-linked to the surfaces of several organic polymers. Polypropylene, poly(vinyl chloride), poly(ethylene terephthalate), poly(bisphenol A carbonate), and poly(methyl methacrylate) were coated with polymer 1, and the coated materials were then exposed to 5 Mrad of Co-60-gamma-rays. The resultant surfaces were studied by ATR-IR, XPS, SEM, and contact angle techniques. The modified surfaces showed marked increases in hydrophilicity or hydrogel character and are excellent candidates for a number of biochemical, biomedical, and electrochemical uses.
C1 PERKIN ELMER CORP,PHYS ELECTR LAB,EDISON,NJ 08820.
RP ALLCOCK, HR (reprint author), PENN STATE UNIV,DEPT CHEM,UNIV PK,PA 16802, USA.
CR ALLCOCK HR, 1972, INORG CHEM, V11, P2584, DOI 10.1021/ic50117a003
   ALLCOCK HR, 1986, MACROMOLECULES, V19, P1508, DOI 10.1021/ma00160a003
   ALLCOCK HR, 1991, CHEM MATER, V3, P442, DOI 10.1021/cm00015a017
   ALLCOCK HR, 1991, CHEM MATER, V3, P450, DOI 10.1021/cm00015a018
   ALLCOCK HR, 1983, MACROMOLECULES, V16, P1401, DOI 10.1021/ma00243a001
   ALLCOCK HR, 1986, MACROMOLECULES, V19, P1502, DOI 10.1021/ma00160a002
   ALLCOCK HR, 1991, CHEM MATER, V3, P1120, DOI 10.1021/cm00018a032
   ALLCOCK HR, IN PRESS CHEM MATER
   ALLCOCK HR, IN PRESS BIOMATERIAL
   ALLCOCK HR, 1988, BIOMATERIALS, V19, P509
   ALLCOCK HR, IN PRESS RING OPENIN
   ALLCOCK HR, 1988, BIOMATERIALS, V19, P500
   BABIC D, 1986, RADIAT PHYS CHEM, V28, P169
   BENNETT JL, 1989, CHEM MATER, V1, P14
   BENNETT JL, 1989, POLYM PREPR AM CHEM, V30, P437
   BLONSKY PM, 1986, SOLID STATE IONICS, V18-9, P258, DOI 10.1016/0167-2738(86)90123-2
   BLONSKY PM, 1984, J AM CHEM SOC, V106, P6854, DOI 10.1021/ja00334a071
   BLONSKY PM, 1985, POLYM MATER SCI ENG, V53, P118
   HOLMESFARLEY SR, 1988, LANGMUIR, V4, P921, DOI 10.1021/la00082a025
   LAI JY, 1990, J APPL POLYM SCI, V39, P2293, DOI 10.1002/app.1990.070391109
   LAURENCIN CT, 1987, J BIOMED MATER RES, V21, P1231, DOI 10.1002/jbm.820211006
   LEE KW, 1988, MACROMOLECULES, V21, P309, DOI 10.1021/ma00180a005
   LERNER MM, 1991, CHEM MATER, V3, P1117, DOI 10.1021/cm00018a031
   NELSON CJ, 1991, CHEM MATER, V3, P786, DOI 10.1021/cm00017a010
   Peppas N. A., 1987, HYDROGELS MED PHARM
   VISSCHER KB, 1990, MACROMOLECULES, V23, P4885, DOI 10.1021/ma00224a022
   VISSCHER KB, UNPUB ACS S SER
   WHITESIDES GM, 1990, LANGMUIR, V6, P87, DOI 10.1021/la00091a013
   WHITESIDES GM, 1988, CHEMTRACTS, V1, P171
   YANAI S, 1984, RADIAT PHYS CHEM, V23, P489, DOI 10.1016/0146-5724(84)90143-2
NR 30
TC 25
Z9 25
U1 0
U2 4
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036
SN 0897-4756
J9 CHEM MATER
JI Chem. Mat.
PD JUL-AUG
PY 1992
VL 4
IS 4
BP 775
EP 780
DI 10.1021/cm00022a007
PG 6
WC Chemistry, Physical; Materials Science, Multidisciplinary
SC Chemistry; Materials Science
GA JG698
UT WOS:A1992JG69800007
DA 2018-10-20
ER

PT J
AU SIGAL, VL
   MYSAK, OA
AF SIGAL, VL
   MYSAK, OA
TI CHARACTER OF THE WETTABILITY OF BIOMEDICAL CARBON DRESSINGS
SO COLLOID JOURNAL OF THE RUSSIAN ACADEMY OF SCIENCES
LA English
DT Article
ID ADSORPTION
AB The kinetics of impregnation of carbon granular and cloth materials used in clinical medicine as dressings for treating wounds and bums with water and decane were investigated and analyzed Impregnation with polar and nonpolar liquids can be used to evaluate the hydrophobic-hydrophilic properties of polymer medical dressings responsible for their protective and therapeutic functions in different stages of the wound process.
RP SIGAL, VL (reprint author), UKRAINIAN ACAD SCI,INST PROBLEMS ONCOL & RADIOBIOL,KIEV,UKRAINE.
CR Aksel'rud G. A., 1983, INTRO CAPILLARY CHEM
   BIZHKO IP, 1988, SORBENTS MED USE MEC, P241
   DERYABIN II, 1985, NEW AGENTS AREAS CLI, P166
   DERYAGIN BV, 1953, INSTRUMENT DETERMINA, P11
   DUNSTAN D, 1986, J COLLOID INTERF SCI, V111, P60, DOI 10.1016/0021-9797(86)90007-X
   FELDSHTEIN MM, 1981, CHEM TECHNOLOGY MACR, V16, P120
   GILES CH, 1974, J COLLOID INTERF SCI, V47, P766, DOI 10.1016/0021-9797(74)90253-7
   KARTEL NT, 1985, NOVYE SREDSTVA SFERY, P176
   KUCHER RV, 1980, KOLLOID ZH, V52, P790
   KUZMICH AV, 1988, ITMO AN BSSR10 PREPR
   LYUBINETSKII AL, 1988, SORBENTS MED USE MEC, P136
   MAEVSKAYA LN, 1977, KOLLOID ZH, V39, P1081
   NIKOLAEV VG, 1984, EXPT CLIN METHOD BLO
   OZEKI S, 1989, LANGMUIR, V5, P186, DOI 10.1021/la00085a035
   Porkhaev A.P, 1949, KOLLOID ZH, V11, P346
   SHEVELEVA IV, ADSORPTION UNCHARGED
   SHOOP G, 1982, SOLUTION ENG PROBLEM
   SIGAL VL, 1991, KOLLOID ZH, V53, P1092
   SIGAL VL, 1987, ZH PRIKL KHIM, V60, P1766
   SOBCHISHIN SN, 1988, SORBENTS MED USE MEC, P192
   Summ B. D., 1976, PHYSICOCHEMICAL PRIN
   TOMASHUK IP, 1988, SORBENTS MED USE MEC, P203
   Volfkovich Yu, 1980, ELEKTROKHIMIYA, V16, P1620
   VOYUTSKII SS, 1969, PHYSICOCHEMICAL PRIN
   WOLKOWA LW, 1934, KOLL Z, V67, P280
   YAMPOLSKY BY, 1968, KOLLOID ZH, V30, P299
   GOST1260582 USSR STA
NR 27
TC 0
Z9 0
U1 0
U2 1
PU PLENUM PUBL CORP
PI NEW YORK
PA CONSULTANTS BUREAU 233 SPRING ST, NEW YORK, NY 10013
SN 1061-933X
J9 COLLOID J RUSS ACAD+
PD JUL-AUG
PY 1992
VL 54
IS 4
BP 586
EP 590
PG 5
WC Chemistry, Physical
SC Chemistry
GA KZ124
UT WOS:A1992KZ12400029
DA 2018-10-20
ER

PT J
AU JOHNSON, SD
   ANDERSON, JM
   MARCHANT, RE
AF JOHNSON, SD
   ANDERSON, JM
   MARCHANT, RE
TI BIOCOMPATIBILITY STUDIES ON PLASMA POLYMERIZED INTERFACE MATERIALS
   ENCOMPASSING BOTH HYDROPHOBIC AND HYDROPHILIC SURFACES
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
ID INVIVO LEUKOCYTE INTERACTIONS; CELL-ADHESION; BIOMEDICAL POLYMERS;
   HUMAN-MONOCYTES; BIOMATERIALS; FIBRONECTIN; INVITRO;
   N-VINYL-2-PYRROLIDONE; INTERLEUKIN-1; POLYSTYRENE
AB The biocompatibility of radiofrequency plasma polymerized films (< 100 nm thick) deposited on biomedical polymer supports has been characterized by in vitro and in vivo methods. The polymer interface materials covered a wide range of elemental composition and surface properties, and were prepared from N-vinyl-2-pyrrolidone, gamma-butyrolactone, n-hexane, and hexamethyldisilazane (PPHMDSZ). The biocompatibility studies showed that the interface materials were noncytotoxic to mouse and human fibroblasts, as shown by morphologic evaluation, and by determination of extracellular LDH; and they did not stimulate interleukin-1-like production from human monocytes, as indicated by a thymocyte proliferation assay. The human fibroblast proliferation assay showed that three of the polymers supported cell growth at levels comparable to, or greater than, polymer controls, while the hydrophobic PPHMDSZ inhibited both cell attachment and proliferation. The response to subcutaneous implantation for all test materials was indicative of biocompatibility, with rapid resolution of the acute phase response and normal wound healing. The wide range of composition and surface properties for the plasma polymerized films evaluated in this study suggest that this general class of materials is likely to exhibit excellent biocompatibility.
C1 CASE WESTERN RESERVE UNIV, DEPT BIOMED ENGN, CLEVELAND, OH 44106 USA.
   CASE WESTERN RESERVE UNIV, DEPT PATHOL, CLEVELAND, OH 44106 USA.
FU NCRR NIH HHS [RR-20224]; NHLBI NIH HHS [HL-33849, HL-40047]
CR ABSOLOM DR, 1988, J BIOMED MATER RES, V22, P215, DOI 10.1002/jbm.820220306
   ANDERSON JM, 1984, BIOMATERIALS, V5, P5, DOI 10.1016/0142-9612(84)90060-7
   AUTIAN J, 1977, ARTIF ORGANS, V1, P53
   BAIER RE, 1982, J BIOMECH ENG-T ASME, V104, P257, DOI 10.1115/1.3138358
   BONFIELD TL, 1989, J BIOMED MATER RES, V23, P535, DOI 10.1002/jbm.820230602
   CURTIS ASG, 1983, J CELL BIOL, V97, P1500, DOI 10.1083/jcb.97.5.1500
   DANILICH MJ, IN PRESS J BIOMATER
   DEKKER A, 1991, BIOMATERIALS, V12, P130, DOI 10.1016/0142-9612(91)90191-C
   DESAI NP, 1991, J BIOMED MATER RES, V25, P829, DOI 10.1002/jbm.820250704
   DUCHEYNE P, 1988, J BIOMED MATER RES, V22, P1137, DOI 10.1002/jbm.820221207
   ERTEL SI, 1990, J BIOMED MATER RES, V24, P1637, DOI 10.1002/jbm.820241207
   Fasol R, 1985, Trans Am Soc Artif Intern Organs, V31, P276
   GRINNELL F, 1982, J BIOL CHEM, V257, P4888
   Grinnell F, 1978, Int Rev Cytol, V53, P65
   HO CP, 1988, J BIOMED MATER RES, V22, P919, DOI 10.1002/jbm.820221007
   HYNES RO, 1982, J CELL BIOL, V95, P369, DOI 10.1083/jcb.95.2.369
   JANSEN JA, 1991, BIOMATERIALS, V12, P25, DOI 10.1016/0142-9612(91)90127-V
   JOHNSON SD, UNPUB EFFECT MONOMER
   LEWANDOWSKA K, 1989, J CELL PHYSIOL, V141, P334, DOI 10.1002/jcp.1041410215
   LYDON MJ, 1985, BIOMATERIALS, V6, P396, DOI 10.1016/0142-9612(85)90100-0
   MARCHANT RE, 1984, J BIOMED MATER RES, V18, P1169, DOI 10.1002/jbm.820180917
   MARCHANT RE, 1992, J COLLOID INTERF SCI, V148, P261, DOI 10.1016/0021-9797(92)90135-9
   MARCHANT RE, 1990, J BIOMED MATER RES, V24, P1521, DOI 10.1002/jbm.820241108
   MARCHANT RE, 1989, FUND APPL TOXICOL, V13, P217, DOI 10.1016/0272-0590(89)90258-3
   MARCHANT RE, 1989, J POLYM SCI POL CHEM, V27, P881, DOI 10.1002/pola.1989.080270314
   MAROUDAS NG, 1975, J THEOR BIOL, V49, P417, DOI 10.1016/0022-5193(75)90182-4
   MCAUSLAN BR, 1988, J BIOMED MATER RES, V22, P963, DOI 10.1002/jbm.820221102
   MCCAULEY R, 1980, J SURG RES, V49, P103
   MILLER KM, 1989, J BIOMED MATER RES, V23, P1007, DOI 10.1002/jbm.820230904
   MILLER KM, 1988, J BIOMED MATER RES, V22, P713, DOI 10.1002/jbm.820220805
   MILLER KM, 1989, J BIOMED MATER RES, V23, P911, DOI 10.1002/jbm.820230808
   NATHAN C, 1991, J CELL BIOL, V113, P981, DOI 10.1083/jcb.113.5.981
   RAE T, 1986, TECHNIQUES BIOCOMPAT, V2, P81
   ROBBINS SL, 1989, PATHOLOGIC BASIS DIS, P39
   SALTHOUSE TN, 1976, J BIOMED MATER RES, V10, P197, DOI 10.1002/jbm.820100204
   SCHMIDT JA, 1991, BIOMATERIALS, V12, P385, DOI 10.1016/0142-9612(91)90006-V
   SPILIZEWSKI KL, 1987, BIOMATERIALS, V8, P12, DOI 10.1016/0142-9612(87)90021-4
   SUKENIK CN, 1990, J BIOMED MATER RES, V24, P1307, DOI 10.1002/jbm.820241004
   UYAMA Y, 1991, BIOMATERIALS, V12, P71, DOI 10.1016/0142-9612(91)90135-W
   VIRTANEN I, 1982, NATURE, V298, P660, DOI 10.1038/298660a0
   YU DS, 1989, MACROMOLECULES, V22, P2957, DOI 10.1021/ma00197a014
   ZIATS NP, 1988, BIOMATERIALS, V9, P5, DOI 10.1016/0142-9612(88)90063-4
NR 42
TC 61
Z9 62
U1 2
U2 8
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD JUL
PY 1992
VL 26
IS 7
BP 915
EP 935
DI 10.1002/jbm.820260707
PG 21
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA HZ522
UT WOS:A1992HZ52200006
PM 1607373
DA 2018-10-20
ER

PT J
AU MCDANIEL, FD
   MATTESON, S
   WEATHERS, DL
   DUGGAN, JL
   MARBLE, DK
   HASSAN, I
   ZHAO, ZY
   ANTHONY, JM
AF MCDANIEL, FD
   MATTESON, S
   WEATHERS, DL
   DUGGAN, JL
   MARBLE, DK
   HASSAN, I
   ZHAO, ZY
   ANTHONY, JM
TI RADIONUCLIDE DATING AND TRACE-ELEMENT ANALYSIS BY ACCELERATOR
   MASS-SPECTROMETRY
SO JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY-ARTICLES
LA English
DT Article
ID MOLECULAR-BEAM EPITAXY; NEGATIVE-IONS; ELECTRONIC MATERIALS;
   COSMIC-RAYS; TIME SCALE; C-14; BE-10; GAAS; AMS; CALIBRATION
AB Accelerator Mass Spectrometry (AMS) is being used for both radionuclide dating and stable isotope trace element determination with limits of high sensitivity. The areas of applications of radionuclide AMS include oceanography, terrestrial studies, glaciology, hydrology, environmental studies, meterology, archaeology, anthropology, analysis of crude oils, biomedical and materials sciences, etc. The techniques and applications of radionuclide AMS are reviewed. The applications of stable element AMS include the measurements of trace impurities in electronic and other materials. The techniques and applications of stable element AMS are discussed with particular emphasis on electronic materials such as Si, GaAs, and HgCdTe. The design of the University of North Texas stable element AMS facility built in collaboration with Texas Instruments Incorporated is discussed.
C1 TEXAS INSTRUMENTS INC, CENT RES LAB, DALLAS, TX 75265 USA.
   UNIV N TEXAS, CTR MAT CHARACTERIZAT, DENTON, TX 76203 USA.
RP MCDANIEL, FD (reprint author), UNIV N TEXAS, DEPT PHYS, DENTON, TX 76203 USA.
CR Alvarez LW, 1939, PHYS REV, V56, P613, DOI 10.1103/PhysRev.56.613
   Alvarez LW, 1939, PHYS REV, V56, P379, DOI 10.1103/PhysRev.56.379.2
   ANDERSON EC, 1947, PHYS REV, V72, P931, DOI 10.1103/PhysRev.72.931
   ANTHONY JM, 1987, NUCL INSTRUM METH B, V29, P77, DOI 10.1016/0168-583X(87)90208-4
   ANTHONY JM, 1991, NUCL INSTRUM METH B, V56-7, P873, DOI 10.1016/0168-583X(91)95050-N
   ANTHONY JM, 1989, NUCL INSTRUM METH B, V40-1, P731, DOI 10.1016/0168-583X(89)90465-5
   ANTHONY JM, 1983, NUCL INSTRUM METHODS, V218, P463, DOI 10.1016/0167-5087(83)91022-0
   ANTHONY JM, 1985, NUCL INSTRUM METH B, V10-1, P498, DOI 10.1016/0168-583X(85)90295-2
   ANTHONY JM, 1990, NUCL INSTRUM METH B, V52, P493, DOI 10.1016/0168-583X(90)90464-6
   ANTHONY JM, 1990, NUCL INSTRUM METH B, V50, P262, DOI 10.1016/0168-583X(90)90365-2
   ARRALE AM, 1991, NUCL INSTRUM METH B, V56-7, P886, DOI 10.1016/0168-583X(91)95053-G
   BARD E, 1990, NATURE, V345, P405, DOI 10.1038/345405a0
   BARD E, 1990, NUCL INSTRUM METH B, V52, P461, DOI 10.1016/0168-583X(90)90458-7
   Bennett C L, 1977, Science, V198, P508
   BENNINGHOVEN A, 1986, SECONDARY ION MASS S
   Bentley HW, 1986, HDB ENV ISOTOPE GE B, V2, P422
   BONANI G, 1986, RADIOCARBON, V28, P246
   CURRIE LA, 1984, NUCL INSTRUM METH B, V5, P371, DOI 10.1016/0168-583X(84)90544-5
   DAMON PE, 1989, NATURE, V337, P611, DOI 10.1038/337611a0
   DAVIS SN, 1981, 1981 WORKSH IS HYDR
   DINAN JH, 1985, J VAC SCI TECHNOL A, V3, P851, DOI 10.1116/1.573329
   DUGGAN JL, 1989, NUCL INSTRUM METH B, V40-1, P709, DOI 10.1016/0168-583X(89)90460-6
   DUPUIS RD, 1987, APPL PHYS LETT, V50, P407, DOI 10.1063/1.98185
   ELMORE D, 1987, SCIENCE, V236, P543, DOI 10.1126/science.236.4801.543
   ELMORE D, 1979, NATURE, V277, P22, DOI 10.1038/277022a0
   ELMORE D, 1979, NATURE, V277, P246, DOI 10.1038/277246c0
   FELDMAN RD, 1988, J APPL PHYS, V63, P2872, DOI 10.1063/1.340944
   FELTON JS, 1990, NUCL INSTRUM METH B, V52, P517, DOI 10.1016/0168-583X(90)90469-B
   FINCH EC, 1973, NUCL INSTRUM METHODS, V113, P41, DOI 10.1016/0029-554X(73)90475-8
   FISCHER CF, 1987, PHYS REV LETT, V59, P2263, DOI 10.1103/PhysRevLett.59.2263
   GARWAN MA, 1990, NUCL INSTRUM METH B, V52, P512, DOI 10.1016/0168-583X(90)90468-A
   GOVE HE, 1990, NUCL INSTRUM METH B, V52, P502, DOI 10.1016/0168-583X(90)90466-8
   GOVE HE, 1987, NUCL INSTRUM METH B, V29, pR7, DOI 10.1016/0168-583X(87)90190-X
   GOVE HE, 1978, 1ST P C RAD DAT ACC
   HEDGES REM, 1987, 1986 P WORKSH TECHN
   HENNING W, 1987, SCIENCE, V236, P725, DOI 10.1126/science.236.4802.725
   HENNING W, 1982, 1981 P S ACC MASS SP
   HENNING W, 1986, P WORKSHOP TECHNIQUE, P196
   Hotop H., 1975, Journal of Physical and Chemical Reference Data, V4, P539
   HOTOP H, 1985, J PHYS CHEM REF DATA, V14, P731, DOI 10.1063/1.555735
   KILIUS LR, 1990, NUCL INSTRUM METH B, V52, P357, DOI 10.1016/0168-583X(90)90437-Y
   KUTSCHERA W, 1988, NUCL INSTRUM METH A, V268, P552, DOI 10.1016/0168-9002(88)90578-5
   KUTSCHERA W, 1986, NUCL INSTRUM METH B, V17, P377, DOI 10.1016/0168-583X(86)90167-9
   KUTSCHERA W, 1990, NUCL INSTRUM METH B, V50, P252, DOI 10.1016/0168-583X(90)90364-Z
   LAL D, 1984, TECTONOPHYSICS, V105, P383, DOI 10.1016/0040-1951(84)90215-4
   LEEM JY, 1990, APPL PHYS LETT, V57, P2228, DOI 10.1063/1.103899
   LIBBY WF, 1949, SCIENCE, V109, P227, DOI 10.1126/science.109.2827.227
   LIBBY WF, 1946, PHYS REV, V69, P671, DOI 10.1103/PhysRev.69.671.2
   LITHERLAND AE, 1980, ANNU REV NUCL PART S, V30, P437, DOI 10.1146/annurev.ns.30.120180.002253
   LOOSLI HH, 1968, EARTH PLANET SC LETT, V5, P191, DOI 10.1016/S0012-821X(68)80039-1
   MANGINI A, 1984, NUCL INSTRUM METH B, V5, P353, DOI 10.1016/0168-583X(84)90541-X
   MATTESON S, 1990, NUCL INSTRUM METH B, V45, P575, DOI 10.1016/0168-583X(90)90903-8
   MATTESON S, 1989, NUCL INSTRUM METH B, V40-1, P759, DOI 10.1016/0168-583X(89)90471-0
   MATTESON S, 1991, NUCL INSTRUM METH B, V56-7, P1091, DOI 10.1016/0168-583X(91)95104-L
   MATTESON S, 1990, NUCL INSTRUM METH B, V52, P237
   MCDANIEL FD, 1990, NUCL INSTRUM METH B, V52, P310, DOI 10.1016/0168-583X(90)90428-W
   MCDANIEL FD, 1990, 1989 P HIGH EN HEAV, P269
   MULLER RA, 1977, SCIENCE, V196, P489, DOI 10.1126/science.196.4289.489
   NELSON DE, 1977, SCIENCE, V198, P507, DOI 10.1126/science.198.4316.507
   NISHIIZUMI K, 1986, NATURE, V319, P134, DOI 10.1038/319134a0
   OESCHGER H, 1982, ACS SYM SER, V176, P5
   PEARSON GW, 1986, RADIOCARBON, V28, P911
   POLACH HA, 1987, NUCL INSTRUM METH B, V29, P415, DOI 10.1016/0168-583X(87)90275-8
   PURSER KH, 1977, REV PHYS APPL, V12, P1487, DOI 10.1051/rphysap:0197700120100148700
   Purser KH, 1977, United States Patent, Patent No. [4,037,100, 4037100]
   RAISBECK GM, 1987, NATURE, V326, P273, DOI 10.1038/326273a0
   RAISBECK GM, 1978, SCIENCE, V202, P215, DOI 10.1126/science.202.4364.215
   RUCKLIDGE JC, 1990, NUCL INSTRUM METH B, V52, P507, DOI 10.1016/0168-583X(90)90467-9
   RUSSELL WA, 1978, GEOCHIM COSMOCHIM AC, V42, P1075, DOI 10.1016/0016-7037(78)90105-9
   SARAFIN R, 1984, NUCL INSTRUM METH B, V5, P411, DOI 10.1016/0168-583X(84)90551-2
   STUIVER M, 1982, RADIOCARBON, V24, P1
   STUIVER M, 1986, RADIOCARBON, V28, P177
   Suess HE, 1979, RADIOCARBON DATING, P777
   SUTER M, 1990, NUCL INSTRUM METH B, V52, P211, DOI 10.1016/0168-583X(90)90409-N
   SUTER M, 1984, NUCL INSTRUM METH B, V5, P242, DOI 10.1016/0168-583X(84)90519-6
   VOSKO SH, 1989, PHYS REV A, V39, P446, DOI 10.1103/PhysRevA.39.446
   WEATHERS DL, 1991, NUCL INSTRUM METH B, V56-7, P889, DOI 10.1016/0168-583X(91)95054-H
   WOLFLI W, 1987, NUCL INSTRUM METH B, V29, P1, DOI 10.1016/0168-583X(87)90193-5
   WOLFLI W, 1984, NUCL INSTRUM METH B, V5, pR5, DOI 10.1016/0168-583X(84)90487-7
   YIOU F, 1990, NUCL INSTRUM METH B, V52, pR5, DOI 10.1016/0168-583X(90)90406-K
   YOKOYAMA Y, 1977, EARTH PLANET SC LETT, V36, P44, DOI 10.1016/0012-821X(77)90186-8
NR 81
TC 7
Z9 7
U1 0
U2 1
PU AKADEMIAI KIADO RT
PI BUDAPEST
PA PRIELLE K U 19, PO BOX 245,, H-1117 BUDAPEST, HUNGARY
SN 0236-5731
J9 J RADIOAN NUCL CH AR
JI J. Radioanal. Nucl. Chem.-Artic.
PD JUL
PY 1992
VL 160
IS 1
BP 119
EP 140
DI 10.1007/BF02041663
PG 22
WC Chemistry, Analytical; Chemistry, Inorganic & Nuclear; Nuclear Science &
   Technology
SC Chemistry; Nuclear Science & Technology
GA JF677
UT WOS:A1992JF67700013
DA 2018-10-20
ER

PT J
AU JEDLINSKI, Z
AF JEDLINSKI, Z
TI NOVEL RING-OPENING POLYMERIZATION INDUCED BY ALKALI-METAL ANIONS
SO MAKROMOLEKULARE CHEMIE-MACROMOLECULAR SYMPOSIA
LA English
DT Article
ID POTASSIUM SOLUTIONS; BETA-LACTONES; CROWN ETHERS; K-39 NMR
AB Novel homogeneous initiation systems consisting of organic alkali metal complexes: Me+/Ligand, Me- enable synthesis of "living" tailor made polymers and copolymers - promising materials for engineering and biomedical applications. The mechanism of this polymerization has been elucidated.
RP JEDLINSKI, Z (reprint author), POLISH ACAD SCI, INST POLYMER CHEM, PL-41800 ZABRZE, POLAND.
CR ALEV S, 1980, J POLYM SCI POL CHEM, V18, P1155, DOI 10.1002/pol.1980.170180402
   ALEV S, 1980, J POLYM SCI POL CHEM, V18, P1166
   BOILEAU S, 1974, J POLYM SCI POL LETT, V12, P211, DOI 10.1002/pol.1974.130120406
   DAINTON FS, 1960, J POLYM SCI, V45, P111, DOI 10.1002/pol.1960.1204514510
   DYE JL, 1970, J AM CHEM SOC, V92, P5226, DOI 10.1021/ja00720a043
   EDWARDS PP, 1985, NATURE, V317, P242, DOI 10.1038/317242a0
   GROBELNY J, 1991, MAGN RES CHEM, V29
   JACOBS C, 1991, MACROMOLECULES, V24, P3027, DOI 10.1021/ma00011a001
   JEDLINSKI Z, 1985, MACROMOLECULES, V18, P2679, DOI 10.1021/ma00154a052
   JEDLINSKI Z, 1989, MACROMOLECULES, V22, P3242, DOI 10.1021/ma00198a008
   JEDLINSKI Z, 1986, MAKROMOL CHEM, V187, P1651
   JEDLINSKI Z, 1988, J CHEM SOC CHEM COMM, P1261, DOI 10.1039/c39880001261
   JEDLINSKI Z, 1989, J ORG CHEM, V54, P1500, DOI 10.1021/jo00268a005
   JEDLINSKI Z, 1983, MAKROMOL CHEM-RAPID, V4, P355
   JEDLINSKI Z, 1984, J PHYS CHEM-US, V88, P6094, DOI 10.1021/j150669a006
   KURCOK P, IN PRESS MACROMOLECU
   LACOSTE J, 1976, J POLYM SCI POL LETT, V14, P201, DOI 10.1002/pol.1976.130140404
   SOKOL M, 1990, MAGN RESON CHEM, V28, P934, DOI 10.1002/mrc.1260281106
   SZWARC M, 1956, NATURE, V178, P1168, DOI 10.1038/1781168a0
   TINKHAM ML, 1985, J AM CHEM SOC, V107, P6129, DOI 10.1021/ja00307a063
   YASUDA T, 1984, MACROMOLECULES, V17, P2217, DOI 10.1021/ma00141a003
NR 21
TC 6
Z9 6
U1 0
U2 1
PU HUTHIG & WEPF VERLAG
PI BASEL
PA AUF DEM WOLF 4, CH-4052 BASEL, SWITZERLAND
SN 0258-0322
J9 MAKROMOL CHEM-M SYMP
PD JUL
PY 1992
VL 60
BP 235
EP 245
DI 10.1002/masy.19920600121
PG 11
WC Polymer Science
SC Polymer Science
GA JH980
UT WOS:A1992JH98000020
DA 2018-10-20
ER

PT J
AU SAGI, A
   AVIDORZEHAVI, A
   SHITZER, A
   GERSTMANN, M
   AKSELROD, S
   KATZIR, A
AF SAGI, A
   AVIDORZEHAVI, A
   SHITZER, A
   GERSTMANN, M
   AKSELROD, S
   KATZIR, A
TI HEATING OF BIOLOGICAL TISSUE BY LASER IRRADIATION - TEMPERATURE
   DISTRIBUTION DURING LASER ABLATION
SO OPTICAL ENGINEERING
LA English
DT Article
DE BIOMEDICAL OPTICS; LASER IRRADIATION; TISSUE DAMAGE; LASER ABLATION
ID ANGIOPLASTY; RADIATION
AB A numerical model was developed for calculating the temperature distribution in material exposed to a laser beam. The model takes into account the different stages undergone by the tissue before material removal is achieved. The consecutive steps considered are: heating to the boiling temperature of water, boiling and evaporation of the water content, heating of the dehydrated tissue to its ablation temperature, removal of the relevant material, and adapting the new geometrical boundaries of the remaining tissue. The temperature field was computed by the model and measured experimentally in biological tissue exposed to pulses of highly absorbed laser radiation. Good agreement was obtained between the theoretical and the experimental results. This model may be applied to optimize the irradiation conditions for a specific application, to determine the temperature distribution during laser cutting, and to minimize the resulting thermal damage.
C1 TECHNION ISRAEL INST TECHNOL,DEPT MECH ENGN,IL-32000 HAIFA,ISRAEL.
RP SAGI, A (reprint author), TEL AVIV UNIV,RAYMOND & BEVERLY SACKLER FAC EXACT SCI,SCH PHYS & ASTRON,IL-69978 TEL AVIV,ISRAEL.
CR BOWMAN HF, 1975, ANNU REV BIOPHYS BIO, V4, P43, DOI 10.1146/annurev.bb.04.060175.000355
   FUKUMOT I, 1981, 4TH P C INT SOC LAS
   HENRIQUES FC, 1947, AM J PATHOL, V23, P531
   HENRIQUES FC, 1947, ARCH PATHOL, V43, P489
   PARTOVI F, 1987, LASER SURG MED, V7, P141, DOI 10.1002/lsm.1900070202
   Poppendiek H. F., 1966, CRYOBIOLOGY, V3, P318
   SAGI A, 1992, OPT ENG, V31, P1417, DOI 10.1117/12.58733
   SPECKHART FH, 1976, CSMP CONTINUOUS SYST
   SPELLS KE, 1960, PHYS MED BIOL, V5, P139, DOI 10.1088/0031-9155/5/2/304
   TAKATA AN, 1977, SAMTR7738 REP
   TAKATA AN, 1974, IITRI JTR746324
   VANGEMERT MJC, 1985, LASER SURG MED, V5, P219, DOI 10.1002/lsm.1900050304
   WALSH JT, 1988, LASER SURG MED, V8, P264, DOI 10.1002/lsm.1900080308
   WELCH AJ, 1984, IEEE J QUANTUM ELECT, V20, P1471, DOI 10.1109/JQE.1984.1072339
   WELCH AJ, 1985, LASER SURG MED, V5, P251, DOI 10.1002/lsm.1900050307
   WELCH AJ, 1987, CIRCULATION, V76, P1353, DOI 10.1161/01.CIR.76.6.1353
NR 16
TC 14
Z9 15
U1 0
U2 0
PU SOC PHOTO-OPT INSTRUM ENG
PI BELLINGHAM
PA PO BOX 10, BELLINGHAM, WA 98227-0010
SN 0091-3286
J9 OPT ENG
JI Opt. Eng.
PD JUL
PY 1992
VL 31
IS 7
BP 1425
EP 1431
DI 10.1117/12.58734
PG 7
WC Optics
SC Optics
GA JD558
UT WOS:A1992JD55800006
DA 2018-10-20
ER

PT J
AU WANG, JY
AF WANG, JY
TI CYLINDRICAL WAVE-GUIDE EVANESCENT FIELD ELLIPSOMETRY
SO OPTICAL ENGINEERING
LA English
DT Article
DE BIOMEDICAL OPTICS; ELLIPSOMETRY; WAVE-GUIDES; BIOSENSORS; LIGHT
   PROPAGATION
ID INTERFACE; SENSORS
AB The recent use of fiber optic waveguides for biochemical analyses is based mainly on light intensity changes. Waveguide evanescent field ellipsometry (WEFE) is proposed for biosensor applications. The WEFE is based on the principle of ellipsometry. A laser beam coupled into the waveguide propagates in the waveguide with two fundamental modes with transverse electric fields parallel and perpendicular to the sensing surface. The evanescent waves interact with the adsorbed or conjugated layer of biomolecules, producing changes in the relative phase and amplitude upon interaction. The ellipsometric parameters change with biomolecule adsorption or conjugation on the sensing surface. From the ellipsometric parameter changes, we can estimate the surface concentration and thus the concentration of the biomolecules in solution. The principles of WEFE including light propagation in the waveguide, ellipsometry parameter analysis, the WEFE arrangement, materials and methods, and preliminary experimental results are presented.
RP WANG, JY (reprint author), UNIV UTAH,DEPT BIOENGN,SALT LAKE CITY,UT 84112, USA.
CR ANDRADE JD, 1985, IEEE T ELECTRON DEV, V32, P1175, DOI 10.1109/T-ED.1985.22096
   ASPNES DE, 1976, OPTICAL PROPERTIES S
   Azzam R. M. A., 1977, ELLIPSOMETRY POLARIZ
   BORN M, 1975, PRINCIPLES OPTICS, P23
   CUYPERS PA, 1983, J BIOL CHEM, V258, P2426
   HARRICK NJ, 1967, INTERNAL REFLECTION, P35
   HIRSCHFELD T, 1984, SCIENCE, V226, P312, DOI 10.1126/science.226.4672.312
   KAWAGUCHI M, 1988, LANGMUIR, V4, P411, DOI 10.1021/la00080a026
   KIM MW, 1989, MACROMOLECULES, V22, P2682, DOI 10.1021/ma00196a026
   KOOYMAN RPH, 1991, TRANSDUCERS 91
   Marcuse D, 1974, THEORY DIELECTRIC OP
   PETERSON JI, 1984, SCIENCE, V224, P123, DOI 10.1126/science.6422554
   SEITZ WR, 1984, ANAL CHEM, V56, pA16, DOI 10.1021/ac00265a001
   SMARDZEWSKI RR, 1988, TALANTA, V35, P95, DOI 10.1016/0039-9140(88)80045-6
   Snyder A.W., 1983, OPTICAL WAVEGUIDE TH
   WOHLTJEN H, 1984, ANAL CHEM, V56, pA87, DOI 10.1021/ac00265a002
NR 16
TC 1
Z9 1
U1 0
U2 2
PU SOC PHOTO-OPT INSTRUM ENG
PI BELLINGHAM
PA PO BOX 10, BELLINGHAM, WA 98227-0010
SN 0091-3286
J9 OPT ENG
JI Opt. Eng.
PD JUL
PY 1992
VL 31
IS 7
BP 1432
EP 1435
DI 10.1117/12.57699
PG 4
WC Optics
SC Optics
GA JD558
UT WOS:A1992JD55800007
DA 2018-10-20
ER

PT J
AU GOLDEN, JP
   SHRIVERLAKE, LC
   ANDERSON, GP
   THOMPSON, RB
   LIGLER, FS
AF GOLDEN, JP
   SHRIVERLAKE, LC
   ANDERSON, GP
   THOMPSON, RB
   LIGLER, FS
TI FLUOROMETER AND TAPERED FIBER OPTIC PROBES FOR SENSING IN THE EVANESCENT
   WAVE
SO OPTICAL ENGINEERING
LA English
DT Article
DE BIOMEDICAL OPTICS; BIOSENSORS; FIBER OPTIC SENSORS; EVANESCENT WAVES
ID IMMUNOASSAY
AB To develop an improved fiber optic biosensor both the optical component selection and the signal coupling efficiency were investigated. The emission filter and fiber connectors were carefully chosen to reduce their contribution to noise in the system. We used long, fused silica fibers that had several centimeters of cladding removed along the distal end. This exposed core is coated with the recognition molecules that bind analyte-fluorophore complexes from the sample solution. A fluorescent signal generated in the evanescent wave region of the unclad, immersed portion of the probe is lost as it enters the cladded portion of the fiber because of a V-number mismatch. To minimize the mismatch, the core radius is reduced along the uncladded region to form a continuous taper. An assay using the tapered fiber and the described optical configuration is presented that demonstrates instantaneous signal generation in response to nanogram amounts of a toxic material.
RP GOLDEN, JP (reprint author), USN,RES LAB,CTR BIOMOLEC SCI & ENGN,CODE 6090,4555 OVERLOOK AVE SW,WASHINGTON,DC 20375, USA.
RI Golden, Joel/K-4567-2017; Anderson, George/D-2461-2011
OI Golden, Joel/0000-0002-6908-0489; Anderson, George/0000-0001-7545-9893
CR ANDERSON G P, 1992, Biophysical Journal, V61, pA169
   ANDERSON GP, 1992, JAN SPIE C BIOM OPT
   ANDRADE JD, 1985, IEEE T ELECTRON DEV, V32, P1175, DOI 10.1109/T-ED.1985.22096
   BHATIA SK, 1989, ANAL BIOCHEM, V178, P408, DOI 10.1016/0003-2697(89)90662-3
   CAMPBELL J, 1990, Patent No. 7635019
   HIRSCHFELD TE, 1984, Patent No. 4447546
   KRONICK MN, 1975, J IMMUNOL METHODS, V8, P235, DOI 10.1016/0022-1759(75)90116-7
   Ligler F. S., 1991, U.S. patent, Patent No. [5,077,210, 5077210]
   MARCUSE D, 1988, IEEE J LIGHTWAVE TEC, V6, P1273
   SNYDER AW, 1983, OPTICAL WAVEGUIDE TH, P315
   Thompson R.B., 1988, P SOC PHOTO-OPT INS, V904, P27
   Thompson R. B., 1991, US Patent, Patent No. [5061857S, 5061857]
   THOMPSON RB, 1990, P SOC PHOTO-OPT INS, V1204, P35, DOI 10.1117/12.17684
   THOMPSON RB, 1990, APPL SPECTROSC, V44, P117, DOI 10.1366/0003702904085958
   THOMPSON RB, 1991, BIOSENSORS FIBEROPTI, P111
   THOMPSON RB, 1989, 11TH P IEEE EMBS INT, P1102
   WISE DL, 1991, BIOSENSORS FIBEROPTI, P1
   Wolfbeis O. S., 1991, FIBER OPTIC CHEM SEN, V1, p303f
NR 18
TC 55
Z9 59
U1 0
U2 3
PU SOC PHOTO-OPT INSTRUM ENG
PI BELLINGHAM
PA PO BOX 10, BELLINGHAM, WA 98227-0010
SN 0091-3286
J9 OPT ENG
JI Opt. Eng.
PD JUL
PY 1992
VL 31
IS 7
BP 1458
EP 1462
DI 10.1117/12.58764
PG 5
WC Optics
SC Optics
GA JD558
UT WOS:A1992JD55800012
DA 2018-10-20
ER

PT J
AU ANDREOPOULOS, AG
AF ANDREOPOULOS, AG
TI PREPARATION OF HYDROPHILIC POLYMER NETWORKS BY POST-CURING REACTION
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
ID POLY(2-HYDROXYETHYL METHACRYLATE); HYDROGEL MATRIX; DRUG DELIVERY;
   RELEASE; WATER
AB Hydrophilic gels are a very important class of polymeric materials with extensive applications as biomedical products. The critical properties of hydrogels, such as sorption and desorption, mechanical behavior, swelling properties, etc., are controlled by network characteristics, i.e. degree of crosslinking and the density, distribution and length of crosslinks. Hydrogels prepared by copolymerization of 2-hydroxyethyl methacrylate (HEMA) with ethylene glycol dimethacrylate (EGDMA) have already been studied in detail. In this work, hydrophilic networks were prepared by crosslinking HEMA with EGDMA, and poly(2-hydroxy-ethel methacrylate) (PHEMA) with diphenylmethane-4,4'-diisocyanate (MDI). The swelling properties of both types of networks were studied and the differences in behavior were attributed to the different techniques applied for network formation.
RP ANDREOPOULOS, AG (reprint author), NATL TECH UNIV ATHENS,DEPT CHEM ENGN,SPECIAL CHEM TECHNOL LAB,42 PATISS STR,GR-10682 ATHENS,GREECE.
CR ANDREOPOULOS AG, 1989, J APPL POLYM SCI, V37, P2121, DOI 10.1002/app.1989.070370804
   ANDREOPOULOS AG, 1989, BIOMATERIALS, V10, P101, DOI 10.1016/0142-9612(89)90040-9
   DAVANKOV VA, 1974, J POLYM SCI PS, V47, P95
   DAVIDSON CWR, 1986, J CONTROL RELEASE, V3, P259
   Davidson III GWR, 1986, J CONTROL RELEASE, V3, P243, DOI DOI 10.1016/0168-3659(86)90096-9
   GREGONIS DE, 1978, POLYMER, V19, P1279, DOI 10.1016/0032-3861(78)90305-1
   HOPFENBERG HB, 1976, POLYMER, V17, P195, DOI 10.1016/0032-3861(76)90099-9
   HUGLIN MB, 1982, POLYMER, V23, P340, DOI 10.1016/0032-3861(82)90331-7
   Korsmeyer R. W., 1983, J CONTROL RELEASE, V1, P89
   LEE PI, 1983, POLYM COMMUN, V24, P45
   LINHARDT RJ, 1983, POLYM PREPR-ACS, V24, P47
   LOSHAEK S, 1953, J AM CHEM SOC, V75, P3544, DOI 10.1021/ja01110a068
   MESLARD JC, 1986, MAKROMOL CHEM, V187, P787
   MIGLIARESI C, 1984, POLYMER, V25, P686, DOI 10.1016/0032-3861(84)90037-5
   MIGLIARESI C, 1980, INT J ARTIF ORGANS, V3, P114
   MIGLIARESI C, 1983, J BIOMED MATER RES, V17, P1
   MITRA SB, 1983, POLYM PREPR-ACS, V24, P51
   NEGRE M, 1979, ANGEW MAKROMOL CHEM, V80, P19, DOI 10.1002/apmc.1979.050800102
   PEPPAS N A, 1987, Journal of Controlled Release, V5, P143, DOI 10.1016/0168-3659(87)90005-8
   PINCHUK L, 1984, J APPL POLYM SCI, V29, P1749, DOI 10.1002/app.1984.070290528
   PONCHEL G, 1987, Journal of Controlled Release, V5, P129, DOI 10.1016/0168-3659(87)90004-6
   RITGER P L, 1987, Journal of Controlled Release, V5, P37, DOI 10.1016/0168-3659(87)90035-6
   RITGER P L, 1987, Journal of Controlled Release, V5, P23, DOI 10.1016/0168-3659(87)90034-4
   SEQOTCHICQ S, 1986, J CONTROL RELEASE, V3, P193
   SUNG YK, 1981, J APPL POLYM SCI, V26, P3719, DOI 10.1002/app.1981.070261118
   Wichterle O., 1971, ENCYCLOPEDIA POLYMER, P273
NR 26
TC 7
Z9 7
U1 0
U2 4
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-8995
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD JUN 25
PY 1992
VL 45
IS 6
BP 1005
EP 1010
DI 10.1002/app.1992.070450609
PG 6
WC Polymer Science
SC Polymer Science
GA HV699
UT WOS:A1992HV69900009
DA 2018-10-20
ER

PT J
AU WHYTE, SR
AF WHYTE, SR
TI PHARMACEUTICALS AS FOLK MEDICINE - TRANSFORMATIONS IN THE
   SOCIAL-RELATIONS OF HEALTH-CARE IN UGANDA
SO CULTURE MEDICINE AND PSYCHIATRY
LA English
DT Article
AB The deterioration of government health services in Uganda since 1971 has been accompanied by a process of privatization which has made pharmaceuticals readily available outside of biomedical institutions. On the basis of material from eastern Uganda, the article analyses this development in terms of the 'sector model' of health care systems, with special attention to the relations between the professional and folk sectors. Folk practitioners of pharmaceutical medicine include a broad range of specialists, from government trained paramedicals in private practice to vendors bringing medicine to local markets. Like other folk specialists, they respect the customer's opinion, provide treatment by proxy and adjust their services to the customer's ability to pay. Although there are negative aspects of this development, from the local point of view there are also positive ones, which deserve the consideration of health planners.
RP WHYTE, SR (reprint author), UNIV COPENHAGEN,INST ANTHROPOL,FREDERIKSHOLMS KANAL 4,DK-1220 COPENHAGEN,DENMARK.
OI Whyte, Susan/0000-0001-7253-6478
CR ALLAND A, 1970, ADAPTATION CULTURAL
   BENNETT FJ, 1989, SOC SCI MED, V28, P1085, DOI 10.1016/0277-9536(89)90392-4
   Bledsoe C., 1988, CONTEXT MED DEV COUN, P253
   BURGHART R, 1988, CONTEXT MED DEV COUN, P289
   Dodge Cole P., 1985, CRISIS UGANDA BREAKD
   DODGE CP, 1987, CRISIS DEV ISSUES UG, P101
   ETKIN NL, 1990, SOC SCI MED, V30, P919, DOI 10.1016/0277-9536(90)90220-M
   FERGUSON A, 1985, CONTEXT MED DEV COUN, P19
   Foster George, 1978, MED ANTHR
   FREIDSON E, 1970, PROFESSIONAL DOMINAN
   *HLTH POL REV COMM, 1987, REP REC HLTH POL REV
   JAMAL V, 1987, CRISIS DEV ISSUES UG, P121
   JANZEN J, 1978, QUEST THERAPY MED PL, P37
   JANZEN JM, 1978, SOC SCI MED-MED ANTH, V12, P121, DOI 10.1016/0160-7987(78)90020-0
   JUSTICE J, 1986, POLICIES PLANS PEOPL
   KINUKA R, 1985, ESSENTIAL DRUGS MANA
   Kironde Erisa, 1985, CRISIS UGANDA BREAKD, P65
   KLEINMAN A, 1980, PATIENTS HEALERS CON, P655
   Last M., 1986, PROFESSIONALISATION, P1
   LESLIE C, 1980, SOC SCI MED-MED ANTH, V14, P191, DOI 10.1016/0160-7987(80)90044-7
   LESLIE C, 1975, COMP STUDIES HLTH CA, P401
   Leslie Charles, 1976, ASIAN MED SYSTEMS CO, P356
   MacCormack C., 1986, PROFESSIONALIZATION, P151
   MINDE KK, 1985, CRISIS UGANDA BREAKD, P239
   NICHTER M, 1989, CULT MED PSYCHIAT, V13, P367, DOI 10.1007/BF00052046
   ODURKENE JN, 1988, THESIS
   PRICE LJ, 1989, SOC SCI MED, V28, P905, DOI 10.1016/0277-9536(89)90315-8
   STOCK R, 1985, STUDIES 3RD WORLD SO, V34, P115
   TAYLOR CE, 1976, ASIAN MED SYSTEMS CO, P285
   *UGANDA ESS DRUGS, 1990, FIND 1986 1989
   van der Geest S., 1989, MED ANTHROPOL Q, V3, P345, DOI DOI 10.1525/MAQ.1989.3A.02A00030
   VANDERGEEST S, 1991, CULT MED PSYCHIAT, V15, P69, DOI 10.1007/BF00050828
   VANDERGEEST S, 1988, CONTEXT MED DEV COUN, P131
   WHYTE M, 1990, CREATIVE COMMUNION A, P307
   WHYTE MA, 1990, ADAPTIVE STRATEGIES IN AFRICAN ARID LANDS, P121
   WHYTE SR, 1982, SOC SCI MED, V16, P2055, DOI 10.1016/0277-9536(82)90161-7
   WHYTE SR, 1988, CONTEXT MED DEV COUN, P217
   Whyte SR, 1991, CHANGING UGANDA DILE, P130
   Whyte Susan R, 1991, AFRICAN DIVINATION S, P153
   Whyte Susan R, 1990, J RELIG AFR, V20, P41
   WOLFFERS I, 1988, CONTEXT MED DEV COUN, P47
NR 41
TC 30
Z9 31
U1 0
U2 6
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA SPUIBOULEVARD 50, PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
SN 0165-005X
J9 CULT MED PSYCHIAT
JI Cult. Med. Psychiatr.
PD JUN
PY 1992
VL 16
IS 2
BP 163
EP 186
DI 10.1007/BF00117017
PG 24
WC Anthropology; Psychiatry; Social Sciences, Biomedical
SC Anthropology; Psychiatry; Biomedical Social Sciences
GA JH295
UT WOS:A1992JH29500002
PM 1395694
DA 2018-10-20
ER

PT J
AU CARENZA, M
AF CARENZA, M
TI RECENT ACHIEVEMENTS IN THE USE OF RADIATION POLYMERIZATION AND GRAFTING
   FOR BIOMEDICAL APPLICATIONS
SO RADIATION PHYSICS AND CHEMISTRY
LA English
DT Article
ID NATURAL-RUBBER TUBES; DRUG DELIVERY; COPOLYMERIC MICROSPHERES;
   N-ACRYLOXYSUCCINIMIDE; GLUCOSE-OXIDASE; IMMOBILIZATION; POLYMERS;
   RELEASE; POLYETHERURETHANE; METHACRYLATE
AB Papers mainly published in the last few years on radiation processing of polymeric systems for biomedical applications carried out in different laboratories are reviewed. Radiation-induced polymerization to obtain hydrogels as carriers for immobilization of bioactive agents and for controlled release of drugs is described. Radiation modification of polymers by graft copolymerization and/or crosslinking for the same purposes is also reported. The second part of the paper deals with the work recently carried out in the author's laboratory. Radiation-induced polymerization at low temperatures to obtain matrices susceptible to entrap drugs, including peptides and proteins, is discussed. Radiation grafting of hydrophilic monomers onto relatively new inorganic polymers, i.e. polyphosphazenes, and the properties of such modified polymeric materials, together with their biocompatibility, are summarized.
RP CARENZA, M (reprint author), CNR,IST FOTOCHIM & RADIAZIONI DALTA ENERGIA,SEZ LEGNARO,VIA ROMEA 4,I-35020 LEGNANO,ITALY.
CR ALBIN G, 1985, Journal of Controlled Release, V2, P153, DOI 10.1016/0168-3659(85)90041-0
   Allcock HR, 1972, PHOSPHORUS NITROGEN
   BEDDOWS CG, 1988, J APPL POLYM SCI, V35, P135, DOI 10.1002/app.1988.070350112
   BOCCU E, 1987, APPL BIOCHEM BIOTECH, V15, P1, DOI 10.1007/BF02798502
   BUSULINI L, 1977, MAKROMOL CHEM, V178, P277
   CARENZA M, 1983, CHIM IND-MILAN, V65, P261
   CARENZA M, 1988, RADIAT PHYS CHEM, V31, P657
   CARENZA M, 1989, Annali di Microbiologia ed Enzimologia, V39, P257
   CARENZA M, 1987, EUR POLYM J, V23, P741, DOI 10.1016/0014-3057(87)90117-0
   CARENZA M, 1990, ANN NY ACAD SCI, V613, P547, DOI 10.1111/j.1749-6632.1990.tb18218.x
   CARENZA M, 1990, CHIM OGGI, V8, P41
   CHABANESARI M, UNPUB
   CHAPIRO A, 1980, RADIAT PHYS CHEM, V15, P423, DOI 10.1016/0146-5724(80)90163-6
   CHAPIRO A, 1983, EUR POLYM J, V19, P859, DOI 10.1016/0014-3057(83)90038-1
   CHAPIRO A, 1981, RADIAT PHYS CHEM, V18, P1203, DOI 10.1016/0146-5724(81)90311-3
   CHARLESBY A, 1987, RAD CHEM PRINCIPLES, P451
   DASILVA MA, 1990, J APPL POLYM SCI, V41, P1629, DOI 10.1002/app.1990.070410722
   DASILVA MA, 1990, RADIAT PHYS CHEM, V35, P98
   DENIZLI A, 1988, BIOMATERIALS, V9, P363, DOI 10.1016/0142-9612(88)90034-8
   DENIZLI A, 1988, BIOMATERIALS, V9, P257, DOI 10.1016/0142-9612(88)90094-4
   DEVI S, 1990, RADIAT PHYS CHEM, V36, P697
   DEVI S, 1990, RADIAT PHYS CHEM, V36, P703
   DOBO J, 1970, ACTA CHIM HUNG, V63, P453
   DONG L C, 1986, Journal of Controlled Release, V4, P223, DOI 10.1016/0168-3659(86)90006-4
   DONG LC, 1990, J CONTROL RELEASE, V13, P21, DOI 10.1016/0168-3659(90)90071-Z
   DONG LC, 1986, RADIAT PHYS CHEM, V28, P177
   FAUCITANO A, 1991, RADIAT PHYS CHEM, V37, P573
   FUJIMURA T, 1988, RADIAT PHYS CHEM, V31, P653
   GARNETT JL, 1985, RADIAT PHYS CHEM, V25, P509, DOI 10.1016/0146-5724(85)90130-X
   GARNETT JL, 1986, RADIAT PHYS CHEM, V27, P301
   GLERIA M, 1988, CHIM IND MILAN S11, V70, P15
   GOMBOTZ W R, 1985, Journal of Controlled Release, V2, P375, DOI 10.1016/0168-3659(85)90059-8
   Gombotz W.R., 1986, HYDROGELS MED PHARM, P95
   HA HF, 1988, RADIAT PHYS CHEM, V31, P761
   HA HF, 1985, RADIAT PHYS CHEM, V25, P501
   HAYASHI K, 1986, RADIAT PHYS CHEM, V27, P317
   HOFFMAN A S, 1987, Journal of Controlled Release, V6, P297, DOI 10.1016/0168-3659(87)90083-6
   HOFFMAN AS, 1986, RADIAT PHYS CHEM, V27, P265
   HOFFMAN AS, 1990, ACS POLYM PREPR, V31, P220
   JANSEN B, 1984, J BIOMED MATER RES, V18, P655, DOI 10.1002/jbm.820180607
   JANSEN B, 1985, J BIOMED MATER RES, V19, P1085, DOI 10.1002/jbm.820190918
   Jansen B, 1987, J Biomater Appl, V1, P502
   KABANOV VY, 1989, RADIAT PHYS CHEM, V33, P51
   KAETSU I, 1972, J POLYM SCI A1, V10, P2203, DOI 10.1002/pol.1972.150100801
   KAETSU I, 1985, RADIAT PHYS CHEM, V25, P517, DOI 10.1016/0146-5724(85)90131-1
   KAETSU I, 1981, RADIAT PHYS CHEM, V18, P343, DOI 10.1016/0146-5724(81)90086-8
   KAETSU I, 1986, RADIAT PHYS CHEM, V27, P245
   Kiremitci M, 1986, PROGR ARTIFICIAL ORG, P1010
   KOST J, 1985, J BIOMED MATER RES, V19, P1117, DOI 10.1002/jbm.820190920
   KUMAKURA M, 1990, J APPL POLYM SCI, V41, P177, DOI 10.1002/app.1990.070410115
   LIU YM, 1990, RADIAT PHYS CHEM, V35, P122
   LIU YM, 1987, RADIAT PHYS CHEM, V30, P215
   LORA S, 1990, RADIAT PHYS CHEM, V35, P117
   LORA S, 1991, BIOMATERIALS, V12, P275, DOI 10.1016/0142-9612(91)90034-8
   LORA S, 1988, RADIAT PHYS CHEM, V31, P629
   LORA S, 1976, MAKROMOL CHEM, V177, P299
   LORA S, 1987, Patent No. 19435
   MECHAIN B, IN PRESS BIOMATERIAL
   MIKI M, 1982, BIOTECHNOL BIOENG, V24, P2587, DOI 10.1002/bit.260241121
   MING LY, 1987, 3RD CHIN JAP BIL S R
   MORITA Y, 1987, COLLOID POLYM SCI, V265, P916, DOI 10.1007/BF01421822
   MULLERSCHULTE D, 1990, J CHROMATOGR, V510, P115, DOI 10.1016/S0021-9673(01)93744-6
   MULLERSCHULTE D, 1990, RADIAT PHYS CHEM, V35, P93
   PEKALA W, 1986, RADIAT PHYS CHEM, V27, P275
   PEZZIN G, 1991, CHEM IND MILAN, V73, P185
   PISKIN K, 1984, APPL BIOCHEM BIOTECH, V10, P73, DOI 10.1007/BF02783737
   RAZZAK MT, 1988, J APPL POLYM SCI, V36, P645, DOI 10.1002/app.1988.070360315
   RAZZAK MT, 1989, J APPL POLYM SCI, V38, P829, DOI 10.1002/app.1989.070380506
   ROSIAK J, 1983, RADIAT PHYS CHEM, V22, P907, DOI 10.1016/0146-5724(83)90111-5
   SAFRANJ A, 1990, 1ST IAEA RES COORD M
   SILVERMAN J, 1977, RADIAT PHYS CHEM, V9, P1, DOI 10.1016/0146-5724(77)90069-3
   SINGLER RE, 1988, ACS SYM SER, V360, P268
   STANNETT VT, 1990, RADIAT PHYS CHEM, V35, P82
   SUN Y, 1987, ACS POLYM PREPR, V28, P292
   SUN YH, 1986, J BIOACT COMPAT POL, V1, P316
   TAKEHISA M, 1987, RAD CHEM, P601
   TAYLOR LD, 1975, J POLYM SCI POL CHEM, V13, P2551, DOI 10.1002/pol.1975.170131113
   UENOYAMA S, 1988, RADIAT PHYS CHEM, V32, P605
   VEONESE FM, 1990, IN PRESS POLYM MED, V4
   Veronese F M, 1988, Ann N Y Acad Sci, V542, P115, DOI 10.1111/j.1749-6632.1988.tb25815.x
   Veronese F. M., 1989, J BIOACT COMPAT POLY, V4, P42
   VERONESE FM, 1991, J CONTROL RELEASE, V16, P291, DOI 10.1016/0168-3659(91)90005-X
   VERONESE FM, 1990, RADIAT PHYS CHEM, V35, P88
   WANG GH, 1988, RADIAT PHYS CHEM, V31, P705
   YANG HC, 1988, RADIAT PHYS CHEM, V31, P721
   YANG HC, 1985, RADIAT PHYS CHEM, V25, P375, DOI 10.1016/0146-5724(85)90285-7
   Yoshida M, 1991, Drug Des Deliv, V7, P159
   YOSHIDA M, 1987, BIOMATERIALS, V8, P124, DOI 10.1016/0142-9612(87)90101-3
   YOSHIDA M, 1989, EUR POLYM J, V25, P1197, DOI 10.1016/0014-3057(89)90081-5
   YOSHIDA M, 1990, EUR POLYM J, V26, P121, DOI 10.1016/0014-3057(90)90174-3
   YOSHIDA M, 1987, RADIAT PHYS CHEM, V30, P39
   YOSHIDA M, 1989, COLLOID POLYM SCI, V267, P986, DOI 10.1007/BF01410159
   YOSHIDA M, 1989, J POLYM SCI POL LETT, V27, P437, DOI 10.1002/pol.1989.140271107
   YOSHIDA M, 1989, BIOMATERIALS, V10, P16, DOI 10.1016/0142-9612(89)90004-5
   YOSHIDA M, 1990, POLYMER, V31, P371, DOI 10.1016/0032-3861(90)90136-M
NR 95
TC 65
Z9 65
U1 0
U2 2
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
SN 0146-5724
J9 RADIAT PHYS CHEM
JI Radiat. Phys. Chem.
PD JUN
PY 1992
VL 39
IS 6
BP 485
EP 493
PG 9
WC Chemistry, Physical; Nuclear Science & Technology; Physics, Atomic,
   Molecular & Chemical
SC Chemistry; Nuclear Science & Technology; Physics
GA JD388
UT WOS:A1992JD38800009
DA 2018-10-20
ER

PT J
AU KUMAKURA, M
   YOSHIDA, M
   ASANO, M
   YAMANAKA, H
AF KUMAKURA, M
   YOSHIDA, M
   ASANO, M
   YAMANAKA, H
TI RADIATION PROCESSING TECHNOLOGY FOR PREPARATION OF FINE SHAPED
   BIOMEDICAL MATERIALS
SO RADIATION PHYSICS AND CHEMISTRY
LA English
DT Article
AB Radiation processing technology for the preparation of fine shaped biomedical materials was studied from the aspect of a development of the technology and its application. Electron beam irradiation technology was applied to the preparation of fine shaped biomedical materials such as thin polymer films in diagnosis, in which enzyme and antibody were used as a bioactive substance. Electron beam cast-polymerization and electron beam repeat surface-polymerization, that are surface irradiation techniques of homogeneous hydrophilic monomer solution containing enzymes made it possible to form the immobilized antibody films. In this technique, the films with various thicknesses (50-500-mu-m) were obtained by regulating the electron beam energy. The thin polymer films immobilizing anti-alpha-fetoprotein were evaluated from the aspect of immunoagents for diagnosis of liver cancer
C1 JAPAN ATOM ENERGY RES INST,TAKASAKI RADIAT CHEM RES ESTAB,TAKASAKI,GUNMA 37012,JAPAN.
   GUNMA UNIV,SCH MED,MAEBASHI,GUNMA 371,JAPAN.
CR DEMARTEAU W, 1984, RAD CURING       FEB, P12
   SCHARPE SL, 1979, CLIN CHEM, V25, P733
   URS VL, 1990, RADIAT PHYS CHEM, V35, P30
   WISDOM GB, 1976, CLIN CHEM, V22, P1243
   WOO J, 1976, AM J CLIN PATHOL, V66, P854
NR 5
TC 3
Z9 3
U1 0
U2 0
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
SN 0146-5724
J9 RADIAT PHYS CHEM
JI Radiat. Phys. Chem.
PD JUN
PY 1992
VL 39
IS 6
BP 577
EP 581
PG 5
WC Chemistry, Physical; Nuclear Science & Technology; Physics, Atomic,
   Molecular & Chemical
SC Chemistry; Nuclear Science & Technology; Physics
GA JD388
UT WOS:A1992JD38800023
DA 2018-10-20
ER

PT J
AU MACHI, S
AF MACHI, S
TI INTERNATIONAL-SYMPOSIUM ON RADIATION TECHNOLOGY IN BIOMEDICAL MATERIALS
   - 18-19 OCTOBER 1990, TAKASAKI, JAPAN - OPENING ADDRESS
SO RADIATION PHYSICS AND CHEMISTRY
LA English
DT Editorial Material
C1 JAPAN ATOM ENERGY RES INST,TAKASAKI RADIAT CHEM RES ESTAB,TAKASAKI,GUNMA 37012,JAPAN.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
SN 0146-5724
J9 RADIAT PHYS CHEM
JI Radiat. Phys. Chem.
PD JUN
PY 1992
VL 39
IS 6
BP R7
EP R7
PG 1
WC Chemistry, Physical; Nuclear Science & Technology; Physics, Atomic,
   Molecular & Chemical
SC Chemistry; Nuclear Science & Technology; Physics
GA JD388
UT WOS:A1992JD38800002
DA 2018-10-20
ER

PT J
AU MACHI, S
   KUMAKURA, M
   TABATA, Y
AF MACHI, S
   KUMAKURA, M
   TABATA, Y
TI INTERNATIONAL-SYMPOSIUM ON RADIATION TECHNOLOGY IN BIOMEDICAL MATERIALS
   - 18-19 OCTOBER 1990, TAKASAKI, JAPAN - PREFACE
SO RADIATION PHYSICS AND CHEMISTRY
LA English
DT Editorial Material
C1 JAPAN ATOM ENERGY RES INST,TAKASAKI RADIAT CHEM RES ESTAB,TAKASAKI,GUNMA 37012,JAPAN.
   TOKAI UNIV,DEPT NUCL ENGN,HIRATSUKA,KANAGAWA 25912,JAPAN.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
SN 0146-5724
J9 RADIAT PHYS CHEM
JI Radiat. Phys. Chem.
PD JUN
PY 1992
VL 39
IS 6
BP R5
EP R5
PG 1
WC Chemistry, Physical; Nuclear Science & Technology; Physics, Atomic,
   Molecular & Chemical
SC Chemistry; Nuclear Science & Technology; Physics
GA JD388
UT WOS:A1992JD38800001
DA 2018-10-20
ER

PT J
AU MARKOVIC, V
AF MARKOVIC, V
TI INTERNATIONAL-SYMPOSIUM ON RADIATION TECHNOLOGY IN BIOMEDICAL MATERIALS
   - 18-19 OCTOBER 1990, TAKASAKI, JAPAN - WELCOME ADDRESS
SO RADIATION PHYSICS AND CHEMISTRY
LA English
DT Editorial Material
C1 INT ATOM ENERGY AGCY,CHEM SECT,A-1011 VIENNA,AUSTRIA.
RP MARKOVIC, V (reprint author), INT ATOM ENERGY AGCY,DEPT RES & ISOTOPES IND APPLICAT,A-1011 VIENNA,AUSTRIA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
SN 0146-5724
J9 RADIAT PHYS CHEM
JI Radiat. Phys. Chem.
PD JUN
PY 1992
VL 39
IS 6
BP R11
EP R11
PG 1
WC Chemistry, Physical; Nuclear Science & Technology; Physics, Atomic,
   Molecular & Chemical
SC Chemistry; Nuclear Science & Technology; Physics
GA JD388
UT WOS:A1992JD38800004
DA 2018-10-20
ER

PT J
AU TABATA, Y
AF TABATA, Y
TI INTERNATIONAL-SYMPOSIUM ON RADIATION TECHNOLOGY IN BIOMEDICAL MATERIALS
   - 18-19 OCTOBER 1990, TAKASAKI, JAPAN - WELCOME ADDRESS
SO RADIATION PHYSICS AND CHEMISTRY
LA English
DT Editorial Material
NR 0
TC 0
Z9 0
U1 0
U2 0
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
SN 0146-5724
J9 RADIAT PHYS CHEM
JI Radiat. Phys. Chem.
PD JUN
PY 1992
VL 39
IS 6
BP R9
EP R9
PG 1
WC Chemistry, Physical; Nuclear Science & Technology; Physics, Atomic,
   Molecular & Chemical
SC Chemistry; Nuclear Science & Technology; Physics
GA JD388
UT WOS:A1992JD38800003
DA 2018-10-20
ER

PT J
AU PARTRIDGE, G
AF PARTRIDGE, G
TI GLASS-CERAMICS IN BIOMEDICAL APPLICATIONS
SO ADVANCED MATERIALS
LA English
DT Editorial Material
ID BIOMATERIALS HIGHLIGHTS; INORGANIC MATERIALS; IMPLANTS
AB Research News/Inorganic Materials VI:  Glass ceramics play a crucial role in many surgical procedures ranging from hip replacements to dentistry.  The surface morhology, chemical composition, and the structural properties of the materials are of utmost importance when deciding the suitability of the materials for particular applications.  The various factors involved are discussed.
CR BARRETT JM, 1983, Patent No. 2041349
   DeGroot K., 1981, SCI CERAM, V11, P433
   GROSSMAN DG, 1985, DENT CLIN N AM, V29, P725
   HAHN C, 1980, BER DENT KERAM GES, V57, P208
   HEIMKE G, 1990, ADV MATER, V2, P548, DOI 10.1002/adma.19900021109
   HEIMKE G, 1990, ADV MATER, V2, P375
   HEIMKE G, 1991, ADV MATER, V3, P108, DOI 10.1002/adma.19910030210
   Heimke G., 1990, Advanced Materials, V2, P189, DOI 10.1002/adma.19900020408
   HEIMKE G, 1991, ADV MATER, V3, P320, DOI 10.1002/adma.19910030613
   HEIMKE G, 1989, ADV MATER, V1, P345
   HEIMKE G, 1990, ADV MATER, V2, P45
   HEIMKE G, 1989, ADV MATER, V1, P60122
   HEIMKE G, 1989, ADV MATER, V1, P234
   HOLAND W, 1991, J NON-CRYST SOLIDS, V129, P152, DOI 10.1016/0022-3093(91)90091-J
   HYDE AR, 1991, 1 MECH ENG C EUR DIR
   KRAJEWSKI A, 1981, SCI CERAM, V11, P85
   LIN FH, 1989, J AUST CERAM SOC, V1, P41
   MACK J, 1987, MATER EDGE       SEP, P38
   MOUATT CAL, 1988, MATER SCI FORUM, V34, P403
   NIEDERAUER GG, 1991, AM CERAM SOC BULL, V70, P1010
   PARTRIDGE G, 1990, ADV MATER, V2, P318, DOI 10.1002/adma.19900020612
   Partridge G., 1990, Advanced Materials, V2, P147, DOI 10.1002/adma.19900020308
   PARTRIDGE G, 1990, ADV MATER, V2, P553, DOI 10.1002/adma.19900021111
   PARTRIDGE G, 1992, ADV MATER, V4, P51, DOI 10.1002/adma.19920040112
   TAIRA M, 1990, BRIT CERAM TRANS J, V89, P203
   TIWARI VP, 1988, CENTRAL GLASS CERAM, V35, P11
   VAJDA TT, 1988, MATER SCI FORUM, V34, P379
   VOGEL W, 1990, J NON-CRYST SOLIDS, V123, P349, DOI 10.1016/0022-3093(90)90807-X
   WIVEN A, 1988, MATER SCI FORUM, V34, P395
   1989, BIOMED MATER, V5, P2
NR 30
TC 1
Z9 1
U1 1
U2 3
PU VCH PUBLISHERS INC
PI DEERFIELD BEACH
PA 303 NW 12TH AVE, DEERFIELD BEACH, FL 33442-1788
SN 0935-9648
J9 ADV MATER
JI Adv. Mater.
PD MAY
PY 1992
VL 4
IS 5
BP 364
EP 367
DI 10.1002/adma.19920040511
PG 4
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA HV497
UT WOS:A1992HV49700010
DA 2018-10-20
ER

PT J
AU SANDERS, AB
   KEIM, SM
   SKLAR, D
   ADAMS, J
AF SANDERS, AB
   KEIM, SM
   SKLAR, D
   ADAMS, J
TI EMERGENCY PHYSICIANS AND THE BIOMEDICAL INDUSTRY
SO ANNALS OF EMERGENCY MEDICINE
LA English
DT Article
DE BIOMEDICAL INDUSTRY
AB The relationship of physicians to biomedical industry has been a matter of concern and scrutiny by medical organizations, the public, industry, and government. 1-10 In a competitive marketplace, the biomedical industry must advertise its products to physician consumers. Nevertheless, gift-giving to physicians, industry support for education and research, and industry promotional activities that reward physicians can result in conflict of interest for physicians. A physician's clinical, educational, and research decisions should be based on scientific evidence and not be influenced by commercialism. Promotional materials developed by biomedical industry may not be designed to give physicians objective scientific data regarding a product. It is particularly disturbing that physicians may not be aware of the undue influence that promotional material and gift-giving has on their clinical decisions. 7 Acceptance of a gift from a biomedical company establishes a relationship between the physician and the company. This relationship may not be in the best interest of the patient and may, in fact, conflict with the physician's obligation to the patient. Furthermore, money spent on promotional materials and gift-giving to physicians ultimately is paid for by patients as part of the cost of the item. 6 The Society for Academic Emergency Medicine is concerned about the ethical conflicts arising from the relationship of physicians to biomedical industry. In this paper, we discuss three general issues related to physicians and the biomedical industry and recommend guidelines for the emergency physician. The three issues are as follows.
RP SANDERS, AB (reprint author), SOC ACAD EMERGENCY MED,ETH COMM,SUBCOMM BIOMED IND RELATIONSHIPS,900 W OTTAWA ST,LANSING,MI 48915, USA.
NR 0
TC 9
Z9 9
U1 1
U2 1
PU MOSBY-YEAR BOOK INC
PI ST LOUIS
PA 11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318
SN 0196-0644
J9 ANN EMERG MED
JI Ann. Emerg. Med.
PD MAY
PY 1992
VL 21
IS 5
BP 556
EP 558
DI 10.1016/S0196-0644(05)82524-7
PG 3
WC Emergency Medicine
SC Emergency Medicine
GA HR031
UT WOS:A1992HR03100014
PM 1570913
DA 2018-10-20
ER

PT J
AU NAGABHOOSHANAM, M
   DUMKE, VR
AF NAGABHOOSHANAM, M
   DUMKE, VR
TI CHEMOMECHANICAL EFFECTS ON CRACK-PROPAGATION - POLYCRYSTALLINE
   ALPHA-AL2O3
SO JOURNAL OF MATERIALS SCIENCE
LA English
DT Article
ID MEASURING FRACTURE-TOUGHNESS; SHARP CONTACT CRACKING; SODA-LIME GLASS;
   INDENTATION TECHNIQUES; MICROHARDNESS; DEFORMATION; HARDNESS
AB The role of environment on microcracks in Al2O3 is important as the material has applications in the biomedical field, such as artificial bones. The indentation method of producing radial cracks and measuring hardness is good in that it is reproducible. The radial crack lengths in alpha-Al2O3 are found to be sensitive towards the environment, and the load applied on the indentor. Long-time Vickers' microhardness and radial crack-length measurements in the presence of bio-simulating, aqueous and non-aqueous environments on the surface of alpha-Al2O3 are analysed. In each environment considered, the crack propagation showed a linear variation with the applied load, and the microhardness decreased similarly with time. Evidence was sought to show that the presence of water in bio-simulating liquid helps crack propagation under load. The results are explained in terms of possible interactions between the molecules of Al2O3 and the chemical environment and surface energies in the presence of that environment.
C1 UNIV FED PARANA,DEPT FIS,BR-81531 CURITIBA,PARANA,BRAZIL.
CR ANSTIS GR, 1981, J AM CERAM SOC, V64, P533, DOI 10.1111/j.1151-2916.1981.tb10320.x
   BERNHARDT EO, 1941, Z METALLKD, V33, P135
   CHAN HM, 1988, J AM CERAM SOC, V71, P29, DOI 10.1111/j.1151-2916.1988.tb05756.x
   CHANTIKUL P, 1981, J AM CERAM SOC, V64, P539, DOI 10.1111/j.1151-2916.1981.tb10321.x
   CHAUDHRI MM, 1986, PHILOS MAG A, V53, pL55
   EVANS AG, 1976, J AM CERAM SOC, V59, P371, DOI 10.1111/j.1151-2916.1976.tb10991.x
   FAIRBANKS CJ, 1982, J MATER SCI LETT, V1, P391, DOI 10.1007/BF00724848
   FROHLICH F, 1977, PHYS STATUS SOLIDI A, V42, P79, DOI 10.1002/pssa.2210420106
   GUNASEKERA SP, 1973, PHYS CHEM GLASSES, V14, P45
   HAGAN JT, 1980, J MATER SCI, V15, P1417, DOI 10.1007/BF00752121
   HAGAN JT, 1978, J PHYS D APPL PHYS, V11, P2091, DOI 10.1088/0022-3727/11/15/007
   HIRAO K, 1987, J AM CERAM SOC, V70, P497, DOI 10.1111/j.1151-2916.1987.tb05683.x
   HIRAO K, 1987, J AM CERAM SOC, V70, P377, DOI 10.1111/j.1151-2916.1987.tb05654.x
   Kranich J. F., 1976, GLASTECH BER, V49, P135
   LAWN B, 1975, J MATER SCI, V10, P1049, DOI 10.1007/BF00823224
   LAWN BR, 1983, J MATER SCI, V18, P2785, DOI 10.1007/BF00547596
   LAWN BR, 1983, FRACTURE MECHANICS C, V5, P1
   LAWN BR, 1985, STRENGTH INORGANIC G, P67
   MARSHALL DB, 1979, J MATER SCI, V14, P2225, DOI 10.1007/BF00688429
   MARSHALL DB, 1979, J MATER SCI, V14, P2001, DOI 10.1007/BF00551043
   MICHALSKE TA, 1984, J APPL PHYS, V56, P2686, DOI 10.1063/1.333789
   MICHALSKE TA, 1985, J AM CERAM SOC, V68, P586, DOI 10.1111/j.1151-2916.1985.tb16160.x
   TOMOZAWA M, 1987, J MATER SCI LETT, V6, P867, DOI 10.1007/BF01729041
   WESTBROOK JH, 1968, AM MINERAL, V53, P1899
   Westbrook JH, 1965, T AIME, V223, P425
   WESTBROOK JH, 1966, ENV SENSITIVE MECHAN, P247
   YAMANAKA K, 1982, J APPL PHYS, V53, P846, DOI 10.1063/1.330591
NR 27
TC 5
Z9 5
U1 0
U2 2
PU CHAPMAN HALL LTD
PI LONDON
PA 2-6 BOUNDARY ROW, LONDON, ENGLAND SE1 8HN
SN 0022-2461
J9 J MATER SCI
JI J. Mater. Sci.
PD MAY 1
PY 1992
VL 27
IS 9
BP 2377
EP 2382
DI 10.1007/BF01105046
PG 6
WC Materials Science, Multidisciplinary
SC Materials Science
GA HT187
UT WOS:A1992HT18700015
DA 2018-10-20
ER

PT J
AU YANCH, JC
   ZHOU, XL
   SHEFER, RE
   KLINKOWSTEIN, RE
AF YANCH, JC
   ZHOU, XL
   SHEFER, RE
   KLINKOWSTEIN, RE
TI ACCELERATOR-BASED EPITHERMAL NEUTRON BEAM DESIGN FOR NEUTRON-CAPTURE
   THERAPY
SO MEDICAL PHYSICS
LA English
DT Article
DE EPITHERMAL NEUTRONS; ACCELERATOR; NCT; MCNP
AB Recent interest in the production of epithermal neutrons for use in boron neutron capture therapy (BNCT) has prompted an investigation into the feasibility of generating such neutrons with a high current proton accelerator. Energetic protons (2.5 MeV) on a Li-7 target produce a spectrum of neutrons with maximum energy of roughly 800 keV. A number of combinations of D2O moderator, lead reflector, Li-6 thermal neutron filtration, and D2O/Li-6 shielding will result in a useful epithermal flux of 1.6 X 10(8) n/s at the patient position. The neutron beam is capable of delivering 3000 RBE-cGy to a tumor at a depth-of 7.5 cm in a total treatment time of 60-93 min (depending on RBE values used and based on a 24-cm diameter X 19-cm length D2O moderator). Treatment of deeper tumors with therapeutic advantage would also be possible. Maximum advantage depths (RBE weighted) of 8.2-9.2 (again depending on RBE values and precise moderator configuration) are obtained in a right-circular cylindrical phantom composed of brain-equivalent material with an advantage ratio of 4.7-6.3. A tandem cascade accelerator (TCA), designed and constructed at Science Research Laboratory (SRL) in Somerville MA, can provide the required proton beam parameters for BNCT of deep-seated tumors. An optimized configuration of materials required to shift the accelerator neutron spectrum down to therapeutically useful energies has been designed using Monte Carlo simulation in the Whitaker College Biomedical Imaging and Computation Laboratory at MIT. Actual construction of the moderator/reflector assembly is currently underway.
C1 MIT,WHITAKER COLL HLTH SCI & TECHNOL,CAMBRIDGE,MA 02139.
   SCI RES LAB INC,SOMERVILLE,MA 02143.
RP YANCH, JC (reprint author), MIT,DEPT NUCL ENGN,CAMBRIDGE,MA 02139, USA.
CR BARTH RF, 1990, CANCER RES, V50, P1061
   BARTH RF, 1990, SCI AM           OCT, P100
   Briesmeister J, 1986, LA7396M LOS AL NAT L
   BROOKS RA, 1980, J COMPUT ASSIST TOMO, V4, P489, DOI 10.1097/00004728-198008000-00016
   BRUGGER RM, 1990, NEUTRON BEAM DESIGN
   CASWELL RS, 1982, INT J APPL RADIAT IS, V33, P1227, DOI 10.1016/0020-708X(82)90246-0
   CHOI JR, 1990, IN PRESS 4TH P INT S
   CHOI JR, 1990, NEUTRON BEAM DESIGN
   CLEMENT SD, 1990, NEUTRON BEAM DESIGN
   FAIRCHILD RG, 1990, MED PHYS, V17, P1045, DOI 10.1118/1.596455
   FAIRCHILD RG, 1990, NEUTRON BEAM DESIGN
   GRUSELL E, 1990, NEUTRON BEAM DESIGN
   Paulsen A., 1975, NUCL DATA TABLES, V15, P57
   ROUSSIN R, 1990, DLC75 RAD SHIELD INF
   SHEFER RE, 1990, IN PRESS 4TH P INT S
   SHEFER RE, 1990, NEUTRON BEAM DESIGN
   WANG CK, 1990, NEUTRON BEAM DESIGN
   WANG CKC, 1989, NUCL TECHNOL, V84, P93, DOI 10.13182/NT89-A34199
   YANCH JC, 1991, RADIAT RES, V126, P1, DOI 10.2307/3578165
   YANCH JC, 1990, IN PRESS 4TH P INT S
   ZAMENHOF R G, 1975, Medical Physics (Woodbury), V2, P47, DOI 10.1118/1.594168
   1960, NUCLEAR DATA TABLE 3
NR 22
TC 61
Z9 61
U1 0
U2 3
PU AMER INST PHYSICS
PI WOODBURY
PA CIRCULATION FULFILLMENT DIV, 500 SUNNYSIDE BLVD, WOODBURY, NY 11797-2999
SN 0094-2405
J9 MED PHYS
JI Med. Phys.
PD MAY-JUN
PY 1992
VL 19
IS 3
BP 709
EP 721
DI 10.1118/1.596815
PG 13
WC Radiology, Nuclear Medicine & Medical Imaging
SC Radiology, Nuclear Medicine & Medical Imaging
GA HZ958
UT WOS:A1992HZ95800028
PM 1324392
DA 2018-10-20
ER

PT J
AU MORRA, M
   OCCHIELLO, E
   GARBASSI, F
AF MORRA, M
   OCCHIELLO, E
   GARBASSI, F
TI ON THE EFFECT OF STAGE SPEED AND VISCOSITY ON SOLID LIQUID INTERFACIAL
   BEHAVIOR DURING DYNAMIC CONTACT-ANGLE MEASUREMENT - APPLICATION TO
   BIOMEDICAL AND COMPOSITE-MATERIALS
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
C1 IST G DONEGANI SPA MONTEDISON,I-28100 NOVARA,ITALY.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD APR 5
PY 1992
VL 203
BP 100
EP COLL
PN 1
PG 0
WC Chemistry, Multidisciplinary
SC Chemistry
GA HK161
UT WOS:A1992HK16101615
DA 2018-10-20
ER

PT J
AU BYRNE, AR
AF BYRNE, AR
TI SOME CONSIDERATIONS REGARDING REFERENCE MATERIALS AND THEIR ROLE IN
   ENVIRONMENTAL MONITORING - PLENARY LECTURE
SO ANALYST
LA English
DT Article
DE REFERENCE MATERIALS; ENVIRONMENTAL MONITORING; QUALITY CONTROL
ID BIOLOGICAL REFERENCE MATERIALS; ATOMIC-ABSORPTION DETERMINATION;
   BOTANICAL REFERENCE MATERIALS; NEUTRON-ACTIVATION ANALYSIS;
   QUALITY-CONTROL; TRACE-METALS; METHYLMERCURY; MERCURY; BLOOD;
   IDENTIFICATION
AB After a brief introduction indicating the principal function of reference materials (RMs) in ensuring that the analytical measurement programme is performing reliably, the availability, different types and sources of information on RMs are described. Next, the correspondence of available RMs to present sample demands is discussed, particularly with regard to the adequacy of matrices and analytes, the availability of RMs for 'difficult' trace elements, and the preparation and certification of speciation RMs. The role of RMs in quality control is indicated, and their usage and certain problems which can thereby arise, including total dissolution, homogeneity and their representativeness in relation to samples, are discussed. The application of truly representative RMs in low-level trace element work, as a means of quality control of sampling and storage procedures, is mentioned. Strategies open to the analyst in the total absence of certified RMs are presented, and the importance of publication of independent results by alternative methods for such materials, as a means of establishing consensus values, is stressed. In the situation where results for a particular analyte obtained by different groups for the same (but not identical) biomedical or environmental system differ markedly, a progressive multi-stage exchange scheme is proposed, which is designed to reveal whether the differences arise from analytical factors, sampling effects or real system differences.
RP BYRNE, AR (reprint author), J STEFAN INST, LJUBLJANA 61000, YUGOSLAVIA.
CR ALVAREZ R, 1982, ANAL CHEM, V54, pA226, DOI 10.1021/ac00249a001
   ANGERER J, 1990, FRESEN J ANAL CHEM, V337, P589, DOI 10.1007/BF00323093
   [Anonymous], 1989, ANALYST, V114, P1693
   BEAUCHEMIN D, 1988, ANAL CHEM, V60, P2209, DOI 10.1021/ac00171a009
   BERMAN SS, 1988, FRESEN Z ANAL CHEM, V332, P546, DOI 10.1007/BF00472639
   BERMAN SS, 1989, FRESEN Z ANAL CHEM, V333, P641, DOI 10.1007/BF00496938
   BOWEN HJM, 1967, ANALYST, V92, P124, DOI 10.1039/an9679200124
   BYRNE AR, 1988, TALANTA, V35, P161, DOI 10.1016/0039-9140(88)80058-4
   BYRNE AR, 1988, FRESEN Z ANAL CHEM, V332, P666, DOI 10.1007/BF00472665
   BYRNE AR, 1986, J ENVIRON RADIOACTIV, V4, P133, DOI 10.1016/0265-931X(86)90038-X
   BYRNE AR, 1987, FRESEN Z ANAL CHEM, V326, P723, DOI 10.1007/BF00473540
   BYRNE AR, 1990, TRACE ELEM BIOL RES, V338, P399
   CALI JP, 1975, NBS SPECIAL PUBLICAT, V148
   CALI JP, 1976, ACCURACY TRACE ANALS
   CANTILLO AY, 1989, NOAA NOS OMA51 NAT O
   CHATT A, 1990, FRESEN J ANAL CHEM, V338, P399, DOI 10.1007/BF00322503
   CHAU YK, 1991, FRESEN J ANAL CHEM, V339, P640, DOI 10.1007/BF00325551
   CLADNEY ES, 1987, NBS260111 SPEC PUBL
   Cortes Toro E., 1990, IAEARL128
   CURRIE LA, 1982, PURE APPL CHEM, V54, P715, DOI 10.1351/pac198254040715
   CURRIE LA, 1991, ACS SYM SER, V445, P74
   DAS HA, 1990, J RADIOAN NUCL CH AR, V140, P387, DOI 10.1007/BF02039511
   DEBRUIN M, 1987, J RADIOAN NUCL CH AR, V112, P199, DOI 10.1007/BF02037291
   DEBRUIN M, 1988, J RADIOAN NUCL CH AR, V123, P227, DOI 10.1007/BF02036393
   DEGOEIJ JJM, 1983, ANAL CHIM ACTA, V146, P161, DOI 10.1016/S0003-2670(00)80602-9
   GREENBERG RR, 1990, FRESEN J ANAL CHEM, V338, P394, DOI 10.1007/BF00322502
   GRIEPINK B, 1991, FRESEN J ANAL CHEM, V339, P599, DOI 10.1007/BF00325544
   GRIFFITHS NM, 1974, NEW ZEAL MED J, V80, P199
   HEYDORN K, 1980, ANAL CHEM, V52, P1045, DOI 10.1021/ac50057a012
   HORVAT M, 1990, TALANTA, V37, P207, DOI 10.1016/0039-9140(90)80024-A
   HORVAT M, 1992, ANALYST, V117, P665, DOI 10.1039/an9921700665
   HORVAT M, 1991, WATER AIR SOIL POLL, V56, P95, DOI 10.1007/BF00342264
   Horvat M, 1988, APPL ORGANOMET CHEM, V2, P515
   HORWITZ W, 1988, PURE APPL CHEM, V60, P855, DOI 10.1351/pac198860060855
   HORWITZ W, 1980, J ASSOC OFF ANA CHEM, V63, P1344
   HORWITZ W, 1991, ACS SYM SER, V445, P50
   IHNAT M, 1982, COMMUN SOIL SCI PLAN, V13, P969, DOI 10.1080/00103628209367325
   IHNAT M, 1988, SCI TOTAL ENVIRON, V71, P85, DOI 10.1016/0048-9697(88)90302-6
   INGAMELLS CO, 1973, TALANTA, V20, P547, DOI 10.1016/0039-9140(73)80135-3
   INGAMELLS CO, 1974, TALANTA, V21, P141, DOI 10.1016/0039-9140(74)80036-6
   IYENGAR GV, 1989, ELEMENTAL ANAL BIOL, V1
   IYENGAR V, 1988, CLIN CHEM, V34, P474
   KLICH H, 1988, FRESEN Z ANAL CHEM, V332, P552, DOI 10.1007/BF00472641
   KOSTA L, 1982, J RADIOANAL CHEM, V69, P117, DOI 10.1007/BF02515918
   KOSTA L, 1980, IAEA TECHNICAL REPOR, V197, P317
   LIBRANDO V, 1991, FRESEN J ANAL CHEM, V339, P613, DOI 10.1007/BF00325547
   LINDSTROM RM, 1990, FRESEN J ANAL CHEM, V338, P569, DOI 10.1007/BF00322541
   MAGOS L, 1971, ANALYST, V96, P847, DOI 10.1039/an9719600847
   MAGOS L, 1972, J ASSOC OFF ANA CHEM, V55, P966
   MANNINEN PKG, 1991, FRESEN J ANAL CHEM, V339, P620, DOI 10.1007/BF00325548
   MARCHANDISE H, 1987, FRESEN Z ANAL CHEM, V326, P613, DOI 10.1007/BF00473514
   MARCHANDUSE H, 1988, EUROANALYSIS, V6, P65
   MAY K, 1987, TOXICOL ENVIRON CHEM, V13, P153, DOI 10.1080/02772248709357178
   MCLAREN JW, 1990, FRESEN J ANAL CHEM, V337, P721, DOI 10.1007/BF00323105
   MEGLEN RR, 1990, FRESEN J ANAL CHEM, V338, P363, DOI 10.1007/BF00322494
   MINOIA C, 1990, SCI TOTAL ENVIRON, V95, P89, DOI 10.1016/0048-9697(90)90055-Y
   PARR RM, 1985, NUTR RES S, V1, P5
   PSENNER R, 1984, Archiv fuer Hydrobiologie Supplement, V70, P111
   RUTLEDGE DN, 1990, FRESEN J ANAL CHEM, V338, P441, DOI 10.1007/BF00322513
   SUTARNO R, 1985, TALANTA, V32, P439, DOI 10.1016/0039-9140(85)80253-8
   TAYLOR JK, 1987, MAR CHEM, V22, P109, DOI 10.1016/0304-4203(87)90002-8
   TAYLOR JK, 1983, ANAL CHEM, V55, pA600, DOI 10.1021/ac00257a001
   TAYLOR JK, 1981, ANAL CHEM, V53, pA588, DOI 10.1021/ac00237a001
   TAYLOR JK, 1987, QUALITY ASSURANCE CH
   TESSIER A, 1979, ANAL CHEM, V51, P844, DOI 10.1021/ac50043a017
   THOMPSON M, 1989, 3RD P INT S HARM QUA, P183
   TOLOSA I, 1991, FRESEN J ANAL CHEM, V339, P646, DOI 10.1007/BF00325552
   TOPPING G, 1986, SCI TOTAL ENVIRON, V49, P9, DOI 10.1016/0048-9697(86)90231-7
   URIANO GA, 1977, ACS SYM SER, P140
   VERSIECK J, 1987, J RADIOAN NUCL CH AR, V113, P299, DOI 10.1007/BF02036070
   VERSIECK J, 1988, ANAL CHIM ACTA, V204, P63, DOI 10.1016/S0003-2670(00)86346-1
   VERSIECK J, 1989, TRACE ELEMENTS HUMAN
   WOLF WR, 1985, BIOL REFERENCE MATER, P89
   WOLF WR, 1987, TRACE ELEMENTS HUMAN, V1, P57
   WOLF WR, 1985, BIOL REFERENCE MATER
   WOLF WR, 1ST P INT S BIOL REF
   1985, INT ORG STANDARDIZAT, V35
   1987, FRESENISU Z ANAL CHE, V326, P597
   1989, ANALYST, V114, P1699
   1989, ISOREMCO18J
   1990, STANDARD REFERENCE M
   1989, INT ORG STANDARDIZAT, V33
   1990, FRESEN Z ANAL CHEM, V338, P359
   1989, ANALYST, V114, P1497
   1981, INT ORG STANDARDIZAT, V30
   1988, FRESENISU Z ANAL CHE, V332, P517
   1989, CERTIFICATE ANAL
NR 87
TC 11
Z9 11
U1 0
U2 0
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 0003-2654
EI 1364-5528
J9 ANALYST
JI Analyst
PD MAR
PY 1992
VL 117
IS 3
BP 251
EP 258
DI 10.1039/an9921700251
PG 8
WC Chemistry, Analytical
SC Chemistry
GA HM863
UT WOS:A1992HM86300008
PM 1580365
DA 2018-10-20
ER

PT J
AU KARLSSON, LM
   CRUZORIVE, LM
AF KARLSSON, LM
   CRUZORIVE, LM
TI THE NEW STEREOLOGICAL TOOLS IN METALLOGRAPHY - ESTIMATION OF PORE-SIZE
   AND NUMBER IN ALUMINUM
SO JOURNAL OF MICROSCOPY-OXFORD
LA English
DT Article
DE ALUMINUM; CAVALIERI PRINCIPLE; DISECTOR; DISTRIBUTION OF PARTICLE
   VOLUMES; ERROR VARIANCE; MEAN PARTICLE VOLUME; POINT-SAMPLED INTERCEPTS;
   PORE NUMBER; PORE VOLUME; SECTION THICKNESS; SELECTOR; STEREOLOGY;
   3-DIMENSIONAL MICROSCOPY; VOLUME-WEIGHTED MEAN PARTICLE VOLUME
ID LINEAR UNBIASED ESTIMATORS; ARBITRARY PARTICLES; SURFACE-AREA;
   PATHOLOGICAL RESEARCH; VERTICAL SECTIONS; VOLUME; EFFICIENCY; DIAGNOSIS;
   DISECTOR; BIOLOGY
AB A number of simple, unbiased and efficient methods are now available in stereology for estimating the number and size of arbitrary particles or voids in a material, with the only assumption that particles must be identifiable on serial sections or confocal planes through the material.  In recent years, these methods have been developed and applied mainly in a biomedical context:  this paper reviews and illustrates them with the aid of a metallographic example, namely the pore population of a sand-cast aluminium alloy.  Our goal is to convey the fact that stereology is sampling in three dimensions, and therefore its principles remain valid and applicable in no matter what context.  The disector, the selector, and an indirect method to estimate the distance between two parallel planes of polish are thereby illustrated.  It is also shown how to split the error variance of the estimator of the pore volume fraction ('porosity') into the three components due to blocks, sections within blocks and systematic point counting on sections.
C1 UNIV BERN,DEPT ANAT,STEREOL UNIT,CH-3000 BERN 9,SWITZERLAND.
RP KARLSSON, LM (reprint author), AVESTA AB,RES & DEV,S-77401 AVESTA,SWEDEN.
CR BADDELEY AJ, 1986, J MICROSC-OXFORD, V142, P259, DOI 10.1111/j.1365-2818.1986.tb04282.x
   Cochran W.G., 1977, SAMPLING TECHNIQUES
   CRUZORIVE LM, 1990, AM J PHYSIOL, V258, pL148
   CRUZORIVE LM, 1987, J MICROSC-OXFORD, V145, P121
   CRUZORIVE LM, 1986, J MICROSC-OXFORD, V143, P47, DOI 10.1111/j.1365-2818.1986.tb02765.x
   CRUZORIVE LM, 1989, J MICROSC-OXFORD, V153, P315, DOI 10.1111/j.1365-2818.1989.tb01480.x
   CRUZORIVE LM, 1980, BIOMETRICS, V36, P595, DOI 10.2307/2556113
   CRUZORIVE LM, 1983, J MICROSC-OXFORD, V131, P265, DOI 10.1111/j.1365-2818.1983.tb04255.x
   CRUZORIVE LM, 1980, J MICROSC-OXFORD, V120, P15
   CRUZORIVE LM, 1982, J MICROSC-OXFORD, V125, P89, DOI 10.1111/j.1365-2818.1982.tb00325.x
   CRUZORIVE LM, 1987, ACTA STEREOL S2, V6, P43
   GUNDERSEN HJG, 1981, J MICROSC-OXFORD, V121, P65, DOI 10.1111/j.1365-2818.1981.tb01199.x
   GUNDERSEN HJG, 1988, APMIS, V96, P379, DOI 10.1111/j.1699-0463.1988.tb05320.x
   GUNDERSEN HJG, 1988, APMIS, V96, P857, DOI 10.1111/j.1699-0463.1988.tb00954.x
   GUNDERSEN HJG, 1977, J MICROSC-OXFORD, V111, P219, DOI 10.1111/j.1365-2818.1977.tb00062.x
   GUNDERSEN HJG, 1985, J MICROSC-OXFORD, V138, P127, DOI 10.1111/j.1365-2818.1985.tb02607.x
   GUNDERSEN HJG, 1986, J MICROSC-OXFORD, V143, P3, DOI 10.1111/j.1365-2818.1986.tb02764.x
   GUNDERSEN HJG, 1987, J MICROSC-OXFORD, V147, P229, DOI 10.1111/j.1365-2818.1987.tb02837.x
   HOWARD V, 1985, J MICROSC-OXFORD, V138, P203, DOI 10.1111/j.1365-2818.1985.tb02613.x
   JENSEN EB, 1987, SCAND J STAT, V14, P161
   JENSEN EB, 1986, BIOMETRICS, V42, P735, DOI 10.2307/2530690
   JENSEN EB, 1985, J APPL PROBAB, V22, P82, DOI 10.2307/3213750
   KARLSSON LM, 1991, AM SOC TEST MATER, V1094, P277, DOI 10.1520/STP17272S
   Matheron G, 1965, VARIABLES REGIONALIS
   Matheron G, 1971, CAHIERS CTR MORPHOLO, V5
   MATTFELDT T, 1990, J MICROSC-OXFORD, V159, P301, DOI 10.1111/j.1365-2818.1990.tb03036.x
   MCCANCE I, 1989, NEWS PHYSIOL SCI, V4, P172
   MICHEL RP, 1988, J MICROSC-OXFORD, V150, P117, DOI 10.1111/j.1365-2818.1988.tb04603.x
   MILES RE, 1977, J MICROSC-OXFORD, V110, P27, DOI 10.1111/j.1365-2818.1977.tb00010.x
   MILES RE, 1976, J MICROSC-OXFORD, V107, P211, DOI 10.1111/j.1365-2818.1976.tb02444.x
   MILES RE, 1978, LECTURE NOTES BIOMAT, V23, P115
   MOSS MC, 1989, J MICROSC-OXFORD, V156, P79, DOI 10.1111/j.1365-2818.1989.tb02907.x
   RUSS JC, 1989, J MICROSC-OXFORD, V155, pRP1
   Saltykov S. A., 1974, STEREOMETRISCHE META
   Silverman BW., 1986, DENSITY ESTIMATION S
   STERIO DC, 1984, J MICROSC-OXFORD, V134, P127, DOI 10.1111/j.1365-2818.1984.tb02501.x
   Stoyan D, 1987, STOCHASTIC GEOMETRY
   UNDERWOOD EE, 1970, QUANTITATIVE STEREOL
   Weibel ER, 1979, STEREOLOGICAL METHOD, VI
   ZHAO HQ, 1991, THESIS U MANCHESTER
NR 40
TC 26
Z9 26
U1 1
U2 5
PU BLACKWELL SCIENCE LTD
PI OXFORD
PA OSNEY MEAD, OXFORD, OXON, ENGLAND OX2 0EL
SN 0022-2720
J9 J MICROSC-OXFORD
JI J. Microsc.-Oxf.
PD MAR
PY 1992
VL 165
BP 391
EP 415
DI 10.1111/j.1365-2818.1992.tb01495.x
PN 3
PG 25
WC Microscopy
SC Microscopy
GA HK455
UT WOS:A1992HK45500005
DA 2018-10-20
ER

PT J
AU EMERY, R
   JEANNETTE, M
   SPRAU, D
AF EMERY, R
   JEANNETTE, M
   SPRAU, D
TI CHARACTERIZATION OF LOW-LEVEL RADIOACTIVE-WASTE GENERATED BY A LARGE
   UNIVERSITY HOSPITAL COMPLEX
SO HEALTH PHYSICS
LA English
DT Article
DE WASTE MANAGEMENT; WASTE, LOW-LEVEL; COMPUTERS; REGULATIONS
ID INCINERATION; MICROSPHERES
AB Descriptions of the physical characteristics and radioactive contents of waste generated by a large university/hospital complex were recorded in a computerized data base for 1 y. The data were summarized to create a waste stream profile so that major waste sources could be identified and minimization efforts quantified. The resultant profile provides a comprehensive description of the low-level radioactive waste produced by a large biomedical research and patient care facility, and projects the methods that will be used to process and ultimately dispose of the material.
RP EMERY, R (reprint author), E CAROLINA UNIV, OFF RADIAT & BIOL SAFETY, GREENVILLE, NC 27834 USA.
CR BREKKE DD, 1985, HEALTH PHYS, V48, P339
   BUSH D, 1973, HEALTH PHYS, V24, P564
   CLASSIC K, 1985, HEALTH PHYS, V49, P1270
   EMERY RJ, 1990, HEALTH PHYS, V59, P911, DOI 10.1097/00004032-199012000-00014
   LANDOLT RR, 1983, HEALTH PHYS, V44, P671
   MCKETTY MH, 1991, HEALTH PHYS, V60, P453, DOI 10.1097/00004032-199103000-00017
   1989, STANDARDS PROTECT 20
   1989, BIOSAFETY LABORATORY
NR 8
TC 7
Z9 7
U1 0
U2 1
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0017-9078
EI 1538-5159
J9 HEALTH PHYS
JI Health Phys.
PD FEB
PY 1992
VL 62
IS 2
BP 183
EP 185
DI 10.1097/00004032-199202000-00009
PG 3
WC Environmental Sciences; Public, Environmental & Occupational Health;
   Nuclear Science & Technology; Radiology, Nuclear Medicine & Medical
   Imaging
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health; Nuclear Science & Technology; Radiology, Nuclear Medicine &
   Medical Imaging
GA HA640
UT WOS:A1992HA64000010
PM 1730561
DA 2018-10-20
ER

PT J
AU DOREMUS, RH
AF DOREMUS, RH
TI BIOCERAMICS
SO JOURNAL OF MATERIALS SCIENCE
LA English
DT Article
ID X-RAY-DIFFRACTION; DENTAL IMPLANTS; HYDROXY-APATITE; GLASS-CERAMICS;
   HYDROXYLAPATITE; BEHAVIOR; TITANIUM; BIOMATERIALS; INTERFACE; COMPOSITE
AB Ceramics, glasses, and glass-ceramics are increasingly being tested for use in the human body. These materials often have excellent chemical properties for biomedical use, but they are brittle and show fatigue. Careful analysis of their mechanical properties is needed to determine appropriate applications. Hydroxylapatite is emerging as the most promising bioceramic because it shows no foreign body reactions and bonds strongly to bone; if properly made without pores or second phases it has excellent fatigue resistance. Glass-ceramics containing hydroxylapatite crystals also show good promise for many applications. Different forms of these materials, such as dense, granular, mixed granular with plaster of Paris, and coatings on metals are being tested and have very good potential as bioceramics.
RP DOREMUS, RH (reprint author), RENSSELAER POLYTECH INST,DEPT MAT ENGN,TROY,NY 12180, USA.
CR Adair P J, 1984, Int J Periodontics Restorative Dent, V4, P32
   BLACK J, 1989, J BIOMED MATER RES, V23, P1243, DOI 10.1002/jbm.820231102
   BLENCKE BA, 1978, J BIOMED MATER RES, V12, P307, DOI 10.1002/jbm.820120305
   BLOCK MS, 1987, J ORAL MAXIL SURG, V45, P601, DOI 10.1016/0278-2391(87)90270-9
   BRACKETT SE, 1989, BIOMEDICAL MATERIALS, P579
   Bucholz R W, 1987, J Orthop Trauma, V1, P260, DOI 10.1097/00005131-198701030-00013
   BUCHOLZ RW, 1989, CLIN ORTHOP RELAT R, V240, P53
   BURKE JE, 1971, CERAMICS SEVERE ENV, P435
   CARNEVALE RA, 1989, BIOMEDICAL MATERIALS, P257
   CHARLES RJ, 1958, J APPL PHYS, V29, P1657, DOI 10.1063/1.1723019
   COOK SD, 1988, CLIN ORTHOP RELAT R, V230, P303
   DALGLEISH BJ, 1981, J BIOMED MATER RES, V15, P527, DOI 10.1002/jbm.820150408
   DAMIEN CJ, 1990, J BIOMED MATER RES, V24, P639, DOI 10.1002/jbm.820240602
   de Groot K, 1989, J Biomed Mater Res, V23, P1367, DOI 10.1002/jbm.820231112
   de Groot K, 1983, BIOCERAMICS CALCIUM
   DEGROOT K, 1987, J BIOMED MATER RES, V21, P1375, DOI 10.1002/jbm.820211203
   DEGROOT K, 1983, BIOCERAMICS CALCIUM, P115
   DELANGE GL, 1990, J BIOMED MATER RES, V24, P829, DOI 10.1002/jbm.820240704
   DELANGE GL, 1989, J DENT RES, V68, P509, DOI 10.1177/00220345890680031601
   DELISLE MP, 1984, UNPUB
   DEWITH G, 1981, J MATER SCI, V16, P1592
   DEWITH G, 1989, J MATER SCI, V24, P3411, DOI 10.1007/BF01139073
   Doremus R., 1973, GLASS SCI, P237
   Doremus R. H., 1982, TREATISE MATERIALS S, V22, P169
   DOREMUS RH, 1980, ENG FRACT MECH, V13, P945, DOI 10.1016/0013-7944(80)90024-7
   DOREMUS RH, 1983, J APPL PHYS, V54, P193, DOI 10.1063/1.331731
   DOREMUS RH, 1984, METAL CERAMIC BIOMAT, V1, P107
   DOREMUS RH, 1984, METAL CERAMIC BIOMAT, V2
   DOREMUS RH, 1985, STRENGTH INORGANIC G, P231
   Douglas R. W., 1972, HIST GLASSMAKING
   DUCHEYNE P, 1988, J BIOMED MATER RES, V22, P1137, DOI 10.1002/jbm.820221207
   Ducheyne P., 1984, METAL CERAMIC BIOMAT, VII
   DUCHEYNE P, 1984, METAL CERAMIC BIOMAT, V1
   DUCHEYNE P, 1988, ANN NEW YORK ACADEMY, V523
   ELDEEB M, 1988, J ORAL MAXIL SURG, V46, P33
   ELDEEB M, 1988, J ORAL MAXIL SURG, V46, P758
   EPSTEIN N, 1989, SMITHSONIAN      DEC, P98
   GROSSMAN DG, 1985, DENT CLIN N AM, V29, P725
   HABAL MB, 1989, BIOMEDICAL MATERIALS, P205
   HANGST K, 1989, BIOMEDICAL MATERIALS, P269
   HANKER JS, 1988, SCIENCE, V242, P885, DOI 10.1126/science.3055300
   HANKER JS, 1989, BIOMEDICAL MATERIALS
   HAYASHI K, 1989, J BIOMED MATER RES, V23, P1247, DOI 10.1002/jbm.820231103
   HENCH LL, 1971, J BIOMED MATER RES S, V2, P117, DOI DOI 10.1002/JBM.820050611
   HOBO S, 1985, QUINTESSENCE INT, V16, P451
   HOBO S, 1985, QUINTESSENCE INT, V16, P135
   Hobo S., 1985, QUINTESSENCE INT, V16, P207
   HOBO S, 1985, QUINTESSENCE INT, V16, P509
   HOLMES RE, 1986, J BONE JOINT SURG AM, V68A, P904, DOI 10.2106/00004623-198668060-00013
   Hulbert SF, 1971, CERAMICS SEVERE ENV, P417
   Inglis C. E, 1913, T I NAVAL ARCHITEC 1, V55, P219
   JARCHO M, 1979, J MATER SCI, V14, P142, DOI 10.1007/BF01028337
   JARCHO M, 1976, J MATER SCI, V11, P2027, DOI 10.1007/BF02403350
   JARCHO M, 1977, J BIOENG, V1, P79
   KABUTANI Y, 1989, J BIOMED MATER RES, V23, P781
   KAY JF, 1977, THESIS RENSSELAER PO
   KITSAGO T, 1990, J BIOMED MATER RES, V24, P331
   KITSUGI T, 1986, J BIOMED MATER RES, V20, P1295, DOI 10.1002/jbm.820200906
   KITSUGI T, 1990, J BIOMED MATER RES, V24, P259, DOI 10.1002/jbm.820240211
   KLEIN CPAT, 1987, BIOMATERIALS, V8, P308
   KOCH B, 1990, J BIOMED MATER RES, V24, P655, DOI 10.1002/jbm.820240603
   KUKUBO T, 1985, J MATER SCI, V20, P2001
   KUKUBO T, 1982, YOGYO-KYOKAI-SHI, V90, P151
   KUKUBO T, 1987, J BIOMED MATER RES, V22, P4067
   KUKUBOI T, 1983, GLASTECH BER, V56, P695
   MALAMENT KA, 1987, J PROSTHET DENT, V57, P674, DOI 10.1016/0022-3913(87)90362-3
   MCLEAN JW, 1987, QUINTESSENCE INT, V18, P97
   NAKAMURA T, 1985, J BIOMED MATER RES, V19, P685, DOI 10.1002/jbm.820190608
   Richerson DW, 1982, MODERN CERAMIC ENG
   RITCHIE RO, 1990, J BIOMED MATER RES, V24, P189, DOI 10.1002/jbm.820240206
   RIVERO DP, 1988, J BIOMED MATER RES, V22, P191, DOI 10.1002/jbm.820220304
   SCHEPERS E, 1977, THESIS U FLORIDA GAI, P178
   TERRY BC, 1989, BIOMEDICAL MATERIALS, P187
   THOMAS KA, 1987, J BIOMED MATER RES, V21, P1395, DOI 10.1002/jbm.820211205
   THOMAS KA, 1989, J BIOMED MATER RES, V23, P1369
   THOMAS MB, 1980, J MATER SCI, V16, P891
   THOMAS MB, 1983, AM CERAM SOC B, V60, P258
   Tooley F. V., 1974, HDB GLASS MANUFACTUR
   TRACY BM, 1984, J BIOMED MATER RES, V18, P719, DOI 10.1002/jbm.820180702
   URATSIYI M, 1989, BIOMEDICAL MATERIALS, P199
   VANBLITTERSWIJK CA, 1990, J BIOMED MATER RES, V24, P433, DOI 10.1002/jbm.820240403
   WALKER MM, 1984, THESIS RENSSELAER PO
   WITTKAMPF ARM, 1988, J ORAL MAXIL SURG, V46, P1019, DOI 10.1016/0278-2391(88)90344-8
   ZIDE MF, 1987, J ORAL MAXIL SURG, V45, P481, DOI 10.1016/S0278-2391(87)80006-X
   1978, ENCY CHEM TECHNOLOGY, V4, P556
NR 85
TC 161
Z9 170
U1 1
U2 23
PU CHAPMAN HALL LTD
PI LONDON
PA 2-6 BOUNDARY ROW, LONDON, ENGLAND SE1 8HN
SN 0022-2461
J9 J MATER SCI
JI J. Mater. Sci.
PD JAN 15
PY 1992
VL 27
IS 2
BP 285
EP 297
DI 10.1007/BF00543915
PG 13
WC Materials Science, Multidisciplinary
SC Materials Science
GA HB978
UT WOS:A1992HB97800001
DA 2018-10-20
ER

PT J
AU DESAI, NP
   HUBBELL, JA
AF DESAI, NP
   HUBBELL, JA
TI SURFACE PHYSICAL INTERPENETRATING NETWORKS OF
   POLY(ETHYLENE-TEREPHTHALATE) AND POLY(ETHYLENE OXIDE) WITH BIOMEDICAL
   APPLICATIONS
SO MACROMOLECULES
LA English
DT Article
ID SLOW SPINODAL DECOMPOSITION; BINARY-LIQUID MIXTURES; POLY(METHYL
   METHACRYLATE); POLYMER NETWORKS; MOLECULAR-WEIGHT; BLENDS; MISCIBILITY;
   HYDROGEL; CHAINS
AB Poly(ethylene terephthalate) (PET) films were modified by diffusing poly(ethylene oxide) (PEO) into the surface of the PET, which was swollen in a mutual solvent.  Subsequent rapid deswelling in a nonsolvent for PET resulted in the stable entrapment of the PEO within the surface of the PET.  The PET/PEO systems produced by this technique were phase-mixed nonequilibrium surface structures, kinetically stable below the T(g) for PET.  The surface-localized structure is referred to as a surface physical interpenetrating network (SPIN), due to the similarity of the forming technique to that for a sequential interpenetrating polymer network.  Analyses of these materials by X-ray photoelectron spectroscopy (XPS) and NMR spectroscopy revealed PEO incoroporation as high as 23 mol % or 6.4 wt %, with a preferential localization of the PEO near the surface of the PET film.  Differential scanning calorimetry (DSC) indicated a phase-mixed structure, despite the thermodynamic incompatibility of PEO and PET, which could be induced to phase separate upon heating above the PET T(g).  These materials were stable at 37-degrees-C for several months in an aqueous environment, but PEO leaching occurred upon incubation in water at temperatures near the PET T(g) as well as upon swelling the PET with organic solvents at room temperature.  These materials have been previously shown by us to be extraordinarily resistant to cellular adhesion.
C1 UNIV TEXAS,DEPT CHEM ENGN,AUSTIN,TX 78712.
RI Hubbell, Jeffrey/A-9266-2008
OI Hubbell, Jeffrey/0000-0003-0276-5456
CR BRINKMAN E, 1990, BIOMATERIALS, V11, P200, DOI 10.1016/0142-9612(90)90156-K
   CHISATO N, 1989, T AM SOC ART INT ORG, V35, P357
   Desai N. P., 1990, POLYM MAT SCI ENG, V62, P731
   DESAI NP, 1991, BIOMATERIALS, V12, P144, DOI 10.1016/0142-9612(91)90193-E
   DESAI NP, 1991, J BIOMED MATER RES, V25, P829, DOI 10.1002/jbm.820250704
   DESAI NP, IN PRESS BIOMATERIAL
   Fox G., 1956, B AM PHYS SOC, V1, P123
   GASHGARI MA, 1988, MACROMOLECULES, V21, P2782, DOI 10.1021/ma00187a024
   GOMBOTZ WR, 1989, J APPL POLYM SCI, V37, P91, DOI 10.1002/app.1989.070370108
   GRAINGER DW, 1989, J BIOMED MATER RES, V23, P979, DOI 10.1002/jbm.820230903
   Grulke E.A., 1989, POLYM HDB, pVII/519
   HUBBELL JA, 1991, BIO-TECHNOL, V9, P568, DOI 10.1038/nbt0691-568
   HUNTER SK, 1983, T AM SOC ART INT ORG, V29, P250
   ICHIHARA S, 1971, POLYM J, V2, P640, DOI 10.1295/polymj.2.640
   IZUMITANI T, 1985, J CHEM PHYS, V83, P3694, DOI 10.1063/1.449124
   LAWTON EL, 1989, POLYM HDB, P101
   LEE JH, 1989, J BIOMED MATER RES, V23, P351, DOI 10.1002/jbm.820230306
   MAECHLINGSTRASSER C, 1989, J BIOMED MATER RES, V23, P1385, DOI 10.1002/jbm.820231202
   MARCO C, 1990, MACROMOLECULES, V23, P2183, DOI 10.1021/ma00210a011
   MARUTA J, 1988, POLYMER, V29, P2056, DOI 10.1016/0032-3861(88)90180-2
   MERRILL EW, 1982, T AM SOC ART INT ORG, V28, P482
   MORI Y, 1982, T AM SOC ART INT ORG, V28, P459
   MUKAE K, 1990, POLYM J, V22, P250, DOI 10.1295/polymj.22.250
   NAGAOKA S, 1990, BIOMATERIALS, V11, P119, DOI 10.1016/0142-9612(90)90126-B
   NISHIMOTO M, 1991, POLYMER, V32, P272, DOI 10.1016/0032-3861(91)90013-9
   PFENNIG JLG, 1986, J APPL POLYM SCI, V32, P3657, DOI 10.1002/app.1986.070320221
   SEFTON MV, 1990, P ACS DIV POLYM MATE, V62, P741
   SHULTZ AR, 1980, MACROMOLECULES, V13, P663, DOI 10.1021/ma60075a034
   SHULTZ AR, 1976, J APPL POLYM SCI PS, V54, P341
   Sperling L. H., 1981, INTERPENETRATING POL
   SUNG C, 1990, POLYMER, V31, P556, DOI 10.1016/0032-3861(90)90402-K
   TAKENAKA M, 1987, MACROMOLECULES, V20, P2257, DOI 10.1021/ma00175a034
   TORNALA P, 1979, EUR POLYM J, V10, P519
NR 33
TC 119
Z9 121
U1 0
U2 18
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036
SN 0024-9297
J9 MACROMOLECULES
JI Macromolecules
PD JAN 6
PY 1992
VL 25
IS 1
BP 226
EP 232
DI 10.1021/ma00027a038
PG 7
WC Polymer Science
SC Polymer Science
GA GZ539
UT WOS:A1992GZ53900038
DA 2018-10-20
ER

PT J
AU PACE, SJ
   HAMERSLAG, JD
AF PACE, SJ
   HAMERSLAG, JD
TI THICK-FILM MULTILAYER ION SENSORS FOR BIOMEDICAL APPLICATIONS
SO ACS SYMPOSIUM SERIES
LA English
DT Review
ID SELECTIVE MEMBRANE ELECTRODE; CARBONATE ION
AB Planar format thick film ion sensors have been designed for biomedical applications. The multilayer sensor structure consists of layers sequentially deposited on a ceramic substrate using a screen printing process. All layers are of solid composition with the uppermost chemically active layer consisting of polyvinyl chloride (PVC). Because no aqueous layers are used in the construction, the resulting devices are stable and robust. The PVC layer serves as a common membrane vehicle for a multitude of ion specific ligands that may be patterned on a substrate. This paper describes the chemical and electrochemical principles of design, construction and measurement of ion sensing devices for blood electrolytes; K+, Na+, Cl-, HCO3-, pH and the potential for many other clinically significant tests. The more pragmatic issues of packaging design and materials of construction are treated in the context of device performance (i.e., analytical efficacy, reliability and stability) for the biological application intended.
RP PACE, SJ (reprint author), DUPONT CO, MED PROD, GLASGOW SITE, BOX 509, POB 6101, NEWARK, DE 19714 USA.
CR AMMANN D, 1981, ANAL CHEM, V53, P2267, DOI 10.1021/ac00237a031
   COETZEE CJ, 1969, ANAL CHEM, V41, P1128, DOI 10.1021/ac60277a017
   COETZEE CJ, 1968, ANAL CHEM, V40, P2071, DOI 10.1021/ac60269a036
   HAMBLEN DP, 1977, Patent No. 4053381
   HERMAN HB, 1975, ANAL CHIM ACTA, V76, P155, DOI 10.1016/S0003-2670(01)81997-8
   HERMAN HB, 1974, SCIENCE, V184, P1074, DOI 10.1126/science.184.4141.1074
   KEDEM O, 1970, Patent No. 2027128
   PACE SJ, 1985, 3RD P INT C SOL STAT
   PACE SJ, 1986, 2ND P INT M CHEM SEN
   PACE SJ, 1980, CHEM SENSITIVE ELECT
   PACE SJ, 1985, MED INSTRUM, V40, P168
   PIODA LAR, 1969, ANAL LETT, V2, P665, DOI 10.1080/00032716908051343
   SHULTHESS P, 1981, ANAL CHIM ACTA, P131
   SIMON W, 1989, Patent No. 479870
   TOHDA K, 1990, ANAL SCI, V6, P227, DOI 10.2116/analsci.6.227
NR 15
TC 1
Z9 1
U1 0
U2 3
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0097-6156
J9 ACS SYM SER
JI ACS Symp. Ser.
PY 1992
VL 487
BP 261
EP 273
PG 13
WC Chemistry, Multidisciplinary
SC Chemistry
GA HX624
UT WOS:A1992HX62400022
DA 2018-10-20
ER

PT J
AU LIM, CK
AF LIM, CK
TI POROUS GRAPHITIC CARBON IN BIOMEDICAL APPLICATIONS
SO ADVANCES IN CHROMATOGRAPHY
LA English
DT Review
ID PERFORMANCE LIQUID-CHROMATOGRAPHY; PACKING MATERIAL; SEPARATION;
   ADSORBENT; RETENTION; COLUMNS; BLACK; PHASE
RP LIM, CK (reprint author), CLIN RES CTR,DIV CLIN CELL BIOL,HARROW HA1 3UJ,MIDDX,ENGLAND.
CR BASSLER BJ, 1989, J CHROMATOGR SCI, V27, P162, DOI 10.1093/chromsci/27.4.162
   BASSLER BJ, 1989, J CHROMATOGR, V461, P139, DOI 10.1016/S0021-9673(00)94283-3
   BERRIDGE JC, 1988, J CHROMATOGR, V449, P317
   CABRERA K, 1990, INT LAB, V20, P28
   CHIANTORE O, 1988, ANAL CHEM, V60, P638, DOI 10.1021/ac00158a007
   CICCIOLI P, 1981, J CHROMATOGR, V206, P35, DOI 10.1016/S0021-9673(00)82603-5
   COLIN H, 1976, J CHROMATOGR, V126, P43, DOI 10.1016/S0021-9673(01)84062-0
   COLIN H, 1976, J CHROMATOGR, V119, P41, DOI 10.1016/S0021-9673(00)86769-2
   COLIN H, 1976, J CHROMATOGR, V122, P233
   DOLPHIN J, 1989, LAB PRACT, V38, P71
   EMERY MF, 1989, J CHROMATOGR, V479, P212, DOI 10.1016/S0021-9673(01)83336-7
   FELL AF, 1988, J CHROMATOGR-BIOMED, V434, P377, DOI 10.1016/S0378-4347(88)80004-5
   GILBERT MT, 1982, CHROMATOGRAPHIA, V16, P138, DOI 10.1007/BF02258884
   GU GH, 1990, J CHROMATOGR, V515, P183, DOI 10.1016/S0021-9673(01)89312-2
   KALISZAN R, 1990, J CHROMATOGR, V499, P333, DOI 10.1016/S0021-9673(00)96983-8
   Kaur B., 1990, LC GC, V3, P41
   KNOX JH, 1986, J CHROMATOGR, V352, P3, DOI 10.1016/S0021-9673(01)83368-9
   KNOX JH, 1983, J LIQ CHROMATOGR, V6, P1, DOI 10.1080/01483918308067647
   KNOX JH, 1989, HIGH PERFORMANCE LIQ, P189
   LIM CK, 1989, BIOMED CHROMATOGR, V3, P92, DOI 10.1002/bmc.1130030212
   MAMA JE, 1989, ANAL P, V26, P7
   PATZELOVA V, 1978, J CHROMATOGR, V148, P53, DOI 10.1016/S0021-9673(00)99321-X
   PLZAK Z, 1978, J CHROMATOGR, V147, P137, DOI 10.1016/S0021-9673(00)85125-0
   SMITH NW, HPLC 88 WASHINGTON
   UNGER K, 1980, J CHROMATOGR, V202, P3, DOI 10.1016/S0021-9673(00)80071-0
   WARD TJ, 1988, CHROMATOGRAPHIC SCI, V40, P131
   ZWIER TA, 1981, ANAL CHEM, V53, P812, DOI 10.1021/ac00229a017
NR 27
TC 19
Z9 19
U1 1
U2 8
PU MARCEL DEKKER INC
PI NEW YORK
PA 270 MADISON AVE, NEW YORK, NY 10016
SN 0065-2415
J9 ADV CHROMATOGR
JI Adv. Chromatogr.
PY 1992
VL 32
BP 1
EP 19
PG 19
WC Chemistry, Analytical
SC Chemistry
GA HF542
UT WOS:A1992HF54200001
PM 1727327
DA 2018-10-20
ER

PT J
AU BEARD, RB
   HUNG, BN
   SCHMUKLER, R
AF BEARD, RB
   HUNG, BN
   SCHMUKLER, R
TI BIOCOMPATIBILITY CONSIDERATIONS AT STIMULATING ELECTRODE INTERFACES
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article; Proceedings Paper
CT MINI SYMP ON BIOELECTRODES, AT THE 12TH ANNUAL MEETING OF THE
   ENGINEERING IN MEDICINE AND BIOLOGY SOC OF IEEE
CY NOV, 1990
CL PHILADELPHIA, PA
SP IEEE, ENGN MED & BIOL SOC, IEEE, ELECTROBIOLOGY, PRINCETON APPL RES
DE BIOCOMPATIBILITY; STIMULATING ELECTRODES; INFLAMMATION; PH AND ELECTRODE
   POTENTIAL
AB The choice of biocompatible stimulating electrodes for various biomedical applications varies with the type of electrode-tissue interface, biomolecules present, electrolyte background, preparation of electrode, interfacial potential current density, electrode material porosity, geometry, and inflammatory response. Illustrative examples are given to demonstrate the importance of these parameters. Topics discussed are: A) DC electrodes applied to partially keratinized epithelial membranes: B) Variation of the electrical impedance and biocompatibility of stimulating electrodes with electrode potential and surrounding pH; C) Influence of electrode geometry, porosity and pore size on biocompatibility: D) Body defense mechanisms at the sites of implantable stimulating electrodes; E) Thrombus formation at stimulating electrode interfaces and F) Sterilization of electrodes to ensure biocompatibility.
C1 US FDA,CTR DEVICES & RADIOL HLTH,ROCKVILLE,MD 20857.
   CHUNG YUAN CHRISTIAN UNIV,CHUNGLI,TAIWAN.
RP BEARD, RB (reprint author), DREXEL UNIV,INST BIOMED ENGN & SCI,PHILADELPHIA,PA 19104, USA.
CR ANDRADE JD, 1985, SURFACE INTERFACIAL, V2
   Bard A.J., 1980, ELECTROCHEMICAL METH
   BATES JB, 1992, ANN BIOMED ENG, V20, P349, DOI 10.1007/BF02368536
   BERNARDE MA, 1970, DISINFECTION
   BROWNSTEIN M, 1979, THESIS DREXEL U PHIL
   BROWNSTEIN M, 1978, THESIS DREXEL U PHIL
   BUCK RP, 1992, ANN BIOMED ENG, V20, P363, DOI 10.1007/BF02368537
   De Levie R., 1965, Electrochimica Acta, V10, P113, DOI 10.1016/0013-4686(65)87012-8
   DELEVIE R, 1992, ANN BIOMED ENG, V20, P337, DOI 10.1007/BF02368535
   DELLAVECCHIA MA, 1984, THESIS DREXEL U PHIL
   DEROSA J, 1973, COMMUNICATION
   DEROSA JF, 1977, IEEE T BIO-MED ENG, V24, P260, DOI 10.1109/TBME.1977.326211
   DYMOND AM, 1976, IEEE T BME, V23
   FENG D, 1991, THESIS DREXEL U PHIL
   GEDDES LA, 1989, PRINCIPLES APPLIED B
   GOULD MR, 1982, THESIS DREXEL U PHIL
   GREENE ND, 1973, CORROSION, V29
   Ham A.W., 1965, HISTOLOGY
   HENCH LL, 1975, ADV BIOMEDICAL ENG, V5
   HIRSHORN MS, 1981, PACE, V4, P380, DOI 10.1111/j.1540-8159.1981.tb03716.x
   Hoare J. P., 1968, ELECTROCHEMISTRY OXY
   Hoare JP, 1967, ADV ELECTROCHEMISTRY, V6
   HUANG MY, 1977, THESIS U PENNSYLVANI
   HULBERT SF, 1972, J BIOMED MATER RES, V6, P347, DOI 10.1002/jbm.820060505
   HUNG BN, 1979, ELECTRICAL PROPERTIE, P249
   HUNG BN, 1979, THESIS DREXEL U PHIL
   HUNG BN, 1975, THESIS DREXEL U PHIL
   LAWRENCE CA, 1968, DISINFECTION STERILI
   LEITES SS, 1973, ELEKTROKHIMIYA, V9, P620
   MALE, 1988, ADV IMMUNOLOGY
   MARGULIES N, 1986, THESIS DREXEL U PHIL
   MCADAMS ET, ANN BIOMED ENG, V20, P307
   MCCREERY DB, 1987, IEEE T BIO-MED ENG, V34, P664, DOI 10.1109/TBME.1987.325990
   MOUSSAURI M, 1991, COMMUNICATION
   MUND M, 1979, SIEMENS FORSCH U ENT, V8, P3
   Neuman M. R., 1978, MED INSTRUMENTATION
   ONARAL B, 1982, MED BIOL ENG COMPUT, V20, P299, DOI 10.1007/BF02442796
   ONARAL B, 1978, THESIS U PENNSYLVANI
   PLONSEY R, 1988, BIOELECTRICITY QUANT
   Pourbaix M., 1974, ATLAS ELECTROCHEMICA
   RANDLES JEB, 1947, DISCUSS FARADAY SOC, V1, P11, DOI 10.1039/df9470100011
   REINMUTH WH, 1962, ANAL CHEM, V34, P1446, DOI 10.1021/ac60191a030
   Richard BB, 1989, US Patent, Patent No. 4854865
   SAWYER PN, 1974, J ELECTROCHEM SOC C, V221
   SCHMUKLER RE, 1976, THESIS DREXEL U PHIL
   SCHWAN HP, 1963, PHYSICAL TECHNIQUE B, V6
   SCOLES KT, 1989, ISHM 89 P
   SIMPSON RW, 1976, THESIS U PENNSYLVANI
   SLUYTERS JH, 1960, RECL TRAV CHIM PAY B, V29, P1092
   STURM LJ, 1974, THESIS DREXEL U PHIL
   SUN HH, 1983, T BIOMED ENG, V30
   TUNIMER B, 1968, J ELECTROANAL CHEM, V18, P93
   WILKINSON PG, 1974, NATURE, V252, P58
NR 53
TC 22
Z9 23
U1 1
U2 8
PU BLACKWELL SCIENCE INC
PI MALDEN
PA 350 MAIN ST, MALDEN, MA 02148
SN 0090-6964
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PY 1992
VL 20
IS 3
BP 395
EP 410
DI 10.1007/BF02368539
PG 16
WC Engineering, Biomedical
SC Engineering
GA JB791
UT WOS:A1992JB79100011
PM 1443832
DA 2018-10-20
ER

PT B
AU SALITO, A
   BARBEZAT, G
   FILMER, H
   HOCHSTRASSER, J
   NICOLL, AR
   TROTTA, F
AF SALITO, A
   BARBEZAT, G
   FILMER, H
   HOCHSTRASSER, J
   NICOLL, AR
   TROTTA, F
BE RAVAGLIOLI, A
   KRAJEWSKI, A
TI PLASMA SPRAY SYSTEMS FOR THE DEPOSITION OF MATERIALS FOR BIOMEDICAL
   APPLICATIONS
SO BIOCERAMICS AND THE HUMAN BODY
LA English
DT Proceedings Paper
CT INTERNATIONAL CONGRESS ON BIOCERAMICS AND THE HUMAN BODY
CY APR 02-05, 1991
CL FAENZA, ITALY
SP CNR
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER APPL SCI PUBL LTD
PI BARKING ESSEX
PA BARKING ESSEX
BN 1-85166-748-2
PY 1992
BP 156
EP 165
PG 10
WC Engineering, Biomedical; Materials Science, Ceramics
SC Engineering; Materials Science
GA BW91A
UT WOS:A1992BW91A00020
DA 2018-10-20
ER

PT B
AU VALLANA, F
   ARRU, P
   SANTI, M
AF VALLANA, F
   ARRU, P
   SANTI, M
BE RAVAGLIOLI, A
   KRAJEWSKI, A
TI BULK AND THIN-FILM CARBON MATERIALS FOR BIOMEDICAL APPLICATIONS -
   QUALITY-CONTROL CRITERIA AND PROCEDURES
SO BIOCERAMICS AND THE HUMAN BODY
LA English
DT Proceedings Paper
CT INTERNATIONAL CONGRESS ON BIOCERAMICS AND THE HUMAN BODY
CY APR 02-05, 1991
CL FAENZA, ITALY
SP CNR
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER APPL SCI PUBL LTD
PI BARKING ESSEX
PA BARKING ESSEX
BN 1-85166-748-2
PY 1992
BP 461
EP 470
PG 10
WC Engineering, Biomedical; Materials Science, Ceramics
SC Engineering; Materials Science
GA BW91A
UT WOS:A1992BW91A00064
DA 2018-10-20
ER

PT J
AU CLAROTTI, G
   SCHUE, F
   SLEDZ, J
   BENAOUMAR, AA
   GECKELER, KE
   ORSETTI, A
   PALEIRAC, G
AF CLAROTTI, G
   SCHUE, F
   SLEDZ, J
   BENAOUMAR, AA
   GECKELER, KE
   ORSETTI, A
   PALEIRAC, G
TI MODIFICATION OF THE BIOCOMPATIBLE AND HAEMOCOMPATIBLE PROPERTIES OF
   POLYMER SUBSTRATES BY PLASMA-DEPOSITED FLUOROCARBON COATINGS
SO BIOMATERIALS
LA English
DT Article
DE PLASMA COATING; SURFACE TREATMENT; SURFACE CHARACTERIZATION
ID SURFACES; FILMS
AB The polymerization of gases present in a low temperature plasma is a technique particularly well suited for biomedical material processing. Therefore, the possibilities this technique offers to increase the biocompatibility and haemocompatibility of polysulphone and poly(hydroxybutyrate) membranes to be used in a new bioartificial pancreas device were studied. The deposition of thin fluorocarbon coatings from an argon plasma containing perfluorohexane gave very smooth and hydrophobic surfaces without affecting the filtering properties of the treated membranes. Adding hydrogen increased the reaction yield, but gave rougher and less hydrophobic coatings. We characterized the biological properties of the treated surfaces and discussed the influence of the modified surface properties on the biological behaviour of the treated polymers. The good biocompatibility of the deposited coatings was established by following in vitro the insulin secretion of Langerhans islets cultured on the treated membranes and by examining the fibrous capsule that developed on plasma-treated polymer disks after three months of in vivo incubation in the peritoneum of Wistar rats. Rough and haemocompatible films of poly(hydroxybutyrate) and smoother, but more thrombogenic, polysulphone films were treated by perfluorohexane and perfluorohexane + H-2 plasmas to study the relative influence of surface roughness and surface energy on polymer thrombogenicity. In vitro protein adsorption and total blood clotting tests proved that the surface roughness influences the thrombogenicity more than the other surface properties. This study seems to show that the plasma deposition of smooth and hydrophobic fluorocarbon coatings can increase the biocompatibility and reduce the surface thrombogenicity of the treated membranes without affecting their filtering properties.
C1 CHR LAPEYRONIE,EXPLORAT HORMONES LAB,MONTPELLIER,FRANCE.
   CTR TRANSFUS SANGUINE,HEMOSTASE LAB,MONTPELLIER,FRANCE.
   UNIV TUBINGEN,INST ORGAN CHEM,W-7400 TUBINGEN 1,GERMANY.
RP CLAROTTI, G (reprint author), UNIV MONTPELLIER 2,CHIM MACROMOLEC LAB,PL E BATAILLON,F-34095 MONTPELLIER 2,FRANCE.
CR ABSOLOM DR, 1987, J BIOMED MATER RES, V21, P161, DOI 10.1002/jbm.820210202
   Andrade JD, 1986, ADV POLYM SCI, V79, P3
   AOUMAR AAB, 1989, C INSERM, V177, P208
   AOUMAR AAB, 1989, THESIS U MONTPELLIER
   BRUCK SD, 1980, PROPERTIES BIOMATERI
   CHAWLA AS, 1986, POLYM BIOMATERIALS, P231
   CHICK WL, 1977, SCIENCE, V197, P780, DOI 10.1126/science.407649
   CLAROTTI G, 1991, MAKROMOL CHEM, V192, P2581
   DAWIDS S, 1986, BLOOD COMPATIBLE MAT
   GIRIFALCO J, 1957, PHYS CHEM, V16, P417
   HOFFMAN AS, 1984, ADV POLYM SCI, V57, P141
   HOFFMANN AS, 1987, CRIT REV BIOCOMPAT, V4, P1
   IKADA Y, 1984, ADV POLYM SCI, V57, P104
   MATSUDA T, 1984, T AM SOC ART INT ORG, V30, P353
   NICHOLS MF, 1979, J BIOMED MATER RES, V13, P299, DOI 10.1002/jbm.820130210
   ORSETTI A, 1986, J EUR SOC ARTIF O S2, V4, P374
   OWENS DK, 1969, J APPL POLYM SCI, V13, P1741, DOI 10.1002/app.1969.070130815
   SCHUE F, 1988, POLYM MED, V3, P136
   VROMAN L, 1977, ANN NY ACAD SCI, V283
   YASUDA H, 1981, MACROMOL REV, V16, P199
   YASUDA H, 1982, BIOMATERIALS, V3, P68, DOI 10.1016/0142-9612(82)90036-9
   1978, US PHARMACOPEIA 19
NR 22
TC 45
Z9 45
U1 3
U2 20
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PY 1992
VL 13
IS 12
BP 832
EP 840
DI 10.1016/0142-9612(92)90176-O
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA JV211
UT WOS:A1992JV21100004
PM 1457676
DA 2018-10-20
ER

PT J
AU SLUTSKII, LI
   SEVASTJANOVA, NA
   OZOLANTA, IL
   KUZMINA, IV
   DOMBROVSKA, LE
AF SLUTSKII, LI
   SEVASTJANOVA, NA
   OZOLANTA, IL
   KUZMINA, IV
   DOMBROVSKA, LE
TI REACTOGENICITY OF BIOMATERIALS AS STUDIED BY BIOCHEMICAL, MORPHOLOGICAL
   AND ULTRASTRUCTURAL TECHNIQUES
SO CELLS AND MATERIALS
LA English
DT Article
DE BIOMATERIALS; IMPLANTS; REACTOGENICITY; CONNECTIVE TISSUE REACTION;
   INFLAMMATION; GRANULOFIBROUS TISSUE; SURGICAL THREADS; METHODS OF STUDY
ID WOUND REPAIR; POLYMER SURFACES; TISSUE REACTION; CARRAGEENIN GRANULOMA;
   BIOMEDICAL POLYMERS; COLLAGEN PRODUCTION; IMPLANT INTERFACE;
   GUINEA-PIGS; FIBRONECTIN; INVITRO
AB Reactogenicity is a characteristic of biocompatible materials that provokes the reparative and proliferative reaction of connective tissues, a compulsory stage of which is inflammation. Thus, reactogenicity studies should include experiments in vivo. A quantitative assessment of reactogenicity can be obtained by subcutaneous implantation of standard olive-shaped specimens covered by the biomaterial under study followed by biochemical, histological and scanning electron microscopical studies of the capsule developing around the implant. Reactogenicity of surgical threads is evaluated by semiquantitative histological analysis of the wound healing process after suture application. Biomaterial reactogenicity can be modified by changing the structure of the surface and its chemical characteristics, and in particular, by applying different biologically active substances including atrane-containing compounds. The reactogenicity indices suggested present the results of the interaction between the biomaterials and the cells.
RP SLUTSKII, LI (reprint author), LATVIAN TRAUMATOL & ORTHOPAED RES INST, 226005 RIGA, LATVIA, USSR.
CR ABSOLOM DR, 1987, J BIOMED MATER RES, V21, P161, DOI 10.1002/jbm.820210202
   AGELLI M, 1986, CLIN EXP RHEUMATOL, V4, P379
   AMUDESWARI S, 1986, J BIOMED MATER RES, V20, P1103, DOI 10.1002/jbm.820200804
   ANDREASSEN TT, 1985, EUR SURG RES, V17, P264, DOI 10.1159/000128477
   ASMAN B, 1988, ARCH ORAL BIOL, V33, P65, DOI 10.1016/0003-9969(88)90097-0
   BAGNALL RD, 1980, BIOMATERIALS, V1, P97, DOI 10.1016/0142-9612(80)90006-X
   BAKKER D, 1988, J BIOMED MATER RES, V22, P423, DOI 10.1002/jbm.820220506
   BARBUL A, 1989, SURGERY, V105, P764
   BARNES D, 1988, METHOD ENZYMOL, V163, P707
   BATEMAN JF, 1986, J BIOL CHEM, V261, P4198
   BEAHAN P, 1982, J BIOMED MATER RES, V16, P827, DOI 10.1002/jbm.820160608
   BELL PB, 1980, BIOMEDICAL RES APPLI, V2, P1
   BERNHARD WF, 1980, J THORAC CARDIOV SUR, V79, P552
   BOBYN JD, 1982, J BIOMED MATER RES, V16, P571, DOI 10.1002/jbm.820160505
   BOYLE E, 1980, BRIT J EXP PATHOL, V61, P351
   BRETCHER MS, 1988, J CELL BIOL, V106, P235, DOI 10.1083/jcb.106.2.235
   BROWDER W, 1988, SURGERY, V104, P224
   BRUIN P, 1990, J BIOMED MATER RES, V24, P217, DOI 10.1002/jbm.820240208
   CAFFEE HH, 1990, ANN PLAS SURG, V24, P197, DOI 10.1097/00000637-199003000-00001
   CHEGINI N, 1988, J BIOMED MATER RES, V22, P71, DOI 10.1002/jbm.820220108
   CHENG CY, 1988, ARCH DERMATOL, V124, P221, DOI 10.1001/archderm.124.2.221
   CHIU TC, 1981, J BIOMED MATER RES, V15, P781, DOI 10.1002/jbm.820150513
   CHRINTZ H, 1989, BRIT J SURG, V76, P204, DOI 10.1002/bjs.1800760232
   CHRISTENSON L, 1989, J BIOMED MATER RES, V23, P705, DOI 10.1002/jbm.820230704
   CLARK AE, 1976, J BIOMED MATER RES, V10, P161, DOI 10.1002/jbm.820100202
   CLARK RAF, 1988, ARCH DERMATOL, V124, P201, DOI 10.1001/archderm.124.2.201
   CLARK RAF, 1985, J AM ACAD DERMATOL, V13, P701, DOI 10.1016/S0190-9622(85)70213-7
   CLERC C, 1990, CLIN CHIM ACTA, V189, P181, DOI 10.1016/0009-8981(90)90090-F
   DANON D, 1989, P NATL ACAD SCI USA, V86, P2018, DOI 10.1073/pnas.86.6.2018
   DATUBOBROWN DD, 1990, BRIT J PLAST SURG, V43, P70, DOI 10.1016/0007-1226(90)90047-4
   DELANGE GL, 1989, BIOMATERIALS, V10, P121, DOI 10.1016/0142-9612(89)90044-6
   DIEGELMANN RF, 1985, FUND APPL TOXICOL, V5, P219, DOI 10.1016/0272-0590(85)90070-3
   DIEGELMANN RF, 1986, J SURG RES, V40, P229, DOI 10.1016/0022-4804(86)90156-3
   DIEGELMANN RF, 1986, CLIN IMMUNOL IMMUNOP, V41, P331, DOI 10.1016/0090-1229(86)90004-8
   DOILLON CJ, 1986, BIOMATERIALS, V7, P3, DOI 10.1016/0142-9612(86)90080-3
   DOILLON CJ, 1985, COLLAGEN REL RES, V5, P481
   ECKERSLEY JRT, 1988, BRIT MED BULL, V44, P423, DOI 10.1093/oxfordjournals.bmb.a072259
   EXBRAYAT P, 1987, BIOMATERIALS, V8, P385, DOI 10.1016/0142-9612(87)90010-X
   FAGA A, 1985, PLAST RECONSTR SURG, V76, P570, DOI 10.1097/00006534-198510000-00016
   FALANGA V, 1988, J AM ACAD DERMATOL, V19, P559, DOI 10.1016/S0190-9622(88)80317-7
   FIGUERAS T, 1986, COLLAGEN REL RES, V6, P379
   FUKASAWA M, 1988, J SURG RES, V45, P460, DOI 10.1016/0022-4804(88)90196-5
   GAY S, 1978, ACTA CHIR SCAND, V144, P205
   GILBERT DL, 1987, J BIOMED MATER RES, V21, P643, DOI 10.1002/jbm.820210509
   GOSLEN JB, 1988, J DERMATOL SURG ONC, V14, P959, DOI 10.1111/j.1524-4725.1988.tb03734.x
   HAYASHI T, 1979, J BIOCHEM-TOKYO, V86, P453, DOI 10.1093/oxfordjournals.jbchem.a132544
   HENSON PM, 1987, J CLIN INVEST, V79, P669, DOI 10.1172/JCI112869
   HORSLEVPETERSEN K, 1988, EUR J CLIN INVEST, V18, P352, DOI 10.1111/j.1365-2362.1988.tb01023.x
   HOUCK JC, 1976, J INVEST DERMATOL, V67, P124, DOI 10.1111/1523-1747.ep12512997
   IGISU K, 1986, THROMB RES, V44, P455, DOI 10.1016/0049-3848(86)90324-5
   ITO G, 1987, J BIOMED MATER RES, V21, P485, DOI 10.1002/jbm.820210408
   JALKANEN M, 1983, CELL BIOL INT REP, V7, P745, DOI 10.1016/0309-1651(83)90202-3
   JAYAKUMARI N, 1989, J BIOMED MATER RES, V23, P1261, DOI 10.1002/jbm.820231104
   KALNBERZS VK, 1983, ADV BIOMATER, V3, P649
   KANZLER MH, 1986, J DERMATOL SURG ONC, V12, P1156, DOI 10.1111/j.1524-4725.1986.tb02099.x
   KAUFMAN T, 1985, ANN PLAS SURG, V14, P420, DOI 10.1097/00000637-198505000-00004
   KELLER F, 1985, Zeitschrift fuer Experimentelle Chirurgie Transplantation und Kuenstliche Organe, V18, P9
   KELLER JC, 1984, J BIOMED MATER RES, V18, P829, DOI 10.1002/jbm.820180713
   KENYON AJ, 1986, AM J VET RES, V47, P96
   Knofler W, 1984, Z Exp Chir Transplant Kunstliche Organe, V17, P316
   KNOX P, 1986, J CELL BIOL, V102, P2318, DOI 10.1083/jcb.102.6.2318
   KOPECEK J, 1983, PROG POLYM SCI, V9, P1
   KOTOURA Y, 1985, ARCH ORTHOP TRAUM SU, V104, P15, DOI 10.1007/BF00449950
   KRAJEWSKI A, 1988, J BIOMED MATER RES, V22, P445, DOI 10.1002/jbm.820220602
   KRIZEK TJ, 1983, BIOMATERIALS RECONST, P9
   KSANDER GA, 1988, ANN PLAS SURG, V20, P215, DOI 10.1097/00000637-198803000-00004
   KSANDER GA, 1981, J SURG RES, V31, P433, DOI 10.1016/0022-4804(81)90083-4
   LANGER RS, 1981, BIOMATERIALS, V2, P201, DOI 10.1016/0142-9612(81)90059-4
   LEAPER DJ, 1986, J ANTIMICROB CHEMOTH, V17, P135, DOI 10.1093/jac/17.2.135
   Lemons J E, 1986, J Arthroplasty, V1, P143, DOI 10.1016/S0883-5403(86)80053-5
   LENTZ AJ, 1985, J BIOMED MATER RES, V19, P1101, DOI 10.1002/jbm.820190919
   LINDNER J, 1983, HAMOSTASEOLOGIE, V1, P8
   LIPATOVA TE, 1979, J POLYM SCI PS, V66, P239
   LIPSKY MH, 1989, J BIOMED MATER RES, V23, P1441, DOI 10.1002/jbm.820231207
   LUNDBERG C, 1983, INFLAMMATORY REACTIO
   LUSTSKII LI, 1982, POLYTRAUMA, P213
   LYDON MJ, 1985, BIOMATERIALS, V6, P396, DOI 10.1016/0142-9612(85)90100-0
   LYNCH SE, 1989, J CLIN INVEST, V84, P640, DOI 10.1172/JCI114210
   MAKISALO SE, 1989, BIOMATERIALS, V10, P105, DOI 10.1016/0142-9612(89)90041-0
   MARCHANT RE, 1984, POLYM BIOMATERIALS, P209
   MARSHALL WR, 1989, ANN PLAS SURG, V23, P401, DOI 10.1097/00000637-198911000-00004
   MARTINEZ IR, 1987, CLIN DERMATOL, V5, P37, DOI 10.1016/0738-081X(87)90026-5
   MATLAGA BF, 1976, J BIOMED MATER RES, V10, P391, DOI 10.1002/jbm.820100308
   MATSUDA T, 1987, J BIOMED MATER RES, V21, P499, DOI 10.1002/jbm.820210409
   MCCAULEY RL, 1990, J SURG RES, V49, P103, DOI 10.1016/0022-4804(90)90118-L
   MCCOY BJ, 1984, PLAST RECONSTR SURG, V73, P924, DOI 10.1097/00006534-198406000-00012
   MENDES DG, 1985, J BONE JOINT SURG BR, V67, P645
   MERKER PC, 1984, FED PROC, V43, P2791
   MILLER KM, 1989, J BIOMED MATER RES, V23, P911, DOI 10.1002/jbm.820230808
   MIYAMOTO T, 1989, J BIOMED MATER RES, V23, P125, DOI 10.1002/jbm.820230110
   MUIR IFK, 1990, BRIT J PLAST SURG, V43, P61, DOI 10.1016/0007-1226(90)90046-3
   MURABAYASHI S, 1986, ARTIF ORGANS, V10, P114, DOI 10.1111/j.1525-1594.1986.tb02529.x
   MURRAY DW, 1989, J BONE JOINT SURG BR, V71, P632
   NAGELSCHMIDT M, 1987, J TRAUMA, V27, P1267
   NEUPERT G, 1987, Zeitschrift fuer Experimentelle Chirurgie Transplantation und Kuenstliche Organe, V20, P139
   NIEDNER R, 1986, BRIT J DERMATOL, V115, P41, DOI 10.1111/j.1365-2133.1986.tb02106.x
   PARDO A, 1983, J HISTOCHEM CYTOCHEM, V31, P641, DOI 10.1177/31.5.6302163
   Park JB, 1979, BIOMATERIALS INTRO
   PARRY DAD, 1982, FEBS LETT, V149, P1, DOI 10.1016/0014-5793(82)81060-0
   PASYK KA, 1984, J SURG RES, V36, P125, DOI 10.1016/0022-4804(84)90077-5
   PESSA ME, 1987, J SURG RES, V42, P207, DOI 10.1016/0022-4804(87)90120-X
   PETERSON JM, 1987, SURGERY, V102, P300
   PICHA GJ, 1990, PLAST RECONSTR SURG, V85, P903, DOI 10.1097/00006534-199006000-00011
   PILLIAR RM, 1987, J BIOMED MATER RES-A, V21, P1
   PIZZOFERRATO A, 1985, BIOMATERIALS, V6, P346
   POSTLETHWAIT RW, 1979, ANN SURG, V190, P54, DOI 10.1097/00000658-197907000-00012
   PREISSNER KT, 1988, BLOOD, V71, P1581
   PRICOLO VE, 1990, J SURG RES, V48, P534, DOI 10.1016/0022-4804(90)90226-R
   QUEEN D, 1987, BURNS, V13, P218, DOI 10.1016/0305-4179(87)90170-7
   RATNR BD, 1987, J BIOMED MATER RES-A, V21, P59
   REICHELT H, 1988, Zeitschrift fuer Experimentelle Chirurgie Transplantation und Kuenstliche Organe, V21, P71
   REILLY JT, 1988, J CLIN PATHOL, V41, P1269, DOI 10.1136/jcp.41.12.1269
   RIGG BM, 1982, PLAST RECONSTR SURG, V69, P566, DOI 10.1097/00006534-198203000-00043
   SALAMON A, 1980, ACTA CHIR HUNG, V21, P32
   SALTHOUSE TN, 1984, J BIOMED MATER RES, V18, P395, DOI 10.1002/jbm.820180407
   SALTHOUSE TN, 1976, J BIOMED MATER RES, V10, P197, DOI 10.1002/jbm.820100204
   SALTHOUSE TN, 1983, BIOMATERIALS RECONST, P131
   SANZ LE, 1988, OBSTET GYNECOL, V71, P418
   SCHAKENRAAD JM, 1988, BIOMATERIALS, V9, P116, DOI 10.1016/0142-9612(88)90082-8
   SCHAKENRAAD JM, 1987, BIOMATERIALS, V8, P207, DOI 10.1016/0142-9612(87)90065-2
   SCHAKENRAAD JM, 1988, CELL BIOPHYS, V13, P75, DOI 10.1007/BF02797367
   SCHAKENRAAD JM, 1986, J BIOMED MATER RES, V20, P773, DOI 10.1002/jbm.820200609
   SCHAKENRAAD JM, 1987, THESIS U GRONINGEN N
   SCHECHTER AB, 1984, ARCH PATHOL, V46, P20
   SCHOEN FJ, 1988, J BIOMED MATER RES-A, V22, P11
   SCHREIBER H, 1990, Zeitschrift fuer Experimentelle Chirurgie Transplantation und Kuenstliche Organe, V23, P23
   SCHREUDERS PD, 1988, J BIOMED MATER RES, V22, P121, DOI 10.1002/jbm.820220205
   SCHUBERT R, 1988, Zeitschrift fuer Experimentelle Chirurgie Transplantation und Kuenstliche Organe, V21, P20
   SEITZ TL, 1982, J BIOMED MATER RES, V16, P195, DOI 10.1002/jbm.820160303
   SEVASTJANOVA NA, 1987, BIOMATERIALS, V8, P242, DOI 10.1016/0142-9612(87)90110-4
   SEWELL WR, 1955, SURG GYNECOL OBSTET, V100, P483
   Slutskii L.I., 1969, BIOCH NORMAL PATHOLO
   SLUTSKII LI, 1984, BIOMATERIALS BIOMECH, P367
   SLUTSKII LI, 1981, P LATVIAN ACAD SCI, P94
   STRONG AB, 1987, J BIOMED MATER RES, V21, P1039, DOI 10.1002/jbm.820210810
   TAYLOR D E M, 1986, Journal of the Royal College of Surgeons of Edinburgh, V31, P13
   TAYLOR SR, 1983, J BIOMED MATER RES, V17, P205, DOI 10.1002/jbm.820170202
   THOMAS IT, 1986, BIOMATERIALS, V7, P301, DOI 10.1016/0142-9612(86)90055-4
   VANMULLEM PJ, 1988, J CRANIO MAXILL SURG, V16, P99, DOI 10.1016/S1010-5182(88)80029-5
   VANMULLEM PJ, 1988, ANN PLAS SURG, V21, P576, DOI 10.1097/00000637-198812000-00015
   VANRIJSSEL EJC, 1988, EUR J OBSTET GYN R B, V27, P165, DOI 10.1016/0028-2243(88)90011-1
   VERBURG AD, 1988, ARCH ORTHOP TRAUM SU, V107, P293, DOI 10.1007/BF00451510
   VITALE T D, 1988, Journal of Foot Surgery, V27, P533
   VONBECKER R, 1985, Z EXP CHIR TRANSPLAN, V18, P318
   Voronkov M G, 1979, Top Curr Chem, V84, P77
   WARD PA, 1980, CLIN BIOCHEM, V13, P187, DOI 10.1016/S0009-9120(80)80021-X
   Whalen R L, 1988, ASAIO Trans, V34, P887
   WILDEVUUR CRH, 1987, BIOMATERIALS, V8, P418, DOI 10.1016/0142-9612(87)90076-7
   YAN JYJ, 1989, J BIOMED MATER RES, V23, P171, DOI 10.1002/jbm.820230204
   ZIATS NP, 1988, BIOMATERIALS, V9, P5, DOI 10.1016/0142-9612(88)90063-4
NR 150
TC 2
Z9 2
U1 0
U2 1
PU SCANNING MICROSCOPY INT
PI CHICAGO
PA PO BOX 66507, AMF O'HARE, CHICAGO, IL 60666 USA
SN 1051-6794
J9 CELL MATER
JI Cells Mat.
PY 1992
VL 2
IS 2
BP 119
EP 134
PG 16
WC Cell Biology; Medicine, Research & Experimental; Materials Science,
   Biomaterials
SC Cell Biology; Research & Experimental Medicine; Materials Science
GA JU596
UT WOS:A1992JU59600004
DA 2018-10-20
ER

PT J
AU CUPERUS, PL
   VANDERMEI, HC
   REID, G
   BRUCE, AW
   KHOURY, AE
   ROUXHET, PG
   BUSSCHER, HJ
AF CUPERUS, PL
   VANDERMEI, HC
   REID, G
   BRUCE, AW
   KHOURY, AE
   ROUXHET, PG
   BUSSCHER, HJ
TI THE EFFECT OF SERIAL PASSAGING OF LACTOBACILLI IN LIQUID-MEDIUM ON THEIR
   PHYSICOCHEMICAL AND STRUCTURAL SURFACE CHARACTERISTICS
SO CELLS AND MATERIALS
LA English
DT Article
DE LACTOBACILLI; SERIAL PASSAGING; ZETA-POTENTIAL; CONTACT ANGLE;
   HYDROPHOBICITY; XPS; FTIR; SURFACE COMPOSITION; RR-STAINING LAYER
ID BACTERIA
AB The aim of this study was to examine the effect of serial passaging in liquid medium on physico-chemical and structural surface characteristics of two lactobacillus strains. To this end, starting cultures (p = 1) of uro-genital isolate L. acidophilus RC14 and poultry isolate L. fermentum B54 were serially passaged in liquid medium up to 20 times (p = 20).  In both strains, similar physico-chemical and structural changes were observed following serial passaging. According to water contact angle measurements, cells in p = 20 cultures became less hydrophobic. Microelectrophoresis showed that isoelectric points shifted towards the acidic region upon serial passaging. In addition, the strains had become heterogeneous with respect to the pH dependence of their zeta potentials. According to FTIR and XPS, the surfaces of p = 20 cultures of both strains showed decreasing amounts of proteinaceous material and increasing amounts of polysaccharide-like substances as compared to p = 1 cultures. Heterogeneity of p = 20 strains was also reflected in structural features of the cell surface at the electron microscopic level. In p = 1 cultures of both strains, all cells had a stained layer: in contrast, in p = 20 cultures about half of the cells became devoid of this layer. The study clearly showed that surface characteristics of lactobacilli may change following serial passaging in liquid medium.  Knowledge of these changes is of importance because these microorganisms are considered for use in biomedical applications like the restoration of a healthy vaginal microflora by cell seeding.
C1 UNIV GRONINGEN,MAT TECHN LAB,ANTONIUS DEUSINGLAAN 1,9713 AV GRONINGEN,NETHERLANDS.
   UNIV WESTERN ONTARIO,DEPT MICROBIOL & IMMUNOL,LONDON N6A 5B8,ON,CANADA.
   UNIV TORONTO,DEPT SURG,DIV UROL,TORONTO M5G 1X8,ON,CANADA.
   UNIV CATHOLIQUE LOUVAIN,FAC SCI AGRON,B-1348 LOUVAIN,BELGIUM.
CR CUPERUS PL, 1993, IN PRESS J COLL INTE
   EISEN A, 1989, MICROBIAL ECOL, V17, P17, DOI 10.1007/BF02025590
   Hiemenz P.C, 1977, PRINCIPLES COLLOID S, P452
   KUNIN CM, 1966, NEW ENGL J MED, V274, P1155, DOI 10.1056/NEJM196605262742101
   MARDH PA, 1991, AM J OBSTET GYNECOL, V165, P1163, DOI 10.1016/S0002-9378(12)90721-8
   NAGY E, 1991, APMIS, V99, P739, DOI 10.1111/j.1699-0463.1991.tb01253.x
   NOORDMANS J, 1993, IN PRESS J COLL INTE
   REID G, 1990, CLIN MICROBIOL REV, V3, P335
   REID G, 1992, APPL ENVIRON MICROB, V58, P1549
   VANDERMEI HC, 1988, COLLOID SURFACE, V32, P297, DOI 10.1016/0166-6622(88)80024-6
   VANDERMEI HC, 1987, J MICROBIOL METH, V6, P277, DOI 10.1016/0167-7012(87)90065-0
   VANDERMEI HC, 1991, MICROBIAL CELL SURFA, P262
   VANOSS CJ, 1972, J RETICULOENDOTH SOC, V12, P283
   WAGNER CD, 1981, SURF INTERFACE ANAL, V3, P211, DOI 10.1002/sia.740030506
   1991, LANCET, V338, P857
NR 15
TC 14
Z9 14
U1 0
U2 0
PU SCANNING MICROSCOPY INT
PI CHICAGO
PA PO BOX 66507, AMF O'HARE, CHICAGO, IL 60666
SN 1051-6794
J9 CELL MATER
JI Cells Mat.
PY 1992
VL 2
IS 4
BP 271
EP 280
PG 10
WC Cell Biology; Medicine, Research & Experimental; Materials Science,
   Biomaterials
SC Cell Biology; Research & Experimental Medicine; Materials Science
GA KP120
UT WOS:A1992KP12000001
DA 2018-10-20
ER

PT J
AU RAWLS, HR
   MARSHALL, MV
   CARDENAS, HL
   BHAGAT, HR
   CABASSO, I
AF RAWLS, HR
   MARSHALL, MV
   CARDENAS, HL
   BHAGAT, HR
   CABASSO, I
TI CYTOTOXICITY EVALUATION OF A NEW RADIOPAQUE RESIN ADDITIVE TRIPHENYL
   BISMUTH
SO DENTAL MATERIALS
LA English
DT Article
ID DENTAL MATERIALS; CELL-CULTURE; INVITRO
AB Triphenyl bismuth (Ph3Bi) is a promising new additive for making biomedical resins visible on x-ray images.  We evaluated the cytotoxicity of Ph3Bi, both alone and as a component of a denture resin, as an initial step in determining its biocompatibility.  These experimental materials were compared with several types of dental materials that are in current clinical use (PMMA denture acrylic resin, two photo-cured sealants, and two glass-ionomer cements).  Human embryonic lung fibroblast tissue cultures (Wl-38 cells) were exposed to 24-hour aqueous extracts of the materials.  Changes in cell growth, cell viability, and the visual appearance of cells were used for the assessment of toxic response.  Only a slight degree of cytotoxicity was observed for Ph3Bi, both alone and in combination with selfcured PMMA.  All clinical materials showed a higher level of cytotoxicity than did Ph3Bi.  The sealants and cements exhibited the most cytotoxicity and PMMA acrylic the least.  The cytotoxicity of PMMA was elevated slightly by inclusion of Ph3Bi, probably due to decreased monomer covnersion.  When stored in water, the already low levels of cytotoxicity of both PMMA and PMMA with added Ph3Bi were reduced even further.  From these results, we can predict a high level of safety for Ph3Bi as a radiopaque additive for biomedical resins.  Any toxicity associated with Ph3Bi-containing resins can be reduced or avoided by prior extraction.  Alternatively, curing conditions can be selected that would drive the polymerization reaction to a higher level of conversion.
C1 SUNY SYRACUSE,DEPT CHEM,INST POLYMER,SYRACUSE,NY.
   UNIV TEXAS,HLTH SCI CTR,DEPT MED,SAN ANTONIO,TX 78284.
   UNIV MARYLAND,DEPT PHARMACEUT,BALTIMORE,MD 21201.
RP RAWLS, HR (reprint author), UNIV TEXAS,HLTH SCI CTR,DIV BIOMAT,7703 FLOYD CURL DR,SAN ANTONIO,TX 78284, USA.
FU NIDCR NIH HHS [R01 DE06179]
CR BRAUER GM, 1981, J AM DENT ASSOC, V101, P347
   CABASSO I, 1990, B BISMUTH I, V60, P1
   DELAVIZ Y, 1989, POLYM PREPR AM CHEM, V30, P215
   HANKS CT, 1981, J ORAL PATHOL MED, V10, P101, DOI 10.1111/j.1600-0714.1981.tb01255.x
   KASTEN FH, 1982, IN VITRO CELL DEV B, V18, P650, DOI 10.1007/BF02796398
   KASTEN FH, 1989, IN VITRO CELL DEV B, V25, P57
   KAWAHARA H, 1977, DENTAL OUTLOOK, V50, P623
   NAKAMURA M, 1984, J PROSTHET DENT, V52, P694, DOI 10.1016/0022-3913(84)90144-6
   RAWLS HR, 1990, J DENT RES, V69, P342
   RAWLS HR, 1990, DENT MATER, V6, P250, DOI 10.1016/S0109-5641(05)80006-5
   RUYTER IE, 1982, J BIOMED MATER RES, V16, P741, DOI 10.1002/jbm.820160520
   SMID J, 1987, MAKROMOL CHEM-RAPID, V8, P543
   Smid J., 1989, U. S. patent, Patent No. 4882392
   WENNBERG A, 1986, ATLA-ALTERN LAB ANIM, V13, P194
NR 14
TC 23
Z9 23
U1 1
U2 8
PU ACAD DENTAL MATERIALS
PI DALLAS
PA BAYLOR COLLEGE DENTISTRY, 3302 GASTON AVE, DALLAS, TX 75266-0677
SN 0109-5641
J9 DENT MATER
JI Dent. Mater.
PD JAN
PY 1992
VL 8
IS 1
BP 54
EP 59
DI 10.1016/0109-5641(92)90054-G
PG 6
WC Dentistry, Oral Surgery & Medicine; Materials Science, Biomaterials
SC Dentistry, Oral Surgery & Medicine; Materials Science
GA HL975
UT WOS:A1992HL97500011
PM 1521685
DA 2018-10-20
ER

PT B
AU HASTINGS, GW
AF HASTINGS, GW
BE CULSHAW, B
   GARDINER, PT
   MCDONACH, AM
TI SMART STRUCTURES AND INTELLIGENT MATERIALS FOR BIOMEDICAL APPLICATIONS
SO FIRST EUROPEAN CONFERENCE ON SMART STRUCTURES AND MATERIALS
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT 1ST EUROPEAN CONF ON SMART STRUCTURES AND MATERIALS
CY MAY 12-14, 1992
CL GLASGOW, SCOTLAND
SP EUROPEAN COMMISS BRITE EURAM, EUROPEAN OPT SOC, SOC PHOTO OPT INSTRUMENTAT ENGINEERS, SMART STRUCTURES RES INST, INST PHYS, GLASGOW DEV AGCY, USN, OFF NAVAL RES, EUROPEAN OFF, USA, RES & DEV STAND GRP, EUROPEAN OFF, NATL WESTMINISTER BANK, IEEE
NR 0
TC 0
Z9 0
U1 0
U2 0
PU IOP PUBLISHING LTD
PI BRISTOL
PA BRISTOL
BN 0-7503-0222-4
J9 P SOC PHOTO-OPT INS
PY 1992
VL 1777
BP 357
EP 362
PG 6
WC Engineering, Electrical & Electronic; Materials Science,
   Multidisciplinary
SC Engineering; Materials Science
GA BW74V
UT WOS:A1992BW74V00075
DA 2018-10-20
ER

PT J
AU RATNER, BD
AF RATNER, BD
TI PLASMA DEPOSITION FOR BIOMEDICAL APPLICATIONS - A BRIEF REVIEW
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE PLASMA DEPOSITION; SURFACE CHARACTERIZATION; VASCULAR GRAFT; CELL
   GROWTH; NONFOULING; PROTEIN ADSORPTION; INTRAOCULAR LENS; CONTACT LENS
ID ENDOTHELIAL-CELL GROWTH; OXYGEN-CONTAINING FILMS; POLYMER SURFACES;
   FIBRONECTIN; POLYSTYRENE; ADSORPTION; PRECURSORS
AB Radio frequency plasma-deposited thin films offer an advantageouS mechanism to alter the surface properties of biomaterials and medical devices without affecting the mechanical properties or primary fabrication. Such coatings are tightly adherent, conformal, and easily applied. They also exhibit excellent biocompatibility qualities. Examples are presented of four different thin film plasma treatments that show promise for reducing the platelet reactivity of materials, enhancing their ability to grow cells, preventing protein pickup by surfaces, and improving the biocompatibility of opthalmic devices.
RP RATNER, BD (reprint author), UNIV WASHINGTON,NATL ESCA & SURF ANAL CTR BIOMED PROBLEMS,BF-10,SEATTLE,WA 98195, USA.
CR Boenig H.V., 1988, FUNDAMENTALS PLASMA
   CHILKOTI A, 1991, CHEM MATER, V3, P51, DOI 10.1021/cm00013a016
   CHILKOTI A, 1991, ANAL CHEM, V63, P1612, DOI 10.1021/ac00015a022
   CHINN JA, 1989, J COLLOID INTERF SCI, V127, P67, DOI 10.1016/0021-9797(89)90008-8
   ERTEL SI, 1990, J BIOMED MATER RES, V24, P1637, DOI 10.1002/jbm.820241207
   ERTEL SI, 1991, J COLLOID INTERF SCI, V147, P433, DOI 10.1016/0021-9797(91)90176-9
   ERTEL SI, 1991, J BIOMAT SCI-POLYM E, V3, P163, DOI 10.1163/156856291X00269
   Feldman LE, 1986, FUNDAMENTALS SURFACE
   GARDELLA JA, 1990, ANAL CHEM, V62, pA645, DOI 10.1021/ac00210a002
   GARFINKLE AM, 1984, T AM SOC ART INT ORG, V30, P432
   HOFFMAN AS, 1985, POLYM MED, V2, P157
   HOFFMAN S, 1986, SURF INTERFACE ANAL, V9, P3
   KANE PF, 1974, CHARACTERIZATION SOL
   LOPEZ GP, 1992, J BIOMED MATER RES, V26, P415, DOI 10.1002/jbm.820260402
   LOPEZ GP, IN PRESS J POLYM S A
   MATEO NB, 1989, INVEST OPHTH VIS SCI, V30, P853
   NAGAOKA S, 1984, POLYM BIOMATERIALS, P361
   Ratner BD, 1990, PLASMA DEPOSITION TR, P463
   RATNER BD, 1990, CONCISE ENCY MED DEN, P337
   RATNER BD, 1988, SURFACE CHARACTERIZA
   RATNR BD, 1987, J BIOMED MATER RES-A, V21, P59
   YASUDA H, 1982, BIOMATERIALS, V3, P68, DOI 10.1016/0142-9612(82)90036-9
NR 22
TC 61
Z9 62
U1 0
U2 18
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 1992
VL 4
IS 1
BP 3
EP 11
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA JX501
UT WOS:A1992JX50100001
PM 1463698
DA 2018-10-20
ER

PT J
AU PISKIN, E
AF PISKIN, E
TI PLASMA PROCESSING OF BIOMATERIALS
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE PLASMA PROCESSING; BIOMATERIALS; HEMOPERFUSION; OXYGENATORS; CELL
   CULTURING; POLYURETHANES
ID SURFACE MODIFICATION; CATHETER MATERIALS; DISCHARGE
AB Surface properties of biomaterials can easily be modified by glow-discharge plasma processing for very diverse biomedical appliations. Activated carbon granules can be coated with a verv thin polymeric membrane by plasma polymerization to improve their blood compatibilities without changing their adsorption capabilities. The problems associated with the microporous polypropylene oxygenator membranes can be eliminated by coating with a nonporous thin polymeric film in a glow-discharge reactor. Cell attachment and growth on polystyrene microcarriers can significantly be increased by alkylamine plasma treatment. Physical and chemical properties of polyurethane biomaterials can be tailor-made by plasma modification.
RP PISKIN, E (reprint author), HACETTEPE UNIV,DEPT CHEM ENGN,ANKARA,TURKEY.
CR CHANG TMS, 1978, ARTIF ORGANS, V2, P359
   ESATO K, 1975, J THORAC CARDIOV SUR, V69, P690
   EVREN V, 1986, PROGR ARTIFICIA ORGA
   GOMBOTZ WR, 1987, CRIT REV BIOCOMPAT, V4, P1
   HOFFMAN AS, 1984, ADV POLYM SCI, V57, P141
   KIREMITCI M, 1991, Clinical Materials, V8, P9, DOI 10.1016/0267-6605(91)90004-Y
   KIREMITCI M, 1990, Clinical Materials, V6, P227, DOI 10.1016/0267-6605(90)90060-9
   KIREMITCI M, 1988, THESIS HACETTEPE U A
   KNIGHT PM, 1975, AM INTRAOCULAR IMPLA, V5, P123
   KREEZE CR, 1983, SCIENCE, V219, P1448
   MUTLU M, 1990, MED BIOL ENG COMPUT, V28, P232, DOI 10.1007/BF02442672
   MUTLU M, 1990, J CLIN MATER, V4, P61
   OZDURAL AR, 1980, AM SOC ARTIF INTERN, V3, P116
   Piskin E, 1986, Life Support Syst, V4 Suppl 1, P2
   PISKIN E, 1983, PAST PRESENT FUTURE
   PISKIN E, 1992, UNPUB J BIOMATER SCI
   TRIOLO PM, 1983, J BIOMED MATER RES, V17, P149, DOI 10.1002/jbm.820170112
   TRIOLO PM, 1983, J BIOMED MATER RES, V17, P129, DOI 10.1002/jbm.820170111
   VANWEZEL AL, 1985, ANIMAL CELL BIOTECHN
   YASUDA H, 1982, BIOMATERIALS, V3, P68, DOI 10.1016/0142-9612(82)90036-9
   1981, PRODUCT INFORMATION
NR 21
TC 25
Z9 25
U1 0
U2 5
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 1992
VL 4
IS 1
BP 45
EP 60
PG 16
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA JX501
UT WOS:A1992JX50100006
PM 1463701
DA 2018-10-20
ER

PT J
AU GROTH, T
   VASSILIEFF, C
   WOLF, H
   RICHTER, G
   FOERSTER, F
AF GROTH, T
   VASSILIEFF, C
   WOLF, H
   RICHTER, G
   FOERSTER, F
TI DEVELOPMENT OF A NEW DYNAMIC METHOD FOR QUANTITATIVE-EVALUATION OF
   INVITRO HEMOCOMPATIBILITY OF BIOMEDICAL MATERIALS
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE HEMOCOMPATIBILITY OF FOILS OR SHEETS; WHOLE BLOOD; LAMINAR FLOW;
   PLATELET RETENTION; LEUKOCYTE ADHESION; DETACHMENT OF PLATELET
   AGGREGATES
ID CELL-ADHESION; PLATELET; SURFACES; AGGREGATION
AB In this study a new dynamic method is introduced allowing the estimation of blood cell adhesion on flat test surfaces by measuring the cell loss in the bulk phase of surface contacting test blood under defined rheological conditions. This was achieved by constructing a novel test chamber permitting the contact of small amounts of blood with a large geometrical test surface. The construction consists of a spiral-shaped flow channel of 0.3 cm width, 0.02 cm height and 78 cm length covered with the biomaterials to be tested from both sides. Laminarity of blood flow in the conduit was confirmed theoretically by the calculation of an equivalent to the Reynolds number for curved systems the so-called Dean number. Furthermore, flow laminarity was proved experimentally finding that the flow rate of blood with different hematocrit values was proportional to the hydrostatic pressure applied. The applicability of the novel 'spiral method' for the estimation of hemocompatibility was demonstrated by evaluation of platelet adhesion onto different polymers in comparison to siliconized and fibrinogen coated glass as reference surfaces. Additionally, it was possible under distinct conditions to determine the adhesion of leucocytes and the detachment of platelet aggregates. Therefore, it was concluded that the spiral method can be used for the assessment of the hemocompatibility of flat biomedical polymers. As main advantages of the new method can be considered the high time efficiency and accuracy without labelling or optical detection of adherent cells.
C1 UNIV SOFIA, FAC CHEM, BU-1126 SOFIA, BULGARIA.
RP GROTH, T (reprint author), HUMBOLDT UNIV, SCH MED, BIOMAT RES UNIT TUCHOLSKYSTR 2, O-1040 BERLIN, GERMANY.
OI Groth, Thomas/0000-0001-6647-9657
CR ADAMS GA, 1985, PLATELETS PHYSL PHAR, P1
   BAIER RE, 1985, J BIOMED MATER RES, V19, P1157, DOI 10.1002/jbm.820190922
   BAUMGARTNER HR, 1976, PLATELETS BIOL PATHO, P23
   BERRETTINI M, 1981, INT J ARTIF ORGANS, V4, P218
   BIRD RB, 1960, TRANSPORT PHENOMENA
   CHIEN S, 1966, J APPL PHYSIOL, V21, P81
   FEUERSTEIN IA, 1987, ANN NY ACAD SCI, V516, P484, DOI 10.1111/j.1749-6632.1987.tb33068.x
   HOENICH NA, 1986, J BIOMED ENG, V8, P3, DOI 10.1016/0141-5425(86)90024-5
   JAMAHA KA, 1983, ANNU REV BIOCHEM, V52, P761
   KANG IK, 1988, J BIOMED MATER RES, V22, P595, DOI 10.1002/jbm.820220702
   KARWATH R, 1989, STUD BIOPHYS, V131, P117
   KATAOKA K, 1980, J BIOMED MATER RES, V14, P817, DOI 10.1002/jbm.820140613
   KVARSTEIN B, 1969, SCAND J CLIN LAB INV, V24, P41, DOI 10.3109/00365516909080130
   LASSLO A, 1983, MED PROG TECHNOL, V10, P71
   LEONARD EF, 1972, ANN NY ACAD SCI, V201, P329, DOI 10.1111/j.1749-6632.1972.tb16309.x
   LINDON JN, 1978, J LAB CLIN MED, V92, P904
   MARCUS AJ, 1987, ANN NY ACAD SCI, V516, P407, DOI 10.1111/j.1749-6632.1987.tb33059.x
   MCINTYRE DE, 1976, PLATELETS BIOL PATHO, P61
   MOHANDAS N, 1974, J BIOMED MATER RES, V8, P119, DOI 10.1002/jbm.820080203
   OWENS NF, 1987, J CELL SCI, V87, P667
   PACKHAM MA, 1969, J LAB CLIN MED, V73, P686
   POOT A, 1988, BIOMATERIALS, V9, P126, DOI 10.1016/0142-9612(88)90110-X
   ROWAN RM, 1983, BLOOD CELL VOLUME AN
   SALZMAN E, 1963, J LAB CLIN MED, V62, P724
   TILSNER V, 1986, GERINNUNGSDIAGNOSTIK
   TRUCKENBRODT E, 1980, FLUID MECHANICS
   WILLIAMS CE, 1985, MED LAB SCI, V42, P262
   WINTER G, 1983, THESIS HUMBOLDT U BE
   WU KK, 1974, LANCET, V2, P924
   ZAPRYANOV Z, 1980, INT J HEAT MASS TRAN, V23, P873, DOI 10.1016/0017-9310(80)90042-3
NR 30
TC 7
Z9 7
U1 0
U2 1
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0920-5063
EI 1568-5624
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 1992
VL 3
IS 4
BP 285
EP 300
DI 10.1163/156856292X00385
PG 16
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA HM117
UT WOS:A1992HM11700002
PM 1596475
DA 2018-10-20
ER

PT J
AU TAMADA, J
   LANGER, R
AF TAMADA, J
   LANGER, R
TI THE DEVELOPMENT OF POLYANHYDRIDES FOR DRUG DELIVERY APPLICATIONS
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Review
DE POLYANHYDRIDE; BIODEGRADABLE POLYMER; DRUG DELIVERY; CONTROLLED RELEASE
ID CONTROLLED-RELEASE POLYMER; BIOERODIBLE POLYANHYDRIDES; CARRIER
   MATRICES; SOLVENT REMOVAL; BIOCOMPATIBILITY; POLY(ANHYDRIDES);
   MICROSPHERES; MORPHOLOGY; SYSTEMS; BRAIN
AB This paper reviews the development of the polyanhydrides as bioerodible polymers for drug delivery applications. The topics include design and synthesis of the polymer, physical properties, techniques to fabricate the polymer into drug delivery devices, evaluation of biocompatibility, and example applications of the polyanhydrides. Discussion of the interrelationship between the physical-chemical properties of the polyanhydrides, fabrication methods, and drug release rates is included. One section is devoted to a case study to provide a historical perspective of the development a polyanhydride-based drug delivery treatment from the conception of the idea to the final stages of human clinical trials. This section includes an outline of the extensive in vitro and in vivo testing that is necessary for development of a new material for biomedical applications.
RP TAMADA, J (reprint author), MIT,DEPT CHEM ENGN,ROOM E25-342,CAMBRIDGE,MA 02139, USA.
CR BINDSCHAEDLER C, 1988, J PHARM SCI, V77, P696, DOI 10.1002/jps.2600770811
   BREM H, 1991, J NEUROSURG, V74, P441, DOI 10.3171/jns.1991.74.3.0441
   BREM H, 1989, SELECT CANCER THER, V5, P55, DOI 10.1089/sct.1989.5.55
   BREM H, 1988, 1988 ANN M AM ASS NE, P212
   Bucher JE, 1909, J AM CHEM SOC, V31, P1319, DOI 10.1021/ja01942a009
   CHASIN M, 1990, DRUG DEV IND PHARM, V16, P2579, DOI 10.3109/03639049009058548
   CHASIN M, 1990, BIODEGRADABLE POLYM, P43
   COHEN S, 1991, PHARMACEUT RES, V8, P713, DOI 10.1023/A:1015841715384
   CONIX A, 1957, MAKROMOLEKUL CHEM, V24, P76
   CONIX A, 1958, J POLYM SCI, V29, P343, DOI 10.1002/pol.1958.1202912002
   DOMB A, 1988, MAKROMOL CHEM-M SYMP, V19, P189, DOI 10.1002/masy.19880190115
   DOMB AJ, 1988, MACROMOLECULES, V21, P1925, DOI 10.1021/ma00185a008
   DOMB AJ, 1989, MACROMOLECULES, V22, P3200, DOI 10.1021/ma00198a002
   DOMB AJ, 1987, J POLYM SCI POL CHEM, V25, P3373, DOI 10.1002/pola.1987.080251217
   DOMB AJ, 1989, MACROMOLECULES, V22, P2117, DOI 10.1021/ma00195a018
   DOMB AJ, 1991, J POLYM SCI POL CHEM, V29, P571, DOI 10.1002/pola.1991.080290413
   GROSSMAN S, UNPUB
   HELLER J, 1990, BIODEGRADABLE POLYM, P121
   HILL J, 1962, J AM CHEM SOC, V54, P1569
   Hill JW, 1930, J AM CHEM SOC, V52, P4110, DOI 10.1021/ja01373a053
   HOWARD MA, 1989, J NEUROSURG, V71, P105, DOI 10.3171/jns.1989.71.1.0105
   LAURENCIN C, 1990, J BIOMED MATER RES, V24, P1463, DOI 10.1002/jbm.820241105
   LAURENCIN C, UNPUB J ORTHOPAEDIC
   LEONG K, 1989, ENCY POLYM SCI ENG S
   LEONG KW, 1986, J BIOMED MATER RES, V20, P51, DOI 10.1002/jbm.820200106
   LEONG KW, 1987, MACROMOLECULES, V20, P705, DOI 10.1021/ma00170a001
   LEONG KW, 1985, J BIOMED MATER RES, V19, P941, DOI 10.1002/jbm.820190806
   Lewis DH, 1990, BIODEGRADABLE POLYM, V45, P1
   MATHIOWITZ E, 1987, Journal of Controlled Release, V5, P13, DOI 10.1016/0168-3659(87)90033-2
   MATHIOWITZ E, 1990, POLYMER, V31, P547, DOI 10.1016/0032-3861(90)90401-J
   MATHIOWITZ E, 1988, J APPL POLYM SCI, V35, P755, DOI 10.1002/app.1988.070350316
   MATHIOWITZ E, 1990, SCANNING MICROSCOPY, V4, P329
   MATHIOWITZ E, 1990, MACROMOLECULES, V23, P3212, DOI 10.1021/ma00215a003
   MATHIOWITZ E, IN PRESS MICROCAPSUL
   MATHIOWITZ E, IN PRESS J APPL POLY
   MIKOS AG, 1991, J COLLOID INTERF SCI, V143, P366, DOI 10.1016/0021-9797(91)90270-I
   RON E, 1991, MACROMOLECULES, V24, P2278, DOI 10.1021/ma00009a024
   ROSEN HB, 1983, BIOMATERIALS, V4, P131, DOI 10.1016/0142-9612(83)90054-6
   STAUBLI A, 1990, J AM CHEM SOC, V112, P4419, DOI 10.1021/ja00167a045
   TAMADA JA, 1990, JUL P INT S CONTR RE, V17, P156
   TAMARGO RJ, 1989, J BIOMED MATER RES, V23, P253, DOI 10.1002/jbm.820230209
   TAMARGO RJ, 1989, 1988 ANN M AM ASS NE, P88
   WEISS R, 1991, SCIENCE, V252, P1037
   YODA N, 1959, B CHEM SOC JPN, V32, P1120, DOI 10.1246/bcsj.32.1120
   YODA N, 1962, MAKROMOLEKUL CHEM, V55, P174
   YODA N, 1963, J POLYM SCI PART A, V1, P1323, DOI 10.1002/pol.1963.100010421
   YODA N, 1962, MAKROMOLEKUL CHEM, V56, P10
   YODA N, 1962, B CHEM SOC JPN, P36
NR 48
TC 147
Z9 149
U1 2
U2 29
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 1992
VL 3
IS 4
BP 315
EP 353
DI 10.1163/156856292X00402
PG 39
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA HM117
UT WOS:A1992HM11700004
PM 1350734
DA 2018-10-20
ER

PT J
AU BRAATZ, JA
   HEIFETZ, AH
   KEHR, CL
AF BRAATZ, JA
   HEIFETZ, AH
   KEHR, CL
TI A NEW HYDROPHILIC POLYMER FOR BIOMATERIAL COATINGS WITH LOW PROTEIN
   ADSORPTION
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE BIOPOL(R) POLYURETHANE POLYMERS; HYPOL(R)POLYMERS; PROTEIN ADSORPTION;
   POLYMER COATED SURFACES; BIOMEDICAL COATINGS
ID PERFORMANCE LIQUID-CHROMATOGRAPHY; SURFACE INTERACTIONS; POLYETHYLENE
   OXIDE; SILICA; PHASE
AB BIOPOL(R) polyurethane polymers, an extension of the HYPOL(R) Polymer series of foamable hydrophilic polymers, have been developed which exhibit improved performance for selected biomedical applications. Members of the BIOPOL polyurethane polymer series, with molecular weights in the range of 7000 to 30000, are larger molecules than HYPOL polymers (MW < 3000) and produce hydrogels, rather than foams, when mixed with water. The prototype material in this series, BIOPOL XP-5, is a liquid prepolymer which chain extends in water and forms a hydrogel which can contain > 85% water. The time required for polymerization with water was dependent on the prepolymer: water ratio. This prepolymer was coated onto silica and medical grade tubing and then cured in place with water to form a stable coating which was resistant to non-specific protein binding. In addition, soluble, isocyanate-free forms of the prepolymer were tested for toxicity and shown to produce no adverse effects when injected intravenously into mice or when applied to a chicken chorioallantoic membrane. BIOPOL polymers can be useful in applications where protein adsorption is an undesirable event.
C1 WR GRACE & CO CONN RES DIV,DEPT DESIGNED POLYMERS RES,COLUMBIA,MD 21044.
RP BRAATZ, JA (reprint author), WR GRACE & CO CONN RES DIV,DEPT MAMMALIAN CELL RES,7379 ROUTE 32,COLUMBIA,MD 21044, USA.
CR Agostoni A, 1989, J Biomater Appl, V4, P102, DOI 10.1177/088532828900400202
   ANDRADE JD, 1987, T AM SOC ART INT ORG, V33, P75
   Andrade JD, 1985, SURFACE INTERFACIAL, V2, P1
   BRAATZ JA, 1984, J NATL CANCER I, V72, P841
   BRAATZ JA, 1991, AM SOC ART INT ORG A, V20, P23
   BRAATZ JA, 1989, Patent No. 4886866
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999
   CHANG JP, 1988, CHROMATOGRAPHIA, V25, P350, DOI 10.1007/BF02324714
   CHANG JP, 1985, J CHROMATOGR, V319, P396, DOI 10.1016/S0021-9673(01)90578-3
   CLAESSON PM, 1986, J CHEM SOC FARAD T 1, V82, P2735, DOI 10.1039/f19868202735
   ENGELHARDT H, 1981, CHROMATOGRAPHIA, V14, P325, DOI 10.1007/BF02259229
   FOLKMAN J, 1986, CANCER RES, V46, P467
   HARDEGEN FJ, 1980, Patent No. 4237229
   HORBETT TA, 1977, J BIOENG, V1, P61
   HORBETT TA, 1987, PROTEINS INTERFACES, P1
   JEON SI, 1991, J COLLOID INTERF SCI, V142, P159, DOI 10.1016/0021-9797(91)90044-9
   JEON SI, 1991, J COLLOID INTERF SCI, V142, P149, DOI 10.1016/0021-9797(91)90043-8
   KILLMANN E, 1975, ANGEW MAKROMOL CHEM, V43, P53, DOI 10.1002/apmc.1975.050430105
   Lelah M. D., 1986, POLYURETHANES MED
   MARCINKA K, 1972, ACTA VIROL, V16, P52
   Merrill EW, 1983, AM SOC ARTIF INTERN, V6, P60
   NAGAOKA S, 1987, J AM SOC ART INT ORG, V10, P76
   PARHAM ME, 1989, Patent No. 4787976
   PARHAM ME, 1989, Patent No. 4794090
   RUBIO J, 1976, J COLLOID INTERF SCI, V57, P132, DOI 10.1016/0021-9797(76)90182-X
   SAUNDERS JH, 1962, POLYURETHANES CHEM T, V1, P11
   SAUNDERS JH, 1964, POLYURETHANES CHEM T, V2, P8
   SIGGIA S, 1963, QUANTITATIVE ORGANIC, P559
   Wood L. L., 1976, J CELL PLAST, V12, P285
NR 29
TC 12
Z9 12
U1 0
U2 6
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 1992
VL 3
IS 6
BP 451
EP 462
DI 10.1163/156856292X00439
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA JH313
UT WOS:A1992JH31300003
PM 1419974
DA 2018-10-20
ER

PT J
AU BARBARO, V
   DANIELE, C
   GRIGIONI, M
   PALOMBO, A
   SARGENTINI, A
AF BARBARO, V
   DANIELE, C
   GRIGIONI, M
   PALOMBO, A
   SARGENTINI, A
TI INVITRO EVALUATION OF PROSTHETIC HEART-VALVES - TOWARDS COMPARABLE
   TESTING
SO JOURNAL OF MEDICAL ENGINEERING & TECHNOLOGY
LA English
DT Article; Proceedings Paper
CT CONF ON HEART VALVE REPLACEMENT : PAST PERFORMANCE AND FUTURE PROSPECTS
CY SEP, 1991
CL SHEFFIELD, ENGLAND
SP DEPT CARDIAC SURG ENGLAND, DEPT MED PHYS & CLIN ENGN ENGLAND, UNIV SHEFFIELD, INST BIOMED EQUIPMENT EVALUAT & SERV
AB The Laboratory of Biomedical Engineering (of the National Health Institute, technical body of the Italian Health Service) performs in vitro testing of prosthetic heart valves for mechanical characteristics of materials, fatigue life, and fluidodynamic performance. Testing of materials is directed towards the physico-mechanical characterization of the structural components. of the valves, e.g. elasticity and resistance to stress of biological tissues and stents. Long-term fatigue life tests are conducted by means of systems which make valves beat at more than 1200 cycles/min. These tests are preceded and followed by geometrical characterization and by steady flow testing in order to obtain information about stenosis and leakage. Special attention is devoted to pulsatile flow testing which is performed on two pulse duplicators: the Dynatek system and the system developed by the University of Sheffield. The same valve was tested with these systems according to their different possible set-ups within the general requirements established by ISO-DIS 5840. This paper presents significant measurements, laking into account their dependence on the systems adopted. Results show (a) the difficulties in comparing test results because of different operating conditions, and (b) the systems' sensitivity with regards to some parameters which affect measurements under comparable set-up conditions (FDA Interlaboratory Comparison Testing Protocol).
RP BARBARO, V (reprint author), IST SUPER SANITA,BIOMED ENGN LAB,I-00161 ROME,ITALY.
RI Grigioni, Mauro/J-8744-2016; DANIELE, CARLA/E-6672-2015
OI Grigioni, Mauro/0000-0002-8231-8156; 
CR BARBARO V, 1991, INT J ARTIF ORGANS, V14, P343
   BARBARO V, 1991, 1ST EUR C BIOM ENG N
   BARBARO V, 1989, 5 P MED C MED BIOL E
   BARBARO V, 1991, WORLD C MED PHYS 2 S, V29, P1269
   GABBAY S, 1986, T AM SOC ART INT ORG, V32, P282
   Martin T. R. P., 1978, Engineering in Medicine, V7, P229
   REUL H, 1984, 2 P INT C APPL PHYS
   REUL H, 1988, J THORACIC CARDIOVAS, V96, P952
   SWANSON WM, 1977, J BIOENG, V1, P135
   1985, TEST PROTOCOL INTERL
NR 10
TC 4
Z9 4
U1 0
U2 5
PU TAYLOR & FRANCIS LTD
PI LONDON
PA ONE GUNDPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE
SN 0309-1902
J9 J MED ENG TECHNOL
JI J. Med. Eng. Technol.
PD JAN-FEB
PY 1992
VL 16
IS 1
BP 10
EP 14
DI 10.3109/03091909209021951
PG 5
WC Engineering, Biomedical; Medical Informatics; Medical Laboratory
   Technology
SC Engineering; Medical Informatics; Medical Laboratory Technology
GA JE697
UT WOS:A1992JE69700003
PM 1640442
DA 2018-10-20
ER

PT B
AU OKI, S
   GOHDA, S
   SHOMURA, T
   KIMURA, TH
   YOSHIOKA, T
AF OKI, S
   GOHDA, S
   SHOMURA, T
   KIMURA, TH
   YOSHIOKA, T
GP AMER SOC MET INT
TI PLASMA SPRAYING OF TITANIUM AND APATITE TO BIOMEDICAL MATERIALS
SO THERMAL SPRAY COATINGS : PROPERTIES, PROCESSES AND APPLICATIONS
LA English
DT Proceedings Paper
CT 4TH NATIONAL CONF ON THERMAL SPRAY
CY MAY 04-10, 1991
CL PITTSBURGH, PA
SP AMER SOC MET INT, THERMAL SPRAY DIV, HIGH TEMP SOC JAPAN, JAPAN THERMAL SPRAY SOC, METALLIZING SERV CONTRACTORS
NR 0
TC 1
Z9 1
U1 0
U2 0
PU ASM INTERNATIONAL
PI MATERIALS PARK
PA MATERIALS PARK
BN 0-87170-437-4
PY 1992
BP 491
EP 495
PG 5
WC Engineering, Multidisciplinary; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA BV92Y
UT WOS:A1992BV92Y00070
DA 2018-10-20
ER

PT J
AU MINOR, JR
   HAMBURG, MA
AF MINOR, JR
   HAMBURG, MA
TI THE AIDS RESEARCH AGENDA AT THE NATIONAL-INSTITUTES-OF-HEALTH
SO AMERICAN JOURNAL OF HOSPITAL PHARMACY
LA English
DT Article
DE ACQUIRED IMMUNODEFICIENCY SYNDROME; ACQUIRED IMMUNODEFICIENCY SYNDROME
   VACCINES; ADMINISTRATION; ANTIVIRALS; DRUG INFORMATION; HIV INFECTIONS;
   INFORMATION; NATIONAL-INSTITUTES-OF-HEALTH; PHARMACISTS; RESEARCH
AB The foundation, goals, and components of the research strategy developed by the National Institutes of Health to combat AIDS and HIV infection are discussed.
   The AIDS research agenda, based on systems originally designed to coordinate cancer research, involves a national effort to study various aspects of the disease, disseminate information, and rapidly develop and test drugs and vaccines to treat and prevent AIDS and HIV disease. AIDS research makes up approximately 10% of the total NIH budget of $7.6 billion, and the largest portion of that allocation goes to improving current treatments and developing new agents. Drug discovery efforts are supported by the National Institute of Allergy and Infectious Diseases (NIAID) through the Division of Intramural Research, in which biomedical and clinical research is conducted, and the Division of AIDS, which coordinates extramural research in university-based centers and community programs. By providing educational materials and sponsoring conferences, NIAID also helps to disseminate the results of the research it coordinates. Pharmacists support AIDS research through their involvement with study drug products and their role in protocol development, regulatory affairs, product development, and accumulation and distribution of drug information.
   Research initiatives sponsored by the federal government combine resources of investigators from government, academia, and the pharmaceutical and biotechnological industries to meet the challenges posed by the AIDS epidemic.
C1 NEW YORK CITY DEPT HLTH,FAMILY HLTH SERV,NEW YORK,NY 10013.
RP MINOR, JR (reprint author), NIH,CTR CLIN,DEPT PHARM,BLDG 10,ROOM 1 N257,BETHESDA,MD 20892, USA.
NR 0
TC 1
Z9 1
U1 0
U2 0
PU AMER SOC HEALTH-SYSTEM PHARMACISTS
PI BETHESDA
PA 7272 WISCONSIN AVE, BETHESDA, MD 20814
SN 0002-9289
J9 AM J HOSP PHARM
JI Am. J. Hosp. Pharm.
PD DEC
PY 1991
VL 48
IS 12
BP 2662
EP 2666
PG 5
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA GR456
UT WOS:A1991GR45600031
PM 1667566
DA 2018-10-20
ER

PT J
AU JAYABALAN, M
   KUMAR, NS
   RATHINAM, K
   KUMARI, TV
AF JAYABALAN, M
   KUMAR, NS
   RATHINAM, K
   KUMARI, TV
TI INVIVO BIOCOMPATIBILITY OF AN ALIPHATIC CROSS-LINKED POLYURETHANE IN
   RABBIT
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
ID LEUKOCYTE INTERACTIONS; POLYETHYLENE; QUANTITATION; KINETICS
AB A cage implantation technique has been adopted in a rabbit animal model to investigate the biocompatibility of an aliphatic crosslinked polyurethane based on hexamethylene diisocyanate (HDI). In this study, four cages are represented; the cage containing the candidate polyurethane material, biomedical grade polyurethane (Tecoflex), the commercial grade polyvinylchloride (PVC), and an empty cage which were implanted subcutaneously in rabbits. Exudates were aspirated from these cages at 4, 7, 14, and 21 days postimplantation. Exudates were analyzed for variations in proteins, cell counts, and extracellular enzymes. Results with the four types of cage implants showed that the candidate polyurethane caused an inflammatory response comparable to that caused by medical-grade Tecoflex and the empty cage control.
C1 SREE CHITRA TIRUNAL INST MED SCI & TECHNOL,DIV TOXICOL SCREENING BIOMAT,TRIVANDRUM 695012,INDIA.
   SREE CHITRA TIRUNAL INST MED SCI & TECHNOL,DIV PATHOPHYSIOL,TRIVANDRUM 695012,INDIA.
RP JAYABALAN, M (reprint author), SREE CHITRA TIRUNAL INST MED SCI & TECHNOL,DIV TECH EVALUAT BIOMAT,BIOMED TECHNOL WING,TRIVANDRUM 695012,INDIA.
CR ANDERSON JM, 1988, T AM SOC ART INT ORG, V34, P101
   Baier R E, 1969, J Biomed Mater Res, V3, P191, DOI 10.1002/jbm.820030115
   BECKER EL, 1974, J IMMUNOL, V112, P2047
   ISSEKUTZ AC, 1980, LAB INVEST, V42, P310
   ISSEKUTZ AC, 1980, CLIN EXP IMMUNOL, V41, P512
   ISSEKUTZ TB, 1981, AM J PATHOL, V103, P47
   JAYABALAN M, 1989, J BIOSCIENCE, V14, P289, DOI 10.1007/BF02716690
   Kozma C, 1974, BIOL LABORATORY RABB, P50
   KOZMA CK, 1967, J AM VET MED ASSOC, V151, P865
   MARCHANT R, 1983, J BIOMED MATER RES, V17, P301, DOI 10.1002/jbm.820170209
   MARCHANT RE, 1984, J BIOMED MATER RES, V18, P1169, DOI 10.1002/jbm.820180917
   MARCHANT RE, 1986, J BIOMED MATER RES, V20, P37, DOI 10.1002/jbm.820200105
   MCNAMARA A, 1981, BIOMATERIALS, V2, P33, DOI 10.1016/0142-9612(81)90085-5
   SPILIZEWSKI KL, 1987, BIOMATERIALS, V8, P12, DOI 10.1016/0142-9612(87)90021-4
   WALTER JB, 1987, GENERAL PATHOLOGY, P81
NR 15
TC 10
Z9 10
U1 0
U2 3
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD DEC
PY 1991
VL 25
IS 12
BP 1431
EP 1442
DI 10.1002/jbm.820251203
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA GQ002
UT WOS:A1991GQ00200002
PM 1794993
DA 2018-10-20
ER

PT J
AU KOHJIYA, S
   YAMASHITA, S
AF KOHJIYA, S
   YAMASHITA, S
TI SYNTHESIS AND PHYSICAL-PROPERTIES OF ELASTOMERIC POLY(OXYTETRAMETHYLENE)
   IONENE
SO KAUTSCHUK GUMMI KUNSTSTOFFE
LA English
DT Article; Proceedings Paper
CT 1991 INTERNATIONAL RUBBER CONFERENCE ( IKT/IRC 91 )
CY JUN 24-27, 1991
CL ESSEN, GERMANY
DE ELASTOMERIC IONENE; POLY(OXYTETRAMETHYLENE); ADHESIVES FOR BIOMEDICAL
   USES; PHOTOCHROMIC AND ELECTROCHROMIC POLYMERS
AB Two ionene-type elastomers were synthesized by living cationic polymerization of tetrahydrofuran. In the synthesis of PTI, dimethylamino terminated poly(oxytetramethylene) was reacted with dihalide via the Menschutkin reaction. Bipyridine was used in the synthesis of PTV which had viologen units in its main chain. The resulted polymers (PTI and PTV) were easily formed into a thin film, and the film was found to be highly elastic. When dissolved in polar solvent, the two polymers displayed polyelectrolyte behaviors, while they were non-polyelectrolytes in nonpolar solvent. This dual behavior suggests that both PTI and PTV have an amphiphilic character due to the presence of ionic charges and relatively non-polar poly(oxytetramethylene) segments in the main chain. Tensile properties of the film were found to be highly elastomeric and excellent; very low modulus up to an intermediate strain region, and then an increase of the stress to attain a very good tensile strength. The tensile properties were influenced by counter anion and by water content. These mechanical behaviors are reasonably explained by assuming the aggregation of ionic sites in relatively nonpolar poly(oxytetramethylene) matrix and, the stress-induced crystallization of poly(oxytetramethylene) chains. The ionic aggregates are equivalent to the hard-segment domains, hence PTI and PTV are thermoplastic elastomers. PTI was also found to be a good adhesive towards polymeric materials including human skin. PTV was a photoresponsive polymer due to the presence of viologen units, i.e., it showed photochromic and photomechanical behaviors as well as electrochromism.
RP KOHJIYA, S (reprint author), KYOTO INST TECHNOL,DEPT MAT SCI,KYOTO 606,JAPAN.
NR 0
TC 8
Z9 8
U1 2
U2 4
PU DR ALFRED HUTHIG VERLAG GMBH
PI HEIDELBERG 1
PA POSTFACH 102869, W-69018 HEIDELBERG 1, GERMANY
SN 0022-9520
J9 KAUT GUMMI KUNSTST
JI Kautsch. Gummi Kunstst.
PD DEC
PY 1991
VL 44
IS 12
BP 1128
EP 1132
PG 5
WC Engineering, Chemical; Polymer Science
SC Engineering; Polymer Science
GA GV413
UT WOS:A1991GV41300007
DA 2018-10-20
ER

PT J
AU TINGEY, KG
   ANDRADE, JD
AF TINGEY, KG
   ANDRADE, JD
TI PROBING SURFACE MICROHETEROGENEITY OF POLY(ETHER URETHANES) IN AN
   AQUEOUS ENVIRONMENT
SO LANGMUIR
LA English
DT Article
ID MICROPHASE SEPARATED STRUCTURE; BLOOD COMPATIBILITY; SEGMENTED
   POLY(URETHANEUREAS); HARD-SEGMENT; POLYMERS
AB The morphology and microheterogeneous composition of polymeric surfaces partially determines their adsorption and absorption characteristics.  The surface structure, often significantly different from that of the bulk, is influenced by the environment, and especially by the interfacial energetics of the surrounding medium.  These effects result in dynamic properties with relaxation times that affect the sorptive properties of the materials.  Microheterogeneity on surfaces has been shown to have significant effects on the biological interactions between synthetic materials and proteins and/or cells; however, the in situ surface character, which determines the blood compatibility of biomedical copolymers, has only recently come under investigation.  The objective of this paper is to present a perspective view of several methods for the characterization of microheterogeneity of dynamic surfaces in an aqueous- or fluid-phase environment.  This work focuses on the investigation of the dynamic properties of microheterogeneous biomedical polyurethanes, and on the characterization of these surfaces with novel spectroscopic, surface energetic, and surface imaging techniques.  Contact angle, infrared spectroscopy, and inverse chromatography are used to characterize the surface reorientation and heterogeneous microphase nature of polyurethane surfaces.  The polyurethanes studied are shown to have a multicomponent surface with detectable hard-segment domains.  The chemical structure of the copolymers suggests that the material is composed of domains 150 angstrom in diameter.  Evidence of these domains at the surface is presented.  We have observed that the concentration of hard-segment surface groups, identified by the aromatic groups in the hard segment, varies as a function of polymer composition.  The composition of surface hard segment is minimized with increasing phase purity, indicating the significance of morphology in determining surface composition of these polyurethanes and the ability of the surface to reorient in response to their environment.  We have observed polyurethane surface structural rearrangements induced by hydration of the polymer film.  These infrared and contact angle data indicate reorientation of the surface phase structure to enhance the surface concentration of the more polar phase in an aqueous environment.  From these studies, structural models of selected polyurethane surfaces have been presented and additional analytical methods sensitive to in situ surface morphology have been proposed.
C1 UNIV UTAH,DEPT BIOENGN,SALT LAKE CITY,UT 84112.
CR ALBRECHT TR, 1988, J APPL PHYS, V64, P1178, DOI 10.1063/1.341881
   Andrade J. D., 1985, SURFACE INTERFACIAL, P249
   ANDRADE JD, 1988, POLYM SURFACE DYNAMI, pCH1
   BELISLE J, 1985, J BIOMED MATER RES, V24, P15
   BLACKWELL J, 1983, J POLYM SCI POL PHYS, V21, P2169, DOI 10.1002/pol.1983.180211024
   BOGUE R, 1986, J ADHESION, V20, P15, DOI 10.1080/00218468608073237
   CAMERON DG, 1982, APPL SPECTROSC, V36, P245, DOI 10.1366/0003702824638610
   COOPER SL, 1966, J APPL POLYM SCI, V10, P1837, DOI 10.1002/app.1966.070101204
   DACOSTA VS, 1981, J COLLOID INTERF SCI, V80, P445
   DETTRE RH, 1965, J PHYS CHEM-US, V69, P1507, DOI 10.1021/j100889a012
   GAO SL, 1989, J LIQ CHROMATOGR, V12, P2083
   GARDELLA JA, 1988, SURFACE CHARACTERIZA, P145
   GENDREAU RM, 1986, SPECTROSCOPY BIOMEDI, pCH1
   GOOD RJ, 1978, J COLLOID INTERF SCI, V66, P360, DOI 10.1016/0021-9797(78)90317-X
   GOODMAN SL, 1988, SURFACE CHARACTERIZA, P281
   GRASEL TG, 1986, BIOMATERIALS, V7, P315, DOI 10.1016/0142-9612(86)90002-5
   HANSON SR, 1980, J LAB CLIN MED, V95, P289
   ISHIHARA H, 1974, J MACROMOL SCI PHY B, V10, P52
   Johnson R.E., 1969, SURF COLLOID SCI, V2, P85
   KNUTSON K, 1982, ACS ADV CHEM SER, V199, P109
   LAMBERT JM, 1989, POLYM PREP-ACS, V30, P583
   Lelah M. D., 1986, POLYURETHANES MED
   MACKENZIE RC, 1981, J THERM ANAL, V22, P269, DOI 10.1007/BF01915274
   MANSFIELD KF, 1989, POLYM PREPR, V30, P76
   MATSUDA T, 1983, ORG COAT APPL POLYM, V48, P647
   NISHIJIMA Y, 1984, S REP PROG POLYM PHY, V33, P237
   OKANO T, 1986, J BIOMED MATER RES, V20, P919, DOI 10.1002/jbm.820200707
   OPHIR Z, 1980, J POLYM SCI PP, V18, P1409
   PORATH J, 1977, J CHROMATOGR, V133, P180, DOI 10.1016/S0021-9673(00)89219-5
   RATNER BD, 1987, POLYURETHANES BIOMED, V2, P213
   RATNER BD, 1983, PHYSICOCHEMICAL ASPE, V2, P969
   SAKASHITA J, 1985, REP PROG POLYM PHYS, V28, P457
   SCHULZ GE, 1979, PRINCIPLES PROTEIN S, P87
   SCHWARTZ LW, 1985, LANGMUIR, V1, P219, DOI 10.1021/la00062a007
   SIBRELL K, 1989, 63RD COLL SURF SCI S
   SIBRELL K, UNPUB
   SUZUKI T, 1981, POLYM J, V13, P1027, DOI 10.1295/polymj.13.1027
   TAKAHARA A, 1985, POLYMER, V26, P978, DOI 10.1016/0032-3861(85)90217-4
   TAKAHARA A, 1985, POLYMER, V26, P987, DOI 10.1016/0032-3861(85)90218-6
   TAKAHARA A, 1989, PROGR BIOMEDICAL POL
   TINGEY KG, 1991, 17TH T M SOC BIOM, P83
   WARD RS, 1980, ORG COAT PLAST CHEM, V42, P227
NR 42
TC 104
Z9 111
U1 1
U2 19
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD NOV
PY 1991
VL 7
IS 11
BP 2471
EP 2478
DI 10.1021/la00059a013
PG 8
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA GQ894
UT WOS:A1991GQ89400015
DA 2018-10-20
ER

PT J
AU BRAYBROOK, JH
AF BRAYBROOK, JH
TI IS IT AS SIMPLE AS ABC - A BIOCOMPATIBILITY CONSENSUS
SO ADVANCED MATERIALS
LA English
DT Editorial Material
AB Research News/Talking Point:  The need for standardization in the analysis of the properties of materials intended for use in biomedical applications is the subject of this discussion-type article.  The various materials and characterization methods are summarized and the status of European and global efforts at coordinating activities examined.
RP BRAYBROOK, JH (reprint author), LAB GOVT CHEMIST,MAT TECHNOL GRP,QUEENS RD,TEDDINGTON TWII 0LY,MIDDX,ENGLAND.
CR BRAYBROOK JH, IN PRESS POLYM INT
   GUESS WL, 1965, J PHARM SCI, V54, P1545, DOI 10.1002/jps.2600541036
   MOSSMANN T, 1983, J IMMUNOL METHODS, V65, P55
   ROSENBLUTH SA, 1965, J PHARM SCI-US, V54, P156, DOI 10.1002/jps.2600540139
   VONRECUM AF, 1986, HDB BIOMATERIALS EVA
   WILLIAMS DF, 1981, CRC SERIES BIOCOMPAT
NR 6
TC 1
Z9 1
U1 0
U2 1
PU VCH PUBLISHERS INC
PI DEERFIELD BEACH
PA 303 NW 12TH AVE, DEERFIELD BEACH, FL 33442-1788
SN 0935-9648
J9 ADV MATER
JI Adv. Mater.
PD OCT
PY 1991
VL 3
IS 10
BP 511
EP 514
DI 10.1002/adma.19910031014
PG 4
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA GL562
UT WOS:A1991GL56200012
DA 2018-10-20
ER

PT J
AU KOKUBO, T
AF KOKUBO, T
TI RECENT PROGRESS IN GLASS-BASED MATERIALS FOR BIOMEDICAL APPLICATIONS
SO NIPPON SERAMIKKUSU KYOKAI GAKUJUTSU RONBUNSHI-JOURNAL OF THE CERAMIC
   SOCIETY OF JAPAN
LA English
DT Article
DE BIOACTIVE GLASS; BIOACTIVE GLASS-CERAMIC; BIOACTIVE CEMENT; BIOACTIVE
   COMPOSITE; BIOACTIVE AND FERRIMAGNETIC GLASS-CERAMIC; RADIOACTIVE GLASS
   SPHERE; GLASS-CERAMIC DENTAL CROWN; HYPERTHERMIA; ARTIFICIAL BONE;
   APATITE; CAO-SIO2-P2O5; BIOACTIVITY
AB Since discovery of Bioglass in 1971, various kinds of bioactive glasses and glass-ceramics with different functions such as high mechanical strength, high machinability, fast-setting ability and ferrimagnetism have been developed. Some of them are already clinically used as important bone-repairing implants and also have been proved to be useful even for cancer treatments. Factors governing the bioactivity have been considerably revealed. On the basis of these findings, new kinds of bioactive materials with other different functions such as high fracture toughness as well as low elastic modulus also might be developed from glasses in near future. Non-bioactive but inert glasses and glass-ceramics with various functions such as good workability, natural appearance and radioactivity also have been shown to be useful for biomedical applications such as dental crown and radioactive carrier for a cancer treatment. Glass-based materials will occupy more important positions in biomedical materials in the next decade.
RP KOKUBO, T (reprint author), KYOTO UNIV,INST CHEM RES,UJI,KYOTO 611,JAPAN.
NR 0
TC 87
Z9 87
U1 1
U2 7
PU CERAMIC SOC JAPAN-NIPPON SERAMIKKUSU KYOKAI
PI TOKYO
PA 22-17 HYAKUNIN-CHO SHINJUKU-KU, TOKYO 169, JAPAN
SN 0914-5400
J9 NIPPON SERAM KYO GAK
PD OCT
PY 1991
VL 99
IS 10
BP 965
EP 973
PG 9
WC Materials Science, Ceramics
SC Materials Science
GA GK934
UT WOS:A1991GK93400014
DA 2018-10-20
ER

PT J
AU KINCHEN, K
   WRIGHT, JD
AF KINCHEN, K
   WRIGHT, JD
TI HYPERTENSION MANAGEMENT IN HEALTH-CARE FOR THE HOMELESS CLINICS -
   RESULTS FROM A SURVEY
SO AMERICAN JOURNAL OF PUBLIC HEALTH
LA English
DT Article
ID PHYSICIANS
AB Background.  With the exception of alcohol abuse, hypertension is the most common chronic physical health problem encountered among homeless persons.  The material conditions of homelessness greatly complicate the management of this disorder.  Some of the complications and their solutions are discussed here, based on the experiences of health clinics for the homeless in large US cities.
   Methods.  In 1988, the Stewart B. McKinney Homeless Assistance Act established health care clinics for homeless persons in 108 cities.  We surveyed medical directors in these clinics, asking about the management of hypertension in this difficult-to-treat population; 65 responded.
   Results.  Comparisons between our survey data and those obtained in two recent surveys of clinicians in "normal" clinical practice provide interesting lessons in how medical practice is adapted to respond to the unique needs and problems of the urban homeless.  Although therapeutic goals are similar, the means chosen to achieve them often are not.
   Conclusions.  The treatment of homeless hypertensives illustrates the problems inherent in strict biomedical models of disease and its alleviation.  Preferred treatments, course of disease, and success of intervention are powerfully affected by social factors.
C1 TULANE UNIV,DEPT SOCIOL,220 NEWCOMB HALL,NEW ORLEANS,LA 70118.
CR ADAMSON TE, 1989, J FAM PRACTICE, V29, P93
   [Anonymous], 1988, ARCH INTERN MED, V148, P1023
   CLOHER TP, 1986, ARCH INTERN MED, V146, P529, DOI 10.1001/archinte.146.3.529
   Fedder D O, 1988, Md Med J, V37, P354
   Institute of Medicine, 1988, HOM HLTH HUM NEEDS
   KAPLAN NM, 1986, CLIN HYPERTENSION
   KELLOGG FR, 1985, HLTH CARE HOMELESS P, P109
   KINCHEN K, 1990, THESIS TULANE U NEW
   Klein LE, 1988, HYPERTENSION S2, V11, pII61
   MACMAHON SW, 1986, ANN INTERN MED, V105, P124
   Nyamathi A, 1989, Nurse Pract, V14, P47
   PIANTERI O, 1990, SAFETY NET HLTH SOCI, P250
   THOMSON GE, 1981, AM J PUBLIC HEALTH, V71, P413, DOI 10.2105/AJPH.71.4.413
   WINICK M, 1985, HLTH CARE HOMELESS P
   WRIGHT JD, 1988, SOC PROBL, V35, P182, DOI 10.1525/sp.1988.35.2.03a00060
   WRIGHT JD, 1987, HOMELESSNESS HLTH
   WRIGHT JD, 1989, ADDRESS UNKNOWN HOME
NR 17
TC 19
Z9 19
U1 0
U2 1
PU AMER PUBLIC HEALTH ASSN INC
PI WASHINGTON
PA 1015 FIFTEENTH ST NW, WASHINGTON, DC 20005
SN 0090-0036
J9 AM J PUBLIC HEALTH
JI Am. J. Public Health
PD SEP
PY 1991
VL 81
IS 9
BP 1163
EP 1165
DI 10.2105/AJPH.81.9.1163
PG 3
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA GJ839
UT WOS:A1991GJ83900013
PM 1951828
OA Bronze
DA 2018-10-20
ER

PT J
AU LININS, I
   KLEIN, RC
   GERSHEY, EL
AF LININS, I
   KLEIN, RC
   GERSHEY, EL
TI MANAGEMENT OF MIXED WASTES FROM BIOMEDICAL-RESEARCH
SO HEALTH PHYSICS
LA English
DT Article
AB Mixed radioactive and chemical wastes generated by biomedical research were characterized, and various treatment methods for reducing their volume were evaluated. These wastes consist primarily of organic solvents used in the extraction and purification of radiolabeled biomolecules that are contaminated with low levels of the long-lived radionuclides, H-3 and C-14. The Rockefeller University's mixed wastes fall into three broad chemical categories: phenol/chloroform, acetonitrile/water, and mixtures of miscellaneous solvents such as carbon tetra-chloride, benzene, and other hazardous chemicals. Currently, with the exception of liquid scintillation cocktails (deregulated in 1981), there are no commercial disposal outlets for mixed wastes nor may they be stored legally for more than 90-180 d. Most of these mixed wastes can be effectively rendered into nonradioactive chemical and aqueous radioactive waste, both of which can be disposed of in accordance with existing regulations. However, to do so requires a Resource Conservation and Recovery Act (RCRA) Part B permit for licensure as a treatment, storage, and disposal facility. For many university research facilities, this may require financial and personnel resources disproportionate to the small amounts of waste produced. Also, such treatment, if not done properly, presents potential occupational hazards from the direct handling of waste materials. Deregulation of certain mixed wastes would be the safest, most cost-effective, and practical method for dealing with many mixed wastes of biomedical origin. In any event, a national regulatory solution must be found.
RP LININS, I (reprint author), ROCKEFELLER UNIV, 1230 YORK AVE, NEW YORK, NY 10021 USA.
CR BARKER RL, 1986, PERFORMANCE PROTECTI
   BOWERMAN BS, 1986, NUREG CR4433 BROOKH
   COYDAN R, 1987, EPA600287104
   HACKMAN E, 1978, TOXIC ORGANIC CHEM D
   Lunn G, 1990, DESTRUCTION HAZARDOU
   SCHOLZE RJ, 1988, BIOTECHNOLOGY DEGRAD
   Schwope AD, 1987, GUIDELINES SELECTION
   SUCIU DF, 1986, ESLTR8560 AIR FORC E
   TEDDER DW, 1990, AM CHEM SOC S SERIES, V422
   1983, PRUDENT PRACTICES DI
NR 10
TC 1
Z9 1
U1 0
U2 3
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0017-9078
EI 1538-5159
J9 HEALTH PHYS
JI Health Phys.
PD SEP
PY 1991
VL 61
IS 3
BP 421
EP 426
DI 10.1097/00004032-199109000-00014
PG 6
WC Environmental Sciences; Public, Environmental & Occupational Health;
   Nuclear Science & Technology; Radiology, Nuclear Medicine & Medical
   Imaging
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health; Nuclear Science & Technology; Radiology, Nuclear Medicine &
   Medical Imaging
GA GD979
UT WOS:A1991GD97900014
PM 1880030
DA 2018-10-20
ER

PT J
AU HIRATA, Y
   IFUKUBE, T
   MATSUSHIMA, J
   TOCHINAI, K
AF HIRATA, Y
   IFUKUBE, T
   MATSUSHIMA, J
   TOCHINAI, K
TI EVALUATION OF A STIMULATION ELECTRODE COVERED WITH POLYVINYL-ALCOHOL GEL
   FOR EXTRACOCHLEAR PROSTHESIS
SO IEICE TRANSACTIONS ON COMMUNICATIONS ELECTRONICS INFORMATION AND SYSTEMS
LA English
DT Article
AB Polyvinyl alcohol gel (PVA gel) has been applied in various fields as a biomedical material in Japan since the mechanical and the electrical characteristics are very similar to the human body.  In this paper, the electrical characteristics of the electrode coated with PVA gel containing saline solution are described.  The electrode has been applied to a stimulation electrode in an extracochlear prosthesis.  It is expected that the coated electrode can stick to the round window membrane without scarring it.  From the experimental results, it was found that the electrical impedance of a stimulation electrode coated with PVA gel exhibited good stability and the effective double-layer capacitance of the coated electrode was less dependent on the current than the capacitance of the Pt-Ir electrode.  The electrical characteristics of the PVA electrode were proved to be very stable for long term use in-vivo.  The coated electrode was ascertained to be able to stimulate reliably the auditory nerves of a guinea pig.
RP HIRATA, Y (reprint author), HOKKAIDO UNIV,APPL ELECT RES INST,SAPPORO,HOKKAIDO 060,JAPAN.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU IEICE-INST ELECTRON INFO COMMUN ENG
PI TOKYO
PA KIKAI-SHINKO-KAIKAN BLDG MINATO-KU SHIBAKOEN 3 CHOME, TOKYO 105, JAPAN
SN 0917-1673
J9 IEICE TRANS COMMUN
PD SEP
PY 1991
VL 74
IS 9
BP 2960
EP 2964
PG 5
WC Engineering, Electrical & Electronic
SC Engineering
GA GG846
UT WOS:A1991GG84600065
DA 2018-10-20
ER

PT J
AU CHRISTENSON, L
   WAHLBERG, L
   AEBISCHER, P
AF CHRISTENSON, L
   WAHLBERG, L
   AEBISCHER, P
TI MAST-CELLS AND TISSUE REACTION TO INTRAPERITONEALLY IMPLANTED POLYMER
   CAPSULES
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
ID BIOMEDICAL POLYMERS; FIBROSIS; INVITRO; DEXAMETHASONE; MACROPHAGES;
   FIBROBLASTS; MODULATION; ACTIVATION; GENERATION; SECRETION
AB The inflammatory reaction to implanted biomaterials often compromises the clinical usefulness of implantable devices.  Dexamethasone, an anti-inflammatory agent, acts on macrophages to decrease production of inflammatory mediators, and on mast cells to prevent degranulation.  Systemic administration of dexamethasone (dms) in rats decreases the tissue reaction to intraperitoneally implanted vinyl chloride-acrylic copolymer capsules.  Local release of even smaller amounts of dms from a polymeric substrate placed inside an acrylic copolymer capsule may control the tissue reaction while avoiding the undesirable side effects of systemic treatment.  Such a system also allows investigation of the local effect of soluble molecules on tissue-material interactions without altering the surface properties of the implant or adding the effect of a releasing material.  In the present study, we investigated the effect of dms released from ethylene vinyl acetate (EVAc) rods placed in acrylic copolymer capsules and implanted in the peritoneal cavity of rats.  In vitro the release of dms from EVAc rods was quasilinear for 5 weeks.  When implanted intraperitoneally into rats, polymer capsules containing EVAc/dms rods generated a tissue reaction that was significantly thinner and featured fewer fibroblast and collagen layers than that around capsules containing pure EVAc rods at all time points studied.  The tissue reaction layer was also thinner than that previously described in rats treated systemically with dms.  The trabeculae of implants with dms-loaded EVAc rods contained significantly more intact mast cells than implants with EVAc alone, suggesting that degranulation of mast cells is involved in the tissue reaction to intraperitoneal polymer implants.
C1 BROWN UNIV,ARTIFICIAL ORGAN LAB,PROVIDENCE,RI 02912.
RI Aebischer, Patrick/E-1387-2013
CR ATKINS FM, 1985, INT ARCH ALLER A IMM, V77, P96, DOI 10.1159/000233760
   CHRISTENSON L, 1989, J BIOMED MATER RES, V23, P705, DOI 10.1002/jbm.820230704
   CLAMAN HN, 1985, IMMUNOL TODAY, V6, P192, DOI 10.1016/0167-5699(85)90115-X
   Cox J S, 1970, Adv Drug Res, V5, P115
   DRUVEFORS P, 1988, VIRCHOWS ARCH B, V55, P187
   Enerback L, 1989, Curr Top Pathol, V79, P169
   FRANZEN L, 1980, CELL TISSUE KINET, V13, P635, DOI 10.1111/j.1365-2184.1980.tb00502.x
   HIGGINBOTHAM RD, 1956, P SOC EXP BIOL MED, V92, P256
   JANES J, 1948, ARCH PATHOL, V45, P622
   LANGER R, 1976, NATURE, V263, P797, DOI 10.1038/263797a0
   MARQUARDT DL, 1983, J IMMUNOL, V131, P934
   MILLER KM, 1989, J BIOMED MATER RES, V23, P1007, DOI 10.1002/jbm.820230904
   MILLER KM, 1988, J BIOMED MATER RES, V22, P713, DOI 10.1002/jbm.820220805
   MILLER KM, 1989, J BIOMED MATER RES, V23, P911, DOI 10.1002/jbm.820230808
   NORRBY K, 1973, VIRCHOWS ARCH B, V15, P75
   NORRBY K, 1984, CELL TISSUE RES, V235, P339
   NORRBY K, 1976, CELL TISSUE RES, V170, P289, DOI 10.1007/BF00219412
   PERSINGER MA, 1983, BRIT J DERMATOL, V108, P179, DOI 10.1111/j.1365-2133.1983.tb00060.x
   RAO PVS, 1983, J IMMUNOL, V130, P341
   SMITH DE, 1958, ANAT RECORD, V132, P93, DOI 10.1002/ar.1091320107
   SNYDER DS, 1982, J IMMUNOL, V129, P1803
   STOSICGRUJICIC S, 1982, CELL IMMUNOL, V69, P235, DOI 10.1016/0008-8749(82)90070-3
   VERGARA JA, 1987, INT J RADIAT ONCOL, V13, P723, DOI 10.1016/0360-3016(87)90291-4
   WAAGE A, 1987, CLIN IMMUNOL IMMUNOP, V45, P348, DOI 10.1016/0090-1229(87)90087-0
   WATANABE S, 1974, LAB INVEST, V31, P555
   YOFFE JR, 1985, BIOCHEM J, V230, P83, DOI 10.1042/bj2300083
NR 26
TC 18
Z9 18
U1 0
U2 0
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD SEP
PY 1991
VL 25
IS 9
BP 1119
EP 1131
DI 10.1002/jbm.820250906
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA GB216
UT WOS:A1991GB21600005
PM 1778997
DA 2018-10-20
ER

PT J
AU CLAROTTI, G
   SCHUE, F
   SLEDZ, J
   GECKELER, KE
   GOPEL, W
   ORSETTI, A
AF CLAROTTI, G
   SCHUE, F
   SLEDZ, J
   GECKELER, KE
   GOPEL, W
   ORSETTI, A
TI PLASMA DEPOSITION OF THIN FLUOROCARBON FILMS FOR INCREASED MEMBRANE
   HEMOCOMPATIBILITY
SO JOURNAL OF MEMBRANE SCIENCE
LA English
DT Article; Proceedings Paper
CT 6TH INTERNATIONAL SYMP ON SYNTHETIC MEMBRANES IN SCIENCE AND INDUSTRY
CY SEP 04-08, 1989
CL TUBINGEN, FED REP GER
DE BIOMEDICAL MEMBRANES; PLASMA POLYMERIZED MEMBRANES; HEMOCOMPATIBILITY;
   BIOCOMPATIBILITY; FLUOROCARBON FILMS; POLYSULFONE MEMBRANE; MEMBRANE
   PREPARATION AND STRUCTURE; SURFACE MODIFICATION; SURFACE
   CHARACTERIZATION
ID POLYMERIZATION
AB Plasma polymerization of gases present in a low temperature plasma is a "clean" technique that is particularly well suited for biomedical material processing.  This paper presents the first results of a project which studies the possibilities offered by this technique to prepare commercial low-cost membranes with the required bio- and hemocompatibility to be implanted in an organism.  The deposition on polysulfone of films from a plasma containing a mixture of ethylene oxide and perfluorohexane in order to obtain very hydrophobic, less hydrophobic and intermediate coatings was studied.  Results obtained by adding hydrogen to perfluorohexane are also discussed.  The deposition of a thin coating from a perfluorohexane and hydrogen to perfluorohexane are also discussed.  The deposition of a thin coating from a perfluorohexane and hydrogen plasma was studied in order to optimize the surface properties of the treated membranes without affecting their filtering properties.  The treated substrates have been characterized by measuring mass variations, by surface profilometry and contact angle techniques as well as by scanning electron microscopy and electron spectroscopy for chemical analysis.
C1 UNIV MONTPELLIER 2,CHIM MACROMOLEC LAB,F-34095 MONTPELLIER 2,FRANCE.
   UNIV TUBINGEN,INST ORGAN CHEM,W-7400 TUBINGEN 1,GERMANY.
   CHR LAPEYRONIE,EXPLORAT HORMONES LAB,MONTPELLIER,FRANCE.
   UNIV TUBINGEN,INST PHYS CHEM,W-7400 TUBINGEN 1,GERMANY.
CR Andrade JD, 1986, ADV POLYM SCI, V79, P3
   Boenig HV, 1982, PLASMA SCI TECHNOLOG
   BROMAN L, 1977, ANN ACAD SCI, P283
   BRUCK SD, 1980, PROPERTIES BIOMATERI
   CHAWLA AS, 1986, REV POLYM BIOMATERIA, P231
   DAWIDS S, 1986, BLOOD COMPATIBLE MAT
   GIRIFALCO J, 1957, PHYS CHEM, V16, P417
   HAQUE Y, 1986, J APPL POLYM SCI, V32, P4369, DOI 10.1002/app.1986.070320407
   HOFFMAN AS, 1984, ADV POLYM SCI, V57, P141
   HOFFMANN AS, 1987, CRIT REV BIOCOMPAT, V4, P1
   IKADA Y, 1984, ADV POLYM SCI, V57, P104
   OWENS DK, 1969, J APPL POLYM SCI, V13, P1741, DOI 10.1002/app.1969.070130815
   SHEN M, 1979, ACS S SER, V108
   YASUDA H, 1981, MACROMOL REV, V16, P199
   YASUDA H, 1978, J POLYM SCI POL CHEM, V16, P743, DOI 10.1002/pol.1978.170160403
   YASUDA H, 1982, BIOMATERIALS, V3, P68, DOI 10.1016/0142-9612(82)90036-9
   YASUDA H, 1978, J POLYM SCI POL CHEM, V16, P229, DOI 10.1002/pol.1978.170160122
   YASUDA H, 1978, J POLYM SCI POL CHEM, V16, P313, DOI 10.1002/pol.1978.170160201
   YASUDA H, 1978, J POLYM SCI POL CHEM, V16, P2587, DOI 10.1002/pol.1978.170161013
NR 19
TC 24
Z9 25
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0376-7388
J9 J MEMBRANE SCI
JI J. Membr. Sci.
PD SEP 1
PY 1991
VL 61
BP 289
EP 301
DI 10.1016/0376-7388(91)80022-X
PG 13
WC Engineering, Chemical; Polymer Science
SC Engineering; Polymer Science
GA GG451
UT WOS:A1991GG45100022
DA 2018-10-20
ER

PT J
AU HELMUS, MN
AF HELMUS, MN
TI OVERVIEW OF BIOMEDICAL MATERIALS
SO MRS BULLETIN
LA English
DT Review
RP HELMUS, MN (reprint author), ST JUDE MED INC,RES PROGRAMS,ST PAUL,MN 55117, USA.
NR 0
TC 9
Z9 9
U1 0
U2 2
PU MATERIALS RESEARCH SOCIETY
PI PITTSBURGH
PA 9800 MC KNIGHT ROAD SUITE 327, PITTSBURGH, PA 15237
SN 0883-7694
J9 MRS BULL
JI MRS Bull.
PD SEP
PY 1991
VL 16
IS 9
BP 33
EP 38
PG 6
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA GF320
UT WOS:A1991GF32000005
DA 2018-10-20
ER

PT J
AU BARBUCCI, R
   MAGNANI, A
   ALBANESE, A
   TEMPESTI, F
AF BARBUCCI, R
   MAGNANI, A
   ALBANESE, A
   TEMPESTI, F
TI HEPARINIZED POLYURETHANE SURFACE THROUGH IONIC BONDING OF HEPARIN
SO INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS
LA English
DT Article
DE BIOMATERIALS; HEPARIN ADSORPTION; POLYURETHANE; BLOOD COMPATIBILITY
ID POLYMER; CHAINS
AB Surface heparinization through an ionic bond is one of the methods used to improve polyurethane blood compatibility.  Chains of poly(amido-amine), a tertiary aminic polymer capable of forming stable complexes with heparin, were either surface-grafted on polyurethane or interconnected with polyurethane chains using hexamethylenediisocyanate as cross-linking agent.  In the latter case, a new material (PUPA) is formed with a heparin adsorbing capacity higher than poly (amido-amine) surface-grafted polyurethane.  By changing the percentages of the components, different series of PUPA materials can be obtained with different physico-chemical properties.  The ATR/FT-IR technique was used to characterize the new materials in the native and in the heparinized state.  PUPA solution was used to coat commercial biomedical devices and they were also characterized physico-chemically using ATR/FT-IR.
RP BARBUCCI, R (reprint author), UNIV SIENA,CTR DIDATTICO,CRISMA,NUOVO POLICLINICO LE SCOTTE,I-53100 SIENA,ITALY.
RI Magnani, Agnese/E-7999-2017
OI Magnani, Agnese/0000-0002-6960-9418
CR AZZUOLI G, 1987, BIOMATERIALS, V8, P61, DOI 10.1016/0142-9612(87)90032-9
   BARBUCCI R, 1985, POLYMER, V26, P1349, DOI 10.1016/0032-3861(85)90310-6
   BARBUCCI R, 1989, BIOMATERIALS, V10, P299, DOI 10.1016/0142-9612(89)90069-0
   BARBUCCI R, 1989, BIOMATERIALS, V10, P429, DOI 10.1016/0142-9612(89)90136-1
   BARBUCCI R, 1985, MAKROMOL CHEM, V186, P2291
   BARBUCCI R, IN PRESS POLYM
   BASMADJIAN D, 1983, J BIOMED MATER RES, V17, P509, DOI 10.1002/jbm.820170310
   DANUSSO F, 1970, POLYMER, V11, P88, DOI 10.1016/0032-3861(70)90029-7
   GARDNER DL, 1969, ASAIO T, V15, P7
   GOOSEN MFA, 1983, J BIOMED MATER RES, V17, P359, DOI 10.1002/jbm.820170212
   GOTT VL, 1963, SCIENCE, V142, P1297, DOI 10.1126/science.142.3597.1297
   GRODE GA, 1969, ASAIO T, V15, P1
   HEYMAN PW, 1985, J BIOMED MATER RES, V19, P419, DOI 10.1002/jbm.820190407
   ITO Y, 1986, J BIOMED MATER RES, V20, P1017, DOI 10.1002/jbm.820200715
   ITO Y, 1987, BIOMATERIALS APPL, V2, P235
   LARM O, 1983, BIOMATER ARTIF CELL, V11, P161, DOI 10.3109/10731198309118804
   MERRILL EW, 1970, J APPL PHYSIOL, V29, P723
   MIURA Y, 1980, J BIOMED MATER RES, V14, P619, DOI 10.1002/jbm.820140508
   NOISHIKI Y, 1981, ASAIO T, V27, P213
   SALZMAN EW, 1980, J CLIN INVEST, V65, P64, DOI 10.1172/JCI109661
   SHIBUTA R, 1986, J BIOMED MATER RES, V20, P971, DOI 10.1002/jbm.820200712
   SHMER G, 1972, ASAIO T, V18, P321
   TANZAWA H, 1973, T AM SOC ART INT ORG, V19, P188
   TANZI MC, 1986, POLYM MED SURGERY V, V2, P1
   YEN S P S, 1971, Journal of Biomedical Materials Research Biomedical Materials Symposium, V1, P83
NR 25
TC 20
Z9 21
U1 0
U2 3
PU WICHTIG EDITORE
PI MILAN
PA 72/74 VIA FRIULI, 20135 MILAN, ITALY
SN 0391-3988
J9 INT J ARTIF ORGANS
JI Int. J. Artif. Organs
PD AUG
PY 1991
VL 14
IS 8
BP 499
EP 507
PG 9
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA GE815
UT WOS:A1991GE81500008
PM 1937939
DA 2018-10-20
ER

PT J
AU PEPPAS, NA
   STAUFFER, SR
AF PEPPAS, NA
   STAUFFER, SR
TI REINFORCED UNCROSSLINKED POLY (VINYL ALCOHOL) GELS PRODUCED BY CYCLIC
   FREEZING-THAWING PROCESSES - A SHORT REVIEW
SO JOURNAL OF CONTROLLED RELEASE
LA English
DT Review
DE POLY (VINYL ALCOHOL); HYDROGEL; BIOMATERIAL; FREEZING OF SOLUTION;
   SUPERMOLECULAR STRUCTURE
AB Novel methods of preparation of strong poly(vinyl alcohol) hydrogels without utilization of chemical crosslinking or reinforcing agents are reviewed.  Aqueous poly (vinyl alcohol) solutions exposed to several freezing-thawing cycles lead to such materials.  The process of reinforcement of these hydrogels is a densification of the macromolecular structure.  This is probably due to the microparticle-microgel formation within the hydrogel or to microcrystalline structural formations or to partial phase separation.  The densification process is more prominent for gels that are exposed to up to five freezing-thawing cycles.  Important biomedical and pharmaceutical applications of these gels are reviewed.
RP PEPPAS, NA (reprint author), PURDUE UNIV,SCH CHEM ENGN,W LAFAYETTE,IN 47907, USA.
NR 0
TC 164
Z9 167
U1 4
U2 76
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-3659
J9 J CONTROL RELEASE
JI J. Control. Release
PD AUG
PY 1991
VL 16
IS 3
BP 305
EP 310
DI 10.1016/0168-3659(91)90007-Z
PG 6
WC Chemistry, Multidisciplinary; Pharmacology & Pharmacy
SC Chemistry; Pharmacology & Pharmacy
GA GB151
UT WOS:A1991GB15100007
DA 2018-10-20
ER

PT J
AU KABANOV, VA
AF KABANOV, VA
TI INTERPOLYMER COMPLEXES AS NEW MATERIALS FOR BIOMEDICAL APPLICATIONS
SO MAKROMOLEKULARE CHEMIE-MACROMOLECULAR SYMPOSIA
LA English
DT Article
ID POLY-ELECTROLYTE COMPLEXES
RP KABANOV, VA (reprint author), MV LOMONOSOV STATE UNIV, FAC CHEM, DEPT POLYMER SCI, LENINSKIE GORY, MOSCOW 234, USSR.
CR KABANOV VA, 1989, MAKROMOL CHEM, V190, P2211
   KABANOV VA, 1982, SOV SCI REV B, V4, P207
   MORRISON WR, 1984, US USSR JOINT STUDIE
   ZEZIN AB, 1987, KHIM FARM ZH+, V21, P788
   ZEZIN AB, 1989, FRONTIERS MACROMOLEC, P219
   ZHELEZNOVA IV, 1986, DOKL AKAD NAUK SSSR+, V287, P662
   ZHELEZNOVA IV, 1987, DOKL AKAD NAUK SSSR+, V295, P1156
NR 7
TC 4
Z9 5
U1 0
U2 0
PU HUTHIG & WEPF VERLAG
PI BASEL
PA AUF DEM WOLF 4, CH-4052 BASEL, SWITZERLAND
SN 0258-0322
J9 MAKROMOL CHEM-M SYMP
PD AUG
PY 1991
VL 48-9
BP 425
EP 426
DI 10.1002/masy.19910480131
PG 2
WC Polymer Science
SC Polymer Science
GA GG244
UT WOS:A1991GG24400029
DA 2018-10-20
ER

PT J
AU SHELLOCK, FG
   CURTIS, JS
AF SHELLOCK, FG
   CURTIS, JS
TI MR IMAGING AND BIOMEDICAL IMPLANTS, MATERIALS, AND DEVICES - AN UPDATED
   REVIEW
SO RADIOLOGY
LA English
DT Review
DE MAGNETIC RESONANCE (MR), SAFETY
ID METALLIC BALLISTIC FRAGMENTS; POTENTIAL HAZARDS; DENTAL MATERIALS;
   SURGICAL CLIPS; RETINAL TACKS; ARTIFACTS; SAFETY; FERROMAGNETISM;
   FILTERS; FORCES
AB Certain ferromagnetic metallic implants, materials, and devices are regarded as contraindications for magnetic resonance imaging, primarily because of the risks associated with their movement or dislodgment.  More than 40 publications have reported the ferromagnetic qualities of 261 different metallic objects (aneurysm and hemostatic clips, 32; carotid artery vascular clamps, five; dental devices or materials, 16; heart valve prostheses, 29; intravascular coils, filters, and stents, 14; ocular implants, 12; orthopedic implants, materials, and devices, 15; otologic implants, 56; pellets and bullets, 23; penile implants, nine; vascular access ports, 33; and miscellaneous, 17) on the basis of measurements of deflection forces or attraction during exposure to static magnetic fields at strengths of 0.147-4.7 T.  The results of these studies are listed with respect to the specific object tested, the material used to construct the object (if known), whether or not the object was deflected or moved during exposure to the static magnetic field, and the highest static magnetic field strength used for testing the object.
C1 UNIV CALIF LOS ANGELES,SCH MED,DEPT DIAGNOST RADIOL,LOS ANGELES,CA 90024.
RP SHELLOCK, FG (reprint author), CEDARS SINAI MED CTR,DEPT DIAGNOST RADIOL,TOWER MUSCULOSKELETAL IMAGING CTR,8700 BEVERLY BLVD,LOS ANGELES,CA 90048, USA.
FU NCI NIH HHS [1 RO1 CA44014-03]
CR ALBERT DW, 1990, ARCH OPHTHALMOL-CHIC, V108, P320, DOI 10.1001/archopht.1990.01070050018007
   APPLEBAUM EL, 1990, ANN OTO RHINOL LARYN, V99, P801, DOI 10.1177/000348949009901009
   APPLEBAUM EL, 1985, ARCH OTOLARYNGOL, V111, P820
   BARRAFATO D, 1984, CAN J SURG, V27, P509
   BECKER RL, 1988, AM J NEURORADIOL, V9, P885
   BELLON EM, 1984, MAGN RESON IMAGING, V2, P41
   BROWN MA, 1987, MAGN RESON IMAGING, V5, P443, DOI 10.1016/0730-725X(87)90378-X
   DAVIS PL, 1981, AM J ROENTGENOL, V137, P857, DOI 10.2214/ajr.137.4.857
   DEKEIZER RJW, 1986, DOC OPHTHALMOL, V61, P281, DOI 10.1007/BF00142354
   DUJOVNY M, 1985, NEUROSURGERY, V17, P543, DOI 10.1227/00006123-198510000-00002
   FACHE JS, 1987, AM J NEURORADIOL, V8, P837
   GEGAUFF AG, 1990, J ORAL REHABIL, V17, P403, DOI 10.1111/j.1365-2842.1990.tb01411.x
   GO KG, 1989, CLIN NEUROL NEUROSUR, V91, P109, DOI 10.1016/S0303-8467(89)80030-7
   GOLD JP, 1989, ANN THORAC SURG, V48, P643, DOI 10.1016/0003-4975(89)90780-7
   HASSLER M, 1986, Journal de Radiologie (Paris), V67, P661
   JOONDEPH BC, 1987, ARCH OPHTHALMOL-CHIC, V105, P1479
   KANAL E, 1990, RADIOLOGY, V176, P593, DOI 10.1148/radiology.176.3.2202008
   Kanal E., 1988, MAGN RESON IMAGIN S1, V7, P106
   KELLY WM, 1986, AM J NEURORADIOL, V7, P243
   KUETHE DO, 1991, INVEST RADIOL, V26, P1, DOI 10.1097/00004424-199101000-00001
   LAAKMAN RW, 1985, RADIOLOGY, V157, P711, DOI 10.1148/radiology.157.3.4059558
   LEON JA, 1987, MAGN RESON IMAGING, V5, P405, DOI 10.1016/0730-725X(87)90130-5
   LIANG MD, 1989, MAGN RESON IMAGING, V7, P541, DOI 10.1016/0730-725X(89)90407-4
   LIEBMAN CE, 1988, AM J ROENTGENOL, V150, P1174, DOI 10.2214/ajr.150.5.1174
   LISSAC M, 1991, INVEST RADIOL, V26, P40, DOI 10.1097/00004424-199101000-00008
   LYONS CJ, 1989, SPINE, V14, P670, DOI 10.1097/00007632-198907000-00004
   MARK AS, 1987, RADIOLOGY, V162, P311, DOI 10.1148/radiology.162.2.3797642
   MATSUMOTO AH, 1989, RADIOLOGY, V170, P753, DOI 10.1148/radiology.170.3.2916029
   MATTUCCI KF, 1986, OTOLARYNG HEAD NECK, V94, P441, DOI 10.1177/019459988609400407
   MECHLIN M, 1984, AM J ROENTGENOL, V143, P1281, DOI 10.2214/ajr.143.6.1281
   NEW PFJ, 1983, RADIOLOGY, V147, P139, DOI 10.1148/radiology.147.1.6828719
   POWER W, 1988, LANCET, V2, P227
   Pusey E, 1986, Radiographics, V6, P891
   ROBERTS CW, 1990, ARCH OPHTHALMOL-CHIC, V108, P320
   SHELLOCK F G, 1989, Magnetic Resonance Quarterly, V5, P243
   SHELLOCK FG, 1988, AM J ROENTGENOL, V151, P811, DOI 10.2214/ajr.151.4.811
   SHELLOCK FG, 1988, AM J ROENTGENOL, V151, P389, DOI 10.2214/ajr.151.2.389
   SHELLOCK FG, 1991, JMRI-J MAGN RESON IM, V1, P97, DOI 10.1002/jmri.1880010114
   SHELLOCK FG, 1991, AM J NEURORADIOL, V12, P279
   SHELLOCK FG, 1991, JMRI, V61, P243
   SHELLOCK FG, 1989, MAGN RESON IMAGIN S1, V7, pP38
   SHELLOCK FG, 1990, RADIOLOGY P, V177, P271
   SHELLOCK FG, 1988, MRI DECISIONS, V2, P25
   SHELLOCK FG, 1987, SOC MAGNETIC RESONAN, P915
   Shellock FG, 1987, RADIOLOGY, V165, P150
   SOULEN RL, 1985, RADIOLOGY, V154, P705, DOI 10.1148/radiology.154.3.3969474
   TEITELBAUM GP, 1990, RADIOLOGY, V175, P855, DOI 10.1148/radiology.175.3.2343136
   TEITELBAUM GP, 1990, RADIOLOGY, V174, P1013, DOI 10.1148/radiology.174.3.174-3-1013
   TEITELBAUM GP, 1988, RADIOLOGY, V168, P713, DOI 10.1148/radiology.168.3.3406402
   TEITELBAUM GP, 1990, RADIOLOGY, V177, P883, DOI 10.1148/radiology.177.3.2244005
   TEITELBAUM GP, 1989, CARDIOVASC INTER RAD, V12, P125, DOI 10.1007/BF02577374
   TEITELBAUM GP, 1988, RADIOLOGY, V166, P657, DOI 10.1148/radiology.166.3.3340759
   TEITELBAUM GP, 1990, AM J NEURORADIOL, V11, P267
   WATANABE AT, 1990, RADIOLOGY, V177, P578, DOI 10.1148/radiology.177.2.2217801
   WHITE DW, 1987, AM J OTOL, V8, P290
   WILLIAMSON MR, 1988, ANGIOLOGY, V12, P1022
   YAMANASHI WS, 1984, PHYSIOL CHEM PHYS, V16, P237
   YUH WTC, IN PRESS AJNR
   ZHEUTLIN JD, 1987, AM J OPHTHALMOL, V103, P831, DOI 10.1016/S0002-9394(14)74404-6
   1988, ECRI HLTH DEVICES AL, P1
NR 60
TC 109
Z9 111
U1 1
U2 3
PU RADIOLOGICAL SOC NORTH AMER
PI EASTON
PA 20TH AND NORTHAMPTON STS, EASTON, PA 18042
SN 0033-8419
J9 RADIOLOGY
JI Radiology
PD AUG
PY 1991
VL 180
IS 2
BP 541
EP 550
DI 10.1148/radiology.180.2.2068325
PG 10
WC Radiology, Nuclear Medicine & Medical Imaging
SC Radiology, Nuclear Medicine & Medical Imaging
GA FW933
UT WOS:A1991FW93300050
PM 2068325
DA 2018-10-20
ER

PT J
AU ANBAR, M
AF ANBAR, M
TI COMPARING ASSESSMENTS OF STUDENTS KNOWLEDGE BY COMPUTERIZED OPEN-ENDED
   AND MULTIPLE-CHOICE TESTS
SO ACADEMIC MEDICINE
LA English
DT Note
AB At the State University of New York at Buffalo School of Medicine and Biomedical Sciences, interactive computerized tests that accept unrestricted natural-language input were used to assess the knowledge of medical students in a sophomore course on clinical biophysics in 1989.  The course covered the physical bases, scopes, and limitations of the most widely used diagnostic, therapeutic, and prosthetic technologies.  The test was composed of both open-ended sequential questions and multiple-choice questions on the same material.  The scores for the two testing modes were correlated, paying special attention to answers that demonstrated a flagrant lack of knowledge, corroborated by subsequent answers.  The correlation between the qualities of the answers for the two testing modalities was found to be significantly positive for the lower half of the class of students and negative for the upper half, suggesting that the two modes of testing measure different aspects of competence.  The implications of the findings to medical education and accreditation are discussed.
C1 SUNY BUFFALO,SCH MED & BIOMED SCI,DEPT BIOPHYS SCI,BUFFALO,NY 14260.
CR ANBAR M, 1988, MED TEACH, V10, P175, DOI 10.3109/01421598809010540
   ANBAR M, 1981, J MED EDUC, V56, P443
   ANBAR M, 1986, RESIDENT STAFF PHYSI, V32, P91
   ANBAR M, 1988, S ENG COMPUTER BASED, P112
   ANBAR M, 1987, MED ELECT, V18, P118
NR 5
TC 19
Z9 19
U1 0
U2 4
PU HANLEY & BELFUS INC
PI PHILADELPHIA
PA 210 S 13TH ST, PHILADELPHIA, PA 19107
SN 1040-2446
J9 ACAD MED
JI Acad. Med.
PD JUL
PY 1991
VL 66
IS 7
BP 420
EP 422
DI 10.1097/00001888-199107000-00012
PG 3
WC Education, Scientific Disciplines; Health Care Sciences & Services
SC Education & Educational Research; Health Care Sciences & Services
GA FX101
UT WOS:A1991FX10100014
PM 2059271
DA 2018-10-20
ER

PT J
AU LIN, FH
   HUANG, YY
   HON, MH
   WU, SC
AF LIN, FH
   HUANG, YY
   HON, MH
   WU, SC
TI FABRICATION AND BIOCOMPATIBILITY OF A POROUS BIOGLASS CERAMIC IN A
   NA2O-CAO-SIO2-P2O5 SYSTEM
SO JOURNAL OF BIOMEDICAL ENGINEERING
LA English
DT Article
DE BIOGLASS CERAMICS; BIOCOMPATIBILITY; MICROSTRUCTURE
ID PHOSPHATE
AB A porous bioglass ceramic was prepared from a finely pulverized bioglass powder mixed with particles of two sizes (5 and 500-mu-m) of 30% by weight with the foaming agent polyethylene glycol 4000 (HO (C2H4O) nH).  The batch composition of the bioglass was Na2O 12%, CaO 28%, SiO2 50% and P2O5 10% by weight.  The specimens, formed by pressing, were sintered in a high temperature furnace.  In this study we are concerned with the preparation and microstructure of the material and its performance in biological tests.  The microstructure and crystalline phases of the material were investigated by differential thermal analysis, X-ray diffraction analysis, transmission electron microscopy and scanning electron microscopy.  In a biomedical examination, it was shown that the porous material was compatible with animal tissues.  The microstructure of the implant indicated that newly grown bone interlocked well with the glass ceramic and that macropores and micropores were distributed uniformly in the material, which provided channels for bone ingrowth and improved the microscopic bioresorption.
C1 NATL CHENG KUNG UNIV,DEPT MAT ENGN,TAINAN,TAIWAN.
RP LIN, FH (reprint author), NATL TAIWAN UNIV,COLL MED,CTR BIOMED ENGN,TAIPEI,TAIWAN.
CR CARPENTER PR, 1986, J MATER SCI LETT, V5, P1309, DOI 10.1007/BF01729402
   DACULSI G, 1990, J BIOMED MATER RES, V24, P379, DOI 10.1002/jbm.820240309
   DEGROOT K, 1980, BIOMATERIALS, V1, P45
   DELLEMAGNE MJ, 1945, SOC CHIM BIOL, V27, P597
   FERRARO JW, 1979, PLAST RECONSTR SURG, V63, P630
   HENCH LL, 1974, P SURFACES INTERFACE, P265
   HENCH LL, 1982, BIOMATERIALS INTERFA, P357
   HON MH, 1988, J MIN METALL ROC, V2, P143
   KINGERY WD, 1976, INTRO CERAMICS, P187
   KLAWITTER JJ, 1971, J BIOMED MATER RES S, V2, P159
   LIN FH, 1987, J MATER SCI LETT, V5, P331
   LIN FH, 1985, J MED ENG ROC, V5, P33
   TOMSON MB, 1977, J DENT RES, V56, P1369, DOI 10.1177/00220345770560111501
   TOMSON MB, 1978, SCIENCE, V200, P1059, DOI 10.1126/science.200.4345.1059
   ZHU PN, 1982, J NON-CRYST SOLIDS, V52, P503, DOI 10.1016/0022-3093(82)90326-X
NR 15
TC 20
Z9 20
U1 0
U2 5
PU BUTTERWORTH-HEINEMANN LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0141-5425
J9 J BIOMED ENG
JI J. Biomed. Eng.
PD JUL
PY 1991
VL 13
IS 4
BP 328
EP 334
DI 10.1016/0141-5425(91)90115-N
PG 7
WC Engineering, Biomedical
SC Engineering
GA FU622
UT WOS:A1991FU62200008
PM 1890828
DA 2018-10-20
ER

PT J
AU GREISLER, HP
   ELLINGER, J
   HENDERSON, SC
   SHAHEEN, AM
   BURGESS, WH
   KIM, DU
   LAM, TM
AF GREISLER, HP
   ELLINGER, J
   HENDERSON, SC
   SHAHEEN, AM
   BURGESS, WH
   KIM, DU
   LAM, TM
TI THE EFFECTS OF AN ATHEROGENIC DIET ON MACROPHAGE BIOMATERIAL
   INTERACTIONS
SO JOURNAL OF VASCULAR SURGERY
LA English
DT Article
ID SMOOTH-MUSCLE CELLS; FACTOR-LIKE PROTEIN; GROWTH-FACTOR; BIOMEDICAL
   POLYMERS; HUMAN-MONOCYTES; INTERLEUKIN-1; INVITRO; PROLIFERATION;
   STIMULATION; CULTURE
AB We previously reported that biomaterials differentially induce macrophages to secrete growth factors that mediate reendothelialization.  The present study evaluates the effect of an atherogenic diet on macrophage/biomaterial interactions.  Female New Zealand white rabbits were fed an atherogenic diet.  Peritoneal macrophages were harvested from these as well as rabbits fed a normal diet and cultured in Minimum Essential Medium with platelet-poor serum.  Dacron or polyglactin 910 were added to two of three conditions of both cell groups in passage 2.  Conditioned media were collected weekly through week 15.  Mitogenicity assays were performed with quiescent mouse embryonal (BALB/c3T3) fibroblasts, atherosclerotic rabbit aortic smooth muscle cells, and murine capillary lung (LE-II) endothelial cells.  Mitogenic activity was assayed by scintillation counting of tritiated thymidine incorporation into deoxyribonucleic acid (DNA).  Results showed increased mitogenic activity released by macrophages from atherosclerotic rabbits, in the absence of prosthetic material, when assayed against every cell line.  In normal diet macrophages, polyglactin 910 stimulated mitogen release for every cell line, and Dacron yielded minimal mitogen release.  In lipid diet macrophages polyglactin 910 slightly increased mitogen release for all three cell lines, whereas Dacron resulted in stimulation of DNA synthesis in smooth muscle cells and BALB/c3T3 cells but less DNA synthesis in LE-II cells than in control, no graft material, media.  Western blotting demonstrated immunoreactivity to basic fibroblast growth factor in media from normal diet macrophages but only in the presence of polyglactin 910 or Dacron.  Radioimmunoassay for platelet-derived growth factor B chain was negative in all groups, and polymerase chain reaction techniques to amplify transforming growth factor-beta messenger ribonucleic was negative.  These data demonstrate the effect of in vivo dietary manipulation on macrophage activation as well as the effect of an atherogenic diet in modulating macrophage/biomaterial interactions.  Additionally, different biomaterials differentially induce macrophages to release factors that stimulate and inhibit growth.
C1 VET ADM MED CTR,HINES,IL 60141.
   ST BARNABAS HOSP,LIVINGSTON,NJ 07039.
   AMER RED CROSS,ROCKVILLE,MD.
RP GREISLER, HP (reprint author), LOYOLA UNIV,MED CTR,DEPT SURG,2160 S 1ST AVE,MAYWOOD,IL 60153, USA.
FU NHLBI NIH HHS [R01 HL41272]
CR ASSOIAN RK, 1983, J BIOL CHEM, V258, P7155
   BAIRD A, 1985, BIOCHEM BIOPH RES CO, V126, P358, DOI 10.1016/0006-291X(85)90614-X
   BIANCO C, 1981, METHODS STUDYING MON, P273
   BONFIELD TL, 1989, J BIOMED MATER RES, V23, P535, DOI 10.1002/jbm.820230602
   COZZOLINO E, 1989, BLOOD S1, V74, pA144
   DICORLETO PE, 1983, P NATL ACAD SCI-BIOL, V80, P1919, DOI 10.1073/pnas.80.7.1919
   Greisler H P, 1987, J Vasc Surg, V5, P393
   GREISLER H P, 1987, Archives of Surgery, V122, P715
   Greisler H P, 1986, ASAIO Trans, V32, P346
   GREISLER H P, 1989, Journal of Vascular Surgery, V10, P566
   GREISLER HP, 1986, J VASC SURG, V3, P747, DOI 10.1067/mva.1986.avs0030747
   GREISLER HP, 1985, ARCH SURG-CHICAGO, V120, P315
   GREISLER HP, 1988, J VASC SURG, V7, P697, DOI 10.1067/mva.1988.avs0070697
   GREISLER HP, 1989, J VASC SURG, V9, P588, DOI 10.1067/mva.1989.vs0090588
   GREISLER HP, 1988, CIRCULATION S1, V78, P112
   Hannan R L, 1988, Growth Factors, V1, P7, DOI 10.3109/08977198809000242
   LIBBY P, 1983, J CELL PHYSIOL, V115, P217, DOI 10.1002/jcp.1041150217
   MILLER KM, 1989, J BIOMED MATER RES, V23, P1007, DOI 10.1002/jbm.820230904
   MILLER KM, 1989, J BIOMED MATER RES, V23, P911, DOI 10.1002/jbm.820230808
   NILSSON J, 1985, P NATL ACAD SCI USA, V82, P4418, DOI 10.1073/pnas.82.13.4418
   OLD LJ, 1985, SCIENCE, V230, P630, DOI 10.1126/science.2413547
   RAINES EW, 1989, SCIENCE, V243, P393, DOI 10.1126/science.2783498
   ROSS R, 1974, P NATL ACAD SCI USA, V71, P1207, DOI 10.1073/pnas.71.4.1207
   SCHMIDT JA, 1982, J IMMUNOL, V128, P2177
   SHIMOKADO K, 1985, CELL, V43, P277, DOI 10.1016/0092-8674(85)90033-9
   TOSATO G, 1988, SCIENCE, V239, P502, DOI 10.1126/science.2829354
   YAM LT, 1971, AM J CLIN PATHOL, V55, P283
   ZACHARIAS RK, 1988, J VASC SURG, V7, P606
NR 28
TC 14
Z9 15
U1 0
U2 0
PU MOSBY-YEAR BOOK INC
PI ST LOUIS
PA 11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318
SN 0741-5214
J9 J VASC SURG
JI J. Vasc. Surg.
PD JUL
PY 1991
VL 14
IS 1
BP 10
EP 23
PG 14
WC Surgery; Peripheral Vascular Disease
SC Surgery; Cardiovascular System & Cardiology
GA FW525
UT WOS:A1991FW52500002
PM 1829487
DA 2018-10-20
ER

PT J
AU DALECKI, D
   CARSTENSEN, EL
   PARKER, KJ
   BACON, DR
AF DALECKI, D
   CARSTENSEN, EL
   PARKER, KJ
   BACON, DR
TI ABSORPTION OF FINITE-AMPLITUDE FOCUSED ULTRASOUND
SO JOURNAL OF THE ACOUSTICAL SOCIETY OF AMERICA
LA English
DT Article
ID BIOMEDICAL FREQUENCIES; DIAGNOSTIC ULTRASOUND; NONLINEAR PROPAGATION;
   SOUND BEAMS; TISSUES; TRANSMISSION; INTENSITIES; DISTORTION; PREDICTION;
   FIELDS
AB Predictions of the absorption of focused finite amplitude waves based on weak shock theory have been tested experimentally.  The characteristics of this absorption are qualitatively different from those associated with small signal losses.  Under appropriate conditions, the absorption of finite amplitude ultrasound is determined largely by source amplitude, field geometry, and the nonlinear properties of the medium and is only weakly dependent upon the small signal absorption coefficient of the material.  These effects are seen most dramatically in sharply focused sound fields.  To emphasize nonlinear absorption in an experimental test of these predictions, measurements of heating were made in agar which has a very small linear absorption coefficient.  Under appropriate conditions, nonlinear losses can make the effective absorption coefficient of this poorly absorbing material somewhat greater than the soft tissues of the body.
C1 UNIV ROCHESTER,ROCHESTER CTR BIOMED ULTRASOUND,ROCHESTER,NY 14627.
   NATL PHYS LAB,DIV RADIAT SCI & ACOUST,TEDDINGTON TW11 0LW,MIDDX,ENGLAND.
RP DALECKI, D (reprint author), UNIV ROCHESTER,DEPT ELECT ENGN,ROCHESTER,NY 14627, USA.
OI Dalecki, Diane/0000-0001-7114-9732
FU NIGMS NIH HHS [GM09933]; NCI NIH HHS [CA39241]
CR BACON DR, 1989, ULTRASOUND MED BIOL, V15, P355, DOI 10.1016/0301-5629(89)90047-1
   BACON DR, 1989, PHYS MED BIOL, V34, P1633, DOI 10.1088/0031-9155/34/11/010
   BACON DR, 1984, ULTRASOUND MED BIOL, V10, P189, DOI 10.1016/0301-5629(84)90217-5
   BACON DR, 1990, J ACOUST SOC AM, V88, P26, DOI 10.1121/1.399950
   BACON DR, 1986, THESIS U BATH UK
   BAKHVALOV NS, 1978, SOV PHYS ACOUST+, V24, P10
   BLACKSTO.DT, 1966, J ACOUST SOC AM, V39, P1019, DOI 10.1121/1.1909986
   BLACKSTOCK DT, 1972, AM I PHYSICS HDB
   BLACKSTOCK DT, 1991, IN PRESS J ACOUST SO
   Carslaw H. S., 1959, CONDUCTION HEAT SOLI
   CARSTENSEN EL, 1982, ACUSTICA, V51, P116
   CARSTENSEN EL, 1980, ULTRASOUND MED BIOL, V6, P359, DOI 10.1016/0301-5629(80)90005-8
   CARSTENSEN EL, 1981, J ACOUST SOC AM, V70, P302, DOI 10.1121/1.386777
   CHRISTOPHER PT, 1990, UNPUB J ACOUST SOC A
   CHRISTOPHER PT, 1990, IN PRESS IBM J SUPER
   DICKINSON RJ, 1985, PHYS MED BIOL, V30, P445, DOI 10.1088/0031-9155/30/5/007
   DUCK FA, 1989, PHYS MED BIOL, V34, P1623, DOI 10.1088/0031-9155/34/11/009
   FRY FJ, 1989, ULTRASOUND MED BIOL, V15, P481, DOI 10.1016/0301-5629(89)90101-4
   FRY WJ, 1954, J ACOUST SOC AM, V26, P311, DOI 10.1121/1.1907333
   GOSS SA, 1981, IEEE T SON ULTRASON, V28, P22
   HARAN ME, 1983, J ACOUST SOC AM, V73, P774, DOI 10.1121/1.389043
   HART TS, 1988, J ACOUST SOC AM, V84, P1488, DOI 10.1121/1.396595
   HYNYNEN K, 1987, ULTRASOUND MED BIOL, V13, P85, DOI 10.1016/0301-5629(87)90078-0
   Lighthill M. J., 1956, SURVEYS MECHANICS, P250
   MUIR TG, 1980, ULTRASOUND MED BIOL, V6, P345, DOI 10.1016/0301-5629(80)90004-6
   SHOOTER JA, 1974, J ACOUST SOC AM, V55, P54, DOI 10.1121/1.1919475
   SWINDELL W, 1985, ULTRASOUND MED BIOL, V11, P121, DOI 10.1016/0301-5629(85)90014-6
   SWINDELL W, 1986, P I ACOUST, V8, P79
   Taylor GI, 1910, P R SOC LOND A-CONTA, V84, P371, DOI 10.1098/rspa.1910.0081
NR 29
TC 41
Z9 42
U1 0
U2 2
PU AMER INST PHYSICS
PI WOODBURY
PA CIRCULATION FULFILLMENT DIV, 500 SUNNYSIDE BLVD, WOODBURY, NY 11797-2999
SN 0001-4966
J9 J ACOUST SOC AM
JI J. Acoust. Soc. Am.
PD MAY
PY 1991
VL 89
IS 5
BP 2435
EP 2447
DI 10.1121/1.400976
PG 13
WC Acoustics; Audiology & Speech-Language Pathology
SC Acoustics; Audiology & Speech-Language Pathology
GA FL775
UT WOS:A1991FL77500043
PM 1861004
DA 2018-10-20
ER

PT J
AU MOORE, RL
   GROBE, GL
   GARDELLA, JA
AF MOORE, RL
   GROBE, GL
   GARDELLA, JA
TI AUGER AND X-RAY PHOTOELECTRON STUDY OF SURFACE HETEROGENEITY IN ASTM
   F-75 ALLOY PREPARED FOR BIOMEDICAL IMPLANTATION
SO JOURNAL OF VACUUM SCIENCE & TECHNOLOGY A-VACUUM SURFACES AND FILMS
LA English
DT Article; Proceedings Paper
CT 37TH NATIONAL SYMP OF THE AMERICAN VACUUM SOC
CY OCT 08-12, 1990
CL TORONTO, CANADA
SP AMER VACUUM SOC
ID COBALT BASE ALLOY; CORROSION PRODUCTS; CHROMIUM; SERUM; RELEASE; ESCA
AB Previous studies, which evaluated the tissue bonding and in vivo stability of biomedical devices, paid little attention to the surface chemistry and properties of the biomaterials prior to their implantation.  Better materials characterization before placement of biomedical devices is necessary for the understanding of the chemical and physical properties, which determine biocompatibility.  Biological adhesion, in particular, is strongly affected by surface chemistry changes, which are in turn drastically affected by differing preparations.  The particular focus of this investigation is on the differences between passivated (acid-treated) and nonpassivated (or untreated) ASTM F-75 alloy.  Both types of surfaces were examined utilizing Auger electron spectroscopy and x-ray photoelectron spectroscopy, with moderate emphasis placed on the detection and identification of nickel species.
C1 SUNY BUFFALO,DEPT CHEM,BUFFALO,NY 14214.
RP MOORE, RL (reprint author), PERKIN ELMER CORP,DIV PHYS ELECTR,5 PROGRESS ST,EDISON,NJ 08820, USA.
CR BAER DR, 1984, APPL SURF SCI, V19, P382
   BARTOLOZZI A, 1985, BIOMATERIALS, V6, P2, DOI 10.1016/0142-9612(85)90030-4
   BLACK J, 1983, BIOMATERIALS, V4, P160, DOI 10.1016/0142-9612(83)90003-0
   ERIKSSON JC, 1983, J COLLOID INTERF SCI, V95, P2
   GRAHAM SW, 1982, ANAL CHEM, V54, P2073, DOI 10.1021/ac00249a037
   GROGAN CH, 1957, CANCER, V10, P625, DOI 10.1002/1097-0142(195705/06)10:3<625::AID-CNCR2820100330>3.0.CO;2-F
   HERCULES DM, 1984, J CHEM EDUC, V61, P5
   KOEGEL A, 1984, J BIOMED MATER RES, V18, P513, DOI 10.1002/jbm.820180505
   LAUSMAA J, 1985, 11TH ANN M SOC BIOM
   LAUSMAA J, 1985, BIOMATER, V9, P23
   LINDBERG B, 1983, J COLLOID INTERF SCI, V95, P308, DOI 10.1016/0021-9797(83)90190-X
   NORSETH T, 1980, CANCER, V33, P1219
   OHNSORGE J, 1978, MED PROG TECHNOL, V5, P171
   OHNSORGE J, 1978, 1ST INT C MECH MED B, P1
   ROE FJC, 1969, BRIT J CANCER, V23, P172, DOI 10.1038/bjc.1969.25
   STORP S, 1977, SURF SCI, V68, P10, DOI 10.1016/0039-6028(77)90185-6
   TURNER NH, 1986, ANAL CHEM, V58, pR153, DOI 10.1021/ac00296a014
   TURNER NH, 1986, ANAL CHEM, V58, P5
   WAPNER KL, 1986, J BIOMED MATER RES, V20, P219, DOI 10.1002/jbm.820200211
   WOODMAN JL, 1983, J BIOMED MATER RES, V100, P655
NR 20
TC 11
Z9 11
U1 0
U2 1
PU AMER INST PHYSICS
PI WOODBURY
PA CIRCULATION FULFILLMENT DIV, 500 SUNNYSIDE BLVD, WOODBURY, NY 11797-2999
SN 0734-2101
J9 J VAC SCI TECHNOL A
JI J. Vac. Sci. Technol. A-Vac. Surf. Films
PD MAY-JUN
PY 1991
VL 9
IS 3
BP 1323
EP 1328
DI 10.1116/1.577620
PN 2
PG 6
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA FR763
UT WOS:A1991FR76300018
DA 2018-10-20
ER

PT J
AU NODA, I
AF NODA, I
TI LATEX ELASTOMER WITH A PERMANENTLY HYDROPHILIC SURFACE
SO NATURE
LA English
DT Article
ID POLYETHYLENE
AB WATER wettability is important in many applications of polymeric materials, including fabrics, printing and biomedical uses 1,2.  Various surface-modification techniques are available to convert the intrinsically hydrophobic surfaces of plastic to water-wettable ones, by incorporating chemically polar functional groups at the surface 4-7.  Although such chemically induced surface hydrophilicity can be relatively long-lived while the substrates remain rigid, increases in the mobility of surface molecules, for example, due to increasing temperature, can cause rapid loss of hydrophilicity, driven by the tendency of surfaces to minimize their free energy 2-5.  As the polar groups are not often bound to the polymer matrix (usually being instead free surfactant molecules), they may also be flushed from the surface by repeated exposure to water.  Here I report the preparation of permanently water-wettable elastomeric films from a latex synthesized by polymerization of monomers in the presence of an amphiphilic block copolymer.  By migration of the hydrophilic segments to the surface during film formation, the film is rendered essentially completely wettable by water.  Applications may include flexible coatings that can introduce spatially selective wettability to solid surfaces, for example one-side wettable perforated films used for bandages and disposable diapers 8.
RP NODA, I (reprint author), PROCTER & GAMBLE CO,MIAMI VALLEY LABS,POB 398707,CINCINNATI,OH 45239, USA.
CR BRIGGS D, 1980, POLYMER, V21, P895, DOI 10.1016/0032-3861(80)90244-X
   Noda I., 1988, [No title captured], Patent No. [US 4,735,843, 4735843]
   NUZZO RG, 1984, MACROMOLECULES, V17, P1013, DOI 10.1021/ma00135a007
   RASMUSSEN JR, 1977, J AM CHEM SOC, V99, P4736, DOI 10.1021/ja00456a035
   RATNER BD, 1978, J APPL POLYM SCI, V22, P643, DOI 10.1002/app.1978.070220306
   RUCKENSTEIN E, 1984, J COLLOID INTERF SCI, V101, P436, DOI 10.1016/0021-9797(84)90055-9
   SHARMA AK, 1981, J APPL POLYM SCI, V26, P2205, DOI 10.1002/app.1981.070260709
   Yasuda H., 1981, Journal of Polymer Science, Polymer Physics Edition, V19, P1285, DOI 10.1002/pol.1981.180190901
NR 8
TC 20
Z9 20
U1 1
U2 13
PU MACMILLAN MAGAZINES LTD
PI LONDON
PA 4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF
SN 0028-0836
J9 NATURE
JI Nature
PD MAR 14
PY 1991
VL 350
IS 6314
BP 143
EP 144
DI 10.1038/350143a0
PG 2
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FB645
UT WOS:A1991FB64500053
DA 2018-10-20
ER

PT J
AU DUNNE, WM
   BURD, EM
AF DUNNE, WM
   BURD, EM
TI INVITRO MEASUREMENT OF THE ADHERENCE OF STAPHYLOCOCCUS-EPIDERMIDIS TO
   PLASTIC BY USING CELLULAR UREASE AS A MARKER
SO APPLIED AND ENVIRONMENTAL MICROBIOLOGY
LA English
DT Note
ID COAGULASE-NEGATIVE STAPHYLOCOCCI; CATHETER SEPSIS; SLIME; PREVENTION;
   STRAINS; MODEL
AB A rapid and sensitive in vitro assay was developed to quantitatively assess the adherence of Staphylococcus epidermidis to a hydrophobic plastic surface.  The assay is based upon the detection of cell-associated urease activity as a marker of bacteria remaining adherent to the polystyrene microwells of flat-bottomed, 96-well tissue culture plates.  Using ATCC 35984, a slime-producing strain of S. epidermidis, the assay could detect as few as 3 X 10(3) bacteria and was linear to 3.5 X 10(7) bacteria.  The adherence of both slime-positive and slime-negative coagulase-negative staphylococci could be evaluated by using this method.  This assay could be used to examine factors which influence the adherence of individual S. epidermidis strains to hydrophobic surfaces and to develop agents or coating materials which suppress the adherence of coagulase-negative staphylococci to biomedical implants.
C1 MED COLL WISCONSIN,CHILDRENS HOSP WISCONSIN,DEPT PEDIAT,MILWAUKEE,WI 53201.
RP DUNNE, WM (reprint author), MED COLL WISCONSIN,CHILDRENS HOSP WISCONSIN,DEPT PATHOL,MILWAUKEE,WI 53201, USA.
CR BAYSTON R, 1987, ZENTRALBL BAKBER 1 S, V16, P133
   CHRISTENSEN GD, 1990, J INFECT DIS, V161, P1153, DOI 10.1093/infdis/161.6.1153
   CHRISTENSEN GD, 1982, INFECT IMMUN, V37, P318
   CHRISTENSEN GD, 1985, J CLIN MICROBIOL, V22, P996
   CHRISTENSEN GD, 1983, J CLIN MICROBIOL, V18, P258
   DUNNE WM, 1990, ANTIMICROB AGENTS CH, V34, P390, DOI 10.1128/AAC.34.3.390
   DUNNE WM, 1987, PEDIATR INFECT DIS J, V6, P1031
   GRAY ED, 1984, LANCET, V1, P365
   HOGT AH, 1986, INFECT IMMUN, V51, P294
   JOHNSON GM, 1986, INFECT IMMUN, V54, P13
   KARCHMER AW, 1983, ANN INTERNMED, V16, P113
   MAKI DG, 1987, JAMA-J AM MED ASSOC, V258, P2396, DOI 10.1001/jama.258.17.2396
   MCCULLOUGH DC, 1980, CHILD BRAIN, V7, P182
   PETERS G, 1981, ZBL BAKT MIK HYG B, V173, P293
   SANFORD BA, 1989, INFECT IMMUN, V57, P3735
   SATTLER FR, 1984, INFECT CONT HOSP EP, V5, P279, DOI 10.1017/S0195941700060331
   SEGURA M, 1989, J CLIN MICROBIOL, V27, P2656
   STOTTER AT, 1987, JPEN-PARENTER ENTER, V11, P159, DOI 10.1177/0148607187011002159
   TOJO M, 1988, J INFECT DIS, V157, P713, DOI 10.1093/infdis/157.4.713
   TROOSKIN SZ, 1985, SURGERY, V97, P547
   WEST TE, 1986, J CLIN MICROBIOL, V23, P809
   WILKINSON BJ, 1987, ZENTRALBLATT BAKTE S, V16, P67
   YOUNGER JJ, 1987, J INFECT DIS, V156, P548, DOI 10.1093/infdis/156.4.548
NR 23
TC 17
Z9 17
U1 0
U2 2
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1325 MASSACHUSETTS AVENUE, NW, WASHINGTON, DC 20005-4171
SN 0099-2240
J9 APPL ENVIRON MICROB
JI Appl. Environ. Microbiol.
PD MAR
PY 1991
VL 57
IS 3
BP 863
EP 866
PG 4
WC Biotechnology & Applied Microbiology; Microbiology
SC Biotechnology & Applied Microbiology; Microbiology
GA FA764
UT WOS:A1991FA76400039
PM 2039236
DA 2018-10-20
ER

PT J
AU ANDERSON, G
   SCOTT, M
AF ANDERSON, G
   SCOTT, M
TI DETERMINATION OF PRODUCT SHELF-LIFE AND ACTIVATION-ENERGY FOR 5 DRUGS OF
   ABUSE
SO CLINICAL CHEMISTRY
LA English
DT Article
DE ARRHENIUS PLOTS; ACCELERATED STABILITY TESTING; CONTROL MATERIALS;
   BRACKET TABLE; Q-RULE; ACTIVATION ENERGY
ID STABILITY
AB Estimating the shelf life of reagents and controls is a critical step in evaluating new formulations. We describe several stability assessment techniques, giving particular attention to experimental design. Activation energy was experimentally determined for five major drugs of abuse and metabolites: morphine, 11-nor-DELTA-9-tetrahydrocannabinol-9-carboxylic acid, amphetamine, phenycyclidine, and benzoylecgonine. The use of activation energy in establishing shelf life is illustrated for SENTRY(TM) (Hycor Biomedical Inc.) Drugs of Abuse Screen Control, a liquid urine-based product.
RP ANDERSON, G (reprint author), HYCOR BIOMED INC, RES DEPT, 7272 CHAPMAN AVE, GARDEN GROVE, CA 92641 USA.
CR BENTLEY DL, 1970, J PHARM SCI, V59, P464, DOI 10.1002/jps.2600590405
   Connors K. A., 1973, CHEM STABILITY PHARM, P8
   KENNON L, 1964, J PHARM SCI, V53, P815, DOI 10.1002/jps.2600530726
   KIRKWOOD T B L, 1977, Biometrics, V33, P736
   Lachman L, 1976, KINETIC PRINCIPLES S, P32
   Porterfield R. I., 1984, MED DEVICE DIAGN APR, P45
NR 6
TC 62
Z9 64
U1 1
U2 5
PU AMER ASSOC CLINICAL CHEMISTRY
PI WASHINGTON
PA 2101 L STREET NW, SUITE 202, WASHINGTON, DC 20037-1526 USA
SN 0009-9147
EI 1530-8561
J9 CLIN CHEM
JI Clin. Chem.
PD MAR
PY 1991
VL 37
IS 3
BP 398
EP 402
PG 5
WC Medical Laboratory Technology
SC Medical Laboratory Technology
GA FB914
UT WOS:A1991FB91400016
PM 2004447
DA 2018-10-20
ER

PT J
AU GRIJPMA, DW
   ZONDERVAN, GJ
   PENNINGS, AJ
AF GRIJPMA, DW
   ZONDERVAN, GJ
   PENNINGS, AJ
TI HIGH-MOLECULAR-WEIGHT COPOLYMERS OF L-LACTIDE AND EPSILON-CAPROLACTONE
   AS BIODEGRADABLE ELASTOMERIC IMPLANT MATERIALS
SO POLYMER BULLETIN
LA English
DT Article
AB High molecular weight copolymers of L-lactide and epsilon-caprolactone have been synthesized by ring opening copolymerization with stannous octoate as catalyst.  The good mechanical properties of the 50/50 copolymers make it a suitable material for biomedical applications such as nerve guides etc., where degradation of the elastomeric implant is required.  In contrast to the frequently used MDI containing polyurethanes, degradation products of the P(LLA-epsilon-CL) are non toxic.  The use of such a material is therefore preferable.
C1 STATE UNIV GRONINGEN,POLYMER CHEM LAB,NIJENBORGH 16,9747 AG GRONINGEN,NETHERLANDS.
CR DEGROOT JH, UNPUB COLLOID POLYM
   DESANTIS P, 1968, BIOPOLYMERS, V6, P299, DOI 10.1002/bip.1968.360060305
   GOGOLEWSKI S, 1983, MAKROMOL CHEM-RAPID, V4, P675
   GOGOLEWSKI S, 1988, P SPE INT C MED PLAS
   HOPPEN HJ, 1990, BIOMATERIALS, V11, P268
   KRISHELDORF HR, 1987, J MACROMOL SCI CHE A, V24, P1345
   LEENSLAG JW, 1987, MAKROMOL CHEM, V188, P1809
   LELAH MD, 1987, POLYURETHANES MED
   MARCHANT RE, 1987, POLYMER, V28, P2032, DOI 10.1016/0032-3861(87)90037-1
   PENNINGS AJ, 1990, COLLOID POLYM SCI, V268, P2, DOI 10.1007/BF01410416
   ROBINSON PH, 1989, THESIS U GRONINGEN, P89
   ROBINSON PH, IN PRESS BRIT J PLAS
   ROBINSON PH, 1989, THESIS U GRONINGEN, P97
   SCHINDLER A, 1982, J POLYM SCI POL CHEM, V20, P319, DOI 10.1002/pol.1982.170200206
   Schindler A, 1977, CONT TOPICS POLYM SC, V2, P251
   SZYCHER M, 1983, J ELASTOM PLAST, V15, P81, DOI 10.1177/009524438301500205
   ZONDERVAN GJ, IN PRESS
NR 17
TC 144
Z9 151
U1 3
U2 39
PU SPRINGER VERLAG
PI NEW YORK
PA 175 FIFTH AVE, NEW YORK, NY 10010
SN 0170-0839
J9 POLYM BULL
JI Polym. Bull.
PD MAR
PY 1991
VL 25
IS 3
BP 327
EP 333
DI 10.1007/BF00316902
PG 7
WC Polymer Science
SC Polymer Science
GA EZ562
UT WOS:A1991EZ56200007
DA 2018-10-20
ER

PT J
AU RAMANI, AV
AF RAMANI, AV
TI PRODUCTION AND USE OF BIO-MEDICAL DEVICES - ITS RELEVANCE TO INDIA
SO CURRENT SCIENCE
LA English
DT Article; Proceedings Paper
CT SYMP ON THE ROLE OF CLINICAL RESEARCH IN HEALTH CARE DELIVERY IN
   DEVELOPING COUNTRIES
CY FEB, 1990
CL MADRAS, INDIA
SP MENON FDN
AB To achieve 'Health for All by 2000 AD.' India needs massive inputs of science and technology.  Rupees 60,000 millions worth of medical supplies will be needed in India by 2000 AD.  The supplies cover biomedical devices made from all classes of materials using precision light engineering techniques.  Indian industry is wary of entering this field because of low perceived demand, unfair competition from imports, need for a strict Good Manufacturing Practice, and unrestricted availability of low cost, poor quality 'look-alikes'.  Education of manufacturers and users, enactment of statutes regulating the making and use of these devices could be the answer.
RP RAMANI, AV (reprint author), SREE CHITRA TIRUNAL INST MED SCI & TECHNOL,BIOTECHNOL WING,TRIVANDRUM 695001,INDIA.
NR 0
TC 0
Z9 0
U1 0
U2 4
PU CURRENT SCIENCE ASSN
PI BANGALORE
PA C V RAMAN AVENUE, PO BOX 8005, BANGALORE 560 080, INDIA
SN 0011-3891
J9 CURR SCI INDIA
JI Curr. Sci.
PD FEB 25
PY 1991
VL 60
IS 4
BP 268
EP 271
PG 4
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FH116
UT WOS:A1991FH11600016
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU HEIMKE, G
AF HEIMKE, G
TI PERCUTANEOUS IMPLANTS
SO ADVANCED MATERIALS
LA English
DT Article
AB Research News/Biomaterials Highlights VIII:  Increase of the functional life of biomedical implants which extend through the skin or other body tissues, such as dental implants, and catheters, can be achieved by careful selection of materials and bioengineering approaches.  Recent developments are discussed.
C1 CLEMSON UNIV,COLL ENGN,DEPT BIOENGN,CLEMSON,SC 29634.
CR BOYD LM, 1991, IN PRESS CLIN MATER
   GROSSESIESTRUP C, 1984, J BIOMED MATER RES, V18, P357, DOI 10.1002/jbm.820180405
   HEIMKE G, 1990, ADV MATER, V2, P375
   Heimke G., 1990, Advanced Materials, V2, P189, DOI 10.1002/adma.19900020408
   HEIMKE G, 1990, Patent No. 4959054
   HEIMKE G, 1990, Patent No. 4946444
   Holgers K M, 1989, J Invest Surg, V2, P7, DOI 10.3109/08941938909016500
   MAKI DG, 1987, 7TH INT C ANT AG CHE, P110
   POWERS D, 1989, COMMUNICATION
   YOSHIYAMA N, 1990, BIOCERAMICS, V2, P375
NR 10
TC 8
Z9 8
U1 0
U2 2
PU VCH PUBLISHERS INC
PI DEERFIELD BEACH
PA 303 NW 12TH AVE, DEERFIELD BEACH, FL 33442-1788
SN 0935-9648
J9 ADV MATER
JI Adv. Mater.
PD FEB
PY 1991
VL 3
IS 2
BP 108
EP 110
DI 10.1002/adma.19910030210
PG 3
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA EY547
UT WOS:A1991EY54700008
DA 2018-10-20
ER

PT J
AU MASSIA, SP
   HUBBELL, JA
AF MASSIA, SP
   HUBBELL, JA
TI HUMAN ENDOTHELIAL-CELL INTERACTIONS WITH SURFACE-COUPLED ADHESION
   PEPTIDES ON A NONADHESIVE GLASS SUBSTRATE AND 2 POLYMERIC BIOMATERIALS
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
ID FIBRONECTIN FRAGMENTS; FIBROBLAST ADHESION; STRESS FIBERS; ATTACHMENT;
   ADHERENCE; ENZYMES; INVIVO; GRAFTS
AB The attachment, spreading, spreading rate, focal contact formation, and cytoskeletal organization of human umbilical vein endothelial cells (HUVECs) were investigated on substrates that had been covalently grafted with the cell adhesion peptides Arg-Gly-Asp (RGD) and Tyr-IIe-Gly-Ser-Arg (YIGSR).  This approach was used to provide substrates that were adhesive to cells even in the absence of serum proteins and with no prior pretreatment of the surface with proteins of the cell adhesion molecule (CAM) family.  This approach was used to dramatically enhance the cell-adhesiveness of substrates that were otherwise cell-nonadhesive and to improve control of cellular interactions with cell-adhesive materials by providing stably bound adhesion ligands.  Glycophase glass was examined as a model cell-nonadhesive substrate prior to modification, and polyethylene terephthalate (PET) and polytetrafluoroethylene (PTFE) were examined as representative materials for biomedical applications.  The peptides were surface-coupled by their N-terminal amine to surface hydroxyl moieties using tresyl chloride chemistry.  Prior to peptide grafting, the PET and PTFE were surface hydroxylated to yield PETOH and PTFE-OH.  The PET-OH was less cell-adhesive and the PTFE-OH was much more cell-adhesive than the native polymers.  Radioiodination of a C-terminal tyrosine residue was used to quantify the amount of peptide coupled to the surface, and these amounts were 12.1 pmol/cm2 on glycophase glass, 139 fmol/cm2 on PETOH, and 31 fmol/cm2 on PTFE-OH.  Although the glycophase glass did not support adhesion or spreading even in the presence of serum, the RGD- and YIGSR-grafted glycophase glass did support adhesion and spreading, even when the only serum protein that was included was albumin.  Although PET and PTFE-OH supported adhesion when incubated in serum-supplemented medium, neither of these materials supported adhesion with only albumin present, indicating that cell adhesion is mediated by adsorbed CAM proteins.  When these materials were peptide-grafted, however, extensive adhesion and spreading did occur even when only albumin was present.  Since the peptide grafting is quite easily controlled and is temporally stable, while protein adsorption is quite difficult to precisely control and is temporally dynamic, peptide grafting may be advantageous over other approaches employed to improve long-term cell adhesion to biomaterials.
C1 UNIV TEXAS,DEPT CHEM ENGN,AUSTIN,TX 78712.
RI Hubbell, Jeffrey/A-9266-2008
OI Hubbell, Jeffrey/0000-0003-0276-5456
CR AKIYAMA SK, 1985, J BIOL CHEM, V260, P3256
   BRANDLEY BK, 1988, ANAL BIOCHEM, V172, P270, DOI 10.1016/0003-2697(88)90442-3
   BURRIDGE K, 1988, ANNU REV CELL BIOL, V4, P487, DOI 10.1146/annurev.cb.04.110188.002415
   CHINN JA, 1989, J COLLOID INTERF SCI, V127, P67, DOI 10.1016/0021-9797(89)90008-8
   COSTELLO CA, 1987, MACROMOLECULES, V20, P2819, DOI 10.1021/ma00177a030
   CURTIS ASG, 1964, J CELL BIOL, V20, P199, DOI 10.1083/jcb.20.2.199
   DANILOV YN, 1989, EXP CELL RES, V182, P186, DOI 10.1016/0014-4827(89)90290-5
   ESKIN SG, 1984, MICROVASC RES, V28, P87, DOI 10.1016/0026-2862(84)90031-1
   IVES CL, 1986, IN VITRO CELL DEV B, V22, P500
   IZZARD CS, 1976, J CELL SCI, V21, P129
   JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470
   KESLER KA, 1986, J VASC SURG, V3, P58
   MASSIA SP, 1990, ANN NY ACAD SCI, V589, P261, DOI 10.1111/j.1749-6632.1990.tb24251.x
   MASSIA SP, 1990, ANAL BIOCHEM, V187, P292, DOI 10.1016/0003-2697(90)90459-M
   MATSUDA T, 1989, T AM SOC ART INT ORG, V35, P677
   NILSSON K, 1981, BIOCHEM BIOPH RES CO, V102, P449, DOI 10.1016/0006-291X(81)91541-2
   OHLSON S, 1978, FEBS LETT, V93, P5, DOI 10.1016/0014-5793(78)80792-3
   PRATT KJ, 1989, J BIOMED MATER RES, V23, P1131, DOI 10.1002/jbm.820231004
   RAMALANJAONA G, 1986, J VASC SURG, V3, P264, DOI 10.1067/mva.1986.avs0030264
   SALACINSKI PRP, 1981, ANAL BIOCHEM, V117, P136, DOI 10.1016/0003-2697(81)90703-X
   SEEGER JM, 1988, J VASC SURG, V8, P476
   STREETER HB, 1987, J CELL BIOL, V105, P507, DOI 10.1083/jcb.105.1.507
   WECHEZAK AR, 1989, J CELL PHYSIOL, V139, P136, DOI 10.1002/jcp.1041390120
   WHITE GE, 1986, J CELL BIOL, V103, P63, DOI 10.1083/jcb.103.1.63
   WONG AJ, 1983, SCIENCE, V219, P867, DOI 10.1126/science.6681677
   WOODS A, 1986, EMBO J, V5, P665, DOI 10.1002/j.1460-2075.1986.tb04265.x
NR 26
TC 230
Z9 234
U1 2
U2 44
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD FEB
PY 1991
VL 25
IS 2
BP 223
EP 242
DI 10.1002/jbm.820250209
PG 20
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA EV472
UT WOS:A1991EV47200008
PM 1829082
DA 2018-10-20
ER

PT J
AU BUSZEWSKI, B
AF BUSZEWSKI, B
TI PROPERTIES AND BIOMEDICAL APPLICATIONS OF PACKINGS WITH HIGH-DENSITY
   COVERAGE OF C-18 CHEMICALLY BONDED PHASE FOR HIGH-PERFORMANCE
   LIQUID-CHROMATOGRAPHY AND SOLID-PHASE EXTRACTION
SO JOURNAL OF CHROMATOGRAPHY
LA English
DT Article
ID MODIFIED SILICA
AB A series of packing materials with high-density coverage of chemically bonded C18 phases (alpha-RP greater-than-or-equal-to 2.8-mu-mol/m2) for high-performance liquid chromatography (HPLC) and clean-up solid-phase extraction columns were prepared.  The resulting packings were characterized by different physico-chemical methods including porosimetric and elemental analysis, cross-polarization magic angle spinning NMR and HPLC.  The packings prepared were used for the purification by solid-phase extraction, isolation and determination of various analytes present in different biological samples.
C1 UNIV TUBINGEN,INST ORGAN CHEM,W-7400 TUBINGEN 1,GERMANY.
RI Buszewski, Boguslaw/A-3187-2009
CR ALBERT K, 1985, J MAGN RESON, V62, P428, DOI 10.1016/0022-2364(85)90212-4
   BAYER E, 1983, J CHROMATOGR, V264, P197, DOI 10.1016/S0021-9673(01)95023-X
   BEREK D, 1981, Patent No. 4255286
   BUSZEWSKI B, 1987, J HIGH RES CHROMATOG, V10, P527
   BUSZEWSKI B, 1987, CHROMATOGRAPHIA, V24, P573, DOI 10.1007/BF02688547
   BUSZEWSKI B, 1990, J CHROMATOGR, V499, P305, DOI 10.1016/S0021-9673(00)96981-4
   BUSZEWSKI B, 1987, CHEM LISTY, V81, P552
   BUSZEWSKI B, 1987, J LIQ CHROMATOGR, V10, P2325, DOI 10.1080/01483918708068915
   BUSZEWSKI B, 1990, J PHARMACEUT BIOMED, V8, P645, DOI 10.1016/0731-7085(90)80095-7
   BUSZEWSKI B, 1987, CHROMATOGRAPHIA, V23, P442, DOI 10.1007/BF02311822
   BUSZEWSKI B, 1990, CHROMATOGRAPHIA, V29, P233, DOI 10.1007/BF02317910
   BUSZEWSKI B, 1988, ANAL CHIM ACTA, V208, P199
   BUSZEWSKI B, 1990, CCHEM STOSOW, V34, P191
   DALDRUP T, 1984, CHROMATOGRAPHIA, V18, P81, DOI 10.1007/BF02268461
   GILPIN RK, 1984, J CHROMATOGR SCI, V22, P371, DOI 10.1093/chromsci/22.9.371
   KNOX JH, 1989, HIGH PERFORMANCE LIQ, P189
   LIM CK, 1986, INT LAB, V16, P60
   NAWROCKI J, 1988, J CHROMATOGR, V449, P1, DOI 10.1016/S0021-9673(00)94364-4
   NOVAK I, 1983, Patent No. 4382070
   PIETRZYK DJ, 1989, HIGH PERFORMANCE LIQ, P223
   SANDER LC, 1987, CRIT REV ANAL CHEM, V18, P299, DOI 10.1080/10408348708545263
   SOLTES L, 1983, Patent No. 234100
   SZABO K, 1984, HELV CHIM ACTA, V67, P2128, DOI 10.1002/hlca.19840670813
   TIPPINS B, 1987, INT LAB, V17, P28
NR 24
TC 9
Z9 9
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0021-9673
J9 J CHROMATOGR
PD FEB 1
PY 1991
VL 538
IS 2
BP 293
EP 301
DI 10.1016/S0021-9673(01)88850-6
PG 9
WC Chemistry, Analytical
SC Chemistry
GA EY985
UT WOS:A1991EY98500008
DA 2018-10-20
ER

PT J
AU KOHN, J
AF KOHN, J
TI DESAMINOTYROSYL TYROSINE ALKYL ESTERS - NEW DIPHENOLIC MONOMERS FOR THE
   DESIGN OF TYROSINE-DERIVED PSEUDOPOLY(AMINO ACIDS)
SO ACS SYMPOSIUM SERIES
LA English
DT Article
ID POLY(IMINOCARBONATES); BIOMATERIALS
AB In peptide chemistry, peptide analogs containing nonnatural backbone linkages are classified as "pseudopeptides".  In analogy, we used the term "pseudopoly(amino acid)" to denote polymers in which amino acids are linked together by bonds other than conventional peptide bonds.  Here we summarize our studies on the identification of desaminotyrosyl-tyrosine alkyl esters as new diphenolic monomers for the design of amino acid derived polyiminocarbonates and polycarbonates.  In particular, desaminotyrosyl-tyrosine hexyl ester was found to lead to mechanically strong polymers with good engineering properties.  These new pseudopoly(amino acids) appear to be promising materials for a number of biomedical applications.
RP KOHN, J (reprint author), RUTGERS STATE UNIV,DEPT CHEM,NEW BRUNSWICK,NJ 08903, USA.
CR BODANSZKY M, 1984, PRACTICE PEPTIDE SYN, P145
   ENGELBERG I, 1991, IN PRESS BIOMATERIAL
   KOHN J, 1986, BIOMATERIALS, V7, P176, DOI 10.1016/0142-9612(86)90098-0
   KOHN J, 1987, J AM CHEM SOC, V109, P817, DOI 10.1021/ja00237a030
   KOHN J, 1988, PEPTIDES CHEM BIOL, P658
   KOHN J, 1984, POLYM MAT SCI ENG, V51, P119
   KOHN JE, UNPUB
   LEONG K, COMMUNICATION
   LI C, 1989, MACROMOLECULES, V22, P2029, DOI 10.1021/ma00195a001
   MOHADGER Y, 1976, J POLYM SCI POL PHYS, V14, P963, DOI 10.1002/pol.1976.180140601
   PULAPURA S, 1990, J BIOMATERIALS, V11, P665
   PULAPURA S, UNPUB TYROSINE DERIV
   PULAPURA S, 1990, POLYM PREPRINTS, V31, P233
   SCHNELL H, 1964, CHEM PHYSICS POLYCAR
   SILVER FH, BIOCOMPATIBILITY DEG
   1982, NAT I OCC SAF HLTH N, P70
NR 16
TC 0
Z9 0
U1 0
U2 4
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036
SN 0097-6156
J9 ACS SYM SER
PY 1991
VL 469
BP 155
EP 169
PG 15
WC Chemistry, Multidisciplinary
SC Chemistry
GA GE122
UT WOS:A1991GE12200017
DA 2018-10-20
ER

PT J
AU FOX, JW
   SHANNON, JD
   BJARNASON, JB
AF FOX, JW
   SHANNON, JD
   BJARNASON, JB
TI PROTEINASES AND THEIR INHIBITORS IN BIOTECHNOLOGY
SO ACS SYMPOSIUM SERIES
LA English
DT Article
ID HUMAN IMMUNODEFICIENCY VIRUS; CYSTEINE PROTEINASES; DISULFIDE BONDS;
   CROTALUS-ATROX; PROTEASE; SPECIFICITY; SUBTILISIN; BINDING; ENZYME;
   CELLS
AB Proteases are used in many industrial areas as well as basic research. They are classified by their mechanism of catalysis. Proteases are used in the pharmacological, food and other consumer industries to convert raw materials into a final product or to alter properties of the raw material. In biomedical research, proteases are used to study the structure of other proteins and for synthesis of peptides. The choice of a protease for an application depends in part on its specificity for peptide bonds, activity and stability. Technical advances in protein engineering have enabled alteration of these properties and allowed proteases to be used more effectively. Some easily obtained proteases can be modified so that they can substitute for proteases whose supply is limited.
C1 UNIV ICELAND, INST SCI, REYKJAVIK, ICELAND.
RP FOX, JW (reprint author), UNIV VIRGINIA, SCH MED, DEPT MICROBIOL, CHARLOTTESVILLE, VA 22908 USA.
CR ASBOTH B, 1985, BIOCHEMISTRY-US, V24, P606, DOI 10.1021/bi00324a010
   ASGEIRSSON B, 1989, EUR J BIOCHEM, V180, P85
   Barrett A.J., 1980, CIBA F S, V75, P1
   BARRETT AJ, 1976, ANAL BIOCHEM, V76, P374, DOI 10.1016/0003-2697(76)90298-0
   BARRETT AJ, 1985, BIOCHEM J, V231, P807, DOI 10.1042/bj2310807
   BARRETT AJ, 1986, RES MONOG CELL TISSU, V12, P515
   BECKERSTOFF GF, 1987, ENZYMES IND MED
   BERGER A, 1970, PHILOS T R SOC B, V257, P249, DOI 10.1098/rstb.1970.0024
   Bergmann M, 1937, J BIOL CHEM, V117, P189
   BICKNELL R, 1987, BIOCHEMISTRY-US, V26, P7291, DOI 10.1021/bi00397a014
   BJARNASON JB, 1983, BIOCHEMISTRY-US, V22, P3770, DOI 10.1021/bi00285a009
   CHEETHAM PSJ, 1985, HDB ENZYME BIOTECHNO
   DEBOUCK C, VIRAL PROTEINASES TA
   FLANNERY AV, 1989, PROTEOLYTIC ENZYMES, P145
   Godfrey T, 1983, IND ENZYMOLOGY
   GRIFFIN PR, 1989, TECHNIQUES PROTEIN C, P160
   HANECAK R, 1982, P NATL ACAD SCI-BIOL, V79, P3973, DOI 10.1073/pnas.79.13.3973
   HARTLEY BS, 1960, ANNU REV BIOCHEM, V29, P45, DOI 10.1146/annurev.bi.29.070160.000401
   HIBBS MS, 1985, J BIOL CHEM, V260, P2493
   HULMES JD, 1989, TECHNIQUES PROTEIN C, P7
   ISAAC O, 1977, Patent No. 4004976
   James M. N. G., 1976, PROTEOLYSIS PHYSL RE, P125
   JENSEN G, 1984, A05845 NOV IND ALS I
   JONGENEEL CV, 1989, FEBS LETT, V242, P211, DOI 10.1016/0014-5793(89)80471-5
   KALISZ HM, 1988, ADV BIOCHEM ENG BIOT, V36, P28
   KOHL NE, 1988, P NATL ACAD SCI USA, V85, P4686, DOI 10.1073/pnas.85.13.4686
   LAYMAN PL, 1986, CHEM ENG NEWS
   LIOTTA LA, 1986, ANNU REV BIOCHEM, V55, P1037, DOI 10.1146/annurev.bi.55.070186.005133
   MAZUR RH, 1969, J AM CHEM SOC, V91, P2684, DOI 10.1021/ja01038a046
   MCKEEVER BM, 1989, J BIOL CHEM, V264, P1919
   MELLONI E, 1982, BIOCHEM BIOPH RES CO, V107, P1053, DOI 10.1016/0006-291X(82)90628-3
   MENON AS, 1987, J BIOL CHEM, V262, P14929
   MITCHINSON C, 1989, BIOCHEMISTRY-US, V28, P4807, DOI 10.1021/bi00437a043
   NEURATH H, 1984, SCIENCE, V224, P350, DOI 10.1126/science.6369538
   OKADA Y, 1986, J BIOL CHEM, V261, P14255
   OLAFSDOTTIR S, 1985, ASPARTIC PROTEINASES
   PALTHY L, 1985, CHEM ENG NEWS, V41, P657
   PANTOLIANO MW, 1987, BIOCHEMISTRY-US, V26, P775
   POLGAR L, 1982, BIOCHEM J, V207, P1
   RITSKES TM, 1971, J FISH RES BOARD CAN, V69, P647
   Salvensen G, 1989, PROTEOLYTIC ENZYMES, P83
   SCHLABACH TD, 1989, TECHNIQUES PROTEIN C, P497
   SHANNON JD, 1989, J BIOL CHEM, V264, P11575
   SHANNON JD, 1989, J BIO CHEM, V264, P1157
   SIMPSON BK, 1987, FOOD BIOTECHNOLOGY
   STAUTON R, 1989, FOOD SCI TECHNOLOGY, V2, P180
   TRYGGVASON K, 1987, BIOCHIM BIOPHYS ACTA, V907, P191, DOI 10.1016/0304-419X(87)90006-0
   WEIL TA, 1982, Patent No. 4338399
   WELLS JA, 1986, J BIOL CHEM, V261, P6564
   WILHELM SM, 1987, P NATL ACAD SCI USA, V84, P6725, DOI 10.1073/pnas.84.19.6725
   Young C.L., 1978, ATLAS PROTEIN SEQUEN, P73
NR 51
TC 1
Z9 1
U1 1
U2 3
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0097-6156
J9 ACS SYM SER
JI ACS Symp. Ser.
PY 1991
VL 460
BP 62
EP 79
PG 18
WC Chemistry, Multidisciplinary
SC Chemistry
GA FM710
UT WOS:A1991FM71000006
DA 2018-10-20
ER

PT J
AU BARNES, RM
AF BARNES, RM
TI INDUCTIVELY COUPLED AND OTHER PLASMA SOURCES - DETERMINATION AND
   SPECIATION OF TRACE-ELEMENTS IN BIOMEDICAL APPLICATIONS
SO ACS SYMPOSIUM SERIES
LA English
DT Review
ID MICROWAVE-INDUCED PLASMA; PERFORMANCE LIQUID-CHROMATOGRAPHY;
   ATOMIC-EMISSION-SPECTROMETRY; SOURCE-MASS SPECTROMETRY; SUPERCRITICAL
   FLUID CHROMATOGRAPHY; LEAD ISOTOPE RATIOS; BIOLOGICAL SAMPLES; STABLE
   ISOTOPES; ABSORPTION SPECTROMETRY; ENVIRONMENTAL-SAMPLES
AB An appraisal of currently popular electrical plasma sources, including the inductively coupled plasma (ICP), microwave induced plasma (MIP), and direct current plasma (DCP), employed with atomic and mass spectrometry is presented for the determination and speciation of trace elements in the biomedical field. The advantages and limitations of the methods based on these techniques, problems of interferences and their resolution, elements that can and cannot be determined relative to their reference values in various biological materials, the current status, and future developments are discussed. Interfacing liquid, gas, and supercritical fluid chromatography with these plasma detectors also is examined. Practical illustrations are given based upon a survey of recent literature.
RP BARNES, RM (reprint author), UNIV MASSACHUSETTS, DEPT CHEM, LEDERLE GRAD RES CTR TOWERS, AMHERST, MA 01003 USA.
CR ALIMONTI A, 1989, J ANAL ATOM SPECTROM, V4, P577, DOI 10.1039/ja9890400577
   Alimonti A, 1987, J Trace Elem Electrolytes Health Dis, V1, P79
   AMARASIRIWARDEN.CJ, 1990, J ANAL AT SPECTROM, V5
   AMARASIRIWARDEN.CJ, 1990, 1990 WINT C PLASM SP, P156
   BAMIRO FO, 1988, J ANAL ATOM SPECTROM, V3, P279, DOI 10.1039/ja9880300279
   BEAUCHEMIN D, 1989, J ANAL ATOM SPECTROM, V4, P285, DOI 10.1039/ja9890400285
   BEHNE D, 1989, FRESEN Z ANAL CHEM, V335, P802, DOI 10.1007/BF01204091
   BONGERS J, 1988, ANAL CHEM, V60, P2683, DOI 10.1021/ac00175a008
   BRATTER P, 1988, TRACE ELEMENT ANAL C, V5, P145
   BRATTER P, 1988, TRACE ELEMENT ANAL C, V5, P120
   BROEKAERT JAC, 1987, ANAL CHIM ACTA, V196, P1, DOI 10.1016/S0003-2670(00)83065-2
   BROEKAERT JAC, 1987, INDUCTIVELY COUPLE 2, pCH12
   BROWN AA, 1988, J ANAL ATOM SPECTROM, V3, pR45, DOI 10.1039/ja988030045r
   BROWN AA, 1989, J ANAL ATOM SPECTROM, V4, pR47, DOI 10.1039/ja989040047r
   BUSHEE DS, 1988, ANALYST, V113, P1167, DOI 10.1039/an9881301167
   BUSHEE DS, 1989, J ANAL ATOM SPECTROM, V4, P773, DOI 10.1039/ja9890400773
   CALABRESE EJ, 1989, REGUL TOXICOL PHARM, V10, P123, DOI 10.1016/0273-2300(89)90019-6
   CAMPBELL MJ, 1989, J ANAL ATOM SPECTROM, V4, P235, DOI 10.1039/ja9890400235
   CAROLI S, 1988, SPECTROCHIM ACTA B, V43, P371, DOI 10.1016/0584-8547(88)80065-X
   CREED JT, 1988, J ANAL ATOM SPECTROM, V3, P923, DOI 10.1039/ja9880300923
   CREWS HM, 1989, ANALYST, V114, P895, DOI 10.1039/an9891400895
   CREWS HM, 1989, J ANAL ATOM SPECTROM, V5, pR75
   DALGARNO BG, 1988, BIOMED ENVIRON MASS, V16, P377, DOI 10.1002/bms.1200160174
   DEAN JR, 1987, J ANAL ATOM SPECTROM, V2, P607, DOI 10.1039/ja9870200607
   DEAN JR, 1989, APPLICATIONS INDUCTI, pCH6
   DELANEY MF, 1983, SPECTROCHIM ACTA B, V38, P399, DOI 10.1016/0584-8547(83)80138-4
   DELVES HT, 1988, J ANAL ATOM SPECTROM, V3, P343, DOI 10.1039/ja9880300343
   DEVER M, 1989, J ANAL ATOM SPECTROM, V4, P361, DOI 10.1039/ja9890400361
   DURRANT SF, 1989, MICRONUTRIENT ANAL, P111
   EBDON L, 1990, MICROCHEM J, V41, P219, DOI 10.1016/0026-265X(90)90121-K
   EBDON L, 1987, ANALYST, V112, P1, DOI 10.1039/an9871200001
   EBDON L, 1986, ANALYST, V111, P1113, DOI 10.1039/an9861101113
   FIROR RL, 1989, AM LAB, V21, P40
   FORBES KA, 1989, ADV CHROMATOGR, V1, P487
   GALANTE LJ, 1988, ANAL CHEM, V60, P1370, DOI 10.1021/ac00165a004
   GARDINER PE, 1987, J ANAL ATOM SPECTROM, V2, P375, DOI 10.1039/ja9870200375
   GARDINER PE, 1988, J ANAL ATOM SPECTROM, V3, P163, DOI 10.1039/ja9880300163
   GARDINER PHE, 1987, TOP CURR CHEM, V141, P145
   GRAY AL, 1989, APPLICATIONS INDUCTI, pCH1
   HAGEN DF, 1987, SPECTROCHIM ACTA B, V42, P253, DOI 10.1016/0584-8547(87)80067-8
   HAGEN DF, 1983, SPECTROCHIM ACTA B, V38, P377, DOI 10.1016/0584-8547(83)80136-0
   HEITKEMPER D, 1989, J ANAL ATOM SPECTROM, V4, P279, DOI 10.1039/ja9890400279
   HIEFTJE GM, 1989, ANAL CHIM ACTA, V216, P1, DOI 10.1016/S0003-2670(00)82002-4
   HOOKER DB, 1989, ANAL CHEM, V61, P2207, DOI 10.1021/ac00194a018
   HOUK RS, 1988, MASS SPECTROM REV, V7, P425, DOI 10.1002/mas.1280070404
   IGARASHI Y, 1989, J ANAL ATOM SPECTROM, V4, P571, DOI 10.1039/ja9890400571
   JANGHORBANI M, 1988, ANALYST, V113, P405, DOI 10.1039/an9881300405
   JANGHORBANI M, 1989, APPLICATIONS INDUCTI, pCH5
   JOSEPH MJ, 1989 PITTS C ATL
   KAWAGUCHI H, 1975, CLIN CHEM, V21, P591
   KAWAGUCHI H, 1975, ANAL CHEM, V47, P1029, DOI 10.1021/ac60357a064
   KELIHER PN, 1987, INDUCTIVELY COUPLED, pCH16
   LASZTITY A, 1989, J ANAL ATOM SPECTROM, V4, P737, DOI 10.1039/ja9890400737
   LASZTITY A, 1989, J ANAL ATOM SPECTROM, V4, P761, DOI 10.1039/ja9890400761
   LEIS F, 1989, FRESEN Z ANAL CHEM, V333, P2, DOI 10.1007/BF00572605
   LUFFER DR, 1988, ANAL CHEM, V60, P1365, DOI 10.1021/ac00165a003
   LYON TDB, 1988, J ANAL ATOM SPECTROM, V3, P265, DOI 10.1039/ja9880300265
   MAESSEN FJMJ, 1987, INDUCTIVELY COUPLE 2, pCH5
   MARSHALL J, 1989, J ANAL ATOM SPECTROM, V4, pR111, DOI 10.1039/ja989040111r
   MCGREGOR DA, 1988, ANAL CHEM, V60, pA1089, DOI 10.1021/ac00170a001
   MICHEL R, 1987, CRIT REV BIOCOMPAT, V3, P235
   MOTLEY CB, 1989, APPL SPECTROSC, V43, P737, DOI 10.1366/0003702894202238
   NIXON DE, 1986, CLIN CHEM, V32, P1660
   PASCHAL DC, 1989, SPECTROCHIM ACTA B, V44, P1229, DOI 10.1016/0584-8547(89)80121-1
   PAUDYN A, 1989, SCI TOTAL ENVIRON, V89, P343, DOI 10.1016/0048-9697(89)90278-7
   POLK D, 1990, PITTSBURGH C NEW YOR
   QUIMBY BD, 1990, J ANAL CHEM+, V62, P1027
   RAMSEY M H, 1987, Analytical Proceedings, V24, P260, DOI 10.1039/ap9872400260
   ROUTH MW, 1987, SPECTROSCOPY, V2, P45
   RUSS GP, 1989, APPLICATIONS INDUCTI, pCH4
   SCHRAMEL P, 1988, BIOL TRACE ELEM RES, V16, P67, DOI 10.1007/BF02795335
   SCHRAMEL P, 1988, SPECTROCHIM ACTA B, V43, P881, DOI 10.1016/0584-8547(88)80194-0
   SCHUETTE S, 1988, ANALYST, V113, P1837, DOI 10.1039/an9881301837
   SHIRAISHI K, 1989, HEALTH PHYS, V57, P551, DOI 10.1097/00004032-198910000-00005
   SIRIRAKS A, 1990, ANAL CHEM, V62, P1185, DOI 10.1021/ac00210a018
   SUBRAMANIAN KS, 1986, PROG ANAL SPECTROSC, V9, P237
   SUBRAMANIAN KS, 1988, PROG ANAL SPECTROSC, V11, P511
   SULLIVAN JJ, 1990, ANAL CHEM, V62, P1034, DOI 10.1021/ac00209a014
   SUN XF, 1987, ANALYST, V112, P1223, DOI 10.1039/an9871201223
   SUYANI H, 1989, APPL SPECTROSC, V43, P962, DOI 10.1366/0003702894203732
   TEMPLETON DM, 1989, BIOL TRACE ELEM RES, V22, P17, DOI 10.1007/BF02917413
   THOMPSON M, 1985, ANALYST, V110, P443, DOI 10.1039/an9851000443
   TING BTG, 1988, J ANAL ATOM SPECTROM, V3, P325, DOI 10.1039/ja9880300325
   TING BTG, 1989, ANALYST, V114, P667, DOI 10.1039/an9891400667
   TOLG G, 1988, FRESEN Z ANAL CHEM, V331, P226, DOI 10.1007/BF00481889
   TSUNODA A, 1986, ANAL SCI, V2, P99
   UDEN PC, 1989, ENVANAL USING CHROMA, P96
   ULDEN PC, 1989, J CHROMATOGR, V468, P319
   VANHOE H, 1989, ANAL CHEM, V61, P1851, DOI 10.1021/ac00192a014
   VEILLON C, 1986, ANAL CHEM, V58, pA851, DOI 10.1021/ac00121a001
   VICZIAN M, 1990, J ANAL AT SPECTROM, V5
   WANG XR, 1989, J ANAL ATOM SPECTROM, V4, P727, DOI 10.1039/ja9890400727
   WHITTAKER PG, 1989, ANALYST, V114, P675, DOI 10.1039/an9891400675
   WILLIAMS T R, 1986, American Biotechnology Laboratory, V4, P56
   WILLIAMS TR, 1986, AM BIOTECHNOL LAB, V4, P54
   WILLIAMS TR, 1986, AM BIOTECHNOL LAB, V4, P56
   WOODHEAD JC, 1988, PEDIATR RES, V23, P495, DOI 10.1203/00006450-198805000-00012
NR 97
TC 2
Z9 2
U1 0
U2 0
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0097-6156
J9 ACS SYM SER
JI ACS Symp. Ser.
PY 1991
VL 445
BP 158
EP 180
PG 23
WC Chemistry, Multidisciplinary
SC Chemistry
GA EV292
UT WOS:A1991EV29200012
DA 2018-10-20
ER

PT J
AU BAQUEY, C
   DUPUY, B
   JANVIER, G
   BORDENAVE, L
   CAIX, J
   BASSECATHALINAT, B
AF BAQUEY, C
   DUPUY, B
   JANVIER, G
   BORDENAVE, L
   CAIX, J
   BASSECATHALINAT, B
TI RATIONALE FOR THE DESIGN OF BIOMATERIALS AND THE EVALUATION OF THEIR
   BIOCOMPATIBILITY
SO BIORHEOLOGY
LA English
DT Article
DE BIOMATERIALS; BIOCOMPATIBILITY; BIOARTIFICIAL PANCREAS; VASCULAR
   SUBSTITUTES
AB The biocompatibility of a material can be considered as the ideally expectable result of its interactions with living tissues with which it is interfaced. This property determines the ability of devices involving this material in their constitution, to correctly assume their ascribed function; reciprocally a bad fitting, between devices and their intended use, coming from a non-optimized design or from an inappropriate prescription, may alter the original biocompatibility of constitutive materials. Accordingly, the actual biocompatibility of a biomaterial depends upon both its intrinsic properties and the application in which it is involved. Such considerations must be taken into account by specialists who try to design more performant biomaterials, or new assist devices, should they be implantable or not; but they draw also methodological guidelines for the evaluation of the biocompatibility of these biomedical products.
RP BAQUEY, C (reprint author), UNIV BORDEAUX 2,INSERM,U306,146 RUE LEO SAIGNAT,F-33076 BORDEAUX,FRANCE.
CR BAMFORD CH, 1985, BLOOD COMPATIBLE MAT, P159
   Baquey C., 1981, ITBM, V2, P378
   BORDENAVE L, 1989, BIOMATERIALS, V10, P235, DOI 10.1016/0142-9612(89)90099-9
   EBERT CD, 1982, J BIOMED MATER RES, V16, P629, DOI 10.1002/jbm.820160510
   FOUGNOT C, 1979, ANN BIOMED ENG, V7, P429, DOI 10.1007/BF02364219
   GIN H, IN PRESS J MICROENCA
   JACOBS HA, 1989, J BIOMED MATER RES, V23, P611, DOI 10.1002/jbm.820230606
   KUSSEROW BK, 1973, T AM SOC ART INT ORG, V19, P8
   Lin J Y, 1985, Trans Am Soc Artif Intern Organs, V31, P468
   MCREA JC, 1981, T AM SOC ART INT ORG, V27, P511
   WILLIAMS DF, 1987, PROGR BIOMEDICAL ENG, V4
NR 11
TC 1
Z9 1
U1 0
U2 1
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
SN 0006-355X
J9 BIORHEOLOGY
JI Biorheology
PY 1991
VL 28
IS 5
BP 463
EP 472
PG 10
WC Biophysics; Engineering, Biomedical; Hematology
SC Biophysics; Engineering; Hematology
GA GM822
UT WOS:A1991GM82200006
PM 1782396
DA 2018-10-20
ER

PT J
AU ZIATS, NP
   TOPHAM, NS
   PANKOWSKY, DA
   ANDERSON, JM
AF ZIATS, NP
   TOPHAM, NS
   PANKOWSKY, DA
   ANDERSON, JM
TI ANALYSIS OF PROTEIN ADSORPTION ON RETRIEVED HUMAN VASCULAR GRAFTS USING
   IMMUNOGOLD LABELING WITH SILVER ENHANCEMENT
SO CELLS AND MATERIALS
LA English
DT Article
DE BIOMATERIALS; BIOCOMPATIBILITY; PROTEIN ADSORPTION; VASCULAR GRAFTS;
   THROMBOSIS; IMMUNOGOLD LABELING; SILVER ENHANCEMENT
ID COLLOIDAL-GOLD; ELECTRON-MICROSCOPY; ARTIFICIAL SURFACES; HUMAN-PLASMA;
   FIBRINOGEN; BIOMATERIALS; BLOOD; IMMUNOCYTOCHEMISTRY; FIBRONECTIN;
   MECHANISM
AB The adsorption of proteins on biomedical materials such as vascular grafts is important in modulating thrombosis, one eventual cause of vascular graft failure. We have identified proteins expressed on the surfaces of retrieved vascular grafts to determine if certain proteins were present at the end stage of vascular failure. Scanning electron microscopic analysis of protein adsorption on the surfaces of retrieved vascular prostheses was determined using antibodies to human blood proteins fibrinogen, fibronectin, Hageman factor (factor XII and factor VIII/von Willebrand Factor. The detection of these proteins on the blood contacting surface was evaluated by immunogold labelling with protein A-gold beads followed by silver enhancement. Fibronectin was the most abundant protein detected on retrieved expanded polytetrafluoroethylene or umbilical vein grafts. Protein adsorption was disperse for all proteins and one protein, fibronectin, was found in great amounts on all surfaces. Proteins such as fibronectin may be important in the adhesion and activation of platelets and leukocytes and thus contribute to the development of thrombosis. These analyses of human vascular grafts indicate that surface proteins can be readily detected by our methods and thus may be useful in determination of specific proteins important in the thrombogenicity and/or biocompatibility of cardiovascular devices.
C1 CASE WESTERN RESERVE UNIV,INST PATHOL,DEPT PATHOL,2085 ADELBERT RD,CLEVELAND,OH 44106.
   CASE WESTERN RESERVE UNIV,DEPT BIOMED ENGN,CLEVELAND,OH 44106.
   CASE WESTERN RESERVE UNIV,DEPT MACROMOLEC SCI,CLEVELAND,OH 44106.
CR ANDERSON JM, 1985, ASAIO, V8, P79
   ANDRADE JD, 1986, ADV POLYM SCI, V79, P1
   Baier R E, 1969, J Biomed Mater Res, V3, P191, DOI 10.1002/jbm.820030115
   BALE MD, 1989, BLOOD, V74, P2698
   BATTEIGER BE, 1988, HDB IMMUNOBLOTTING P, V1, P145
   BELLISSIMO JA, 1984, T AM SOC ART INT ORG, V30, P359
   BRASH JL, 1988, BLOOD, V71, P932
   BREEMHAAR W, 1984, BIOMATERIALS, V5, P269, DOI 10.1016/0142-9612(84)90071-1
   CHUANG HYK, 1985, J BIOMED MATER RES, V19, P813, DOI 10.1002/jbm.820190707
   CHUANG HYK, 1984, J BIOMED MATER RES, V18, P547, DOI 10.1002/jbm.820180508
   COX D P, 1986, American Biotechnology Laboratory, V4, P22
   DEHARVEN E, 1984, J CELL BIOL, V99, P53, DOI 10.1083/jcb.99.1.53
   ESQUIVEL CO, 1986, J SURG RES, V41, P1, DOI 10.1016/0022-4804(86)90002-8
   GODING JW, 1978, J IMMUNOL METHODS, V20, P241, DOI 10.1016/0022-1759(78)90259-4
   GOODMAN S L, 1979, Scanning Electron Microscopy, P619
   GOODMAN SL, 1987, SCANNING MICROSCOPY, V1, P727
   GRINNELL F, 1982, J BIOL CHEM, V257, P4888
   HATTON MWC, 1989, AM J PATHOL, V135, P499
   HODGES GM, 1987, SCANNING MICROSCOPY, V1, P301
   HORBETT T, 1989, TECHNIQUES BIOCOMPAT, V2, P183
   HORBETT TA, 1984, THROMB RES, V36, P599, DOI 10.1016/0049-3848(84)90199-3
   MATSUDA T, 1984, T AM SOC ART INT ORG, V30, P353
   MURTHY KD, 1987, SCANNING MICROSCOPY, V1, P765
   OLIVER JA, 1987, SCANNING MICROSCOPY, V1, P745
   PANKOWSKY DA, 1990, J VASC SURG, V11, P599, DOI 10.1067/mva.1990.18272
   PARK K, 1986, J COLLOID INTERF SCI, V111, P197, DOI 10.1016/0021-9797(86)90019-6
   PARK K, 1987, SCANNING MICROSCOPY, V1, P339
   PASQUINELLI G, 1987, SCANNING MICROSCOPY, V1, P1327
   PITT WG, 1986, J COLLOID INTERF SCI, V111, P343, DOI 10.1016/0021-9797(86)90039-1
   RATNOFF OD, 1983, ARCH DERMATOL, V119, P432, DOI 10.1001/archderm.119.5.432
   RICCITELLI SD, 1984, T AM SOC ART INT ORG, V30, P420
   SCHOEN FJ, 1989, INTERVENTIONAL SURGE, P241
   SPRINGALL DR, 1984, HISTOCHEMISTRY, V81, P603, DOI 10.1007/BF00489542
   VEITH FJ, 1986, J VASC SURG, V3, P104
   VROMAN L, 1988, B NEW YORK ACAD MED, V64, P352
   VROMAN L, 1980, BLOOD, V55, P156
   ZIATS NP, 1988, BIOMATERIALS, V9, P5, DOI 10.1016/0142-9612(88)90063-4
   ZIATS NP, 1989, ATHEROSCLEROSIS ARTE, P289
   ZIATS NP, 1990, IN PRESS J LAB CLIN
NR 39
TC 20
Z9 20
U1 1
U2 3
PU SCANNING MICROSCOPY INT
PI CHICAGO
PA PO BOX 66507, AMF O'HARE, CHICAGO, IL 60666
SN 1051-6794
J9 CELL MATER
JI Cells Mat.
PY 1991
VL 1
IS 1
BP 73
EP 82
PG 10
WC Cell Biology; Medicine, Research & Experimental; Materials Science,
   Biomaterials
SC Cell Biology; Research & Experimental Medicine; Materials Science
GA GK711
UT WOS:A1991GK71100009
DA 2018-10-20
ER

PT J
AU KIRKPATRICK, CJ
   MUELLERSCHULTE, D
   ROYE, M
   HOLLWEG, G
   GOSSEN, C
   RICHTER, H
   MITTERMAYER, C
AF KIRKPATRICK, CJ
   MUELLERSCHULTE, D
   ROYE, M
   HOLLWEG, G
   GOSSEN, C
   RICHTER, H
   MITTERMAYER, C
TI SURFACE MODIFICATION OF POLYMERS TO PERMIT ENDOTHELIAL-CELL GROWTH
SO CELLS AND MATERIALS
LA English
DT Review
DE ENDOTHELIAL CELLS; POLYMERS; SURFACE MODIFICATION; GRAFTING; TISSUE
   CULTURE; SEEDING; SCANNING ELECTRON MICROSCOPY
ID VASCULAR PROSTHESES INVITRO; POROUS ARTERIAL PROSTHESES; SMALL-CALIBER
   DACRON; POLYTETRAFLUOROETHYLENE GRAFTS; SMALL-DIAMETER; CULTURED HUMAN;
   BIOMEDICAL APPLICATIONS; EXTRACELLULAR-MATRIX; FIBRONECTIN; CAPILLARY
AB The interaction between endothelial cells (EC) and polymers has become relevant to medicine as a result of attempts to improve the biocompatibility of vascular prostheses. In man, endothelialization is minimal, so that vascular surgeons have attempted to pre-seed vascular grafts with autologous EC. The poor results of EC seeding of commonly used materials for vascular rafts, such as expanded polytetrafluoroethylene (ePTFE) or woven polyester (Dacron) has led to attempts to modify the surface of these and other polymers. Three principal modification techniques have been employed:  1. adsorption of bioactive molecules from applied solutions. Examples are fibronectin, collagen types I and IV and fibrin-containing mixtures. 2.  Formation of reactive groups. This includes carbon coating, plasma discharge and hydrolytic etching. We describe new experiments, using radiation induced grafting (RIG) techniques, with which polymers such as polyamide, polyethylene and ePTFE were surface modified to form electroneutral or positively or negatively charged groups. Scanning electron microscopy (SEM) following in vitro seeding of these modified polymers with both bovine and adult human EC showed that such techniques can be successfully applied to make an unreceptive polymer surface able to promote EC adhesion, spreading and growth. The numerous permutations available for RIG offer a promising method to improve vascular graft surfaces for EC seeding. Such modification techniques are readily applicable to industry. 3. Covalent coupling of bioactive molecules.  Techniques have been developed to allow proteins or oligopeptides to be covalently coupled via bifunctional spacer molecules on to polymer surfaces.
C1 RHEIN WESTFAL TH AACHEN,INST PATHOL,W-5100 AACHEN,GERMANY.
CR ALLEN BT, 1984, J VASC SURG, V1, P224, DOI 10.1067/mva.1984.avs0010224
   ANDERSON JS, 1987, SURGERY, V101, P577
   BEDDOWS CG, 1988, J APPL POLYM SCI, V35, P135, DOI 10.1002/app.1988.070350112
   BERGER K, 1972, ANN SURG, V175, P118, DOI 10.1097/00000658-197201000-00018
   BOYD KL, 1988, J BIOMED MATER RES, V22, P163, DOI 10.1002/jbm.820220302
   BREUERS W, 1987, KUNSTST-GER PLAST+, V77, P1273
   BREUERS W, 1988, ADV BIOMATER, V8, P297
   BREUERS W, 1989, THESIS TU AACHEN RWT
   CALLOW AD, 1987, ENDOTHELIAZATION VAS, P10
   CHAN V, 1979, THROMB RES, V5, P209
   CHARD RB, 1987, J THORAC CARDIOV SUR, V94, P132
   CLAGETT GP, 1982, SURGERY, V91, P87
   CLOWES AW, 1986, AM J PATHOL, V123, P220
   COHN D, 1984, J APPL POLYM SCI, V29, P2645, DOI 10.1002/app.1984.070290819
   CURTIS ASG, 1983, J CELL BIOL, V97, P1500, DOI 10.1083/jcb.97.5.1500
   CURTIS ASG, 1986, J CELL SCI, V86, P9
   DEBSKI R, 1982, T AM SOC ART INT ORG, V28, P456
   DILLEY R, 1979, J SURG RES, V27, P149, DOI 10.1016/0022-4804(79)90124-0
   ELDOR A, 1983, J CELL PHYSIOL, V114, P179, DOI 10.1002/jcp.1041140206
   ELLINGHORST G, 1983, RADIAT PHYS CHEM, V22, P635, DOI 10.1016/0146-5724(83)90073-0
   ESKIN SG, 1978, J BIOMED MATER RES, V12, P517, DOI 10.1002/jbm.820120406
   ESQUIVEL CO, 1986, J SURG RES, V41, P1, DOI 10.1016/0022-4804(86)90002-8
   FAJARDO LF, 1989, AM J CLIN PATHOL, V92, P241, DOI 10.1093/ajcp/92.2.241
   FASOL R, 1989, J VASC SURG, V9, P432, DOI 10.1067/mva.1989.vs0090432
   FASOL R, 1987, ENDOTHELIALIZATION V, P233
   FOXALL TL, 1986, J SURG RES, V41, P158, DOI 10.1016/0022-4804(86)90021-1
   GOMBOTZ W, 1985, RADIAT PHYS CHEM, V25, P549, DOI 10.1016/0146-5724(85)90134-7
   GOSPODAROWICZ D, 1977, EXP EYE RES, V25, P75, DOI 10.1016/0014-4835(77)90248-2
   GRAHAM LM, 1982, SURGERY, V91, P550
   GRAHAM LM, 1980, ARCH SURG-CHICAGO, V115, P1289
   GREISLER HP, 1989, ARCH SURG-CHICAGO, V124, P429
   GROSS JL, 1982, J CELL BIOL, V95, P974, DOI 10.1083/jcb.95.3.974
   GUPTA SK, 1980, AM J SURG, V140, P214, DOI 10.1016/0002-9610(80)90009-4
   HASEGAWA T, 1987, SURGERY, V102, P498
   HASSON JE, 1986, SURGERY, V100, P884
   HERRING M, 1978, SURGERY, V84, P498
   HERRING M, 1984, J VASC SURG, V1, P279, DOI 10.1067/mva.1984.avs0010279
   HERRING M, 1984, SURGERY, V96, P745
   HERRING MB, 1979, ANN SURG, V190, P84, DOI 10.1097/00000658-197907000-00019
   HORBETT TA, 1985, J COLLOID INTERF SCI, V104, P28, DOI 10.1016/0021-9797(85)90006-2
   HUSSAIN S, 1989, J VASC SURG, V9, P656, DOI 10.1067/mva.1989.vs0090656
   JAFFE EA, 1987, HUM PATHOL, V18, P234, DOI 10.1016/S0046-8177(87)80005-9
   JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470
   JAFFE EA, 1978, J EXP MED, V147, P1779, DOI 10.1084/jem.147.6.1779
   JAFFE EA, 1976, J EXP MED, V144, P209, DOI 10.1084/jem.144.1.209
   JANSEN B, 1985, J BIOMED MATER RES, V19, P1085, DOI 10.1002/jbm.820190918
   JARRELL BE, 1987, B NEW YORK ACAD MED, V63, P156
   JARRELL BE, 1986, SURGERY, V100, P392
   JARRELL BE, 1986, ANN SURG, V203, P6571
   KADLETZ M, 1987, THORAC CARDIOV SURG, V35, P143, DOI 10.1055/s-2007-1020277
   KAEHLER J, 1989, J VASC SURG, V9, P535, DOI 10.1067/mva.1989.vs0090535
   KELLER R, 1987, AM J PATHOL, V128, P299
   KEMPCZINSKI RF, 1987, SURGERY, V101, P439
   KENT KC, 1989, J VASC SURG, V9, P271, DOI 10.1067/mva.1989.vs0090271
   KEOUGH EM, 1984, J BIOMED MATER RES, V18, P281, DOI 10.1002/jbm.820180305
   KESLER KA, 1986, J VASC SURG, V3, P58
   KIRKPATRICK CJ, 1985, BIOCHIM BIOPHYS ACTA, V846, P120, DOI 10.1016/0167-4889(85)90117-X
   LESECHE G, 1989, SURGERY, V105, P36
   LEVIN EG, 1982, J CELL BIOL, V94, P631, DOI 10.1083/jcb.94.3.631
   LINDBLAD B, 1987, J BIOMED MATER RES, V21, P1013, DOI 10.1002/jbm.820210807
   LYDON MJ, 1986, BR POLYM J, V18, P22
   MADRI JA, 1980, LAB INVEST, V43, P303
   MATHISEN SR, 1986, J VASC SURG, V4, P33
   MCAUSLAN BR, 1987, J BIOMED MATER RES, V21, P921, DOI 10.1002/jbm.820210708
   MUELLER-SCHULTE D, 1990, Journal of Chromatography, V510, P115
   MUELLERSCHULTE D, 1982, POLYM B, V7, P395
   MUELLERSCHULTE D, 1987, Patent No. 214
   MUELLERSCHULTE D, 1982, POLYM B, V7, P77
   MUELLERSCHULTE D, 1987, Patent No. 3644987
   NICHOLS WK, 1981, T AM SOC ART INT ORG, V27, P208
   OERTENWALL P, 1989, J VASC SURG, V10, P374
   OERTENWALL P, 1987, J VASC SURG, V6, P17
   PLOW EF, 1981, J BIOL CHEM, V256, P9477
   PRATT KJ, 1989, J BIOMED MATER RES, V23, P1131, DOI 10.1002/jbm.820231004
   RAMALANJAONA G, 1986, J VASC SURG, V3, P264, DOI 10.1067/mva.1986.avs0030264
   RATNER BD, 1983, ANN BIOMED ENG, V11, P313, DOI 10.1007/BF02363290
   RATNER BD, 1980, J BIOMED MATER RES, V14, P665, DOI 10.1002/jbm.820140512
   RATNR BD, 1987, J BIOMED MATER RES-A, V21, P59
   ROSENMAN JE, 1985, J VASC SURG, V2, P778, DOI 10.1067/mva.1985.avs0020778
   SAGE H, 1981, ARTERIOSCLEROSIS, V1, P427, DOI 10.1161/01.ATV.1.6.427
   SAUVAGE LR, 1974, ARCH SURG-CHICAGO, V109, P698
   SAUVAGE LR, 1975, ANN SURG, V182, P749, DOI 10.1097/00000658-197512000-00017
   SCHMIDT SP, 1987, ENDOTHELIALIZATION V, P145
   SCHNEIDER PA, 1988, SURGERY, V103, P456
   SCHOR AM, 1984, TISSUE CELL, V16, P677, DOI 10.1016/0040-8166(84)90002-8
   SEEGER JM, 1985, J SURG RES, V38, P641, DOI 10.1016/0022-4804(85)90087-3
   SENTISSI JM, 1986, SURGERY, V99, P337
   SHAREFKIN JB, 1982, SURGERY, V92, P385
   SHARP WV, 1978, T AM SOC ART INT ORG, V24, P223
   SHINDO S, 1987, J VASC SURG, V6, P325, DOI 10.1067/mva.1987.avs0060325
   STANLEY JC, 1982, SURGERY, V92, P994
   STERN D, 1986, J CELL BIOL, V102, P1971, DOI 10.1083/jcb.102.5.1971
   THORNTON SC, 1983, SCIENCE, V222, P623, DOI 10.1126/science.6635659
   VANWACHEM PB, 1989, BIOMATERIALS, V10, P532, DOI 10.1016/0142-9612(89)90058-6
   WEKSLER BB, 1977, P NATL ACAD SCI USA, V74, P3922, DOI 10.1073/pnas.74.9.3922
   WILLIAMS SK, 1990, SCANNING MICROSCOPY, V4, P181
   YASUDA H, 1982, BIOMATERIALS, V3, P68, DOI 10.1016/0142-9612(82)90036-9
   YATES SG, 1978, ANN SURG, V188, P611, DOI 10.1097/00000658-197811000-00005
   ZILLA P, 1987, ENDOTHELIALIZATION V, P195
NR 99
TC 22
Z9 22
U1 0
U2 11
PU SCANNING MICROSCOPY INT
PI CHICAGO
PA PO BOX 66507, AMF O'HARE, CHICAGO, IL 60666
SN 1051-6794
J9 CELL MATER
JI Cells Mat.
PY 1991
VL 1
IS 2
BP 93
EP 108
PG 16
WC Cell Biology; Medicine, Research & Experimental; Materials Science,
   Biomaterials
SC Cell Biology; Research & Experimental Medicine; Materials Science
GA GK712
UT WOS:A1991GK71200001
DA 2018-10-20
ER

PT J
AU TIEN, HT
   SALAMON, Z
   OTTOVA, A
AF TIEN, HT
   SALAMON, Z
   OTTOVA, A
TI LIPID BILAYER-BASED SENSORS AND BIOMOLECULAR ELECTRONICS
SO CRITICAL REVIEWS IN BIOMEDICAL ENGINEERING
LA English
DT Review
ID CHEMISORBED MOLECULES; SELECTIVE SENSOR; CALCIUM-CHANNEL; MEMBRANES;
   ENZYME; BLM; SYSTEMS; GLUCOSE; DESIGN; ELECTROCHEMISTRY
AB The lipid bilayer postulated as the basic structural matrix of biological membranes is widely accepted.1  Experiments in the early 1960s have made direct studies of lipid bilayers possible.  At present, the planar bilayer lipid membrane (BLM) together with spherical lipid bilayers (liposomes), upon suitable modification, serves as a most appropriate model for biological membranes.  In recent years, advances in microelectronics and interest in ultrathin organic films, including BLMs, have resulted in a unique fusion of ideas toward the development of biosensors and transducers.  Furthermore, recent trends in interdisciplinary studies in chemistry, electronics, and biology have led to a new field or research:  biomolecular electronics.  This exciting new field of scientific-technological endeavor is part of a more general approach toward the development of a new, postsemiconductor electronic technology, namely, molecular electronics with a long-term goal of molecular computers.
   Experimental BLMs have been mainly used in the past as models of biological membranes.2,3  The methods of BLM studies may not be familiar to those outside biomedical research.  Therefore, a brief description of the experimental techniques will be given in Section IV.
   Recently, it has been demonstrated that BLMs, after suitable modification, can function as electrodes and exhibit nonlinear electronic properties.  These and other experimental findings relevant to sensor development and to "biomolecular electronic devices" (BED) will be covered in Section V, after a brief description of biomembranes which have been suggested as nature's molecular devices (Section III).  In the last section, the potential use of the BLM system together with its modifications in the development of a new class of organic diodes, switches, biosensors, electrochemical photocells, and biofuel cells will be presented (Section VI).  Additionally, this paper, besides presenting a review of our work and those of others on BLMs and liposomes in relation to biosensors and molecular electronics, reports a novel technique for obtaining BLMs (or lipid bilayers) on solid supports.  The presence of solid support on one side of the BLM greatly enhances its mechanical stability, while retaining the dynamic properties of the lipid bilayer.  Advantages of the new technique for self-assembling amphiphilic molecules on rigid substrates are discussed in terms of their possible uses.  That is, the new BLM system (s-BLMs) is potentially useful for technological applications in the area of biosensors, enzyme electrodes, and molecular electronics as well as biochips (Section IV.C).
   The dividing line between the present microscopic and the future molecular electronics is 1-mu-m.  Below this level, a new realm of quantum mechanics is starting to play a role and the classic rules of microelectronics ceases to function.  Taking into account that current high-density silicon technology can pack 50,000 transistors and more into a square millimeter, with a spacing between components on the order of 1 mm, together with the fact that below this dimensional level the physical properties of materials are fundamentally different, one has to come to the conclusion that microelectronic technology stands on the threshold of a new revolutionary change.  The era of this new type of electronics is going to be based on the power of molecules and atoms themselves, instead of the thin semi-conductor films used as a basis for the present microelectronics.
   Although in the world of molecules and atoms a number of physical phenomena can be used as reasonable candidates for the new post-semiconductor technology (specific electrical properties of molecules and atoms, quantum effects, and superconducting electronics and bioelectronics), there are two main directions in this field of research:  (1) molecular electronics based upon properties of molecules and atoms and (2) nanoelectronics using quantum effects.4  As expected, these new approaches will provide the means to develop the electronic circuits not only faster (a molecular circuit is expected to be 100,000 times faster than the ones in the present PC computers), but also with fundamentally new properties.  The latter is based on the fact that information-processing capabilities of molecules can be realized through the changes of electronic as well as their geometric structures.  This seems to be especially promising in the case of biological systems where the conformational properties of protein enzymes allow for ligand-receptor contact (lock-and-key) types of interaction.  This allows the recognition of specific molecular objects by exploring their shapes.5  The unique information processing capabilities of protein enzymes could be adapted for computers basically by changing von Neumann's approach and giving entirely new type of computer with a significantly increased computational power for such tasks as pattern recognition and process control.5  To reach this final goal in biomolecular electronics, researchers have to explore the possibility of developing bioelectronic devices from conceptually relatively simple biosensors to very advanced "biological electronic chips" which will function as a control-center processor.5,6
   Biosensors and simple bioelectronic devices have already been developing as a result of efforts on several scientific fronts.7-10  In this review, attention is focused upon BLM-based experiments as related to sensors and BED.  Thus, the BLM system may be viewed as a unique way to study the characteristic of a molecular junction free from the usual bulk-phase effects.  It will be seen that the approach used by various investigators is based upon a melange of ideas gathered from the fields of membrane biophysics, electrochemistry, photobiology, solid-state physics, and organic materials science.9.10
RP TIEN, HT (reprint author), MICHIGAN STATE UNIV,DEPT PHYSIOL,E LANSING,MI 48824, USA.
FU NIGMS NIH HHS [GM-14971]
CR AIZAWA M, 1977, J SOL-PHASE BIOCHEM, V2, P111
   ANTOLINI R, 1982, TRANSPORT MEMBRANES, P57
   ARNDT R, 1982, BIOCHEM PHARMACOL, V31, P3120, DOI 10.1016/0006-2952(82)90090-9
   ARNOLD MA, 1987, BIOSENSORS FUNDAMENT, pCH3
   BADLEY RA, 1987, PHILOS T ROY SOC B, V316, P143, DOI 10.1098/rstb.1987.0024
   BANGHAM AD, 1983, LIPOSOMES, P1
   BARBER J, 1979, TOPICS PHOTOSYNTHESI, V3, P115
   BARKER SA, 1987, BIOSENSORS FUNDAMENT, pCH6
   Bartlett P.N., 1987, BIOSENSORS FUNDAMENT
   BIRGE R, 1990, SOVIET E EUROPEAN RE, V7
   BLANK M, 1986, ELECTRICAL DOUBLE LA, P149
   BLANK M, 1970, SURFACE CHEM BIOL SY, P135
   BLUMENTHAL R, 1984, J BACTERIOL, V157, P321
   BROWN HD, 1971, CHEM CELL INTERFACE, P205
   BRYNDA E, 1985, CZECH J PHYS, V35, P873, DOI 10.1007/BF01959455
   BURKHANOV A, 1987, OTKRYT IZOBRET OTIZD, V13, P16
   CARTER FL, 1988, MOL ELECTRONIC DEVIC
   CASTLEDEN JA, 1969, J PHARM SCI, V58, P169
   CENAS NK, 1983, BIOELECTROCH BIOENER, V11, P61, DOI 10.1016/0302-4598(83)85101-0
   CENAS NK, 1984, BIOCHIM BIOPHYS ACTA, V767, P108
   CHERNY VV, 1989, BIOELECTROCH BIOENER, V21, P373, DOI 10.1016/0302-4598(89)85015-9
   CLARK LC, 1962, ANN NY ACAD SCI, V102, P29, DOI 10.1111/j.1749-6632.1962.tb13623.x
   CLARKSON MA, 1989, BYTE             MAY, P268
   Connolly J. S., 1988, PHOTOINDUCED ELECT D, P303
   CONRAD M, 1985, COMMUN ACM, V28, P464, DOI 10.1145/3532.3533
   CULLEN DC, 1988, BIOSENSORS, V3, P211
   CUNNANE VJ, J ELECTROANAL CHEM, V243, P455
   Danielsson B., 1987, BIOSENSORS FUNDAMENT, P575
   DATTA DB, 1987, MEMBRANE BIOCH
   DAUNERT S, 1989, BIOL SYNTHETIC MEMBR, P292
   DAVIS G, 1985, BIOSENSORS, V1, P161, DOI 10.1016/0265-928X(85)80002-X
   DAVISON SG, 1989, PROGR SURFACE SCI, V30, P1
   DELCASTI.J, 1966, SCIENCE, V153, P185, DOI 10.1126/science.153.3732.185
   DRYHURST G, 1988, REDOX CHEM INTERFACI, P529
   FABIANOWSKI W, 1989, LANGMUIR, V5, P35, DOI 10.1021/la00085a008
   FAULKNER LR, 1984, CHEM ENG NEWS   0227
   FAULKNER LR, 1984, CHEM ENG NEWS   0228, P411
   FISHERMAN AP, 1962, NATURE, V194, P979
   GORSKAYA I A, 1984, Biokhimiya, V49, P821
   GORTON L, 1984, J ELECTROANAL CHEM, V161, P103, DOI 10.1016/S0022-0728(84)80253-3
   Green M.J., 1987, BIOSENSORS FUNDAMENT
   Gregoriadis G, 1984, LIPOSOME TECHNOLOGY
   HAIR ML, 1971, CHEM BIOSURFACES, P234
   HALE PD, 1989, J AM CHEM SOC, V111, P3482, DOI 10.1021/ja00191a084
   Hameroff S., 1987, ULTIMATE COMPUTING
   HARRIS JR, 1989, SUBCELL BIOCH, V14, P97
   HENDRY SP, 1988, HORM METAB RES, V20, P37
   HONEYBOURNE CL, 1987, J PHYS CHEM SOLIDS, V48, P109, DOI 10.1016/0022-3697(87)90077-1
   HONG FT, 1989, MOL ELECT BIOSENSORS, P259
   HUCK H, 1984, ANALYST, V109, P147, DOI 10.1039/an9840900147
   IVANOV I, 1988, THIN LIQUID FILMS, P827
   Janata J., 1987, Proceedings of the Symposium on Chemical Sensors, P258
   KARADAGHI SE, 1984, BIOCHIM BIOPHYS ACTA, V778, P269
   KARUBE I, 1989, ANAL LETT, V22, P731
   KELL DB, 1985, J BIOELECTRICITY, V4, P317, DOI 10.3109/15368378509033261
   KELL DB, 1985, EUR BIOPHYS J BIOPHY, V12, P181
   KITANO H, 1988, BIOCHIM BIOPHYS ACTA, V942, P131, DOI 10.1016/0005-2736(88)90282-9
   KOSSI CN, 1981, J COLLOID INTERF SCI, V80, P426, DOI 10.1016/0021-9797(81)90201-0
   KRUGLYAKOV PM, 1988, THIN LIQUID FILMS, P767
   KRULL UJ, 1987, ANAL CHIM ACTA, V197, P203, DOI 10.1016/S0003-2670(00)84729-7
   KRULL VJ, 1986, FUNDAMENTALS APPLICA, P351
   KULYS JJ, 1981, ENZYME MICROB TECHNO, V3, P342
   KURIHARA K, 1987, 4TH INT C SOL STAT S, P569
   KUTNIK J, 1987, PHOTOCHEM PHOTOBIOL, V46, P413, DOI 10.1111/j.1751-1097.1987.tb04788.x
   LANE RF, 1973, J PHYS CHEM-US, V77, P1411, DOI 10.1021/j100630a019
   LANE RF, 1973, J PHYS CHEM-US, V77, P1401, DOI 10.1021/j100630a018
   LIEDBERG B, 1983, SENSOR ACTUATOR, V4, P299, DOI 10.1016/0250-6874(83)85036-7
   LIN AWC, 1977, J ELECTROANAL CHEM, V84, P411, DOI 10.1016/S0022-0728(77)80394-X
   LOEW LM, 1982, J BIOCHEM BIOPH METH, V6, P243, DOI 10.1016/0165-022X(82)90047-1
   LUO SF, 1989, ANAL CHEM, V61, P1069, DOI 10.1021/ac00185a005
   MARGULES GS, 1986, BIOELECTROCH BIOENER, V16, P361, DOI 10.1016/0302-4598(86)80060-5
   MARTIN MJ, 1987, MED BIOL ENG COMPUT, P597
   MARTONOSI AN, 1981, MEMBRANE TRANSPORT, P165
   MATSUMOTO G, 1987, J THEOR BIOL, V107, P649
   MAUZERALL D, 1909, LIGHT INDUCED CHARGE, P241
   MILLER C, 1986, ION CHANNEL RECONSTI
   MITTAL KL, 1990, SURFACTANTS SOLUTION, V8, P133
   MIYANO K, 1985, JPN J APPL PHYS 1, V24, P1379, DOI 10.1143/JJAP.24.1379
   MOHANSSON G, 1985, BIOSENSORS, V1, P355
   MOSBACH K, 1983, NEW BIOSENSOR DEVICE, P65
   MOUNTZ JD, 1978, J BIOENERG BIOMEMBR, V10, P139, DOI 10.1007/BF00743104
   MOUNTZ JM, 1978, PHOTOCHEM PHOTOBIOL, V28, P395, DOI 10.1111/j.1751-1097.1978.tb07724.x
   MUELLER P, 1967, BIOCHEM BIOPH RES CO, V26, P398, DOI 10.1016/0006-291X(67)90559-1
   MUNN RW, 1988, J MOL ELECTRON, V4, P31
   MURRAY RW, 1984, ELECTROANAL CHEM, V13, P191
   OBOYLE KP, 1984, IMMUNOL COMMUN, V13, P85, DOI 10.3109/08820138409025453
   OKAHATA Y, 1987, ANN M CHEM SOC JPN, P26
   OLLSHER U, 1989, J AM CHEM SOC, V111, P9217
   OLSON JM, 1977, BROOKHAVEN SYM BIOL, V28, P105
   PICKUP JC, 1988, HORM METAB RES, V20, P34
   PYATNITSKY AM, 1984, BIOFIZIKA+, V29, P615
   REICHERT WM, 1987, THIN SOLID FILMS, V152, P345, DOI 10.1016/0040-6090(87)90426-3
   REIG F, 1981, FETT SEIFEN ANSTR, V83, P267
   RINGSDORF H, 1988, ANGEW CHEM INT EDIT, V27, P113, DOI 10.1002/anie.198801131
   Robertson JD, 1981, J CELL BIOL, V91, P189
   RUDNEV VS, 1984, BIOL MEMBRANY, V1, P1019
   SALAMON Z, 1988, PHOTOCHEM PHOTOBIOL, V48, P281, DOI 10.1111/j.1751-1097.1988.tb02822.x
   SALMON Z, 1989, J PHOTOCHEM PHOTOBIO, V3, P351
   SCHMIDT W, 1984, J MEMBRANE BIOL, V82, P113, DOI 10.1007/BF01868936
   SCHULTZ PG, 1988, SCIENCE, V240, P426, DOI 10.1126/science.2833815
   SEMENOVA AN, 1987, J PHOTOCHEM PHOTOBIO, V1, P185
   SETA P, 1989, ELECTROCHIM ACTA, V34, P1723, DOI 10.1016/0013-4686(89)85055-8
   SHARP M, 1971, ANAL CHIM ACTA, V54, P13, DOI 10.1016/S0003-2670(01)81850-X
   SHEN XC, 1986, BIOELECTROCH BIOENER, V16, P13
   SHUETZLE D, 1986, FUNDAMENTALS APPLICA
   SOKOLOV YV, 1985, J MEMBRANE BIOL, V2, P943
   SUTERLAND RM, 1987, BIOSENSORS FUNDAMENT, P655
   SZOKA F, 1980, ANNU REV BIOPHYS BIO, V9, P467, DOI 10.1146/annurev.bb.09.060180.002343
   TABUSHI I, 1989, J CHEM SOC PERK T 1, P383, DOI 10.1039/p19890000383
   TANCREDE P, 1983, J BIOCHEM BIOPH METH, V7, P299, DOI 10.1016/0165-022X(83)90055-6
   TAYLOR RF, 1987, BIOSENSORS BIOCHIPS
   THOMPSON M, 1983, TALANTA, V30, P919, DOI 10.1016/0039-9140(83)80214-8
   TIEN HT, 1986, BIOELECTROCH BIOENER, V15, P19, DOI 10.1016/0302-4598(86)80002-2
   TIEN HT, 1989, BIOELECTROCH BIOENER, V22, P211, DOI 10.1016/0302-4598(89)87040-0
   TIEN HT, 1984, BIOELECTROCH BIOENER, V13, P299, DOI 10.1016/0302-4598(84)87033-6
   TIEN HT, 1988, J CLIN LAB ANAL, V2, P256, DOI 10.1002/jcla.1860020414
   TIEN HT, 1988, J MOL ELECTRON, V4, pS1
   TIEN HT, 1976, PHOTOCHEM PHOTOBIOL, V24, P95, DOI 10.1111/j.1751-1097.1976.tb06805.x
   TIEN HT, 1988, J SURFACE SCI TECHNO, V4, P1
   TIEN HT, IN PRESS P S MOL ELE
   TIEN HT, 1974, BILAYER LIPID MEMBRA
   TSE DCS, 1977, ANAL CHEM, V49, P1589
   TSUCHIDA E, 1988, J PHYS CHEM-US, V92, P4255, DOI 10.1021/j100326a001
   Turner A. P. F., 1987, BIOSENSORS FUNDAMENT
   TURNER APF, 1988, AM BIOTECHNOL LAB, V6, P10
   VANROGGEN A, 1988, MOL ELECTRONIC DEVIC, P427
   VASSILEV PM, 1987, BIOCHIM BIOPHYS ACTA, V897, P324, DOI 10.1016/0005-2736(87)90428-7
   VASSILEV PM, 1987, CANCER RES, V47, P519
   VASSILEV PM, 1986, CANCER BIOCHEM BIOPH, V9, P85
   VASSILEV PM, 1989, SUBCELLULAR BIOCH, V14, pCH3
   WANGERMANN G, 1989, STUD BIOPHYS, V132, P9
   WARNER PG, 1987, BIOSENSORS FUNDAMENT, pCH7
   WILLIAMS DE, IN PRESS S BIOSENSOR
   YAMASAKI Y, 1989, CLIN CHIM ACTA, V180, P93, DOI 10.1016/0009-8981(89)90301-X
   YEGOROVA YM, 1984, ELEKTROKHIMIYA, V20, P1527
   YOSHIKAWA K, 1987, BIOCHEM BIOPH RES CO, V145, P1092, DOI 10.1016/0006-291X(87)91549-X
NR 136
TC 36
Z9 37
U1 2
U2 35
PU BEGELL HOUSE INC
PI NEW YORK
PA 79 MADISON AVE, SUITE 1205, NEW YORK, NY 10016-7892
SN 0278-940X
J9 CRIT REV BIOMED ENG
JI Crit. Rev. Biomed. Eng.
PY 1991
VL 18
IS 5
BP 323
EP 340
PG 18
WC Engineering, Biomedical
SC Engineering
GA FE201
UT WOS:A1991FE20100002
PM 2036800
DA 2018-10-20
ER

PT J
AU HANSEN, JT
   GASH, DM
AF HANSEN, JT
   GASH, DM
TI FUNCTIONAL-ASPECTS OF MAMMALIAN NEURAL TRANSPLANTATION
SO CRITICAL REVIEWS IN NEUROBIOLOGY
LA English
DT Review
DE NEURAL TRANSPLANTS; MAMMALIAN; PARKINSONS DISEASE; NEURODEGENERATION;
   NEURAL PLASTICITY; BLOOD-BRAIN BARRIER
ID NERVE GROWTH-FACTOR; ADRENAL CHROMAFFIN CELLS; ADULT-RAT-BRAIN; INDUCED
   NEURONOTROPHIC ACTIVITY; ADVANCED PARKINSONS-DISEASE; GENETICALLY
   MODIFIED CELLS; SUBSTANTIA NIGRA; CAUDATE-NUCLEUS; MEDULLARY TISSUE;
   BASAL GANGLIA
AB Although initially perceived as a method to study neural development and regeneration, neural transplantation has recently become a very promising approach in its own right as a therapeutic tool to treat neurodegenerative disorders. The development of several animal models which mimic aspects of clinical disorders such as Parkinson's disease, Alzheimer's disease, and Huntington's chorea, provides systems in which to study the potential benefits of grafts derived from different sources. Both fetal and adult donor tissues presently are under investigation. Additionally, cell lines and genetically engineered cells also are being developed as suitable graft material. Important aspects of graft-host interaction, including cell survival, host regeneration, immune interactions, improved behavior, and blood-brain barrier phenomena, may be studied in these transplant models. Advances in this field of biomedical research have led to clinical trials in patients afflicted with Parkinson's disease who now are undergoing transplantation therapy. Thus far, the results have been equivocal, raising important ethical questions about continued clinical studies until more is understood about how neural transplants function and interact with the host. Nevertheless, neural transplantation holds tremendous promise as a future therapeutic tool to treat progressive and irreversible neural disorders.
RP HANSEN, JT (reprint author), UNIV ROCHESTER, SCH MED, DEPT NEUROBIOL & ANAT, BOX 603, 601 ELMWOOD AVE, ROCHESTER, NY 14642 USA.
FU NINDS NIH HHS [NS 25778]
CR AEBISCHER P, 1988, BRAIN RES, V448, P364, DOI 10.1016/0006-8993(88)91278-4
   AGUAYO AJ, 1987, ANN NY ACAD SCI, V495, P1, DOI 10.1111/j.1749-6632.1987.tb23661.x
   AGUAYO AJ, 1984, NEUROSCI LETT, V45, P53, DOI 10.1016/0304-3940(84)90328-8
   AHLSKOG JE, 1990, MAYO CLIN PROC, V65, P305, DOI 10.1016/S0025-6196(12)62532-4
   ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X
   ALLEN GS, 1989, ARCH NEUROL-CHICAGO, V46, P487, DOI 10.1001/archneur.1989.00520410021016
   ANDY OJ, 1963, J NEUROSURG, V20, P860, DOI 10.3171/jns.1963.20.10.0860
   APPEL SH, 1981, ANN NEUROL, V10, P499, DOI 10.1002/ana.410100602
   APUZZO MLJ, 1990, NEUROSURGERY, V26, P746, DOI 10.1227/00006123-199005000-00003
   BACKLUND EO, 1985, J NEUROSURG, V62, P169, DOI 10.3171/jns.1985.62.2.0169
   BAKAY RAE, 1988, PROG BRAIN RES, V78, P463
   BANKIEWICZ KS, 1990, J NEUROSURG, V72, P231, DOI 10.3171/jns.1990.72.2.0231
   BANKIEWICZ KS, 1986, LIFE SCI, V39, P7, DOI 10.1016/0024-3205(86)90431-5
   BANKIEWICZ KS, 1988, PROG BRAIN RES, V78, P543
   Barbeau A., 1986, HDB CLIN NEUROLOGY, P87
   BARKER CF, 1977, ADV IMMUNOL, V25, P1
   BING G, 1988, BRAIN RES BULL, V20, P399, DOI 10.1016/0361-9230(88)90069-X
   BING G, 1987, Society for Neuroscience Abstracts, V13, P161
   BJORKLUND A, 1977, CELL TISSUE RES, V185, P289
   BJORKLUND A, 1980, BRAIN RES, V199, P307, DOI 10.1016/0006-8993(80)90692-7
   BJORKLUND A, 1979, BRAIN RES, V177, P555, DOI 10.1016/0006-8993(79)90472-4
   BJORKLUND A, 1976, NATURE, V262, P787, DOI 10.1038/262787a0
   BJORKLUND A, 1982, NATURE, V298, P652, DOI 10.1038/298652a0
   BJORKLUND A, 1980, CELL TISSUE RES, V212, P39
   Bjorklund A., 1985, NEURAL GRAFTING MAMM, P3
   BOHN MC, 1987, SCIENCE, V237, P913, DOI 10.1126/science.2887034
   BOTTENSTEIN JE, 1981, FUNCTIONALLY DIFFERE, P155
   BREGMAN BS, 1986, J COMP NEUROL, V244, P86, DOI 10.1002/cne.902440107
   BRIGHTMAN MW, 1982, CEREBROSPINAL FLUID, P36
   BROADWELL RD, 1987, J COMP NEUROL, V260, P47, DOI 10.1002/cne.902600105
   BRUNDIN P, 1986, EXP BRAIN RES, V65, P235
   BRUNDIN P, 1988, PROG BRAIN RES, V78, P441
   BRUNDIN P, 1988, DEV BRAIN RES, V39, P233, DOI 10.1016/0165-3806(88)90027-2
   BRUNDIN P, 1985, EXP BRAIN RES, V60, P204
   BURNS RS, 1983, P NATL ACAD SCI-BIOL, V80, P4546, DOI 10.1073/pnas.80.14.4546
   BUZSAKI G, 1988, PROG BRAIN RES, V78, P69
   CATTANACH BM, 1977, NATURE, V269, P338, DOI 10.1038/269338a0
   COOPER IS, 1955, SCIENCE, V121, P217, DOI 10.1126/science.121.3137.217
   COOPER IS, 1965, ANNU REV MED, V16, P309, DOI 10.1146/annurev.me.16.020165.001521
   COTMAN CW, 1983, 15 COLD SPR HARB LAB, P275
   COYLE JT, 1979, ADV NEUROL, V23, P593
   DELCERRO M, 1988, PROG BRAIN RES, V78, P125
   DELCERRO M, 1985, INVEST OPHTH VIS SCI, V26, P1182
   DIFIGLIA M, 1988, J NEUROSCI, V8, P1112
   DOUPE AJ, 1985, J NEUROSCI, V5, P2143
   DOUPE AJ, 1985, J NEUROSCI, V5, P2119
   DUBACH M, 1988, PROG BRAIN RES, V78, P491
   DUNNETT SB, 1982, BRAIN RES, V251, P335, DOI 10.1016/0006-8993(82)90751-X
   DUNNETT SB, 1985, NEURAL GRAFTIN MAMMA, pCH59
   FEED WJ, 1984, NEURAL TRANSPLANTS D, P373
   FIANDACA MS, 1988, EXP NEUROL, V102, P76, DOI 10.1016/0014-4886(88)90080-5
   FINE A, 1988, PROG BRAIN RES, V78, P479
   Forno L. S., 1973, ADV NEUROL, V1, P453
   FREED WJ, 1990, PROG BRAIN RES, V82, P11
   FREED WJ, 1980, ANN NEUROL, V8, P510, DOI 10.1002/ana.410080508
   FREED WJ, 1983, SCIENCE, V222, P937, DOI 10.1126/science.6635666
   FREED WJ, 1981, NATURE, V292, P351, DOI 10.1038/292351a0
   FRIEDMANN T, 1972, SCIENCE, V175, P949, DOI 10.1126/science.175.4025.949
   FRIEDMANN T, 1983, GENE THERAPY FACT FI
   GAGE FH, 1988, J COMP NEUROL, V269, P147, DOI 10.1002/cne.902690112
   GAGE FH, 1987, NEUROSCIENCE, V23, P795, DOI 10.1016/0306-4522(87)90159-X
   GAGE FH, 1986, NEUROSCIENCE, V19, P241, DOI 10.1016/0306-4522(86)90018-7
   GASH D, 1980, SCIENCE, V210, P1367, DOI 10.1126/science.7434031
   GASH DM, 1985, NEUROBIOL AGING, V6, P131, DOI 10.1016/0197-4580(85)90031-4
   GASH DM, IN PRESS FERNSTROM S
   GIBSON MJ, 1984, ENDOCRINOLOGY, V114, P1938, DOI 10.1210/endo-114-5-1938
   GOETZ CG, 1990, NEUROLOGY, V40, P273, DOI 10.1212/WNL.40.2.273
   GOETZ CG, 1989, NEW ENGL J MED, V320, P337, DOI 10.1056/NEJM198902093200601
   GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424
   GUPTA M, 1985, DEV BRAIN RES, V19, P21, DOI 10.1016/0165-3806(85)90227-5
   HANSEN JT, 1988, PROG BRAIN RES, V78, P507
   HANSEN JT, 1990, PROG BRAIN RES, V82, P573
   HANSEN JT, 1988, EXP NEUROL, V102, P65, DOI 10.1016/0014-4886(88)90079-9
   HARRIS WA, 1983, TRENDS NEUROSCI, V6, P505, DOI 10.1016/0166-2236(83)90236-9
   HEFTI F, 1986, ANN NEUROL, V20, P275, DOI 10.1002/ana.410200302
   HEFTI F, 1985, BRAIN RES, V348, P283, DOI 10.1016/0006-8993(85)90446-9
   HEFTI F, 1983, ANN NEUROL, V13, P109, DOI 10.1002/ana.410130127
   HIRSCH EC, 1990, ANN NEUROL, V27, P676, DOI 10.1002/ana.410270615
   HURTIG H, 1989, ANN NEUROL, V25, P607, DOI 10.1002/ana.410250613
   ISACSON O, 1988, PROG BRAIN RES, V78, P13
   JAEGER CB, 1990, PROG BRAIN RES, V82, P41
   JANKOVIC J, 1989, NEW ENGL J MED, V321, P325
   JANKOVIC J, 1989, NEUROLOGY, V39, P1227, DOI 10.1212/WNL.39.9.1227
   JIAO S, 1988, PROG BRAIN RES, V78, P575
   KELLY PJ, 1989, MAYO CLIN PROC, V64, P282, DOI 10.1016/S0025-6196(12)65248-3
   KOPIN IJ, 1987, MPTP INDUCED NEUROTO, P163
   KORDOWER JH, 1986, INTEGRATIVE PSYCHIAT, V4, P64
   KORDOWER JH, 1990, J NEUROSURG, V73, P418, DOI 10.3171/jns.1990.73.3.0418
   KRIEGER DT, 1982, NATURE, V298, P468, DOI 10.1038/298468a0
   KRUM JM, 1989, EXP NEUROL, V103, P203, DOI 10.1016/0014-4886(89)90044-7
   KRUM JM, 1988, J COMP NEUROL, V271, P331, DOI 10.1002/cne.902710304
   LANGSTON JW, 1984, BRAIN RES, V292, P390
   Le Douarin N., 1982, NEURAL CREST
   LEDOURAIN NM, 1976, CIBA F S, V40, P71
   LINDER JC, 1987, NEUROSCI LETT, V82, P221, DOI 10.1016/0304-3940(87)90134-0
   LINDVALL O, 1990, SCIENCE, V247, P574, DOI 10.1126/science.2105529
   LINDVALL O, 1989, ARCH NEUROL-CHICAGO, V46, P615, DOI 10.1001/archneur.1989.00520420033021
   LINDVALL O, 1987, ANN NEUROL, V22, P457, DOI 10.1002/ana.410220403
   LUND RD, 1987, TRANSPLANT P, V19, P1128
   MADRAZO I, 1987, NEW ENGL J MED, V316, P831, DOI 10.1056/NEJM198704023161402
   MARTIN JB, 1986, NEW ENGL J MED, V315, P1267
   MASON DW, 1986, NEUROSCIENCE, V19, P685, DOI 10.1016/0306-4522(86)90292-7
   MOORE KL, 1988, DEV HUMAN, pCH4
   MORIHISA JM, 1984, EXP NEUROL, V84, P643, DOI 10.1016/0014-4886(84)90211-5
   NELSON PG, 1971, J CELL PHYSIOL, V77, P337, DOI 10.1002/jcp.1040770308
   NIETOSAMPEDRO M, 1982, SCIENCE, V217, P860, DOI 10.1126/science.7100931
   NIETOSAMPEDRO M, 1983, J NEUROSCI, V3, P2219
   NOTTER MFD, 1986, CELL TISSUE RES, V244, P69
   OLSON L, 1970, HISTOCHEMISTRY, V22, P1, DOI 10.1007/BF00310543
   OLSON L, 1970, ACTA PHYSIOL SCAND, P1
   OLSON L, 1972, Z ZELLFORSCH MIK ANA, V135, P175, DOI 10.1007/BF00315125
   OLSON L, 1982, BRAIN RES BULL, V9, P519, DOI 10.1016/0361-9230(82)90160-5
   OLSON L, 1985, SYNAPTIC PLASTICITY, P488
   OLSON L, 1984, NEURAL TRANSPLANTS D, P125
   ORDY JM, 1988, NEUROBIOL AGING, V9, P667, DOI 10.1016/S0197-4580(88)80131-3
   PERESE DA, 1989, BRAIN RES, V494, P285, DOI 10.1016/0006-8993(89)90597-0
   PERLOW MJ, 1979, SCIENCE, V204, P643, DOI 10.1126/science.571147
   PERLOW MJ, 1980, P NATL ACAD SCI-BIOL, V77, P5278, DOI 10.1073/pnas.77.9.5278
   PETERSON DI, 1989, NEUROLOGY, V39, P235, DOI 10.1212/WNL.39.2.235
   PRICE DL, 1983, ANNU REV NEUROSCI, P65
   Ranson SW, 1914, J COMP NEUROL, V24, P547
   REDMOND DE, 1986, LANCET, V1, P1125
   REIER PJ, 1988, PROG BRAIN RES, V78, P173
   ROSENBERG MB, 1988, SCIENCE, V242, P1575, DOI 10.1126/science.3201248
   ROSENSTEIN JM, 1979, J NEUROCYTOL, V8, P359, DOI 10.1007/BF01236126
   ROSENSTEIN JM, 1987, BRAIN RES, V414, P192, DOI 10.1016/0006-8993(87)91346-1
   ROSENSTEIN JM, 1984, NEURAL TRANSPLANTS D, P24
   Rubin E., 1988, PATHOLOGY
   SAGEN J, 1987, EXP BRAIN RES, V67, P380
   SAGEN J, 1986, BRAIN RES, V384, P189, DOI 10.1016/0006-8993(86)91238-2
   SCHMIDT RH, 1982, J NEUROCHEM, V38, P737, DOI 10.1111/j.1471-4159.1982.tb08693.x
   SCHMIDT RH, 1981, BRAIN RES, V218, P347, DOI 10.1016/0006-8993(81)91313-5
   SCHMIDT RH, 1983, ACTA PHYSIOL SCAND, P19
   SLADEK JR, 1988, J NEUROSURG, V68, P337, DOI 10.3171/jns.1988.68.3.0337
   SLADEK JR, 1988, SCIENCE, V240, P1386, DOI 10.1126/science.3375820
   SLADEK JR, 1986, BRAIN RES BULL, V17, P809, DOI 10.1016/0361-9230(86)90092-4
   SPRINGER JE, 1988, PROG BRAIN RES, V78, P401
   STENEVI U, 1980, PEPTIDES, V1, P111, DOI 10.1016/0196-9781(80)90108-4
   STENEVI U, 1976, BRAIN RES, V114, P1, DOI 10.1016/0006-8993(76)91003-9
   STROMBERG I, 1985, EXP BRAIN RES, V60, P335
   TANIUCHI M, 1986, P NATL ACAD SCI USA, V83, P4094, DOI 10.1073/pnas.83.11.4094
   TANIUCHI M, 1988, J NEUROSCI, V8, P664
   THOMAS GJ, 1984, BEHAV NEUROSCI, V98, P394, DOI 10.1037//0735-7044.98.3.394
   TISCHLER AS, 1980, LAB INVEST, V43, P399
   TUMILOWICZ JJ, 1970, CANCER RES, V30, P2110
   UNGERSTEDT U, 1971, ACTA PHYSIOL SCAND, P69
   UNGERSTEDT U, 1970, Brain Research, V24, P485, DOI 10.1016/0006-8993(70)90187-3
   UNSICKER K, 1985, DEV BIOL, V111, P425, DOI 10.1016/0012-1606(85)90495-6
   UNSICKER K, 1981, CELL TISSUE RES, V215, P341
   VALTIN H, 1982, ANN NY ACAD SCI, V394, P1, DOI 10.1111/j.1749-6632.1982.tb37405.x
   VALTIN H, 1967, AM J MED, V42, P814, DOI 10.1016/0002-9343(67)90098-8
   WATERS C H, 1989, Neurology, V39, P127
   WATERS CM, 1988, NEUROSCIENCE, V25, P419, DOI 10.1016/0306-4522(88)90249-7
   WHITEHOUSE PJ, 1982, SCIENCE, V215, P1237, DOI 10.1126/science.7058341
   WHITEHOUSE PJ, 1981, ANN NEUROL, V10, P122, DOI 10.1002/ana.410100203
   WIDNER H, 1988, PROG BRAIN RES, V78, P303
   WIEGAND SJ, 1988, BRAIN RES BULL, V20, P105, DOI 10.1016/0361-9230(88)90014-7
   WILLIAMS LR, 1986, P NATL ACAD SCI USA, V83, P9231, DOI 10.1073/pnas.83.23.9231
   WINN SR, 1989, EXP NEUROL, V105, P244, DOI 10.1016/0014-4886(89)90126-X
   WUERTHELE SM, 1981, EXP BRAIN RES, V44, P1
   WYATT RJ, 1988, PROG BRAIN RES, V78, P625
   ZALEWSKI AA, 1971, EXP NEUROL, V30, P510, DOI 10.1016/0014-4886(71)90151-8
NR 162
TC 4
Z9 4
U1 0
U2 0
PU BEGELL HOUSE INC
PI DANBURY
PA 50 NORTH ST, DANBURY, CT 06810 USA
SN 0892-0915
J9 CRIT REV NEUROBIOL
JI Crit. Rev. Neurobiol.
PY 1991
VL 6
IS 2
BP 79
EP 98
PG 20
WC Neurosciences
SC Neurosciences & Neurology
GA FY173
UT WOS:A1991FY17300001
PM 1934089
DA 2018-10-20
ER

PT J
AU MIMI, M
   LAND, DV
AF MIMI, M
   LAND, DV
TI NONRESONANT PERTURBATION MEASUREMENT OF ANTENNA ELECTROMAGNETIC-FIELD
   CONFIGURATIONS FOR BIOMEDICAL APPLICATIONS
SO JOURNAL OF PHOTOGRAPHIC SCIENCE
LA English
DT Article; Proceedings Paper
CT MEETING ON ADVANCES IN MEDICAL MICROWAVE IMAGING
CY NOV   17, 1989
CL LILLE, FRANCE
SP EUROPEAN ASSOC THERMOL
AB The nonresonant perturbation technique has been used to develop the measurement of antenna electromagnetic field configurations for medical applications.  Antenna near-field configurations and the contour patterns in phantom materials have been analysed numerically and experimentally measured.  This study has shown both methods to be in fair agreement.  The penetration depth naturally depends on lossy dielectric properties through "2-alpha" for wave propagation, and it also depends on the relative permittivity of the medium and the antenna form, the two factors causing the effective penetration distance to be less than the plane wave value.
RP MIMI, M (reprint author), UNIV GLASGOW,DEPT PHYS & ASTRON,GLASGOW G12 8QQ,SCOTLAND.
CR AUDET J, 1980, J MICROWAVE POWER, P177
   CHEUNG AY, 1981, J MICROWAVE POWER, P151
   LAND DV, 1988, ELECTRON LETT, P70
   ROBILLARD M, 1982, J MICROWAVE POWER, P97
   ROBILLARD M, 1980, 1980 P URSI S OND EL, P213
NR 5
TC 0
Z9 0
U1 0
U2 0
PU ROYAL PHOTOGRAPHIC SOC
PI BATH
PA OCTAGON-MILSOM ST, BATH, AVON, ENGLAND BA1 1DN
SN 0022-3638
J9 J PHOTOGR SCI
JI J. Photogr. Sci.
PY 1991
VL 39
IS 4
BP 161
EP 163
PG 3
WC Imaging Science & Photographic Technology
SC Imaging Science & Photographic Technology
GA GT261
UT WOS:A1991GT26100005
DA 2018-10-20
ER

PT J
AU MANSFIELD, P
   BOWTELL, RW
   BLACKBAND, SJ
   CAWLEY, M
AF MANSFIELD, P
   BOWTELL, RW
   BLACKBAND, SJ
   CAWLEY, M
TI INGRESS OF WATER INTO SOLID NYLON - DIFFUSION STUDIES BY NMR IMAGING
SO MAGNETIC RESONANCE IMAGING
LA English
DT Article; Proceedings Paper
CT 1ST INTERNATIONAL MEETING ON RECENT ADVANCES IN NMR APPLICATIONS TO
   POROUS MEDIA
CY NOV 14-16, 1990
CL UNIV BOLOGNA, BOLOGNA, ITALY
SP BANCA POPOLARE PESARESE & RAVENNATE, IST NAZL FIS NUCL, STELAR, ZURIGO ASSICURAZIONI, UNIV BOLOGNA, ASSOC NAZL INGEGNERI MINERARI, AGIP, SCHLUMBERGER ITALIANA, SELM PETR, CNR
HO UNIV BOLOGNA
DE NMR IMAGING; TRANSLATIONAL DIFFUSION
AB The ingress of fluids into solids is important in the study of interfacial problems since the surface properties of the solid may be considerably modified by the presence of the fluid. This is especially the case for many synthetic plastic materials like nylon, where water uptake at the surface can impair their characteristics in a range of biomedical and industrial applications. We have used NMR imaging to study the diffusion of water into solid blocks of nylon over a range of temperatures. The results have enabled the diffusion coefficient and its concentration dependence to be determined. Further modifications of the imaging method have been used to extract localised T1 and T2 values as a function of temperature and concentration. From these measurements we are able to measure the diffusional activation energies and the activation energies associated with the relaxation processes. The relaxation time results are interpreted in terms of a two-phase exchange model. The consequences of this model will be discussed.
RP MANSFIELD, P (reprint author), UNIV NOTTINGHAM,DEPT PHYS,UNIV PK,NOTTINGHAM NG7 2RD,ENGLAND.
OI Bowtell, Richard/0000-0001-8656-412X
NR 0
TC 7
Z9 7
U1 0
U2 3
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
SN 0730-725X
J9 MAGN RESON IMAGING
JI Magn. Reson. Imaging
PY 1991
VL 9
IS 5
BP 763
EP 765
DI 10.1016/0730-725X(91)90373-T
PG 3
WC Radiology, Nuclear Medicine & Medical Imaging
SC Radiology, Nuclear Medicine & Medical Imaging
GA GT656
UT WOS:A1991GT65600028
DA 2018-10-20
ER

PT J
AU KELLNER, R
AF KELLNER, R
TI REPORT OF THE WPAC-STUDY GROUP - EDUCATION IN ANALYTICAL-CHEMISTRY AT
   UNIVERSITY LEVEL 1989 90 - UPDATE AND REFLECTIONS
SO MIKROCHIMICA ACTA
LA English
DT Article
DE EDUCATION; ANALYTICAL CHEMISTRY; WPAC FECS
AB The importance of education and training grows with the complexity and practical need of a given subject. Especially in times of rapid evolution such as the introduction of new measurement principles and advanced computers into Analytical Chemistry (AC) a quick update of curricula is necessary. A basic equivalence of undergraduate curricula should be reached to stimulate the worldwide exchange of students. This is underlined by the increasing role of Analytical Chemistry as problem solving science and as main source for reliable data needed in product- and environmental quality control often as basis for far reaching political decision, such as the setting of quality standards.
   AC-curricula in Europa-as shown in a WPAC-enquiry in 1983/84-are, however, highly differentiated and suffer significantly from a historic burden. 110 from 229 universities still offered a conventional curriculum based on the classical scheme of chemical analysis and mainly linked to inorganic or physical chemistry. Modern physical methods or the treatment of problem solving in environmental, life and material sciences was much better treated in the 119 universities with a separate chair of AC. In its latest enquiry in 1989/90 (180 universities), WPAC still identified almost-equal-to 50% traditional, incomplete AC-curricula (21 European countries). However, only 13 institutions consider this as ideal for the future. The vast majority supports the inclusion of basic principles and modern methods into the-extended-AC-curricula as well as the exemplary treatment of major applications to materials sciences, food production, environmental systems, pharmaceutical and biomedical sciences, biotechnology as well as arts and archeology. WPAC activities are therefore aimed at deriving recommendations for future oriented curricula in AC-education and training.
   Finally a "hit list" of textbooks of Analytical Chemistry and future needs of AC-curricula including Ph.D. studies and postgraduate specialization extracted from the WPAC-enquiry 1989/90 will be presented and critically discussed.
RP KELLNER, R (reprint author), VIENNA TECH UNIV,INST ANALYT CHEM,GETREIDEMARKT 9,A-1060 VIENNA,AUSTRIA.
CR KELLNER R, 1988, ANAL CHEM, V60, pA623
   KELLNER R, 1985, TRAC, V4
   KELLNER R, 1984, FRESNIUS Z ANAL CHEM, V319
   MALISSA H, 1979, FRESENIUS Z ANAL CHE, V297
   MALISSA H, 1981, FRESENIUS Z ANAL CHE, V305
   1988, REPORT COMMISSION MU
NR 6
TC 4
Z9 4
U1 0
U2 2
PU SPRINGER-VERLAG WIEN
PI VIENNA
PA SACHSENPLATZ 4-6, PO BOX 89, A-1201 VIENNA, AUSTRIA
SN 0026-3672
J9 MIKROCHIM ACTA
JI Mikrochim. Acta
PY 1991
VL 2
IS 1-6
BP 555
EP 564
PG 10
WC Chemistry, Analytical
SC Chemistry
GA GK819
UT WOS:A1991GK81900053
DA 2018-10-20
ER

PT J
AU GRIESSER, HJ
AF GRIESSER, HJ
TI DEGRADATION OF POLYURETHANES IN BIOMEDICAL APPLICATIONS - A REVIEW
SO POLYMER DEGRADATION AND STABILITY
LA English
DT Review
ID RAY PHOTOELECTRON-SPECTROSCOPY; POLY(ETHER URETHANE UREA); SOLUTION-CAST
   EXTRACTS; FT-IR; SURFACE; BIODEGRADATION; BIOMER; ESCA; BIOMATERIALS;
   INVITRO
AB Polyurethanes are used in biomedical devices because they constitute one of the few classes of polymers that are highly elastomeric and show good biocompatibility.  However, there is continuing debate in the literature regarding their long term stability in biomedical environments, and the validity of using polyurethanes for extended implant applications is still very much in question.  While evidence of polymer degradation in explanted devices has been reported by a number of workers, other studies conclude that degradation is minimal.  This review discusses possible pathways of biomedical degradation, such as enzymatic and oxidative attack, as well as observed effects such as cracking and calcification.  Metal catalyzed degradation may also occur in devices such as pacemaker leads.  While a number of model studies have assessed various modes of degradation, reliable accelerated tests for the prediction of the rates of biomedical ageing effects have apparently not been established.  The role of additives and surface contaminants in biocompatibility and degradation is also discussed.  Finally, as important interactions between a polyurethane polymer and the host body occur at the interface, the surface analysis of polyurethanes is discussed, and it is concluded that proper characterization of the implant surface before and after degradation studies is important for the understanding of degradation, in particular to exclude effects caused not by the polyurethane itself, but by surface contaminants which appear to have been present on the majority of materials subjected to detailed characterization so far.
RP GRIESSER, HJ (reprint author), CSIRO,DIV CHEM & POLYMERS,PRIVATE BAG 10,CLAYTON,VIC 3168,AUSTRALIA.
RI Griesser, Hans/E-5628-2011
OI Griesser, Hans/0000-0003-1072-7863
CR ANDERSON JM, 1986, NATO ASI SER E, V106, P29
   ANDERSON JM, 1984, PROGR BIOMEDICAL ENG, V1, P143
   Andrade J. D., 1988, POLYM SURFACE DYNAMI
   ANDRADE JD, 1990, 1990 ACS SPR M BOST
   BRIGGS D, 1987, POLYM SURFACES INTER, P33
   BYRD CL, 1987, PROGR BIOMEDICAL ENG, V3, P65
   CASTNER D G, 1990, Journal of Biomaterials Science Polymer Edition, V1, P191
   CHAWLA AS, 1988, BIOMATER ARTIF CELL, V16, P785, DOI 10.3109/10731198809117569
   CHIEN JCW, 1978, ADV CHEM SER, V169, P175
   CHINN JA, 1989, J COLLOID INTERF SCI, V127, P67, DOI 10.1016/0021-9797(89)90008-8
   COLEMAN DL, 1981, T AM SOC ART INT ORG, V27, P97
   COLEMAN DL, 1981, T AM SOC ART INT ORG, V27, P708
   COURY A, 1988, 3RD P WORLD BIOM C K, P432
   Coury A J, 1988, J Biomater Appl, V3, P130, DOI 10.1177/088532828800300202
   COURY AJ, 1987, LIFE SUPPORT SYST, V5, P25
   DARBY RT, 1968, APPL MICROBIOL, V16, P900
   DARBY TD, 1978, TOXICOL APPL PHARM, V46, P449, DOI 10.1016/0041-008X(78)90090-X
   Fadley C. S., 1976, Progress in Solid State Chemistry, P265, DOI 10.1016/0079-6786(76)90013-3
   FROMMELT H, 1987, MAKROMOL CHEM-M SYMP, V12, P281, DOI 10.1002/masy.19870120114
   GILDING DK, 1987, LIFE SUPPORT SYST, V5, P19
   GLASMACHER B, 1987, PROGR BIOMEDICAL ENG, V3, P151
   GRAHAM SW, 1981, J BIOMED MATER RES, V15, P349, DOI 10.1002/jbm.820150307
   GRAHAM SW, 1981, J BIOMED MATER RES, V15, P465, DOI 10.1002/jbm.820150403
   GRASEL TG, 1990, J BIOMED MATER RES, V24, P605, DOI 10.1002/jbm.820240507
   GRIESSER HJ, 1990, POLYM MATER SCI ENG, V62, P828
   GROBE GL, 1988, APPL SPECTROSC, V42, P980, DOI 10.1366/0003702884430506
   GROBE GL, 1987, J BIOMED MATER RES, V21, P211, DOI 10.1002/jbm.820210206
   GROBE GL, 1988, APPL SPECTROSC, V42, P989, DOI 10.1366/0003702884430489
   HANSEN RH, 1964, J POLYM SCI PART A, V2, P587, DOI 10.1002/pol.1964.100020204
   HEARN MJ, 1988, MACROMOLECULES, V21, P2950, DOI 10.1021/ma00188a011
   HEARN MJ, 1987, SURF INTERFACE ANAL, V10, P384, DOI 10.1002/sia.740100803
   HENNIG E, 1988, INT J ARTIF ORGANS, V11, P416
   HENNIG E, 1984, PROGR BIOMEDICAL ENG, V1, P109
   HERCULES DM, 1988, POLYM MATER SCI ENG, V59, P724
   HETENYI J, 1987, PROGR BIOMEDICAL ENG, V3, P51
   HORBETT TA, 1982, ADV CHEM SER, V199, P233
   Hu C. B., 1980, AM CHEM SOC DIV POLY, V21, P156
   HUNTER SK, 1982, T AM SOC ART INT ORG, V28, P473
   KNUTSON K, 1982, ACS ADV CHEM SER, V199, P109
   LELAH MD, 1983, J BIOMED MATER RES, V17, P1, DOI 10.1002/jbm.820170102
   LEMM W, 1984, POLYURETHANES BIOMED, V1, P103
   LEMM W, 1984, BIOMATERIALS BIOMECH, P319
   LEMM W, 1980, P EUR SOC ARTIF ORGA, V7, P86
   LOPEZ LC, 1988, J APPL POLYM SCI, V36, P1401, DOI 10.1002/app.1988.070360611
   LUBIN M, 1986, PACE, V9, P1154, DOI 10.1111/j.1540-8159.1986.tb06686.x
   MAHMUD NA, 1986, POLYM MAT SCI ENG, V55, P751
   MARCHANT RE, 1987, POLYMER, V28, P2032, DOI 10.1016/0032-3861(87)90037-1
   MARCHANT RE, 1986, J BIOMED MATER RES, V20, P153, DOI 10.1002/jbm.820200205
   MARCHANT RE, 1988, PROGR BIOMEDICAL ENG, V6, P297
   MARCHANT RE, 1984, J BIOMED MATER RES, V18, P1189
   NORMANN SJ, 1982, MACROPHAGES NATURAL
   OSAWA Z, 1988, POLYM DEGRAD STABIL, V20, P203, DOI 10.1016/0141-3910(88)90070-5
   PANDE GS, 1984, ELASTOMERICS, P17
   PAYNTER RW, 1988, J BIOMED MATER RES, V22, P687, DOI 10.1002/jbm.820220803
   PAYNTER RW, 1987, BIOMATERIALS, V8, P94, DOI 10.1016/0142-9612(87)90096-2
   PHILLIPS RE, 1987, PROGR BIOMEDICAL ENG, V3, P91
   PHUA SK, 1987, J BIOMED MATER RES, V21, P231, DOI 10.1002/jbm.820210207
   RATNER BD, 1988, J BIOMED MATER RES, V22, P509, DOI 10.1002/jbm.820220607
   RATNER BD, 1978, J APPL POLYM SCI, V22, P643, DOI 10.1002/app.1978.070220306
   RATNER BD, 1983, ANN BIOMED ENG, V11, P313, DOI 10.1007/BF02363290
   RATNER BD, 1987, POLYM SURFACES INTER, P231
   RATNER BD, 1982, ACS SYM SER, V199, P9
   RATNER BD, 1988, PROGR BIOMEDICAL ENG, V6
   RATNER BD, 1984, PROGR BIOMEDICAL ENG, V1, P41
   RATNER BD, 1987, PROGR BIOMEDICAL ENG, V3, P213
   RATNER BD, 1984, PROGR BIOMEDICAL ENG, V1, P399
   SALTHOUSE TN, 1976, J BIOMED MATER RES, V10, P197, DOI 10.1002/jbm.820100204
   SCOTT G, 1978, ADV CHEM SER, V169, P30
   SHUTTLEWORTH WA, 1986, APPL MICROBIOL BIOT, V23, P407
   SKALSKY M, 1987, PROGR BIOMEDICAL ENG, V3, P75
   SMITH R, 1987, J BIOMED MATER RES, V21, P1149, DOI 10.1002/jbm.820210908
   STOKES K, 1987, PROGR BIOMEDICAL ENG, V3, P109
   STOKES K, 1988, 3RD P WORLD BIOM C K, P434
   Stokes K B, 1988, J Biomater Appl, V3, P228, DOI 10.1177/088532828800300205
   STOKES KB, 1986, PACE, V9, P1160, DOI 10.1111/j.1540-8159.1986.tb06687.x
   STOKES KB, 1985, POLYM MATER SCI ENG, V53, P6
   SUNG CSP, 1979, J BIOMED MATER RES, V13, P161
   Szycher M, 1988, J Biomater Appl, V3, P297, DOI 10.1177/088532828800300207
   SZYCHER M, 1984, T SOC BIOMATER, V7, P24
   Thoma R J, 1988, J Biomater Appl, V3, P180, DOI 10.1177/088532828800300203
   THOMAS RJ, 1988, POLYM MATER SCI ENG, V59, P674
   TINGEY KG, 1988, PROGR BIOMEDICAL ENG, V6, P255
   ULRICH H, 1984, PROGR BIOMEDICAL ENG, V1, P165
   WILLIAMS DF, 1982, J MATER SCI, V17, P1233, DOI 10.1007/BF00752233
   WILLIAMS DF, 1986, BIOL BIOMECHANICAL P, P239
   WILLIAMS DF, 1988, MAY P C I MET MAT AU, P137
   WILSON RS, 1986, NATO ASI E, V106, P15
   WOUTERS LHG, 1987, PROGR BIOMED ENG, V3, P169
   ZDRAHALA RJ, 1986, MATER RES SOC S P, V55, P407
   ZDRAHALA RJ, 1987, PROGR BIOMEDICAL ENG, V3, P1
   ZHAO Q, 1990, J BIOMED MATER RES, V24, P621, DOI 10.1002/jbm.820240508
   ZHAO Q, 1987, POLYMER, V28, P2040, DOI 10.1016/0032-3861(87)90038-3
NR 92
TC 62
Z9 62
U1 5
U2 31
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0141-3910
J9 POLYM DEGRAD STABIL
JI Polym. Degrad. Stabil.
PY 1991
VL 33
IS 3
BP 329
EP 354
DI 10.1016/0141-3910(91)90080-B
PG 26
WC Polymer Science
SC Polymer Science
GA GF010
UT WOS:A1991GF01000001
DA 2018-10-20
ER

PT B
AU TOLK, NH
   BRAU, CA
   EDWARDS, GS
   MARGARITONDO, G
   MCKINLEY, JT
AF TOLK, NH
   BRAU, CA
   EDWARDS, GS
   MARGARITONDO, G
   MCKINLEY, JT
BE SPRANGLE, P
TI THE VANDERBILT FREE-ELECTRON LASER CENTER FOR BIOMEDICAL AND MATERIALS
   RESEARCH
SO SHORT-WAVELENGTH RADIATION SOURCES
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT CONF ON SHORT-WAVELENGTH RADIATION SOURCES
CY JUL 21-26, 1991
CL SAN DIEGO, CA
SP SOC PHOTO OPT INSTRUMENTAT ENGINEERS
NR 0
TC 1
Z9 1
U1 0
U2 0
PU SPIE - INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA BELLINGHAM
BN 0-8194-0680-5
J9 P SOC PHOTO-OPT INS
PY 1991
VL 1552
BP 7
EP 13
DI 10.1117/12.50587
PG 7
WC Optics
SC Optics
GA BV30T
UT WOS:A1991BV30T00002
DA 2018-10-20
ER

PT J
AU PRESTON, RC
   SHAW, A
   ZEQIRI, B
AF PRESTON, RC
   SHAW, A
   ZEQIRI, B
TI PREDICTION OF INSITU EXPOSURE TO ULTRASOUND - AN ACOUSTICAL ATTENUATION
   METHOD
SO ULTRASOUND IN MEDICINE AND BIOLOGY
LA English
DT Article
DE BIOMEDICAL ULTRASOUND; SAFETY; STANDARDS; ULTRASOUND; HUMAN EXPOSURE
ID FINITE-AMPLITUDE DISTORTION; BIOMEDICAL FREQUENCIES; INTENSITIES; MODEL
AB The prediction of the acoustic levels occurring in a patient during ultrasound examination is important for the  assessment of equipment safety.  While considerable effort has been devoted to theoretical methods of predicting exposure levels, there is a need to develop simple experimental methods which are universally applicable to the wide range of ultrasonic fields generated by medical ultrasonic equipment.  This article outlines a number of methods that have been proposed and explores in detail a new experimental method based on the use of acoustical attenuators, made of low-density polyethylene, which are placed in the ultrasound beam between the transducer  and the measuring hydrophone.  Measurements of important acoustical quantities have been made using a measurement system based on a multielement hydrophone and comparisons made between this new method and other methods such as electrical attenuation and linear derating theory.  The acoustical attenuation technique has been systematically studied, and results are compared with reference levels obtained using tissue-mimicking material.
   A procedure involving making measurements with the attenuator placed first at the face of the transducer and then at the hydrophone has been developed.  By taking the mean value of these two measurements, it has been shown that this new method can simulate within +/- 10% the acoustic levels obtained using the reference.  It is concluded that it could be the basis of a universally applicable method.
RP PRESTON, RC (reprint author), NATL PHYS LAB,DIV RADIAT SCI & ACOUST,TEDDINGTON TW11 0LW,MIDDX,ENGLAND.
RI shaw, adam/G-4475-2012
OI shaw, adam/0000-0003-4531-2537
CR BACON DR, 1989, ULTRASOUND MED BIOL, V15, P355, DOI 10.1016/0301-5629(89)90047-1
   BACON DR, 1984, ULTRASOUND MED BIOL, V10, P189, DOI 10.1016/0301-5629(84)90217-5
   BEISSNER K, 1982, J ACOUST SOC AM, V71, P1406, DOI 10.1121/1.387835
   BJORNO L, 1976, ACOUSTICS VIBRATION, V2, P101
   CARSON PL, 1989, ULTRASOUND MED BIOL, V15, P27, DOI 10.1016/0301-5629(89)90210-X
   CARSTENSEN EL, 1980, ULTRASOUND MED BIOL, V6, P359, DOI 10.1016/0301-5629(80)90005-8
   CARSTENSEN EL, 1989, ULTRASOUND MED BIOL, V15, P31, DOI 10.1016/0301-5629(89)90211-1
   DUCK FA, 1988, ULTRASOUND MED BIOL, V14, P305, DOI 10.1016/0301-5629(88)90097-X
   DUCK FA, 1988, IEEE T ULTRASON FERR, V35, P232, DOI 10.1109/58.4173
   HARRIS GR, 1988, IEEE T ULTRASON FERR, V35
   KOSSOFF G, 1984, ULTRASOUND MED BIOL, V10, P197, DOI 10.1016/0301-5629(84)90218-7
   MUIR TG, 1980, ULTRASOUND MED BIOL, V6, P345, DOI 10.1016/0301-5629(80)90004-6
   PRESTON RC, 1991, ULTRASOUND MED BIOL, V17, P333, DOI 10.1016/0301-5629(91)90132-G
   PRESTON RC, 1988, IEEE T ULTRASON FERR, V35, P122, DOI 10.1109/58.4162
   RUF HJ, 1988, THESIS GEORGETOWN U
   STARRITT HC, 1986, PHYS MED BIOL, V31, P1401, DOI 10.1088/0031-9155/31/12/007
   STARRITT HC, 1985, J ACOUST SOC AM, V77, P302, DOI 10.1121/1.392272
   STRATMEYER ME, 1989, ULTRASOUND MED BIOL, V15, P35, DOI 10.1016/0301-5629(89)90212-3
   ZEQIRI B, 1988, IPSM REPORT I PHYSIC, V57, P27
   1981, AIUMNEMA UL11981 NAT
   1985, GUIDE MEASURING REPO
   1990, NCRP66 NAT COUNC RAD
   1983, NCRP74 NAT COUNC RAD
NR 23
TC 16
Z9 16
U1 0
U2 3
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
SN 0301-5629
J9 ULTRASOUND MED BIOL
JI Ultrasound Med. Biol.
PY 1991
VL 17
IS 4
BP 317
EP 332
DI 10.1016/0301-5629(91)90131-F
PG 16
WC Acoustics; Radiology, Nuclear Medicine & Medical Imaging
SC Acoustics; Radiology, Nuclear Medicine & Medical Imaging
GA GA349
UT WOS:A1991GA34900001
PM 1949344
DA 2018-10-20
ER

PT J
AU PRESTON, RC
   SHAW, A
   ZEQIRI, B
AF PRESTON, RC
   SHAW, A
   ZEQIRI, B
TI PREDICTION OF INSITU EXPOSURE TO ULTRASOUND - A PROPOSED STANDARD
   EXPERIMENTAL-METHOD
SO ULTRASOUND IN MEDICINE AND BIOLOGY
LA English
DT Article
DE BIOMEDICAL ULTRASOUND; SAFETY; STANDARDS; ULTRASOUND; HUMAN EXPOSURE
AB This article presents results for the prediction of in situ exposure levels using a new experimental technique based on the use of acoustical attenuators.  These are made of low-density polyethylene and are placed in the ultrasound beam between the transducer face and the measuring hydrophone.  The method has been tested for a number of different ultrasonic fields including those generated by diagnostic medical ultrasonic equipment.  Using a tissue-mimicking material as a reference, it is shown that it is possible to use this new method to simulate acoustic pressure levels to within +/- 10% and acoustic intensity and power levels within +/- 20%.  The method is proposed as the basis for a standard test method with wide applicability.
RP PRESTON, RC (reprint author), NATL PHYS LAB,DIV RADIAT SCI & ACOUST,TEDDINGTON TW11 0LW,MIDDX,ENGLAND.
RI shaw, adam/G-4475-2012
OI shaw, adam/0000-0003-4531-2537
CR BACON DR, 1984, ULTRASOUND MED BIOL, V10, P189, DOI 10.1016/0301-5629(84)90217-5
   PRESTON RC, 1991, ULTRASOUND MED BIOL, V17, P317, DOI 10.1016/0301-5629(91)90131-F
   PRESTON RC, 1988, IEEE T ULTRASON FERR, V35, P122, DOI 10.1109/58.4162
NR 3
TC 9
Z9 9
U1 0
U2 1
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
SN 0301-5629
J9 ULTRASOUND MED BIOL
JI Ultrasound Med. Biol.
PY 1991
VL 17
IS 4
BP 333
EP 339
DI 10.1016/0301-5629(91)90132-G
PG 7
WC Acoustics; Radiology, Nuclear Medicine & Medical Imaging
SC Acoustics; Radiology, Nuclear Medicine & Medical Imaging
GA GA349
UT WOS:A1991GA34900002
PM 1949345
DA 2018-10-20
ER

PT J
AU FELTON, JS
   TURTELTAUB, KW
   VOGEL, JS
   BALHORN, R
   GLEDHILL, BL
   SOUTHON, JR
   CAFFEE, MW
   FINKEL, RC
   NELSON, DE
   PROCTOR, ID
   DAVIS, JC
AF FELTON, JS
   TURTELTAUB, KW
   VOGEL, JS
   BALHORN, R
   GLEDHILL, BL
   SOUTHON, JR
   CAFFEE, MW
   FINKEL, RC
   NELSON, DE
   PROCTOR, ID
   DAVIS, JC
TI ACCELERATOR MASS-SPECTROMETRY IN THE BIO-MEDICAL SCIENCES - APPLICATIONS
   IN LOW-EXPOSURE BIO-MEDICAL AND ENVIRONMENTAL DOSIMETRY
SO NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION B-BEAM
   INTERACTIONS WITH MATERIALS AND ATOMS
LA English
DT Article; Proceedings Paper
CT 5TH INTERNATIONAL CONF ON ACCELERATOR MASS SPECTROMETRY ( AMS-5 )
CY APR 23-27, 1990
CL PARIS, FRANCE
SP CNRS, CEA, INST NATL PHYS NUCL & PHYS PARTICLES, HIGH VOLTAGE ENGN EUROPA, ELECTROSTAT INT, ACCELERATOR MASS SPECTROMETRY, ALCATEL
ID DNA ADDUCTS; P-32-POSTLABELING ANALYSIS; ENHANCED SENSITIVITY;
   METABOLITES; IDENTIFICATION; BINDING; RAT
AB We are utilizing accelerator mass spectrometry as a sensitive detector for tracking the disposition of radioisotopically labeled molecules in the biomedical sciences.  These applications have shown the effectiveness of AMS as a tool to quantify biologically important molecules at extremely low levels.  For example, AMS is being used to determine the amount of carcinogen covalently bound to animal DNA (DNA adduct) at levels relevent to human exposure.  Detection sensitivities are 1 carcinogen molecule bound in 10(11) to 10(12) DNA bases, depending on the specific activity of the radiolabeled carcinogen.  Studies have been undertaken in our laboratory utilizing heterocyclic amine food-borne carcinogens and 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), a potent environmental carcinogen, to study the metabolism of carcinogens at low doses.  In addition, AMS is being used to detect the presence of rare proteins (mutant forms of protamine) in human sperm.  Approximately 1 per 10(6) sperm analyzed contain the rare form of the protamine.  Protamine isolated from this small number of cells is being analyzed by AMS, following C-14 labeling.  Thus, AMS can be used to verify the identity of an extremely small amount of biological material.  Furthermore, an additional improvement of 2 orders of magnitude in the sensitivity of biomedical tracer studies is suggested by preliminary work with bacterial hosts depleted in radiocarbon.  Other problems in the life sciences where detection sensitivity or sample sizes are limitations should also benefit from AMS.  Studies are underway to measure the molecular targeting of cancer chemotherapeutics in human tissue and to pursue applications for receptor biology.  We are also applying other candidate isotopes, such as H-3 (double labeling with C-14) and Ca-41 (bone absorption) to problems in biology.  The detection of Cl-36 and Al-26 have applications for determination of human neutron exposure and understanding neurological toxicity, respectively.  The results described here with C-14-labeled molecules coupled with new isotope applications clearly show AMS technology to be an important new tool for the biomedical sciences community.
C1 UNIV CALIF LAWRENCE LIVERMORE NATL LAB,DIV NUCL CHEM,LIVERMORE,CA 94550.
   UNIV CALIF LAWRENCE LIVERMORE NATL LAB,CTR ACCELERATOR MASS SPECTROMETRY,LIVERMORE,CA 94550.
RP FELTON, JS (reprint author), UNIV CALIF LAWRENCE LIVERMORE NATL LAB,DIV BIOMED SCI,7000 E AVE,LIVERMORE,CA 94550, USA.
RI Caffee, Marc/K-7025-2015
OI Caffee, Marc/0000-0002-6846-8967
CR BASSOSI R, 1983, ANGEW CHEM, V95, P55
   DINH TV, 1987, ANAL CHEM, V59, P1093
   DINH TV, 1987, APPL SPECTROSC, V41, P605
   DUNN BP, 1988, CARCINOGENESIS, V9, P1055, DOI 10.1093/carcin/9.6.1055
   ELMORE D, 1987, SCIENCE, V236, P543, DOI 10.1126/science.236.4801.543
   ELMORE D, 1987, BIOL TRACE ELEM RES, V12, P231, DOI 10.1007/BF02796683
   FELTON JS, 1986, ENVIRON HEALTH PERSP, V67, P17, DOI 10.2307/3430312
   GRIVAS S, 1985, ACTA CHEM SCAND B, V39, P213, DOI 10.3891/acta.chem.scand.39b-0213
   GUPTA RC, 1984, P NATL ACAD SCI-BIOL, V81, P6943, DOI 10.1073/pnas.81.22.6943
   GUPTA RC, 1985, CANCER RES, V45, P5656
   GUPTA RC, 1988, CARCINOGENESIS, V9, P1697
   HARRIS CC, 1985, P NATL ACAD SCI USA, V82, P6672, DOI 10.1073/pnas.82.19.6672
   HSU IC, 1981, CANCER RES, V41, P1091
   LITCHFIELD JH, 1977, ADV APPL MICROBIOL, V22, P266
   MEIRAV O, 1990, NUCL INSTRUM METH B, V52, P536, DOI 10.1016/0168-583X(90)90472-7
   MOHAMED GB, 1984, J CHROMATOGR, V314, P211, DOI 10.1016/S0021-9673(01)97735-0
   RAHN RO, 1982, BIOCHEM BIOPH RES CO, V109, P262, DOI 10.1016/0006-291X(82)91594-7
   RANDERATH K, 1988, CARCINOGENESIS, V9, P2285, DOI 10.1093/carcin/9.12.2285
   REDDY MV, 1986, CARCINOGENESIS, V7, P1543, DOI 10.1093/carcin/7.9.1543
   SANDERS MJ, 1985, ANAL CHEM, V57, P1148, DOI 10.1021/ac00283a042
   TURESKY RJ, 1988, FOOD CHEM TOXICOL, V26, P105, DOI 10.1016/0278-6915(88)90106-8
   TURTELTAUB KW, 1990, CARCINOGENESIS, V11, P43, DOI 10.1093/carcin/11.1.43
   TURTELTAUB KW, 1990, P NATL ACAD SCI USA, V87, P5288, DOI 10.1073/pnas.87.14.5288
   VAHAKANGAS K, 1985, ENVIRON HEALTH PERSP, V62, P101, DOI 10.2307/3430099
   VOGEL JS, 1987, RADIOCARBON, V29, P323
   VOGEL JS, 1990, NUCL INSTRUM METH B, V52, P524, DOI 10.1016/0168-583X(90)90470-F
   VOGEL JS, 1990, RADIOCARBON, V32, P81
   YAMASHITA K, 1990, MUTAGENESIS, V3, P515
   1988, A4345 UN SCI COMM EF
NR 29
TC 43
Z9 44
U1 0
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-583X
J9 NUCL INSTRUM METH B
JI Nucl. Instrum. Methods Phys. Res. Sect. B-Beam Interact. Mater. Atoms
PD DEC
PY 1990
VL 52
IS 3-4
BP 517
EP 523
DI 10.1016/0168-583X(90)90469-B
PG 7
WC Instruments & Instrumentation; Nuclear Science & Technology; Physics,
   Atomic, Molecular & Chemical; Physics, Nuclear
SC Instruments & Instrumentation; Nuclear Science & Technology; Physics
GA EV368
UT WOS:A1990EV36800062
DA 2018-10-20
ER

PT J
AU VOGEL, JS
   TURTELTAUB, KW
   FELTON, JS
   GLEDHILL, BL
   NELSON, DE
   SOUTHON, JR
   PROCTOR, ID
   DAVIS, JC
AF VOGEL, JS
   TURTELTAUB, KW
   FELTON, JS
   GLEDHILL, BL
   NELSON, DE
   SOUTHON, JR
   PROCTOR, ID
   DAVIS, JC
TI APPLICATION OF AMS TO THE BIO-MEDICAL SCIENCES
SO NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION B-BEAM
   INTERACTIONS WITH MATERIALS AND ATOMS
LA English
DT Article; Proceedings Paper
CT 5TH INTERNATIONAL CONF ON ACCELERATOR MASS SPECTROMETRY ( AMS-5 )
CY APR 23-27, 1990
CL PARIS, FRANCE
SP CNRS, CEA, INST NATL PHYS NUCL & PHYS PARTICLES, HIGH VOLTAGE ENGN EUROPA, ELECTROSTAT INT, ACCELERATOR MASS SPECTROMETRY, ALCATEL
ID ACCELERATOR MASS-SPECTROMETRY; RADIOCARBON; ISOTOPE
AB Radio-isotopic tracers are a useful tool in numerous areas of biomedical research, including metabolism, pharmacokinetics, and the detailed study of biomolecular interactions.  Accelerator mass spectrometry was suggested as a tool for the biomedical sciences shortly after its invention, but few attempts to use its sensitivity in such research have been reported.  We have examined some of the strengths and limitations of the technique and find that AMS has a sensitivity advantage over decay-counting for the long-lived radio-isotopes and for shorter-lived, common radiotracers.  The advantage can be translated into the use of much smaller sample sizes and much lower radio-isotope concentrations, both of which present new opportunities for biochemical tracing and human research.  New approaches to separation and preparation of the material to be assayed for radio-tracers will be developed to take advantage of the sensitivity and specificity.  Most biochemical laboratories have used radioactive isotopes as tracers and their facilities have been contaminated with unacceptably high levels of these tracers.  Careful protocols and/or new facilities are required to prevent contamination of the AMS samples.
C1 UNIV CALIF LAWRENCE LIVERMORE NATL LAB,DIV BIOMED SCI,LIVERMORE,CA 94550.
RP VOGEL, JS (reprint author), UNIV CALIF LAWRENCE LIVERMORE NATL LAB,CTR ACCELERATOR MASS SPECTROMETRY,LIVERMORE,CA 94550, USA.
CR BROWN TA, 1988, RADIOCARBON, V30, P171
   ELMORE D, 1987, BIOL TRACE ELEM RES, V12, P231, DOI 10.1007/BF02796683
   ELMORE D, 1986, NUCL INSTRUM METH B, V5, P106
   FELTON JS, 1990, NUCL INSTRUM METH B, V52, P517, DOI 10.1016/0168-583X(90)90469-B
   FINK D, 1990, NUCL INSTRUM METH B, V47, P79, DOI 10.1016/0168-583X(90)90049-Z
   FOWLER AJ, 1986, RADIOCARBON, V28, P441
   GILLESPIE R, 1986, RADIOCARBON, V28, P1065
   GREENWOOD FC, 1963, BIOCHEM J, V89, P114, DOI 10.1042/bj0890114
   KEILSON J, 1978, 1ST P C RAD DAT ACC, P391
   KILIUS LR, 1987, NUCL INSTRUM METH B, V29, P72, DOI 10.1016/0168-583X(87)90207-2
   LOY TH, 1990, ANTIQUITY, V64, P110, DOI 10.1017/S0003598X00077346
   MATZKU S, 1977, IMMUNOCHEMISTRY, V14, P367, DOI 10.1016/0019-2791(77)90238-5
   NELSON DE, 1986, RADIOCARBON, V28, P170
   PARAS P, 1985, DOE S SERIES, V56
   Shamberger RJ, 1984, BIOCH ESSENTIAL ULTR, P201
   SHARMA P, 1987, NUCL INSTRUM METH B, V29, P63, DOI 10.1016/0168-583X(87)90205-9
   SHARMA P, 1987, NUCL INSTRUM METH B, V29, P335, DOI 10.1016/0168-583X(87)90261-8
   SOUTHON JR, 1990, NUCL INSTRUM METH B, V52, P301, DOI 10.1016/0168-583X(90)90426-U
   STAFFORD TW, 1988, GEOCHIM COSMOCHIM AC, V52, P2257, DOI 10.1016/0016-7037(88)90128-7
   TURTELTAUB KW, 1990, UNPUB P NATL ACAD SC
   VOGEL J, UNPUB
   VOGEL JS, 1987, RADIOCARBON, V29, P323
   VOGEL JS, 1990, RADIOCARBON, V32, P81
NR 23
TC 41
Z9 41
U1 0
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-583X
J9 NUCL INSTRUM METH B
JI Nucl. Instrum. Methods Phys. Res. Sect. B-Beam Interact. Mater. Atoms
PD DEC
PY 1990
VL 52
IS 3-4
BP 524
EP 530
DI 10.1016/0168-583X(90)90470-F
PG 7
WC Instruments & Instrumentation; Nuclear Science & Technology; Physics,
   Atomic, Molecular & Chemical; Physics, Nuclear
SC Instruments & Instrumentation; Nuclear Science & Technology; Physics
GA EV368
UT WOS:A1990EV36800063
DA 2018-10-20
ER

PT J
AU LABOW, RS
   BARRY, YA
   TOCCHI, M
   KEON, WJ
AF LABOW, RS
   BARRY, YA
   TOCCHI, M
   KEON, WJ
TI THE EFFECT OF MONO(2-ETHYLHEXYL)PHTHALATE ON AN ISOLATED PERFUSED RAT
   HEART-LUNG PREPARATION
SO ENVIRONMENTAL HEALTH PERSPECTIVES
LA English
DT Article; Proceedings Paper
CT CONF ON ADVANCES IN LEAD RESEARCH : IMPLICATIONS FOR ENVIRONMENTAL
   HEALTH
CY JAN 09-11, 1989
CL RESEARCH TRIANGLE PARK, NC
SP NIEHS, NICHHD
ID PHTHALATE-ESTERS; TRIMELLITIC ANHYDRIDE; PULMONARY HEMORRHAGE; MEHP;
   SYSTEMS; STORAGE; MUSCLE; BLOOD
AB Di(2-ethylhexyl)phthalate (DEHP), the plasticizer used in the biomedical production of blood storage bags, hemodialysis systems, cardiopulmonary bypass (CPB) circuitry, and intubation tubes, is extracted from the plastic material when it comes into contact with biological fluids and is converted to its principal metabolite, mono(2-ethylhexyl)phthalate (MEHP).  We have shown that MEHP causes cardiac and respiratory arrest, as well as hypotension, when infused into anesthetized rats.  Using a well-ventilated in vitro rat heart-lung preparation, we investigated the effect of MEHP on pulmonary artery pressure (PAP) and found that MEHP had a hypertensive effect on the pulmonary vasculature ending in constriction and edema.  There was significant increase of 0.58 mm Hg/min in the PAP of isolated rat lungs when perfused with MEHP dissolved in Krebs-Henseleit (K-H) buffer (p = 0.0003).  The rat lungs that were perfused with K-H buffer only increased 0.094 mm Hg/min during the same perfusion time of 20 min.  The water gained during this time was 0.22 g/min with MEHP in the buffer compared to 0.04 g/min with buffer alone.  The pO2 in the effluent did not decrease during the perfusion time.  The concentration of MEHP in the rat lungs after perfusion varied from 20 to 40-mu-g/g.  Although the mechanism of action of MEHP on PAP is too complex to be fully elucidated by this model, the increase in PAP which we have demonstrated is significant and adds yet another toxic effect of this major metabolite of the ubiquitous plasticizer, DEHP.
C1 CANADIAN RED CROSS,OTTAWA CTR,OTTAWA,ONTARIO,CANADA.
RP LABOW, RS (reprint author), UNIV OTTAWA,OTTAWA CIVIC HOSP,INST HEART,1053 CARLING AVE,OTTAWA K1Y 4E9,ONTARIO,CANADA.
CR ACOTT PD, 1987, B ENVIRON CONTAM TOX, V38, P363, DOI 10.1007/BF01606599
   AHMAD D, 1979, LANCET, V2, P328
   AUTIAN J, 1978, VOX SANG, V34, P244
   BARRY YA, 1988, BLOOD, V72, P1438
   BARRY YA, 1989, J THORAC CARDIOV SUR, V97, P900
   BARRYYA, UNPUB TOXICOL APPL P
   CARILLI AD, 1978, CHEST, V74, P311
   EAGLE H, 1959, SCIENCE, V130, P432, DOI 10.1126/science.130.3373.432
   FANBURG B L, 1988, Chest, V93, p101S, DOI 10.1378/chest.93.3.101S
   FAWCETT IW, 1977, CLIN ALLERGY, V7, P1, DOI 10.1111/j.1365-2222.1977.tb01418.x
   FURCHGOTT RF, 1983, CIRC RES, V53, P557, DOI 10.1161/01.RES.53.5.557
   GANGOLLI SD, 1982, ENVIRON HEALTH PERSP, V45, P77, DOI 10.2307/3429387
   HERBERT FA, 1979, CHEST, V76, P546, DOI 10.1378/chest.76.5.546
   KARNOVSKY MH, 1970, J GEN PHYSIOL, V52, P645
   KENNEDY T, 1988, Chest, V93, p149S, DOI 10.1378/chest.93.3_Supplement.149S
   LABOW RS, 1986, J TOXICOL ENV HEALTH, V19, P591, DOI 10.1080/15287398609530955
   LABOW RS, 1988, ENV HLTH PERSPECT, V78, P178
   MITCHELL FE, 1986, BIOCHEM PHARMACOL, V35, P2941, DOI 10.1016/0006-2952(86)90490-9
   MOSELEY RV, 1970, ANN SURG, V171, P336, DOI 10.1097/00000658-197003000-00003
   NEELY JR, 1967, AM J PHYSIOL, V212, P804
   NEWMAN J H, 1988, Chest, V93, p139S
   PFUDERER P, 1975, B ENVIRON CONTAM TOX, V13, P275, DOI 10.1007/BF01685335
   REDDY JK, 1984, CRC CRIT R TOXICOL, V12, P1
   ROCK G, 1978, TRANSFUSION, V18, P553, DOI 10.1046/j.1537-2995.1978.18579036383.x
   ROCK G, 1987, NEW ENGL J MED, V316, P1218
   ROTH B, 1988, EUR J PEDIATR, V147, P41, DOI 10.1007/BF00442609
   RUBIN RJ, 1976, TOXICOL APPL PHARM, V37, P154
   TAVARES IA, 1984, EUR J PHARMACOL, V106, P449, DOI 10.1016/0014-2999(84)90738-6
   TOMITA I, 1986, ENVIRON HEALTH PERSP, V65, P249, DOI 10.2307/3430190
   ZEISS CR, 1977, J ALLERGY CLIN IMMUN, V60, P96, DOI 10.1016/0091-6749(77)90033-1
NR 30
TC 16
Z9 19
U1 0
U2 3
PU NATL INST ENVIRON HEALTH SCI
PI RES TRIANGLE PK
PA PO BOX 12233, RES TRIANGLE PK, NC 27709
SN 0091-6765
J9 ENVIRON HEALTH PERSP
JI Environ. Health Perspect.
PD NOV
PY 1990
VL 89
BP 189
EP 193
DI 10.2307/3430916
PG 5
WC Environmental Sciences; Public, Environmental & Occupational Health;
   Toxicology
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health; Toxicology
GA EV023
UT WOS:A1990EV02300028
PM 2088746
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU LAURENCIN, CT
   PIERREJACQUES, HM
   LANGER, R
AF LAURENCIN, CT
   PIERREJACQUES, HM
   LANGER, R
TI TOXICOLOGY AND BIOCOMPATIBILITY CONSIDERATIONS IN THE EVALUATION OF
   POLYMERIC MATERIALS FOR BIOMEDICAL APPLICATIONS
SO CLINICS IN LABORATORY MEDICINE
LA English
DT Article
C1 MIT,77 MASSACHUSETTS AVE,BLDG E25,ROOM 342,CAMBRIDGE,MA 02139.
NR 0
TC 15
Z9 15
U1 0
U2 4
PU W B SAUNDERS CO
PI PHILADELPHIA
PA INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA
   19106-3399
SN 0272-2712
J9 CLIN LAB MED
JI Clin. Lab. Med.
PD SEP
PY 1990
VL 10
IS 3
BP 549
EP 570
PG 22
WC Medical Laboratory Technology
SC Medical Laboratory Technology
GA DY137
UT WOS:A1990DY13700010
PM 2253450
DA 2018-10-20
ER

PT J
AU MALMQVIST, KG
AF MALMQVIST, KG
TI QUANTITATIVE PIXE ANALYSIS OF BIOMEDICAL MATERIAL - SAMPLE PREPARATION,
   IRRADIATION AND QUALITY-CONTROL
SO NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION B-BEAM
   INTERACTIONS WITH MATERIALS AND ATOMS
LA English
DT Article; Proceedings Paper
CT 5TH INTERNATIONAL CONF ON PARTICLE INDUCED X-RAY EMISSION AND ITS
   ANALYTICAL APPLICATIONS
CY AUG, 1989
CL FREE UNIV, AMSTERDAM, NETHERLANDS
SP FREE UNIV AMSTERDAM, DEPT PHYS & ASTRON, HIGH VOLTAGE ENGN EUROPA, NATL ELECTROSTAT, KLM ROYAL DUTCH AIRLINES
HO FREE UNIV
RP MALMQVIST, KG (reprint author), LUND INST SCI TECHNOL,DEPT NUCL PHYS,SOLVEGATAN 14,S-22362 LUND,SWEDEN.
CR ANNEGARN HJ, 1988, NUCL INSTRUM METH B, V35, P415, DOI 10.1016/0168-583X(88)90303-5
   CAMPBELL JL, 1989, SCANNING MICROSCOPY, V3, P449
   CAMPBELL JL, 1986, NUCL INSTRUM METH B, V14, P204, DOI 10.1016/0168-583X(86)90045-5
   CAMPBELL JL, 1990, NUCL INSTRUM METH B, V49, P115, DOI 10.1016/0168-583X(90)90227-L
   CHAUDHRI MA, 1981, NUCL INSTRUM METHODS, V181, P327
   CHOLEWA M, 1989, NUCL INSTRUM METH B, V40-1, P651, DOI 10.1016/0168-583X(89)91068-9
   DOOLITTLE LR, 1986, NUCL INSTRUM METH B, V15, P227, DOI 10.1016/0168-583X(86)90291-0
   DUFLOU H, 1987, BIOL TRACE ELEM RES, V13, P1, DOI 10.1007/BF02796617
   FOLKMANN F, 1984, NUCL INSTRUM METH B, V3, P11, DOI 10.1016/0168-583X(84)90327-6
   HASSELMANN I, 1977, NUCL INSTRUM METHODS, V142, P163, DOI 10.1016/0029-554X(77)90825-4
   HULT M, 1989, THESIS, P89
   IYENGAR GV, 1977, J RADIOANAL CHEM, V39, P301, DOI 10.1007/BF02517236
   LI HK, 1990, NUCL INSTRUM METH B, V49, P85
   LINDH U, 1990, NUCL INSTR METH B, V49
   LIPWORTH AD, 1990, NUCL INSTRUM METH B, V49, P173, DOI 10.1016/0168-583X(90)90237-O
   LOVESTAM NEG, 1989, NUCL INSTRUM METH B, V43, P104, DOI 10.1016/0168-583X(89)90087-6
   MAENHAUT W, 1988, NUCL INSTRUM METH B, V35, P388, DOI 10.1016/0168-583X(88)90300-X
   MAENHAUT W, 1987, FRESEN Z ANAL CHEM, V326, P736, DOI 10.1007/BF00473543
   MAENHAUT W, 1984, NUCL INSTRUM METH B, V3, P135, DOI 10.1016/0168-583X(84)90350-1
   MANGELSON NF, 1977, NUCL INSTRUM METHODS, V142, P133, DOI 10.1016/0029-554X(77)90821-7
   MANGELSON NF, IN PRESS SCANNING MI
   MARTINSSON BG, 1987, NUCL INSTRUM METH B, V22, P356, DOI 10.1016/0168-583X(87)90358-2
   MOLLER B, 1984, SWED DENT J, V8, P67
   PAKARINEN P, 1990, NUCL INSTRUM METH B, V49, P241, DOI 10.1016/0168-583X(90)90253-Q
   PAKARINEN P, 1986, THESIS TURKU
   PALLON J, 1981, NUCL INSTRUM METHODS, V181, P71, DOI 10.1016/0029-554X(81)90583-8
   PALLON J, 1987, BIOL TRACE ELEM RES, V13, P401
   PALLON J, COMMUNICATION
   PINHEIRO T, 1989, 5TH IN C PIXE AMST
   PINHEIRO T, IN PRESS BIOL TRACE
   RAISANEN J, 1987, BIOL TRACE ELEM RES, V12, P55, DOI 10.1007/BF02796666
   RAISANEN J, 1987, APPL RADIAT ISOTOPES, V38, P573
   SALFORD LG, THESIS
   SIMONOFF M, 1988, NUCL INSTRUM METH B, V31, P442, DOI 10.1016/0168-583X(88)90344-8
   SWANN CP, 1984, NUCL INSTRUM METH B, V3, P392, DOI 10.1016/0168-583X(84)90403-8
   SWIETLICKI E, 1987, NUCL INSTRUM METH B, V22, P264, DOI 10.1016/0168-583X(87)90340-5
   SWIETLICKI E, COMMUNICATION
   SZOKEFALVINAGY Z, 1987, NUCL INSTRUM METH B, V22, P156, DOI 10.1016/0168-583X(87)90315-6
   TAPPER UAS, 1987, NUCL INSTRUM METH B, V22, P176, DOI 10.1016/0168-583X(87)90320-X
   THEMNER K, 1990, NUCL INSTRUM METH B, V49, P52, DOI 10.1016/0168-583X(90)90215-G
   VARGA L, 1984, NUCL INSTRUM METH B, V3, P357, DOI 10.1016/0168-583X(84)90394-X
   VERSIECK J, 1987, BIOL TRACE ELEM RES, V12, P45, DOI 10.1007/BF02796665
   WATJEN U, 1987, NUCL INSTRUM METH B, V22, P29, DOI 10.1016/0168-583X(87)90288-6
   WATJEN U, 1983, THESIS
   WATTERSON JIW, 1987, NUCL INSTRUM METH B, V28, P554, DOI 10.1016/0168-583X(87)90502-7
   WILLIAMS ET, 1984, NUCL INSTRUM METH B, V3, P211, DOI 10.1016/0168-583X(84)90365-3
   XENOULIS AC, 1983, J RADIOANAL CHEM, V77, P207, DOI 10.1007/BF02525367
   YAGI M, 1987, J RADIOAN NUCL CH AR, V116, P213, DOI 10.1007/BF02037224
NR 48
TC 10
Z9 10
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-583X
J9 NUCL INSTRUM METH B
JI Nucl. Instrum. Methods Phys. Res. Sect. B-Beam Interact. Mater. Atoms
PD APR
PY 1990
VL 49
IS 1-4
BP 183
EP 190
DI 10.1016/0168-583X(90)90239-Q
PG 8
WC Instruments & Instrumentation; Nuclear Science & Technology; Physics,
   Atomic, Molecular & Chemical; Physics, Nuclear
SC Instruments & Instrumentation; Nuclear Science & Technology; Physics
GA DE299
UT WOS:A1990DE29900035
DA 2018-10-20
ER

PT J
AU KUTAY, S
   TINCER, T
   HASIRCI, N
AF KUTAY, S
   TINCER, T
   HASIRCI, N
TI POLYURETHANES AS BIOMEDICAL MATERIALS
SO BRITISH POLYMER JOURNAL
LA English
DT Article
C1 MIDDLE E TECH UNIV,FAC ARTS & SCI,DEPT CHEM,ANKARA 06531,TURKEY.
OI HASIRCI, Nesrin/0000-0002-4497-0194
CR AUTIAN J, 1977, ARTIF ORGANS, V1, P53
   BORETOS JW, 1967, SCIENCE, V158, P1481, DOI 10.1126/science.158.3807.1481
   BORETOS JW, 1973, CONCISE GUIDE BIOMEC, P10
   BURKE A, 1988, J BIOACT COMPAT POLY, V3, P232
   FLEMING DG, 1981, BIOMEDICAL MATERIALS, P255
   GOLAN J, 1982, P BRUSSELS INT C BUR
   HASIRCI N, 1987, BIOACT COMPT POLYM, V2, P131
   Leininger R I, 1968, Ann N Y Acad Sci, V146, P11, DOI 10.1111/j.1749-6632.1968.tb20267.x
   LYMAN DJ, 1969, P ARTIFICIAL HEART P, P113
   LYMAN DONALD J., 1967, J BIOMED MAT RES, V1, P17, DOI 10.1002/jbm.820010105
   MIRKOVITCH V, 1962, T AM SOC ART INT ORG, V8, P79
   NYILAS E, 1970, 23RD P C ENG MED BIO, P147
   PARK GB, 1978, BIOMATER ARTIF CELL, V6, P1
   PIERCE WS, 1975, POLYM MED SURGERY, P263
   REMBAUM A, 1973, BIOMAT MED DEV ARTIF, V1, P53
   SHARP MV, 1966, T AM SOC ART INT ORG, V12, P1979
   SZYCHER M, 1984, PLASTIC TECHNOLOGY, P45
   TRAPPE G, 1968, ADV POLYURETHANE TEC, P89
   Wilkes G.L., 1975, POLYM MED SURGERY, P45
   WONG EW, 1969, URETHANE POLYETHER B
NR 20
TC 21
Z9 21
U1 0
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0007-1641
J9 BRIT POLYM J
PY 1990
VL 23
IS 3
BP 267
EP 272
DI 10.1002/pi.4980230316
PG 6
WC Polymer Science
SC Polymer Science
GA DZ653
UT WOS:A1990DZ65300013
DA 2018-10-20
ER

PT J
AU MADHAVAN, C
   SRINIVASAN, TT
   XU, QC
   NEWNHAM, RE
   GURURAJA, TR
   MEYER, P
AF MADHAVAN, C
   SRINIVASAN, TT
   XU, QC
   NEWNHAM, RE
   GURURAJA, TR
   MEYER, P
TI PROPERTIES OF FIRED 0-3 PIEZOELECTRIC MATERIALS FOR BIOMEDICAL
   ULTRASONIC-IMAGING APPLICATIONS
SO FERROELECTRICS
LA English
DT Article; Proceedings Paper
CT INDO/UNITED-STATES WORKSHOP ON ELECTRONIC CERAMICS AND MATERIALS
CY JAN 14-16, 1989
CL POONA, INDIA
SP USN, OFF NAVAL RES, DEPT SCI & TECHNOL INDIA, COUNCIL SCI & IND RES INDIA, DEF RES & DEV ORG INDIA, DEPT ELECTR INDIA, TATA RES DEV & DESIGN CTR INDIA, PUBLIC & PRIVATE SECTOR IND INDIA
RP MADHAVAN, C (reprint author), PENN STATE UNIV,MAT RES LAB,UNIVERSITY PK,PA 16802, USA.
CR BANNO H, 1983, FERROELECTRICS, V5, P3
   DRAGAN M, 1987, THESIS PENNSYLVANIA, P118
   Gururaja T. R., 1986, IEEE 1986 Ultrasonics Symposium Proceedings (Cat. No.86CH2375-4), P703
   Hadjicostis AN, 1984, FERROELECTRICS, V60, P107, DOI 10.1080/00150198408017515
   HIROZHI T, 1983, FERROELECTRICS, V51, P71
   JOHN R, 1987, AM CERA SOC B, V66, P664
   Newnham RE, 1984, FERROELECTRICS, V60, P15, DOI 10.1080/00150198408017505
   Newnham R. E., 1986, Ferroelectrics, V68, P1, DOI 10.1080/00150198608238734
   NEWNHAM RE, 1980, MATERIALS ENG, V112, P93
   XU QC, 1987, J WAVE MAT INTERACTI, V2, P105
NR 10
TC 2
Z9 2
U1 0
U2 0
PU GORDON BREACH SCI PUBL LTD
PI READING
PA C/O STBS LTD PO BOX 90, READING, BERKS, ENGLAND RG1 8JL
SN 0015-0193
J9 FERROELECTRICS
PY 1990
VL 102
BP 235
EP 242
DI 10.1080/00150199008221483
PG 8
WC Materials Science, Multidisciplinary; Physics, Condensed Matter
SC Materials Science; Physics
GA DK127
UT WOS:A1990DK12700024
DA 2018-10-20
ER

PT J
AU DIXON, AJ
AF DIXON, AJ
TI PRINCIPLES AND APPLICATIONS OF CONFOCAL FLUORESCENCE MICROSCOPY
SO INSTITUTE OF PHYSICS CONFERENCE SERIES
LA English
DT Article
AB Confocal microscopy allows direct non-invasive visualisation and analysis of three-dimensional structure in complex or fragile material.  This paper describes the basic principles of the confocal imaging technique and its particular applications in fluorescence microscopy.  Both biomedical and materials science applications are briefly discussed.
RP DIXON, AJ (reprint author), BIORAD LASERSHARP,MAYLANDS AVE,HEMEL HEMPSTEAD,HERTS,ENGLAND.
CR BRAKENHOFF GJ, 1989, J MICROSC-OXFORD, V153, P151, DOI 10.1111/j.1365-2818.1989.tb00555.x
   FINE A, 1988, TRENDS NEUROSCI, V11, P346, DOI 10.1016/0166-2236(88)90056-2
   WHITE JG, 1987, J CELL BIOL, V105, P41, DOI 10.1083/jcb.105.1.41
   WILSON T, 1988, J MICROSC-OXFORD, V149, P51, DOI 10.1111/j.1365-2818.1988.tb04561.x
NR 4
TC 0
Z9 0
U1 0
U2 7
PU IOP PUBLISHING LTD
PI BRISTOL
PA TECHNO HOUSE, REDCLIFFE WAY, BRISTOL, ENGLAND BS1 6NX
SN 0951-3248
J9 INST PHYS CONF SER
JI Inst. Phys. Conf. Ser.
PY 1990
IS 98
BP 643
EP 650
PG 8
WC Physics, Multidisciplinary
SC Physics
GA FP296
UT WOS:A1990FP29600151
DA 2018-10-20
ER

PT J
AU VANDERLEI, B
AF VANDERLEI, B
TI ELECTRON-MICROSCOPY OF IMPLANTED BIOMEDICAL MATERIALS
SO ULTRAMICROSCOPY
LA English
DT Meeting Abstract
C1 STATE UNIV GRONINGEN HOSP,DEPT SURG,9700 RB GRONINGEN,NETHERLANDS.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0304-3991
J9 ULTRAMICROSCOPY
JI Ultramicroscopy
PD DEC
PY 1989
VL 31
IS 4
BP 474
EP 474
DI 10.1016/0304-3991(89)90392-6
PG 1
WC Microscopy
SC Microscopy
GA CP773
UT WOS:A1989CP77300061
DA 2018-10-20
ER

PT J
AU HEIMKE, G
AF HEIMKE, G
TI BIOMATERIALS HIGHLIGHTS .2. MATERIALS FOR BIOMEDICAL APPLICATIONS - HIGH
   LONG-TERM SUCCESS RATES MIGHT POSE NEW PROBLEMS
SO ANGEWANDTE CHEMIE-INTERNATIONAL EDITION IN ENGLISH
LA English
DT Article
RP HEIMKE, G (reprint author), CLEMSON UNIV,COLL ENGN,DEPT BIOENGN,CLEMSON,SC 29631, USA.
CR BETTS F, 1989, 15TH T ANN M SOC BIO, P145
   BLACK J, 1988, J BONE JOINT SURG BR, V70, P517
   COOK SD, 1985, CLIN ORTHOPAEDICS, V194, P236
   GILLESPIE WJ, 1988, J BONE JOINT SURG BR, V70, P539
   GRISS P, 1977, ARCH ORTHOP TRAUM SU, V90, P29, DOI 10.1007/BF00415892
   GRISS P, 1981, BIOCOMPATIBILITY CLI, V1, P155
   HEIMKE G, 1989, ANGEW CHEM INT EDIT, V28, P111, DOI 10.1002/anie.198901111
   HEIMKE G, 1989, ANGEW CHEM ADV MATER, V101, P113
   HEIMKE G, 1989, ADV MATER, P7
   SCHULTE W, 1981, ZAHNARZTL MITT, V71
   SEMLITSCH M, 1977, J BIOMED MATER RES, V11, P537, DOI 10.1002/jbm.820110409
   Steinemann S. G., 1980, EVALUATION BIOMATERI, P1
   STEINEMANN SG, 1985, TITANIUM SCI TECHNOL, V2, P1373
NR 13
TC 1
Z9 1
U1 0
U2 1
PU VCH PUBLISHERS INC
PI DEERFIELD BEACH
PA 303 NW 12TH AVE, DEERFIELD BEACH, FL 33442-1788
SN 0570-0833
J9 ANGEW CHEM INT EDIT
JI Angew. Chem.-Int. Edit. Engl.
PD JUL
PY 1989
VL 28
IS 7
BP 956
EP 958
DI 10.1002/anie.198909561
PG 3
WC Chemistry, Multidisciplinary
SC Chemistry
GA AH967
UT WOS:A1989AH96700030
DA 2018-10-20
ER

PT J
AU HEIMKE, G
AF HEIMKE, G
TI BIOMATERIALS HIGHLIGHTS - MATERIALS FOR BIOMEDICAL APPLICATIONS - BONE
   AND JOINT REPLACEMENTS
SO ANGEWANDTE CHEMIE-INTERNATIONAL EDITION IN ENGLISH
LA English
DT Editorial Material
RP HEIMKE, G (reprint author), CLEMSON UNIV,DEPT BIOENGN,CLEMSON,SC 29634, USA.
CR DHOEDT B, 1986, DEUT ZAHNAERZTL Z, V41, P1068
   DHOEDT B, 1985, FORTSCHR ZAHNARZTL I, V1, P150
   DHOEDT B, 1986, DTSCH Z ZAHNARZTL IM, V2, P6
   EBERT R, 1979, 12TH INT C MED BIOL
   HEIMKE G, 1989, ANGEW CHEM INT EDIT, V28, P111, DOI 10.1002/anie.198901111
   HEIMKE G, 1989, ADV MATER, P7
   HEIMKE G, 1985, BIOMECHANICS CURRENT, P141
   MOUNTVALA AJ, 1973, AM CERAM SOC BULL, V52, P479
   VOLZ RG, 1988, CLIN ORTHOP RELAT R, V226, P38
NR 9
TC 0
Z9 0
U1 0
U2 3
PU VCH PUBLISHERS INC
PI DEERFIELD BEACH
PA 303 NW 12TH AVE, DEERFIELD BEACH, FL 33442-1788
SN 0570-0833
J9 ANGEW CHEM INT EDIT
JI Angew. Chem.-Int. Edit. Engl.
PD APR
PY 1989
VL 28
IS 4
BP 518
EP 520
DI 10.1002/anie.198905181
PG 3
WC Chemistry, Multidisciplinary
SC Chemistry
GA U8005
UT WOS:A1989U800500043
DA 2018-10-20
ER

PT J
AU EDWARDS, GS
   TOLK, NH
AF EDWARDS, GS
   TOLK, NH
TI VANDERBILT-UNIVERSITY FEL CENTER FOR BIOMEDICAL AND MATERIALS RESEARCH
SO NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION A-ACCELERATORS
   SPECTROMETERS DETECTORS AND ASSOCIATED EQUIPMENT
LA English
DT Article
RP EDWARDS, GS (reprint author), VANDERBILT UNIV,DEPT PHYS & ASTRON,NASHVILLE,TN 37235, USA.
CR EDWARDS G, 1987, IN PRESS 6TH P INT C
   EDWARDS GS, 1984, PHYS REV LETT, V53, P1284, DOI 10.1103/PhysRevLett.53.1284
   OSSOFF R, 1987, IN PRESS 6TH P INT C
   POWELL J, 1987, PHYS REV A, V25, P3929
   TOLK N, 1987, IN PRESS 6TH P INT C
   VANZANDT LL, 1986, PHYS REV LETT, V57, P2085, DOI 10.1103/PhysRevLett.57.2085
NR 6
TC 3
Z9 3
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-9002
J9 NUCL INSTRUM METH A
JI Nucl. Instrum. Methods Phys. Res. Sect. A-Accel. Spectrom. Dect. Assoc.
   Equip.
PD OCT
PY 1988
VL 272
IS 1-2
BP 37
EP 39
DI 10.1016/0168-9002(88)90191-X
PG 3
WC Instruments & Instrumentation; Nuclear Science & Technology; Physics,
   Nuclear; Physics, Particles & Fields
SC Instruments & Instrumentation; Nuclear Science & Technology; Physics
GA Q3255
UT WOS:A1988Q325500009
DA 2018-10-20
ER

PT J
AU LUDBROOK, J
AF LUDBROOK, J
TI MATERIAL NEEDS FOR BIOMEDICAL APPLICATIONS
SO BIOMATERIALS
LA English
DT Meeting Abstract
C1 BAKER MED RES INST,PRAHRAN,VIC 3181,AUSTRALIA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAY
PY 1988
VL 9
IS 3
BP 291
EP 291
DI 10.1016/0142-9612(88)90103-2
PG 1
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA N6578
UT WOS:A1988N657800019
DA 2018-10-20
ER

PT J
AU HUANG, HN
   PERSICO, DF
   LAGOW, RJ
   CLARK, LC
AF HUANG, HN
   PERSICO, DF
   LAGOW, RJ
   CLARK, LC
TI SYNTHESIS OF UNUSUAL PERFLUOROCARBON ETHERS AND AMINES CONTAINING BULKY
   FLUOROCARBON GROUPS - NEW BIOMEDICAL MATERIALS
SO JOURNAL OF ORGANIC CHEMISTRY
LA English
DT Article
C1 UNIV TEXAS,DEPT CHEM,AUSTIN,TX 78712.
   CHILDRENS HOSP MED CTR,CINCINNATI,OH 45229.
CR ABE T, 1979, J FLUORINE CHEM, V13, P519, DOI 10.1016/S0022-1139(00)83098-5
   ADCOCK JL, 1976, J FLUORINE CHEM, V7, P197, DOI 10.1016/S0022-1139(00)83996-2
   ADCOCK JL, 1975, J ORG CHEM, V40, P3271, DOI 10.1021/jo00910a024
   BANKS RE, 1982, PREPARATION PROPERTI, P45
   CHANG C, 1982, RADIAT PHYS CHEM, V19, P361, DOI 10.1016/0146-5724(82)90002-4
   CLARK LC, 1973, SCIENCE, V181, P680, DOI 10.1126/science.181.4100.680
   CLARK WC, IN PRESS
   DANIELSON RD, 1979, ENCY CHEM TECHNOL, V10, P874
   EVANS TW, 1936, IND ENG CHEM, V28, P1184
   FLORIN RE, 1972, J CHEM PHYS, V57, P1791, DOI 10.1063/1.1678473
   GERHARDT GE, 1978, J ORG CHEM, V43, P4505, DOI 10.1021/jo00417a026
   GORDON AS, 1962, J CHEM PHYS, V36, P1130
   HUANG H, IN PRESS
   HUANG HK, UNPUB
   LIU EKS, 1979, J FLUORINE CHEM, V13, P71
   MARASCHIN NJ, 1975, J AM CHEM SOC, V97, P513, DOI 10.1021/ja00836a008
   MUSHER JI, 1962, J CHEM PHYS, V36, P1086, DOI 10.1063/1.1732644
   NAGASE S, COMMUNICATION
   Norris JF, 1932, J AM CHEM SOC, V54, P2088, DOI 10.1021/ja01344a062
   OLAH GA, 1966, J AM CHEM SOC, V88, P3310, DOI 10.1021/ja00966a024
   PERSICO DF, 1985, J ORG CHEM, V50, P5156, DOI 10.1021/jo00225a036
   PETRAKIS L, 1961, J CHEM PHYS, V35, P1243, DOI 10.1063/1.1732030
   RIESS JG, 1978, ANGEW CHEM INT EDIT, V17, P621, DOI 10.1002/anie.197806213
   SEYDENPENNE J, 1965, B SOC CHIM FR, V3, P700
   SHIMP LA, 1977, J ORG CHEM, V42, P3437, DOI 10.1021/jo00441a025
   SHOULDERS BA, IN PRESS
   Simons J. H, 1950, FLUORINE CHEM, V1, P414
   SIMONS JH, 1954, FLUORINE CHEM, V2, P1350
   STACEY M, 1960, ADVANCES FLUORINE CH, V1, P166
   TIRES GVD, 1955, J AM CHEM SOC, V77, P4837
   TOY MS, 1975, J FLUORINE CHEM, V5, P25, DOI 10.1016/S0022-1139(00)82910-3
NR 31
TC 21
Z9 21
U1 0
U2 1
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036
SN 0022-3263
J9 J ORG CHEM
JI J. Org. Chem.
PD JAN 8
PY 1988
VL 53
IS 1
BP 78
EP 85
DI 10.1021/jo00236a016
PG 8
WC Chemistry, Organic
SC Chemistry
GA L7413
UT WOS:A1988L741300016
DA 2018-10-20
ER

PT J
AU GRAHAM, JW
AF GRAHAM, JW
TI BIOMEDICAL MATERIALS EMERGE THROUGH TEAMWORK
SO ADVANCED MATERIALS & PROCESSES
LA English
DT Article
RP GRAHAM, JW (reprint author), ASTROMET ASSOCIATES INC,CINCINNATI,OH, USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ASM INTERNATIONAL
PI MATERIALS PARK
PA SUBSCRIPTIONS SPECIALIST CUSTOMER SERVICE, MATERIALS PARK, OH 44073-0002
SN 0026-0665
J9 ADV MATER PROCESS
JI Adv. Mater. Process.
PD JAN
PY 1988
VL 133
IS 1
BP 41
EP 42
PG 2
WC Materials Science, Multidisciplinary
SC Materials Science
GA L8262
UT WOS:A1988L826200003
DA 2018-10-20
ER

PT J
AU SMITH, TI
   SCHWETTMAN, HA
   ROHATGI, R
   LAPIERRE, Y
   EDIGHOFFER, J
AF SMITH, TI
   SCHWETTMAN, HA
   ROHATGI, R
   LAPIERRE, Y
   EDIGHOFFER, J
TI DEVELOPMENT OF THE SCA/FEL FOR USE IN BIOMEDICAL AND MATERIALS SCIENCE
   EXPERIMENTS
SO NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION A-ACCELERATORS
   SPECTROMETERS DETECTORS AND ASSOCIATED EQUIPMENT
LA English
DT Article
RP SMITH, TI (reprint author), STANFORD UNIV,HIGH ENERGY PHYS LAB,STANFORD,CA 94305, USA.
CR BRAU CA, 1979, DEC P INT C LAS 79
   BROWN KL, SLAC911974
   RAND RE, 1984, RECIRCULATING ELECTR, P95
   SHIH CC, 1983, IEEE J QUANTUM ELECT, V19, P369, DOI 10.1109/JQE.1983.1071851
   Smith T. I., 1982, PHYSICS QUANTUM ELEC, V8, P77
   SMITH TI, 1986, 1986 P SLAC LIN ACC
NR 6
TC 37
Z9 37
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-9002
J9 NUCL INSTRUM METH A
JI Nucl. Instrum. Methods Phys. Res. Sect. A-Accel. Spectrom. Dect. Assoc.
   Equip.
PD SEP 1
PY 1987
VL 259
IS 1-2
BP 1
EP 7
DI 10.1016/0168-9002(87)90421-9
PG 7
WC Instruments & Instrumentation; Nuclear Science & Technology; Physics,
   Nuclear; Physics, Particles & Fields
SC Instruments & Instrumentation; Nuclear Science & Technology; Physics
GA J7656
UT WOS:A1987J765600002
DA 2018-10-20
ER

PT J
AU PETERSEN, RV
AF PETERSEN, RV
TI INVITRO ALTERNATIVES TO ANIMAL TESTING FOR TOXICITY OF RAW-MATERIALS AND
   BIOMEDICAL POLYMERS - PROPOSED TEST
SO PHARMACOPEIAL FORUM
LA English
DT Article
RP PETERSEN, RV (reprint author), US PHARMACOPEIAL CONVENT INC,SUBCOMM INVITRO TOXIC,ROCKVILLE,MD 20852, USA.
CR BENSON WH, 1986, DRUG CHEM TOXICOL, V9, P275
   Bulich A. A., 1979, AQUAT TOXICOL, P98
   BULICH AA, 1986, TOXICITY TESTING USI, V1, P57
   BURTON SA, 1986, J BIOMED MATER RES, V20, P827, DOI 10.1002/jbm.820200613
   Johnson F. H., 1974, THEORY RATE PROCESSE
   KAISER KL, 1987, IN PRESS TOXICITY AS, V2
   QURESHI AA, 1987, 3RD INT S TOX TEST U
   WALKER JD, 1987, J WATER POLLUT CON F, V59, P614
NR 8
TC 0
Z9 0
U1 0
U2 1
PU US PHARMACOPEIAL CONVENTION
PI ROCKVILLE
PA 12601 TWINBROOK PKWY, ROCKVILLE, MD 20852
SN 0363-4655
J9 PHARMACOPEIAL FORUM
JI Pharmacop. Forum
PD SEP-OCT
PY 1987
VL 13
IS 5
BP 2937
EP 2938
PG 2
WC Medicine, Legal; Pharmacology & Pharmacy
SC Legal Medicine; Pharmacology & Pharmacy
GA J9959
UT WOS:A1987J995900001
DA 2018-10-20
ER

PT J
AU WILLIAMS, D
AF WILLIAMS, D
TI BIOMEDICAL MATERIALS - MATERIALS-RESEARCH-SOCIETY, BOSTON, USA, 3-6
   DECEMBER, 1985
SO BIOMATERIALS
LA English
DT Editorial Material
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAR
PY 1986
VL 7
IS 2
BP 158
EP 159
DI 10.1016/0142-9612(86)90077-3
PG 2
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA A7518
UT WOS:A1986A751800016
DA 2018-10-20
ER

PT J
AU HAYASHI, K
AF HAYASHI, K
TI APPLICATION OF RADIATION TECHNOLOGY IN BIOMEDICAL MATERIALS -
   FUNDAMENTALS AND APPLIED
SO RADIATION PHYSICS AND CHEMISTRY
LA English
DT Article
RP HAYASHI, K (reprint author), OSAKA UNIV,INST SCI & IND RES,8-1 MIHOGAOKA,IBARAKI,OSAKA 567,JAPAN.
CR ARAKAWA M, 1977, CAN J PHYSIOL PHARM, V55, P1378, DOI 10.1139/y77-183
   CHANG TMS, 1972, ARTIFICIAL CELLS
   GOLDMAN R, 1971, BIOCHEMISTRY-US, V10, P165
   HAYASHI K, 1978, MEM I SCI IND RES OS, V34, P75
   IMAI K, 1970, Biochimica et Biophysica Acta, V200, P189, DOI 10.1016/0005-2795(70)90163-7
   ISHIKAWA T, 1980, J BIOL CHEM, V255, P764
   KAETSU I, 1979, BIOTECHNOL BIOENG, V21, P847, DOI 10.1002/bit.260210508
   KAETSU I, 1979, BIOTECHNOL BIOENG, V21, P863, DOI 10.1002/bit.260210509
   KONDO T, 1976, MICROENCAPSULATION, P163
   MIKI M, 1982, BIOTECHNOL BIOENG, V24, P1587
   MOULLEC JML, 1977, J BIOL CHEM, V252, P2611
   TAMURA M, UNPUB
   THOMAS D, 1974, BIOCHEMISTRY-US, V13, P2995, DOI 10.1021/bi00711a032
   WILTING J, 1974, J BIOL CHEM, V249, P6325
NR 14
TC 2
Z9 2
U1 0
U2 0
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
J9 RADIAT PHYS CHEM
JI Radiat. Phys. Chem.
PY 1986
VL 27
IS 4
BP 317
EP 321
PG 5
WC Chemistry, Physical; Nuclear Science & Technology; Physics, Atomic,
   Molecular & Chemical
SC Chemistry; Nuclear Science & Technology; Physics
GA A9042
UT WOS:A1986A904200009
DA 2018-10-20
ER

PT J
AU CHARLES, HK
   WEINER, JA
   BLUM, NA
AF CHARLES, HK
   WEINER, JA
   BLUM, NA
TI MATERIALS CHARACTERIZATION AND ANALYSIS - APPLICATIONS IN BIOMEDICAL
   ELECTRONICS
SO SAMPE QUARTERLY-SOCIETY FOR THE ADVANCEMENT OF MATERIAL AND PROCESS
   ENGINEERING
LA English
DT Article
RP CHARLES, HK (reprint author), JOHNS HOPKINS UNIV,APPL PHYS LAB,JOHNS HOPKINS RD,LAUREL,MD 20707, USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU SAMPE PUBLISHERS
PI COVINA
PA 1161 PARKVIEW DRIVE, COVINA, CA 91722
SN 0036-0821
J9 SAMPE QUART
PD JAN
PY 1986
VL 17
IS 2
BP 40
EP 49
PG 10
WC Engineering, Multidisciplinary; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA AYJ62
UT WOS:A1986AYJ6200006
DA 2018-10-20
ER

PT J
AU HIRANO, S
   NOISHIKI, Y
   KINUGAWA, J
AF HIRANO, S
   NOISHIKI, Y
   KINUGAWA, J
TI CHITIN AND CHITOSAN FOR USE AS A NOVEL BIOMEDICAL MATERIAL
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
C1 TOTTORI UNIV,DEPT AGR BIOCHEM,TOTTORI 680,JAPAN.
NR 0
TC 0
Z9 0
U1 1
U2 2
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PY 1985
VL 190
IS SEP
BP 130
EP PME
PG 0
WC Chemistry, Multidisciplinary
SC Chemistry
GA APH03
UT WOS:A1985APH0303390
DA 2018-10-20
ER

PT J
AU SOSA, K
   MORI, A
   SISIDO, M
   IMANISHI, Y
AF SOSA, K
   MORI, A
   SISIDO, M
   IMANISHI, Y
TI SYNTHESIS OF POLYETHERURETHANES CONTAINING L-SERINE DIPEPTIDE AND THEIR
   USE AS MATERIALS FOR BIOMEDICAL FILMS
SO BIOMATERIALS
LA English
DT Article
C1 KYOTO UNIV,MED POLYMERS & BIOMAT RES CTR,SAKYO KU,KYOTO 606,JAPAN.
RP SOSA, K (reprint author), KYOTO UNIV,FAC ENGN,DEPT POLYMER CHEM,SAKYO KU,KYOTO 606,JAPAN.
CR BLACKWELL J, 1979, POLYMER, V20, P13, DOI 10.1016/0032-3861(79)90035-1
   BONART R, 1969, J MACROMOL SCI PHYS, VB  3, P337, DOI 10.1080/00222346908205099
   BROWN HH, 1959, ANAL CHEM, V31, P1844, DOI 10.1021/ac60155a049
   Fischer E, 1906, BER DTSCH CHEM GES, V39, P2942, DOI 10.1002/cber.190603903106
   Fruton JS, 1942, J BIOL CHEM, V146, P0463
   HASSALL CH, 1967, J CHEM SOC C, P997, DOI 10.1039/j39670000997
   HOLLAND RV, 1980, ANGEW MAKROMOL CHEM, V88, P209, DOI 10.1002/apmc.1980.050880116
   HU CB, 1982, J APPL POLYM SCI, V27, P2167, DOI 10.1002/app.1982.070270627
   IMAI Y, 1972, J BIOMED MATER RES, V6, P165, DOI 10.1002/jbm.820060305
   IMANISHI Y, 1981, POLYMER, V22, P1548, DOI 10.1016/0032-3861(81)90328-1
   IMANISHI Y, 1983, Membrane, V8, P75
   Imanishi Y., 1976, ADV POLYM SCI, V20, P1
   KATO T, 1971, PROTEIN NUCLEIC ACID, V16, P56
   KINIWA H, 1983, POLYM COMMUN, V24, P188
   KURITA T, 1980, MEMBRANE SEPARATION, P303
   LYMAN DJ, 1975, T AM SOC ART INT ORG, V21, P49
   MICHAELS AS, 1961, J POLYM SCI, V50, P393, DOI 10.1002/pol.1961.1205015411
   MORI A, 1984, POLYMER, V25, P1837, DOI 10.1016/0032-3861(84)90259-3
   RATNER BD, 1982, ACS SYM SER, V199, P9
   RILEY G, 1957, J CHEM SOC, P1373, DOI 10.1039/jr9570001373
   SORM M, 1979, J POLYM SCI POLYM S, V66, P349
   TAKIGAMI S, 1979, J APPL POLYM SCI, V24, P1419, DOI 10.1002/app.1979.070240603
   TERASHIMA S, 1973, TETRAHEDRON, V29, P1487, DOI 10.1016/S0040-4020(01)83388-3
   WAKI M, 1968, B CHEM SOC JPN, V41, P669, DOI 10.1246/bcsj.41.669
   YASUDA H, 1971, J POLYM SCI A2, V9, P1117, DOI 10.1002/pol.1971.160090608
   1976, SHIN ZIKKEN KAGAKU K, V9, P242
NR 26
TC 16
Z9 16
U1 0
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PY 1985
VL 6
IS 5
BP 312
EP 324
DI 10.1016/0142-9612(85)90087-0
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA ARU26
UT WOS:A1985ARU2600004
PM 3931715
DA 2018-10-20
ER

PT J
AU NAIR, PD
   SREENIVASAN, K
   JAYABALAN, M
AF NAIR, PD
   SREENIVASAN, K
   JAYABALAN, M
TI CHARACTERIZATION OF A POLYESTER MATERIAL FOR BIOMEDICAL APPLICATIONS
SO BIOMATERIALS MEDICAL DEVICES AND ARTIFICIAL ORGANS
LA English
DT Article
RP NAIR, PD (reprint author), SREE CHITRA TIRUNAL INST MED SCI & TECHNOL,DIV TECH EVALUAT BIOMAT,TRIVANDRUM 695012,INDIA.
CR BOUKEL J, 1967, J APPL POLYM SCI, V11, P1983
   BRUCK SD, 1974, BLOOD COMPATIBILITY, P113
   DIDELY MA, 1972, J APPL POLYM SCI, V16, P493
   DROTT EE, 1977, CHROMATOGRAPHIC SCI, V8
   EDE PS, 1971, J CHROMATOGR SCI, V9, P275, DOI 10.1093/chromsci/9.5.275
   ERIKSSON KE, 1972, BIODETERIORATION MAT, V2, P116
   GUIDOIN R, 1980, MECHANICAL PROPERTIE, P547
   GUIDOIN R, 1980, MECHANICAL PROPERTIE, P549
   GUMARGALIEVA KZ, 1982, BIOMATERIALS, V3, P177, DOI 10.1016/0142-9612(82)90008-4
   ILLERS KH, 1980, COLLOID POLYM SCI, V258, P117, DOI 10.1007/BF01498267
   MERILL EW, 1977, AM NY ACAD SCI, V6, P283
   NAIR PB, UNPUB
   NAIR PD, 1985, 2ND INT C POL MED CA
   PANARIS R, 1970, J POLYM SCI, V16, P493
   RICHARDSON MJ, 1978, POLYM CHARACTERISATI, P225
   SAWYER PN, 1979, J BIOMED MATER RES, V13, P937, DOI 10.1002/jbm.820130611
   SCREENIVASAN KR, UNPUB
   SNYDER LR, 1979, INTRO MODERN LIQUID, P523
   SREENIVASAN K, 1983, B MATER SCI, V5, P123
   Williams DF, 1979, CORROSION DEGRADATIO, P61
   Williams DF, 1981, ENG MED, V10, P5, DOI DOI 10.1243/EMED_JOUR_1981_010_004_02
   WILLIAMS DF, 1977, J BIOENG, V1, P251
   1980, NIH802186 US DEP HLT
NR 23
TC 0
Z9 0
U1 0
U2 0
PU MARCEL DEKKER INC
PI NEW YORK
PA 270 MADISON AVE, NEW YORK, NY 10016
SN 0090-5488
J9 BIOMATER ARTIF CELL
PY 1985
VL 13
IS 3-4
BP 115
EP 131
DI 10.3109/10731198509118846
PG 17
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA D7603
UT WOS:A1985D760300001
PM 2944551
DA 2018-10-20
ER

PT J
AU WAGNER, AB
AF WAGNER, AB
TI THE LEGAL IMPACT OF PATIENT MATERIALS USED FOR PRODUCT DEVELOPMENT IN
   THE BIOMEDICAL INDUSTRY
SO CLINICAL RESEARCH
LA English
DT Article
RP WAGNER, AB (reprint author), UNIV CALIF BERKELEY,UNIV COUNSEL,590 UNIV HALL,BERKELEY,CA 94720, USA.
NR 0
TC 4
Z9 4
U1 0
U2 0
PU SLACK INC
PI THOROFARE
PA 6900 GROVE RD, THOROFARE, NJ 08086
SN 0009-9279
J9 CLIN RES
JI Clin. Res.
PY 1985
VL 33
IS 4
BP 444
EP 447
PG 4
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA ARV18
UT WOS:A1985ARV1800002
PM 4053501
DA 2018-10-20
ER

PT J
AU BROWN, J
   DILLMAN, R
   WAGNER, A
   HEMBREE, W
   ROSENBERG, L
   JAMESON, R
   SOLOMONS, N
   CADMAN, E
   CAPLAN, A
AF BROWN, J
   DILLMAN, R
   WAGNER, A
   HEMBREE, W
   ROSENBERG, L
   JAMESON, R
   SOLOMONS, N
   CADMAN, E
   CAPLAN, A
TI THE-AMERICAN-FEDERATION-FOR-CLINICAL-RESEARCH - PUBLIC-POLICY SYMPOSIUM
   - THE LEGAL, ETHICAL, AND ECONOMIC-IMPACT OF PATIENT MATERIALS USED FOR
   PRODUCT DEVELOPMENT IN THE BIOMEDICAL INDUSTRY - DISCUSSION
SO CLINICAL RESEARCH
LA English
DT Editorial Material
C1 HASTINGS CTR,360 BROADWAY,HASTINGS ON HUDSON,NY 10706.
   UNIV CALIF BERKELEY,BERKELEY,CA 94720.
   YALE UNIV,SCH MED,NEW HAVEN,CT 06510.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU SLACK INC
PI THOROFARE
PA 6900 GROVE RD, THOROFARE, NJ 08086
SN 0009-9279
J9 CLIN RES
JI Clin. Res.
PY 1985
VL 33
IS 4
BP 455
EP 458
PG 4
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA ARV18
UT WOS:A1985ARV1800005
DA 2018-10-20
ER

PT J
AU SOUYRIS, F
   PELLEQUER, C
   PAYROT, C
   SERVERA, C
AF SOUYRIS, F
   PELLEQUER, C
   PAYROT, C
   SERVERA, C
TI CORAL, A NEW BIOMEDICAL MATERIAL - EXPERIMENTAL AND 1ST CLINICAL
   INVESTIGATIONS ON MADREPORARIA
SO JOURNAL OF MAXILLOFACIAL SURGERY
LA English
DT Article
C1 UNIV HOSP CTR MONTPELLIER, DEPT MAXILLOFACIAL SURG & STOMATOL, MONTPELLIER, FRANCE.
CR Anderson K J, 1964, Clin Orthop Relat Res, V33, P220
   CHIROFF RT, 1975, J BIOMED MATER RES, V11, P165
   ENNEKING WF, 1972, CLIN ORTHOP RELAT R, P28
   GUILLEMIN G, 1981, CR ACAD SCI III-VIE, V293, P371
   HOLMES RE, 1979, PLAST RECONSTR SURG, V63, P626, DOI 10.1097/00006534-197905000-00004
   LEVET Y, 1983, ANN CHIR PLAST ESTH, V28, P180
   PATEL A, 1980, CHIRURGIE, V106, P199
   Schuhmacher H., 1976, KORALLENRIFFE
   SOUYRIS F, 1973, ANN CHIR PLAST ESTH, V18, P149
   SOUYRIS F, 1983, REV CHIR ORTHOP, V69, P577
   Tessier P, 1967, Ann Chir Plast, V12, P273
   WOLFE SA, 1982, J MAXILLOFAC SURG, V10, P212, DOI 10.1016/S0301-0503(82)80043-X
NR 12
TC 35
Z9 38
U1 0
U2 3
PU GEORG THIEME VERLAG KG
PI STUTTGART
PA RUDIGERSTR 14, D-70469 STUTTGART, GERMANY
SN 0301-0503
J9 J MAXILLOFAC SURG
PY 1985
VL 13
IS 2
BP 64
EP 69
DI 10.1016/S0301-0503(85)80018-7
PG 6
WC Dentistry, Oral Surgery & Medicine; Surgery
SC Dentistry, Oral Surgery & Medicine; Surgery
GA AFY94
UT WOS:A1985AFY9400003
PM 2860194
DA 2018-10-20
ER

PT J
AU MARCHANT, RE
   ANDERSON, JM
AF MARCHANT, RE
   ANDERSON, JM
TI TISSUE MATERIAL INTERACTIONS OF BIOMEDICAL POLYMERS
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
C1 CASE WESTERN RESERVE UNIV,DEPT MACROMOLEC SCI,CLEVELAND,OH 44106.
   CASE WESTERN RESERVE UNIV,DEPT PATHOL,CLEVELAND,OH 44106.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PY 1984
VL 188
IS AUG
BP 65
EP PMSE
PG 0
WC Chemistry, Multidisciplinary
SC Chemistry
GA ABA40
UT WOS:A1984ABA4002932
DA 2018-10-20
ER

PT J
AU WHITFORD, MJ
AF WHITFORD, MJ
TI THE CHEMISTRY OF SILICONE MATERIALS FOR BIOMEDICAL DEVICES AND
   CONTACT-LENSES
SO BIOMATERIALS
LA English
DT Note
RP WHITFORD, MJ (reprint author), CLM GRP LTD,CHILDS PL,LONDON SW5 9RX,ENGLAND.
CR ARKLES BC, 1981, MED DEVICE DIAGNOSTI, V3
   BRADLEY S, 1970, J MACROMOL SCI CHEM, V4, P529
   Chen RY, 1979, US Patent, Patent No. [4,143,949, 4143949]
   COURTNEY JM, 1980, MED BIOL ENG COMPUT, V18, P538, DOI 10.1007/BF02443332
   ELLIS E, 1979, Patent No. 4152508
   Gaylord N., 1974, Oxygen-Permeable Contact Lens Composition, Methods and Article of Manufacture, Patent No. [US3808178 A, 3808178]
   LEE H, 1970, J MACROMOL SCI CHEM, VA  4, P757, DOI 10.1080/00222337008074374
   LEMM W, 1980, MED BIOL ENG COMPUT, V18, P521, DOI 10.1007/BF02443330
   REFOJO MF, 1976, CONTACT LENSES S, V1
   TIGHE BJ, 1980, MACROMOL CHEM, V1, P416
   WILLIAMS DF, 1971, BIOMED ENG 3, P153
   WILLIAMS DF, 1971, BIOMED ENG 3, P205
   2012070
   BIOMEDICAL PROPERTIE
   1969, CHEM SILICONE ELASTO, V18, P221
   BIOMEDICAL USES POLY
   SILICONES COPOLYMERS
   4188546
   4242483
   2813558
NR 20
TC 5
Z9 5
U1 0
U2 5
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PY 1984
VL 5
IS 5
BP 298
EP 300
DI 10.1016/0142-9612(84)90077-2
PG 3
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA TK781
UT WOS:A1984TK78100010
PM 6487713
DA 2018-10-20
ER

PT J
AU BAIER, RE
AF BAIER, RE
TI INTERFACIAL FACTORS IN THE DESIGN OF BIOMEDICAL MATERIALS
SO BIOPHYSICAL JOURNAL
LA English
DT Meeting Abstract
C1 CALSPAN CORP,CTR ADV TECHNOL,BUFFALO,NY 14225.
   SUNY BUFFALO,DEPT BIOPHYS,BUFFALO,NY 14214.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU BIOPHYSICAL SOCIETY
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998
SN 0006-3495
J9 BIOPHYS J
JI Biophys. J.
PY 1984
VL 45
IS 2
BP A25
EP A25
PG 1
WC Biophysics
SC Biophysics
GA SC967
UT WOS:A1984SC96700069
DA 2018-10-20
ER

PT J
AU SCHWAN, HP
AF SCHWAN, HP
TI PROPERTIES OF BIOLOGICAL-MATERIALS AND BIOMEDICAL APPLICATIONS
SO IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING
LA English
DT Meeting Abstract
NR 0
TC 0
Z9 0
U1 0
U2 1
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI PISCATAWAY
PA 445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA
SN 0018-9294
J9 IEEE T BIO-MED ENG
JI IEEE Trans. Biomed. Eng.
PY 1984
VL 31
IS 8
BP 571
EP 571
PG 1
WC Engineering, Biomedical
SC Engineering
GA TF118
UT WOS:A1984TF11800080
DA 2018-10-20
ER

PT J
AU SCHWAN, HP
AF SCHWAN, HP
TI ELECTRICAL AND ACOUSTIC PROPERTIES OF BIOLOGICAL-MATERIALS AND
   BIOMEDICAL APPLICATIONS
SO IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING
LA English
DT Article
C1 DREXEL UNIV,INST BIOMED ENGN & SCI,PHILADELPHIA,PA 19104.
RP SCHWAN, HP (reprint author), UNIV PENN,DEPT BIOENGN,PHILADELPHIA,PA 19104, USA.
CR ANNE A, 1961, BIOL EFFECTS MICROWA, V1, P153
   CARSTENSEN EL, 1953, J ACOUST SOC AM, V25, P286, DOI 10.1121/1.1907033
   CARSTENSEN EL, 1959, J ACOUST SOC AM, V31, P185, DOI 10.1121/1.1907690
   CARSTENSEN EL, 1959, J ACOUST SOC AM, V31, P305, DOI 10.1121/1.1907716
   CARSTENSEN EL, 1976, ULTRASONIC BIOPHYSIC, V7, P38
   COLE KS, 1968, MEMBRANES IONS IMPUL
   EDMONDS PD, 1970, BIOCHIM BIOPHYS ACTA, V200, P174, DOI 10.1016/0005-2795(70)90058-9
   EDMONDS PD, 1976, ULTRASONIC BIOPHYSIC, V7, P50
   FOSTER KR, 1980, BIOPHYS J, V29, P271, DOI 10.1016/S0006-3495(80)85131-9
   FOSTER KR, 1984, BIOPHYS J, V45, P975, DOI 10.1016/S0006-3495(84)84242-3
   FOSTER KR, 1978, IEEE T BIO-MED ENG, V25, P313, DOI 10.1109/TBME.1978.326313
   FOSTER KR, UNPUB DIELECTRIC P A, V6
   FRICKE H, 1956, NATURE, V177, P134, DOI 10.1038/177134a0
   GRANT EH, 1965, ANN NY ACAD SCI, V125, P418, DOI 10.1111/j.1749-6632.1965.tb45407.x
   KRITIKOS HN, 1975, IEEE T BIO-MED ENG, V22, P457, DOI 10.1109/TBME.1975.324465
   KRITIKOS HN, 1981, J MICROWAVE POWER EE, V16, P327, DOI 10.1080/16070658.1981.11689256
   PAULY H, 1959, Z NATURFORSCH PT B, V14, P125
   PAULY H, 1971, J ACOUST SOC AM, V50, P692, DOI 10.1121/1.1912685
   PAULY H, 1966, BIOPHYS J, V6, P621, DOI 10.1016/S0006-3495(66)86682-1
   PAULY H, 1976, ULTRASONIC BIOPHYSIC, V7, P54
   PENNOCK BE, 1969, J PHYS CHEM-US, V73, P2600, DOI 10.1021/j100842a024
   RAJEWSKY B, 1948, NATURWISSENSCHAFTEN, V35, P315, DOI 10.1007/BF00626639
   RAJEWSKY B, 1938, ULTRAKURZWELLEN ERGE, V1
   SALATI OM, 1962, ELECTRON IND     NOV
   SCHWAN H, 1954, Z NATURFORSCH B, V9, P245
   Schwan H, 1965, THERAPEUTIC HEAT COL, P63
   SCHWAN H P, 1954, Am J Phys Med, V33, P371
   SCHWAN H P, 1957, Adv Biol Med Phys, V5, P147
   Schwan H. P., 1983, BIOL EFFECTS DOSIMET, P213
   Schwan H. P., 1963, PHYSICAL TECHNIQUE B, V6, P323, DOI DOI 10.1002/JCP.1030660505
   SCHWAN HERMAN P., 1963, BIOPHYSIK, V1, P198, DOI 10.1007/BF01195396
   SCHWAN HP, 1953, P IRE, V41, P1735, DOI 10.1109/JRPROC.1953.274358
   SCHWAN HP, 1962, J PHYS CHEM-US, V66, P2626, DOI 10.1021/j100818a066
   SCHWAN HP, 1980, P IEEE, V68, P104, DOI 10.1109/PROC.1980.11589
   SCHWAN HP, 1957, CIRC RES, V5, P439, DOI 10.1161/01.RES.5.4.439
   SCHWAN HP, 1962, BIOPHYS J, V2, P395, DOI 10.1016/S0006-3495(62)86863-5
   SCHWAN HP, 1965, ANN NY ACAD SCI, V125, P344, DOI 10.1111/j.1749-6632.1965.tb45401.x
   SCHWAN HP, 1982, J MICROWAVE POWER EE, V17, P1
   SCHWAN HP, 1982, BRIT J CANCER, V45, P220
   SCHWAN HP, 1983, BLUT, V46, P185, DOI 10.1007/BF00320638
   SCHWAN HP, 1958, THERAPEUTIC HEAT, V2, P55
   SCHWAN HP, 1969, J ELECTROCHEMICAL SO, V116, P170
   SCHWAN HP, UNPUB BIOL EFFECTS D
   SCHWAN HP, 1983, P C BIOPHYS CORRELAT
   SCHWAN HP, 1959, 1ST P NAT BIOPH C, P348
   SCHWAN HP, 1953, T AIEE, P114
   Schwartz H. F., 1981, BIOPHYSICAL APPROACH, P3
   SCHWARZ G, 1962, J PHYS CHEM-US, V66, P2636, DOI 10.1021/j100818a067
   STOY RD, 1982, PHYS MED BIOL, V27, P501, DOI 10.1088/0031-9155/27/4/002
   WAY WI, 1981, BIOELECTROMAGNETICS, V2, P341, DOI 10.1002/bem.2250020406
NR 50
TC 19
Z9 19
U1 1
U2 1
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017-2394
SN 0018-9294
J9 IEEE T BIO-MED ENG
JI IEEE Trans. Biomed. Eng.
PY 1984
VL 31
IS 12
BP 872
EP 878
DI 10.1109/TBME.1984.325251
PG 7
WC Engineering, Biomedical
SC Engineering
GA AAV20
UT WOS:A1984AAV2000022
PM 6396212
DA 2018-10-20
ER

PT J
AU MARCONI, W
   DIGREGORIO, F
   MANTOVANI, E
   SISTO, R
   TOGNA, G
AF MARCONI, W
   DIGREGORIO, F
   MANTOVANI, E
   SISTO, R
   TOGNA, G
TI CHARACTERIZATION OF 2 CRYSTALLINE POLYURETHANE HOMOPOLYMERS AS POTENTIAL
   MATERIALS FOR BIOMEDICAL APPLICATIONS
SO INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS
LA English
DT Article
C1 UNIV CATTOLICA SACRO CUORE, I-00168 ROME, ITALY.
RP MARCONI, W (reprint author), ASSORENI, I-00015 MONTEROTONDO, ITALY.
CR BIESTER FD, 1982, INT J ARTIF ORGANS, V5, P191
   BRUCK S, 1980, PROPERTIES BIOMATERI, P122
   KUTSON K, 1981, POLYM SCI TECHNOL BI, V14, P173
   LELAH MD, 1983, J BIOMED MATER RES, V17, P1, DOI 10.1002/jbm.820170102
   LYMAN DJ, 1981, STRUCTURAL ORDER POL, P205
   MANTOVANI E, INT J ARTIF ORG
   MANTOVANI F, 1980, INT J ARTIF ORGANS, V3, P305
   PATRONO C, 1980, THROMB RES, V17, P317, DOI 10.1016/0049-3848(80)90066-3
   SAUNDERS JH, 1964, POLYURETHANES CHEM 2, V16, P769
   SHUMAN MA, 1980, J CLIN INVEST, V65, P307, DOI 10.1172/JCI109673
   SORENSON RW, 1968, PREPARATIVE METHODS, P126
   STOKES K, 1982, BIOMATERIALS, V3, P225, DOI 10.1016/0142-9612(82)90024-2
NR 12
TC 2
Z9 2
U1 0
U2 0
PU WICHTIG EDITORE
PI MILAN
PA 72/74 VIA FRIULI, 20135 MILAN, ITALY
SN 0391-3988
J9 INT J ARTIF ORGANS
JI Int. J. Artif. Organs
PY 1984
VL 7
IS 6
BP 349
EP 352
PG 4
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA TY484
UT WOS:A1984TY48400012
PM 6549308
DA 2018-10-20
ER

PT J
AU KRISHNAN, VK
   PAL, SN
AF KRISHNAN, VK
   PAL, SN
TI CRITERIA FOR DEVELOPING BIOMEDICAL DEVICES FROM POLYMERIC MATERIALS
SO POLYMER-PLASTICS TECHNOLOGY AND ENGINEERING
LA English
DT Article
C1 SREE CHITRA TIRUNAL INST MED SCI & TECHNOL,DEPT BIOMED ENGN,DIV POLYMER TECHNOL,TRIVANDRUM 695012,INDIA.
CR ANDRADE JD, 1979, J POLYM SCI POL SYM, P313
   Brash J L, 1969, J Biomed Mater Res, V3, P175, DOI 10.1002/jbm.820030114
   BRUCK SD, 1980, PROPERTIES BIOMATERI, P1
   COOPER J, 1974, PLASTIC CONTAINERS P
   DUNCAN MN, 1975, EVALUATION POTENTIAL
   KRISHNAN VK, 1982, PLAST IND, V9, P5
   NASS LI, 1976, ENCY PVC, V1, P9
   RATNER BD, 1980, J BIOMED MATER RES, V14, P655
   RATNER BD, 1975, BIOMEDICAL APPLICATI, P159
   SHARMA CP, 1982, POLYM-PLAST TECHNOL, V18, P233, DOI 10.1080/03602558208067723
   WILLIAMS DF, 1981, FUNDAMENTAL ASPECTS, V2, P113
   WILLIAMS DF, 1973, IMPLANTS SURGERY, P359
   1979, NIH802186 PUBL
   1980, NIH802185 PUBL
NR 14
TC 13
Z9 13
U1 0
U2 0
PU MARCEL DEKKER INC
PI NEW YORK
PA 270 MADISON AVE, NEW YORK, NY 10016
SN 0360-2559
J9 POLYM-PLAST TECHNOL
JI Polym.-Plast. Technol. Eng.
PY 1984
VL 23
IS 2
BP 185
EP 192
DI 10.1080/03602558408070049
PG 8
WC Polymer Science
SC Polymer Science
GA ACT22
UT WOS:A1984ACT2200004
DA 2018-10-20
ER

PT J
AU ANDERSON, JM
AF ANDERSON, JM
TI SPECIAL REPORT - BIOMEDICAL MATERIALS RESEARCH IN JAPAN
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Review
C1 CASE WESTERN RESERVE UNIV,DEPT MACROMOLEC SCI,CLEVELAND,OH 44106.
RP ANDERSON, JM (reprint author), CASE WESTERN RESERVE UNIV,DEPT PATHOL,CLEVELAND,OH 44106, USA.
CR AKAO M, 1981, J MATER SCI, V16, P809, DOI 10.1007/BF02402799
   FUKADA E, 1980, BIOMEDICAL POLYM POL, P31
   FURUSAWA K, 1979, KOBUNSHI RONBUNSHU, V36, P273, DOI 10.1295/koron.36.273
   FURUSAWA K, UNPUB J BIOMED MATER
   HAYAKAWA I, UNPUB J PROSTHET DEN
   HAYASHI K, 1980, ARTIFICIAL ORGANS J, V9, P629
   HAYASHI K, 1981, ARTIF ORGANS JPN, V10, P667
   HOSAKA S, 1979, J APPL POLYM SCI, V23, P2089, DOI 10.1002/app.1979.070230719
   HOSAKA S, 1980, J BIOMED MATER RES, V14, P557, DOI 10.1002/jbm.820140503
   HOSAKA S, UNPUB J BIOMED MATER
   ICHIMURA K, 1980, J POLYM SCI POL CHEM, V18, P891, DOI 10.1002/pol.1980.170180310
   IKADA Y, 1981, J BIOMED MATER RES, V15, P697, DOI 10.1002/jbm.820150507
   IMACHI K, 1980, ARTIF ORGANS JPN, V9, P593
   IMACHI K, 1981, ARTIF ORGANS JPN, V10, P406
   IMACHI K, 1979, 2ND P M ISAO, P257
   IMAI Y, 1979, 2ND P M ISAO, P249
   Imai Y., 1980, ARTIF ORGANS, V9, P911
   IMAI Y, 1980, ARTIF ORGANS JPN, V9, P260
   IMAI Y, J DENT RES
   IMAI Y, UNPUB J BIOMED MATER
   ISHIHARA Y, 1981, POLYM PREPR JPN, V30, P275
   JOHNSON DR, 1981, MACROMOLECULES, V14, P118, DOI 10.1021/ma50002a024
   KADOMA Y, 1981, MACROMOL CHEM PHYS, V182, P273
   KADOMA Y, 1978, KOBUNSHI RONBUNSHU, V35, P423, DOI 10.1295/koron.35.423
   KAIFU K, J BIOMED MATER RES
   KATAOKA K, 1980, J BIOMED MATER RES, V14, P817, DOI 10.1002/jbm.820140613
   KATAOKA K, 1980, MAKROMOL CHEM, V181, P1363
   KATAOKA K, 1980, BIOMATERIALS 1980, P493
   KATAOKA K, 1981, ARTIF ORGANS JPN, V10, P106
   MAEDA M, 1980, MAKROMOL CHEM, V181, P2251
   MAEDA M, 1980, MAKROMOL CHEM, V181, P2245
   MASUHO Y, 1980, GANN, V71, P759
   MASUHO Y, 1979, BIOCHEM BIOPH RES CO, V90, P320, DOI 10.1016/0006-291X(79)91627-9
   MATSUMOTO H, UNPUB EFFECT COPOLYM
   MORI Y, 1982, J BIOMED MATER RES, V16, P17, DOI 10.1002/jbm.820160105
   NAKABAYASHI N, 1982, J BIOMED MATER RES, V16, P265, DOI 10.1002/jbm.820160307
   NAKABAYASHI N, 1980, KIDNEY LIVER SUPPO 1, P57
   NAKABAYASHI N, 1980, BIOMEDICAL POLYM POL, P85
   NAKABAYSHI N, UNPUB ADHESION POLYM
   Nakajima A, 1980, BIOMEDICAL POLYM, P243
   NAKANISHI E, 1980, POLYM BULL, V3, P655, DOI 10.1007/BF00285302
   NISHIMURA T, 1980, MAKROMOL CHEM-RAPID, V1, P573
   NOISHIKI Y, 1980, Japanese Journal of Surgery, V10, P77, DOI 10.1007/BF02468652
   NOISHIKI Y, 1980, ARTIF ORGANS JPN, V9, P928
   NOISHIKI Y, 1981, ARTIF ORGANS JPN, V10, P494
   NOISHIKI Y, 1980, ARTIF ORG, V9, P678
   NOISHIKI Y, UNPUB J BIOMED MATER
   OGATA N, 1981, J APPL POLYM SCI, V26, P2293, DOI 10.1002/app.1981.070260716
   OKAHATA Y, 1979, J AM CHEM SOC, V101, P5231, DOI 10.1021/ja00512a020
   OKANO T, 1978, POLYM J, V10, P223, DOI 10.1295/polymj.10.223
   OKANO T, 1981, ARTIF ORGANS JPN, V10, P671
   OKANO T, 1979, 2ND P M ISAO, P253
   OSADA Y, 1979, ACS SYM SER, V108, P253
   SAKAI Y, 1980, ULTRAFILTRATION MEMB, P99
   SAKURAI Y, 1980, BIOMEDICAL POLYM, P335
   SHIMIZU Y, 1978, BIOMATER ARTIF CELL, V6, P375, DOI 10.3109/10731197809119795
   SUGITACHI A, 1980, T AM SOC ART INT ORG, V26, P274
   SUGITACHI A, J BIOMED MATER RES
   SUNAMOTO J, 1980, J BIOCHEM-TOKYO, V88, P1219, DOI 10.1093/oxfordjournals.jbchem.a133089
   SUZUKI S, 1982, J BIOMED MATER RES, V16, P275, DOI 10.1002/jbm.820160308
   TAHARA H, 1981, POLYM PREPR JPN, V30, P307
   TAKAHARA A, 1981, REP PROGR POLYM PHYS, V24
   TAKAMATSU T, 1979, KOBUNSHI RONBUNSHU, V36, P231, DOI 10.1295/koron.36.231
   TAKAMATSU T, 1980, KOBUNSHI RONBUNSHU, V37, P781, DOI 10.1295/koron.37.781
   TAKANASHI M, 1981, POLYM PREP JPN, V30, P133
   TAKANO H, 1981, ARTIF ORGANS JPN, V10, P647
   TANAKA T, J DENT RES
   TANZAWA H, 1980, BIOMEDICAL POLYM, P189
   TSURUTA T, 1980, POLYM AMINES AMMONIU, P163
   TSURUTA T, 1980, BIOMEDICAL POLYM POL, P431
   UNOKI M, 1981, POLYM PREPR JPN, V30, P306
   WANG CL, 1978, BIOCHIM BIOPHYS ACTA, V544, P555, DOI 10.1016/0304-4165(78)90330-6
   WANG CL, 1978, BIOCHIM BIOPHYS ACTA, V544, P568, DOI 10.1016/0304-4165(78)90331-8
   Yamagata S, 1979, J Microsurg, V1, P208
   YOSHIZATO K, 1981, DEV GROWTH DIFFER, V23, P175
NR 75
TC 2
Z9 2
U1 0
U2 0
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PY 1982
VL 16
IS 5
BP 721
EP 733
DI 10.1002/jbm.820160518
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA PG378
UT WOS:A1982PG37800017
PM 6752149
DA 2018-10-20
ER

PT J
AU GOGOLEWSKI, S
   PENNINGS, AJ
AF GOGOLEWSKI, S
   PENNINGS, AJ
TI BIODEGRADABLE MATERIALS OF POLYLACTIDES, .4. POROUS BIOMEDICAL MATERIALS
   BASED ON MIXTURES OF POLYLACTIDES AND POLYURETHANES
SO MAKROMOLEKULARE CHEMIE-RAPID COMMUNICATIONS
LA English
DT Article
C1 STATE UNIV GRONINGEN,DEPT POLYMER CHEM,9747 AG GRONINGEN,NETHERLANDS.
CR AK Schneider, 1972, [US Patent, 3, 636, 956], Patent No. [3636956, 3,636,956]
   ANNIS D, 1979, SHELL POLYM, V3, P52
   BORETOS JOHN W., 1968, J BIOMED MAT RES, V2, P121, DOI 10.1002/jbm.820020109
   Bruck S. D, 1977, J BIOMED MATER RES S, V8, P1
   BRUCK SD, 1977, BIOMATER ARTIF CELL, V5, P97, DOI 10.3109/10731197709118667
   BRUCK SD, 1977, J POLYM SCI PS, V66, P283
   ELING B, 1982, POLYMER, V23, P1587, DOI 10.1016/0032-3861(82)90176-8
   FORBES CD, 1978, BRIT MED BULL, V34, P201, DOI 10.1093/oxfordjournals.bmb.a071492
   GOGOLEWSKI S, UNPUB
   GOGOLEWSKI S, Patent No. 8202893
   GOGOLEWSKI S, Patent No. 8202894
   GOGOLEWSKI S, UNPUB BIOMATERIALS
   GOGOLEWSKI S, J APPL POLYM SCI
   HALPERN BD, 1977, ENCY POLYM SCI TEC S, V2
   HOFFMANN AS, 1977, J APPL POLYM SCI APP, V31, P313
   KATZ AR, 1970, SURG GYNECOL OBSTETR, V131, P701
   KINLEY CE, 1980, J CARDIOVASC SURG, V21, P163
   KULKARNI R K, 1971, Journal of Biomedical Materials Research, V5, P169, DOI 10.1002/jbm.820050305
   KULKARNI RK, 1966, ARCH SURG-CHICAGO, V93, P839
   LIPATOVA TE, 1979, J POLYM SCI PS, V66, P239
   LOMMEN E, UNPUB
   OPPENHEIMER E, 1961, CANCER RES, V21, P132
   REED AM, 1981, POLYMER, V22, P494, DOI 10.1016/0032-3861(81)90168-3
   RUDERMAN RJ, 1972, T AM SOC ART INT ORG, V18, P30
   SCHINDLER A, 1977, CONT TOPICS POLYM SC, V2
   Tanquary A. C., 1974, CONTROLLED RELEASE B
   VERT M, 1981, MAKROMOL CHEM S, V5, P30, DOI DOI 10.1002/MACP.1981.020051981103
   YANNAS IV, 1980, J BIOMED MATER RES, V14, P65, DOI 10.1002/jbm.820140108
NR 28
TC 69
Z9 68
U1 2
U2 13
PU HUTHIG & WEPF VERLAG
PI BASEL
PA AUF DEM WOLF 4, CH-4052 BASEL, SWITZERLAND
SN 0173-2803
J9 MAKROMOL CHEM-RAPID
PY 1982
VL 3
IS 12
BP 839
EP 845
PG 7
WC Polymer Science
SC Polymer Science
GA PW992
UT WOS:A1982PW99200001
DA 2018-10-20
ER

PT J
AU MIURA, Y
   AOYAGI, S
   ARITA, Y
   MIYAMOTO, K
AF MIURA, Y
   AOYAGI, S
   ARITA, Y
   MIYAMOTO, K
TI A NEW METHOD FOR ESTIMATING BLOOD COMPATIBILITY OF BIOMEDICAL MATERIALS
SO ARTIFICIAL ORGANS
LA English
DT Meeting Abstract
C1 OSAKA UNIV,FAC PHARMACEUT SCI,DEPT BIOCHEM ENGN,OSAKA,JAPAN.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU BLACKWELL SCIENCE INC
PI MALDEN
PA 350 MAIN ST, MALDEN, MA 02148
SN 0160-564X
J9 ARTIF ORGANS
JI Artif. Organs
PY 1981
VL 5
IS 3
BP 308
EP 308
PG 1
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA MM858
UT WOS:A1981MM85800034
DA 2018-10-20
ER

PT J
AU ROBAYE, G
   WEBER, G
   DELBROUCK, JM
   ROELANDTS, I
   BARTSCH, P
   COLLIGNON, A
AF ROBAYE, G
   WEBER, G
   DELBROUCK, JM
   ROELANDTS, I
   BARTSCH, P
   COLLIGNON, A
TI ATTEMPTS TO IMPROVE PIXE QUANTITATIVE TRACE-ELEMENT ANALYSIS OF
   BIOMEDICAL MATERIALS
SO NUCLEAR INSTRUMENTS & METHODS
LA English
DT Article
C1 UNIV LIEGE,DEPT GEOCHEM,B-4000 LIEGE,BELGIUM.
   UNIV LIEGE,DEPT INTERNAL MED,B-4000 LIEGE,BELGIUM.
RP ROBAYE, G (reprint author), UNIV LIEGE,DEPT NUCL PHYS,B-4000 LIEGE,BELGIUM.
CR DIDEBERG O, UNPUBLISHED
   KASPEREK K, 1972, IAEASM15735
   LEAR RD, 1976, ADV XRAY ANAL, V19, P521
   LECOMTE R, 1979, INT J NUCL MED BIOL, V6, P207, DOI 10.1016/0047-0740(79)90040-8
   MOLOKHIA M, 1967, ARCH ENV HLTH, V15, P746
   ROBAYE G, NUCL INSTR METH
   VIS RD, 1979, RADIOCHEM RADIOA LET, V41, P245
   WEBER G, 1980, NUCL INSTRUM METHODS, V168, P551, DOI 10.1016/0029-554X(80)91309-9
NR 8
TC 5
Z9 5
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0029-554X
J9 NUCL INSTRUM METHODS
PY 1981
VL 181
IS 1-3
BP 59
EP 62
DI 10.1016/0029-554X(81)90580-2
PG 4
WC Instruments & Instrumentation; Nuclear Science & Technology
SC Instruments & Instrumentation; Nuclear Science & Technology
GA LH811
UT WOS:A1981LH81100013
DA 2018-10-20
ER

PT J
AU MIURA, Y
   AOYAGI, S
   IKEDA, F
   MIYAMOTO, K
AF MIURA, Y
   AOYAGI, S
   IKEDA, F
   MIYAMOTO, K
TI ANTI-COAGULANT ACTIVITY OF ARTIFICIAL BIOMEDICAL MATERIALS WITH
   CO-IMMOBILIZED ANTI-THROMBIN-III AND HEPARIN
SO BIOCHIMIE
LA English
DT Article
RP MIURA, Y (reprint author), OSAKA UNIV,FAC PHARMACEUT SCI,DEPT BIOCHEM ENGN,SUITA,OSAKA 565,JAPAN.
CR ABLIGAARD U, 1969, SCAND J CLIN LAB INV, V24, P23
   ANDERSON MM, 1974, THROMBOSIS RESEARCH, V5, P439
   ANDERSSON LO, 1977, J IMMUNOL METHODS, V14, P271, DOI 10.1016/0022-1759(77)90138-7
   ARONSON DL, 1969, BIOCHIM BIOPHYS ACTA, V188, P25, DOI 10.1016/0005-2795(69)90041-5
   ASAI K, 1976, JPN J CLIN PATHOL, V27, P143
   BINDER B, 1973, THROMB DIATH HAEMOST, V30, P280, DOI 10.1055/s-0038-1649075
   BJORK I, 1976, EUR J BIOCHEM, V68, P507, DOI 10.1111/j.1432-1033.1976.tb10838.x
   DAMUS PS, 1973, NATURE, V246, P355, DOI 10.1038/246355a0
   DAMUS PS, 1974, BIOCHEM BIOPH RES CO, V61, P1147, DOI 10.1016/S0006-291X(74)80403-1
   EINARSSON R, 1977, BIOCHIM BIOPHYS ACTA, V490, P104, DOI 10.1016/0005-2795(77)90110-6
   FUJIKAWA K, 1972, BIOCHEMISTRY-US, V11, P4892, DOI 10.1021/bi00776a003
   GOOSEN MFA, 1979, J BIOMED MATER RES, V13, P347, DOI 10.1002/jbm.820130302
   GOTT VL, 1963, SCIENCE, V142, P1297, DOI 10.1126/science.142.3597.1297
   HOFFMAN AS, 1972, T AM SOC ART INT ORG, V18, P10
   HOLMER E, 1979, EUR J BIOCHEM, V93, P1, DOI 10.1111/j.1432-1033.1979.tb12787.x
   HOOH M, 1976, FEBS LETT, V66, P90
   IVERIUS PH, 1971, BIOCHEM J, V124, P677, DOI 10.1042/bj1240677
   JESTY J, 1979, J BIOL CHEM, V254, P1044
   JESTY J, 1978, ARCH BIOCHEM BIOPHYS, V185, P165, DOI 10.1016/0003-9861(78)90156-X
   JOIST JH, 1975, HEPARIN STRUCTURE FU, P255
   LARGERGREN H, 1971, T AM SOC ARTIF INT O, V17, P10
   LI EHH, 1976, ARCH BIOCHEM BIOPHYS, V175, P153, DOI 10.1016/0003-9861(76)90494-X
   MERKER RL, 1969, ARTIFICIAL HEART PRO, P29
   MIURA Y, UNPUBLISHED
   MIURA Y, 1979, ARTIF ORGANS, V8, P288
   MIURA Y, 1978, ARTIF ORGANS, V7, P193
   MORITA T, 1977, J BIOCHEM-TOKYO, V82, P1495, DOI 10.1093/oxfordjournals.jbchem.a131840
   MUSTARD JF, 1970, PHARMACOL REV, V22, P97
   REMBAUM A, 1969, NASA6910299 TECH BRI
   ROSENBERG RD, 1973, J BIOL CHEM, V248, P6490
   SAKURAGAWA N, 1976, JPN J CLIN PATHOL, V27, P130
   SCHMER G, 1972, T AM SOC ART INT ORG, V18, P321
   SCHMER G, 1976, T AM SOC ART INT ORG, V22, P654
   YEN S P S, 1971, Journal of Biomedical Materials Research Biomedical Materials Symposium, V1, P83
   YIN ET, 1968, J BIOL CHEM, V243, P112
NR 35
TC 1
Z9 1
U1 0
U2 0
PU EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
PI PARIS CEDEX 15
PA 141 RUE JAVEL, 75747 PARIS CEDEX 15, FRANCE
SN 0300-9084
J9 BIOCHIMIE
JI Biochimie
PY 1980
VL 62
IS 8-9
BP 595
EP 601
DI 10.1016/S0300-9084(80)80106-4
PG 7
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA KH488
UT WOS:A1980KH48800011
PM 7417594
DA 2018-10-20
ER

PT J
AU MIGLIARESI, C
   NICOLAIS, L
AF MIGLIARESI, C
   NICOLAIS, L
TI COMPOSITE-MATERIALS FOR BIOMEDICAL APPLICATIONS
SO INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS
LA English
DT Article
RP MIGLIARESI, C (reprint author), UNIV NAPLES,IST PRINCIPI INGN CHIM,I-80125 NAPLES,ITALY.
CR BRUCK SD, 1973, J BIOMED MATER RES, V7, P387, DOI 10.1002/jbm.820070503
   Ferry JD, 1936, CHEM REV, V18, P373, DOI 10.1021/cr60061a001
   HOFFMAN AS, 1975, POLYM MED SURG, P33
   KENEDI RM, 1975, PHYS MED BIOL, V20, P699, DOI 10.1088/0031-9155/20/5/001
   KRONENTAL RL, 1975, POLYMERS MEDICINE SU
   LYMAN DJ, 1975, POLYM MED SURG, P29
   MATZ R, 1980, HYDRODYNAMIC ASPECTS
   MIGLIARESI C, UNPUBLISHED
   NICOLAIS L, 1975, POLYM ENG SCI, V15, P137, DOI 10.1002/pen.760150305
   SPRINCL L, 1973, J BIOMED MATER RES, V7, P123, DOI 10.1002/jbm.820070110
   WADDOUPS ME, 1975, POLYM ENG SCI, V15, P160, DOI 10.1002/pen.760150307
   WICHTERLE O, 1960, NATURE, V185, P117, DOI 10.1038/185117a0
NR 12
TC 20
Z9 20
U1 2
U2 5
PU WICHTIG EDITORE
PI MILAN
PA 72/74 VIA FRIULI, 20135 MILAN, ITALY
SN 0391-3988
J9 INT J ARTIF ORGANS
JI Int. J. Artif. Organs
PY 1980
VL 3
IS 2
BP 114
EP 118
PG 5
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA JQ853
UT WOS:A1980JQ85300013
PM 7364506
DA 2018-10-20
ER

PT J
AU HASTINGS, GW
AF HASTINGS, GW
TI BIOMEDICAL-ENGINEERING AND MATERIALS FOR ORTHOPEDIC IMPLANTS
SO JOURNAL OF PHYSICS E-SCIENTIFIC INSTRUMENTS
LA English
DT Review
RP HASTINGS, GW (reprint author), N STAFFORDSHIRE POLYTECH, STRAFFORDSHIRE AREA HLTH, INST MED, BIOMED ENGN UNIT, STOKE ON TRENT, STAFFORDSHIRE, ENGLAND.
CR ADAMS D, 1978, J BIOMED MATER RES, V12, P35, DOI 10.1002/jbm.820120104
   ANNIS D, 1978, 3RD INT C MAT MED BI
   BANDHARI V, 1975, 15TH P ANN INT C ED
   BARDOS I, 1978, 1978 INT S BIOM DENT
   BASSETT CAL, 1968, CALC TISS RES, V1, P252
   Bechtol C. O., 1975, ORTHOP REV, V4, P23
   BJORK V O, 1972, Scandinavian Journal of Thoracic and Cardiovascular Surgery, V6, P109, DOI 10.3109/14017437209134787
   BLACK J, 1978, J BONE JOINT SURG BR, V60, P303
   BLACK J, 1976, J BIOMED MATER RES, V10, P377, DOI 10.1002/jbm.820100307
   BLOCH B, 1958, J BONE JOINT SURG BR, V40, P804
   BLOCH B, 1973, PLASTICS MATERIALS S
   BONFIELD W, 1977, NATURE, V270, P453, DOI 10.1038/270453a0
   Bourne GH, 1972, BIOCH PHYSL BONE
   BOUTIN P, 1972, REV CHIR ORTHOP, V58, P229
   BOUTIN P, 1974, REV CHIR ORTHOP, V60, P233
   BRADLEY J, 1980, 3RD INT C MAT US MED
   BRADLEY JS, 1980, BIOMATERIALS, V1, P38, DOI 10.1016/0142-9612(80)90057-5
   BRADLEY JS, 1977, ENG MED, V6, P25
   BRADLEY JS, ENG MED
   BRAIDEN PM, 1978, 1978 BIOC S KEEL
   BREIER M, 1978, 3RD INT C MAT US MED
   BROCKHURST PJ, 1977, MED PROG TECHNOL, V5, P73
   BRUCK SD, 1978, BIOMATER ARTIF CELL, V6, P57, DOI 10.3109/10731197809118692
   CARNOCHAN JM, 1860, ARCH MED, V284
   CHARNLEY J, 1970, CLIN ORTHOP RELAT R, P7
   CHARNLEY J, 1965, J Bone Joint Surg Br, V47, P354
   CHARNLEY J, 1964, J BONE JOINT SURG BR, V46, P518
   CHRISTIANSEN T, 1969, ACTA CHIR SCAND, V135, P43
   CLARK AE, 1976, J BIOMED MATER RES, V10, P161, DOI 10.1002/jbm.820100202
   CURREY JD, 1969, J BIOMECH, V2, P477, DOI 10.1016/0021-9290(69)90023-2
   DENISSEN H, 1978, 1978 BIOC S KEEL LON
   DORRE E, 1976, J BIOMED MATER RES, V10, P493, DOI 10.1002/jbm.820100404
   DORRE E, 1975, ARCH ORTHOP TRAUM SU, V83, P269, DOI 10.1007/BF00416280
   DOWLING JM, 1978, J BONE JOINT SURG BR, V60, P375
   El Messiery M A, 1979, J Biomed Eng, V1, P63
   EVANS FG, 1973, MECHANICAL PROPERTIE
   FARLING GM, 1978, 3RD INT C MAT US MED
   FREEMAN MAR, 1978, CLIN ORTHOP, V134
   FROST HM, 1973, ORTHOPAEDIC LECTURES, V5
   FU JC, 1978, J BIOMED MATER RES, V12, P249, DOI 10.1002/jbm.820120302
   GENTLE CR, 1978, 1978 BIOC S KEEL LON
   GERENDAS N, 1959, THER HUNG, V7, P8
   GLUCK T, 1891, ARCH KLIN CHIR, V41, P186
   GREENSPAN DC, 1976, J BIOMED MATER RES, V10, P503, DOI 10.1002/jbm.820100405
   GRENOBLE DE, 1975, BIOMATER ARTIF CELL, V3, P245, DOI 10.3109/10731197509118625
   GRISS P, 1975, ARCH ORTHOP TRAUM SU, V81, P259, DOI 10.1007/BF00416952
   HASTINGS GW, 1978, COMPOSITES, V9, P193, DOI 10.1016/0010-4361(78)90345-2
   HASTINGS GW, 1979, WEAR, V55, P1, DOI 10.1016/0043-1648(79)90175-3
   HASTINGS GW, 1975, PLASTICS MEDICI 0801
   HAUBOLD A, 1978, 1978 INT S BIOM DENT
   HEIMKE G, 1974, ARCH ORTHOP TRAUM SU, V78, P216, DOI 10.1007/BF02433478
   HENCH LL, 1979, BIOMATER ARTIF CELL, V7, P339, DOI 10.3109/10731197909117590
   HENCH LL, 1977, CERAMURGIA INT, V7, P252
   HENRICHSEN E, 1952, Acta Orthop Scand, V22, P141, DOI 10.3109/17453675208989001
   HODOSH M, 1978, J BIOMED MATER RES, V12, P167, DOI 10.1002/jbm.820120204
   HUNTER J, 1965, AM J SURG, V109, P325, DOI 10.1016/S0002-9610(65)80081-2
   JUDET J, 1954, RESECTION RECONSTRUC
   KATO K, 1979, BIOMATER ARTIF CELL, V7, P291, DOI 10.3109/10731197909117584
   KATZ JL, 1971, J BIOMECH, V4, P455, DOI 10.1016/0021-9290(71)90064-9
   KATZ JL, 1979, S MECHANICAL PROPERT
   KOROSTOFF E, 1979, 1978 S U PENNS PHIL
   LACH S, 1979, THESIS N STAFFORDSHI
   LEAKE DL, 1976, J BIOMED MATER RES, V10, P555, DOI 10.1002/jbm.820100412
   Lorenz M., 1978, Engineering in Medicine, V7, P241
   LORENZ M, 1978, SULZER TECH REV, V1, P31
   MAIER HR, 1978, 3RD INT C MATS US ME
   MARK H F, 1968, Pure and Applied Chemistry, V16, P201, DOI 10.1351/pac196816020201
   McKee G K, 1966, J Bone Joint Surg Br, V48, P245
   MCKIBBIN B, 1978, J BONE JOINT SURG BR, V60, P150
   MERCER R, 1966, ANTHOLOGY ORTHOPAEDI, P194
   MORSCHER E, 1976, ADV ARTIFICIAL HIP K, P403
   NEUMANN AW, 1975, J BIOMED MATER RES, V9, P127, DOI 10.1002/jbm.820090203
   PARK GB, 1978, BIOMATER ARTIF CELL, V6, P1
   Paul J. P., 1976, ADV HIP KNEE JOINT T, P53
   PAUL JP, 1973, PERSPECTIVES BIOMEDI
   PAUWELS F, 1973, BIOMECHANICS DISEASE
   PERREN SM, 1969, ACTA ORTHOP SCAND, P17
   PERREN SM, 1969, ACTA ORTHOP SCAND, P5
   PHOENIX OF, UNPUBLISHED
   Pilla AA, 1977, J ELECTROCHEM SOC, V124, P1697, DOI 10.1149/1.2133139
   PILLIAR RM, 1976, J BIOMED MATER RES, V10, P893, DOI 10.1002/jbm.820100608
   POLLACK S, IN PRESS
   PUGH PDG, 1968, NELSON HIS SURGEONS
   ROSTOKER W, 1976, J BIOMED MATER RES, V10, P303, DOI 10.1002/jbm.820100211
   SAGI L, 1978, 3RD JNT C MAT MED BI
   SALZER M, 1976, J BIOMED MATER RES, V10, P847, DOI 10.1002/jbm.820100604
   SALZER M, 1976, ARTIFICIAL HIP KNEE
   SCLIPPA E, 1973, J BIOMED MATER RES, V7, P59, DOI 10.1002/jbm.820070105
   SEMLITSCH M, 1977, J BIOMED MATER RES, V11, P537, DOI 10.1002/jbm.820110409
   SEMPLE JC, 1976, J BONE JOINT SURG BR, V58, P253
   SHIM HS, 1977, J BIOMED MATER RES, V11, P435, DOI 10.1002/jbm.820110310
   SMITHPETERSEN MN, 1978, CLIN ORTHOP RELAT R, V134, P5
   SPECTOR M, 1978, J BIOMED MATER RES, V12, P665, DOI 10.1002/jbm.820120508
   SPENCE WT, 1954, J NEUROSURG, V11, P219, DOI 10.3171/jns.1954.11.3.0219
   SVENSSON NL, 1977, J BIOMECH, V10, P581
   TAGAI H, 1978, 1978 BIOC S KEEL LON
   Thompson F R, 1966, Clin Orthop Relat Res, V44, P73
   Vaughan JM, 1975, PHYSL BONE
   VOLZ RG, 1978, J BONE JOINT SURG AM, V60, P662, DOI 10.2106/00004623-197860050-00013
   WILLIAMS DF, 1973, IMPLANTS SURGERY
   WILTSE LL, 1957, J BONE JOINT SURG AM, V39, P961, DOI 10.2106/00004623-195739040-00019
   WOOD CB, 1976, ANN ROY COLL SURG, V58, P401
NR 102
TC 8
Z9 9
U1 1
U2 2
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 0022-3735
J9 J PHYS E SCI INSTRUM
PY 1980
VL 13
IS 6
BP 599
EP 607
DI 10.1088/0022-3735/13/6/001
PG 9
WC Instruments & Instrumentation
SC Instruments & Instrumentation
GA JY187
UT WOS:A1980JY18700001
PM 6993661
DA 2018-10-20
ER

PT J
AU WALTON, AG
AF WALTON, AG
TI SYNTHETIC POLYPEPTIDES AS BIOMEDICAL MATERIALS
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
C1 CASE WESTERN RESERVE UNIV,DEPT MACROMOLEC SCI,CLEVELAND,OH 44106.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PY 1979
IS APR
BP 133
EP 133
PG 1
WC Chemistry, Multidisciplinary
SC Chemistry
GA GN806
UT WOS:A1979GN80601578
DA 2018-10-20
ER

PT J
AU [Anonymous]
AF [Anonymous]
TI POLYMERIC BIOMEDICAL MATERIALS SYMPOSIUM, MANCHESTER, 18-19 APRIL 1978 -
   PREFACE
SO BRITISH POLYMER JOURNAL
LA English
DT Editorial Material
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0007-1641
J9 BRIT POLYM J
PY 1978
VL 10
IS 4
BP 231
EP 231
PG 1
WC Polymer Science
SC Polymer Science
GA GK234
UT WOS:A1978GK23400001
DA 2018-10-20
ER

PT J
AU GIBBONS, DF
AF GIBBONS, DF
TI POLYMERIC BIOMEDICAL MATERIALS
SO BRITISH POLYMER JOURNAL
LA English
DT Article
RP GIBBONS, DF (reprint author), CASE WESTERN RESERVE UNIV,DEPT BIOMED ENGN & PATHOL,CLEVELAND,OH 44106, USA.
NR 0
TC 4
Z9 4
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0007-1641
J9 BRIT POLYM J
PY 1978
VL 10
IS 4
BP 232
EP 237
DI 10.1002/pi.4980100403
PG 6
WC Polymer Science
SC Polymer Science
GA GK234
UT WOS:A1978GK23400002
DA 2018-10-20
ER

PT J
AU IMAI, Y
   KUO, YS
   WATANABE, A
   MASUHARA, E
AF IMAI, Y
   KUO, YS
   WATANABE, A
   MASUHARA, E
TI EVALUATION OF POLYSULFONE AS A POTENTIAL BIOMEDICAL MATERIAL
SO JOURNAL OF BIOENGINEERING
LA English
DT Note
RP IMAI, Y (reprint author), TOKYO MED & DENT UNIV,INST MED & DENT ENGN,TOKYO 113,JAPAN.
CR AUTIAN J, 1977, ARTIF ORGANS, V1, P53
   HOMSY C A, 1970, Journal of Biomedical Materials Research, V4, P341, DOI 10.1002/jbm.820040306
   IMAI Y, 1975, ARTIFICIAL ORGANS JA, V4, P344
   KOJIMA K, 1975, Bulletin of Tokyo Medical and Dental University, V22, P263
   LAWRENCE H, 1971, PB205740, P65
   TAYLOR JA, 1973, T AM SOC ART INT ORG, V19, P175
   WATANABE A, 1976, REPORTS I MED DENT E, V10, P69
   WILSNACK KE, 1976, BIOMAT MED DIV ART O, V4, P235
NR 8
TC 3
Z9 3
U1 0
U2 1
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
J9 J BIOENG
PY 1978
VL 2
IS 1-2
BP 103
EP 107
PG 5
WC Engineering, Biomedical
SC Engineering
GA EZ227
UT WOS:A1978EZ22700012
PM 681310
DA 2018-10-20
ER

PT J
AU LYMAN, DJ
AF LYMAN, DJ
TI NEW PROGRESS IN BIOMEDICAL POLYMER MATERIALS
SO PURE AND APPLIED CHEMISTRY
LA English
DT Article
C1 UNIV UTAH,DEPT BIOENGN,SALT LAKE CITY,UT 84112.
   UNIV UTAH,DEPT SURG,SALT LAKE CITY,UT 84112.
RP LYMAN, DJ (reprint author), UNIV UTAH,DEPT MAT SCI & ENGN,SALT LAKE CITY,UT 84112, USA.
CR Baier R E, 1969, J Biomed Mater Res, V3, P191, DOI 10.1002/jbm.820030115
   BAIER RE, 1971, FED PROC, V30, P1523
   Bellamy L.J., 1975, INFRARED SPECTRA COM, V1-2
   BOWER R, 1960, SURGERY, V47, P132
   COLLINS HA, 1960, AM J SURG, V99, P40, DOI 10.1016/0002-9610(60)90246-4
   DALE WA, 1963, SURGERY, V53, P52
   DUTTON RC, 1968, T AM SOC ART INT ORG, V14, P57
   GLYNN MF, 1966, J CLIN INVEST, V45, P1013
   GOTT VL, 1971, FED PROC, V30, P1679
   GOZNA ER, 1974, CAN J SURG, V17, P176
   HOKANSON DE, 1968, SURG GYNECOL OBSTETR, V127, P57
   JENKINS CSP, 1973, J LAB CLIN MED, V81, P280
   KARDOS IL, 1974, BIOMAT MED DEV ART O, V4, P387
   KIM SW, 1973, PREPRINTS DIV PLASTI, V165, P36
   KIM SW, 1973, APPL POLYM S, V22, P289
   KINELY CE, 1974, SURGERY, V75, P28
   KNUTSON K, UNPUBLISHED
   LANDE AJ, 1970, T AM SOC ART INT ORG, V16, P352
   LAWSON JH, 1975, T AM SOC ART INT ORG, V21, P368
   Lyman D. J., 1971, THROMB DIATH HAEMO, V42, P109
   LYMAN DJ, 1971, T AM SOC ART INT ORG, V17, P456
   LYMAN DJ, 1975, T AM SOC ART INT ORG, V21, P49
   LYMAN DJ, 1974, T AM SOC ART INT ORG, VB 20, P474
   LYMAN DJ, 1972, T AM SOC ART INT ORG, V18, P19
   LYMAN DJ, 1970, THROMB DIATH HAEMOST, V23, P120, DOI 10.1055/s-0038-1654126
   LYMAN DJ, THESIS
   LYMAN DJ, 1977, T AM SOC ARTIF INT O, V23
   LYMAN DJ, 1977, J BIOMED MAT RES, V11
   MUSTARD JF, 1967, FED PROC, V26, P106
   NAJAFI H, 1967, J THORAC CARDIOV SUR, V53, P243
   NYILAS E, 1970, 23 C ENG MED BIOL, V12, P147
   NYILAS E, 1973, PB226839
   PACKHAM MA, 1969, J LAB CLIN MED, V73, P686
   PETSCHEK H, 1968, T AM SOC ART INT ORG, V14, P256
   SALZMAN EW, 1971, FED PROC, V30, P1503
   SCARBOROUGH DE, 1969, LAB INVEST, V20, P164
   Seare W. J., 1974, ANNU REV MATER SCI, V4, P415
   ZUCKER MB, 1969, P SOC EXP BIOL MED, V131, P318
NR 38
TC 5
Z9 5
U1 0
U2 1
PU BLACKWELL SCIENCE LTD
PI OXFORD
PA OSNEY MEAD, OXFORD, OXON, ENGLAND OX2 0EL
SN 0033-4545
J9 PURE APPL CHEM
JI Pure Appl. Chem.
PY 1978
VL 50
IS 5
BP 427
EP 433
DI 10.1351/pac197850050427
PG 7
WC Chemistry, Multidisciplinary
SC Chemistry
GA FK795
UT WOS:A1978FK79500006
OA Bronze
DA 2018-10-20
ER

PT J
AU GIBBONS, DF
AF GIBBONS, DF
TI BIOMEDICAL MATERIALS
SO ANNUAL REVIEW OF BIOPHYSICS AND BIOENGINEERING
LA English
DT Review
C1 CASE WESTERN RESERVE UNIV,DEPT BIOMED ENGN,CLEVELAND,OH 44106.
CR ANDERSON JM, 1974, BIOMAT MED DEV ARTIF, V3, P235
   BAIER RE, 1970, SURFACE CHEM BIOL SY, P235
   Beall A C Jr, 1973, Ann Thorac Surg, V15, P601
   BERNHARD WF, 1969, J THORAC CARDIOV SUR, V58, P801
   Bokros J. C., 1972, CHEMISTRY PHYSICS CA, V9, P103
   BOKROS JC, COMMUNICATION
   BORETOS JOHN W., 1968, J BIOMED MAT RES, V2, P121, DOI 10.1002/jbm.820020109
   Buehler WJ, 1968, OCEAN ENGNG, V1, P105
   CALNAN J S, 1971, British Journal of Plastic Surgery, V24, P113, DOI 10.1016/S0007-1226(71)80029-2
   CASTLEMAN LS, 1974, FINAL REP JA HARTFOR
   CHARNLEY J, 1964, J BONE JOINT SURG BR, V46, P518
   COLEMAN DL, 1974, J BIOMED MATER RES, V8, P65, DOI 10.1002/jbm.820080308
   DAVIS SD, 1972, J BIOMED MATER RES, V6, P425, DOI 10.1002/jbm.820060509
   DYMOND AM, 1970, J NEUROSURG, V33, P574, DOI 10.3171/jns.1970.33.5.0574
   FERGUSON AB, 1962, J BONE JOINT SURG AM, V44, P323, DOI 10.2106/00004623-196244020-00009
   FERGUSON AB, 1960, J BONE JOINT SURG AM, V42, P77, DOI 10.2106/00004623-196042010-00007
   FRAZZA E J, 1971, Journal of Biomedical Materials Research Biomedical Materials Symposium, V1, P43
   FUNCKBENTANO JL, 1974, BIOMAT MED DEV ARTIF, V3
   GIBBONS DF, UNPUBLISHED RESULTS
   GOTT VL, 1969, NIH P ARTIF HEART PR, P181
   GUESS W L, 1968, Journal of Biomedical Materials Research, V2, P313, DOI 10.1002/jbm.820020304
   HENSCH LL, 1973, J BIOMED MATER RES S, V4, P25
   HENSCH LL, 1973, NSF ANN REP
   HOFFMAN AS, 1972, T AM SOC ART INT ORG, V18, P10
   HOMSY CA, 1970, J MACROMOL SCI CHEM, VA  4, P615, DOI 10.1080/00222337008074366
   HOMSY CA, 1972, CLIN ORTHOPAEDICS, V89, P220
   HULBERT SF, 1973, J BIOMED MATER RES S, V7, P43
   HULBERT SF, 1973, J BIOMED MATER RES S, V7, P25
   HULBERT SF, 1973, J BIOMED MATER RES S, V7, P63
   JANACEK J, 1973, J MACROMOL SCI R M C, VC  9, P1
   JECMEN RM, 1973, J BIOMED MATER RES, V7, P369, DOI 10.1002/jbm.820070408
   JHON MS, 1973, J BIOMED MATER RES, V7, P509, DOI 10.1002/jbm.820070604
   KADEFORS R, 1970, MED BIOL ENG, V8, P129, DOI 10.1007/BF02509321
   KAMINSKL EDWARD J., 1968, J BIOMED MAT RES, V2, P81, DOI 10.1002/jbm.820020106
   KASTER RL, 1970, T AM SOC ART INT ORG, V16, P233
   KULKARNI R K, 1971, Journal of Biomedical Materials Research, V5, P169, DOI 10.1002/jbm.820050305
   KUSSEROW BK, 1972, B NEW YORK ACAD MED, V48, P468
   LAING PATRICK G., 1967, J BIOMED MAT RES, V1, P135, DOI 10.1002/jbm.820010113
   LEE HB, 1972, POLYM PREPR, V13, P729
   LEONARD F, 1966, J APPL POLYM SCI, V10, P259, DOI 10.1002/app.1966.070100208
   Leonard F, 1970, ADHESION BIOL SYSTEM, P185
   LEVITSKY S, 1962, SURGERY, V52, P64
   LILLEHEI CW, 1972, 8TH P BIEN CARD C DU
   LYMAN DJ, 1971, T AM SOC ART INT ORG, V17, P456
   LYMAN DJ, 1974, T AM SOC ART INT ORG, VB 20, P474
   LYMAN DJ, 1965, T AM SOC ART INT ORG, V11, P301
   LYMAN DJ, 1970, THROMB DIATH HAEMOST, V23, P120, DOI 10.1055/s-0038-1654126
   LYMAN DJ, 1969, NIH P ARTIF HEART PR, P113
   LYMAN DJ, 1972, ACTUAL NEPHROL, V13, P96
   MASON R G, 1973, Biomaterials Medical Devices and Artificial Organs, V1, P131
   MASON RG, 1972, B NEW YORK ACAD MED, V48, P407
   MCFADDEN JT, 1969, J NEUROSURG, V31, P373, DOI 10.3171/jns.1969.31.4.0373
   MOONEY V, 1973, 1ST P INT C BIOM EL, P112
   NOSE Y, 1971, T AM SOC ART INT ORG, V17, P482
   Nose Y., COMMUNICATION
   NYILAS E, 1972, J BIOMED MAT RES S, V3, P129
   NYILAS E, 1972, J BIOMED MAT RES S, V3, P97
   PICHA G, 1975, P C MATER MED BIOL
   Robb W L, 1968, Ann N Y Acad Sci, V146, P119, DOI 10.1111/j.1749-6632.1968.tb20277.x
   ROBB WL, 1971, BIOMATERIALS, P313
   ROSTOKER W, 1973, J BIOMED MATER RES, V7, P43
   ROSTOKER W, COMMUNICATION
   RUBIN AL, 1969, BIOMATERIALS, P157
   SALTHOUSE TN, 1972, J BIOMED MATER RES, V6, P105, DOI 10.1002/jbm.820060210
   Seare W. J., 1974, ANNU REV MATER SCI, V4, P415
   SEMLITSCH M, 1973, SULZER TECH REV, V2, P1
   SRINIVASAN S, 1969, J ASSOC ADV MED INST, V3, P1161
   SYMEONIDES PP, 1973, J ALLERGY CLIN IMMUN, V51, P251, DOI 10.1016/0091-6749(73)90145-0
   VROMAN L, 1967, BLOOD CLOTTING ENZYM, P279
   WESOLOWSKI SA, 1972, B NEW YORK ACAD MED, V48, P331
   WICHTERLE O, 1960, NATURE, V185, P117, DOI 10.1038/185117a0
   WILLERT HG, 1972, 5TH INT S ARTHR HIP, P11
   WINTER GD, 1970, P ROY SOC MED, V63, P1111
   WOOD N K, 1970, Journal of Biomedical Materials Research, V4, P1, DOI 10.1002/jbm.820040102
   YAMADA S, 1968, 682 DEF CER INF CTR
   1972, B NY ACAD MED, V48, P216
   1971, FED P, P30
   F36172 ASTM STAND RE
NR 78
TC 5
Z9 5
U1 0
U2 3
PU ANNUAL REVIEWS INC
PI PALO ALTO
PA 4139 EL CAMINO WAY, PO BOX 10139, PALO ALTO, CA 94303-0139
SN 0084-6589
J9 ANNU REV BIOPHYS BIO
PY 1975
VL 4
BP 367
EP 375
DI 10.1146/annurev.bb.04.060175.002055
PG 9
WC Biophysics; Engineering, Biomedical
SC Biophysics; Engineering
GA AG638
UT WOS:A1975AG63800016
PM 1098561
DA 2018-10-20
ER

PT J
AU CHATFIELD, V
AF CHATFIELD, V
TI BIOMEDICAL MATERIALS - IMPLANTS HAVE A HOSTILE HOST
SO MATERIALS ENGINEERING
LA English
DT Article
CR BRALEY SA, SILICONES ARTIFICIAL
   DUSTOOR MR, 1973, POWDER METALLURGY IN, V5
   HARTH GH, MCIC7418 BATT COL LA
   NIESZ DE, MCIC7421 BATT COL LA
   ROSE RM, 1972, ORTHOPEDIC IMPLANTS
   WEISMAN S, ANN NEW YORK ACADEMY, V146
   SP5958 NASA
NR 7
TC 0
Z9 0
U1 0
U2 0
PU PENTON PUBL INC
PI CLEVELAND
PA 1100 SUPERIOR AVE, CLEVELAND, OH 44114
SN 0025-5319
J9 MATER ENG
PY 1975
VL 81
IS 3
BP 14
EP &
PG 0
WC Materials Science, Multidisciplinary
SC Materials Science
GA AQ174
UT WOS:A1975AQ17400001
DA 2018-10-20
ER

PT J
AU BRUCK, SD
AF BRUCK, SD
TI BIOMEDICAL APPLICATIONS OF POLYMERIC MATERIALS AND THEIR INTERACTIONS
   WITH BLOOD COMPONENTS - CRITICAL REVIEW OF CURRENT DEVELOPMENTS
SO POLYMER
LA English
DT Review
C1 NHLI,BETHESDA,MD 20014.
CR AISENBERG S, 1973, PB229810 NAT TECHN I
   ALTSCHUL R, 1954, ENDOTHELIUM ITS DEVE
   ANDRADE JD, 1971, T AM SOC ART INT ORG, V17, P222
   ANDRADE JD, 1973, T AM SOC ART INT ORG, V19, P1
   ANDRADE JD, 1972, T AM SOC ART INT ORG, V18, P473
   BARBER AJ, 1971, BIOCHIM BIOPHYS ACTA, V252, P533, DOI 10.1016/0304-4165(71)90156-5
   BARDELMEYER GH, 1973, BIOPOLYMERS, V12, P2289, DOI 10.1002/bip.1973.360121008
   Berger S, 1974, Prog Hemost Thromb, V2, P273
   BERNSTEIN EF, 1971, FED PROC, V30, P1510
   BIGGS R, 1962, HUMAN BLOOD COAGULAT
   BOSMANN HB, 1971, BIOCHEM BIOPH RES CO, V43, P1118, DOI 10.1016/0006-291X(71)90578-X
   BRASH JL, 1973, J BIOMED MATER RES, V7, P313, DOI 10.1002/jbm.820070405
   BRASH JL, 1972, PB210665 NAT TECHN I
   BRASH JL, 1973, PB223165 NAT TECHN I
   BRUCK S D, 1973, Biomaterials Medical Devices and Artificial Organs, V1, P191
   BRUCK S D, 1971, Journal of Biomedical Materials Research, V5, P139, DOI 10.1002/jbm.820050303
   BRUCK S D, 1973, Biomaterials Medical Devices and Artificial Organs, V1, P79
   BRUCK SD, 1972, J BIOMED MATER RES, V6, P173, DOI 10.1002/jbm.820060306
   BRUCK SD, 1973, J BIOMED MATER RES, V7, P387, DOI 10.1002/jbm.820070503
   BRUCK SD, 1972, T AM SOC ART INT ORG, V18, P1
   BRUCK SD, 1973, NATURE, V243, P416, DOI 10.1038/243416a0
   BRUCK SD, 1975, POLYMER, V16, P25, DOI 10.1016/0032-3861(75)90091-9
   BRUCK SD, 1974, BLOOD COMPATIBLE SYN
   BRUCK SD, 1973, INT J RAD STERILIZ, V1, P177
   BUTLER WT, 1966, J BIOL CHEM, V241, P3882
   CASTINO F, 1974, 20TH A M AM SOC ART, V3, P12
   CAZENAVE JP, 1974, J LAB CLIN MED, V83, P797
   CHANG EP, 1973, BIOPOLYMERS, V12, P1063, DOI 10.1002/bip.1973.360120510
   CHANG TMS, 1973, T AM SOC ART INT ORG, V19, P314
   CHANG TMS, 1964, SCIENCE, V146, P524, DOI 10.1126/science.146.3643.524
   CHANG TMS, 1972, ARTIFICIAL CELLS
   CLARK RE, 1973, J THORAC CARDIOV SUR, V66, P202
   CREASY WS, 1974, 20TH M AM SOC ART IN, V3, P14
   CREASY WS, 1973, PB225636 NAT TECHN I
   CREASY WS, 1972, PB211790 NAT TECHN I
   DEHL RE, 1973, BIOPOLYMERS, V12, P2329, DOI 10.1002/bip.1973.360121011
   Dickerson R.E., 1969, STRUCTURE ACTION PRO
   DISCHE Z, 1966, SMALL BLOOD VESSEL I
   FENSTERMAKER CA, 1974, PB232629 NAT TECHN I
   GAARDER A., 1961, NATURE, V192, P531, DOI 10.1038/192531a0
   GANGULY P, 1974, NATURE, V247, P306, DOI 10.1038/247306a0
   GLUSA E, 1974, THROMB DIATH HAEMOST, V31, P172, DOI 10.1055/s-0038-1649155
   GOTT VL, 1961, SURGERY, V50, P382
   GRANT ME, 1973, J BIOL CHEM, V248, P7432
   Grassmann W, 1935, BIOCHEM Z, V277, P320
   GRAY WR, 1973, NATURE, V246, P461, DOI 10.1038/246461a0
   GRODE GA, 1974, 20TH A M AM SOC ART, V3, P29
   HALPERN BD, 1972, PB212724 NAT TECHN I
   HALPERN BD, 1973, PB215886 NAT TECHN I
   HALPERN BD, 1971, PB200987 NAT TECHN I
   HALPERN BD, 1974, PB230310 NAT TECHN I
   HELLEM AJ, 1961, BRIT J HAEMATOL, V7, P42, DOI 10.1111/j.1365-2141.1961.tb00318.x
   HELLEM AJ, 1960, SCANDINAVIAN J CHE S, V12, P51
   HOFFMAN AS, 1972, T AM SOC ART INT ORG, V18, P10
   HOVIG T, 1968, SER HAEMATOL, V1, P3
   HUGUES J, 1970, THROMB DIATH HAEMOST, V24, P395, DOI 10.1055/s-0038-1654249
   INDEGLIA RA, 1970, T AM SOC ART INT ORG, V16, P37
   JAFFE EA, 1972, 3RD C INT SOC THROMB, P366
   JENKINS CSP, 1973, J LAB CLIN MED, V81, P280
   JIMENEZ S, 1973, BIOCHEM BIOPH RES CO, V52, P106, DOI 10.1016/0006-291X(73)90960-1
   JIRGENCENS B, 1962, SHORT TXB COLLOID CH, P377
   KAHN RH, 1973, IN VITRO CELL DEV B, V8, P451
   KAHN RH, 1973, PB226863 NAT TECHN I
   KARDOS JL, 1974, PB230309 NAT TECHN I
   KETTERINGHAM JM, 1973, T AM SOC ART INT ORG, V19, P61
   KETTERINGHAM JM, 1974, PB231328 NAT TECHN I
   KUSSEROW B, 1971, FED PROC, V30, P1516
   KUSSEROW BK, 1971, T AM SOC ART INT ORG, V17, P1
   KWAAN HC, 1965, CIRC RES, V17, P477, DOI 10.1161/01.RES.17.6.477
   LAGERGREN H, 1964, THORAXCHIRURGIE, V12, P172
   LAGERGREN HR, 1971, T AM SOC ART INT ORG, V17, P10
   LAMPERT RH, 1972, J BIOMED MATER RES, V6, P499, DOI 10.1002/jbm.820060604
   LAZAROW A, 1966, SMALL BLOOD VESSEL I
   Lechler E, 1967, Thromb Diath Haemorrh Suppl, V22, P139
   Leininger R I, 1972, CRC Crit Rev Bioeng, V1, P333
   LEININGER RI, 1966, SCIENCE, V152, P1625, DOI 10.1126/science.152.3729.1625
   LEININGER RI, 1966, T AM SOC ART INT ORG, V12, P151
   LEONARD F, 1969, T AM SOC ART INT ORG, V15, P15
   LITWAK RS, 1972, B NEW YORK ACAD MED, V48, P406
   LOVELOCK JE, 1951, NATURE, V167, P39, DOI 10.1038/167039a0
   LUFT JH, 1966, FED PROC, V25, P1773
   MAJNO G., 1965, HANDBOOK PHYSIOL, V3, P2293
   MARSHALL D W, 1970, Journal of Biomedical Materials Research, V4, P357, DOI 10.1002/jbm.820040307
   Mason R G, 1972, Prog Hemost Thromb, V1, P141
   MERKER RL, 1969, P ARTIFICIAL HEART P, P29
   MERRILL EW, 1966, T AM SOC ART INT ORG, V12, P139
   MEYER CH, 1974, PB228964 NAT TECHN I
   MOACANIN J, 1974, PB232641 NAT TECHN I
   MOHANDAS N, 1974, J BIOMED MATER RES, V8, P119, DOI 10.1002/jbm.820080203
   MONSON JM, 1973, P NATL ACAD SCI USA, V70, P3521, DOI 10.1073/pnas.70.12.3521
   MORRISSEY BW, 1974, J COLLOID INTERF SCI, V46, P152, DOI 10.1016/0021-9797(74)90036-8
   MUGGLI R, 1973, Thrombosis Research, V3, P715, DOI 10.1016/0049-3848(73)90018-2
   MURPHY EA, 1962, CAN MED ASSOC J, V87, P259
   MUSTARD JF, 1969, RESEARCH ACUTE MYOCA, pR4
   Nemerson Y, 1972, Prog Hemost Thromb, V1, P1
   NOSSEL HL, 1969, NATURE, V221, P75, DOI 10.1038/221075a0
   NYILAS E, 1974, 20TH M AM SOC ART IN, V3, P52
   NYILAS E, 1974, PB231776 NAT TECHN I
   PACKHAM MA, 1969, J LAB CLIN MED, V73, P686
   PARTRIDG.SM, 1967, NATURE, V213, P1123, DOI 10.1038/2131123a0
   PATEL DJ, 1969, CIRC RES, V25, P765, DOI 10.1161/01.RES.25.6.765
   QUICK AJ, 1954, AM J MED SCI, V228, P207, DOI 10.1097/00000441-195408000-00009
   RAMACHANDRAN GN, 1968, BIOPOLYMERS, V6, P1649, DOI 10.1002/bip.1968.360061109
   RAMACHANDRAN GN, 1967, TREATISE COLLAGEN, V1, pCH3
   RATNOFF OD, 1973, SCIENCE, V179, P1291, DOI 10.1126/science.179.4080.1291
   RICH A, 1961, J MOL BIOL, V3, P483, DOI 10.1016/S0022-2836(61)80016-8
   ROTHEN A, 1945, REV SCI INSTRUM, V16, P26, DOI 10.1063/1.1770315
   ROTHEN A, 1974, PROGR SURFACE MEMBRA, V8
   ROZELLE LT, 1974, PB231324 NAT TECHN I
   SALZMAN EW, 1971, BLOOD-J HEMATOL, V38, P509
   SALZMAN EW, 1967, SURGERY, V61, P1
   SANDBERG LB, 1969, BIOCHEMISTRY-US, V8, P2940, DOI 10.1021/bi00835a037
   SCHOFIELD JD, 1974, BIOCHEMISTRY-US, V13, P1801, DOI 10.1021/bi00706a004
   Scott H, 1973, Biomater Med Devices Artif Organs, V1, P681
   SCOTT H, 1974, PB230308 NAT TECHN I
   SCOTT H, 1971, PB206499 NAT TECHN I
   SHIO H, 1972, NATURE-NEW BIOL, V236, P45
   SMITH DW, 1972, J BIOL CHEM, V247, P2427
   Spaet T H, 1966, Thromb Diath Haemorrh Suppl, V21, P67
   STATTON WO, 1973, PB229335 NAT TECHN I
   Stemerman M B, 1974, Prog Hemost Thromb, V2, P1
   STEMERMAN MB, 1971, LAB INVEST, V24, P179
   STORMORKEN H, 1971, FED PROC, V30, P1551
   SWEDENBORG J, 1974, THROMB RES, V4, P687, DOI 10.1016/0049-3848(74)90223-0
   THOMAS J, 1963, NATURE, V200, P651, DOI 10.1038/200651a0
   THOMSON C, 1973, THROMB DIATH HAEMOST, V30, P547, DOI 10.1055/s-0038-1649133
   TODD A S, 1964, J Clin Pathol, V17, P324, DOI 10.1136/jcp.17.3.324
   UITTO J, 1973, BIOCHEM BIOPH RES CO, V55, P904, DOI 10.1016/0006-291X(73)91229-1
   Vroman L, 1969, J Biomed Mater Res, V3, P43, DOI 10.1002/jbm.820030106
   VROMAN L, 1971, FED PROC, V30, P1494
   WEEKS JR, 1969, J PHARM PHARMACOL, V21, P103, DOI 10.1111/j.2042-7158.1969.tb08205.x
   WICHTERLE O, 1960, NATURE, V185, P117, DOI 10.1038/185117a0
   WILNER GD, 1971, AM J PHYSIOL, V220, P1074
   WILNER GD, 1968, J CLIN INVEST, V47, P2608, DOI 10.1172/JCI105943
   YAMADA H, 1970, STRENGTH BIOLOGICAL
   YASUDA H, 1973, J APPL POLYM SCI, V17, P1519, DOI 10.1002/app.1973.070170517
   YASUDA H, 1973, J APPL POLYM SCI, V17, P137, DOI 10.1002/app.1973.070170111
   YASUDA H, 1973, PB229097 NAT TECHN I
   ZUCKER MB, 1969, P SOC EXP BIOL MED, V131, P318
NR 139
TC 24
Z9 25
U1 0
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0032-3861
J9 POLYMER
JI Polymer
PY 1975
VL 16
IS 6
BP 409
EP 417
DI 10.1016/0032-3861(75)90249-9
PG 9
WC Polymer Science
SC Polymer Science
GA AF355
UT WOS:A1975AF35500005
DA 2018-10-20
ER

PT J
AU LEMAY, I
   LAPPI, VG
   WHITE, WE
AF LEMAY, I
   LAPPI, VG
   WHITE, WE
TI MATERIALS FOR BIOMEDICAL APPLICATIONS
SO POLYMER ENGINEERING AND SCIENCE
LA English
DT Article
C1 UNIV SASKATCHEWAN,DIV BIOMED ENGN,SASKATOON,SASKATCHEWAN,CANADA.
CR BENSON J, 1971, J BIOMED MATER RES S, V2, P41
   CAHOON JR, 1975, COMMUNICATION
   COOK W E, 1972, Journal of Biomedical Materials Research Biomedical Materials Symposium, V2, P443
   HENTRICH R L, 1971, Journal of Biomedical Materials Research, V5, P25, DOI 10.1002/jbm.820050104
   HIRSCHHORN JS, 1971, J BIOMED MATER RES S, V2, P49
   HULBERT SF, 1972, MATER RES BULL, V7, P1239, DOI 10.1016/0025-5408(72)90103-1
   KLAWITTER J J, 1972, Journal of Biomedical Materials Research Biomedical Materials Symposium, V2, P161
   KROUSKOP TA, 1973, 73WABIO36 ASME PAP
   MATHER BS, 1968, J BIOMECH, V4, P331
   Mooney V, 1971, J BIOMED MATER RES S, V2, P143
   MURPHY P V, 1971, Journal of Biomedical Materials Research Biomedical Materials Symposium, V1, P59
   MUSIKANT S, 1971, Journal of Biomedical Materials Research Biomedical Materials Symposium, V1, P225
   PILLIAR RM, 1974, 13TH ANN C MET
   PREDECKI P, 1972, J BIOMED MATER RES, V6, P201
   ROSE RM, 1974, TECHNOL REV US   MAR, P33
   WEISMAN S, 1967, BIOMECHANICS HUMAN F, P87
   WEISMAN S, 1973, 1973 P NEW ENGL C BI, P124
   WELSH RP, 1971, J BIOMED MATER RES 1, V2, P231
   WHITE WE, 1975, MICROSTRUCTURAL SCIE
   Williams D. F., 1972, Metals and Materials, V6, P387
   1973, ASTM STANDARDS SURGI
NR 21
TC 4
Z9 4
U1 0
U2 0
PU SOC PLASTICS ENG INC
PI BROOKFIELD CENTER
PA 14 FAIRFIELD DR, BROOKFIELD CENTER, CT 06804-0403
SN 0032-3888
J9 POLYM ENG SCI
JI Polym. Eng. Sci.
PY 1975
VL 15
IS 11
BP 789
EP 794
DI 10.1002/pen.760151105
PG 6
WC Engineering, Chemical; Polymer Science
SC Engineering; Polymer Science
GA AX783
UT WOS:A1975AX78300004
DA 2018-10-20
ER

PT J
AU ABODEELY, RA
   BORICK, PM
AF ABODEELY, RA
   BORICK, PM
TI TISSUE-CULTURE AS A METHOD FOR EVALUATION OF BIOMEDICAL MATERIALS
SO IN VITRO-JOURNAL OF THE TISSUE CULTURE ASSOCIATION
LA English
DT Meeting Abstract
C1 ETHICON INC,SOMERVILLE,NJ 08876.
NR 0
TC 0
Z9 0
U1 1
U2 1
PU SOC IN VITRO BIOLOGY
PI LARGO
PA 9315 LARGO DR WEST, STE 25, LARGO, MD 20774
SN 0073-5655
J9 IN VITRO CELL DEV B
PY 1973
VL 8
IS 5
BP 415
EP &
PG 0
WC Pathology
SC Pathology
GA P5636
UT WOS:A1973P563600069
DA 2018-10-20
ER

PT J
AU SIMMONDS, RC
   YOUNG, EL
   HOLLAND, JM
   BOYD, J
AF SIMMONDS, RC
   YOUNG, EL
   HOLLAND, JM
   BOYD, J
TI ANIMAL MAINTENANCE FOR BIOMEDICAL EVALUATION OF LUNAR MATERIAL
SO JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION
LA English
DT Article
CR BENSCHOTER CA, 1970, SCIENCE, V169, P470, DOI 10.1126/science.169.3944.470
   BOYD JF, 1972, LAB ANIM SCI, V22, P416
   KEMMERER WW, 1969, BIOSCIENCE, V19, P712, DOI 10.2307/1294901
NR 3
TC 3
Z9 3
U1 0
U2 0
PU AMER VETERINARY MEDICAL ASSOC
PI SCHAUMBURG
PA 1931 N MEACHAM RD SUITE 100, SCHAUMBURG, IL 60173-4360
SN 0003-1488
J9 J AM VET MED ASSOC
JI J. Am. Vet. Med. Assoc.
PY 1972
VL 161
IS 6
BP 720
EP &
PG 0
WC Veterinary Sciences
SC Veterinary Sciences
GA N5152
UT WOS:A1972N515200039
PM 4403463
DA 2018-10-20
ER

EF